PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nichols, JL; Gladwell, W; Verhein, KC; Cho, HY; Wess, J; Suzuki, O; Wiltshire, T; Kleeberger, SR				Nichols, Jennifer L.; Gladwell, Wesley; Verhein, Kirsten C.; Cho, Hye-Youn; Wess, Jurgen; Suzuki, Oscar; Wiltshire, Tim; Kleeberger, Steven R.			Genome-wide association mapping of acute lung injury in neonatal inbred mice	FASEB JOURNAL			English	Article						bronchopulmonary dysplasia; inflammation; quantitative trait locus; cholinergic receptor; muscarinic 2; cardiac	NONNEURONAL CHOLINERGIC SYSTEM; BRONCHOPULMONARY DYSPLASIA; RECEPTOR STIMULATION; IN-VITRO; INFLAMMATION; DISEASE; STRAIN; DELETION; AIRWAYS; SUSCEPTIBILITY	Reactive oxygen species (ROS) contribute to the pathogenesis of many acute and chronic pulmonary disorders, including bronchopulmonary dysplasia (BPD), a respiratory condition that affects preterm infants. However, the mechanisms of susceptibility to oxidant stress in neonatal lungs are not completely understood. We evaluated the role of genetic background in response to oxidant stress in the neonatal lung by exposing mice from 36 inbred strains to hyperoxia (95% O-2) for 72 h after birth. Hyperoxia-induced lung injury was evaluated by using bronchoalveolar lavage fluid (BALF) analysis and pathology. Statistically significant interstrain variation was found for BALF inflammatory cells and protein (heritability estimates range: 33.6-55.7%). Genome-wide association mapping using injury phenotypes identified quantitative trait loci (QTLs) on chromosomes 1, 2, 4, 6, and 7. Comparative mapping of the chromosome 6 QTLs identified Chrm2 (cholinergic receptor, muscarinic 2, cardiac) as a candidate susceptibility gene, and mouse strains with a nonsynonymous coding single-nucleotide polymorphism (SNP) in Chrm2 that causes an amino acid substitution (P265L) had significantly reduced hyperoxia-induced inflammation compared to strains without the SNP. Further, hyperoxia-induced lung injury was significantly reduced in neonatal mice with targeted deletion of Chrm2, relative to wild-type controls. This study has important implications for understanding the mechanisms of oxidative lung injury in neonates.	[Nichols, Jennifer L.; Gladwell, Wesley; Verhein, Kirsten C.; Cho, Hye-Youn; Kleeberger, Steven R.] Natl Inst Environm Hlth Sci, US Natl Inst Hlth, Lab Resp Biol, Res Triangle Pk, NC USA; [Nichols, Jennifer L.] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Curriculum Toxicol, Chapel Hill, NC USA; [Suzuki, Oscar] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Wess, Jurgen] Natl Inst Diabet & Digest & Kidney Dis, Bioorgan Chem Lab, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kleeberger, SR (corresponding author), NIEHS, 111 T W Alexander Dr,Bldg 101,MD 201, Res Triangle Pk, NC 27709 USA.	kleeber1@niehs.nih.gov	Kleeberger, Steven R/F-1807-2019	Kleeberger, Steven R/0000-0003-2948-8452	NIEHS, National Institutes of Health, U.S. Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100513, T32ES007126] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health, U.S. Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank L. M. DeGraff [National Institute of Environmental Health Sciences (NIEHS)], L. Perrow (NIEHS), and H. Price (Alion Science and Technology, McLean, VA, USA) for assistance with animal breeding and exposures; the NIEHS Histology Core for tissue processing and staining; and Drs. D. Cook and M. Fessler for critical review of the manuscript. This work was supported by a Director's Challenge Program and the Intramural Research Program, NIEHS, National Institutes of Health, U.S. Department of Health and Human Services. Author contributions: J.L.N., W.G., H.-Y.C., and S.R.K. conceived and designed the experiments; J.L.N., W.G., and K.C.V. performed the experiments; J.L.N., O.S., J.W., T.W., and K.C.V. analyzed the data; J.L.N. and S.R.K. wrote the paper; J.W. contributed animals.	Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; Baraldi E, 2009, EARLY HUM DEV, V85, pS1, DOI 10.1016/j.earlhumdev.2009.08.002; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bhandari V, 2006, SEMIN PERINATOL, V30, P185, DOI 10.1053/j.semperi.2006.05.005; Bokodi G, 2007, PEDIATR PULM, V42, P952, DOI 10.1002/ppul.20689; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333, DOI 10.1164/ajrccm.160.4.9810071; Collard KJ, 2004, ARCH DIS CHILD-FETAL, V89, pF412, DOI 10.1136/adc.2002.016717; Dauger S, 2003, CHEST, V123, P530, DOI 10.1378/chest.123.2.530; Deng H, 2000, AM J RESP CRIT CARE, V162, P2316, DOI 10.1164/ajrccm.162.6.9911020; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Gatti DM, 2009, BIOINFORMATICS, V25, P482, DOI 10.1093/bioinformatics/btn648; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gu F, 2009, BRIT J DERMATOL, V161, P209, DOI 10.1111/j.1365-2133.2009.09219.x; Gwilt CR, 2007, PHARMACOL THERAPEUT, V115, P208, DOI 10.1016/j.pharmthera.2007.05.007; Hallman Mikko, 2003, Semin Neonatol, V8, P19, DOI 10.1016/S1084-2756(02)00196-3; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; HUDAK BB, 1993, PHARMACOGENETICS, V3, P135, DOI 10.1097/00008571-199306000-00003; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Joss-Moore LA, 2011, MOL GENET METAB, V104, P61, DOI 10.1016/j.ymgme.2011.07.018; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Lavoie PM, 2008, PEDIATRICS, V122, P479, DOI 10.1542/peds.2007-2313; Leontyev D, 2012, BLOOD, V119, P5261, DOI 10.1182/blood-2012-03-415695; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; Londhe VA, 2011, PEDIATR RES, V69, P371, DOI 10.1203/PDR.0b013e318211c917; Ma JX, 2002, BIOCHEM PHARMACOL, V64, P1447, DOI 10.1016/S0006-2952(02)01393-X; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; Mosha KS, 2008, J CELL PHYSIOL, V215, P771, DOI 10.1002/jcp.21356; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Oenema TA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-130; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Parker RA, 1996, SEMIN PERINATOL, V20, P206, DOI 10.1016/S0146-0005(96)80049-8; Parton LA, 2006, FRONT BIOSCI-LANDMRK, V11, P1854, DOI 10.2741/1928; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Profita M, 2011, LIFE SCI, V89, P36, DOI 10.1016/j.lfs.2011.04.025; Prows DR, 2007, PHYSIOL GENOMICS, V30, P262, DOI 10.1152/physiolgenomics.00232.2006; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Sato E, 1998, AM J PHYSIOL-LUNG C, V274, pL970, DOI 10.1152/ajplung.1998.274.6.L970; Saugstad Ola Didrik, 2003, Semin Neonatol, V8, P39, DOI 10.1016/S1084-2756(02)00194-X; Stoilov I, 2006, ARCH BIOCHEM BIOPHYS, V456, P30, DOI 10.1016/j.abb.2006.09.029; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Thompson A, 2008, BIOMARK INSIGHTS, V3, P361; Tiozzo C, 2012, ENDOCR-RELAT CANCER, V19, P111, DOI 10.1530/ERC-10-0327; Trakhtenberg EF, 2011, SCIENCE, V334, P47, DOI 10.1126/science.1213099; van den Buuse M, 2007, PSYCHOPHARMACOLOGY, V195, P273, DOI 10.1007/s00213-007-0888-7; Vancza EM, 2009, TOXICOL SCI, V107, P535, DOI 10.1093/toxsci/kfn253; Verhein KC, 2009, CURR ALLERGY ASTHM R, V9, P484, DOI 10.1007/s11882-009-0071-9; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145	56	17	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2538	2550		10.1096/fj.13-247221	http://dx.doi.org/10.1096/fj.13-247221			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24571919	Green Published			2022-12-25	WOS:000339883600014
J	Kok, BPC; Skene-Arnold, TD; Ling, J; Benesch, MGK; Dewald, J; Harris, TE; Holmes, CFB; Brindley, DN				Kok, Bernard P. C.; Skene-Arnold, Tamara D.; Ling, Ji; Benesch, Matthew G. K.; Dewald, Jay; Harris, Thurl E.; Holmes, Charles F. B.; Brindley, David N.			Conserved Residues in the N Terminus of Lipin-1 Are Required for Binding to Protein Phosphatase-1c, Nuclear Translocation, and Phosphatidate Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Nuclear Translocation; Phosphatidate; Protein Phosphatase; Protein Phosphorylation; Transcription Regulation; Yeast Metabolism; Lipin	UNSATURATED FATTY-ACIDS; RAT HEPATOCYTES; SUBCELLULAR-LOCALIZATION; AFFINITY-CHROMATOGRAPHY; MICROCYSTIN-SEPHAROSE; STRUCTURAL BASIS; PHOSPHORYLATION; PHOSPHOHYDROLASE; YEAST; METABOLISM	Background: Lipin-1 functions as a phosphatidate phosphatase in glycerolipid synthesis and as a co-transcriptional regulator. Results: Lipin-1 contains conserved N-terminal motifs, which when mutated decrease phosphatase activity, nuclear localization, and binding to protein phosphatase-1c. Conclusion: The lipin-1 N-terminal domain is important in regulating its activities. Significance: Lipin-1 binds to protein phosphatase-1c through its N-terminal domain, and this potentially regulates lipin-1 localization and function. Lipin-1 is a phosphatidate phosphatase in glycerolipid biosynthesis and signal transduction. It also serves as a transcriptional co-regulator to control lipid metabolism and adipogenesis. These functions are controlled partly by its subcellular distribution. Hyperphosphorylated lipin-1 remains sequestered in the cytosol, whereas hypophosphorylated lipin-1 translocates to the endoplasmic reticulum and nucleus. The serine/threonine protein phosphatase-1 catalytic subunit (PP-1c) is a major protein dephosphorylation enzyme. Its activity is controlled by interactions with different regulatory proteins, many of which contain conserved RVXF binding motifs. We found that lipin-1 binds to PP-1c through a similar HVRF binding motif. This interaction depends on Mg2+ or Mn2+ and is competitively inhibited by (R/H)VXF-containing peptides. Mutating the HVRF motif in the highly conserved N terminus of lipin-1 greatly decreases PP-1c interaction. Moreover, mutations of other residues in the N terminus of lipin-1 also modulate PP-1c binding. PP-1c binds poorly to a phosphomimetic mutant of lipin-1 and binds well to the non-phosphorylatable lipin-1 mutant. This indicates that lipin-1 is dephosphorylated before PP-1c binds to its HVRF motif. Importantly, mutating the HVRF motif also abrogates the nuclear translocation and phosphatidate phosphatase activity of lipin-1. In conclusion, we provide novel evidence of the importance of the lipin-1 N-terminal domain for its catalytic activity, nuclear localization, and binding to PP-1c.	[Kok, Bernard P. C.; Skene-Arnold, Tamara D.; Ling, Ji; Benesch, Matthew G. K.; Dewald, Jay; Holmes, Charles F. B.; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada; [Harris, Thurl E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Alberta; University of Virginia	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Heritage Med Res Ctr 357, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Benesch, Matthew/0000-0002-1326-684X; Kok, Bernard/0000-0002-9073-9700	Canadian Institutes of Health Research [CIHR 89726]; Heart and Stroke Foundation of Alberta; Northwest Territories; American Diabetes Association Junior Investigator Award [7-11-JF-21]; Alberta Ingenuity Graduate Studentship; Government of Canada CIHR Vanier Studentship; Alberta Innovates-Health Solutions MD/PhD Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories; American Diabetes Association Junior Investigator Award(American Diabetes Association); Alberta Ingenuity Graduate Studentship; Government of Canada CIHR Vanier Studentship; Alberta Innovates-Health Solutions MD/PhD Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR 89726) (to D. N. B. and C. F. B. H.) and the Heart and Stroke Foundation of Alberta and the Northwest Territories (to D. N. B.) and American Diabetes Association Junior Investigator Award 7-11-JF-21 (to T. E. H.).; Supported by an Alberta Ingenuity Graduate Studentship.; Recipient of a Government of Canada CIHR Vanier Studentship and an Alberta Innovates-Health Solutions MD/PhD Studentship.	BOWLEY M, 1977, BIOCHEM J, V165, P447, DOI 10.1042/bj1650447; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; GOMEZMUNOZ A, 1992, BIOCHIM BIOPHYS ACTA, V1127, P49, DOI 10.1016/0005-2760(92)90200-F; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kok BPC, 2012, CHEM REV, V112, P5121, DOI 10.1021/cr200433m; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MARTIN A, 1986, BIOCHIM BIOPHYS ACTA, V876, P581, DOI 10.1016/0005-2760(86)90047-0; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Moorhead Greg B. G., 2007, V365, P39; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Skene-Arnold TD, 2013, BIOCHEM J, V449, P649, DOI 10.1042/BJ20120506; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Ulke-Lemee A, 2007, BBA-PROTEINS PROTEOM, V1774, P1339, DOI 10.1016/j.bbapap.2007.07.015; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200	45	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10876	10886		10.1074/jbc.M114.552612	http://dx.doi.org/10.1074/jbc.M114.552612			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558042	Green Published, hybrid			2022-12-25	WOS:000334226400055
J	Li, W; Zhang, XL; Zhuang, HX; Chen, HG; Chen, YQ; Tian, WL; Wu, WX; Li, Y; Wang, SJ; Zhang, LQ; Chen, YS; Li, LX; Zhao, B; Sui, SF; Hu, Z; Feng, D				Li, Wen; Zhang, Xingli; Zhuang, Haixia; Chen, He-ge; Chen, Yinqin; Tian, Weili; Wu, Wenxian; Li, Ying; Wang, Sijie; Zhang, Liangqing; Chen, Yusen; Li, Longxuan; Zhao, Bin; Sui, Senfang; Hu, Zhe; Feng, Du			MicroRNA-137 Is a Novel Hypoxia-responsive MicroRNA That Inhibits Mitophagy via Regulation of Two Mitophagy Receptors FUNDC1 and NIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Hypoxia; MicroRNA; Mitochondria; Parkin; FUNDC1; Mitophagy; NIX	MITOCHONDRIAL AUTOPHAGY; OXIDATIVE STRESS; IN-VIVO; PARKIN; PROTEIN; MIR-137; MECHANISMS; INDUCTION; BNIP3; GLIOBLASTOMA	Background: Mitophagy and microRNA both regulate the occurrence of neurodegenerative diseases and cancers. Results: MicroRNA-137, a hypoxia responsive microRNA, inhibits mitophagy via targeting two mitophagy receptors. Conclusion: A novel link between miR-137 and mitophagy has been revealed. Significance: Understanding mitophagy regulation and microRNA functions may provide new concepts to fight human diseases. Mitophagy receptors mediate the selective recognition and targeting of damaged mitochondria by autophagosomes. The mechanism for the regulation of these receptors remains unknown. Here, we demonstrated that a novel hypoxia-responsive microRNA, microRNA-137 (miR-137), markedly inhibits mitochondrial degradation by autophagy without affecting global autophagy. miR-137 targets the expression of two mitophagy receptors NIX and FUNDC1. Impaired mitophagy in response to hypoxia caused by miR-137 is reversed by re-expression of FUNDC1 and NIX expression vectors lacking the miR-137 recognition sites at their 3 UTR. Conversely, miR-137 also suppresses the mitophagy induced by fundc1 (CDS+3UTR) but not fundc1 (CDS) overexpression. Finally, we found that miR-137 inhibits mitophagy by reducing the expression of the mitophagy receptor thereby leads to inadequate interaction between mitophagy receptor and LC3. Our results demonstrated the regulatory role of miRNA to mitophagy receptors and revealed a novel link between miR-137 and mitophagy.	[Li, Wen; Zhang, Xingli; Tian, Weili; Wu, Wenxian; Chen, Yusen; Li, Longxuan; Zhao, Bin; Feng, Du] Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac Cerebral Va, Zhanjiang 524001, Guangdong, Peoples R China; [Zhuang, Haixia; Zhang, Liangqing; Hu, Zhe] Guangdong Med Coll, Affiliated Hosp, Dept Anesthesiol, Zhanjiang 524001, Guangdong, Peoples R China; [Chen, He-ge] Guangdong Med Coll, Affiliated Hosp, Dept Urol, Zhanjiang 524001, Guangdong, Peoples R China; [Chen, Yinqin] Guangdong Med Coll, Affiliated Hosp, Dept Intervent Radiol, Zhanjiang 524001, Guangdong, Peoples R China; [Wang, Sijie] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang 524001, Guangdong, Peoples R China; [Li, Ying] Tsinghua Univ, Ctr Biomed Anal, Cell Biol Core Facil, Beijing 100084, Peoples R China; [Li, Longxuan] Gongli Hosp, Dept Neurol, Shanghai 200135, Peoples R China; [Sui, Senfang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Tsinghua University; Tsinghua University	Hu, Z (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Anesthesiol, Zhanjiang 524001, Guangdong, Peoples R China.	biohuzhe@hotmail.com; feng_du@foxmail.com	Wu, Wenxian/AAG-9752-2019; chen, hege/GYV-5810-2022	Feng, Du/0000-0002-2489-4702; Li, Wen/0000-0001-7530-199X; Wu, Wenxian/0000-0003-4059-5945	Guangdong Medical College [B2012043, B2012044, 701B01206]; National Natural Science Foundation of China [81171244, 31301104]; Guangdong Natural Science Foundation of China [S2011010004095]; Ministry of Education for returning-back scholars of China [[2012]940]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [2013LYM_0035]	Guangdong Medical College; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Ministry of Education for returning-back scholars of China; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China	This work was supported by grants from the Scientific Research Start-up from Guangdong Medical College (B2012043, B2012044, and 701B01206), the National Natural Science Foundation of China (81171244 and 31301104), the Guangdong Natural Science Foundation of China (S2011010004095), the Startup fund of the Ministry of Education for returning-back scholars of China ([2012]940), and the Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (2013LYM_0035).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Attaix D, 2012, CELL METAB, V16, P551, DOI 10.1016/j.cmet.2012.10.013; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Birse-Archbold JLA, 2005, J CEREBR BLOOD F MET, V25, P1356, DOI 10.1038/sj.jcbfm.9600133; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007; Chen Z, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/378484; Chu CT, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/789431; de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Feng D, 2013, EXP CELL RES, V319, P1697, DOI 10.1016/j.yexcr.2013.03.034; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lisanti MP, 2010, CANCER BIOL THER, V10, P537, DOI 10.4161/cbt.10.6.13370; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang PP, 2013, EMBO REP, V14, P568, DOI 10.1038/embor.2013.53	55	98	107	7	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10691	10701		10.1074/jbc.M113.537050	http://dx.doi.org/10.1074/jbc.M113.537050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573672	hybrid, Green Published			2022-12-25	WOS:000334226400039
J	Ohnishi, T; Murata, T; Watanabe, A; Hida, A; Ohba, H; Iwayama, Y; Mishima, K; Gondo, Y; Yoshikawa, T				Ohnishi, Tetsuo; Murata, Takuya; Watanabe, Akiko; Hida, Akiko; Ohba, Hisako; Iwayama, Yoshimi; Mishima, Kazuo; Gondo, Yoichi; Yoshikawa, Takeo			Defective Craniofacial Development and Brain Function in a Mouse Model for Depletion of Intracellular Inositol Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Brain; Circadian Rhythms; Craniofacial Development; Inositol Phosphates; Mouse Genetics; Mutagenesis; Neurodevelopment; Phosphatase	MYOINOSITOL MONOPHOSPHATASE GENE; BIPOLAR DISORDER; MOOD DISORDER; MISSENSE MUTATIONS; CIRCADIAN-RHYTHMS; TARGETING SYSTEM; FEBRILE SEIZURES; MESSENGER-RNA; IMPA2 GENE; MICE	Background: Lithium exerts a mood-stabilizing effect and inhibits myo-inositol monophosphatase (IMPase). Results: IMPase mutant mice had impaired jaw formation and mimicked lithium-induced behaviors. Conclusion: Craniofacial development and brain function require intracellular inositol production. Significance: This mouse model reveals molecular mechanisms relevant to understanding lithium's efficacy and inositol-mediated developmental processes. myo-Inositol is an essential biomolecule that is synthesized by myo-inositol monophosphatase (IMPase) from inositol monophosphate species. The enzymatic activity of IMPase is inhibited by lithium, a drug used for the treatment of mood swings seen in bipolar disorder. Therefore, myo-inositol is thought to have an important role in the mechanism of bipolar disorder, although the details remain elusive. We screened an ethyl nitrosourea mutant mouse library for IMPase gene (Impa) mutations and identified an Impa1 T95K missense mutation. The mutant protein possessed undetectable enzymatic activity. Homozygotes died perinatally, and E18.5 embryos exhibited striking developmental defects, including hypoplasia of the mandible and asymmetric fusion of ribs to the sternum. Perinatal lethality and morphological defects in homozygotes were rescued by dietary myo-inositol. Rescued homozygotes raised on normal drinking water after weaning exhibited a hyper-locomotive trait and prolonged circadian periods, as reported in rodents treated with lithium. Our mice should be advantageous, compared with those generated by the conventional gene knock-out strategy, because they carry minimal genomic damage, e.g. a point mutation. In conclusion, our results reveal critical roles for intracellular myo-inositol synthesis in craniofacial development and the maintenance of proper brain function. Furthermore, this mouse model for cellular inositol depletion could be beneficial for understanding the molecular mechanisms underlying the clinical effect of lithium and myo-inositol-mediated skeletal development.	[Ohnishi, Tetsuo; Watanabe, Akiko; Ohba, Hisako; Iwayama, Yoshimi; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan; [Murata, Takuya; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan; [Hida, Akiko; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo 1878553, Japan	RIKEN; RIKEN; National Center for Neurology & Psychiatry - Japan	Ohnishi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan.	tohnishi@brain.riken.jp	Murata, Takuya/L-3298-2016; Gondo, Yoichi/A-5375-2016; Murata, Takuya/AAE-8001-2020; Yoshikawa, Takeo/F-9599-2019; Ohnishi, Tetsuo/AAC-2767-2022; Ohnishi, Tetsuo/D-3791-2018; Ohnishi, Tetsuo/AAC-5694-2019	Murata, Takuya/0000-0003-4185-1883; Gondo, Yoichi/0000-0003-2184-6489; Murata, Takuya/0000-0003-4185-1883; Ohnishi, Tetsuo/0000-0002-6696-9725; Ohnishi, Tetsuo/0000-0002-6696-9725; MISHIMA, KAZUO/0000-0003-1182-1181	Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN BSI funds; Mitsubishi Pharma Research Foundation; Astra Zeneca; Takeda Science Foundation; JSPS KAKENHI Grants [15200032, 21240043, 25241016]; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN BSI funds; Mitsubishi Pharma Research Foundation; Astra Zeneca(AstraZeneca); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI Grants; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by in part by grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. O. and T. Y.), RIKEN BSI funds, grants from the Mitsubishi Pharma Research Foundation (to T. Y.), Astra Zeneca (to T. O.), Takeda Science Foundation (to T. O.), JSPS KAKENHI Grants 15200032 (to Y. G.), 21240043 (to Y. G. and T. M.), and 25241016 (to Y. G.), and grant-in-aid for scientific research on innovative areas (Unraveling the Micro-endophenotypes of Psychiatric Disorders at the Molecular, Cellular and Circuit Levels) from the Ministry of Education, Culture, Sports, Science and Technology (to T. Y.). A portion of this study is the result of the "Development of Biomarker Candidates for Social Behavior" Project carried out under the Strategic Research Program for Brain Sciences from Ministry of Education, Culture, Sports, Science and Technology (to T. Y.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Arai R, 2007, PROTEINS, V67, P732, DOI 10.1002/prot.21299; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Artioli P, 2007, EUR NEUROPSYCHOPHARM, V17, P587, DOI 10.1016/j.euroneuro.2007.03.004; Baker M, 2011, NATURE, V475, P123, DOI 10.1038/475123a; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Cryns K, 2008, NEUROPSYCHOPHARMACOL, V33, P674, DOI 10.1038/sj.npp.1301431; Cryns K, 2007, NEUROPSYCHOPHARMACOL, V32, P881, DOI 10.1038/sj.npp.1301154; Dai ZJ, 2011, J BONE MINER RES, V26, P582, DOI 10.1002/jbmr.240; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; DIEHL RE, 1990, J BIOL CHEM, V265, P5946; Dokucu ME, 2005, NEUROPSYCHOPHARMACOL, V30, P2216, DOI 10.1038/sj.npp.1300764; Fujita S, 2011, J MOL MODEL, V17, P2559, DOI 10.1007/s00894-010-0937-8; Gondo Y, 2010, EXP ANIM TOKYO, V59, P537, DOI 10.1538/expanim.59.537; Gondo Y, 2009, PROG BRAIN RES, V179, P29, DOI 10.1016/S0079-6123(09)17904-9; Gondo Y, 2009, BMB REP, V42, P315, DOI 10.5483/BMBRep.2009.42.6.315; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824; Kimata T, 2012, GENETICS, V191, P509, DOI 10.1534/genetics.111.137844; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lavoie J, 2013, BEHAV BRAIN RES, V253, P262, DOI 10.1016/j.bbr.2013.08.001; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; MCALLISTER G, 1992, BIOCHEM J, V284, P749, DOI 10.1042/bj2840749; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; McClung CA, 2011, EUR NEUROPSYCHOPHARM, V21, pS683, DOI 10.1016/j.euroneuro.2011.07.008; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Nakayama J, 2004, NEUROLOGY, V63, P1803, DOI 10.1212/01.WNL.0000144499.34164.E0; Ohnishi T, 2007, NEUROPSYCHOPHARMACOL, V32, P1727, DOI 10.1038/sj.npp.1301307; Ohnishi T, 2007, J BIOL CHEM, V282, P637, DOI 10.1074/jbc.M604474200; Ohnishi T, 2013, J NEUROCHEM, V124, P685, DOI 10.1111/jnc.12112; Ohnishi T, 2010, NEUROSCI RES, V67, P86, DOI 10.1016/j.neures.2010.02.003; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Singh N, 2012, ACTA CRYSTALLOGR F, V68, P1149, DOI 10.1107/S1744309112035191; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Sjoholt G, 1997, GENOMICS, V45, P113, DOI 10.1006/geno.1997.4862; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoshikawa T, 1997, MOL PSYCHIATR, V2, P393, DOI 10.1038/sj.mp.4000325; Yoshikawa T, 2001, MOL PSYCHIATR, V6, P202, DOI 10.1038/sj.mp.4000835	55	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10785	10796		10.1074/jbc.M113.536706	http://dx.doi.org/10.1074/jbc.M113.536706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24554717	Green Published, hybrid			2022-12-25	WOS:000334226400047
J	Pan, TC; Zhang, RZ; Arita, M; Bogdanovich, S; Adams, SM; Gara, SK; Wagener, R; Khurana, TS; Birk, DE; Chu, ML				Pan, Te-Cheng; Zhang, Rui-Zhu; Arita, Machiko; Bogdanovich, Sasha; Adams, Sheila M.; Gara, Sudheer Kumar; Wagener, Raimund; Khurana, Tejvior S.; Birk, David E.; Chu, Mon-Li			A Mouse Model for Dominant Collagen VI Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Connective Tissue; Extracellular Matrix; Fibroblast; Muscle; Tendon	CONGENITAL MUSCULAR-DYSTROPHY; MITOCHONDRIAL DYSFUNCTION; BETHLEM MYOPATHY; TENASCIN-X; VONWILLEBRAND-FACTOR; ALPHA-2(VI) CHAINS; GLOBULAR DOMAINS; MUSCLE; MUTATIONS; DEFICIENCY	Background: Dominant collagen VI gene mutations cause the severe Ullrich congenital muscular dystrophy (UCMD) and mild Bethlem myopathy. Results: A mutant mouse mimicking the most common molecular defect in dominant UCMD patients was generated and characterized. Conclusion: The mutant mouse displays muscle and connective tissue abnormalities. Significance: The mutant mouse provides an animal model for dominant collagen VI disorders. Dominant and recessive mutations in collagen VI genes, COL6A1, COL6A2, and COL6A3, cause a continuous spectrum of disorders characterized by muscle weakness and connective tissue abnormalities ranging from the severe Ullrich congenital muscular dystrophy to the mild Bethlem myopathy. Herein, we report the development of a mouse model for dominant collagen VI disorders by deleting exon 16 in the Col6a3 gene. The resulting heterozygous mouse, Col6a3(+/d16), produced comparable amounts of normal Col6a3 mRNA and a mutant transcript with an in-frame deletion of 54 bp of triple-helical coding sequences, thus mimicking the most common molecular defect found in dominant Ullrich congenital muscular dystrophy patients. Biosynthetic studies of mutant fibroblasts indicated that the mutant 3(VI) collagen protein was produced and exerted a dominant-negative effect on collagen VI microfibrillar assembly. The distribution of the 3(VI)-like chains of collagen VI was not altered in mutant mice during development. The Col6a3(+/d16) mice developed histopathologic signs of myopathy and showed ultrastructural alterations of mitochondria and sarcoplasmic reticulum in muscle and abnormal collagen fibrils in tendons. The Col6a3(+/d16) mice displayed compromised muscle contractile functions and thereby provide an essential preclinical platform for developing treatment strategies for dominant collagen VI disorders.	[Pan, Te-Cheng; Zhang, Rui-Zhu; Arita, Machiko; Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Bogdanovich, Sasha; Khurana, Tejvior S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Bogdanovich, Sasha; Khurana, Tejvior S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Adams, Sheila M.; Birk, David E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Gara, Sudheer Kumar; Wagener, Raimund] Univ Cologne, Med Fac Cologne, Ctr Biochem, D-50931 Cologne, Germany; [Wagener, Raimund] Univ Cologne, Med Fac Cologne, Ctr Mol Med, D-50931 Cologne, Germany	Jefferson University; University of Pennsylvania; University of Pennsylvania; State University System of Florida; University of South Florida; University of Cologne; University of Cologne	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 South 10th St, Philadelphia, PA 19107 USA.	mon-li.chu@jefferson.edu	Gara, Sudheer Kumar/E-8084-2016; Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088	National Institutes of Health [AR053251, AR44745]; German Research Foundation [SFB829]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053251, R01AR044745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053251 (to M.-L.C.) and AR44745 (to D.E.B.). This work was also supported by the German Research Foundation (SFB829; to R.W.).	Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Camacho V.O., 2001, P NATL ACAD SCI USA, V98, P7516, DOI DOI 10.1073/PNAS.121027598; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Giusti B, 2005, ANN NEUROL, V58, P400, DOI 10.1002/ana.20586; Gualandi F, 2012, HUM GENE THER, V23, P1313, DOI 10.1089/hum.2012.109; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Peat RA, 2007, NEUROMUSCULAR DISORD, V17, P547, DOI 10.1016/j.nmd.2007.03.017; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Voermans NC, 2011, CONNECT TISSUE RES, V52, P422, DOI 10.3109/03008207.2010.551616; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200	50	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10293	10307		10.1074/jbc.M114.549311	http://dx.doi.org/10.1074/jbc.M114.549311			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563484	Green Published, hybrid			2022-12-25	WOS:000334226400006
J	Simon, NC; Barbieri, JT				Simon, Nathan C.; Barbieri, Joseph T.			Bacillus cereus Certhrax ADP-ribosylates Vinculin to Disrupt Focal Adhesion Complexes and Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ADP-ribosylation; Bacillus; Bacterial Toxins; Microscopic Imaging	ANTHRACIS LETHAL TOXIN; EXOENZYME-S; ESCHERICHIA-COLI; STRUCTURAL BASIS; RIBOSYLTRANSFERASE; ACTIVATION; PROTEIN; ACTIN; MACROPHAGES; EXPRESSION	Background: The host substrate for Certhrax toxin is unknown. Results: Certhrax toxin ADP-ribosylates vinculin at Arg-433, which disrupts focal adhesion complexes and host cell adhesion. Conclusion: Certhrax toxin is the first bacterial toxin to add a post-translational modification to vinculin to disrupt the actin cytoskeleton. Significance: This explains how Certhrax toxin can contribute to evasion of the host innate immune system. Bacillus cereus is often associated with mild to moderate gastroenteritis; however, some recent isolates cause inhalational anthrax-like diseases and death. These potential emerging human pathogens express multiple virulence factors. B. cereus strain G9241 expresses anthrax toxin, several polysaccharide capsules, and the novel ADP-ribosyltransferase, Certhrax. In this study, we show that Certhrax ADP-ribosylates Arg-433 of vinculin, a protein that coordinates actin cytoskeleton and extracellular matrix interactions. ADP-ribosylation of vinculin disrupted focal adhesion complexes and redistributed vinculin to the cytoplasm. Exogenous vinculin rescued these phenotypes. This provides a mechanism for strain G9241 to breach host barrier defenses and promote bacterial growth and spread. Certhrax is the first bacterial toxin to add a post-translational modification to vinculin to disrupt the actin cytoskeleton.	[Simon, Nathan C.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Barbieri, JT (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu			National Institutes of Health [R01 AI031062, U54 AI057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111101, U54AI057153, R01AI030162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI031062 and U54 AI057153.	AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BOBAK DA, 1990, BIOCHEMISTRY-US, V29, P855, DOI 10.1021/bi00456a600; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Cappello RE, 2011, FEMS IMMUNOL MED MIC, V61, P301, DOI 10.1111/j.1574-695X.2010.00776.x; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; COBURN J, 1991, J BIOL CHEM, V266, P6438; Davies JA, 1997, BIOESSAYS, V19, P699, DOI 10.1002/bies.950190810; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Garlick KM, 2012, BIOCHEMISTRY-US, V51, P1249, DOI 10.1021/bi2016469; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Go MY, 2009, INFECT IMMUN, V77, P52, DOI 10.1128/IAI.01073-08; Golji J, 2012, BIOPHYS J, V102, P2022, DOI 10.1016/j.bpj.2012.01.062; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; Kupper K, 2010, BIOCHEM BIOPH RES CO, V399, P560, DOI 10.1016/j.bbrc.2010.07.110; Langer M, 2012, INFECT IMMUN, V80, P4374, DOI 10.1128/IAI.01011-12; Lehmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004755; Liu SY, 1997, J BACTERIOL, V179, P1609, DOI 10.1128/jb.179.5.1609-1613.1997; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Oh SY, 2013, INFECT IMMUN, V81, P1008, DOI 10.1128/IAI.01346-12; Oh SY, 2011, MOL MICROBIOL, V80, P455, DOI 10.1111/j.1365-2958.2011.07582.x; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pederson KJ, 1998, MOL MICROBIOL, V30, P751, DOI 10.1046/j.1365-2958.1998.01106.x; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Simon NC, 2013, BIOCHEMISTRY-US, V52, P2309, DOI 10.1021/bi300692g; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wilson MK, 2011, INFECT IMMUN, V79, P3012, DOI 10.1128/IAI.00205-11; Xu WM, 1998, DEVELOPMENT, V125, P327; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	66	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10650	10659		10.1074/jbc.M113.500710	http://dx.doi.org/10.1074/jbc.M113.500710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573681	Green Published, hybrid			2022-12-25	WOS:000334226400035
J	Wehmeyer, L; Du Toit, A; Lang, DM; Hapgood, JP				Wehmeyer, Lancelot; Du Toit, Andrea; Lang, Dirk M.; Hapgood, Janet P.			Lipid Raft-and Protein Kinase C-mediated Synergism between Glucocorticoid-and Gonadotropin-releasing Hormone Signaling Results in Decreased Cell Proliferation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Gene Regulation; Glucocorticoid Receptor; Glucocorticoids; Protein Kinase C (PKC); GnRH Receptor; SGK-1; Flotillin-1; Lipid Rafts; Synergism	FOLLICLE-STIMULATING-HORMONE; GENE-EXPRESSION; GNRH RECEPTOR; CYCLE REGULATION; JNK PATHWAY; IN-VITRO; MEMBRANE; PHOSPHORYLATION; TRANSCRIPTION; INHIBITION	Background: The glucocorticoid receptor cross-talks with other receptors to integrate cell signaling. Results: Glucocorticoids and GnRH synergistically up-regulate select mRNA levels via protein kinase C and flotillin-1 to repress cell proliferation. Conclusion: Cross-talk between membrane-associated receptors modulates protein kinase C-dependent synergistic and gene-specific transcription by intracellular glucocorticoid receptor. Significance: Glucocorticoid and GnRH receptor cross-talk integrates adrenal and gonadal signaling to fine-tune cell proliferation. Cross-talk between the glucocorticoid receptor (GR) and other receptors is emerging as a mechanism for fine-tuning cellular responses. We have previously shown that gonadotropin-releasing hormone (GnRH) ligand-independently activates the GR and synergistically modulates glucocorticoid-induced transcription of an endogenous gene in LT2 pituitary gonadotrope precursor cells. Here, we investigated GR and GnRH receptor (GnRHR) cross-talk that involves co-localization with lipid rafts in LT2 cells. We report that the GnRHR and a small population of the GR co-localize with the lipid raft protein flotillin-1 (Flot-1) at the plasma membrane and that the GR is present in a complex with Flot-1, independent of the presence of ligands. We found that the SGK-1 gene is up-regulated by Dex and GnRH alone, whereas a combination of both ligands resulted in a synergistic increase in SGK-1 mRNA levels. Using siRNA-mediated knockdown and antagonist strategies, we show that the gene-specific synergistic transcriptional response requires the GR, GnRHR, and Flot-1 as well as the protein kinase C pathway. Interestingly, although several GR cofactors are differentially recruited to the SGK-1 promoter in the presence of Dex and GnRH, GR levels remain unchanged compared with Dex treatment alone, suggesting that lipid raft association of the GR has a role in enhancing its transcriptional output in the nucleus. Finally, we show that Dex plus GnRH synergistically inhibit cell proliferation in a manner dependent on SGK-1 and Flot-1. Collectively the results support a mechanism whereby GR and GnRHR cross-talk within Flot-1-containing lipid rafts modulates cell proliferation via PKC activation and SGK-1 up-regulation.	[Wehmeyer, Lancelot; Du Toit, Andrea; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, Fac Sci, ZA-7700 Rondebosch, South Africa; [Lang, Dirk M.] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Fac Sci, Private Bag X1, ZA-7700 Rondebosch, South Africa.	Janet.Hapgood@uct.ac.za	Lang, Dirk/I-2554-2015; Hapgood, Janet P/P-2549-2018	Lang, Dirk/0000-0003-3901-2079; Hapgood, Janet P/0000-0002-4414-4861	National Research Foundation, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was supported by the National Research Foundation, South Africa (to J. H.).	Abel GA, 2002, MOL ENDOCRINOL, V16, P1352, DOI 10.1210/me.16.6.1352; Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barr FD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006766; Bartholome B, 2004, FASEB J, V18, P70, DOI 10.1096/fj.03-0328com; Bartis D, 2006, J STEROID BIOCHEM, V98, P147, DOI 10.1016/j.jsbmb.2005.01.032; Bartis D, 2007, BIOCHEM BIOPH RES CO, V354, P253, DOI 10.1016/j.bbrc.2006.12.211; Bliss SP, 2007, MOL ENDOCRINOL, V21, P538, DOI 10.1210/me.2006-0289; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Cheung LWT, 2011, CARDIOVASC RES, V89, P419, DOI 10.1093/cvr/cvq300; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Feng J, 2008, BIOL REPROD, V79, P546, DOI 10.1095/biolreprod.108.068106; FERNANDES PA, 1989, AM J VET RES, V50, P64; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Gametchu B, 1999, STEROIDS, V64, P107, DOI 10.1016/S0039-128X(98)00097-X; GAMETCHU B, 1993, FASEB J, V7, P1283, DOI 10.1096/fasebj.7.13.8405814; Grafer CM, 2009, MOL ENDOCRINOL, V23, P1022, DOI 10.1210/me.2008-0477; Grossmann C, 2010, BBA-MOL CELL RES, V1803, P584, DOI 10.1016/j.bbamcr.2010.02.008; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; Hu AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060452; Jain S, 2005, BIOCHEM BIOPH RES CO, V336, P3, DOI 10.1016/j.bbrc.2005.08.057; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; Langlais D, 2013, MOL ENDOCRINOL, V27, P1103, DOI 10.1210/me.2012-1407; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Lariviere S, 2007, ENDOCRINOLOGY, V148, P1099, DOI 10.1210/en.2006-1473; Li LB, 2010, AM J RESP CRIT CARE, V182, P877, DOI 10.1164/rccm.201001-0015OC; LIPOSITS Z, 1993, J NEUROSCI RES, V35, P14, DOI 10.1002/jnr.490350103; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; Manders E., 1993, Acta Oto-Rhino-Laryngologica Belgica, V47, P27; Mathews WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024946; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Matthews L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022289; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Rees DA, 2002, ENDOCRINOLOGY, V143, P2427, DOI 10.1210/en.143.6.2427; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; Sasson R, 2003, BIOCHEM BIOPH RES CO, V311, P1047, DOI 10.1016/j.bbrc.2003.10.097; Schmidt P, 2001, MOL ENDOCRINOL, V15, P553, DOI 10.1210/me.15.4.553; Shen L, 2004, LEUKEMIA, V18, P1850; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasudevan N, 2001, MOL BRAIN RES, V95, P9, DOI 10.1016/S0169-328X(01)00165-6; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Wang JR, 2004, BIOL REPROD, V70, P577, DOI 10.1095/biolreprod.103.023234; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Wu J, 2007, MOL CELL BIOL, V27, P2411, DOI 10.1128/MCB.02152-06	69	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10235	10251		10.1074/jbc.M113.544742	http://dx.doi.org/10.1074/jbc.M113.544742			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558046	hybrid, Green Published			2022-12-25	WOS:000333807000068
J	Zhang, ZY; Yang, QY; Sun, GY; Chen, S; He, Q; Li, SJ; Liu, Y				Zhang, Zhenyu; Yang, Qiuying; Sun, Guangyan; Chen, She; He, Qun; Li, Shaojie; Liu, Yi			Histone H3K56 Acetylation Is Required for Quelling-induced Small RNA Production through Its Role in Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Homologous Recombination; Neurospora; RNA Interference (RNAi); RNA Silencing; siRNA	INTERFERENCE PATHWAYS; NEUROSPORA-CRASSA; DNA; GENE; LYSINE-56; RTT109; PROTEIN; H3; ACETYLTRANSFERASE; TRANSCRIPTION	Background: Quelling and DNA damage induce small RNA from repetitive DNA regions. Results: Genetic Screen identified RTT109 as a critical component of the siRNA production pathway in Neurospora. Conclusion: RTT109 acts as a histone H3K56 acetyltransferase to mediate siRNA biogenesis through its role in homologous recombination. Significance: This study identifies a new link between DNA damage response and small RNA production at the chromatin level. Quelling and DNA damage-induced small RNA (qiRNA) production are RNA interference (RNAi)-related phenomenon from repetitive genomic loci in Neurospora. We have recently proposed that homologous recombination from repetitive DNA loci allows the RNAi pathway to recognize repetitive DNA to produce small RNA. However, the mechanistic detail of this pathway remains largely unclear. By systematically screening the Neurospora knock-out library, we identified RTT109 as a novel component required for small RNA production. RTT109 is a histone acetyltransferase for histone H3 lysine 56 (H3K56) and H3K56 acetylation is essential for the small RNA biogenesis pathway. Furthermore, we showed that RTT109 is required for homologous recombination and H3K56Ac is enriched around double strand break, which overlaps with RAD51 binding. Taken together, our results suggest that H3K56 acetylation is required for small RNA production through its role in homologous recombination.	[Zhang, Zhenyu; Yang, Qiuying; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Sun, Guangyan; He, Qun] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Li, Shaojie] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100080, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND13-214A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu		Yang, Qiuying/0000-0002-9168-7842	National Institutes of Health [GM084283]; Welch Foundation [I-1560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118118, R01GM084283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM084283) and the Welch Foundation (I-1560) (to Y. L.).	Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Cecere G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-44; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Ishibashi K, 2006, P NATL ACAD SCI USA, V103, P14871, DOI 10.1073/pnas.0604477103; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Lee HC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000496; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Li LD, 2010, CELL MOL LIFE SCI, V67, P3849, DOI 10.1007/s00018-010-0471-y; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michalik KM, 2012, NUCLEIC ACIDS RES, V40, P9596, DOI 10.1093/nar/gks711; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zhang ZY, 2013, GENE DEV, V27, P145, DOI 10.1101/gad.209494.112	42	13	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9365	9371		10.1074/jbc.M113.528521	http://dx.doi.org/10.1074/jbc.M113.528521			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554705	Green Published, hybrid			2022-12-25	WOS:000333472100052
J	Francischetti, IMB; Gordon, E; Bizzarro, B; Gera, N; Andrade, BB; Oliveira, F; Ma, DY; Assumpcao, TCF; Ribeiro, JMC; Pena, M; Qi, CF; Diouf, A; Moretz, SE; Long, CA; Ackerman, HC; Pierce, SK; Sa-Nunes, A; Waisberg, M				Francischetti, Ivo M. B.; Gordon, Emile; Bizzarro, Bruna; Gera, Nidhi; Andrade, Bruno B.; Oliveira, Fabiano; Ma, Dongying; Assumpcao, Teresa C. F.; Ribeiro, Jose M. C.; Pena, Mirna; Qi, Chen-Feng; Diouf, Ababacar; Moretz, Samuel E.; Long, Carole A.; Ackerman, Hans C.; Pierce, Susan K.; Sa-Nunes, Anderson; Waisberg, Michael			Tempol, an Intracellular Antioxidant, Inhibits Tissue Factor Expression, Attenuates Dendritic Cell Function, and Is Partially Protective in a Murine Model of Cerebral Malaria	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; FACTOR-KAPPA-B; BLOOD-BRAIN-BARRIER; INNATE IMMUNE-RESPONSE; PLASMODIUM-FALCIPARUM; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; PLATELET ACTIVATION; HEME OXYGENASE-1; FACTOR INDUCTION	Background: The role of intracellular radical oxygen species (ROS) in pathogenesis of cerebral malaria (CM) remains incompletely understood. Methods and Findings: We undertook testing Tempol-a superoxide dismutase (SOD) mimetic and pleiotropic intracellular antioxidant-in cells relevant to malaria pathogenesis in the context of coagulation and inflammation. Tempol was also tested in a murine model of CM induced by Plasmodium berghei Anka infection. Tempol was found to prevent transcription and functional expression of procoagulant tissue factor in endothelial cells (ECs) stimulated by lipopolysaccharide (LPS). This effect was accompanied by inhibition of IL-6, IL-8, and monocyte chemoattractant protein (MCP-1) production. Tempol also attenuated platelet aggregation and human promyelocytic leukemia HL60 cells oxidative burst. In dendritic cells, Tempol inhibited LPS-induced production of TNF-alpha, IL-6, and IL-12p70, downregulated expression of co-stimulatory molecules, and prevented antigen-dependent lymphocyte proliferation. Notably, Tempol (20 mg/kg) partially increased the survival of mice with CM. Mechanistically, treated mice had lowered plasma levels of MCP-1, suggesting that Tempol downmodulates EC function and vascular inflammation. Tempol also diminished blood brain barrier permeability associated with CM when started at day 4 post infection but not at day 1, suggesting that ROS production is tightly regulated. Other antioxidants-such as a-phenyl N-tertiary-butyl nitrone (PBN; a spin trap), MnTe-2-PyP and MnTBAP (Mn-phorphyrin), Mitoquinone (MitoQ) and Mitotempo (mitochondrial antioxidants), M30 (an iron chelator), and epigallocatechin gallate (EGCG; polyphenol from green tea) did not improve survival. By contrast, these compounds (except PBN) inhibited Plasmodium falciparum growth in culture with different IC50s. Knockout mice for SOD1 or phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (gp91(phox-/-)) or mice treated with inhibitors of SOD (diethyldithiocarbamate) or NADPH oxidase (diphenyleneiodonium) did not show protection or exacerbation for CM. Conclusion: Results with Tempol suggest that intracellular ROS contribute, in part, to CM pathogenesis. Therapeutic targeting of intracellular ROS in CM is discussed.	[Francischetti, Ivo M. B.; Oliveira, Fabiano; Ma, Dongying; Assumpcao, Teresa C. F.; Ribeiro, Jose M. C.; Diouf, Ababacar; Moretz, Samuel E.; Long, Carole A.; Ackerman, Hans C.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Gordon, Emile; Gera, Nidhi; Pena, Mirna; Qi, Chen-Feng; Pierce, Susan K.; Waisberg, Michael] NIAID, Immunogenet Lab, NIH, Rockville, MD USA; [Bizzarro, Bruna; Sa-Nunes, Anderson] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Expt Immunol Lab, Sao Paulo, Brazil; [Andrade, Bruno B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Waisberg, Michael] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Virginia	Francischetti, IMB (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	ifrancischetti@niaid.nih.gov; waisberg@gmail.com	Sa-Nunes, Anderson/D-8667-2012; Oliveira, Fabiano/AAG-5388-2019; Sa-Nunes, Anderson/M-5654-2019; ma, dongying/D-8623-2012; Andrade, Bruno/AAI-2248-2020; Ackerman, Hans/U-9621-2019; Andrade, Bruno/J-9111-2012; Ribeiro, Jose/J-7011-2015; Bizzarro, Bruna/K-4778-2016	Sa-Nunes, Anderson/0000-0002-1859-4973; Oliveira, Fabiano/0000-0002-7924-8038; Sa-Nunes, Anderson/0000-0002-1859-4973; Ackerman, Hans/0000-0003-4940-3305; Andrade, Bruno/0000-0001-6833-3811; Bizzarro, Bruna/0000-0001-6315-0549; Ribeiro, Jose/0000-0002-9107-0818	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX) [555648/2009-5]; Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo); PATH/Malaria Vaccine Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001064, ZIAAI000810, ZIAAI001150, ZIAAI001020] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX); Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo); PATH/Malaria Vaccine Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. Dr. Anderson Sa-Nunes is recipient of grants from Brazilian Malaria Network (MCT/CNPq/MS/SCTIE/DECIT/PRONEX - 555648/2009-5) and from the Research Network on Bioactive Molecules from Arthropod Vectors (NAP-MOBIARVE, University of Sao Paulo). GIA Reference Center is supported by the PATH/Malaria Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000650; Anidi IU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071010; Assumpcao TCF, 2013, J BIOL CHEM, V288, P14341, DOI 10.1074/jbc.M113.466995; Avery JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031090; Banfi C, 2011, J THROMB HAEMOST, V9, P1608, DOI 10.1111/j.1538-7836.2011.04366.x; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Batinic-Haberle I, 2009, FREE RADICAL BIO MED, V46, P192, DOI 10.1016/j.freeradbiomed.2008.09.042; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; BIERHAUS A, 1995, THROMB HAEMOSTASIS, V73, P39; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Charunwatthana P, 2009, CRIT CARE MED, V37, P516, DOI 10.1097/CCM.0b013e3181958dfd; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; COCCO D, 1981, J BIOL CHEM, V256, P8983; CONRAD ME, 1969, ANN INTERN MED, V70, P134, DOI 10.7326/0003-4819-70-1-134; COOPER JM, 1988, J NEUROL SCI, V83, P335, DOI 10.1016/0022-510X(88)90079-2; COOPER JM, 1988, BIOCHEM PHARMACOL, V37, P687, DOI 10.1016/0006-2952(88)90143-8; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Cuzzocrea S, 2004, FREE RADICAL RES, V38, P813, DOI 10.1080/10715760410001710829; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; Dasari P, 2012, BLOOD, V119, P4301, DOI 10.1182/blood-2011-11-392134; de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x; de Mast Q, 2009, AM J TROP MED HYG, V80, P492, DOI 10.4269/ajtmh.2009.80.492; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; DENNIS LH, 1967, BLOOD-J HEMATOL, V29, P713; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Esmon CT, 2011, ANNU REV PHYSIOL, V73, P503, DOI 10.1146/annurev-physiol-012110-142300; Faille D, 2009, THROMB HAEMOSTASIS, V102, P1093, DOI 10.1160/TH09-05-0337; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2008, TRENDS PARASITOL, V24, P258, DOI 10.1016/j.pt.2008.03.009; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Francischetti IMB, 2012, ARTERIOSCL THROM VAS, V32, P786, DOI 10.1161/ATVBAHA.111.240291; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gal S, 2006, J NEURAL TRANSM-SUPP, P447; GATLEY SJ, 1979, XENOBIOTICA, V9, P539, DOI 10.3109/00498257909042319; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Golenser J, 1998, FREE RADICAL BIO MED, V24, P1504, DOI 10.1016/S0891-5849(98)00026-4; Goyal M, 2012, CURR MED CHEM, V19, P1475, DOI 10.2174/092986712799828328; Gozzelino R, 2012, CELL HOST MICROBE, V12, P693, DOI 10.1016/j.chom.2012.10.011; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; HEMMER CJ, 1991, AM J MED, V91, P37, DOI 10.1016/0002-9343(91)90071-5; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; HIGUCHI DA, 1992, BLOOD, V79, P1712; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Karlsson M, 2013, INT J BIOCHEM CELL B, V45, P151, DOI 10.1016/j.biocel.2012.08.008; Kim YS, 2007, J CARDIOVASC PHARM, V49, P376, DOI 10.1097/FJC.0b013e31804a5e34; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1005, DOI 10.1152/ajpgi.2001.280.5.G1005; Kremsner PG, 2000, LANCET, V355, P40, DOI 10.1016/S0140-6736(99)04761-3; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Langhorne J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-23; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Leonarduzzi G, 2011, CURR PHARM DESIGN, V17, P3994, DOI 10.2174/138161211798764906; Li XH, 2008, J IMMUNOL, V181, P1215, DOI 10.4049/jimmunol.181.2.1215; Linares M, 2013, BBA-MOL BASIS DIS, V1832, P2009, DOI 10.1016/j.bbadis.2013.07.010; Liu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034280; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Luyendyk JP, 2007, ARTERIOSCL THROM VAS, V27, P1857, DOI 10.1161/ATVBAHA.107.143552; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; MANWELL RD, 1976, J PARASITOL, V62, P110, DOI 10.2307/3279052; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Metz JM, 2004, CLIN CANCER RES, V10, P6411, DOI 10.1158/1078-0432.CCR-04-0658; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Milner DA, 2010, CURR OPIN INFECT DIS, V23, P456, DOI 10.1097/QCO.0b013e32833c3dbe; Moore JM, 2012, ARTERIOSCL THROM VAS, V32, P541, DOI 10.1161/ATVBAHA.111.242776; Moreno A, 2013, INFECT IMMUN, V81, P1889, DOI 10.1128/IAI.00027-13; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Narsaria N, 2012, J TROP PEDIATRICS, V58, P147, DOI 10.1093/tropej/fmr043; Ndonwi M, 2011, BLOOD, V117, P6347, DOI 10.1182/blood-2010-12-326876; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Oberley-Deegan RE, 2009, AM J RESP CELL MOL, V41, P170, DOI 10.1165/rcmb.2008-0138OC; OLEARY DS, 1972, AM J TROP MED HYG, V21, P282, DOI 10.4269/ajtmh.1972.21.282; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Owens AP, 2012, J CLIN INVEST, V122, P558, DOI 10.1172/JCI58969; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; Paiva CN, 2013, ANTIOXID REDOX SIGN; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; PECANHA LMT, 1988, ANN TROP MED PARASIT, V82, P429, DOI 10.1080/00034983.1988.11812272; Pendurthi UR, 1999, ARTERIOSCL THROM VAS, V19, P419, DOI 10.1161/01.ATV.19.2.419; Percario S, 2012, INT J MOL SCI, V13, P16346, DOI 10.3390/ijms131216346; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Pino P, 2005, THROMB HAEMOSTASIS, V94, P336, DOI 10.1160/TH05-05-0354; Pino P, 2003, ANN NY ACAD SCI, V1010, P582, DOI 10.1196/annals.1299.109; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Postma NS, 1996, PHARM WORLD SCI, V18, P121, DOI 10.1007/BF00717727; Prommano Oranan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1359; Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260; Punsawad C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-191; REINER G, 1991, ACTA TROP, V50, P59, DOI 10.1016/0001-706X(91)90073-S; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Ruf W, 2004, CRIT CARE MED, V32, pS287, DOI 10.1097/01.CCM.0000126364.46191.12; Ruf W, 2009, J THROMB HAEMOST, V7, P118, DOI 10.1111/j.1538-7836.2009.03374.x; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; Sa-Nunes A, 2009, J IMMUNOL, V182, P7422, DOI 10.4049/jimmunol.0900075; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sanni LA, 1999, J INFECT DIS, V179, P217, DOI 10.1086/314552; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Schwartz E, 1999, INFLAMMATION, V23, P361; Seixas E, 2009, EUR J IMMUNOL, V39, P1850, DOI 10.1002/eji.200838403; Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078; Silver KL, 2010, CELL MICROBIOL, V12, P1036, DOI 10.1111/j.1462-5822.2010.01492.x; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Taoufiq Z, 2006, MOL BIOCHEM PARASIT, V150, P166, DOI 10.1016/j.molbiopara.2006.07.008; Tardif JC, 2008, LANCET, V371, P1761, DOI 10.1016/S0140-6736(08)60763-1; Thuma PE, 1998, T ROY SOC TROP MED H, V92, P214, DOI 10.1016/S0035-9203(98)90753-2; THUMWOOD CM, 1989, BRIT J EXP PATHOL, V70, P293; Tripathi AK, 2006, INFECT IMMUN, V74, P3262, DOI 10.1128/IAI.01625-05; Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Tsuhako MH, 2010, FREE RADICAL BIO MED, V48, P704, DOI 10.1016/j.freeradbiomed.2009.12.013; van der Poll T, 2011, CURR OPIN INFECT DIS, V24, P273, DOI 10.1097/QCO.0b013e328344c078; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; von Montfort C, 2012, J HEPATOL, V57, P852, DOI 10.1016/j.jhep.2012.05.024; Waisberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062820; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; Watson SP, 2009, CURR PHARM DESIGN, V15, P1358, DOI 10.2174/138161209787846702; Weinberg JM, 2008, CUTIS, V81, P21; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Zhu JH, 2011, BIOCHEM BIOPH RES CO, V404, P559, DOI 10.1016/j.bbrc.2010.12.025	142	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87140	10.1371/journal.pone.0087140	http://dx.doi.org/10.1371/journal.pone.0087140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586264	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200011
J	Trachtenberg, S; Schuck, P; Phillips, TM; Andrews, SB; Leapman, RD				Trachtenberg, Shlomo; Schuck, Peter; Phillips, Terry M.; Andrews, S. Brian; Leapman, Richard D.			A Structural Framework for a Near-Minimal Form of Life: Mass and Compositional Analysis of the Helical Mollicute Spiroplasma melliferum BC3	PLOS ONE			English	Article							BACTERIAL LINEAR MOTOR; CRYOELECTRON TOMOGRAPHY; SYNTHETIC BIOLOGY; MYCOPLASMA-PNEUMONIAE; PHYLOGENETIC ANALYSIS; GENOME; CITRI; CELLS; ORGANIZATION; TRANSMISSION	Spiroplasma melliferum is a wall-less bacterium with dynamic helical geometry. This organism is geometrically well defined and internally well ordered, and has an exceedingly small genome. Individual cells are chemotactic, polar, and swim actively. Their dynamic helicity can be traced at the molecular level to a highly ordered linear motor (composed essentially of the proteins fib and MreB) that is positioned on a defined helical line along the internal face of the cell's membrane. Using an array of complementary, informationally overlapping approaches, we have taken advantage of this uniquely simple, near-minimal life-form and its helical geometry to analyze the copy numbers of Spiroplasma's essential parts, as well as to elucidate how these components are spatially organized to subserve the whole living cell. Scanning transmission electron microscopy (STEM) was used to measure the mass-per-length and mass-per-area of whole cells, membrane fractions, intact cytoskeletons and cytoskeletal components. These local data were fit into whole-cell geometric parameters determined by a variety of light microscopy modalities. Hydrodynamic data obtained by analytical ultracentrifugation allowed computation of the hydration state of whole living cells, for which the relative amounts of protein, lipid, carbohydrate, DNA, and RNA were also estimated analytically. Finally, ribosome and RNA content, genome size and gene expression were also estimated (using stereology, spectroscopy and 2D-gel analysis, respectively). Taken together, the results provide a general framework for a minimal inventory and arrangement of the major cellular components needed to support life.	[Trachtenberg, Shlomo] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Andrews, S. Brian] NINDS, Neurobiol Lab, NIH, Bethesda, MD 20892 USA; [Schuck, Peter; Phillips, Terry M.; Leapman, Richard D.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Trachtenberg, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	shlomot@ekmd.huji.ac.il	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Leapman, Richard/0000-0002-8575-4084	Israel Science Foundation (ISF); US-Israel Science Foundation (BSF); Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institute of Neurological Disorders and Stroke (NINDS); National Institutes of Health (NIH), USA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000017, ZIAEB000006, ZIAEB000008] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); US-Israel Science Foundation (BSF); Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by funds from the Israel Science Foundation (ISF) and US-Israel Science Foundation (BSF) and in part by the Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev D, 2012, J PROTEOME RES, V11, P224, DOI 10.1021/pr2008626; BASTIAN FO, 1979, ARCH PATHOL LAB MED, V103, P665; Bastian FO, 2007, J MED MICROBIOL, V56, P1235, DOI 10.1099/jmm.0.47159-0; Bastian FO, 2011, VET OPHTHALMOL, V14, P10, DOI 10.1111/j.1463-5224.2010.00833.x; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; CARLE P, 1995, INT J SYST BACTERIOL, V45, P178, DOI 10.1099/00207713-45-1-178; Carle P, 2010, APPL ENVIRON MICROB, V76, P3420, DOI 10.1128/AEM.02954-09; Carpane P, 2013, PHYTOPATHOLOGY, V103, P129, DOI 10.1094/PHYTO-07-12-0158-R; Cohen-Krausz S, 2011, J MOL BIOL, V410, P194, DOI 10.1016/j.jmb.2011.04.067; DANIELS MJ, 1984, CURR MICROBIOL, V10, P191, DOI 10.1007/BF01627253; DANIELS MJ, 1980, J GEN MICROBIOL, V118, P429; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; DAVIS PJ, 1985, J BACTERIOL, V161, P118, DOI 10.1128/JB.161.1.118-122.1985; DAVIS RE, 1973, PHYTOPATHOLOGY, V63, P403, DOI 10.1094/Phyto-63-403; DAVIS RE, 1972, SCIENCE, V176, P521, DOI 10.1126/science.176.4034.521; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Duret S, 2003, APPL ENVIRON MICROB, V69, P6225, DOI 10.1128/AEM.69.10.6225-6234.2003; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gasparich GE, 2002, FRONT BIOSCI, V7, pD619, DOI 10.2741/gaspari; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gilad R, 2003, MOL MICROBIOL, V47, P657, DOI 10.1046/j.1365-2958.2003.03200.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Guell O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00621; HOLMES A., 1927, PETROGRAPHIC METHODS; Killiny N, 2005, PHYTOPATHOLOGY, V95, P541, DOI 10.1094/PHYTO-95-0541; Ku CA, 2013, GENOME BIOL EVOL, V5, P1151, DOI 10.1093/gbe/evt084; Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; LIVESEY AK, 1986, J CHEM PHYS, V84, P5102, DOI 10.1063/1.450663; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Luisi PL, 2011, NAT CHEM, V3, P755, DOI 10.1038/nchem.1156; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mayer F, 2006, J MOL MICROB BIOTECH, V11, P228, DOI 10.1159/000094057; Merkle D, 2008, CHEMBIOCHEM, V9, P2673, DOI 10.1002/cbic.200800340; Miyata M, 2010, ANNU REV MICROBIOL, V64, P519, DOI 10.1146/annurev.micro.112408.134116; Moya A, 2009, FEMS MICROBIOL REV, V33, P225, DOI 10.1111/j.1574-6976.2008.00151.x; Murtas G, 2007, BIOCHEM BIOPH RES CO, V363, P12, DOI 10.1016/j.bbrc.2007.07.201; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; Oshima K, 2007, J MOL EVOL, V65, P249, DOI 10.1007/s00239-007-9010-3; Phillips TM, 2000, AFFINITY IMMUNOAFFIN, P317; Purcell O, 2013, CHAOS, V23, DOI 10.1063/1.4811182; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; Russ J.C., 1999, PRACTICAL STEREOLOGY; Saillard C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-195; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schwille P, 2011, SCIENCE, V333, P1252, DOI 10.1126/science.1211701; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Shaevitz JW, 2005, CELL, V122, P941, DOI 10.1016/j.cell.2005.07.004; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Sousa AA, 2012, ULTRAMICROSCOPY, V123, P38, DOI 10.1016/j.ultramic.2012.04.005; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stano P, 2011, BIOTECHNOL J, V6, P850, DOI 10.1002/biot.201100079; Svedberg T, 1940, THE ULTRACENTRIFUGE; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 1998, J STRUCT BIOL, V123, P45, DOI 10.1006/jsbi.1998.4015; Trachtenberg S, 2005, CURR BIOL, V15, pR483, DOI 10.1016/j.cub.2005.06.049; TRACHTENBERG S, 1993, MICROSC RES TECHNIQ, V24, P173, DOI 10.1002/jemt.1070240209; Trachtenberg S, 2000, J STRUCT BIOL, V130, P10, DOI 10.1006/jsbi.2000.4215; Trachtenberg S, 2004, J MOL MICROB BIOTECH, V7, P78, DOI 10.1159/000077872; Trachtenberg S, 2003, J BACTERIOL, V185, P1987, DOI 10.1128/JB.185.6.1987-1994.2003; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; TRACHTENBERG S, 1992, ULTRAMICROSCOPY, V45, P307, DOI 10.1016/0304-3991(92)90142-7; Trachtenberg S, 2008, J MOL BIOL, V378, P778, DOI 10.1016/j.jmb.2008.02.020; Trachtenberg S, 2006, J MOL MICROB BIOTECH, V11, P265, DOI 10.1159/000094060; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Wang X, 1996, J BACTERIOL, V178, P2314, DOI 10.1128/jb.178.8.2314-2319.1996; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Wieslander A, 2002, MOL BIOL PATHOGENICI, P131; WILLIAMSON DL, 1991, J BACTERIOL, V173, P4353, DOI 10.1128/JB.173.14.4353-4362.1991; Wodke JAH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.6; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494; Zhao Y, 2004, DNA CELL BIOL, V23, P127, DOI 10.1089/104454904322759948	79	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87921	10.1371/journal.pone.0087921	http://dx.doi.org/10.1371/journal.pone.0087921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586297	Green Published, Green Submitted, gold			2022-12-25	WOS:000331717900015
J	Rutledge, CE; Lau, HT; Mangan, H; Hardy, LL; Sunnotel, O; Guo, F; MacNicol, AM; Walsh, CP; Lees-Murdock, DJ				Rutledge, Charlotte E.; Lau, Ho-Tak; Mangan, Hazel; Hardy, Linda L.; Sunnotel, Olaf; Guo, Fan; MacNicol, Angus M.; Walsh, Colum P.; Lees-Murdock, Diane J.			Efficient Translation of Dnmt1 Requires Cytoplasmic Polyadenylation and Musashi Binding Elements	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; XENOPUS OOCYTE MATURATION; CELL-CYCLE PROGRESSION; DNA METHYLTRANSFERASE; CYTOSINE METHYLATION; POSTMITOTIC NEURONS; MEIOTIC PROGRESSION; TEMPORAL CONTROL; STEM-CELLS; GERM-CELLS	Regulation of DNMT1 is critical for epigenetic control of many genes and for genome stability. Using phylogenetic analysis we characterized a block of 27 nucleotides in the 3'UTR of Dnmt1 mRNA identical between humans and Xenopus and investigated the role of the individual elements contained within it. This region contains a cytoplasmic polyadenylation element (CPE) and a Musashi binding element (MBE), with CPE binding protein 1 (CPEB1) known to bind to the former in mouse oocytes. The presence of these elements usually indicates translational control by elongation and shortening of the poly(A) tail in the cytoplasm of the oocyte and in some somatic cell types. We demonstrate for the first time cytoplasmic polyadenylation of Dnmt1 during periods of oocyte growth in mouse and during oocyte activation in Xenopus. Furthermore we show by RNA immunoprecipitation that Musashi1 (MSI1) binds to the MBE and that this element is required for polyadenylation in oocytes. As well as a role in oocytes, site-directed mutagenesis and reporter assays confirm that mutation of either the MBE or CPE reduce DNMT1 translation in somatic cells, but likely act in the same pathway: deletion of the whole conserved region has more severe effects on translation in both ES and differentiated cells. In adult cells lacking MSI1 there is a greater dependency on the CPE, with depletion of CPEB1 or CPEB4 by RNAi resulting in substantially reduced levels of endogenous DNMT1 protein and concurrent upregulation of the well characterised CPEB target mRNA cyclin B1. Our findings demonstrate that CPE-and MBE-mediated translation regulate DNMT1 expression, representing a novel mechanism of post-transcriptional control for this gene.	[Rutledge, Charlotte E.; Lau, Ho-Tak; Mangan, Hazel; Sunnotel, Olaf; Walsh, Colum P.; Lees-Murdock, Diane J.] Univ Ulster, Transcript Regulat & Epigenet Res Grp, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Hardy, Linda L.; MacNicol, Angus M.] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [Guo, Fan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai, Peoples R China	Ulster University; University of Arkansas System; University of Arkansas Medical Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lees-Murdock, DJ (corresponding author), Univ Ulster, Transcript Regulat & Epigenet Res Grp, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	dj.lees@ulster.ac.uk	Guo, Fan/AAX-4952-2021; Walsh, Colum/ABD-7013-2020; Guo, Fan/J-1857-2019	Walsh, Colum/0000-0001-9921-7506; Guo, Fan/0000-0002-0165-073X; Lees-Murdock, Diane/0000-0002-1309-1605	Wellcome Trust [082595]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035688] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from The Wellcome Trust (www.wellcome.ac.uk grant number 082595) to DLM and CPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002457; Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060; Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Ding F, 2002, P NATL ACAD SCI USA, V99, P14861, DOI 10.1073/pnas.232565599; Dunican DS, 2008, DEVELOPMENT, V135, P1295, DOI 10.1242/dev.016402; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gaudet F, 1998, J BIOL CHEM, V273, P32725, DOI 10.1074/jbc.273.49.32725; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Groppo R, 2011, MOL CELL BIOL, V31, P2707, DOI 10.1128/MCB.05133-11; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Inano K, 2000, J BIOCHEM-TOKYO, V128, P315, DOI 10.1093/oxfordjournals.jbchem.a022755; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kim KC, 2011, J NEUROSCI, V21, P1621; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; KOI M, 1994, CANCER RES, V54, P4308; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lees-Murdock DJ, 2004, GENOMICS, V84, P193, DOI 10.1016/j.ygeno.2004.02.004; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Liu LO, 2000, MOL BRAIN RES, V82, P150, DOI 10.1016/S0169-328X(00)00203-5; Loughery JEP, 2011, HUM MOL GENET, V20, P3241, DOI 10.1093/hmg/ddr236; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Mertineit C, 1998, DEVELOPMENT, V125, P889; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; PARIS J, 1990, MOL CELL BIOL, V10, P5634, DOI 10.1128/MCB.10.11.5634; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Prasad CK, 2008, MOL REPROD DEV, V75, P1258, DOI 10.1002/mrd.20877; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rassa JC, 2000, VIROLOGY, V274, P438, DOI 10.1006/viro.2000.0494; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stancheva I, 2000, GENE DEV, V14, P313; Tay J, 2003, GENE DEV, V17, P1457, DOI 10.1101/gad.1071403; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torrisani J, 2007, MOL CELL BIOL, V27, P395, DOI 10.1128/MCB.01236-06; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	61	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88385	10.1371/journal.pone.0088385	http://dx.doi.org/10.1371/journal.pone.0088385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586322	Green Published, gold, Green Submitted			2022-12-25	WOS:000331714700017
J	Li, LL; Jiang, ZG				Li, Linlin; Jiang, Zhigang			International Trade of CITES Listed Bird Species in China	PLOS ONE			English	Article							AMAZON PARROTS; SOUTH-AMERICA; WILDLIFE; CONSERVATION; ISLAND; BIODIVERSITY; POPULATION; ABUNDANCE; INDONESIA; IMPACTS	Commercial trade of wild birds may devastate wild bird populations. Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) controls the trade of wild species listed in its appendices to avoid these species being threatened by international trade. China used to be one of the major trading countries with significant bird trade with foreign countries; on the other hand, China is a country with unique avian fauna, many Important Bird Areas and critically endangered bird species. What is the role of the country in world wild bird trade? What kind of insights can we extract from trade records for improving future management of wild bird trade in the country? We retrieved and analyzed international trade records of the CITES listed bird species of China from 1981 to 2010 from the CITES Trade Database maintained by United Nations Environment Program and World Conservation Monitoring Centre (UNEP-WCMC). We found that: (1) International trade of live birds in China peaked during the late 1990s, then decreased to the level before the surge of trade in a few years, the trade dynamics of wild birds may be affected by governmental policy and the outbreak of avian influenza during the period. (2) Most frequently traded CITES Appendix listed birds in China were parrots, most of which were exotic species to the country. (3) Birds were mainly traded for commercial purpose. Exotic birds in trade were mainly captive-bred while the most Chinese birds traded internationally were captured from the wild. Since many bird species in international trade are threatened to extinction, China should take stricter measures on importing of wild-captured birds and should collaborate with the countries of original in the international bird trade to avoid unsustainable harvesting of wild birds. It is urgent for China to carry out population surveys on those domestic bird species once in significant international trade and to make better conservation decisions based on population status of those birds. In addition, more scientific researchers should be encouraged to participate in the wildlife trade management to avoid misreporting trade data or biased analyses of the trade records.	[Li, Linlin; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Li, Linlin; Jiang, Zhigang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Zhigang] Endangered Species Sci Commiss Peoples Republ Chi, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, ZG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588	Key Program of Knowledge Innovation Program of Chinese Academy of Sciences [KSCX2-EW-Z-4]	Key Program of Knowledge Innovation Program of Chinese Academy of Sciences	This study was supported by the Key Program of Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-EW-Z-4, http://www.bio.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2011, ECOL ECON, V70, P721, DOI 10.1016/j.ecolecon.2010.11.006; An R, 2006, CHINESE WILDLIFE, V27, P25; Bi J, 2005, J INNER MONGOLIA NOR, V34, P93; BirdLife International, 2012, IUCN 2012 IUCN RED L; BirdLife International, 2008, CRIT END BIRDS GLOB; BirdLife International, 2012, IUCN 2012 RED LIST T; Birdlife International, 2008, STAT WORLDS BIRDS IN; Blundell AG, 2005, CONSERV BIOL, V19, P2020, DOI 10.1111/j.1523-1739.2005.00253.x; Brooks EGE, 2010, BIOL CONSERV, V143, P2808, DOI 10.1016/j.biocon.2010.07.030; Brooks-Moizer F, 2009, ECOL SOC, V14; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2008, BIRD CONSERV INT, V18, pS245, DOI 10.1017/S095927090800035X; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cahill AJ, 2006, ORYX, V40, P161, DOI 10.1017/S0030605306000366; Monterrubio-Rico TC, 2010, ORYX, V44, P602, DOI 10.1017/S0030605310000980; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; CITES, 1979, CONV INT TRAD END SP; Collar N. J., 2000, International Zoo Yearbook, V37, P21, DOI 10.1111/j.1748-1090.2000.tb00704.x; Cooney R, 2006, ORYX, V40, P18, DOI 10.1017/S0030605306000056; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Alves RRD, 2010, HUM ECOL, V38, P147, DOI 10.1007/s10745-009-9295-5; Dallimer M, 2008, AFR J ECOL, V46, P258, DOI 10.1111/j.1365-2028.2007.00891.x; Damania R, 2007, ECOL ECON, V62, P461, DOI 10.1016/j.ecolecon.2006.07.007; Raso TD, 2006, VET MICROBIOL, V117, P235, DOI 10.1016/j.vetmic.2006.06.025; De Labra MA, 2010, ORNITOL NEOTROP, V21, P599; Deem SL, 2005, J ZOO WILDLIFE MED, V36, P598, DOI 10.1638/04094.1; Downs CT, 2005, AFR ZOOL, V40, P15; Dutton AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021243; Gastanaga M, 2011, BIRD CONSERV INT, V21, P76, DOI 10.1017/S0959270910000249; Ginsberg J, 2002, CONSERV BIOL, V16, P1184, DOI 10.1046/j.1523-1739.2002.16504.x; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Herrera M, 2007, BIRD CONSERV INT, V17, P295, DOI 10.1017/S0959270907000858; Huo Ya-peng, 2009, Shenyang Shifan Daxue Xuebao Ziran Kexue Ban, V27, P245; Jarry Guy, 2004, Bulletin de la Societe Zoologique de France, V129, P103; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Jiang ZG, 2013, ORYX, V47, P532, DOI 10.1017/S0030605313000057; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Li S, 2004, CHINA POULTRY, V26, P51; LI Y, 2010, CHINESE J WILDLIFE, V31, P280; Ngenyi A., 2003, Journal of the Cameroon Academy of Sciences, V3, P11; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Nogueira SSC, 2011, BIODIVERS CONSERV, V20, P1385, DOI 10.1007/s10531-011-0047-7; Persulessy Yan E., 2009, ZGAP Mitteilungen, V25, P17; Phelps J, 2011, SCIENCE, V331, P400; Rivera L, 2010, ORYX, V44, P110, DOI 10.1017/S0030605309990950; Rodriguez-Ferraro A, 2007, WILSON J ORNITHOL, V119, P602, DOI 10.1676/06-028.1; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; Sanz V, 1998, CONSERV BIOL, V12, P430, DOI 10.1046/j.1523-1739.1998.96261.x; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Shepherd C.R., 2007, Traffic Bulletin, V21, P85; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; Shitaye JE, 2010, VET MED-CZECH, V55, P339, DOI 10.17221/2927-VETMED; State Forestry Administration, 1999, URG ANN STRENGTH MAN; State Forestry Administration, 2003, PROCL STAT FOR ADM C; Strandby U, 2008, BIOL CONSERV, V141, P2959, DOI 10.1016/j.biocon.2008.08.023; UNEP-WCMC, 2010, GUID US CITES TRADE; Wang J, 2001, ANIMAL SCI VET MED, V18, P67; Wang J., 2001, MOD ANIM HUSB, V4, P38; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P221, DOI 10.1007/s12024-010-9167-8; Xu Jiliang, 2002, Journal of Beijing Normal University (Natural Science), V38, P535; Zheng G, 1998, RED DATA BOOK BIRDS; Zhou ZH, 2004, CONSERV BIOL, V18, P1386, DOI 10.1111/j.1523-1739.2004.00251.x; Zhou Zhihua, 2004, Scientia Silvae Sinicae, V40, P151	64	43	45	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e85012	10.1371/journal.pone.0085012	http://dx.doi.org/10.1371/journal.pone.0085012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586234	gold, Green Published, Green Submitted			2022-12-25	WOS:000331711900004
J	Chou, WC; Chung, YT; Chen, HY; Wang, CJ; Ying, TH; Chuang, CY; Tseng, YC; Wang, SL				Chou, Wei-Chun; Chung, Yu-The; Chen, Hsiao-Yen; Wang, Chien-Jen; Ying, Tsung-Ho; Chuang, Chun-Yu; Tseng, Ying-Chih; Wang, Shu-Li			Maternal Arsenic Exposure and DNA Damage Biomarkers, and the Associations with Birth Outcomes in a General Population from Taiwan	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; DIMETHYLARSINIC ACID; METHYLATION; METABOLITES; PREGNANCY; PROMOTES; WEIGHT; URINE; EXPRESSION; PROTEIN	Inorganic arsenic (iAs) is an established transplacental agent known to affect fetal development in animal studies. However, iAs has not been adequately studied in the general population with respect to iAs exposure during pregnancy and its impact on the health status of newborns. The aims of this study were to 1) elucidate the association between arsenic exposure and oxidative/methylated DNA damage in pregnant women, and 2) determine the association with birth outcomes. A birth cohort study of 299 pregnant mother-newborn pairs was recruited during 2001-2002 in Taiwan. We collected maternal urine samples during the 3rd trimester for measuring iAs and its metabolites. We used high-performance liquid chromatography/inductively coupled plasma mass spectrometry (HPLC-ICP-MS) for quantifications of the arsenic species. Liquid chromatography/tandem mass spectrometer (LC-MS/MS) was used to measure the 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) and N-7-methylguanosine (N-7-MeG) DNA damage biomarkers. Birth outcomes were collected to assess the associations with maternal arsenic exposure and the DNA damage biomarkers. Multiple regression analyses showed that maternal urinary iAs had positive associations with the methylated N-7-MeG (beta = 0.35, p<0.001) and oxidative 8-oxodG (beta = 0.24, p<0.001) DNA damage biomarkers, and a decreased one-minute (1-min) Apgar score (beta = -0.23, p = 0.041). Maternal N-7-MeG was also associated with a decreased 1-min Apgar score (beta = -0.25, p = 0.042). Mutual adjustment for iAs and N-7-MeG showed an independent and significant prediction for a decreased 1-min Apgar score of iAs (beta = -0.28, p = 0.036). Maternal iAs exposure was associated with both maternal DNA damage and adverse newborn health. Maternal N-7-MeG levels might be a novel biomarker for monitoring fetal health related to iAs.	[Chou, Wei-Chun; Chuang, Chun-Yu] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Chou, Wei-Chun; Chung, Yu-The; Chen, Hsiao-Yen; Wang, Chien-Jen; Wang, Shu-Li] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli County, Taiwan; [Ying, Tsung-Ho] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Tseng, Ying-Chih] Hsinchu Cathay Gen Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Wang, Shu-Li] NIEHS, Epidemiol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Tsing Hua University; National Health Research Institutes - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Cathay General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chuang, CY (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	slwang@nhri.org.tw	Wang, Shu-Li/C-1367-2010; Chou, Wei-Chun/AAO-6532-2020	Chou, Wei-Chun/0000-0003-3355-6921; Wang, Shu-Li/0000-0002-0686-4729	National Science Council, Taiwan [NSC98-2314-B-400-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Financial support received from the National Science Council, Taiwan, is gratefully acknowledged (grants no.: NSC98-2314-B-400-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Baskett TF, 2000, RESUSCITATION, V47, P215, DOI 10.1016/S0300-9572(00)00340-3; Bjerg A, 2011, PEDIATRICS, V127, pE905, DOI 10.1542/peds.2010-2850; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chao MR, 2008, CANCER EPIDEM BIOMAR, V17, P3381, DOI 10.1158/1055-9965.EPI-08-0721; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chiang SY, 2005, RAPID COMMUN MASS SP, V19, P1915, DOI 10.1002/rcm.2003; Chou WC, 2012, ARSEN ENVIR, P157; Christian WJ, 2006, ENVIRON RES, V100, P115, DOI 10.1016/j.envres.2005.03.009; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Davey JC, 2008, ENVIRON HEALTH PERSP, V116, P165, DOI 10.1289/ehp.10131; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Engstrom KS, 2010, FREE RADICAL BIO MED, V48, P1211, DOI 10.1016/j.freeradbiomed.2010.02.004; Gardner RM, 2011, REPROD TOXICOL, V31, P210, DOI 10.1016/j.reprotox.2010.11.002; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hill DS, 2008, BIRTH DEFECTS RES B, V83, P40, DOI 10.1002/bdrb.20142; Huyck KL, 2007, J OCCUP ENVIRON MED, V49, P1097, DOI 10.1097/JOM.0b013e3181566ba0; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; LEE MMS, 1992, INT J EPIDEMIOL, V21, P922, DOI 10.1093/ije/21.5.922; Lin IH, 2009, TOXICOLOGY, V260, P1, DOI 10.1016/j.tox.2009.02.015; MANDEL LR, 1966, NATURE, V209, P586, DOI 10.1038/209586a0; Myers SL, 2010, J EPIDEMIOL COMMUN H, V64, P325, DOI 10.1136/jech.2008.084392; Navas-Acien A, 2011, ENVIRON RES, V111, P110, DOI 10.1016/j.envres.2010.10.009; Odd DE, 2008, ARCH DIS CHILD-FETAL, V93, pF115, DOI 10.1136/adc.2007.123745; Piao FY, 2005, J OCCUP HEALTH, V47, P445, DOI 10.1539/joh.47.445; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Ritsema R, 1998, APPL ORGANOMET CHEM, V12, P591, DOI 10.1002/(SICI)1099-0739(199808/09)12:8/9<591::AID-AOC767>3.0.CO;2-E; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; SHUKER DEG, 1992, CHEM RES TOXICOL, V5, P450, DOI 10.1021/tx00028a001; STILLWELL WG, 1989, CHEM RES TOXICOL, V2, P94, DOI 10.1021/tx00008a004; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Vijayaraghavan M, 2001, CANCER LETT, V165, P11, DOI 10.1016/S0304-3835(00)00711-4; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Wang SL, 2004, CHEMOSPHERE, V54, P1459, DOI 10.1016/j.chemosphere.2003.08.012; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yamanaka K, 2001, BIOL PHARM BULL, V24, P510, DOI 10.1248/bpb.24.510; Yang CY, 2003, EPIDEMIOLOGY, V14, pS127, DOI 10.1097/00001648-200309001-00311	43	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86398	10.1371/journal.pone.0086398	http://dx.doi.org/10.1371/journal.pone.0086398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558361	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700007
J	Gerard, FCA; Yang, RF; Romani, B; Poisson, A; Belzile, JP; Rougeau, N; Cohen, EA				Gerard, Francine C. A.; Yang, Ruifeng; Romani, Bizhan; Poisson, Alexis; Belzile, Jean-Philippe; Rougeau, Nicole; Cohen, Eric A.			Defining the Interactions and Role of DCAF1/VPRBP in the DDB1-Cullin4A E3 Ubiquitin Ligase Complex Engaged by HIV-1 Vpr to Induce a G(2) Cell Cycle Arrest	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 VPR; PROTEASOMAL DEGRADATION; PROTEIN VPR; IN-VIVO; DDB1; ACTIVATION; BINDING; ATR; LOCALIZATION	HIV viral protein R (Vpr) induces a cell cycle arrest at the G(2)/M phase by activating the ATR DNA damage/replication stress signalling pathway through engagement of the DDB1-CUL4A-DCAF1 E3 ubiquitin ligase via a direct binding to the substrate specificity receptor DCAF1. Since no high resolution structures of the DDB1-DCAF1-Vpr substrate recognition module currently exist, we used a mutagenesis approach to better define motifs in DCAF1 that are crucial for Vpr and DDB1 binding. Herein, we show that the minimal domain of DCAF1 that retained the ability to bind Vpr and DDB1 was mapped to residues 1041 to 1393 (DCAF1 WD). Mutagenic analyses identified an alpha-helical H-box motif and F/YxxF/Y motifs located in the N-terminal domain of DCAF1 WD that are involved in exclusive binding to DDB1. While we could not identify elements specifically involved in Vpr binding, overall, the mutagenesis data suggest that the predicted beta-propeller conformation of DCAF1 is likely to be critical for Vpr association. Importantly, we provide evidence that binding of Vpr to DCAF1 appears to modulate the formation of a DDB1/DCAF1 complex. Lastly, we show that expression of DCAF1 WD in the absence of endogenous DCAF1 was not sufficient to enable Vpr-mediated G(2) arrest activity. Overall, our results reveal that Vpr and DDB1 binding on DCAF1 can be genetically separated and further suggest that DCAF1 contains determinants in addition to the Vpr and DDB1 minimal binding domain, which are required for Vpr to enable the induction of a G(2) arrest.	[Gerard, Francine C. A.; Yang, Ruifeng; Romani, Bizhan; Poisson, Alexis; Belzile, Jean-Philippe; Rougeau, Nicole; Cohen, Eric A.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Cohen, EA (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	eric.cohen@ircm.qc.ca			Canadian Institutes of Health Research (CIHR) [MOP 12381]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by grant MOP 12381 from the Canadian Institutes of Health Research (CIHR) to EAC. FCAG is supported by a post-doctoral fellowship from CIHR. EAC holds the Canada Research Chair in Human Retrovirology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; BouHamdan M, 1998, J BIOL CHEM, V273, P8009, DOI 10.1074/jbc.273.14.8009; DeHart JL, 2008, J VIROL, V82, P1066, DOI 10.1128/JVI.01628-07; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kaur M, 2012, NUCLEIC ACIDS RES, V40, P7332, DOI 10.1093/nar/gks366; Kulkosky J, 1999, VIROLOGY, V255, P77, DOI 10.1006/viro.1998.9544; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Okui N, 2000, HUM GENE THER, V11, P537, DOI 10.1089/10430340050015725; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06	41	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89195	10.1371/journal.pone.0089195	http://dx.doi.org/10.1371/journal.pone.0089195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558487	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700133
J	Gladine, C; Newman, JW; Durand, T; Pedersen, TL; Galano, JM; Demougeot, C; Berdeaux, O; Pujos-Guillot, E; Mazur, A; Comte, B				Gladine, Cecile; Newman, John W.; Durand, Thierry; Pedersen, Theresa L.; Galano, Jean-Marie; Demougeot, Celine; Berdeaux, Olivier; Pujos-Guillot, Estelle; Mazur, Andrzej; Comte, Blandine			Lipid Profiling following Intake of the Omega 3 Fatty Acid DHA Identifies the Peroxidized Metabolites F-4-Neuroprostanes as the Best Predictors of Atherosclerosis Prevention	PLOS ONE			English	Article							N-3 FATTY-ACIDS; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; IN-VIVO; FISH INTAKE; NEUROPROSTANES; QUANTIFICATION; PEROXIDATION; MEDIATORS; HUMANS	The anti-atherogenic effects of omega 3 fatty acids, namely eicosapentaenoic (EPA) and docosahexaenoic acids (DHA) are well recognized but the impact of dietary intake on bioactive lipid mediator profiles remains unclear. Such a profiling effort may offer novel targets for future studies into the mechanism of action of omega 3 fatty acids. The present study aimed to determine the impact of DHA supplementation on the profiles of polyunsaturated fatty acids (PUFA) oxygenated metabolites and to investigate their contribution to atherosclerosis prevention. A special emphasis was given to the nonenzymatic metabolites knowing the high susceptibility of DHA to free radical-mediated peroxidation and the increased oxidative stress associated with plaque formation. Atherosclerosis prone mice (LDLR-/-) received increasing doses of DHA (0, 0.1, 1 or 2% of energy) during 20 weeks leading to a dose-dependent reduction of atherosclerosis (R-2 = 0.97, p = 0.02), triglyceridemia (R-2 = 0.97, p = 0.01) and cholesterolemia (R-2 = 0.96, p, 0.01). Targeted lipidomic analyses revealed that both the profiles of EPA and DHA and their corresponding oxygenated metabolites were substantially modulated in plasma and liver. Notably, the hepatic level of F-4-neuroprostanes, a specific class of DHA peroxidized metabolites, was strongly correlated with the hepatic DHA level. Moreover, unbiased statistical analysis including correlation analyses, hierarchical cluster and projection to latent structure discriminate analysis revealed that the hepatic level of F4-neuroprostanes was the variable most negatively correlated with the plaque extent (p<0.001) and along with plasma EPA-derived diols was an important mathematical positive predictor of atherosclerosis prevention. Thus, oxygenated n-3 PUFAs, and F-4-neuroprostanes in particular, are potential biomarkers of DHA-associated atherosclerosis prevention. While these may contribute to the anti-atherogenic effects of DHA, further in vitro investigations are needed to confirm such a contention and to decipher the molecular mechanisms of action.	[Gladine, Cecile; Pujos-Guillot, Estelle; Mazur, Andrzej; Comte, Blandine] Univ Auvergne, Clermont Univ, CRNH Auvergne, UMR1019,INRA,UNH, Clermont Ferrand, France; [Newman, John W.; Pedersen, Theresa L.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Durand, Thierry; Galano, Jean-Marie] Univ Montpellier I, IBMM, CNRS, UMR 5247, Montpellier, France; [Durand, Thierry; Galano, Jean-Marie] Univ Montpellier 2, IBMM, CNRS, UMR 5247, Montpellier, France; [Demougeot, Celine] Univ Franche Comte, EA Fonct & Dysfonct Epitheliales 4267, F-25030 Besancon, France; [Berdeaux, Olivier] CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France; [Berdeaux, Olivier] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21034 Dijon, France; [Berdeaux, Olivier] Univ Bourgogne, Ctr Sci Gout & Alimentat, UMR, Dijon, France; [Pujos-Guillot, Estelle] INRA, Plateforme Explorat Metab, UMR 1019, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA); United States Department of Agriculture (USDA); University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE	Comte, B (corresponding author), Univ Auvergne, Clermont Univ, CRNH Auvergne, UMR1019,INRA,UNH, Clermont Ferrand, France.	blandine.comte@clermont.inra.fr	Mazur, Andre/AAG-9751-2020; Gladine, Cecile/W-9843-2018	Mazur, Andre/0000-0002-1067-5066; Gladine, Cecile/0000-0001-7693-6241; PUJOS-GUILLOT, Estelle/0000-0002-4693-5712; Comte, Blandine/0000-0002-4662-6581; Newman, John/0000-0001-9632-6571; Demougeot, Celine/0000-0003-0639-9756	intramural French National Institute for Agricultural Research (INRA); United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [5306-51530-019-00D]	intramural French National Institute for Agricultural Research (INRA); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was partially supported by intramural French National Institute for Agricultural Research (INRA, http://www.alimh.inra.fr/) and United States Department of Agriculture-Agricultural Research Service (USDA-ARS, http://www.ars.usda.gov/main/main.htm), Project 5306-51530-019-00D (JWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan Y, 1999, BIOSCI BIOTECH BIOCH, V63, P111, DOI 10.1271/bbb.63.111; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brooks JD, 2008, J BIOL CHEM, V283, P12043, DOI 10.1074/jbc.M800122200; Brooks JD, 2011, J NEUROCHEM, V119, P604, DOI 10.1111/j.1471-4159.2011.07422.x; Brossard N, 1996, AM J CLIN NUTR, V64, P577, DOI 10.1093/ajcn/64.4.577; Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435; Calder PC, 2012, MOL NUTR FOOD RES, V56, P1073, DOI 10.1002/mnfr.201100710; COSGROVE JP, 1987, LIPIDS, V22, P299, DOI 10.1007/BF02533996; De Caterina R, 2001, LIPIDS, V36, pS69, DOI 10.1007/s11745-001-0685-9; Erkkila AT, 2004, AM J CLIN NUTR, V80, P626; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Gladine C., 2011, BR J NUTR, P1; Grapov D, 2012, BIOINFORMATICS; Jahn U, 2008, ANGEW CHEM INT EDIT, V47, P5894, DOI 10.1002/anie.200705122; Jude S, 2003, BRIT J PHARMACOL, V139, P816, DOI 10.1038/sj.bjp.0705308; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Matsumoto M, 2008, ATHEROSCLEROSIS, V197, P524, DOI 10.1016/j.atherosclerosis.2007.07.023; MAZUR A, 1990, J NUTR, V120, P1037, DOI 10.1093/jn/120.9.1037; Miles EA, 2012, BRIT J NUTR, V107, pS171, DOI 10.1017/S0007114512001560; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Musiek ES, 2008, J BIOL CHEM, V283, P19927, DOI 10.1074/jbc.M803625200; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Nakajima K, 2011, ARTERIOSCL THROM VAS, V31, P1963, DOI 10.1161/ATVBAHA.111.229443; Newman JW, 2007, J LIPID RES, V48, P1792, DOI 10.1194/jlr.M700146-JLR200; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Oger C, 2008, ORG LETT, V10, P5087, DOI 10.1021/ol802104z; Oger C, 2010, CHEM-EUR J, V16, P13976, DOI 10.1002/chem.201002304; PERERA SK, 1979, J AM CHEM SOC, V101, P7390, DOI 10.1021/ja00518a043; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qu L, 2009, IEEE T INTELL TRANSP, V10, P512, DOI 10.1109/TITS.2009.2026312; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Saito M, 1998, J AGR FOOD CHEM, V46, P184, DOI 10.1021/jf970385d; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023; Simopoulos AP, 2000, PROSTAG LEUKOTR ESS, V63, P119, DOI 10.1054/plef.2000.0176; Smedes F, 1999, ANALYST, V124, P1711, DOI 10.1039/a905904k; Stephensen CB, 2011, J LIPID RES, V52, P991, DOI 10.1194/jlr.P012864; Stocker R, 2005, J THROMB HAEMOST, V3, P1825, DOI 10.1111/j.1538-7836.2005.01370.x; Ulu A, 2008, J CARDIOVASC PHARM, V52, P314, DOI 10.1097/FJC.0b013e318185fa3c; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Vila L, 2004, MED RES REV, V24, P399, DOI 10.1002/med.10065; Chong W, 2006, IEEE T NEURAL NETWOR, V17, P789, DOI 10.1109/TNN.2006.871718; Wang S, 2009, ATHEROSCLEROSIS, V204, P147, DOI 10.1016/j.atherosclerosis.2008.08.024; Zampolli A, 2006, ATHEROSCLEROSIS, V184, P78, DOI 10.1016/j.atherosclerosis.2005.04.018; Zhao Z, 2001, CLIN CHEM, V47, P1306	52	60	60	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89393	10.1371/journal.pone.0089393	http://dx.doi.org/10.1371/journal.pone.0089393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558496	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700142
J	Jefferson, M; Whelband, M; Mohorianu, I; Powell, PP				Jefferson, Matthew; Whelband, Matthew; Mohorianu, Irina; Powell, Penny P.			The Pestivirus N Terminal Protease N-pro Redistributes to Mitochondria and Peroxisomes Suggesting New Sites for Regulation of IRF3 by N-pro	PLOS ONE			English	Article							SWINE-FEVER VIRUS; KAPPA-B; ANTIVIRAL RESPONSE; VIRAL EVASION; INTERFERON; MAVS; APOPTOSIS; DEGRADATION; BAX; IDENTIFICATION	The N-terminal protease of pestiviruses, N-pro is a unique viral protein, both because it is a distinct autoprotease that cleaves itself from the following polyprotein chain, and also because it binds and inactivates IRF3, a central regulator of interferon production. An important question remains the role of N-pro in the inhibition of apoptosis. In this study, apoptotic signals induced by staurosporine, interferon, double stranded RNA, sodium arsenate and hydrogen peroxide were inhibited by expression of wild type N-pro, but not by mutant protein N-pro C112R, which we show is less efficient at promoting degradation of IRF3, and led to the conclusion that N-pro inhibits the stress-induced intrinsic mitochondrial pathway through inhibition of IRF3-dependent Bax activation. Both expression of N-pro and infection with Bovine Viral Diarrhea Virus (BVDV) prevented Bax redistribution and mitochondrial fragmentation. Given the role played by signaling platforms during IRF3 activation, we have studied the subcellular distribution of N-pro and we show that, in common with many other viral proteins, N-pro targets mitochondria to inhibit apoptosis in response to cell stress. N-pro itself not only relocated to mitochondria but in addition, both N-pro and IRF3 associated with peroxisomes, with over 85% of N-pro puncta co-distributing with PMP70, a marker for peroxisomes. In addition, peroxisomes containing N-pro and IRF3 associated with ubiquitin. IRF3 was degraded, whereas N-pro accumulated in response to cell stress. These results implicate mitochondria and peroxisomes as new sites for IRF3 regulation by N-pro, and highlight the role of these organelles in the anti-viral pathway.	[Jefferson, Matthew; Whelband, Matthew; Mohorianu, Irina; Powell, Penny P.] Univ E Anglia, Norwich Med Sch & Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Powell, PP (corresponding author), Univ E Anglia, Norwich Med Sch & Biol Sci, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England.	P.Powell@uea.ac.uk	Mohorianu, Irina/J-2549-2019	Powell, Penny/0000-0002-5347-0490; Mohorianu, Irina/0000-0003-4863-761X	Biotechnology and Biological Sciences Research Council [BBS/B/00686]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding came from a Biotechnology and Biological Sciences Research Council grant BBS/B/00686 to PPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achmuller C, 2007, NAT METHODS, V4, P1037, DOI 10.1038/nmeth1116; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Castanier C, 2010, BIOCHIM BIOPHYS ACTA, V1813, P575; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doceul V, 2008, J GEN VIROL, V89, P1881, DOI 10.1099/vir.0.83643-0; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Killip MJ, 2013, J VIROL, V87, P4798, DOI 10.1128/JVI.03383-12; La Rocca SA, 2005, J VIROL, V79, P7239, DOI 10.1128/JVI.79.11.7239-7247.2005; Lazarow PB, 2011, CURR OPIN MICROBIOL, V14, P458, DOI 10.1016/j.mib.2011.07.009; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Lloyd RE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002741; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MOENNIG V, 1992, ADV VIRUS RES, V41, P53, DOI 10.1016/S0065-3527(08)60035-4; Mohan KVK, 2002, J VIROL, V76, P2543, DOI 10.1128/JVI.76.5.2543-2547.2002; Paz S, 2009, MOL CELL BIOL, V29, P3401, DOI 10.1128/MCB.00880-08; Peterhans E, 2010, VET MICROBIOL, V142, P18, DOI 10.1016/j.vetmic.2009.09.038; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; Ruggli N, 2009, J VIROL, V83, P817, DOI 10.1128/JVI.01509-08; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2010, CELL, V141, P570, DOI 10.1016/j.cell.2010.04.043; Szymanski MR, 2009, J MOL BIOL, V391, P438, DOI 10.1016/j.jmb.2009.06.040; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; Vince JE, 2010, EMBO J, V29, P1627, DOI 10.1038/emboj.2010.79; Wolff T, 1996, J VIROL, V70, P5363, DOI 10.1128/JVI.70.8.5363-5372.1996; Zemirli N, 2012, INT J BIOCHEM CELL B, V44, P1473, DOI 10.1016/j.biocel.2012.05.018	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88838	10.1371/journal.pone.0088838	http://dx.doi.org/10.1371/journal.pone.0088838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551175	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500075
J	Buchanan, AM; Dow, DE; Massambu, CG; Nyombi, B; Shayo, A; Musoke, R; Feng, S; Bartlett, JA; Cunningham, CK; Schimana, W				Buchanan, Ann M.; Dow, Dorothy E.; Massambu, Charles G.; Nyombi, Balthazar; Shayo, Aisa; Musoke, Rahma; Feng, Sheng; Bartlett, John A.; Cunningham, Coleen K.; Schimana, Werner			Progress in the Prevention of Mother to Child Transmission of HIV in Three Regions of Tanzania: A Retrospective Analysis	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PREGNANT-WOMEN; ZIDOVUDINE; NEVIRAPINE; LAMIVUDINE; RECOMMENDATIONS; COMBINATION; MORTALITY; BOTSWANA; REGIMENS	Background: Mother to child transmission (MTCT) of HIV-1 remains an important problem in sub-Saharan Africa where most new pediatric HIV-1 infections occur. Early infant diagnosis of HIV-1 using dried blood spot (DBS) PCR among exposed infants provides an opportunity to assess current MTCT rates. Methods: We conducted a retrospective data analysis on mother-infant pairs from all PMTCT programs in three regions of northern Tanzania to determine MTCT rates from 2008-2010. Records of 3,016 mother-infant pairs were assessed to determine early transmission among HIV-exposed infants in the first 75 days of life. Results: Of 2,266 evaluable infants in our cohort, 143 had a positive DBS PCR result at <= 75 days of life, for an overall transmission rate of 6.3%. Transmission decreased substantially over the period of study as more effective regimens became available. Transmission rates were tightly correlated to maternal regimen: 14.9% (9.5, 20.3) of infants became infected when women received no therapy; 8.8% (6.9, 10.7) and 3.6% (2.4, 4.8) became infected when women received single-dose nevirapine (sdNVP) or combination prophylaxis, respectively; the lowest MTCT rates occurred when women were on HAART, with 2.1% transmission (0.3, 3.9). Treatment regimens changed dramatically over the study period, with an increase in combination prophylaxis and a decrease in the use of sdNVP. Uptake of DBS PCR more than tripled over the period of study for the three regions surveyed. Conclusions: Our study demonstrates significant reductions in MTCT of HIV-1 in three regions of Tanzania coincident with increased use of more effective PMTCT interventions. The changes we demonstrate for the period of 2008-2010 occurred prior to major changes in WHO PMTCT guidelines.	[Buchanan, Ann M.; Dow, Dorothy E.; Shayo, Aisa; Musoke, Rahma; Bartlett, John A.; Cunningham, Coleen K.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Buchanan, Ann M.; Dow, Dorothy E.] Duke Univ, Med Ctr, Div Infect Dis, Dept Pediat, Durham, NC USA; [Buchanan, Ann M.; Bartlett, John A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Massambu, Charles G.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Nyombi, Balthazar] Kilimanjaro Christian Med Ctr Clin Lab, Moshi, Tanzania; [Feng, Sheng] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Bartlett, John A.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC USA; [Schimana, Werner] Elizabeth Glaser Pediat AIDS Fdn, Dar Es Salaam, Tanzania	Kilimanjaro Christian Medical Centre; Duke University; Duke University; Kilimanjaro Christian Medical Centre; Duke University; Duke University	Buchanan, AM (corresponding author), Kilimanjaro Christian Med Ctr, Moshi, Tanzania.	ann.buchanan@duke.edu	Dow, Dorothy/H-8164-2019		President's Emergency Plan for AIDS Relief (PEPFAR) through the National Institute of Allergy and Infectious Diseases (NIAID) [NOT-A1-10-023 (3UO1 A1069484 A4S2)]; Duke Clinical Trials Unit and Clinical Research Sites [U01 AI069484]; Duke Center for AIDS Research [5P30 AI064518]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [T32 HD060558 to DED]; HRSA [T84HS21123]; NIH [P30AI064518, D43CA153722, D43TW06732]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW009985, D43TW006732] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [D43CA153722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, U01AI069484] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the National Institute of Allergy and Infectious Diseases (NIAID); Duke Clinical Trials Unit and Clinical Research Sites; Duke Center for AIDS Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through a supplement to the National Institute of Allergy and Infectious Diseases (NIAID): NOT-A1-10-023 (3UO1 A1069484 A4S2); the Duke Clinical Trials Unit and Clinical Research Sites (U01 AI069484 to CKC, JAB, and AMB); the Duke Center for AIDS Research (5P30 AI064518 to CKC and AMB); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant to the Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center (T32 HD060558 to DED); and HRSA grant T84HS21123 and NIH grants P30AI064518, D43CA153722, and D43TW06732 to JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; [Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], NAT GUID MAN HIV AID; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 2000, ANN NY ACAD SCI, V918, P136; Dabis F, 2005, AIDS, V19, P309; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Dorenbaum A, 2002, JAMA-J AM MED ASSOC, V288, P189, DOI 10.1001/jama.288.2.189; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS26, DOI 10.1016/j.ajog.2007.03.087; Jaspan HB, 2003, CURR HIV RES, V1, P321, DOI 10.2174/1570162033485221; Kouanda S, 2010, AIDS CARE, V22, P843, DOI 10.1080/09540120903499204; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; Ministry of Health and Social Welfare National AIDS Control Programme (NACP), 2012, TANZ EL MOTH CHILD T; Ministry of Health and Social Welfare United Republic of Tanzania, 2011, PREV MOTH TO CHILD T; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Olayinka BA, 2000, J PAEDIATR CHILD H, V36, P313, DOI 10.1046/j.1440-1754.2000.00528.x; Saba J, 2002, LANCET, V359, P1178; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Simpson BJ, 2000, PEDIATR INFECT DIS J, V19, P618, DOI 10.1097/00006454-200007000-00007; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; UNAIDS, 2012, GLOBAL REPORT UNAIDS	26	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88679	10.1371/journal.pone.0088679	http://dx.doi.org/10.1371/journal.pone.0088679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551134	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000054
J	Goshima, T; Shimada, M; Sharif, J; Matsuo, H; Misaki, T; Johmura, Y; Murata, K; Koseki, H; Nakanishi, M				Goshima, Takahiro; Shimada, Midori; Sharif, Jafar; Matsuo, Hiromi; Misaki, Toshinori; Johmura, Yoshikazu; Murata, Kazuhiro; Koseki, Haruhiko; Nakanishi, Makoto			Mammal-specific H2A Variant, H2ABbd, Is Involved in Apoptotic Induction via Activation of NF- kappa B Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Cycle; Chromatin Histone Modification; DNA Damage; Gene Expression; Histones	DNA-DAMAGE; TRANSCRIPTIONAL REPRESSION; HISTONE VARIANTS; CELL-DEATH; NUCLEOSOME; PROTEIN; KINASE; SPERMATOGENESIS; CHROMOSOME; H2A.BBD	Background: H2ABbd is an H2A variant possessing a highly divergent structure. However, the in vivo function of H2ABbd is not understood. Results: Expression of H2ABbd caused DNA damage, induced apoptotis, and finally led to cell death. Conclusion: H2ABbd caused apoptosis in caspase 3- and NF-B-dependent manners. Significance: This work describes a novel role for human H2ABbd in gene regulation and cell death. Histone variants play specific roles in maintenance and regulation of chromatin structures. H2ABbd, an H2A variant, possesses a highly divergent structure compared with canonical H2A and is highly expressed in postmeiotic germ cells, but its functions in the regulation of gene expression are largely unknown. In the present study, we investigated the cellular phenotype associated with enforced H2ABbd expression. Among H2A variants, H2ABbd specifically caused growth defect in human cells and induced apoptosis. H2ABbd expression resulted in degradation of inhibitor of B- and translocation of NF-B into nuclei, indicating the activation of NF-B. Intriguingly, NF-B activity was essential for H2ABbd-induced apoptosis. H2ABbd overexpression resulted in DNA damage after release from G(1)/S, progressed through the S phase slowly, and induced apoptosis. Furthermore, gene expression microarray analysis revealed that expression of H2ABbd activates groups of genes involved in apoptosis and postmeiotic germ cell development, suggesting that H2ABbd might influence transcription. Taken together, our data suggest that H2ABbd may contribute to specific chromatin structures and promote NF-B activation, which could in turn induce apoptosis in mammalian cells.	[Goshima, Takahiro; Shimada, Midori; Matsuo, Hiromi; Misaki, Toshinori; Johmura, Yoshikazu; Murata, Kazuhiro; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Sharif, Jafar; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci IMS, Dev Genet Grp, Yokohama, Kanagawa 2300045, Japan	Nagoya City University; RIKEN	Shimada, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	midorism@med.nagoya-cu.ac.jp; mkt-naka@med.nagoya-cu.ac.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854; Goshima, Takahiro/0000-0002-9284-2584	NEXT program [LS105]; Naito Foundation; Grants-in-Aid for Scientific Research [24659137] Funding Source: KAKEN	NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the NEXT program (LS105) and the Naito Foundation (to M. S.).	Angelov D, 2004, EMBO J, V23, P3815, DOI 10.1038/sj.emboj.7600400; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Gu CH, 2010, GENOMICS, V95, P278, DOI 10.1016/j.ygeno.2010.02.005; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Ioudinkova ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047157; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Montel F, 2007, BIOPHYS J, V93, P566, DOI 10.1529/biophysj.107.105569; Nowsheen S., 2012, Experimental Oncology, V34, P243; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Shimada M, 2010, EMBO REP, V11, P883, DOI 10.1038/embor.2010.152; Soboleva TA, 2012, NAT STRUCT MOL BIOL, V19, P25, DOI 10.1038/nsmb.2161; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	25	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11656	11666		10.1074/jbc.M113.541664	http://dx.doi.org/10.1074/jbc.M113.541664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24584930	hybrid, Green Published			2022-12-25	WOS:000335010600009
J	Zheng, ZQ; Keifer, J				Zheng, Zhaoqing; Keifer, Joyce			Sequential Delivery of Synaptic GluA1-and GluA4-containing AMPA Receptors ( AMPARs) by SAP97 Anchored Protein Complexes in Classical Conditioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Confocal Microscopy; Glutamate Receptors Ionotropic (AMPA; NMDA); Neuroscience; Protein Targeting; Signal Transduction	LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; PHOSPHORYLATION; TRAFFICKING; SUBUNIT; GLUR1; STARGAZIN; PLASTICITY; REQUIRES; MEMORY	Background: Subunit-specific synaptic delivery of AMPARs during associative learning is not well characterized. Results: SAP97-AKAP/PKA-GluA1 followed by SAP97-KSR1/PKC-GluA4 complexes function for surface delivery of AMPARs. Conclusion: SAP97 interacts with AKAP and KSR1 proteins to coordinate the sequential synaptic delivery of AMPAR subunits during in vitro classical conditioning. Significance: A cooperative interaction of multiple scaffolding proteins selectively delivers AMPARs to synapses during conditioning. Multiple signaling pathways are involved in AMPAR trafficking to synapses during synaptic plasticity and learning. The mechanisms for how these pathways are coordinated in parallel but maintain their functional specificity involves subcellular compartmentalization of kinase function by scaffolding proteins, but how this is accomplished is not well understood. Here, we focused on characterizing the molecular machinery that functions in the sequential synaptic delivery of GluA1- and GluA4-containing AMPARs using an in vitro model of eyeblink classical conditioning. We show that conditioning induces the interaction of selective protein complexes with the key structural protein SAP97, which tightly regulates the synaptic delivery of GluA1 and GluA4 AMPAR subunits. The results demonstrate that in the early stages of conditioning the initial activation of PKA stimulates the formation of a SAP97-AKAP/PKA-GluA1 protein complex leading to synaptic delivery of GluA1-containing AMPARs through a SAP97-PSD95 interaction. This is followed shortly thereafter by generation of a SAP97-KSR1/PKC-GluA4 complex for GluA4 AMPAR subunit delivery again through a SAP97-PSD95 interaction. These data suggest that SAP97 forms the molecular backbone of a protein scaffold critical for delivery of AMPARs to the PSD during conditioning. Together, the findings reveal a cooperative interaction of multiple scaffolding proteins for appropriately timed delivery of subunit-specific AMPARs to synapses and support a sequential two-stage model of AMPAR synaptic delivery during classical conditioning.	[Zheng, Zhaoqing; Keifer, Joyce] Univ S Dakota, Neurosci Grp, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA	University of South Dakota	Keifer, J (corresponding author), Univ S Dakota, Neurosci Grp, Sanford Sch Med, 414 E Clark St, Vermillion, SD 57069 USA.	jkeifer@usd.edu		Keifer, Joyce/0000-0002-5900-0414	National Institutes of Health [NS051187]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS051187 (to J.K.).	Anderson CW, 1999, J NEUROPHYSIOL, V81, P1242, DOI 10.1152/jn.1999.81.3.1242; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Keifer J, 2010, EUR J NEUROSCI, V32, P269, DOI 10.1111/j.1460-9568.2010.07339.x; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Nie T, 2007, J NEUROSCI, V27, P10278, DOI 10.1523/JNEUROSCI.1602-07.2007; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zheng Z, 2008, NEUROSCIENCE, V156, P872, DOI 10.1016/j.neuroscience.2008.08.042; Zheng ZQ, 2012, J NEUROPHYSIOL, V108, P101, DOI 10.1152/jn.01097.2011; Zheng ZQ, 2009, J NEUROPHYSIOL, V101, P2539, DOI 10.1152/jn.91282.2008	26	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10540	10550		10.1074/jbc.M113.535179	http://dx.doi.org/10.1074/jbc.M113.535179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567325	Green Published, hybrid			2022-12-25	WOS:000334226400027
J	Nakamura, Y; Hasebe, A; Takahashi, K; Iijima, M; Yoshimoto, N; Maturana, AD; Ting, K; Kuroda, S; Niimi, T				Nakamura, Yoko; Hasebe, Ai; Takahashi, Kaneyoshi; Iijima, Masumi; Yoshimoto, Nobuo; Maturana, Andres D.; Ting, Kang; Kuroda, Shun'ichi; Niimi, Tomoaki			Oligomerization-induced Conformational Change in the C-terminal Region of Nel-like Molecule 1 (NELL1) Protein Is Necessary for the Efficient Mediation of Murine MC3T3-E1 Cell Adhesion and Spreading*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Disulfide; Extracellular Matrix; Osteoblasts; Protein Conformation	IN-VIVO; INTEGRIN; CRANIOSYNOSTOSIS; DIFFERENTIATION; EXPRESSION; THROMBOSPONDIN-1; LAMININ-10/11; REGENERATION; INVOLVEMENT; ECHISTATIN	Background: NELL1, an oligomeric glycoprotein, is an osteoinductive factor. Results: The C-terminal cysteine-rich region of NELL1 has cell-binding activity. Intermolecular, but not intramolecular, disulfide bonding is important for the oligomerization and cell adhesion activity of NELL1. Conclusion: NELL1 requires oligomerization-induced conformational change for efficient mediation of cell adhesion and spreading. Significance: The structural basis of NELL1-mediated cell adhesion is identified. NELL1 is a large oligomeric secretory glycoprotein that functions as an osteoinductive factor. NELL1 contains several conserved domains, has structural similarities to thrombospondin 1, and supports osteoblastic cell adhesion through integrins. To define the structural requirements for NELL1-mediated cell adhesion, we prepared a series of recombinant NELL1 proteins (intact, deleted, and cysteine-mutant) from a mammalian expression system and tested their activities. A deletion analysis demonstrated that the C-terminal cysteine-rich region of NELL1 is critical for the cell adhesion activity of NELL1. Reducing agent treatment decreased the cell adhesion activity of full-length NELL1 but not of its C-terminal fragments, suggesting that the intramolecular disulfide bonds within this region are not functionally necessary but that other disulfide linkages in the N-terminal region of NELL1 may be involved in cell adhesion activity. By replacing cysteine residues with serines around the coiled-coil domain of NELL1, which is responsible for oligomerization, we created a mutant NELL1 protein that was unable to form homo-oligomers, and this monomeric mutant showed substantially lower cell adhesion activity than intact NELL1. These results suggest that an oligomerization-induced conformational change in the C-terminal region of NELL1 is important for the efficient mediation of cell adhesion and spreading by NELL1.	[Nakamura, Yoko; Hasebe, Ai; Takahashi, Kaneyoshi; Iijima, Masumi; Yoshimoto, Nobuo; Maturana, Andres D.; Kuroda, Shun'ichi; Niimi, Tomoaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90095 USA	Nagoya University; University of California System; University of California Los Angeles	Kuroda, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	skuroda@agr.nagoya-u.ac.jp; tniimi@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23510255]; Grants-in-Aid for Scientific Research [25870310] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research 23510255.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210; Aghaloo T, 2010, J ORAL MAXIL SURG, V68, P300, DOI 10.1016/j.joms.2009.03.066; Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Anilkumar N, 2002, J CELL SCI, V115, P2357; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Cowan CM, 2007, J BONE MINER RES, V22, P918, DOI 10.1359/JBMR.070312; Cowan CM, 2006, BONE, V38, P48, DOI 10.1016/j.bone.2005.06.023; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hasebe A, 2012, FEBS LETT, V586, P2500, DOI 10.1016/j.febslet.2012.06.014; Hasebe A, 2012, MOL BIOTECHNOL, V51, P58, DOI 10.1007/s12033-011-9440-4; HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012; Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x; James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P752, DOI 10.1006/bbrc.1999.1753; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lu SS, 2007, SPINE J, V7, P50, DOI 10.1016/j.spinee.2006.04.020; Maeda K, 2001, NEUROL MED-CHIR, V41, P582, DOI 10.2176/nmc.41.582; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/00001756-200403010-00007; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; Nakamura R, 2012, J BIOL CHEM, V287, P3282, DOI 10.1074/jbc.M111.281485; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Phan HP, 2009, PROTEIN EXPRES PURIF, V68, P79, DOI 10.1016/j.pep.2009.07.005; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Siu RK, 2012, TISSUE ENG PT A, V18, P252, DOI [10.1089/ten.tea.2011.0142, 10.1089/ten.TEA.2011.0142]; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Xue J, 2011, BONE, V48, P485, DOI 10.1016/j.bone.2010.10.166; Yamada T, 1996, FEBS LETT, V387, P11, DOI 10.1016/0014-5793(96)00409-7; Zhang X, 2010, J DENT RES, V89, P865, DOI 10.1177/0022034510376401; Zhang XL, 2012, J CRANIOFAC SURG, V23, P61, DOI 10.1097/SCS.0b013e318240c8c4; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375; Zhang XL, 2003, J BONE MINER RES, V18, P2126, DOI 10.1359/jbmr.2003.18.12.2126; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	45	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9781	9794		10.1074/jbc.M113.507020	http://dx.doi.org/10.1074/jbc.M113.507020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563467	hybrid, Green Published			2022-12-25	WOS:000333807000029
J	Herrera-Molina, R; Sarto-Jackson, I; Montenegro-Venegas, C; Heine, M; Smalla, KH; Seidenbecher, CI; Beesley, PW; Gundelfinger, ED; Montag, D				Herrera-Molina, Rodrigo; Sarto-Jackson, Isabella; Montenegro-Venegas, Carolina; Heine, Martin; Smalla, Karl-Heinz; Seidenbecher, Constanze I.; Beesley, Philip W.; Gundelfinger, Eckart D.; Montag, Dirk			Structure of Excitatory Synapses and GABAA Receptor Localization at Inhibitory Synapses Are Regulated by Neuroplastin-65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; GABA Receptors; Neurons; Synapses; Synaptic Plasticity; Cell Adhesion Molecule CAM; Ig-superfamily; Neuroplastin; Synapse Formation and Maintenance	LONG-TERM POTENTIATION; CELL-ADHESION MOLECULE; SYNAPTIC GLYCOPROTEIN NEUROPLASTIN; HIPPOCAMPAL; NEURONS; NEUROLIGIN-1; TRANSMITTER; RECRUITMENT; ACTIVATION; MECHANISMS	Background: Synaptic excitatory to inhibitory ratio is crucial for brain function but its regulation is poorly understood. Results: The cell adhesion molecule neuroplastin-65 regulates contact and stability of excitatory synapses and localization of GABA(A)R 2 subunits at inhibitory synapses. Conclusion: Neuroplastin-65 mediates specific neuronal connections and regulates the number and function of synapses in hippocampal neurons. Significance: Correct neuronal network activity in specific brain regions may depend on neuroplastin-65. Formation, maintenance, and activity of excitatory and inhibitory synapses are essential for neuronal network function. Cell adhesion molecules (CAMs) are crucially involved in these processes. The CAM neuroplastin-65 (Np65) highly expressed during periods of synapse formation and stabilization is present at the pre- and postsynaptic membranes. Np65 can translocate into synapses in response to electrical stimulation and it interacts with subtypes of GABA(A) receptors in inhibitory synapses. Here, we report that in the murine hippocampus and in hippocampal primary culture, neurons of the CA1 region and the dentate gyrus (DG) express high Np65 levels, whereas expression in CA3 neurons is lower. In neuroplastin-deficient (Np-/-) mice the number of excitatory synapses in CA1 and DG, but not CA3 regions is reduced. Notably this picture is mirrored in mature Np-/- hippocampal cultures or in mature CA1 and DG wild-type (Np+/+) neurons treated with a function-blocking recombinant Np65-Fc extracellular fragment. Although the number of GABAergic synapses was unchanged in Np-/- neurons or in mature Np65-Fc-treated Np+/+ neurons, the ratio of excitatory to inhibitory synapses was significantly lower in Np-/- cultures. Furthermore, GABA(A) receptor composition was altered at inhibitory synapses in Np-/- neurons as the 1 to 2 GABA(A) receptor subunit ratio was increased. Changes of excitatory and inhibitory synaptic function in Np-/- neurons were confirmed evaluating the presynaptic release function and using patch clamp recording. These data demonstrate that Np65 is an important regulator of the number and function of synapses in the hippocampus.	[Herrera-Molina, Rodrigo; Montenegro-Venegas, Carolina; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.] Otto Von Guericke Univ, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Herrera-Molina, Rodrigo; Smalla, Karl-Heinz] Otto Von Guericke Univ, Special Lab Mol Biol Techn, D-39118 Magdeburg, Germany; [Heine, Martin] Otto Von Guericke Univ, Res Grp Mol Physiol, D-39118 Magdeburg, Germany; [Montag, Dirk] Otto Von Guericke Univ, Neurogenet Special Lab, Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; [Smalla, Karl-Heinz; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.] Otto Von Guericke Univ, CBBS, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Otto Von Guericke Univ, Fac Med, D-39118 Magdeburg, Germany; [Sarto-Jackson, Isabella] Med Univ Vienna, Dept Biochem & Mol Biol Nervous Syst, Ctr Brain Res, A-1090 Vienna, Austria; [Beesley, Philip W.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Herrera-Molina, Rodrigo] Univ Chile, Programa Biol Celular & Mol, Inst Ciencias Biomed, Fac Med, Independencia Santiago 8380453, Chile	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Medical University of Vienna; University of London; Royal Holloway University London; Universidad de Chile	Montag, D (corresponding author), Leibniz Inst Neurobiol, Brenneckestr 6, D-39118 Magdeburg, Germany.	montag@LIN-magdeburg.de	Smalla, Dr. Karl-Heinz/C-3950-2012; Montag, Dirk/D-3925-2014; Herrera-Molina, Rodrigo/GLU-3904-2022	Smalla, Dr. Karl-Heinz/0000-0002-0269-0311; Montag, Dirk/0000-0002-4964-1330; Seidenbecher, Constanze/0000-0002-7433-2716	Deutsche Forschungsgemeinschaft [SFB426, SFB779, GRK1167, GU 230/6-1, SM38/8-1]; COST action ECMNet; Federal State of Saxony-Anhalt; European Regional Development Fund [ERDF 2007-2013]; Center for Dynamic Systems at the Otto von Guericke University Magdeburg; Deutscher Akademischer Austauschdienst; ERANET-Neuron/BMBF AMRePACELL; Land Sachsen-Anhalt Research Group Molecular Physiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); COST action ECMNet(European Cooperation in Science and Technology (COST)); Federal State of Saxony-Anhalt; European Regional Development Fund(European Commission); Center for Dynamic Systems at the Otto von Guericke University Magdeburg; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); ERANET-Neuron/BMBF AMRePACELL; Land Sachsen-Anhalt Research Group Molecular Physiology	* This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB426, SFB779, GRK1167, GU 230/6-1, and SM38/8-1), the COST action ECMNet, the Federal State of Saxony-Anhalt, the "European Regional Development Fund" (ERDF 2007-2013), and the Center for Dynamic Systems at the Otto von Guericke University Magdeburg (to D. M., C. I. S., K-H. S., and E. D. G.).; <SUP>1</SUP> Supported by Deutscher Akademischer Austauschdienst.; <SUP>2</SUP> Supported by ERANET-Neuron/BMBF AMRePACELL.; <SUP>3</SUP> Supported by Land Sachsen-Anhalt Research Group Molecular Physiology.	Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bagri A, 2002, DEVELOPMENT, V129, P4249; BENARI Y, 1994, PROG BRAIN RES, V102, P261; Benson DL, 2012, CURR OPIN NEUROBIOL, V22, P397, DOI 10.1016/j.conb.2011.09.011; Boyken J, 2013, NEURON, V78, P285, DOI 10.1016/j.neuron.2013.02.027; Brussaard AB, 1997, NEURON, V19, P1103, DOI 10.1016/S0896-6273(00)80401-8; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Desrivieres S, 2015, MOL PSYCHIATR, V20, P263, DOI 10.1038/mp.2013.197; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Engin E, 2012, PHARMACOL THERAPEUT, V136, P142, DOI 10.1016/j.pharmthera.2012.08.006; Giannone G, 2013, CELL REP, V3, P1996, DOI 10.1016/j.celrep.2013.05.013; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Herrera-Molina R, 2012, J NEUROCHEM, V123, P113, DOI 10.1111/j.1471-4159.2012.07887.x; Herrera-Molina R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034295; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Kreutz MR, 2001, INVEST OPHTH VIS SCI, V42, P1907; Langnaese K, 1997, J BIOL CHEM, V272, P821, DOI 10.1074/jbc.272.2.821; Lauri SE, 1999, J NEUROSCI, V19, P1226; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; Lisman J, 2012, CURR OPIN NEUROBIOL, V22, P537, DOI 10.1016/j.conb.2011.10.018; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; Owczarek S, 2012, INT J BIOCHEM CELL B, V44, P1, DOI 10.1016/j.biocel.2011.10.006; Owczarek S, 2011, J NEUROCHEM, V117, P984, DOI 10.1111/j.1471-4159.2011.07269.x; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; Saito A, 2007, NEUROSCI LETT, V411, P168, DOI 10.1016/j.neulet.2006.08.042; Sakurai E, 1998, NEUROREPORT, V9, P881, DOI 10.1097/00001756-199803300-00022; Sarto-Jackson I, 2012, J BIOL CHEM, V287, P14201, DOI 10.1074/jbc.M111.293175; Schneider Gasser E. M., 2007, EUR J NEUROSCI, V25, P3287, DOI DOI 10.1111/J.1460-9568.2007.05558.X; Schobel SA, 2009, ARCH GEN PSYCHIAT, V66, P938, DOI 10.1001/archgenpsychiatry.2009.115; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Wouterlood FG, 2008, J NEUROSCI METH, V171, P296, DOI 10.1016/j.jneumeth.2008.03.014; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	53	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8973	8988		10.1074/jbc.M113.514992	http://dx.doi.org/10.1074/jbc.M113.514992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554721	Green Published, hybrid			2022-12-25	WOS:000333472100020
J	Stewart, SE; Kondos, SC; Matthews, AY; D'Angelo, ME; Dunstone, MA; Whisstock, JC; Trapani, JA; Bird, PI				Stewart, Sarah E.; Kondos, Stephanie C.; Matthews, Antony Y.; D'Angelo, Michael E.; Dunstone, Michelle A.; Whisstock, James C.; Trapani, Joseph A.; Bird, Phillip I.			The Perforin Pore Facilitates the Delivery of Cationic Cargos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Permeabilization; Cellular Immune Response; Natural Killer (NK) Cell; T Cell Biology; Granzyme; MACPF; Perforin; Pore; Streptolysin O	HUMAN GRANZYME-B; PLASMA-MEMBRANE-REPAIR; MOUSE GRANZYME; CYTOCHROME-C; KILLER-CELLS; 2-COMPONENT CYTOLYSIN; CRYSTAL-STRUCTURE; STREPTOLYSIN-O; PROTEIN; TRANSLOCATION	Background: Perforin is a pore-forming protein that delivers granzymes to eliminate compromised cells. Results: The perforin pore preferentially delivers cationic molecules in comparison to anionic or neutrally charged cargo, which are inefficiently delivered. Conclusion: Perforin delivers cationic cargos more efficiently than anionic or neutral cargos. Significance: This is the first report of charge-based discrimination by the perforin pore. Cytotoxic lymphocytes eliminate virally infected or neoplastic cells through the action of cytotoxic proteases (granzymes). The pore-forming protein perforin is essential for delivery of granzymes into the cytoplasm of target cells; however the mechanism of this delivery is incompletely understood. Perforin contains a membrane attack complex/perforin (MACPF) domain and oligomerizes to form an aqueous pore in the plasma membrane; therefore the simplest (and best supported) model suggests that granzymes passively diffuse through the perforin pore into the cytoplasm of the target cell. Here we demonstrate that perforin preferentially delivers cationic molecules while anionic and neutral cargoes are delivered inefficiently. Furthermore, another distantly related pore-forming MACPF protein, pleurotolysin (from the oyster mushroom), also favors the delivery of cationic molecules, and efficiently delivers human granzyme B. We propose that this facilitated diffusion is due to conserved features of oligomerized MACPF proteins, which may include an anionic lumen.	[Whisstock, James C.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Dunstone, Michelle A.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, East Melbourne, Vic 3002, Australia	Monash University; Monash University; Monash University; Peter Maccallum Cancer Center	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phil.bird@monash.edu	; Dunstone, Michelle/I-2895-2014	Trapani, Joseph/0000-0003-0983-1532; Whisstock, James/0000-0003-4200-5611; D'Angelo, Michael/0000-0001-9342-0132; Stewart, Sarah E/0000-0003-3712-9898; Dunstone, Michelle/0000-0002-6026-648X; Bird, Phillip/0000-0002-6695-606X	National Health and Medical Research Council (Australia)	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants (to P. I. B., J. C. W., and J. A. T.) from the National Health and Medical Research Council (Australia).	Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; Browne KA, 1999, MOL CELL BIOL, V19, P8604; CHAN SK, 1966, BIOCHEMISTRY-US, V5, P2586, DOI 10.1021/bi00872a016; CRIADO M, 1985, J IMMUNOL, V135, P4245; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Esposti MD, 2002, APOPTOSIS, V7, P433, DOI 10.1023/A:1020035124855; Estebanez-Perpina E, 2000, BIOL CHEM, V381, P1203, DOI 10.1515/BC.2000.148; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Gilbert RJC, 2013, CELL MOL LIFE SCI, V70, P2083, DOI 10.1007/s00018-012-1153-8; Granath KA., 1958, J COLLOID SCI, V13, P308; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kawasaki Y, 2000, J IMMUNOL, V164, P4641, DOI 10.4049/jimmunol.164.9.4641; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lopez JA, 2013, J IMMUNOL, V191, P2328, DOI 10.4049/jimmunol.1301205; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; MALMGREN L, 1978, BRAIN RES, V153, P477, DOI 10.1016/0006-8993(78)90333-5; MASSON D, 1985, J BIOL CHEM, V260, P9069; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PETERS R, 1990, EMBO J, V9, P2447, DOI 10.1002/j.1460-2075.1990.tb07421.x; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Richards DP, 1999, J CHROMATOGR A, V853, P21, DOI 10.1016/S0021-9673(99)00687-1; Rotonda J, 2001, CHEM BIOL, V8, P357, DOI 10.1016/S1074-5521(01)00018-7; Saini RV, 2011, J IMMUNOL, V186, P3497, DOI 10.4049/jimmunol.1003409; Sakurai N, 2004, BBA-GENE STRUCT EXPR, V1679, P65, DOI 10.1016/j.bbaexp.2004.05.002; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; Shi L, 2005, J IMMUNOL, V174, P5456, DOI 10.4049/jimmunol.174.9.5456; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; Stewart SE, 2012, METHODS MOL BIOL, V844, P251, DOI 10.1007/978-1-61779-527-5_18; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sun JR, 2004, J BIOL CHEM, V279, P16907, DOI 10.1074/jbc.M400563200; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Trapani JA, 1998, CELL DEATH DIFFER, V5, P488, DOI 10.1038/sj.cdd.4400373; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x; Wilkins MR, 1999, METH MOL B, V112, P531; Wu JR, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940576	60	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9172	9181		10.1074/jbc.M113.544890	http://dx.doi.org/10.1074/jbc.M113.544890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24558045	hybrid, Green Published			2022-12-25	WOS:000333472100036
J	Phelps, NBD; Mor, SK; Armien, AG; Batts, W; Goodwin, AE; Hopper, L; McCann, R; Ng, TFF; Puzach, C; Waltzek, TB; Delwart, E; Winton, J; Goyal, SM				Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Batts, William; Goodwin, Andrew E.; Hopper, Lacey; McCann, Rebekah; Ng, Terry Fei Fan; Puzach, Corey; Waltzek, Thomas B.; Delwart, Eric; Winton, James; Goyal, Sagar M.			Isolation and Molecular Characterization of a Novel Picornavirus from Baitfish in the USA	PLOS ONE			English	Article							VIRUS; PROTEIN; RNA; ECOLOGY; FAMILY; MEMBER; WILD	During both regulatory and routine surveillance sampling of baitfish from the states of Illinois, Minnesota, Montana, and Wisconsin, USA, isolates (n = 20) of a previously unknown picornavirus were obtained from kidney/spleen or entire viscera of fathead minnows (Pimephales promelas) and brassy minnows (Hybognathus hankinsoni). Following the appearance of a diffuse cytopathic effect, examination of cell culture supernatant by negative contrast electron microscopy revealed the presence of small, round virus particles (similar to 30-32 nm), with picornavirus-like morphology. Amplification and sequence analysis of viral RNA identified the agent as a novel member of the Picornaviridae family, tentatively named fathead minnow picornavirus (FHMPV). The full FHMPV genome consisted of 7834 nucleotides. Phylogenetic analysis based on 491 amino acid residues of the 3D gene showed 98.6% to 100% identity among the 20 isolates of FHMPV compared in this study while only 49.5% identity with its nearest neighbor, the bluegill picornavirus (BGPV) isolated from bluegill (Lepomis macrochirus). Based on complete polyprotein analysis, the FHMPV shared 58% (P1), 33% (P2) and 43% (P3) amino acid identities with BGPV and shared less than 40% amino acid identity with all other picornaviruses. Hence, we propose the creation of a new genus (Piscevirus) within the Picornaviridae family. The impact of FHMPV on the health of fish populations is unknown at present.	[Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Goyal, Sagar M.] Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA; [Phelps, Nicholas B. D.; Armien, Anibal G.; Goyal, Sagar M.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Batts, William; Winton, James] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Goodwin, Andrew E.] US Fish & Wildlife Serv, Portland, OR USA; [Hopper, Lacey] US Fish & Wildlife Serv, Bozeman Fish Hlth Ctr, Bozeman, MT USA; [McCann, Rebekah; Puzach, Corey] US Fish & Wildlife Serv, La Crosse Fish Hlth Ctr, Onalaska, WI USA; [Ng, Terry Fei Fan; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Ng, Terry Fei Fan; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Waltzek, Thomas B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; State University System of Florida; University of Florida	Phelps, NBD (corresponding author), Minnesota Vet Diagnost Lab, St Paul, MN 55108 USA.	phelp083@umn.edu	Waltzek, Thomas/AHD-3209-2022; Ng, Terry Fei Fan/H-5305-2019; Mor, Sunil Kumar/M-6325-2018	Ng, Terry Fei Fan/0000-0002-4815-8697; Mor, Sunil Kumar/0000-0002-1112-088X; Delwart, Eric/0000-0002-6296-4484; Waltzek, Thomas/0000-0001-6383-5978; Phelps, Nicholas/0000-0003-3116-860X				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; AMBROS V, 1978, J BIOL CHEM, V253, P5263; Barbknecht M, 2009, THESIS U WISCONSIN C; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Batts WN, 2012, J GEN VIROL, V93, P1247, DOI 10.1099/vir.0.041210-0; BLOCH B, 1991, DIS AQUAT ORGAN, V10, P65, DOI 10.3354/dao010065; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Drummond A., 2011, GENEIOUS V5 5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fichtner D, 2013, J VIROL, V87, P10895, DOI 10.1128/JVI.01094-13; Gaughan DJ, 2001, REV FISH BIOL FISHER, V11, P113, DOI 10.1023/A:1015255900836; Goodwin AE, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:TOEFV]2.0.CO;2; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gunderson JL, 2000, WHITE PAPER STATUS; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HEDRICK RP, 1991, CAN J FISH AQUAT SCI, V48, P99, DOI 10.1139/f91-014; Hedrick RP, 1996, REV SCI TECH OIE, V15, P523, DOI 10.20506/rst.15.2.938; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Iwanowicz LR, 2000, J FISH DIS, V23, P349, DOI 10.1046/j.1365-2761.2000.00245.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Kim R, 2011, J ADV RES, V2, P9, DOI 10.1016/j.jare.2010.05.007; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; LITVAK MK, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:EOFBUI>2.0.CO;2; McCann R, 2012, THESIS U WISCONSIN L; McEntire ME, 2003, J AQUAT ANIM HEALTH, V15, P257, DOI 10.1577/H03-046.1; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Nanda S, 2008, J VIROL METHODS, V152, P18, DOI 10.1016/j.jviromet.2008.06.007; OIE (World Organization for Animal Health), 2011, MAN DIAGN AQ AN; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, P1, DOI DOI 10.1093/NAR/G5R408; Sauvage V, 2012, J VIROL, V86, P10036, DOI 10.1128/JVI.00046-12; STANWAY G, 1994, J VIROL, V68, P8232, DOI 10.1128/JVI.68.12.8232-8238.1994; Stone N, 2001, USDA PUBLICATION, V120; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; USDA (United States Department of Agriculture), 2008, FED ORD PREV SPREAD; USDA (United States Department of Agriculture), 2006, AC02SP2 USDA; USFWS and AFS-FHS (U.S. Fish and Wildlife Service and American Fisheries Society-Fish Health Section), 2010, AFS FHS FHS BLUE BOO; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08	44	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87593	10.1371/journal.pone.0087593	http://dx.doi.org/10.1371/journal.pone.0087593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586283	Green Published, gold, Green Submitted			2022-12-25	WOS:000331717900012
J	Moussaoui, N; Braniste, V; Ait-Belgnaoui, A; Gabanou, M; Sekkal, S; Olier, M; Theodorou, V; Martin, PGP; Houdeau, E				Moussaoui, Nabila; Braniste, Viorica; Ait-Belgnaoui, Afifa; Gabanou, Melissa; Sekkal, Soraya; Olier, Maiwenn; Theodorou, Vassilia; Martin, Pascal G. P.; Houdeau, Eric			Changes in Intestinal Glucocorticoid Sensitivity in Early Life Shape the Risk of Epithelial Barrier Defect in Maternal-Deprived Rats	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; LONG-TERM ALTERATIONS; NECROTIZING ENTEROCOLITIS; BACTERIAL TRANSLOCATION; COLONIC PERMEABILITY; MUCOSAL BARRIER; IMMUNE-SYSTEM; STRESS; MATURATION; CELLS	Glucocorticoids (GC) contribute to human intestine ontogeny and accelerate gut barrier development in preparation to birth. Rat gut is immature at birth, and high intestinal GC sensitivity during the first two weeks of life resembles that of premature infants. This makes suckling rats a model to investigate postpartum impact of maternal separation (MS)-associated GC release in preterm babies, and whether GC sensitivity may shape MS effects in immature gut. A 4 hours-MS applied once at postnatal day (PND) 10 enhanced plasma corticosterone in male and female pups, increased by two times the total in vivo intestinal permeability (IP) to oral FITC-Dextran 4 kDa (FD4) immediately after the end of MS, and induced bacterial translocation (BT) to liver and spleen. Ussing chamber experiments demonstrated a 2-fold increase of permeability to FD4 in the colon immediately after the end of MS, but not in the ileum. Colonic permeability was not only increased for FD4 but also to intact horseradish peroxidase 44 kDa in MS pups. In vivo, the glucocorticoid receptor (GR) antagonist RU486 or ML7 blockade of myosin light chain kinase controlling epithelial cytoskeleton contraction prevented MS-induced IP increase to oral FD4 and BT. In addition, the GR agonist dexamethasone dose-dependently mimicked MS-increase of IP to oral FD4. In contrast, MS effects on IP to oral FD4 and BT were absent at PND20, a model for full-term infant, characterized by a marked drop of IP to FD4 in response to dexamethasone, and decreased GR expression in the colon only compared to PND10 pups. These results show that high intestinal GC responsiveness in a rat model of prematurity defines a vulnerable window for a post-delivery MS, evoking immediate disruption of epithelial integrity in the large intestine, and increasing susceptibility to macromolecule passage and bacteremia.	[Moussaoui, Nabila; Braniste, Viorica; Gabanou, Melissa; Houdeau, Eric] INRA, Res Ctr Food Toxicol Toxalim, F-31931 Toulouse, France; [Moussaoui, Nabila; Ait-Belgnaoui, Afifa; Sekkal, Soraya; Olier, Maiwenn; Theodorou, Vassilia; Martin, Pascal G. P.] INRA, Toxalim, F-31931 Toulouse, France; [Martin, Pascal G. P.] INRA, Toxalim, GeT TRiX Facil, F-31931 Toulouse, France	INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Houdeau, E (corresponding author), INRA, Toxalim UMR1331, 180 Chemin Tournefeuille,BP 93173, F-31027 Toulouse 3, France.	eric.houdeau@toulouse.inra.fr	Olier, Maïwenn/N-3383-2019; Martin, Pascal/K-8184-2019; Olier, Maïwenn/C-4971-2015	Olier, Maïwenn/0000-0001-7214-1134; Martin, Pascal/0000-0002-4271-658X; Olier, Maïwenn/0000-0001-7214-1134; Braniste, Viorica/0000-0003-1992-3609	Institut National de la Recherche Agronomique (INRA); Region Midi-Pyrenees	Institut National de la Recherche Agronomique (INRA); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie)	This work was supported by the Institut National de la Recherche Agronomique (INRA) and Grant from the Region Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; ARTURSSON P, 1990, J PHARM SCI, V79, P595, DOI 10.1002/jps.2600790710; Barreau F, 2008, GUT, V57, P582, DOI 10.1136/gut.2007.126680; Barreau F, 2004, GUT, V53, P501, DOI 10.1136/gut.2003.024174; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Braniste V, 2009, J PHYSIOL-LONDON, V587, P3317, DOI 10.1113/jphysiol.2009.169300; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Colome G, 2007, ACTA PAEDIATR, V96, P69, DOI 10.1111/j.1651-2227.2007.00030.x; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Dageville C, 2011, ARCH PEDIATRIE, V18, P994, DOI 10.1016/j.arcped.2011.06.007; Dong P, 2010, EARLY HUM DEV, V86, P51, DOI 10.1016/j.earlhumdev.2010.01.002; Flacking R, 2012, ACTA PAEDIATR, V101, P1032, DOI 10.1111/j.1651-2227.2012.02787.x; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gordon P V, 2001, J Perinatol, V21, P156, DOI 10.1038/sj.jp.7200520; HENNING SJ, 1975, J BIOL CHEM, V250, P2073; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Maayan-Metzger Ayala, 2004, J Perinatol, V24, P494, DOI 10.1038/sj.jp.7211135; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Maheshwari A, 2006, HEMATOL MEET REP, V2, P18; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Moore ER, 2012, COCHRANE DB SYST REV, V16; Morgan BE, 2011, BIOL PSYCHIAT, V70, P817, DOI 10.1016/j.biopsych.2011.06.018; Moriez R, 2007, SHOCK, V28, P118, DOI 10.1097/SHK.0b013e3180315ba9; Nanthakumar NN, 2005, AM J PHYSIOL-GASTR L, V288, pG85, DOI 10.1152/ajpgi.00169.2004; Nanthakumar NN, 2003, AM J PHYSIOL-REG I, V285, pR162, DOI 10.1152/ajpregu.00721.2001; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Oines E, 2012, PHYSIOL BEHAV, V105, P1058, DOI 10.1016/j.physbeh.2011.11.024; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Perez-Cano FJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/537310; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Puiman P, 2008, CURR OPIN CLIN NUTR, V11, P601, DOI 10.1097/MCO.0b013e32830b5b15; Quaroni A, 1999, AM J PHYSIOL-GASTR L, V277, pG1027, DOI 10.1152/ajpgi.1999.277.5.G1027; Schmidt M, 2004, J NEUROENDOCRINOL, V16, P52, DOI 10.1111/j.1365-2826.2004.01123.x; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; UDALL JN, 1981, PEDIATR RES, V15, P241, DOI 10.1203/00006450-198103000-00008; Urao M, 1996, J PEDIATR SURG, V31, P1482, DOI 10.1016/S0022-3468(96)90160-8; VANELBURG RM, 1992, SCAND J GASTROENTERO, V27, P19, DOI 10.3109/00365529209096021; Vazquez DM, 1998, PSYCHONEUROENDOCRINO, V23, P663; Wagner CL, 2008, CLIN REV ALLERG IMMU, V34, P191, DOI 10.1007/s12016-007-8032-3; WEAVER LT, 1984, ARCH DIS CHILD, V59, P236, DOI 10.1136/adc.59.3.236; Yajima M, 2001, J PEDIATR GASTR NUTR, V33, P592, DOI 10.1097/00005176-200111000-00015; Zeuthen LH, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-2; Zheng G, 2013, NEUROGASTROENT MOTIL, V25, pE127, DOI 10.1111/nmo.12066	51	56	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88382	10.1371/journal.pone.0088382	http://dx.doi.org/10.1371/journal.pone.0088382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586321	Green Published, Green Submitted, gold			2022-12-25	WOS:000331714700016
J	Pearce, B; Crichton, S; Mackiewicz, M; Finlayson, GD; Hurlbert, A				Pearce, Bradley; Crichton, Stuart; Mackiewicz, Michal; Finlayson, Graham D.; Hurlbert, Anya			Chromatic Illumination Discrimination Ability Reveals that Human Colour Constancy Is Optimised for Blue Daylight Illuminations	PLOS ONE			English	Article							NATURAL IMAGES; CONE-EXCITATION; STATISTICS; ARTICULATION; ADAPTATION; VISION; MECHANISMS; FOLIAGE; SCENES	The phenomenon of colour constancy in human visual perception keeps surface colours constant, despite changes in their reflected light due to changing illumination. Although colour constancy has evolved under a constrained subset of illuminations, it is unknown whether its underlying mechanisms, thought to involve multiple components from retina to cortex, are optimised for particular environmental variations. Here we demonstrate a new method for investigating colour constancy using illumination matching in real scenes which, unlike previous methods using surface matching and simulated scenes, allows testing of multiple, real illuminations. We use real scenes consisting of solid familiar or unfamiliar objects against uniform or variegated backgrounds and compare discrimination performance for typical illuminations from the daylight chromaticity locus (approximately blue-yellow) and atypical spectra from an orthogonal locus (approximately red-green, at correlated colour temperature 6700 K), all produced in real time by a 10-channel LED illuminator. We find that discrimination of illumination changes is poorer along the daylight locus than the atypical locus, and is poorest particularly for bluer illumination changes, demonstrating conversely that surface colour constancy is best for blue daylight illuminations. Illumination discrimination is also enhanced, and therefore colour constancy diminished, for uniform backgrounds, irrespective of the object type. These results are not explained by statistical properties of the scene signal changes at the retinal level. We conclude that high-level mechanisms of colour constancy are biased for the blue daylight illuminations and variegated backgrounds to which the human visual system has typically been exposed.	[Pearce, Bradley; Crichton, Stuart; Hurlbert, Anya] Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mackiewicz, Michal; Finlayson, Graham D.] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England	Newcastle University - UK; University of East Anglia	Pearce, B (corresponding author), Newcastle Univ, Fac Med Sci, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	b.m.pearce@ncl.ac.uk		Mackiewicz, Michal/0000-0002-8777-8880; Hurlbert, Anya/0000-0002-9879-5758	Engineering and Physical Sciences Research Council (EPSRC) [EP/H022236/1]; EPSRC [EP/H022236/1, EP/H022325/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H022325/1, 980601, EP/H022236/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This project was part of a larger project funded by the Engineering and Physical Sciences Research Council (EPSRC), grant number: EP/H022236/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND L, 1986, J OPT SOC AM A, V3, P1743, DOI 10.1364/JOSAA.3.001743; Brainard DH, 2004, J VISION, V4, pII, DOI 10.1167/4.9.i; Brainard DH, 1998, J OPT SOC AM A, V15, P307, DOI 10.1364/JOSAA.15.000307; Cecchi GA, 2010, J VISION, V10, DOI 10.1167/10.11.21; CRAVEN BJ, 1992, VISION RES, V32, P1359, DOI 10.1016/0042-6989(92)90228-B; Danilova MV, 2010, J VISION, V10, DOI 10.1167/10.1.4; de Almeida VMN, 2010, PERCEPTION, V39, P770, DOI 10.1068/p6485; FEDERER CA, 1966, ECOLOGY, V47, P555, DOI 10.2307/1933932; Finlayson GD, 2005, J OPT SOC AM A, V22, P810, DOI 10.1364/JOSAA.22.000810; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; FOSTER DH, 1994, P ROY SOC B-BIOL SCI, V257, P115, DOI 10.1098/rspb.1994.0103; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Giesel M, 2009, J VISION, V9, DOI 10.1167/9.9.11; Granzier JJM, 2012, I-PERCEPTION, V3, P190, DOI 10.1068/i0461; Hernandez-Andres J, 2001, J OPT SOC AM A, V18, P1325, DOI 10.1364/JOSAA.18.001325; Hunt RWG, 1957, REPROD COLOUR; Hurlbert A., PERCEPTUAL CONSTANCY, V1998, P283; Hurlbert A, 2007, CURR BIOL, V17, pR906, DOI 10.1016/j.cub.2007.08.022; Kanematsu E, 2013, COLOR RES APPL, P1; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; KRAUSKOPF J, 1992, VISION RES, V32, P2165, DOI 10.1016/0042-6989(92)90077-V; LAND EH, 1959, P NATL ACAD SCI USA, V45, P115, DOI 10.1073/pnas.45.1.115; Linnell KJ, 2002, PERCEPTION, V31, P151, DOI 10.1068/p03sp; MacAdam DL, 1942, J OPT SOC AM, V32, P247, DOI 10.1364/JOSA.32.000247; Mackiewicz M, 2012, P 6 COL GRAPH IM VIS; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Maloney LT, 2002, PERCEPTION, V31, P135, DOI 10.1068/p12sp; McDermott KC, 2012, J OPT SOC AM A, V29, pA182, DOI 10.1364/JOSAA.29.00A182; Olkkonen M, 2008, J VISION, V8, DOI [10.1167/8.5.13, 10.1167/8.8.8]; Olkkonen M, 2009, J VISION, V9, DOI 10.1167/9.12.6; Parraga CA, 2000, CURR BIOL, V10, P35, DOI 10.1016/S0960-9822(99)00262-6; Parraga CA, 2005, VISION RES, V45, P3145, DOI 10.1016/j.visres.2005.08.006; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Schirillo JA, 1999, J OPT SOC AM A, V16, P793, DOI 10.1364/JOSAA.16.000793; Smithson HE, 2005, PHILOS T R SOC B, V360, P1329, DOI 10.1098/rstb.2005.1633; Sumner P, 2000, J EXP BIOL, V203, P1963; van Bommel W. J. M., 2004, Lighting Research & Technology, V36, P255, DOI 10.1191/1365782804li122oa; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Webster MA, 2007, NETWORK-COMP NEURAL, V18, P213, DOI 10.1080/09548980701654405; Werner A, 2000, VISION RES, V40, P1101, DOI 10.1016/S0042-6989(00)00012-2; WORTHEY JA, 1985, J OPT SOC AM A, V2, P1014, DOI 10.1364/JOSAA.2.001014; Wyszecki Gn, 1982, COLOR SCI CONCEPTS M, Vxv; Yang JN, 2001, VISION RES, V41, P2581, DOI 10.1016/S0042-6989(01)00143-2	44	63	63	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87989	10.1371/journal.pone.0087989	http://dx.doi.org/10.1371/journal.pone.0087989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586299	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000331711900021
J	Jiang, JL; Wang, XR; Shan, ZJ; Yang, LY; Zhou, JY; Bu, YQ				Jiang, Jinlin; Wang, Xiaorong; Shan, Zhengjun; Yang, Liuyan; Zhou, Junying; Bu, Yuanqin			Proteomic Analysis of Hepatic Tissue of Cyprinus carpio L. Exposed to Cyanobacterial Blooms in Lake Taihu, China	PLOS ONE			English	Article							FRESH-WATER FISH; MICROCYSTIN-LR; OXIDATIVE STRESS; CARASSIUS-AURATUS; AQUATIC ORGANISMS; RAT HEPATOCYTES; SILVER CARP; BIOACCUMULATION; PEROXIREDOXIN; CELLS	With the rapid development of industry and agriculture and associated pollution, the cyanobacterial blooms in Lake Taihu have become a major threat to aquatic wildlife and human health. In this study, the ecotoxicological effects of cyanobacterial blooms on cage-cultured carp (Cyprinus carpio L.) in Meiliang Bay of Lake Taihu were investigated. Microcystins (MCs), major cyanobacterial toxins, have been detected in carp cultured at different experimental sites of Meiliang Bay. We observed that the accumulation of MCs in carp was closely associated with several environmental factors, including temperature, pH value, and density of cyanobacterial blooms. The proteomic profile of carp liver exposed to cyanobacterial blooms was analyzed using two-dimensional difference in-gel electrophoresis (2D-DIGE) and mass spectrometry. The toxic effects of cyanobacterial blooms on carp liver were similar to changes caused by MCs. MCs were transported into liver cells and induced the excessive production of reactive oxygen species (ROS). MCs and ROS inhibited protein phosphatase and aldehyde dehydrogenase (ALDH), directly or indirectly resulting in oxidative stress and disruption of the cytoskeleton. These effects further interfered with metabolic pathways in the liver through the regulation of series of related proteins. The results of this study indicated that cyanobacterial blooms pose a major threat to aquatic wildlife in Meiliang Bay in Lake Taihu. These results provided evidence of the molecular mechanisms underlying liver damage in carp exposed to cyanobacterial blooms.	[Jiang, Jinlin; Shan, Zhengjun; Zhou, Junying; Bu, Yuanqin] Nanjing Inst Environm Sci, Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaorong; Yang, Liuyan] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Jiang, JL (corresponding author), Nanjing Inst Environm Sci, Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China.	jjl@nies.org; ekxr@nju.edu.cn	wang, xiao/HGB-7081-2022; yang, liu/GVU-8760-2022; Jiang, Jinlin/GQB-2974-2022; liu, yang/HHY-8583-2022	wang, xiao/0000-0002-4088-3341; 	Special Funds of the National Natural Science Foundation of China [31340017]; National Basic Research Program of China [2008CB418102]	Special Funds of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research was financially supported by the Special Funds of the National Natural Science Foundation of China (Grant number 31340017) and the National Basic Research Program of China (Grant number 2008CB418102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 1995, STANDARD METHODS EXA; Aranda-Rodriguez R, 2005, ENVIRON TOXICOL, V20, P390, DOI 10.1002/tox.20116; Behnisch PA, 2001, ENVIRON INT, V27, P441, DOI 10.1016/S0160-4120(01)00114-3; Blaha L, 2004, ACTA VET BRNO, V73, P477, DOI 10.2754/avb200473040477; Chen YM, 2006, TOXICON, V47, P742, DOI 10.1016/j.toxicon.2006.01.026; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Cossu C, 2000, ECOTOX ENVIRON SAFE, V45, P106, DOI 10.1006/eesa.1999.1842; de Magalhaes VF, 2001, TOXICON, V39, P1077; Dietrich D, 2005, TOXICOL APPL PHARM, V203, P273, DOI 10.1016/j.taap.2004.09.005; Ding WX, 2000, HEPATOLOGY, V32, P547, DOI 10.1053/jhep.2000.16183; Ding WX, 2003, FEMS MICROBIOL LETT, V220, P1, DOI 10.1016/S0378-1097(03)00100-9; Harford J. B., 1997, POSTTRANSCRIPTIONAL; Jiang JL, 2012, COMP BIOCHEM PHYS C, V155, P483, DOI 10.1016/j.cbpc.2011.12.008; Jiang JL, 2011, ECOTOXICOLOGY, V20, P1000, DOI 10.1007/s10646-011-0646-9; Jiang JL, 2011, J HAZARD MATER, V190, P188, DOI 10.1016/j.jhazmat.2011.03.023; KACZMAREK MJ, 1977, CLIN CHIM ACTA, V79, P69, DOI 10.1016/0009-8981(77)90462-4; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kopp R, 2009, AQUAC RES, V40, P1683, DOI 10.1111/j.1365-2109.2009.02285.x; Li L, 2008, THESCIENTIFICWORLDJO, V8, P121, DOI 10.1100/tsw.2008.32; Li XY, 2005, COMP BIOCHEM PHYS C, V141, P292, DOI 10.1016/j.cca.2005.07.004; Li XY, 2003, TOXICON, V42, P85, DOI 10.1016/S0041-0101(03)00104-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Luo Y, 2005, ENVIRON TOXICOL CHEM, V24, P2145, DOI 10.1897/04-640R.1; Magalhaes VF, 2003, TOXICON, V42, P289, DOI 10.1016/S0041-0101(03)00144-2; Malbrouck C, 2003, COMP BIOCHEM PHYS C, V135, P39, DOI 10.1016/S1532-0456(03)00047-4; Malecot M, 2009, AQUAT TOXICOL, V94, P153, DOI 10.1016/j.aquatox.2009.06.012; Mezhoud K, 2008, TOXICON, V51, P1431, DOI 10.1016/j.toxicon.2008.03.017; Ministry of Environmental Protection of the People's Republic of China, 2002, STANDARD METHODS EXA; Park SH, 2000, CLIN CANCER RES, V6, P4915; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220, DOI 10.1046/j.1432-1327.2000.01345.x; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Runnegar M, 1997, HEPATOLOGY, V26, P176; Snape JR, 2004, AQUAT TOXICOL, V67, P143, DOI 10.1016/j.aquatox.2003.11.011; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Wang H, 2013, RES VET SCI, V95, P1125, DOI 10.1016/j.rvsc.2013.07.022; Wang MH, 2010, TOXICOL SCI, V113, P60, DOI 10.1093/toxsci/kfp248; [王晓蓉 WANG Xiaorong], 2006, [环境化学, Environmental Chemistry], V25, P320; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; [吴庆龙 WU Qinglong], 2008, [地球科学进展, Advance in Earth Sciences], V23, P1115; Xie LQ, 2007, TOXICON, V49, P646, DOI 10.1016/j.toxicon.2006.11.004; Xie LQ, 2005, ENVIRON TOXICOL, V20, P293, DOI 10.1002/tox.20120; Xie LQ, 2004, ENVIRON POLLUT, V127, P431, DOI 10.1016/j.envpol.2003.08.011; Zeng J, 2009, WORLD J MICROB BIOT, V25, P225, DOI 10.1007/s11274-008-9883-3	46	14	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88211	10.1371/journal.pone.0088211	http://dx.doi.org/10.1371/journal.pone.0088211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558380	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700026
J	Mir, M; Bergamaschi, A; Katzenellenbogen, BS; Popescu, G				Mir, Mustafa; Bergamaschi, Anna; Katzenellenbogen, Benita S.; Popescu, Gabriel			Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CYCLE PROGRESSION; GENE-EXPRESSION; C-MYC; PROLIFERATION; ANTIESTROGEN; ACTIVATION; MCF-7; ASSAY; LINE	The detection and treatment of cancer has advanced significantly in the past several decades, with important improvements in our understanding of the fundamental molecular and genetic basis of the disease. Despite these advancements, drug-screening methodologies have remained essentially unchanged since the introduction of the in vitro human cell line screen in 1990. Although the existing methods provide information on the overall effects of compounds on cell viability, they are restricted by bulk measurements, large sample sizes, and lack capability to measure proliferation kinetics at the individual cell level. To truly understand the nature of cancer cell proliferation and to develop personalized adjuvant therapies, there is a need for new methodologies that provide quantitative information to monitor the effect of drugs on cell growth as well as morphological and phenotypic changes at the single cell level. Here we show that a quantitative phase imaging modality known as spatial light interference microscopy (SLIM) addresses these needs and provides additional advantages over existing proliferation assays. We demonstrate these capabilities through measurements on the effects of the hormone estradiol and the antiestrogen ICI182,780 (Faslodex) on the growth of MCF-7 breast cancer cells. Along with providing information on changes in the overall growth, SLIM provides additional biologically relevant information. For example, we find that exposure to estradiol results in rapidly growing cells with lower dry mass than the control population. Subsequently blocking the estrogen receptor with ICI results in slower growing cells, with lower dry masses than the control. This ability to measure changes in growth kinetics in response to environmental conditions provides new insight on growth regulation mechanisms. Our results establish the capabilities of SLIM as an advanced drug screening technology that provides information on changes in proliferation kinetics at the cellular level with greater sensitivity than any existing method.	[Mir, Mustafa; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61801 USA; [Bergamaschi, Anna; Katzenellenbogen, Benita S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61801 USA.	gpopescu@illinois.edu		Mir, Mustafa/0000-0001-8280-2821	National Science Foundation (NSF) Grants: Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems CBET [0939511]; NSF [08-46660]; Breast Cancer Research Foundation; National Institutes of Health (NIH) [P50 AT006268]; Department of Defense [W81XWH-09-1-0398];  [CBET-1040461 MRI]; National Center for Complementary & Integrative Health [P50AT006268] Funding Source: NIH RePORTER	National Science Foundation (NSF) Grants: Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems CBET; NSF(National Science Foundation (NSF)); Breast Cancer Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (NSF) Grants: Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems CBET 0939511 (to G. P.), NSF CAREER 08-46660 (to G. P.), CBET-1040461 MRI (to G. P.), Breast Cancer Research Foundation (to B. S. K.), National Institutes of Health (NIH) P50 AT006268 (to B. S. K.), and a Postdoctoral Fellowship from the Department of Defense, W81XWH-09-1-0398 (to A. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Dalvai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011011; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; DRISCOLL JS, 1984, CANCER TREAT REP, V68, P63; DUBIK D, 1992, ONCOGENE, V7, P1587; Dunn GA, 1998, CELL BIOL LAB HDB; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Manual, 2013, WST 1 CELL PROL ASS; McGowan EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020623; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Obiorah I, 2011, MATURITAS, V70, P315, DOI 10.1016/j.maturitas.2011.09.006; Park K, 2010, P NAT ACAD SCI; PAULL KD, 1988, J HETEROCYCLIC CHEM, V25, P911, DOI 10.1002/jhet.5570250340; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Society AC, 2012, CANC FACTS FIG 2012; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Sridharan S, 2011, BIOMED OPT EXPRESS, V2, P2815, DOI 10.1364/BOE.2.002815; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Teicher BA, 2004, BRIT J CANCER, V91, P1977, DOI 10.1038/sj.bjc.6602286; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Wang Z, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304787	40	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89000	10.1371/journal.pone.0089000	http://dx.doi.org/10.1371/journal.pone.0089000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558461	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700107
J	Virk, J; Obel, C; Li, J; Olsen, J				Virk, Jasveer; Obel, Carsten; Li, Jiong; Olsen, Jorn			In-Utero Exposure to Bereavement and Offspring IQ: A Danish National Cohort Study	PLOS ONE			English	Article							MATERNAL ANTENATAL ANXIETY; CIVIL REGISTRATION SYSTEM; PRENATAL STRESS; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; BEHAVIOURAL/EMOTIONAL PROBLEMS; COGNITIVE-ABILITY; GESTATIONAL-AGE; BIRTH-WEIGHT; INTELLIGENCE; CHILDREN	Background: Intelligence is a life-long trait that has strong influences on lifestyle, adult morbidity and life expectancy. Hence, lower cognitive abilities are therefore of public health interest. Our primary aim was to examine if prenatal bereavement measured as exposure to death of a close family member is associated with the intelligence quotient (IQ) scores at 18-years of age of adult Danish males completing a military cognitive screening examination. Methods: We extracted records for the Danish military screening test and found kinship links with biological parents, siblings, and maternal grandparents using the Danish Civil Registration System (N = 167,900). The prenatal exposure period was defined as 12 months before conception until birth of the child. We categorized children as exposed in utero to severe stress (bereavement) during prenatal life if their mothers lost an elder child, husband, parent or sibling during the prenatal period; the remaining children were included in the unexposed cohort. Mean score estimates were adjusted for maternal and paternal age at birth, residence, income, maternal education, gestational age at birth and birth weight. Results: When exposure was due to death of a father the offsprings' mean IQ scores were lower among men completing the military recruitment exam compared to their unexposed counterparts, adjusted difference of 6.5 standard IQ points (p-value = 0.01). We did not observe a clinically significant association between exposure to prenatal maternal bereavement caused by death of a sibling, maternal uncle/aunt or maternal grandparent even after stratifying deaths only due to traumatic events. Conclusion: We found maternal bereavement to be adversely associated with IQ in male offspring, which could be related to prenatal stress exposure though more likely is due to changes in family conditions after death of the father. This finding supports other literature on maternal adversity during fetal life and cognitive development in the offspring.	[Virk, Jasveer] Univ Calif Los Angeles, Dept Epidemiol, UCLA Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Li, Jiong; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	University of California System; University of California Los Angeles; Aarhus University; Aarhus University	Virk, J (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, UCLA Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	jasvirk@ucla.edu	li, jiong/L-6534-2014; Olsen, Jørn/F-8801-2015; Obel, Carsten/H-9605-2016	li, jiong/0000-0002-1716-8067; Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0003-1125-026X; Obel, Carsten/0000-0001-5004-1933	Danish Medical Research Council [271-05-0616, 271-07-0437]; NordForsk [070331]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk	The study was supported by Danish Medical Research Council (projects no. 271-05-0616 and 271-07-0437), and NordForsk (070331). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PERS SOC PSYCHOL B, V38, P1157; Baibazarova E, 2013, PSYCHONEUROENDOCRINO, V38, P907, DOI 10.1016/j.psyneuen.2012.09.015; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; BROWN RW, 1993, ENDOCRINOLOGY, V132, P2614, DOI 10.1210/en.132.6.2614; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Eriksen W, 2010, AM J EPIDEMIOL, V172, P530, DOI 10.1093/aje/kwq199; Gutteling BM, 2005, EUR CHILD ADOLES PSY, V14, P41, DOI 10.1007/s00787-005-0435-1; HENRY C, 1994, J NEUROENDOCRINOL, V6, P341, DOI 10.1111/j.1365-2826.1994.tb00591.x; Huizink AC, 2004, PSYCHOL BULL, V130, P115, DOI 10.1037/0033-2909.130.1.115; Kaltman S, 2003, J ANXIETY DISORD, V17, P131, DOI 10.1016/S0887-6185(02)00184-6; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kilgour AHM, 2010, MATURITAS, V65, P98, DOI 10.1016/j.maturitas.2009.09.021; Kirkegaard I, 2006, PEDIATRICS, V118, P1600, DOI 10.1542/peds.2005-2700; Kristensen P BT, SCIENCE, V316, P1717; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Krozowski Z, 1999, MOL CELL ENDOCRINOL, V151, P121, DOI 10.1016/S0303-7207(98)00256-1; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Li J, 2008, EPILEPSY RES, V81, P52, DOI 10.1016/j.eplepsyres.2008.04.014; Li JO, 2010, EUR CHILD ADOLES PSY, V19, P747, DOI 10.1007/s00787-010-0113-9; Li J, 2009, PSYCHOSOM MED, V71, P615, DOI 10.1097/PSY.0b013e3181a56ca1; Li J, 2009, J AUTISM DEV DISORD, V39, P1047, DOI 10.1007/s10803-009-0717-4; Lohaugen GCC, 2013, J PEDIAT NULL, DOI DOI 10.1016/J.JPEDS.2013.01.060.ACCESSED; MORTENSEN EL, 1989, SCAND J PSYCHOL, V30, P315, DOI 10.1111/j.1467-9450.1989.tb01094.x; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Salaria S, 2006, NEUROBIOL DIS, V23, P630, DOI 10.1016/j.nbd.2006.05.003; Schneider ML, 1999, CHILD DEV, V70, P263, DOI 10.1111/1467-8624.00020; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; Sjostrom K, 1997, EUR J OBSTET GYN R B, V74, P149, DOI 10.1016/S0301-2115(97)00100-0; Staud F, 2006, PLACENTA, V27, P171, DOI 10.1016/j.placenta.2005.01.001; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	39	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88477	10.1371/journal.pone.0088477	http://dx.doi.org/10.1371/journal.pone.0088477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558394	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700040
J	Lu, W; Zhong, M; Chai, Q; Wang, ZS; Yu, LL; Wei, YA				Lu, Wei; Zhong, Meng; Chai, Qian; Wang, Zhaoshuai; Yu, Linliang; Wei, Yinan			Functional Relevance of AcrB Trimerization in Pump Assembly and Substrate Binding	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; ESCHERICHIA-COLI; TRANSPORTER ACRB; CRYSTAL-STRUCTURE; PERIPLASMIC DOMAIN; EXPORTER ACRB; RESISTANCE; SITE; REVEALS; COMPLEX	AcrB is a multidrug transporter in the inner membrane of Escherichia coli. It is an obligate homotrimer and forms a tripartite efflux complex with AcrA and TolC. AcrB is the engine of the efflux machinery and determines substrate specificity. Active efflux depends on several functional features including proton translocation across the inner membrane through a proton relay pathway in the transmembrane domain of AcrB; substrate binding and migration through the substrate translocation pathway; the interaction of AcrB with AcrA and TolC; and the formation of AcrB homotrimer. Here we investigated two aspects of the inter-correlation between these functional features, the dependence of AcrA-AcrB interaction on AcrB trimerization, and the reliance of substrate binding and penetration on protein-protein interaction. Interaction between AcrA and AcrB was investigated through chemical crosslinking, and a previously established in vivo fluorescent labeling method was used to probe substrate binding. Our data suggested that dissociation of the AcrB trimer drastically decreased its interaction with AcrA. In addition, while substrate binding with AcrB seemed to be irrelevant to the presence or absence of AcrA and TolC, the capability of trimerization and conduction of proton influx did affect substrate binding at selected sites along the substrate translocation pathway in AcrB.	[Lu, Wei; Zhong, Meng; Chai, Qian; Wang, Zhaoshuai; Yu, Linliang; Wei, Yinan] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Wei, YA (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	yinan.wei@uky.edu	Zhong, Meng/O-5070-2016	Wang, Zhaoshuai/0000-0002-5593-368X	National Science Foundation [MCB-1158036]; National Institute of Health [1R21AI103717-01]; Kentucky NASA EPSCoR program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103717] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky NASA EPSCoR program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Science Foundation (MCB-1158036, YW), National Institute of Health (1R21AI103717-01, YW), and Kentucky NASA EPSCoR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Das D, 2007, J STRUCT BIOL, V158, P494, DOI 10.1016/j.jsb.2006.12.004; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Feng ZW, 2012, MOL BIOSYST, V8, P2699, DOI 10.1039/c2mb25184a; Hearn EM, 2006, J BACTERIOL, V188, P115, DOI 10.1128/JB.188.1.115-123.2006; Husain F, 2011, J BACTERIOL, V193, P5847, DOI 10.1128/JB.05759-11; Husain F, 2010, MOL MICROBIOL, V78, P320, DOI 10.1111/j.1365-2958.2010.07330.x; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lu W, 2012, J MOL BIOL, V423, P123, DOI 10.1016/j.jmb.2012.06.036; Lu W, 2011, PROTEIN PEPTIDE LETT, V18, P863, DOI 10.2174/092986611796011446; Lu W, 2011, J MOL BIOL, V411, P264, DOI 10.1016/j.jmb.2011.05.042; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1998, CURR OPIN MICROBIOL, V1, P516, DOI 10.1016/S1369-5274(98)80083-0; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Schulz R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000806; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Takatsuka Y, 2007, J BACTERIOL, V189, P8677, DOI 10.1128/JB.01127-07; Takatsuka Y, 2006, J BACTERIOL, V188, P7284, DOI 10.1128/JB.00683-06; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Vargiu AV, 2012, P NATL ACAD SCI USA, V109, P20637, DOI 10.1073/pnas.1218348109; Veesler D, 2008, ACTA CRYSTALLOGR F, V64, P880, DOI 10.1107/S1744309108028248; Weeks JW, 2010, MOL MICROBIOL, V75, P1468, DOI 10.1111/j.1365-2958.2010.07068.x; Yu LL, 2013, BIOCHEMISTRY-US, V52, P6790, DOI 10.1021/bi400452v; Zgurskaya HI, 2000, J BACTERIOL, V182, P4264, DOI 10.1128/JB.182.15.4264-4267.2000	42	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89143	10.1371/journal.pone.0089143	http://dx.doi.org/10.1371/journal.pone.0089143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551234	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500100
J	Ziemlinska, E; Kugler, S; Schachner, M; Wewior, I; Czarkowska-Bauch, J; Skup, M				Ziemlinska, Ewelina; Kuegler, Sebastian; Schachner, Melitta; Wewior, Iwona; Czarkowska-Bauch, Julita; Skup, Malgorzata			Overexpression of BDNF Increases Excitability of the Lumbar Spinal Network and Leads to Robust Early Locomotor Recovery in Completely Spinalized Rats	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; VESICULAR GLUTAMATE TRANSPORTERS; KCL COTRANSPORTER KCC2; NEUROTROPHIC FACTOR; CORD TRANSECTION; AMINO-ACIDS; DOWN-REGULATION; SYNAPTIC PLASTICITY; TRANSMITTER SYSTEMS; GENE-EXPRESSION	Strategies to induce recovery from lesions of the spinal cord have not fully resulted in clinical applications. This is a consequence of a number of impediments that axons encounter when trying to regrow beyond the lesion site, and that intraspinal rearrangements are subjected to. In the present study we evaluated (1) the possibility to improve locomotor recovery after complete transection of the spinal cord by means of an adeno-associated (AAV) viral vector expressing the neurotrophin brain-derived neurotrophic factor (BDNF) in lumbar spinal neurons caudal to the lesion site and (2) how the spinal cord transection and BDNF treatment affected neurotransmission in the segments caudal to the lesion site. BDNF overexpression resulted in clear increases in expression levels of molecules involved in glutamatergic (VGluT2) and GABAergic (GABA, GAD65, GAD67) neurotransmission in parallel with a reduction of the potassium-chloride co-transporter (KCC2) which contributes to an inhibitory neurotransmission. BDNF treated animals showed significant improvements in assisted locomotor performance, and performed locomotor movements with body weight support and plantar foot placement on a moving treadmill. These positive effects of BDNF local overexpression were detectable as early as two weeks after spinal cord transection and viral vector application and lasted for at least 7 weeks. Gradually increasing frequencies of clonic movements at the end of the experiment attenuated the quality of treadmill walking. These data indicate that BDNF has the potential to enhance the functionality of isolated lumbar circuits, but also that BDNF levels have to be tightly controlled to prevent hyperexcitability.	[Ziemlinska, Ewelina; Wewior, Iwona; Czarkowska-Bauch, Julita; Skup, Malgorzata] Nencki Inst Expt Biol, Warsaw, Poland; [Kuegler, Sebastian] Univ Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Gottingen; Shantou University	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China.	mskup@nencki.gov.pl; schachner@stu.edu.ch	Czarkowska-Bauch, Julita/AAB-6872-2020	Ziemlinska, Ewelina/0000-0002-7602-3239; Skup, Malgorzata/0000-0002-2605-0124	Polish-German cooperation [S007/P-N/2007/01]; EMBO Short-Term Fellowship [ASTF 211.00.2007]; Bio-Imagine grant [264173]; Nencki Institute	Polish-German cooperation; EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO)); Bio-Imagine grant; Nencki Institute	This work was supported by a Polish-German cooperation grant (S007/P-N/2007/01), an EMBO Short-Term Fellowship to E. Ziemlinska (ASTF 211.00.2007), GA No 264173 Bio-Imagine grant and statutory funds for the Nencki Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Antri M, 2002, EUR J NEUROSCI, V16, P467, DOI 10.1046/j.1460-9568.2002.02088.x; Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bardoni R, 2007, DEV NEUROBIOL, V67, P960, DOI 10.1002/dneu.20401; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beaumont E, 2008, NEUROSCI RES, V62, P147, DOI 10.1016/j.neures.2008.07.003; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1972, DOI 10.1152/jn.2001.86.4.1972; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Blum R, 2002, NATURE, V419, P687, DOI 10.1038/nature01085; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caesar K, 2008, J CEREBR BLOOD F MET, V28, P906, DOI 10.1038/sj.jcbfm.9600581; Cantoria MJ, 2011, J NEUROSCI, V31, P18598, DOI 10.1523/JNEUROSCI.3499-11.2011; Cheung G, 2009, J PHYSIOL-LONDON, V587, P753, DOI 10.1113/jphysiol.2008.163923; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de Leon RD, 1999, J NEUROPHYSIOL, V82, P359, DOI 10.1152/jn.1999.82.1.359; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; Di Luca M, 2001, NEUROREPORT, V12, P1301, DOI 10.1097/00001756-200105080-00049; Diaz-Ruiz A, 2007, NEUROCHEM RES, V32, P57, DOI 10.1007/s11064-006-9225-5; Drinkut A, 2012, MOL THER, V20, P534, DOI 10.1038/mt.2011.249; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Frank L, 1997, EXP NEUROL, V145, P62, DOI 10.1006/exnr.1997.6440; Gajewska-Wozniak O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065937; Gazula VR, 2004, J COMP NEUROL, V476, P130, DOI 10.1002/cne.20204; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2004, J NEUROPHYSIOL, V92, P3423, DOI 10.1152/jn.00432.2004; Guidotti G, 2012, NEUROPSYCHOPHARMACOL, V37, P746, DOI 10.1038/npp.2011.252; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ichiyama RM, 2006, J COMP NEUROL, V499, P306, DOI 10.1002/cne.21110; Ichiyama RM, 2011, J NEUROSCI, V31, P26, DOI 10.1523/JNEUROSCI.6433-09.2011; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Joseph MS, 2012, NEUROSCIENCE, V224, P135, DOI 10.1016/j.neuroscience.2012.08.024; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Khristy W, 2009, BRAIN RES, V1273, P9, DOI 10.1016/j.brainres.2009.03.060; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kiehn O, 2010, BIOCHEM BIOPH RES CO, V396, P11, DOI 10.1016/j.bbrc.2010.02.107; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; Kitzman P, 2006, EXP NEUROL, V197, P407, DOI 10.1016/j.expneurol.2005.10.005; KOERBER HR, 1994, J NEUROSCI, V14, P3655; Kong XY, 2011, NEUROSCIENCE, V177, P114, DOI 10.1016/j.neuroscience.2010.12.062; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Krauss Gregory L., 2003, Epilepsy Curr, V3, P19, DOI 10.1046/j.1535-7597.2003.03107.x; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Kuhn SA, 2004, MOL CELL NEUROSCI, V25, P312, DOI 10.1016/j.mcn.2003.10.023; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Llewellyn-Smith IJ, 2007, J COMP NEUROL, V503, P741, DOI 10.1002/cne.21414; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Lu VB, 2012, J NEUROPHYSIOL; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Macias M, 2007, EUR J NEUROSCI, V25, P2425, DOI 10.1111/j.1460-9568.2007.05498.x; Macias M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-144; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; MCBRIDE WJ, 1984, J NEUROCHEM, V42, P1625, DOI 10.1111/j.1471-4159.1984.tb12752.x; MCBRIDE WJ, 1988, J NEUROCHEM, V50, P603, DOI 10.1111/j.1471-4159.1988.tb02953.x; Norreel JC, 2003, J NEUROSCI, V23, P1924; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Ornung G, 1996, J COMP NEUROL, V365, P413; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Reed WR, 2006, NEUROSCIENCE, V142, P1195, DOI 10.1016/j.neuroscience.2006.07.017; Ren LQ, 2013, NEUROSCIENCE, V236, P31, DOI 10.1016/j.neuroscience.2012.12.063; Rivera C, 2005, J PHYSIOL-LONDON, V562, P27, DOI 10.1113/jphysiol.2004.077495; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Roach JD, 2008, NEUROIMMUNOMODULAT, V15, P117, DOI 10.1159/000148194; ROBINSON GA, 1986, EXP BRAIN RES, V62, P387, DOI 10.1007/BF00238858; Rossignol S, 2004, CAN J PHYSIOL PHARM, V82, P617, DOI 10.1139/Y04-068; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Seidel J, 2007, STEM CELLS DEV, V16, P827, DOI 10.1089/scd.2007.0004; Shapiro S, 1997, NEUROSURGERY, V40, P168, DOI 10.1097/00006123-199701000-00037; Shevtsova Z, 2010, AM J PATHOL, V177, P271, DOI 10.2353/ajpath.2010.091267; Skup M, 2007, SPINAL CORD, V45, P140, DOI 10.1038/sj.sc.3101945; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Skup M, 2012, EUR J NEUROSCI; Skup M, 2011, ISN ESN 23 BIENN M A; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; Slack SE, 2004, EUR J NEUROSCI, V20, P1769, DOI 10.1111/j.1460-9568.2004.03656.x; Stil A, 2011, EUR J NEUROSCI, V33, P1212, DOI 10.1111/j.1460-9568.2010.07592.x; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Tan AM, 2012, J NEUROSCI, V32, P12896, DOI 10.1523/JNEUROSCI.6451-11.2012; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Tillakaratne NJK, 2000, J NEUROSCI RES, V60, P219, DOI 10.1002/(SICI)1097-4547(20000415)60:2<219::AID-JNR11>3.0.CO;2-F; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Todd AJ, 1996, J NEUROSCI, V16, P974; Toyoda H, 2003, J NEUROPHYSIOL, V89, P1353, DOI 10.1152/jn.00721.2002; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Wardle RA, 2003, J NEUROSCI, V23, P8722; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7; Wienecke J, 2010, J NEUROPHYSIOL, V103, P761, DOI 10.1152/jn.00609.2009; Wienecke J RL, 2012, NEUR M PLANN PROGR; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Ziemlinska E, 2008, 6 FOR EUR NEUR GEN S, V4; Ziemlinska E, 2010, NEUR M PLANN SAN DIE; Ziemlinska E, 2010, 7 FOR EUR NEUR AMST, V5	113	39	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88833	10.1371/journal.pone.0088833	http://dx.doi.org/10.1371/journal.pone.0088833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551172	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500072
J	Li, WJ; Zhao, JM; Zou, ZS; Liu, Y; Li, BS; Sun, Y; Li, XD; Liu, SH; Cai, SP; Yao, WM; Xin, SJ; Lu, FM; Xu, DP				Li, Weijie; Zhao, Jingmin; Zou, Zhengsheng; Liu, Yan; Li, Baosen; Sun, Ying; Li, Xiaodong; Liu, Shuhong; Cai, Shaoping; Yao, Weimin; Xin, Shaojie; Lu, Fengmin; Xu, Dongping			Analysis of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA and Serum Viral Markers in Treatment-Naive Patients with Acute and Chronic HBV Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN; NATURAL-HISTORY; REPLICATIVE ACTIVITY; LIVER-TISSUE; CCCDNA; QUANTITATION; PERSISTENCE; REDUCTION; DECLINE	Background: This study aimed to investigate the relationships of intrahepatic cccDNA with serum HBsAg and with HBV DNA in treatment-naive patients throughout acute and chronic HBV infection. Methods: A total of 120 patients who had a liver biopsy were enrolled, including 19 with acute hepatitis B (AHB), and 101 patients with chronic HBV infection (CHB) of whom were 10 in immune-tolerant (IT) phase, 59 in immune-clearance (IC) phase, 8 in low-replicative (LR) phase, and 24 in HBeAg-negative hepatitis (ENH) phase. Intrahepatic cccDNA, serum HBsAg and serum HBV DNA levels were comparatively analyzed. Results: The median intrahepatic cccDNA levels were 0.18 4.80, 3.81, 0.22 and 0.97 copies/cell for patients with AHB, CHB-IT, CHB-IC, CHB-LR, and CHB-ENH, respectively. In AHB patients, intrahepatic cccDNA was positively correlated with serum HBsAg (r = 0.665, P = 0.003), as well as serum HBV DNA (r = 0.536, P = 0.022). In CHB patients, intrahepatic cccDNA was positively correlated with serum HBsAg in the IC phase (r = 0.392, P = 0.005), and with serum HBV DNA in the IC phase (r = 0.301, P = 0.036) and ENH phase (r = 0.588, P = 0.013). HBV replicative efficiency, defined as the ratio of serum HBV DNA to intrahepatic cccDNA, was obviously lower in AHB and CHB-LR patients than in CHB-IT, CHB-IC and CHB-ENH patients (0.70 and 0.53 vs. 1.12, 1.09 and 0.99, P<0.001, values were logarithmic transformed for analysis). In CHB-IC patients, HBV replicative efficiency was positively correlated with histological activity index of liver inflammation (r = 0.308, P = 0.009). Conclusion: Serum HBsAg and HBV DNA levels may reflect the amount of active intrahepatic cccDNA in treatment-naive AHB and CHB-IC patients. Reduced intrahepatic cccDNA and HBV replicative efficiency may imply effective immune control of HBV infection.	[Li, Weijie; Lu, Fengmin; Xu, Dongping] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Li, Weijie; Zou, Zhengsheng; Liu, Yan; Li, Baosen; Sun, Ying; Li, Xiaodong; Cai, Shaoping; Yao, Weimin; Xin, Shaojie; Xu, Dongping] Beijing 302 Hosp, Inst Infect Dis, Beijing, Peoples R China; [Li, Weijie; Zou, Zhengsheng; Liu, Yan; Li, Baosen; Sun, Ying; Li, Xiaodong; Cai, Shaoping; Yao, Weimin; Xin, Shaojie; Xu, Dongping] Beijing 302 Hosp, Med Ctr Liver Failure, Beijing, Peoples R China; [Zhao, Jingmin; Liu, Shuhong] Beijing 302 Hosp, Dept Pathol, Beijing, Peoples R China	Peking University; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Lu, FM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China.	lu.fengmin@hsc.pku.edu.cn; xudongping302@sina.com			National Natural Science Foundation of China [81171617]; 12th Five-Year High-Tech Grand [2010gxjs009]; 12th Five-Year Special Grand project for Infectious Diseases [2012ZX10004503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-Year High-Tech Grand; 12th Five-Year Special Grand project for Infectious Diseases	This work was supported by the National Natural Science Foundation of China (81171617), and 12th Five-Year High-Tech Grand (2010gxjs009), and 12th Five-Year Special Grand project for Infectious Diseases (2012ZX10004503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Guner R, 2011, EUR J GASTROEN HEPAT, V23, P1185, DOI 10.1097/MEG.0b013e32834ba13a; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Kim JW, 2011, INTERVIROLOGY, V54, P316, DOI 10.1159/000321450; Laras A, 2006, HEPATOLOGY, V44, P694, DOI 10.1002/hep.21299; LARSSON SB, 2013, LIVER INT, DOI DOI 10.1111/LIV.12345.[; Lenci I, 2010, DIGEST LIVER DIS, V42, P578, DOI 10.1016/j.dld.2009.12.003; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li XD, 2010, J CLIN MICROBIOL, V48, P4363, DOI 10.1128/JCM.01518-10; Lin LY, 2010, J MED VIROL, V82, P1494, DOI 10.1002/jmv.21863; Liu Y, 2010, J CLIN VIROL, V47, P243, DOI 10.1016/j.jcv.2009.12.013; Lu L, 2009, J VIRAL HEPATITIS, V16, P104, DOI 10.1111/j.1365-2893.2008.01054.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Popotheodoridis GV, 2008, LANCET INFECT DIS, V8, P167, DOI 10.1016/S1473-3099(07)70264-5; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043087; Sung JJY, 2005, GASTROENTEROLOGY, V128, P1890, DOI 10.1053/j.gastro.2005.03.009; Takkenberg B, 2011, J GASTROEN HEPATOL, V26, P1527, DOI 10.1111/j.1440-1746.2011.06766.x; Takkenberg RB, 2010, EUR J GASTROEN HEPAT, V22, P952, DOI 10.1097/MEG.0b013e3283376a63; Wang MR, 2013, J MED VIROL, V85, P219, DOI 10.1002/jmv.23461; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2013, CLIN GASTROENTEROL H, V11, P1004, DOI 10.1016/j.cgh.2013.01.026; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Xu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072799; Zhang Xiaoyong, 2013, Frontiers in Genetics, V4, P202, DOI 10.3389/fgene.2013.00202; Zhong YW, 2011, CLIN CHIM ACTA, V412, P1905, DOI 10.1016/j.cca.2011.06.031; Zoulim F, 2005, J HEPATOL, V42, P302, DOI 10.1016/j.jhep.2004.12.015	31	27	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89046	10.1371/journal.pone.0089046	http://dx.doi.org/10.1371/journal.pone.0089046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551214	Green Submitted, gold, Green Published			2022-12-25	WOS:000331266000094
J	Schile, LM; Callaway, JC; Morris, JT; Stralberg, D; Parker, VT; Kelly, M				Schile, Lisa M.; Callaway, John C.; Morris, James T.; Stralberg, Diana; Parker, V. Thomas; Kelly, Maggi			Modeling Tidal Marsh Distribution with Sea-Level Rise: Evaluating the Role of Vegetation, Sediment, and Upland Habitat in Marsh Resiliency	PLOS ONE			English	Article							COASTAL MARSHES; SOIL FORMATION; CLIMATE-CHANGE; SALT MARSHES; ACCRETION; RIVER; BAY; RATES; PRODUCTIVITY; INUNDATION	Tidal marshes maintain elevation relative to sea level through accumulation of mineral and organic matter, yet this dynamic accumulation feedback mechanism has not been modeled widely in the context of accelerated sea-level rise. Uncertainties exist about tidal marsh resiliency to accelerated sea-level rise, reduced sediment supply, reduced plant productivity under increased inundation, and limited upland habitat for marsh migration. We examined marsh resiliency under these uncertainties using the Marsh Equilibrium Model, a mechanistic, elevation-based soil cohort model, using a rich data set of plant productivity and physical properties from sites across the estuarine salinity gradient. Four tidal marshes were chosen along this gradient: two islands and two with adjacent uplands. Varying century sea-level rise (52, 100, 165, 180 cm) and suspended sediment concentrations (100%, 50%, and 25% of current concentrations), we simulated marsh accretion across vegetated elevations for 100 years, applying the results to high spatial resolution digital elevation models to quantify potential changes in marsh distributions. At low rates of sea-level rise and mid-high sediment concentrations, all marshes maintained vegetated elevations indicative of mid/high marsh habitat. With century sea-level rise at 100 and 165 cm, marshes shifted to low marsh elevations; mid/high marsh elevations were found only in former uplands. At the highest century sea-level rise and lowest sediment concentrations, the island marshes became dominated by mudflat elevations. Under the same sediment concentrations, low salinity brackish marshes containing highly productive vegetation had slower elevation loss compared to more saline sites with lower productivity. A similar trend was documented when comparing against a marsh accretion model that did not model vegetation feedbacks. Elevation predictions using the Marsh Equilibrium Model highlight the importance of including vegetation responses to sea-level rise. These results also emphasize the importance of adjacent uplands for long-term marsh survival and incorporating such areas in conservation planning efforts.	[Schile, Lisa M.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Schile, Lisa M.; Kelly, Maggi] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Callaway, John C.] Univ San Francisco, Dept Environm Sci, San Francisco, CA 94117 USA; [Morris, James T.] Univ S Carolina, Belle W Baruch Inst Marine Biol & Coastal Res, Columbia, SC 29208 USA; [Stralberg, Diana] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Parker, V. Thomas] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Smithsonian Institution; Smithsonian Environmental Research Center; University of California System; University of California Berkeley; University of San Francisco; Clemson University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Alberta; California State University System; San Francisco State University	Schile, LM (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	lschile@berkeley.edu	morris, james/AAQ-5605-2020; Stralberg, Diana/W-9267-2019; morris, james/ABC-8111-2020	morris, james/0000-0002-0511-642X; Stralberg, Diana/0000-0003-4900-024X; 	California Bay-Delta Authority for research under California Bay-Delta Authority [U-04-SC-005]; CALFED Science Program [1037]	California Bay-Delta Authority for research under California Bay-Delta Authority; CALFED Science Program	This paper was prepared in cooperation with the California Bay-Delta Authority for research funded under California Bay-Delta Authority Agreement No. U-04-SC-005 and under CALFED Science Program Grant #1037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Callaway J.C., 1996, CURRENT TOPICS WETLA, V2, P2; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Chen ZY, 2001, GEOMORPHOLOGY, V41, P77, DOI 10.1016/S0169-555X(01)00106-4; Cloern JE, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000397; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; DAY JW, 1995, ESTUARIES, V18, P636, DOI 10.2307/1352382; Department of Commerce National Oceanic and Atmospheric Administration National Ocean Service Coastal Services Center, 2012, 2009 2011 CAL COAST; Deverel SJ, 2010, SAN FRANCISCO ESTUAR, V8; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Drexler JZ, 2009, ESTUAR COAST, V32, P871, DOI 10.1007/s12237-009-9202-8; Elsey-Quirk T, 2011, WETLANDS, V31; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Hladik C, 2012, REMOTE SENS ENVIRON, V121, P224, DOI 10.1016/j.rse.2012.01.018; Ibanez C, 1996, REGUL RIVER, V12, P51, DOI 10.1002/(SICI)1099-1646(199601)12:1&lt;51::AID-RRR376&gt;3.0.CO;2-I; Intergovernmental Panel on Climate Change, 2007, SUMM POL; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2012, NATURE, V489, P550, DOI 10.1038/nature11440; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Krone R.B., 1987, COASTAL SEDIMENTS 87, P316; Marion C, 2009, ESTUAR COAST SHELF S, V83, P475, DOI 10.1016/j.ecss.2009.03.039; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Morecroft MD, 2012, J APPL ECOL, V49, P547, DOI [10.1111/j.1365-2664.2012.02136.x, 10.1111/j.1365-2664.2012.02147.x]; Morris JT, 2013, WETLANDS, V33, P975, DOI 10.1007/s13157-013-0480-3; Morris J.T., 2012, RECARBONIZATION BIOS, P517; MORRIS JT, 1990, ECOLOGY, V71, P2209, DOI 10.2307/1938633; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; MORRIS JT, 1986, SOIL SCI SOC AM J, V50, P96, DOI 10.2136/sssaj1986.03615995005000010019x; Morris JT, 2007, ESTIMATING NET PRIMA; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; National Research Council, 2012, SEA LEVEL RISE COAST; National Research Council, 1987, RESP CHANG SEA LEV E; Neubauer SC, 2002, ESTUAR COAST SHELF S, V54, P713, DOI 10.1006/ecss.2001.0854; Nur N, 2012, TECHNICAL REPORT; NYMAN JA, 1990, ESTUAR COAST SHELF S, V31, P57, DOI 10.1016/0272-7714(90)90028-P; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Orr M., 2003, SAN FRANC ESTUARY WA, V1, DOI [10.15447/sfews.2003v1iss1art5, DOI 10.15447/SFEWS.2003V1ISS1ART5]; Parker VT, 2012, ECOLOGY, CONSERVATION, AND RESTORATION OF TIDAL MARSHES: THE SAN FRANCISCO ESTUARY, P97; Prahalad VN, 2011, AUST J BOT, V59, P741, DOI 10.1071/BT11206; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Rogers K, 2012, ECOL MODEL, V244, P148, DOI 10.1016/j.ecolmodel.2012.06.014; Rybczyk J.M., 2009, COASTAL WETLANDS INT, P835; Rybczyk JM, 1998, ECOL MODEL, V112, P23, DOI 10.1016/S0304-3800(98)00125-2; Sanderson EW, 2000, PLANT ECOL, V146, P29, DOI 10.1023/A:1009882110988; Schile LM, 2011, WETLANDS, V31, P1165, DOI 10.1007/s13157-011-0227-y; Schoellhamer D.H., 2004, SAN FRANCISCO ESTUAR, V2; Schoellhamer DH, 2011, ESTUAR COAST, V34, P885, DOI 10.1007/s12237-011-9382-x; Schwimmer RA, 2001, J COASTAL RES, V17, P672; Stralberg D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027388; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; THOM RM, 1992, WETLANDS, V12, P147, DOI 10.1007/BF03160603; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; Turner RE, 2004, ECOL RES, V19, P29, DOI 10.1111/j.1440-1703.2003.00610.x; Turner RE, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P583; Tuxen K, 2011, WETL ECOL MANAG, V19, P141, DOI 10.1007/s11273-010-9207-x; Tweel AW, 2012, LIMNOL OCEANOGR, V57, P18, DOI 10.4319/lo.2012.57.1.0018; van der Wal D, 2004, GEOMORPHOLOGY, V61, P373, DOI 10.1016/j.geomorph.2004.02.005; Vasey MC, 2012, SAN FRANC ESTUARY WA, V10, P1; Veloz SD, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00341.1; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Voss CM, 2012, MARINE BIOL; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; Williams PB, 2002, RESTOR ECOL, V10, P527, DOI 10.1046/j.1526-100X.2002.02031.x; Zedler JB, 1999, ECOSYSTEMS, V2, P19, DOI 10.1007/s100219900055	75	119	119	1	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88760	10.1371/journal.pone.0088760	http://dx.doi.org/10.1371/journal.pone.0088760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551156	Green Published, gold			2022-12-25	WOS:000331266000064
J	Shabaneh, M; Rosental, N; Kanner, BI				Shabaneh, Mustafa; Rosental, Noa; Kanner, Baruch I.			Disulfide Cross-linking of Transport and Trimerization Domains of a Neuronal Glutamate Transporter Restricts the Role of the Substrate to the Gating of the Anion Conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gating; Glutamate; Membrane Biophysics; Membrane Energetics; Membrane Transport; Neurotransmitter Transport	PAIRED CYSTEINE MUTAGENESIS; AMINO-ACID TRANSPORTER; RAT-BRAIN; SULFHYDRYL MODIFICATION; CHLORIDE CONDUCTANCE; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; REENTRANT LOOP; SODIUM; GLT-1	Background: Glutamate transporters gate anion conductance and structures of homologues are available. Results: Disulfide cross-linking of transport and trimerization domains leaves the anion conductance intact. Conclusion: The anion conducting conformation of brain glutamate transporters is associated with a limited inward movement of the transport domain. Significance: The new insights into ion conducting modes may be relevant for other transporters. Excitatory amino acid transporters remove synaptically released glutamate and maintain its concentrations below neurotoxic levels. EAATs also mediate a thermodynamically uncoupled substrate-gated anion conductance that may modulate cell excitability. A structure of an archeal homologue, which reflects an early intermediate on the proposed substrate translocation path, has been suggested to be similar to an anion conducting conformation. To probe this idea by functional studies, we have introduced two cysteine residues in the neuronal glutamate transporter EAAC1 at positions predicted to be close enough to form a disulfide bond only in outward-facing and early intermediate conformations of the homologue. Upon treatment of Xenopus laevis oocytes expressing the W441C/K269C double mutant with dithiothreitol, radioactive transport was stimulated >2-fold but potently inhibited by low micromolar concentrations of the oxidizing reagent copper(II)(1,10-phenanthroline)(3). The substrate-induced currents by the untreated double mutant, reversed at approximately -20 mV, close to the reversal potential of chloride, but treatment with dithiothreitol resulted in transport currents with the same voltage dependence as the wild type. It appears therefore that in the oocyte expression system the introduced cysteine residues in many of the mutant transporters are already cross-linked and are only capable of mediating the substrate-gated anion conductance. Reduction of the disulfide bond now allows these transporters to execute the full transport cycle. Our functional data support the idea that the anion conducting conformation of the neuronal glutamate transporter is associated with an early step of the transport cycle.	[Shabaneh, Mustafa; Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			National Institutes of Health from NINDS [NS 16708]; United States-Israel Binational Science Foundation [2011268]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 16708 from NINDS. This work was also supported by United States-Israel Binational Science Foundation Grant 2011268.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Focke PJ, 2011, J NEUROSCI, V31, P6255, DOI 10.1523/JNEUROSCI.6096-10.2011; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Otis TS, 2000, J NEUROSCI, V20, P2749; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	52	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11175	11182		10.1074/jbc.M114.550277	http://dx.doi.org/10.1074/jbc.M114.550277			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584931	hybrid, Green Published			2022-12-25	WOS:000334638500021
J	Galkin, A; Kulakova, L; Lim, K; Chen, CZ; Zheng, W; Turko, IV; Herzberg, O				Galkin, Andrey; Kulakova, Liudmila; Lim, Kap; Chen, Catherine Z.; Zheng, Wei; Turko, Illarion V.; Herzberg, Osnat			Structural Basis for Inactivation of Giardia lamblia Carbamate Kinase by Disulfiram	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Models; Crystallography; Drug Discovery; Enzyme Inhibitors; Enzyme Structure; Parasite; Carbamate Kinase; Disulfiram; Giardia lamblia	ALDEHYDE DEHYDROGENASE; METRONIDAZOLE; RESISTANCE; MECHANISMS; TINIDAZOLE; RADIATION; CHILDREN; DAMAGE	Background: Carbamate kinase is an essential Giardia lamblia enzyme, and the anti-alcoholism drug disulfiram kills the trophozoites and inhibits the enzyme. Results: Disulfiram acts by modifying Cys-242 adjacent to the active site and cures giardiasis in mice. Conclusion:G. lamblia CK is a good drug target and disulfiram may be repurposed as antigiardiasis drug. Significance: We need new antigiardiasis drugs because current treatments fail frequently. Carbamate kinase from Giardia lamblia is an essential enzyme for the survival of the organism. The enzyme catalyzes the final step in the arginine dihydrolase pathway converting ADP and carbamoyl phosphate to ATP and carbamate. We previously reported that disulfiram, a drug used to treat chronic alcoholism, inhibits G. lamblia CK and kills G. lamblia trophozoites in vitro at submicromolar IC50 values. Here, we examine the structural basis for G. lamblia CK inhibition of disulfiram and its analog, thiram, their activities against both metronidazole-susceptible and metronidazole-resistant G. lamblia isolates, and their efficacy in a mouse model of giardiasis. The crystal structure of G. lamblia CK soaked with disulfiram revealed that the compound thiocarbamoylated Cys-242, a residue located at the edge of the active site. The modified Cys-242 prevents a conformational transition of a loop adjacent to the ADP/ATP binding site, which is required for the stacking of Tyr-245 side chain against the adenine moiety, an interaction seen in the structure of G. lamblia CK in complex with AMP-PNP. Mass spectrometry coupled with trypsin digestion confirmed the selective covalent thiocarbamoylation of Cys-242 in solution. The Giardia viability studies in the metronidazole-resistant strain and the G. lamblia CK irreversible inactivation mechanism show that the thiuram compounds can circumvent the resistance mechanism that renders metronidazole ineffectiveness in drug resistance cases of giardiasis. Together, the studies suggest that G. lamblia CK is an attractive drug target for development of novel antigiardial therapies and that disulfiram, an FDA-approved drug, is a promising candidate for drug repurposing.	[Galkin, Andrey; Kulakova, Liudmila; Lim, Kap; Turko, Illarion V.; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Chen, Catherine Z.; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Turko, Illarion V.] NIST, Gaithersburg, MD 20899 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu	Zheng, Wei/GOE-5990-2022; Zheng, Wei/J-8889-2014	Zheng, Wei/0000-0003-1034-0757; Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health [R56AI059733, 11XS049]; Science Applications International Corporation/NCI; Intramural Research Programs of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Applications International Corporation/NCI; Intramural Research Programs of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant R56AI059733 (to O. H.) and Science Applications International Corporation/NCI, National Institutes of Health contract 11XS049 (to O. H.), and the Intramural Research Programs of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health (to C. Z. C. and W. Z.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BYRD LG, 1994, INFECT IMMUN, V62, P3583, DOI 10.1128/IAI.62.8.3583-3585.1994; Canete R, 2006, CURR MED RES OPIN, V22, P2131, DOI 10.1185/030079906X132497; Chen Catherine Z, 2012, Curr Chem Genomics, V6, P93, DOI 10.2174/1875397301206010093; Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escobedo AA, 2008, ANN TROP MED PARASIT, V102, P199, DOI 10.1179/136485908X267894; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; Galkin A, 2010, ACTA CRYSTALLOGR F, V66, P386, DOI 10.1107/S1744309110004665; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLE IL, 1967, ACTA CRYSTALLOGR, V22, P273, DOI 10.1107/S0365110X67000465; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KITSON TM, 1983, BIOCHEM J, V213, P551, DOI 10.1042/bj2130551; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemee V, 2000, J ANTIMICROB CHEMOTH, V46, P819, DOI 10.1093/jac/46.5.819; Lim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064004; Lipsky JJ, 2001, CHEM-BIOL INTERACT, V130, P93, DOI 10.1016/S0009-2797(00)00225-8; Malcolm R, 2008, EXPERT OPIN DRUG SAF, V7, P459, DOI [10.1517/14740338.7.4.459, 10.1517/14740338.7.4.459 ]; Nash T, 1998, ANTIMICROB AGENTS CH, V42, P1488, DOI 10.1128/AAC.42.6.1488; NASH TE, 1985, J INFECT DIS, V152, P64, DOI 10.1093/infdis/152.1.64; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; SCHOFIELD PJ, 1990, INT J PARASITOL, V20, P697, DOI 10.1016/0020-7519(90)90133-8; Tejman-Yarden N, 2011, ANTIMICROB AGENTS CH, V55, P4643, DOI 10.1128/AAC.00384-11; TOWNSON SM, 1992, T ROY SOC TROP MED H, V86, P521, DOI 10.1016/0035-9203(92)90095-T; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Wensaas KA, 2009, SCAND J PRIM HEALTH, V27, P12, DOI 10.1080/02813430802602393; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	44	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10502	10509		10.1074/jbc.M114.553123	http://dx.doi.org/10.1074/jbc.M114.553123			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558036	Green Published, hybrid			2022-12-25	WOS:000334226400023
J	Kayama, T; Yamashita, H; Fukao, A; Kubota, I; Kato, T; Kitanaka, C; Sato, S; Ueno, Y; Kubota, I; Sato, S; Konta, T; Shibata, Y; Watanabe, T; Abe, S; Miyamoto, T; Inoue, S; Miyashita, T; Ichikawa, K; Shishido, T; Arimoto, T; Takahashi, H; Nishiyama, S; Ikeda, A; Kato, T; Daimon, M; Kawanami, T; Wada, M; Arawaka, S; Oizumi, H; Kuro-Kawa, K; Susa, S; Katou, Y; Kameda, W; Koyama, S; Karasawa, S; Iseki, C; Takahashi, Y; Kitanaka, C; Ueno, Y; Ueno, Y; Kawata, S; Saito, T; Makino, N; Okumoto, K; Haga, H; Sato, T; Sato, C; Watanabe, H; Nishise, Y; Ishii, R; Matsuda, A; Tozawa, T; Yamashita, H; Honma, K; Fukao, A; Narimatsu, H; Shibata, K; Miura, A; Inoue, R; Numazawa, A; Kudo, K; Aita, Y; Umezawa, N; Saito, Y; Takahashi, Y; Suzuki, Y; Otani, K; Hozawa, A; Shao, L; Orui, M; Kobayashi, A; Kanoya, Y; Hosoya, T; Suzuki, I; Otake, M; Morikagi, Y; Sekimata, A; Hiraka, M; Matsuda, Y; Sato, C; Takeda, Y; Matsunami, Y; Horie, T; Sato, S; Inoue, M; Baba, K; Tamiya, G; Ueki, M; Nakamura, T; Tamiya, G; Jambaldorj, J; Araki, S; Nakajima, O; Takahashi, K; Goto, K; Ishizaka, K				Kayama, Takamasa; Yamashita, Hidetoshi; Fukao, Akira; Kubota, Isao; Kato, Takeo; Kitanaka, Chifumi; Sato, Shinya; Ueno, Yoshiyuki; Kubota, Isao; Sato, Shinya; Konta, Tsuneo; Shibata, Yoko; Watanabe, Tetsu; Abe, Shuichi; Miyamoto, Takuya; Inoue, Sumito; Miyashita, Takehiko; Ichikawa, Kazunobu; Shishido, Tetsuro; Arimoto, Takanori; Takahashi, Hiroki; Nishiyama, Satoshi; Ikeda, Ami; Kato, Takeo; Daimon, Makoto; Kawanami, Toru; Wada, Manabu; Arawaka, Shigeki; Oizumi, Hidetoshi; Kuro-Kawa, Katsuro; Susa, Shingi; Katou, Yuichi; Kameda, Wataru; Koyama, Shingo; Karasawa, Shigeru; Iseki, Chifumi; Takahashi, Yoshimi; Kitanaka, Chifumi; Ueno, Yoshiyuki; Ueno, Yoshiyuki; Kawata, Sumio; Saito, Takafumi; Makino, Naohiko; Okumoto, Kazuo; Haga, Hiroaki; Sato, Takeshi; Sato, Chikako; Watanabe, Hisayoshi; Nishise, Yuko; Ishii, Rika; Matsuda, Akiko; Tozawa, Tomohiro; Yamashita, Hidetoshi; Honma, Kei; Fukao, Akira; Narimatsu, Hiroto; Shibata, Kyoko; Miura, Akiko; Inoue, Rina; Numazawa, Ai; Kudo, Kahori; Aita, Yoko; Umezawa, Noriko; Saito, Yuko; Takahashi, Yumi; Suzuki, Yuka; Otani, Katsumi; Hozawa, Atsushi; Shao, Li; Orui, Masatsugu; Kobayashi, Atsuko; Kanoya, Yuka; Hosoya, Takiko; Suzuki, Ikuko; Otake, Mariko; Morikagi, Yuko; Sekimata, Akiko; Hiraka, Manami; Matsuda, Yumi; Sato, Chika; Takeda, Yoko; Matsunami, Yoko; Horie, Tatsuya; Sato, Shiho; Inoue, Mizue; Baba, Kaoru; Tamiya, Gen; Ueki, Masao; Nakamura, Tomohiro; Tamiya, Gen; Jambaldorj, Jamiyansuren; Araki, Satoko; Nakajima, Osamu; Takahashi, Kazuei; Goto, Kazuo; Ishizaka, Kimishige		YUGCC	Pleiotropic Effect of Common Variants at ABO Glycosyltranferase Locus in 9q32 on Plasma Levels of Pancreatic Lipase and Angiotensin Converting Enzyme	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; JAPANESE POPULATION; DISEASES; SUSCEPTIBILITY; CANCER; STEATOSIS; GENETICS; TRAITS; RISK	For forty-three clinical test values presumably associated to common complex human diseases, we carried out a genome-wide association study using 600K SNPs in a general Japanese population of 1,639 individuals (1,252 after quality control procedures) drawn from a regional cohort, followed by a replication study for statistically significant SNPs (p = 1.95x10(-9)-8.34x10(-39)) using an independent population of 1,671 from another cohort. In this single two-stage study, we newly found strong and robust associations of common variants at the ABO histo-blood glycosyltransferase locus in 9q32 with the plasma levels of pancreatic lipase (P-LIP), in addition to successful confirmation of the known ABO association of angiotensin converting enzyme (ACE) independent of the ACE1 gene in 17q23.2 with the ACE level. Our results are compatible with the previously reported association between the ABO gene and pancreatic cancer, and show that the effect of these common variants at the ABO locus on the P-LIP and ACE levels is largely opposing and pleiotropic.	[Kayama, Takamasa; Sato, Shinya] Yamagata Univ, Grad Sch Med, Dept Neurosurg, Yamagata 990, Japan; [Makino, Naohiko; Matsuda, Akiko; Tozawa, Tomohiro] Yamagata Univ Hosp, Div Endoscopy, Yamagata, Japan; [Orui, Masatsugu] Yamagata Prefectural Tsuruoka Hosp, Yamagata, Japan	Yamagata University; Yamagata University	Kawata, S (corresponding author), Hyogo Prefectural Nishinomiya Hosp, Hyogo, Japan.	shibata@med.id.yamagata-u.ac.jp; namakino@med.id.yamagata-u.ac.jp; gtamiya@genetix-h.com	Daimon, Makoto/AAY-1289-2020; Narimatsu, Hiroto/ABC-9150-2021; ISEKI, CHIFUMI/AIE-8333-2022; Konta, Tsuneo/AAO-9286-2021; Jamiyansuren, Jambaldorj/X-6016-2019; Ueno, Yoshiyuki/R-9242-2019	Daimon, Makoto/0000-0002-3775-1719; Narimatsu, Hiroto/0000-0002-5302-5872; Jamiyansuren, Jambaldorj/0000-0001-6240-5108; Ueno, Yoshiyuki/0000-0001-5623-4250; Tamiya, Gen/0000-0002-0597-415X	Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology"; Grants-in-Aid for Scientific Research [25870074] Funding Source: KAKEN	Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project study was fully supported by a Grant-in-aid from the Global Center of Excellence program of the Japan Society for the Promotion of Science, "Formation of an International Network for Education and Research of Molecular Epidemiology" (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Falconer D. S, 1996, INTRO QUANTITATIVE G; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; King R.C., 2006, DICT GENETICS; Konta T, 2006, KIDNEY INT, V70, P751, DOI 10.1038/sj.ki.5001504; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MARCUS DM, 1969, NEW ENGL J MED, V280, P994, DOI 10.1056/NEJM196905012801806; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahman P, 2003, AM J HUM GENET, V73, P677, DOI 10.1086/378076; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Shintani-Ishida K, 2008, INT J LEGAL MED, V122, P7, DOI 10.1007/s00414-006-0148-0; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; van Raalte DH, 2010, CURR OPIN CLIN NUTR, V13, P478, DOI 10.1097/MCO.0b013e32833aa1ef; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vogel F, 1982, HUMAN GENETICS PROBL, V2nd; Wray NR, 2007, GENES AND COMMON DISEASES: GENETICS IN MODERN MEDICINE, P59; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e55903	10.1371/journal.pone.0055903	http://dx.doi.org/10.1371/journal.pone.0055903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586218	Green Published, Green Submitted, gold			2022-12-25	WOS:000332396200001
J	Clemente, MI; Alvarez, S; Serramia, MJ; Martinez-Bonet, M; Munoz-Fernandez, MA				Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria			Prostaglandin E-2 Reduces the Release and Infectivity of New Cell-Free Virions and Cell-To-Cell HIV-1 Transfer	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-KINASE-A; VIROLOGICAL SYNAPSE FORMATION; ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; CYCLIC-AMP; CYTOKINE SECRETION; OXIDATIVE STRESS; EXCHANGE FACTOR; EPAC PROTEINS	Background: The course of human immunodeficiency virus type-1 (HIV-1) infection is influenced by a complex interplay between viral and host factors. HIV infection stimulates several proinflammatory genes, such as cyclooxigense-2 (COX-2), which leads to an increase in prostaglandin (PG) levels in the plasma of HIV-1-infected patients. These genes play an indeterminate role in HIV replication and pathogenesis. The effect of prostaglandin E-2 (PGE(2)) on HIV infection is quite controversial and even contradictory, so we sought to determine the role of PGE(2) and the signal transduction pathways involved in HIV infection to elucidate possible new targets for antiretrovirals. Results: Our results suggest that PGE(2) post-infection treatment acts in the late stages of the viral cycle to reduce HIV replication. Interestingly, viral protein synthesis was not affected, but a loss of progeny virus production was observed. No modulation of CD4 CXCR4 and CCR5 receptor expression, cell proliferation, or activation after PGE(2) treatment was detected. Moreover, PGE(2) induced an increase in intracellular cAMP (cyclic AMP) levels through the EP2/EP4 receptors. PGE(2) effects were mimicked by dbcAMP and by a specific Epac (exchange protein directly activated by cyclic AMP) agonist, 8-Cpt-cAMP. Treatment with PGE(2) increased Rap1 activity, decreased RhoA activity and subsequently reduced the polymerization of actin by approximately 30% compared with untreated cells. In connection with this finding, polarized viral assembly platforms enriched in Gag were disrupted, altering HIV cell-to-cell transfer and the infectivity of new virions. Conclusions: Our results demonstrate that PGE(2), through Epac and Rap activation, alters the transport of newly synthesized HIV-1 components to the assembly site, reducing the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer.	[Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria] Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain; [Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Isabel Clemente, Maria; Alvarez, Susana; Jesus Serramia, Maria; Martinez-Bonet, Marta; Angeles Munoz-Fernandez, Maria] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza, Spain	General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Munoz-Fernandez, MA (corresponding author), Hosp Gen Univ Gregorio Maranon, Lab InmunoBiol Mol, Madrid, Spain.	mmunoz.hgugm@gmail.com	sourisseau, marion/M-7542-2014	Martinez Bonet, Marta/0000-0003-0715-403X; Munoz-Fernandez/0000-0002-0813-4500	Fondo de Investigacion Sanitaria en Espana (FIS) [INTRASALUD PS09/02029, RD09/0076/00103]; Fundacion Eugenio Rodriguez Pascual; Red Espanola de Investigacion en SIDA (RIS) [RETIC RD06/0006/0035, RD12-0017-0037]; "Fundacion para la Investigacion y la Prevencion del Sida en Espana'' (FIPSE); Comunidad de Madrid [INDISNET S-2010/BMD-2332]; Fondo de Investigacion Sanitaria [CA10/01274]	Fondo de Investigacion Sanitaria en Espana (FIS); Fundacion Eugenio Rodriguez Pascual; Red Espanola de Investigacion en SIDA (RIS); "Fundacion para la Investigacion y la Prevencion del Sida en Espana'' (FIPSE); Comunidad de Madrid(Comunidad de Madrid); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was supported by grants provided by Fondo de Investigacion Sanitaria en Espana (FIS) [grant numbers INTRASALUD PS09/02029, RD09/0076/00103]; the Fundacion Eugenio Rodriguez Pascual; Red Espanola de Investigacion en SIDA (RIS) [grant numbers RETIC RD06/0006/0035, RD12-0017-0037]; "Fundacion para la Investigacion y la Prevencion del Sida en Espana'' (FIPSE); and Comunidad de Madrid [INDISNET S-2010/BMD-2332]. MIC is supported by Fondo de Investigacion Sanitaria (CA10/01274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; BETZ M, 1991, J IMMUNOL, V146, P108; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Breen EC, 2000, CLIN DIAGN LAB IMMUN, V7, P769, DOI 10.1128/CDLI.7.5.769-773.2000; Bukrinsky M, 2004, MOL MED, V10, P1; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; Cui Qi, 2004, Anatomical Science International, V79, P209, DOI 10.1111/j.1447-073x.2004.00089.x; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dumais N, 2002, J IMMUNOL, V168, P274, DOI 10.4049/jimmunol.168.1.274; Dumais N, 1998, J BIOL CHEM, V273, P27306, DOI 10.1074/jbc.273.42.27306; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Elbim C, 2001, J CLIN VIROL, V20, P99, DOI 10.1016/S1386-6532(00)00133-5; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; GENDELMAN HE, 1987, VIROLOGY, V160, P323, DOI 10.1016/0042-6822(87)90002-X; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Goetzl EJ, 1995, J IMMUNOL; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Graziano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023674; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Haraguchi H, 2010, MICROBIOL IMMUNOL, V54, P734, DOI 10.1111/j.1348-0421.2010.00276.x; HASLER F, 1983, J IMMUNOL, V131, P768; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Janelle ME, 2002, J BIOL CHEM, V277, P30665, DOI 10.1074/jbc.M203041200; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P7873, DOI 10.1128/JVI.01845-06; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; KRAAN TCTMV, 1995, MOL MED TODAY, V1, P61; LAURENCE J, 1990, BLOOD, V75, P696; Lehmann M, 2011, VIRUSES-BASEL, V3, P1757, DOI 10.3390/v3091757; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Nisole Sebastien, 2004, Retrovirology, V1, P9, DOI 10.1186/1742-4690-1-9; Noda S, 2010, EUR J CANCER, V46, P995, DOI 10.1016/j.ejca.2010.01.007; Pereira CF, 2000, J LEUKOCYTE BIOL, V68, P423; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Pyeon D, 2000, J VIROL, V74, P5740, DOI 10.1128/JVI.74.12.5740-5745.2000; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Roper R L, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P101; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; SASAKI H, 1995, P NATL ACAD SCI USA, V92, P2026, DOI 10.1073/pnas.92.6.2026; Sasaki H, 2004, BIOCHEM BIOPH RES CO, V316, P588, DOI 10.1016/j.bbrc.2004.02.088; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Symensma TL, 2003, J VIROL, V77, P12753, DOI 10.1128/JVI.77.23.12753-12763.2003; Thivierge M, 1998, BLOOD, V92, P40, DOI 10.1182/blood.V92.1.40.413k43_40_45; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; van Oirschot BA, 2001, J BIOL CHEM, V276, P33854, DOI 10.1074/jbc.M104395200; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Watzer B, 2009, J MATER SCI-MATER M, V20, P1357, DOI 10.1007/s10856-008-3678-9	74	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e85230	10.1371/journal.pone.0085230	http://dx.doi.org/10.1371/journal.pone.0085230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586238	gold, Green Published, Green Submitted			2022-12-25	WOS:000332385900003
J	Yang, F; Zhang, L; Wu, H; Zou, HB; Du, YJ				Yang, Fan; Zhang, Li; Wu, Hao; Zou, Hongbin; Du, Yujun			Clinical Analysis of Cause, Treatment and Prognosis in Acute Kidney Injury Patients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTENSIVE-CARE-UNIT; EPIDEMIOLOGY; OUTCOMES; DEATH; RISK; DIALYSIS; MANNITOL; CRITERIA	Acute kidney injury (AKI) is characterized by an abrupt decline in renal function, resulting in an inability to secrete waste products and maintain electrolyte and water balance, and is associated with high risks of morbidity and mortality. This study retrospectively analyzed clinical data, treatment, and prognosis of 271 hospitalized patients (172 males and 99 females) diagnosed with AKI from December, 2008 to December, 2011. In addition, this study explored the association between the cause of AKI and prognosis, severity and treatment of AKI. The severity of AKI was classified according to the Acute Kidney Injury Network (AKIN) criteria. Renal recovery was defined as a decrease in a serum creatinine level to the normal value. Prerenal, renal, and postrenal causes accounted for 36.5% (99 patients), 46.5% (126 patients) and 17.0% (46 patients), respectively, of the incidence of AKI. Conservative, surgical, and renal replacement treatments were given to 180 (66.4%), 30 (11.1%) and 61 patients (22.5%), respectively. The overall recovery rate was 21.0%, and the mortality rate was 19.6%. Levels of Cl-, Na+ and carbon dioxide combining power decreased with increasing severity of AKI. Cause and treatment were significantly associated with AKI prognosis. Likewise, the severity of AKI was significantly associated with cause, treatment and prognosis. Multivariate logistic regression analysis found that respiratory injury and multiple organ dysfunction syndrome (MODS) were associated with AKI patient death. Cause, treatment and AKIN stage are associated with the prognosis of AKI. Respiratory injury and MODS are prognostic factors for death of AKI patients.	[Yang, Fan; Zhang, Li; Wu, Hao; Zou, Hongbin; Du, Yujun] Jilin Univ, Dept Nephrol, Bethune Hosp 1, Changchun, Jilin, Peoples R China	Jilin University	Du, YJ (corresponding author), Jilin Univ, Dept Nephrol, Bethune Hosp 1, Changchun, Jilin, Peoples R China.	kjkduyujun@126.com						Akcay A, 2010, INT J NEPHROL RENOV, V3, P129, DOI 10.2147/IJNRD.S8641; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Barretti P, 1997, RENAL FAILURE, V19, P253, DOI 10.3109/08860229709026285; Bernieh B, 2004, TRANSPL P, V36, P1784, DOI 10.1016/j.transproceed.2004.07.016; BRADY HR, 1995, LANCET, V346, P1533, DOI 10.1016/S0140-6736(95)92057-9; Chen YC, 2001, RENAL FAILURE, V23, P207, DOI 10.1081/JDI-100103492; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Hilton R, 2006, BMJ-BRIT MED J, V333, P786, DOI 10.1136/bmj.38975.657639.AE; Hoste EAJ, 2008, CRIT CARE MED, V36, pS146, DOI 10.1097/CCM.0b013e318168c590; Hoste EAJ, 2006, CURR OPIN CRIT CARE, V12, P531, DOI 10.1097/MCC.0b013e3280102af7; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lameire Norbert H, 2003, Curr Opin Crit Care, V9, P481, DOI 10.1097/00075198-200312000-00004; Mataloun SE, 2006, BRAZ J MED BIOL RES, V39, P1339, DOI 10.1590/S0100-879X2006001000010; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MORAN M, 1987, NEW ENGL J MED, V317, P150, DOI 10.1056/NEJM198707163170306; Pannu N, 2008, JAMA-J AM MED ASSOC, V299, P793, DOI 10.1001/jama.299.7.793; Pereira MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047746; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230, DOI 10.1093/oxfordjournals.ndt.a092111	26	20	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85214	10.1371/journal.pone.0085214	http://dx.doi.org/10.1371/journal.pone.0085214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586237	Green Submitted, Green Published, gold			2022-12-25	WOS:000331717900003
J	Haug, U; Engel, S; Verheyen, F; Linder, R				Haug, Ulrike; Engel, Susanne; Verheyen, Frank; Linder, Roland			Estimating Colorectal Cancer Treatment Costs: A Pragmatic Approach Exemplified by Health Insurance Data from Germany	PLOS ONE			English	Article							CARE; COLONOSCOPY; DIAGNOSIS; ILLNESS	Background: The cost of colorectal cancer (CRC) treatment is a crucial parameter to inform cost-effectiveness analyses on CRC screening but it is not readily available and therefore often lacking. We aimed to elaborate and exemplify a pragmatic approach to estimate CRC treatment cost based on health insurance data from Germany. Methods: We included two groups of persons who were continuously health-insured between 2005-2010: A) Cases: Persons with a hospital discharge diagnosis of CRC (ICD C18-C20) between 2007-2010 and no such a diagnosis between 2005-2006 (to focus on incident CRC cases); B) Controls: Persons without a diagnosis of CRC during the observation period, matched to CRC cases by age and sex (matching factor: 1: 5). We considered in-patient, out-patient and drug costs and calculated incremental costs as the difference in means between cases and controls. We divided costs into three phases of care (initial, intermediate and end-of-life phase). Results: The initial, the intermediate and the end-of-life phase included 12,792, 5,280, and 3,779 CRC cases, respectively, and 63,960, 26,400, and 18,895 controls. The mean incremental costs -annualized for each phase -were (sic)26,000, (sic)2,300, and (sic)51,700, respectively. The costs of the initial phase of care were higher for rectal than for colon cancer. Annualized stagespecific cost estimates ranged from (sic)15,000 to (sic)21,300 for early stages and from (sic)29,800 to (sic)35,000 for late stages. Conclusion: This pragmatic and feasible approach provided plausible estimates of CRC treatment costs in Germany; being transferable to other settings, it may thus facilitate to weigh up potential savings in treatment costs against the resources required for CRC control programs in various countries.	[Haug, Ulrike] German Canc Res Ctr, Epidemiol Canc Registry Baden Wuerttemberg, Heidelberg, Germany; [Engel, Susanne; Verheyen, Frank; Linder, Roland] WINEG Sci Inst Techniker Krankenkasse TK Benefit, Hamburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Haug, U (corresponding author), German Canc Res Ctr, Epidemiol Canc Registry Baden Wuerttemberg, Heidelberg, Germany.	u.haug@dkfz.de		Haug, Ulrike/0000-0002-1886-2923				BARNETT V, 1994, OUTLIERS STAT DATA; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Breckenkamp J, 2012, GESUNDHEITSWESEN, V74, pE52, DOI 10.1055/s-0031-1286274; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Brown ML, 1999, MED CARE, V37, P1249, DOI 10.1097/00005650-199912000-00008; Clerc L, 2008, EUR J HEALTH ECON, V9, P361, DOI 10.1007/s10198-007-0083-0; Delco F, 2005, ALIMENT PHARM THER, V21, P615, DOI 10.1111/j.1365-2036.2005.02362.x; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Gutierrez-Ibarluzea I, 2008, INT J TECHNOL ASSESS, V24, P270, DOI 10.1017/S0266462308080367; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanavos P, 2010, EUR J HEALTH ECON, V10, P115, DOI 10.1007/s10198-009-0201-2; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kriza C, 2013, PHARMACOECONOMICS, V31, P577, DOI 10.1007/s40273-013-0055-4; Lansdorp-Vogelaar I, 2009, JNCI-J NATL CANCER I, V101, P1412, DOI 10.1093/jnci/djp319; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Neubauer G, 2007, BKK, V06/2007, P265; Sieg A, 2007, Z GASTROENTEROL, V45, P945, DOI 10.1055/s-2007-963435; Tilson L, 2012, EUR J HEALTH ECON, V13, P511, DOI 10.1007/s10198-011-0325-z; Wilschut JA, 2011, GASTROENTEROLOGY, V141, P1648, DOI 10.1053/j.gastro.2011.07.020; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Yabroff KR, 2009, MED CARE, V47, pS56, DOI 10.1097/MLR.0b013e3181a4f482	22	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88407	10.1371/journal.pone.0088407	http://dx.doi.org/10.1371/journal.pone.0088407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586324	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900028
J	Dithmer, M; Fuchs, S; Shi, Y; Schmidt, H; Richert, E; Roider, J; Klettner, A				Dithmer, Michaela; Fuchs, Sabine; Shi, Yang; Schmidt, Harald; Richert, Elisabeth; Roider, Johann; Klettner, Alexa			Fucoidan Reduces Secretion and Expression of Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium and Reduces Angiogenesis In Vitro	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; MACULAR DEGENERATION; CELLS; PHAGOCYTOSIS; ACTIVATION; MECHANISMS; INGESTION; APOPTOSIS; ANTITUMOR; SURVIVAL	Fucoidan is a polysaccharide isolated from brown algae which is of current interest for anti-tumor therapy. In this study, we investigated the effect of fucoidan on the retinal pigment epithelium (RPE), looking at physiology, vascular endothelial growth factor (VEGF) secretion, and angiogenesis, thus investigating a potential use of fucoidan for the treatment of exudative age-related macular degeneration. For this study, human RPE cell line ARPE-19 and primary porcine RPE cells were used, as well as RPE/choroid perfusion organ cultures. The effect of fucoidan on RPE cells was investigated with methyl thiazolyl tetrazolium - assay, trypan blue exclusion assay, phagocytosis assay and a wound healing assay. VEGF expression was evaluated in immunocytochemistry and Western blot, VEGF secretion was evaluated in ELISA. The effect of fucoidan on angiogenesis was tested in a Matrigel assay using calcein-AM vital staining, evaluated by confocal laser scanning microcopy and quantitative image analysis. Fucoidan displays no toxicity and does not diminish proliferation or phagocytosis, but reduces wound healing in RPE cells. Fucoidan decreases VEGF secretion in RPE/choroid explants and RPE cells. Furthermore, it diminishes VEGF expression in RPE cells even when co-applied with bevacizumab. Furthermore, fucoidan reduces RPE-supernatant- and VEGF-induced angiogenesis of peripheral endothelial cells. In conclusion, fucoidan is a non-toxic agent that reduces VEGF expression and angiogenesis in vitro and may be of interest for further studies as a potential therapy against exudative age-related macular degeneration.	[Dithmer, Michaela; Richert, Elisabeth; Roider, Johann; Klettner, Alexa] Univ Kiel, Dept Ophthalmol, Univ Med Ctr, Kiel, Germany; [Fuchs, Sabine; Shi, Yang] Univ Kiel, Univ Med Ctr, Kiel, Germany; [Schmidt, Harald] MetaPhysiol, Essenheim, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Klettner, A (corresponding author), Univ Kiel, Dept Ophthalmol, Univ Med Ctr, Kiel, Germany.	aklettner@auge.uni-kiel.de	Klettner, Alexa Karina/M-8344-2018	Klettner, Alexa/0000-0002-2709-1059	DFG [KL2425]; Hermann Wacker Fond	DFG(German Research Foundation (DFG)); Hermann Wacker Fond	This study has been partly supported by a DFG research grand (KL2425) and the Hermann Wacker Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2013, J FOOD SCI, V78, pT648, DOI 10.1111/j.1750-3841.2012.02966.x; Aisa Y, 2005, AM J HEMATOL, V78, P7, DOI 10.1002/ajh.20182; Araya N, 2011, ANTIVIR THER, V16, P89, DOI 10.3851/IMP1699; Azuma K, 2012, MAR DRUGS, V10, P2337, DOI 10.3390/md10102337; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Cai H, 2006, MOL VIS, V12, P1; Campochiaro P A, 1999, Mol Vis, V5, P34; Caramoy A, 2012, BRIT J OPHTHALMOL, V96, P1211, DOI 10.1136/bjophthalmol-2012-301750; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Fitton JH, 2011, MAR DRUGS, V9, P1731, DOI 10.3390/md9101731; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015; Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ho J, 2011, OPHTHALMOLOGY, V118, P687, DOI 10.1016/j.ophtha.2010.08.010; Hodge W, 2010, CAN J OPHTHALMOL, V45, P223, DOI 10.3129/i10-047; Irhimeh MR, 2007, EXP HEMATOL, V35, P989, DOI 10.1016/j.exphem.2007.02.009; Johnson JD, 2003, J LEUKOCYTE BIOL, V74, P810, DOI 10.1189/jlb.0303092; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; Klettner A, 2008, INVEST OPHTH VIS SCI, V49, P4523, DOI 10.1167/iovs.08-2055; Klettner A, 2013, MOL VIS, V19, P281; Klettner A, 2012, OXID STRESS APPL BAS, P277, DOI 10.1007/978-1-61779-606-7_13; Klettner A, 2011, OPHTHALMIC RES, V46, P88, DOI 10.1159/000323271; Klettner A, 2010, CUTAN OCUL TOXICOL, V29, P122, DOI 10.3109/15569521003745685; Klettner AK, 2009, GRAEF ARCH CLIN EXP, V247, P1601, DOI 10.1007/s00417-009-1136-0; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Li N, 2005, FOOD CHEM TOXICOL, V43, P421, DOI 10.1016/j.fct.2004.12.001; Liu RM, 2005, ANTICANCER RES, V25, P2129; LOPEZ PF, 1995, ARCH OPHTHALMOL-CHIC, V113, P1437, DOI 10.1001/archopht.1995.01100110097032; Lu Ming, 2006, Ophthalmol Clin North Am, V19, P323; Matou S, 2002, THROMB RES, V106, P213, DOI 10.1016/S0049-3848(02)00136-6; Miller DW, 2003, OPHTHALMOLOGE, V100, P92, DOI 10.1007/s00347-002-0760-4; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Minuth WW, 1999, EXP NEPHROL, V7, P394; Miura Y, 2010, OPHTHAL RES, V43, P122, DOI 10.1159/000252979; Myers SP, 2010, BIOL-TARGETS THER, V4, P33; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Parmeggiani F, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/546786; Peters S, 2007, AM J OPHTHALMOL, V143, P995, DOI 10.1016/j.ajo.2007.03.007; Rasband W., 2006, IMAGEJ; Riou D, 1996, ANTICANCER RES, V16, P1213; de Souza MCR, 2007, J APPL PHYCOL, V19, P153, DOI 10.1007/s10811-006-9121-z; ROIDER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1786, DOI 10.1001/archopht.1992.01080240126045; Rosenfeld Philip J, 2006, Ophthalmol Clin North Am, V19, P361; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; Schrader WF, 2006, OPHTHALMOLOGE, V103, P742, DOI 10.1007/s00347-006-1418-4; Sparrow JR, 2012, MOL ASPECTS MED, V33, P436, DOI 10.1016/j.mam.2012.03.007; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tissot B, 2003, BBA-PROTEINS PROTEOM, V1651, P5, DOI 10.1016/S1570-9639(03)00230-9; Wiencke AK, 2003, ACTA OPHTHALMOL SCAN, V81, P170, DOI 10.1034/j.1600-0420.2003.00030.x; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	52	52	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89150	10.1371/journal.pone.0089150	http://dx.doi.org/10.1371/journal.pone.0089150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558482	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700128
J	Kiene, M; Rethi, B; Jansson, M; Dillon, S; Lee, E; Lantto, R; Wilson, C; Pohlmann, S; Chiodi, F				Kiene, Miriam; Rethi, Bence; Jansson, Marianne; Dillon, Stephanie; Lee, Eric; Lantto, Rebecka; Wilson, Cara; Poehlmann, Stefan; Chiodi, Francesca			Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4(+) T Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DOUBLE-STRANDED-RNA; SIMIAN IMMUNODEFICIENCY; ANTIRETROVIRAL THERAPY; GASTROINTESTINAL-TRACT; CLINICAL-SIGNIFICANCE; CELLULAR SUBSETS; DENDRITIC CELLS; EARLY INFECTION; CENTRAL MEMORY	Background: Many HIV-2 and SIV isolates, as well as some HIV-1 strains, can use the orphan 7-transmembrane receptor GPR15 as co-receptor for efficient entry into host cells. GPR15 is expressed on central memory and effector memory CD4(+) T cells in healthy individuals and a subset of these cells is susceptible to HIV-1 and SIV infection. However, it has not been determined whether GPR15 expression is altered in the context of HIV-1 infection. Results: Here, we show that GPR15 expression in CD4(+) T cells is markedly up-regulated in some HIV-1 infected individuals compared to the rest of the infected patients and to healthy controls. Infection of the PM1 T cell line with primary HIV-1 isolates was found to up-regulate GPR15 expression on the infected cells, indicating that viral components can induce GPR15 expression. Up-regulation of GPR15 expression on CD4(+) T cells was induced by activation of Toll-like receptor 3 signalling via TIR-domain-containing adapter-inducing interferon-beta (TRIF) and was more prominent on gut-homing compared to lymph node-homing CD4(+) T cells. Conclusion: These results suggest that infection-induced up-regulation of GPR15 expression could increase susceptibility of CD4(+) T cells to HIV infection and target cell availability in the gut in some infected individuals.	[Kiene, Miriam] Hannover Med Sch, Inst Virol, Hannover, Germany; [Kiene, Miriam; Rethi, Bence; Lantto, Rebecka; Chiodi, Francesca] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Jansson, Marianne] Lund Univ, Dept Lab Med, Lund, Sweden; [Dillon, Stephanie; Lee, Eric; Wilson, Cara] Univ Colorado, Div Infect Dis, Aurora, CO USA	Hannover Medical School; Karolinska Institutet; Deutsches Primatenzentrum (DPZ); Lund University; University of Colorado System; University of Colorado Anschutz Medical Campus	Chiodi, F (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	francesca.chiodi@ki.se	Pöhlmann, Stefan/H-2395-2011; Rethi, Bence/C-5770-2013	Pöhlmann, Stefan/0000-0001-6086-9136; Dillon, Stephanie/0000-0003-0174-3263; Rethi, Bence/0000-0001-8220-5015	International Research Training Group 1273; Swedish Medical Research Council	International Research Training Group 1273; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work is supported by the International Research Training Group 1273 (MK) and by the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bjorndal A, 1997, J VIROL, V71, P7478; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Chung JJ, 2009, FEBS J, V276, P5547, DOI 10.1111/j.1742-4658.2009.07241.x; Cilliers T, 2005, VIROLOGY, V339, P136, DOI 10.1016/j.virol.2005.05.027; Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dillon SM, 2012, J IMMUNOL, V189, P885, DOI 10.4049/jimmunol.1200681; Dillon SM, 2010, J IMMUNOL, V184, P6612, DOI 10.4049/jimmunol.1000041; Dolganiuc A, 2006, WORLD J GASTROENTERO, V12, P1198, DOI 10.3748/wjg.v12.i8.1198; Edinger AL, 1997, P NATL ACAD SCI USA, V94, P4005, DOI 10.1073/pnas.94.8.4005; Elliott STC, 2012, J VIROL, V86, P898, DOI 10.1128/JVI.06415-11; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Fenyo EM, 2011, J INTERN MED, V270, P520, DOI 10.1111/j.1365-2796.2011.02455.x; Frange P, 2013, CLIN MICROBIOL INFEC, V19, pE252, DOI 10.1111/1469-0691.12127; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-52; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hammond T, 2010, CELL IMMUNOL, V264, P150, DOI 10.1016/j.cellimm.2010.06.001; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Howe R, 2009, CLIN IMMUNOL, V131, P317, DOI 10.1016/j.clim.2008.12.003; Huang W, 2009, AIDS RES HUM RETROV, V25, P795, DOI 10.1089/aid.2008.0252; Jansson M, 1996, P NATL ACAD SCI USA, V93, P15382, DOI 10.1073/pnas.93.26.15382; Jiang CL, 2011, J VIROL, V85, P10669, DOI 10.1128/JVI.05249-11; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kiene M, 2012, VIROLOGY, V433, P73, DOI 10.1016/j.virol.2012.07.012; Kim SV, 2013, SCIENCE, V340, P1456, DOI 10.1126/science.1237013; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Morner A, 1999, J VIROL, V73, P2343; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pohlmann S, 1999, J INFECT DIS, V180, P1494, DOI 10.1086/315097; Pohlmann S, 1999, J GEN VIROL, V80, P1241, DOI 10.1099/0022-1317-80-5-1241; Poveda E, 2012, AIDS REV, V14, P208; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sanghavi SK, 2005, J IMMUNOL, V175, P5314, DOI 10.4049/jimmunol.175.8.5314; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Schacker T, 2001, J INFECT DIS, V183, P555, DOI 10.1086/318524; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Sharron M, 2000, BLOOD, V96, P41, DOI 10.1182/blood.V96.1.41.013k53_41_49; Simone Rita, 2009, Open Microbiol J, V3, P1, DOI 10.2174/1874285800903010001; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tomchuck SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039592; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Yang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049526; Zhang LQ, 1998, J VIROL, V72, P9307, DOI 10.1128/JVI.72.11.9307-9312.1998; Zhang YJ, 2001, AIDS RES HUM RETROV, V17, P217, DOI 10.1089/088922201750063133	65	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88195	10.1371/journal.pone.0088195	http://dx.doi.org/10.1371/journal.pone.0088195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558379	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700025
J	Santruckova, E; Dolezal, V; El-Fakahany, EE; Jakubik, J				Santruckova, Eva; Dolezal, Vladimir; El-Fakahany, Esam E.; Jakubik, Jan			Long-Term Activation upon Brief Exposure to Xanomleline Is Unique to M-1 and M-4 Subtypes of Muscarinic Acetylcholine Receptors	PLOS ONE			English	Article							ANTIPSYCHOTIC-LIKE ACTIVITY; AGONIST XANOMELINE; DIFFERENTIAL REGULATION; PERSISTENT ACTIVATION; BINDING; SELECTIVITY; PROTEIN; IDENTIFICATION	Xanomeline is an agonist endowed with functional preference for M-1/M-4 muscarinic acetylcholine receptors. It also exhibits both reversible and wash-resistant binding to and activation of these receptors. So far the mechanisms of xanomeline selectivity remain unknown. To address this question we employed microfluorometric measurements of intracellular calcium levels and radioligand binding to investigate differences in the short-and long-term effects of xanomeline among muscarinic receptors expressed individually in Chinese hamster ovary cells. 1/One-min exposure of cells to xanomeline markedly increased intracellular calcium at hM(1) and hM(4), and to a lesser extent at hM(2) and hM(3) muscarinic receptors for more than 1 hour. 2/Unlike the classic agonists carbachol, oxotremorine, and pilocarpine 10-min exposure to xanomeline did not cause internalization of any receptor subtype. 3/Wash-resistant xanomeline selectively prevented further increase in intracellular calcium by carbachol at hM(1) and hM(4) receptors. 4/After transient activation xanomeline behaved as a long-term antagonist at hM(5) receptors. 5/The antagonist N-methylscopolamine (NMS) reversibly blocked activation of hM(1) through hM(4) receptors by xanomeline. 6/NMS prevented formation of xanomeline wash-resistant binding and activation at hM(2) and hM(4) receptors and slowed them at hM(1), hM(3) and hM(5) receptors. Our results show commonalities of xanomeline reversible and wash-resistant binding and short-time activation among the five muscarinic receptor subtypes. However long-term receptor activation takes place in full only at hM(1) and hM(4) receptors. Moreover xanomeline displays higher efficacy at hM(1) and hM(4) receptors in primary phasic intracellular calcium release. These findings suggest the existence of particular activation mechanisms specific to these two receptors.	[Dolezal, Vladimir; Jakubik, Jan] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Santruckova, Eva; El-Fakahany, Esam E.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Minnesota System; University of Minnesota Twin Cities	Jakubik, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	jakubik@biomed.cas.cz	Jakubik, Jan/B-7461-2012; Dolejsi, Eva/AAM-9473-2020; Dolejsi, Eva/G-1341-2016; Dolezal, Vladimir/A-8732-2008	Jakubik, Jan/0000-0002-1737-1487; Dolejsi, Eva/0000-0002-5845-182X; Dolejsi, Eva/0000-0002-5845-182X; Dolezal, Vladimir/0000-0003-3412-256X	Academy of Sciences of the Czech Republic [AV0Z 50110509, RVO:67985823]; Grant Agency of the Czech Republic [305/09/0681, P304/12/G069]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Academy of Sciences of the Czech Republic project [AV0Z 50110509] and support [RVO:67985823], the Grant Agency of the Czech Republic grants [305/09/0681] and [P304/12/G069]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1168, DOI 10.1038/sj.npp.1300151; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200; Bymaster FP, 1998, BRAIN RES, V795, P179, DOI 10.1016/S0006-8993(98)00267-4; Bymaster FP, 2002, CNS NEUROL DISORD-DR, V1, P163, DOI 10.2174/1568007024606249; CHRISTIE JE, 1981, BRIT J PSYCHIAT, V138, P46, DOI 10.1192/bjp.138.1.46; Christopoulos A, 1998, MOL PHARMACOL, V53, P1120; Christopoulos A, 1997, EUR J PHARMACOL, V334, pR3, DOI 10.1016/S0014-2999(97)01162-X; Davis Christopher N., 2009, BMC Pharmacology, V9, P14, DOI 10.1186/1471-2210-9-14; Felder CC, 2001, LIFE SCI, V68, P2605, DOI 10.1016/S0024-3205(01)01059-1; Grant MKO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015722; Grant MKO, 2005, J PHARMACOL EXP THER, V315, P313, DOI 10.1124/jpet.105.090134; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Jakubik J, 2004, J PHARMACOL EXP THER, V308, P105, DOI 10.1124/jpet.103.058594; Jakubik J, 2002, J PHARMACOL EXP THER, V301, P1033, DOI 10.1124/jpet.301.3.1033; Jakubik J, 2008, PHYSIOL RES, V57, pS39, DOI 10.33549/physiolres.931449; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Jakubik J, 2010, PHARMACEUTICALS, V3, P2838, DOI 10.3390/ph3092838; Koenig JA, 1996, MOL PHARMACOL, V49, P351; Krudewig R, 2000, J NEUROCHEM, V74, P1721, DOI 10.1046/j.1471-4159.2000.0741721.x; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Machova E, 2007, J PHARMACOL EXP THER, V322, P316, DOI 10.1124/jpet.107.122093; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Mirza NR, 2003, CNS DRUG REV, V9, P159; Noetzel MJ, 2009, PHARMACOLOGY, V83, P301, DOI 10.1159/000214843; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SHANNON HE, 1994, J PHARMACOL EXP THER, V269, P271; Shannon HE, 2000, SCHIZOPHR RES, V42, P249, DOI 10.1016/S0920-9964(99)00138-3; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shockley MS, 1999, EUR J PHARMACOL, V377, P137, DOI 10.1016/S0014-2999(99)00303-9; Stanhope KJ, 2001, J PHARMACOL EXP THER, V299, P782; Wood MD, 1999, BRIT J PHARMACOL, V126, P1620, DOI 10.1038/sj.bjp.0702463	35	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88910	10.1371/journal.pone.0088910	http://dx.doi.org/10.1371/journal.pone.0088910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558448	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700094
J	Maltha, J; Guiraud, I; Kabore, B; Lompo, P; Ley, B; Bottieau, E; Van Geet, C; Tinto, H; Jacobs, J				Maltha, Jessica; Guiraud, Issa; Kabore, Berenger; Lompo, Palpouguini; Ley, Benedikt; Bottieau, Emmanuel; Van Geet, Chris; Tinto, Halidou; Jacobs, Jan			Frequency of Severe Malaria and Invasive Bacterial Infections among Children Admitted to a Rural Hospital in Burkina Faso	PLOS ONE			English	Article							SEVERE FEBRILE ILLNESS; FALCIPARUM-MALARIA; BACTEREMIA; SALMONELLA; PREVALENCE; DIAGNOSIS	Background: Although severe malaria is an important cause of mortality among children in Burkina Faso, data on community-acquired invasive bacterial infections (IBI, bacteremia and meningitis) are lacking, as well as data on the involved pathogens and their antibiotic resistance rates. Methods: The present study was conducted in a rural hospital and health center in Burkina Faso, in a seasonal malaria transmission area. Hospitalized children (<15 years) presenting with T >= 38.0 degrees C and/or signs of severe illness were enrolled upon admission. Malaria diagnosis and blood culture were performed for all participants, lumbar puncture when clinically indicated. We assessed the frequency of severe malaria (microscopically confirmed, according to World Health Organization definitions) and IBI, and the species distribution and antibiotic resistance of the bacterial pathogens causing IBI. Results: From July 2012 to July 2013, a total of 711 patients were included. Severe malaria was diagnosed in 292 (41.1%) children, including 8 (2.7%) with IBI co-infection. IBI was demonstrated in 67 (9.7%) children (bacteremia, n = 63; meningitis, n = 6), 8 (11.8%) were co-infected with malaria. Non-Typhoid Salmonella spp. (NTS) was the predominant isolate from blood culture (32.8%), followed by Salmonella Typhi (18.8%), Streptococcus pneumoniae (18.8%) and Escherichia coli (12.5%). High antibiotic resistance rates to first line antibiotics were observed, particularly among Gram-negative pathogens. In addition, decreased ciprofloxacin susceptibility and extended-spectrum beta lactamase (ESBL) production was reported for one NTS isolate each. ESBL production was observed in 3/8 E. coli isolates. In-hospital mortality was 8.2% and case-fatality rates for IBI (23.4%) were significantly higher compared to severe malaria (6.8%, p<0.001). Conclusions: Although severe malaria was the main cause of illness, IBI were not uncommon and had higher case-fatality rates. The high frequency, antibiotic resistance rates and mortality rates of community acquired IBI require improvement in hygiene, better diagnostic methods and revision of current treatment guidelines.	[Maltha, Jessica; Ley, Benedikt; Bottieau, Emmanuel; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Maltha, Jessica; Van Geet, Chris] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Guiraud, Issa; Kabore, Berenger; Lompo, Palpouguini; Tinto, Halidou] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Van Geet, Chris] Katholieke Univ Leuven, Louvain, Belgium	Institute of Tropical Medicine (ITM); KU Leuven; KU Leuven	Maltha, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jessicamaltha@gmail.com	Jacobs, Jan/GRX-7316-2022; Issa, GUIRAUD/AGU-8073-2022; Kaboré, Bérenger/J-2773-2017	Kaboré, Bérenger/0000-0002-3719-7033; Tinto, Halidou/0000-0002-0472-3586; Ley, Benedikt/0000-0002-5734-0845	Steunfonds Margeurite-Marie Delacroix; Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium); Junior Mobility program of KU Leuven; McKinsey Company	Steunfonds Margeurite-Marie Delacroix; Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium)(FWO); Junior Mobility program of KU Leuven; McKinsey Company	The work of JM was funded by "Steunfonds Margeurite-Marie Delacroix''. For this study, JM received additional grants from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen, Belgium), the Junior Mobility program of KU Leuven and McKinsey & Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, 2006, PED ADV LIF SUPP; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; CLSI, 2013, PERFORMANCE STANDARD; Crawley J, 2010, LANCET, V375, P1468, DOI 10.1016/S0140-6736(10)60447-3; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27; Grimont F, 2007, J MED MICROBIOL, V56, P749, DOI 10.1099/jmm.0.46818-0; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hendriksen ICE, 2013, J INFECT DIS, V207, P351, DOI 10.1093/infdis/jis675; Institut National de la Statistique et de la Demographie (INSD) et ICF International, 2012, ENQ DEM SANT IND MUL; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mallewa M, 2013, LANCET GLOBAL HLTH, V1; Manyando C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056916; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Ministere de la Sante, 2012, PLANT ACT 2013 DISTR; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, 2012, T ROY SOC TROP MED H, V106, P688, DOI 10.1016/j.trstmh.2012.08.006; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Ouedraogo Abdoul-Salam, 2011, Sante, V21, P221, DOI 10.1684/san.2011.0273; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 1991, BAS MAL MICR 1	39	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89103	10.1371/journal.pone.0089103	http://dx.doi.org/10.1371/journal.pone.0089103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551225	Green Submitted, gold, Green Published			2022-12-25	WOS:000331271500097
J	Teo, JDW; MacAry, PA; Tan, KSW				Teo, Joshua D. W.; MacAry, Paul A.; Tan, Kevin S. W.			Pleiotropic Effects of Blastocystis spp. Subtypes 4 and 7 on Ligand-Specific Toll-Like Receptor Signaling and NF-kappa B Activation in a Human Monocyte Cell Line	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; CYSTEINE PROTEASES; GENETIC DIVERSITY; FOOD ALLERGY; INFLAMMATION; HOMINIS; RECOGNITION; EXPRESSION; RESISTANT; INFECTION	Blastocystis spp. is a common enteric stramenopile parasite that colonizes the colon of hosts of a diverse array of species, including humans. It has been shown to compromise intestinal epithelial cell barrier integrity and mediate the production of pro-inflammatory cytokines and chemokines. Mucosal epithelial surfaces, including the intestinal epithelium, are increasingly recognized to perform a vital surveillance role in the context of innate immunity, through the expression of pathogen recognition receptors, such as Toll-like receptors (TLRs). In this study, we use the human TLR reporter monocytic cell line, THP1-Blue, which expresses all human TLRs, to investigate effects of Blastocystis on TLR activation, more specifically the activation of TLR-2, -4 and -5. We have observed that live Blastocystis spp. parasites and whole cell lysate (WCL) alone do not activate TLRs in THP1-Blue. Live ST4-WR1 parasites inhibited LPS-mediated NF-kappa B activation in THP1-Blue. In contrast, ST7-B WCL and ST4-WR1 WCL induced pleiotropic modulation of ligand-specific TLR-2 and TLR-4 activation, with no significant effects on flagellin-mediated TLR-5 activation. Real time-qPCR analysis on SEAP reporter gene confirmed the augmenting effect of ST7-B on LPS-mediated NF-kappa B activation in THP1-Blue. Taken together, this is the first study to characterize interactions between Blastocystis spp. and host TLR activation using an in vitro reporter model.	[Teo, Joshua D. W.; MacAry, Paul A.; Tan, Kevin S. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117548, Singapore; [MacAry, Paul A.] Natl Univ Singapore, Program Immunol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Tan, KSW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117548, Singapore.	mictank@nus.edu.sg			National University of Singapore	National University of Singapore(National University of Singapore)	JDWT acknowledges a generous research scholarship from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Arisue N, 2002, J EUKARYOT MICROBIOL, V49, P42, DOI 10.1111/j.1550-7408.2002.tb00339.x; Bart A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-389; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Bobo LD, 2013, INFECT IMMUN, V81, P713, DOI 10.1128/IAI.00186-12; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2006, ANN NY ACAD SCI, V1072, P332, DOI 10.1196/annals.1326.006; Cekin AH, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-122; Chen LW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-48; Chen XQ, 1997, LAB ANIM SCI, V47, P91; Cobo ER, 2012, INFECT IMMUN, V80, P143, DOI 10.1128/IAI.05029-11; Fukata M, 2011, INFLAMM BOWEL DIS, V17, P1464, DOI 10.1002/ibd.21527; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; HO LC, 1993, PARASITOL RES, V79, P614, DOI 10.1007/BF00932249; HUANG CM, 1990, ANTIMICROB AGENTS CH, V34, P1824, DOI 10.1128/AAC.34.9.1824; Iguchi A, 2009, PARASITOL RES, V105, P135, DOI 10.1007/s00436-009-1373-5; Kida Y, 2008, CELL MICROBIOL, V10, P1491, DOI 10.1111/j.1462-5822.2008.01142.x; Kida Y, 2007, INFECT IMMUN, V75, P164, DOI 10.1128/IAI.01239-06; Long HY, 2001, PARASITOL RES, V87, P1029; Mirza H, 2012, CELL MICROBIOL, V14, P1474, DOI 10.1111/j.1462-5822.2012.01814.x; Mirza H, 2011, INFECT IMMUN, V79, P5019, DOI 10.1128/IAI.05632-11; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Puthia MK, 2006, INFECT IMMUN, V74, P4114, DOI 10.1128/IAI.00328-06; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rathinam VAK, 2013, NATURE, V501, P173, DOI 10.1038/nature12556; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Scanlan PD, 2012, TRENDS PARASITOL, V28, P327, DOI 10.1016/j.pt.2012.05.001; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Stenson WF, 2001, INFECT IMMUN, V69, P3382, DOI 10.1128/IAI.69.5.3382-3388.2001; Stensvold CR, 2009, EPIDEMIOL INFECT, V137, P1655, DOI 10.1017/S0950268809002672; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2012, INFECT GENET EVOL, V12, P263, DOI 10.1016/j.meegid.2011.11.002; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Uematsu S, 2010, MICROBIOL IMMUNOL, V54, P645, DOI 10.1111/j.1348-0421.2010.00267.x; Westerholm-Ormio M, 2010, J PEDIATR GASTR NUTR, V50, P367, DOI 10.1097/MPG.0b013e3181cd2636; Yamamoto-Furusho JK, 2010, DIGESTION, V82, P18, DOI 10.1159/000273871	45	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89036	10.1371/journal.pone.0089036	http://dx.doi.org/10.1371/journal.pone.0089036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551212	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500093
J	Wang, YX; Xu, L; Li, JJ; Yang, H; Zhang, YQ; Jonas, JB				Wang, Ya Xing; Xu, Liang; Li, Jian Jun; Yang, Hua; Zhang, Ya Qin; Jonas, Jost B.			Snoring and Glaucoma	PLOS ONE			English	Article							SLEEP-APNEA SYNDROME; ISCHEMIC OPTIC NEUROPATHY; BEIJING EYE; HIGH PREVALENCE; POPULATION; PRESSURE; CHINA; ANGLE	Purpose: To examine a potential association between snoring and glaucoma in a population-based setting. Methods: The population-based Beijing Eye Study 2011 included 3468 subjects with an age of 50+ years. The participants underwent a detailed ophthalmic examination. Glaucoma was determined according to the ophthalmoscopic appearance of the optic nerve head. Snoring assessed in an interview was graded into "severe snoring'', "moderate snoring'', and "no snoring''. Results: Data on snoring and glaucoma were available for 3146 subjects. Snoring was reported for 1787 (66.8%) subjects, with moderate snoring reported for 1384 (44.0%) subjects and severe snoring for 403 (12.8%) subjects. In multivariate analysis, prevalence of severe snoring was significantly associated with male gender (P = 0.002; regression coefficient B: 0.36; Odds ratio (OR): 1.44 (95% confidence interval (CI): 1.14, 1.81)), higher body mass index (P<0.001; B: 0.12; OR: 1.13 (95% CI: 1.09, 1.16)), higher systolic blood pressure (P<0.001; B: 0.01; OR: 1.01 (95% CI: 1.005, 1.02)), younger age (P = 0.007; B: -0.018; OR: 0.98 (95% CI: 0.97, 0.995)), and higher cognitive function (P = 0.03; B: 0.04; OR: 1.04 (95% CI: 1.004, 1.08)), however it was not significantly associated with the prevalence of open-angle glaucoma (P = 0.10; B: -0.63; OR: 0.53 (95% CI: 0.25, 1.12)). Prevalence of severe snoring was neither significantly associated with the prevalence of angle-closure glaucoma (P = 0.65), retinal vein occlusions (P = 0.24), neuroretinal rim area (P = 0.19), retinal nerve fiber layer thickness (P = 0.16) nor vertical cup/disc ratio (P = 0.64). Conclusions: Severe snoring was not significantly associated with the prevalence of open-angle glaucoma, angle-closure glaucoma or retinal vein occlusions after adjustment for age, gender, body mass index, systolic blood pressure and cognitive function score. Our population-based study did not reveal that snoring was a risk factor for glaucoma and thus did not provide a reason to assess or to treat snoring in patients with glaucoma.	[Wang, Ya Xing; Xu, Liang; Li, Jian Jun; Yang, Hua; Zhang, Ya Qin; Jonas, Jost B.] Capital Univ Med Sci, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.	xlbio@163.com; jost.jonas@medma.uni-heidelberg.de	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793	National Natural Science Foundation of China [81770890]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program)	This study was supported by National Natural Science Foundation of China (grant # 81770890); National Key Technology R&D Program of the Ministry of Science and Technology (numbers 2012BAH05F05 and 2013BAH19F04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdal H, 2006, SLEEP MED, V7, P107, DOI 10.1016/j.sleep.2005.08.010; Behbehani R, 2005, AM J OPHTHALMOL, V139, P518, DOI 10.1016/j.ajo.2004.11.004; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Geyer O, 2003, AM J OPHTHALMOL, V136, P1093, DOI 10.1016/S0002-9394(03)00709-8; Hayreh S., 1996, OPHTHALMOL CLIN N AM, V9, P407; Karakucuk S, 2008, GRAEF ARCH CLIN EXP, V246, P129, DOI 10.1007/s00417-007-0656-8; Lee AG, 2002, OPHTHALMOLOGY, V109, P482, DOI 10.1016/S0161-6420(01)00987-3; Li YB, 2006, AM J OPHTHALMOL, V142, P788, DOI 10.1016/j.ajo.2006.06.001; Lin CC, 2013, OPHTHALMOLOGY, V120, P1559, DOI 10.1016/j.ophtha.2013.01.006; Lin PW, 2011, GRAEF ARCH CLIN EXP, V249, P585, DOI 10.1007/s00417-010-1544-1; Lin PW, 2011, J GLAUCOMA, V20, P553, DOI 10.1097/IJG.0b013e3181f3eb81; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Mojon DS, 1998, OPHTHALMOLOGY, V105, P874, DOI 10.1016/S0161-6420(98)95030-8; Mojon DS, 1999, OPHTHALMOLOGY, V106, P1009, DOI 10.1016/S0161-6420(99)00525-4; Mojon DS, 2002, ARCH OPHTHALMOL-CHIC, V120, P601, DOI 10.1001/archopht.120.5.601; Ohana EB, 2010, EUR ANN OTORHINOLARY, V127, P159, DOI 10.1016/j.anorl.2010.07.003; Onen SH, 2000, ACTA OPHTHALMOL SCAN, V78, P638, DOI 10.1034/j.1600-0420.2000.078006638.x; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; WALSH JT, 1982, THORAX, V37, P845, DOI 10.1136/thx.37.11.845; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Yip JLY, 2011, INVEST OPHTH VIS SCI, V52, P8186, DOI 10.1167/iovs.11-8267	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88949	10.1371/journal.pone.0088949	http://dx.doi.org/10.1371/journal.pone.0088949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551196	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000085
J	Xu, F; Ware, RS; Tse, LA; Wang, YF; Wang, ZY; Hong, X; Chan, EYY; Dunstan, DW; Owen, N				Xu, Fei; Ware, Robert S.; Tse, Lap Ah; Wang, YouFa; Wang, ZhiYong; Hong, Xin; Chan, Emily Ying Yang; Dunstan, David W.; Owen, Neville			Joint Associations of Physical Activity and Hypertension with the Development of Type 2 Diabetes among Urban Men and Women in Mainland China	PLOS ONE			English	Article							PREVALENCE; RISK; RELIABILITY; PRESSURE; VALIDITY	Background: Physical activity (PA) and hypertension (HTN) are important influences on the development of type 2 diabetes (T2D). However, the joint impact of PA and HTN on T2D development is unknown. Methods: Two community-based prospective cohort studies, with the same protocols, instruments and questionnaires, were conducted among adults in urban areas of Nanjing, China, during 2004-2007 and 2007-2010. T2D was defined using World Health Organization criteria based on physicians' diagnosis and fasting blood glucose concentration. PA level (sufficient/insufficient) and blood pressure status (hypertensive/normotensive) were assessed at baseline and the third year of follow-up. We pooled and analyzed data from these two studies. Results: Among 4550 participants aged 35 years or older, the three-year cumulative incidence of T2D was 5.1%. After adjusting for potential confounders, participants with sufficient PA were less likely to develop T2D than those with insufficient PA (OR = 0.43, 95%CI = 0.27, 0.68) and those who were normotensive were less likely to develop T2D than those who were hypertensive (OR = 0.39, 95%CI = 0.29, 0.51). Compared to participants with insufficient PA and who were hypertensive, those with sufficient PA and hypertension were at lower risk of developing T2D (OR = 0.36, 95%CI = 0.19, 0.69), as were those with insufficient PA who were normotensive (OR = 0.37, 95%CI = 0.28, 0.50) and those with sufficient PA who were normotensive (OR = 0.19, 95%CI = 0.10, 0.37). Conclusions: Insufficient PA was found to be associated with the development of T2D among adults with and without hypertension. These findings support a role for promoting higher physical activity levels to lower T2D risk in both hypertensive and non-hypertensive individuals.	[Xu, Fei; Wang, ZhiYong; Hong, Xin] Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Ware, Robert S.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Tse, Lap Ah; Chan, Emily Ying Yang] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, YouFa] Univ Baltimore, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21201 USA; [Dunstan, David W.; Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Queensland; Chinese University of Hong Kong; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Baltimore; Baker Heart and Diabetes Institute	Xu, F (corresponding author), Nanjing Municipal Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	f.xufei@gmail.com	Dunstan, David Wayne/E-8473-2010; Owen, Neville/K-5986-2012; Ware, Robert S./B-2024-2014; Chan, Emily Ying Yang/H-6849-2017	Dunstan, David Wayne/0000-0003-2629-9568; Owen, Neville/0000-0003-2784-4820; Ware, Robert S./0000-0002-6129-6736; Tse, Lap Ah/0000-0003-0355-6218; Chan, Emily Ying Yang/0000-0002-8854-5093	Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation, China [QRX11038]; Nanjing Medical Science and Technique Development Foundation, China [2003-ZKK0310, 2007-ZKX07026]; Jiangsu Provincial Science and Technology Foundation, China [2003-BS200231]; Jiangsu Provincial Government Scholarship for Overseas Studies, China [JS-2010-109]; National Health and Medical Research Council of Australia Program Grant (NHMRC) [569940]; Senior Principal Research Fellowship (NHMRC) [1003960]; Victorian Government's Operational Infrastructure Support Program; Australian Research Council Future Fellowship [FT100100918]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD070725] Funding Source: NIH RePORTER	Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation, China; Nanjing Medical Science and Technique Development Foundation, China; Jiangsu Provincial Science and Technology Foundation, China; Jiangsu Provincial Government Scholarship for Overseas Studies, China; National Health and Medical Research Council of Australia Program Grant (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Senior Principal Research Fellowship (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Research Council Future Fellowship(Australian Research Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by The Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation (QRX11038), Nanjing Medical Science and Technique Development Foundation (2003-ZKK0310 and 2007-ZKX07026) and Jiangsu Provincial Science and Technology Foundation (2003-BS200231) and Jiangsu Provincial Government Scholarship for Overseas Studies, China (JS-2010-109), China. NO was supported by National Health and Medical Research Council of Australia Program Grant (NHMRC # 569940), a Senior Principal Research Fellowship (NHMRC # 1003960) and by the Victorian Government's Operational Infrastructure Support Program. DWD was supported by an Australian Research Council Future Fellowship (FT100100918) and by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2002, HYPERTENSION, V39, P197, DOI 10.1161/hy0202.104270; [Anonymous], 2011, CHIN J HYPERTENS; Cooperative Meta-analysis Group of China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Deng HB, 2008, MED SCI SPORT EXER, V40, P303, DOI 10.1249/mss.0b013e31815b0db5; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Gavin JR, 1997, DIABETES CARE, V20, P1183; Geiss Linda S., 2012, Morbidity and Mortality Weekly Report, V61, P918; Ginter E, 2013, ADV EXP MED BIOL, V771, P35; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Lonati C, 2008, J HYPERTENS, V26, P1801, DOI 10.1097/HJH.0b013e328307a07f; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; SocietyC, 2010, CLIN J DIABETES, V22, P865; Sowers JR, 2004, AM J PHYSIOL-HEART C, V286, pH1597, DOI 10.1152/ajpheart.00026.2004; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Weycker D, 2009, J DIABETES COMPLICAT, V23, P330, DOI 10.1016/j.jdiacomp.2008.04.002; Writing group of 2004 Chinese guidelines for the management of hypertension, 2004, CHINESE J HYPERTENSI, V12, P483; Xu F, ASIA PAC J IN PRESS; Xu LZ, 2004, PUBLIC HEALTH NUTR, V7, P91, DOI 10.1079/PHN2003510; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	24	11	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88719	10.1371/journal.pone.0088719	http://dx.doi.org/10.1371/journal.pone.0088719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551143	Green Published, gold			2022-12-25	WOS:000331266000058
J	Kuo, IY; Keeler, C; Corbin, R; Celic, A; Petri, ET; Hodsdon, ME; Ehrlich, BE				Kuo, Ivana Y.; Keeler, Camille; Corbin, Rachel; Celic, Andjelka; Petri, Edward T.; Hodsdon, Michael E.; Ehrlich, Barbara E.			The number and location of EF hand motifs dictates the calcium dependence of polycystin-2 function	FASEB JOURNAL			English	Article						TRP channels; kidney; ion channels; intracellular release; signaling	C-TERMINAL TAIL; NMR STRUCTURE; BINDING; DYNAMICS; RECEPTOR; DOMAIN; ACTIVATION; PROTEINS; CHANNELS	Polycystin 2 (PC2) is a calcium-dependent calcium channel, and mutations to human PC2 (hPC2) are associated with polycystic kidney disease. The C-terminal tail of hPC2 contains 2 EF hand motifs, but only the second binds calcium. Here, we investigate whether these EF hand motifs serve as a calcium sensor responsible for the calcium dependence of PC2 function. Using NMR and bioinformatics, we show that the overall fold is highly conserved, but in evolutionarily earlier species, both EF hands bind calcium. To test whether the EF hand motif is truly a calcium sensor controlling PC2 channel function, we altered the number of calcium binding sites in hPC2. NMR studies confirmed that modified hPC2 binds an additional calcium ion. Single-channel recordings demonstrated a leftward shift in the calcium dependence, and imaging studies in cells showed that calcium transients were enhanced compared with wild-type hPC2. However, biophysics and functional studies showed that the first EF hand can only bind calcium and be functionally active if the second (native) calcium-binding EF hand is intact. These results suggest that the number and location of calcium-binding sites in the EF hand senses the concentration of calcium required for PC2 channel activity and cellular function.Kuo, I. Y., Keeler, C., Corbin, R., Celi, A., Petri, E. T., Hodsdon, M. E., Ehrlich, B. E. The number and location of EF hand motifs dictates the calcium dependence of polycystin-2 function.	[Kuo, Ivana Y.; Corbin, Rachel; Celic, Andjelka; Petri, Edward T.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Keeler, Camille; Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	michael.hodsdon@yale.edu; barbara.ehrlich@yale.edu	Celic, Andjeka S/AAC-1865-2022; /AAX-8408-2021	/0000-0001-9657-9704; Celic, Andjelka/0000-0002-1058-6872; Petri, Edward/0000-0002-3650-1523; Kuo, Ivana/0000-0002-9867-2408	Ministry of Education and Science, Republic of Serbia [173014, 172021]; U.S. National Institutes of Health (NIH) [1S10RR023748-01]; NIH [P30 DK090744I, R01 DK61747, R01 DK087844]; American Heart Association [R10682]	Ministry of Education and Science, Republic of Serbia; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	The authors thank Victor Vacquier (Scripps Institution of Oceanography, University of California-San Diego, La Jolla, CA, USA) for providing the sea urchin cDNA library. The authors thank Yifei Yang for helpful discussions. The authors thank Yiqiang Cai and Stephan Somlo (Yale University) for providing the PC2 construct and PC2 antibodies. Salim Acimi assisted with early Ca<SUP>2+</SUP> imaging experiments. E. T. P. and A. C. thank the Ministry of Education and Science, Republic of Serbia, for support (projects 173014 and 172021) during preparation of this article. The SEC-LS/UV/RI instrumentation was supported by U.S. National Institutes of Health (NIH) award 1S10RR023748-01 (Keck Facility, Yale University). This work was funded by NIH grants P30 DK090744I, R01 DK61747, and R01 DK087844 (B. E. E. and M. E. H), and by American Heart Association postdoctoral fellowship R10682 (I.Y.K).	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Brunet S, 2005, J GEN PHYSIOL, V126, P311, DOI 10.1085/jgp.200509333; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Capozzi F, 2006, J BIOL INORG CHEM, V11, P949, DOI 10.1007/s00775-006-0163-0; Celic A, 2008, J BIOL CHEM, V283, P28305, DOI 10.1074/jbc.M802743200; Celic AS, 2012, J BIOL CHEM, V287, P17232, DOI 10.1074/jbc.M112.354613; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hateboer N, 2000, KIDNEY INT, V57, P1444, DOI 10.1046/j.1523-1755.2000.00989.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Keeler C, 2013, BIOPHYS J, V105, P2843, DOI 10.1016/j.bpj.2013.11.017; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kuo IY, 2012, CHEM REV, V112, P6353, DOI 10.1021/cr3001077; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Mekahli D, 2012, CELL CALCIUM, V51, P452, DOI 10.1016/j.ceca.2012.03.002; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Neill AT, 2004, MOL REPROD DEV, V67, P472, DOI 10.1002/mrd.20033; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Schulze C, 2011, PLANT J, V68, P424, DOI 10.1111/j.1365-313X.2011.04697.x; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	37	16	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2332	2346		10.1096/fj.13-247106	http://dx.doi.org/10.1096/fj.13-247106			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24558196	Green Published			2022-12-25	WOS:000335336000034
J	Kemter, E; Sklenak, S; Rathkolb, B; Hrabe de Angelis, M; Wolf, E; Aigner, B; Wanke, R				Kemter, Elisabeth; Sklenak, Stefanie; Rathkolb, Birgit; Hrabe de Angelis, Martin; Wolf, Eckhard; Aigner, Bernhard; Wanke, Ruediger			No Amelioration of Uromodulin Maturation and Trafficking Defect by Sodium 4-Phenylbutyrate in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum Stress; Genetic Diseases; Histone Deacetylase Inhibitors; Kidney; Molecular Chaperone; NF-B (NF-KB); 4-PBA; RelB; UAKD; Uromodulin (UMOD)	TAMM-HORSFALL GLYCOPROTEIN; KIDNEY-DISEASE; ER STRESS; UMOD GENE; PHENYLBUTYRATE; MUTATIONS; PROTEIN; EXPRESSION; NEPHROPATHY; SECRETION	Background:In vitro studies suggested the chemical chaperone 4-PBA as treatment of uromodulin-associated kidney disease (UAKD). Results: 4-PBA did not ameliorate uromodulin maturation defects in two UAKD mouse models. Renal abundance/phosphorylation of several NF-B pathway components was increased. Conclusion: 4-PBA failed to cure UAKD in vivo but deteriorated kidney function. Significance: NF-B pathway was revealed as a potential target for UAKD treatment. Uromodulin (UMOD)-associated kidney disease (UAKD) belongs to the hereditary progressive ER storage diseases caused by maturation defects of mutant UMOD protein. Current treatments of UAKD patients are symptomatic and cannot prevent disease progression. Two in vitro studies reported a positive effect of the chemical chaperone sodium 4-phenylbutyrate (4-PBA) on mutant UMOD maturation. Thus, 4-PBA was suggested as a potential treatment for UAKD. This study evaluated the effects of 4-PBA in two mouse models of UAKD. In contrast to previous in vitro studies, treatment with 4-PBA did not increase HSP70 expression or improve maturation and trafficking of mutant UMOD in vivo. Kidney function of UAKD mice was actually deteriorated by 4-PBA treatment. In transfected tubular epithelial cells, 4-PBA did not improve maturation but increased the expression level of both mutant and wild-type UMOD protein. Activation of NF-B pathway in thick ascending limb of Henle's loop cells of UAKD mice was detected by increased abundance of RelB and phospho-IB kinase /, an indirect activator of NF-B. Furthermore, the abundance of NF-B1 p105/p50, NF-B2 p100/p52, and TRAF2 was increased in UAKD. NF-B activation was identified as a novel disease mechanism of UAKD and might be a target for therapeutic intervention.	[Kemter, Elisabeth; Sklenak, Stefanie; Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Rathkolb, Birgit; Hrabe de Angelis, Martin] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Rathkolb, Birgit; Hrabe de Angelis, Martin] Helmholtz Zentrum Munchen, German Res Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Wanke, Ruediger] Univ Munich, Inst Vet Pathol, Ctr Clin Vet Med, D-80539 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Kemter, E (corresponding author), Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Feodor Lynen Str 25, D-81377 Munich, Germany.	kemter@lmb.uni-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Wolf, Eckhard/0000-0002-0430-9510; Kemter, Elisabeth/0000-0001-7785-7502; Aigner, Bernhard/0000-0003-1644-2711; Wanke, Rudiger/0000-0002-0153-224X	German Research Foundation (DFG) [KE1673/1-1]; Infrafrontier [01KX1012]	German Research Foundation (DFG)(German Research Foundation (DFG)); Infrafrontier	This work was supported by the German Research Foundation (DFG grant KE1673/1-1) and by Infrafrontier Grant 01KX1012.	Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bleyer AJ, 2003, KIDNEY INT, V64, P36, DOI 10.1046/j.1523-1755.2003.00081.x; Bleyer AJ, 2011, NEPHRON CLIN PRACT, V118, pC31, DOI 10.1159/000320889; Bollee G, 2011, CLIN J AM SOC NEPHRO, V6, P2429, DOI 10.2215/CJN.01220211; Brusilow S W, 1996, Adv Pediatr, V43, P127; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Lim M, 2004, AM J RESP CELL MOL, V31, P351, DOI 10.1165/rcmb.2002-0086OC; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P130, DOI 10.1016/j.nmd.2003.11.006; Nasr SH, 2008, KIDNEY INT, V73, P971, DOI 10.1038/sj.ki.5002679; Neuhofer W, 2005, J PHYSIOL-LONDON, V564, P715, DOI 10.1113/jphysiol.2004.081463; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rathkolb B., 2011, CURRENT PROTOCOLS MO, P69; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Suaud L, 2011, J BIOL CHEM, V286, P45083, DOI 10.1074/jbc.M111.293282; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Wadman RI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006282.pub4; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; WOLF G, 1994, J AM SOC NEPHROL, V4, P1995; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077	40	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10715	10726		10.1074/jbc.M113.537035	http://dx.doi.org/10.1074/jbc.M113.537035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567330	hybrid, Green Published			2022-12-25	WOS:000334226400041
J	Zhang, J; Xu, D; Nie, J; Cao, JS; Zhai, YG; Tong, DW; Shi, YG				Zhang, Jun; Xu, Dan; Nie, Jia; Cao, Jingsong; Zhai, Yonggong; Tong, Dewen; Shi, Yuguang			Monoacylglycerol Acyltransferase-2 Is a Tetrameric Enzyme That Selectively Heterodimerizes with Diacylglycerol Acyltransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Diacylglycerol; Lipid Absorption; Lipid Metabolism; Metabolism	DIETARY-FAT ABSORPTION; RAT INTESTINAL-MUCOSA; ACYL-COA; TRIACYLGLYCEROL SYNTHESIS; ENDOPLASMIC-RETICULUM; DRUG TARGETS; 1 DGAT1; MGAT2; IDENTIFICATION; MICE	Background: MGAT2 and DGAT1 play essential role in catalyzing the biosynthesis of triglyceride and mediating intestinal fat absorption. Results: MGAT2 heterodimerizes with DGAT1, a process that is mediated by amino acids 35-80 of DGAT1 but not an N-signal peptide of MGAT2. Conclusion: MGAT2 may be part of an enzyme complex. Significance: Our findings provide direct molecular evidence of the interactions of essential enzymes for fat absorption. Acyl-CoA:monoacylglycerol acyltransferases (MGATs) and diacylglycerol acyltransferases (DGATs) catalyze the two consecutive steps in the synthesis of triacylglycerol, a key process required for dietary fat absorption into the enterocytes of the small intestine. In this report, we investigated the tendency of MGAT2 to form an enzyme complex with DGAT1 and DGAT2 in intact cells. We demonstrated that in addition to the 38-kDa monomer of the MGAT2 enzyme predicted by its peptide sequence, a 76-kDa moiety was detected in SDS-PAGE without reducing agent and heat inactivation. The 76-kDa MGAT2 moiety was greatly enhanced by treatment with a cross-linking reagent in intact cells. Additionally, the cross-linking reagent dose-dependently yielded a band corresponding to the tetramer (152 kDa) in SDS-PAGE, suggesting that the MGAT2 enzyme primarily functions as a homotetrameric protein and as a tetrameric protein. Likewise, DGAT1 also forms a homodimer under nondenaturing conditions. When co-expressed in COS-7 cells, MGAT2 heterodimerized with DGAT1 without treatment with a cross-linking reagent. MGAT2 also co-eluted with DGAT1 on a gel filtration column, suggesting that the two enzymes form a complex in intact cells. In contrast, MGAT2 did not heterodimerize with DGAT2 when co-expressed in COS-7 cells, despite high sequence homology between the two enzymes. Furthermore, systematic deletion analysis demonstrates that N-terminal amino acids 35-80 of DGAT1, but not a signal peptide at the N terminus of MGAT2, is required for the heterodimerization. Finally, co-expression of MGAT2 with DGAT1 significantly increased lipogenesis in COS-7 cells, indicating the functional importance of the dimerization.	[Zhang, Jun; Xu, Dan; Nie, Jia; Cao, Jingsong; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Xu, Dan; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Jun; Zhai, Yonggong] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwest A&F University - China; Beijing Normal University	Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	dwtong@nwsuaf.edu.cn; yus11@psu.edu	nie, jia/AAE-8355-2019; Zhang, Jun/W-5146-2019	nie, jia/0000-0001-9085-7224; Zhang, Jun/0000-0002-8489-3699	National Institutes of Health Grant [DK076685]; Chinese National Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076685, R01DK076685] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S.). This work was also supported by a scholarship from the Chinese National Scholarship Council (to D. X.).	Barlind JG, 2013, BIOORG MED CHEM LETT, V23, P2721, DOI 10.1016/j.bmcl.2013.02.084; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Cao Guoqing, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P197; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Dow RL, 2013, BIOORGAN MED CHEM, V21, P5081, DOI 10.1016/j.bmc.2013.06.045; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Lin L, 2001, AM J PHYSIOL-REG I, V280, pR504, DOI 10.1152/ajpregu.2001.280.2.R504; MANGANARO F, 1985, CAN J BIOCHEM CELL B, V63, P107, DOI 10.1139/o85-016; Mansbach CM, 1998, J LIPID RES, V39, P963; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Nordskog BK, 2001, ADV DRUG DELIVER REV, V50, P21, DOI 10.1016/S0169-409X(01)00147-8; Phan CT, 2001, FRONT BIOSCI-LANDMRK, V6, pD299, DOI 10.2741/Phan; Schober G, 2013, J LIPID RES, V54, P1369, DOI 10.1194/jlr.M035154; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; TSO P, 2000, BIOCH PHYSL ASPECTS, P125; Tsuchida T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-75; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Yeh VSC, 2012, J MED CHEM, V55, P1751, DOI 10.1021/jm201524g; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	35	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10909	10918		10.1074/jbc.M113.530022	http://dx.doi.org/10.1074/jbc.M113.530022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573674	hybrid, Green Published			2022-12-25	WOS:000334226400058
J	Pascual, F; Hsieh, LS; Soto-Cardalda, A; Carman, GM				Pascual, Florencia; Hsieh, Lu-Sheng; Soto-Cardalda, Anibal; Carman, George M.			Yeast Pah1p Phosphatidate Phosphatase Is Regulated by Proteasome-mediated Degradation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Glycerophospholipid; Phosphatidate; Phospholipid; Phospholipid Metabolism; Proteasome; Yeast	NUCLEAR-MEMBRANE GROWTH; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; ENDOPLASMIC-RETICULUM; DIACYLGLYCEROL KINASE; LIPID-METABOLISM; DEUBIQUITINATING ENZYME; TRANSCRIPTION FACTOR; PROTEIN-DEGRADATION; SIGNALING FUNCTIONS	Background: Yeast Pah1p phosphatidate phosphatase is most active in stationary phase to produce diacylglycerol for triacylglycerol synthesis. Results: Pah1p is degraded in stationary phase and stabilized by proteasome inhibitor MG132, mutations in proteasome function and ubiquitination, and elevated levels of phosphatidate. Conclusion: Pah1p is regulated by proteasome-mediated degradation. Significance: Regulation of Pah1p stability/degradation is important to lipid homeostatic mechanisms. Yeast PAH1-encoded phosphatidate phosphatase is the enzyme responsible for the production of the diacylglycerol used for the synthesis of triacylglycerol that accumulates in the stationary phase of growth. Paradoxically, the growth phase-mediated inductions of PAH1 and phosphatidate phosphatase activity do not correlate with the amount of Pah1p; enzyme abundance declined in a growth phase-dependent manner. Pah1p from exponential phase cells was a relatively stable protein, and its abundance was not affected by incubation with an extract from stationary phase cells. Recombinant Pah1p was degraded upon incubation with the 100,000 x g pellet fraction of stationary phase cells, although the enzyme was stable when incubated with the same fraction of exponential phase cells. MG132, an inhibitor of proteasome function, prevented degradation of the recombinant enzyme. Endogenously expressed and plasmid-mediated overexpressed levels of Pah1p were more abundant in the stationary phase of cells treated with MG132. Pah1p was stabilized in mutants with impaired proteasome (rpn4, blm10, ump1, and pre1 pre2) and ubiquitination (hrd1, ubc4, ubc7, ubc8, and doa4) functions. The pre1 pre2 mutations that eliminate nearly all chymotrypsin-like activity of the 20 S proteasome had the greatest stabilizing effect on enzyme levels. Taken together, these results supported the conclusion that Pah1p is subject to proteasome-mediated degradation in the stationary phase. That Pah1p abundance was stabilized in pah1 mutant cells expressing catalytically inactive forms of Pah1p and dgk1 mutant cells with induced expression of DGK1-encoded diacylglycerol kinase indicated that alteration in phosphatidate and/or diacylglycerol levels might be the signal that triggers Pah1p degradation.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Lu-Sheng, Hsieh/AAZ-9188-2020	Lu-Sheng, Hsieh/0000-0001-7555-759X	National Institutes of Health from USPHS [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 from USPHS.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BAELEE M, 1990, J BIOL CHEM, V265, P7221; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BROWN MG, 1993, ENZYME PROTEIN, V47, P343, DOI 10.1159/000468692; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman George M, 2011, Front Biol (Beijing), V6, P172; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; HAID A, 1983, METHOD ENZYMOL, V96, P192; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HILT W, 1993, J BIOL CHEM, V268, P3479; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LEPPERT G, 1990, GENETICS, V125, P13; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; QIN S, 1991, J BIOL CHEM, V266, P15549; Qiu YX, 2013, J BIOL CHEM, V288, P29124, DOI 10.1074/jbc.M113.507392; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; VASSAL A, 1992, BIOCHIM BIOPHYS ACTA, V1132, P211, DOI 10.1016/0167-4781(92)90015-R; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WOOLFORD CA, 1993, J BIOL CHEM, V268, P8990; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798	115	28	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9811	9822		10.1074/jbc.M114.550103	http://dx.doi.org/10.1074/jbc.M114.550103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563465	hybrid, Green Published			2022-12-25	WOS:000333807000031
J	Peshenko, IV; Olshevskaya, EV; Lim, S; Ames, JB; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Lim, Sunghyuk; Ames, James B.; Dizhoor, Alexander M.			Identification of Target Binding Site in Photoreceptor Guanylyl Cyclase-activating Protein 1 (GCAP1)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Proteins; Cyclic GMP (cGMP); Eye; Guanylate Cyclase; Neurobiology; Phototransduction	LEBER CONGENITAL AMAUROSIS; NEURONAL CALCIUM SENSOR; CRYSTAL-STRUCTURE; ROD; MUTATION; GCAP1; GENE; DEGENERATION; RETGC; CA2+	Background: GCAP1 regulates cGMP synthesis in photoreceptors in response to light. Results: Mutagenesis of the entire GCAP1 surface reveals its guanylyl cyclase interface. Conclusion: The interface forms a compact patch that enables both primary binding to and allosteric activation of the target enzyme. Significance: Guanylyl cyclase activation by GCAP1 is indispensable for vision and survival of photoreceptors. Retinal guanylyl cyclase (RetGC)-activating proteins (GCAPs) regulate visual photoresponse and trigger congenital retinal diseases in humans, but GCAP interaction with its target enzyme remains obscure. We mapped GCAP1 residues comprising the RetGC1 binding site by mutagenizing the entire surface of GCAP1 and testing the ability of each mutant to bind RetGC1 in a cell-based assay and to activate it in vitro. Mutations that most strongly affected the activation of RetGC1 localized to a distinct patch formed by the surface of non-metal-binding EF-hand 1, the loop and the exiting helix of EF-hand 2, and the entering helix of EF-hand 3. Mutations in the binding patch completely blocked activation of the cyclase without affecting Ca2+ binding stoichiometry of GCAP1 or its tertiary fold. Exposed residues in the C-terminal portion of GCAP1, including EF-hand 4 and the helix connecting it with the N-terminal lobe of GCAP1, are not critical for activation of the cyclase. GCAP1 mutants that failed to activate RetGC1 in vitro were GFP-tagged and co-expressed in HEK293 cells with mOrange-tagged RetGC1 to test their direct binding in cyto. Most of the GCAP1 mutations introduced into the binding patch prevented co-localization with RetGC1, except for Met-26, Lys-85, and Trp-94. With these residues mutated, GCAP1 completely failed to stimulate cyclase activity but still bound RetGC1 and competed with the wild type GCAP1. Thus, RetGC1 activation by GCAP1 involves establishing a tight complex through the binding patch with an additional activation step involving Met-26, Lys-85, and Trp-94.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Basic Sci, Elkins Pk, PA 19027 USA; [Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Dizhoor, AM (corresponding author), Salus Univ, Dept Basic Sci, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from NEI [EY11522, EY012347]; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11522 (to A. M. D.) and EY012347 (to J. B. A.) from NEI. This work was also supported by a CURE Formula Grant (to A. M. D.) from the Pennsylvania Department of Health.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081822; Lim S, 2013, BIOMOL NMR ASSIGN, V7, P39, DOI 10.1007/s12104-012-9373-2; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1998, AM J HUM GENET, V63, P651, DOI 10.1086/301985; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato M, 2005, GRAEF ARCH CLIN EXP, V243, P235, DOI 10.1007/s00417-004-1015-7; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; Zinchuk V Zinchuk O., 2008, CURR PROTOC CELL BIO, V39	67	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10140	10154		10.1074/jbc.M113.540716	http://dx.doi.org/10.1074/jbc.M113.540716			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567338	Green Published, hybrid			2022-12-25	WOS:000333807000060
J	Schlatterer, JC; Martin, JS; Laederach, A; Brenowitz, M				Schlatterer, Joerg C.; Martin, Joshua S.; Laederach, Alain; Brenowitz, Michael			Mapping the Kinetic Barriers of a Large RNA Molecule's Folding Landscape	PLOS ONE			English	Article							GROUP-I RIBOZYME; HYDROGEN-BONDS; TETRAHYMENA RIBOZYME; PATHWAYS; ENERGETICS; STABILITY; FORM; PROTEINS; REVEAL	The folding of linear polymers into discrete three-dimensional structures is often required for biological function. The formation of long-lived intermediates is a hallmark of the folding of large RNA molecules due to the ruggedness of their energy landscapes. The precise thermodynamic nature of the barriers (whether enthalpic or entropic) that leads to intermediate formation is still poorly characterized in large structured RNA molecules. A classic approach to analyzing kinetic barriers are temperature dependent studies analyzed with Eyring's transition state theory. We applied Eyring's theory to time-resolved hydroxyl radical (center dot OH) footprinting kinetics progress curves collected at eight temperature from 21.5 degrees C to 51 degrees C to characterize the thermodynamic nature of folding intermediate formation for the Mg2+-mediated folding of the Tetrahymena thermophila group I ribozyme. A common kinetic model configuration describes this RNA folding reaction over the entire temperature range studied consisting of primary (fast) transitions to misfolded intermediates followed by much slower secondary transitions, consistent with previous studies. Eyring analysis reveals that the primary transitions are moderate in magnitude and primarily enthalpic in nature. In contrast, the secondary transitions are daunting in magnitude and entropic in nature. The entropic character of the secondary transitions is consistent with structural rearrangement of the intermediate species to the final folded form. This segregation of kinetic control reveals distinctly different molecular mechanisms during the two stages of RNA folding and documents the importance of entropic barriers to defining rugged RNA folding landscapes.	[Schlatterer, Joerg C.; Brenowitz, Michael] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Martin, Joshua S.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Martin, Joshua S.; Laederach, Alain] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Yeshiva University; Albert Einstein College of Medicine; The National Evolutionary Synthesis Center; University of North Carolina; University of North Carolina Chapel Hill	Brenowitz, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	michael.brenowitz@einstein.yu.edu		Schlatterer, Joerg/0000-0002-2637-978X; Laederach, Alain/0000-0002-5088-9907	National Institutes of Health [1RO1-GM085130, R01-HL111527, R01- GM101237]; National Evolutionary Synthesis Center by National Science Foundation [EF-0905606]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085130, R01GM101237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Evolutionary Synthesis Center by National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Institutes of Health through grants 1RO1-GM085130, R01-HL111527 and R01- GM101237 supported this study. JSM was partially supported through the National Evolutionary Synthesis Center by National Science Foundation grant #EF-0905606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Bachu R, 2011, JOVE-J VIS EXP, DOI 10.3791/3244; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BRENOWITZ M, 1986, P NATL ACAD SCI USA, V83, P8462, DOI 10.1073/pnas.83.22.8462; Eyring H, 1935, CHEM REV, V17, P65, DOI 10.1021/cr60056a006; Fleming PJ, 2005, PROTEIN SCI, V14, P1911, DOI 10.1110/ps.051454805; FREIER SM, 1986, BIOCHEMISTRY-US, V25, P3214, DOI 10.1021/bi00359a020; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hougland JL, 2004, J AM CHEM SOC, V126, P13578, DOI 10.1021/ja0469129; IKEMURA T, 1989, METHOD ENZYMOL, V180, P14; Klostermeier D, 2002, BIOCHEMISTRY-US, V41, P14095, DOI 10.1021/bi025551b; Kwok LW, 2006, J MOL BIOL, V355, P282, DOI 10.1016/j.jmb.2005.10.070; Laederach A, 2007, P NATL ACAD SCI USA, V104, P7045, DOI 10.1073/pnas.0608765104; Laederach A, 2006, J MOL BIOL, V358, P1179, DOI 10.1016/j.jmb.2006.02.075; Martin JS, 2009, ALGORITHMS, V2, P200, DOI 10.3390/a2010200; Mitra S, 2011, RNA, V17, P1589, DOI 10.1261/rna.2694811; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Rook MS, 1998, J MOL BIOL, V281, P609, DOI 10.1006/jmbi.1998.1960; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Schlatterer JC, 2008, J MOL BIOL, V379, P859, DOI 10.1016/j.jmb.2008.04.013; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Shcherbakova I, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl055; Shcherbakova I, 2008, CURR OPIN CHEM BIOL, V12, P655, DOI 10.1016/j.cbpa.2008.09.017; Shi XS, 2012, J AM CHEM SOC, V134, P1910, DOI 10.1021/ja2083575; Silverman SK, 2000, BIOCHEMISTRY-US, V39, P12465, DOI 10.1021/bi000828y; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Suresh SJ, 2000, J CHEM PHYS, V113, P9727, DOI 10.1063/1.1320822; Thirumalai D, 2000, RNA, V6, P790, DOI 10.1017/S1355838200000522; Thirumalai D, 2001, ANNU REV PHYS CHEM, V52, P751, DOI 10.1146/annurev.physchem.52.1.751; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tinoco I., 1995, PHYS CHEM PRINCIPLES; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Treiber DK, 2001, J MOL BIOL, V305, P11, DOI 10.1006/jmbi.2000.4253; TURNER DH, 1987, J AM CHEM SOC, V109, P3783, DOI 10.1021/ja00246a047; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	37	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e85041	10.1371/journal.pone.0085041	http://dx.doi.org/10.1371/journal.pone.0085041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586236	Green Submitted, Green Published, gold			2022-12-25	WOS:000332385900002
J	Ohiorhenuan, IE; Mechler, F; Purpura, KP; Schmid, AM; Hu, Q; Victor, JD				Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.			Cannabinoid Neuromodulation in the Adult Early Visual Cortex	PLOS ONE			English	Article							GABAERGIC TRANSMISSION; SOMATOSENSORY CORTEX; CORTICAL-NEURONS; CRITICAL PERIOD; SYNAPTIC INPUT; IN-VIVO; STATE; MODULATION; ATTENTION; SYNCHRONIZATION	Sensory processing is an active process involving the interaction of ongoing cortical activity with incoming stimulus information. However, the modulators and circuits involved in this interaction are incompletely understood. One potential candidate is the cannabinoid-signaling system, which is known to modulate the dynamics of cortical networks. Here, we show that in the primate primary and secondary visual cortices, the cannabinoid CP55940 modulates not only population dynamics but also influences the dynamics of the stimulus-response relationship of individual neurons. At the population level, CP55940 decreases EEG power, LFP power, and LFP coherence. At the single-neuron level, intrinsic spike train dynamics appear relatively unchanged, but visual receptive fields are altered: CP55940 induced an overall delay and broadening of the temporal component of V1 and V2 spatiotemporal receptive fields. Our findings provide neurophysiologic evidence for a link between cannabinoid-signaling, network dynamics and the function of a canonical cortical circuit.	[Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.] Weill Cornell Med Coll, Brain & Mind Res Inst, Div Syst Neurol & Neurosci, New York, NY 10021 USA	Cornell University	Ohiorhenuan, IE (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, Div Syst Neurol & Neurosci, New York, NY 10021 USA.	ifije.ohiorhenuan@usc.edu			NIH [F31-EY019454, GM7739, R01-EY9314]; NATIONAL EYE INSTITUTE [R01EY009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH F31-EY019454 and NIH GM7739 (IEO) and NIH R01-EY9314 (JDV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Brusberg M, 2009, J NEUROSCI, V29, P1554, DOI 10.1523/JNEUROSCI.5166-08.2009; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Eggan SM, 2007, CEREB CORTEX, V17, P175, DOI 10.1093/cercor/bhj136; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Holderith N, 2011, J PHYSIOL-LONDON, V589, P4921, DOI 10.1113/jphysiol.2011.216259; Jiang B, 2010, J NEUROSCI, V30, P14261, DOI 10.1523/JNEUROSCI.2979-10.2010; Jiang B, 2010, NEURON, V66, P248, DOI 10.1016/j.neuron.2010.03.021; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Koethe D, 2006, SCHIZOPHR RES, V88, P142, DOI 10.1016/j.schres.2006.07.023; Li L, 2009, NEURON, V64, P537, DOI 10.1016/j.neuron.2009.10.005; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Liu CH, 2008, NEURON, V58, P340, DOI 10.1016/j.neuron.2008.02.020; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Muthukumaraswamy SD, 2013, J NEUROSCI, V33, P15171, DOI 10.1523/JNEUROSCI.2063-13.2013; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Schmid AM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.015.2009; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sippy T, 2013, J NEUROSCI, V33, P9813, DOI 10.1523/JNEUROSCI.4579-12.2013; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Yazulla S, 2008, PROG RETIN EYE RES, V27, P501, DOI 10.1016/j.preteyeres.2008.07.002	33	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87362	10.1371/journal.pone.0087362	http://dx.doi.org/10.1371/journal.pone.0087362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586271	Green Published, gold, Green Submitted			2022-12-25	WOS:000331711900012
J	Chiou, WF; Huang, YL; Liu, YW				Chiou, Wen-Fei; Huang, Yu-Ling; Liu, Yen-Wenn			(+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation	PLOS ONE			English	Article							NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; RECEPTOR ACTIVATOR; BONE-RESORPTION; C-FOS; NUCLEAR-FACTOR; MEDIATED OSTEOCLASTOGENESIS; VITIS-THUNBERGII; SODIUM-BUTYRATE; TERMINAL KINASE	We recently reported that oral administration of a (+)-vitisin A-enriched product prepared from Vitis thunbergii obviously ameliorated bone loss in ovariectomized mice and (+)-vitisin A was able to inhibit receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast differentiation in RAW264.7 cells. Here we further clarified the mechanism(s) by which (+)-vitisin A targets osteoclastic differentiation and activity. Osteoclast-characteristic enzyme activity was determined using gel zymography or spectroflurometric-based assay. Expression of signal molecules was analyzed via Western blot or immunoprecipitation. Results showed that (+)-vitisin A suppressed RANKL-induced multinuclear cells (MNCs) formation and bone resorption which was accompanied with reduction in beta 3 integrin, osteoclast stimulatory transmembrane protein (OC-STAMP), matrix metalloproteinase-9 (MMP-9) and cathepsin K proteins expression. (+)-Vitisin A also down-regulated the proteolytic activities of MMP-9 and cathepsin K via targeting at the late stage function. (+)-Vitisin A prominently abrogated RANKL-triggered nuclear translocations of NF-kappa B, AP-1 (c-Fos/c-Jun dimer) and associated induction and nuclear accumulation of nuclear factor of activated T cells c1 (NFATc1). The upstream I kappa B degradation as well as ERK and JNK phosphorylation were also substantially repressed. Transfection with siRNA targeting tumor necrosis factor receptor associated factor 6 (TRAF6) clearly restrained RANKL-induced MNCs formation and NFATc1 induction. Interesting, RANKL triggered poly-ubiquitination of TRAF6 and associated TRAF6-TAK1 (transforming growth factor beta-activated kinase 1) complex formation was prominently attenuated by (+)-vitisin A. Furthermore, the interaction between c-src tyrosine kinase (c-Src) and beta 3 was markedly induced by RANKL stimulation. (+)-Vitisin A significantly attenuated this interaction when concomitant treated with RANKL in RAW264.7 cells, but failed to affect c-Src/beta 3 complex formation when post-cultured with MNCs. Taken together, (+)-vitisin A suppressed bone resorption possibly via interruption of RANKL-induced TRAF6 ubiquitination and associated downstream signaling pathways. Furthermore, action through negative regulation of the proteolytic activity of MMP-9 and cathepsin K might also contribute to the anti-resorption effect of (+)-vitisin A.	[Chiou, Wen-Fei; Huang, Yu-Ling; Liu, Yen-Wenn] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan; [Chiou, Wen-Fei] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan; [Huang, Yu-Ling] Chang Gung Univ Sci & Technol, Dept Cosmet Sci, Tao Yuan, Taiwan	National Research Institute of Chinese Medicine; Hungkuang University; Chang Gung University of Science & Technology	Chiou, WF (corresponding author), Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan.	wfchiou@nricm.edu.tw			National Science Council Foundation [NSC 101-2320-B-077-009-MY3]; National Research Institute of Chinese Medicine Foundation [NRICM101-DBCM-02, NRICM100-DMC-05]	National Science Council Foundation(Ministry of Science and Technology, Taiwan); National Research Institute of Chinese Medicine Foundation	This work was supported by National Science Council Foundation grant (NSC 101-2320-B-077-009-MY3 to W.F.C.) and National Research Institute of Chinese Medicine Foundation grants (NRICM101-DBCM-02 to W.F.C. and NRICM100-DMC-05 to Y.L.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiou WF, 2010, BRIT J PHARMACOL, V161, P321, DOI 10.1111/j.1476-5381.2010.00823.x; Chiou WF, 2011, BIOCHEM PHARMACOL, V81, P752, DOI 10.1016/j.bcp.2010.12.022; Chiou WF, 2009, PLANTA MED, V75, P856, DOI 10.1055/s-0029-1185404; Chiu N.Y., 1995, ILLUSTRATED MED PLAN; Collin-Osdoby P, 2012, METHODS MOL BIOL, V816, P187, DOI 10.1007/978-1-61779-415-5_13; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Dossetter AG, 2012, J MED CHEM, V55, P6363, DOI 10.1021/jm3007257; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Fretz JA, 2008, MOL ENDOCRINOL, V22, P737, DOI 10.1210/me.2007-0333; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Huang YL, 2005, J NAT PROD, V68, P217, DOI 10.1021/np049686p; Huang YL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/409421; Hwang YS, 2013, J BONE MINER METAB; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Izawa T, 2012, MOL CELL BIOL, V32, P2943, DOI 10.1128/MCB.00077-12; Jensen AB, 2010, CLIN BREAST CANCER, V10, P452, DOI 10.3816/CBC.2010.n.059; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Milner JM, 2003, ARTHRITIS RHEUM-US, V48, P1057, DOI 10.1002/art.10873; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura T, 2005, J IMMUNOL, V175, P5809, DOI 10.4049/jimmunol.175.9.5809; NESBITT S, 1993, J BIOL CHEM, V268, P16737; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Seo SW, 2010, BONE, V46, P695, DOI 10.1016/j.bone.2009.10.032; Szewczyk KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060285; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Takatsuna H, 2005, J BONE MINER RES, V20, P653, DOI 10.1359/JBMR.041213; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Touaitahuata H, 2013, EUR J CELL BIOL, V92, P139, DOI 10.1016/j.ejcb.2013.03.001; Votta BJ, 1997, J BONE MINER RES, V12, P1396, DOI 10.1359/jbmr.1997.12.9.1396; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	64	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89159	10.1371/journal.pone.0089159	http://dx.doi.org/10.1371/journal.pone.0089159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558484	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700130
J	Dunning, JL; Pant, S; Bass, A; Coburn, Z; Prather, JF				Dunning, Jeffery L.; Pant, Santosh; Bass, Aaron; Coburn, Zachary; Prather, Jonathan F.			Mate Choice in Adult Female Bengalese Finches: Females Express Consistent Preferences for Individual Males and Prefer Female-Directed Song Performances	PLOS ONE			English	Article							ZEBRA FINCH; SPECIES RECOGNITION; EARLY EXPERIENCE; BEAK COLOR; CANARIES; DISCRIMINATION; RESPONSES; EXPOSURE; VARIABILITY; COMPLEXITY	In the process of mate selection by female songbirds, male suitors advertise their quality through reproductive displays in which song plays an important role. Females evaluate the quality of each signal and the associated male, and the results of that evaluation guide expression of selective courtship displays. Some studies reveal broad agreement among females in their preferences for specific signal characteristics, indicating that those features are especially salient in female mate choice. Other studies reveal that females differ in their preference for specific characteristics, indicating that in those cases female evaluation of signal quality is influenced by factors other than simply the physical properties of the signal. Thus, both the physical properties of male signals and specific traits of female signal evaluation can impact female mate choice. Here, we characterized the mate preferences of female Bengalese finches. We found that calls and copulation solicitation displays are equally reliable indicators of female preference. In response to songs from an array of males, each female expressed an individual-specific song preference, and those preferences were consistent across tests spanning many months. Across a population of females, songs of some males were more commonly preferred than others, and females preferred female-directed songs more than undirected songs, suggesting that some song features are broadly attractive. Preferences were indistinguishable for females that did or did not have social experience with the singers, indicating that female preference is strongly directed by song features rather than experiences associated with the singer. Analysis of song properties revealed several candidate parameters that may influence female evaluation. In an initial investigation of those parameters, females could be very selective for one song feature yet not selective for another. Therefore, multiple song parameters are evaluated independently. Together these findings reveal the nature of signal evaluation and mate choice in this species.	[Dunning, Jeffery L.; Pant, Santosh; Bass, Aaron; Coburn, Zachary; Prather, Jonathan F.] Univ Wyoming, Dept Zool & Physiol, Program Neurosci, Laramie, WY 82071 USA	University of Wyoming	Prather, JF (corresponding author), Univ Wyoming, Dept Zool & Physiol, Program Neurosci, Laramie, WY 82071 USA.	Jonathan.Prather@uwyo.edu		Dunning, Jeffery/0000-0003-0397-4006	National Institute of General Medical Sciences of the National Institutes of Health [P 30 GM 103398]; University of Wyoming INBRE Program of the National Institutes of Health; University of Wyoming EPSCoR Program of the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103398] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wyoming INBRE Program of the National Institutes of Health; University of Wyoming EPSCoR Program of the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by startup funds provided by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P 30 GM 103398. This research was also supported by the University of Wyoming INBRE Program of the National Institutes of Health (JFP) and by an Undergraduate Research Fellowship (ZC) from the University of Wyoming EPSCoR Program of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2009, BEHAV ECOL SOCIOBIOL, V64, P215, DOI 10.1007/s00265-009-0838-y; BAKER MC, 1981, SCIENCE, V214, P819, DOI 10.1126/science.214.4522.819; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Banerjee SB, 2011, HORM BEHAV, V60, P233, DOI 10.1016/j.yhbeh.2011.05.011; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; CLAYTON N, 1989, ANIM BEHAV, V38, P352, DOI 10.1016/S0003-3472(89)80096-X; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Collins SA, 1996, ANIM BEHAV, V52, P105, DOI 10.1006/anbe.1996.0156; COLLINS SA, 1995, ANIM BEHAV, V49, P479, DOI 10.1006/anbe.1995.0062; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; Dugatkin L, 1992, AM NATURALIST, V139; Eda-Fujiwara H, 2003, EUR J NEUROSCI, V17, P149, DOI 10.1046/j.1460-9568.2003.02414.x; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kato Y, 2010, J ETHOL, V28, P447, DOI 10.1007/s10164-010-0203-7; KROODSMA DE, 1976, SCIENCE, V192, P574, DOI 10.1126/science.192.4239.574; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; Leitao A, 2006, ANIM BEHAV, V71, P1289, DOI 10.1016/j.anbehav.2005.08.008; MacDougall-Shackleton S, 1998, NEUROREPORT, V9, P3047; Menardy F, 2012, EUR J NEUROSCI, V35, P1322, DOI 10.1111/j.1460-9568.2012.08047.x; Morisaka Tadamichi, 2008, Ornithological Science, V7, P75, DOI 10.2326/1347-0558(2008)7[75:VIPFCS]2.0.CO;2; Nagle L, 1997, BEHAVIOUR, V134, P89, DOI 10.1163/156853997X00296; Nagle L, 1997, CAN J ZOOL, V75, P1346, DOI 10.1139/z97-759; Nagle L, 2002, ETHOLOGY, V108, P463, DOI 10.1046/j.1439-0310.2002.00790.x; NAGLE L, 1993, EXPERIENTIA, V49, P1022, DOI 10.1007/BF02125652; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; O'Loghlen A. B., 1996, ANIM BEHAV, V53, P835; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Okanoya K., 1997, T TECH COMM PSYCHOL, V27, P1; Okanoya K., 1998, T TECH COMM PSYCHOL, V28, P1; Prather JF, 2013, HEARING RES, V305, P144, DOI 10.1016/j.heares.2013.06.007; Remage-Healey L, 2010, P NATL ACAD SCI USA, V107, P3852, DOI 10.1073/pnas.0906572107; Riebel K, 1998, ANIM BEHAV, V56, P1443, DOI 10.1006/anbe.1998.0933; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Searcy WA, 1997, CONDOR, V99, P826, DOI 10.2307/1370497; SEARCY WA, 1992, NATO ADV SCI I A-LIF, V228, P175; SEARCY WA, 1981, ANIM BEHAV, V29, P997, DOI 10.1016/S0003-3472(81)80053-X; SEARCY WA, 1992, AM ZOOL, V32, P71; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; SEARCY WA, 1990, ANIM BEHAV, V40, P1119, DOI 10.1016/S0003-3472(05)80178-2; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; Seki Y, 2008, J COMP PSYCHOL, V122, P26, DOI 10.1037/0735-7036.122.1.26; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; WEST MJ, 1981, ANIM BEHAV, V29, P490, DOI 10.1016/S0003-3472(81)80110-8; WEST MJ, 1988, DEV PSYCHOBIOL, V21, P543, DOI 10.1002/dev.420210605; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; YONEDA T, 1991, J ETHOL, V9, P41, DOI 10.1007/BF02350206	59	30	32	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89438	10.1371/journal.pone.0089438	http://dx.doi.org/10.1371/journal.pone.0089438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558501	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700147
J	Tang, LY; Peng, H; Xu, T; Wang, AL; Wang, GY; Tong, WJ; Zhang, YH				Tang, Lingyan; Peng, Hao; Xu, Tian; Wang, Aili; Wang, Guiyan; Tong, Weijun; Zhang, Yonghong			Association of Biomarkers of Inflammation with Dyslipidemia and Its Components among Mongolians in China	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; E-SELECTIN; INSULIN-RESISTANCE; NITRIC-OXIDE; P-SELECTIN; HYPERTENSION	Objective: This study aims to examine the association between inflammatory biomarkers and dyslipidemia and its components among Mongolians in China. Methods: Data were obtained from 2544 Mongolians via standard questionnaires and blood samples in Inner Mongolia, China. High sensitivity C-reactive protein (hsCRP), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) as well as blood lipids were examined. Results: Individuals with dyslipidemia had higher levels of hsCRP, sICAM-1 and sE-selectin than those without dyslipidemia (all P values<0.001). Compared to the lowest quartile of inflammatory biomarkers, individuals with the highest quartile were more likely to have dyslipidemia (odds ratio, 95% confidence interval: 3.215, 2.551-4.116 for hsCRP; 1.575, 1.253-1.980 for sICAM-1; 1.495, 1.193-1.873 for sE-selectin). Moreover, hsCRP was associated with all the components of dyslipidemia, whereas, sICAM-1 was not related to high density lipoprotein cholesterol (HDL-c) or triglycerides (TAG). Additionally, sE-selectin was just associated with TAG. Conclusion: Our study indicated that elevated plasma levels of hsCRP, sICAM-1 and sE-selectin were positively and significantly associated with increased risk of dyslipidemia among Mongolians. However, the associations were not identical for different inflammatory biomarkers with the components of dyslipidemia.	[Tang, Lingyan; Peng, Hao; Xu, Tian; Wang, Aili; Wang, Guiyan; Tong, Weijun; Zhang, Yonghong] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China; [Wang, Guiyan] Xiamen Maternal & Child Care Hosp, Dept Hlth Care, Xiamen, Fujian, Peoples R China	Soochow University - China	Zhang, YH (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China.	yhzhang@suda.edu.cn	Peng, Hao/I-1134-2014; Peng, Hao/AAB-4759-2022	Peng, Hao/0000-0001-6277-662X; 	National Natural Science Foundation of China [30972531]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by National Natural Science Foundation of China (Grant No. 30972531) and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, ARTERIOSCL THROM VAS, V18, P723, DOI 10.1161/01.ATV.18.5.723; Alvarez-Sala LA, 2008, CLIN THER, V30, P84, DOI 10.1016/j.linthera.2008.01.013; Anderson KM, 1998, JAMA-J AM MED ASSOC, V257, P2176; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Cannon RO, 1998, CLIN CHEM, V44, P1809; Cesari M, 2009, J NUTR HEALTH AGING, V13, P587, DOI 10.1007/s12603-009-0168-9; Cucuzzella M, 2004, J FAM PRACTICE, V53, P142; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; Duarte MMMF, 2009, CLIN BIOCHEM, V42, P666, DOI 10.1016/j.clinbiochem.2009.01.010; Ferroni P, 1999, HAEMOSTASIS, V29, P277; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goswami B, 2010, CARDIOVASC J AFR, V21, P41; Hackman A, 1996, CIRCULATION, V93, P1334, DOI 10.1161/01.CIR.93.7.1334; HALLER H, 1995, HYPERTENSION, V25, P511, DOI 10.1161/01.HYP.25.4.511; Hsu LA, 2009, METABOLISM, V58, P983, DOI 10.1016/j.metabol.2009.02.021; Hwang SJ, 1997, CIRCULATION, V96, P4219; Keles T, 2008, ANATOL J CARDIOL, V8, P407; Li HM, 2008, CIRC J, V72, P1666, DOI 10.1253/circj.CJ-08-0138; Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9; Martinez-Hervas S, 2010, NUTR METAB CARDIOVAS, V20, P734, DOI 10.1016/j.numecd.2009.06.003; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Moriarty PM, 2003, ATHEROSCLEROSIS, V166, P201, DOI 10.1016/S0021-9150(02)00319-2; OHARA Y, 1994, ARTERIOSCLER THROMB, V14, P1007, DOI 10.1161/01.ATV.14.6.1007; Pasceri V, 2000, CIRCULATION, V102, P2165; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1595, DOI 10.1161/01.ATV.19.7.1595; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Stanojevic NB, 2005, INT HEART J, V46, P593, DOI 10.1536/ihj.46.593; Sun ZQ, 2008, INT J CARDIOL, V128, P250, DOI 10.1016/j.ijcard.2007.08.127; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Vidal F, 1998, EUR J BIOCHEM, V252, P378, DOI 10.1046/j.1432-1327.1998.2520378.x; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zhao WH, 2007, BIOMED ENVIRON SCI, V20, P329	35	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89023	10.1371/journal.pone.0089023	http://dx.doi.org/10.1371/journal.pone.0089023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558466	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700112
J	Lohelaid, H; Teder, T; Toldsepp, K; Ekins, M; Samel, N				Lohelaid, Helike; Teder, Tarvi; Toldsepp, Kadri; Ekins, Merrick; Samel, Nigulas			Up-Regulated Expression of AOS-LOXa and Increased Eicosanoid Synthesis in Response to Coral Wounding	PLOS ONE			English	Article							ALLENE OXIDE SYNTHASE; LIPOXYGENASE FUSION PROTEIN; CARIBBEAN GORGONIAN CORALS; GENE-EXPRESSION; PROSTAGLANDIN SYNTHESIS; HYDROPEROXIDE LYASE; CLAVULARIA-VIRIDIS; GERSEMIA-FRUTICOSA; MOLECULAR-CLONING; ARACHIDONIC-ACID	In octocorals, a catalase-like allene oxide synthase (AOS) and an 8R-lipoxygenase (LOX) gene are fused together encoding for a single AOS-LOX fusion protein. Although the AOS-LOX pathway is central to the arachidonate metabolism in corals, its biological function in coral homeostasis is unclear. Using an acute incision wound model in the soft coral Capnella imbricata, we here test whether LOX pathway, similar to its role in plants, can contribute to the coral damage response and regeneration. Analysis of metabolites formed from exogenous arachidonate before and after fixed time intervals following wounding indicated a significant increase in AOS-LOX activity in response to mechanical injury. Two AOS-LOX isoforms, AOS-LOXa and AOS-LOXb, were cloned and expressed in bacterial expression system as active fusion proteins. Transcription levels of corresponding genes were measured in normal and stressed coral by qPCR. After wounding, AOS-LOXa was markedly up-regulated in both, the tissue adjacent to the incision and distal parts of a coral colony (with the maximum reached at 1 h and 6 h post wounding, respectively), while AOS-LOXb was stable. According to mRNA expression analysis, combined with detection of eicosanoid product formation for the first time, the AOS-LOX was identified as an early stress response gene which is induced by mechanical injury in coral.	[Lohelaid, Helike; Teder, Tarvi; Toldsepp, Kadri; Samel, Nigulas] Tallinn Univ Technol, Dept Chem, EE-19086 Tallinn, Estonia; [Ekins, Merrick] Queensland Museum, Brisbane, Qld 4101, Australia	Tallinn University of Technology; Queensland Museum	Samel, N (corresponding author), Tallinn Univ Technol, Dept Chem, EE-19086 Tallinn, Estonia.	nigulas.samel@ttu.ee	Lõhelaid, Helike/G-5425-2013; Teder, Tarvi/M-6893-2018; Samel, Nigulas/A-1420-2019; Ekins, Merrick G/B-8256-2015	Lõhelaid, Helike/0000-0002-6885-8666; Teder, Tarvi/0000-0002-8489-3955; Ekins, Merrick G/0000-0002-4825-462X	Estonian Science Foundation [9410]; Estonian Ministry of Education and Research [0140010s08]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by the Estonian Science Foundation Grant 9410 and the Estonian Ministry of Education and Research Grant 0140010s08 (both to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Ariel A, 2013, J PATHOL, V229, P250, DOI 10.1002/path.4108; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BRASH AR, 1987, J BIOL CHEM, V262, P15829; BUNDY GL, 1986, J BIOL CHEM, V261, P747; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; COREY EJ, 1985, TETRAHEDRON LETT, V26, P4171, DOI 10.1016/S0040-4039(00)98982-2; COREY EJ, 1987, J AM CHEM SOC, V109, P289, DOI 10.1021/ja00235a053; COREY EJ, 1973, J AM CHEM SOC, V95, P2054, DOI 10.1021/ja00787a079; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; GERHART DJ, 1991, AM J PHYSIOL, V260, pR839, DOI 10.1152/ajpregu.1991.260.5.R839; Gfeller A, 2011, PLANT PHYSIOL, V156, P1797, DOI 10.1104/pp.111.181008; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; Grechkin AN, 2004, BBA-MOL CELL BIOL L, V1636, P47, DOI 10.1016/j.bbalip.2003.12.003; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Hashimoto N, 2003, LIPIDS, V38, P991, DOI 10.1007/s11745-003-1153-2; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kalish BT, 2013, PROSTAG OTH LIPID M, V104, P130, DOI 10.1016/j.prostaglandins.2013.05.002; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Koljak R, 2001, J BIOL CHEM, V276, P7033, DOI 10.1074/jbc.M009803200; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Laudert D, 1996, PLANT MOL BIOL, V31, P323, DOI 10.1007/BF00021793; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohelaid H, 2008, BBA-GEN SUBJECTS, V1780, P315, DOI 10.1016/j.bbagen.2007.10.010; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Mauch F, 1997, PLANT PHYSIOL, V114, P1561, DOI 10.1104/pp.114.4.1561; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; O'Neal W, 2002, MAR ECOL PROG SER, V240, P117, DOI 10.3354/meps240117; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023992; PAWLIK JR, 1987, J EXP MAR BIOL ECOL, V108, P55, DOI 10.1016/0022-0981(87)90130-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rodriguez PG, 2008, DERMATOL SURG, V34, P1159, DOI 10.1111/j.1524-4725.2008.34254.x; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sivasankar S, 2000, PLANT PHYSIOL, V122, P1335, DOI 10.1104/pp.122.4.1335; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; SU X, 1988, ANAL BIOCHEM, V174, P650, DOI 10.1016/0003-2697(88)90068-1; Valmsen K, 2004, EUR J BIOCHEM, V271, P3533, DOI 10.1111/j.0014-2956.2004.04289.x; VARVAS K, 1994, TETRAHEDRON LETT, V35, P8267, DOI 10.1016/0040-4039(94)88299-1; VARVAS K, 1993, TETRAHEDRON LETT, V34, P3643, DOI 10.1016/S0040-4039(00)73658-6; Varvas K, 1999, J BIOL CHEM, V274, P9923, DOI 10.1074/jbc.274.15.9923; VICK BA, 1987, PLANT PHYSIOL, V85, P1073, DOI 10.1104/pp.85.4.1073; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Whalen Kristen E., 2010, BMC Ecology, V10, P24, DOI 10.1186/1472-6785-10-24; Woo S, 2010, MOL CELL TOXICOL, V6, P387, DOI 10.1007/s13273-010-0051-0; Work TM, 2010, J INVERTEBR PATHOL, V105, P116, DOI 10.1016/j.jip.2010.05.009	68	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89215	10.1371/journal.pone.0089215	http://dx.doi.org/10.1371/journal.pone.0089215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551239	Green Submitted, Green Published, gold			2022-12-25	WOS:000331271500104
J	Xia, WL; Gooden, D; Liu, LH; Zhao, SM; Soderblom, EJ; Toone, EJ; Beyer, WF; Walder, H; Spector, NL				Xia, Wenle; Gooden, David; Liu, Leihua; Zhao, Sumin; Soderblom, Erik J.; Toone, Eric J.; Beyer, Wayne F., Jr.; Walder, Harold; Spector, Neil L.			Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis	PLOS ONE			English	Article							BREAST-CANCER; EXTRACORPOREAL PHOTOCHEMOTHERAPY; INHIBITOR; RESISTANCE; HER-2	Photo-activation of psoralen with UVA irradiation, referred to as PUVA, is used in the treatment of proliferative skin disorders. The anti-proliferative effects of PUVA have been largely attributed to psoralen intercalation of DNA, which upon UV treatment, triggers the formation of interstrand DNA crosslinks (ICL) that inhibit transcription and DNA replication. Here, we show that PUVA exerts antitumor effects in models of human breast cancer that overexpress the ErbB2 receptor tyrosine kinase oncogene, through a new mechanism. Independent of ICL formation, the antitumor effects of PUVA in ErbB2+ breast cancer models can instead be mediated through inhibition of ErbB2 activation and signaling. Using a mass spectroscopy-based approach, we show for the first time that photo-activated 8MOP (8-methoxypsoralen) interacts with the ErbB2 catalytic autokinase domain. Furthermore, PUVA can reverse therapeutic resistance to lapatinib and other ErbB2 targeted therapies, including resistance mediated via expression of a phosphorylated, truncated form of ErbB2 (p85(ErbB2)) that is preferentially expressed in tumor cell nuclei. Current ErbB2 targeted therapies, small molecule kinase inhibitors or antibodies, do not block the phosphorylated, activated state of p85(ErbB2). Here we show that PUVA reduced p85(ErbB2) phosphorylation leading to tumor cell apoptosis. Thus, in addition to its effects on DNA and the formation of ICL, PUVA represents a novel ErbB2 targeted therapy for the treatment of ErbB2+ breast cancers, including those that have developed resistance to other ErbB2 targeted therapies.	[Xia, Wenle; Spector, Neil L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Xia, Wenle; Liu, Leihua; Zhao, Sumin; Spector, Neil L.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Gooden, David; Soderblom, Erik J.; Toone, Eric J.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Beyer, Wayne F., Jr.] QNS Grp LLC, Bahama, NC USA; [Walder, Harold] Immunolight LLC, Detroit, MI USA	Duke University; Duke University; Duke University	Xia, WL (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	wenle.xia@duke.edu; Neil.Spector@duke.edu			Immunolight LLC; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER	Immunolight LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funding from Immunolight LLC. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; BERGER CL, 1985, ANN NY ACAD SCI, V453, P80, DOI 10.1111/j.1749-6632.1985.tb11800.x; Canton M, 2002, FEBS LETT, V522, P168, DOI 10.1016/S0014-5793(02)02926-5; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Greinix HT, 1998, BLOOD, V92, P3098, DOI 10.1182/blood.V92.9.3098.421k32_3098_3104; HEARST JE, 1984, Q REV BIOPHYS, V17, P1, DOI 10.1017/S0033583500005242; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; LASKIN JD, 1985, P NATL ACAD SCI USA, V82, P6158, DOI 10.1073/pnas.82.18.6158; Liang K, 2003, MOL CANCER THER, V2, P1113; MERMELSTEIN FH, 1989, MOL PHARMACOL, V36, P848; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Toyooka T, 2009, CANCER RES, V69, P3492, DOI 10.1158/0008-5472.CAN-08-2546; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Xia WL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3480; Xia WL, 2011, MOL CANCER THER, V10, P1367, DOI 10.1158/1535-7163.MCT-10-0991; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774	25	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88983	10.1371/journal.pone.0088983	http://dx.doi.org/10.1371/journal.pone.0088983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551203	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500089
J	Shim, HJ; Lee, EM; Nguyen, LD; Shim, J; Song, YH				Shim, Hee Jin; Lee, Eun-Mi; Long Duy Nguyen; Shim, Jaekyung; Song, Young-Han			High-Dose Irradiation Induces Cell Cycle Arrest, Apoptosis, and Developmental Defects during Drosophila Oogenesis	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; IONIZING-RADIATION; MEIOTIC CHECKPOINT; MELANOGASTER; ACTIVATION; REPAIR; ATM; TRANSLATION; GURKEN; STRESS	Ionizing radiation (IR) treatment induces a DNA damage response, including cell cycle arrest, DNA repair, and apoptosis in metazoan somatic cells. Because little has been reported in germline cells, we performed a temporal analysis of the DNA damage response utilizing Drosophila oogenesis as a model system. Oogenesis in the adult Drosophila female begins with the generation of 16-cell cyst by four mitotic divisions of a cystoblast derived from the germline stem cells. We found that high-dose irradiation induced S and G2 arrests in these mitotically dividing germline cells in a grp/Chk1- and mnk/Chk2-dependent manner. However, the upstream kinase mei-41, Drosophila ATR ortholog, was required for the S-phase checkpoint but not for the G2 arrest. As in somatic cells, mnk/Chk2 and dp53 were required for the major cell death observed in early oogenesis when oocyte selection and meiotic recombination occurs. Similar to the unscheduled DNA double-strand breaks (DSBs) generated from defective repair during meiotic recombination, IR-induced DSBs produced developmental defects affecting the spherical morphology of meiotic chromosomes and dorsal-ventral patterning. Moreover, various morphological abnormalities in the ovary were detected after irradiation. Most of the IR-induced defects observed in oogenesis were reversible and were restored between 24 and 96 h after irradiation. These defects in oogenesis severely reduced daily egg production and the hatch rate of the embryos of irradiated female. In summary, irradiated germline cells induced DSBs, cell cycle arrest, apoptosis, and developmental defects resulting in reduction of egg production and defective embryogenesis.	[Shim, Hee Jin; Lee, Eun-Mi; Long Duy Nguyen; Song, Young-Han] Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea; [Shim, Jaekyung] Sejong Univ, Dept Mol Biol, Seoul, South Korea	Hallym University; Sejong University	Song, YH (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea.	ysong@hallym.ac.kr		Song, Young-Han/0000-0002-0758-3654	Mid-career Researcher Program through the NRF; MEST Korea [NRF-2007-0054123]	Mid-career Researcher Program through the NRF(National Research Foundation of Korea); MEST Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Mid-career Researcher Program through the NRF grant funded by the MEST (NRF-2007-0054123) Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Ashburner M, 2005, DROSOPHILA LAB HDB; Bi XL, 2005, GENETICS, V171, P845, DOI 10.1534/genetics.105.047720; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Ghabrial A, 1999, NAT CELL BIOL, V1, P354, DOI 10.1038/14046; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; Jaklevic BR, 2004, CURR BIOL, V14, P23, DOI 10.1016/j.cub.2003.12.032; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Kondo S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001350; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lancaster OM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001179; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lee EM, 2012, DNA REPAIR, V11, P741, DOI 10.1016/j.dnarep.2012.06.007; Mathe E, 2004, METH MOL B, V247, P89; Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200; Mehrotra S, 2008, GENE DEV, V22, P3158, DOI 10.1101/gad.1710208; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Song YH, 2005, MOL CELLS, V19, P167; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; TOUCHBERRY RW, 1964, GENETICS, V49, P387; Vermezovic J, 2012, CELL DEATH DIFFER, V19, P1847, DOI 10.1038/cdd.2012.69; Wichmann A, 2006, P NATL ACAD SCI USA, V103, P9952, DOI 10.1073/pnas.0510528103; WIESCHAUS E, 1979, DEV BIOL, V68, P29, DOI 10.1016/0012-1606(79)90241-0	27	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89009	10.1371/journal.pone.0089009	http://dx.doi.org/10.1371/journal.pone.0089009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551207	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000088
J	Sierra, E; Fernandez, A; de los Monteros, AE; Arbelo, M; Diaz-Delgado, J; Andrada, M; Herraez, P				Sierra, Eva; Fernandez, Antonio; Espinosa de los Monteros, Antonio; Arbelo, Manuel; Diaz-Delgado, Josue; Andrada, Marisa; Herraez, Pedro			Histopathological Muscle Findings May Be Essential for a Definitive Diagnosis of Suspected Sharp Trauma Associated with Ship Strikes in Stranded Cetaceans	PLOS ONE			English	Article							SKELETAL-MUSCLE; CAPTURE MYOPATHY; WHALES; STRESS; INJURY; DEATH; RHABDOMYOLYSIS; PATHOGENESIS; ADAPTATION; COLLISIONS	Ship strikes are a major issue for the conservation of may cetacean species. Certain gross and microscopic criteria have been previously reported for establishing a diagnosis of death due to ship strikes in these animals. However, some ship-strike injuries may be masked by advanced carcass decomposition and may be undetectable due to restricted access to the animals. In this report we describe histopathological muscular findings in 13 cetaceans with sharp trauma from ship strikes as the cause of death. Skeletal muscle samples were taken from the incision site and from the main locomotor muscle, the longissimus dorsi, in areas not directly affected by the sharp injury. The microscopic findings in tissues from both sites mainly consisted of haemorrhages; oedema; flocculent, granular or/ and hyalinised segmentary degeneration; contraction band necrosis; and discoid degeneration or fragmentation of myofibres. We propose that skeletal muscle histopathology provides evidence of ante-mortem injuries even if the sample was taken elsewhere in the carcass and not only within or adjacent to the sharp trauma site and despite the advanced decomposition of some of the carcasses. This method helps to establish the diagnosis of ship strike as the cause of death.	[Sierra, Eva; Fernandez, Antonio; Espinosa de los Monteros, Antonio; Arbelo, Manuel; Diaz-Delgado, Josue; Andrada, Marisa; Herraez, Pedro] Univ Las Palmas Gran Canaria, Sch Vet, Inst Anim Hlth, Unit Histol & Vet Pathol, Arucas Las Palmas, Canary Islands, Spain	Universidad de Las Palmas de Gran Canaria	Sierra, E (corresponding author), Univ Las Palmas Gran Canaria, Sch Vet, Inst Anim Hlth, Unit Histol & Vet Pathol, Arucas Las Palmas, Canary Islands, Spain.	esierra@becarios.ulpgc.es	Borzollino, Marisa Ana Andrada/M-3870-2014; Arbelo, Manuel/D-6789-2013; Sierra, Eva/H-9352-2015; Fernandez, Antonio/G-3448-2015	Arbelo, Manuel/0000-0002-1623-5010; Sierra, Eva/0000-0003-3749-8845; Fernandez, Antonio/0000-0001-5281-0521; Herraez, Pedro/0000-0001-9316-2882	Ministerio de Ciencia, Investigacion e Innovacion [CGL2009-13052]; Ministerio de Economia e Innovacion [CGL2012-39681]; Direccion General de Innovacion, Spain [C200801000288]	Ministerio de Ciencia, Investigacion e Innovacion; Ministerio de Economia e Innovacion(Spanish Government); Direccion General de Innovacion, Spain	This study was supported by the following projects: CGL2009-13052, from the Ministerio de Ciencia, Investigacion e Innovacion; CGL2012-39681, from the Ministerio de Economia e Innovacion; and the C200801000288, from the Direccion General de Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboyega PA, 1996, CARDIOVASC PATHOL, V5, P315, DOI 10.1016/S1054-8807(96)00041-5; Allen C., 1992, ARMED FORCES I PATHO, P53; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Arnicia E., 1992, AFIP LAB METHODS HIS, V1st, P98; Campbell-Malone R, 2008, J ZOO WILDLIFE MED, V39, P37, DOI 10.1638/2006-0057.1; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Chapman CR, 2008, J PAIN, V9, P122, DOI 10.1016/j.jpain.2007.09.006; Cowan DF, 2008, J COMP PATHOL, V139, P24, DOI 10.1016/j.jcpa.2007.11.009; Cowan DF, 2002, LJ0224C NAT MAR FISH; De Kloet ER, 2004, ANN NY ACAD SCI, V1032, P14, DOI 10.1196/annals.1314.003; Dhalla N, 1992, CARDIOTOXICITY CATEC; FECHNER G, 1991, INT J LEGAL MED, V104, P215, DOI 10.1007/BF01369810; Fieguth A, 2003, FORENSIC SCI INT, V135, P218, DOI 10.1016/S0379-0738(03)00210-X; Gaffney E, 1992, AM REGISTRY PATHOLOG, P149; Geraci JR, 2005, MARINE MAMMALS ASHOR, P182; GONCHAR' M G, 1990, Arkhiv Anatomii Gistologii i Embriologii, V98, P13; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Herraez P, 2013, VET J, V196, P181, DOI 10.1016/j.tvjl.2012.09.021; HOWELL A. BRAZIER, 1928, PROC U S NATION MUS, V73, P1; Hulland TJ, 1993, PATHOLOGY DOMESTIC A, V1, P220; Johnson FB, 1992, AFIP LAB METHODS HIS, P197; Kuiken T, 1993, NEWSLETTER, V17; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Martin V, 2009, P 18 C BIOL MAR MAMM; MCEWEN SA, 1986, VET PATHOL, V23, P400, DOI 10.1177/030098588602300409; MOORE DH, 1956, J BIOPHYS BIOCHEM CY, V2, P755, DOI 10.1083/jcb.2.6.755; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; Pabst DA, 1993, J ZOOLOGY LONDON, V230, P1; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Pugliares K, 2007, 200706 WOODS HOL OC, P117; SEKAMOVA S M, 1976, Arkhiv Patologii, V38, P25; SEKAMOVA SM, 1986, ARK PATOL, V48, P39; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; SELYE H, 1946, J CLIN ENDOCR METAB, V6, P117, DOI 10.1210/jcem-6-2-117; Shkrum M.J., 2007, FORENSIC PATHOLOGY T; Sierra E, 2012, VET J, V193, P152, DOI 10.1016/j.tvjl.2011.09.021; Sierra E, 2013, J WILDLIFE DIS, V49, P679, DOI 10.7589/2012-04-103; Sierra E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01795; Stekelenburg A, 2006, J APPL PHYSIOL, V100, P1946, DOI 10.1152/japplphysiol.00889.2005; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; TULSI RS, 1975, J ANAT, V119, P39; Turnbull BS, 1998, J COMP PATHOL, V118, P317, DOI 10.1016/S0021-9975(07)80007-7; Valentine BA, 2007, VET REC, V161, P786; Valentine BA, 2007, PATHOLOGIC BASES VET, V63149, P989; Van der Hoop JM, 2013, CONSERV BIOL, V27, P121, DOI 10.1111/j.1523-1739.2012.01934.x; Van Waerebeek K, 2007, SC59BC12 INT WHAL CO; Van Waerebeek K, 2008, SC60BC5 INT WHAL COM; YOUNG JG, 1956, AM J PHYSIOL, V186, P67, DOI 10.1152/ajplegacy.1956.186.1.67; [No title captured]; [No title captured]	52	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88780	10.1371/journal.pone.0088780	http://dx.doi.org/10.1371/journal.pone.0088780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551162	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000068
J	Hasan, S; Van der Veen, DR; Winsky-Sommerer, R; Hogben, A; Laing, EE; Koentgen, F; Dijk, DJ; Archer, SN				Hasan, Sibah; Van der Veen, Daan R.; Winsky-Sommerer, Raphaelle; Hogben, Alexandra; Laing, Emma E.; Koentgen, Frank; Dijk, Derk-Jan; Archer, Simon N.			A human sleep homeostasis phenotype in mice expressing a primate-specific PER3 variable-number tandem-repeat coding-region polymorphism	FASEB JOURNAL			English	Article						circadian; sleep deprivation; EEG; clock genes	EYE-MOVEMENT SLEEP; INTERINDIVIDUAL DIFFERENCES; TARGETED DISRUPTION; LENGTH POLYMORPHISM; CIRCADIAN-RHYTHMS; GENETIC-VARIATION; PHASE SYNDROME; ASSOCIATION	In humans, a primate-specific variable-number tandem-repeat (VNTR) polymorphism (4 or 5 repeats 54 nt in length) in the circadian gene PER3 is associated with differences in sleep timing and homeostatic responses to sleep loss. We investigated the effects of this polymorphism on circadian rhythmicity and sleep homeostasis by introducing the polymorphism into mice and assessing circadian and sleep parameters at baseline and during and after 12 h of sleep deprivation (SD). Microarray analysis was used to measure hypothalamic and cortical gene expression. Circadian behavior and sleep were normal at baseline. The response to SD of 2 electrophysiological markers of sleep homeostasis, electroencephalography (EEG) theta power during wakefulness and delta power during sleep, were greater in the Per3(5/5) mice. During recovery, the Per3(5/5) mice fully compensated for the SD-induced deficit in delta power, but the Per3(4/4) and wild-type mice did not. Sleep homeostasis-related transcripts (e. g., Homer1, Ptgs2, and Kcna2) were differentially expressed between the humanized mice, but circadian clock genes were not. These data are in accordance with the hypothesis derived from human data that the PER3 VNTR polymorphism modifies the sleep homeostatic response without significantly influencing circadian parameters.	[Hasan, Sibah; Van der Veen, Daan R.; Winsky-Sommerer, Raphaelle; Hogben, Alexandra; Laing, Emma E.; Dijk, Derk-Jan; Archer, Simon N.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Koentgen, Frank] Ozgene Pty Ltd, Bentley, WA, Australia	University of Surrey	Archer, SN (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.	simon.archer@surrey.ac.uk	van der Veen, Daan R/T-1013-2017	van der Veen, Daan R/0000-0001-8037-1407	UK Biotechnology and Biological Sciences Research Council [BB/F022883/1, BB/E003672/1]; Royal Society; BBSRC [BB/E003672/1, BB/F022883/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F022883/1, BB/E003672/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank A. Slak, S. Wehrens, S. Bae, S. Maentele, B. Martynhak, and I. Wright for their help with the SD experiments. This research was supported by grants from the UK Biotechnology and Biological Sciences Research Council (BB/F022883/1 and BB/E003672/1) and the Royal Society (to D.J.D.). F.K. is director and CEO of Ozgene Pty. Ltd. (Bentley, WA, Australia). Gene expression data are archived as Ancillary Data files on University of Surrey servers (http://sleep-sysbio.fhms.surrey.ac.uk/Hasan_14/).	Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Allebrandt KV, 2013, MOL PSYCHIATR, V18, P122, DOI 10.1038/mp.2011.142; Allebrandt KV, 2010, BIOL PSYCHIAT, V67, P1040, DOI 10.1016/j.biopsych.2009.12.026; Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Borbely A A, 1982, Hum Neurobiol, V1, P195; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Dijk DJ, 2010, SLEEP MED REV, V14, P151, DOI 10.1016/j.smrv.2009.07.002; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Groeger JA, 2008, SLEEP, V31, P1159; Hasan S, 2012, FASEB J, V26, P2414, DOI 10.1096/fj.11-201699; Hasan S, 2011, AM J PHYSIOL-REG I, V301, pR1821, DOI 10.1152/ajpregu.00260.2011; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026622; Naylor E, 2000, J NEUROSCI, V20, P8138; Obal F, 2005, J NEUROSCI, V25, P10282, DOI 10.1523/JNEUROSCI.2572-05.2005; Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254; Pereira DS, 2005, SLEEP, V28, P29; Rusterholz T, 2010, SLEEP, V33, P491, DOI 10.1093/sleep/33.4.491; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Thakkar MM, 2008, NEUROSCIENCE, V153, P875, DOI 10.1016/j.neuroscience.2008.01.017; van der Veen DR, 2010, J BIOL RHYTHM, V25, P3, DOI 10.1177/0748730409356680; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Viola AU, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.024; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yagita K, 2000, GENE DEV, V14, P1353	49	22	23	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2441	2454		10.1096/fj.13-240135	http://dx.doi.org/10.1096/fj.13-240135			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24577121	Green Published, Green Submitted			2022-12-25	WOS:000339883600006
J	Guo, MH; Vidhyasagar, V; Ding, H; Wu, YL				Guo, Manhong; Vidhyasagar, Venkatasubramanian; Ding, Hao; Wu, Yuliang			Insight into the Roles of Helicase Motif Ia by Characterizing Fanconi Anemia Group J Protein ( FANCJ) Patient Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; DNA Repair; Enzymes; Mutant; Pathogenesis; FANCJ; Fanconi Anemia; Helicase; Motif Ia	FAMILIAL BREAST-CANCER; DNA-REPAIR FUNCTION; G-QUADRUPLEX DNA; SINGLE-STRANDED-DNA; CROSS-LINK REPAIR; INACTIVATING MUTATIONS; CRYSTAL-STRUCTURES; BINDING PROTEIN; OVARIAN-CANCER; BACH1	Background: Two Fanconi anemia patient missense mutations are localized in FANCJ helicase motif Ia. Results: Mutant R251C impairs the DNA binding ability of FANCJ; Q255H uncouples DNA translocation from helicase activity. Conclusion: Helicase motif Ia plays critical roles in FANCJ enzymatic activity and DNA repair. Significance: Helicase motif Ia is involved not only in nucleic acid binding but also ATP binding and coupling ATP hydrolysis to unwinding. Helicases are molecular motors that couple the energy of ATP hydrolysis to the unwinding and remodeling of structured DNA or RNA, which is coordinated by conserved helicase motifs. FANCJ is a DNA helicase that is genetically linked to Fanconi anemia, breast cancer, and ovarian cancer. Here, we characterized two Fanconi anemia patient mutations, R251C and Q255H, that are localized in helicase motif Ia. Our genetic complementation analysis revealed that both the R251C and Q255H alleles failed to rescue cisplatin sensitivity of a FANCJ null cell line as detected by cell survival or -H2AX foci formation. Furthermore, our biochemical assays demonstrated that both purified recombinant proteins abolished DNA helicase activity and failed to disrupt the DNA-protein complex. Intriguingly, R251C impaired DNA binding ability to single-strand DNA and double-strand DNA, whereas Q255H retained higher binding activity to these DNA substrates compared with wild-type FANCJ protein. Consequently, R251C abolished its DNA-dependent ATP hydrolysis activity, whereas Q255H retained normal ATPase activity. Physically, R251C had reduced ATP binding ability, whereas Q255H had normal ATP binding ability and could translocate on single-strand DNA. Although both proteins were recruited to damage sites in our laser-activated confocal assays, they lost their DNA repair function, which explains why they exerted a domain negative effect when expressed in a wild-type background. Taken together, our work not only reveals the structural function of helicase motif Ia but also provides the molecular pathology of FANCJ in related diseases.	[Guo, Manhong; Vidhyasagar, Venkatasubramanian; Ding, Hao; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Wu, YL (corresponding author), Univ Saskatchewan, Dept Biochem, Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Yuliang.wu@usask.ca	Vidhyasagar, Venkatasubramanian/M-9442-2013	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021	Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada; Canadian Breast Cancer Foundation	Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported, in whole or in part, by the Saskatchewan Health Research Foundation, the Natural Sciences and Engineering Research Council of Canada, and the Canadian Breast Cancer Foundation (to Y.W.).	Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cao AY, 2009, BREAST CANCER RES TR, V115, P51, DOI 10.1007/s10549-008-0052-z; Chang TH, 1997, NUCLEIC ACIDS RES, V25, P5033, DOI 10.1093/nar/25.24.5033; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Frank B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-83; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lewis AG, 2005, BREAST CANCER RES, V7, pR1005, DOI 10.1186/bcr1336; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Marintcheva B, 2003, J VIROL, V77, P2477, DOI 10.1128/JVI.77.4.2477-2488.2003; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rutter JL, 2003, HUM MUTAT, V22, P121, DOI 10.1002/humu.10238; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sigurdson AJ, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-9; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Suhasini AN, 2013, MOL CELL BIOL, V33, P2212, DOI 10.1128/MCB.01256-12; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tanaka N, 2006, BIOCHEMISTRY-US, V45, P6510, DOI 10.1021/bi052656g; Vahteristo P, 2005, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-19; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Wu YL, 2010, CELL CYCLE, V9, P4080, DOI 10.4161/cc.9.20.13667; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	56	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10551	10565		10.1074/jbc.M113.538892	http://dx.doi.org/10.1074/jbc.M113.538892			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573678	hybrid, Green Published			2022-12-25	WOS:000334226400028
J	Kobayashi, N; Tamura, N; van Veen, HW; Yamaguchi, A; Murakami, S				Kobayashi, Naoki; Tamura, Norihisa; van Veen, Hendrik W.; Yamaguchi, Akihito; Murakami, Satoshi			beta-Lactam Selectivity of Multidrug Transporters AcrB and AcrD Resides in the Proximal Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Drug Resistance; Membrane Proteins; Membrane Transport; Multidrug Transporters	GRAM-NEGATIVE BACTERIA; RESISTANCE PROTEIN ABCG2; LARGE PERIPLASMIC LOOPS; EFFLUX PUMP ACRB; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EXPORTER ACRB; SUBSTRATE-SPECIFICITY; CLONING VECTORS; MECHANISM	Background: Bacterial multidrug transporters AcrB and AcrD export -lactam antibiotics. Results: Charged residues in the proximal binding pocket play a crucial role in -lactam selectivity. Conclusion: Proximal pocket acts as a substrate selection filter at the site of entry into the substrate translocation pathway. Significance: Our understanding of molecular mechanisms of antibiotic recognition is essential for overcoming drug resistance. -Lactams are mainstream antibiotics that are indicated for the prophylaxis and treatment of bacterial infections. The AcrA-AcrD-TolC multidrug efflux system confers much stronger resistance on Escherichia coli to clinically relevant anionic -lactam antibiotics than the homologous AcrA-AcrB-TolC system. Using an extensive combination of chimeric analysis and site-directed mutagenesis, we searched for residues that determine the difference in -lactam specificity between AcrB and AcrD. We identified three crucial residues at the proximal (or access) substrate binding pocket. The simultaneous replacement of these residues in AcrB by those in AcrD (Q569R, I626R, and E673G) transferred the -lactam specificity of AcrD to AcrB. Our findings indicate for the first time that the difference in -lactam specificity between AcrB and AcrD relates to interactions of the antibiotic with residues in the proximal binding pocket.	[Kobayashi, Naoki; Tamura, Norihisa; Yamaguchi, Akihito; Murakami, Satoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan; [Kobayashi, Naoki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Kobayashi, Naoki; Tamura, Norihisa; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Murakami, Satoshi] Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Osaka University; Osaka University; University of Cambridge; Tokyo Institute of Technology	Murakami, S (corresponding author), Tokyo Inst Technol, Dept Life Sci, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	murakami@bio.titech.ac.jp	Murakami, Satoshi/E-8155-2015; van Veen, Hendrik W./A-4162-2008	Murakami, Satoshi/0000-0001-5553-7663; van Veen, Hendrik W./0000-0002-9658-8077	Ministry of Education, Culture, Sports, Science and Technology of Japan; Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST); Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), Japan; Strategic International Cooperative Program (JST, Japan); Royal Society (UK); International Human Frontier Science Program Organization (HFSPO); BBSRC [BB/K017713/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017713/1] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), Japan; Strategic International Cooperative Program (JST, Japan); Royal Society (UK)(Royal Society of London); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant-in-aid for Targeted Proteins Research Program (to S. M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the funding program for Next Generation World-Leading Researchers (NEXT Program), the Japan Society for the Promotion of Science (JSPS), ERATO "Lipid Active Structure Project" from the Japan Science and Technology Agency (JST) and the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), Japan, and also supported by grants from the Strategic International Cooperative Program (JST, Japan), Royal Society (UK), and International Human Frontier Science Program Organization (HFSPO) for collaborative research (to S. M. and H. W. v. V.).	Allen JD, 2002, CANCER RES, V62, P2294; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Chen ZS, 2003, CANCER RES, V63, P4048; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Eda S, 2003, J BIOL CHEM, V278, P2085, DOI 10.1074/jbc.C200661200; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Ejendal KFK, 2006, PROTEIN SCI, V15, P1597, DOI 10.1110/ps.051998406; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hardwick LJA, 2007, BRIT J PHARMACOL, V151, P163, DOI 10.1038/sj.bjp.0707218; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Miwa M, 2003, INT J CANCER, V107, P757, DOI 10.1002/ijc.11484; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2003, CURR OPIN STRUC BIOL, V13, P443, DOI 10.1016/S0959-440X(03)00109-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; Tikhonova EB, 2002, J BACTERIOL, V184, P6499, DOI 10.1128/JB.184.23.6499-6507.2002; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	42	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10680	10690		10.1074/jbc.M114.547794	http://dx.doi.org/10.1074/jbc.M114.547794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558035	hybrid, Green Published			2022-12-25	WOS:000334226400038
J	Namadurai, S; Balasuriya, D; Rajappa, R; Wiemhofer, M; Stott, K; Klingauf, J; Edwardson, JM; Chirgadze, DY; Jackson, AP				Namadurai, Sivakumar; Balasuriya, Dilshan; Rajappa, Rajit; Wiemhoefer, Martin; Stott, Katherine; Klingauf, Jurgen; Edwardson, J. Michael; Chirgadze, Dimitri Y.; Jackson, Antony P.			Crystal Structure and Molecular Imaging of the Nav Channel beta 3 Subunit Indicates a Trimeric Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Atomic Force Microscopy; In Vivo Imaging; Sodium Channels; X-ray Crystallography; Photoactivated Localization Microscopy; Protein Trimerization	GATED SODIUM-CHANNELS; AUXILIARY SUBUNIT; SIGMA-1 RECEPTOR; MUTATION; ADHESION; DOMAIN; DETERMINANTS; DIMERIZATION; TRAFFICKING; KINETICS	Background: The vertebrate sodium channel 3 subunit regulates channel behavior. Results: The immunoglobulin domain of the human 3 subunit crystallizes as a trimer, and the full-length protein assembles as a trimer in vivo. Conclusion: Our results reveal an unexpected organization of the 3 subunit. Significance: A new structural insight into the sodium channel is presented. The vertebrate sodium (Na-v) channel is composed of an ion-conducting subunit and associated subunits. Here, we report the crystal structure of the human 3 subunit immunoglobulin (Ig) domain, a functionally important component of Na-v channels in neurons and cardiomyocytes. Surprisingly, we found that the 3 subunit Ig domain assembles as a trimer in the crystal asymmetric unit. Analytical ultracentrifugation confirmed the presence of Ig domain monomers, dimers, and trimers in free solution, and atomic force microscopy imaging also detected full-length 3 subunit monomers, dimers, and trimers. Mutation of a cysteine residue critical for maintaining the trimer interface destabilized both dimers and trimers. Using fluorescence photoactivated localization microscopy, we detected full-length 3 subunit trimers on the plasma membrane of transfected HEK293 cells. We further show that 3 subunits can bind to more than one site on the Na-v 1.5 subunit and induce the formation of subunit oligomers, including trimers. Our results suggest a new and unexpected role for the 3 subunits in Na-v channel cross-linking and provide new structural insights into some pathological Na-v channel mutations.	[Namadurai, Sivakumar; Stott, Katherine; Chirgadze, Dimitri Y.; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Balasuriya, Dilshan; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Rajappa, Rajit; Wiemhoefer, Martin; Klingauf, Jurgen] Univ Munster, Inst Med Phys & Biophys, D-3148149 Munster, Germany	University of Cambridge; University of Cambridge; University of Munster	Chirgadze, DY (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	dyc21@cam.ac.uk; apj10@cam.ac.uk		Jackson, Antony Philip/0000-0002-2895-7387; Chirgadze, Dimitri/0000-0001-9942-0993; Stott, Katherine/0000-0002-4014-1188	Parke Davis/Pfizer; University of Cambridge	Parke Davis/Pfizer; University of Cambridge(University of Cambridge)	This work was supported in part by an unrestricted grant from Parke Davis/Pfizer (to A. P. J.) and funds from the University of Cambridge.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balasuriya D, 2013, J NEUROSCI, V33, P18219, DOI 10.1523/JNEUROSCI.3360-13.2013; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chaudhuri S, 2011, BIOPHYS CHEM, V154, P26, DOI 10.1016/j.bpc.2010.12.003; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Fendri-Kriaa N, 2011, EUR J NEUROL, V18, P695, DOI 10.1111/j.1468-1331.2010.03216.x; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hakim P, 2010, ACTA PHYSIOL, V198, P47, DOI 10.1111/j.1748-1716.2009.02048.x; Hakim P, 2008, PROG BIOPHYS MOL BIO, V98, P251, DOI 10.1016/j.pbiomolbio.2009.01.005; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Ishikawa T, 2013, CIRC J, V77, P959, DOI 10.1253/circj.CJ-12-0995; Islas AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081995; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lei M, 2008, PROG BIOPHYS MOL BIO, V98, P171, DOI 10.1016/j.pbiomolbio.2008.10.003; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mercier A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048690; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tan BH, 2010, HEART RHYTHM, V7, P771, DOI 10.1016/j.hrthm.2010.01.032; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valdivia CR, 2010, CARDIOVASC RES, V86, P392, DOI 10.1093/cvr/cvp417; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Veitia RA, 2007, PLANT CELL, V19, P3843, DOI 10.1105/tpc.107.055053; Wang PY, 2010, BIOCHEM BIOPH RES CO, V398, P98, DOI 10.1016/j.bbrc.2010.06.042; Waxman SG, 2012, J PHYSIOL-LONDON, V590, P2601, DOI 10.1113/jphysiol.2012.228460; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yereddi NR, 2013, FASEB J, V27, P568, DOI 10.1096/fj.12-209445; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Yu FH, 2003, J NEUROSCI, V23, P7577	62	52	53	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10797	10811		10.1074/jbc.M113.527994	http://dx.doi.org/10.1074/jbc.M113.527994			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567321	hybrid, Green Published			2022-12-25	WOS:000334226400048
J	Saha, PP; Kumar, SKP; Srivastava, S; Sinha, D; Pareek, G; D'Silva, P				Saha, Prasenjit Prasad; Kumar, Praveen S. K.; Srivastava, Shubhi; Sinha, Devanjan; Pareek, Gautam; D'Silva, Patrick			The Presence of Multiple Cellular Defects Associated with a Novel G50E Iron-Sulfur Cluster Scaffold Protein ( ISCU) Mutation Leads to Development of Mitochondrial Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Transport System (ETS); Iron-Sulfur Protein; Mitochondrial Diseases; Molecular Chaperone; Reactive Oxygen Species (ROS); Hsp70; J-protein; Iron-Sulfur Cluster; Myopathy	RESPIRATORY COMPLEX-I; SACCHAROMYCES-CEREVISIAE; SUCCINATE-DEHYDROGENASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; CHAPERONE JAC1; ATP SYNTHESIS; CO-CHAPERONE; BIOGENESIS; METABOLISM	Background: Muscle-specific deficiency of iron-sulfur (Fe-S) cluster scaffold protein (ISCU) leads to myopathy. Results: Cells carrying the myopathy-associated G50E ISCU mutation demonstrate impaired Fe-S cluster biogenesis and mitochondrial dysfunction. Conclusion: Reduced mitochondrial respiration as a result of diminished Fe-S cluster synthesis results in muscle weakness in myopathy patients. Significance: The molecular mechanism behind disease progression should provide invaluable information to combat ISCU myopathy. Iron-sulfur (Fe-S) clusters are versatile cofactors involved in regulating multiple physiological activities, including energy generation through cellular respiration. Initially, the Fe-S clusters are assembled on a conserved scaffold protein, iron-sulfur cluster scaffold protein (ISCU), in coordination with iron and sulfur donor proteins in human mitochondria. Loss of ISCU function leads to myopathy, characterized by muscle wasting and cardiac hypertrophy. In addition to the homozygous ISCU mutation (g.7044GC), compound heterozygous patients with severe myopathy have been identified to carry the c.149GA missense mutation converting the glycine 50 residue to glutamate. However, the physiological defects and molecular mechanism associated with G50E mutation have not been elucidated. In this report, we uncover mechanistic insights concerning how the G50E ISCU mutation in humans leads to the development of severe ISCU myopathy, using a human cell line and yeast as the model systems. The biochemical results highlight that the G50E mutation results in compromised interaction with the sulfur donor NFS1 and the J-protein HSCB, thus impairing the rate of Fe-S cluster synthesis. As a result, electron transport chain complexes show significant reduction in their redox properties, leading to loss of cellular respiration. Furthermore, the G50E mutant mitochondria display enhancement in iron level and reactive oxygen species, thereby causing oxidative stress leading to impairment in the mitochondrial functions. Thus, our findings provide compelling evidence that the respiration defect due to impaired biogenesis of Fe-S clusters in myopathy patients leads to manifestation of complex clinical symptoms.	[Saha, Prasenjit Prasad; Kumar, Praveen S. K.; Srivastava, Shubhi; Sinha, Devanjan; Pareek, Gautam; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	S K, Praveen Kumar/AAA-8999-2022; PAREEK, GAUTAM/AAN-4638-2020; D'Silva, Patrick/L-6653-2019; Saha, Prasenjit/ABC-6481-2020; Sinha, Devanjan/A-3953-2017	S K, Praveen Kumar/0000-0002-9696-9734; PAREEK, GAUTAM/0000-0001-8430-9870; Sinha, Devanjan/0000-0001-5060-2075; Saha, Prasenjit/0000-0003-4679-2368	Council of Scientific and Industrial Research, India [37(1534)/12/EMR-II]; Department of Biotechnology, India; Department of Science and Technology (DST), India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India))	This work was supported by Council of Scientific and Industrial Research, India, Grant 37(1534)/12/EMR-II (to P. D. S).; Recipient of a research associate fellowship from the Department of Biotechnology, India.; Recipient of an INSPIRE fellowship from the Department of Science and Technology (DST), India.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Craig EA, 1999, BIOL CHEM, V380, P1167, DOI 10.1515/BC.1999.148; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; GALLET PF, 1995, EUR J BIOCHEM, V228, P113, DOI 10.1111/j.1432-1033.1995.tb20238.x; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Goswami AV, 2012, HUM MOL GENET, V21, P3317, DOI 10.1093/hmg/dds162; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kollberg G, 2011, NEUROMUSCULAR DISORD, V21, P115, DOI 10.1016/j.nmd.2010.11.010; Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P833, DOI 10.1016/j.nmd.2009.09.011; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Levi S, 2009, BBA-GEN SUBJECTS, V1790, P629, DOI 10.1016/j.bbagen.2008.09.008; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Shimomura Y, 2007, J BIOCHEM, V142, P577, DOI 10.1093/jb/mvm163; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wu G, 2002, BIOCHEMISTRY-US, V41, P5024, DOI 10.1021/bi016073s	64	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10359	10377		10.1074/jbc.M113.526665	http://dx.doi.org/10.1074/jbc.M113.526665			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573684	Green Published, hybrid			2022-12-25	WOS:000334226400011
J	Wie, SM; Adwan, TS; DeGregori, J; Anderson, SM; Reyland, ME				Wie, Sten M.; Adwan, Tariq S.; DeGregori, James; Anderson, Steven M.; Reyland, Mary E.			Inhibiting Tyrosine Phosphorylation of Protein Kinase C delta( PKC delta) Protects the Salivary Gland from Radiation Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Nonreceptor Tyrosine Kinase; Protein Kinase C (PKC); Radiation Biology; Salivary Gland	GROWTH-FACTOR RECEPTOR; C-DELTA; PKC-DELTA; INDUCED APOPTOSIS; INDUCED ACTIVATION; SRC FAMILY; DASATINIB; ABL; ALPHA; HEAD	Background: Nuclear import of protein kinase C is required for DNA-damage-induced apoptosis. Results: c-Src and c-Abl phosphorylate PKC to regulate nuclear import. Tyrosine kinase inhibitors block nuclear translocation of PKC and suppress apoptosis. Conclusion: Tyrosine kinase inhibitors can regulate the pro-apoptotic function of protein kinase C. Significance: Tyrosine kinase inhibitors may improve the quality of life in cancer patients receiving radiation therapy. Radiation therapy for head and neck cancer can result in extensive damage to normal adjacent tissues such as the salivary gland and oral mucosa. We have shown previously that tyrosine phosphorylation at Tyr-64 and Tyr-155 activates PKC in response to apoptotic stimuli by facilitating its nuclear import. Here we have identified the tyrosine kinases that mediate activation of PKC in apoptotic cells and have explored the use of tyrosine kinase inhibitors for suppression of irradiation-induced apoptosis. We identify the damage-inducible kinase, c-Abl, as the PKC Tyr-155 kinase and c-Src as the Tyr-64 kinase. Depletion of c-Abl or c-Src with shRNA decreased irradiation- and etoposide-induced apoptosis, suggesting that inhibitors of these kinases may be useful therapeutically. Pretreatment with dasatinib, a broad spectrum tyrosine kinase inhibitor, blocked phosphorylation of PKC at both Tyr-64 and Tyr-155. Expression of gate-keeper mutants of c-Abl or c-Src that are active in the presence of dasatinib restored phosphorylation of PKC at Tyr-155 and Tyr-64, respectively. Imatinib, a c-Abl-selective inhibitor, also specifically blocked PKC Tyr-155 phosphorylation. Dasatinib and imatinib both blocked binding of PKC to importin- and nuclear import, demonstrating that tyrosine kinase inhibitors can inhibit nuclear accumulation of PKC. Likewise, pretreatment with dasatinib also suppressed etoposide and radiation induced apoptosis in vitro. In vivo, pre-treatment of mice with dasatinib blocked radiation-induced apoptosis in the salivary gland by >60%. These data suggest that tyrosine kinase inhibitors may be useful prophylactically for protection of nontumor tissues in patients undergoing radiotherapy of the head and neck.	[Wie, Sten M.] Univ Colorado, Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA; [DeGregori, James] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Wie, Sten M.; Adwan, Tariq S.; Reyland, Mary E.] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, MS 8120,Med Campus, Aurora, CO 80045 USA.	mary.reyland@ucdenver.edu		DeGregori, James/0000-0002-1287-1976	National Institutes of Health Grants [5R01DE015648, 1R01CA180175, R01CA138482, P30CA046934]; NATIONAL CANCER INSTITUTE [R01CA138482, R01CA180175, R21CA179501, R01CA157850, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015648] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01DE015648 (to M. E. R.), 1R01CA180175 (to J. D.), R01CA138482 (to S. M. A.), and P30CA046934 (Cancer Center Support; DNA Sequencing, Tissue Culture, Histology and Radiation Cores).	Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Arany S, 2013, MOL THER, V21, P1182, DOI 10.1038/mt.2013.42; Arany S, 2012, J CELL BIOCHEM, V113, P1955, DOI 10.1002/jcb.24064; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Banninger GP, 2011, ORAL DIS, V17, P601, DOI 10.1111/j.1601-0825.2011.01819.x; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Chari R, 2009, BLOOD, V114, P3056, DOI 10.1182/blood-2008-11-188516; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Furmanski BD, 2013, CLIN CANCER RES, V19, P4359, DOI 10.1158/1078-0432.CCR-13-0980; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; Gonfloni S., 2012, INT J CELL BIOL, V2012; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Haughian JM, 2006, ENDOCR-RELAT CANCER, V13, P1251, DOI 10.1677/erc.1.01278; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kajimoto T, 2010, J BIOL CHEM, V285, P41896, DOI 10.1074/jbc.M110.184028; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Leitges M, 2001, J CLIN INVEST, V108, P1505; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Lin DB, 2005, J BIOL CHEM, V280, P13682, DOI 10.1074/jbc.M407762200; Lin YC, 2012, NEOPLASIA, V14, P463, DOI 10.1596/neo.12300; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015; Rybin VO, 2008, J BIOL CHEM, V283, P17777, DOI 10.1074/jbc.M800333200; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Saito S, 2002, J BIOL CHEM, V277, P44695, DOI 10.1074/jbc.M208332200; Soref CM, 2012, INT J RADIAT ONCOL, V82, pE701, DOI 10.1016/j.ijrobp.2011.11.038; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Yamanouchi D, 2010, CARDIOVASC RES, V85, P434, DOI 10.1093/cvr/cvp328; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698	49	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10900	10908		10.1074/jbc.M114.551366	http://dx.doi.org/10.1074/jbc.M114.551366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569990	Green Published, hybrid			2022-12-25	WOS:000334226400057
J	Jain, M; Lim, Y; Arce-Nazario, JA; Uriarte, M				Jain, Meha; Lim, Yili; Arce-Nazario, Javier A.; Uriarte, Maria			Perceptional and Socio-Demographic Factors Associated with Household Drinking Water Management Strategies in Rural Puerto Rico	PLOS ONE			English	Article							POINT-OF-USE; QUALITY; REGRESSION; MODELS	Identifying which factors influence household water management can help policy makers target interventions to improve drinking water quality for communities that may not receive adequate water quality at the tap. We assessed which perceptional and socio-demographic factors are associated with household drinking water management strategies in rural Puerto Rico. Specifically, we examined which factors were associated with household decisions to boil or filter tap water before drinking, or to obtain drinking water from multiple sources. We find that households differ in their management strategies depending on the institution that distributes water (i.e. government PRASA vs community-managed non-PRASA), perceptions of institutional efficacy, and perceptions of water quality. Specifically, households in PRASA communities are more likely to boil and filter their tap water due to perceptions of low water quality. Households in non-PRASA communities are more likely to procure water from multiple sources due to perceptions of institutional inefficacy. Based on informal discussions with community members, we suggest that water quality may be improved if PRASA systems improve the taste and odor of tap water, possibly by allowing for dechlorination prior to distribution, and if non-PRASA systems reduce the turbidity of water at the tap, possibly by increasing the degree of chlorination and filtering prior to distribution. Future studies should examine objective water quality standards to identify whether current management strategies are effective at improving water quality prior to consumption.	[Jain, Meha; Lim, Yili; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Arce-Nazario, Javier A.] Univ Puerto Rico Cayey, Dept Biol, Cayey, PR USA	Columbia University; University of Puerto Rico; University of Puerto Rico at Cayey	Jain, M (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mj2415@columbia.edu			National Science Foundation [DEB 0620910]; Crosscutting Initiatives program, Earth Institute, Columbia University; National Center on Minority Health and Health Disparities [P20MD006144]; National Science Foundation Graduate Research Fellowship [11-44155]; National Institute on Minority Health and Health Disparities [P20MD006144] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Crosscutting Initiatives program, Earth Institute, Columbia University; National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding was provided by awards to MU from National Science Foundation DEB 0620910 and the Crosscutting Initiatives program, Earth Institute, Columbia University. This study was partially supported by Award Number P20MD006144 from the National Center on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center on Minority Health and Health Disparities or the National Institutes of Health. This work was also supported by the National Science Foundation Graduate Research Fellowship under Grant No. 11-44155 awarded to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Autoridad de Acueductos y Alcantarillados, 2001, WAT QUAL REP; Below TB, 2012, GLOBAL ENVIRON CHANG, V22, P223, DOI 10.1016/j.gloenvcha.2011.11.012; Berkes F, 2006, ECOL SOC, V11; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; Cash DW, 2006, ECOL SOC, V11; Chowdhury S, 2009, SCI TOTAL ENVIRON, V407, P4189, DOI 10.1016/j.scitotenv.2009.04.006; Clasen TF, 2004, TROP MED INT HEALTH, V9, P187, DOI 10.1046/j.1365-3156.2003.01191.x; de Cardenas SC, 2011, DOES PRIVATE MANAGEM; Environmental Protection Agency, 2010, PUERT RIC AQ SEW AUT; Fielding KS, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012398; Gartin M, 2010, ECOL SOC, V15; Gelman A., 2007, ANAL METHODS SOCIAL, DOI 10.1017/CBO9780511790942; Gueprero-Preston R, 2008, P R HEALTH SCI J, V27, P229; Hellard ME, 2001, ENVIRON HEALTH PERSP, V109, P773, DOI 10.2307/3454818; Hu ZH, 2011, INT J ENV RES PUB HE, V8, P565, DOI 10.3390/ijerph8020565; Hunter PR, 2010, BMC PUBLIC HLTH, V10; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Jehu-Appiah C, 2012, HEALTH POLICY PLANN, V27, P222, DOI 10.1093/heapol/czr032; Jorgensen B, 2009, J ENVIRON MANAGE, V91, P227, DOI 10.1016/j.jenvman.2009.08.009; Katuwal H, 2011, J WATER HEALTH, V9, P143, DOI 10.2166/wh.2010.151; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Lebel L, 2005, ECOLOGY SOC, V10; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Makutsa P, 2001, AM J PUBLIC HEALTH, V91, P1571, DOI 10.2105/AJPH.91.10.1571; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; Molina-Rivera W, 1998, ESTIMATED WATER USE; NORTH DC, 1991, J ECON PERSPECT, V5, P97, DOI 10.1257/jep.5.1.97; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; Palanski ME, 2011, J BUS ETHICS, V99, P201, DOI 10.1007/s10551-010-0650-7; PAYMENT P, 1985, APPL ENVIRON MICROB, V49, P1418, DOI 10.1128/AEM.49.6.1418-1428.1985; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Puerto Rico Department of Public Health, 1996, WAT QUAL REP; Quinones F, 2005, PRASA HAS AMPLE WATE; Sabau G, 2008, WATER ENVIRON J, V22, P168, DOI 10.1111/j.1747-6593.2007.00096.x; Sangodoyin AY, 1993, ENV MANAGEMENT HLTH; Saravanan VS, 2008, ECOL COMPLEX, V5, P202, DOI 10.1016/j.ecocom.2008.04.003; Sarker A, 2008, ECOL ECON, V68, P461, DOI 10.1016/j.ecolecon.2008.05.001; Sobsey M. D., 2002, MANAGING WATER HOME; Teunis P, 1997, WATER RES; Toro GR, 2004, REGULATION FINANCING; Trevett AF, 2004, INT J ENVIRON HEAL R, V14, P273, DOI 10.1080/09603120410001725612; US Bureau of the Census, 2000, CENS POP SOC EC CHAR; Worley JL, 2000, EVALUATION DECHLORIN; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5; Zerah, 2000, WATER UNRELIABLE SUP	49	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88059	10.1371/journal.pone.0088059	http://dx.doi.org/10.1371/journal.pone.0088059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3DW	24586302	Green Submitted, Green Published, gold			2022-12-25	WOS:000332396200015
J	Li, H; Glusman, G; Huff, C; Caballero, J; Roach, JC				Li, Hong; Glusman, Gustavo; Huff, Chad; Caballero, Juan; Roach, Jared C.			Accurate and Robust Prediction of Genetic Relationship from Whole-Genome Sequences	PLOS ONE			English	Article							ASSOCIATION; PEDIGREE; GENOTYPE; FORMAT; LOCI	Computing the genetic relationship between two humans is important to studies in genetics, genomics, genealogy, and forensics. Relationship algorithms may be sensitive to noise, such as that arising from sequencing errors or imperfect reference genomes. We developed an algorithm for estimation of genetic relationship by averaged blocks (GRAB) that is designed for whole-genome sequencing (WGS) data. GRAB segments the genome into blocks, calculates the fraction of blocks sharing identity, and then uses a classification tree to infer 1st- to 5th-degree relationships and unrelated individuals. We evaluated GRAB on simulated and real sequenced families, and compared it with other software. GRAB achieves similar performance, and does not require knowledge of population background or phasing. GRAB can be used in workflows for identifying unreported relationships, validating reported relationships in family-based studies, and detection of sample-tracking errors or duplicate inclusion. The software is available at familygenomics.systemsbiology.net/grab.	[Li, Hong; Glusman, Gustavo; Caballero, Juan; Roach, Jared C.] Inst Syst Biol, Seattle, WA USA; [Huff, Chad] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center	Roach, JC (corresponding author), Inst Syst Biol, Seattle, WA USA.	jroach@systemsbiology.org		Glusman, Gustavo/0000-0001-8060-5955; Caballero Perez, Juan/0000-0002-6160-3644	National Institutes of Health [GM076547]; University of Luxembourg - ISB Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Luxembourg - ISB Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health [grant GM076547] and the University of Luxembourg - ISB Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brush G, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S41; Cherny SS, 2001, GENET EPIDEMIOL, V21, pS117, DOI 10.1002/gepi.2001.21.s1.s117; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reese MG, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r88; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roberson EDO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006711; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960	15	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e85437	10.1371/journal.pone.0085437	http://dx.doi.org/10.1371/journal.pone.0085437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586241	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200007
J	Yap, L; Carruthers, S; Thompson, S; Cheng, W; Jones, J; Simpson, P; Richards, A; Thein, HH; Haber, P; Lloyd, A; Butler, T				Yap, Lorraine; Carruthers, Susan; Thompson, Sandra; Cheng, Wendy; Jones, Jocelyn; Simpson, Paul; Richards, Alun; Thein, Hla-Hla; Haber, Paul; Lloyd, Andrew; Butler, Tony			A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners	PLOS ONE			English	Article							INJECTION-DRUG USERS; VIRUS HCV INFECTION; COINFECTION; BARRIERS; ACCESS; CARE; FEASIBILITY; CLIENTS; PEOPLE; SYSTEM	Background: Hepatitis C virus infection (HCV) has a significant global health burden with an estimated 2%-3% of the world's population infected, and more than 350,000 dying annually from HCV-related conditions including liver failure and liver cancer. Prisons potentially offer a relatively stable environment in which to commence treatment as they usually provide good access to health care providers, and are organised around routine and structure. Uptake of treatment of HCV, however, remains low in the community and in prisons. In this study, we explored factors affecting treatment uptake inside prisons and hypothesised that prisoners have unique issues influencing HCV treatment uptake as a consequence of their incarceration which are not experienced in other populations. Method and Findings: We undertook a qualitative study exploring prisoners' accounts of why they refused, deferred, delayed or discontinued HCV treatment in prison. Between 2010 and 2013, 116 Australian inmates were interviewed from prisons in New South Wales, Queensland, and Western Australia. Prisoners experienced many factors similar to those which influence treatment uptake of those living with HCV infection in the community. Incarceration, however, provides different circumstances of how these factors are experienced which need to be better understood if the number of prisoners receiving treatment is to be increased. We developed a descriptive model of patient readiness and motivators for HCV treatment inside prisons and discussed how we can improve treatment uptake among prisoners. Conclusion: This study identified a broad and unique range of challenges to treatment of HCV in prison. Some of these are likely to be diminished by improving treatment options and improved models of health care delivery. Other barriers relate to inmate understanding of their illness and stigmatisation by other inmates and custodial staff and generally appear less amenable to change although there is potential for peer-based education to address lack of knowledge and stigma.	[Yap, Lorraine; Simpson, Paul; Thein, Hla-Hla; Butler, Tony] Univ New S Wales, Kirby Inst, Justice Hlth Res Program, Sydney, NSW, Australia; [Carruthers, Susan; Jones, Jocelyn] Curtin Univ, Natl Drug Res Inst, Perth, WA 6845, Australia; [Thompson, Sandra] Combined Univ Rural Hlth, Geraldton, WA, Australia; [Cheng, Wendy] Royal Perth Hosp, Perth, WA 6001, Australia; [Richards, Alun] Queensland Hlth, Offender Hlth Serv, Brisbane, Qld, Australia; [Thein, Hla-Hla] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Haber, Paul] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lloyd, Andrew] Univ New S Wales, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Curtin University; Royal Perth Hospital; University of Western Australia; Queensland Health; University of Toronto; University of Sydney; University of New South Wales Sydney	Yap, L (corresponding author), Univ New S Wales, Kirby Inst, Justice Hlth Res Program, Sydney, NSW, Australia.	l.yap@unsw.edu.au	Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/E-7334-2017; Lloyd, Andrew/AAF-6071-2022	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Jones, Jocelyn/0000-0001-6260-0472; Butler, Tony/0000-0002-2679-2769; Thein, Hla-Hla/0000-0003-4950-187X	National Health and Medical Research Council (NHMRC) [594444]; Australian Research Council (ARC) [FT0991864]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This study was supported by a National Health and Medical Research Council (NHMRC) grant (No. 594444). Tony Butler is supported by an Australian Research Council (ARC) Future Fellowship (No. FT0991864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Material in this paper cannot be considered as either endorsed by or an expression of the policies or views of the departments of corrective services.	Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Boonwaat L, 2010, MED J AUSTRALIA, V192, P496, DOI 10.5694/j.1326-5377.2010.tb03605.x; Butler T, 2001, 2001 INMATE HLTH SUR; Butler T., 2017, NATL PRISON ENTRANTS; Butler T, 2007, AUST NZ J PUBL HEAL, V31, P44, DOI 10.1111/j.1753-6405.2007.00009.x; Coupland H, 2009, HEALTH PROMOT J AUST, V20, P234, DOI 10.1071/HE09234; Crofts, 1997, Health Hum Rights, V2, P86, DOI 10.2307/4065273; Dai CY, 2010, DIGEST DIS SCI, V55, P3300, DOI 10.1007/s10620-010-1452-6; DOHA, 2012, COMM DIS INT AUSTR N; Dore GJ, 2012, MED J AUSTRALIA, V196, P629, DOI 10.5694/mja11.11531; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gidding HF, 2009, J GASTROEN HEPATOL, V24, P1648, DOI 10.1111/j.1440-1746.2009.05910.x; Glaser B, 1978, DISCOV GROUNDED THEO; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Grebely J, 2013, J INFECT DIS, V207, pS19, DOI 10.1093/infdis/jis928; Grebely J, 2011, CURR OPIN HIV AIDS, V6, P501, DOI 10.1097/COH.0b013e32834bcb36; Holt DT, 2007, RES ORGAN CHAN DEV, V16, P289, DOI 10.1016/S0897-3016(06)16009-7; Khaw FM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-98; Lloyd AR, 2013, CLIN INFECT DIS, V56, P1078, DOI 10.1093/cid/cis1202; Maru DSR, 2008, CLIN INFECT DIS, V47, P952, DOI 10.1086/591707; McLaren M, 2008, CAN J GASTROENTEROL, V22, P133, DOI 10.1155/2008/949582; McNally S, 2009, RECOGNISING RESPONDI; Mehta SH, 2005, AIDS, V19, pS179, DOI 10.1097/01.aids.0000192088.72055.90; Norman J, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-8; Osilla KC, 2009, AIDS PATIENT CARE ST, V23, P993, DOI 10.1089/apc.2009.0153; Post JJ, 2013, CLIN INFECT DIS, V57, pS70, DOI 10.1093/cid/cit265; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Scheft H, 2005, CLIN INFECT DIS, V40, pS292, DOI 10.1086/427443; Strathdee SA, 2005, CLIN INFECT DIS, V40, pS304, DOI 10.1086/427445; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; Treloar C, 2010, J VIRAL HEPATITIS, V17, P839, DOI 10.1111/j.1365-2893.2009.01250.x; Treloar C, 2008, AUST HEALTH REV, V32, P570, DOI 10.1071/AH080570; Vickerman P, 2011, DRUG ALCOHOL DEPEN, V113, P83, DOI 10.1016/j.drugalcdep.2010.08.001; Wagner GJ, 2005, AIDS, V19, pS190, DOI 10.1097/01.aids.0000192089.54130.b6; Walsh N, 2008, J GASTROEN HEPATOL, V23, P1891, DOI 10.1111/j.1440-1746.2008.05508.x; Ward JW, 2012, GASTROENTEROLOGY, V143, P887, DOI 10.1053/j.gastro.2012.08.027; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	40	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e87564	10.1371/journal.pone.0087564	http://dx.doi.org/10.1371/journal.pone.0087564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586281	Green Published, gold			2022-12-25	WOS:000332390800004
J	Volakis, LI; Li, R; Ackerman, WE; Mihai, C; Bechel, M; Summerfield, TL; Ahn, CS; Powell, HM; Zielinski, R; Rosol, TJ; Ghadiali, SN; Kniss, DA				Volakis, Leonithas I.; Li, Ruth; Ackerman, William E.; Mihai, Cosmin; Bechel, Meagan; Summerfield, Taryn L.; Ahn, Christopher S.; Powell, Heather M.; Zielinski, Rachel; Rosol, Thomas J.; Ghadiali, Samir N.; Kniss, Douglas A.			Loss of Myoferlin Redirects Breast Cancer Cell Motility towards Collective Migration	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MEMBRANE TENSION; EXPRESSION; STABILITY; SIGNATURE; FILOPODIA; DYNAMICS; PROGRAMS; FUSION	Cell migration plays a central role in the invasion and metastasis of tumors. As cells leave the primary tumor, they undergo an epithelial to mesenchymal transition (EMT) and migrate as single cells. Epithelial tumor cells may also migrate in a highly directional manner as a collective group in some settings. We previously discovered that myoferlin (MYOF) is overexpressed in breast cancer cells and depletion of MYOF results in a mesenchymal to epithelial transition (MET) and reduced invasion through extracellular matrix (ECM). However, the biomechanical mechanisms governing cell motility during MYOF depletion are poorly understood. We first demonstrated that lentivirus-driven shRNA-induced MYOF loss in MDA-MB-231 breast cancer cells (MDA-231 MYOF-KD) leads to an epithelial morphology compared to the mesenchymal morphology observed in control (MDA-231 LTVC) and wild-type cells. Knockdown of MYOF led to significant reductions in cell migration velocity and MDA-231 MYOF-KD cells migrated directionally and collectively, while MDA-231 LTVC cells exhibited single cell migration. Decreased migration velocity and collective migration were accompanied by significant changes in cell mechanics. MDA-231 MYOF-KD cells exhibited a 2-fold decrease in cell stiffness, a 2-fold increase in cell-substrate adhesion and a 1.5-fold decrease in traction force generation. In vivo studies demonstrated that when immunocompromised mice were implanted with MDA-231 MYOF-KD cells, tumors were smaller and demonstrated lower tumor burden. Moreover, MDA-231 MYOF-KD tumors were highly circularized and did not invade locally into the adventia in contrast to MDA-231(LTVC)-injected animals. Thus MYOF loss is associated with a change in tumor formation in xenografts and leads to smaller, less invasive tumors. These data indicate that MYOF, a previously unrecognized protein in cancer, is involved in MDA-MB-231 cell migration and contributes to biomechanical alterations. Our results indicate that changes in biomechanical properties following loss of this protein may be an effective way to alter the invasive capacity of cancer cells.	[Volakis, Leonithas I.; Mihai, Cosmin; Ahn, Christopher S.; Powell, Heather M.; Zielinski, Rachel; Ghadiali, Samir N.; Kniss, Douglas A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Li, Ruth; Ackerman, William E.; Bechel, Meagan; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Columbus, OH 43210 USA; [Li, Ruth; Ackerman, William E.; Bechel, Meagan; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Lab Perinatal Res, Columbus, OH 43210 USA; [Powell, Heather M.] Ohio State Univ, Dept Mat Sci Engn, Columbus, OH 43210 USA; [Rosol, Thomas J.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA; [Ghadiali, Samir N.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kniss, DA (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.	kniss.1@osu.edu	Ghadiali, Samir/AAN-7772-2020; Ghadiali, Samir N./C-5463-2012; Ackerman, William Edward/GRS-5804-2022; Rosol, Thomas/G-9585-2011	Ghadiali, Samir/0000-0002-6845-774X; Ghadiali, Samir N./0000-0002-6845-774X; Ackerman, William Edward/0000-0001-7366-3903; Rosol, Thomas/0000-0003-3737-1190; Powell, Heather/0000-0002-6845-8101; Ahn, Christopher/0000-0003-4036-5656	NSF CBET [1134201]; NSF EEC [042562]; Ohio State University Wexner Medical Center's Perinatal Research and Development Fund	NSF CBET(National Science Foundation (NSF)); NSF EEC(National Science Foundation (NSF)); Ohio State University Wexner Medical Center's Perinatal Research and Development Fund	The authors acknowledge grant support from NSF CBET#1134201, NSF EEC#042562 (http://NSF.gov), and The Ohio State University Wexner Medical Center's Perinatal Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; ARGON Y, 1980, GENETICS, V96, P413; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Dusheck J, 2012, NATURE, V491, pS50, DOI 10.1038/491S50a; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Guck J, 2010, INTEGR BIOL-UK, V2, P575, DOI 10.1039/c0ib00050g; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lek A, 2012, TRAFFIC, V13, P185, DOI 10.1111/j.1600-0854.2011.01267.x; Leung C, 2013, AM J PATHOL, V182, P1900, DOI 10.1016/j.ajpath.2013.01.041; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039766; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mihai C, 2012, AM J PHYSIOL-LUNG C, V302, pL287, DOI 10.1152/ajplung.00037.2011; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rorth P, 2012, EMBO REP, V13, P984, DOI 10.1038/embor.2012.149; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vedel S, 2013, P NATL ACAD SCI USA, V110, P129, DOI 10.1073/pnas.1204291110; Weiger MC, 2010, BIOPHYS J, V98, P67, DOI 10.1016/j.bpj.2009.09.051; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu C, 2011, VASC PHARMACOL, V55, P26, DOI 10.1016/j.vph.2011.04.001; Zielinski R, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024467	55	44	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e86110	10.1371/journal.pone.0086110	http://dx.doi.org/10.1371/journal.pone.0086110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586247	gold, Green Submitted, Green Published			2022-12-25	WOS:000332389000004
J	Qian, J; Zhou, H; Chen, JW; Ding, Q; Cao, Q; Qin, C; Shao, PF; Li, P; Cai, HZ; Meng, XX; Ju, XB; Wang, ML; Zhang, ZD; Li, J; Hua, LX; Yin, CJ				Qian, Jian; Zhou, Hai; Chen, Jiawei; Ding, Qi; Cao, Qiang; Qin, Chao; Shao, Pengfei; Li, Pu; Cai, Hongzhou; Meng, Xiaoxin; Ju, Xiaobing; Wang, Meilin; Zhang, Zhengdong; Li, Jie; Hua, Lixin; Yin, Changjun			Genetic Polymorphisms in IGF-I and IGFBP-3 Are Associated with Prostate Cancer in the Chinese Population	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR-BINDING-PROTEINS; COLORECTAL-CANCER; BREAST-CANCER; PLASMA-LEVELS; RISK-FACTORS; LUNG-CANCER; SURVIVAL; MORTALITY; COHORT	Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) are members of the insulin-like growth factor (IGF) family that play important roles in carcinogenesis. We hypothesized that the functional polymorphisms in IGF-I and IGFBP-3 may be associated with the risk of prostate cancer (PCa) in the Chinese population. This hospital-based case-control study included 664 PCa patients and 702 cancer-free controls. Nine SNPs in IGF-I and IGFBP-3 were genotyped using the TaqMan assay. The genetic associations between the pathogenesis and progression of PCa were assessed by logistic regression. We found that the genotype and allele frequency distribution of rs6218, rs35767 and rs5742612 were significantly different when comparing PCa cases to controls (P = 0.005, 0.005 and 0.020, respectively). In the combined analysis, individuals with 2-6 risk alleles had an elevated risk of PCa compared to those with 0-1 risk alleles. We also found that the association between the combined risk alleles and the risk of PCa appeared stronger in the following subgroups: individuals older than 71 years of age (OR = 1.41, 95% CI = 1.05-1.91, P = 0.020), nonsmokers (OR = 1.68, 95% CI = 1.21-2.32, P = 0.002), nondrinkers (OR = 1.32, 95% CI = 1.02-1.61, P = 0.002), and those with a negative family history of PCa (OR = 1.28, 95% CI = 1.02-1.71, P = 0.022). Our results indicate that the three SNPs (rs6218, rs35767 and rs5742612) and the joint genotypes with 2-6 risk alleles, may contribute to the susceptibility to PCa, but not the progression, in the Chinese population.	[Qian, Jian; Zhou, Hai; Cao, Qiang; Qin, Chao; Shao, Pengfei; Li, Pu; Cai, Hongzhou; Meng, Xiaoxin; Ju, Xiaobing; Li, Jie; Hua, Lixin; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chen, Jiawei] Shandong Univ, Qiluhospital, Dept Pediat Surg, Jinan 250100, Peoples R China; [Ding, Qi] Suzhou Univ, Changshu Hosp, Dept Urol, Changshu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol & Genet Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Shandong University; Nanjing Medical University	Hua, LX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	hlx5858@163.com; drcjyin@gmail.com	Cao, Qiang/K-2349-2019; zhang, zheng/HCH-9684-2022	Cai, Hongzhou/0000-0001-6915-564X	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science [BL2012027]; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China [81171963, 81201998, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Provincial Special Program of Medical Science; Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Jiangsu Provincial Special Program of Medical Science (BL2012027), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, by the National Natural Science Foundation of China [grant number 81171963, 81201998, 81201571]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chen WS, 2009, EUR J HUM GENET, V17, P1668, DOI 10.1038/ejhg.2009.86; Cheng I, 2006, JNCI-J NATL CANCER I, V98, P123, DOI 10.1093/jnci/djj013; Darago A, 2011, CLIN CHEM LAB MED, V49, P1699, DOI 10.1515/CCLM.2011.651; Deming SL, 2007, BREAST CANCER RES TR, V104, P309, DOI 10.1007/s10549-006-9420-8; Dianat SS, 2009, BJU INT, V104, P1560, DOI 10.1111/j.1464-410X.2009.08973.x; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Harrela M, 1996, J CLIN INVEST, V98, P2612, DOI 10.1172/JCI119081; Johansson M, 2009, PROSTATE, V69, P1281, DOI 10.1002/pros.20972; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Lin J-K, 2010, INT J BIOL MARKERS; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Maroni Paul D, 2004, Cell Commun Signal, V2, P5, DOI 10.1186/1478-811X-2-5; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; McCracken M, 2007, CA-CANCER J CLIN, V57, P190, DOI 10.3322/canjclin.57.4.190; McGrath M, 2011, GYNECOL ONCOL, V120, P174, DOI 10.1016/j.ygyno.2010.10.012; McIntosh J, 2010, J BIOL CHEM, V285, P38788, DOI 10.1074/jbc.M110.177311; Morimoto LM, 2005, CANCER EPIDEM BIOMAR, V14, P1394, DOI 10.1158/1055-9965.EPI-04-0694; Peehl DM, 1996, J ANDROL, V17, P2; Peng Liming, 2002, Journal of West China University of Medical Sciences, V33, P137; Pollak M, 2000, GROWTH HORM IGF RES, V10, pS6, DOI 10.1016/S1096-6374(00)90002-9; Qian BY, 2011, BREAST CANCER RES TR, V130, P217, DOI 10.1007/s10549-011-1552-9; Qu BH, 1999, J BIOL CHEM, V274, P31179, DOI 10.1074/jbc.274.44.31179; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Rosen CJ, 1999, CLIN CHEM, V45, P1384; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schumacher FR, 2010, HUM MOL GENET, V19, P3089, DOI 10.1093/hmg/ddq210; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Terry KL, 2009, CARCINOGENESIS, V30, P2042, DOI 10.1093/carcin/bgp257; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zecevic M, 2006, JNCI-J NATL CANCER I, V98, P139, DOI 10.1093/jnci/djj016; Zhang MF, 2010, CLIN CANCER RES, V16, P1236, DOI 10.1158/1078-0432.CCR-09-2719	38	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85609	10.1371/journal.pone.0085609	http://dx.doi.org/10.1371/journal.pone.0085609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586243	Green Published, Green Submitted, gold			2022-12-25	WOS:000331717900005
J	Henriques, R; Potts, WM; Santos, CV; Sauer, WHH; Shaw, PW				Henriques, Romina; Potts, Warren M.; Santos, Carmen V.; Sauer, Warwick H. H.; Shaw, Paul W.			Population Connectivity and Phylogeography of a Coastal Fish, Atractoscion aequidens (Sciaenidae), across the Benguela Current Region: Evidence of an Ancient Vicariant Event	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; MITOCHONDRIAL-DNA VARIATION; GENETIC DIVERSITY; LIFE-HISTORY; PATAGONIAN TOOTHFISH; UPWELLING SYSTEM; ATLANTIC; SOUTHERN; MARINE; SPECIATION	Contemporary patterns of genetic diversity and population connectivity within species can be influenced by both historical and contemporary barriers to gene flow. In the marine environment, present day oceanographic features such as currents, fronts and upwelling systems can influence dispersal of eggs/larvae and/juveniles/adults, shaping population substructuring. The Benguela Current system in the southeastern Atlantic is one of the oldest upwelling systems in the world, and provides a unique opportunity to investigate the relative influence of contemporary and historical mechanisms shaping the evolutionary history of warm-temperate fish species. Using the genetic variation in the mitochondrial DNA Control Region and eight nuclear microsatellite DNA loci, we identified the presence of two highly divergent populations in a vagile and warm-temperate fish species, Atractoscion aequidens, across the Benguela region. The geographical distributions of the two populations, on either side of the perennial upwelling cell, suggest a strong correlation between the oceanographic features of the system and the breakdown of gene flow within this species. Genetic divergence (mtDNA phi(ST) = 0.902, microsatellite F-ST = 0.055: probability of genetic homogeneity for either marker = p < 0.001), absence of migrants (less than 1% per generation) between populations and coalescent estimates of time since most recent common ancestor suggest that the establishment of the main oceanographic features of the system (2 million years ago), particularly the strengthening and position of the perennial upwelling cell, is the most likely mechanism behind the observed isolation. Concordance between mitochondrial and nuclear genetic markers indicates that isolation and divergence of the northern and southern Benguela populations of A. aequidens occurred deep in the past and has continued to the present day. These findings suggest that the Benguela Current system may constitute an ancient and impermeable barrier to gene flow for warm-temperate fish species.	[Henriques, Romina] Royal Holloway Univ London, Sch Biol Sci, Ctr Ecol Evolut & Behav, Egham, Surrey, England; [Henriques, Romina; Potts, Warren M.; Sauer, Warwick H. H.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Santos, Carmen V.] Univ Agostinho Neto, Fac Ciencias, Luanda, Angola; [Shaw, Paul W.] Aberystwyth Univ, Inst Biol Environm & Rural Sci IBERS, Aberystwyth, Dyfed, Wales	University of London; Royal Holloway University London; Rhodes University; University Agostinho Neto; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Henriques, R (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Ctr Ecol Evolut & Behav, Egham, Surrey, England.	rhenriques@sun.ac.za	Santos, Carmen Van-Dúnem/O-1778-2014; Sauer, Warwick/GJI-2267-2022	Santos, Carmen Van-Dúnem/0000-0003-0643-5462; Sauer, Warwick/0000-0002-9756-1757; Henriques, Romina/0000-0002-6544-5532; Shaw, Paul/0000-0003-2637-6332	Fundacao da Ciencia e Tecnologia (FCT) [SFRH/BD/36176/2007]	Fundacao da Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology)	The molecular work and R. Henriques were supported by a Fundacao da Ciencia e Tecnologia (FCT) grant (ref. SFRH/BD/36176/2007). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2004, COASTAL FISHES SO AF; [Anonymous], [No title captured]; Appleyard SA, 2002, ANTARCT SCI, V14, P364, DOI 10.1017/S0954102002000238; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli Peter, 2009, V17, P42; Bernardi G, 2005, MOL ECOL, V14, P4085, DOI 10.1111/j.1365-294X.2005.02729.x; Bester-van der Merwe AE, 2011, CONSERV GENET, V12, P543, DOI 10.1007/s10592-010-0162-0; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Diaz-Jaimes P, 2010, MOL PHYLOGENET EVOL, V57, P1209, DOI 10.1016/j.ympev.2010.10.005; Diester-Haass L, 2002, MAR GEOL, V180, P87, DOI 10.1016/S0025-3227(01)00207-9; Diester-Haass L, 1990, PALEOCEANOGRAPHY, V5, P685, DOI 10.1029/PA005i005p00685; Domingues VS, 2007, J EXP MAR BIOL ECOL, V346, P102, DOI 10.1016/j.jembe.2007.03.002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2012, MOL PHYLOGENET EVOL, V62, P159, DOI 10.1016/j.ympev.2011.09.028; Faria R, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-194; Fennel W, 1999, J PHYS OCEANOGR, V29, P177, DOI 10.1175/1520-0485(1999)029<0177:TOTBUS>2.0.CO;2; Francisco SM, 2011, J EXP MAR BIOL ECOL, V403, P14, DOI 10.1016/j.jembe.2011.03.020; Fu YX, 1997, GENETICS, V147, P915; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gopal K, 2006, MAR ECOL PROG SER, V319, P191, DOI 10.3354/meps319191; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant WS, 2006, BIOL J LINN SOC, V88, P673, DOI 10.1111/j.1095-8312.2006.00651.x; Griffiths MH, 1995, J FISH BIOL, V47, P962, DOI 10.1111/j.1095-8649.1995.tb06022.x; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; Henriques R, 2012, AFR J MAR SCI, V34, P585, DOI 10.2989/1814232X.2012.749809; Henriques R, 2011, CONSERV GENET, V4, P85; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Hutchings L, 2002, MAR FRESHWATER RES, V53, P307, DOI 10.1071/MF01147; Hutchings L, 2009, PROG OCEANOGR, V83, P15, DOI 10.1016/j.pocean.2009.07.046; Jahn B, 2003, PALAEOGEOGR PALAEOCL, V193, P515, DOI 10.1016/S0031-0182(03)00264-5; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Kirst GJ, 1999, QUATERNARY RES, V52, P92, DOI 10.1006/qres.1999.2040; Krammer R, 2006, PALAEOGEOGR PALAEOCL, V230, P319, DOI 10.1016/j.palaeo.2005.07.022; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; Lecomte F, 2004, MOL ECOL, V13, P2169, DOI 10.1111/j.1365-294X.2004.02229.x; Lett C, 2007, MAR ECOL PROG SER, V347, P247, DOI 10.3354/meps06982; Marlow JR, 2000, SCIENCE, V290, P2288; Martinez P, 2006, MOL PHYLOGENET EVOL, V39, P404, DOI 10.1016/j.ympev.2005.07.022; Matthee CA, 2007, MAR FRESHWATER RES, V58, P1130, DOI 10.1071/MF07138; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2014, TRACER V1 6; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rock J, 2009, GENE, V437, P60, DOI 10.1016/j.gene.2009.02.008; ROFF DA, 1988, ENVIRON BIOL FISH, V22, P133, DOI 10.1007/BF00001543; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SHANNON LV, 1985, OCEANOGR MAR BIOL, V23, P105; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Shen KN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-83; SIESSER WG, 1981, J GEOL, V89, P523, DOI 10.1086/628618; TAJIMA F, 1989, GENETICS, V123, P585; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; von der Heyden S, 2007, MOL PHYLOGENET EVOL, V42, P517, DOI 10.1016/j.ympev.2006.08.004; von der Heyden S, 2010, MOL PHYLOGENET EVOL, V55, P1183, DOI 10.1016/j.ympev.2009.09.018; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Waters JM, 2004, MOL ECOL, V13, P2797, DOI 10.1111/j.1365-294X.2004.02282.x; Weir BS, 1996, GENETC DATA ANAL; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Wilson GA, 2003, GENETICS, V163, P1177	71	51	53	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87907	10.1371/journal.pone.0087907	http://dx.doi.org/10.1371/journal.pone.0087907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586296	Green Submitted, gold, Green Published			2022-12-25	WOS:000331714700008
J	Okuno, A; Hirano, K; Asano, K; Takase, W; Masuda, R; Morinaka, Y; Ueguchi-Tanaka, M; Kitano, H; Matsuoka, M				Okuno, Ayako; Hirano, Ko; Asano, Kenji; Takase, Wakana; Masuda, Reiko; Morinaka, Yoichi; Ueguchi-Tanaka, Miyako; Kitano, Hidemi; Matsuoka, Makoto			New Approach to Increasing Rice Lodging Resistance and Biomass Yield Through the Use of High Gibberellin Producing Varieties	PLOS ONE			English	Article							GREEN-REVOLUTION; CYTOCHROME-P450 MONOOXYGENASE; GENE; BIOSYNTHESIS; ENCODES; CULM; DIFFERENCE; LIGNIN; IMPACT; LOCUS	Traditional breeding for high-yielding rice has been dependent on the widespread use of fertilizers and the cultivation of gibberellin (GA)-deficient semi-dwarf varieties. The use of semi-dwarf plants facilitates high grain yield since these varieties possess high levels of lodging resistance, and thus could support the high grain weight. Although this approach has been successful in increasing grain yield, it is desirable to further improve grain production and also to breed for high biomass. In this study, we re-examined the effect of GA on rice lodging resistance and biomass yield using several GA-deficient mutants (e.g. having defects in the biosynthesis or perception of GA), and high-GA producing line or mutant. GA-deficient mutants displayed improved bending-type lodging resistance due to their short stature; however they showed reduced breaking-ype lodging resistance and reduced total biomass. In plants producing high amounts of GA, the bending-type lodging resistance was inferior to the original cultivars. The breaking-type lodging resistance was improved due to increased lignin accumulation and/or larger culm diameters. Further, these lines had an increase in total biomass weight. These results show that the use of rice cultivars producing high levels of GA would be a novel approach to create higher lodging resistance and biomass.	[Okuno, Ayako; Hirano, Ko; Asano, Kenji; Takase, Wakana; Masuda, Reiko; Morinaka, Yoichi; Ueguchi-Tanaka, Miyako; Kitano, Hidemi; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University	Hirano, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	khirano@agr.nagoya-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [IPG-0003]; NC-CARP project; Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (MU-T)''	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); NC-CARP project; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (MU-T)''(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, IPG-0003 for MM,), partly by Grants-in-Aid from the NC-CARP project, the Ministry of Education, Science, Sports and Culture of Japan, to HK and KH, and partly by Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (MU-T)'', Grant-in-Aid for Scientific Research on Innovative Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Asano K, 2009, MOL GENET GENOMICS, V281, P223, DOI 10.1007/s00438-008-0406-6; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Asano Kenji, 2007, Tanpakushitsu Kakusan Koso, V52, P1931; Biemelt S, 2004, PLANT PHYSIOL, V135, P254, DOI 10.1104/pp.103.036988; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GRAFIUS JE, 1954, AGRON J, V46, P414, DOI 10.2134/agronj1954.00021962004600090006x; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; Hirano K, 2013, PLANT CELL PHYSIOL, V54, P1803, DOI 10.1093/pcp/pct121; Hirano K, 2012, PLANT CELL REP, V31, P91, DOI 10.1007/s00299-011-1142-7; Irie Kenji, 2008, Journal of Agricultural Science Tokyo Nogyo Daigaku, V53, P69; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Kashiwagi T., 2007, Japanese Journal of Crop Science, V76, P1, DOI 10.1626/jcs.76.1; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Kono M, 1995, SCI RICE PLANT PHYSL, V2, P971; Lin SY, 1998, THEOR APPL GENET, V96, P997, DOI 10.1007/s001220050831; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; OGI Y, 1993, JPN J BREED, V43, P267; OOKAWA T, 1992, JPN J CROP SCI, V61, P419, DOI 10.1626/jcs.61.419; OOKAWA T, 1993, JPN J CROP SCI, V62, P378, DOI 10.1626/jcs.62.378; Ookawa T, 2010, PLANT PROD SCI, V13, P58, DOI 10.1626/pps.13.58; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Suzuki S, 2009, PLANT BIOTECHNOL-NAR, V26, P337, DOI 10.5511/plantbiotechnology.26.337; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; XIA BS, 1991, JPN J CROP SCI, V60, P36, DOI 10.1626/jcs.60.36; Zhang KW, 2006, PLANT PHYSIOL, V140, P972, DOI 10.1104/pp.105.073007; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	33	86	92	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e86870	10.1371/journal.pone.0086870	http://dx.doi.org/10.1371/journal.pone.0086870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586255	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900006
J	Eijkelkamp, BA; Morey, JR; Ween, MP; Ong, CIY; McEwan, AG; Paton, JC; McDevitt, CA				Eijkelkamp, Bart A.; Morey, Jacqueline R.; Ween, Miranda P.; Ong, Cheryl-Iynn Y.; McEwan, Alastair G.; Paton, James C.; McDevitt, Christopher A.			Extracellular Zinc Competitively Inhibits Manganese Uptake and Compromises Oxidative Stress Management in Streptococcus pneumoniae	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; SUPEROXIDE-DISMUTASE; STAPHYLOCOCCUS-AUREUS; NASOPHARYNGEAL CARRIAGE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; GENOME SEQUENCE; YOUNG-CHILDREN; PSAA MUTANTS; NADH OXIDASE	Streptococcus pneumoniae requires manganese for colonization of the human host, but the underlying molecular basis for this requirement has not been elucidated. Recently, it was shown that zinc could compromise manganese uptake and that zinc levels increased during infection by S. pneumoniae in all the niches that it colonized. Here we show, by quantitative means, that extracellular zinc acts in a dose dependent manner to competitively inhibit manganese uptake by S. pneumoniae, with an EC50 of 30.2 mu M for zinc in cation-defined media. By exploiting the ability to directly manipulate S. pneumoniae accumulation of manganese, we analyzed the connection between manganese and superoxide dismutase (SodA), a primary source of protection for S. pneumoniae against oxidative stress. We show that manganese starvation led to a decrease in sodA transcription indicating that expression of sodA was regulated through an unknown manganese responsive pathway. Intriguingly, examination of recombinant SodA revealed that the enzyme was potentially a cambialistic superoxide dismutase with an iron/manganese cofactor. SodA was also shown to provide the majority of protection against oxidative stress as a S. pneumoniae Delta sodA mutant strain was found to be hypersensitive to oxidative stress, despite having wild-type manganese levels, indicating that the metal ion alone was not sufficiently protective. Collectively, these results provide a quantitative assessment of the competitive effect of zinc upon manganese uptake and provide a molecular basis for how extracellular zinc exerts a 'toxic' effect on bacterial pathogens, such as S. pneumoniae.	[Eijkelkamp, Bart A.; Morey, Jacqueline R.; Ween, Miranda P.; Paton, James C.; McDevitt, Christopher A.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Ong, Cheryl-Iynn Y.; McEwan, Alastair G.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Ong, Cheryl-Iynn Y.; McEwan, Alastair G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Adelaide; University of Queensland; University of Queensland	McDevitt, CA (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia.	christopher.mcdevitt@adelaide.edu.au	Eijkelkamp, Bart/G-7109-2015; McDevitt, Christopher A./A-4940-2009; Ong, Cheryl-lynn Y/C-5238-2014	Eijkelkamp, Bart/0000-0003-0179-8977; McDevitt, Christopher A./0000-0003-1596-4841; Ong, Cheryl-lynn Y/0000-0001-6036-6889; ween, miranda/0000-0002-0600-4585; McEwan, Alastair/0000-0002-2419-1003	Australian Research Council (ARC) [DP0986578, DP120103957]; National Health & Medical Research Council (NHMRC) [1022240, 565526]	Australian Research Council (ARC)(Australian Research Council); National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (ARC) grants DP0986578 to A.G.M. and DP120103957 to C.A.M., and the National Health & Medical Research Council (NHMRC) Project grant 1022240 to C.A.M. and Program grant 565526 to J.C.P. and A.G.M. J.C.P. is a NHMRC Senior Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; [Anonymous], 2003, Weekly Epidemiological Record, V78, P110; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Brooks WA, 2004, LANCET, V363, P1683, DOI 10.1016/S0140-6736(04)16252-1; Broome C, 1996, PROGR VACCINE RES DE, P28; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Counago RM, 2012, CURR DRUG TARGETS, V13, P1400; Damo SM, 2013, P NATL ACAD SCI US; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Vendittis A, 2010, MOL BIOSYST, V6, P1973, DOI 10.1039/c003557b; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Hardie J. M., 1986, BERGEYS MANUAL SYSTE, V2, P1043; Hendriksen WT, 2009, MICROBIOL-SGM, V155, P1569, DOI 10.1099/mic.0.025072-0; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; IRVING H, 1953, J CHEM SOC, P3192, DOI 10.1039/jr9530003192; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Ispahani P, 2004, ARCH DIS CHILD, V89, P757, DOI 10.1136/adc.2003.036921; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Kehl-Fie TE, 2013, INFECT IMMUN, V81, P3395, DOI 10.1128/IAI.00420-13; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lewis VG, 2012, PROTOPLASMA, V249, P919, DOI 10.1007/s00709-011-0360-8; Mahalanabis D, 2004, AM J CLIN NUTR, V79, P430; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Plumptre CD, 2014, MOL MICROBIOL, V91, P834, DOI 10.1111/mmi.12504; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Strand TA, 2003, INFECT IMMUN, V71, P2009, DOI 10.1128/IAI.71.4.2009-2013.2003; Strand TA, 2001, BRIT J NUTR, V86, P301, DOI 10.1079/BJN2001399; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Varon E, 2010, CLIN MICROBIOL INFEC, V16, P401, DOI 10.1111/j.1469-0691.2010.03190.x; WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431; Zaidi AKM, 2009, PEDIATR INFECT DIS J, V28, pS10, DOI 10.1097/INF.0b013e3181958769	61	82	83	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89427	10.1371/journal.pone.0089427	http://dx.doi.org/10.1371/journal.pone.0089427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558498	Green Published, gold			2022-12-25	WOS:000331706700144
J	Gregg, RD; Rouse, EJ; Hargrove, LJ; Sensinger, JW				Gregg, Robert D.; Rouse, Elliott J.; Hargrove, Levi J.; Sensinger, Jonathon W.			Evidence for a Time-Invariant Phase Variable in Human Ankle Control	PLOS ONE			English	Article							STANCE PHASE; HUMAN LOCOMOTION; SWING PHASE; WALKING; LOAD; ROLLOVER; GAIT; ADAPTATION; CONTRIBUTE; PROSTHESES	Human locomotion is a rhythmic task in which patterns of muscle activity are modulated by state-dependent feedback to accommodate perturbations. Two popular theories have been proposed for the underlying embodiment of phase in the human pattern generator: a time-dependent internal representation or a time-invariant feedback representation (i.e., reflex mechanisms). In either case the neuromuscular system must update or represent the phase of locomotor patterns based on the system state, which can include measurements of hundreds of variables. However, a much simpler representation of phase has emerged in recent designs for legged robots, which control joint patterns as functions of a single monotonic mechanical variable, termed a phase variable. We propose that human joint patterns may similarly depend on a physical phase variable, specifically the heel-to-toe movement of the Center of Pressure under the foot. We found that when the ankle is unexpectedly rotated to a position it would have encountered later in the step, the Center of Pressure also shifts forward to the corresponding later position, and the remaining portion of the gait pattern ensues. This phase shift suggests that the progression of the stance ankle is controlled by a biomechanical phase variable, motivating future investigations of phase variables in human locomotor control.	[Gregg, Robert D.] Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA; [Gregg, Robert D.] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Rouse, Elliott J.] MIT, Dept Media Arts & Sci, Cambridge, MA 02139 USA; [Hargrove, Levi J.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Hargrove, Levi J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Sensinger, Jonathon W.] Univ New Brunswick, Inst Biomed Engn, Fredericton, NB, Canada; [Sensinger, Jonathon W.] Univ New Brunswick, Dept Elect & Comp Engn, Fredericton, NB, Canada	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; Massachusetts Institute of Technology (MIT); Shirley Ryan AbilityLab; Northwestern University; University of New Brunswick; University of New Brunswick	Gregg, RD (corresponding author), Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA.	rgregg@ieee.org	Rouse, Elliott/AAP-1756-2021	Rouse, Elliott/0000-0003-3880-1527; Gregg, Robert/0000-0002-0729-2857	USAMRAA [W81XWH-09-2-0020]; National Institutes of Health from the National Institute of Neurological Disorders and Stroke [F31NS074687]; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD080349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS074687] Funding Source: NIH RePORTER	USAMRAA; National Institutes of Health from the National Institute of Neurological Disorders and Stroke; Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by USAMRAA grant W81XWH-09-2-0020 (www.usamraa.army.mil) and National Institutes of Health award number F31NS074687 from the National Institute of Neurological Disorders and Stroke (www.nih.gov). Robert D. Gregg, IV, Ph.D., holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (www.bwfund.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett-Cowan M, 2009, EXP BRAIN RES, V198, P221, DOI 10.1007/s00221-009-1779-4; BUEHLER M, 1994, INT J ROBOT RES, V13, P101, DOI 10.1177/027836499401300201; Chevallereau C, 2003, IEEE CONTR SYST MAG, V23, P57, DOI 10.1109/MCS.2003.1234651; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; DiBerardino LA, 2012, J APPL BIOMECH, V28, P210, DOI 10.1123/jab.28.2.210; Dietz V, 2000, GAIT POSTURE, V11, P102, DOI 10.1016/S0966-6362(99)00052-1; DIETZ V, 1992, EXP BRAIN RES, V89, P229; Donelan JM, 2004, CAN J PHYSIOL PHARM, V82, P589, DOI 10.1139/Y04-043; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Earhart GM, 2000, J NEUROPHYSIOL, V84, P605, DOI 10.1152/jn.2000.84.2.605; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Gordon KE, 2010, J NEUROPHYSIOL, V104, P1325, DOI 10.1152/jn.00604.2009; Gordon KE, 2009, J NEUROPHYSIOL, V101, P2062, DOI 10.1152/jn.90949.2008; Gregg RD, 2013, INT C REHAB ROBOT; Gregg RD, 2014, IEEE T CONTR SYST T, V22, P246, DOI 10.1109/TCST.2012.2236840; Gregg RD, 2013, P AMER CONTR CONF, P5702; Grey MJ, 2004, CAN J PHYSIOL PHARM, V82, P610, DOI 10.1139/y04-077; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; Grizzle JW, 2001, IEEE T AUTOMAT CONTR, V46, P51, DOI 10.1109/9.898695; Gruben KG, 2012, HUM MOVEMENT SCI, V31, P649, DOI 10.1016/j.humov.2011.07.006; Hansen AH, 2004, HUM MOVEMENT SCI, V23, P807, DOI 10.1016/j.humov.2004.08.023; Hansen AH, 2010, DISABIL REHABIL, V32, P2201, DOI 10.3109/09638288.2010.502586; Hiebert GW, 1996, J NEUROPHYSIOL, V75, P1126, DOI 10.1152/jn.1996.75.3.1126; HOGAN N, 1985, J DYN SYST-T ASME, V107, P8, DOI 10.1115/1.3140713; Holgate MA, 2009, IEEE INT CONF ROBOT, P2435; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; KAWAMURA K, 1991, ACTA MED OKAYAMA, V45, P179; KODITSCHEK DE, 1991, INT J ROBOT RES, V10, P587, DOI 10.1177/027836499101000601; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leroux A, 1999, EXP BRAIN RES, V126, P359, DOI 10.1007/s002210050743; Ljung L., 1999, SYSTEM IDENTIFICATIO; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Pang MYC, 2000, J PHYSIOL-LONDON, V528, P389, DOI 10.1111/j.1469-7793.2000.00389.x; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Poppele RE, 2002, J NEUROPHYSIOL, V87, P409, DOI 10.1152/jn.00022.2001; Prochazka A, 2007, PROG BRAIN RES, V165, P255, DOI 10.1016/S0079-6123(06)65016-4; Ramezani A, 2014, J DYN SYST-T ASME, V136, DOI 10.1115/1.4025693; REDFERN MS, 1994, J BIOMECH, V27, P1339, DOI 10.1016/0021-9290(94)90043-4; Redfern MS, 1997, GAIT POSTURE, V6, P119; Revzen S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051907; Revzen S, 2009, ADV EXP MED BIOL, V629, P25, DOI [10.1007/978-0-357-77064-2_3, 10.1007/978-0-387-77064-2_3]; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rouse EJ, 2013, ASME T BIOMECH ENG, V135; Rouse EJ, 2011, IEEE ENG MED BIO, P8179, DOI 10.1109/IEMBS.2011.6092017; Sacco ICN, 2009, CLIN BIOMECH, V24, P687, DOI 10.1016/j.clinbiomech.2009.05.003; Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104; Solomon JH, 2010, ADAPT BEHAV, V18, P492, DOI 10.1177/1059712310389624; Spong M.W., 2006, ROBOT MODELING CONTR, VVolume 3; Sreenath K, 2011, INT J ROBOT RES, V30, P1170, DOI 10.1177/0278364910379882; STEIN JL, 1987, J BIOMECH, V20, P19, DOI 10.1016/0021-9290(87)90263-6; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; Tilton AK, 2012, P AMER CONTR CONF, P3433; Valero-Cuevas FJ, 2009, J NEUROPHYSIOL, V102, P59, DOI 10.1152/jn.90324.2008; Vogelstein RJ, 2006, IEEE T NEUR SYS REH, V14, P257, DOI 10.1109/TNSRE.2006.881586; Westervelt E R, 2007, FEEDBACK CONTROL DYN; Winter D.A., 2009, BIOMECHANICS MOTOR C, V370; Yang T, 2009, AUTON ROBOT, V27, P277, DOI 10.1007/s10514-009-9126-y	60	34	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89163	10.1371/journal.pone.0089163	http://dx.doi.org/10.1371/journal.pone.0089163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558485	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700131
J	Kirui, DK; Mai, JH; Palange, AL; Qin, GT; van de Ven, AL; Liu, XW; Shen, HF; Ferrari, M				Kirui, Dickson K.; Mai, Juahua; Palange, Anna-Lisa; Qin, Guoting; van de Ven, Anne L.; Liu, Xuewu; Shen, Haifa; Ferrari, Mauro			Transient Mild Hyperthermia Induces E-selectin Mediated Localization of Mesoporous Silicon Vectors in Solid Tumors	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NANOPARTICLE EXTRAVASATION; MULTISTAGE NANOVECTORS; IN-VIVO; DELIVERY; ACCUMULATION; PENETRATION; DOXORUBICIN; RECEPTORS; LIPOSOMES	Background: Hyperthermia treatment has been explored as a strategy to overcome biological barriers that hinder effective drug delivery in solid tumors. Most studies have used mild hyperthermia treatment (MHT) to target the delivery of thermo-sensitive liposomes carriers. Others have studied its application to permeabilize tumor vessels and improve tumor interstitial transport. However, the role of MHT in altering tumor vessel interfacial and adhesion properties and its relationship to improved delivery has not been established. In the present study, we evaluated effects of MHT treatment on tumor vessel flow dynamics and expression of adhesion molecules and assessed enhancement in particle localization using mesoporous silicon vectors (MSVs). We also determined the optimal time window at which maximal accumulation occur. Results: In this study, using intravital microscopy analyses, we showed that temporal mild hyperthermia (similar to 1 W/cm(2)) amplified delivery and accumulation of MSVs in orthotopic breast cancer tumors. The number of discoidal MSVs (1000x400 nm) adhering to tumor vasculature increased 6-fold for SUM159 tumors and 3-fold for MCF-7 breast cancer tumors. By flow chamber experiments and Western blotting, we established that a temporal increase in E-selectin expression correlated with enhanced particle accumulation. Furthermore, MHT treatment was shown to increase tumor perfusion in a time-dependent fashion. Conclusions: Our findings reveal that well-timed mild hyperthermia treatment can transiently elevate tumor transport and alter vascular adhesion properties and thereby provides a means to enhance tumor localization of non-thermally sensitive particles such as MSVs. Such enhancement in accumulation could be leveraged to increase therapeutic efficacy and reduce drug dosing in cancer therapy.	[Kirui, Dickson K.; Mai, Juahua; Palange, Anna-Lisa; Qin, Guoting; van de Ven, Anne L.; Liu, Xuewu; Shen, Haifa; Ferrari, Mauro] Houston Methodist Res Inst, Dept NanoMed, Houston, TX 77030 USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Ferrari, Mauro] Weill Cornell Med Coll, Dept Internal Med, New York, NY USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University	Ferrari, M (corresponding author), Houston Methodist Res Inst, Dept NanoMed, Houston, TX 77030 USA.	mferrari@houstonmethodist.org	Qin, Guoting/A-7847-2010	Palange, Anna Lisa/0000-0002-2584-7297; van de Ven, Anne/0000-0002-0347-4004; Qin, Guoting/0000-0001-8916-6311; Mai, Junhua/0000-0001-8374-4352	Methodist Hospital Research Institute; Ernest Cockrell Jr. Distinguished Endowed Chair; National Institute of Health (NIH)'s Physical Sciences Oncology Center (PS-OC) [U54CA143837]; Department of Defense [W81XWH-09-1-0212]; NIH [U54CA151668]; NATIONAL CANCER INSTITUTE [U54CA143837, U54CA151668] Funding Source: NIH RePORTER	Methodist Hospital Research Institute; Ernest Cockrell Jr. Distinguished Endowed Chair; National Institute of Health (NIH)'s Physical Sciences Oncology Center (PS-OC); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge funding provided by the Methodist Hospital Research Institute, including the Ernest Cockrell Jr. Distinguished Endowed Chair and National Institute of Health (NIH)'s Physical Sciences Oncology Center (PS-OC) U54CA143837. Authors also acknowledge partial supports from the following funding sources: Department of Defense (W81XWH-09-1-0212) and NIH (U54CA151668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani G, 2012, BIOMATERIALS, V33, P5504, DOI 10.1016/j.biomaterials.2012.04.027; Agarwal A, 2011, ACS NANO, V5, P4919, DOI 10.1021/nn201010q; Atkinson RL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001447; BICHER HI, 1980, RADIOLOGY, V137, P523, DOI 10.1148/radiology.137.2.7433686; Blanco E, 2013, CANCER LETT, V334, P245, DOI 10.1016/j.canlet.2012.07.027; Choi R, 2010, LANGMUIR, V26, P17520, DOI 10.1021/la1029728; Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Godin B, 2011, ACCOUNTS CHEM RES, V44, P979, DOI 10.1021/ar200077p; Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; JANSEN W, 1990, PATHOL RES PRACT, V186, P247, DOI 10.1016/S0344-0338(11)80542-X; Joshi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032067; Kapp D. S., 2000, PRINCIPLES HYPERTHER; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Kim P, 2013, PROTOCOL EXCHANGE; Kirui D, 2013, NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2013.11.001, DOI 10.1016/J.NAN0.2013.11.001]; Kong G, 2001, CANCER RES, V61, P3027; Kong G, 2000, CANCER RES, V60, P4440; Kruskal JB, 2001, J VASC INTERV RADIOL, V12, P1193, DOI 10.1016/S1051-0443(07)61679-0; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Li L, 2013, J CONTROL RELEASE, V167, P130, DOI 10.1016/j.jconrel.2013.01.026; Liu M, 2012, PLOS ONE, V7; Mann AP, 2011, ADV MATER, V23, pH278, DOI 10.1002/adma.201101541; Martinez JO, 2013, BIOMATERIALS, V34, P8469, DOI 10.1016/j.biomaterials.2013.07.049; Melancon MP, 2011, J CONTROL RELEASE, V156, P265, DOI 10.1016/j.jconrel.2011.06.030; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; OVERGAARD J, 1995, LANCET, V345, P540, DOI 10.1016/S0140-6736(95)90463-8; Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; Shen HF, 2013, CLIN CANCER RES, V19, P1806, DOI 10.1158/1078-0432.CCR-12-2764; SONG CW, 1984, CANCER RES, V44, P4721; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; Vertrees RA, 2005, CANCER BIOL THER, V4, P1144, DOI 10.4161/cbt.4.10.2074; Visaria RK, 2006, MOL CANCER THER, V5, P1014, DOI 10.1158/1535-7163.MCT-05-0381; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; Xiaojing Z, 2009, NANOTECHNOLOGY; Xu R, 2013, SMALL, V9, P1799, DOI 10.1002/smll.201201510; Yokoi K, 2013, CANCER LETT, V334, P319, DOI 10.1016/j.canlet.2012.09.001; You J, 2012, CANCER RES, V72, P4777, DOI 10.1158/0008-5472.CAN-12-1003; Yudina A, 2012, J CONTROL RELEASE, V161, P90, DOI 10.1016/j.jconrel.2012.04.018; Zhu L, 2013, INTEGR BIOL-UK, V5, P96, DOI 10.1039/c2ib20135f	52	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86489	10.1371/journal.pone.0086489	http://dx.doi.org/10.1371/journal.pone.0086489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558362	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700008
J	Lin, L; Tian, SL; Kaeppler, S; Liu, ZR; An, YQ				Lin, Li; Tian, Shulan; Kaeppler, Shawn; Liu, Zongrang; An, Yong-Qiang (Charles)			Conserved Transcriptional Regulatory Programs Underlying Rice and Barley Germination	PLOS ONE			English	Article							SEED-GERMINATION; ARABIDOPSIS-THALIANA; ACTIN SUBCLASS; ALPHA-AMYLASE; ABSCISIC-ACID; BETA-AMYLASE; EXPRESSION; GENES; GIBBERELLIN; ENDOSPERM	Germination is a biological process important to plant development and agricultural production. Barley and rice diverged 50 million years ago, but share a similar germination process. To gain insight into the conservation of their underlying gene regulatory programs, we compared transcriptomes of barley and rice at start, middle and end points of germination, and revealed that germination regulated barley and rice genes (BRs) diverged significantly in expression patterns and/or protein sequences. However, BRs with higher protein sequence similarity tended to have more conserved expression patterns. We identified and characterized 316 sets of conserved barley and rice genes (cBRs) with high similarity in both protein sequences and expression patterns, and provided a comprehensive depiction of the transcriptional regulatory program conserved in barley and rice germination at gene, pathway and systems levels. The cBRs encoded proteins involved in a variety of biological pathways and had a wide range of expression patterns. The cBRs encoding key regulatory components in signaling pathways often had diverse expression patterns. Early germination up-regulation of cell wall metabolic pathway and peroxidases, and late germination up-regulation of chromatin structure and remodeling pathways were conserved in both barley and rice. Protein sequence and expression pattern of a gene change quickly if it is not subjected to a functional constraint. Preserving germination-regulated expression patterns and protein sequences of those cBRs for 50 million years strongly suggests that the cBRs are functionally significant and equivalent in germination, and contribute to the ancient characteristics of germination preserved in barley and rice. The functional significance and equivalence of the cBR genes predicted here can serve as a foundation to further characterize their biological functions and facilitate bridging rice and barley germination research with greater confidence.	[Lin, Li; Tian, Shulan; An, Yong-Qiang (Charles)] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Tian, Shulan] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Lin, Li; Kaeppler, Shawn] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Liu, Zongrang] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	An, YQ (corresponding author), ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA.	yong-qiang.an@ars.usda.gov		Kaeppler, Shawn/0000-0002-5964-1668	USDA-ARS; American Malting and Barley Association, Inc.	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); American Malting and Barley Association, Inc.	The research is supported by funds from USDA-ARS and American Malting and Barley Association, Inc. to Yong-Qiang An. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; An YQC, 2010, PLANT MOL BIOL REP, V28, P481, DOI 10.1007/s11105-009-0171-7; An YQ, 1996, PLANT CELL, V8, P15, DOI 10.1105/tpc.8.1.15; An YQ, 1996, PLANT J, V10, P107, DOI 10.1046/j.1365-313X.1996.10010107.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Bewley J.D, 1985, SEEDS PHYSL DEV GERM; Chen F, 2000, PLANT PHYSIOL, V124, P1265, DOI 10.1104/pp.124.3.1265; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chen KG, 2006, J INTEGR PLANT BIOL, V48, P591, DOI 10.1111/j.1744-7909.2006.00270.x; CHRISPEE.MJ, 1967, PLANT PHYSIOL, V42, P398, DOI 10.1104/pp.42.3.398; Dubcovsky J, 2001, PLANT PHYSIOL, V125, P1342, DOI 10.1104/pp.125.3.1342; FINCHER GB, 1989, ANNU REV PLANT PHYS, V40, P305, DOI 10.1146/annurev.pp.40.060189.001513; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KREIS M, 1987, EUR J BIOCHEM, V169, P517, DOI 10.1111/j.1432-1033.1987.tb13640.x; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; LAURIERE C, 1986, PHYSIOL PLANTARUM, V67, P383, DOI 10.1111/j.1399-3054.1986.tb05752.x; Li W. H, 1997, MOL EVOLUTION; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; MacGregor A.W., 1993, CARBOHYDRATES BARLEY; MAYER AM, 1974, ANNU REV PLANT PHYS, V25, P167, DOI 10.1146/annurev.pp.25.060174.001123; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Meagher RB, 1999, TRENDS GENET, V15, P278, DOI 10.1016/S0168-9525(99)01759-X; Morohashi Y, 2002, J EXP BOT, V53, P1643, DOI 10.1093/jxb/erf012; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Parrish Rudolph S, 2004, J Biopharm Stat, V14, P575, DOI 10.1081/BIP-200025650; Peng JR, 2002, CURR OPIN PLANT BIOL, V5, P376, DOI 10.1016/S1369-5266(02)00279-0; Potokina E, 2002, FUNCT INTEGR GENOMIC, V2, P28, DOI 10.1007/s10142-002-0050-x; SHUTOV AD, 1987, PHYTOCHEMISTRY, V26, P1557, DOI 10.1016/S0031-9422(00)82245-1; SKADSEN RW, 1993, PLANT PHYSIOL, V102, P195, DOI 10.1104/pp.102.1.195; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tai HH, 2005, PLANT MOL BIOL, V59, P909, DOI 10.1007/s11103-005-2081-x; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Watson Loraine, 2005, Functional & Integrative Genomics, V5, P155, DOI 10.1007/s10142-005-0133-6; White J, 2006, PLANT BIOTECHNOL J, V4, P289, DOI 10.1111/j.1467-7652.2006.00181.x; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	49	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87261	10.1371/journal.pone.0087261	http://dx.doi.org/10.1371/journal.pone.0087261			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558366	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700012
J	Santana, SS; Gennari-Cardoso, ML; Carvalho, FC; Roque-Barreira, MC; Santiago, AD; Alvim, FC; Pirovani, CP				Santana, Sanzio Silva; Gennari-Cardoso, Margareth Leitao; Carvalho, Fernanda Caroline; Roque-Barreira, Maria Cristina; Santiago, Andre da Silva; Alvim, Fatima Cerqueira; Pirovani, Carlos Priminho			Eutirucallin, a RIP-2 Type Lectin from the Latex of Euphorbia tirucalli L. Presents Proinflammatory Properties	PLOS ONE			English	Article							GALACTOSE-BINDING LECTIN; SHIGA TOXIN; PROTEINS; PLANTS; TREE; PURIFICATION; RECOGNITION; QUANTITIES; ACTIVATION; PRINCIPLES	Lectins are carbohydrate-binding proteins that recognize and modulate physiological activities and have been used as a toll for detection and identification of biomolecules, and therapy of diseases. In this study we have isolated a lectin present in the latex of Euphorbia tirucalli, and named it Eutirucallin. The latex protein extract was subjected to ion exchange chromatography and showed two peaks with haemagglutinating activity. Polypeptides of 32 kDa protein extract strongly interacted with immobilized galactose (alpha-lactose > D-N-acetylgalactosamine). The Eutirucallin was obtained with a yield of 5.6% using the a-lactose column. The lectin domain has 32 kDa subunits and at least two of which are joined by disulfide bridges. The agglutinating capacity for human erythrocytes A(+), B+ and O+ is inhibited by D-galactose. The haemagglutinating activity of Eutirucallin was independent of Ca2+ and maintained until the temperature of 55 degrees C. Eutirucallin presented biological activities such as neutrophils recruitment and cytokine prodution by macrophages. The analysis of the trypsin-digested Eutirucallin by ms/ms in ESI-Q-TOFF resulted in nine peptides similar to type 2 ribosome-inactivating protein (type-2 RIP). It's partial sequence showed a similarity of 67.4 - 83.1% for the lectin domain of type-2 RIP [Ricin and Abrin (83.1%), Viscumin, Ebulin, Pulchellin, Cinnamomin, Volkensin and type-2 RIP Iris hollandica]. Our data suggest that Eutirucallin is a new member of type 2 ribosome-inactivating protein and presents biotechnological potential.	[Santana, Sanzio Silva; Gennari-Cardoso, Margareth Leitao; Santiago, Andre da Silva; Alvim, Fatima Cerqueira; Pirovani, Carlos Priminho] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil; [Carvalho, Fernanda Caroline; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Med Sch Ribeirao Preto, Sao Paulo, Brazil	Universidade Estadual de Santa Cruz; Universidade de Sao Paulo	Pirovani, CP (corresponding author), Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	pirovani@uesc.br	Pirovani, Carlos P/J-3426-2017; Pirovani, Carlos Priminho/N-1153-2019; Ibrahim, Essam Hassan/G-1960-2018; Roque-Barreira, Maria-Cristina/A-4552-2008	Pirovani, Carlos P/0000-0002-6176-4069; Pirovani, Carlos Priminho/0000-0002-6176-4069; Ibrahim, Essam Hassan/0000-0003-0130-2257; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908	Fundacao de Amparo Pesquisa of Bahia (FAPESB - PRONEM) [PNE0005/2011]	Fundacao de Amparo Pesquisa of Bahia (FAPESB - PRONEM)	Funding from Fundacao de Amparo Pesquisa of Bahia (FAPESB - PRONEM, TO No. no PNE0005/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g; BARBIERI L, 1983, BIOCHEM J, V215, P433, DOI 10.1042/bj2150433; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasileiro Beatriz Gonçalves, 2006, Rev. Bras. Cienc. Farm., V42, P195, DOI 10.1590/S1516-93322006000200004; Coelho LCBB, 2000, PHYTOCHEM ANALYSIS, V11, P295, DOI 10.1002/1099-1565(200009/10)11:5&lt;295::AID-PCA517&gt;3.0.CO;2-S; Elifio-Esposito S, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-10; EMMERICH C, 1994, ACTA CRYSTALLOGR D, V50, P749, DOI 10.1107/S0907444994002143; FURSTENBERGER G, 1985, Z NATURFORSCH C, V40, P631; Goldstein J, 1989, Transfus Med Rev, V3, P206, DOI 10.1016/S0887-7963(89)70080-8; Hartley MR, 2004, BBA-PROTEINS PROTEOM, V1701, P1, DOI 10.1016/j.bbapap.2004.06.004; Konozy EHE, 2003, ARCH BIOCHEM BIOPHYS, V410, P222, DOI 10.1016/S0003-9861(02)00695-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Loyola W, 2012, INT IMMUNOPHARMACOL, V12, P378, DOI 10.1016/j.intimp.2011.12.010; Machuka JS, 1999, PHYTOCHEMISTRY, V51, P721, DOI 10.1016/S0031-9422(99)00136-3; MacNeil A, 2003, BRIT J CANCER, V88, P1566, DOI 10.1038/sj.bjc.6600929; OLSNES S, 1974, J BIOL CHEM, V249, P803; Pajic I, 2002, COMP BIOCHEM PHYS C, V132, P213, DOI 10.1016/S1532-0456(02)00068-6; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; Sharon N, 2002, J AGR FOOD CHEM, V50, P6586, DOI 10.1021/jf020190s; Sharon N, 2001, ADV EXP MED BIOL, V491, P1; Souza MA, 2005, BRAZ ARCH BIOL TECHN, V48, P705, DOI 10.1590/S1516-89132005000600005; STIRPE F, 1983, BIOCHEM J, V216, P617, DOI 10.1042/bj2160617; Tiwari S, 2005, ENVIRON RES, V99, P378, DOI 10.1016/j.envres.2004.12.008; Turton K, 2004, GLYCOBIOLOGY, V14, P923, DOI 10.1093/glycob/cwh114; Valadares MC, 2006, INT IMMUNOPHARMACOL, V6, P294, DOI 10.1016/j.intimp.2005.07.013; Wititsuwannakul R, 1998, PHYTOCHEMISTRY, V47, P183, DOI 10.1016/S0031-9422(97)00329-4; Xu H, 2004, ACTA BIOCH BIOPH SIN, V36, P169, DOI 10.1093/abbs/36.3.169; Yamamoto Y, 1981, Plant Cell Rep, V1, P29, DOI 10.1007/BF00267653; Yamasaki C, 2004, BBA-GEN SUBJECTS, V1671, P44, DOI 10.1016/j.bbagen.2004.01.002	33	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88422	10.1371/journal.pone.0088422	http://dx.doi.org/10.1371/journal.pone.0088422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558388	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700034
J	Suh, JH; Kanathezhath, B; Shenvi, S; Guo, H; Zhou, A; Tiwana, A; Kuypers, F; Ames, BN; Walters, MC				Suh, Jung H.; Kanathezhath, Bindu; Shenvi, Swapna; Guo, Hua; Zhou, Alicia; Tiwana, Anureet; Kuypers, Frans; Ames, Bruce N.; Walters, Mark C.			Thiol/Redox Metabolomic Profiling Implicates GSH Dysregulation in Early Experimental Graft versus Host Disease (GVHD)	PLOS ONE			English	Article							NF-KAPPA-B; STEM-CELL TRANSPLANTATION; NITRIC-OXIDE; GLUTATHIONE DISULFIDE; OXIDATIVE STRESS; REDOX REGULATION; MOLECULAR-BASIS; IN-VIVO; EFFLUX; LIVER	Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation (BMT). Upregulation of inflammatory cytokines precedes the clinical presentation of GVHD and predicts its severity. In this report, thiol/redox metabolomics was used to identify metabolic perturbations associated with early preclinical (Day+4) and clinical (Day+10) stages of GVHD by comparing effects in Syngeneic (Syn; major histocompatibility complex-identical) and allogeneic transplant recipients (Allo BMT) in experimental models. While most metabolic changes were similar in both groups, plasma glutathione (GSH) was significantly decreased, and GSH disulfide (GSSG) was increased after allogeneic compared to syngeneic recipient and non-transplant controls. The early oxidation of the plasma GSH/GSSG redox couple was also observed irrespective of radiation conditioning treatment and was accompanied by significant rise in hepatic protein oxidative damage and ROS generation. Despite a significant rise in oxidative stress, compensatory increase in hepatic GSH synthesis was absent following Allo BMT. Early shifts in hepatic oxidative stress and plasma GSH loss preceded a statistically significant rise in TNF-alpha. To identify metabolomic biomarkers of hepatic GVHD injury, plasma metabolite concentrations analyzed at Day+10 were correlated with hepatic organ injury. GSSG (oxidized GSH) and beta-alanine, were positively correlated, and plasma GSH cysteinylglycine, and branched chain amino acids were inversely correlated with hepatic injury. Although changes in plasma concentrations of cysteine, cystathionine (GSH precursors) and cysteinylglycine (a GSH catabolite) were not significant by univariate analysis, principal component analysis (PCA) indicated that accumulation of these metabolites after Allo BMT contributed significantly to early GVHD in contrast to Syn BMT. In conclusion, thiol/redox metabolomic profiling implicates that early dysregulation of host hepatic GSH metabolism and oxidative stress in subclinical GVHD before elevated TNF-alpha levels is associated with GVHD pathogenesis. Future studies will probe the mechanisms for these changes and examine the potential of antioxidant intervention strategies to modulate GVHD.	[Suh, Jung H.; Shenvi, Swapna; Zhou, Alicia; Tiwana, Anureet; Kuypers, Frans; Ames, Bruce N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Kanathezhath, Bindu; Guo, Hua; Walters, Mark C.] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [Kanathezhath, Bindu; Walters, Mark C.] Childrens Hosp & Res Ctr Oakland, Div Blood & Marrow Transplantat, Oakland, CA USA; [Guo, Hua] Childrens Hosp & Res Ctr Oakland, Dept Pathol, Oakland, CA USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Suh, JH (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	jsuh@chori.org; mwalters@mail.cho.org			CHORI-Ames Supporting Foundation; Bechtel SD Jr. Foundation; CIRM [T10007]; CHORI; Jordan Foundation Endowment Award	CHORI-Ames Supporting Foundation; Bechtel SD Jr. Foundation; CIRM(California Institute for Regenerative Medicine); CHORI; Jordan Foundation Endowment Award	This study was funded by The CHORI-Ames Supporting Foundation, Bechtel SD Jr. Foundation http://www.sdbjrfoundation.org/grant to JHS, CIRM T10007 http://www.cirm.ca.gov/grants award to BK, CHORI Clinical Research Award to JHS and BK and the Jordan Foundation Endowment Award to MCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABHYANKAR S, 1993, TRANSPLANTATION, V56, P1518, DOI 10.1097/00007890-199312000-00045; ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; Amer J, 2007, ANN HEMATOL, V86, P753, DOI 10.1007/s00277-007-0321-7; ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; Barkholt L, 2008, BONE MARROW TRANSPL, V41, P785, DOI 10.1038/sj.bmt.1705969; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Blackwell TS, 2000, ANTIOXID REDOX SIGN, V2, P93, DOI 10.1089/ars.2000.2.1-93; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Brechbuhl HM, 2010, J BIOL CHEM, V285, P16582, DOI 10.1074/jbc.M109.090506; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Ellison CA, 2003, IMMUNOLOGY, V109, P440, DOI 10.1046/j.1365-2567.2003.01663.x; Evens AM, 2004, BONE MARROW TRANSPL, V34, P561, DOI 10.1038/sj.bmt.1704591; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Franco R, 2012, ANTIOXID REDOX SIGN, V17, P1694, DOI 10.1089/ars.2012.4553; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Go YM, 2011, FREE RADICAL BIO MED, V50, P495, DOI 10.1016/j.freeradbiomed.2010.11.029; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Iyer SS, 2009, AM J RESP CELL MOL, V40, P90, DOI 10.1165/rcmb.2007-0447OC; Iyer SS, 2010, STEM CELLS INT, V2010, P1, DOI [10.1182/blood-2008-09-176198, DOI 10.1182/BL00D-2008-09-176198]; Jonas CR, 2000, AM J CLIN NUTR, V72, P181; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jung YY, 2008, J BIOL CHEM, V283, P23863, DOI 10.1074/jbc.M803072200; Kanathezhath B, 2011, EXP BIOL MED, V236, P492, DOI 10.1258/ebm.2011.010216; Karlsson H, 2011, EUR J IMMUNOL, V41, P1143, DOI 10.1002/eji.201040589; Kuypers FA, 2005, ANN NY ACAD SCI, V1054, P214, DOI 10.1196/annals.1345.026; Liu SY, 2008, EUR J IMMUNOL, V38, P410, DOI 10.1002/eji.200737556; Maccarrone M, 2009, CELL DEATH DIFFER, V16, P1184, DOI 10.1038/cdd.2009.65; Maeda Y, 2005, BLOOD, V105, P2023, DOI 10.1182/blood-2004-08-3036; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; OOKHTENS M, 1985, J CLIN INVEST, V75, P258, DOI 10.1172/JCI111682; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Pullarkat V, 2008, BONE MARROW TRANSPL, V42, P799, DOI 10.1038/bmt.2008.262; Ratajczak P, 2012, BIOL BLOOD MARROW TR, V18, P150, DOI 10.1016/j.bbmt.2011.08.002; Sari I, 2008, ANN CLIN LAB SCI, V38, P120; SCHLEGEL PG, 1995, J IMMUNOL, V155, P3856; Shelton MD, 2008, MOL CELLS, V25, P332; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; SIES H, 1984, METHOD ENZYMOL, V105, P445; Sprangers B, 2011, BONE MARROW TRANSPL, V46, P586, DOI 10.1038/bmt.2010.162; Suh JH, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-37; Suh JH, 2009, J CHROMATOGR B, V877, P3418, DOI 10.1016/j.jchromb.2009.06.041; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; Themeli M, 2010, LEUKEMIA, V24, P536, DOI 10.1038/leu.2009.284; Tschetter JR, 2000, J IMMUNOL, V165, P5987, DOI 10.4049/jimmunol.165.10.5987; Ullala AJ, 2009, EPIGENETICS AUTOIMMU, P165; Vodanovic-Jankovic S, 2006, BLOOD, V107, P827, DOI 10.1182/blood-2005-05-1820; Vora A, 1997, BONE MARROW TRANSPL, V20, P385, DOI 10.1038/sj.bmt.1700898; Weiss G, 1995, TRANSPLANTATION, V60, P1239; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yang SX, 2001, AM J PHYSIOL-LUNG C, V281, pL922, DOI 10.1152/ajplung.2001.281.4.L922; Ziegler TR, 2001, TRANSPLANTATION, V72, P1354, DOI 10.1097/00007890-200110270-00004	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88868	10.1371/journal.pone.0088868	http://dx.doi.org/10.1371/journal.pone.0088868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558439	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700085
J	Wakai, M; Abe, S; Kazuki, Y; Oshimura, M; Ishikawa, F				Wakai, Michihito; Abe, Satoshi; Kazuki, Yasuhiro; Oshimura, Mitsuo; Ishikawa, Fuyuki			A Human Artificial Chromosome Recapitulates the Metabolism of Native Telomeres in Mammalian Cells	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; POLYMERASE-II; REPLICATION; TERRA; DNA; PROTECTION; BINDING; TRANSCRIPTION; RECRUITMENT; EFFICIENT	Telomeric and subtelomeric regions of human chromosomes largely consist of highly repetitive and redundant DNA sequences, resulting in a paucity of unique DNA sequences specific to individual telomeres. Accordingly, it is difficult to analyze telomere metabolism on a single-telomere basis. To circumvent this problem, we have exploited a human artificial chromosome (HAC#21) derived from human chromosome 21 (hChr21). HAC#21 was generated through truncation of the long arm of native hChr21 by the targeted telomere seeding technique. The newly established telomere of HAC#21 lacks canonical subtelomere structures but possesses unique sequences derived from the target vector backbone and the internal region of hChr21 used for telomere targeting, which enabled us to molecularly characterize the single HAC telomere. We established HeLa and NIH-3T3 sub-lines containing a single copy of HAC#21, where it was robustly maintained. The seeded telomere is associated with telomeric proteins over a length similar to that reported in native telomeres, and is faithfully replicated in mid-S phase in HeLa cells. We found that the seeded telomere on HAC#21 is transcribed from the newly juxtaposed site. The transcript, HAC-telRNA, shares several features with TERRA (telomeric repeat-containing RNA): it is a short-lived RNA polymerase II transcript, rarely contains a poly(A) tail, and associates with chromatin. Interestingly, HAC-telRNA undergoes splicing. These results suggest that transcription into TERRA is locally influenced by the subtelomeric context. Taken together, we have established human and mouse cell lines that will be useful for analyzing the behavior of a uniquely identifiable, functional telomere.	[Wakai, Michihito; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto, Japan; [Abe, Satoshi; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan	Kyoto University; Tottori University; Tottori University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	fishikaw@lif.kyoto-u.ac.jp	Ishikawa, Fuyuki/AAU-4056-2021	Ishikawa, Fuyuki/0000-0002-5580-2305	Ministry of Education, Culture, Sports, Science and Technology, Japan [22220012]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (22220012). URL: http://kaken.nii.ac.jp/d/p/22220012.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Azzalin CM, 2008, CELL CYCLE, V7, P1161, DOI 10.4161/cc.7.9.5836; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Caslini C, 2009, MOL CELL BIOL, V29, P4519, DOI 10.1128/MCB.00195-09; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2012, EMBO J, V31, P4165, DOI 10.1038/emboj.2012.266; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Drosopoulos WC, 2012, J CELL BIOL, V197, P253, DOI 10.1083/jcb.201112083; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Giannone RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012407; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GUIALIS A, 1977, CELL, V10, P53, DOI 10.1016/0092-8674(77)90139-8; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; Hirai Y, 2012, GENES CELLS, V17, P186, DOI 10.1111/j.1365-2443.2012.01581.x; Hiratani I, 2009, EPIGENETICS-US, V4, P93, DOI 10.4161/epi.4.2.7772; IKENO M, 1994, HUM MOL GENET, V3, P1245, DOI 10.1093/hmg/3.8.1245; ITZHAKI JE, 1992, NAT GENET, V2, P283, DOI 10.1038/ng1292-283; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nergadze SG, 2009, RNA, V15, P2186, DOI 10.1261/rna.1748309; Nittis T, 2010, MOL CELL PROTEOMICS, V9, P1144, DOI 10.1074/mcp.M900490-MCP200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Silahtaroglu A, 2004, CYTOGENET GENOME RES, V107, P32, DOI 10.1159/000079569; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Weuts A, 2012, NUCLEIC ACIDS RES, V40, P11477, DOI 10.1093/nar/gks926; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Yehezkel S, 2011, EPIGENETICS-US, V6, P63, DOI 10.4161/epi.6.1.13390; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88530	10.1371/journal.pone.0088530	http://dx.doi.org/10.1371/journal.pone.0088530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558398	gold, Green Published			2022-12-25	WOS:000331706700044
J	Wang, GS; Mayes, MA; Gu, LH; Schadt, CW				Wang, Gangsheng; Mayes, Melanie A.; Gu, Lianhong; Schadt, Christopher W.			Representation of Dormant and Active Microbial Dynamics for Ecosystem Modeling	PLOS ONE			English	Article							MAINTENANCE CARBON REQUIREMENTS; NITROGEN TURNOVER; THEORETICAL-MODEL; FUNCTIONAL-GROUPS; SOIL; BIOMASS; GROWTH; DECOMPOSITION; RESPIRATION; BACTERIA	Dormancy is an essential strategy for microorganisms to cope with environmental stress. However, global ecosystem models typically ignore microbial dormancy, resulting in notable model uncertainties. To facilitate the consideration of dormancy in these large-scale models, we propose a new microbial physiology component that works for a wide range of substrate availabilities. This new model is based on microbial physiological states and the major parameters are the maximum specific growth and maintenance rates of active microbes and the ratio of dormant to active maintenance rates. A major improvement of our model over extant models is that it can explain the low active microbial fractions commonly observed in undisturbed soils. Our new model shows that the exponentially-increasing respiration from substrate-induced respiration experiments can only be used to determine the maximum specific growth rate and initial active microbial biomass, while the respiration data representing both exponentially-increasing and non-exponentially-increasing phases can robustly determine a range of key parameters including the initial total live biomass, initial active fraction, the maximum specific growth and maintenance rates, and the half-saturation constant. Our new model can be incorporated into existing ecosystem models to account for dormancy in microbially-driven processes and to provide improved estimates of microbial activities.	[Wang, Gangsheng; Mayes, Melanie A.; Gu, Lianhong; Schadt, Christopher W.] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA; [Wang, Gangsheng; Mayes, Melanie A.; Gu, Lianhong] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Wang, GS (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37831 USA.	wangg@ornl.gov	Gu, Lianhong/H-8241-2014; Schadt, Christopher W./B-7143-2008; Schadt, Christopher/M-8746-2019; Wang, Gangsheng/F-8940-2012	Gu, Lianhong/0000-0001-5756-8738; Schadt, Christopher W./0000-0001-8759-2448; Schadt, Christopher/0000-0001-8759-2448; Wang, Gangsheng/0000-0002-8117-5034	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL); U.S. Department of Energy Biological and Environmental Research (BER) program; U.S. Department of Energy [DE-AC05-00OR22725]	Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL); U.S. Department of Energy Biological and Environmental Research (BER) program(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was funded by the Laboratory Directed Research and Development (LDRD) Program of the Oak Ridge National Laboratory (ORNL) and by the U.S. Department of Energy Biological and Environmental Research (BER) program. ORNL is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; ANDERSON TH, 1985, SOIL BIOL BIOCHEM, V17, P197, DOI 10.1016/0038-0717(85)90115-4; ANDERSON TH, 1985, BIOL FERT SOILS, V1, P81, DOI 10.1007/BF00255134; Ayati BP, 2012, J THEOR BIOL, V293, P34, DOI 10.1016/j.jtbi.2011.10.003; Bar M, 2002, P ROY SOC B-BIOL SCI, V269, P937, DOI 10.1098/rspb.2002.1958; BEEFTINK HH, 1990, FEMS MICROBIOL ECOL, V73, P203, DOI 10.1016/0378-1097(90)90731-5; Blagodatsky SA, 2000, BIOL FERT SOILS, V32, P73, DOI 10.1007/s003740000219; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1743, DOI 10.1016/S0038-0717(98)00028-5; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1757, DOI 10.1016/S0038-0717(98)00029-7; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Buerger S, 2012, APPL ENVIRON MICROB, V78, P3221, DOI 10.1128/AEM.07307-11; Colores GM, 1996, SOIL BIOL BIOCHEM, V28, P1569, DOI 10.1016/S0038-0717(96)00253-2; DUAN QY, 1992, WATER RESOUR RES, V28, P1015, DOI 10.1029/91WR02985; Gignoux J, 2001, GLOBAL ECOL BIOGEOGR, V10, P639, DOI 10.1046/j.1466-822X.2001.00250.x; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; HUNT HW, 1977, ECOLOGY, V58, P469, DOI 10.2307/1938998; JENKINSON DS, 1976, SOIL BIOL BIOCHEM, V8, P209, DOI 10.1016/0038-0717(76)90005-5; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Khomutova TE, 2004, MICROBIOLOGY+, V73, P196, DOI 10.1023/B:MICI.0000023989.04745.7b; Konopka A, 1999, MICROBIAL ECOL, V38, P321, DOI 10.1007/s002489900178; Lawrence CR, 2009, SOIL BIOL BIOCHEM, V41, P1923, DOI 10.1016/j.soilbio.2009.06.016; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Locey KJ, 2010, J BIOGEOGR, V37, P1835, DOI 10.1111/j.1365-2699.2010.02357.x; Lodge D.J., 1993, BMS S SERIES, V19, P37; MASON CA, 1986, FEMS MICROBIOL LETT, V39, P373; Moorhead DL, 2012, SOIL BIOL BIOCHEM, V53, P133, DOI 10.1016/j.soilbio.2012.05.011; Orwin KH, 2006, OIKOS, V112, P196, DOI 10.1111/j.0030-1299.2006.13813.x; Panikov NS, 1996, MATH COMPUT SIMULAT, V42, P179, DOI 10.1016/0378-4754(95)00127-1; Panikov NS, 1996, J MICROBIOL METH, V24, P219, DOI 10.1016/0167-7012(95)00074-7; Panikov NS, 1995, MICROBIAL GROWTH KIN; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schulz S, 2010, J MICROBIOL METH, V80, P295, DOI 10.1016/j.mimet.2010.01.005; Sinsabaugh RL, 2013, ECOL LETT, V16, P930, DOI 10.1111/ele.12113; Stenstrom J, 2001, FEMS MICROBIOL ECOL, V36, P93, DOI 10.1016/S0168-6496(01)00122-2; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; Stolpovsky K, 2011, ECOL MODEL, V222, P3092, DOI 10.1016/j.ecolmodel.2011.07.006; Todd-Brown KEO, 2012, BIOGEOCHEMISTRY, V109, P19, DOI 10.1007/s10533-011-9635-6; Treseder KK, 2012, BIOGEOCHEMISTRY, V109, P7, DOI 10.1007/s10533-011-9636-5; VANDEWERF H, 1987, SOIL BIOL BIOCHEM, V19, P261, DOI 10.1016/0038-0717(87)90007-1; Wang G., 2009, WATER RESOUR RES, V45; Wang GS, 2013, SOIL BIOL BIOCHEM, V57, P946, DOI 10.1016/j.soilbio.2012.08.028; Wang GS, 2013, ECOL APPL, V23, P255, DOI 10.1890/12-0681.1; Wang GS, 2012, FEMS MICROBIOL ECOL, V81, P610, DOI 10.1111/j.1574-6941.2012.01389.x; Wang GS, 2012, SOIL BIOL BIOCHEM, V48, P28, DOI 10.1016/j.soilbio.2012.01.011; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Wirtz KW, 2003, FEMS MICROBIOL ECOL, V46, P295, DOI 10.1016/S0168-6496(03)00196-X; Yarwood S, 2013, APPL ENVIRON MICROB, V79, P1385, DOI 10.1128/AEM.03181-12	52	61	61	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89252	10.1371/journal.pone.0089252	http://dx.doi.org/10.1371/journal.pone.0089252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558490	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700136
J	Wolf, M; Baumer, P; Pedro, M; Dombert, T; Staub, F; Heiland, S; Bendszus, M; Pham, M				Wolf, Marcel; Baeumer, Philipp; Pedro, Maria; Dombert, Thomas; Staub, Frank; Heiland, Sabine; Bendszus, Martin; Pham, Mirko			Sciatic Nerve Injury Related to Hip Replacement Surgery: Imaging Detection by MR Neurography Despite Susceptibility Artifacts	PLOS ONE			English	Article							MAGNETIC-RESONANCE NEUROGRAPHY; ARTHROPLASTY; LESIONS; PALSY; EXPERIENCE; MANAGEMENT; NEUROPATHY; PROGNOSIS; DIAGNOSIS; OUTCOMES	Sciatic nerve palsy related to hip replacement surgery (HRS) is among the most common causes of sciatic neuropathies. The sciatic nerve may be injured by various different periprocedural mechanisms. The precise localization and extension of the nerve lesion, the determination of nerve continuity, lesion severity, and fascicular lesion distribution are essential for assessing the potential of spontaneous recovery and thereby avoiding delayed or inappropriate therapy. Adequate therapy is in many cases limited to conservative management, but in certain cases early surgical exploration and release of the nerve is indicated. Nerve-conduction-studies and electromyography are essential in the diagnosis of nerve injuries. In postsurgical nerve injuries, additional diagnostic imaging is important as well, in particular to detect or rule out direct mechanical compromise. Especially in the presence of metallic implants, commonly applied diagnostic imaging tests generally fail to adequately visualize nervous tissue. MRI has been deemed problematic due to implant-related artifacts after HRS. In this study, we describe for the first time the spectrum of imaging findings of Magnetic Resonance neurography (MRN) employing pulse sequences relatively insensitive to susceptibility artifacts (susceptibility insensitive MRN, siMRN) in a series of 9 patients with HRS procedure related sciatic nerve palsy. We were able to determine the localization and fascicular distribution of the sciatic nerve lesion in all 9 patients, which clearly showed on imaging predominant involvement of the peroneal more than the tibial division of the sciatic nerve. In 2 patients siMRN revealed direct mechanical compromise of the nerve by surgical material, and in one of these cases indication for surgical release of the sciatic nerve was based on siMRN. Thus, in selected cases of HRS related neuropathies, especially when surgical exploration of the nerve is considered, siMRN, with its potential to largely overcome implant related artifacts, is a useful diagnostic addition to nerve-conduction-studies and electromyography.	[Wolf, Marcel; Baeumer, Philipp; Bendszus, Martin; Pham, Mirko] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Pedro, Maria] Univ Ulm, Dept Neurosurg, Gunzburg, Germany; [Dombert, Thomas; Staub, Frank] Ctr Peripheral Nerve Surg, Dossenheim Heidelberg, Germany; [Heiland, Sabine] Heidelberg Univ, Sect Expt Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ulm University; Ruprecht Karls University Heidelberg	Wolf, M (corresponding author), Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany.	marcel.wolf@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020		Medical Faculty of the University of Heidelberg; German Osteoarthritis Foundation (Deutsche Arthrose Hilfe e.V.) [P215-A482]	Medical Faculty of the University of Heidelberg; German Osteoarthritis Foundation (Deutsche Arthrose Hilfe e.V.)	This study was supported by a Postdoctoral-Fellowship granted to MP from the Medical Faculty of the University of Heidelberg and a project grant from the German Osteoarthritis Foundation (Deutsche Arthrose Hilfe e.V.), Grant number P215-A482. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357; Cahir JG, 2007, CLIN RADIOL, V62, P1163, DOI 10.1016/j.crad.2007.04.018; Duffy Patrick, 2006, Instr Course Lect, V55, P223; EDWARDS BN, 1987, CLIN ORTHOP RELAT R, P136; Farrell CM, 2005, J BONE JOINT SURG AM, V87A, P2619, DOI 10.2106/JBJS.C.01564; Farrelly C, 2010, AM J ROENTGENOL, V194, pW60, DOI 10.2214/AJR.08.1740; Filler A, 2009, NEUROSURGERY, V65, pA29, DOI 10.1227/01.NEU.0000351279.78110.00; Filler Aaron G, 2009, Neurosurg Focus, V26, pE9, DOI 10.3171/FOC.2009.26.2.E9; Filler AG, 2005, J NEUROSURG-SPINE, V2, P99, DOI 10.3171/spi.2005.2.2.0099; Filler AG, 2004, NEUROL CLIN, V22, P643, DOI 10.1016/j.ncl.2004.03.005; Hargreaves BA, 2011, AM J ROENTGENOL, V197, P547, DOI 10.2214/AJR.11.7364; Kim DH, 1996, NEUROSURGERY, V39, P312, DOI 10.1097/00006123-199608000-00014; KIM DH, 1995, J NEUROSURG, V83, P783, DOI 10.3171/jns.1995.83.5.0783; Kim DH, 2004, J NEUROSURG, V101, P8, DOI 10.3171/jns.2004.101.1.0008; Koltzenburg M, 2004, CURR OPIN NEUROL, V17, P621, DOI 10.1097/00019052-200410000-00013; Kuntz C, 1996, NEUROSURGERY, V39, P750, DOI 10.1097/00006123-199610000-00021; Lee MJ, 2007, RADIOGRAPHICS, V27, P791, DOI 10.1148/rg.273065087; Miller TT, 2012, EUR J RADIOL, V81, P3802, DOI 10.1016/j.ejrad.2011.03.103; Nercessian O A, 1994, J Arthroplasty, V9, P645; Oldenburg M, 1997, INT ORTHOP, V21, P1, DOI 10.1007/s002640050107; Pham M, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2009.12.046; Pham M, 2011, J NEUROL, V258, P1120, DOI 10.1007/s00415-010-5895-7; Plewnia C, 1999, J TRAUMA, V47, P986, DOI 10.1097/00005373-199911000-00036; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SCHMALZRIED TP, 1991, J BONE JOINT SURG AM, V73A, P1074, DOI 10.2106/00004623-199173070-00018; Simon J P, 1993, Acta Orthop Belg, V59, P156; Stoll G, 2009, J NEUROL, V256, P1043, DOI 10.1007/s00415-009-5064-z; Toms AP, 2010, CLIN RADIOL, V65, P447, DOI 10.1016/j.crad.2009.12.014; Unwin A, 1999, INT ORTHOP, V23, P133, DOI 10.1007/s002640050329; WEBER ER, 1976, J BONE JOINT SURG AM, V58, P66, DOI 10.2106/00004623-197658010-00011; Wessig C, 2004, EXP NEUROL, V185, P254, DOI 10.1016/j.expneurol.2003.10.012; Yeremeyeva E, 2009, NEUROSURGERY, V65, pA63, DOI 10.1227/01.NEU.0000346265.17661.1E; Zhan CL, 2007, J BONE JOINT SURG AM, V89A, P526, DOI 10.2106/JBJS.F.00952	33	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89154	10.1371/journal.pone.0089154	http://dx.doi.org/10.1371/journal.pone.0089154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558483	Green Submitted, gold, Green Published			2022-12-25	WOS:000331706700129
J	Wong, TM; Boyapalle, S; Sampayo, V; Nguyen, HD; Bedi, R; Kamath, SG; Moore, ML; Mohapatra, S; Mohapatra, SS				Wong, Terianne M.; Boyapalle, Sandhya; Sampayo, Viviana; Nguyen, Huy D.; Bedi, Raminder; Kamath, Siddharth G.; Moore, Martin L.; Mohapatra, Subhra; Mohapatra, Shyam S.			Respiratory Syncytial Virus (RSV) Infection in Elderly Mice Results in Altered Antiviral Gene Expression and Enhanced Pathology	PLOS ONE			English	Article							DENDRITIC CELLS; FUSION PROTEIN; VIRAL-INFECTION; BALB/C MICE; IN-VITRO; T-CELLS; OSTEOPONTIN; INFLUENZA; LUNG; DISEASE	Elderly persons are more susceptible to RSV-induced pneumonia than young people, but the molecular mechanism underlying this susceptibility is not well understood. In this study, we used an aged mouse model of RSV-induced pneumonia to examine how aging alters the lung pathology, modulates antiviral gene expressions, and the production of inflammatory cytokines in response to RSV infection. Young (2-3 months) and aged (19-21 months) mice were intranasally infected with mucogenic or non-mucogenic RSV strains, lung histology was examined, and gene expression was analyzed. Upon infection with mucogenic strains of RSV, leukocyte infiltration in the airways was elevated and prolonged in aged mice compared to young mice. Minitab factorial analysis identified several antiviral genes that are influenced by age, infection, and a combination of both factors. The expression of five antiviral genes, including pro-inflammatory cytokines IL-1b and osteopontin (OPN), was altered by both age and infection, while age was associated with the expression of 15 antiviral genes. Both kinetics and magnitude of antiviral gene expression were diminished as a result of older age. In addition to delays in cytokine signaling and pattern recognition receptor induction, we found TLR7/8 signaling to be impaired in alveolar macrophages in aged mice. In vivo, induction of IL-1b and OPN were delayed but prolonged in aged mice upon RSV infection compared to young. In conclusion, this study demonstrates inherent differences in response to RSV infection in young vs. aged mice, accompanied by delayed antiviral gene induction and cytokine signaling.	[Wong, Terianne M.; Boyapalle, Sandhya; Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley Vet Affairs Hosp, Dept Internal Med, Tampa, FL 33612 USA; [Wong, Terianne M.; Boyapalle, Sandhya; Sampayo, Viviana; Nguyen, Huy D.; Bedi, Raminder; Kamath, Siddharth G.; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Div Translat Med, Morsani Coll Med, Tampa, FL 33612 USA; [Wong, Terianne M.; Boyapalle, Sandhya; Sampayo, Viviana; Nguyen, Huy D.; Bedi, Raminder; Kamath, Siddharth G.; Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Nanomed Res Ctr, Morsani Coll Med, Tampa, FL 33612 USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Mohapatra, Subhra] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Emory University; Children's Healthcare of Atlanta (CHOA); State University System of Florida; University of South Florida	Mohapatra, SS (corresponding author), James A Haley Vet Affairs Hosp, Dept Internal Med, Tampa, FL 33612 USA.	smohapat@health.usf.edu	Mohapatra, Shyam/C-2500-2012		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Research Career Scientist and Veterans Affairs Merit Review Award; University of South Florida; NIH [1R01AI087798, 1U19AI095227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087798, U19AI095227] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Research Career Scientist and Veterans Affairs Merit Review Award; University of South Florida; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This material is based upon work supported in part by Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. The contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government. Work in this study was financially supported with Research Career Scientist and Veterans Affairs Merit Review Award to Dr. Shyam Mohapatra and University of South Florida Signature Research Fellowship to Mrs. Terianne Wong. Martin L. Moore was supported by NIH 1R01AI087798 and NIH 1U19AI095227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Aeffner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046660; Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Bendelja K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-143; Boehmer ED, 2005, MECH AGEING DEV, V126, P1305, DOI 10.1016/j.mad.2005.07.009; Boukhvalova MS, 2007, J INFECT DIS, V195, P511, DOI 10.1086/510628; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Cabalka AK, 2004, PEDIATR INFECT DIS J, V23, pS41, DOI 10.1097/01.inf.0000108220.94201.1a; Camous X, 2012, J BIOMED BIOTECHNOL, V2012, P8; Cherukuri A, 2013, CLIN VACCINE IMMUNOL, V20, P239, DOI 10.1128/CVI.00580-12; Cherukuri A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-21; Chiba S, 2000, MICROBIOL IMMUNOL, V44, P319, DOI 10.1111/j.1348-0421.2000.tb02501.x; Curtis SJ, 2002, EXP BIOL MED, V227, P799, DOI 10.1177/153537020222700912; Cyr SL, 2007, VACCINE, V25, P3228, DOI 10.1016/j.vaccine.2007.01.037; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Eisenhut M, 2006, CRIT CARE, V10, DOI 10.1186/cc4984; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fulton Ross B, 2009, Aging health, V5, P775, DOI 10.2217/ahe.09.69; Gern JE, 2009, CURR OPIN ALLERGY CL, V9, P73, DOI 10.1097/ACI.0b013e32831f8f1b; Giles BM, 2011, VACCINE, V29, P3043, DOI 10.1016/j.vaccine.2011.01.100; Gonzalez PA, 2008, P NATL ACAD SCI USA, V105, P14999, DOI 10.1073/pnas.0802555105; Harker JA, 2010, J VIROL, V84, P4073, DOI 10.1128/JVI.02014-09; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Johnstone J, 2008, CHEST, V134, P1141, DOI 10.1378/chest.08-0888; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Liang S, 2009, MECH AGEING DEV, V130, P538, DOI 10.1016/j.mad.2009.06.006; Lindell DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021823; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Matsui Y, 2009, ARTHRITIS RHEUM-US, V60, P2362, DOI 10.1002/art.24705; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Morimoto J, 2011, J IMMUNOL, V187, P5671, DOI 10.4049/jimmunol.1101825; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Paliwal P, 2012, AGING-US, V4, P553, DOI 10.18632/aging.100477; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Prasse A, 2009, AM J PATHOL, V174, P1683, DOI 10.2353/ajpath.2009.080689; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Ramirez A, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-27; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Sato K, 2012, BIOCHEM BIOPH RES CO, V417, P274, DOI 10.1016/j.bbrc.2011.11.100; Schlafer S, 2012, J NAT PROD, V75, P2108, DOI 10.1021/np300514z; Schlender J, 2000, J VIROL, V74, P8234, DOI 10.1128/JVI.74.18.8234-8242.2000; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003; Stokes KL, 2011, J VIROL, V85, P5782, DOI 10.1128/JVI.01693-10; Stout-Delgado HW, 2012, J IMMUNOL, V188, P2815, DOI 10.4049/jimmunol.1103051; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tran KC, 2004, J VIROL, V78, P692, DOI 10.1128/JVI.78.2.692-699.2004; van der Windt GJW, 2010, EUR RESPIR J, V36, P1337, DOI 10.1183/09031936.00002710; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; XUAN JW, 1995, J CELL BIOCHEM, V57, P680, DOI 10.1002/jcb.240570413; Zhang Y, 2002, EXP BIOL MED; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zhou W, 2006, MICROBES INFECT, V8, P2880, DOI 10.1016/j.micinf.2006.09.007	66	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88764	10.1371/journal.pone.0088764	http://dx.doi.org/10.1371/journal.pone.0088764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558422	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700068
J	Yang, B; Wagner, J; Damaschke, N; Yao, TY; Wuerzberger-Davis, SM; Lee, MH; Svaren, J; Miyamoto, S; Jarrard, DF				Yang, Bing; Wagner, Jennifer; Damaschke, Nathan; Yao, Tianyu; Wuerzberger-Davis, Shelly M.; Lee, Moon-Hee; Svaren, John; Miyamoto, Shigeki; Jarrard, David F.			A Novel Pathway Links Oxidative Stress to Loss of Insulin Growth Factor-2 (IGF2) Imprinting through NF-kappa B Activation	PLOS ONE			English	Article							CTCF BINDING-SITES; PROSTATE-CANCER; DNA METHYLATION; EXPRESSION; INDUCTION; MOUSE; TRANSCRIPTION; CELLS	Genomic imprinting is the allele-specific expression of a gene based on parental origin. Loss of imprinting(LOI) of Insulin-like Growth Factor 2 (IGF2) during aging is important in tumorigenesis, yet the regulatory mechanisms driving this event are largely unknown. In this study oxidative stress, measured by increased NF-kappa B activity, induces LOI in both cancerous and noncancerous human prostate cells. Decreased expression of the enhancer-blocking element CCCTC-binding factor(CTCF) results in reduced binding of CTCF to the H19-ICR (imprint control region), a major factor in the allelic silencing of IGF2. This ICR then develops increased DNA methylation. Assays identify a recruitment of the canonical pathway proteins NF-kappa B p65 and p50 to the CTCF promoter associated with the co-repressor HDAC1 explaining gene repression. An I kappa B alpha super-repressor blocks oxidative stress-induced activation of NF-kappa B and IGF2 imprinting is maintained. In vivo experiments using I kappa B alpha mutant mice with continuous NF-kappa B activation demonstrate increased IGF2 LOI further confirming a central role for canonical NF-kappa B signaling. We conclude CTCF plays a central role in mediating the effects of NF-kappa B activation that result in altered imprinting both in vitro and in vivo. This novel finding connects inflammation found in aging prostate tissues with the altered epigenetic landscape.	[Yang, Bing; Wagner, Jennifer; Damaschke, Nathan; Yao, Tianyu; Jarrard, David F.] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Wuerzberger-Davis, Shelly M.; Lee, Moon-Hee; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53706 USA; [Svaren, John; Jarrard, David F.] Univ Wisconsin, Madison, WI USA; [Miyamoto, Shigeki; Jarrard, David F.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jarrard, DF (corresponding author), Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jarrard@urology.wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Damaschke, Nathan/0000-0002-0216-1516	National Institutes of Health [2R01CA097131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520, R01CA097131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, No. 2R01CA097131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bennett-Baker PE, 2003, GENETICS, V165, P2055; Bhusari SS, 2010, EPIGENETICS-US, V5, P402, DOI 10.4161/epi.5.5.11853; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen CL, 2000, J IMMUNOL, V165, P5418, DOI 10.4049/jimmunol.165.10.5418; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Fu VX, 2008, CANCER RES, V68, P6797, DOI 10.1158/0008-5472.CAN-08-1714; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; Jarrard DF, 1999, CANCER RES, V59, P2957; Jin R, 2013, CANC RES IN PRESS; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0; Koul HK, 2010, DRUG TODAY, V46, P929, DOI 10.1358/dot.2010.46.12.1537942; Lee MH, 2011, MOL CELL, V43, P180, DOI 10.1016/j.molcel.2011.06.017; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; Malins DC, 2001, CANCER RES, V61, P6025; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Miyamoto S, 2004, MOL CELL, V13, P763, DOI 10.1016/S1097-2765(04)00158-3; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; O'Conner JL, 1997, MOL CELL ENDOCRINOL, V136, P67, DOI 10.1016/S0303-7207(97)00216-5; Paradowska A, 2009, INT J ONCOL, V35, P87, DOI 10.3892/ijo_00000316; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Shen T, 2010, BIOL PHARM BULL, V33, P1159, DOI 10.1248/bpb.33.1159; Siddiqui IA, 2008, PHARM RES-DORDR, V25, P2135, DOI 10.1007/s11095-008-9553-z; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Yang B, 2013, NEOPLASIA, V15, P399, DOI 10.1593/neo.13280; Yang YW, 2003, J CELL BIOCHEM, V90, P1038, DOI 10.1002/jcb.10684	43	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88052	10.1371/journal.pone.0088052	http://dx.doi.org/10.1371/journal.pone.0088052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558376	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700022
J	Yurube, T; Sumi, M; Nishida, K; Miyamoto, H; Kohyama, K; Matsubara, T; Miura, Y; Hirata, H; Sugiyama, D; Doita, M				Yurube, Takashi; Sumi, Masatoshi; Nishida, Kotaro; Miyamoto, Hiroshi; Kohyama, Kozo; Matsubara, Tsukasa; Miura, Yasushi; Hirata, Hiroaki; Sugiyama, Daisuke; Doita, Minoru			Accelerated Development of Cervical Spine Instabilities in Rheumatoid Arthritis: A Prospective Minimum 5-Year Cohort Study	PLOS ONE			English	Article							ATLANTO-AXIAL SUBLUXATION; RADIOLOGICAL CHANGES; FOLLOW-UP; VERTICAL TRANSLOCATION; NATURAL-HISTORY; LESIONS; PROGRESSION; RECOMMENDATIONS; DISLOCATION; PREDICTORS	Objective: To clarify the incidence and predictive risk factors of cervical spine instabilities which may induce compression myelopathy in patients with rheumatoid arthritis (RA). Methods: Three types of cervical spine instability were radiographically categorized into "moderate" and "severe" based on atlantoaxial subluxation (AAS: atlantodental interval >3 mm versus >= 10 mm), vertical subluxation (VS: Ranawat value < 13 mm versus <= 10 mm), and subaxial subluxation (SAS: irreducible translation >= 2 mm versus >= 4 mm or at multiple). 228 "definite" or "classical" RA patients (140 without instability and 88 with "moderate" instability) were prospectively followed for >5 years. The endpoint incidence of "severe" instabilities and predictors for "severe" instability were determined. Results: Patients with baseline "moderate" instability, including all sub-groups (AAS(+) [VS- SAS(-)], VS+ [SAS(-) AAS(-)], and SAS(+) [AAS(-) VS-]), developed "severe" instabilities more frequently (33.3% with AAS(+), 75.0% with VS+, and 42.9% with SAS(+)) than those initially without instability (12.9%; p<0.003, p<0.003, and p = 0.061, respectively). The incidence of cervical canal stenosis and/or basilar invagination was also higher in patients with initial instability (17.5% with AAS(+), 37.5% with VS+, and 14.3% with SAS(+)) than in those without instability (7.1%; p = 0.028, p<0.003, and p = 0.427, respectively). Multivariable logistic regression analysis identified corticosteroid administration, Steinbrocker stage III or IV at baseline, mutilating changes at baseline, and the development of mutilans during the follow-up period correlated with the progression to "severe" instability (p<0.05). Conclusions: This prospective cohort study demonstrates accelerated development of cervical spine involvement in RA patients with pre-existing instability-especially VS. Advanced peripheral erosiveness and concomitant corticosteroid treatment are indicators for poor prognosis of the cervical spine in RA.	[Yurube, Takashi; Nishida, Kotaro; Miura, Yasushi; Hirata, Hiroaki] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 657, Japan; [Sumi, Masatoshi] Kobe Rosai Hosp, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo, Japan; [Miyamoto, Hiroshi] Kobe Med Ctr, Dept Orthopaed Surg, Suma Ku, Kobe, Hyogo, Japan; [Kohyama, Kozo] Kohnan Kakogawa Hosp, Dept Orthopaed Surg, Kakogawa, Hyogo, Japan; [Matsubara, Tsukasa] Matsubara Mayflower Hosp, Dept Orthopaed Surg, Fujita, Kato, Japan; [Sugiyama, Daisuke] Kobe Univ, Grad Sch Med, Dept Evidence Based Lab Med, Chuo Ku, Kobe, Hyogo 657, Japan	Kobe University; Kobe City Medical Center General Hospital; Kobe University	Sumi, M (corresponding author), Kobe Rosai Hosp, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo, Japan.	sumim@kobeh.rofuku.go.jp	Sugiyama, Daisuke/L-4347-2013; Sokabe, Masahiro/I-1565-2012	Sugiyama, Daisuke/0000-0002-6487-8934; 				Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BALL J, 1971, ANN RHEUM DIS, V30, P213, DOI 10.1136/ard.30.3.213; Belt EA, 1999, ANN RHEUM DIS, V58, P250, DOI 10.1136/ard.58.4.250; BODEN SD, 1993, J BONE JOINT SURG AM, V75A, P1282, DOI 10.2106/00004623-199309000-00004; Casey ATH, 1996, LANCET, V347, P1004, DOI 10.1016/S0140-6736(96)90146-4; Casey ATH, 1997, J NEUROSURG, V87, P863, DOI 10.3171/jns.1997.87.6.0863; Casey ATH, 1997, J NEUROSURG, V87, P856, DOI 10.3171/jns.1997.87.6.0856; CLARK CR, 1989, J BONE JOINT SURG AM, V71A, P381, DOI 10.2106/00004623-198971030-00012; COLLINS DN, 1991, CLIN ORTHOP RELAT R, P127; CONLON PW, 1966, ANN RHEUM DIS, V25, P120, DOI 10.1136/ard.25.2.120; Farkas B, 2010, CLIN ORTHOP RELAT R, V468, P3112, DOI 10.1007/s11999-010-1443-0; Fujiwara K, 1998, SPINE, V23, P2052, DOI 10.1097/00007632-199810010-00003; Fujiwara K, 2000, J SPINAL DISORD, V13, P519, DOI 10.1097/00002517-200012000-00010; Grauer JN, 2004, J BONE JOINT SURG AM, V86A, P1420, DOI 10.2106/00004623-200407000-00009; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; HALLA JT, 1990, ARTHRITIS RHEUM, V33, P325, DOI 10.1002/art.1780330304; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; ISDALE IC, 1971, ANN RHEUM DIS, V30, P387, DOI 10.1136/ard.30.4.387; Kaito T, 2012, SPINE, V37, P1742, DOI 10.1097/BRS.0b013e318256b584; Kataoka O, 1977, J W PACIFIC ORTHOP A, V14, P1; KAUPPI M, 1990, J RHEUMATOL, V17, P167; Laiho K, 2001, RHEUMATOL INT, V20, P225, DOI 10.1007/s002960100114; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; LOURIE H, 1961, NEW ENGL J MED, V265, P677, DOI 10.1056/NEJM196110052651405; MARTEL W, 1961, AMER J ROENTGENOL RA, V86, P223; MATHEWS JA, 1974, ANN RHEUM DIS, V33, P526, DOI 10.1136/ard.33.6.526; MATHEWS JA, 1969, ANN RHEUM DIS, V28, P260, DOI 10.1136/ard.28.3.260; MCRAE DL, 1953, AM J ROENTGENOL, V70, P23; Neva MH, 2003, ARTHRITIS RHEUM-US, V48, P1808, DOI 10.1002/art.11086; Neva MH, 2000, J RHEUMATOL, V27, P90; Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515; Paimela L, 1997, J RHEUMATOL, V24, P1280; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PELLICCI PM, 1981, J BONE JOINT SURG AM, V63, P342, DOI 10.2106/00004623-198163030-00003; RANA NA, 1989, SPINE, V14, P1054, DOI 10.1097/00007632-198910000-00005; RANAWAT CS, 1979, J BONE JOINT SURG AM, V61, P1003, DOI 10.2106/00004623-197961070-00006; RASKER JJ, 1978, ANN RHEUM DIS, V37, P529, DOI 10.1136/ard.37.6.529; REDLUNDJOHNELL I, 1984, ACTA RADIOL DIAGN, V25, P23, DOI 10.1177/028418518402500105; ROPES M W, 1958, Bull Rheum Dis, V9, P175; RUDGE SR, 1981, RHEUMATOL REHABIL, V20, P102, DOI 10.1093/rheumatology/20.2.102; Seki E, 2009, CLIN RHEUMATOL, V28, P453, DOI 10.1007/s10067-008-1076-9; SHARP J, 1961, ANN RHEUM DIS, V20, P47, DOI 10.1136/ard.20.1.47; SMITH PH, 1972, ANN RHEUM DIS, V31, P431, DOI 10.1136/ard.31.6.431; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; WEISSMAN BNW, 1982, RADIOLOGY, V144, P745, DOI 10.1148/radiology.144.4.7111719; WINFIELD J, 1981, ANN RHEUM DIS, V40, P109, DOI 10.1136/ard.40.2.109; WINFIELD J, 1983, ANN RHEUM DIS, V42, P613, DOI 10.1136/ard.42.6.613; YONEZAWA T, 1995, SPINE, V20, P208, DOI 10.1097/00007632-199501150-00015; Yurube T, 2012, SPINE, V37, P2136, DOI 10.1097/BRS.0b013e31826def1c; Yurube T, 2011, SPINE, V36, P647, DOI 10.1097/BRS.0b013e3181da21c5	53	17	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88970	10.1371/journal.pone.0088970	http://dx.doi.org/10.1371/journal.pone.0088970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558457	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700103
J	He, YDD; Karbowski, CM; Werner, J; Everds, N; Di Palma, C; Chen, Y; Higgins-Garn, M; Tran, S; Afshari, CA; Hamadeh, HK				He, Yudong D.; Karbowski, Christine M.; Werner, Jon; Everds, Nancy; Di Palma, Chris; Chen, Yuan; Higgins-Garn, Marnie; Tran, Sandra; Afshari, Cynthia A.; Hamadeh, Hisham K.			Common Handling Procedures Conducted in Preclinical Safety Studies Result in Minimal Hepatic Gene Expression Changes in Sprague-Dawley Rats	PLOS ONE			English	Article							CHRONIC STRESS; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; VACCINATION; ACTIVATION; SIZE	Gene expression profiling is a tool to gain mechanistic understanding of adverse effects in response to compound exposure. However, little is known about how the common handling procedures of experimental animals during a preclinical study alter baseline gene expression. We report gene expression changes in the livers of female Sprague-Dawley rats following common handling procedures. Baseline gene expression changes identified in this study provide insight on how these changes may affect interpretation of gene expression profiles following compound exposure. Rats were divided into three groups. One group was not subjected to handling procedures and served as controls for both handled groups. Animals in the other two groups were weighed, subjected to restraint in Broome restrainers, and administered water via oral gavage daily for 1 or 4 days with tail vein blood collections at 1, 2, 4, and 8 hours postdose on days 1 and 4. Significantly altered genes were identified in livers of animals following 1 or 4 days of handling when compared to the unhandled animals. Gene changes in animals handled for 4 days were similar to those handled for 1 day, suggesting a lack of habituation. The altered genes were primarily immune function related genes. These findings, along with a correlating increase in corticosterone levels suggest that common handling procedures may cause a minor immune system perturbance.	[He, Yudong D.; Everds, Nancy; Di Palma, Chris] Amgen Inc, Comparat Biol & Safety Sci, Seattle, WA USA; [Karbowski, Christine M.; Werner, Jon; Chen, Yuan; Higgins-Garn, Marnie; Tran, Sandra; Afshari, Cynthia A.; Hamadeh, Hisham K.] Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Hamadeh, HK (corresponding author), Amgen Inc, Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA.	hhamadeh@amgen.com						Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Burns VE, 2003, VACCINE, V21, P2523, DOI 10.1016/S0264-410X(03)00041-0; Burns VE, 2002, PSYCHOSOM MED, V64, P963, DOI 10.1097/01.PSY.0000038936.67401.28; Burns VE, 2008, PSYCHOSOM MED, V70, P387, DOI 10.1097/PSY.0b013e31816ded22; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2000, ANN NY ACAD SCI, V917, P876, DOI 10.1111/j.1749-6632.2000.tb05454.x; Dragos Dorin, 2010, J Med Life, V3, P10; Fielden MR, 2005, AM J PHARMACOGENOMIC, V5, P161, DOI 10.2165/00129785-200505030-00003; Fleshner M, 2001, J IMMUNOL, V166, P3813, DOI 10.4049/jimmunol.166.6.3813; Fleshner M, 1998, AM J PHYSIOL-REG I, V275, pR870, DOI 10.1152/ajpregu.1998.275.3.R870; Freudenberg JM, 2011, BIOINFORMATICS, V27, P70, DOI 10.1093/bioinformatics/btq593; Glaser R, 2000, PSYCHOSOM MED, V62, P804, DOI 10.1097/00006842-200011000-00010; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; IoLAR, 1996, GUIDE CARE USE LAB A; Mongan MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015595; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Sharp J, 2003, CONTEMP TOP LAB ANIM, V42, P8; Sharp JL, 2002, CONTEMP TOP LAB ANIM, V41, P8; Silberman DM, 2003, J NEUROIMMUNOL, V144, P53, DOI 10.1016/j.jneuroim.2003.08.031; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Tournier JN, 2001, IMMUNOLOGY, V102, P87, DOI 10.1046/j.1365-2567.2001.01152.x; VANDERLINDEN PWG, 1990, LANCET, V336, P904, DOI 10.1016/0140-6736(90)92272-J	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88750	10.1371/journal.pone.0088750	http://dx.doi.org/10.1371/journal.pone.0088750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551150	Green Submitted, Green Published, gold			2022-12-25	WOS:000331271500063
J	Krushelnycky, PD				Krushelnycky, Paul D.			Evaluating the Interacting Influences of Pollination, Seed Predation, Invasive Species and Isolation on Reproductive Success in a Threatened Alpine Plant	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ARGENTINE ANT; FLORAL VISITORS; FRASERA-SPECIOSA; POPULATION-SIZE; PATCH SIZE; HONEY-BEES; DENSITY; PATTERNS; VISITATION	Reproduction in rare plants may be influenced and limited by a complex combination of factors. External threats such as invasive species and landscape characteristics such as isolation may impinge on both pollination and seed predation dynamics, which in turn can strongly affect reproduction. I assessed how patterns in floral visitation, seed predation, invasive ant presence, and plant isolation influenced one another and ultimately affected viable seed production in Haleakala silverswords (Argyroxiphium sandwicense subsp. macrocephalum) of Hawai'i. Floral visitation was dominated by endemic Hylaeus bees, and patterns of visitation were influenced by floral display size and number of plants clustered together, but not by floral herbivory or nearest flowering neighbor distance. There was also some indication that Argentine ant presence impacted floral visitation, but contradictory evidence and limitations of the study design make this result uncertain. Degree of seed predation was associated only with plant isolation, with the two main herbivores partitioning resources such that one preferentially attacked isolated plants while the other attacked clumped plants; total seed predation was greater in more isolated plants. Net viable seed production was highly variable among individuals (0-55% seed set), and was affected mainly by nearest neighbor distance, apparently owing to low cross-pollination among plants separated by even short distances (> 10-20 m). This isolation effect dominated net seed set, with no apparent influence from floral visitation rates, percent seed predation, or invasive ant presence. The measured steep decline in seed set with isolation distance may not be typical of the entire silversword range, and may indicate that pollinators in addition to Hylaeus bees could be important for greater gene flow. Management aimed at maintaining or maximizing silversword reproduction should focus on the spatial context of field populations and outplanting efforts, as well as on conserving the widest possible range of pollinator taxa.	Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Krushelnycky, PD (corresponding author), Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	pauldk@hawaii.edu			U.S. Geological Survey; National Park Service through University of Hawai'i	U.S. Geological Survey(United States Geological Survey); National Park Service through University of Hawai'i	Funding came from the U.S. Geological Survey through the Park Oriented Biological Support program, and from the National Park Service through a cooperative agreement with the University of Hawai'i, administered by the Hawai'i Pacific Islands Cooperative Ecosystems Studies Unit and the College of Tropical Agriculture and Human Resources of the University of Hawai'i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abe T, 2008, BIODIVERS CONSERV, V17, P1465, DOI 10.1007/s10531-008-9355-y; Abe T, 2011, BIOL INVASIONS, V13, P957, DOI 10.1007/s10530-010-9882-9; Agren J, 1996, ECOLOGY, V77, P1779, DOI 10.2307/2265783; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; BEATTIE AJ, 1973, ECOLOGY, V54, P81, DOI 10.2307/1934376; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; Bleil R, 2011, PAC SCI, V65, P291, DOI 10.2984/65.3.291; Burgman MA, 2007, BIOL CONSERV, V134, P73, DOI 10.1016/j.biocon.2006.08.005; CAPPUCCINO N, 1992, ECOL ENTOMOL, V17, P109, DOI 10.1111/j.1365-2311.1992.tb01166.x; Caraballo-Ortiz MA, 2011, J TROP ECOL, V27, P521, DOI 10.1017/S0266467411000289; CARR GD, 1986, EVOLUTION, V40, P430, DOI 10.1111/j.1558-5646.1986.tb00485.x; COLE FR, 1992, ECOLOGY, V73, P1313, DOI 10.2307/1940678; COURTNEY SP, 1982, ECOL ENTOMOL, V7, P131, DOI 10.1111/j.1365-2311.1982.tb00651.x; Daly HV, 2003, INSECTS HAWAII, V17; Degener O, 1930, FERNS FLOWERING PLAN; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; Elzinga JA, 2005, OECOLOGIA, V144, P416, DOI 10.1007/s00442-005-0096-2; FEINSINGER P, 1991, ECOLOGY, V72, P1953, DOI 10.2307/1941550; Fenner M, 2002, OECOLOGIA, V130, P72, DOI 10.1007/s004420100773; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fishbein M, 1996, ECOLOGY, V77, P1061, DOI 10.2307/2265576; Forsyth SA, 2003, OECOLOGIA, V136, P551, DOI 10.1007/s00442-003-1295-3; Forsyth SA, 2002, THESIS U ARIZONA TUS; Ghazoul J, 1998, J ECOL, V86, P462, DOI 10.1046/j.1365-2745.1998.00270.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gonzalez-Varo JP, 2009, BIOL CONSERV, V142, P1058, DOI 10.1016/j.biocon.2009.01.017; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hartley S, 2010, ECOGRAPHY, V33, P83, DOI 10.1111/j.1600-0587.2009.06037.x; HERRERA CM, 1987, OIKOS, V50, P79, DOI 10.2307/3565403; Hopper D. R, 2002, THESIS U HAWAII MANO; INOUYE DW, 1979, ECOLOGY, V60, P1, DOI 10.2307/1936460; Ivey CT, 2003, AM J BOT, V90, P214, DOI 10.3732/ajb.90.2.214; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JENNERSTEN O, 1988, CONSERV BIOL, V2, P359, DOI 10.1111/j.1523-1739.1988.tb00200.x; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; KOBAYASHI H, 1974, P HAWAII ENTOMOL SOC, V21, P397; Kobayashi S, 1965, RES POPUL ECOL, V7, P109; Koch JB, 2013, PAC SCI, V67, P253, DOI 10.2984/67.2.8; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Krushelnycky PD, 2008, ECOL APPL, V18, P1547, DOI 10.1890/07-1293.1; Krushelnycky PD, 2013, GLOBAL CHANGE BIOL, V19, P911, DOI 10.1111/gcb.12111; Krushelnycky PD, 2010, BIODIVERS CONSERV, V19, P1971, DOI 10.1007/s10531-010-9819-8; Krushelnycky PD, 2005, DIVERS DISTRIB, V11, P319, DOI 10.1111/j.1366-9516.2005.00151.x; KUNIN WE, 1992, OECOLOGIA, V91, P129, DOI 10.1007/BF00317251; Kunin WE, 1999, OIKOS, V84, P515, DOI 10.2307/3546430; Lach L, 2008, ECOL ENTOMOL, V33, P155, DOI 10.1111/j.1365-2311.2007.00969.x; LINDSEY AH, 1984, AM J BOT, V71, P375, DOI 10.2307/2443496; Loope LL, 1986, CNPRSU58 U HAW; LOOPE LL, 1994, TROPICAL ALPINE ENV, P337; Magnacca KN, 2007, PAC SCI, V61, P173, DOI 10.2984/1534-6188(2007)61[173:CSOTEB]2.0.CO;2; Ollerton J, 1996, J ECOL, V84, P767, DOI 10.2307/2261338; PLATT WJ, 1974, OECOLOGIA, V17, P55, DOI 10.1007/BF00345095; Powell EA, 1992, THESIS U HAWAII MANO; Rhainds M, 2003, ECOL ENTOMOL, V28, P348, DOI 10.1046/j.1365-2311.2003.00508.x; RODRIGUEZROBLES JA, 1992, AM J BOT, V79, P1009, DOI 10.2307/2444910; Sahli HF, 2007, AM J BOT, V94, P203, DOI 10.3732/ajb.94.2.203; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Sakai AK, 2002, SYST BIOL, V51, P276, DOI 10.1080/10635150252899770; SCHEMSKE DW, 1984, SCIENCE, V225, P519, DOI 10.1126/science.225.4661.519; Selling OH, 1946, STUDIES HAWAIIAN POL; SIH A, 1987, ECOLOGY, V68, P1679, DOI 10.2307/1939860; SILANDER JA, 1978, BIOTROPICA, V10, P292, DOI 10.2307/2387681; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; SUGDEN EA, 1986, AM J BOT, V73, P919, DOI 10.2307/2444305; Swezey OH, 1928, P HAWAIIAN ENTOMOL S, V7, P183; Swezey OH, 1954, BP BISHOP MUSEUM SPE, V44; TAYLOR OR, 1985, ECOLOGY, V66, P521, DOI 10.2307/1940400; US Fish & Wildlife Service, 1997, REC PLAN MAUI PLANT; Valido A, 2002, ACTA OECOL, V23, P413, DOI 10.1016/S1146-609X(02)01167-0; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Wagenius S, 2006, ECOLOGY, V87, P931, DOI 10.1890/0012-9658(2006)87[931:SDORFI]2.0.CO;2; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilson EE, 2010, ECOLOGY, V91, P3294, DOI 10.1890/09-1187.1; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; WILSON P, 1991, ECOLOGY, V72, P1503, DOI 10.2307/1941124	82	17	17	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88948	10.1371/journal.pone.0088948	http://dx.doi.org/10.1371/journal.pone.0088948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551195	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500084
J	Oberst, S; Evans, TA; Lai, JCS				Oberst, Sebastian; Evans, Theodore A.; Lai, Joseph C. S.			Novel Method for Pairing Wood Samples in Choice Tests	PLOS ONE			English	Article							SUBTERRANEAN TERMITES ISOPTERA; COPTOTERMES-FORMOSANUS SHIRAKI; RHINOTERMITIDAE; PREFERENCE; RESISTANCE; TOXICITY	Choice tests are a standard method to determine preferences in bio-assays, e. g. for food types and food additives such as bait attractants and toxicants. Choice between food additives can be determined only when the food substrate is sufficiently homogeneous. This is difficult to achieve for wood eating organisms as wood is a highly variable biological material, even within a tree species due to the age of the tree (e.g. sapwood vs. heartwood), and components therein (sugar, starch, cellulose and lignin). The current practice to minimise variation is to use wood from the same tree, yet the variation can still be large and the quantity of wood from one tree may be insufficient. We used wood samples of identical volume from multiple sources, measured three physical properties (dry weight, moisture absorption and reflected light intensity), then ranked and clustered the samples using fuzzy c-means clustering. A reverse analysis of the clustered samples found a high correlation between their physical properties and their source of origin. This suggested approach allows a quantifiable, consistent, repeatable, simple and quick method to maximize control over similarity of wood used in choice tests.	[Oberst, Sebastian; Lai, Joseph C. S.] Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia; [Evans, Theodore A.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of New South Wales Sydney; National University of Singapore	Oberst, S (corresponding author), Univ New S Wales, Sch Engn & Informat Technol, Acoust & Vibrat Unit, Canberra, ACT, Australia.	s.oberst@adfa.edu.au	Oberst, Sebastian/AAQ-2854-2020; Evans, Theodore A/A-6020-2008	Oberst, Sebastian/0000-0002-1388-2749; Evans, Theodore A/0000-0002-0558-3036; Lai, Joseph/0000-0002-8946-9993	Australian Research Council's Discovery Projects [DP110102564]	Australian Research Council's Discovery Projects(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme (project number DP110102564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezdek JC, 1981, PATTERN RECOGNITION, DOI 10.1007/978-1-4757-0450-1; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bowyer J. L, 2007, FOREST PRODUCTS WOOD; Bucur V., 2006, ACOUSTICS WOOD, V2nd ed., P403; CARTWRIGHT K. St. G., 1941, FORESTRY, V15, P65, DOI 10.1093/forestry/15.1.65; Chen J, 1996, J CHEM ECOL, V22, P2359, DOI 10.1007/BF02029552; DELAPLANE KS, 1989, J ECON ENTOMOL, V82, P95, DOI 10.1093/jee/82.1.95; DELAPLANE KS, 1989, J ECON ENTOMOL, V82, P1363, DOI 10.1093/jee/82.5.1363; Evans TA, 2005, P NATL ACAD SCI USA, V102, P3732, DOI 10.1073/pnas.0408649102; Evans TA, 2009, P ROY SOC B-BIOL SCI, V276, P4035, DOI 10.1098/rspb.2009.1147; FARRAR RR, 1994, J ECON ENTOMOL, V87, P44, DOI 10.1093/jee/87.1.44; Gautam BK, 2011, ENVIRON ENTOMOL, V40, P1232, DOI 10.1603/EN11062; Gominho J, 2001, IND CROP PROD, V13, P1, DOI 10.1016/S0926-6690(00)00044-3; Gore JC, 2004, J MED ENTOMOL, V41, P953, DOI 10.1603/0022-2585-41.5.953; Ilic J, 1990, HARDWOOD IDENTIFICAT; Inta R, 2007, J R SOC INTERFACE, V4, P735, DOI 10.1098/rsif.2007.0223; Kay S., 2012, INTUITIVE PROBABILIT, V4th; Kenney J.F., 1962, MATH STAT, V3rd ed., P101; LENZ M, 1985, B ENTOMOL RES, V75, P13, DOI 10.1017/S0007485300014139; Lenz Michael, 1994, P159; Lukmandaru G, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008047; PAL NR, 1995, IEEE T FUZZY SYST, V3, P370, DOI 10.1109/91.413225; Peters BC, 1997, MATER ORGANISMEN, V31, P293; RUDMAN P, 1967, HOLZFORSCHUNG, V21, P21, DOI 10.1515/hfsg.1967.21.1.21; Rudman P, 1963, HOLZFORSCHUNG, V17, P2125; Rust MK, 2004, J ECON ENTOMOL, V97, P1017, DOI 10.1603/0022-0493(2004)097[1017:DTAACF]2.0.CO;2; Sornnuwat Yupaporn, 1995, Wood Research, V82, P8; STRONG CA, 1993, J ECON ENTOMOL, V86, P1458, DOI 10.1093/jee/86.5.1458; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; WALLER DA, 1987, B ENTOMOL RES, V77, P417, DOI 10.1017/S0007485300011883; Zobel B.J., 1989, WOOD VARIATION ITS C	31	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88835	10.1371/journal.pone.0088835	http://dx.doi.org/10.1371/journal.pone.0088835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551173	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500073
J	Shao, C; Liao, CP; Hu, PZ; Chu, CY; Zhang, L; Bui, MHT; Ng, CS; Josephson, DY; Knudsen, B; Tighiouart, M; Kim, HL; Zhau, HYE; Chung, LWK; Wang, RX; Posadas, EM				Shao, Chen; Liao, Chun-Peng; Hu, Peizhen; Chu, Chia-Yi; Zhang, Lei; Bui, Matthew H. T.; Ng, Christopher S.; Josephson, David Y.; Knudsen, Beatrice; Tighiouart, Mourad; Kim, Hyung L.; Zhau, Haiyen E.; Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.			Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer	PLOS ONE			English	Article							BREAST-CANCER; PERIPHERAL-BLOOD; EXPRESSION; APOPTOSIS; HETEROGENEITY; TRANSPORTERS; ENUMERATION; CARCINOMAS; KIDNEY; GUIDE	Tumor cells are inherently heterogeneous and often exhibit diminished adhesion, resulting in the shedding of tumor cells into the circulation to form circulating tumor cells (CTCs). A fraction of these are live CTCs with potential of metastatic colonization whereas others are at various stages of apoptosis making them likely to be less relevant to understanding the disease. Isolation and characterization of live CTCs may augment information yielded by standard enumeration to help physicians to more accurately establish diagnosis, choose therapy, monitor response, and provide prognosis. We previously reported on a group of near-infrared (NIR) heptamethine carbocyanine dyes that are specifically and actively transported into live cancer cells. In this study, this viable tumor cell-specific behavior was utilized to detect live CTCs in prostate cancer patients. Peripheral blood mononuclear cells (PBMCs) from 40 patients with localized prostate cancer together with 5 patients with metastatic disease were stained with IR-783, the prototype heptamethine cyanine dye. Stained cells were subjected to flow cytometric analysis to identify live (NIR+) CTCs from the pool of total CTCs, which were identified by EpCAM staining. In patients with localized tumor, live CTC counts corresponded with total CTC numbers. Higher live CTC counts were seen in patients with larger tumors and those with more aggressive pathologic features including positive margins and/or lymph node invasion. Even higher CTC numbers (live and total) were detected in patients with metastatic disease. Live CTC counts declined when patients were receiving effective treatments, and conversely the counts tended to rise at the time of disease progression. Our study demonstrates the feasibility of applying of this staining technique to identify live CTCs, creating an opportunity for further molecular interrogation of a more biologically relevant CTC population.	[Shao, Chen; Liao, Chun-Peng; Hu, Peizhen; Chu, Chia-Yi; Knudsen, Beatrice; Kim, Hyung L.; Zhau, Haiyen E.; Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Urooncol Res Labs, Los Angeles, CA 90048 USA; [Shao, Chen; Liao, Chun-Peng; Hu, Peizhen; Chu, Chia-Yi; Knudsen, Beatrice; Kim, Hyung L.; Zhau, Haiyen E.; Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Urol Oncol Program, Los Angeles, CA 90048 USA; [Chung, Leland W. K.; Wang, Ruoxiang; Posadas, Edwin M.] Cedars Sinai Med Ctr, Dept Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Bui, Matthew H. T.; Ng, Christopher S.; Josephson, David Y.; Kim, Hyung L.] Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA 90048 USA; [Knudsen, Beatrice] Cedars Sinai Med Ctr, Translat Pathol & Biobank, Los Angeles, CA 90048 USA; [Tighiouart, Mourad] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Shao, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Lei] Fourth Mil Med Univ, Xijing Hosp, Dept Epidemiol, Xian 710032, Shaanxi, Peoples R China	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Air Force Military Medical University; Air Force Military Medical University	Chung, LWK (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Urooncol Res Labs, Los Angeles, CA 90048 USA.	Leland.chung@cshs.org; Ruoxiang.wang@cshs.org; Edwin.Posadas@scmc.edu	Kim, Hyung/F-5129-2017	Kim, Hyung/0000-0003-2085-6140	Prostate Cancer Foundation; National Institutes of Health/National Cancer Institute [2PO1CA098912, 1RO1CA122602]; Board of Governors Cancer Research Chair (LWKC); Program of International Science and Technology Cooperation of China [2011DFA33110]; NATIONAL CANCER INSTITUTE [R01CA122602, P01CA098912] Funding Source: NIH RePORTER	Prostate Cancer Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Board of Governors Cancer Research Chair (LWKC); Program of International Science and Technology Cooperation of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the Prostate Cancer Foundation, National Institutes of Health/National Cancer Institute (2PO1CA098912 and 1RO1CA122602) and the Board of Governors Cancer Research Chair (LWKC), and by the Program of International Science and Technology Cooperation of China (No. 2011DFA33110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2014, LAB CHIP, V14, P57, DOI 10.1039/c3lc50644d; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Becker TM, 2014, INT J CANCER, V134, P2523, DOI 10.1002/ijc.28516; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Diaz-Cano SJ, 2012, INT J MOL SCI, V13, P1951, DOI 10.3390/ijms13021951; Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Harouaka R, 2013, PHARMACOL THERAPEUT, DOI [10.1016/j.pharmthera.2013.10.004, DOI 10.1016/J.PHARMTHERA.2013.10.004.[]; Hogan BV, 2008, MOL MED REP, V1, P775, DOI 10.3892/mmr_00000027; Hu Brian, 2013, Cancers (Basel), V5, P1676, DOI 10.3390/cancers5041676; Hu PZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028670; Ito A, 2003, INVEST OPHTH VIS SCI, V44, P4877, DOI 10.1167/iovs.02-1108; Kallergi G, 2013, MOL CANCER THER, V12, P1886, DOI 10.1158/1535-7163.MCT-12-1167; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Karlsson M, 2008, J IMMUNOL METHODS, V334, P122, DOI 10.1016/j.jim.2008.02.008; Larson CJ, 2004, CYTOM PART A, V62A, P46, DOI 10.1002/cyto.a.20073; Lu YT, 2013, METHODS, V64, P144, DOI 10.1016/j.ymeth.2013.06.019; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; Pantel K, 2012, CANCER DISCOV, V2, P974, DOI 10.1158/2159-8290.CD-12-0432; POSADAS EM, 2005, PRINCIPLES PRACTICE, P73; POSTE G, 1982, P NATL ACAD SCI-BIOL, V79, P6574, DOI 10.1073/pnas.79.21.6574; Rao CG, 2005, INT J ONCOL, V27, P49; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Robinson VL, 2004, BIOL SKELETAL METAST; Rossi E, 2010, CLIN CANCER RES, V16, P5233, DOI 10.1158/1078-0432.CCR-10-1449; Schilling D, 2012, NAT REV UROL, DOI [10.1038/nrurol.2012.1136, DOI 10.1038/NRUR0L.2012.1136.[]; Shi GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058017; Smerage JB, 2013, MOL ONCOL, V7, P680, DOI 10.1016/j.molonc.2013.02.013; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Thalgott M, 2013, J CANCER RES CLIN, V139, P755, DOI 10.1007/s00432-013-1377-5; Watanabe M, 2013, CYTOM PART A, DOI [10.1002/cyto.a.22422, DOI 10.1002/CYT0.A.22422.[]; Williams Anthony, 2012, Recent Results Cancer Res, V195, P87, DOI 10.1007/978-3-642-28160-0_8; Yang XJ, 2013, J UROLOGY, V189, P702, DOI 10.1016/j.juro.2012.09.056; Yang XJ, 2010, CLIN CANCER RES, V16, P2833, DOI 10.1158/1078-0432.CCR-10-0059; Zair ZM, 2008, PHARMACOGENOMICS, V9, P597, DOI 10.2217/14622416.9.5.597; Zhao L, 2013, ADV MATER, DOI [10.1002/adma.201205237, DOI 10.1002/ADMA.201205237.[]	37	39	43	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88967	10.1371/journal.pone.0088967	http://dx.doi.org/10.1371/journal.pone.0088967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551200	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500087
J	Wolfe, F; Walitt, BT; Katz, RS; Hauser, W				Wolfe, Frederick; Walitt, Brian T.; Katz, Robert S.; Haeuser, Winfried			Symptoms, the Nature of Fibromyalgia, and Diagnostic and Statistical Manual 5 (DSM-5) Defined Mental Illness in Patients with Rheumatoid Arthritis and Fibromyalgia	PLOS ONE			English	Article							FUNCTIONAL SOMATIC SYNDROMES; HEALTH SURVEY SF-36; SOMATOFORM DISORDERS; PRIMARY-CARE; UNITED-STATES; FIELD TRIALS; SOMATIZATION; CRITERIA; CLASSIFICATION; RELIABILITY	Purpose: To describe and evaluate somatic symptoms in patients with rheumatoid arthritis (RA) and fibromyalgia, determine the relation between somatization syndromes and fibromyalgia, and evaluate symptom data in light of the Diagnostic and Statistical Manual-5 (DSM-5) criteria for somatic symptom disorder. Methods: We administered the Patient Health Questionnaire-15 (PHQ-15), a measure of somatic symptom severity to 6,233 persons with fibromyalgia, RA, and osteoarthritis. PHQ-15 scores of 5, 10, and 15 represent low, medium, and high somatic symptom severity cut-points. A likely somatization syndrome was diagnosed when PHQ-15 score was >= 10. The intensity of fibromyalgia diagnostic symptoms was measured by the polysymptomatic distress (PSD) scale. Results: 26.4% of RA patients and 88.9% with fibromyalgia had PHQ-15 scores >= 10 compared with 9.3% in the general population. With each step-wise increase in PHQ-15 category, more abnormal mental and physical health status scores were observed. RA patients satisfying fibromyalgia criteria increased from 1.2% in the PHQ-15 low category to 88.9% in the high category. The sensitivity and specificity of PHQ-15 >= 10 for fibromyalgia diagnosis was 80.9% and 80.0% (correctly classified = 80.3%) compared with 84.3% and 93.7% (correctly classified = 91.7%) for the PSD scale. 51.4% of fibromyalgia patients and 14.8% with RA had fatigue, sleep or cognitive problems that were severe, continuous, and life-disturbing; and almost all fibromyalgia patients had severe impairments of function and quality of life. Conclusions: All patients with fibromyalgia will satisfy the DSM-5 "A'' criterion for distressing somatic symptoms, and most would seem to satisfy DSM-5 "B'' criterion because symptom impact is life-disturbing or associated with substantial impairment of function and quality of life. But the "B'' designation requires special knowledge that symptoms are "disproportionate'' or "excessive,'' something that is uncertain and controversial. The reliability and validity of DSM-5 criteria in this population is likely to be low.	[Wolfe, Frederick] Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA; [Wolfe, Frederick] Univ Kansas, Sch Med, Wichita, KS 67214 USA; [Walitt, Brian T.] Washington Hosp Ctr, Washington, DC 20010 USA; [Katz, Robert S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Haeuser, Winfried] Tech Univ Munich, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany; [Haeuser, Winfried] Klinikum Saarbrucken, Dept Internal Med 1, Saarbrucken, Germany	National Data Bank for Rheumatic Diseases; University of Kansas; University of Kansas Medical Center; MedStar Washington Hospital Center; Rush University; Technical University of Munich	Wolfe, F (corresponding author), Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA.	fwolfe@arthritis-research.org	Häuser, Winfried/AAX-6231-2021; Häuser, Winfried/AAH-6633-2021	Wolfe, Frederick/0000-0002-2801-6413; Hauser, Winfried/0000-0002-3742-729X				American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Association AP, 1980, DIAGN STAT MAN MENT; Barker KK, 2011, SOCIAL SCI MED; Barker Kristin, 2009, FIBROMYALGIA STORY M; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Clarke DE, 2013, AM J PSYCHIAT, V170, P43, DOI 10.1176/appi.ajp.2012.12070998; Creed FH, 2012, J PSYCHOSOMATIC RES; Crombez G, 2009, PAIN, V145, P31, DOI 10.1016/j.pain.2009.04.006; Dimsdale JE, 2013, J PSYCHOSOMATIC RES; Fink P, 2005, PSYCHOSOMATICS, V46, P540, DOI 10.1176/appi.psy.46.6.540; Fink P, 1999, PSYCHOSOMATICS, V40, P330, DOI 10.1016/S0033-3182(99)71228-4; Fink P, 2010, J PSYCHOSOM RES, V68, P415, DOI 10.1016/j.jpsychores.2010.02.004; Frances A, 2013, AUST NZ J PSYCHIAT, V47, P483, DOI 10.1177/0004867413484525; Frances A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1580; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Grabe HJ, 2003, PSYCHOSOMATICS, V44, P304, DOI 10.1176/appi.psy.44.4.304; Gross M, 2013, CURR BIOL, V23, pR295, DOI 10.1016/j.cub.2013.04.009; HIDDING A, 1994, J RHEUMATOL, V21, P818; Houtveen JH, 2003, J PSYCHOSOM RES, V55, P481, DOI 10.1016/S0022-3999(03)00011-4; Kocalevent RD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-91; Korber S, 2011, J PSYCHOSOM RES, V71, P142, DOI 10.1016/j.jpsychores.2011.01.006; Kroenke K, 2006, J PSYCHOSOM RES, V60, P335, DOI 10.1016/j.jpsychores.2006.01.022; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leeb BF, 2004, RHEUMATOLOGY, V43, P1504, DOI 10.1093/rheumatology/keh322; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Obradovic M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-110; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Sharpe M, 2001, ANN INTERN MED, V134, P926, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00018; Speckens AEM, 1996, J PSYCHOSOM RES, V40, P95, DOI 10.1016/0022-3999(95)00561-7; van Ravesteijn H, 2009, ANN FAM MED, V7, P232, DOI 10.1370/afm.985; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Walitt B, 2011, J RHEUMATOLOGY; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 2004, BRIT J PSYCHIAT, V185, P95, DOI 10.1192/bjp.185.2.95; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, NATURE REV RHEUMATOL; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2011, RHEUMATOLOGY, V50, P16, DOI 10.1093/rheumatology/keq155; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolfe F, 2010, ARTHRIT CARE RES, V62, P583, DOI 10.1002/acr.20156; YUNUS M, 1981, SEMIN ARTHRITIS RHEU, V11, P151, DOI 10.1016/0049-0172(81)90096-2	52	55	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88740	10.1371/journal.pone.0088740	http://dx.doi.org/10.1371/journal.pone.0088740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551146	Green Published, gold			2022-12-25	WOS:000331271500061
J	Bello-Morales, R; Crespillo, AJ; Garcia, B; Dorado, LA; Martin, B; Tabares, E; Krummenacher, C; de Castro, F; Lopez-Guerrero, JA				Bello-Morales, Raquel; Jesus Crespillo, Antonio; Garcia, Beatriz; Dorado, Luis Angel; Martin, Beatriz; Tabares, Enrique; Krummenacher, Claude; de Castro, Fernando; Antonio Lopez-Guerrero, Jose			The Effect of Cellular Differentiation on HSV-1 Infection of Oligodendrocytic Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MYELIN-ASSOCIATED GLYCOPROTEIN; MULTIPLE-SCLEROSIS; HEPARAN-SULFATE; ENTRY MEDIATOR; SENSORY NEURONS; ENDOCYTIC ENTRY; BINDING-SITE; IN-VITRO; LOW-PH	Herpes simplex type 1 (HSV-1) is a neurotropic virus that infects many types of cells. Previous studies have demonstrated that oligodendrocytic cells are highly susceptible to HSV-1 infection. Here we analysed HSV-1 infection of a human oligodendrocytic cell line, HOG, and oligodendrocyte precursor cells (OPCs) cultured under growth or differentiation conditions. In addition to cell susceptibility, the role of the major cell receptors for viral entry was assessed. Our results revealed that OPCs and HOG cells cultured under differentiation conditions became more susceptible to HSV-1. On the other hand, viral infection induced morphological changes corresponding to differentiated cells, suggesting that HSV-1 might be inducing cell differentiation. We also observed colocalization of HVEM and nectin-1 with viral particles, suggesting that these two major HSV-1 receptors are functional in HOG cells. Finally, electron microscopy assays indicated that HSV-1 may be also entering OLs by macropinocytosis depending on their differentiation stage. In addition, vesicles containing intracellular enveloped virions observed in differentiated cells point to an endocytic mechanism of virus entry. All these data are indicative of diverse entry pathways dependent on the maturation stage of OLs.	[Bello-Morales, Raquel; Dorado, Luis Angel] Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain; [Jesus Crespillo, Antonio; Garcia, Beatriz; Antonio Lopez-Guerrero, Jose] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Martin, Beatriz; Tabares, Enrique] Univ Autonoma Madrid, Fac Med, Madrid, Spain; [Krummenacher, Claude] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA USA; [de Castro, Fernando] Hosp Nacl Paraplj, Grp Neurobiol Desarrollo GNDe, Toledo, OH, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of Pennsylvania; Hospital Nacional de Paraplejicos	Lopez-Guerrero, JA (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Edificio Biol Darwin 2, Madrid, Spain.	rbellomorales@cbm.uam.es	Guerrero, Jose Antonio Lopez/Z-2413-2019; de Castro, Fernando/Q-8624-2018; Tabares, Enrique/AAA-4492-2019; LÓPEZ-GUERRERO, JOSÉ ANTONIO/L-5667-2017; Bello-Morales, Raquel/AHD-5028-2022	Guerrero, Jose Antonio Lopez/0000-0002-7369-8388; de Castro, Fernando/0000-0002-7018-8032; LÓPEZ-GUERRERO, JOSÉ ANTONIO/0000-0003-2817-5956; Krummenacher, Claude/0000-0002-3492-4987; Bello-Morales, Raquel/0000-0002-4415-6483; Bello-Morales, Raquel/0000-0002-8526-6590	Ministerio de Economia y Competitividad-MINECO [SAF2012-40023, RD12-0032-12]; FEDER-European Union/Una manera de hacer Europa; National Institute of Allergy and Infectious Diseases [AI-097171]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097171] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad-MINECO; FEDER-European Union/Una manera de hacer Europa; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was partially supported by the Ministerio de Economia y Competitividad-MINECO (SAF2012-40023 and RD12-0032-12 -partially funded by FEDER-European Union/Una manera de hacer Europa). FdeC is hired by Gobierno de Castilla-La Mancha-SESCAM. CK is supported by Public Health Service grant AI-097171 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2008, INVEST OPHTH VIS SCI, V49, P4026, DOI 10.1167/iovs.08-1807; Alvarez-Lafuente R, 2008, MULT SCLER J, V14, P595, DOI 10.1177/1352458507086425; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; BANSAL R, 1994, DEV BIOL, V162, P511, DOI 10.1006/dbio.1994.1105; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bello-Morales R, 2005, J NEUROVIROL, V11, P190, DOI 10.1080/13550280590924179; Bello-Morales R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-265; Bello-Morales R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019388; Bello-Morales R, 2009, EXP CELL RES, V315, P3453, DOI 10.1016/j.yexcr.2009.08.003; Bertke AS, 2013, J VIROL, V87, P6512, DOI 10.1128/JVI.00383-13; Bribian A, 2008, DEV NEUROBIOL, V68, P1503, DOI 10.1002/dneu.20678; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Cheshenko N, 2013, FASEB J, V27, P2584, DOI 10.1096/fj.12-220285; Choudhary S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/264350; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; de Castro F, 2013, CELL MOL LIFE SCI, V70, P4355, DOI 10.1007/s00018-013-1365-6; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Ferrante P, 2000, J NEUROVIROL, V6, pS109; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2012, J VIROL, V86, P2850, DOI 10.1128/JVI.06689-11; Giraudon P, 2009, REV NEUROL-FRANCE, V165, P789, DOI 10.1016/j.neurol.2009.07.004; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Krummenacher C, 2004, VIROLOGY, V322, P286, DOI 10.1016/j.virol.2004.02.005; Krummenacher C, 2000, J VIROL, V74, P10863, DOI 10.1128/JVI.74.23.10863-10872.2000; Lara-Pezzi E, 2001, HEPATOLOGY, V33, P1270, DOI 10.1053/jhep.2001.1270; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; MacLeod IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009560; Medina-Rodriguez EM, 2013, CELL MOL LIFE SCI, V70, P3449, DOI 10.1007/s00018-013-1340-2; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Mitchell BM, 2003, J NEUROVIROL, V9, P194, DOI 10.1080/13550280390194000; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; O'Donnell CD, 2010, VIROLOGY, V397, P389, DOI 10.1016/j.virol.2009.11.011; Pietropaolo V, 2005, NEW MICROBIOL, V28, P199; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Properzi F, 2008, EUR J NEUROSCI, V27, P593, DOI 10.1111/j.1460-9568.2008.06042.x; QUARLES RH, 1989, CRIT REV NEUROBIOL, V5, P1; Reske A, 2007, REV MED VIROL, V17, P205, DOI 10.1002/rmv.531; Richart SM, 2003, J VIROL, V77, P3307, DOI 10.1128/JVI.77.5.3307-3311.2003; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Rizzo R, 2012, J NEUROIMMUNOL, V251, P55, DOI 10.1016/j.jneuroim.2012.07.004; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; Sanders VJ, 1996, ARCH NEUROL-CHICAGO, V53, P125, DOI 10.1001/archneur.1996.00550020029012; Sanderson C M, 1999, Expert Rev Mol Med, V1999, P1, DOI 10.1017/S1462399499000629; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Schnaar RL, 2009, J NEUROSCI RES, V87, P3267, DOI 10.1002/jnr.21992; Schretlen DJ, 2010, SCHIZOPHR RES, V118, P224, DOI 10.1016/j.schres.2010.01.008; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Silva MA, 2012, J CROHNS COLITIS, V6, P454, DOI 10.1016/j.crohns.2011.09.015; Simmons A, 2001, Herpes, V8, P60; Simpson SA, 2005, J NEUROVIROL, V11, P208, DOI 10.1080/13550280590924214; Sotelo J, 2007, J NEUROL SCI, V262, P113, DOI 10.1016/j.jns.2007.07.001; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stiles KM, 2010, VIROLOGY, V399, P109, DOI 10.1016/j.virol.2009.12.034; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Swanborg RH, 2003, J NEUROIMMUNOL, V136, P1, DOI 10.1016/S0165-5728(02)00465-4; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Terry-Allison T, 1998, J VIROL, V72, P5802, DOI 10.1128/JVI.72.7.5802-5810.1998; Tiwari V, 2008, FEBS J, V275, P5272, DOI 10.1111/j.1742-4658.2008.06655.x; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006	77	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89141	10.1371/journal.pone.0089141	http://dx.doi.org/10.1371/journal.pone.0089141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551233	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000107
J	Bodewes, R; van de Bildt, MWG; van Elk, CE; Bunskoek, PE; van de Vijver, DAMC; Smits, SL; Osterhaus, ADME; Kuiken, T				Bodewes, Rogier; van de Bildt, Marco W. G.; van Elk, Cornelis E.; Bunskoek, Paulien E.; van de Vijver, David A. M. C.; Smits, Saskia L.; Osterhaus, Albert D. M. E.; Kuiken, Thijs			No Serological Evidence that Harbour Porpoises Are Additional Hosts of Influenza B Viruses	PLOS ONE			English	Article							MARINE MAMMALS; SEALS; ANTIBODIES	Influenza A and B viruses circulate among humans causing epidemics almost annually. While various hosts for influenza A viruses exist, influenza B viruses have been detected only in humans and seals. However, recurrent infections of seals in Dutch coastal waters with influenza B viruses that are antigenetically distinct from influenza B viruses circulating among humans suggest that influenza B viruses have been introduced into this seal population by another, non-human, host. Harbour porpoises (Phocoena phocoena) are sympatric with seals in these waters and are also occasionally in close contact with humans after stranding and subsequent rehabilitation. In addition, virus attachment studies demonstrated that influenza B viruses can bind to cells of the respiratory tract of these animals. Therefore, we hypothesized that harbour porpoises might be a reservoir of influenza B viruses. In the present study, an unique set of serum samples from 79 harbour porpoises, stranded alive on the Dutch coast between 2003 and 2013, was tested for the presence of antibodies against influenza B viruses by use of the hemagglutination inhibition test and for antibodies against influenza A viruses by use of a competitive influenza A nucleoprotein ELISA. No antibodies were detected against either virus, suggesting that influenza A and B virus infections of harbour porpoises in Dutch coastal waters are not common, which was supported by statistical analysis of the dataset.	[Bodewes, Rogier; van de Bildt, Marco W. G.; van Elk, Cornelis E.; van de Vijver, David A. M. C.; Smits, Saskia L.; Osterhaus, Albert D. M. E.; Kuiken, Thijs] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Elk, Cornelis E.; Bunskoek, Paulien E.] SOS Dolphin Fdn, Harderwijk, Netherlands; [van Elk, Cornelis E.; Bunskoek, Paulien E.] Dolfinarium Harderwijk, Harderwijk, Netherlands; [Smits, Saskia L.; Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Bodewes, R (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.bodewes@erasmusmc.nl		van de Vijver, David/0000-0001-5877-8526; Kuiken, Thijs/0000-0001-5501-9049; Bodewes, Rogier/0000-0002-0689-7889	European Community [223498]; VIRGO Consortium	European Community(European Commission); VIRGO Consortium	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under the project "European Management Platform for Emerging and Re-emerging Infectious disease Entities'' (EMPERIE) EC grant agreement number 223498 and the VIRGO Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 2002, STAT METHODS MED RES, P1; Blanc A, 2009, J WILDLIFE DIS, V45, P519, DOI 10.7589/0090-3558-45.2.519; Bland M., 2000, INTRO MED STAT, V3rd; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Bodewes R, 2013, EMERG INFECT DIS, V19, P511, DOI 10.3201/eid1903.120965; De Jong JC., 2011, NED TIJDSCHR MED MIC, V19, P21; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Geelhoed Steve C. V., 2013, Lutra, V56, P45; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Harkonen T, 2006, DIS AQUAT ORGAN, V68, P115, DOI 10.3354/dao068115; Lebarbenchon C, 2012, J VET DIAGN INVEST, V24, P161, DOI 10.1177/1040638711416626; Nielsen O, 2001, J WILDLIFE DIS, V37, P820, DOI 10.7589/0090-3558-37.4.820; Ohishi K, 2002, MICROBIOL IMMUNOL, V46, P639, DOI 10.1111/j.1348-0421.2002.tb02746.x; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; Palmer DF, 1975, ADV LAB TECHNIQUES I, P25; Ramis AJ, 2012, EMERG INFECT DIS, V18, P817, DOI 10.3201/eid1805.111828; Read AJ, 1998, HDB MARINE MAMMALS, P336; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Runstadler J, 2013, INFECT GENET EVOL, V17, P162, DOI 10.1016/j.meegid.2013.02.020; SCANS-II, 2008, SMALL CET EUR ATL N; Scheidat M, 2012, J SEA RES, V69, P1, DOI 10.1016/j.seares.2011.12.004	21	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89058	10.1371/journal.pone.0089058	http://dx.doi.org/10.1371/journal.pone.0089058			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551217	Green Published, gold			2022-12-25	WOS:000331266000096
J	Saeki, T; Hosokawa, M; Lim, T; Harada, M; Matsunaga, T; Tanaka, T				Saeki, Tatsuya; Hosokawa, Masahito; Lim, Tae-kyu; Harada, Manabu; Matsunaga, Tadashi; Tanaka, Tsuyoshi			Digital Cell Counting Device Integrated with a Single-Cell Array	PLOS ONE			English	Article							MICROCAVITY ARRAY; CHIP; SENSOR	In this paper, we present a novel cell counting method accomplished using a single-cell array fabricated on an image sensor, complementary metal oxide semiconductor sensor. The single-cell array was constructed using a microcavity array, which can trap up to 7,500 single cells on microcavities periodically arranged on a plane metallic substrate via the application of a negative pressure. The proposed method for cell counting is based on shadow imaging, which uses a light diffraction pattern generated by the microcavity array and trapped cells. Under illumination, the cell-occupied microcavities are visualized as shadow patterns in an image recorded by the complementary metal oxide semiconductor sensor due to light attenuation. The cell count is determined by enumerating the uniform shadow patterns created from one-on-one relationships with single cells trapped on the microcavities in digital format. In the experiment, all cell counting processes including entrapment of non-labeled HeLa cells from suspensions on the array and image acquisition of a wide-field-of-view of 30 mm(2) in 1/60 seconds were implemented in a single integrated device. As a result, the results from the digital cell counting had a linear relationship with those obtained from microscopic observation (r(2) = 0.99). This platform could be used at extremely low cell concentrations, i. e., 25-15,000 cells/mL. Our proposed system provides a simple and rapid miniaturized cell counting device for routine laboratory use.	[Saeki, Tatsuya; Hosokawa, Masahito; Matsunaga, Tadashi; Tanaka, Tsuyoshi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Lim, Tae-kyu; Harada, Manabu] Malcom Co Ltd, Tokyo, Japan	Tokyo University of Agriculture & Technology	Tanaka, T (corresponding author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan.	tsuyo@cc.tuat.ac.jp	Tanaka, Tsuyoshi/B-9949-2013; Matsunaga, Tadashi/A-6293-2015	Tanaka, Tsuyoshi/0000-0003-2601-2256; Matsunaga, Tadashi/0000-0002-6216-3687; Hosokawa, Masahito/0000-0002-7070-4690	The New Energy and Industrial Technology Development Organization [P03040]; Japan Society for the Promotion of Science [12J03043]; Grants-in-Aid for Scientific Research [23360363] Funding Source: KAKEN	The New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded in part by a support program for technology development based on academic findings from The New Energy and Industrial Technology Development Organization (P03040). TS is supported in part by the Japan Society for the Promotion of Science (12J03043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkes CA, 2012, J MICROBIOL METH, V91, P468, DOI 10.1016/j.mimet.2012.09.008; D'Anto V, 2012, OPEN DENT J, V6, P177, DOI 10.2174/1874210601206010177; Hosokawa M, 2013, BIOSENS BIOELECTRON, V40, P110, DOI 10.1016/j.bios.2012.06.043; Hosokawa M, 2012, BIOTECHNOL BIOENG, V109, P2017, DOI 10.1002/bit.24471; Hosokawa M, 2010, ANAL CHEM, V82, P6629, DOI 10.1021/ac101222x; Hosokawa M, 2009, ANAL CHEM, V81, P5308, DOI 10.1021/ac900535h; Hosseini Y, 2010, SENSOR ACTUAT A-PHYS, V157, P1, DOI 10.1016/j.sna.2009.10.018; Huang LC, 2010, BIOLOGICALS, V38, P393, DOI 10.1016/j.biologicals.2010.01.009; Kang-Ho L, 2012, SOL STAT CIRC C ISSC, p[19, 304]; Kim SB, 2011, LAB CHIP, V11, P1801, DOI [10.1039/c1lc20098d, 10.1039/c11c20098d]; Lindstrom S, 2010, LAB CHIP, V10, P3363, DOI [10.1039/c0lc00150c, 10.1039/c01c00150c]; Matsunaga T, 2008, ANAL CHEM, V80, P5139, DOI 10.1021/ac800352j; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Peng L, 2007, INT J LAB HEMATOL, V29, P361, DOI 10.1111/j.1751-553X.2007.00868.x; Seo S, 2010, ANAL CHEM, V82, P4621, DOI 10.1021/ac1007915; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Su TW, 2010, ANAL CHEM, V82, P8307, DOI 10.1021/ac101845q; Su TW, 2009, BIOTECHNOL BIOENG, V102, P856, DOI 10.1002/bit.22116; Tanaka T, 2010, LAB CHIP, V10, P3348, DOI [10.1039/c0lc00039f, 10.1039/c01c00039f]; Tanaka T, 2010, BIOSENS BIOELECTRON, V26, P1460, DOI 10.1016/j.bios.2010.07.081; Wu YF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3462327; Zhao YX, 2009, ANAL CHEM, V81, P1285, DOI 10.1021/ac802250d	22	15	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89011	10.1371/journal.pone.0089011	http://dx.doi.org/10.1371/journal.pone.0089011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551208	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000089
J	Fermin, S; Bastin, C; Salmon, E; Goriz, JM; Ramirez, J; Phillips, C				Segovia, Fermin; Bastin, Christine; Salmon, Eric; Goriz, Juan Manuel; Ramirez, Javier; Phillips, Christophe			Combining PET Images and Neuropsychological Test Data for Automatic Diagnosis of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; VECTOR MACHINE; BRAIN ATROPHY; MCI PATIENTS; CLASSIFICATION; PATTERNS; OPTIMIZATION; VALIDATION; DEMENTIA	In recent years, several approaches to develop computer aided diagnosis (CAD) systems for dementia have been proposed. Some of these systems analyze neurological brain images by means of machine learning algorithms in order to find the patterns that characterize the disorder, and a few combine several imaging modalities to improve the diagnostic accuracy. However, they usually do not use neuropsychological testing data in that analysis. The purpose of this work is to measure the advantages of using not only neuroimages as data source in CAD systems for dementia but also neuropsychological scores. To this aim, we compared the accuracy rates achieved by systems that use neuropsychological scores beside the imaging data in the classification step and systems that use only one of these data sources. In order to address the small sample size problem and facilitate the data combination, a dimensionality reduction step (implemented using three different algorithms) was also applied on the imaging data. After each image is summarized in a reduced set of image features, the data sources were combined and classified using three different data combination approaches and a Support Vector Machine classifier. That way, by testing different dimensionality reduction methods and several data combination approaches, we aim not only highlighting the advantages of using neuropsychological scores in the classification, but also implementing the most accurate computer system for early dementia detention. The accuracy of the CAD systems were estimated using a database with records from 46 subjects, diagnosed with MCI or AD. A peak accuracy rate of 89% was obtained. In all cases the accuracy achieved using both, neuropsychological scores and imaging data, was substantially higher than the one obtained using only the imaging data.	[Segovia, Fermin; Bastin, Christine; Salmon, Eric] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Goriz, Juan Manuel; Ramirez, Javier] Univ Granada, Dept Signal Theory Networking & Commun, Granada, Spain; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; University of Granada; University of Liege	Fermin, S (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	fsegovia@ulg.ac.be	Salmon, Eric/AAE-4901-2020; Gorriz, Juan Manuel/C-2385-2012; Román, Fermín Segovia/M-3306-2014; Ramírez, Javier/B-1836-2012; Phillips, Christophe/M-3025-2017	Salmon, Eric/0000-0003-2520-9241; Gorriz, Juan Manuel/0000-0001-7069-1714; Román, Fermín Segovia/0000-0003-1940-8834; Ramírez, Javier/0000-0002-6229-2921; Phillips, Christophe/0000-0002-4990-425X; Bastin, Christine/0000-0002-4556-9490	University of Liege; "Fonds de la Recherche Scientifique'' (FRS-FNRS); "Stichting Alzheimer Onderzoek/Fondation Recherche Alzheimer'' (SAO-FRA); Inter University Attraction Pole [P7/11]	University of Liege(University of Liege); "Fonds de la Recherche Scientifique'' (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); "Stichting Alzheimer Onderzoek/Fondation Recherche Alzheimer'' (SAO-FRA); Inter University Attraction Pole(Belgian Federal Science Policy Office)	This work was supported by the University of Liege, the "Fonds de la Recherche Scientifique'' (FRS-FNRS), the "Stichting Alzheimer Onderzoek/Fondation Recherche Alzheimer'' (SAO-FRA), and the Inter University Attraction Pole P7/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2007, J CLIN EXP NEUROPSYC, V29, P477, DOI 10.1080/13803390600775339; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Chincarini A, 2011, NEUROIMAGE, V58, P469, DOI 10.1016/j.neuroimage.2011.05.083; Cortes C., 2010, ICML, P239; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Duin RPW, 2000, INT C PATT RECOG, P1, DOI 10.1109/ICPR.2000.906006; Dukart J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055415; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Garraux G, 2013, NEUROIMAGE-CLIN, V2, P883, DOI 10.1016/j.nicl.2013.06.004; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Good P, 2000, PERMUTATION TESTS PR; Gu┬nen M., 2008, P 25 INT C MACH LEAR, P352, DOI DOI 10.1145/1390156.1390201; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Horn JF, 2009, ARTIF INTELL MED, V47, P147, DOI 10.1016/j.artmed.2009.05.001; Igel C, 2007, IEEE ACM T COMPUT BI, V4, P216, DOI [10.1109/TCBB.2007.070208, 10.1109/tcbb.2007.070208]; Illan IA, 2011, INFORM SCIENCES, V181, P903, DOI 10.1016/j.ins.2010.10.027; Ivanoiu A, 2005, J NEUROL, V252, P47, DOI 10.1007/s00415-005-0597-2; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; Jolliffe, 2002, PRINCIPAL COMPONENT; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lee WJ, 2007, LECT NOTES COMPUT SC, V4472, P22; Lopez M, 2009, ELECTRON LETT, V45, P389, DOI 10.1049/el.2009.0176; LOPEZ M, 2009, NEUROSCIENCE LETT; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; NOBLE WS, 2004, KERNEL METHODS COMPU, P71; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Phillips CL, 2011, NEUROIMAGE, V56, P797, DOI 10.1016/j.neuroimage.2010.05.083; Schrouff J., 2013, NEUROINFORMATICS; Segovia F, 2012, FRONT ARTIF INTEL AP, V243, P2241, DOI 10.3233/978-1-61499-105-2-2241; Segovia F, 2012, NEUROCOMPUTING, V75, P64, DOI 10.1016/j.neucom.2011.03.050; Signorini M, 1999, NEUROIMAGE, V9, P63, DOI 10.1006/nimg.1998.0381; STOECKEL J, 2001, P 4 INT C MED IM COM, P666; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vapnik V., 1999, NATURE STAT LEARNING; Vapnik V., 1998, STAT LEARNING THEORY; Varma M, 2009, P 26 ANN INT C MACH, P1065; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Wang SG, 2011, EXPERT SYST APPL, V38, P8696, DOI 10.1016/j.eswa.2011.01.077; Webb A. R., 2003, STAT PATTERN RECOGNI; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Woods RP, 2000, BIOMED EN S, P465; Yang JJ, 2009, IEEE I CONF COMP VIS, P436, DOI 10.1109/ICCV.2009.5459172; ZWEIG MH, 1993, CLIN CHEM, V39, P561	55	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88687	10.1371/journal.pone.0088687	http://dx.doi.org/10.1371/journal.pone.0088687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551135	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000055
J	Vetrovsky, T; Steffen, KT; Baldrian, P				Vetrovsky, Tomas; Steffen, Kari Timo; Baldrian, Petr			Potential of Cometabolic Transformation of Polysaccharides and Lignin in Lignocellulose by Soil Actinobacteria	PLOS ONE			English	Article							BETA-GLUCOSIDASE; CELLULOSE UTILIZATION; C-14-LABELED LIGNIN; SELECTIVE ISOLATION; GLYCOSYL HYDROLASE; GINSENOSIDE RB1; STREPTOMYCES SP; LEAF-LITTER; PURIFICATION; DEGRADATION	While it is known that several Actinobacteria produce enzymes that decompose polysaccharides or phenolic compounds in dead plant biomass, the occurrence of these traits in the environment remains largely unclear. The aim of this work was to screen isolated actinobacterial strains to explore their ability to produce extracellular enzymes that participate in the degradation of polysaccharides and their ability to cometabolically transform phenolic compounds of various complexities. Actinobacterial strains were isolated from meadow and forest soils and screened for their ability to grow on lignocellulose. The potential to transform C-14-labelled phenolic substrates (dehydrogenation polymer (DHP), lignin and catechol) and to produce a range of extracellular, hydrolytic enzymes was investigated in three strains of Streptomyces spp. that possessed high lignocellulose degrading activity. Isolated strains showed high variation in their ability to produce cellulose- and hemicellulose-degrading enzymes and were able to mineralise up to 1.1% and to solubilise up to 4% of poplar lignin and to mineralise up to 11.4% and to solubilise up to 64% of catechol, while only minimal mineralisation of DHP was observed. The results confirm the potential importance of Actinobacteria in lignocellulose degradation, although it is likely that the decomposition of biopolymers is limited to strains that represent only a minor portion of the entire community, while the range of simple, carbon-containing compounds that serve as sources for actinobacterial growth is relatively wide.	[Vetrovsky, Tomas; Baldrian, Petr] Inst Microbiol ASCR, Vvi, Lab Environm Microbiol, Prague, Czech Republic; [Steffen, Kari Timo] Univ Helsinki, Dept Appl Chem & Microbiol, Helsinki, Finland	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Helsinki	Baldrian, P (corresponding author), Inst Microbiol ASCR, Vvi, Lab Environm Microbiol, Prague, Czech Republic.	baldrian@biomed.cas.cz	Baldrian, Petr/A-9170-2009; Steffen, Kari T./A-5353-2008; Vetrovsky, Tomas/R-5817-2017	Baldrian, Petr/0000-0002-8983-2721; 	Academy of Sciences of the Czech Republic [IAA603020901]; Institute of Microbiology of the ASCR, v.v.i. [RVO61388971]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Institute of Microbiology of the ASCR, v.v.i.(Czech Academy of Sciences)	This work was supported by the Academy of Sciences of the Czech Republic (IAA603020901) and by the research concept of the Institute of Microbiology of the ASCR, v.v.i. (RVO61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2010, APPL ENVIRON MICROB, V76, P5827, DOI 10.1128/AEM.00106-10; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Baldrian P, 2009, PLANT SOIL ENVIRON, V55, P370, DOI 10.17221/134/2009-PSE; Baldrian P, 2008, BR MYCOL SY, V28, P19; Baldrian P, 2011, SOIL BIOL, V22, P167, DOI 10.1007/978-3-642-14225-3_9; Baldrian P, 2011, PLANT SOIL, V338, P111, DOI 10.1007/s11104-010-0324-3; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Brunow G, 1998, PHYTOCHEMISTRY, V47, P1495, DOI 10.1016/S0031-9422(98)80013-7; Caliz J, 2013, J SOIL SEDIMENT, V13, P413, DOI 10.1007/s11368-012-0609-7; CARTWRIGHT NJ, 1973, MICROBIOS, V8, P7; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; CRAWFORD DL, 1982, ARCH MICROBIOL, V131, P140, DOI 10.1007/BF01053996; CRAWFORD DL, 1978, APPL ENVIRON MICROB, V35, P1041, DOI 10.1128/AEM.35.6.1041-1045.1978; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; El Azhari N, 2010, J HAZARD MATER, V177, P593, DOI 10.1016/j.jhazmat.2009.12.074; Enkhbaatar B, 2012, APPL ENVIRON MICROB, V78, P607, DOI 10.1128/AEM.06482-11; Fan HX, 2011, ENZYME MICROB TECH, V49, P94, DOI 10.1016/j.enzmictec.2011.03.001; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Harichova J, 2012, BIOLOGIA, V67, P1038, DOI 10.2478/s11756-012-0123-9; Hayakawa M, 1996, J APPL BACTERIOL, V80, P375, DOI 10.1111/j.1365-2672.1996.tb03232.x; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; KERR TJ, 1983, APPL ENVIRON MICROB, V46, P1201, DOI 10.1128/AEM.46.5.1201-1206.1983; KHANNA S, 1993, ENZYME MICROB TECH, V15, P990, DOI 10.1016/0141-0229(93)90177-4; Krastanov A, 2013, ENG LIFE SCI, V13, P76, DOI 10.1002/elsc.201100227; Li CJ, 2009, J MICROBIOL BIOTECHN, V19, P873, DOI 10.4014/jmb.0812.689; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martinez AT, 2005, INT MICROBIOL, V8, P195; MCCARTHY AJ, 1987, FEMS MICROBIOL LETT, V46, P145, DOI 10.1111/j.1574-6968.1987.tb02456.x; Muhlbachova G, 2011, ECOL ENG, V37, P1064, DOI 10.1016/j.ecoleng.2010.08.004; Nakano H, 1998, J FERMENT BIOENG, V85, P162, DOI 10.1016/S0922-338X(97)86761-X; Nunoura N, 1996, BIOSCI BIOTECH BIOCH, V60, P188, DOI 10.1271/bbb.60.188; ODIER E, 1981, APPL ENVIRON MICROB, V41, P337, DOI 10.1128/AEM.41.2.337-341.1981; Oh HW, 2008, ANTON LEEUW INT J G, V93, P437, DOI 10.1007/s10482-007-9210-2; Osono T, 2005, ECOL RES, V20, P41, DOI 10.1007/s11284-004-0002-0; Pasti MB, APPL ENV MICROBIOL, V56, P2213; Petrosyan P, 2002, BIOTECHNOL LETT, V24, P1473, DOI 10.1023/A:1019879200497; Post DA, 2005, APPL MICROBIOL BIOT, V67, P91, DOI 10.1007/s00253-004-1764-6; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; ROBINSON LE, 1978, FEMS MICROBIOL LETT, V4, P301; Sagova-Mareckova M, 2008, APPL ENVIRON MICROB, V74, P2902, DOI 10.1128/AEM.02161-07; She YL, 2012, ADV MATER RES-SWITZ, V365, P332, DOI 10.4028/www.scientific.net/AMR.365.332; Shi PJ, 2011, ENZYME MICROB TECH, V49, P277, DOI 10.1016/j.enzmictec.2011.06.003; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Snajdr J, 2010, SOIL BIOL BIOCHEM, V42, P1541, DOI 10.1016/j.soilbio.2010.05.023; Song JM, 2010, BIOMASS BIOENERG, V34, P1930, DOI 10.1016/j.biombioe.2010.08.010; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Sun Y, 2007, BIORESOURCE TECHNOL, V98, P2866, DOI 10.1016/j.biortech.2006.09.055; SUTHERLAND JB, 1979, CURR MICROBIOL, V2, P123, DOI 10.1007/BF02603069; TAJANA E, 1992, APPL ENVIRON MICROB, V58, P1447, DOI 10.1128/AEM.58.5.1447-1450.1992; Theuerl S, 2010, BIOL FERT SOILS, V46, P215, DOI 10.1007/s00374-010-0440-5; TROJANOWSKI J, 1977, ARCH MICROBIOL, V114, P149, DOI 10.1007/BF00410776; Tuomela M, 2002, SOIL BIOL BIOCHEM, V34, P1613, DOI 10.1016/S0038-0717(02)00145-1; Valaskova V, 2007, SOIL BIOL BIOCHEM, V39, P2651, DOI 10.1016/j.soilbio.2007.05.023; VICUNA R, 1988, ENZYME MICROB TECH, V10, P646, DOI 10.1016/0141-0229(88)90055-5; Wang GZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043480; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Yin LJ, 2010, J AGR FOOD CHEM, V58, P9833, DOI 10.1021/jf1019104; Yoon MH, 2007, J MICROBIOL BIOTECHN, V17, P1291; Zhang F, 2012, PROCESS BIOCHEM, V47, P225, DOI 10.1016/j.procbio.2011.10.032; ZIMMERMANN W, 1990, J BIOTECHNOL, V13, P119, DOI 10.1016/0168-1656(90)90098-V	62	105	109	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89108	10.1371/journal.pone.0089108	http://dx.doi.org/10.1371/journal.pone.0089108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551229	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000103
J	Lei, Z; Xu, GL; Wang, LQ; Yang, HP; Liu, X; Zhao, J; Zhang, HT				Lei, Zhe; Xu, Guili; Wang, Longqiang; Yang, Haiping; Liu, Xia; Zhao, Jun; Zhang, Hong-Tao			MiR-142-3p represses TGF-beta-induced growth inhibition through repression of TGF beta R1 in non-small cell lung cancer	FASEB JOURNAL			English	Article						NSCLC; miRNAs; cell proliferation; epigenetic mechanism; p-SMAD3	RECEPTOR-TYPE-I; EXPRESSION; MICRORNA; PROLIFERATION; CARCINOMA; GENE; ADENOCARCINOMA; MECHANISMS; PROGNOSIS; SURVIVAL	TGF beta R1 plays an important role in TGF-beta signaling transduction and serves as a tumor suppressor. Our previous studies show that reduced expression of TGF beta R1 is common in non-small cell lung cancer (NSCLC) and TGF beta R1 variants confer risk of NSCLC. However, the epigenetic mechanisms underlying the role of TGF beta R1 in NSCLC carcinogenesis are still elusive. We investigated the function and regulation of TGF-beta signaling-based miRNAs in NSCLC. Computational algorithms predicted that the 3'=untranslated region (3'=UTR) of TGF beta R1 is a target of miR-142-3p. Here a luciferase reporter assay confirmed that miR-142-3p can directly bind to 3'=UTR of TGF beta R1. Overexpression of miR-142-3p in NSCLC A549 cells suppressed expression of TGF beta R1 mRNA and protein, while knockdown of endogenous miR142-3p led to increased expression of TGF beta R1. On TGF-beta 1 stimulation, stable overexpression of miR142-3p attenuated phosphorylation of SMAD3, an indispensable downstream effector in canonical TGF-beta/Smad signaling, via repression of TGF beta R1 in A549 cells. Furthermore, miR-142-3p-mediated down-regulation of TGF beta R1 weakened TGF-beta-induced growth inhibition effect, and this effect was reversed by stable knockdown of endogenous miR-142-3p in A549 cells. In NSCLC tissues, miR-142-3p expression was increased and inversely correlated with TGF beta R1 expression. These data demonstrate that miR-142-3p influences the proliferation of NSCLC cells through repression of TGF beta R1.	[Lei, Zhe; Xu, Guili; Wang, Longqiang; Yang, Haiping; Liu, Xia; Zhang, Hong-Tao] Soochow Univ, Lab Canc Mol Genet, Suzhou 215123, Peoples R China; [Zhao, Jun] Soochow Univ, Affiliated Hosp 1, Coll Med, Suzhou 215123, Peoples R China; [Lei, Zhe; Xu, Guili; Wang, Longqiang; Yang, Haiping; Liu, Xia; Zhao, Jun; Zhang, Hong-Tao] Suzhou Key Lab Mol Canc Genet, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Zhang, HT (corresponding author), Soochow Univ, Lab Canc Mol Genet, Coll Med, 199 Renai Rd,Sino Singapore Ind Pk, Suzhou 215123, Peoples R China.	htzhang@suda.edu.cn	Lei, Zhe/AGZ-4963-2022; Zhang, Hong-Tao/P-9661-2017	Zhang, Hong-Tao/0000-0003-4182-421X	National Natural Science Foundation of China [81372277, 81171894]; Jiangsu Province Key Provincial Talents Program [RC2011106]; Jiangsu Province Outstanding Medical Academic Leader Program [LJ201138]; 333 Project of the Jiangsu Province government; Graduate Innovation Project of Jiangsu Province [CXZZ13_0830]; Soochow Scholar Project of Soochow University; Suzhou Key Laboratory for Molecular Cancer Genetics [SZS201209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Key Provincial Talents Program; Jiangsu Province Outstanding Medical Academic Leader Program; 333 Project of the Jiangsu Province government; Graduate Innovation Project of Jiangsu Province; Soochow Scholar Project of Soochow University; Suzhou Key Laboratory for Molecular Cancer Genetics	This work was supported in part by grants from the National Natural Science Foundation of China (81372277 and 81171894 to H.-T.Z.), the Jiangsu Province Key Provincial Talents Program (RC2011106 to J.Z.), the Jiangsu Province Outstanding Medical Academic Leader Program (LJ201138), the 333 Project of the Jiangsu Province government (to H.-T.Z.), the Graduate Innovation Project of Jiangsu Province (CXZZ13_0830 to Z.L.), the Soochow Scholar Project of Soochow University (to H.-T.Z.), and the Suzhou Key Laboratory for Molecular Cancer Genetics (SZS201209 to H.-T.Z.).	Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Colasante A, 2003, CYTOKINE, V24, P182, DOI 10.1016/j.cyto.2003.08.008; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Dou LP, 2013, MOL BIOL REP, V40, P6811, DOI 10.1007/s11033-013-2798-6; Feng J, 2012, AM J CLIN PATHOL, V138, P230, DOI 10.1309/AJCPDHQFNYJZ01YG; Fukai Y, 2003, INT J CANCER, V104, P161, DOI 10.1002/ijc.10929; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim WS, 1999, ANTICANCER RES, V19, P301; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Lei Z, 2009, CANCER RES, V69, P7046, DOI 10.1158/0008-5472.CAN-08-4602; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin RJ, 2012, J SURG ONCOL, V105, P175, DOI 10.1002/jso.22066; Ling N, 2013, ONCOL REP, V30, P2111, DOI 10.3892/or.2013.2685; MacKenzie TN, 2013, MOL CANCER THER, V12, P1266, DOI 10.1158/1535-7163.MCT-12-1231; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Park C, 2002, LUNG CANCER-J IASLC, V38, P143, DOI 10.1016/S0169-5002(02)00182-4; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Schneider MR, 2012, BRIT J DERMATOL, V166, P22, DOI 10.1111/j.1365-2133.2011.10568.x; Sessa R, 2013, PULM CIRC, V3, P315, DOI 10.4103/2045-8932.114758; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun JX, 2011, ONCOL REP, V25, P685, DOI 10.3892/or.2011.1135; Tanaka K, 2013, J BIOL CHEM, V288, P23990, DOI 10.1074/jbc.M113.478891; Tokunaga H, 1999, CLIN CANCER RES, V5, P2520; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073985; Wang Y, 2013, CANCER RES, V73, P4801, DOI 10.1158/0008-5472.CAN-12-3273; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang HT, 2003, LUNG CANCER-J IASLC, V40, P281, DOI 10.1016/S0169-5002(03)00121-1; Zhao J, 2008, J CANCER RES CLIN, V134, P919, DOI 10.1007/s00432-008-0392-4	37	82	83	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2696	2704		10.1096/fj.13-247288	http://dx.doi.org/10.1096/fj.13-247288			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24558198				2022-12-25	WOS:000339883600027
J	Minicozzi, V; Chiaraluce, R; Consalvi, V; Giordano, C; Narcisi, C; Punzi, P; Rossi, GC; Morante, S				Minicozzi, Velia; Chiaraluce, Roberta; Consalvi, Valerio; Giordano, Cesare; Narcisi, Claudia; Punzi, Pasqualina; Rossi, Giancarlo C.; Morante, Silvia			Computational and Experimental Studies on beta-Sheet Breakers Targeting A beta(1-40) Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Fluorescence; Mass Spectrometry (MS); Molecular Dynamics; Protein Misfolding; Amyloid Peptide; -Sheet Breakers	IONIZATION MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; AMYLOID FIBRILS; PEPTIDE; AGGREGATION; INHIBITORS; FIBRILLOGENESIS; CONFORMATION; SIMULATIONS	Background: -Amyloid aggregates are at the basis of Alzheimer disease development. Short synthetic peptides are seen to inhibit polymerization. Results: Various synthetic peptides have been studied by MD simulations and tested experimentally. Conclusion: Combined results indicate Ac-LPFFN-NH2 as an effective lead compound able to slow down A(1-40) aggregation. Significance: Designing potential A aggregation inhibitors will help fight Alzheimer disease. In this work we present and compare the results of extensive molecular dynamics simulations of model systems comprising an A(1-40) peptide in water in interaction with short peptides (-sheet breakers) mimicking the 17-21 region of the A(1-40) sequence. Various systems differing in the customized -sheet breaker structure have been studied. Specifically we have considered three kinds of -sheet breakers, namely Ac-LPFFD-NH2 and two variants thereof, one obtained by substituting the acetyl group with the sulfonic amino acid taurine (Tau-LPFFD-NH2) and a second novel one in which the aspartic acid is substituted by an asparagine (Ac-LPFFN-NH2). Thioflavin T fluorescence, circular dichroism, and mass spectrometry experiments have been performed indicating that -sheet breakers are able to inhibit in vitro fibril formation and prevent the sheet folding of portions of the A(1-40) peptide. We show that molecular dynamics simulations and far UV circular dichroism provide consistent evidence that the new Ac-LPFFN-NH2 -sheet breaker is more effective than the other two in stabilizing the native -helix structure of A(1-40). In agreement with these results thioflavin T fluorescence experiments confirm the higher efficiency in inhibiting A(1-40) aggregation. Furthermore, mass spectrometry data and molecular dynamics simulations consistently identified the 17-21 A(1-40) portion as the location of the interaction region between peptide and the Ac-LPFFN-NH2 -sheet breaker.	[Minicozzi, Velia; Narcisi, Claudia; Rossi, Giancarlo C.; Morante, Silvia] Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; [Minicozzi, Velia; Narcisi, Claudia; Rossi, Giancarlo C.; Morante, Silvia] Ist Nazl Fis Nucl, I-00133 Rome, Italy; [Chiaraluce, Roberta; Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem, I-00185 Rome, Italy; [Giordano, Cesare] Univ Roma La Sapienza, Biomol Chem CNR Inst, I-00185 Rome, Italy; [Punzi, Pasqualina] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy	University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Minicozzi, V (corresponding author), Univ Roma Tor Vergata, Dept Phys, Viadella Ric,Sci 1, I-00133 Rome, Italy.	minicozzi@roma2.infn.it	consalvi, valerio/F-1918-2011	Minicozzi, Velia/0000-0001-9851-9932; Morante, Silvia/0000-0002-3913-5733; Rossi, Giancarlo/0000-0001-9688-9454	PAT; INFN	PAT; INFN(Istituto Nazionale di Fisica Nucleare (INFN))	We thank the AuroraScience project (funded by PAT and INFN) for allocating the computing resources for this project.	Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Allen M. P., 1987, COMPUTER SIMULATIONS; Atherton E., 1989, SOLID PHASE SYNTHESI; Bartolini M, 2007, CHEMBIOCHEM, V8, P2152, DOI 10.1002/cbic.200700427; Bazoti FN, 2005, J MASS SPECTROM, V40, P182, DOI 10.1002/jms.738; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brouwer AJ, 2000, SYNTHESIS-STUTTGART, P1579; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Giannozzi P, 2012, METALLOMICS, V4, P156, DOI 10.1039/c2mt00148a; Giordano C, 2012, CHEM BIOL DRUG DES, V79, P30, DOI 10.1111/j.1747-0285.2011.01259.x; Giordano C, 2009, EUR J MED CHEM, V44, P179, DOI 10.1016/j.ejmech.2008.03.036; Gordon DJ, 2003, BIOCHEMISTRY-US, V42, P475, DOI 10.1021/bi0259857; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Ionescu RM, 2000, BIOCHEMISTRY-US, V39, P9540, DOI 10.1021/bi000511y; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030510; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; JOHNSON WC, 1992, METHOD ENZYMOL, V210, P426; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Laczko I, 2008, J PEPT SCI, V14, P731, DOI 10.1002/psc.990; Lemkul JA, 2012, ACS CHEM NEUROSCI, V3, P845, DOI 10.1021/cn300091a; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; MAIOROV VN, 1995, PROTEINS, V22, P273, DOI 10.1002/prot.340220308; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Novick PA, 2012, J MED CHEM, V55, P3002, DOI 10.1021/jm201332p; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Permanne B, 2002, FASEB J, V16, P860, DOI 10.1096/fj.01-0841fje; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Woody R. W., 1996, CIRCULAR DICHROISM C, P25	49	54	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11242	11252		10.1074/jbc.M113.537472	http://dx.doi.org/10.1074/jbc.M113.537472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584938	hybrid, Green Published			2022-12-25	WOS:000334638500027
J	Liu, ZH; Li, FD; Ruan, K; Zhang, JH; Mei, YD; Wu, JH; Shi, YY				Liu, Zhonghua; Li, Fudong; Ruan, Ke; Zhang, Jiahai; Mei, Yide; Wu, Jihui; Shi, Yunyu			Structural and Functional Insights into the Human Borjeson- Forssman- Lehmann Syndrome- associated Protein PHF6*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Diseases; Protein-DNA Interaction; Protein Folding; Transcription Regulation; Tumor Suppressor Gene; BFLS; NuRD; PHF6; RBBP4; Extended PHD	ACUTE LYMPHOBLASTIC-LEUKEMIA; PHF6 MUTATION; PHD FINGER; INTELLECTUAL DISABILITY; BINDING; REFINEMENT; ALIGNMENT; FEATURES; NETWORK; COMPLEX	Background:PHF6 gene is mutated in BFLS and adult acute myeloid and T-cell acute lymphoblastic leukemias. Results: Crystal structure of the second extended PHD domain of PHF6 was solved. Conclusion: PHF6-ePHD2 is a novel structural module and binds dsDNA. Significance: PHF6 may function as a transcriptional repressor using its ePHD domains binding to DNA and recruiting NuRD complex through its NoLS region to regulate gene transcription. The plant homeodomain finger 6 (PHF6) was originally identified as the gene mutated in the X-linked mental retardation disorder Borjeson-Forssman-Lehmann syndrome. Mutations in the PHF6 gene have also been associated with T-cell acute lymphoblastic leukemia and acute myeloid leukemia. Approximately half of the disease-associated mutations are distributed in the second conserved extended plant homeodomain (ePHD2) of PHF6, indicating the functional importance of the ePHD2 domain. Here, we report the high resolution crystal structure of the ePHD2 domain of PHF6, which contains an N-terminal pre-PHD (C2HC zinc finger), a long linker, and an atypical PHD finger. PHF6-ePHD2 appears to fold as a novel integrated structural module. Structural analysis of PHF6-ePHD2 reveals pathological implication of PHF6 gene mutations in Borjeson-Forssman-Lehmann syndrome, T-cell acute lymphoblastic leukemia, and acute myeloid leukemia. The binding experiments show that PHF6-ePHD2 can bind dsDNA but not histones. We also demonstrate PHF6 protein directly interacts with the nucleosome remodeling and deacetylation complex component RBBP4. Via this interaction, PHF6 exerts its transcriptional repression activity. Taken together, these data support the hypothesis that PHF6 may function as a transcriptional repressor using its ePHD domains binding to the promoter region of its repressed gene, and this process was regulated by the nucleosome remodeling and deacetylation complex that was recruited to the genomic target site by NoLS region of PHF6.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Mei, Yide/M-4468-2013; Shi, Yunyu/B-3240-2009; Ruan, Ke/N-1995-2013	Shi, Yunyu/0000-0002-1348-4759; Ruan, Ke/0000-0001-9358-0451	National Basic Research Program of China, 973 Program [2011CB966302, 2012CB917201, 2011CB911104]; Chinese National Natural Science Foundation [31170693, 31330018]; Chinese Academy of Science [KJZD-EW-L05]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010100]	National Basic Research Program of China, 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China, 973 Program, Grants 2011CB966302, 2012CB917201, and 2011CB911104, Chinese National Natural Science Foundation Grants 31170693 and 31330018, Chinese Academy of Science Grant KJZD-EW-L05, and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010100.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baumstark A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e50; Berland S, 2010, MOL SYNDROMOL, V1, P294, DOI 10.1159/000330111; BORJESON M, 1962, ACTA MED SCAND, V171, P13; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Carter MT, 2009, AM J MED GENET A, V149A, P246, DOI 10.1002/ajmg.a.32624; Chao MM, 2010, PEDIATR BLOOD CANCER, V55, P722, DOI 10.1002/pbc.22574; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; de Winter CF, 2009, J INTELL DISABIL RES, V53, P319, DOI 10.1111/j.1365-2788.2009.01156.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Gecz J, 2006, EUR J HUM GENET, V14, P1233, DOI 10.1038/sj.ejhg.5201639; Gedeon AK, 1996, AM J MED GENET, V64, P63, DOI 10.1002/(SICI)1096-8628(19960712)64:1<63::AID-AJMG9>3.0.CO;2-S; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; He C, 2013, J BIOL CHEM, V288, P4692, DOI 10.1074/jbc.M112.426148; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huh HJ, 2013, ANN HEMATOL, V92, P635, DOI 10.1007/s00277-012-1664-2; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Lower KM, 2004, EUR J HUM GENET, V12, P787, DOI 10.1038/sj.ejhg.5201228; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Mangelsdorf M, 2009, J CHILD NEUROL, V24, P610, DOI 10.1177/0883073808327830; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Vallee D, 2004, J MED GENET, V41, P778, DOI 10.1136/jmg.2004.020370; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Visootsak J, 2004, J PEDIATR-US, V145, P819, DOI 10.1016/j.jpeds.2004.07.041; Voss AK, 2007, GENE EXPR PATTERNS, V7, P858, DOI 10.1016/j.modgep.2007.06.007; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wang QJ, 2011, BIORESOURCES, V6, P1; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	49	44	48	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10069	10083		10.1074/jbc.M113.535351	http://dx.doi.org/10.1074/jbc.M113.535351			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554700	hybrid, Green Published			2022-12-25	WOS:000333807000054
J	Lorca, RA; Stamnes, SJ; Pillai, MK; Hsiao, JJ; Wright, ME; England, SK				Lorca, Ramon A.; Stamnes, Susan J.; Pillai, Meghan K.; Hsiao, Jordy J.; Wright, Michael E.; England, Sarah K.			N-terminal Isoforms of the Large- conductance Ca2-activated K Channel Are Differentially Modulated by the Auxiliary beta 1-Subunit*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Ion Channels; Patch Clamp Electrophysiology; Potassium Channels; Smooth Muscle; BKCa Channel; Auxiliary Subunits; Single-Channel Recordings	ACTIVATED POTASSIUM CHANNEL; ALTERNATIVE TRANSLATION INITIATION; BETA-SUBUNIT; BK CHANNEL; SMOOTH-MUSCLE; CA2+ SENSITIVITY; ALPHA-SUBUNITS; CALCIUM; VOLTAGE; DOMAINS	Background: The large-conductance Ca2+-activated K+ channel (BKCa) is an important regulator of membrane excitability. Results: N-terminal isoforms of the BKCa channel are differentially modulated by the regulatory 1-subunit. Conclusion: Expression of different N-terminal isoforms is a novel mechanism of BKCa channel regulation. Significance: Elucidating the modulation of BKCa activity by 1 provides a new understanding of ion channel physiology. The large-conductance Ca2+-activated K+ (BKCa) channel is essential for maintaining the membrane in a hyperpolarized state, thereby regulating neuronal excitability, smooth muscle contraction, and secretion. The BKCa -subunit has three predicted initiation codons that generate proteins with N-terminal ends starting with the amino acid sequences MANG, MSSN, or MDAL. Because the N-terminal region and first transmembrane domain of the -subunit are required for modulation by auxiliary 1-subunits, we examined whether 1 differentially modulates the N-terminal BKCa -subunit isoforms. In the absence of 1, all isoforms had similar single-channel conductances and voltage-dependent activation. However, whereas 1 did not modulate the voltage-activation curve of MSSN, 1 induced a significant leftward shift of the voltage activation curves of both the MDAL and MANG isoforms. These shifts, of which the MDAL was larger, occurred at both 10 m and 100 m Ca2+. The 1-subunit increased the open dwell times of all three isoforms and decreased the closed dwell times of MANG and MDAL but increased the closed dwell times of MSSN. The distinct modulation of voltage activation by the 1-subunit may be due to the differential effect of 1 on burst duration and interburst intervals observed among these isoforms. Additionally, we observed that the related 2-subunit induced comparable leftward shifts in the voltage-activation curves of all three isoforms, indicating that the differential modulation of these isoforms was specific to 1. These findings suggest that the relative expression of the N-terminal isoforms can fine-tune BKCa channel activity in cells, highlighting a novel mechanism of BKCa channel regulation.	[Lorca, Ramon A.; Pillai, Meghan K.; England, Sarah K.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Lorca, Ramon A.; Stamnes, Susan J.; Hsiao, Jordy J.; Wright, Michael E.; England, Sarah K.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Washington University (WUSTL); University of Iowa	England, SK (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 425 South Euclid Ave,Campus Bx 8064, St Louis, MO 63110 USA.	englands@wustl.edu		Wright, Michael/0000-0002-4243-2931; Hsiao, Jordy/0000-0002-2487-5034	National Institutes of Health [R01 HD037831]; American Heart Association [12GRNT10990002]; American Heart Association Postdoctoral Fellowship [12POST10660000]; National Center for Research Resources, Clinical and Translational Science Award [M01-RR-00059]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association Postdoctoral Fellowship(American Heart Association); National Center for Research Resources, Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health Grant R01 HD037831 and American Heart Association Grant 12GRNT10990002 (to S. K. E.), American Heart Association Postdoctoral Fellowship 12POST10660000 (to R. A. L.), and National Center for Research Resources, Clinical and Translational Science Award M01-RR-00059 for human tissue obtainment.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brainard AM, 2007, SEMIN CELL DEV BIOL, V18, P332, DOI 10.1016/j.semcdb.2007.05.008; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Cai J, 2006, PROTEINS, V62, P793, DOI 10.1002/prot.20785; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Korovkina VP, 2006, J PHYSIOL-LONDON, V573, P329, DOI 10.1113/jphysiol.2006.106922; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lee US, 2010, J NEUROSCI, V30, P16170, DOI 10.1523/JNEUROSCI.2323-10.2010; Matharoo-Ball B, 2003, BIOL REPROD, V68, P2135, DOI 10.1095/biolreprod.102.010454; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Nimigean CM, 2000, J GEN PHYSIOL, V115, P719, DOI 10.1085/jgp.115.6.719; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Scott RS, 2011, PFLUG ARCH EUR J PHY, V462, P545, DOI 10.1007/s00424-011-0991-9; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yang HH, 2008, BIOPHYS J, V94, P4678, DOI 10.1529/biophysj.107.121590; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737	43	10	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10095	10103		10.1074/jbc.M113.521526	http://dx.doi.org/10.1074/jbc.M113.521526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569989	hybrid, Green Published			2022-12-25	WOS:000333807000056
J	Song, WS; Wang, F; Lotfi, P; Sardiello, M; Segatori, L				Song, Wensi; Wang, Fan; Lotfi, Parisa; Sardiello, Marco; Segatori, Laura			2-Hydroxypropyl-beta-cyclodextrin Promotes Transcription Factor EB- mediated Activation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Lipoprotein; Lysosomal Storage Disease; Lysosomes; Ceroid Lipopigment; Cyclodextrin; Neuronal Ceroid Lipofuscinosis; TFEB	CELL-DEATH; CHOLESTEROL; DISEASE; CYCLODEXTRINS; PROTEIN; LIFE; NEURODEGENERATION; RECOGNITION; DEGRADATION; HOMEOSTASIS	Background: The drug delivery vehicle 2-hydroxypropyl--cyclodextrin (HPCD) prevents cholesterol storage. Results: HPCD treatment induces TFEB mediated activation of autophagy and clearance of the autophagic substrate ceroid lipopigment. Conclusion: HPCD administration results in enhancement of the innate autophagic clearance capacity. Significance: Dissecting the cellular pathways impacted by HPCD is crucial to design HPCD-based therapeutic modalities. 2-Hydroxypropyl--cyclodextrin (HPCD) is a Food and Drug Administration-approved excipient used to improve the stability and bioavailability of drugs. Despite its wide use as a drug delivery vehicle and the recent approval of a clinical trial to evaluate its potential for the treatment of a cholesterol storage disorder, the cellular pathways involved in the adaptive response that is activated upon exposure to HPCD are still poorly defined. Here, we show that cell treatment with HPCD results in the activation of the transcription factor EB, a master regulator of lysosomal function and autophagy, and in enhancement of the cellular autophagic clearance capacity. HPCD administration promotes transcription factor EB-mediated clearance of proteolipid aggregates that accumulate due to inefficient activity of the lysosome-autophagy system in cells derived from a patient with a lysosomal storage disorder. Interestingly, HPCD-mediated activation of autophagy was found not to be associated with activation of apoptotic pathways. This study provides a mechanistic understanding of the cellular response to HPCD treatment, which will inform the development of safe HPCD-based therapeutic modalities and may enable engineering HPCD as a platform technology to reduce the accumulation of lysosomal storage material.	Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Lotfi, Parisa; Sardiello, Marco] Texas Childrens Hosp, Dept Mol & Human Genet, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Rice University; Rice University; Rice University; Baylor College of Medicine	Segatori, L (corresponding author), Rice Univ, MS-362,6100 Main St, Houston, TX 77005 USA.	segatori@rice.edu			Welch Foundation [C-1824]; National Science Foundation [CBET 1254318]; Beyond Batten Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084005] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Beyond Batten Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Welch Foundation (C-1824; to L. S.), the National Science Foundation (CBET 1254318; to L. S.), and the Beyond Batten Disease Foundation (to M. S.).	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Christian AE, 1997, J LIPID RES, V38, P2264; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Hait WN, 2006, CLIN CANCER RES, V12, P1961, DOI 10.1158/1078-0432.CCR-06-0011; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Oh JE, 2012, YONSEI MED J, V53, P241, DOI 10.3349/ymj.2012.53.2.241; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Persaud-Sawin DA, 2007, PEDIATR RES, V61, P146, DOI 10.1203/pdr.0b013e31802d8a4a; Pierret C, 2008, ACTA NEUROBIOL EXP, V68, P429; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Song WS, 2013, HUM MOL GENET, V22, P1994, DOI 10.1093/hmg/ddt052; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang F, 2011, CHEM BIOL, V18, P766, DOI 10.1016/j.chembiol.2011.04.008; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547	57	80	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10211	10222		10.1074/jbc.M113.506246	http://dx.doi.org/10.1074/jbc.M113.506246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558044	Green Published, hybrid			2022-12-25	WOS:000333807000066
J	Wei, SS; Wang, HB; Lu, CW; Malmut, S; Zhang, JQ; Ren, SM; Yu, GH; Wang, W; Tang, DD; Yan, CH				Wei, Saisai; Wang, Hongbo; Lu, Chunwan; Malmut, Sarah; Zhang, Jianqiao; Ren, Shumei; Yu, Guohua; Wang, Wei; Tang, Dale D.; Yan, Chunhong			The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Resistance; Invasion; Lung Cancer; Migration; p53; ATF3; Mutant p53	PROSTATE-CANCER; GENE-EXPRESSION; ATF3; GAIN; METASTASIS; DEGRADATION; UBIQUITINATION; REPRESSION; MUTATIONS; STABILITY	Background: Mutant p53 often acquires tumor-promoting activities, including the promotion of cancer cell survival, invasion, and metastasis. Results: Activating transcription factor 3 (ATF3) bound mutant p53 proteins, sensitized cancer cells to chemotherapy, and suppressed mutant p53-mediated cell migration. Conclusion: ATF3 suppressed the tumor-promoting function of mutant p53. Significance: Targeting ATF3 could be a novel strategy for treating p53-mutated cancer. Mutant p53 proteins (mutp53) often acquire oncogenic activities, conferring drug resistance and/or promoting cancer cell migration and invasion. Although it has been well established that such a gain of function is mainly achieved through interaction with transcriptional regulators, thereby modulating cancer-associated gene expression, how the mutp53 function is regulated remains elusive. Here we report that activating transcription factor 3 (ATF3) bound common mutp53 (e.g. R175H and R273H) and, subsequently, suppressed their oncogenic activities. ATF3 repressed mutp53-induced NFKB2 expression and sensitized R175H-expressing cancer cells to cisplatin and etoposide treatments. Moreover, ATF3 appeared to suppress R175H- and R273H-mediated cancer cell migration and invasion as a consequence of preventing the transcription factor p63 from inactivation by mutp53. Accordingly, ATF3 promoted the expression of the metastasis suppressor SHARP1 in mutp53-expressing cells. An ATF3 mutant devoid of the mutp53-binding domain failed to disrupt the mutp53-p63 binding and, thus, lost the activity to suppress mutp53-mediated migration, suggesting that ATF3 binds to mutp53 to suppress its oncogenic function. In line with these results, we found that down-regulation of ATF3 expression correlated with lymph node metastasis in TP53-mutated human lung cancer. We conclude that ATF3 can suppress mutp53 oncogenic function, thereby contributing to tumor suppression in TP53-mutated cancer.	[Wei, Saisai; Wang, Hongbo; Malmut, Sarah; Ren, Shumei; Yan, Chunhong] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Wei, Saisai; Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Lu, Chunwan; Yan, Chunhong] Georgia Regents Univ, GRU Canc Ctr, Augusta, GA 30912 USA; [Yan, Chunhong] Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Wang, Hongbo; Zhang, Jianqiao] Yantai Univ, Key Lab Mol Pharmacol & Drug Evaluat, Sch Pharm, Yantai 264005, Peoples R China; [Yu, Guohua; Wang, Wei] Qingdao Univ, Coll Med, Dept Pathol, Affiliated Yantai Yuhuangding Hosp, Yantai 264000, Peoples R China	Albany Medical College; Albany Medical College; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Yantai University; Qingdao University	Yan, CH (corresponding author), GRU Canc Ctr, 1410 Laney Walker Blvd,CN 2134, Augusta, GA 30912 USA.	cyan@gru.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022; T, Dale/AAE-9643-2020; Lu, Chunwan/V-6216-2019	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; T, Dale/0000-0002-7339-9249; Yan, Chunhong/0000-0002-3974-7991; qiao, jian/0000-0002-4941-7013	NCI, National Institutes of Health [RO1CA139107, RO1CA164006]; National Natural Science Foundation of China [81202038]; Scientific Research Foundation for Returned Overseas Chinese Scholars; NATIONAL CANCER INSTITUTE [R01CA139107, R01CA164006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110951, R01HL113208] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	* This work was supported, in whole or in part, by NCI, National Institutes of Health Grants RO1CA139107 and RO1CA164006 (to C. Y.).; <SUP>1</SUP> Supported by National Natural Science Foundation of China Grant 81202038 and by the Scientific Research Foundation for Returned Overseas Chinese Scholars.	Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buganim Y, 2006, CANCER RES, V66, P10750, DOI 10.1158/0008-5472.CAN-06-0916; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ishiguro T, 1996, CANCER RES, V56, P875; Jan YH, 2012, CANCER RES, V72, P5119, DOI 10.1158/0008-5472.CAN-12-1842; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nair RR, 2008, MOL PHARMACOL, V73, P919, DOI 10.1124/mol.107.042606; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Stearns ME, 2004, MOL CANCER RES, V2, P403; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Valenti F, 2011, CELL CYCLE, V10, P4330, DOI 10.4161/cc.10.24.18682; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zigler M, 2011, CANCER RES, V71, P3494, DOI 10.1158/0008-5472.CAN-10-3555	47	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8947	8959		10.1074/jbc.M113.503755	http://dx.doi.org/10.1074/jbc.M113.503755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554706	Green Published, hybrid			2022-12-25	WOS:000333472100018
J	Ghassemi, R; Narayanan, S; Banwell, B; Sled, JG; Shroff, M; Arnold, DL				Ghassemi, Rezwan; Narayanan, Sridar; Banwell, Brenda; Sled, John G.; Shroff, Manohar; Arnold, Douglas L.		Canadian Pediatric Demyelinating D	Quantitative Determination of Regional Lesion Volume and Distribution in Children and Adults with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIC-RESONANCE; WHITE-MATTER; DIAGNOSTIC-CRITERIA; BRAIN; MRI; ONSET; REGISTRATION; DISABILITY; INSIGHTS; BURDEN	Introduction: Onset of MS occurs during childhood in about 5% of cases. It is unclear whether very young age at MS onset, when the nervous system is still myelinating, affects MS lesion accrual or regional distribution. Objective: To compare the frequency, volume and distribution of T2 and T1 lesions in children and adults with relapsing-remitting multiple sclerosis (RRMS). Methods: Lesions were segmented on T2- and T1-weighted MRI images from 29 children and 29 adults with RRMS, matched for disease duration. Results: All subjects exhibited T2-weighted brain lesions. Children had higher whole-brain T2-weighted-lesion-volume (T2LV) compared to adults (mean (SD) in cm 3 : 12.76(2.7) vs. 10.03(3.4), p<0.0013). The supratentorial-T2LV was similar in children and adults (8.45(1.7) vs. 7.94(1.7), mean (SD), p = 0.2582), but adults were more likely to have supratentorial lesions (96.5% vs. 68.9%, p<0.012). Children were more likely to have infratentorial-T2-weighted lesions (75.9% vs. 43.4%, p<0.03), specifically in the brainstem (62.1% vs. 26.7%, p<0.019) and the pons (48.3% vs. 17.24%, p<0.024), had higher infratentorial-T2-weighted-lesion counts (4.1(5.6) vs. 1.45(2.3), p<0.021), a greater infratentorial-T2LV (4.31(2.7) vs. 2.08(2.4), p<0.0013), and a greater infratentorial-T1-weighted-lesion-volume (T1LV) (3.7(2.5) vs. 1.08(1.9), p<0.0007). Whole-brain-T1LV was higher in children (9.3(2.5) vs. 6.43(2.1), p>0.001). Adult MS patients had higher supratentorial-T1LV (5.5(0.92) vs. 6.41(2.1), mean (SD), p<0.034), whereas children were more likely to have infratentorial-T1-weighted lesions (58.6% vs. 23.3%, p<0.015). Discussion: Onset of MS during childhood is associated with a higher volume of brain lesions in the first few years of disease relative to adults. Children with MS are more likely than adults to have T2 and T1 lesions in the infratentorial white matter, raising the possibility of preferential immune targeting of more mature myelin. Children with MS have a lower supratentorial T1 lesion burden, possibly reflecting more effective remyelination and repair in brain regions that are still engaged in active primary myelination.	[Ghassemi, Rezwan; Narayanan, Sridar; Arnold, Douglas L.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Banwell, Brenda; Sled, John G.; Shroff, Manohar] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Banwell, Brenda] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Arnold, DL (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	douglas.arnold@mcgill.ca	Shroff, Manohar/AAM-2418-2020; Sled, John G/D-8268-2012	Sled, John G/0000-0002-4461-283X; Arnold, Douglas/0000-0003-4266-0106	Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Canadian Multiple Sclerosis Scientific Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Canadian Multiple Sclerosis Scientific Research Foundation	This study was funded by the Canadian Institutes of Health Research, the Multiple Sclerosis Society of Canada, and the Canadian Multiple Sclerosis Scientific Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi AA, 2007, ANNU REV PUBL HEALTH, V28, P95, DOI 10.1146/annurev.publhealth.28.082206.094100; Banwell B, 2011, NAT REV NEUROL, V7, P109, DOI 10.1038/nrneurol.2010.198; Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barkhof F, 2007, ARCH NEUROL-CHICAGO, V64, P1292, DOI 10.1001/archneur.64.9.1292; Callen DJA, 2009, NEUROLOGY, V72, P961, DOI 10.1212/01.wnl.0000338629.01627.54; Caramanos Z, 2012, ARCH NEUROL-CHICAGO, V69, P89, DOI 10.1001/archneurol.2011.765; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Francis SJ., 2004, THESIS MCGILL U MONT; Gallucci M, 2001, CHILD NERV SYST, V17, P202, DOI 10.1007/s003810000331; Gedamu EL, 2008, J MAGN RESON IMAGING, V28, P308, DOI 10.1002/jmri.21434; Ghassemi R, 2008, ANN NEUROL, V63, P401, DOI 10.1002/ana.21322; Ketelslegers IA, 2010, NEUROLOGY, V74, P1412, DOI 10.1212/WNL.0b013e3181dc138b; Krupp LB, 2007, NEUROLOGY, V68, pS7, DOI 10.1212/01.wnl.0000259422.44235.a8; Laribiere A, 2005, EUR J CLIN PHARMACOL, V61, P907, DOI 10.1007/s00228-005-0053-3; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Narayanan S, 1997, ANN NEUROL, V41, P385, DOI 10.1002/ana.410410314; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Steen RG, 1997, AM J NEURORADIOL, V18, P819; Till C, 2011, NEUROPSYCHOLOGY, V25, P319, DOI 10.1037/a0022051; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Verhey LH, 2011, LANCET NEUROL, V10, P1065, DOI 10.1016/S1474-4422(11)70250-2; Waubant E, 2009, ARCH NEUROL-CHICAGO, V66, P967, DOI 10.1001/archneurol.2009.135; Yeh EA, 2009, BRAIN, V132, P3392, DOI 10.1093/brain/awp278	32	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e85741	10.1371/journal.pone.0085741	http://dx.doi.org/10.1371/journal.pone.0085741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586244	Green Published, gold, Green Submitted			2022-12-25	WOS:000332389000002
J	Makrantoni, V; Corbishley, SJ; Rachidi, N; Morrice, NA; Robinson, DA; Stark, MJR				Makrantoni, Vasso; Corbishley, Stephen J.; Rachidi, Najma; Morrice, Nicholas A.; Robinson, David A.; Stark, Michael J. R.			Phosphorylation of Sli15 by Ipl1 Is Important for Proper CPC Localization and Chromosome Stability in Saccharomyces cerevisiae	PLOS ONE			English	Article							AURORA-B KINASE; BUDDING YEAST; SPINDLE CHECKPOINT; INNER CENTROMERE; HISTONE H3; COMPLEX; TENSION; INCENP; BIORIENTATION; ORIENTATION	The chromosomal passenger complex (CPC) is a key regulator of eukaryotic cell division, consisting of the protein kinase Aurora B/Ipl1 in association with its activator (INCENP/Sli15) and two additional proteins (Survivin/Bir1 and Borealin/Nbl1). Here we have identified multiple sites of CPC autophosphorylation on yeast Sli15 that are located within its central microtubule-binding domain and examined the functional significance of their phosphorylation by Ipl1 through mutation of these sites, either to non-phosphorylatable alanine (sli15-20A) or to acidic residues to mimic constitutive phosphorylation (sli15-20D). Both mutant sli15 alleles confer chromosome instability, but this is mediated neither by changes in the capacity of Sli15 to activate Ipl1 kinase nor by decreased efficiency of chromosome biorientation, a key process in cell division that requires CPC function. Instead, we find that mimicking constitutive phosphorylation of Sli15 on the Ipl1 phosphorylation sites causes delocalization of the CPC in metaphase, whereas blocking phosphorylation of Sli15 on the Ipl1 sites drives excessive localization of Sli15 to the mitotic spindle in pre-anaphase cells. Consistent with these results, direct interaction of Sli15 with microtubules in vitro is greatly reduced either following phosphorylation by Ipl1 or when constitutive phosphorylation at the Ipl1-dependent phosphorylation sites is mimicked by aspartate or glutamate substitutions. Furthermore, we find that mimicking Ipl1 phosphorylation of Sli15 interferes with the 'tension checkpoint' - the CPC-dependent mechanism through which cells activate the spindle assembly checkpoint to delay anaphase in the absence of tension on kinetochore-microtubule attachments. Ipl1-dependent phosphorylation of Sli15 therefore inhibits its association with microtubules both in vivo and in vitro and may negatively regulate the tension checkpoint mechanism.	[Makrantoni, Vasso; Corbishley, Stephen J.; Rachidi, Najma; Stark, Michael J. R.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 4HN, Scotland; [Morrice, Nicholas A.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 4HN, Scotland; [Robinson, David A.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 4HN, Scotland	University of Dundee; University of Dundee; University of Dundee	Stark, MJR (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 4HN, Scotland.	m.j.r.stark@dundee.ac.uk	Stark, Michael J. R./B-2815-2014	Stark, Michael J. R./0000-0001-9086-191X; Rachidi, Najma/0000-0002-1247-7768; Makrantoni, Vasso/0000-0003-0668-6157; Robinson, David/0000-0003-1979-5918	Biotechnology and Biological Sciences Research Council [BB/G003440/1]; Wellcome Trust [083524/Z/07/Z]; BBSRC [BB/G003440/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by Project Grant BB/G003440/1 from the Biotechnology and Biological Sciences Research Council awarded to Michael Stark. We also gratefully acknowledge support from the Wellcome Trust (083524/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Campbell CS, 2013, NATURE, V497, P118, DOI 10.1038/nature12057; Campbell David G, 2002, J Biomol Tech, V13, P119; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cho US, 2012, NAT STRUCT MOL BIOL, V19, P48, DOI 10.1038/nsmb.2178; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hummer S, 2009, CURR BIOL, V19, P607, DOI 10.1016/j.cub.2009.02.046; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Keating P, 2009, J CELL SCI, V122, P4375, DOI 10.1242/jcs.055566; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; King EMJ, 2007, GENE DEV, V21, P1163, DOI 10.1101/gad.431507; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Nakajima Y, 2009, MOL BIOL CELL, V20, P1772, DOI 10.1091/mbc.E08-10-1011; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Sadowski I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat026; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Shimogawa MM, 2009, MOL BIOL CELL, V20, P915, DOI 10.1091/mbc.E08-07-0723; SPENCER F, 1992, P NATL ACAD SCI USA, V89, P8908, DOI 10.1073/pnas.89.19.8908; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Storchova Z, 2011, MOL BIOL CELL, V22, P1473, DOI 10.1091/mbc.E10-08-0673; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Woodruff JB, 2010, J CELL BIOL, V191, P795, DOI 10.1083/jcb.201006028; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208; Zimniak T, 2012, CURR BIOL, V22, P787, DOI 10.1016/j.cub.2012.03.007; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89399	10.1371/journal.pone.0089399	http://dx.doi.org/10.1371/journal.pone.0089399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558497	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700143
J	Mentaberre, G; Romero, B; de Juan, L; Navarro-Gonzalez, N; Velarde, R; Mateos, A; Marco, I; Olive-Boix, X; Dominguez, L; Lavin, S; Serrano, E				Mentaberre, Gregorio; Romero, Beatriz; de Juan, Lucia; Navarro-Gonzalez, Nora; Velarde, Roser; Mateos, Ana; Marco, Ignasi; Olive-Boix, Xavier; Dominguez, Lucas; Lavin, Santiago; Serrano, Emmanuel			Long-Term Assessment of Wild Boar Harvesting and Cattle Removal for Bovine Tuberculosis Control in Free Ranging Populations	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; SPATIAL-DISTRIBUTION; RISK-FACTORS; RED DEER; MANAGEMENT; EPIDEMIOLOGY; ERADICATION; INFECTIONS; LESIONS; PREVALENCE	Wild boar is a recognized reservoir of bovine tuberculosis (TB) in the Mediterranean ecosystems, but information is scarce outside of hotspots in southern Spain. We describe the first high-prevalence focus of TB in a non-managed wild boar population in northern Spain and the result of eight years of TB management. Measures implemented for disease control included the control of the local wild boar population through culling and stamping out of a sympatric infected cattle herd. Post-mortem inspection for detection of tuberculosis-like lesions as well as cultures from selected head and cervical lymph nodes was done in 745 wild boar, 355 Iberian ibexes and five cattle between 2004 and 2012. The seasonal prevalence of TB reached 70% amongst adult wild boar and ten different spoligotypes and 13 MIRU-VNTR profiles were detected, although more than half of the isolates were included in the same clonal complex. Only 11% of infected boars had generalized lesions. None of the ibexes were affected, supporting their irrelevance in the epidemiology of TB. An infected cattle herd grazed the zone where 168 of the 197 infected boars were harvested. Cattle removal and wild boar culling together contributed to a decrease in TB prevalence. The need for holistic, sustained over time, intensive and adapted TB control strategies taking into account the multi-host nature of the disease is highlighted. The potential risk for tuberculosis emergence in wildlife scenarios where the risk is assumed to be low should be addressed.	[Mentaberre, Gregorio; Navarro-Gonzalez, Nora; Velarde, Roser; Marco, Ignasi; Lavin, Santiago; Serrano, Emmanuel] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain; [Romero, Beatriz; de Juan, Lucia; Dominguez, Lucas] Univ Complutense, VISAVET Hlth Surveillance Ctr, E-28040 Madrid, Spain; [Romero, Beatriz; de Juan, Lucia; Mateos, Ana; Dominguez, Lucas] Univ Complutense, Fac Vet, Dept Sanidad Anim, E-28040 Madrid, Spain; [Serrano, Emmanuel] Univ Lleida, Dept Matemat, Lleida, Spain; [Olive-Boix, Xavier] Reserva Nacl Caca Ports Tortosa & Beseit, Tarragona, Spain	Autonomous University of Barcelona; Complutense University of Madrid; Complutense University of Madrid; Universitat de Lleida	Mentaberre, G (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, E-08193 Barcelona, Spain.	caprapyrenaica@gmail.com	Lavín, Santiago/L-5975-2014; SERRANO-FERRON, Emmanuel/J-4489-2013; studies, IT VISAVET Account for bibliometric/C-3115-2014; Mentaberre, Gregorio A/H-4629-2015; Navarro-Gonzalez, Nora/N-9799-2017; Marco, Ignasi/E-8633-2015; de Juan, Lucía/I-6465-2016; Rodríguez, Lucas Domínguez/B-9668-2014; Velarde, Roser/M-1614-2014; Romero, Beatriz/J-5942-2015; Navarro-Gonzalez, Nora/GYD-6516-2022; Mentaberre, Gregorio/AAB-5912-2020	Lavín, Santiago/0000-0001-5655-588X; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; studies, IT VISAVET Account for bibliometric/0000-0003-3319-0050; Mentaberre, Gregorio A/0000-0001-9542-7514; Navarro-Gonzalez, Nora/0000-0002-1878-1242; Marco, Ignasi/0000-0001-7479-3419; de Juan, Lucía/0000-0002-7070-6872; Rodríguez, Lucas Domínguez/0000-0001-8843-0010; Velarde, Roser/0000-0003-3332-6405; Romero, Beatriz/0000-0001-5263-1806; Mentaberre, Gregorio/0000-0001-9542-7514	Ministry of Science and Innovation [FAU2006-00011, FAU2008-00021]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been funded by the Ministry of Science and Innovation within the Programme of Interaction between wild animals and livestock (FAU2006-00011 and FAU2008-00021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo Pelayo, 2009, Galemys, V21, P13; Allepuz A, 2011, PREV VET MED, V100, P44, DOI 10.1016/j.prevetmed.2011.02.012; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Boadella M, 2012, PREV VET MED; Boadella M, 2011, ECOHEALTH; BOITANI L, 1992, ONGULES / UNGULATES 91, P419; Buddle BM, 2000, VET IMMUNOL IMMUNOP, V74, P1, DOI 10.1016/S0165-2427(00)00163-X; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CORNER LA, 1988, VET MICROBIOL, V18, P127, DOI 10.1016/0378-1135(88)90058-2; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cowled BD, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-3; Dandy N, 2012, EUR J WILDLIFE RES, V58, P695, DOI 10.1007/s10344-012-0619-1; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Delahay RJ, 2007, VET J, V173, P287, DOI 10.1016/j.tvjl.2005.11.011; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; FANDOS P, 1995, MAMMALIA, V59, P229, DOI 10.1515/mamm.1995.59.2.229; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Gamelon M, 2012, J APPL ECOL, V49, P833, DOI 10.1111/j.1365-2664.2012.02160.x; Garcia-Jimenez WL, 2013, TRANSBOUND EMERG DIS, V60, P102, DOI 10.1111/j.1865-1682.2012.01321.x; Garcia-Jimenez WL, 2013, PREV VET MED; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keet DF, 2000, ONDERSTEPOORT J VET, V67, P115; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lisle G. W. de, 1994, Surveillance (Wellington), V21, P23; Lopez-Olvera JR, 2006, PARASITOL RES, V98, P582, DOI 10.1007/s00436-005-0099-2; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Mentaberre G, 2012, ZOONOSES PUBLIC HLTH; Mentaberre G, 2010, VET REC, V166, P700, DOI 10.1136/vr.c2552; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nishi JS, 2006, VET MICROBIOL, V112, P325, DOI 10.1016/j.vetmic.2005.11.013; O'Brien DJ, 2011, VET MICROBIOL, V151, P23, DOI 10.1016/j.vetmic.2011.02.022; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; R Development Core Team, LANG ENV STAT COMP; Radunz B, 2006, VET MICROBIOL, V112, P283, DOI 10.1016/j.vetmic.2005.11.017; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Riordan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028904; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; Rodriguez-Campos S, 2011, J CLIN MICROBIOL, V49, P3361, DOI 10.1128/JCM.00301-11; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Van Campen H, 2010, VET CLIN N AM-FOOD A, V26, P147, DOI 10.1016/j.cvfa.2009.10.008; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Wilton S, 1992, PCR Methods Appl, V1, P269; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zar J.H., 2009, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	60	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88824	10.1371/journal.pone.0088824	http://dx.doi.org/10.1371/journal.pone.0088824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558435	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000331706700081
J	Pirog, KA; Irman, A; Young, S; Halai, P; Bell, PA; Boot-Handford, RP; Briggs, MD				Pirog, Katarzyna A.; Irman, Andreja; Young, Siobhan; Halai, Poonam; Bell, Peter A.; Boot-Handford, Raymond P.; Briggs, Michael D.			Abnormal Chondrocyte Apoptosis in the Cartilage Growth Plate is Influenced by Genetic Background and Deletion of CHOP in a Targeted Mouse Model of Pseudoachondroplasia	PLOS ONE			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; C/EBP-HOMOLOGOUS PROTEIN; CELL-DEATH; IX COLLAGEN; COMP; MUTATION; TRANSCRIPTION; MECHANISMS; ATTACHMENT	Pseudoachondroplasia (PSACH) is an autosomal dominant skeletal dysplasia caused by mutations in cartilage oligomeric matrix protein (COMP) and characterised by short limbed dwarfism and early onset osteoarthritis. Mouse models of PSACH show variable retention of mutant COMP in the ER of chondrocytes, however, in each case a different stress pathway is activated and the underlying disease mechanisms remain largely unknown. T585M COMP mutant mice are a model of moderate PSACH and demonstrate a mild ER stress response. Although mutant COMP is not retained in significant quantities within the ER of chondrocytes, both BiP and the pro-apoptotic ER stress-related transcription factor CHOP are mildly elevated, whilst bcl-2 levels are decreased, resulting in increased and spatially dysregulated chondrocyte apoptosis. To determine whether the abnormal chondrocyte apoptosis observed in the growth plate of mutant mice is CHOP-mediated, we bred T585M COMP mutant mice with CHOP-null mice to homozygosity, and analysed the resulting phenotype. Although abnormal apoptosis was alleviated in the resting zone following CHOP deletion, the mutant growth plates were generally more disorganised. Furthermore, the bone lengths of COMP mutant CHOP null mice were significantly shorter at 9 weeks of age when compared to the COMP mutant mice, including a significant difference in the skull length. Overall, these data demonstrate that CHOP-mediated apoptosis is an early event in the pathobiology of PSACH and suggest that the lack of CHOP, in conjunction with a COMP mutation, may lead to aggravation of the skeletal phenotype via a potentially synergistic effect on endochondral ossification.	[Pirog, Katarzyna A.; Bell, Peter A.; Briggs, Michael D.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Irman, Andreja; Young, Siobhan; Halai, Poonam; Boot-Handford, Raymond P.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	Newcastle University - UK; University of Manchester	Pirog, KA (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Katarzyna.Pirog@ncl.ac.uk; Michael.Briggs@ncl.ac.uk	Pirog, Katarzyna/AAD-6682-2021	Pirog, Katarzyna/0000-0003-0736-3296; Boot-Handford, Raymond/0000-0002-6167-8419	Wellcome Trust [071161/Z/03/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust Senior Research Fellowship in Basic Biomedical Science, Grant 071161/Z/03/Z (MDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chapman KL, 2003, PEDIATR PATHOL MOL M, V22, P53, DOI 10.1080/15227950307699; Chen FH, 2007, J BIOL CHEM, V282, P24591, DOI 10.1074/jbc.M611390200; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen RH, 2000, RES COMMUN MOL PATH, V108, P3; Delot E, 1999, HUM MOL GENET, V8, P123, DOI 10.1093/hmg/8.1.123; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; Dixon J, 2004, DEV DYNAM, V229, P907, DOI 10.1002/dvdy.20004; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Gal I, 2000, J HISTOCHEM CYTOCHEM, V48, P963, DOI 10.1177/002215540004800709; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hecht JT, 2004, J ORTHOP RES, V22, P759, DOI 10.1016/j.orthres.2003.11.010; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Kennedy Jason, 2005, Hum Mutat, V25, P593, DOI 10.1002/humu.9342; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Marciniak S, 2004, GENES DEV, V18; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKeand J, 1996, AM J MED GENET, V63, P406; McLaughlin M, 2007, NEUROCHEM RES, V32, P167, DOI 10.1007/s11064-006-9122-y; Moore K, 2012, ANNU REV GENET; Nundlall S, 2010, CELL STRESS CHAPERON, V15, P835, DOI 10.1007/s12192-010-0193-y; Pereira RC, 2006, J CELL BIOCHEM, V97, P633, DOI 10.1002/jcb.20660; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2012, AM J PATHOL, V180, P727, DOI 10.1016/j.ajpath.2011.10.035; Posey KL, 2009, AM J PATHOL, V175, P1555, DOI 10.2353/ajpath.2009.090184; Rock MJ, 2010, MOL CELL BIOCHEM, V338, P215, DOI 10.1007/s11010-009-0355-3; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Spitznagel L, 2004, BIOCHEM J, V377, P479, DOI 10.1042/BJ20031179; Suleman F, 2012, HUM MUTAT, V33, P218, DOI 10.1002/humu.21631; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Unger SL, 2001, PEDIATR RADIOL, V31, P10, DOI 10.1007/s002470000362; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	42	27	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e85145	10.1371/journal.pone.0085145	http://dx.doi.org/10.1371/journal.pone.0085145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558358	gold, Green Published			2022-12-25	WOS:000331706700004
J	Page, M; Quartey-Papafio, R; Robinson, M; Hassall, M; Cranage, M; Stott, J; Almond, N				Page, Mark; Quartey-Papafio, Ruby; Robinson, Mark; Hassall, Mark; Cranage, Martin; Stott, James; Almond, Neil			Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HUMAN MONOCLONAL-ANTIBODIES; HIV-1 PLASMA VIRUS; RHESUS MACAQUES; PASSIVE-IMMUNIZATION; VACCINE PROTECTION; LEUKOCYTE ANTIGEN; IN-VIVO; TYPE-1; CELLS	Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV) and has been observed in the macaque model using inactivated simian immunodeficiency virus (SIV). This protection was attributed to antibodies specific for cell proteins including human leucocyte antigens (HLA) class I and II incorporated into virions during vaccine and challenge virus preparation. We show here, using HLA bead arrays, that vaccinated macaques protected from virus challenge had higher serum antibody reactivity compared with non-protected animals. Moreover, reactivity was shown to be directed against HLA framework determinants. Previous studies failed to correlate serum antibody mediated virus neutralisation with protection and were confounded by cytotoxic effects. Using a virus entry assay based on TZM-bl cells we now report that, in the presence of complement, serum antibody titres that neutralise virus infectivity were higher in protected animals. We propose that complement-augmented virus neutralisation is a key factor in inducing sterilising immunity and may be difficult to achieve with HIV/SIV Env-based vaccines. Understanding how to overcome the apparent block of inactivated SIV vaccines to elicit anti-envelope protein antibodies that effectively engage the complement system could enable novel anti-HIV antibody vaccines that induce potent, virolytic serological response to be developed.	[Page, Mark; Quartey-Papafio, Ruby; Robinson, Mark; Hassall, Mark; Stott, James; Almond, Neil] Natl Inst Biol Stand & Controls, Div Virol, Potters Bar EN6 3QG, Herts, England; [Cranage, Martin] St Georges Univ London, Div Clin Sci, Ctr Infect & Immun, London, England	National Institute for Biological Standards & Control; St Georges University London	Page, M (corresponding author), Natl Inst Biol Stand & Controls, Div Virol, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England.	mark.page@nibsc.org			Medical Research Council [G9025730]; Europrise; EU FP6; Medical Research Council [G0601201] Funding Source: researchfish; MRC [G9025730, G0601201] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Europrise; EU FP6(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This report is work commissioned in part by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health. This work was supported in part by grants from the Medical Research Council G9025730 and also EU FP6 funding from Europrise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akari H, 1996, VIROLOGY, V218, P382, DOI 10.1006/viro.1996.0207; ARTHUR LO, 1995, J VIROL, V69, P3117, DOI 10.1128/JVI.69.5.3117-3124.1995; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bower JF, 2006, VACCINE, V24, P5442, DOI 10.1016/j.vaccine.2006.03.063; CARLSON JR, 1990, AIDS RES HUM RETROV, V6, P1239, DOI 10.1089/aid.1990.6.1239; CHAN WL, 1995, AIDS, V9, P223, DOI 10.1097/00002030-199509030-00002; CHAN WL, 1992, J EXP MED, V176, P1203, DOI 10.1084/jem.176.4.1203; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; CRANAGE MP, 1992, LANCET, V339, P273, DOI 10.1016/0140-6736(92)91335-6; CRANAGE MP, 1993, AIDS RES HUM RETROV, V9, P13, DOI 10.1089/aid.1993.9.13; Cranage MP, 1990, ELSEVIER SCI, P103; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; DORMONT D, 1995, VACCINE, V13, P295; GARDNER M, 1995, AIDS RES HUM RETROV, V11, P843, DOI 10.1089/aid.1995.11.843; HAHN B, 1983, NATURE, V303, P253, DOI 10.1038/303253a0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; HIRSCH VM, 1994, VIRUS RES, V32, P183, DOI 10.1016/0168-1702(94)90041-8; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; HULSKOTTE EGJ, 1995, J VIROL, V69, P6289, DOI 10.1128/JVI.69.10.6289-6296.1995; Jiang HX, 2011, IMMUNOL RES, V49, P147, DOI 10.1007/s12026-010-8178-6; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; LEGRAND R, 1992, VACCINE, V10, P873, DOI 10.1016/0264-410X(92)90052-L; Leith JG, 2003, AIDS RES HUM RETROV, V19, P957, DOI 10.1089/088922203322588305; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Morner A, 2011, J VIROL, V85, P6442, DOI 10.1128/JVI.00129-11; Mouquet H, 2013, NATURE, V496, P441, DOI 10.1038/nature12091; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; Page M, 2007, AIDS, V21, P375, DOI 10.1097/QAD.0b013e328012b873; PUTKONEN P, 1993, J MED PRIMATOL, V22, P100; Ranjbar S, 1997, AIDS RES HUM RETROV, V13, P797, DOI 10.1089/aid.1997.13.797; ROSE J, 1995, J VIROL METHODS, V51, P229, DOI 10.1016/0166-0934(94)00109-T; Sattentau QJ, 1999, IMMUNOL LETT, V66, P143, DOI 10.1016/S0165-2478(98)00174-6; SPEAR GT, 1993, J VIROL, V67, P53, DOI 10.1128/JVI.67.1.53-59.1993; SPEAR GT, 1993, VIROLOGY, V195, P475, DOI 10.1006/viro.1993.1398; Spruth M, 1999, AIDS RES HUM RETROV, V15, P533, DOI 10.1089/088922299311051; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; STOTT EJ, 1990, LANCET, V336, P1538, DOI 10.1016/0140-6736(90)93310-L; STOTT EJ, 1984, J HYG-CAMBRIDGE, V93, P251, DOI 10.1017/S0022172400064779; STOTT EJ, 1991, NATURE, V353, P393, DOI 10.1038/353393a0; Stott EJ, 1998, J GEN VIROL, V79, P423; Stott EJ, 1993, HUITIEME COLLOQUE DE, P131; Stott J, 1994, BIOTECHNOLOGY AIDS, P151; Sullivan BL, 1996, J IMMUNOL, V157, P1791; Sullivan BL, 1998, VIROLOGY, V248, P173, DOI 10.1006/viro.1998.9289; VALIM YML, 1991, CLIN EXP IMMUNOL, V84, P1, DOI 10.1111/j.1365-2249.1991.tb08115.x; Wang YF, 1999, NAT MED, V5, P1004, DOI 10.1038/12440; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88735	10.1371/journal.pone.0088735	http://dx.doi.org/10.1371/journal.pone.0088735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551145	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500060
J	Sharma, Y; Chilamakuri, CSR; Bakke, M; Lenhard, B				Sharma, Yogita; Chilamakuri, Chandra Sekhar Reddy; Bakke, Marit; Lenhard, Boris			Computational Characterization of Modes of Transcriptional Regulation of Nuclear Receptor Genes	PLOS ONE			English	Article							KEY DEVELOPMENTAL GENES; EMBRYONIC STEM-CELLS; COMPARATIVE GENOMICS; VERTEBRATE GENOMES; DRUG TARGETS; SUPERFAMILY; ELEMENTS; BLOCKS; EXPRESSION; ENHANCERS	Background: Nuclear receptors are a large structural class of transcription factors that act with their co-regulators and repressors to maintain a variety of biological and physiological processes such as metabolism, development and reproduction. They are activated through the binding of small ligands, which can be replaced by drug molecules, making nuclear receptors promising drug targets. Transcriptional regulation of the genes that encode them is central to gaining a deeper understanding of the diversity of their biochemical and biophysical roles and their role in disease and therapy. Even though they share evolutionary history, nuclear receptor genes have fundamentally different expression patterns, ranging from ubiquitously expressed to tissue-specific and spatiotemporally complex. However, current understanding of regulation in nuclear receptor gene family is still nascent. Methodology/Principal Findings: In this study, we investigate the relationship between long-range regulation of nuclear receptor family and their known functionality. Towards this goal, we identify the nuclear receptor genes that are potential targets based on counts of highly conserved non-coding elements. We validate our results using publicly available expression (RNA-seq) and histone modification (ChIP-seq) data from the ENCODE project. We find that nuclear receptor genes involved in developmental roles show strong evidence of long-range mechanism of transcription regulation with distinct cis-regulatory content they feature clusters of highly conserved non-coding elements distributed in regions spanning several Megabases, long and multiple CpG islands, bivalent promoter marks and statistically significant higher enrichment of enhancer mark around their gene loci. On the other hand nuclear receptor genes that are involved in tissue-specific roles lack these features, having simple transcriptional controls and a greater variety of mechanisms for producing paralogs. We further examine the combinatorial patterns of histone maps associated with dynamic functional elements in order to explore the regulatory landscape of the gene family. The results show that our proposed classification capturing long-range regulation is strongly indicative of the functional roles of the nuclear receptors compared to existing classifications. Conclusions/Significanc: We present a new classification for nuclear receptor gene family capturing whether a nuclear receptor is a possible target of long-range regulation or not. We compare our classification to existing structural (mechanism of action) and homology-based classifications. Our results show that understanding long-range regulation of nuclear receptors can provide key insight into their functional roles as well as evolutionary history; and this strongly merits further study.	[Sharma, Yogita; Bakke, Marit] Univ Bergen, Dept Biomed, Bergen, Norway; [Chilamakuri, Chandra Sekhar Reddy] Univ Bergen, Dept Clin Med, Bergen, Norway; [Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, London, England; [Lenhard, Boris] MRC Clin Sci Ctr, London, England; [Lenhard, Boris] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	University of Bergen; University of Bergen; Imperial College London; University of Bergen	Lenhard, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Inst Clin Sci, London, England.	b.lenhard@imperial.ac.uk		Lenhard, Boris/0000-0002-1114-1509	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway; EU project NeuroXsys (FP7) [223262]; Norwegian Research Council (YFF scheme); Bergen Research Foundation; Medical Research Council (UK); MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish	National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway(Research Council of Norway); EU project NeuroXsys (FP7); Norwegian Research Council (YFF scheme); Bergen Research Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	YS was supported by the National Program for Research in Functional Genomics in Norway (FUGE) in the Research Council of Norway. CSRC was supported by the EU project NeuroXsys (FP7 grant 223262). BL was supported by Norwegian Research Council (YFF scheme), Bergen Research Foundation and Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2013, MOL CELL ENDOCRINOL, V368, P120, DOI 10.1016/j.mce.2012.10.027; Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biddie SC, 2011, J NEUROENDOCRINOL, V23, P94, DOI 10.1111/j.1365-2826.2010.02079.x; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engstrom PG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r34; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Gao F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01588; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hokamp Karsten, 2003, Journal of Structural and Functional Genomics, V3, P95, DOI 10.1023/A:1022661917301; Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Linja MJ, 2004, CLIN CANCER RES, V10, P1032, DOI 10.1158/1078-0432.CCR-0990-3; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Navratilova Pavla, 2009, Briefings in Functional Genomics & Proteomics, V8, P333, DOI 10.1093/bfgp/elp019; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; Park SP, 2013, GRAEF ARCH CLIN EXP, V251, P2299, DOI 10.1007/s00417-013-2296-5; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Saez PJ, 2010, ELS; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; Takeda Y, 2009, J BIOCHEM, V146, P113, DOI 10.1093/jb/mvp049; Tobin JF, 2006, TRENDS ENDOCRIN MET, V17, P284, DOI 10.1016/j.tem.2006.07.004; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88880	10.1371/journal.pone.0088880	http://dx.doi.org/10.1371/journal.pone.0088880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551185	Green Published, gold			2022-12-25	WOS:000331266000080
J	Santos-Sacchi, J; Song, L				Santos-Sacchi, Joseph; Song, Lei			Chloride and Salicylate Influence Prestin-dependent Specific Membrane Capacitance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosensors; Chloride Transport; Hair Cell; Kinetics; Molecular Motors; Capacitance; Kinetic Model; slc26	OUTER HAIR CELL; MAMMALIAN COCHLEAR AMPLIFICATION; EXTERNAL ELECTRIC-FIELD; LATERAL MEMBRANE; GUINEA-PIG; MOTOR PROTEIN; MECHANICAL RESPONSES; VOLTAGE-SENSOR; GATING CHARGE; MOTILITY	Background: The SLC26a5 outer hair cell motor drives electromechanical behavior of this sensory/effector cell. Results: A kinetic model fits the combined effects of salicylate and chloride on prestin-associated membrane capacitance. Conclusion: Data support a theory whereby prestin differentially changes area state upon binding of chloride and salicylate. Significance: The model of prestin activity points to the molecular underpinnings of electromotility in outer hair cells. The outer hair cell is electromotile, its membrane motor identified as the protein SLC26a5 (prestin). An area motor model, based on two-state Boltzmann statistics, was developed about two decades ago and derives from the observation that outer hair cell surface area is voltage-dependent. Indeed, aside from the nonlinear capacitance imparted by the voltage sensor charge movement of prestin, linear capacitance (C-lin) also displays voltage dependence as motors move between expanded and compact states. Naturally, motor surface area changes alter membrane capacitance. Unit linear motor capacitance fluctuation (C-sa) is on the order of 140 zeptofarads. A recent three-state model of prestin provides an alternative view, suggesting that voltage-dependent linear capacitance changes are not real but only apparent because the two component Boltzmann functions shift their midpoint voltages (V-h) in opposite directions during treatment with salicylate, a known competitor of required chloride binding. We show here using manipulations of nonlinear capacitance with both salicylate and chloride that an enhanced area motor model, including augmented C-sa by salicylate, can accurately account for our novel findings. We also show that although the three-state model implicitly avoids measuring voltage-dependent motor capacitance, it registers C-sa effects as a byproduct of its assessment of C-lin, which increases during salicylate treatment as motors are locked in the expanded state. The area motor model, in contrast, captures the characteristics of the voltage dependence of C-sa, leading to a better understanding of prestin.	Yale Univ Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Santos-Sacchi, J (corresponding author), Yale Univ Sch Med, Dept Surg Otolaryngol, BML 224, 333 Cedar St, New Haven, CT 06510 USA.	joseph.santos-sacchi@yale.edu			National Institutes of Health [NIDCD DC00273]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant NIDCD DC00273 (to J. S. S.).	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Adachi M, 1999, P NATL ACAD SCI USA, V96, P7244, DOI 10.1073/pnas.96.13.7244; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASHMORE JF, 1990, NEUROSCI RES       S, V12, P39; Bezanilla F, 2013, J GEN PHYSIOL, V142, P575, DOI 10.1085/jgp.201311056; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Homma Kazuaki, 2011, Commun Integr Biol, V4, P450, DOI 10.4161/cib.4.4.15463; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; IWASA KH, 1994, J ACOUST SOC AM, V96, P2216, DOI 10.1121/1.410094; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Iwasa KH, 2001, BIOPHYS J, V81, P2495, DOI 10.1016/S0006-3495(01)75895-X; IWASA KH, 1989, HEARING RES, V40, P247, DOI 10.1016/0378-5955(89)90165-2; JERRY RA, 1995, J ACOUST SOC AM, V98, P2000, DOI 10.1121/1.413318; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; Kakehata S, 1996, J NEUROSCI, V16, P4881; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Okunade O, 2013, BIOPHYS J, V105, P1822, DOI 10.1016/j.bpj.2013.09.008; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1993, BIOPHYS J, V65, P2217, DOI 10.1016/S0006-3495(93)81247-5; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; Santos-Sacchi J, 2009, BIOPHYS J, V96, P739, DOI 10.1016/j.bpj.2008.10.015; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L., 2012, AIP C P, V1403, P179; Song L., 2011, ABSTRACTS ASS RES OT; Song L, 2013, P NATL ACAD SCI USA, V110, P3883, DOI 10.1073/pnas.1218341110; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10823	10830		10.1074/jbc.M114.549329	http://dx.doi.org/10.1074/jbc.M114.549329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24554714	Green Published, hybrid			2022-12-25	WOS:000334226400050
J	Plante, S; Ioannoni, R; Beaudoin, J; Labbe, S				Plante, Samuel; Ioannoni, Raphael; Beaudoin, Jude; Labbe, Simon			Characterization of Schizosaccharomyces pombe Copper Transporter Proteins in Meiotic and Sporulating Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Copper; Gene Regulation; Meiosis; Metalloproteins; Yeast	FORESPORE MEMBRANE FORMATION; BINDING FACTOR PHP4; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; MAMMALIAN OOCYTES; IRON-DEFICIENCY; MEIOSIS; HOMOLOG; IDENTIFICATION	Background: Despite a requirement for copper during meiosis, the role of copper transporters (Ctrs) in this process remains poorly understood. Results: Ctrs exhibit temporal and dynamic cellular localization patterns during meiotic differentiation. Conclusion: Whereas Ctr4/5 is primarily involved during early meiosis, Ctr6 is present throughout the entire program and is associated with a non-canonical cellular location. Significance: A dynamic interplay between copper transport systems occurs during meiosis. Meiosis requires copper to undertake its program in which haploid gametes are produced from diploid precursor cells. In Schizosaccharomyces pombe, copper is transported by three members of the copper transporter (Ctr) family, namely Ctr4, Ctr5, and Ctr6. Although central for sexual differentiation, very little is known about the expression profile, cellular localization, and physiological contribution of the Ctr proteins during meiosis. Analysis of gene expression of ctr4(+) and ctr5(+) revealed that they are primarily expressed in early meiosis under low copper conditions. In the case of ctr6(+), its expression is broader, being detected throughout the entire meiotic process with an increase during middle- and late-phase meiosis. Whereas the expression of ctr4(+) and ctr5(+) is exclusively dependent on the presence of Cuf1, ctr6(+) gene expression relies on two distinct regulators, Cuf1 and Mei4. Ctr4 and Ctr5 proteins co-localize at the plasma membrane shortly after meiotic induction, whereas Ctr6 is located on the membrane of vacuoles. After meiotic divisions, Ctr4 and Ctr5 disappear from the cell surface, whereas Ctr6 undergoes an intracellular re-location to co-localize with the forespore membrane. Under copper-limiting conditions, disruption of ctr4(+) and ctr6(+) results in altered SOD1 activity, whereas these mutant cells exhibit substantially decreased levels of CAO activity mostly in early- and middle-phase meiosis. Collectively, these results emphasize the notion that Ctr proteins exhibit differential expression, localization, and contribution in delivering copper to SOD1 and Cao1 proteins during meiosis.	[Plante, Samuel; Ioannoni, Raphael; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci Sante, 3201 Pavillon Z-8, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca			Canadian Institutes of Health Research [MOP-CP-243929]; Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Grant MOP-CP-243929 (to S. L.).; Recipient of a studentship from the Foundation of Stars for Children's Health Research.; Recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada.	Abe H, 2000, GENETICS, V154, P1497; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bernhardt ML, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097253; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Ioannoni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036338; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; KEENEY JB, 1994, GENETICS, V136, P849; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S., 2013, METALS IN CELLS, P163; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; LIU XF, 1992, J BIOL CHEM, V267, P18298; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; Nakamura T, 2005, CELL STRUCT FUNCT, V30, P15, DOI 10.1247/csf.30.15; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nakamura-Kubo M, 2003, MOL BIOL CELL, V14, P1109, DOI 10.1091/mbc.E02-08-0504; Nakase Y, 2001, MOL BIOL CELL, V12, P901, DOI 10.1091/mbc.12.4.901; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Ohtaka A, 2008, J CELL SCI, V121, P1547, DOI 10.1242/jcs.022830; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	50	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10168	10181		10.1074/jbc.M113.543678	http://dx.doi.org/10.1074/jbc.M113.543678			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569997	hybrid, Green Published			2022-12-25	WOS:000333807000062
J	Robillard, R; Naismith, SL; Smith, KL; Rogers, NL; White, D; Terpening, Z; Ip, TKC; Hermens, DF; Whitwell, B; Scott, EM; Hickie, IB				Robillard, Rebecca; Naismith, Sharon L.; Smith, Kristie Leigh; Rogers, Naomi L.; White, Django; Terpening, Zoe; Ip, Tony K. C.; Hermens, Daniel F.; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.			Sleep-Wake Cycle in Young and Older Persons with a Lifetime History of Mood Disorders	PLOS ONE			English	Article							HUMAN CIRCADIAN-RHYTHMS; MENTAL-HEALTH-SERVICES; AGE-RELATED-CHANGES; PHYSICAL-ACTIVITY; MAJOR DEPRESSION; DAYTIME SLEEPINESS; PHASE ADVANCE; UNITED-STATES; LIGHT THERAPY; EEG SLEEP	Considering the marked changes in sleep and circadian rhythms across the lifespan, age may contribute to the heterogeneity in sleep-wake profiles linked to mood disorders. This study aimed to investigate the contributions of age and depression severity to sleep-wake disturbances. The Hamilton Depression Rating Scale (HDRS) was administered to assess current symptoms severity in 238 persons with a history of a mood disorder between 12 and 90 years of age (y.o.). Actigraphy was recorded over five to 22 days. Regression analyses and analyses of variance [age (12-19 y.o., 20-39 y.o., 40-59 y.o., and >= 60 y.o.) by depression severity (HDRS< and >= 8)] were conducted. The 12-19 y.o. and 20-39 y.o. groups had a delayed sleep schedule and acrophase compared to all other groups. The >= 60 y.o. group had a lower rhythmicity and amplitude (p <=.006) than the 12-19 y.o. group (p <=.046). Participants with a HDRS >= 8 spent longer time in bed, had later sleep offset times and had lower circadian rhythmicity than those with a HDRS < 8 (p <=.036). Younger age and higher HDRS score correlated with later sleep onset and offset times, longer time in bed, higher WASO, lower sleep efficiency and later acrophase (p <=.023). Age was a significant predictor of delayed sleep and activity schedules (p <=.001). The profile of sleep-wake cycle disturbances associated with mood disorders changes with age, with prominent sleep phase delay during youth and reduced circadian strength in older persons. Conversely, disruptions in sleep consolidation seem more stable across age.	[Robillard, Rebecca; Naismith, Sharon L.; Smith, Kristie Leigh; White, Django; Terpening, Zoe; Ip, Tony K. C.; Hermens, Daniel F.; Whitwell, Bradley; Scott, Elizabeth M.; Hickie, Ian B.] Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Naismith, Sharon L.; Terpening, Zoe] Univ Sydney, Hlth Brain Ageing Clin, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Rogers, Naomi L.] Univ Sydney, Concord Clin Sch, Concord, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Hickie, IB (corresponding author), Univ Sydney, Clin Res Unit, Brain & Mind Res Inst, Camperdown, NSW, Australia.	ian.hickie@sydney.edu.au	Hickie, Ian B/K-8975-2015; Robillard, Rebecca/G-9045-2017	Hickie, Ian B/0000-0001-8832-9895; Hermens, Daniel/0000-0002-8570-2663; Naismith, Sharon/0000-0001-9076-2778	National Health and Medical Research Council (NHMRC) Australia Fellowship; Fonds de la recherche en sante du Quebec; NHMRC Career Development Award; National Health and Medical Research Council Australia Fellowship [464914]; Servier; Pfizer; AstraZeneca; Eli Lilly	National Health and Medical Research Council (NHMRC) Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Servier(Servier); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly)	This study was funded from a National Health and Medical Research Council (NHMRC) Australia Fellowship awarded to IBH. RR received a postdoctoral training award from the Fonds de la recherche en sante du Quebec. Associate SLN is supported by an NHMRC Career Development Award. DFH has received honoraria for educational seminars from Janssen-Cilag and Eli Lilly. EMS is the (unpaid) Clinical Director of Headspace Services at the BMRI, the (unpaid) Coordinator of the Youth Mental Health Research Program at the BMRI, and Deputy Director of St Vincent's Private Hospital Young Adult Mental Health Unit. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier and Eli Lilly pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. IBH is supported by a National Health and Medical Research Council Australia Fellowship (No. 464914). He was a director of headspace: the national youth mental health foundation until January 2012. He is the executive director of the Brain and Mind Research Institute, which operates two early-intervention youth services under contract to headspace. He is a member of the new Australian National Mental Health commission and was previously the CEO of beyondblue: the national depression initiative. He has led a range of community-based and pharmaceutical industry-supported depression awareness and education and training programs. He has led depression and other mental health research projects that have been supported by a variety of pharmaceutical partners. Current investigator-initiated studies are supported by Servier and Pfizer. He has received honoraria for his contributions to professional educational seminars supported by the pharmaceutical industry (including Servier, Pfizer, AstraZeneca, and Eli Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 1997, J PSYCHOSOM RES, V43, P359, DOI 10.1016/S0022-3999(97)00126-8; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benedetti F, 2007, CHRONOBIOL INT, V24, P921, DOI 10.1080/07420520701649455; Bertocci MA, 2005, J AM ACAD CHILD PSY, V44, P1158, DOI 10.1097/01.chi.0000179057.54419.17; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Buysse DJ, 1997, BIOL PSYCHIAT, V41, P406, DOI 10.1016/S0006-3223(96)00041-8; Campbell IG, 2009, P NATL ACAD SCI USA, V106, P5177, DOI 10.1073/pnas.0812947106; Carrier J, 2002, NEUROSCI LETT, V320, P1, DOI 10.1016/S0304-3940(02)00038-1; Carrier J, 2009, PRINCIPLES PRACTICE, P22; Cho HJ, 2008, AM J PSYCHIAT, V165, P1543, DOI 10.1176/appi.ajp.2008.07121882; Colrain IM, 2011, SLEEP, V34, P1287, DOI 10.5665/SLEEP.1260; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; DOYNE EJ, 1987, J CONSULT CLIN PSYCH, V55, P748, DOI 10.1037/0022-006X.55.5.748; DRENNAN MD, 1991, J AFFECT DISORDERS, V23, P93, DOI 10.1016/0165-0327(91)90096-B; FEINBERG M, 1982, BIOL PSYCHIAT, V17, P305; Flausino NH, 2012, PSYCHOPHYSIOLOGY, V49, P186, DOI 10.1111/j.1469-8986.2011.01300.x; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007; GILLIN JC, 1981, PSYCHIAT RES, V4, P73, DOI 10.1016/0165-1781(81)90010-X; GISLASON T, 1993, J INTERN MED, V234, P31, DOI 10.1111/j.1365-2796.1993.tb00701.x; Glozier N, 2010, SLEEP, V33, P1139, DOI 10.1093/sleep/33.9.1139; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harris AHS, 2006, J AFFECT DISORDERS, V93, P79, DOI 10.1016/j.jad.2006.02.013; Hickie I, 2001, PSYCHOL MED, V31, P1403, DOI 10.1017/S0033291701004731; Hickie IB, 2009, INTERN MED J, V39, P720, DOI 10.1111/j.1445-5994.2009.02016.x; Hickie IB, 2007, PSYCHIAT RES-NEUROIM, V155, P211, DOI 10.1016/j.pscychresns.2007.01.006; Hickie IB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-79; Hickie IB, 2011, LANCET, V378, P621, DOI 10.1016/S0140-6736(11)60095-0; Hickie IB, 1996, MED J AUSTRALIA, V164, P585, DOI 10.5694/j.1326-5377.1996.tb122199.x; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; KERKHOFS M, 1988, ACTA PSYCHIAT SCAND, V77, P463, DOI 10.1111/j.1600-0447.1988.tb05152.x; Klerman EB, 2005, J BIOL RHYTHM, V20, P375, DOI 10.1177/0748730405278353; KNOWLES JB, 1990, NEUROPSYCHOPHARMACOL, V3, P251; LAUER CJ, 1991, BIOL PSYCHIAT, V29, P979, DOI 10.1016/0006-3223(91)90355-P; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Manber R, 2003, SLEEP, V26, P130, DOI 10.1093/sleep/26.2.130; Manber R, 2009, CURR PSYCHIAT REP, V11, P437, DOI 10.1007/s11920-009-0066-1; Mansour HA, 2005, CHRONOBIOL INT, V22, P571, DOI 10.1081/CBI-200062413; Marler MR, 2006, STAT MED, V25, P3893, DOI 10.1002/sim.2466; Mendlowicz MV, 1999, AUST NZ J PSYCHIAT, V33, P553, DOI 10.1080/j.1440-1614.1999.00585.x; Naismith SL, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.47; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Naismith SL, 2011, J AFFECT DISORDERS, V132, P139, DOI 10.1016/j.jad.2011.02.027; Naismith SL, 2010, J GERIATR PSYCH NEUR, V23, P123, DOI 10.1177/0891988710363710; Nowakowski S, 2009, CURR NEUROL NEUROSCI, V9, P165, DOI 10.1007/s11910-009-0025-6; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ohayon MM, 1997, ARCH INTERN MED, V157, P2645, DOI 10.1001/archinte.157.22.2645; Pandi-Perumal SR, 2009, PRINCIPLES PRACTICE, P3; Perlis ML, 1997, J AFFECT DISORDERS, V42, P209, DOI 10.1016/S0165-0327(96)01411-5; Redlin U, 1997, CHRONOBIOL INT, V14, P221, DOI 10.3109/07420529709001157; Robert JJT, 2006, SLEEP, V29, P351, DOI 10.1093/sleep/29.3.351; Robillard R, 2013, EUROPEAN PS IN PRESS; Robillard R, 2013, J AFFECT DISORDERS, V145, P260, DOI 10.1016/j.jad.2012.06.006; Robillard R, 2010, J SLEEP RES, V19, P455, DOI 10.1111/j.1365-2869.2010.00820.x; SADEH A, 1995, J AM ACAD CHILD PSY, V34, P813, DOI 10.1097/00004583-199506000-00023; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; Schmitt FA, 1996, SLEEP, V19, P59; Scott E, 2009, AUSTRALAS PSYCHIATRY, V17, P189, DOI 10.1080/10398560802657322; Scott EM, 2012, MED J AUSTRALIA, V196, P136, DOI 10.5694/mja11.10481; SHAPIRO CM, 1981, SCIENCE, V214, P1253, DOI 10.1126/science.7302594; SPIKER DG, 1978, BIOL PSYCHIAT, V13, P485; STEPHENS T, 1988, PREV MED, V17, P35, DOI 10.1016/0091-7435(88)90070-9; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Touitou Y, 2000, CHRONOBIOL INT, V17, P369, DOI 10.1081/CBI-100101052; TUREK FW, 1989, J BIOL RHYTHM, V4, P135; VUORI I, 1988, ACTA PHYSL SCAND S, V574, P3; WEYERER S, 1992, INT J SPORTS MED, V13, P492, DOI 10.1055/s-2007-1021304; Wirz-Justice A, 2009, J AFFECT DISORDERS, V116, P159, DOI 10.1016/j.jad.2009.04.024; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; Zhang JH, 2013, SLEEP, V36, P671, DOI 10.5665/sleep.2624	73	45	45	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87763	10.1371/journal.pone.0087763	http://dx.doi.org/10.1371/journal.pone.0087763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586290	Green Published, Green Submitted, gold			2022-12-25	WOS:000332385900008
J	Hsieh, KP; Chen, LC; Cheung, KL; Chang, CS; Yang, YH				Hsieh, Kun-Pin; Chen, Li-Chia; Cheung, Kwok-Leung; Chang, Chao-Sung; Yang, Yi-Hsin			Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study	PLOS ONE			English	Article							ENDOCRINE THERAPY; ADHERENCE; TAMOXIFEN; RECURRENCE; MORTALITY; COHORT; RATES	This study aimed to evaluate the survival rate of women with breast cancer (BC) comparing persistence versus interruption and adherence versus non-adherence to adjuvant hormonal therapy (HT) in Asian population. Newly-diagnosed BC women from 2003 to 2010 were retrospectively identified from the Taiwan National Health Insurance Research Database. HT prescriptions were extracted to define treatment interruption and medication possession ratio. Their impacts on mortality were estimated by Cox regression with time dependent covariates. Interruption (HR: 1.32; 95% CI: 1.20, 1.46; P<0.0001) and non-adherence (HR: 1.45; 95% CI: 1.32, 1.59; P<0.0001) to adjuvant HT were significantly associated with increased mortality. Interruption to tamoxifen in younger patients and in patients receiving surgery (OP) with adjuvant chemotherapy (CT) was associated with increasing mortality rate when compared with their counterparts. Non-adherence to AIs in both younger and senior age groups and in OP with CT group also resulted in increasing risk. Treatment interruption and non-adherence to adjuvant HT were found to be associated with the increasing all-cause mortality of the Asian BC women; a greater impact of interruption and non-adherence on mortality was especially found in the younger BC population.	[Hsieh, Kun-Pin; Yang, Yi-Hsin] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Hsieh, Kun-Pin] Kaohsiung Med Univ Hosp, Dept Pharm, Kaohsiung, Taiwan; [Chen, Li-Chia] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham NG7 2RD, England; [Cheung, Kwok-Leung] Univ Nottingham, Sch Grad Entry Med & Hlth, Div Breast Surg, Derby, England; [Chang, Chao-Sung] Kaohsiung Med Univ, Coll Hlth Sci, Dept Hlth Adm & Med Informat, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Nottingham; University of Nottingham; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yang, YH (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.	yihsya@kmu.edu.tw	Thomas, Kendra/Y-2600-2019; Yang, Yi-Hsin/D-6471-2012	Yang, Yi-Hsin/0000-0002-9581-2778; Cheung, Kwok-Leung/0000-0003-2973-0755; Chen, Li-Chia/0000-0002-6158-6645; Hsieh, Kun-Pin/0000-0003-1565-2936	National Science Council, Taiwan [NSC 101-2320-B-037-028]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (NSC 101-2320-B-037-028), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Barron TI, 2007, CANCER-AM CANCER SOC, V109, P832, DOI 10.1002/cncr.22485; Bureau of Health Promotion, 2012, CANC REG ANN REP 200; Chlebowski RT, 2006, ONCOLOGY-BASEL, V71, P1, DOI 10.1159/000100444; Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Makubate B, 2013, BRIT J CANCER, V108, P1515, DOI 10.1038/bjc.2013.116; McCowan C, 2008, BRIT J CANCER, V99, P1763, DOI 10.1038/sj.bjc.6604758; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; NCCN Clinical Practice Guidelines in Oncology, 2012, NCCN CLIN PRACT GUID; Nekhlyudov L, 2011, BREAST CANCER RES TR, V130, P681, DOI 10.1007/s10549-011-1703-z; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Ruddy KJ, 2009, ANN ONCOL, V20, P401, DOI 10.1093/annonc/mdp039; Rutqvist LE, 1996, J NATL CANCER I, V88, P1543; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	20	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87027	10.1371/journal.pone.0087027	http://dx.doi.org/10.1371/journal.pone.0087027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586261	Green Published, Green Submitted, gold			2022-12-25	WOS:000331717900007
J	Horta, MAC; Vicentini, R; Delabona, PD; Laborda, P; Crucello, A; Freitas, S; Kuroshu, RM; Polikarpov, I; Pradella, JGD; Souza, AP				Crivelente Horta, Maria Augusta; Vicentini, Renato; Delabona, Priscila da Silva; Laborda, Prianda; Crucello, Aline; Freitas, Sindelia; Kuroshu, Reginaldo Massanobu; Polikarpov, Igor; da Cruz Pradella, Jose Geraldo; Souza, Anete Pereira			Transcriptome Profile of Trichoderma harzianum IOC-3844 Induced by Sugarcane Bagasse	PLOS ONE			English	Article							SEQUENCE-BASED CLASSIFICATION; CELLULASE PRODUCTION; CELLOBIOHYDROLASE-I; GENE-EXPRESSION; HYDROLYSIS; BIOETHANOL; ENZYMES; LACTOSE; FAMILY; SCALE	Profiling the transcriptome that underlies biomass degradation by the fungus Trichoderma harzianum allows the identification of gene sequences with potential application in enzymatic hydrolysis processing. In the present study, the transcriptome of T. harzianum IOC-3844 was analyzed using RNA-seq technology. The sequencing generated 14.7 Gbp for downstream analyses. De novo assembly resulted in 32,396 contigs, which were submitted for identification and classified according to their identities. This analysis allowed us to define a principal set of T. harzianum genes that are involved in the degradation of cellulose and hemicellulose and the accessory genes that are involved in the depolymerization of biomass. An additional analysis of expression levels identified a set of carbohydrate-active enzymes that are upregulated under different conditions. The present study provides valuable information for future studies on biomass degradation and contributes to a better understanding of the role of the genes that are involved in this process.	[Crivelente Horta, Maria Augusta; Vicentini, Renato; Laborda, Prianda; Crucello, Aline; Souza, Anete Pereira] Univ Campinas UNICAMP, CBMEG, Campinas, SP, Brazil; [Delabona, Priscila da Silva; Freitas, Sindelia; da Cruz Pradella, Jose Geraldo] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Bioethanol Sci & Technol Lab CTBE, Campinas, SP, Brazil; [Kuroshu, Reginaldo Massanobu; Polikarpov, Igor] Univ Sao Paulo, Phys Inst Sao Carlos, Sao Carlos, SP, Brazil; [Kuroshu, Reginaldo Massanobu] Fed Univ Sao Paulo UNIFESP, Inst Sci & Technol, Sao Jose Dos Campos, SP, Brazil; [Souza, Anete Pereira] Univ Campinas UNICAMP, Dept Plant Biol, Inst Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas	Souza, AP (corresponding author), Univ Campinas UNICAMP, CBMEG, Campinas, SP, Brazil.	anete@unicamp.br	Horta, Maria/Q-6194-2019; Laborda, Prianda/E-9911-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; da Silva Delabona, Priscila/Q-9515-2016; DA CRUZ PRADELLA, JOSE GERALDO/AAA-7022-2019; Polikarpov, Igor/D-2575-2012; Horta, Maria/N-5051-2016; Vicentini, Renato/C-5967-2012; Crucello, Aline/AHD-3584-2022	Horta, Maria/0000-0003-2159-5296; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; DA CRUZ PRADELLA, JOSE GERALDO/0000-0002-2902-0983; Horta, Maria/0000-0003-2159-5296; Polikarpov, Igor/0000-0001-9496-4174; Freitas, Sindelia/0000-0002-9641-8844	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (http://www.fapesp.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee G, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-22; Banerjee G, 2010, BIOENERG RES, V3, P82, DOI 10.1007/s12155-009-9067-5; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Colussi F, 2011, J MICROBIOL BIOTECHN, V21, P808, DOI 10.4014/jmb.1010.10037; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Castro AM, 2010, APPL BIOCHEM BIOTECH, V162, P1612, DOI 10.1007/s12010-010-8942-z; Delabona PD, 2012, BIORESOURCE TECHNOL, V107, P517, DOI 10.1016/j.biortech.2011.12.048; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fang X, 2008, J BIOSCI BIOENG, V106, P115, DOI 10.1263/jbb.106.115; Fuglsang CC, 2000, J BIOL CHEM, V275, P2009, DOI 10.1074/jbc.275.3.2009; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karaffa L, 2006, MICROBIOL-SGM, V152, P1507, DOI 10.1099/mic.0.28719-0; Liu HQ, 2012, BIODEGRADATION, V23, P465, DOI 10.1007/s10532-011-9525-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CM, 2010, PROCESS BIOCHEM, V45, P1494, DOI 10.1016/j.procbio.2010.05.031; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Maeda RN, 2011, PROCESS BIOCHEM, V46, P1196, DOI 10.1016/j.procbio.2011.01.022; Mandel M, 1969, ADV CHEM SER, V95, P391, DOI [10.1021/ba-1969-0095.ch023, DOI 10.1021/BA-1969-0095.CH023]; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Meyer AS, 2009, J CEREAL SCI, V50, P337, DOI 10.1016/j.jcs.2009.01.010; Pearson WR, 2013, CURRENT PROTOCOLS BI, V42; Rocha GJM, 2012, IND CROP PROD, V35, P274, DOI 10.1016/j.indcrop.2011.07.010; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Soccol CR, 2010, BIORESOURCE TECHNOL, V101, P4820, DOI 10.1016/j.biortech.2009.11.067; Sorensen A, 2011, APPL BIOCHEM BIOTECH, V164, P1058, DOI 10.1007/s12010-011-9194-2; Steindorff AS, 2012, BIOL CONTROL, V61, P134, DOI 10.1016/j.biocontrol.2012.01.014; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Urbanszki K, 2000, BIOTECHNOL LETT, V22, P65, DOI 10.1023/A:1005654514980; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002	47	22	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88689	10.1371/journal.pone.0088689	http://dx.doi.org/10.1371/journal.pone.0088689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558413	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700059
J	Zhang, J; Wang, YZ; Li, GL; Yu, HT; Xie, XY				Zhang, Jun; Wang, Yanzhong; Li, Guiling; Yu, Haitao; Xie, Xinyou			Down-Regulation of Nicotinamide N-methyltransferase Induces Apoptosis in Human Breast Cancer Cells via the Mitochondria-Mediated Pathway	PLOS ONE			English	Article							CYTOCHROME-C; SH-SY5Y NEUROBLASTOMA; PROTEIN EXPRESSION; TUMOR-MARKER; CARCINOMA; IDENTIFICATION; BCL-2; GENE; BAX; ACTIVATION	Nicotinamide N-methyltransferase (NNMT) has been found involved in cell proliferation of several malignancies. However, the functional role of NNMT in breast cancer has not been elucidated. In the present study, we showed that NNMT was selectively expressed in some breast cancer cell lines, down-regulation of NNMT expression in Bcap-37 and MDA-MB-231 cell lines by NNMT shRNA significantly inhibited cell growth in vitro, decreased tumorigenicity in mice and induced apoptosis. The silencing reciprocal effect of NNMT was confirmed by over-expressing NNMT in the MCF-7 and SK-BR-3 breast cancer cell lines which lack constitutive expression of NNMT. In addition, down-regulation of NNMT expression resulted in reducing expression of Bcl-2 and Bcl-xL, up-regulation of Bax, Puma, cleaved caspase-9, cleaved caspase-3 and cleaved PARP, increasing reactive oxygen species production and release of cytochrome c from mitochondria, and decreasing the phosphorylation of Akt and ERK1/2. These data suggest that down-regulation of NNMT induces apoptosis via the mitochondria-mediated pathway in breast cancer cells.	[Zhang, Jun; Wang, Yanzhong; Li, Guiling; Yu, Haitao; Xie, Xinyou] Zhejiang Univ, Sch Med, Sir RunRun Shaw Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Xie, Xinyou] Key Lab Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xie, XY (corresponding author), Zhejiang Univ, Sch Med, Sir RunRun Shaw Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	scottxie@mail.hz.zj.cn			National natural Science Foundation of China [81271914]; Zhejiang Provincial Natural Science Foundation [LY12H16025]; Science Foundation of Health Bureau of Zhejiang Province [2008B114, 2011KYA081]; Science Foundation of Education Bureau of Zhejiang Province [Y201121182]; Funds for Key Program of the Science Technology Department Zhejiang Province [2012C13019-2]	National natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Science Foundation of Health Bureau of Zhejiang Province; Science Foundation of Education Bureau of Zhejiang Province; Funds for Key Program of the Science Technology Department Zhejiang Province	This study was supported partly by the grants from National natural Science Foundation of China (81271914), Zhejiang Provincial Natural Science Foundation (LY12H16025), Science Foundation of Health Bureau of Zhejiang Province (Nos. 2008B114 and 2011KYA081), Science Foundation of Education Bureau of Zhejiang Province (Y201121182) and Funds for Key Program of the Science Technology Department Zhejiang Province (2012C13019-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; AKSOY S, 1994, J BIOL CHEM, V269, P14835; AKSOY S, 1995, GENOMICS, V29, P555, DOI 10.1006/geno.1995.9966; Bhattarai G, 2012, BIOL PHARM BULL, V35, P1711, DOI 10.1248/bpb.b12-00297; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Gehrmann ML, 2004, J PROTEOME RES, V3, P403, DOI 10.1021/pr0340577; He J., 2012, CHINESE CANC REGISTR; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kassem HS, 2002, INT J CANCER, V101, P454, DOI 10.1002/ijc.10631; Kim BM, 2009, TOXICOL APPL PHARM, V239, P87, DOI 10.1016/j.taap.2009.05.020; Kim DS, 2010, J PROTEOME RES, V9, P3710, DOI 10.1021/pr100236r; Kim J, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-20; Krech T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-287; Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w; Lim BH, 2006, EXP MOL MED, V38, P455, DOI 10.1038/emm.2006.54; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parsons RB, 2011, BIOCHEM J, V436, P145, DOI 10.1042/BJ20101685; Pei JS, 2012, IN VIVO, V26, P963; Pozzi V, 2011, INT J IMMUNOPATH PH, V24, P69, DOI 10.1177/039463201102400109; Pozzi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071272; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; RINI J, 1990, CLIN CHIM ACTA, V186, P359, DOI 10.1016/0009-8981(90)90322-J; Roessler M, 2005, CLIN CANCER RES, V11, P6550, DOI 10.1158/1078-0432.CCR-05-0983; Rogers CD, 2006, CANCER BIOL THER, V5, P1383, DOI 10.4161/cbt.5.10.3323; Sartini D, 2007, MOL MED, V13, P415, DOI 10.2119/2007-00035.Sartini; Sartini D, 2006, J UROLOGY, V176, P2248, DOI 10.1016/j.juro.2006.07.046; Shi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064266; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043646; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smith ML, 1998, BBA-GENE STRUCT EXPR, V1442, P238, DOI 10.1016/S0167-4781(98)00177-8; Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225; Thomas MG, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.200; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Tomida M, 2009, J CANCER RES CLIN, V135, P1223, DOI 10.1007/s00432-009-0563-y; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Vyssokikh MY, 2002, MOL BIOL REP, V29, P93, DOI 10.1023/A:1020383108620; Williams AC, 2005, MED HYPOTHESES, V65, P353, DOI 10.1016/j.mehy.2005.01.042; Win KT, 2013, NICOTINAMIDE N METHY, P1010; Xu JM, 2003, J CLIN ENDOCR METAB, V88, P4990, DOI 10.1210/jc.2002-021843; Yamada K, 2010, J NUTR SCI VITAMINOL, V56, P83, DOI 10.3177/jnsv.56.83; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhang J, 2010, J ZHEJIANG UNIV-SC B, V11, P136, DOI 10.1631/jzus.B0900249; Zhang YF, 2010, ANTI-CANCER DRUG, V21, P494, DOI 10.1097/CAD.0b013e328336e927; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	54	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89202	10.1371/journal.pone.0089202	http://dx.doi.org/10.1371/journal.pone.0089202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558488	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700134
J	Bedo, N; Ribary, U; Ward, LM				Bedo, Nicolas; Ribary, Urs; Ward, Lawrence M.			Fast Dynamics of Cortical Functional and Effective Connectivity during Word Reading	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; FORM AREA; PLANUM-TEMPORALE; ANGULAR GYRUS; EEG DYNAMICS; SYNCHRONIZATION; RECOGNITION; LANGUAGE; NETWORK; MODEL	We describe for the first time the fast dynamics of functional and effective (causal) connectivity during word reading. Independent component analysis of high-density EEG recorded during a word reading task recovered multiple sources of electrical brain activity previously identified by fMRI and PET. Results confirmed the ventral occipito-temporal cortex (vOT) as a central hub for word reading, showing a progression of theta-band (3-7 Hz) and gamma-band (30-50 Hz) phase synchronization and directed theta-band and gamma-band information flow with both early visual areas and high-level language-processing areas. These results highlight the interplay between local and long-distance neural dynamics involved at each stage of the reading process. Moreover, these measures of functional and causal connectivity dynamics may be used as a benchmark for comparison with clinical populations (e.g. individuals with developmental dyslexia), such that disturbances in connectivity dynamics may provide insight as to underlying neurological problems with language processing, and their potential remediation.	[Bedo, Nicolas; Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ribary, Urs] Simon Fraser Univ, Behav & Cognit Neurosci Inst, Burnaby, BC V5A 1S6, Canada; [Ribary, Urs] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Simon Fraser University; Simon Fraser University; University of British Columbia	Ward, LM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	lward@psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015; Ribary, Urs/0000-0002-1182-8052	Natural Sciences and Engineering Research Council (NSERC) of Canada [A9958]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Discovery Grant (A9958) from the Natural Sciences and Engineering Research Council (NSERC) of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Buchsbaum BR, 2005, NEURON, V48, P687, DOI 10.1016/j.neuron.2005.09.029; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cohen L, 2004, NEUROPSYCHOLOGIA, V42, P1768, DOI 10.1016/j.neuropsychologia.2004.04.018; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; DEMB JB, 1995, J NEUROSCI, V15, P5870; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Gomez-Herrero G, 2010, ASSESSING COUPLING D; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Herdman AT, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00199; Herdman AT, 2011, J CLIN NEUROPHYSIOL, V28, P441, DOI 10.1097/WNP.0b013e318230da5f; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; LARSEN JP, 1990, BRAIN LANG, V39, P289, DOI 10.1016/0093-934X(90)90015-9; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Mainy N, 2008, HUM BRAIN MAPP, V29, P1215, DOI 10.1002/hbm.20457; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Molinaro N, 2013, NEUROIMAGE, V72, P120, DOI 10.1016/j.neuroimage.2013.01.031; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; Ramus F, 2004, TRENDS NEUROSCI, V27, P720, DOI 10.1016/j.tins.2004.10.004; Ribary U, 2005, PROG BRAIN RES, V150, P127, DOI 10.1016/S0079-6123(05)50010-4; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Stone J.V., 2004, INDEPENDENT COMPONEN; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vidal JR, 2012, J NEUROSCI, V32, P6421, DOI 10.1523/JNEUROSCI.4363-11.2012; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Wandell BA, 2012, ANNU REV PSYCHOL, V63, P31, DOI 10.1146/annurev-psych-120710-100434; Weiss S, 2000, COGNITIVE BRAIN RES, V9, P299, DOI 10.1016/S0926-6410(00)00011-2; Wheat KL, 2010, J NEUROSCI, V30, P5229, DOI 10.1523/JNEUROSCI.4448-09.2010; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Yvert G, 2012, J NEUROSCI, V32, P4297, DOI 10.1523/JNEUROSCI.6434-11.2012	60	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88940	10.1371/journal.pone.0088940	http://dx.doi.org/10.1371/journal.pone.0088940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551193	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500083
J	Krop, EJM; Jacobs, JH; Sander, I; Raulf-Heimsoth, M; Heederik, DJJ				Krop, Esmeralda J. M.; Jacobs, Jose H.; Sander, Ingrid; Raulf-Heimsoth, Monika; Heederik, Dick J. J.			Allergens and beta-Glucans in Dutch Homes and Schools: Characterizing Airborne Levels	PLOS ONE			English	Article							FLUORESCENT MULTIPLEX ARRAY; IN-HOUSE DUST; CAT ALLERGEN; EXPOSURE ASSESSMENT; ENDOTOXIN EXPOSURE; EXTRACELLULAR POLYSACCHARIDES; RESPIRATORY HEALTH; DOG ALLERGEN; CHILDREN; ASTHMA	Background: Indoor air quality has an effect on respiratory health. Children are more vulnerable to a decreased indoor air quality as their lungs are still developing. We measured levels of allergens and beta-(1,3)-glucans in 19 school buildings and determined whether measured levels could be reproduced. School levels were compared to those in 169 homes and the effect of building characteristics on both home and school exposure was explored. Methods: Electrostatic Dust fall Collectors were placed in school buildings for 8 weeks and in homes for 2 weeks to collect settled airborne dust. Cat, dog, and mouse allergen levels, domestic mite antigen levels and beta-(1,3)-glucans were measured in the extracts from the collectors. Results were corrected for sampling duration. Using questionnaire data, relations between measured levels and building and classroom characteristics were explored. Results: In schools, exposure levels were highest in classrooms and were influenced by the socioeconomic status of the children, the season measurements were performed, moisture status of the building and pet ownership. Repeated measurements in different seasons and over the years showed significantly different levels. Home exposure was influenced by socioeconomic status, occupancy and pet ownership. Domestic mite antigen was found in higher levels in extracts from homes compared to schools while pet allergen levels were 13 times higher in schools compared to homes without pets. For mouse allergen overall levels of exposure were low but still two times higher in schools compared to homes. Levels of beta-(1,3)-glucans were also approximately two times higher in schools than in homes. Conclusion: Exposure levels of several allergens and beta-(1,3)-glucans in schools differ over time and are higher than in homes. For children, exposure levels measured at school could contribute to their total exposure as especially animal allergen levels can be much higher in schools compared to homes.	[Krop, Esmeralda J. M.; Jacobs, Jose H.; Heederik, Dick J. J.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Sander, Ingrid; Raulf-Heimsoth, Monika] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany	Utrecht University; Ruhr University Bochum	Krop, EJM (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	e.j.m.krop@uu.nl	Sander, Ingrid/R-8940-2017	Sander, Ingrid/0000-0002-5014-4112; Heederik, Dick/0000-0002-4550-1437; Krop, Esmeralda/0000-0002-6009-1181	European Commission [211488]; Lung Foundation Netherlands [3.2.08.018]; Stichting Astma Bestrijding [SAB2011/013]	European Commission(European CommissionEuropean Commission Joint Research Centre); Lung Foundation Netherlands; Stichting Astma Bestrijding	The cohort described in the study and exposure assessment in schools were financially supported by the European Commission, Grant agreement no: 211488 under the Seventh Framework Programme, Topic ENV.2007.1.2.1.1 (http://cordis.europa.eu/fp7/home_en.html). The exposure assessment in the homes and HDM and pet allergen measurements in schools were financially supported by the Lung Foundation Netherlands, project no: 3.2.08.018 (http://research.longfonds.nl/). The measurements of Mus m 1 were supported by a grant from Stichting Astma Bestrijding, project no: SAB2011/013 (http://www.astmabestrijding.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 1999, J ALLERGY CLIN IMMUN, V103, P1012, DOI 10.1016/S0091-6749(99)70172-7; Almqvist C, 2001, AM J RESP CRIT CARE, V163, P694, DOI 10.1164/ajrccm.163.3.2006114; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; Berge M, 1998, PEDIATR ALLERGY IMMU, V9, P25, DOI 10.1111/j.1399-3038.1998.tb00296.x; Borras-Santos A, 2013, OCCUP ENVIRON MED, V70, P681, DOI 10.1136/oemed-2012-101286; Casas L, 2013, INDOOR AIR, V23, P208, DOI 10.1111/ina.12017; Dotterud LK, 1997, CLIN EXP ALLERGY, V27, P252, DOI 10.1111/j.1365-2222.1997.tb00703.x; Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348, DOI 10.1164/ajrccm.162.4.9909118; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Foarde K, 2004, J EXPO ANAL ENV EPID, V14, pS41, DOI 10.1038/sj.jea.7500357; Giovannangelo MECA, 2007, ENVIRON INT, V33, P9, DOI 10.1016/j.envint.2006.06.018; Haverinen-Shaughnessy U, 2012, INDOOR AIR, V22, P457, DOI 10.1111/j.1600-0668.2012.00780.x; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Jacobs JH, 2014, INDOOR AIR, V24, P148, DOI 10.1111/ina.12064; Jacobs JH, 2013, EUR RESPIR J, V42, P314, DOI 10.1183/09031936.00084612; Karlsson AS, 2005, ALLERGY, V60, P961, DOI 10.1111/j.1398-9995.2005.00796.x; Karlsson AS, 2002, CLIN EXP ALLERGY, V32, P1776, DOI 10.1046/j.1365-2222.2002.01553.x; Karlsson AS, 2002, ALLERGY, V57, P164, DOI 10.1034/j.1398-9995.2002.1s3297.x; King EM, 2013, J IMMUNOL METHODS, V387, P89, DOI 10.1016/j.jim.2012.09.015; Kitch BT, 2000, ENVIRON HEALTH PERSP, V108, P301, DOI 10.2307/3454347; Krop EJM, 2007, OCCUP ENVIRON MED, V64, P267, DOI 10.1136/oem.2006.028845; Leaderer BP, 2002, ENVIRON HEALTH PERSP, V110, P419, DOI 10.1289/ehp.02110419; MUNIR AKM, 1993, J ALLERGY CLIN IMMUN, V91, P1067, DOI 10.1016/0091-6749(93)90221-Z; Muti D, 2012, EUR ANN ALLERGY CLIN, V44, P93; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Noss I, 2010, ANN OCCUP HYG, V54, P651, DOI 10.1093/annhyg/meq026; Noss I, 2010, APPL ENVIRON MICROB, V76, P1158, DOI 10.1128/AEM.01486-09; Permaul P, 2012, PEDIAT ALLERG IMM-UK, V23, P543, DOI 10.1111/j.1399-3038.2012.01327.x; Perzanowski MS, 1999, J ALLERGY CLIN IMMUN, V103, P1018, DOI 10.1016/S0091-6749(99)70173-9; Samadi S, 2010, OCCUP ENVIRON MED, V67, P486, DOI 10.1136/oem.2009.051342; Sander I, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052981, DOI 10.1371/J0URNAL.P0NE.0052981]; Sheehan WJ, 2012, ANN ALLERG ASTHMA IM, V108, P418, DOI 10.1016/j.anai.2012.04.003; Sheehan WJ, 2009, ANN ALLERG ASTHMA IM, V102, P125, DOI 10.1016/S1081-1206(10)60242-6; Simpson A, 2002, CLIN EXP ALLERGY, V32, P1413, DOI 10.1046/j.1365-2745.2002.01496.x; Tischer C, 2011, EUR RESPIR J, V37, P1050, DOI 10.1183/09031936.00091210; Zhang L, 1997, CLIN EXP ALLERGY, V27, P876, DOI 10.1111/j.1365-2222.1997.tb01227.x; Zhao ZH, 2006, INDOOR AIR, V16, P404, DOI 10.1111/j.1600-0668.2006.00433.x	38	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88871	10.1371/journal.pone.0088871	http://dx.doi.org/10.1371/journal.pone.0088871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551183	Green Submitted, Green Published, gold			2022-12-25	WOS:000331271500078
J	Lu, P; Qiao, JJ; He, W; Wang, J; Jia, YX; Sun, Y; Tang, SW; Fu, L; Qin, YR				Lu, Pei; Qiao, Junjing; He, Wei; Wang, Jin; Jia, Yongxu; Sun, Yan; Tang, Senwei; Fu, Li; Qin, Yanru			Genome-Wide Gene Expression Profile Analyses Identify CTTN as a Potential Prognostic Marker in Esophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; TISSUE MICROARRAYS; CORTACTIN; GROWTH; OVEREXPRESSION; CARCINOGENESIS; IDENTIFICATION; OSTEOSARCOMA; PREDICTION	Aim: Esophageal squamous cell carcinoma (ESCC) is one of the most common fatal malignances of the digestive tract. Its prognosis is poor mainly due to the lack of reliable markers for early detection and prognostic prediction. Here we aim to identify the molecules involved in ESCC carcinogenesis and those as potential markers for prognosis and as new molecular therapeutic targets. Methods: We performed genome-wide gene expression profile analyses of 10 primary ESCCs and their adjacent normal tissues by cDNA microarrays representing 47,000 transcripts and variants. Candidate genes were then validated by semi quantitative reverse transcription-PCR (RT-PCR), tissue microarrays (TMAs) and immunohistochemistry (IHC) staining. Results: Using an arbitrary cutoff line of signal log ratio of >= 1.5 or <=-1.5, we observed 549 up-regulated genes and 766 down-regulated genes in ESCCs compared with normal esophageal tissues. The functions of 302 differentially expressed genes were associated with cell metabolism, cell adhesion and immune response. Several candidate deregulated genes including four overexpressed (CTTN, DMRT2, MCM10 and SCYA26) and two underexpressed (HMGCS2 and SORBS2) were subsequently verified, which can be served as biomarkers for ESCC. Moreover, overexpression of cortactin (CTTN) was observed in 126/198 (63.6%) of ESCC cases and was significantly associated with lymph node metastasis (P = 0.000), pathologic stage (P = 0.000) and poor survival (P<0.001) of ESCC patients. Furthermore, a significant correlation between CTTN overexpression and shorter disease-specific survival rate was found in different subgroups of ESCC patient stratified by the pathologic stage (P<0.05). Conclusion: Our data provide valuable information for establishing molecules as candidates for prognostic and/or as therapeutic targets.	[Lu, Pei; Qiao, Junjing; He, Wei; Wang, Jin; Jia, Yongxu; Sun, Yan; Qin, Yanru] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China; [Tang, Senwei; Fu, Li] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Zhengzhou University; Chinese University of Hong Kong	Qin, YR (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Oncol, Zhengzhou, Peoples R China.	yanruqin@zzu.edu.cn	Tang, Senwei/F-2278-2015; Fu, Li/F-7182-2010	Tang, Senwei/0000-0001-6112-4232; Fu, Li/0000-0003-2643-6278	National Natural Science Foundation of China [81150010, 81272227, 81372583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81150010, 81272227 and 81372583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ashburner M, 2001, GENOME RES, V11, P1425; Bird-Lieberman EL, 2009, BRIT J CANCER, V101, P1, DOI 10.1038/sj.bjc.6605126; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Callagy G, 2005, J PATHOL, V205, P388, DOI 10.1002/path.1694; Callagy G, 2003, DIAGN MOL PATHOL, V12, P27, DOI 10.1097/00019606-200303000-00004; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Folio C, 2011, CANCER BIOMARK, V10, P35, DOI 10.3233/CBM-2012-0227; Fu L, 2007, CANCER RES, V67, P10720, DOI 10.1158/0008-5472.CAN-07-2411; Hu JG, 2011, TOHOKU J EXP MED, V223, P161, DOI 10.1620/tjem.223.161; Hu YC, 2001, CLIN CANCER RES, V7, P2213; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kakiuchi S, 2004, HUM MOL GENET, V13, P3029, DOI 10.1093/hmg/ddh331; Kan T, 2001, BIOCHEM BIOPH RES CO, V286, P792, DOI 10.1006/bbrc.2001.5400; Kato T, 2005, CANCER RES, V65, P5638, DOI 10.1158/0008-5472.CAN-05-0600; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Kitahara O, 2001, CANCER RES, V61, P3544; Lambert R, 2007, BEST PRACT RES CL GA, V21, P921, DOI 10.1016/j.bpg.2007.10.001; Li LW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-52; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Mimura K, 2011, INT J CANCER, V129, P2408, DOI 10.1002/ijc.25896; Ochi K, 2004, INT J ONCOL, V24, P647; Portale G, 2006, J AM COLL SURGEONS, V202, P588, DOI 10.1016/j.jamcollsurg.2005.12.022; Sarwar CMS, 2010, INT J SURG, V8, P417, DOI 10.1016/j.ijsu.2010.06.011; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Takikita M, 2011, ANTICANCER RES, V31, P945; van Rossum AGSH, 2006, EXP CELL RES, V312, P1658, DOI 10.1016/j.yexcr.2006.01.033; Zhao G, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-74; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	30	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88918	10.1371/journal.pone.0088918	http://dx.doi.org/10.1371/journal.pone.0088918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551190	Green Submitted, Green Published, gold			2022-12-25	WOS:000331271500081
J	Haddad, LE; Sirois, MG				Haddad, Lydia E.; Sirois, Martin G.			Angiopoietin-1 Upregulates De Novo Expression of II-1 beta and II1-Ra, and the Exclusive Release of II1-Ra from Human Neutrophils	PLOS ONE			English	Article							ENDOTHELIAL-CELL SURVIVAL; ACTIVATED PROTEIN-KINASE; P-SELECTIN TRANSLOCATION; RECEPTOR ANTAGONIST; TNF-ALPHA; IL-1-BETA; CYTOKINE; INTERLEUKIN-1-BETA; MONOCYTES; IL-8	The expression of the angiopoietin (Ang) receptor, Tie2, on both endothelial and inflammatory cells supports the idea that Ang signaling may play a fundamental role in initiating and maintaining the inflammatory response. We have previously shown that Ang1 and/or Ang2 alter the innate immune response by enhancing human neutrophil survival, chemotaxis and production of inflammatory cytokine interleukin-8 (IL-8) in vitro. Thus, we hypothesized that Ang1 and Ang2 could modulate other inflammatory signals in neutrophils, a possibility we explored through a gene-based assay looking at changes in the mRNA expression of 84 inflammatory cytokines and their receptors. We observed that Ang1 (10(-8) M), but not Ang2, increased mRNA expression of prominent pro-inflammatory cytokine IL-1 beta and its natural antagonist IL-1RA, by up to 32.6- and 10.0-fold respectively, compared to PBS-control. The effects of Ang1 extended to the proteins, as Ang1 increased intracellular levels of precursor and mature IL-1 beta, and extracellular levels of IL-1RA proteins, by up to 4.2-, 5.0- and 4.4-fold respectively, compared to PBS-control. Interestingly, Ang1 failed at inducing IL-1 beta protein release or at increasing intracellular IL-1RA, but the ratio of IL-1RA to mature IL-1 beta remained above 100-fold molar excess inside and outside the cells. The above-noted effects of Ang1 were mediated by MAP kinases, whereby inhibiting MEK1/2 lead to up to 70% effect reduction, whereas the blockade of p38MAPK activity doubled Ang1's effect. These findings suggest that Ang1 selectively alters the balance of neutrophil-derived inflammatory cytokines, favoring the blockade of IL-1 activity, a consideration for future therapies of inflammatory diseases.	[Haddad, Lydia E.; Sirois, Martin G.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Haddad, Lydia E.; Sirois, Martin G.] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Sirois, MG (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	Martin.Sirois@Icm-Mhi.Org			Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec;  [MOP-97943]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; 	Contract grant sponsor: Canadian Institutes of Health Research (CIHR); Contract grant number: MOP-97943; http://www.cihr-irsc.gc.ca/. Contract grant sponsor: Heart and Stroke Foundation of Quebec; http://www.heartandstroke.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Alvarez ME, 2006, J IMMUNOL, V177, P4037, DOI 10.4049/jimmunol.177.6.4037; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; AREND WP, 1991, J IMMUNOL, V147, P1530; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Brkovic A, 2007, J LEUKOCYTE BIOL, V81, P1093, DOI 10.1189/jlb.0906580; Brough D, 2002, MOL CELL NEUROSCI, V19, P272, DOI 10.1006/mcne.2001.1054; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; CHIN J, 1993, J IMMUNOL, V151, P5574; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dumas E, 2012, BBA-MOL CELL RES, V1823, P358, DOI 10.1016/j.bbamcr.2011.12.002; ELY EW, 1995, BBA-LIPID LIPID MET, V1258, P135; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feistritzer C, 2004, J ALLERGY CLIN IMMUN, V114, P1077, DOI 10.1016/j.jaci.2004.06.045; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Jablonska E, 2001, ARCH IMMUNOL THER EX, V49, P63; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kim I, 2001, FASEB J, V15, P126, DOI 10.1096/fj.01-0556fje; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kuhns D, 1998, J IMMUNOL, V161, P4332; Langereis JD, 2011, EUR RESPIR J, V37, P406, DOI 10.1183/09031936.00170409; Lapinet JA, 2000, INFECT IMMUN, V68, P6917, DOI 10.1128/IAI.68.12.6917-6923.2000; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Lu PR, 2003, AM J PATHOL, V162, P1249, DOI 10.1016/S0002-9440(10)63921-1; Maliba R, 2008, J LEUKOCYTE BIOL, V83, P352, DOI 10.1189/jlb.0107056; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Neagoe PE, 2012, J CELL PHYSIOL, V227, P3099, DOI 10.1002/jcp.23061; Neagoe PE, 2009, GROWTH FACTORS, V27, P335, DOI 10.3109/08977190903155043; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Rollin S, 2004, BLOOD, V103, P3789, DOI 10.1182/blood-2003-07-2272; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sturn DH, 2005, MICROCIRCULATION, V12, P393, DOI 10.1080/10739680590960296; Sun J, 2009, FASEB J, V23, P997, DOI 10.1096/fj.08-121756; Theoret JF, 2001, J PHARMACOL EXP THER, V298, P658; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Xing LY, 2003, SHOCK, V20, P10, DOI 10.1097/01.shk.0000065704.84144.a4; Young RE, 2004, J IMMUNOL, V172, P4493, DOI 10.4049/jimmunol.172.7.4493	59	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88980	10.1371/journal.pone.0088980	http://dx.doi.org/10.1371/journal.pone.0088980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563688	Green Submitted, gold, Green Published			2022-12-25	WOS:000331262600123
J	Lanz, MA; Farhat, M; Klostermeier, D				Lanz, Martin A.; Farhat, Mohamad; Klostermeier, Dagmar			The Acidic C-terminal Tail of the GyrA Subunit Moderates the DNA Supercoiling Activity of Bacillus subtilis Gyrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Gyrase; DNA Topology; Enzyme Mechanisms; Protein Conformation; Single Molecule Biophysics; ATP-dependent Conformational Changes; C-terminal Domain; Negative Supercoiling; Regulation	STRAND-PASSAGE; 2-GATE MECHANISM; TOPOISOMERASE-II; CONFORMATIONAL-CHANGES; CLOSED CONFORMATION; CRYSTAL-STRUCTURE; NUCLEOTIDE CYCLE; B-PROTEIN; SET-POINT; BINDING	Background: DNA gyrase catalyzes ATP-dependent negative DNA supercoiling. Results: Deletion of the acidic C-terminal tail causes stronger DNA bending by the B. subtilis gyrase C-terminal domains and accelerated DNA-stimulated ATPase and supercoiling activities of gyrase. Conclusion: The C-tail down-regulates negative supercoiling by B. subtilis gyrase. Significance: The C-tail is a versatile element that differentially regulates the activity of different gyrases. Gyrase is a type II DNA topoisomerase that introduces negative supercoils into DNA in an ATP-dependent reaction. It consists of a topoisomerase core, formed by the N-terminal domains of the two GyrA subunits and by the two GyrB subunits, that catalyzes double-stranded DNA cleavage and passage of a second double-stranded DNA through the gap in the first. The C-terminal domains (CTDs) of the GyrA subunits form a -pinwheel and bind DNA around their positively charged perimeter. As a result, DNA is bound as a positive supercoil that is converted into a negative supercoil by strand passage. The CTDs contain a conserved 7-amino acid motif that connects blades 1 and 6 of the -pinwheel and is a hallmark feature of gyrases. Deletion of this so-called GyrA-box abrogates DNA bending by the CTDs and DNA-induced narrowing of the N-gate, affects T-segment presentation, reduces the coupling of DNA binding to ATP hydrolysis, and leads to supercoiling deficiency. Recently, a severe loss of supercoiling activity of Escherichia coli gyrase upon deletion of the non-conserved acidic C-terminal tail (C-tail) of the CTDs has been reported. We show here that, in contrast to E. coli gyrase, the C-tail is a very moderate negative regulator of Bacillus subtilis gyrase activity. The C-tail reduces the degree of DNA bending by the CTDs but has no effect on DNA-induced conformational changes of gyrase that precede strand passage and reduces DNA-stimulated ATPase and DNA supercoiling activities only 2-fold. Our results are in agreement with species-specific, differential regulatory effects of the C-tail in gyrases from different organisms.	[Lanz, Martin A.; Farhat, Mohamad; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany	University of Munster	Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.	dagmar.klostermeier@uni-muenster.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; Andreou AZ, 2012, METHOD ENZYMOL, V511, P75, DOI 10.1016/B978-0-12-396546-2.00004-8; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gubaev A, 2014, DNA REPAIR, V16, P23, DOI 10.1016/j.dnarep.2014.01.011; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; KIRKEGAARD K, 1981, CELL, V23, P721, DOI 10.1016/0092-8674(81)90435-9; KLEVAN L, 1980, BIOCHEMISTRY-US, V19, P5229, DOI 10.1021/bi00564a012; Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; Lanz MA, 2012, NUCLEIC ACIDS RES, V40, P10893, DOI 10.1093/nar/gks852; Lanz MA, 2011, NUCLEIC ACIDS RES, V39, P9681, DOI 10.1093/nar/gkr680; LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Papillon J, 2013, NUCLEIC ACIDS RES, V41, P7815, DOI 10.1093/nar/gkt560; REECE RJ, 1989, J BIOL CHEM, V264, P19648; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Roca J, 2004, J BIOL CHEM, V279, P25783, DOI 10.1074/jbc.M402555200; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; SUGINO A, 1980, NUCLEIC ACIDS RES, V8, P3865, DOI 10.1093/nar/8.17.3865; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868; Tretter EM, 2012, J BIOL CHEM, V287, P18636, DOI 10.1074/jbc.M112.345678; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488	39	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12275	12285		10.1074/jbc.M114.547745	http://dx.doi.org/10.1074/jbc.M114.547745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24563461	Green Published, hybrid			2022-12-25	WOS:000335581400008
J	Ablonczy, Z; Dahrouj, M; Marneros, AG				Ablonczy, Zsolt; Dahrouj, Mohammad; Marneros, Alexander G.			Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels	FASEB JOURNAL			English	Article						age-related macular degeneration; visual cycle; retinoids; choroidal neovascularization	AGE-RELATED MACULOPATHY; SUBRETINAL DRUSENOID DEPOSITS; MACULAR DEGENERATION; RANIBIZUMAB; PREVALENCE; EXPRESSION; EYES; RPE	Patients with nonexudative (dry) age-related macular degeneration (AMD) frequently also develop neovascular (wet) AMD, suggesting a common pathomechanism. Increased vascular endothelial growth factor A (VEGF-A) has been implicated in the pathogenesis of choroidal neovascularization (CNV) in neovascular AMD, while its role in nonexudative AMD that manifests with progressive retinal pigment epithelium (RPE) and photoreceptor degeneration is not well defined. Mice with overall increased VEGF-A levels develop progressive morphological features of both forms of AMD, suggesting that an increase in VEGF-A has a direct age-dependent adverse effect on RPE and photoreceptor function independently of its CNV-promoting proangiogenic effect. Here we provide evidence for this hypothesis and show that morphological RPE abnormalities and retinal thinning in mice with increased VEGF-A levels correlate with progressive age-dependent attenuation of visual function with abnormal electroretinograms and reduced retinal rhodopsin levels. Retinoid profiling revealed a progressive reduction of 11-cis and all-trans retinal in the retinas of these mice, consistent with an impaired retinoid transport between the RPE and photoreceptors. These findings suggest that increased VEGF-A leads to an age-dependent RPE and retinal dysfunction that occurs also at sites where no CNV lesions form. The data support a central role of increased VEGF-A not only in the pathogenesis of neovascular but also of nonexudative AMD.Ablonczy, Z., Dahrouj, M., Marneros, A. G. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.	[Ablonczy, Zsolt; Dahrouj, Mohammad] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Marneros, Alexander G.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Marneros, Alexander G.] Harvard Univ, Sch Med, Dept Dermatol, Charlestown, MA USA	Medical University of South Carolina; Harvard University; Massachusetts General Hospital; Harvard University	Marneros, AG (corresponding author), CNY 149,Room 3-216,CBRC,MGH East,13thSt, Charlestown, MA 02129 USA.	amarneros@mgh.harvard.edu		Marneros, Alexander/0000-0003-3866-020X	U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) [NEI R01-EY019297]; NIH/NEI [NEI R01-EY019065]; Medical Scientist Training Program at the Medical University of South Carolina (MUSC); NIH/National Institute of General Medical Sciences [T32 GM008716]; Research to Prevent Blindness; South Carolina Lions Association; NATIONAL EYE INSTITUTE [R01EY019065, R01EY019297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Scientist Training Program at the Medical University of South Carolina (MUSC); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); South Carolina Lions Association; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Andras Nagy, Lucile Miquerol, and Annette Damert (University of Toronto, Toronto, ON, Canada) for providing VEGF-A<SUP>hyper</SUP> mice and VEGF-A<SUP>hypo</SUP> mice, Patrice Goletz for technical help, and Drs. Rosalie Crouch and Jie Fan for helpful discussions. This work was supported by a U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) grant to A.G.M. (NEI R01-EY019297), an NIH/NEI grant to Z.A. (NEI R01-EY019065), funding from the Medical Scientist Training Program at the Medical University of South Carolina (MUSC; NIH/National Institute of General Medical Sciences grant T32 GM008716) to M. D., an unrestricted grant of Research to Prevent Blindness to the Department of Ophthalmology at MUSC, and the South Carolina Lions Association.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; Curcio CA, 2005, EXP EYE RES, V80, P761, DOI 10.1016/j.exer.2004.09.017; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Damert A, 2002, DEVELOPMENT, V129, P1881; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x; Kliffen M, 1997, MICROSC RES TECHNIQ, V36, P106, DOI 10.1002/(SICI)1097-0029(19970115)36:2<106::AID-JEMT4>3.3.CO;2-E; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Spilsbury K, 2000, AM J PATHOL, V157, P135, DOI 10.1016/S0002-9440(10)64525-7; Sunness JS, 1999, OPHTHALMOLOGY, V106, P910, DOI 10.1016/S0161-6420(99)00509-6; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270	27	42	43	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2369	2379		10.1096/fj.13-248021	http://dx.doi.org/10.1096/fj.13-248021			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24558195	Green Published			2022-12-25	WOS:000335336000037
J	Jongkees, SAK; Yoo, H; Withers, SG				Jongkees, Seino A. K.; Yoo, Hayoung; Withers, Stephen G.			Mechanistic Investigations of Unsaturated Glucuronyl Hydrolase from Clostridium perfringens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Chemical Biology; Enzyme Mechanisms; Glycosaminoglycan; Glycosidases; Glycoside Hydrolases; Isotope Effects; Enzyme; Hydratases	VINYL ETHER HYDROLYSIS; ACID-CATALYZED HYDROLYSIS; ENOLPYRUVYLSHIKIMATE 3-PHOSPHATE EPSP; TRANSITION-STATE ANALYSIS; BACILLUS-SP GL1; POLYSACCHARIDE LYASES; ESCHERICHIA-COLI; METHYL 2,3-ANHYDRO-ALPHA-D-MANNOSIDE; CARBON PROTONATION; CRYSTAL-STRUCTURE	Background: Unsaturated glucuronyl hydrolases (UGL) from GH88 are bacterial enzymes involved in the degradation of glycosaminoglycans and are virulence factors. Results: Mechanistic data inconsistent with the currently accepted mechanism of UGL are presented. Conclusion: A revised mechanism is proposed to explain all mechanistic data published to date. Significance: Understanding of the mechanism of UGL may allow design of bacteriostatic agents. Experiments were carried out to probe the details of the hydration-initiated hydrolysis catalyzed by the Clostridium perfringens unsaturated glucuronyl hydrolase of glycoside hydrolase family 88 in the CAZy classification system. Direct H-1 NMR monitoring of the enzymatic reaction detected no accumulated reaction intermediates in solution, suggesting that rearrangement of the initial hydration product occurs on-enzyme. An attempt at mechanism-based trapping of on-enzyme intermediates using a 1,1-difluoro-substrate was unsuccessful because the probe was too deactivated to be turned over by the enzyme. Kinetic isotope effects arising from deuterium-for-hydrogen substitution at carbons 1 and 4 provide evidence for separate first-irreversible and overall rate-determining steps in the hydration reaction, with two potential mechanisms proposed to explain these results. Based on the positioning of catalytic residues in the enzyme active site, the lack of efficient turnover of a 2-deoxy-2-fluoro-substrate, and several unsuccessful attempts at confirmation of a simpler mechanism involving a covalent glycosyl-enzyme intermediate, the most plausible mechanism is one involving an intermediate bearing an epoxide on carbons 1 and 2.	[Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Jongkees, Seino A K/I-7722-2016	Jongkees, Seino A K/0000-0002-4796-0557	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund	This work was supported in part by funding from the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, and the British Columbia Knowledge Development Fund.	BRIMACOMBE JS, 1968, J CHEM SOC C, P562, DOI 10.1039/j39680000562; BROCKHAUS M, 1979, CARBOHYD RES, V69, P264, DOI 10.1016/S0008-6215(00)85773-0; BUCHANAN JG, 1958, J CHEM SOC, P2511, DOI 10.1039/jr9580002511; BUCHANAN JG, 1962, J CHEM SOC, P4770, DOI 10.1039/jr9620004770; BUCHANAN JG, 1964, J CHEM SOC, P1791, DOI 10.1039/jr9640001791; BURT RA, 1980, CAN J CHEM, V58, P2199, DOI 10.1139/v80-353; BURT RA, 1987, J AM CHEM SOC, V109, P3787, DOI 10.1021/ja00246a050; CAPON B, 1969, CHEM REV, V69, P407, DOI 10.1021/cr60260a001; CHIANG Y, 1989, J AM CHEM SOC, V111, P7185, DOI 10.1021/ja00200a043; CLAYTON CJ, 1967, J CHEM SOC C, P644, DOI 10.1039/j39670000644; COOPER JD, 1971, J AM CHEM SOC, V93, P6294, DOI 10.1021/ja00752a064; Duran-Reynals F, 1933, J EXP MED, V58, P161, DOI 10.1084/jem.58.2.161; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; FRANCK RW, 1992, BIOORG CHEM, V20, P77, DOI 10.1016/0045-2068(92)90028-2; FRIEBOLIN H, 1981, TETRAHEDRON LETT, V22, P1383, DOI 10.1016/S0040-4039(01)90327-2; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; GASMAN RC, 1966, J ORG CHEM, V31, P1830, DOI 10.1021/jo01344a037; Guazzelli L, 2010, CARBOHYD RES, V345, P369, DOI 10.1016/j.carres.2009.11.027; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jongkees SAK, 2014, ACCOUNTS CHEM RES, V47, P226, DOI 10.1021/ar4001313; Jongkees SAK, 2014, CHEMBIOCHEM, V15, P124, DOI 10.1002/cbic.201300547; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Klinman J P, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P415; KONSTANTINIDIS A, 1991, BIOCHEM J, V279, P587, DOI 10.1042/bj2790587; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; KRESGE AJ, 1987, CAN J CHEM, V65, P1753, DOI 10.1139/v87-295; KRESGE AJ, 1991, CAN J CHEM, V69, P84, DOI 10.1139/v91-012; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LEGLER G, 1990, ADV CARBOHYD CHEM BI, V48, P319, DOI 10.1016/S0065-2318(08)60034-7; Lou MY, 2012, J AM CHEM SOC, V134, P12947, DOI 10.1021/ja3043382; Lou MY, 2012, J AM CHEM SOC, V134, P12958, DOI 10.1021/ja304339h; MCCARTER JD, 1992, BIOCHEM J, V286, P721, DOI 10.1042/bj2860721; MCCLOSKEY CM, 1945, J ORG CHEM, V10, P184, DOI 10.1021/jo01179a004; Namchuk MN, 2000, J AM CHEM SOC, V122, P1270, DOI 10.1021/ja992044h; Namchuk MN, 1995, BIOCHEMISTRY-US, V34, P16194, DOI 10.1021/bi00049a035; Pearce AJ, 1999, EUR J ORG CHEM, V1999, P2103; REIST EJ, 1958, J AM CHEM SOC, V80, P3962, DOI 10.1021/ja01548a041; Satoh H, 2011, J AM CHEM SOC, V133, P5610, DOI 10.1021/ja201024a; SHIPLEY DS, 1994, J ORG CHEM, V59, P977, DOI 10.1021/jo00084a012; SONE T, 1989, CHEM PHARM BULL, V37, P1922; SUTHERLAND IW, 1995, FEMS MICROBIOL REV, V16, P323, DOI 10.1016/0168-6445(95)00020-D; Telford JC, 2011, J BIOL CHEM, V286, P10783, DOI 10.1074/jbc.M110.207043; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; WITHERS SG, 1986, CARBOHYD RES, V154, P127, DOI 10.1016/S0008-6215(00)90028-4; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; Wong AW, 2001, CAN J CHEM, V79, P510, DOI 10.1139/cjc-79-5-6-510; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	53	7	7	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11385	11395		10.1074/jbc.M113.545293	http://dx.doi.org/10.1074/jbc.M113.545293			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573682	Green Published, hybrid			2022-12-25	WOS:000334638500040
J	Cole, CL; Rushton, G; Jayson, GC; Avizienyte, E				Cole, Claire L.; Rushton, Graham; Jayson, Gordon C.; Avizienyte, Egle			Ovarian Cancer Cell Heparan Sulfate 6-O-Sulfotransferases Regulate an Angiogenic Program Induced by Heparin-binding Epidermal Growth Factor ( EGF)-like Growth Factor/EGF Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Epidermal Growth Factor Receptor (EGFR); Heparan Sulfate; Sulfotransferase; Tumor Microenvironment; HB-EGF; IL-6; IL-8	EPITHELIAL OVARIAN; DOMAIN; BEVACIZUMAB; OLIGOSACCHARIDES; 6-O-SULFATION; INTERLEUKIN-8; REQUIREMENTS; SITES; TRIAL; FGF-2	Background: Numerous angiogenic growth factors depend on heparan sulfate for their activity. Results: Heparan sulfate 6-O-sulfotransferases induce angiogenesis through HB-EGF/EGFR signaling and angiogenic cytokine expression in ovarian cancer cells. Conclusion: Ovarian cancer cell 6-O-sulfation levels influence angiogenic responses. Significance: HS6ST inhibitors and HS mimetics should be explored in the development of new anti-angiogenic agents. Heparan sulfate (HS) is a component of cell surface and extracellular matrix proteoglycans that regulates numerous signaling pathways by binding and activating multiple growth factors and chemokines. The amount and pattern of HS sulfation are key determinants for the assembly of the trimolecular, HS-growth factor-receptor, signaling complex. Here we demonstrate that HS 6-O-sulfotransferases 1 and 2 (HS6ST-1 and HS6ST-2), which perform sulfation at 6-O position in glucosamine in HS, impact ovarian cancer angiogenesis through the HS-dependent HB-EGF/EGFR axis that subsequently modulates the expression of multiple angiogenic cytokines. Down-regulation of HS6ST-1 or HS6ST-2 in human ovarian cancer cell lines results in 30-50% reduction in glucosamine 6-O-sulfate levels in HS, impairing HB-EGF-dependent EGFR signaling and diminishing FGF2, IL-6, and IL-8 mRNA and protein levels in cancer cells. These cancer cell-related changes reduce endothelial cell signaling and tubule formation in vitro. In vivo, the development of subcutaneous tumor nodules with reduced 6-O-sulfation is significantly delayed at the initial stages of tumor establishment with further reduction in angiogenesis occurring throughout tumor growth. Our results show that in addition to the critical role that 6-O-sulfate moieties play in angiogenic cytokine activation, HS 6-O-sulfation level, determined by the expression of HS6ST isoforms in ovarian cancer cells, is a major regulator of angiogenic program in ovarian cancer cells impacting HB-EGF signaling and subsequent expression of angiogenic cytokines by cancer cells.	[Cole, Claire L.; Rushton, Graham; Jayson, Gordon C.; Avizienyte, Egle] Univ Manchester, Fac Med & Human Sci, Inst Canc Sci, Manchester M20 4BX, Lancs, England	University of Manchester	Avizienyte, E (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Canc Sci, Paterson Bldg,Wilmslow Rd, Manchester M20 4BX, Lancs, England.	egle.avizienyte@ics.manchester.ac.uk	Jayson, Gordon C/O-8224-2015	Jayson, Gordon C/0000-0002-8515-8944	Medical Research Council [G0902173] Funding Source: Medline; MRC [G0902173] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Ashikari-Hada S, 2009, GLYCOBIOLOGY, V19, P644, DOI 10.1093/glycob/cwp031; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Backen AC, 2007, BRIT J CANCER, V96, P1544, DOI 10.1038/sj.bjc.6603747; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chu CL, 2005, BIOCHEMISTRY-US, V44, P12203, DOI 10.1021/bi050241p; Cole CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011644; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Hansen SU, 2013, ORG LETT, V15, P88, DOI 10.1021/ol303112y; Hansen SU, 2012, J ORG CHEM, V77, P7823, DOI 10.1021/jo300722y; Hansen SU, 2009, ORG LETT, V11, P4528, DOI 10.1021/ol901723m; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Khurana A, 2013, AM J CANCER RES, V3, P34; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Peifley KA, 1996, CIRC RES, V79, P263, DOI 10.1161/01.RES.79.2.263; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Pinciroli P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-508; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Schlorke D, 2012, CARBOHYD RES, V356, P196, DOI 10.1016/j.carres.2012.02.025; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Tsujioka H, 2011, CURR OPIN OBSTET GYN, V23, P24, DOI 10.1097/GCO.0b013e3283409c91; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Yagi H, 2009, INT J CANCER, V124, P1429, DOI 10.1002/ijc.24031	41	41	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10488	10501		10.1074/jbc.M113.534263	http://dx.doi.org/10.1074/jbc.M113.534263			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563483	Green Published, hybrid			2022-12-25	WOS:000334226400022
J	Jiang, K; Rankin, CR; Nava, P; Sumagin, R; Kamekura, R; Stowell, SR; Feng, ML; Parkos, CA; Nusrat, A				Jiang, Kun; Rankin, Carl R.; Nava, Porfirio; Sumagin, Ronen; Kamekura, Ryuta; Stowell, Sean R.; Feng, Mingli; Parkos, Charles A.; Nusrat, Asma			Galectin-3 Regulates Desmoglein-2 and Intestinal Epithelial Intercellular Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-Cell Interaction; Desmosome; Galectin; Intestinal Epithelium; Protein Stability; Desmoglein-2; Galectin-3f	CELL-ADHESION; CROHNS-DISEASE; DESMOSOMAL CADHERINS; CARCINOMA CELLS; MESSENGER-RNA; BRUSH-BORDER; EXPRESSION; BINDING; LECTIN; INTERNALIZATION	Background: Desmoglein-2 mediates intestinal epithelial intercellular adhesion. Results: Galectin-3 was identified to associate with the ectodomain of desmoglein-2 and inhibit the degradation of desmoglein-2 and enhance intercellular adhesion. Conclusion: Galectin-3 lattices stabilize desmoglein-2 at the cell surface to regulate intercellular adhesion in intestinal epithelial cells. Significance: This study identifies a novel role of galectin-3 in controlling desmosome structure and function. The desmosomal cadherins, desmogleins, and desmocollins mediate strong intercellular adhesion. Human intestinal epithelial cells express the desmoglein-2 isoform. A proteomic screen for Dsg2-associated proteins in intestinal epithelial cells identified a lectin referred to as galectin-3 (Gal3). Gal3 bound to N-linked -galactosides in Dsg2 extracellular domain and co-sedimented with caveolin-1 in lipid rafts. Down-regulation of Gal3 protein or incubation with lactose, a galactose-containing disaccharide that competitively inhibits galectin binding to Dsg2, decreased intercellular adhesion in intestinal epithelial cells. In the absence of functional Gal3, Dsg2 protein was internalized from the plasma membrane and degraded in the proteasome. These results report a novel role of Gal3 in stabilizing a desmosomal cadherin and intercellular adhesion in intestinal epithelial cells.	[Jiang, Kun; Rankin, Carl R.; Nava, Porfirio; Sumagin, Ronen; Kamekura, Ryuta; Stowell, Sean R.; Feng, Mingli; Parkos, Charles A.; Nusrat, Asma] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA; [Nava, Porfirio] CINVESTAV IPN, Dept Physiol Biophys & Neurosci, Ciudad De Mexico 07360, DF, Mexico	Emory University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Nusrat, A (corresponding author), Emory Univ, Dept Pathol & Lab Med, Whitehead Res Bldg,Rm 105E,615 Michael St, Atlanta, GA 30322 USA.	anusrat@emory.edu	Nava, Porfirio/D-8306-2012	Nava, Porfirio/0000-0002-0506-1510; JIANG, KUN/0000-0001-8531-7813	National Institutes of Health [R01 DK072564, R01 DK061379, R01 DK079392, R01 DK055679, DK059888, DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007771, R24DK064399, R01DK055679, R01DK079392, R01DK061379, R01DK072564, R01DK059888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK072564, R01 DK061379, and R01 DK079392 (to C. A. P.); R01 DK055679 and DK059888 (to A. N.); and DK064399 (National Institutes of Health Digestive Diseases Research Development Center (DDRDC) tissue culture and morphology grant).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Bodger K, 2006, GUT, V55, P973, DOI 10.1136/gut.2005.086413; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Brazowski E, 2009, PATHOL RES PRACT, V205, P551, DOI 10.1016/j.prp.2009.02.001; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Campbell B, 2001, SMITHSONIAN, V32, P18; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Cheng X, 2004, J DERMATOL, V31, P171, DOI 10.1111/j.1346-8138.2004.tb00654.x; CHERAYIL BJ, 1990, P NATL ACAD SCI USA, V87, P7324, DOI 10.1073/pnas.87.18.7324; CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207; Danielsen EM, 1997, MOL BIOL CELL, V8, P2241, DOI 10.1091/mbc.8.11.2241; Dusek RL, 2011, NAT REV CANCER, V11, P317, DOI 10.1038/nrc3051; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Fukushima K, 2003, INFLAMM BOWEL DIS, V9, P290, DOI 10.1097/00054725-200309000-00002; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hartsock A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037476; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HO MK, 1982, J IMMUNOL, V128, P1221; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; Inohara H, 1996, CANCER RES, V56, P4530; INOHARA H, 1995, CANCER RES, V55, P3267; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; Jensen-Jarolim E, 2001, J CLIN IMMUNOL, V21, P348, DOI 10.1023/A:1012240719801; Kamekura R, 2014, ONCOGENE, V33, P4531, DOI 10.1038/onc.2013.442; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kolegraff K, 2011, CELL ADHES MIGR, V5, P306, DOI 10.4161/cam.5.4.16911; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Marcozzi C, 1998, J CELL SCI, V111, P495; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; MOUTSATSOS IK, 1986, J CELL BIOL, V102, P477, DOI 10.1083/jcb.102.2.477; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shinzaki S, 2013, INFLAMM BOWEL DIS, V19, P321, DOI 10.1097/MIB.0b013e318280eade; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Thomsen MK, 2009, MOL MEMBR BIOL, V26, P347, DOI 10.1080/09687680903167781; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Wang HJ, 2013, J VIROL, V87, P11346, DOI 10.1128/JVI.01825-13; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Zou J, 2005, CARCINOGENESIS, V26, P309, DOI 10.1093/carcin/bgh329	59	38	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10510	10517		10.1074/jbc.M113.538538	http://dx.doi.org/10.1074/jbc.M113.538538			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567334	Green Published, hybrid			2022-12-25	WOS:000334226400024
J	Tanaka, T; Doe, JM; Horstmann, SA; Ahmad, S; Ahmad, A; Min, SJ; Reynolds, PR; Suram, S; Gaydos, J; Burnham, EL; Vandivier, RW				Tanaka, Takeshi; Doe, Jenna M.; Horstmann, Sarah A.; Ahmad, Shama; Ahmad, Aftab; Min, Sung-Joon; Reynolds, Paul R.; Suram, Saritha; Gaydos, Jeanette; Burnham, Ellen L.; Vandivier, R. William			Neuroendocrine Signaling Via the Serotonin Transporter Regulates Clearance of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Inflammation; Lung; Phagocytosis; RhoA; Efferocytosis; Rho Kinase; Serotonin Receptors	OBSTRUCTIVE PULMONARY-DISEASE; RED-BLOOD-CELLS; DEFICIENT MICE; ALVEOLAR MACROPHAGES; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; LUNG-DISEASE; PHAGOCYTOSIS; PHOSPHATIDYLSERINE	Background: Serotonin (5-HT) contributes to the pathogenesis of chronic inflammatory diseases known to have defects in apoptotic cell removal (i.e. efferocytosis). Results: 5-HT impairs macrophage efferocytosis via 5-HT transporter-dependent activation of the RhoA/Rho kinase pathway. Conclusion: Results show a novel mechanism by which 5-HT might disrupt resolution of inflammation. Significance: Targeting the 5-HT transporter may have a therapeutic role in chronic inflammatory disorders. Serotonin (5-hydroxytryptamine; 5-HT) is a CNS neurotransmitter increasingly recognized to exert immunomodulatory effects outside the CNS that contribute to the pathogenesis of autoimmune and chronic inflammatory diseases. 5-HT signals to activate the RhoA/Rho kinase (ROCK) pathway, a pathway known for its ability to regulate phagocytosis. The clearance of apoptotic cells (i.e. efferocytosis) is a key modulator of the immune response that is inhibited by the RhoA/ROCK pathway. Because efferocytosis is defective in many of the same illnesses where 5-HT has been implicated in disease pathogenesis, we hypothesized that 5-HT would suppress efferocytosis via activation of RhoA/ROCK. The effect of 5-HT on efferocytosis was examined in murine peritoneal and human alveolar macrophages, and its mechanisms were investigated using pharmacologic blockade and genetic deletion. 5-HT impaired efferocytosis by murine peritoneal macrophages and human alveolar macrophages. 5-HT increased phosphorylation of myosin phosphatase subunit 1 (Mypt-1), a known ROCK target, and inhibitors of RhoA and ROCK reversed the suppressive effect of 5-HT on efferocytosis. Peritoneal macrophages expressed the 5-HT transporter and 5-HT receptors (R) 2a, 2b, but not 2c. Inhibition of 5-HTR2a and 5-HTR2b had no effect on efferocytosis, but blockade of the 5-HT transporter prevented 5-HT-impaired efferocytosis. Genetic deletion of the 5-HT transporter inhibited 5-HT uptake into peritoneal macrophages, prevented 5-HT-induced phosphorylation of Mypt-1, reversed the inhibitory effect of 5-HT on efferocytosis, and decreased cellular peritoneal inflammation. These results suggest a novel mechanism by which 5-HT might disrupt efferocytosis and contribute to the pathogenesis of autoimmune and chronic inflammatory diseases.	[Tanaka, Takeshi; Doe, Jenna M.; Horstmann, Sarah A.; Suram, Saritha; Gaydos, Jeanette; Burnham, Ellen L.; Vandivier, R. William] Univ Colorado, COPD Ctr, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Ahmad, Shama; Ahmad, Aftab] Univ Colorado, Pediat Airway Res Ctr, Dept Pediat, Aurora, CO 80045 USA; [Min, Sung-Joon] Univ Colorado, Div Hlth Care Policy & Res, Aurora, CO 80045 USA; [Reynolds, Paul R.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Vandivier, RW (corresponding author), Box C272,9th Floor,12700 East 19th Ave, Aurora, CO 80045 USA.	Bill.Vandivier@ucdenver.edu	ahmad, shama/GNH-1803-2022; Ahmad, Aftab/ABC-2734-2020	ahmad, shama/0000-0003-1049-5054; Ahmad, Aftab/0000-0003-0686-0987	National Institutes of Health from the NHLBI [HL-088138]; National Institutes of Health from the NIAAA [R24 AAO19661]; Flight Attendant Medical Research Institute [CIA092054]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA019661] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from the NIAAA; Flight Attendant Medical Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-088138 from the NHLBI (to R. W. V.) and Grant R24 AAO19661 from the NIAAA (to E. L. B.) and Clinical Innovator Award CIA092054 from the Flight Attendant Medical Research Institute.	Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Boe DM, 2010, ALCOHOL CLIN EXP RES, V34, P1723, DOI 10.1111/j.1530-0277.2010.01259.x; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Durk T, 2013, AM J RESP CRIT CARE, V187, P476, DOI 10.1164/rccm.201208-1440OC; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fernandez-Boyanapalli R, 2013, J ALLERGY CLIN IMMUN, V131, P1041, DOI 10.1016/j.jaci.2012.09.028; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Freire-Garabal M, 2003, BRIT J PHARMACOL, V139, P457, DOI 10.1038/sj.bjp.0705188; GERSHON MD, 1965, SCIENCE, V149, P197, DOI 10.1126/science.149.3680.197; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Goolaerts A, 2010, AM J RESP CELL MOL, V43, P99, DOI 10.1165/rcmb.2008-0472OC; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Hummerich R, 2012, FEBS LETT, V586, P3421, DOI 10.1016/j.febslet.2012.07.062; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Krabbe G, 2012, BRAIN BEHAV IMMUN, V26, P419, DOI 10.1016/j.bbi.2011.12.002; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lau W. K., 2012, PLOS ONE, V7; Margolis KG, 2009, GASTROENTEROLOGY, V137, P1562, DOI 10.1053/j.gastro.2009.09.027; MCEVOY L, 1986, P NATL ACAD SCI USA, V83, P3311, DOI 10.1073/pnas.83.10.3311; Mikulski Z, 2010, AM J PHYSIOL-LUNG C, V299, pL272, DOI 10.1152/ajplung.00032.2010; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Morimoto K, 2006, J IMMUNOL, V176, P7657, DOI 10.4049/jimmunol.176.12.7657; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Rudd ML, 2005, J NEUROIMMUNOL, V159, P113, DOI 10.1016/j.jneuroim.2004.10.013; Seddighzadeh M, 2010, EUR J HUM GENET, V18, P821, DOI 10.1038/ejhg.2010.12; Snir O, 2013, GENES IMMUN, V14, P83, DOI 10.1038/gene.2012.56; STERNBERG EM, 1987, J IMMUNOL, V138, P4360; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Walther DJ, 2011, FEBS J, V278, P4740, DOI 10.1111/j.1742-4658.2011.08347.x; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Wei L, 2012, AM J PHYSIOL-LUNG C, V302, pL1273, DOI 10.1152/ajplung.00082.2012; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC	55	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10466	10475		10.1074/jbc.M113.482299	http://dx.doi.org/10.1074/jbc.M113.482299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570000	hybrid, Green Published			2022-12-25	WOS:000334226400020
J	Guzman, C; Solman, M; Ligabue, A; Blazevits, O; Andrade, DM; Reymond, L; Eggeling, C; Abankwa, D				Guzman, Camilo; Solman, Maja; Ligabue, Alessio; Blazevits, Olga; Andrade, Debora M.; Reymond, Luc; Eggeling, Christian; Abankwa, Daniel			The Efficacy of Raf Kinase Recruitment to the GTPase H-ras Depends on H-ras Membrane Conformer-specific Nanoclustering*.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Fluorescence Correlation Spectroscopy; Fluorescence Resonance Energy Transfer (FRET); Ras; Signaling; Fluorescence Recovery after Photobleaching (FRAP); Fluorescence-lifetime Microscopy Imaging (FLIM); Stimulated Emission Depletion (STED); Membrane; Nanocluster	PLASMA-MEMBRANE; SINGLE-MOLECULE; K-RAS; ESCHERICHIA-COLI; PROTEIN; BINDING; ORGANIZATION; ORIENTATION; GALECTIN-1; DYNAMICS	Background: Ras nanoclusters contain 6-8 Ras proteins on the plasma membrane and serve as indispensable signaling platforms for Ras-MAPK signaling. Results: Ras membrane conformer mutants impart specific galectin-1-dependent nanoclustering responses. Conclusion: Mutations in Ras can affect its nanoclustering response and thus allosterically effector recruitment and downstream signaling. Significance: Disease-associated mutations that perturb Ras membrane conformers may alter signaling through nanoclustering. Solution structures and biochemical data have provided a wealth of mechanistic insight into Ras GTPases. However, information on how much the membrane organization of these lipid-modified proteins impacts on their signaling is still scarce. Ras proteins are organized into membrane nanoclusters, which are necessary for Ras-MAPK signaling. Using quantitative conventional and super-resolution fluorescence methods, as well as mathematical modeling, we investigated nanoclustering of H-ras helix 4 and hypervariable region mutants that have different bona fide conformations on the membrane. By following the emergence of conformer-specific nanoclusters in the plasma membrane of mammalian cells, we found that conformers impart distinct nanoclustering responses depending on the cytoplasmic levels of the nanocluster scaffold galectin-1. Computational modeling revealed that complexes containing H-ras conformers and galectin-1 affect both the number and lifetime of nanoclusters and thus determine the specific Raf effector recruitment. Our results show that mutations in Ras can affect its nanoclustering response and thus allosterically effector recruitment and downstream signaling. We postulate that cancer- and developmental disease-linked mutations that are associated with the Ras membrane conformation may exhibit so far unrecognized Ras nanoclustering and therefore signaling alterations.	[Guzman, Camilo; Solman, Maja; Ligabue, Alessio; Blazevits, Olga; Abankwa, Daniel] Abo Akad Univ, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Andrade, Debora M.; Eggeling, Christian] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Reymond, Luc] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	Abo Akademi University; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Oxford	Abankwa, D (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	daniel.abankwa@btk.fi		REYMOND, Luc/0000-0001-5282-9273; Abankwa, Daniel/0000-0003-2769-0745	Academy of Finland; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration Grant; Medical Research Council [MR/K01577X/1, MC_UU_12010/9] Funding Source: researchfish; Cancer Foundation Finland sr [130067, 110051] Funding Source: researchfish; MRC [MC_UU_12010/9, MR/K01577X/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration Grant(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cancer Foundation Finland sr; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an Academy of Finland fellowship grant, the Sigrid Juselius Foundation, the Cancer Society of Finland, and a Marie-Curie Reintegration Grant (to D. A.).	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Billaudeau C, 2013, METHOD ENZYMOL, V519, P277, DOI 10.1016/B978-0-12-405539-1.00010-5; Cho KJ, 2012, CURR BIOL, V22, P945, DOI 10.1016/j.cub.2012.03.067; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; Grunberg R, 2013, NAT METHODS, V10, P1021, DOI [10.1038/nmeth.2625, 10.1038/NMETH.2625]; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; He HT, 2011, ANNU REV PHYS CHEM, V62, P417, DOI 10.1146/annurev-physchem-032210-103402; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; Kapoor S, 2012, EUR BIOPHYS J BIOPHY, V41, P801, DOI 10.1007/s00249-012-0841-5; Kapoor S, 2012, P NATL ACAD SCI USA, V109, P460, DOI 10.1073/pnas.1110553109; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Kiel C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000245; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lee HW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2507; Levy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027490; Li HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071018; Li ZL, 2012, J AM CHEM SOC, V134, P17278, DOI 10.1021/ja307716z; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/nchem.1546, 10.1038/NCHEM.1546]; Majoul I., HDB BIOL CONFOCAL MI, P788, DOI DOI 10.1007/978-0-387-45524-2_45; Mazhab-Jafari MT, 2013, J AM CHEM SOC, V135, P3367, DOI 10.1021/ja312508w; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Najumudeen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066425; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045360; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhou Y, 2012, J BIOL CHEM, V287, P16586, DOI 10.1074/jbc.M112.348490; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	64	35	35	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9519	9533		10.1074/jbc.M113.537001	http://dx.doi.org/10.1074/jbc.M113.537001			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569991	Green Published, hybrid			2022-12-25	WOS:000333807000009
J	Trcka, F; Durech, M; Man, P; Hernychova, L; Muller, P; Vojtesek, B				Trcka, Filip; Durech, Michal; Man, Petr; Hernychova, Lenka; Muller, Petr; Vojtesek, Borivoj			The Assembly and Intermolecular Properties of the Hsp70-Tomm34-Hsp90 Molecular Chaperone Complex*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hsp90; Molecular Chaperone; Protein Assembly; Protein Folding; Protein-Protein Interactions; Co-chaperone; H; D Exchange; Hsp70; TPR Domain	TETRATRICOPEPTIDE REPEAT DOMAIN; MITOCHONDRIAL PROTEIN IMPORT; ORGANIZING PROTEIN; HSP90; BINDING; TPR; HSP70; HOP; COCHAPERONE; SEQUENCES	Background: Hsp70 and Hsp90 molecular chaperones associate with the network of co-chaperone proteins. Results: Tomm34 protein interacts with both Hsp70 and Hsp90 chaperones. Conclusion: Tomm34 scaffolds Hsp70/Hsp90 chaperones by their simultaneous binding. Significance: Tomm34 represents a novel Hsp70/Hsp90 co-chaperone. Maintenance of protein homeostasis by molecular chaperones Hsp70 and Hsp90 requires their spatial and functional coordination. The cooperation of Hsp70 and Hsp90 is influenced by their interaction with the network of co-chaperone proteins, some of which contain tetratricopeptide repeat (TPR) domains. Critical to these interactions are TPR domains that target co-chaperone binding to the EEVD-COOH motif that terminates Hsp70/Hsp90. Recently, the two-TPR domain-containing protein, Tomm34, was reported to bind both Hsp70 and Hsp90. Here we characterize the structural basis of Tomm34-Hsp70/Hsp90 interactions. Using multiple methods, including pull-down assays, fluorescence polarization, hydrogen/deuterium exchange, and site-directed mutagenesis, we defined the binding activities and specificities of Tomm34 TPR domains toward Hsp70 and Hsp90. We found that Tomm34 TPR1 domain specifically binds Hsp70. This interaction is partly mediated by a non-canonical TPR1 two-carboxylate clamp and is strengthened by so far unidentified additional intermolecular contacts. The two-carboxylate clamp of the isolated TPR2 domain has affinity for both chaperones, but as part of the full-length Tomm34 protein, the TPR2 domain binds specifically Hsp90. These binding properties of Tomm34 TPR domains thus enable simultaneous binding of Hsp70 and Hsp90. Importantly, we provide evidence for the existence of an Hsp70-Tomm34-Hsp90 tripartite complex. In addition, we defined the basic conformational demands of the Tomm34-Hsp90 interaction. These results suggest that Tomm34 represents a novel scaffolding co-chaperone of Hsp70 and Hsp90, which may facilitate Hsp70/Hsp90 cooperation during protein folding.	[Trcka, Filip; Durech, Michal; Hernychova, Lenka; Muller, Petr; Vojtesek, Borivoj] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno 65653, Czech Republic; [Man, Petr] Acad Sci Czech Republic, Inst Microbiol, Vvi, Prague 14220, Czech Republic; [Man, Petr] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic	Masaryk Memorial Cancer Institute; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Muller, P (corresponding author), Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Zluty Kopec 7, Brno 65653, Czech Republic.	muller@mou.cz; vojtesek@mou.cz	Muller, Petr/AAK-5014-2021; Muller, Petr/F-7762-2015; Man, Petr/H-2451-2014; Hernychova, Lenka/J-6714-2014	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Man, Petr/0000-0002-1485-2197; Hernychova, Lenka/0000-0002-4352-0626; Durech, Michal/0000-0002-4054-4315; Trcka, Filip/0000-0001-6307-8129	Czech Science Foundation [P301/11/1678]; European Regional Development Fund; State Budget of the Czech Republic (Regional Center for Applied Molecular Oncology) [CZ.1.05/2.1.00/03.0101]; Ministr of Health, Czech Republic, conceptual development of research organization Masaryk Memorial Cancer Institute [00209805]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); State Budget of the Czech Republic (Regional Center for Applied Molecular Oncology); Ministr of Health, Czech Republic, conceptual development of research organization Masaryk Memorial Cancer Institute	This work was supported by Czech Science Foundation Grant P301/11/1678, by the European Regional Development Fund and the State Budget of the Czech Republic (Regional Center for Applied Molecular Oncology), CZ.1.05/2.1.00/03.0101), and by the Ministr of Health, Czech Republic, conceptual development of research organization Masaryk Memorial Cancer Institute Grant, 00209805.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Carrigan PE, 2006, PROTEIN SCI, V15, P522, DOI 10.1110/ps.051810106; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cheung-Flynn J, 2003, J BIOL CHEM, V278, P17388, DOI 10.1074/jbc.M300955200; Chewawiwat N, 1999, J BIOCHEM, V125, P721, DOI 10.1093/oxfordjournals.jbchem.a022342; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Faou P, 2012, BBA-MOL CELL RES, V1823, P348, DOI 10.1016/j.bbamcr.2011.12.001; Glover D. M., 1986, DNA CLONING PRACTICA, VI, II, P1985; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Kajander T, 2009, J BIOL CHEM, V284, P25364, DOI 10.1074/jbc.M109.033894; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuttall SD, 1997, DNA CELL BIOL, V16, P1067, DOI 10.1089/dna.1997.16.1067; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Sun L, 2012, BBA-MOL CELL RES, V1823, P1092, DOI 10.1016/j.bbamcr.2012.03.014; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	37	35	35	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9887	9901		10.1074/jbc.M113.526046	http://dx.doi.org/10.1074/jbc.M113.526046			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567332	Green Published, hybrid			2022-12-25	WOS:000333807000038
J	Hoskins, LM; Werner-Lin, A; Greene, MH				Hoskins, Lindsey M.; Werner-Lin, Allison; Greene, Mark H.			In Their Own Words: Treating Very Young BRCA1/2 Mutation-Positive Women with Care and Caution	PLOS ONE			English	Article							OVARIAN-CANCER RISK; BREAST-CANCER; CARRIERS; TAMOXIFEN; MULTICENTER; MASTECTOMY; PREVENTION; MANAGEMENT; IMPACT	Purpose: Young women who have been identified as carrying a deleterious mutation in BRCA1 or BRCA2 face a unique set of challenges related to managing cancer risk during a demographically-dense stage of life. They may struggle with decision-making in the absence of clear age-specific guidelines for medical management and because they have not yet fully developed the capacity to make life-altering decisions confidently. This study sought a patient-centered perspective on the dilemmas faced by 18-24 year olds who completed BRCA1/2 gene mutation testing prior to their 25th birthdays. Patients and Method: This study integrated qualitative data from three independent investigations of BRCA1/2-positive women recruited through cancer risk clinics, hospital-based research centers, and online organizations. All 32 participants were women aged 21-25 who tested positive for a BRCA1/2 gene mutation between 2 and 60 months prior to data collection. Investigators used techniques of grounded theory and interpretive description to conduct both within and cross-study analysis. Results: Participants expressed needs for (1) greater clarity in recommendations for screening and prevention before age 25, especially with consideration of early and regular exposure to radiation associated with mammography or to hormones used in birth control, and (2) ongoing contact with providers to discuss risk management protocols as they become available. Conclusions: Health care needs during the young adult years evolve with the cognitive capacity to address abrupt and pressing change. Specific needs of women in this population include a desire to balance autonomous decision-making with supportive guidance, a need for clear, accurate and consistent medical recommendations. Optimally, these women are best cared for by a team of genetically-oriented providers as part of a sustained program of ongoing support, rather than seen in an episodic, crisis-driven fashion. A discussion of insurance issues and provider-patient cultural differences is presented.	[Hoskins, Lindsey M.; Greene, Mark H.] NCI, Clin Genet Branch, Bethesda, MD 20892 USA; [Werner-Lin, Allison] Univ Penn, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania	Werner-Lin, A (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	awer@sp2.upenn.edu			intramural program of the National Cancer Institute, Division of Cancer Genetics and Epidemiology, Clinical Genetics Branch	intramural program of the National Cancer Institute, Division of Cancer Genetics and Epidemiology, Clinical Genetics Branch	This study was funded through the intramural program of the National Cancer Institute, Division of Cancer Genetics and Epidemiology, Clinical Genetics Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou AC, 2009, CANCER EPIDEM BIOMAR, V18, P601, DOI 10.1158/1055-9965.EPI-08-0546; Arnett J.J., 2004, EMERGING ADULTHOOD W; de Gonzalez A, 2009, JNCI-J NATL CANCER I, V101, P205, DOI 10.1093/jnci/djn440; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Clark AS, 2011, J MAMMARY GLAND BIOL, V16, P17, DOI 10.1007/s10911-011-9200-x; Crum CP, 2009, MOL ONCOL, V3, P165, DOI 10.1016/j.molonc.2009.01.004; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Evans James P, 2005, Breast Dis, V23, P17; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Greene MH, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.05.038; Halbert CH, 2006, PREV MED, V43, P385, DOI 10.1016/j.ypmed.2006.06.003; Hoskins LM, 2012, QUAL HEALTH RES, V22, P1633, DOI 10.1177/1049732312458182; Hoskins LM, 2012, FAM SYST HEALTH, V30, P32, DOI 10.1037/a0027276; Hoskins Lindsey M, 2008, Fam Syst Health, V26, P296, DOI 10.1037/a0012914; Hoskins LM, 2010, NEGOTIATION HLTH RIS; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Iodice S, 2010, EUR J CANCER, V46, P2275, DOI 10.1016/j.ejca.2010.04.018; Kauff ND, 2008, J CLIN ONCOL, V26, P1331, DOI 10.1200/JCO.2007.13.9626; Lea DH, 2011, PUBLIC HEALTH GENOM, V14, P279, DOI 10.1159/000294191; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Nanda R, 2005, JAMA-J AM MED ASSOC, V294, P1925, DOI 10.1001/jama.294.15.1925; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; Narod SA, 2010, NAT REV CLIN ONCOL, V7, P702, DOI 10.1038/nrclinonc.2010.166; NEWCOMB PA, 1991, J NATL CANCER I, V83, P260, DOI 10.1093/jnci/83.4.260; Petrucelli N, 2010, GENET MED, V12, P245, DOI 10.1097/GIM.0b013e3181d38f2f; Pruthi S, 2010, MAYO CLIN PROC, V85, P1111, DOI 10.4065/mcp.2010.0414; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Samuel Jonathan C, 2005, Breast Dis, V23, P31; Segev Y, 2013, GYNECOL ONCOL, V130, P127, DOI 10.1016/j.ygyno.2013.03.027; Sivell Stephanie, 2008, J Genet Couns, V17, P30, DOI 10.1007/s10897-007-9132-1; Trepanier Angela, 2004, J Genet Couns, V13, P83, DOI 10.1023/B:JOGC.0000018821.48330.77; van Oostrom I, 2003, J CLIN ONCOL, V21, P3867, DOI 10.1200/JCO.2003.10.100; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Watson M, 2004, BRIT J CANCER, V91, P1787, DOI 10.1038/sj.bjc.6602207; Werner-Lin A, 2010, J SOC SOC WORK RES, V1, P26; Werner-Lin A, 2008, J PSYCHOSOC ONCOL, V26, P111, DOI 10.1080/07347330802359776; Werner-Lin A, 2012, HEALTH-LONDON, V16, P636, DOI 10.1177/1363459312442420; Werner-Lin A, 2008, SOC WORK HEALTH CARE, V47, P416, DOI 10.1080/00981380802173509; Werner-Lin AV, 2007, FAM PROCESS, V46, P335, DOI 10.1111/j.1545-5300.2007.00215.x	41	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87696	10.1371/journal.pone.0087696	http://dx.doi.org/10.1371/journal.pone.0087696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586286	Green Submitted, gold, Green Published			2022-12-25	WOS:000332396200014
J	Murmann, T; Carrillo-Garcia, C; Veit, N; Courts, C; Glassmann, A; Janzen, V; Madea, B; Reinartz, M; Harzen, A; Nowak, M; Perner, S; Winter, J; Probstmeier, R				Murmann, Tamara; Carrillo-Garcia, Carmen; Veit, Nadine; Courts, Cornelius; Glassmann, Alexander; Janzen, Viktor; Madea, Burkhard; Reinartz, Markus; Harzen, Anne; Nowak, Michael; Perner, Sven; Winter, Jochen; Probstmeier, Rainer			Staurosporine and Extracellular Matrix Proteins Mediate the Conversion of Small Cell Lung Carcinoma Cells into a Neuron-Like Phenotype	PLOS ONE			English	Article							CANCER CELLS; INDUCED APOPTOSIS; DIFFERENTIATION; NEUROENDOCRINE; PROLIFERATION; EXPRESSION; ACTIVATION; OUTGROWTH; ARREST; GROWTH	Small cell lung carcinomas (SCLCs) represent highly aggressive tumors with an overall five-year survival rate in the range of 5 to 10%. Here, we show that four out of five SCLC cell lines reversibly develop a neuron-like phenotype on extracellular matrix constituents such as fibronectin, laminin or thrombospondin upon staurosporine treatment in an RGD/integrinmediated manner. Neurite-like processes extend rapidly with an average speed of 10 mm per hour. Depending on the cell line, staurosporine treatment affects either cell cycle arrest in G2/M phase or induction of polyploidy. Neuron-like conversion, although not accompanied by alterations in the expression pattern of a panel of neuroendocrine genes, leads to changes in protein expression as determined by two-dimensional gel electrophoresis. It is likely that SCLC cells already harbour the complete molecular repertoire to convert into a neuron-like phenotype. More extensive studies are needed to evaluate whether the conversion potential of SCLC cells is suitable for therapeutic interventions.	[Murmann, Tamara; Veit, Nadine; Probstmeier, Rainer] Univ Hosp Bonn, Dept Nucl Med, Neuro & Tumor Cell Biol Grp, Bonn, Germany; [Carrillo-Garcia, Carmen; Janzen, Viktor] Univ Hosp Bonn, Dept Hematol & Oncol, Bonn, Germany; [Courts, Cornelius; Madea, Burkhard] Univ Bonn, Inst Legal Med, Bonn, Germany; [Glassmann, Alexander] Univ Bonn, Inst Anat & Cell Biol, Bonn, Germany; [Reinartz, Markus; Winter, Jochen] Dept Periodontol Operat & Prevent Dent, Oral Cell Biol Grp, Bonn, Germany; [Harzen, Anne] Max Planck Inst Plant Breeding Res, Prote Grp, Cologne, Germany; [Nowak, Michael; Perner, Sven] Univ Hosp Bonn, Inst Pathol, Dept Prostate Canc Res, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Max Planck Society; University of Bonn	Probstmeier, R (corresponding author), Univ Hosp Bonn, Dept Nucl Med, Neuro & Tumor Cell Biol Grp, Bonn, Germany.	r.probstmeier@uni-bonn.de		Glassmann, Alexander/0000-0001-9600-8610; Carrillo Garcia, Carmen/0000-0003-1692-7460; Harzen, Anne/0000-0001-7370-4939; Courts, Cornelius/0000-0002-9811-8482				Ablain J, 2011, BLOOD, V117, P5795, DOI 10.1182/blood-2011-02-329367; Arriola E, 2008, CLIN TRANSL ONCOL, V10, P189, DOI 10.1007/s12094-008-0181-1; Azzi S, 2011, J NATL CANCER I, V103, P1884, DOI 10.1093/jnci/djr451; Bernard B, 2001, CELL DEATH DIFFER, V8, P234, DOI 10.1038/sj.cdd.4400796; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Busby EC, 2000, CANCER RES, V60, P2108; Buttery R, 2004, HISTOPATHOLOGY, V44, P339, DOI 10.1111/j.1365-2559.2004.01815.x; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; DELEIJ L, 1985, CANCER RES, V45, P6024; Deshmukh M, 2000, CELL DEATH DIFFER, V7, P250, DOI 10.1038/sj.cdd.4400641; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Faghihi F, 2008, YAKHTEH, V10, P33; Gabius HJ, 2002, ANTICANCER RES, V22, P405; GIACCONE G, 1992, BRIT J CANCER, V66, P488, DOI 10.1038/bjc.1992.301; Glassmann A, 2011, INT J ONCOL, V39, P1567, DOI 10.3892/ijo.2011.1165; Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200; Guo NH, 2000, CANCER RES, V60, P457; Haddadin S, 2011, CLIN LUNG CANCER, V12, P87, DOI 10.1016/j.cllc.2011.03.002; Hodkinson PS, 2007, INT J RADIAT BIOL, V83, P733, DOI 10.1080/09553000701570204; Hodkinson PS, 2006, CELL DEATH DIFFER, V13, P1776, DOI 10.1038/sj.cdd.4401849; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; Konig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057996; Kohmo S, 2010, CANCER RES, V70, P8025, DOI 10.1158/0008-5472.CAN-10-0996; Lahm H, 2001, J CANCER RES CLIN, V127, P375, DOI 10.1007/s004320000207; McGahren-Murray M, 2006, CANCER RES, V66, P9744, DOI 10.1158/0008-5472.CAN-06-1809; Missale C, 1998, P NATL ACAD SCI USA, V95, P5366, DOI 10.1073/pnas.95.9.5366; Park KS, 2011, CELL CYCLE, V10, P2806, DOI 10.4161/cc.10.16.17012; Pedersen N, 2003, CANCER RES, V63, P1943; Peng HY, 2011, ANN HEMATOL, V90, P1017, DOI 10.1007/s00277-011-1186-3; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Riaz SP, 2012, LUNG CANCER, V75, P280, DOI 10.1016/j.lungcan.2011.08.004; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schumacher A, 2003, MOL CELL NEUROSCI, V23, P669, DOI 10.1016/S1044-7431(03)00170-2; Senderowicz AM, 2003, ONCOGENE, V22, P6609, DOI 10.1038/sj.onc.1206954; Stovold R, 2012, LUNG CANCER, V76, P263, DOI 10.1016/j.lungcan.2011.11.015; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; Thompson AF, 2010, NEUROCHEM INT, V56, P554, DOI 10.1016/j.neuint.2009.12.018; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Yao RJ, 1997, J BIOL CHEM, V272, P18261, DOI 10.1074/jbc.272.29.18261; Yuste VJ, 2002, J NEUROCHEM, V80, P126, DOI 10.1046/j.0022-3042.2001.00695.x	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e86910	10.1371/journal.pone.0086910	http://dx.doi.org/10.1371/journal.pone.0086910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586258	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200010
J	Groger, JP; Hinrichsen, HH; Polte, P				Groeger, Joachim P.; Hinrichsen, Hans-Harald; Polte, Patrick			Broad-Scale Climate Influences on Spring-Spawning Herring (Clupea harengus, L.) Recruitment in the Western Baltic Sea	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; SPRAT SPRATTUS-SPRATTUS; COD GADUS-MORHUA; POPULATION-DYNAMICS; PLANKTON PRODUCTION; TEMPERATURE; LARVAL; VARIABILITY; ENVIRONMENT; ABUNDANCE	Climate forcing in complex ecosystems can have profound implications for ecosystem sustainability and may thus challenge a precautionary ecosystem management. Climatic influences documented to affect various ecological functions on a global scale, may themselves be observed on quantitative or qualitative scales including regime shifts in complex marine ecosystems. This study investigates the potential climatic impact on the reproduction success of spring-spawning herring (Clupea harengus) in the Western Baltic Sea (WBSS herring). To test for climate effects on reproduction success, the regionally determined and scientifically well-documented spawning grounds of WBSS herring represent an ideal model system. Climate effects on herring reproduction were investigated using two global indices of atmospheric variability and sea surface temperature, represented by the North Atlantic Oscillation (NAO) and the Atlantic Multi-decadal Oscillation (AMO), respectively, and the Baltic Sea Index (BSI) which is a regional-scale atmospheric index for the Baltic Sea. Moreover, we combined a traditional approach with modern time series analysis based on a recruitment model connecting parental population components with reproduction success. Generalized transfer functions (ARIMAX models) allowed evaluating the dynamic nature of exogenous climate processes interacting with the endogenous recruitment process. Using different model selection criteria our results reveal that in contrast to NAO and AMO, the BSI shows a significant positive but delayed signal on the annual dynamics of herring recruitment. The westward influence of the Siberian high is considered strongly suppressing the influence of the NAO in this area leading to a higher explanatory power of the BSI reflecting the atmospheric pressure regime on a North-South transect between Oslo, Norway and Szczecin, Poland. We suggest incorporating climate-induced effects into stock and risk assessments and management strategies as part of the EU ecosystem approach to support sustainable herring fisheries in the Western Baltic Sea.	[Groeger, Joachim P.] Thunen Inst Sea Fisheries, Hamburg, Germany; [Groeger, Joachim P.] Univ Rostock, Inst Biosci, D-18055 Rostock, Germany; [Hinrichsen, Hans-Harald] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Polte, Patrick] Thunen Inst Balt Sea Fisheries, Rostock, Germany	Johann Heinrich von Thunen Institute; University of Rostock; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Johann Heinrich von Thunen Institute	Groger, JP (corresponding author), Thunen Inst Sea Fisheries, Hamburg, Germany.	joachim.groeger@t-online.de			European Community [266445]	European Community(European Commission)	For one of the authors (Hans-Harald Hinrichsen) the research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement No. 266445 for the project "Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arula T, 2012, THESIS U TARTU ESTON, V226; BAKUN A, 1991, ICES J MAR SCI, V48, P343, DOI 10.1093/icesjms/48.3.343; Baumann H, 2006, CAN J FISH AQUAT SCI, V63, P2191, DOI 10.1139/F06-112; Biester E, 1979, ICES CM J; BLAXTER JHS, 1985, CAN J FISH AQUAT SCI, V42, P21; Borja A, 1998, FISH OCEANOGR, V7, P375, DOI 10.1046/j.1365-2419.1998.00064.x; Box G., 1970, TIME SERIES ANAL; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Brander K, 2004, CAN J FISH AQUAT SCI, V61, P1558, DOI 10.1139/F04-087; Brodziak J, 2005, ICES J MAR SCI, V62, P1394, DOI 10.1016/j.icesjms.2005.04.019; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KP, 2004, AMST WORKSH MOD SEL; Cardinale M, 2009, MAR ECOL PROG SER, V388, P221, DOI 10.3354/meps08125; Clark RA, 2003, GLOBAL CHANGE BIOL, V9, P1669, DOI 10.1046/j.1365-2486.2003.00685.x; Cushing D.H., 1982, CLIMATE FISHERIES; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cushing DH, 1975, MARINE ECOLOGY FISHE; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fahrmeir  L., 1996, MULTIVARIATE STAT VE; Fassler SMM, 2011, FISH OCEANOGR, V20, P530, DOI 10.1111/j.1365-2419.2011.00600.x; Finney BP, 2000, SCIENCE, V290, P795, DOI 10.1126/science.290.5492.795; Fogarty M, 2008, MITIG ADAPT STRAT GL, V13, P453, DOI 10.1007/s11027-007-9131-4; Fogarty MJ, 2002, GLO CH IGBP, P27; Glantz M. H., 1992, CLIMATE VARIABILITY; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Groger J, 2006, J SEA RES, V55, P266, DOI 10.1016/j.seares.2005.11.005; Groger JP, 2011, ICES J MAR SCI, V68, P592, DOI 10.1093/icesjms/fsq196; Groger JP, 2010, ICES J MAR SCI, V67, P454, DOI 10.1093/icesjms/fsp259; Groger JP, 2007, FISH RES, V84, P189, DOI 10.1016/j.fishres.2006.10.018; Groger JP, 2011, ECOL INDIC, V11, P1084, DOI 10.1016/j.ecolind.2010.12.008; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hartung J, 2002, STATISTIK; Hinrichsen HH, 2007, OCEANOLOGIA, V49, P381; Hinrichsen HH, 2003, J SEA RES, V49, P187, DOI 10.1016/S1385-1101(03)00006-6; Hinrichsen HH, 2002, J MARINE SYST, V32, P281, DOI 10.1016/S0924-7963(02)00040-4; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X; ICES, 2012, REP ICES WORK GROUP; ICES, 2011, REP ICES HELCOM WORK; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Luatkepohl H., 1993, INTRO MULTIPLE TIME, DOI 10.1007/978-3-642-61695-2; Mollmann C, 2005, ICES J MAR SCI, V62, P1270, DOI 10.1016/j.icesjms.2005.04.021; Nielsen JR, 2001, FISH RES, V50, P235; Nissling A, 2003, J FISH BIOL, V63, P280, DOI 10.1046/j.1095-8649.2003.00139.x; Noakes D, 1987, NAT RESOUR MODEL, V2, P213; Osborn TJ, 1999, CLIM DYNAM, V15, P685, DOI 10.1007/s003820050310; Ottersen G, 2006, FISH OCEANOGR, V15, P230, DOI 10.1111/j.1365-2419.2006.00404.x; Petereit C, 2009, SCI MAR, V73, P59, DOI 10.3989/scimar.2009.73s1059; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Polte P, 2014, ICES J MAR SCI, V71, P982, DOI 10.1093/icesjms/fst050; Post E, 2004, MARINE ECOSYSTEMS AND CLIMATE VARIATION, P165; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Reum JCP, 2011, MAR ECOL PROG SER, V425, P203, DOI 10.3354/meps08997; Schlittgen R., 2001, ANGEW ZEITREIHENANAL; Schlittgen R, 2001, ZEITREIHENANALYSE; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sissenwine M.P., 1988, P129; Skogen MD, 2005, FISH OCEANOGR, V14, P64, DOI 10.1111/j.1365-2419.2004.00324.x; Solow AR, 2001, CLIMATIC CHANGE, V49, P359, DOI 10.1023/A:1010720408793; Stenseth N., 2004, MARINE ECOSYSTEMS CL; Tunberg BG, 1998, MAR ECOL PROG SER, V170, P85, DOI 10.3354/meps170085; van Deurs Mikael, 2007, Acta Ichthyologica et Piscatoria, V37, P73, DOI 10.3750/AIP2007.37.2.01; Wood C.M., 1997, GLOBAL WARMING IMPLI; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	13	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87525	10.1371/journal.pone.0087525	http://dx.doi.org/10.1371/journal.pone.0087525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586279	Green Accepted, Green Published, gold			2022-12-25	WOS:000332385900007
J	Valdiani, A; Talei, D; Tan, SG; Kadir, MA; Maziah, M; Rafii, MY; Sagineedu, SR				Valdiani, Alireza; Talei, Daryush; Tan, Soon Guan; Kadir, Mihdzar Abdul; Maziah, Mahmood; Rafii, Mohd Yusop; Sagineedu, Sreenivasa Rao			A Classical Genetic Solution to Enhance the Biosynthesis of Anticancer Phytochemicals in Andrographis paniculata Nees	PLOS ONE			English	Article							PLANT-GROWTH REGULATORS; QUANTITATIVE CHARACTERS; INBREEDING DEPRESSION; ACTIVE DITERPENOIDS; DIALLEL CROSS; YIELD; HETEROSIS; 14-DEOXY-11,12-DIDEHYDROANDROGRAPHOLIDE; DIFFERENTIATION; DOMINANCE	Andrographolides, the diterpene lactones, are major bioactive phytochemicals which could be found in different parts of the medicinal herb Andrographis paniculata. A number of such compounds namely andrographolide (AG), neoandrographolide (NAG), and 14-deoxy-11,12-didehydroandrographolide (DDAG) have already attracted a great deal of attention due to their potential therapeutic effects in hard-to-treat diseases such as cancers and HIV. Recently, they have also been considered as substrates for the discovery of novel pharmaceutical compounds. Nevertheless, there is still a huge gap in knowledge on the genetic pattern of the biosynthesis of these bioactive compounds. Hence, the present study aimed to investigate the genetic mechanisms controlling the biosynthesis of these phytochemicals using a diallel analysis. The high performance liquid chromatography analysis of the three andrographolides in 210 F-1 progenies confirmed that the biosynthesis of these andrographolides was considerably increased via intraspecific hybridization. The results revealed high, moderate and low heterosis for DDAG, AG and NAG, respectively. Furthermore, the preponderance of non-additive gene actions was affirmed in the enhancement of the three andrographolides contents. The consequence of this type of gene action was the occurrence of high broad-sense and low narrow-sense heritabilities for the above mentioned andrographolides. The prevalence of non-additive gene action suggests the suitability of heterosis breeding and hybrid seed production as a preferred option to produce new plant varieties with higher andrographolide contents using the wild accessions of A. paniculata. Moreover, from an evolutionary point of view, the occurrence of population bottlenecks in the Malaysian accessions of A. paniculata was unveiled by observing a low level of additive genetic variance (V-A) for all the andrographolides.	[Valdiani, Alireza; Maziah, Mahmood] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor De, Malaysia; [Talei, Daryush; Tan, Soon Guan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor De, Malaysia; [Talei, Daryush] Shahed Univ, Med Plant Res Ctr, Tehran, Iran; [Kadir, Mihdzar Abdul] Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Serdang, Selangor De, Malaysia; [Rafii, Mohd Yusop] Univ Putra Malaysia, Inst Trop Agr, Serdang, Selangor De, Malaysia; [Sagineedu, Sreenivasa Rao] Int Med Univ, Dept Pharmaceut Chem, Sch Pharm, Kuala Lumpur 57000, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Shahed University; Universiti Putra Malaysia; Universiti Putra Malaysia; International Medical University Malaysia	Valdiani, A (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor De, Malaysia.	alireza.valdiani@gmail.com	Rafii, M.Y./G-9925-2015; Tan, S G/B-2448-2010; Talei, Daryush/V-9062-2019; Sagineedu, Sreenivasa Rao/G-3910-2013; Tan, Soon Guan/V-1782-2019	Rafii, M.Y./0000-0003-4763-6367; Tan, S G/0000-0001-9960-4493; Talei, Daryush/0000-0001-8699-850X; Sagineedu, Sreenivasa Rao/0000-0002-4746-1432; Tan, Soon Guan/0000-0001-9960-4493; Valdiani, Alireza/0000-0003-4290-8730	Universiti Putra Malaysia	Universiti Putra Malaysia	Authors appreciate Universiti Putra Malaysia for supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaah G., 2012, PRINCIPLES PLANT GEN; Alireza Biabani, 2012, Australian Journal of Crop Science, V6, P1030; Anuradha VE, 2010, PESTIC BIOCHEM PHYS, V98, P312, DOI 10.1016/j.pestbp.2010.07.002; Aromdee C, 2012, EXPERT OPIN THER PAT, V22, P169, DOI 10.1517/13543776.2012.661718; BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; BALMAIN A, 1973, J CHEM SOC PERK T 1, P1247, DOI 10.1039/p19730001247; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Birchler JA, 2006, P NATL ACAD SCI USA, V103, P12957, DOI 10.1073/pnas.0605627103; BOORSMA WA, 1896, MEDS LANDS PLANT, V18, P63; CHAKRABORTY R, 1982, GENET RES, V39, P303, DOI 10.1017/S0016672300020978; Chao W. W., 2010, CHIN MED, V5, P1, DOI DOI 10.1186/1749-8546-5-17; CRUSIO WE, 1984, BEHAV GENET, V14, P81, DOI 10.1007/BF01066070; Dabholkar A.R., 1999, ELEMENTS BIOMETRICAL; Daryush Talei, 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V10, P639; Dordevic R, 2010, GENETIKA-BELGRADE, V42, P575, DOI 10.2298/GENSR1003575D; Falconer D. S., 1989, Introduction to quantitative genetics.; Gjuvsland AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009379; Gorter K., 1911, REC TRAV CHIM, V30, P151; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Gudhate PP, 2009, PHARMACOGN MAG, V5, P249; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Holt-Gimenez E., 2009, FOOD REBELLIONS CRIS; Jebril A.A., 2003, 5 NAT GEN C KUAL LUM; KLEIPOOL RJC, 1952, NATURE, V169, P33, DOI 10.1038/169033c0; Laddha K. S., 2010, International Journal of Pharma and Bio Sciences, V1, P1, DOI 10.5138/ijaps.2010.0976.1055.01001; Lee MJ, 2010, J ETHNOPHARMACOL, V132, P497, DOI 10.1016/j.jep.2010.07.057; Leimu R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012614; Li ZK, 2001, GENETICS, V158, P1737; Lomlim L, 2003, CHEM PHARM BULL, V51, P24, DOI 10.1248/cpb.51.24; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Man Singh, 2011, Agricultural Journal, V6, P115, DOI 10.3923/aj.2011.115.118; MATSUDA T, 1994, CHEM PHARM BULL, V42, P1216, DOI 10.1248/cpb.42.1216; Mc-Whirter K. S., 1979, PLANT BREEDING, P79; Omholt SW, 2000, GENETICS, V155, P969; Ooi JP, 2011, LIFE SCI, V88, P447, DOI 10.1016/j.lfs.2010.12.019; PETR FC, 1966, CROP SCI, V6, P259, DOI 10.2135/cropsci1966.0011183X000600030013x; Pholphana N, 2004, PHYTOCHEM ANALYSIS, V15, P365, DOI 10.1002/pca.789; Rajpar I, 2011, J MED PLANTS RES, V5, P5528; Sanjay Patidar, 2011, World Applied Sciences Journal, V15, P1095; Sanjutha S., 2008, Research Journal of Agriculture and Biological Sciences, V4, P141; Saravanan R, 2008, INDIAN J HORTIC, V65, P220; *SAS I INC, 2009, JMP 8 US GUID; SAS Institute Inc, 2009, SAS SAS SAT US GUID; Schmidt J., 1919, COMPT REND LAB CALSB, V14, P33; SECANSKI M., 2004, GENETIKA, V36, P121; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; Subbaraju, 2007, INT J APPL SCI ENG, V5, P27; Talei D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/319047; Talei D, 2013, EUPHYTICA, V189, P147, DOI 10.1007/s10681-012-0782-1; Tan ML, 2012, FOOD CHEM TOXICOL, V50, P431, DOI 10.1016/j.fct.2011.11.001; Tang CL, 2012, ARCH PHARM, V345, P647, DOI 10.1002/ardp.201200008; Teklewold A, 2005, CROP SCI, V45, P2629, DOI 10.2135/cropsci2005.0085; Thisoda P, 2006, EUR J PHARMACOL, V553, P39, DOI 10.1016/j.ejphar.2006.09.052; Tzeng YM, 2012, LIFE SCI, V90, P257, DOI 10.1016/j.lfs.2011.11.004; UNDP, 2002, PROMOTING HERBAL DRU, V10, P45; Valdiani A, 2013, MOL BIOL REP, V40, P1775, DOI 10.1007/s11033-012-2231-6; Valdiani A, 2012, SCI WORLD J, DOI 10.1100/2012/297545; Valdiani A, 2012, GENE, V505, P23, DOI 10.1016/j.gene.2012.05.056; Valdiani A, 2012, MOL BIOL REP, V39, P5409, DOI 10.1007/s11033-011-1341-x; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768; Wang JL, 1998, GENETICS, V150, P435; Williams CG, 2001, GENETICS, V159, P1283; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu J, 2012, INT J BIOL MACROMOL, V51, P738, DOI 10.1016/j.ijbiomac.2012.06.035; Zdravkovic J, 2000, ACTA PHYSIOL PLANT, V22, P261, DOI 10.1007/s11738-000-0027-0; Zhang YD, 2005, AGRON J, V97, P1097, DOI 10.2134/agronj2004.0260; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zhao YF, 2006, J PHARMACEUT BIOMED, V40, P157, DOI 10.1016/j.jpba.2005.04.003; Zivanovic T., 2005, Journal of Agricultural Sciences, Belgrade, V50, P9	70	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87034	10.1371/journal.pone.0087034	http://dx.doi.org/10.1371/journal.pone.0087034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586262	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000332385900005
J	Cruz-Guilloty, F; Saeed, AM; Duffort, S; Cano, M; Ebrahimi, KB; Ballmick, A; Tan, YH; Wang, H; Laird, JM; Salomon, RG; Handa, JT; Perez, VL				Cruz-Guilloty, Fernando; Saeed, Ali M.; Duffort, Stephanie; Cano, Marisol; Ebrahimi, Katayoon B.; Ballmick, Asha; Tan, Yaohong; Wang, Hua; Laird, James M.; Salomon, Robert G.; Handa, James T.; Perez, Victor L.			T Cells and Macrophages Responding to Oxidative Damage Cooperate in Pathogenesis of a Mouse Model of Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; ADAPTIVE IMMUNITY; DRUSEN; ACTIVATION; BIOMARKERS; RISK; IDENTIFICATION; POLARIZATION; PLASTICITY; INDUCTION	Age-related macular degeneration (AMD) is a major disease affecting central vision, but the pathogenic mechanisms are not fully understood. Using a mouse model, we examined the relationship of two factors implicated in AMD development: oxidative stress and the immune system. Carboxyethylpyrrole (CEP) is a lipid peroxidation product associated with AMD in humans and AMD-like pathology in mice. Previously, we demonstrated that CEP immunization leads to retinal infiltration of pro-inflammatory M1 macrophages before overt retinal degeneration. Here, we provide direct and indirect mechanisms for the effect of CEP on macrophages, and show for the first time that antigen-specific T cells play a leading role in AMD pathogenesis. In vitro, CEP directly induced M1 macrophage polarization and production of M1-related factors by retinal pigment epithelial (RPE) cells. In vivo, CEP eye injections in mice induced acute pro-inflammatory gene expression in the retina and human AMD eyes showed distinctively diffuse CEP immunolabeling within RPE cells. Importantly, interferon-gamma (IFN-gamma ) and interleukin-17 (IL-17)-producing CEP-specific T cells were identified ex vivo after CEP immunization and promoted M1 polarization in co-culture experiments. Finally, T cell immunosuppressive therapy inhibited CEP-mediated pathology. These data indicate that T cells and M1 macrophages activated by oxidative damage cooperate in AMD pathogenesis.	[Cruz-Guilloty, Fernando; Saeed, Ali M.; Duffort, Stephanie; Ballmick, Asha; Tan, Yaohong; Perez, Victor L.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Cruz-Guilloty, Fernando; Perez, Victor L.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Cano, Marisol; Ebrahimi, Katayoon B.; Handa, James T.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Wang, Hua; Laird, James M.; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University	Cruz-Guilloty, F (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	fcruzguilloty@gmail.com; Vperez4@med.miami.edu	Wang, Hua/N-9400-2015; Perez, Victor L./AAY-8633-2020	Wang, Hua/0000-0002-2109-5497; Salomon, Robert/0000-0001-9456-3557	Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research; NIH [P30EY14801]; Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute) [NIH R01-GM21249, NIH EY14005, EY019904]; RPB Senior Scientist Award; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; NATIONAL EYE INSTITUTE [P30EY014801, R01EY019904, R01EY014005, R01EY016813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute); RPB Senior Scientist Award; Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Edward N. & Della L. Thome Memorial Foundation Bank of America N.A. Trustee Award Program in Macular Degeneration Research (VLP, JTH); NIH P30EY14801 (Center Grant); Research to Prevent Blindness (Unrestricted Grant to the Bascom Palmer Eye Institute); NIH R01-GM21249 (RGS), NIH EY14005 (JTH), EY019904 (JTH), and RPB Senior Scientist Award (JTH). JTH is the Robert Bond Welch Professor. A. M. S. acknowledges partial support and assistance from the Sheila and David Fuente Graduate Program in Cancer Biology, Sylvester Comprehensive Cancer Center. FCG was supported by a Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Barshes NR, 2004, FRONT BIOSCI-LANDMRK, V9, P411, DOI 10.2741/1249; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Cherepanoff S, 2010, BRIT J OPHTHALMOL, V94, P918, DOI 10.1136/bjo.2009.165563; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Cousins SW, 2004, ARCH OPHTHALMOL-CHIC, V122, P1013, DOI 10.1001/archopht.122.7.1013; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cruz-Guilloty F, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/503725; Cruz-Guilloty F, 2011, NATURE, V478, P42, DOI 10.1038/478042a; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Faber C, 2013, OPHTHALMOLOGY; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gu JY, 2010, ADV EXP MED BIOL, V664, P411, DOI 10.1007/978-1-4419-1399-9_47; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hermansson A, 2010, J EXP MED, V207, P1081, DOI 10.1084/jem.20092243; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, MOL NEUROBIOL, V41, P290, DOI 10.1007/s12035-010-8110-z; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Lu L, 2009, BIOORGAN MED CHEM, V17, P7548, DOI 10.1016/j.bmc.2009.09.009; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Morohoshi K, 2009, J AUTOIMMUN, V33, P247, DOI 10.1016/j.jaut.2009.09.003; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Parmeggiani F, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/546786; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; SARKS SH, 1980, T OPHTHAL SOC UK, V100, P414; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tuo JS, 2012, OCUL IMMUNOL INFLAMM, V20, P27, DOI 10.3109/09273948.2011.628432; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/348092; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan C, 1998, COMP BIOCHEM PHYS B, V120, P785, DOI 10.1016/S0305-0491(98)10079-2; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	60	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88201	10.1371/journal.pone.0088201	http://dx.doi.org/10.1371/journal.pone.0088201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586307	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900025
J	Amouzou, A; Banda, B; Kachaka, W; Joos, O; Kanyuka, M; Hill, K; Bryce, J				Amouzou, Agbessi; Banda, Benjamin; Kachaka, Willie; Joos, Olga; Kanyuka, Mercy; Hill, Kenneth; Bryce, Jennifer			Monitoring Child Mortality through Community Health Worker Reporting of Births and Deaths in Malawi: Validation against a Household Mortality Survey	PLOS ONE			English	Article							STATISTICS; SYSTEMS	Background: The rate of decline in child mortality is too slow in most African countries to achieve the Millennium Development Goal of reducing under-five mortality by two-thirds between 1990 and 2015. Effective strategies to monitor child mortality are needed where accurate vital registration data are lacking to help governments assess and report on progress in child survival. We present results from a test of a mortality monitoring approach based on recording of births and deaths by specially trained community health workers (CHWs) in Malawi. Methods and Findings: Government-employed community health workers in Malawi are responsible for maintaining a Village Health Register, in which they record births and deaths that occur in their catchment area. We expanded on this system to provide additional training, supervision and incentives. We tested the equivalence between child mortality rates obtained from data on births and deaths collected by 160 randomly-selected and trained CHWs over twenty months in two districts to those computed through a standard household mortality survey. CHW reports produced an under-five mortality rate that was 84% (95% CI: [0.71,1.00]) of the household survey mortality rate and statistically equivalent to it. However, CHW data consistently underestimated under-five mortality, with levels of under-estimation increasing over time. Under-five deaths were more likely to be missed than births. Neonatal and infant deaths were more likely to be missed than older deaths. Conclusion: This first test of the accuracy and completeness of vital events data reported by CHWs in Malawi as a strategy for monitoring child mortality shows promising results but underestimated child mortality and was not stable over the four periods assessed. Given the Malawi government's commitment to strengthen its vital registration system, we are working with the Ministry of Health to implement a revised version of the approach that provides increased support to CHWs.	[Amouzou, Agbessi; Joos, Olga; Hill, Kenneth; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Banda, Benjamin; Kachaka, Willie; Kanyuka, Mercy] Malawi Natl Stat Off, Zomba, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Amouzou, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	aamouzou@jhsph.edu		Amouzou, Agbessi/0000-0002-6262-3866; Joos, Olga/0000-0003-0335-4982	Canadian Cooperation through the Real-Time Results Tracking grant [7056791]	Canadian Cooperation through the Real-Time Results Tracking grant	The RMM project was funded by the Canadian Cooperation through the Real-Time Results Tracking grant (#7056791) implemented by the Institute for International Programs (IIP) at the Johns Hopkins Bloomberg School of Public Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; [Anonymous], LEV TRENDS CHILD MOR; Arudo J, 2003, AM J TROP MED HYG, V68, P30, DOI 10.4269/ajtmh.2003.68.30; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Edward A, 2007, T ROY SOC TROP MED H, V101, P814, DOI 10.1016/j.trstmh.2007.02.025; International Programs Center for Technical Assistance, 2013, CSPRO US GUID VERS 5; Kok MC, 2013, MALAWI MED J, V25, P5; Korenromp EL, 2004, INT J EPIDEMIOL, V33, P1293, DOI 10.1093/ije/dyh182; Lohr SL, 1999, SAMPLING DESIGN ANAL, P489; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Mathers C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000265; Ministry of Health, 2008, HLTH SURV ASS TRAIN; National Statistical Office (NSO), 2009, POP HOUS CENS 2008; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Nsona H, 2012, AM J TROP MED HYG, V87, P54, DOI 10.4269/ajtmh.2012.11-0759; Requejo J, 2012, COUNTDOWN 2015 BUILD; Rosner B., 2000, FUNDAMENTALS BIOSTAT, P792; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; StataCorp, 2011, STAT REL 12 STAT SOF; The Institute for International Programs, 2007, EXP CONS METH ALT MO	21	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88939	10.1371/journal.pone.0088939	http://dx.doi.org/10.1371/journal.pone.0088939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558453	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700099
J	de Ronde, JJ; Bonder, MJ; Lips, EH; Rodenhuis, S; Wessels, LFA				de Ronde, Jorma J.; Bonder, Marc Jan; Lips, Esther H.; Rodenhuis, Sjoerd; Wessels, Lodewyk F. A.			Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; GENE-EXPRESSION PROFILES; CYCLOPHOSPHAMIDE CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; DOXORUBICIN; PACLITAXEL; FLUOROURACIL; PREDICTOR; TRASTUZUMAB; RESISTANCE	Introduction: Despite continuous efforts, not a single predictor of breast cancer chemotherapy resistance has made it into the clinic yet. However, it has become clear in recent years that breast cancer is a collection of molecularly distinct diseases. With ever increasing amounts of breast cancer data becoming available, we set out to study if gene expression based predictors of chemotherapy resistance that are specific for breast cancer subtypes can improve upon the performance of generic predictors. Methods: We trained predictors of resistance that were specific for a subtype and generic predictors that were not specific for a particular subtype, i.e. trained on all subtypes simultaneously. Through a rigorous double-loop cross-validation we compared the performance of these two types of predictors on the different subtypes on a large set of tumors all profiled on the same expression platform (n = 394). We evaluated predictors based on either mRNA gene expression or clinical features. Results: For HER2+, ER- breast cancer, subtype specific predictor based on clinical features outperformed the generic, nonspecific predictor. This can be explained by the fact that the generic predictor included HER2 and ER status, features that are predictive over the whole set, but not within this subtype. In all other scenarios the generic predictors outperformed the subtype specific predictors or showed equal performance. Conclusions: Since it depends on the specific context which type of predictor - subtype specific or generic-performed better, it is highly recommended to evaluate both specific and generic predictors when attempting to predict treatment response in breast cancer.	[de Ronde, Jorma J.; Bonder, Marc Jan; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands; [de Ronde, Jorma J.; Lips, Esther H.] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands; [Lips, Esther H.] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [Rodenhuis, Sjoerd] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Delft Univ Technol, Fac EEMCS, Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology	de Ronde, JJ (corresponding author), Netherlands Canc Inst, Dept Mol Carcinogenesis, Amsterdam, Netherlands.	jorma.deronde@gmail.com		Bonder, Marc Jan/0000-0002-8431-3180	CTMM, the Center for Translational Molecular Medicine, project Breast CARE [03O-104]	CTMM, the Center for Translational Molecular Medicine, project Breast CARE	JR and EL were funded by CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project Breast CARE (Grant 03O-104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2011, BRIEFINGS BIOINFORMA; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Bertucci F, 2004, CANCER RES, V64, P8558, DOI 10.1158/0008-5472.CAN-04-2696; Borst P, 2010, CELL CYCLE, V9, P4836, DOI 10.4161/cc.9.24.14326; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Horiguchi J, 2011, ANTICANCER RES, V31, P3041; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Miyake T, 2012, CANCER SCI, V103, P913, DOI 10.1111/j.1349-7006.2012.02231.x; Naoi Y, 2011, CANCER-AM CANCER SOC, V117, P3682, DOI 10.1002/cncr.25953; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; R Development Core Team, 2012, R LANG ENV STAT COMP; Romanski P, 2009, FSELECTOR SELECTING; Sorlie T, 2006, MOL CANCER THER, V5, P2914, DOI 10.1158/1535-7163.MCT-06-0126; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Valachis A, 2011, BREAST, V20, P485, DOI 10.1016/j.breast.2011.06.009; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Witten IH, 2011, MOR KAUF D, P1; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88551	10.1371/journal.pone.0088551	http://dx.doi.org/10.1371/journal.pone.0088551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558399	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700045
J	Hu, G; Lu, F; Zhai, BP; Lu, MH; Liu, WC; Zhu, F; Wu, XW; Chen, GH; Zhang, XX				Hu, Gao; Lu, Fang; Zhai, Bao-Ping; Lu, Ming-Hong; Liu, Wan-Cai; Zhu, Feng; Wu, Xiang-Wen; Chen, Gui-Hua; Zhang, Xiao-Xi			Outbreaks of the Brown Planthopper Nilaparvata lugens (Stal) in the Yangtze River Delta: Immigration or Local Reproduction?	PLOS ONE			English	Article							RICE PLANTHOPPERS; MIGRATION; DELPHACIDAE; HOMOPTERA; FLIGHT; PESTS; CHINA	An effective control strategy for migratory pests is difficult to implement because the cause of infestation (i.e., immigration or local reproduction) is often not established. In particular, the outbreak mechanisms of the brown planthopper, Nilaparvata lugens (Stal), an insect causing massive losses in rice fields in the Yangtze River Delta in China, are frequently unclear. Field surveys of N. lugens were performed in Jiangsu and Zhejiang Provinces in 2008 to 2010 and related historical data from 2003 onwards were collected and analyzed to clarify the cause of these infestations. Results showed that outbreaks of N. lugens in the Yangtze River Delta were mostly associated with an extremely high increase in population. Thus, reproduction rather than immigration from distant sources were the cause of the infestations. Although mass migration occurred late in the season (late August and early September), the source areas of N. lugens catches in the Yangtze River Delta were mainly located in nearby areas, including the Yangtze River Delta itself, Anhui and northern Jiangxi Provinces. These regions collectively form the lower-middle reaches of the Yangtze River, and the late migration can thus be considered as an internal bioflow within one population.	[Hu, Gao; Lu, Fang; Zhai, Bao-Ping; Zhang, Xiao-Xi] Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Lu, Ming-Hong; Liu, Wan-Cai] China Natl Agrotec Extens & Serv Ctr, Div Pest Forecasting, Beijing, Peoples R China; [Zhu, Feng] Plant Protect Stn Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Wu, Xiang-Wen] Plant Protect Stn Shanghai City, Shanghai, Peoples R China; [Chen, Gui-Hua] Plant Protect Stn Jinhua City, Jinhua, Peoples R China	Nanjing Agricultural University	Hu, G (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.	hugao@njau.edu.cn		Hu, Gao/0000-0002-1000-5687	National '973' Program of China [2010CB126200]; Shanghai City Sci-Tech Joint Research Project in Yangtze River Delta of Shanghai Municipal Science and Technology Commission [13395810100]	National '973' Program of China(National Basic Research Program of China); Shanghai City Sci-Tech Joint Research Project in Yangtze River Delta of Shanghai Municipal Science and Technology Commission	Funding provided by the National '973' Program of China (2010CB126200), Shanghai City Sci-Tech Joint Research Project in Yangtze River Delta of Shanghai Municipal Science and Technology Commission (13395810100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[包云轩 BAO Yunxuan], 2008, [中国农业气象, Chinese Journal of Agrometeorology], V29, P347; Bottrell DG, 2012, J ASIA-PAC ENTOMOL, V15, P122, DOI 10.1016/j.aspen.2011.09.004; Brar D.S., 2009, PLANT HOPPERS NEW TH, P401; CHANG SS, 1980, ACTA ENTOMOL SINICA, V23, P130; CHEN JC, 1979, ACTA ENTOMOL SINICA, V22, P280; CHEN RC, 1984, ACTA ENTOMOL SINICA, V27, P121; CHEN RC, 1980, J NANJING AGR U, V2, P42; Chen Y. Y., 1996, JIANGSU AGR SCI, V24, P29; Cheng J. A., 1992, Chinese Journal of Rice Science, V6, P21; [程家安 Cheng Jiaan], 2006, [植物保护, Plant Protection], V32, P1; CHENG SN, 1979, ACTA ENTOMOL SINICA, V22, P1; Cheng X. N., 2003, BROWN PLANTHOPPER OC; DAY RK, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P323; Deng W., 1981, ACTA PHYTOPHYL SIN, V8, P73; Deveson ED, 2005, AUSTRAL ECOL, V30, P928, DOI 10.1111/j.1442-9993.2005.01536.x; Ding ZZ, 1985, JIANGSU AGR SCI, V13, P1; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; GUO R, 2006, CHIN AGR YB, P376; [侯婷婷 Hou Tingting], 2004, [中国农业气象, Agricultural Meteorology of China], V25, P28; Hu G, 2011, B ENTOMOL RES, V101, P187, DOI 10.1017/S0007485310000313; Hu G, 2010, ENVIRON ENTOMOL, V39, P1705, DOI 10.1603/EN09214; Kisimoto R., 1985, Chinese Journal of Entomology, V4, P39; Kisimoto R, 1995, INSECT MIGRATION TRA, P93; Li Y. D., 1984, ACTA PHYTOPHYLACICA, V11, P101; [芦芳 Lu Fang], 2010, [生态学报, Acta Ecologica Sinica], V30, P3215; MA S. C., 1958, ACTA ENT SINICA, V8, P1; (MAPRC) Ministry of Agriculture of the People's Republic of China, 1995, 157941995 MAPRC GBT; Ohkubo N, 1971, Japanese Journal of Applied Entomology and Zoology, V15, P8; Otuka A, 2008, APPL ENTOMOL ZOOL, V43, P527, DOI 10.1303/aez.2008.527; PEDGLEY DE, 1993, INT J PEST MANAGE, V39, P3, DOI 10.1080/09670879309371751; PU MH, 1979, PLANT PROTECTION, V5, P1; Qi Guojun, 2010, Acta Phytophylacica Sinica, V37, P193; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1991, ECOL ENTOMOL, V16, P471, DOI 10.1111/j.1365-2311.1991.tb00240.x; ROSENBERG LJ, 1987, J ANIM ECOL, V56, P39, DOI 10.2307/4798; Sogawa K, 2003, CHINESE J RICE SCI, V17, P20; Wang YH, 2008, J ECON ENTOMOL, V101, P515, DOI 10.1603/0022-0493(2008)101[515:ISSASR]2.0.CO;2; Ye ZC, 1981, CHINESE BULL ENTOMOL, V18, P97; Zang Wei, 1997, Nanjing Nongye Daxue Xuebao, V20, P32; Zhai B.-P., 2006, CHINESE BULL ENTOMOL, V43, P585; Zhai Bao-Ping, 2011, Chinese Journal of Applied Entomology, V48, P1184; Zhao S. F, 1992, JIANGXI NONGYE DAXUE, V4, P74; Zheng DB, 2014, J APPL ENTOMOL, V138, P67, DOI 10.1111/jen.12067; Zhong DL, 1984, CHINESE BULL ENTOMOL, V22, P97; Zhu M, 2006, AGR FOREST METEOROL, V138, P192, DOI 10.1016/j.agrformet.2006.05.001	45	64	76	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88973	10.1371/journal.pone.0088973	http://dx.doi.org/10.1371/journal.pone.0088973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558459	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700105
J	Lu, FM; Huo, YJ; Li, ML; Chen, H; Liu, F; Wang, YF; Long, ZL; Duan, XJ; Zhang, J; Zeng, L; Chen, HF				Lu, Fengmei; Huo, Yajun; Li, Meiling; Chen, Heng; Liu, Feng; Wang, Yifeng; Long, Zhiliang; Duan, Xujun; Zhang, Jiang; Zeng, Ling; Chen, Huafu			Relationship between Personality and Gray Matter Volume in Healthy Young Adults: A Voxel-Based Morphometric Study	PLOS ONE			English	Article							REGIONAL BRAIN VOLUME; EXTROVERSION-INTROVERSION; CEREBELLUM; AMYGDALA; STIMULATION; NEUROTICISM; MATURATION; FMRI; SELF	This study aims to investigate the neurostructural foundations of the human personality in young adults. High-resolution structural T1-weighted MR images of 71 healthy young individuals were processed using voxel-based morphometric (VBM) approach. Multiple regression analyses were performed to identify the associations between personality traits and gray matter volume (GMV). The Eysenck Personality Questionnaire-Revised, Short Scale for Chinese was chosen to assess the personality traits. This scale includes four dimensions, namely, extraversion, neuroticism, psychoticism, and lie. Particularly, we studied on two dimensions (extraversion and neuroticism) of Eysenck's personality. Our results showed that extraversion was negatively correlated with GMV of the bilateral amygdala, the bilateral parahippocampal gyrus, the right middle temporal gyrus, and the left superior frontal gyrus, all of which are involved in emotional and social cognitive processes. These results might suggest an association between extraversion and affective processing. In addition, a positive correlation was detected between neuroticism and GMV of the right cerebellum, a key brain region for negative affect coordination. Meanwhile, a negative association was revealed between GMV of the left superior frontal gyrus and neuroticism. These results may prove that neuroticism is related to several brain regions involved in regulating negative emotions. Based on those findings, we concluded that brain regions involved in social cognition and affective process accounted for modulation and shaping of personality traits among young individuals. Results of this study may serve as a basis for elucidating the anatomical factors of personality.	[Lu, Fengmei; Huo, Yajun; Li, Meiling; Chen, Heng; Liu, Feng; Wang, Yifeng; Long, Zhiliang; Duan, Xujun; Zhang, Jiang; Zeng, Ling; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China	Chen, HF (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Sichuan, Peoples R China.	chenhf@uestc.edu.cn	Li, Meiling/AAF-1917-2020; Liu, Feng/W-7572-2019	Li, Meiling/0000-0001-6378-5579; Liu, Feng/0000-0002-3570-4222	973 project [2012CB517901]; Natural Science Foundation of China [61035006, 61125304, 81171406, 61273361]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120185110028]; Key Technology R&D Program of Sichuan Province [2012SZ0159]	973 project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Technology R&D Program of Sichuan Province	This work was supported by the 973 project 2012CB517901; and Natural Science Foundation of China (Grant Nos. 61035006, 61125304, 81171406 and 61273361), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20120185110028), and the Key Technology R&D Program of Sichuan Province (Grant No. 2012SZ0159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barros-Loscertales A, 2006, EUR J NEUROSCI, V24, P2071, DOI 10.1111/j.1460-9568.2006.05084.x; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; COSTA PT, 1988, J PERS SOC PSYCHOL, V54, P853, DOI 10.1037/0022-3514.54.5.853; Coutinho J. F., 2013, BRAIN IMAGING BEHAV, P1; Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421; Depue RA, 1999, BEHAV BRAIN SCI, V22, P541, DOI 10.1017/S0140525X99462041; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; EYSENCK HJ, 1992, PERS INDIV DIFFER, V13, P757, DOI 10.1016/0191-8869(92)90050-Y; Eysenck HJ, 1997, J PERS SOC PSYCHOL, V73, P1224, DOI 10.1037/0022-3514.73.6.1224; EYSENCK HJ, 1946, P ROY SOC MED, V40, P75, DOI 10.1177/003591574604000209; Eysenck HJ, 1967, T PUB, V199, P1031; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Eysenck HJ, 1990, BIOL DIMENSIONS PERS, P244; Ferrucci R, 2012, COGNITION EMOTION, V26, P786, DOI 10.1080/02699931.2011.619520; Forsman LJ, 2012, NEUROSCI RES, V72, P59, DOI 10.1016/j.neures.2011.10.001; Foti F, 2010, CEREBELLUM, V9, P29, DOI 10.1007/s12311-009-0134-4; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hagemann D, 2009, PERS INDIV DIFFER, V47, P717, DOI 10.1016/j.paid.2009.06.009; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Jackson J, 2011, NEUROBIOL AGING, V32, P2162, DOI 10.1016/j.neurobiolaging.2009.12.009; Kim SH, 2008, NEUROREPORT, V19, P883, DOI 10.1097/WNR.0b013e328300080f; Kunisato Y, 2011, NEUROSCI LETT, V492, P109, DOI 10.1016/j.neulet.2011.01.067; Laricchiuta D, 2012, HUMAN BRAIN MAPPING; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Lieberman MD, 2001, J PERS SOC PSYCHOL, V80, P294, DOI 10.1037//0022-3514.80.2.294; Liu F, 2012, PROGR NEUROPSYCHOPHA; Liu F, 2012, J AFFECTIVE DISORDER; Liu F, 2015, BRAIN STRUCT FUNCT, V220, P101, DOI 10.1007/s00429-013-0641-4; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040968; Mak AKY, 2009, NEUROSCI LETT, V457, P101, DOI 10.1016/j.neulet.2009.03.094; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mingyi Q., 2000, ACTA PSYCHOL SIN, V32, P317, DOI DOI 10.1007/S11769-000-0010-0; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1573, DOI 10.1016/j.psyneuen.2010.02.017; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Gorman RL, 2006, NEUROIMAGE, V31, P489, DOI 10.1016/j.neuroimage.2005.12.048; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2007, CEREBELLUM, V6, P95, DOI 10.1080/14734220701213421; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Picerni E, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00133; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Rusting C, 1997, PERSONALITY INDIVIDU; Rusting CL, 1997, PERS INDIV DIFFER, V22, P607, DOI 10.1016/S0191-8869(96)00246-2; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schutter DJLG, 2005, CEREBELLUM, V4, P290, DOI 10.1080/14734220500348584; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V281, P1197, DOI 10.1001/jama.281.13.1197; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Tran Y, 2001, PERS INDIV DIFFER, V30, P205, DOI 10.1016/S0191-8869(00)00027-1; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Vince G, 2006, DANA FDN BRAIN NEWS, V13, P2; Wei L, 2012, HUM BRAIN MAPP; Wei LQ, 2011, BRAIN RES, V1419, P68, DOI 10.1016/j.brainres.2011.08.060; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	75	43	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88763	10.1371/journal.pone.0088763	http://dx.doi.org/10.1371/journal.pone.0088763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551159	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500067
J	Scheuren, R; Anton, F; Erpelding, N; Michaux, G				Scheuren, Raymonde; Anton, Fernand; Erpelding, Nathalie; Michaux, Gilles			Beep Tones Attenuate Pain following Pavlovian Conditioning of an Endogenous Pain Control Mechanism	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; NOCICEPTIVE FLEXOR REFLEX; TEMPORAL SUMMATION; FLEXION REFLEX; MODULATION; STIMULATION; PERCEPTION; EXPRESSION; SYSTEMS	Heterotopic noxious counter-stimulation (HNCS) is commonly used to study endogenous pain control systems. The resulting pain inhibition is primarily based on spinal cord-brainstem loops. Recently, functional imaging studies have shown that limbic structures like the anterior cingulate cortex and amygdala are also implicated. Since these structures are involved in learning processes, it is possible that the HNCS-induced pain inhibition may depend on specific cues from the environment that have been associated with pain reduction through associative learning. We investigated the influence of Pavlovian conditioning on HNCS-induced pain inhibition in 32 healthy subjects by using a differential conditioning paradigm in which two different acoustic stimuli were either repeatedly paired or unpaired with HNCS. Series of noxious electrical pulse trains delivered to the non-dominant foot served as test stimuli. Diffuse noxious inhibitory control (DNIC)like effects were induced by concurrent application of tonic HNCS (immersion of the contralateral hand in ice water). Subjective pain intensity and pain unpleasantness ratings and electromyographic recordings of the facial corrugator muscle and the nocifensive RIII flexion reflex were used to measure changes in pain sensitivity. HNCS induced significant pain and reflex inhibitions. In the post-conditioning phase, only the paired auditory cue was able to significantly reduce pain perceptions and corrugator muscle activity. No conditioned effect could be observed in RIII reflex responses. Our results indicate that the functional state of endogenous pain control systems may depend on associative learning processes that, like in the present study, may lead to an attenuation of pain perception. Similar albeit opposite conditioning of pain control mechanisms may significantly be involved in the exacerbation and chronification of pain states.	[Scheuren, Raymonde; Anton, Fernand] Univ Luxembourg, Integrat Res Unit Social & Individual Dev, Lab Psychobiol & Neurophysiol, Luxembourg, Luxembourg; [Erpelding, Nathalie] Boston Childrens Hosp, PAIN Grp, Waltham, MA USA; [Erpelding, Nathalie] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Michaux, Gilles] St Theresa Clin, Inst Hlth Promot, Luxembourg, Luxembourg	University of Luxembourg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Anton, F (corresponding author), Univ Luxembourg, Integrat Res Unit Social & Individual Dev, Lab Psychobiol & Neurophysiol, Luxembourg, Luxembourg.	fernand.anton@uni.lu			University of Luxembourg [F3R-INS-PUL09/PAMO]; National research council of Luxembourg (Fonds National de la Recherche) [AFR-PhD2010 1/784732]	University of Luxembourg; National research council of Luxembourg (Fonds National de la Recherche)	This work was supported by the University of Luxembourg grant to Fernand Anton: F3R-INS-PUL09/PAMO (www.uni.lu) and National research council of Luxembourg (Fonds National de la Recherche) grant to Raymonde Scheuren: AFR-PhD2010 1/784732 (www.fnr.lu;www.afr.lu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al'Absi M, 2000, PAIN, V88, P61, DOI 10.1016/S0304-3959(00)00306-7; ARENDTNIELSEN L, 1994, EUR J APPL PHYSIOL O, V68, P266, DOI 10.1007/BF00376776; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BINI G, 1981, J NEUROSCI METH, V3, P301, DOI 10.1016/0165-0270(81)90066-2; Bouhassira D, 2003, BRAIN, V126, P1068, DOI 10.1093/brain/awg106; Bruehl S, 2004, NEUROSCI BIOBEHAV R, V28, P395, DOI 10.1016/j.neubiorev.2004.06.004; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Carlsson CPO, 2002, INT CONGR SER, V1238, P31, DOI 10.1016/S0531-5131(02)00407-7; Charlton E, 1995, Pain, V63, P277, DOI 10.1016/0304-3959(95)90040-3; CRAIG KD, 1985, J PERS SOC PSYCHOL, V48, P1080, DOI 10.1037/0022-3514.48.4.1089; Cramp FL, 2000, ARCH PHYS MED REHAB, V81, P324, DOI 10.1016/S0003-9993(00)90079-0; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Flor H, 2002, EUR J PAIN-LONDON, V6, P395, DOI 10.1016/S1090-3801(02)00043-5; Flor H, 2011, CHRONIC PAIN INTEGRA; France CR, 1999, PAIN, V81, P77, DOI 10.1016/S0304-3959(98)00272-3; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Hadjistavropoulos HD, 1996, PAIN, V65, P251, DOI 10.1016/0304-3959(95)00218-9; Hermann C, 2000, EXP BRAIN RES, V132, P203, DOI 10.1007/s002210000343; Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004; Lapate RC, 2012, J COGNITIVE NEUROSCI, V24, P148, DOI 10.1162/jocn_a_00125; Le Bars D, 2002, INT CONGR SER, V1238, P11, DOI 10.1016/S0531-5131(02)00412-0; Le Bars D, 1988, SCI BASES ACUPUNCTUR, P79; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Li J, 2011, NAT NEUROSCI, V14, P1250, DOI 10.1038/nn.2904; Micalos PS, 2009, EUR J APPL PHYSIOL, V105, P55, DOI 10.1007/s00421-008-0872-x; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Piche M, 2010, PAIN, V148, P49, DOI 10.1016/j.pain.2009.10.005; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Plaghki L, 1998, J NEUROPHYSIOL, V79, P2557, DOI 10.1152/jn.1998.79.5.2557; Prevost C, 2011, EUR J NEUROSCI, V34, P134, DOI 10.1111/j.1460-9568.2011.07686.x; PRICE DD, 1984, PAIN, V19, P27, DOI 10.1016/0304-3959(84)90062-9; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Reinert A, 2000, BRAIN RES, V862, P103, DOI 10.1016/S0006-8993(00)02077-1; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Rhudy JL, 2006, PAIN, V126, P221, DOI 10.1016/j.pain.2006.06.027; Ruscheweyh R, 2011, PAIN, V152, P2662, DOI 10.1016/j.pain.2011.08.016; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Sandrini G, 1999, NEUROSCI LETT, V261, P5, DOI 10.1016/S0304-3940(98)01000-3; Schaefer F, 2000, PSYCHOPHYSIOLOGY, V37, P85; Serrao M, 2004, PAIN, V112, P353, DOI 10.1016/j.pain.2004.09.018; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Staud R, 2003, PAIN, V101, P167, DOI 10.1016/S0304-3959(02)00325-1; Streff A, 2011, EUR J PAIN, V15, P45, DOI 10.1016/j.ejpain.2010.05.011; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; Villanueva Luis, 1995, Biological Research, V28, P113; WILLER JC, 1990, EUR J PHARMACOL, V182, P347, DOI 10.1016/0014-2999(90)90293-F; WILLER JC, 1984, BRAIN, V107, P1095, DOI 10.1093/brain/107.4.1095; Wolf S, 1941, J CLIN INVEST, V20, P521, DOI 10.1172/JCI101245; Yarnitsky D, 2008, PAIN, V138, P22, DOI 10.1016/j.pain.2007.10.033; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	54	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88710	10.1371/journal.pone.0088710	http://dx.doi.org/10.1371/journal.pone.0088710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551138	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000057
J	Branham-O'Connor, M; Robichaux, WG; Zhang, XK; Cho, H; Kehrl, JH; Lanier, SM; Blumer, JB				Branham-O'Connor, Melissa; Robichaux, William G., III; Zhang, Xian-Kui; Cho, Hyeseon; Kehrl, John H.; Lanier, Stephen M.; Blumer, Joe B.			Defective Chemokine Signal Integration in Leukocytes Lacking Activator of G Protein Signaling 3 ( AGS3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Chemotaxis; Cxcr4; G-protein-coupled Receptors (GPCR); G Proteins; AGS3; Gi; G; GPR Motif; Gpsm1	G-BETA-GAMMA; ASYMMETRIC CELL-DIVISION; RECEPTOR-INDEPENDENT ACTIVATORS; NUCLEOTIDE EXCHANGE FACTOR; DIFFERENTIAL REGULATION; NEUTROPHIL CHEMOTAXIS; GOLOCO MOTIF; KINASE; EXPRESSION; MIGRATION	Background: Roles for AGS3/Gpsm1 in the immune system are not defined. Results: Loss of AGS3 expression results in defective leukocyte chemotaxis, calcium mobilization, and ERK1/2 and Akt activation. Conclusion: AGS3 is required for efficient chemokine receptor signal integration. Significance: These studies extend the functional repertoire for AGS3 in the immune system, providing unexpected regulatory mechanisms for immune function. Activator of G-protein signaling 3 (AGS3, gene name G-protein signaling modulator-1, Gpsm1), an accessory protein for G-protein signaling, has functional roles in the kidney and CNS. Here we show that AGS3 is expressed in spleen, thymus, and bone marrow-derived dendritic cells, and is up-regulated upon leukocyte activation. We explored the role of AGS3 in immune cell function by characterizing chemokine receptor signaling in leukocytes from mice lacking AGS3. No obvious differences in lymphocyte subsets were observed. Interestingly, however, AGS3-null B and T lymphocytes and bone marrow-derived dendritic cells exhibited significant chemotactic defects as well as reductions in chemokine-stimulated calcium mobilization and altered ERK and Akt activation. These studies indicate a role for AGS3 in the regulation of G-protein signaling in the immune system, providing unexpected venues for the potential development of therapeutic agents that modulate immune function by targeting these regulatory mechanisms.	[Branham-O'Connor, Melissa; Robichaux, William G., III; Lanier, Stephen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Zhang, Xian-Kui] Med Univ S Carolina, Div Rheumatol, Dept Med, Charleston, SC 29425 USA; [Cho, Hyeseon; Kehrl, John H.] NIAID, B Cell Sect, NIH, Bethesda, MD 20892 USA	Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Blumer, JB (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 173 Ashley Ave,BSB358,MSC509, Charleston, SC 29425 USA.	blumerjb@musc.edu	Kehrl, John/AAE-6292-2019	Blumer, Joe/0000-0002-0020-3815; Lanier, Stephen/0000-0002-2740-7607; Kehrl, John/0000-0002-6526-159X	Cancer Center Support grant [P30 CA138313]; National Center for Research Resources; Office of the Director of the National Institutes of Health [C06 RR015455, S10 RR027777]; Medical University of South Carolina (MUSC) institutional funds; National Institutes of Health [GM086510, DA025896, AR056670, T32CA119945]; Department of Veterans Affairs; National Institutes of Health NIGMS SC-INBRE [P20GM103499]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000961, ZIAAI000738] Funding Source: NIH RePORTER	Cancer Center Support grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina (MUSC) institutional funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health NIGMS SC-INBRE; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research presented in this article was supported in part by the Flow Cytometry and Cell Sorting Shared Resource, funded by a Cancer Center Support grant P30 CA138313 to the Hollings Cancer Center at the Medical University of South Carolina and in part by the National Center for Research Resources and the Office of the Director of the National Institutes of Health through grant number C06 RR015455 and S10 RR027777. This work was supported by Medical University of South Carolina (MUSC) institutional funds (to J. B. B.); National Institutes of Health Grants GM086510 (to J. B. B.), DA025896 (to S. M. L.), AR056670 (to X. Z.), and T32CA119945 (to M. B. O.); the Merit Review Award from the Department of Veterans Affairs (to X. Z.); National Institutes of Health NIGMS SC-INBRE Grant P20GM103499 (to M. B. O.); and the intramural research program of the National Institute of Allergy and Infectious Diseases (to H. C. and J. H. K.).	Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Cho H, 2009, PROG MOL BIOL TRANSL, V86, P249, DOI 10.1016/S1877-1173(09)86009-2; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Conley JM, 2013, CELL MOL NEUROBIOL, V33, P551, DOI 10.1007/s10571-013-9925-8; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dalwadi H, 2003, J IMMUNOL, V170, P1707, DOI 10.4049/jimmunol.170.4.1707; Dehring DAK, 2011, J IMMUNOL, V186, P4805, DOI 10.4049/jimmunol.1003102; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Giguere PM, 2013, MOL IMMUNOL, V54, P193, DOI 10.1016/j.molimm.2012.12.001; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Humrich JY, 2006, IMMUNOLOGY, V117, P238, DOI 10.1111/j.1365-2567.2005.02292.x; Hwang IY, 2007, J IMMUNOL, V179, P439, DOI 10.4049/jimmunol.179.1.439; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kehrl JH, 2009, CURR TOP MICROBIOL, V334, P107, DOI 10.1007/978-3-540-93864-4_5; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kinoshita-Kawada M, 2004, MOL BRAIN RES, V132, P73, DOI 10.1016/j.molbrainres.2004.09.007; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kwon M, 2012, P NATL ACAD SCI USA, V109, P21462, DOI 10.1073/pnas.1216830110; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Moratz C, 2004, METHOD ENZYMOL, V389, P15; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peracino B, 1998, J CELL BIOL, V141, P1529, DOI 10.1083/jcb.141.7.1529; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; Ricart BG, 2011, J IMMUNOL, V186, P53, DOI 10.4049/jimmunol.1002358; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sagar D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-245; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Sozzani S, 1998, J IMMUNOL, V161, P1083; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565	76	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10738	10747		10.1074/jbc.M113.515031	http://dx.doi.org/10.1074/jbc.M113.515031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573680	Green Published, hybrid			2022-12-25	WOS:000334226400043
J	Jensen, CS; Watanabe, S; Rasmussen, HB; Schmitt, N; Olesen, SP; Frost, NA; Blanpied, TA; Misonou, H				Jensen, Camilla Stampe; Watanabe, Shoji; Rasmussen, Hanne Borger; Schmitt, Nicole; Olesen, Soren-Peter; Frost, Nicholas A.; Blanpied, Thomas A.; Misonou, Hiroaki			Specific Sorting and Post-Golgi Trafficking of Dendritic Potassium Channels in Living Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Golgi; Intracellular Trafficking; Ion Channels; Myosin; Protein Sorting; Myosin	KV2.1 K+ CHANNEL; TRANSPORT; PROTEINS; ACTIN; IDENTIFICATION; LOCALIZATION; MICROTUBULES; MODULATION; EXPRESSION; RECEPTORS	Background: Voltage-gated K+ (Kv) channels are localized in specific dendritic subcompartments of neurons to regulate dendritic excitability. Results: Dendritic Kv channels are sorted and trafficked in distinct populations of post-Golgi transport vesicles. Conclusion: Sorting of Kv channels and their subsequent trafficking by unique mechanisms are crucial for their specific localizations within dendrites. Significance: Our study reveals the existence of novel subcompartment-specific trafficking pathways for dendritic ion channels. Proper membrane localization of ion channels is essential for the function of neuronal cells. Particularly, the computational ability of dendrites depends on the localization of different ion channels in specific subcompartments. However, the molecular mechanisms that control ion channel localization in distinct dendritic subcompartments are largely unknown. Here, we developed a quantitative live cell imaging method to analyze protein sorting and post-Golgi vesicular trafficking. We focused on two dendritic voltage-gated potassium channels that exhibit distinct localizations: Kv2.1 in proximal dendrites and Kv4.2 in distal dendrites. Our results show that Kv2.1 and Kv4.2 channels are sorted into two distinct populations of vesicles at the Golgi apparatus. The targeting of Kv2.1 and Kv4.2 vesicles occurred by distinct mechanisms as evidenced by their requirement for specific peptide motifs, cytoskeletal elements, and motor proteins. By live cell and super-resolution imaging, we identified a novel trafficking machinery important for the localization of Kv2.1 channels. Particularly, we identified non-muscle myosin II as an important factor in Kv2.1 trafficking. These findings reveal that the sorting of ion channels at the Golgi apparatus and their subsequent trafficking by unique molecular mechanisms are crucial for their specific localizations within dendrites.	[Jensen, Camilla Stampe; Rasmussen, Hanne Borger; Schmitt, Nicole; Olesen, Soren-Peter] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Jensen, Camilla Stampe; Misonou, Hiroaki] Univ Maryland, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Frost, Nicholas A.; Blanpied, Thomas A.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Watanabe, Shoji; Misonou, Hiroaki] Doshisha Univ, Grad Sch Brain Sci, Unit Brain Pathol, Kyoto 61902225, Japan	University of Copenhagen; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Doshisha University	Misonou, H (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Unit Brain Pathol, Kyoto 61902225, Japan.	h_misonou@mac.com	Rasmussen, Hanne B/N-9652-2016; Schmitt, Nicole/B-8725-2012; Olesen, Soren-Peter/H-4206-2011	Rasmussen, Hanne B/0000-0002-2218-5646; Frost, Nicholas/0000-0002-2270-643X; Schmitt, Nicole/0000-0001-9482-9749; Blanpied, Thomas/0000-0003-4957-557X; Olesen, Soren-Peter/0000-0002-4381-5192; Misono, Hiroaki/0000-0001-5892-1804; Jensen, Camilla Stampe/0000-0001-6546-8630	Epilepsy Foundation; Takeda Science Foundation; Naito Foundation; Danish Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080046] Funding Source: NIH RePORTER; Lundbeck Foundation [R19-2008-2141] Funding Source: researchfish	Epilepsy Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by a grant from the Epilepsy Foundation (to H. M.), the Takeda Science Foundation (to H. M.), the Naito Foundation (to H. M.), and a framework grant from the Danish Medical Research Council (to S. P. O.).	Al-Bassam S, 2012, CELL REPORTS, V2, P89, DOI 10.1016/j.celrep.2012.05.018; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brown JR, 2004, J NEUROBIOL, V58, P175, DOI 10.1002/neu.10317; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Howard J., 2001, MECH MOTOR PROTEINS; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Menegola M, 2008, NEUROSCIENCE, V154, P953, DOI 10.1016/j.neuroscience.2008.04.022; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Norstrom MF, 2010, J BIOL CHEM, V285, P26326, DOI 10.1074/jbc.M110.123851; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Toomre D, 1999, J CELL SCI, V112, P21; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Watanabe K, 2012, CELL REP, V2, P1546, DOI 10.1016/j.celrep.2012.11.015; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	49	33	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10566	10581		10.1074/jbc.M113.534495	http://dx.doi.org/10.1074/jbc.M113.534495			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569993	hybrid, Green Published			2022-12-25	WOS:000334226400029
J	Qi, YL; Zhang, MF; Li, H; Frank, JA; Dai, L; Liu, HJ; Chen, G				Qi, Yuanlin; Zhang, Mingfang; Li, Hui; Frank, Jacqueline A.; Dai, Lu; Liu, Huijuan; Chen, Gang			MicroRNA-29b Regulates Ethanol-induced Neuronal Apoptosis in the Developing Cerebellum through SP1/RAX/PKR Cascade*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cerebellum; MicroRNA; Neurons; Signal Transduction; Ethanol; Fetal; PKR; MiR-29b	TRANSCRIPTION FACTOR SP1; INDUCED CELL-DEATH; ALZHEIMERS-DISEASE; RESISTANT PERIODS; MYELOID-LEUKEMIA; DEVELOPING MOUSE; GRANULE NEURONS; GENE-EXPRESSION; PROTEIN-KINASE; NEURAL CELLS	Background: We investigated the role of microRNAs in ethanol neurotoxicity in the developing cerebellum. Results: MiR-29b regulates ethanol-induced apoptosis of cerebellar granule neurons in the developing cerebellum via SP1/RAX/PKR cascade. Conclusion: MiR-29b plays an important role in ethanol neurotoxicity in the developing cerebellum. Significance: MiR-29b may be a new preventive/therapeutic target for fetal alcohol spectrum disorders. Neuronal loss is a prominent etiological factor for fetal alcohol spectrum disorders. The cerebellum is one of the areas in the developing central nervous system that is most sensitive to ethanol, especially during the temporal window of ethanol vulnerability. MicroRNAs are small, non-coding RNAs capable of regulating diverse cellular functions including apoptosis. Ethanol exposure has been shown to interfere with the expression of microRNAs. However, the role of microRNAs in ethanol neurotoxicity is still not clear. In the present study, we identified a particular microRNA, miR-29b, as a novel target of ethanol in the developing cerebellar granule neurons. We discovered that ethanol exposure suppressed miR-29b and induced neuronal apoptosis. Overexpression of miR-29b rendered neurons protection against ethanol-induced apoptosis. Furthermore, our data indicated that miR-29b mediated ethanol neurotoxicity through the SP1/RAX/PKR cascade. More importantly, the expression of miR-29b is developmentally regulated, which may account for, at least partially, the temporal window of ethanol sensitivity in the developing cerebellum.	[Qi, Yuanlin; Zhang, Mingfang; Li, Hui; Frank, Jacqueline A.; Liu, Huijuan; Chen, Gang] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Dai, Lu] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Qi, Yuanlin] Fujian Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Fuzhou 350004, Fujian, Peoples R China; [Zhang, Mingfang] Fujian Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Fuzhou 350004, Fujian, Peoples R China	University of Kentucky; University of Kentucky; Fujian Medical University; Fujian Medical University	Chen, G (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, 125 Hlth Sci Res Bldg,800 Rose St, Lexington, KY 40536 USA.	gangchen6@uky.edu	Qi, Yuanlin/GLT-5376-2022	Qi, Yuanlin/0000-0002-5253-9732; Zhang, Mingfang/0000-0001-8061-5694	National Institutes of Health [RO1AA020051]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AA020051 (to G. C.).	Alimov A, 2013, METAB BRAIN DIS, V28, P667, DOI 10.1007/s11011-013-9430-2; Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dong XL, 2014, ALCOHOL CLIN EXP RES, V38, P68, DOI 10.1111/acer.12209; Fang MR, 2012, TOXICOL LETT, V209, P94, DOI 10.1016/j.toxlet.2011.11.032; Fasciano S, 2007, GENE, V388, P74, DOI 10.1016/j.gene.2006.10.003; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Giordano G, 2011, METHODS MOL BIOL, V758, P13, DOI 10.1007/978-1-61779-170-3_2; Goodlett CR, 1996, PHARMACOL BIOCHEM BE, V55, P531, DOI 10.1016/S0091-3057(96)00248-1; Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Kang R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003511; Karagay B, 2008, ALCOHOL CLIN EXP RES, V32, P1439, DOI 10.1111/j.1530-0277.2008.00720.x; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031022; Kouzoukas DE, 2013, J NEUROCHEM, V124, P323, DOI 10.1111/jnc.12076; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Li Z, 2001, DEV BRAIN RES, V132, P47, DOI 10.1016/S0165-3806(01)00294-2; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Long JM, 2012, J BIOL CHEM, V287, P31298, DOI 10.1074/jbc.M112.366336; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Luo J, 1997, ALCOHOL CLIN EXP RES, V21, P1108; MARCUSSEN BL, 1994, ALCOHOL, V11, P147, DOI 10.1016/0741-8329(94)90056-6; Reyes-Fermin LM, 2012, NUTR NEUROSCI, V15, P34, DOI 10.1179/1476830512Y.0000000011; Mooney SM, 2003, DEV BRAIN RES, V147, P135, DOI 10.1016/j.devbrainres.2003.08.012; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Russell JC, 2007, NEUROSCIENCE, V150, P563, DOI 10.1016/j.neuroscience.2007.09.076; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Shi GD, 2012, EXP BRAIN RES, V216, P225, DOI 10.1007/s00221-011-2925-3; Silva VAO, 2011, MOL VIS, V17, P2228; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Villa C, 2013, J ALZHEIMERS DIS, V35, P487, DOI 10.3233/JAD-122263; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; WILKE N, 1994, EXS, V71, P49; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211	55	44	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10201	10210		10.1074/jbc.M113.535195	http://dx.doi.org/10.1074/jbc.M113.535195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554719	hybrid, Green Published			2022-12-25	WOS:000333807000065
J	Jayasekera, N; Aprato, A; Villar, RN				Jayasekera, Narlaka; Aprato, Alessandro; Villar, Richard N.			Fat Pad Entrapment at the Hip: A New Diagnosis	PLOS ONE			English	Article							FINITE-ELEMENT MODEL; FEMOROACETABULAR IMPINGEMENT; ACETABULAR LABRUM; JOINT; OSTEOARTHRITIS; ARTHROSCOPY; PATHOLOGY; CARTILAGE; LESIONS; TEARS	Purpose: To establish if a positive impingement sign in femoroacetabular impingement (FAI) may result from entrapment of the fat pad located at the anterior head-neck junction of the upper femur. This fat pad is routinely removed before any cam lesion excision. Methods: We report a prospective study of 142 consecutive hip arthroscopies for symptomatic FAI where the aim was to remove the arthroscopically identified area of impingement, not necessarily to create a spherical femoral head. Patients were divided into two groups. Group 1 (n = 92; 34 females, 58 males), where a cam-type bony FAI lesion was identified and excised in addition to the fat pad which overlay it, and Group 2 (n = 50; 29 females, 21 males) where the only identified point of impingement was a prominent fat pad. In this situation the fat pad was excised in isolation and the underlying bone preserved. Patients were assessed preoperatively, at six weeks, six months, one year and two years with a modified Harris hip score (mHHS). Results: Both groups were comparable preoperatively for mean age, mean alpha angle and mean anterior offset ratio. Both groups improved significantly after surgery at all time points. However, Group 1 (fat pad and bone resection) demonstrated 16.0% improvement in mHHS by two years while for Group 2 (fat pad resection only) the improvement was 18.9% (p = 0.628). Conclusions: The fat pad found at the anterior head/neck junction of the hip joint can be a source of pain and we propose fat pad entrapment as a new, previously undescribed diagnosis. Our findings also suggest that a large number of cam lesions are being excised unnecessarily and that further efforts should be made to understand the role of the fat pad as a source of groin discomfort.	[Jayasekera, Narlaka; Aprato, Alessandro; Villar, Richard N.] Spire Cambridge Lea Hosp, Cambridge, England		Jayasekera, N (corresponding author), Spire Cambridge Lea Hosp, Cambridge, England.	naja01@doctors.org.uk	Aprato, Alessandro/J-9592-2014	Aprato, Alessandro/0000-0002-2514-4719				ALTENBERG AR, 1977, SOUTHERN MED J, V70, P174, DOI 10.1097/00007611-197702000-00019; Bastiaansen-Jenniskens YM, 2012, ANN RHEUM DIS, V71, P288, DOI 10.1136/ard.2011.153858; Byrd JWT, 1996, ARTHROSCOPY, V12, P603, DOI 10.1016/S0749-8063(96)90201-7; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Dragoo JL, 2012, SPORTS MED, V42, P51, DOI 10.2165/11595680-000000000-00000; Eijer H, 2001, HIP INT, V11, P37, DOI DOI 10.1177/112070000101100104; Farjo LA, 1999, ARTHROSCOPY, V15, P132, DOI 10.1053/ar.1999.v15.015013; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; Ferguson SJ, 2000, J BIOMECH, V33, P953, DOI 10.1016/S0021-9290(00)00042-7; Ferguson SJ, 2000, CLIN BIOMECH, V15, P463, DOI 10.1016/S0268-0033(99)00099-6; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Hoffa A, 1904, J AMER MED ASSOC, V43, P0795; Hogervorst T, 2012, BONE JOINT 360, V1, P2; Jacobson JA, 1997, RADIOGRAPHICS, V17, P675, DOI 10.1148/radiographics.17.3.9153705; Kapandji IA, 1985, FUNKTIONELLE ANATOMI, P24; Kemp JL, 2012, BRIT J SPORT MED, V46, P632, DOI 10.1136/bjsports-2011-090428; KLAUE K, 1991, J BONE JOINT SURG BR, V73, P423, DOI 10.1302/0301-620X.73B3.1670443; Matsuda DK, 2011, ARTHROSCOPY, V27, P870, DOI 10.1016/j.arthro.2010.12.002; McCarthy JC, 2001, CLIN ORTHOP RELAT R, P25; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; OGILVIEHARRIS DJ, 1994, ARTHROSCOPY, V10, P184, DOI 10.1016/S0749-8063(05)80091-X; Pollard TCB, 2010, ACTA ORTHOP, V81, P134, DOI 10.3109/17453671003619011; Robertson WJ, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO0b013e31802c7e0f; Souza BGSE, 2010, ARTHROSCOPY, V26, P1053, DOI 10.1016/j.arthro.2009.12.021; Schwab JH., 2007, ADULT HIP, P559; Seldes RM, 2001, CLIN ORTHOP RELAT R, V382, P32; Simpson J, 2010, ORTHOP TRAUMATOL-SUR, V96, pS68, DOI 10.1016/j.otsr.2010.09.010; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; Engelhardt LVV, 2010, ARCH ORTHOP TRAUM SU, V130, P1041, DOI 10.1007/s00402-010-1133-0	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e83503	10.1371/journal.pone.0083503	http://dx.doi.org/10.1371/journal.pone.0083503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586225	Green Published, Green Submitted, gold			2022-12-25	WOS:000332389000001
J	Christensen, AS; Steinmann, C; Fedorov, DG; Jensen, JH				Christensen, Anders S.; Steinmann, Casper; Fedorov, Dmitri G.; Jensen, Jan H.			Hybrid RHF/MP2 Geometry Optimizations with the Effective Fragment Molecular Orbital Method	PLOS ONE			English	Article							TRANSITION-STATE STABILIZATION; QUANTUM-CHEMICAL CALCULATION; CHORISMATE MUTASE; ENZYME CATALYSIS; COMPUTATIONAL METHOD; REACTION BARRIERS; REACTION PATHS; LEVEL; PREDICTION; CHEMISTRY	The frozen domain effective fragment molecular orbital method is extended to allow for the treatment of a single fragment at the MP2 level of theory. The approach is applied to the conversion of chorismate to prephenate by Chorismate Mutase, where the substrate is treated at the MP2 level of theory while the rest of the system is treated at the RHF level. MP2 geometry optimization is found to lower the barrier by up to 3.5 kcal/mol compared to RHF optimzations and ONIOM energy refinement and leads to a smoother convergence with respect to the basis set for the reaction profile. For double zeta basis sets the increase in CPU time relative to RHF is roughly a factor of two.	[Christensen, Anders S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Steinmann, Casper] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Fedorov, Dmitri G.] Natl Inst Adv Ind Sci & Technol, NRI, Tsukuba, Ibaraki, Japan	University of Copenhagen; University of Southern Denmark; National Institute of Advanced Industrial Science & Technology (AIST)	Jensen, JH (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	jhjensen@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; Svendsen, Casper/T-6775-2018	Jensen, Jan Halborg/0000-0002-1465-1010; Svendsen, Casper/0000-0002-5638-1346	Novo Nordisk STAR PhD program; Next Generation Super Computing Project, Nanoscience Program (NEXT, Japan); Computational Materials Science Initiative (CMSI, Japan)	Novo Nordisk STAR PhD program(Novo Nordisk); Next Generation Super Computing Project, Nanoscience Program (NEXT, Japan); Computational Materials Science Initiative (CMSI, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	ASC is funded by the Novo Nordisk STAR PhD program. DGF is supported by the Next Generation Super Computing Project, Nanoscience Program (NEXT, Japan) and Computational Materials Science Initiative (CMSI, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen XH, 2004, J THEOR COMPUT CHEM, V3, P277, DOI 10.1142/S0219633604001045; Claeyssens F, 2005, CHEM COMMUN, P5068, DOI 10.1039/b508181e; Claeyssens F, 2006, ANGEW CHEM INT EDIT, V45, P6856, DOI 10.1002/anie.200602711; Claeyssens F, 2011, ORG BIOMOL CHEM, V9, P1578, DOI 10.1039/c0ob00691b; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; Fedorov DG, 2004, J COMPUT CHEM, V25, P872, DOI 10.1002/jcc.20018; Fedorov DG, 2008, J PHYS CHEM A, V112, P11808, DOI 10.1021/jp805435n; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2011, J PHYS CHEM LETT, V2, P282, DOI 10.1021/jz1016894; Flick JC, 2012, J CHEM THEORY COMPUT, V8, P2835, DOI 10.1021/ct200673a; Frank A, 2012, J CHEM THEORY COMPUT, V8, P1480, DOI 10.1021/ct200913r; Gao JL, 1997, J PHYS CHEM B, V101, P657, DOI 10.1021/jp962833a; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Gordon MS, 2009, J PHYS CHEM B, V113, P9646, DOI 10.1021/jp811519x; Hediger MR, 2013, PEERJ, V1, DOI 10.7717/peerj.111; Huang LL, 2012, FUTURE MED CHEM, V4, P1479, DOI [10.4155/fmc.12.92, 10.4155/FMC.12.92]; Ishida T, 2006, J PHYS CHEM B, V110, P1457, DOI 10.1021/jp0557159; Kast P, 1996, P NATL ACAD SCI USA, V93, P5043, DOI 10.1073/pnas.93.10.5043; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Kobayashi M, 2012, PHYS CHEM CHEM PHYS, V14, P7629, DOI 10.1039/c2cp40153c; Korchowiec J, 2005, INT J QUANTUM CHEM, V105, P875, DOI 10.1002/qua.20684; Kurbanov EK, 2012, J CHEM THEORY COMPUT, V8, P1, DOI 10.1021/ct200637v; LYNE PD, 1995, J AM CHEM SOC, V117, P11345, DOI 10.1021/ja00150a037; OTTO P, 1975, CHEM PHYS, V8, P192, DOI 10.1016/0301-0104(75)80107-8; Ranaghan KE, 2004, CHEM COMMUN, P1238, DOI 10.1039/b402388a; Ranaghan KE, 2003, MOL PHYS, V101, P2695, DOI 10.1080/00268970310001593286; Sahu N, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793706; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Soderhjelm P, 2010, J CHEM THEORY COMPUT, V6, P1726, DOI 10.1021/ct9006986; Steinmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060602; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044480; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041117; Steinmann C, 2010, J PHYS CHEM A, V114, P8705, DOI 10.1021/jp101498m; Szefczyk B, 2004, J AM CHEM SOC, V126, P16148, DOI 10.1021/ja049376t; Szefczyk B, 2007, INT J QUANTUM CHEM, V107, P2274, DOI 10.1002/qua.21354	37	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88800	10.1371/journal.pone.0088800	http://dx.doi.org/10.1371/journal.pone.0088800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558430	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700076
J	Samuel, A; Housset, M; Fant, B; Lamonerie, T				Samuel, Alexander; Housset, Michael; Fant, Bruno; Lamonerie, Thomas			Otx2 ChIP-seq Reveals Unique and Redundant Functions in the Mature Mouse Retina	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; ROSTRAL HEAD; PHOTORECEPTOR; CRX; CELLS; MUTATIONS; IDENTIFICATION; DEGENERATION	During mouse retinal development and into adulthood, the transcription factor Otx2 is expressed in pigment epithelium, photoreceptors and bipolar cells. In the mature retina, Otx2 ablation causes photoreceptor degeneration through a non-cell-autonomous mechanism involving Otx2 function in the supporting RPE. Surprisingly, photoreceptor survival does not require Otx2 expression in the neural retina, where the related Crx homeobox gene, a major regulator of photoreceptor development, is also expressed. To get a deeper view of mouse Otx2 activities in the neural retina, we performed chromatin-immunoprecipitation followed by massively parallel sequencing (ChIP-seq) on Otx2. Using two independent ChIP-seq assays, we identified consistent sets of Otx2-bound cis-regulatory elements. Comparison with our previous RPE-specific Otx2 ChIP-seq data shows that Otx2 occupies different functional domains of the genome in RPE cells and in neural retina cells and regulates mostly different sets of genes. To assess the potential redundancy of Otx2 and Crx, we compared our data with Crx ChIP-seq data. While Crx genome occupancy markedly differs from Otx2 genome occupancy in the RPE, it largely overlaps that of Otx2 in the neural retina. Thus, in accordance with its essential role in the RPE and its non-essential role in the neural retina, Otx2 regulates different gene sets in the RPE and the neural retina, and shares an important part of its repertoire with Crx in the neural retina. Overall, this study provides a better understanding of gene-regulatory networks controlling photoreceptor homeostasis and disease.	[Samuel, Alexander; Housset, Michael; Fant, Bruno; Lamonerie, Thomas] Univ Nice Sophia Antipolis, Inst Biol Valrose, INSERM, U1091,CNRS,UMR7277, F-06189 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Lamonerie, T (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, INSERM, U1091,CNRS,UMR7277, F-06189 Nice, France.	lamonerie@unice.fr	Samuel, Alexander/GYA-5341-2022	Samuel, Alexander/0000-0003-4547-5280; Lamonerie, Thomas/0000-0003-2371-2708	CNRS [7277]; ARC; Retina France; French Research Ministry; University of Nice; Fondation Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council); Retina France; French Research Ministry(Ministry of Research, France); University of Nice; Fondation Recherche Medicale	This work was supported by grants from the CNRS to UMR 7277, ARC-projet 2011-2013 and Retina France-2012 to TL. AS was supported by a fellowship from French Research Ministry and University of Nice, MH was supported by a fellowship from the French Research Ministry and The Fondation Recherche Medicale, BF was supported by a fellowship from French Research Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P1417; Akagi T, 2004, INVEST OPHTH VIS SCI, V45, P4570, DOI 10.1167/iovs.04-0697; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Barbosa-Sabanero K, 2012, BIOCHEM J, V447, P321, DOI 10.1042/BJ20120813; Beby F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011673; Boucherie C, 2013, STEM CELLS, V31, P408, DOI 10.1002/stem.1268; Cai X, 2010, EXP EYE RES, V91, P186, DOI 10.1016/j.exer.2010.04.017; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fong SL, 1999, CURR EYE RES, V18, P283, DOI 10.1076/ceyr.18.4.283.5360; Fossat N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-122; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Housset M, 2013, J NEUROSCI, V33, P9890, DOI 10.1523/JNEUROSCI.1099-13.2013; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Klepper K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-9; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Kusakabe T, 2001, DEV GENES EVOL, V211, P145, DOI 10.1007/s004270100136; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; Loots GG, 2008, ADV GENET, V61, P269, DOI 10.1016/S0065-2660(07)00010-7; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MAROTTE LR, 1980, J COMP NEUROL, V193, P319, DOI 10.1002/cne.901930202; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Nandi S, 2013, NUCLEIC ACIDS RES, V41, P8822, DOI 10.1093/nar/gkt578; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Spieler D, 2004, DEV BIOL, V269, P567, DOI 10.1016/j.ydbio.2004.01.044; Suda Y, 1999, DEVELOPMENT, V126, P743; Terrell D, 2012, DEV DYNAM, V241, P215, DOI 10.1002/dvdy.22782; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Yin J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-56; Young JE, 2003, INVEST OPHTH VIS SCI, V44, P4076, DOI 10.1167/iovs.03-0197	48	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89110	10.1371/journal.pone.0089110	http://dx.doi.org/10.1371/journal.pone.0089110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558479	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700125
J	Zhou, ZJ; Zhang, JF; Xia, P; Wang, JY; Chen, S; Fang, XQ; Fan, SW				Zhou, Zhi-Jie; Zhang, Jian-Feng; Xia, Ping; Wang, Ji-Ying; Chen, Shuai; Fang, Xiang-Qian; Fan, Shun-Wu			Selection of Suitable Reference Genes for Normalization of Quantitative Real-Time Polymerase Chain Reaction in Human Cartilage Endplate of the Lumbar Spine	PLOS ONE			English	Article							HOUSEKEEPING GENES; RNA EXPRESSION; MODIC CHANGES; PCR DATA; VALIDATION	The quantitative real-time polymerase chain reaction (qRT-PCR) is one of the most widely used methods to study gene expression profiles, and it requires appropriate normalization for accurate and reliable results. Although several genes are commonly used as reference genes (such as GAPDH, ACTB, and 18S rRNA), they are also regulated and can be expressed at varying levels. In this study, we evaluated twelve well-known reference genes to identify the most suitable housekeeping gene for normalization of qRT-PCR in human lumbar vertebral endplate with Modic changes, by using the geNorm, NormFinder, and BestKeeper algorithms. Our results showed that the rarely-used SDHA was the most stable single reference gene, and a combination of three, SDHA, B2M, and LDHA, was the most suitable gene set for normalization in all samples. In addition, the commonly-used genes, GAPDH, ACTB and 18S rRNA, were all inappropriate as internal standards. The rankings of reference genes for the three types of Modic change differed, although SDHA and RPL13A uniformly ranked in the first and last position, respectively. Further simulated expression analysis validated that the arbitrary use of a reference gene could lead to the misinterpretation of data. Our study confirmed the necessity of exploring the expression stability of potential reference genes in each specific tissue and experimental situation before quantitative evaluation of gene expression by qRT-PCR.	[Zhou, Zhi-Jie; Zhang, Jian-Feng; Wang, Ji-Ying; Chen, Shuai; Fang, Xiang-Qian; Fan, Shun-Wu] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Ping] Zhejiang Univ, Sch Med, Dept Neurol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Zhi-Jie; Zhang, Jian-Feng; Xia, Ping; Wang, Ji-Ying; Chen, Shuai; Fang, Xiang-Qian; Fan, Shun-Wu] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Fang, XQ (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed Surg, Hangzhou 310003, Zhejiang, Peoples R China.	fangxq@srrsh.com; zzj-0708@163.com			National Natural Science Fund of China [81301587, 81271971, 81171739, 81101378]; Natural Science Fund of Zhejiang Province [Y2110372, LQ13H060002]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents	The study was supported by the National Natural Science Fund of China (81301587, 81271971, 81171739, 81101378), the Natural Science Fund of Zhejiang Province (Y2110372, LQ13H060002), and the Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cong F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-743; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Gebhardt FM, 2010, ALZHEIMERS DEMENT, V6, P465, DOI 10.1016/j.jalz.2009.11.002; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Mallein-Gerin F, 2004, METH MOLEC MED, V100, P101; Markova DZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4301; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Ren SW, 2010, MOL VIS, V16, P1076; Subkhankulova T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r18; Untergasser A., 2008, RNAPREP TRIZOL COMBI; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 2003, BIOTECHNIQUES, V34, P396; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Zhang YH, 2008, EUR SPINE J, V17, P1289, DOI 10.1007/s00586-008-0758-y	27	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88892	10.1371/journal.pone.0088892	http://dx.doi.org/10.1371/journal.pone.0088892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558443	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700089
J	Sato, S; Yamamoto, H; Mukaisho, K; Saito, S; Hattori, T; Yamamoto, G; Sugihara, H				Sato, Sho; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Saito, Shota; Hattori, Takanori; Yamamoto, Gaku; Sugihara, Hiroyuki			Continuous Taurocholic Acid Exposure Promotes Esophageal Squamous Cell Carcinoma Progression Due to Reduced Cell Loss Resulting from Enhanced Vascular Development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DUODENAL-CONTENTS REFLUX; CONJUGATED BILE-SALTS; GASTROESOPHAGEAL-REFLUX; BARRETTS-ESOPHAGUS; DUODENOGASTRIC REFLUX; FILOPODIA FORMATION; CIGARETTE-SMOKING; POOR-PROGNOSIS; CANCER	Background: Refluxogenic effects of smoking and alcohol abuse may be related to the risk of esophageal squamous cell carcinoma (ESCC). The present study attempts to clarify the effects of continuous taurocholic acid (TCA) exposure, which is neither mutagenic nor genotoxic, on ESCC progression. Methods: A squamous carcinoma cell line (ESCC-DR) was established from a tumor induced in a rat model of gastroduodenal reflux. ESCC-DR cells were incubated with 2 mM TCA for >= 2 months. The effects of continuous TCA exposure were evaluated in vitro on cell morphology, growth, and invasion and in vivo on xenograft tumor growth in nude mice. Moreover, the mean level of secreted transforming growth factor (TGF)-beta 1 and vascular endothelial growth factor (VEGF) proteins in cell culture supernatants and mRNA synthesis of TGF-beta 1 and VEGF-A of ESCC cells were measured. The angiogenic potential was further examined by a migration assay using human umbilical vein endothelial cells (HUVECs). Results: Continuous TCA exposure induced marked formation of filopodia in vitro. Expression levels of angiogenic factors were significantly higher in the cells treated with TCA than in control cells. Tumor xenografts derived from cells pre-exposed to TCA were larger and more vascularized than those derived from control cells. In addition, TCA exposure increased HUVEC migration. Conclusion: Continuous TCA exposure enhanced ESCC progression due to reduced cell loss in vivo. Cell loss was inhibited by TCA-induced vascular endothelial cell migration, which was mediated by TGF-beta 1 and VEGF-A released from ESCC cells.	[Sato, Sho; Yamamoto, Hiroto; Mukaisho, Ken-ichi; Saito, Shota; Hattori, Takanori; Sugihara, Hiroyuki] Shiga Univ Med Sci, Div Mol & Diagnost Pathol, Dept Pathol, Shiga, Japan; [Sato, Sho; Saito, Shota; Yamamoto, Gaku] Shiga Univ Med Sci, Dept Oral & Maxillofacial Surg, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science	Mukaisho, K (corresponding author), Shiga Univ Med Sci, Div Mol & Diagnost Pathol, Dept Pathol, Shiga, Japan.	mukaisho@belle.shiga-med.ac.jp	Mukaisho, Ken-ichi/AAI-7262-2020					Barthlen W, 1994, DIS ESO, V7, P27; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Burnat G, 2007, SCAND J GASTROENTERO, V42, P1460, DOI 10.1080/00365520701452209; Chen KH, 2007, CANCER SCI, V98, P1683, DOI 10.1111/j.1349-7006.2007.00605.x; Chen KH, 2007, ANTICANCER RES, V27, P175; DENNISH GW, 1971, NEW ENGL J MED, V284, P1136, DOI 10.1056/NEJM197105202842007; DOWLING RH, 1968, GASTROENTEROLOGY, V54, P1291; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Fein M, 2000, CARCINOGENESIS, V21, P2079, DOI 10.1093/carcin/21.11.2079; FOLKMAN J, 1974, CANCER RES, V34, P2109; FUJITA S, 1978, PATHOL RES PRACT, V163, P297, DOI 10.1016/S0344-0338(78)80028-4; Fukuchi M, 2004, CLIN CANCER RES, V10, P2738, DOI 10.1158/1078-0432.CCR-1096-03; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; GRAFFNER H, 1984, SCAND J GASTROENTERO, V19, P116, DOI 10.1080/00365521.1984.12005695; Hashimoto N, 2006, DIS ESOPHAGUS, V19, P346, DOI 10.1111/j.1442-2050.2006.00599.x; HEUMAN DM, 1994, GASTROENTEROLOGY, V106, P1333, DOI 10.1016/0016-5085(94)90027-2; IFTIKHAR SY, 1993, ANN ROY COLL SURG, V75, P411; Jurgens S, 2012, Z GASTROENTEROL, V50, P1028, DOI 10.1055/s-0032-1312922; KADAKIA SC, 1995, AM J GASTROENTEROL, V90, P1785; KAUFMAN SE, 1978, GUT, V19, P336, DOI 10.1136/gut.19.4.336; Kleespies A, 2004, J SURG ONCOL, V87, P95, DOI 10.1002/jso.20070; Kumagai H, 2004, CARCINOGENESIS, V25, P723, DOI 10.1093/carcin/bgh067; Kumagai H, 2003, SCAND J GASTROENTERO, V38, P687, DOI 10.1080/00365520310003435; Lamireau T, 2003, LIFE SCI, V72, P1401, DOI 10.1016/S0024-3205(02)02408-6; MAETA M, 1986, SURGERY, V99, P87; McQuaid KR, 2011, ALIMENT PHARM THER, V34, P146, DOI 10.1111/j.1365-2036.2011.04709.x; Miwa K, 1996, INT J CANCER, V67, P269, DOI 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6; MOORADIAN DL, 1992, J NATL CANCER I, V84, P523, DOI 10.1093/jnci/84.7.523; Nishioka K, 2006, J SURG RES, V132, P130, DOI 10.1016/j.jss.2005.09.024; Nozoe T, 2002, CANCER LETT, V184, P49, DOI 10.1016/S0304-3835(02)00188-X; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; PERA M, 1993, ANN THORAC SURG, V55, P1386, DOI 10.1016/0003-4975(93)91077-Z; Pera M, 1993, ANN THORAC SURG, V55, P1392; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Prins MJD, 2012, J GASTROINTEST SURG, V16, P956, DOI 10.1007/s11605-011-1814-1; SEARS RJ, 1995, AM J GASTROENTEROL, V90, P211; SHEARMAN DJ, 1970, LANCET, V1, P581; SILVERMAN SJ, 1977, J NATL CANCER I, V59, P1557, DOI 10.1093/jnci/59.5.1557; Small J. Victor, 1994, Seminars in Cell Biology, V5, P157, DOI 10.1006/scel.1994.1020; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smit CF, 2001, ANN OTO RHINOL LARYN, V110, P190, DOI 10.1177/000348940111000216; Soma T, 2006, INT J CANCER, V119, P771, DOI 10.1002/ijc.21917; Song S, 2007, GUT, V56, P1512, DOI 10.1136/gut.2007.121244; Stamp DH, 2002, MED HYPOTHESES, V59, P398, DOI 10.1016/S0306-9877(02)00125-1; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Tatsugami M, 2012, CANCER EPIDEM BIOMAR, V21, P2101, DOI 10.1158/1055-9965.EPI-12-0730; VITALE GC, 1987, JAMA-J AM MED ASSOC, V258, P2077, DOI 10.1001/jama.258.15.2077; von Rahden BHA, 2006, MOL CARCINOGEN, V45, P786, DOI 10.1002/mc.20259; Yokoyama A, 1996, INT J CANCER, V68, P313, DOI 10.1002/(SICI)1097-0215(19961104)68:3&lt;313::AID-IJC8&gt;3.0.CO;2-4; Zhang R, 2005, WORLD J GASTROENTERO, V11, P5109	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88831	10.1371/journal.pone.0088831	http://dx.doi.org/10.1371/journal.pone.0088831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551170	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500071
J	Suzuki, M; Minh, LN; Yoshimine, H; Inoue, K; Yoshida, LM; Morimoto, K; Ariyoshi, K				Suzuki, Motoi; Minh, Le Nhat; Yoshimine, Hiroyuki; Inoue, Kenichiro; Yoshida, Lay Myint; Morimoto, Konosuke; Ariyoshi, Koya			Vaccine Effectiveness against Medically Attended Laboratory-Confirmed Influenza in Japan, 2011-2012 Season	PLOS ONE			English	Article							INFECTIONS	The objective of this study was to estimate influenza vaccine effectiveness (VE) against medically attended, laboratory-confirmed influenza during the 2011-2012 season in Japan using a test-negative case-control study design. The effect of co-circulating non-influenza respiratory viruses (NIRVs) on VE estimates was also explored. Nasopharyngeal swab samples were collected from outpatients with influenza-like illnesses (ILIs) in a community hospital in Nagasaki, Japan. Thirteen respiratory viruses (RVs), including influenza A and B, were identified from the samples using a multiplex polymerase chain reaction. The difference in VE point estimates was assessed using three different controls: ILI patients that tested negative for influenza, those that tested negative for all RVs, and those that tested positive for NIRVs. The adjusted VE against medically attended, laboratory-confirmed influenza using all influenza-negative controls was 5.3% (95% confidence interval [CI], -60.5 to 44.1). The adjusted VEs using RV-negative and NIRV-positive controls were -1.5% (95% CI, -74.7 to 41) and 50% (95% CI, -43.2 to 82.5), respectively. Influenza VE was limited in Japan during the 2011-2012 season. Although the evidence is not conclusive, co-circulating NIRVs may affect influenza VE estimates in test-negative case-control studies.	[Suzuki, Motoi; Minh, Le Nhat; Morimoto, Konosuke; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Yoshimine, Hiroyuki; Inoue, Kenichiro] Inoue Hosp, Nagasaki, Japan; [Yoshida, Lay Myint] Nagasaki Univ, Inst Trop Med, Dept Paediat Infect Dis, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan.	kari@nagasaki-u.ac.jp		YOSHIDA, LAYMYINT/0000-0002-7567-3248; Suzuki, Motoi/0000-0002-8340-0880	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); "Improvement of Research Environment for Young Researchers'' program	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Improvement of Research Environment for Young Researchers'' program	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) and the "Improvement of Research Environment for Young Researchers'' program organised by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castilla J, 2013, EURO SURVEILL, V18; Castilla J, 2011, EURO SURVEILL, V16; *CNRL ECDC, 2013, INFL VIR CHAR; Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; KELLY H, 2013, EURO SURVEILL, V18; Kelly H, 2011, PEDIATR INFECT DIS J, V30, P107, DOI 10.1097/INF.0b013e318201811c; Kissling E, 2013, EURO SURVEILL, V18; Li DJ, 2008, J CLIN MICROBIOL, V46, P399, DOI 10.1128/JCM.01549-07; *MIN HLTH LAB WELF, 2011, VACC INFL; NIID J, 2012, INFECT DIS WEEKLY RE; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pebody R., 2013, EURO SURVEILL, V18; Pebody RG, 2012, EPIDEMIOL INFECT, P1; Sundaram ME, 2013, CLIN INFECT DIS; Suzuki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052103; WHO, 2012, REC COMP INFL VIR VA; World Health Organization (WHO), 2011, REC COMP INFL VIR VA; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9; Yoshida LM, 2013, EUR RESPIR J, V42, P461, DOI 10.1183/09031936.00101812	24	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88813	10.1371/journal.pone.0088813	http://dx.doi.org/10.1371/journal.pone.0088813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551167	gold, Green Submitted, Green Published			2022-12-25	WOS:000331266000071
J	Ure, AE; Forslund, O				Ure, Agustin Enrique; Forslund, Ola			Characterization of Human Papillomavirus Type 154 and Tissue Tropism of Gammapapillomaviruses	PLOS ONE			English	Article							CUTANEOUS HUMAN PAPILLOMAVIRUSES; EPIDERMODYSPLASIA-VERRUCIFORMIS; MOLECULAR-CLONING; BINDING-SITE; HEALTHY SKIN; HPV; DNA; CLASSIFICATION; INFECTIONS; SEQUENCES	The novel human papillomavirus type 154 (HPV154) was characterized from a wart on the crena ani of a three-year-old boy. It was previously designated as the putative HPV type FADI3 by sequencing of a subgenomic FAP amplicon. We obtained the complete genome by combined methods including rolling circle amplification (RCA), genome walking through an adapted method for detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR), long-range PCR, and finally by cloning of four overlapping amplicons. Phylogenetically, the HPV154 genome clustered together with members of the proposed species Gammapapillomavirus 11, and demonstrated the highest identity in L1 to HPV136 (68.6%). The HPV154 was detected in 3% (2/62) of forehead skin swabs from healthy children. In addition, the different detection sites of 62 gammapapillomaviruses were summarized in order to analyze their tissue tropism. Several of these HPV types have been detected from multiple sources such as skin, oral, nasal, and genital sites, suggesting that the gammapapillomaviruses are generalists with a broader tissue tropism than previously appreciated. The study expands current knowledge concerning genetic diversity and tropism among HPV types in the rapidly growing gammapapillomavirus genus.	[Ure, Agustin Enrique; Forslund, Ola] Lund Univ, Dept Lab Med, Sect Med Microbiol, Malmo, Sweden	Lund University	Forslund, O (corresponding author), Lund Univ, Dept Lab Med, Sect Med Microbiol, Malmo, Sweden.	ola.forslund@med.lu.se	Ure, Agustín Enrique/AAG-9078-2021	Ure, Agustín Enrique/0000-0001-6494-2003	Swedish Cancer Society [CAN2009/67]; Skane Regional Research Funds [ALF12711]	Swedish Cancer Society(Swedish Cancer Society); Skane Regional Research Funds	This work was supported by the Swedish Cancer Society (http://www.cancerfonden.se/), grant CAN2009/67, and by the Skane Regional Research Funds (http://www.skane.se), grant ALF12711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2012, VIRUS TAXONOMY, P235; Bottalico D, 2012, J GEN VIROL, V93, P1774, DOI 10.1099/vir.0.041897-0; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Chen G, 2001, J VIROL, V75, P292, DOI 10.1128/JVI.75.1.292-302.2001; Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022; Chouhy D, 2013, J GEN VIROL, V94, P524, DOI 10.1099/vir.0.048157-0; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Doorbar J, 1996, E4 PROTEIN HUMAN PAP, P58; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egawa K, 2005, BRIT J DERMATOL, V153, P688, DOI 10.1111/j.1365-2133.2005.06825.x; EGAWA K, 1993, VIROLOGY, V194, P789, DOI 10.1006/viro.1993.1320; Egawa N, 2012, VIROLOGY, V422, P99, DOI 10.1016/j.virol.2011.10.011; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; FAVRE M, 1989, J VIROL, V63, P4910, DOI 10.1128/JVI.63.11.4910-.1989; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, BRIT J DERMATOL, V149, P64, DOI 10.1046/j.1365-2133.2003.05376.x; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DI IN PRESS; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; GISSMANN L, 1977, VIROLOGY, V76, P569, DOI 10.1016/0042-6822(77)90239-2; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Hazard K, 2007, J INVEST DERMATOL, V127, P116, DOI 10.1038/sj.jid.5700570; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hsu JYC, 2009, J MED VIROL, V81, P1444, DOI 10.1002/jmv.21529; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157; JABLONSKA S, 1972, CANCER RES, V32, P583; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022529; Kullander J, 2008, INT J CANCER, V122, P477, DOI 10.1002/ijc.23115; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Li LL, 2009, J GEN VIROL, V90, P2413, DOI 10.1099/vir.0.012344-0; Liu XF, 2010, J VIROL, V84, P4264, DOI 10.1128/JVI.02214-09; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; MATSUKURA T, 1992, VIROLOGY, V190, P561, DOI 10.1016/0042-6822(92)91254-R; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; MULLER M, 1989, J VIROL, V63, P4907; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Nordin P, 2007, ACTA DERM-VENEREOL, V87, P219, DOI 10.2340/00015555-0235; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Phan TG, 2013, GENOME ANNOUNC, V1; RADULESCU RT, 1995, BIOCHEM BIOPH RES CO, V206, P97, DOI 10.1006/bbrc.1995.1014; RAMBAUT A, 2009, FIGTREE V1 3; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Sichero L, 2013, VIROLOGY IN PRESS; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3; Ullman CG, 1996, BIOCHEM J, V319, P229, DOI 10.1042/bj3190229; USTAV E, 1993, P NATL ACAD SCI USA, V90, P898, DOI 10.1073/pnas.90.3.898; van Regenmortel MHV, 2000, VIRUS TAXONOMY, P3; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140; Weissenborn S, 2012, MED MICROBIOL IMMUN, V201, P117, DOI 10.1007/s00430-011-0212-3; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zakrzewska K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-309; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	73	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89342	10.1371/journal.pone.0089342	http://dx.doi.org/10.1371/journal.pone.0089342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551244	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000109
J	Miyake, M; Goodison, S; Lawton, A; Gomes-Giacoia, E; Rosser, CJ				Miyake, M.; Goodison, S.; Lawton, A.; Gomes-Giacoia, E.; Rosser, C. J.			Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway	ONCOGENE			English	Article							BLADDER-CANCER; PROSTATE-CANCER; ENDOTHELIAL-CELLS; RIBONUCLEOLYTIC ACTIVITY; NUCLEAR TRANSLOCATION; UROTHELIAL CARCINOMA; BINDING-PROTEIN; ATHYMIC MICE; TISSUE; THERAPY	Tumor angiogenesis is essential for tumor growth and metastasis and is dependent on key angiogenic factors. Angiogenin (ANG), a 14.2-kDa polypeptide member of the RNase A superfamily, is an angiogenic protein that has been reported to be upregulated and associated with poor prognosis in some human cancers. The mechanisms through which aberrant ANG levels promote specific steps in tumor progression are unknown. Here, we show that ANG expression in human tissues is strongly correlated with an invasive cancer phenotype. We also show that ANG induces cellular survival, proliferation, endothelial tube formation and xenograft angiogenesis and growth. Novel mechanistic investigations revealed that ANG expression stimulated matrix metallopeptidase-2 (MMP2) expression through the phosphorylation of ERK1/2. Targeting ANG in vivo with N65828, a small-molecule inhibitor of the ribonucleolytic activity of human ANG, resulted in the diminution of xenograft tumoral growth through the inhibition of angiogenesis. Our findings support an unrecognized interplay between ANG, ERK1/2 and MMP2 that can impact tumor growth and progression. The targeting of ANG and associated factors could provide a novel strategy to inhibit tumor establishment and growth.	[Miyake, M.; Goodison, S.; Gomes-Giacoia, E.; Rosser, C. J.] MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL USA; [Goodison, S.; Rosser, C. J.] Nonagen Biosci Corp, Orlando, FL USA; [Lawton, A.] Orlando Hlth, Dept Pathol, Orlando, FL USA	University of Texas System; UTMD Anderson Cancer Center	Rosser, CJ (corresponding author), Univ Hawaii, Ctr Canc, Sch Med, Clin & Translat Program, 701 Ilalo St, Honolulu, HI 96813 USA.	crosser@cc.hawaii.edu			Florida Biomedical Program James and Esther King Team Science Project [1KT-01]; NATIONAL CANCER INSTITUTE [R01CA116161] Funding Source: NIH RePORTER	Florida Biomedical Program James and Esther King Team Science Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Florida Biomedical Program James and Esther King Team Science Project 1KT-01 (CJR). Dr Kwai Wa Cheng for reading this manuscript and offering editorial suggestions.	Anai S, 2007, MOL CANCER THER, V6, P101, DOI 10.1158/1535-7163.MCT-06-0367; Anai S, 2011, UROL ONCOL-SEMIN ORI, V29, P421, DOI 10.1016/j.urolonc.2009.04.009; BOCHNER BH, 1995, J NATL CANCER I, V87, P1603, DOI 10.1093/jnci/87.21.1603; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Chuang CK, 2010, ONCOL LETT, V1, P691, DOI 10.3892/ol_00000121; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gontero P, 2004, EUR UROL, V46, P296, DOI 10.1016/j.eururo.2004.04.001; Goodison S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047469; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; Hartmann A, 1999, CANCER RES, V59, P1578; Hirukawa S, 2005, CLIN CANCER RES, V11, P8745, DOI 10.1158/1078-0432.CCR-05-1495; Hisai H, 2003, CLIN CANCER RES, V9, P4852; HU GF, 1994, P NATL ACAD SCI USA, V91, P12096, DOI 10.1073/pnas.91.25.12096; HU GF, 1993, P NATL ACAD SCI USA, V90, P1217, DOI 10.1073/pnas.90.4.1217; HU GF, 1991, P NATL ACAD SCI USA, V88, P2227, DOI 10.1073/pnas.88.6.2227; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Kao RYT, 2002, P NATL ACAD SCI USA, V99, P10066, DOI 10.1073/pnas.152342999; Katona TM, 2005, CLIN CANCER RES, V11, P8358, DOI 10.1158/1078-0432.CCR-05-0962; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; Knowles MA, 2006, CARCINOGENESIS, V27, P361, DOI 10.1093/carcin/bgi310; Kollermann J, 2001, AM J CLIN PATHOL, V116, P115; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; LEE FS, 1989, BIOCHEM BIOPH RES CO, V161, P121, DOI 10.1016/0006-291X(89)91569-6; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LIOTTA LA, 1974, CANCER RES, V34, P997; Miyake H, 1999, CANCER, V86, P316, DOI 10.1002/(SICI)1097-0142(19990715)86:2<316::AID-CNCR16>3.0.CO;2-T; Miyake M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-322; Miyake M, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-23; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; OBrien T, 1997, CANCER RES, V57, P136; OBrien TS, 1996, CANCER RES, V56, P4799; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccoli R, 1998, P NATL ACAD SCI USA, V95, P4579, DOI 10.1073/pnas.95.8.4579; Sakai Y, 2009, WORLD J UROL, V27, P659, DOI 10.1007/s00345-009-0422-0; Shapiro R, 2000, J MOL BIOL, V302, P497, DOI 10.1006/jmbi.2000.4075; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Uehara H, 2005, PROSTATE, V64, P40, DOI 10.1002/pros.20223; Urquidi V, 2012, CANCER EPIDEM BIOMAR, V21, P2149, DOI 10.1158/1055-9965.EPI-12-0428; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zhao H, 2005, CANCER-AM CANCER SOC, V104, P30, DOI 10.1002/cncr.21136	46	63	67	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 12	2015	34	7					890	901		10.1038/onc.2014.2	http://dx.doi.org/10.1038/onc.2014.2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB2QF	24561529	Green Accepted			2022-12-25	WOS:000349472000009
J	Zimmermann, J; Latta, L; Beck, A; Leidinger, P; Fecher-Trost, C; Schlenstedt, G; Meese, E; Wissenbach, U; Flockerzi, V				Zimmermann, Jasmin; Latta, Lorenz; Beck, Andreas; Leidinger, Petra; Fecher-Trost, Claudia; Schlenstedt, Gabriel; Meese, Eckart; Wissenbach, Ulrich; Flockerzi, Veit			Trans-activation Response ( TAR) RNA-binding Protein 2 Is a Novel Modulator of Transient Receptor Potential Canonical 4 (TRPC4) Protein*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Cell Signaling; Dicer; Protein-Protein Interactions; TRP Channels	HUMAN DICER; CATION CHANNEL; S4-S5 LINKER; DOMAIN; TRBP; ACTIVATION; CALMODULIN; IDENTIFICATION; ROLES; MICE	Background: The molecular composition of native TRPC4 channels is unknown. Results: Tarbp2, like Ago2 and Dicer, a protein of the RNA-induced silencing complex, binds to and functionally interacts with TRPC4. Conclusion: Upon TRPC4 binding, Tarbp2 modulates Ca2+ entry and promotes Ca2+-dependent proteolytic activation of Dicer. Significance: Mechanistic insight into coupling TRPC4 activity and Dicer-dependent formation of noncoding RNAs is provided. TRPC4 proteins function as Ca2+ conducting, non-selective cation channels in endothelial, smooth muscle, and neuronal cells. To further characterize the roles of TRPC4 in vivo, detailed information about the molecular composition of native channel complexes and their association with cellular signaling networks is needed. Therefore, a mouse brain cDNA library was searched for novel TRPC4-interacting proteins using a modified yeast two-hybrid assay. This screen identified Trans-activation Response RNA-binding protein 2 (Tarpb2), a protein that recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Tarbp2 was found to bind to the C terminus of TRPC4 and TRPC5 and to modulate agonist-dependent TRPC4-induced Ca2+ entry. A stretch of basic residues within the Tarbp2 protein is required for these actions. Tarbp2 binding to and modulation of TRPC4 occurs in the presence of endogenously expressed Dicer but is no longer detectable when the Dicer cDNA is overexpressed. Dicer activity in crude cell lysates is increased in the presence of Ca2+, most probably by Ca2+-dependent proteolytic activation of Dicer. Apparently, Tarbp2 binding to TRPC4 promotes changes of cytosolic Ca2+ and, thereby, leads to a dynamic regulation of Dicer activity, essentially at low endogenous Dicer concentrations.	[Zimmermann, Jasmin; Latta, Lorenz; Beck, Andreas; Fecher-Trost, Claudia; Wissenbach, Ulrich; Flockerzi, Veit] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Leidinger, Petra; Meese, Eckart] Univ Saarland, Inst Humangenet, D-66421 Homburg, Germany; [Schlenstedt, Gabriel] Univ Saarland, Inst Med Biochem & Mol Biol, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Flockerzi, V (corresponding author), Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany.	veit.flockerzi@uniklinikum-saarland.de	Meese, Eckart Ulrich/ABD-1983-2021		Deutsche Forschungsgemeinschaft; Forschungsausschuss der Medizinischen Fakultat "HOMFOR"; Forschungsausschuss der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsausschuss der Medizinischen Fakultat "HOMFOR"; Forschungsausschuss der Universitat des Saarlandes	This work was supported by the Deutsche Forschungsgemeinschaft (to A. B., P. L., and V. F.), by the Forschungsausschuss der Medizinischen Fakultat "HOMFOR," and by the Forschungsausschuss der Universitat des Saarlandes (to P. L., E. M., C. F.-T., and V. F.).	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Daniels SM, 2012, MICROBIOL MOL BIOL R, V76, P652, DOI 10.1128/MMBR.00012-12; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flockerzi V., 2007, V179, P1; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rossi JJ, 2005, EMBO REP, V6, P927, DOI 10.1038/sj.embor.7400531; Sawh AN, 2013, CELL REP, V4, P454, DOI 10.1016/j.celrep.2013.07.013; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Trost C, 2001, BIOCHEM J, V355, P663, DOI 10.1042/bj3550663; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	54	6	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9766	9780		10.1074/jbc.M114.557066	http://dx.doi.org/10.1074/jbc.M114.557066			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563462	hybrid, Green Published			2022-12-25	WOS:000333807000028
J	Jozsef, L; Tashiro, K; Kuo, A; Park, E; Skoura, A; Albinsson, S; Rivera-Molina, F; Harrison, KD; Iwakiri, Y; Toomre, D; Sessa, WC				Jozsef, Levente; Tashiro, Keitaro; Kuo, Andrew; Park, Eonjoo; Skoura, Athanasia; Albinsson, Sebastian; Rivera-Molina, Felix; Harrison, Kenneth D.; Iwakiri, Yasuko; Toomre, Derek; Sessa, William C.			Reticulon 4 Is Necessary for Endoplasmic Reticulum Tubulation, STIM1-Orai1 Coupling, and Store-operated Calcium Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Signaling; Endoplasmic Reticulum (ER); Imaging; Membrane; reticulons	MITOTIC HELA-CELLS; INTRACELLULAR CA2+; CANCER CELLS; MEMBRANE-PROTEINS; CHANNEL FUNCTION; CRAC CHANNELS; ER STRUCTURE; GENE FAMILY; STIM1; NOGO	Background: Store-operated calcium entry requires the redistribution of ER localized STIM1 to ER-PM junctions. Results: Altering ER morphology by modulating reticulon expression affects STIM1 redistribution and consequently calcium entry. Conclusion: Reticulon shaping of the ER is critical for store-operated calcium entry. Significance: Understanding how membrane shaping proteins participate in the regulation of organelle function is essential in elucidating the structure-function interdependence of organelles. Despite recent advances in understanding store-operated calcium entry (SOCE) regulation, the fundamental question of how ER morphology affects this process remains unanswered. Here we show that the loss of RTN4, is sufficient to alter ER morphology and severely compromise SOCE. Mechanistically, we show this to be the result of defective STIM1-Orai1 coupling because of loss of ER tubulation and redistribution of STIM1 to ER sheets. As a functional consequence, RTN4-depleted cells fail to sustain elevated cytoplasmic Ca2+ levels via SOCE and therefor are less susceptible to Ca2+ overload induced apoptosis. Thus, for the first time, our results show a direct correlation between ER morphology and SOCE and highlight the importance of RTN4 in cellular Ca2+ homeostasis.	[Jozsef, Levente; Kuo, Andrew; Park, Eonjoo; Skoura, Athanasia; Albinsson, Sebastian; Harrison, Kenneth D.; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, Dept Pharmacol, New Haven, CT 06520 USA; [Tashiro, Keitaro; Iwakiri, Yasuko] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Rivera-Molina, Felix; Toomre, Derek] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Sessa, WC (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Albinsson, Sebastian/B-4105-2010; Sessa, William C/B-6844-2011	Albinsson, Sebastian/0000-0001-6936-3967; Sessa, William C/0000-0001-5759-1938	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082600, P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081190] Funding Source: Medline; NIDDK NIH HHS [R01 DK082600, P30 DK034989] Funding Source: Medline; NIGMS NIH HHS [T32 GM007324] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; FURUYA Y, 1994, CANCER RES, V54, P6167; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Iwahashi J, 2007, BIOCHEM BIOPH RES CO, V355, P508, DOI 10.1016/j.bbrc.2007.02.001; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; Kim KD, 2011, J IMMUNOL, V187, P3620, DOI 10.4049/jimmunol.1100847; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu HM, 2012, TOXICOL LETT, V208, P254, DOI 10.1016/j.toxlet.2011.11.007; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Oertle T, 2003, J NEUROSCI, V23, P5393; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Pigozzi D, 2004, CELL CALCIUM, V36, P421, DOI 10.1016/j.ceca.2004.04.002; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Russa AD, 2008, ARCH HISTOL CYTOL, V71, P249, DOI 10.1679/aohc.71.249; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Seo SR, 2009, EXP MOL MED, V41, P269, DOI 10.3858/emm.2009.41.4.030; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sun SX, 2012, BIOSCIENCE REP, V32, P83, DOI 10.1042/BSR20110062; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Verkhratsky A., 2007, V45, P465; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Xu YK, 2011, CURR OPIN CHEM BIOL, V15, P822, DOI 10.1016/j.cbpa.2011.10.016; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	65	45	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9380	9395		10.1074/jbc.M114.548602	http://dx.doi.org/10.1074/jbc.M114.548602			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24558039	Green Published, hybrid			2022-12-25	WOS:000333472100054
J	Swinnen, TW; Scheers, T; Lefevre, J; Dankaerts, W; Westhovens, R; de Vlam, K				Swinnen, Thijs Willem; Scheers, Tineke; Lefevre, Johan; Dankaerts, Wim; Westhovens, Rene; de Vlam, Kurt			Physical Activity Assessment in Patients with Axial Spondyloarthritis Compared to Healthy Controls: A Technology-Based Approach	PLOS ONE			English	Article							SPONDYLITIS DISEASE-ACTIVITY; ANKYLOSING-SPONDYLITIS; ARTHRITIS; CLASSIFICATION; INTERVENTIONS; LIMITATION; RELEVANT; MONITORS; EXERCISE; UPDATE	Introduction: Traditionally, assessment in axial Spondyloarthritis (aSpA) includes the evaluation of the capacity to execute tasks, conceptualized as physical function. The role of physical activity, defined as movement-related energy expenditure, is largely unknown and almost exclusively studied using patient-reported outcome measures. The aims of this observational cross-sectional study are to compare physical activity between patients with aSpA and healthy controls (HC) and to evaluate the contribution of disease activity to physical activity differences between groups. Methods: Forty patients with aSpA were matched by age, gender, period of data acquisition in terms of days and season to 40 HC. Physical activity was measured during five consecutive days (three weekdays and two weekend days) using ambulatory monitoring (SenseWear Armband). Self-reported disease activity was measured by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Differences in physical activity between patients with aSpA and HC were examined with Wilcoxon signed-rank tests and a mixed linear model. Difference scores between patients and HC were correlated with disease activity. Results: Average weekly physical activity level (Med(IQR); HC: 1.54(1.41-1.73); aSpA: 1.45(1.31-1.67), MET) and energy expenditure (HC: 36.40(33.43-41.01); aSpA: 34.55(31.08-39.41), MET. hrs/day) were significantly lower in patients with aSpA. Analyses across intensity levels revealed no significant differences between groups for inactivity and time spent at light or moderate physical activities. In contrast, weekly averages of vigorous (HC: 4.02(1.20-12.60); aSpA: 0.00(0.00-1.20), min/d), very vigorous physical activities (HC0.00(0.00-1.08); aSpA: 0.00(0.00-0.00), mind/d) and moderate/(very) vigorous combined (HC2.41(1.62-3.48); aSpA: 1.63(1.20-2.82), hrs/d) were significantly lower in patients with aSpA. Disease activity did not interact with differences in physical activity between patients with aSpA and HC, evidenced by non-significant and very low correlations (range: 20.06-0.17) between BASDAI and HC-aSpA patients' difference scores. Conclusions: Patients with aSpA exhibit lower physical activity compared to HC and these differences are independent of self-reported disease activity. Further research on PA in patients with aSpA should be prioritized.	[Swinnen, Thijs Willem; Westhovens, Rene; de Vlam, Kurt] Katholieke Univ Leuven Hosp, Louvain, Belgium; [Swinnen, Thijs Willem; Westhovens, Rene; de Vlam, Kurt] Katholieke Univ Leuven, Dept Dev & Regenerat, Louvain, Belgium; [Swinnen, Thijs Willem; Dankaerts, Wim] Katholieke Univ Leuven, Dept Rehabil Sci, Heverlee, Belgium; [Scheers, Tineke; Lefevre, Johan] Katholieke Univ Leuven, Dept Kinesiol, Heverlee, Belgium; [Scheers, Tineke] Res Fdn Flanders, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; KU Leuven	de Vlam, K (corresponding author), Katholieke Univ Leuven Hosp, Louvain, Belgium.	kurt.devlam@uzleuven.be	de Vlam, Kurt/AAF-2842-2019		Division of Rheumatology, University Hospitals Leuven; Research Foundation Flanders (F.W.O. Vlaanderen) [1134711N/1134709N]	Division of Rheumatology, University Hospitals Leuven; Research Foundation Flanders (F.W.O. Vlaanderen)(FWO)	Thijs Swinnen was funded by the Division of Rheumatology, University Hospitals Leuven (www.uzleuven.be) and Tineke Scheers was funded by the Research Foundation Flanders (F.W.O. Vlaanderen, www.fwo.be, 1134711N/1134709N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 2001, HUMAN ENERGY REQUIRE; [Anonymous], 2001, INT CLASSIFICATION F; Baruth M, 2011, ARTHRIT CARE RES, V63, P1038, DOI 10.1002/acr.20463; Benjamin M, 2009, ADV EXP MED BIOL, V649, P57; Biasi D, 1996, J RHEUMATOL, V23, P407; Boonen A, 2010, ANN RHEUM DIS, V69, P102, DOI 10.1136/ard.2008.104117; Boonen A, 2009, J RHEUMATOL, V36, P2501, DOI 10.3899/jrheum.090156; Boonen A, 2009, RHEUMATOLOGY, V48, P997, DOI 10.1093/rheumatology/kep150; Brady TJ, 2009, J WOMENS HEALTH, V18, P1905, DOI 10.1089/jwh.2009.1571; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Brazeau AS, 2011, APPL PHYSIOL NUTR ME, V36, P339, DOI [10.1139/H11-016, 10.1139/h11-016]; Brionez TF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2874; CALIN A, 1994, J RHEUMATOL, V21, P2281; Calin A, 1999, RHEUMATOLOGY, V38, P878, DOI 10.1093/rheumatology/38.9.878; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V0100; Cieza A, 2009, DISABIL REHABIL, V31, P528, DOI 10.1080/09638280802173475; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Conn VS, 2008, SEMIN ARTHRITIS RHEU, V37, P307, DOI 10.1016/j.semarthrit.2007.07.006; D'Ambrosia P, 2010, EUR SPINE J, V19, P1330, DOI 10.1007/s00586-010-1371-4; Da Costa D, 2004, ARTHRIT RHEUM-ARTHR, V51, P1004, DOI 10.1002/art.20841; Dagfinrud H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002822.pub3; Dagfinrud H, 2005, J RHEUMATOL, V32, P516; Dagfinrud H, 2011, ARTHRIT CARE RES, V63, P597, DOI 10.1002/acr.20415; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Dunlop DD, 2011, ARTHRITIS RHEUM-US, V63, P127, DOI 10.1002/art.27760; Farr JN, 2008, ARTHRIT RHEUM-ARTHR, V59, P1229, DOI 10.1002/art.24007; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Haglund E, 2012, ARTHRITIS CARE RES H; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Langer D, 2009, THORAX, V64, P641, DOI 10.1136/thx.2008.112102; Luyten FR, 2006, BEST PRACT RES CL RH, V20, P829, DOI 10.1016/j.berh.2006.06.009; Marcora S, 2006, RHEUMATOLOGY, V45, P1385, DOI 10.1093/rheumatology/kel127; Mathieu S, 2011, ARTHRIT CARE RES, V63, P557, DOI 10.1002/acr.20364; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Mihai B, 2005, Eura Medicophys, V41, P149; Piva SR, 2010, ARTHRIT CARE RES, V62, P1144, DOI 10.1002/acr.20177; Plasqui G, 2012, ARTHRIT CARE RES, V64, P101, DOI 10.1002/acr.20566; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Scaglioni F, 2012, CLIN RES HEPATOL GAS; Scheers T, 2011, EUR J APPL PHYSL; Shih M, 2006, AM J PREV MED, V30, P385, DOI 10.1016/j.amepre.2005.12.005; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; van der Heijde D, 1999, J RHEUMATOL, V26, P951; van der Heijde D, 1999, J RHEUMATOL, V26, P1003; Ward MM, 2008, ARTHRIT RHEUM-ARTHR, V59, P822, DOI 10.1002/art.23704; Wilcox S, 2006, ARTHRIT RHEUM-ARTHR, V55, P616, DOI 10.1002/art.22098; Woolf CJ, 2010, J CLIN INVEST, V120, P3742, DOI 10.1172/JCI45178	50	56	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e85309	10.1371/journal.pone.0085309	http://dx.doi.org/10.1371/journal.pone.0085309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586239	Green Submitted, Green Published, gold			2022-12-25	WOS:000332396200006
J	Lederman, M; Hagbi-Levi, S; Grunin, M; Obolensky, A; Berenshtein, E; Banin, E; Chevion, M; Chowers, I				Lederman, Michal; Hagbi-Levi, Shira; Grunin, Michelle; Obolensky, Alexey; Berenshtein, Eduard; Banin, Eyal; Chevion, Mordechai; Chowers, Itay			Degeneration Modulates Retinal Response to Transient Exogenous Oxidative Injury	PLOS ONE			English	Article							CONE CELL-DEATH; PHOTORECEPTOR DEGENERATION; MITOCHONDRIAL DYSFUNCTION; SPECTROPHOTOMETRIC METHOD; PIGMENT EPITHELIUM; IRON; STRESS; DAMAGE; MOUSE; PROTECTS	Purpose Oxidative injury is involved in retinal and macular degeneration. We aim to assess if retinal degeneration associated with genetic defect modulates the retinal threshold for encountering additional oxidative challenges. Methods: Retinal oxidative injury was induced in degenerating retinas (rd10) and in control mice (WT) by intravitreal injections of paraquat (PQ). Retinal function and structure was evaluated by electroretinogram (ERG) and histology, respectively. Oxidative injury was assessed by immunohistochemistry for 4-Hydroxy-2-nonenal (HNE), and by Thiobarbituric Acid Reactive Substances (TBARS) and protein carbonyl content (PCC) assays. Anti-oxidant mechanism was assessed by quantitative real time PCR (QPCR) for mRNA of antioxidant genes and genes related to iron metabolism, and by catalase activity assay. Results: Three days following PQ injections (1 mu l of 0.25, 0.75, and 2 mM) the average ERG amplitudes decreased more in the WT mice compared with the rd10 mice. For example, following 2 mM PQ injection, ERG amplitudes reduced 1.84-fold more in WT compared with rd10 mice (p = 0.02). Injection of 4 mM PQ resulted in retinal destruction. Altered retina morphology associated with PQ was substantially more severe in WT eyes compared with rd10 eyes. Oxidative injury according to HNE staining and TBARS assay increased 1.3-fold and 2.1-fold more, respectively, in WT compared with rd10 mice. At baseline, prior to PQ injection, mRNA levels of antioxidant genes (Superoxide Dismutase1, Glutathione Peroxidase1, Catalase) and of Transferrin measured by quantitative PCR were 2.1-7.8-fold higher in rd10 compared with WT mice (p < 0.01 each), and catalase activity was 1.7-fold higher in rd10 (p = 0.0006). Conclusions: This data suggests that degenerating rd10 retinas encounter a relatively lower degree of damage in response to oxidative injury compared with normal retinas. Constitutive up-regulation of the oxidative defense mechanism in degenerating retinas may confer such relative protection from oxidative injury.	[Lederman, Michal; Hagbi-Levi, Shira; Grunin, Michelle; Obolensky, Alexey; Banin, Eyal; Chowers, Itay] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Lederman, Michal; Hagbi-Levi, Shira; Grunin, Michelle; Obolensky, Alexey; Berenshtein, Eduard; Banin, Eyal; Chevion, Mordechai; Chowers, Itay] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Lederman, Michal; Obolensky, Alexey; Berenshtein, Eduard; Chevion, Mordechai] Hadassah Hebrew Univ, Med Ctr, Dept Cellular Biochem & Human Genet, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Chowers, I (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel.	chowers@hadassah.org.il	Grunin, Michelle/O-6044-2019	Grunin, Michelle/0000-0002-3155-2858; Hagbi-Levi, Shira/0000-0002-2891-0079	research grant from the Israeli Science Fund [ISF 849/08]	research grant from the Israeli Science Fund	This study was supported by a research grant from the Israeli Science Fund (ISF 849/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1994, ADV EXP MED BIOL, V366, P73; Banin E, 2000, FREE RADICAL BIO MED, V28, P315, DOI 10.1016/S0891-5849(99)00227-0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chen HY, 2009, NEUROBIOL AGING, V30, P1865, DOI 10.1016/j.neurobiolaging.2008.01.002; Chen M, 2013, INVEST OPHTH VIS SCI, V54, P682, DOI 10.1167/iovs.12-10888; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Chowers I, 2006, INVEST OPHTH VIS SCI, V47, P2135, DOI 10.1167/iovs.05-1135; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Deleon E, 2009, INVEST OPHTH VIS SCI, V50, P1360, DOI 10.1167/iovs.08-1856; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Dunaief JL, 2011, FREE RADICAL BIO MED, V51, P1480, DOI 10.1016/j.freeradbiomed.2011.05.009; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Hadziahmetovic M, 2012, INVEST OPHTH VIS SCI, V53, P5231, DOI 10.1167/iovs.12-10204; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; KONIJN AM, 1982, J IMMUNOL METHODS, V54, P297, DOI 10.1016/0022-1759(82)90314-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meir T, 2007, INVEST OPHTH VIS SCI, V48, P4890, DOI 10.1167/iovs.07-0215; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Obolensky A, 2008, FREE RADICAL BIO MED, V44, P1286, DOI 10.1016/j.freeradbiomed.2007.10.060; Obolensky A, 2011, FREE RADICAL BIO MED, V51, P1482, DOI 10.1016/j.freeradbiomed.2011.07.014; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Picard E, 2010, MOL VIS, V16, P2612; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; REZNICK AZ, 1992, BIOCHEM J, V286, P607, DOI 10.1042/bj2860607; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Shen JK, 2007, HISTOL HISTOPATHOL, V22, P1301, DOI 10.14670/HH-22.1301; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87751	10.1371/journal.pone.0087751	http://dx.doi.org/10.1371/journal.pone.0087751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586289	Green Published, gold, Green Submitted			2022-12-25	WOS:000331717900013
J	Barbosa, RL; Legrand, P; Wien, F; Pineau, B; Thompson, A; Guimaraes, BG				Barbosa, Rosicler L.; Legrand, Pierre; Wien, Frank; Pineau, Blandine; Thompson, Andrew; Guimaraes, Beatriz G.			RRP6 from Trypanosoma brucei : Crystal Structure of the Catalytic Domain, Association with EAP3 and Activity towards Structured and Non-Structured RNA Substrates	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; YEAST EXOSOME CORE; HUMAN PM-SCL; SUBUNIT; EXPRESSION; BINDING; RRP47P	RRP6 is a 3'-5' exoribonuclease associated to the eukaryotic exosome, a multiprotein complex essential for various RNA processing and degradation pathways. In Trypanosoma brucei, RRP6 associates with the exosome in stoichiometric amounts and was localized in both cytoplasm and nucleus, in contrast to yeast Rrp6 which is exclusively nuclear. Here we report the biochemical and structural characterization of T. brucei RRP6 (TbRRP6) and its interaction with the so-called T. brucei Exosome Associated Protein 3 (TbEAP3), a potential orthologue of the yeast Rrp6 interacting protein, Rrp47. Recombinant TbEAP3 is a thermo stable homodimer in solution, however it forms a heterodimeric complex with TbRRP6 with 1: 1 stoichiometry. The crystallographic structure of the TbRRP6 catalytic core exposes for the first time the native catalytic site of this RNase and also reveals a disulfide bond linking two helices of the HRDC domain. RNA degradation assays show the distributive exoribonuclease activity of TbRRP6 and novel findings regarding the structural range of its RNA substrates. TbRRP6 was able to degrade single and double-stranded RNAs and also RNA substrates containing stem-loops including those with 39 stem-loop lacking single-stranded extensions. Finally, association with TbEAP3 did not significantly interfere with the TbRRP6 catalytic activity in vitro.	[Barbosa, Rosicler L.; Legrand, Pierre; Wien, Frank; Pineau, Blandine; Thompson, Andrew; Guimaraes, Beatriz G.] Synchrotron SOLEIL, Gif Sur Yvette, France	SOLEIL Synchrotron	Guimaraes, BG (corresponding author), Synchrotron SOLEIL, Gif Sur Yvette, France.	beatriz.guimaraes@synchrotron-soleil.fr	LEGRAND, Pierre/G-7709-2011; Wien, Frank/B-7846-2012; Guimarães, Beatriz G/D-3858-2014	LEGRAND, Pierre/0000-0003-2431-2255; Wien, Frank/0000-0002-0752-8735; 	Synchrotron Soleil, France; CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Synchrotron Soleil, France; CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Synchrotron Soleil, France. RLB received a fellowship from CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bricogne G., 2009, BUSTER VERSION 2 9 1; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Cristodero M, 2008, MOL BIOCHEM PARASIT, V159, P24, DOI 10.1016/j.molbiopara.2007.12.012; CUDNY H, 1981, J BIOL CHEM, V256, P5633; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fadda A, 2013, RNA, V19, P937, DOI 10.1261/rna.038430.113; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Fernandez-Moya SM, 2010, WIRES RNA, V1, P34, DOI 10.1002/wrna.6; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Refregiers M, 2012, J SYNCHROTRON RADIAT, V19, P831, DOI 10.1107/S0909049512030002; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wien F, 2005, APPL SPECTROSC, V59, P1109, DOI 10.1366/0003702055012546; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89138	10.1371/journal.pone.0089138	http://dx.doi.org/10.1371/journal.pone.0089138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558481	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700127
J	Prendergast, AJ; Rukobo, S; Chasekwa, B; Mutasa, K; Ntozini, R; Mbuya, MNN; Jones, A; Moulton, LH; Stoltzfus, RJ; Humphrey, JH				Prendergast, Andrew J.; Rukobo, Sandra; Chasekwa, Bernard; Mutasa, Kuda; Ntozini, Robert; Mbuya, Mduduzi N. N.; Jones, Andrew; Moulton, Lawrence H.; Stoltzfus, Rebecca J.; Humphrey, Jean H.			Stunting Is Characterized by Chronic Inflammation in Zimbabwean Infants	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHILD UNDERNUTRITION; INTESTINAL PERMEABILITY; DIARRHEA; DISEASE; MALNUTRITION; ENTEROPATHY; IMPAIRMENT; PREVALENCE; MECHANISMS	Background: Stunting affects one-third of children in developing countries, but the causes remain unclear. We hypothesized that enteropathy leads to low-grade inflammation, which suppresses the growth hormone-IGF axis and mediates stunting. Methods: We conducted a case-control study of 202 HIV-unexposed Zimbabwean infants who were stunted (height-for-age Z-score (HAZ), <-2; cases) or non-stunted (HAZ >-0.5; controls) at 18 months. We measured biomarkers of intestinal damage (I-FABP), inflammation (CRP, AGP, IL-6) and growth hormone-IGF axis (IGF-1, IGFBP3) in infant plasma at 6 weeks and 3, 6, 12 and 18 months, and in paired maternal-infant plasma at birth. Adjusted mean differences between biomarkers were estimated using regression models. Multivariate odds ratios of stunting were estimated by logistic regression. Results: At birth, cases were shorter (median (IQR) HAZ -1.00 (-1.53, -0.08) vs 0.03 (-0.57, 0.62,); P<0.001) than controls and their mothers had lower levels of IGF-1 (adjusted mean difference (95% CI) -21.4 (-39.8, -3.1) ng/mL). From 6 weeks to 12 months of age, levels of CRP and AGP were consistently higher and IGF-1 and IGFBP3 lower in cases versus controls; IGF-1 correlated inversely with inflammatory markers at all time-points. I-FABP increased between 3-12 months, indicating extensive intestinal damage during infancy, which was similar in cases and controls. In multivariate analysis, higher log(10) levels of CRP (aOR 3.06 (95% CI 1.34, 6.99); P = 0.008) and AGP (aOR 7.87 (95% CI 0.74, 83.74); P = 0.087) during infancy were associated with stunting. There were no associations between levels of I-FABP, IL-6, sCD14 or EndoCAb and stunting. Conclusions: Stunting began in utero and was associated with low maternal IGF-1 levels at birth. Inflammatory markers were higher in cases than controls from 6 weeks of age and were associated with lower levels of IGF-1 throughout infancy. Higher levels of CRP and AGP during infancy were associated with stunting. These findings suggest that an extensive enteropathy occurs during infancy and that low-grade chronic inflammation may impair infant growth.	[Prendergast, Andrew J.] Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England; [Prendergast, Andrew J.; Rukobo, Sandra; Chasekwa, Bernard; Mutasa, Kuda; Ntozini, Robert; Mbuya, Mduduzi N. N.; Humphrey, Jean H.] Zvitambo Inst Maternal Child Hlth Res, Harare, Zimbabwe; [Prendergast, Andrew J.; Mbuya, Mduduzi N. N.; Moulton, Lawrence H.; Humphrey, Jean H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Jones, Andrew] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of London; Queen Mary University London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan; Cornell University	Prendergast, AJ (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England.	a.prendergast@qmul.ac.uk	Ntozini, Robert/AFU-4878-2022; Mbuya, Mduduzi/AAJ-2833-2021	Ntozini, Robert/0000-0002-8543-2835; Moulton, Lawrence/0000-0001-7041-7387; Chasekwa, Bernard/0000-0001-8080-7573; Prendergast, Andrew/0000-0001-7904-7992	Wellcome Trust [093768/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (wellcome.ac.uk), grant number 093768/Z/10/Z to AJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baalwa J, 2010, AFR HEALTH SCI, V10, P367; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BRIEND A, 1990, EUR J CLIN NUTR, V44, P611; BRIEND A, 1989, LANCET, V2, P319; Campbell DI, 2003, J NUTR, V133, P1332; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; Derikx JPM, 2010, CRIT CARE MED, V38, P133, DOI 10.1097/CCM.0b013e3181b4a5ed; Derikx JPM, 2009, J CLIN GASTROENTEROL, V43, P727, DOI 10.1097/MCG.0b013e31819194b0; DESAI H G, 1969, Indian Journal of Medical Sciences, V23, P1; Dewey K. G., 2008, SYSTEMATIC REV EFFIC; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Gibson RS, 1990, Q REV BIOL; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Humphrey JH, 2006, J INFECT DIS, V193, P960; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jensen RB, 2005, HORM RES, V63, P15, DOI 10.1159/000082456; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Liu JR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-129; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; Menzies IS, 1999, GUT, V44, P483, DOI 10.1136/gut.44.4.483; MOY RJD, 1994, EUR J CLIN NUTR, V48, P810; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Peterson KM, 2013, AM J CLIN NUTR, V97, P1129, DOI 10.3945/ajcn.112.048306; Poskitt EME, 1999, ARCH DIS CHILD, V80, P115, DOI 10.1136/adc.80.2.115; Prendergast A, 2012, AM J TROP MED HYG, V86, P756, DOI 10.4269/ajtmh.2012.11-0743; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; SCHENK EA, 1968, AM J CLIN NUTR, V21, P944, DOI 10.1093/ajcn/21.9.944; Semple S, 2010, ENVIRON HEALTH PERSP, V118, P988, DOI 10.1289/ehp.0901605; Shayo GA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-365; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vreugdenhil AC, 2011, SCAND J GASTROENTERO, V46, P1435, DOI 10.3109/00365521.2011.627447; Walters TD, 2009, NAT REV GASTRO HEPAT, V6, P513, DOI 10.1038/nrgastro.2009.124; Yuksel B, 2011, J CLIN RES PEDIATR E, V3, P84, DOI 10.4274/jcrpe.v3i2.17	40	160	161	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86928	10.1371/journal.pone.0086928	http://dx.doi.org/10.1371/journal.pone.0086928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558364	Green Published, gold			2022-12-25	WOS:000331706700010
J	Su, Q; Xie, W; Wang, SL; Wu, QJ; Liu, BM; Fang, Y; Xu, BY; Zhang, YJ				Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Liu, Baiming; Fang, Yong; Xu, Baoyun; Zhang, Youjun			The Endosymbiont Hamiltonella Increases the Growth Rate of Its Host Bemisia tabaci during Periods of Nutritional Stress	PLOS ONE			English	Article							CANDIDATUS PORTIERA ALEYRODIDARUM; SECONDARY SYMBIONTS; ACYRTHOSIPHON-PISUM; OBLIGATE SYMBIONT; GENOME SEQUENCE; METABOLIC INTERDEPENDENCE; BACTERIAL ENDOSYMBIONTS; HORIZONTAL TRANSFER; PEA APHID; BENEFITS	The whitefly Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae) harbors several bacterial symbionts. Among the secondary (facultative) symbionts, Hamiltonella has high prevalence and high infection frequencies, suggesting that it may be important for the biology and ecology of its hosts. Previous reports indicated that Hamiltonella increases whitefly fitness and, based on the complete sequencing of its genome, may have the ability to synthesize cofactors and amino acids that are required by its host but that are not sufficiently synthesized by the host or by the primary endosymbiont, Portiera. Here, we assessed the effects of Hamiltonella infection on the growth of B. tabaci reared on low-, standard-, or high-nitrogen diets. When B. tabaci was reared on a standard-nitrogen diet, no cost or benefit was associated with Hamiltonella infection. But, if we reared whiteflies on low-nitrogen diets, Hamiltonella-infected whiteflies often grew better than uninfected whiteflies. Furthermore, nitrogen levels in field-collected whiteflies indicated that the nutritional conditions in the field were comparable to the low-nitrogen diet in our laboratory experiment. These data suggest that Hamiltonella may play a previously unrecognized role as a nutritional mutualist in B. tabaci.	[Su, Qi] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Su, Qi; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Liu, Baiming; Fang, Yong; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2013CB127602]; National Natural Science Foundation of China [31171857]; Beijing Natural Science Foundation [6131002]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2013CB127602), the National Natural Science Foundation of China (31171857), the Beijing Natural Science Foundation (6131002), and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Baumann P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P403, DOI 10.1007/0-387-30741-9_16; Ben-Yosef M, 2008, J APPL ENTOMOL, V132, P690, DOI 10.1111/j.1439-0418.2008.01330.x; Bourtzis K, 2003, INSECT SYMBIOSIS, V1; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; BYRNE DN, 1990, J INSECT PHYSIOL, V36, P433, DOI 10.1016/0022-1910(90)90061-J; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Darby AC, 2001, FEMS MICROBIOL ECOL, V36, P43, DOI 10.1111/j.1574-6941.2001.tb00824.x; Dasch GA, 1984, BERGEYS MANUAL SYSTE, V1, P811; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jancovich JK, 1997, J ECON ENTOMOL, V90, P628, DOI 10.1093/jee/90.2.628; Jiang ZF, 2012, J BACTERIOL, V194, P6678, DOI 10.1128/JB.01841-12; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Montllor C.B., 1991, P125; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Rao Q, 2012, J BACTERIOL, V194, P3558, DOI 10.1128/JB.00069-12; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Santos-Garcia D, 2012, J BACTERIOL, V194, P6654, DOI 10.1128/JB.01793-12; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Sloan DB, 2012, BIOL LETTERS, V8, P986, DOI 10.1098/rsbl.2012.0664; Su Q, 2013, ENVIRON ENTOMOL, V42, P1265, DOI 10.1603/EN13182; Su Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01367; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wernegreen JJ, 2012, CURR OPIN MICROBIOL, V15, P255, DOI 10.1016/j.mib.2012.02.001; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; [No title captured]	60	41	44	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89002	10.1371/journal.pone.0089002	http://dx.doi.org/10.1371/journal.pone.0089002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558462	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700108
J	Yang, WT; Zheng, PS				Yang, Wen-Ting; Zheng, Peng-Sheng			Promoter Hypermethylation of KLF4 Inactivates Its Tumor Suppressor Function in Cervical Carcinogenesis	PLOS ONE			English	Article							DOWN-REGULATION; EPIGENETIC INACTIVATION; DNA-METHYLATION; CANCER; GENE; EXPRESSION; KRUPPEL-LIKE-FACTOR-4; TRANSFORMATION; GROWTH; TRANSCRIPTION	Objective: The KLF4 gene has been shown to be inactivated in cervical carcinogenesis as a tumor suppressor. However, the mechanism of KLF4 silencing in cervical carcinomas has not yet been identified. DNA methylation plays a key role in stable suppression of gene expression. Methods: The methylation status of the KLF4 promoter CpG islands was analyzed by bisulfite sequencing (BSQ) in tissues of normal cervix and cervical cancer. KLF4 gene expression was detected by RT-PCR, immunohistochemistry and western blot. KLF4 promoter methylation in cervical cancer cell line was determined by BSQ and methylation-specific polymerase chain reaction (MS-PCR). Cell proliferation ability was detected by cell growth curve and MTT assay. Results: The methylated allele was found in 41.90% of 24 cervical cancer tissues but only in 11.11% of 11 normal cervix tissues (P<0.005). KLF4 mRNA levels were significantly reduced in cervical cancer tissues compared with normal cervix tissues (P<0.01) and KLF4 mRNA expression showed a significant negative correlation with the promoter hypermethylation (r = -0.486, P = 0.003). Cervical cancer cell lines also showed a significant negative correlation between KLF4 expression and hypermethylation. After treatment with the demethylating agent 5-Azacytidine (5-Aza), the expression of KLF4 in the cervical cancer cell lines at both mRNA and protein levels was drastically increased, the cell proliferation ability was inhibited and the chemosensitivity for cisplatin was significantly increased. Conclusion: KLF4 gene is inactivated by methylation-induced silencing mechanisms in a large subset of cervical carcinomas and KLF4 promoter hypermethylation inactivates the gene's function as a tumor suppressor in cervical carcinogenesis.	[Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China; [Yang, Wen-Ting; Zheng, Peng-Sheng] Xi An Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Xian 710049, Peoples R China; [Zheng, Peng-Sheng] Minist Educ Peoples Republ China, Key Lab Environm & Genes Related Dis, Sect Canc Stem Cell Res, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Ministry of Education, China	Zheng, PS (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Reprod Med, Xian 710049, Peoples R China.	zpsheng@mail.xjtu.edu.cn			special scientific Distinguished Young Scientists Fund [30725043]; National Natural Science Foundation of China; Young grant from the National Natural Science Foundation [81302278];  [30571951]	special scientific Distinguished Young Scientists Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young grant from the National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 	This work was supported by a general grant (No. 30571951) and a special scientific Distinguished Young Scientists Fund grant (No. 30725043) to Prof. Peng-Sheng Zheng from the National Natural Science Foundation of China and a Young grant (No. 81302278) from the National Natural Science Foundation to Wen-ting Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudukadeer A, 2012, INT J MOL SCI, V13, P8353, DOI 10.3390/ijms13078353; Bajaj J, 2011, CANCER RES, V71, P4888, DOI 10.1158/0008-5472.CAN-11-0543; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Chen CL, 2003, EUR J CANCER, V39, P517, DOI 10.1016/S0959-8049(02)00175-2; Cho YG, 2007, APMIS, V115, P802, DOI 10.1111/j.1600-0463.2007.apm_643.x; Clarke MA, 2012, CANC EPIDEMIOL BIOMA; Coronel J, 2011, MED ONCOL, V28, pS540, DOI 10.1007/s12032-010-9700-3; Eiben GL, 2003, VIRAL IMMUNOL, V16, P111, DOI 10.1089/088282403322017866; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Huang LW, 2002, GYNECOL ONCOL, V85, P524, DOI 10.1006/gyno.2002.6666; Jeong DH, 2006, INT J GYNECOL CANCER, V16, P1234, DOI 10.1111/j.1525-1438.2006.00522.x; Jha AK, 2012, ONCOL LETT, V3, P1331, DOI 10.3892/ol.2012.655; Kang WS, 2012, J CANC RES CLIN ONCO; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Liu ZL, 2009, CANCER BIOL THER, V8, P1840, DOI 10.4161/cbt.8.19.9440; Maliekal TT, 2008, ONCOGENE, V27, P5110, DOI 10.1038/onc.2008.224; Masuda K, 2012, ONCOL REP, V28, P1146, DOI 10.3892/or.2012.1912; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nakahara Y, 2010, NEOPLASIA, V12, P20, DOI 10.1593/neo.91122; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Ramachandran I, 2012, ONCOGENE, V31, P2725, DOI 10.1038/onc.2011.455; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Tai SK, 2011, CANC SCI; Uren A, 2005, CANCER RES, V65, P6199, DOI 10.1158/0008-5472.CAN-05-0455; Van de Putte G, 2003, GYNECOL ONCOL, V89, P140, DOI 10.1016/S0090-8258(03)00010-6; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Xu J, 2008, J CANCER RES CLIN, V134, P891, DOI 10.1007/s00432-008-0353-y; Yang WT, 2012, CANCER-AM CANCER SOC, V118, P3691, DOI 10.1002/cncr.26698; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zammarchi F, 2011, AM J PATHOL, V178, P361, DOI 10.1016/j.ajpath.2010.11.021; Zhang G, 2009, BIOL CHEM, V390, P463, DOI 10.1515/BC.2009.060; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zhou YB, 2010, CANCER BIOL THER, V9, P507, DOI 10.4161/cbt.9.7.11106; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	40	40	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88827	10.1371/journal.pone.0088827	http://dx.doi.org/10.1371/journal.pone.0088827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551169	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500070
J	Bush, AA; Nipperess, DA; Duursma, DE; Theischinger, G; Turak, E; Hughes, L				Bush, Alex A.; Nipperess, David A.; Duursma, Daisy E.; Theischinger, Gunther; Turak, Eren; Hughes, Lesley			Continental-Scale Assessment of Risk to the Australian Odonata from Climate Change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; FRESH-WATER BIODIVERSITY; MULTIPLE STRESSORS; FOOD-WEB; DISTRIBUTIONS; RANGE; VULNERABILITY; CONSERVATION; RIVER; PREDICTION	Climate change is expected to have substantial impacts on the composition of freshwater communities, and many species are threatened by the loss of climatically suitable habitat. In this study we identify Australian Odonata (dragonflies and damselflies) vulnerable to the effects of climate change on the basis of exposure, sensitivity and pressure to disperse in the future. We used an ensemble of species distribution models to predict the distribution of 270 (85%) species of Australian Odonata, continent-wide at the subcatchment scale, and for both current and future climates using two emissions scenarios each for 2055 and 2085. Exposure was scored according to the departure of temperature, precipitation and hydrology from current conditions. Sensitivity accounted for change in the area and suitability of projected climatic habitat, and pressure to disperse combined measurements of average habitat shifts and the loss experienced with lower dispersal rates. Streams and rivers important to future conservation efforts were identified based on the sensitivity-weighted sum of habitat suitability for the most vulnerable species. The overall extent of suitable habitat declined for 56-69% of the species modelled by 2085 depending on emissions scenario. The proportion of species at risk across all components (exposure, sensitivity, pressure to disperse) varied between 7 and 17% from 2055 to 2085 and a further 3-17% of species were also projected to be at high risk due to declines that did not require range shifts. If dispersal to Tasmania was limited, many south-eastern species are at significantly increased risk. Conservation efforts will need to focus on creating and preserving freshwater refugia as part of a broader conservation strategy that improves connectivity and promotes adaptive range shifts. The significant predicted shifts in suitable habitat could potentially exceed the dispersal capacity of Odonata and highlights the challenge faced by other freshwater species.	[Bush, Alex A.; Nipperess, David A.; Duursma, Daisy E.; Hughes, Lesley] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Theischinger, Gunther; Turak, Eren] Off Environm & Heritage, Sydney, NSW, Australia	Macquarie University; Office of Environment & Heritage - New South Wales	Bush, AA (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.		Nipperess, David/H-2707-2019	Turak, Eren/0000-0001-7383-9112; Hughes, Lesley/0000-0003-0313-9780; Bush, Alex/0000-0002-0679-6666	Macquarie University	Macquarie University	Research was part of Alex Bush's PhD, funded by Macquarie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alexander LV, 2009, INT J CLIMATOL, V29, P417, DOI 10.1002/joc.1730; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Arribas P, 2012, GLOBAL CHANGE BIOL, V18, P2135, DOI 10.1111/j.1365-2486.2012.02691.x; ARTHINGTON AH, 1982, AUST J MAR FRESH RES, V33, P77; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barmuta L, 2013, JOINING DOTS HYDROLO; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bond N, 2011, MAR FRESHWATER RES, V62, P1043, DOI 10.1071/MF10286; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Buisson L, 2013, GLOBAL CHANGE BIOL, V19, P387, DOI 10.1111/gcb.12056; Bush A, 2013, DIVERS DISTRIB, V19, P86, DOI 10.1111/ddi.12007; Bush A, 2012, FRESHWATER BIOL, V57, P1689, DOI 10.1111/j.1365-2427.2012.02835.x; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Chessman BC, 2009, GLOBAL CHANGE BIOL, V15, P2791, DOI 10.1111/j.1365-2486.2008.01840.x; Chester ET, 2011, FRESHWATER BIOL, V56, P2094, DOI 10.1111/j.1365-2427.2011.02644.x; Chiew FHS, 2002, HYDROL PROCESS, V16, P1235, DOI 10.1002/hyp.1059; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Crossman ND, 2012, DIVERS DISTRIB, V18, P60, DOI 10.1111/j.1472-4642.2011.00851.x; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Davis J, 2013, GLOBAL CHANGE BIOL, V19, P1970, DOI 10.1111/gcb.12203; Doll P, 2010, HYDROL EARTH SYST SC, V14, P783, DOI 10.5194/hess-14-783-2010; Domisch S, 2013, ECOL MODEL, V257, P1, DOI 10.1016/j.ecolmodel.2013.02.019; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Donohue RJ, 2012, J HYDROL, V436, P35, DOI 10.1016/j.jhydrol.2012.02.033; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Flenner I, 2008, INSECT CONSERV DIVER, V1, P169, DOI 10.1111/j.1752-4598.2008.00020.x; Flenner I, 2010, FRESHWATER BIOL, V55, P397, DOI 10.1111/j.1365-2427.2009.02289.x; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Fordham DA, 2012, ECOGRAPHY, V35, P4, DOI 10.1111/j.1600-0587.2011.07398.x; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Garnett S., 2013, CLIMATE CHANGE ADAPT; GEOFABRIC, 2011, AUSTR HYDR GEOSP FAB; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Grewe Y, 2013, GLOBAL ECOL BIOGEOGR, V22, P403, DOI 10.1111/geb.12004; Hagger V, 2013, AUSTRAL ECOL, V38, P465, DOI 10.1111/j.1442-9993.2012.02437.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobday AJ, 2011, MAR FRESHWATER RES, V62, P1000, DOI 10.1071/MF10302; Hughes JM, 2013, FRESHWATER BIOL, V58, P951, DOI 10.1111/fwb.12099; Jaeschke A, 2013, INSECT CONSERV DIVER, V6, P93, DOI 10.1111/j.1752-4598.2012.00194.x; James C., 2013, IDENTIFYING CLIMATE; Kalkman VJ, 2012, HYDROBIOLOGIA, V693, P55, DOI 10.1007/s10750-012-1086-0; Keller D, 2010, BIOL CONSERV, V143, P2658, DOI 10.1016/j.biocon.2010.07.008; Kennard MJ, 2010, IDENTIFYING HIGH CON; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Langhammer PF, 2007, IDENTIFICATION GAP A, P29; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lorenz AW, 2013, HYDROBIOLOGIA, V704, P489, DOI 10.1007/s10750-012-1326-3; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; McPeek MA, 1998, ECOL MONOGR, V68, P1, DOI 10.1890/0012-9615(1998)068[0001:TCOCTT]2.0.CO;2; Meier ES, 2012, GLOBAL ECOL BIOGEOGR, V21, P164, DOI 10.1111/j.1466-8238.2011.00669.x; Morimoto M, 2010, ODONATOLOGICA, V39, P333; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Nicola GG, 2010, AQUAT SCI, V72, P419, DOI 10.1007/s00027-010-0145-8; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Ott J, 2010, BIORISK, V5; Pace G, 2013, FRESHWATER BIOL, V58, P1313, DOI 10.1111/fwb.12129; Palmer TN, 2002, NATURE, V415, P512, DOI 10.1038/415512a; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pellissier L, 2013, J BIOGEOGR, V40, P1939, DOI 10.1111/jbi.12140; Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; PINDER AM, 2010, RECORDS W AUSTR MUSE, V78, P205, DOI DOI 10.18195/ISSN.0313-122X.78(1).2010.205-246; Pineda E, 2012, GLOBAL ECOL BIOGEOGR, V21, P935, DOI 10.1111/j.1466-8238.2011.00741.x; R Core Team, 2016, R FDN STAT COMP; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Reside A. E., 2013, CLIMATE CHANGE REFUG; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Rohr JR, 2013, CONSERV BIOL, V27, P741, DOI 10.1111/cobi.12086; Rosset V, 2011, BIOL CONSERV, V144, P2311, DOI 10.1016/j.biocon.2011.06.009; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Shoo LP, 2013, CLIMATIC CHANGE, V119, P239, DOI 10.1007/s10584-013-0699-2; Simaika JP, 2013, BIOL CONSERV, V157, P245, DOI 10.1016/j.biocon.2012.08.039; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Smith AB, 2013, DIVERS DISTRIB, V19, P867, DOI 10.1111/ddi.12031; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Storlie CJ, 2013, DIVERS DISTRIB, V19, P1106, DOI 10.1111/ddi.12068; Suhling I, 2013, FRESHWATER BIOL, V58, P705, DOI 10.1111/fwb.12074; Taubmann J, 2011, CONSERV GENET, V12, P503, DOI 10.1007/s10592-010-0157-x; Theischinger G., 2009, IDENTIFICATION GUIDE; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0157-y, 10.1007/s10584-011-0152-3]; VanDerWal J, 2012, CLIMATES METHODS WOR; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Winn KO, 2006, J COASTAL RES, V22, P137, DOI 10.2112/05A-0011.1; Winterbourn MJ, 2011, NEW ZEAL J ZOOL, V38, P173, DOI 10.1080/03014223.2010.548561; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055	122	34	38	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88958	10.1371/journal.pone.0088958	http://dx.doi.org/10.1371/journal.pone.0088958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551197	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000331266000086
J	Bui, THH; Lee, SY				Thi Hong Hanh Bui; Lee, Shing Yip			Does "You Are What You Eat' Apply to Mangrove Grapsid Crabs?	PLOS ONE			English	Article							NITROGEN-STABLE-ISOTOPES; ORGANIC-MATTER; LEAF-LITTER; FATTY-ACIDS; FOOD-WEB; DISCRIMINATION FACTORS; PRIMARY PRODUCERS; CARBON ISOTOPES; SESARMA-MESSA; SALT-MARSH	In tropical mangroves, brachyuran crabs have been observed to consume high percentages of leaf litter production. However, questions concerning their ability to assimilate this low-quality food remain, as stable isotope analysis of C and N does not seem to support assimilation. Individuals of the common eastern Australian mangrove grapsid Parasesarma erythodactyla feeding on a mangrove leaf litter or mangrove+microphytobenthos diet developed a significantly higher hepatosomatic index than those with access to only sediment. Lipid biomarker analysis and feeding experiments using C-13 and N-15-enriched mangrove leaf litter confirmed rapid assimilation of mangrove C and N by P. erythodactyla. Eight-week feeding experiments utilizing three food types (mangrove leaf litter, microphytobenthos and prawn muscle) established different food-specific trophic discrimination values (Delta delta C-13 and Delta delta N-15) that are significantly different from those commonly applied to mixing model calculations. The mean Delta delta C-13((crab-mangrove)) of +5.45 parts per thousand was close to the mean and median literature values for grapsid-mangrove pairs in 29 past studies (+5.2 +/- 1.8 parts per thousand and +5.6 parts per thousand, respectively), suggesting that this large discrimination may generally be characteristic of detritivorous grapsid crabs. Solutions from the IsoConc mixing model using our determined trophic discrimination values suggest significantly higher and dominant contributions of mangrove C to the diet than those based on the global mean trophic discrimination values. Our results reaffirm the physiological capacity for and important mediating role of grapsid crabs in processing low-quality mangrove C in tropical estuaries, and caution against the use of global trophic discrimination values in stable isotope analysis of food-web data, especially those involving detritivores. While recent studies have questioned the trophic significance of mangrove detritus in coastal food chains, the contribution of this productive carbon source needs to be re-assessed in the light of these data.	[Lee, Shing Yip] Griffith Univ, Australian Rivers Inst, Southport, Qld 4215, Australia; Griffith Univ, Sch Environm, Southport, Qld 4215, Australia	Griffith University; Griffith University	Lee, SY (corresponding author), Griffith Univ, Australian Rivers Inst, Gold Coast Campus, Southport, Qld 4215, Australia.	joe.lee@griffith.edu.au	Lee, Joe S. Y./B-9185-2008	Lee, Joe S. Y./0000-0001-9336-2323; Bui, Thi Hong Hanh/0000-0002-9193-011X	Australian Endeavour Postgraduate Award	Australian Endeavour Postgraduate Award(Australian GovernmentDepartment of Industry, Innovation and Science)	THHB is supported by an Australian Endeavour Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir S, 2008, J EXP MAR BIOL ECOL, V354, P1, DOI 10.1016/j.jembe.2007.08.024; Adachi K, 2012, FISHERIES SCI, V78, P1309, DOI 10.1007/s12562-012-0547-8; Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Alongi DM, 2012, CARBON MANAG, V3, P313, DOI [10.4155/cmt.12.20, 10.4155/CMT.12.20]; ALONGI DM, 1994, OECOLOGIA, V98, P320, DOI 10.1007/BF00324220; Alongi DM, 2009, ENERGETICS MANGROVE; [Anonymous], 2007, WORLDS MANGR 1980 20; Bishop MJ, 2008, MAR ECOL PROG SER, V354, P75, DOI 10.3354/meps07219; Bouillon S, 2002, OECOLOGIA, V130, P441, DOI 10.1007/s004420100814; Bouillon S, 2004, MAR ECOL PROG SER, V278, P77, DOI 10.3354/meps278077; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Bromand S, 2001, PLANT SOIL, V235, P253, DOI 10.1023/A:1011922103323; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; CAMILLERI J, 1989, MAR BIOL, V102, P453, DOI 10.1007/BF00438346; CAMILLERI JC, 1992, MAR BIOL, V114, P139; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chong VC, 2001, MAR BIOL, V138, P77, DOI 10.1007/s002270000434; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338, DOI 10.4319/lo.1966.11.3.0338; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Dungait JAJ, 2010, PHYTOCHEMISTRY, V71, P415, DOI 10.1016/j.phytochem.2009.10.010; EMMERSON WD, 1992, J EXP MAR BIOL ECOL, V157, P41, DOI 10.1016/0022-0981(92)90073-J; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Fratini S, 2004, MAR BIOL, V144, P1173, DOI 10.1007/s00227-003-1282-6; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GIDDINS RL, 1986, MAR ECOL PROG SER, V33, P147, DOI 10.3354/meps033147; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Guest MA, 2004, AQUAT ECOL, V38, P599, DOI 10.1007/s10452-004-0442-1; Hall D, 2006, J EXP MAR BIOL ECOL, V336, P42, DOI 10.1016/j.jembe.2006.04.004; Herbon CM, 2013, MAR ECOL PROG SER, V490, P91, DOI 10.3354/meps10421; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hsieh HL, 2002, MAR ECOL PROG SER, V227, P145, DOI 10.3354/meps227145; Hyodo F, 2010, ECOL RES, V25, P745, DOI 10.1007/s11284-010-0719-x; Kennish R, 1997, OECOLOGIA, V109, P209, DOI 10.1007/s004420050075; Kristensen DK, 2010, ESTUAR COAST SHELF S, V87, P583, DOI 10.1016/j.ecss.2010.02.016; KWOK PW, 1995, HYDROBIOLOGIA, V295, P141, DOI 10.1007/BF00029121; Larsen T, 2012, RAPID COMMUN MASS SP, V26, P1541, DOI 10.1002/rcm.6259; Larsen T, 2009, ECOLOGY, V90, P3526, DOI 10.1890/08-1695.1; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Lee SY, 2008, J SEA RES, V59, P16, DOI 10.1016/j.seares.2007.05.002; Lee S. Y., 2005, INT J ECOLOGY ENV SC, V31, P163; Lee SY, 2000, MAR ECOL PROG SER, V205, P1, DOI 10.3354/meps205001; LEE SY, 1990, MAR BIOL, V106, P453, DOI 10.1007/BF01344326; LEE SY, 1989, J EXP MAR BIOL ECOL, V131, P23, DOI 10.1016/0022-0981(89)90009-9; Lee SY, 1997, MAR ECOL PROG SER, V159, P275, DOI 10.3354/meps159275; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Lopez B, 2013, CRUSTACEANA, V86, P1051, DOI 10.1163/15685403-00003220; MACKO SA, 1991, CHEM GEOL, V93, P147, DOI 10.1016/0009-2541(91)90069-4; MALLEY DF, 1978, MAR BIOL, V49, P377, DOI 10.1007/BF00455032; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; Mazumder D, 2010, WETLANDS, V30, P375, DOI 10.1007/s13157-010-0021-2; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Meziane T, 2000, MAR ECOL PROG SER, V200, P49, DOI 10.3354/meps200049; MICHELI F, 1993, J EXP MAR BIOL ECOL, V171, P149, DOI 10.1016/0022-0981(93)90001-5; MOERS MEC, 1993, ORG GEOCHEM, V20, P927, DOI 10.1016/0146-6380(93)90104-J; Nerot C, 2009, MAR BIOL, V156, P2343, DOI 10.1007/s00227-009-1262-6; NEWELL RIE, 1995, MAR BIOL, V123, P595, DOI 10.1007/BF00349238; Niiyama T, 2012, JARQ-JPN AGR RES Q, V46, P355, DOI 10.6090/jarq.46.355; Oakes JM, 2010, LIMNOL OCEANOGR, V55, P393, DOI 10.4319/lo.2010.55.1.0393; Odum E.P., 1980, ESTUARINE PERSPECTIV, P485; Odum WE, 1975, ESTUARINE RES, P265; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Olive PJW, 2003, J ANIM ECOL, V72, P608, DOI 10.1046/j.1365-2656.2003.00730.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Poovachiranon Sombat, 1991, Phuket Marine Biological Center Research Bulletin, V56, P63; QUINN RH, 1980, J EXP MAR BIOL ECOL, V43, P49, DOI 10.1016/0022-0981(80)90146-X; ROBERTSON AI, 1989, OECOLOGIA, V78, P191, DOI 10.1007/BF00377155; RODELLI MR, 1984, OECOLOGIA, V61, P326, DOI 10.1007/BF00379629; SCRIMGEOUR CM, 1995, ISOT ENVIRON HEALT S, V31, P107, DOI 10.1080/10256019508036256; Sheaves M, 2000, MAR ECOL PROG SER, V199, P97, DOI 10.3354/meps199097; Skov MW, 2002, OECOLOGIA, V131, P1, DOI 10.1007/s00442-001-0847-7; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Thongtham N, 2005, ESTUAR COAST SHELF S, V65, P213, DOI 10.1016/j.ecss.2005.05.014; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Unsicker SB, 2005, ENTOMOL EXP APPL, V116, P219, DOI 10.1111/j.1570-7458.2005.00327.x; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Webb SC, 1998, J EXP BIOL, V201, P2903; Werry J, 2005, MAR ECOL PROG SER, V293, P165, DOI 10.3354/meps293165	83	51	53	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89074	10.1371/journal.pone.0089074	http://dx.doi.org/10.1371/journal.pone.0089074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551220	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000099
J	Roberts, VHJ; Pound, LD; Thorn, SR; Gillingham, MB; Thornburg, KL; Friedman, JE; Frias, AE; Grove, KL				Roberts, Victoria H. J.; Pound, Lynley D.; Thorn, Stephanie R.; Gillingham, Melanie B.; Thornburg, Kent L.; Friedman, Jacob E.; Frias, Antonio E.; Grove, Kevin L.			Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates	FASEB JOURNAL			English	Article						insulin resistance; pancreas; uterine blood flow; Western-style diet	ALCOHOLIC FATTY LIVER; BLOOD-FLOW; MODEL; MICE; DIET; RESTRICTION; METABOLISM; HUMANS; OBESITY; SHEEP	Resveratrol has been proposed as a potential therapeutic to improve metabolic health during pregnancy, yet little is known about the fetal effects of this maternal dietary supplement. We hypothesized that when administered to pregnant nonhuman primates (NHPs), resveratrol would increase uterine blood flow and mitigate the harmful consequences of maternal Western-style diet (WSD) consumption. NHPs were fed a WSD (36% fat) supplemented with 0.37% resveratrol throughout pregnancy. Outcomes were compared with cohorts fed WSD alone and control chow (14% fat) to distinguish between WSD and resveratrol-specific effects in these animals. In the early third trimester, uterine blood flow was measured by Doppler ultrasound before fetal delivery and tissue collection. Resveratrol resulted in 30% maternal weight loss and improved glucose tolerance, increased uterine artery volume blood flow, and decreased placental inflammation and liver triglyceride deposition. In addition, fetal pancreatic mass was enlarged by 42%, with a 12-fold increase in proliferation by Ki67 immunohistochemistry. These results demonstrate that resveratrol use during pregnancy yields improvements in maternal and placental phenotype with beneficial effects in the fetal liver but an unexplained and concerning alteration in fetal pancreatic development, which strongly cautions against the use of resveratrol by pregnant women.	[Roberts, Victoria H. J.; Pound, Lynley D.; Frias, Antonio E.; Grove, Kevin L.] Oregon Natl Primate Res Ctr, Div Diabet Obes & Metab, Beaverton, OR 97006 USA; [Grove, Kevin L.] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Thorn, Stephanie R.; Friedman, Jacob E.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Friedman, Jacob E.] Univ Colorado Denver, Dept Reprod Sci, Aurora, CO USA; [Gillingham, Melanie B.] Oregon Hlth & Sci Univ, Dept Med & Mol Genet, Portland, OR 97201 USA; [Thornburg, Kent L.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Frias, Antonio E.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Grove, KL (corresponding author), Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	grovek@ohsu.edu		Wesolowski, Stephanie/0000-0001-7523-0394; Gillingham, Melanie/0000-0003-0897-8268	U.S. National Institutes of Health [R24-DK-090964, P51-OD-011092, K01-DK-090199, S10-RR-024585]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090199, R01DK079194, R24DK090964] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Diana Takahashi, Karalee Baquero, Ashley Kostrba, India Tindale, Peter Blundell, Jessica Walker, and Tyler Dean (Oregon National Primate Research Center) for technical assistance and guidance with the animal studies; Dr. Dennis Koop (Pharmacokinetics Core, Oregon Health and Science University) for developing the resveratrol assay; Melissa Kirigiti for confocal images; Anda Cornea for microscopy assistance; Barbra Mason for histology; and Francis Pau and the Endocrine Technology Support Core Laboratory (Oregon Health and Science University) for performing hormone assay measurements. This work was supported by U.S. National Institutes of Health grants R24-DK-090964 (to K.L.G., K.L.T., and J.E.F.), P51-OD-011092 (partial salary support for K.L.G. and A.E.F. and Marianas imaging use), K01-DK-090199 (S.T.), and S10-RR-024585 (Leica confocal imaging).	Acharya G, 2007, ULTRASOUND OBST GYN, V29, P401, DOI 10.1002/uog.3977; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Arrick DM, 2011, AM J PHYSIOL-HEART C, V301, pH696, DOI 10.1152/ajpheart.00312.2011; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bourque SL, 2012, PLACENTA, V33, P449, DOI 10.1016/j.placenta.2012.01.012; Carrizzo A, 2013, HYPERTENSION, V62, P359, DOI 10.1161/HYPERTENSIONAHA.111.01009; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Comstock SM, 2013, MOL METAB, V2, P10, DOI 10.1016/j.molmet.2012.11.001; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Henson MC, 2000, BIOL REPROD, V63, P1219, DOI 10.1095/biolreprod63.5.1219; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Konje JC, 2001, AM J OBSTET GYNECOL, V185, P608, DOI 10.1067/mob.2001.117187; Lagerstedt SA, 2001, MOL GENET METAB, V73, P38, DOI 10.1006/mgme.2001.3170; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lam YY, 2013, EXP GERONTOL, V48, P1018, DOI 10.1016/j.exger.2013.04.005; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Naderali EK, 2000, CLIN SCI, V98, P537, DOI 10.1042/CS19990303; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poudel R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064401; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Roberts VHJ, 2012, PLACENTA, V33, P73, DOI 10.1016/j.placenta.2011.10.003; Shiozaki M, 2011, HISTOCHEM CELL BIOL, V136, P475, DOI 10.1007/s00418-011-0847-6; Singh CK, 2013, EXP BIOL MED, V238, P482, DOI 10.1177/1535370212473704; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Varlamov O, 2010, AM J PHYSIOL-ENDOC M, V299, pE486, DOI 10.1152/ajpendo.00330.2010; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Wallace JM, 2002, AM J PHYSIOL-REG I, V282, pR1027, DOI 10.1152/ajpregu.00465.2001; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002; Wong RHX, 2013, J HYPERTENS, V31, P1819, DOI 10.1097/HJH.0b013e328362b9d6; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497	41	82	83	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2466	2477		10.1096/fj.13-245472	http://dx.doi.org/10.1096/fj.13-245472			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24563374	Green Published			2022-12-25	WOS:000339883600008
J	Girotto, S; Cendron, L; Bisaglia, M; Tessari, I; Mammi, S; Zanotti, G; Bubacco, L				Girotto, Stefania; Cendron, Laura; Bisaglia, Marco; Tessari, Isabella; Mammi, Stefano; Zanotti, Giuseppe; Bubacco, Luigi			DJ-1 Is a Copper Chaperone Acting on SOD1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Copper; DJ-1; Metalloproteins; Parkinson Disease; Superoxide Dismutase (SOD); Cys-106	ZINC SUPEROXIDE-DISMUTASE; CYSTEINE-SULFINIC ACID; DISEASE PROTEIN DJ-1; ALCALIGENES-DENITRIFICANS; CRYSTAL-STRUCTURE; BINDING SITE; MUTANT SOD1; FORMS; AZURIN; APO	Background: DJ-1 and SOD1 are proteins involved in Parkinson disease and ALS, respectively. Results: A novel DJ-1 copper binding site is characterized together with its ability to activate SOD1 through copper transfer. Conclusion: We have identified a putative role for DJ-1 as a copper chaperone. Significance: Alterations of the coordination of the copper ion in DJ-1 may affect neurodegenerative etiopathogenesis. Lack of oxidative stress control is a common and often prime feature observed in many neurodegenerative diseases. Both DJ-1 and SOD1, proteins involved in familial Parkinson disease and amyotrophic lateral sclerosis, respectively, play a protective role against oxidative stress. Impaired activity and modified expression of both proteins have been observed in different neurodegenerative diseases. A potential cooperative action of DJ-1 and SOD1 in the same oxidative stress response pathway may be suggested based on a copper-mediated interaction between the two proteins reported here. To investigate the mechanisms underlying the antioxidative function of DJ-1 in relation to SOD1 activity, we investigated the ability of DJ-1 to bind copper ions. We structurally characterized a novel copper binding site involving Cys-106, and we investigated, using different techniques, the kinetics of DJ-1 binding to copper ions. The copper transfer between the two proteins was also examined using both fluorescence spectroscopy and specific biochemical assays for SOD1 activity. The structural and functional analysis of the novel DJ-1 copper binding site led us to identify a putative role for DJ-1 as a copper chaperone. Alteration of the coordination geometry of the copper ion in DJ-1 may be correlated to the physiological role of the protein, to a potential failure in metal transfer to SOD1, and to successive implications in neurodegenerative etiopathogenesis.	[Girotto, Stefania; Mammi, Stefano] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy; [Girotto, Stefania] Ist Italiano Tecnol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Cendron, Laura; Bisaglia, Marco; Tessari, Isabella; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy	University of Padua; Istituto Italiano di Tecnologia - IIT; University of Padua; University of Padua	Bubacco, L (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58b, I-35121 Padua, Italy.	luigi.bubacco@unipd.it	Tessari, Isabella/K-7847-2016; Bubacco, Luigi/B-5602-2012	Tessari, Isabella/0000-0002-5823-645X; Bubacco, Luigi/0000-0001-7927-9208; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501	Italian Ministry of Education, University and Research Grant [PRIN2010-M2JARJ]; University of Padova Grant [PRAT2010-CPDA103503]	Italian Ministry of Education, University and Research Grant; University of Padova Grant	This work was supported by Italian Ministry of Education, University and Research Grant PRIN2010-M2JARJ and University of Padova Grant PRAT2010-CPDA103503.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1988, J MOL BIOL, V203, P1071, DOI 10.1016/0022-2836(88)90129-5; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, HFSP J, V3, P165, DOI 10.2976/1.3078306; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bjorkblom B, 2013, J BIOL CHEM, V288, P22809, DOI 10.1074/jbc.M113.482091; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; DURLEY R, 1993, PROTEIN SCI, V2, P739, DOI 10.1002/pro.5560020506; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Girotto S, 2012, J BIOL CHEM, V287, P18738, DOI 10.1074/jbc.M111.311589; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Lacroix JS, 1996, BRIT J PHARMACOL, V118, P2079, DOI 10.1111/j.1476-5381.1996.tb15647.x; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lev N, 2009, J MOL NEUROSCI, V38, P94, DOI 10.1007/s12031-008-9138-7; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noor R, 2002, MED SCI MONITOR, V8, P210; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Puno MR, 2013, J AM CHEM SOC, V135, P15974, DOI 10.1021/ja406010m; ROSATO N, 1990, BIOPHYS CHEM, V36, P41, DOI 10.1016/0301-4622(90)85005-Q; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; SHEPARD WEB, 1993, ACTA CRYSTALLOGR D, V49, P331, DOI 10.1107/S0907444992013544; SZABO AG, 1983, BIOPHYS J, V41, P233, DOI 10.1016/S0006-3495(83)84433-6; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yamashita S, 2010, J NEUROCHEM, V113, P860, DOI 10.1111/j.1471-4159.2010.06658.x; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	54	62	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10887	10899		10.1074/jbc.M113.535112	http://dx.doi.org/10.1074/jbc.M113.535112			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567322	Green Published, hybrid			2022-12-25	WOS:000334226400056
J	Casoni, GL; Tomassetti, S; Cavazza, A; Colby, TV; Dubini, A; Ryu, JH; Carretta, E; Tantalocco, P; Piciucchi, S; Ravaglia, C; Gurioli, C; Romagnoli, M; Gurioli, C; Chilosi, M; Poletti, V				Casoni, Gian Luca; Tomassetti, Sara; Cavazza, Alberto; Colby, Thomas V.; Dubini, Alessandra; Ryu, Jay H.; Carretta, Elisa; Tantalocco, Paola; Piciucchi, Sara; Ravaglia, Claudia; Gurioli, Christian; Romagnoli, Micaela; Gurioli, Carlo; Chilosi, Marco; Poletti, Venerino			Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases	PLOS ONE			English	Article							PULMONARY-FIBROSIS; RISK-FACTORS; BIOPSY; PNEUMONIA; MORTALITY; SURGERY	Background: Histology is a key element for the multidisciplinary diagnosis of fibrotic diffuse parenchymal lung diseases (f-DPLD) when the clinical-radiological picture is nondiagnostic. Transbronchial lung cryobiopsy (TBLC) have been shown to be useful for obtaining large and well-preserved biopsies of lung parenchyma, but experience with TBLC in f-DPLD is limited. Objectives: To evaluate safety, feasibility and diagnostic yield of TBLC in f-DPLD. Method: Prospective study of 69 cases of TBLC using flexible cryoprobe in the clinical-radiological setting of f-DPLD with nondiagnostic high resolution computed tomography (HRCT) features. Results: Safety: pneumothorax occurred in 19 patients (28%). One patient (1.4%) died of acute exacerbation. Feasibility: adequate cryobiopsies were obtained in 68 cases (99%). The median size of cryobiopsies was 43.11 mm(2) (range, 11.94-76.25). Diagnostic yield: among adequate TBLC the pathologists were confident ("high confidence") that histopathologic criteria sufficient to define a specific pattern in 52 patients (76%), including 36 of 47 with UIP (77%) and 9 nonspecific interstitial pneumonia (6 fibrosing and 3 cellular), 2 desquamative interstitial pneumonia/respiratory bronchiolitis-interstitial lung disease, 1 organizing pneumonia, 1 eosinophilic pneumonia, 1 diffuse alveolar damage, 1 hypersensitivity pneumonitis and 1 follicular bronchiolitis. In 11 diagnoses of UIP the pathologists were less confident ("low confidence"). Agreement between pathologists in the detection of UIP was very good with a Kappa coefficient of 0.83 (95% CI, 0.69-0.97). Using the current consensus guidelines for clinical-radiologic-pathologic correlation 32% (20/63) of cases were classified as Idiopathic Pulmonary Fibrosis (IPF), 30% (19/63) as possible IPF, 25% (16/63) as other f-DPLDs and 13% (8/63) were unclassifiable. Conclusions: TBLC in the diagnosis of f-DPLD appears safe and feasible. TBLC has a good diagnostic yield in the clinical-radiological setting of f-DPLD without diagnostic HRCT features of usual interstitial pneumonia. Future studies should consider TBLC as a potential alternative to SLBx in f-DPLD.	[Casoni, Gian Luca; Tomassetti, Sara; Tantalocco, Paola; Ravaglia, Claudia; Gurioli, Christian; Romagnoli, Micaela; Gurioli, Carlo; Poletti, Venerino] GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy; [Cavazza, Alberto] S Maria Nuova Hosp IRCCS, Dept Pathol, Reggio Emilia, Italy; [Colby, Thomas V.] Mayo Clin, Dept Pathol, Scottsdale, AZ USA; [Dubini, Alessandra] GB Morgagni L Pierantoni Hosp, Dept Pathol, Forli, Italy; [Ryu, Jay H.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Carretta, Elisa] Ist Sci Romagnolo Studio & Cura Tumori, Biostat & Clin Trials Unit, Meldola Forli Cesena, Italy; [Piciucchi, Sara] GB Morgagni L Pierantoni Hosp, Dept Radiol, Forli, Italy; [Chilosi, Marco] Univ Verona, Dept Pathol, I-37100 Verona, Italy	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; IRCCS Meldola (IRST); University of Verona	Poletti, V (corresponding author), GB Morgagni L Pierantoni Hosp, Dept Dis Thorax, Forli, Italy.	venerino.poletti@gmail.com	Poletti, Venerino/K-8821-2016; Casoni, Gian Luca/K-6113-2016; CHILOSI, MARCO/ABB-8028-2021; Cavazza, Alberto/K-2531-2018	Poletti, Venerino/0000-0002-8634-2284; Cavazza, Alberto/0000-0003-3590-319X; Casoni, Gian Luca/0000-0002-7218-7914; Ryu, Jay/0000-0002-9576-2272	Associazione Morgagni Malattie Polmonari	Associazione Morgagni Malattie Polmonari	This study is supported by Associazione Morgagni Malattie Polmonari. The sponsor covers only the publication's costs. The entire study was realized without any financial support. In particular the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiak A, 2009, RESPIRATION, V78, P203, DOI 10.1159/000203987; Berbescu EA, 2006, CHEST, V129, P1126, DOI 10.1378/chest.129.5.1126; Casoni G L, 2008, Monaldi Arch Chest Dis, V69, P59; Cavazza A, 2010, RESP MED, V104, pS11, DOI 10.1016/j.rmed.2010.03.013; Churg A, 2006, CHEST, V129, P1117, DOI 10.1378/chest.129.5.1117; Griff S, 2011, DIAGN PATHOL, V16, P6; Katzenstein ALA, 2008, HUM PATHOL, V39, P1275, DOI 10.1016/j.humpath.2008.05.009; Kondoh Y, 2006, RESP MED, V100, P1753, DOI 10.1016/j.rmed.2006.02.002; Kreider ME, 2007, ANN THORAC SURG, V83, P1140, DOI 10.1016/j.athoracsur.2006.10.002; Matsuoka K, 2013, ANN THORAC CARDIOVAS, V19, P18, DOI 10.5761/atcs.oa.12.01909; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Monaghan H, 2004, CHEST, V125, P522, DOI 10.1378/chest.125.2.522; Nicholson AG, 2004, THORAX, V59, P500, DOI 10.1136/thx.2003.011734; Pajares V, 2010, ARCH BRONCONEUMOL, V46, P111, DOI 10.1016/j.arbres.2009.09.012; Park JH, 2007, EUR J CARDIO-THORAC, V31, P1115, DOI 10.1016/j.ejcts.2007.02.035; Plones T, 2013, RESP MED, V107, P629, DOI 10.1016/j.rmed.2012.11.020; Poletti V, 1996, EUR RESPIR J, V9, P2513, DOI 10.1183/09031936.96.09122513; Poletti V, 2004, RESPIRATION, V71, P107, DOI 10.1159/000076670; POLETTI V, 1988, Respiration, V54, P66; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rena O, 1999, EUR J CARDIO-THORAC, V16, P624, DOI 10.1016/S1010-7940(99)00320-6; Shim HS, 2010, PATHOL INT, V60, P373, DOI 10.1111/j.1440-1827.2010.02528.x; Sverzellati N, 2010, RADIOLOGY, V254, P957, DOI 10.1148/radiol.0990898; Tomassetti S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-96; Trahan S, 2008, CHEST, V134, P126, DOI 10.1378/chest.08-0033; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Utz JP, 2001, EUR RESPIR J, V17, P175, DOI 10.1183/09031936.01.17201750; Yarmus L, 2013, CHEST, V143, P621, DOI 10.1378/chest.12-2290	28	222	234	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e86716	10.1371/journal.pone.0086716	http://dx.doi.org/10.1371/journal.pone.0086716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586252	Green Published, Green Submitted, gold			2022-12-25	WOS:000332396200009
J	Kong, L; Welge, JA; Powell, EA; Blackard, JT				Kong, Ling; Welge, Jeffrey A.; Powell, Eleanor A.; Blackard, Jason T.			HIV Infection of Hepatocytes Results in a Modest Increase in Hepatitis C Virus Expression In Vitro	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN HEPATOMA-CELLS; ENVELOPE PROTEINS; TYPE-1 INFECTION; HCV REPLICATION; LIVER FIBROSIS; COINFECTION; INTERLEUKIN-8; MECHANISM	Previous studies demonstrate that soluble HIV proteins impact both hepatocyte function and HCV replication in vitro. It has also been reported that HIV can productively infect hepatocytes. We therefore investigated the impact of HIV infection of hepatocytes on HCV expression. The Huh7.5(JFH1) cell line that constitutively expresses infectious HCV was infected with the lab-adapted strains HIVNL4-3 or HIVYK-JRCSF. HCV expression was quantified via HCV core antigen ELISA, Western blot, and strand-specific real-time PCR for positive-sense and negative-sense HCV RNA. After HIVNL4-3 infection of Huh7.5JFH1 cells, positive-sense and negative-sense HCV RNA levels were elevated compared to HIV uninfected cells. Increased HCV RNA synthesis was also observed after infection of Huh7.5(JFH1) cells with HIVYK-JRCSF. HIV-induced HCV core production was decreased in the presence of the anti-HIV drugs AZT, T20, and raltegravir, although these medications had a minimal effect on HCV expression in the absence of HIV. HCV core, NS3, and NS5A protein expression were increased after HIV infection of Huh7.5(JFH1) cells. Chemically inactivated HIV had a minimal effect on HCV expression in Huh7.5(JFH1) cells suggesting that ongoing viral replication was critical. These data demonstrate that HIV induces HCV RNA synthesis and protein production in vitro and complement previous in vivo reports that HCV RNA levels are elevated in individuals with HIV/HCV co-infection compared to those with HCV mono-infection. These findings suggest that HIV suppression may be a critical factor in controlling liver disease, particularly if the underlying liver disease is not treated.	[Kong, Ling; Powell, Eleanor A.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH USA; [Welge, Jeffrey A.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA.	jason.blackard@uc.edu			Merck, Inc.; National Center for Research Resources, National Institutes of Health; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000077-04]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Merck, Inc.(Merck & Company); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Merck, Inc. and the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (UL1 TR000077-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Mata-Marin JA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-181; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Balasubramanian A, 2005, CLIN INFECT DIS, V41, pS32, DOI 10.1086/429493; Balasubramanian A, 2003, J BIOL CHEM, V278, P35755, DOI 10.1074/jbc.M302889200; Balasubramanian A, 2006, J INFECT DIS, V194, P670, DOI 10.1086/505708; Bansal M, 2012, EFFECTS HIV LIVER CE; Beld M, 1998, VIROLOGY, V244, P504, DOI 10.1006/viro.1998.9130; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Blackard JT, 2008, J VIRAL HEPATITIS, V15, P323, DOI 10.1111/j.1365-2893.2008.00970.x; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; BONACINI M, 1992, AM J MED, V92, P404, DOI 10.1016/0002-9343(92)90271-C; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; CAO YZ, 1990, J VIROL, V64, P2553, DOI 10.1128/JVI.64.6.2553-2559.1990; CAO YZ, 1992, AIDS, V6, P65, DOI 10.1097/00002030-199201000-00008; Chen YJ, 2010, J MICROBIOL IMMUNOL, V43, P175, DOI 10.1016/S1684-1182(10)60028-X; Fromentin R, 2010, VIROLOGY, V398, P168, DOI 10.1016/j.virol.2009.12.008; HALTINER M, 1985, NUCLEIC ACIDS RES, V13, P1015, DOI 10.1093/nar/13.3.1015; HODA SA, 1991, MODERN PATHOL, V4, P578; HOUSSET C, 1990, RES VIROLOGY, V141, P153, DOI 10.1016/0923-2516(90)90017-D; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Jia YT, 2007, J GASTROEN HEPATOL, V22, P1278, DOI 10.1111/j.1440-1746.2007.04957.x; Jiang Tian-jun, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P152; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Keaveny AP, 1998, AIDS PATIENT CARE ST, V12, P347, DOI 10.1089/apc.1998.12.347; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kong L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-157; Lang Zhen-wei, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P930; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Lin WY, 2005, GASTROENTEROLOGY, V128, P1034, DOI 10.1053/j.gastro.2005.02.006; Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Price JC, 2012, J INFECT DIS, V205, P1005, DOI 10.1093/infdis/jir885; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Sherman KE, 1996, HEPATOLOGY, V23, P688, DOI 10.1002/hep.510230405; Sterling RK, 2004, CLIN GASTROENTEROL H, V2, P432, DOI 10.1016/S1542-3565(04)00129-6; Tedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953; Thomas DL, 2001, J INFECT DIS, V183, P973, DOI 10.1086/319256; Towner WJ, 2012, JAIDS-J ACQ IMM DEF, V60, P321, DOI 10.1097/QAI.0b013e31824e9ef2; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Yokozaki S, 2000, BLOOD, V96, P4293; Zhang XZ, 2012, J MED VIROL, V84, P1344, DOI 10.1002/jmv.23315	49	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e83728	10.1371/journal.pone.0083728	http://dx.doi.org/10.1371/journal.pone.0083728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586227	Green Published, Green Submitted, gold			2022-12-25	WOS:000332396200004
J	Shin, MR; Natsuume, M; Matsumoto, T; Hanaoka, M; Imai, M; Iijima, K; Oka, S; Adachi, E; Kodama, H				Shin, Mi-Rae; Natsuume, Masaya; Matsumoto, Takashi; Hanaoka, Mitsumasa; Imai, Misaki; Iijima, Ken; Oka, Shin-ichiro; Adachi, Eri; Kodama, Hiroaki			Sense Transgene-Induced Post-Transcriptional Gene Silencing in Tobacco Compromises the Splicing of Endogenous Counterpart Genes	PLOS ONE			English	Article							CALMODULIN-RELATED PROTEIN; DIRECTED DNA METHYLATION; CHALCONE-SYNTHASE-A; VIRUS-RESISTANCE; RNA-POLYMERASE; CO-SUPPRESSION; PETUNIA; ARABIDOPSIS; PLANTS; DEGRADATION	Sense transgene-induced post-transcriptional gene silencing (S-PTGS) is thought to be a type of RNA silencing in which ARGONAUTE1 directs the small interfering RNA (siRNA)-mediated cleavage of a target mRNA in the cytoplasm. Here, we report that the altered splicing of endogenous counterpart genes is a main cause for the reduction of their mature mRNA levels. After the S-PTGS of a tobacco endoplasmic reticulum omega-3 fatty acid desaturase (NtFAD3) gene, 3'-truncated, polyadenylated endo-NtFAD3 transcripts and 5'-truncated, intron-containing endo-NtFAD3 transcripts were detected in the total RNA fraction. Although transcription proceeded until the last exon of the endogenous NtFAD3 gene, intron-containing NtFAD3 transcripts accumulated in the nucleus of the S-PTGS plants. Several intron-containing NtFAD3 transcripts harboring most of the exon sequences were generated when an endogenous silencing suppressor gene, rgs-CaM, was overexpressed in the S-PTGS plants. These intron-containing NtFAD3 splice variants were generated in the presence of NtFAD3 siRNAs that are homologous to the nucleotide sequences of these splice variants. The results of this study indicate that the inhibition of endo-NtFAD3 gene expression is primarily directed via the alteration of splicing and not by cytoplasmic slicer activity. Our results suggest that the transgene and intron-containing endogenous counterpart genes are differentially suppressed in SPTGS plants.	[Shin, Mi-Rae; Kodama, Hiroaki] Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Japan; [Natsuume, Masaya; Hanaoka, Mitsumasa; Oka, Shin-ichiro] Chiba Univ, Grad Sch Hort, Chiba, Japan; [Matsumoto, Takashi; Imai, Misaki] Tokyo Univ Agr, Genome Res Ctr, NODAI Res Inst, Setagaya Ku, Tokyo, Japan; [Iijima, Ken] Tokyo Univ Agr, Dept Appl Biol & Chem, Setagaya Ku, Tokyo, Japan; [Adachi, Eri] Chiba Univ, Grad Sch Sci & Technol, Inage Ku, Chiba 260, Japan	Chiba University; Chiba University; Tokyo University of Agriculture; Tokyo University of Agriculture; Chiba University	Kodama, H (corresponding author), Chiba Univ, Grad Sch Adv Integrat Sci, Inage Ku, Chiba, Japan.	kodama@faculty.chiba-u.jp	Hanaoka, Mitsumasa/M-9904-2015		Ministry of Education, Science and Culture, Japan [17570030]; MEXT; Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research [24117505, 26292191] Funding Source: KAKEN	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partly supported by Grants-in-Aid from the Ministry of Education, Science and Culture, Japan (17570030), and in part by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Anandalakshmi R, 2000, SCIENCE, V290, P142, DOI 10.1126/science.290.5489.142; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Dubrovina AS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/264314; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Grangeon Romain, 2010, Commun Integr Biol, V3, P363; HAMADA T, 1994, GENE, V147, P293, DOI 10.1016/0378-1119(94)90084-1; Han YH, 2004, FEBS LETT, V563, P123, DOI 10.1016/S0014-5793(04)00280-7; Han YH, 2002, PLANT J, V29, P509, DOI 10.1046/j.1365-313x.2002.01236.x; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hanaoka M, 2012, INT J MOL SCI, V13, P12182, DOI 10.3390/ijms131012182; Hirai S, 2010, FEBS J, V277, P1695, DOI 10.1111/j.1742-4658.2010.07591.x; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Kasai M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-63; Kasai M, 2012, PLANT MOL BIOL, V78, P259, DOI 10.1007/s11103-011-9863-0; Litiere K, 1999, RNA, V5, P1364, DOI 10.1017/S1355838299990799; Metzlaff M, 2000, PLANT J, V23, P63, DOI 10.1046/j.1365-313x.2000.00793.x; Mishra KK, 1998, PLANT J, V14, P583, DOI 10.1046/j.1365-313X.1998.00157.x; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Nakamura H, 2014, PLANT CELL TISS ORG, V116, P47, DOI 10.1007/s11240-013-0381-4; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Thran M, 2012, PLANT J, V72, P368, DOI 10.1111/j.1365-313X.2012.05066.x; Tomita R, 2004, FEBS LETT, V573, P117, DOI 10.1016/j.febslet.2004.07.063; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Eldik GJ, 1998, NUCLEIC ACIDS RES, V26, P5176, DOI 10.1093/nar/26.22.5176; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003	41	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87869	10.1371/journal.pone.0087869	http://dx.doi.org/10.1371/journal.pone.0087869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586294	Green Published, Green Submitted, gold			2022-12-25	WOS:000331717900014
J	Friedrichs, K; Adam, M; Remane, L; Mollenhauer, M; Rudolph, V; Rudolph, TK; Andrie, RP; Stockigt, F; Schrickel, JW; Ravekes, T; Deuschl, F; Nickenig, G; Willems, S; Baldus, S; Klinke, A				Friedrichs, Kai; Adam, Matti; Remane, Lisa; Mollenhauer, Martin; Rudolph, Volker; Rudolph, Tanja K.; Andrie, Rene P.; Stoeckigt, Florian; Schrickel, Jan W.; Ravekes, Thorben; Deuschl, Florian; Nickenig, Georg; Willems, Stephan; Baldus, Stephan; Klinke, Anna			Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CATHETER ABLATION; MAC-1 CD11B/CD18; INFLAMMATION; MYELOPEROXIDASE; MARKERS; OVEREXPRESSION; INTERLEUKIN-6; ARRHYTHMIAS; RECURRENCE	Background: Recent observational clinical and ex-vivo studies suggest that inflammation and in particular leukocyte activation predisposes to atrial fibrillation (AF). However, whether local binding and extravasation of leukocytes into atrial myocardium is an essential prerequisite for the initiation and propagation of AF remains elusive. Here we investigated the role of atrial CD11b/CD18 mediated infiltration of polymorphonuclear neutrophils (PMN) for the susceptibility to AF. Methods and Results: C57bl/6J wildtype (WT) and CD11b/CD18 knock-out (CD11b(-/-)) mice were treated for 14 days with subcutaneous infusion of angiotensin II (Ang II), a known stimulus for PMN activation. Atria of Ang II-treated WT mice were characterized by increased PMN infiltration assessed in immunohistochemically stained sections. In contrast, atrial sections of CD11b(-/-) mice lacked a significant increase in PMN infiltration upon Ang II infusion. PMN infiltration was accompanied by profoundly enhanced atrial fibrosis in Ang II treated WT as compared to CD11b(-/-) mice. Upon in-vivo electrophysiological investigation, Ang II treatment significantly elevated the susceptibility for AF in WT mice if compared to vehicle treated animals given an increased number and increased duration of AF episodes. In contrast, animals deficient of CD11b/CD18 were entirely protected from AF induction. Likewise, epicardial activation mapping revealed decreased electrical conduction velocity in atria of Ang II treated WT mice, which was preserved in CD11b(-/-) mice. In addition, atrial PMN infiltration was enhanced in atrial appendage sections of patients with persistent AF as compared to patients without AF. Conclusions: The current data critically link CD11b-integrin mediated atrial PMN infiltration to the formation of fibrosis, which promotes the initiation and propagation of AF. These findings not only reveal a mechanistic role of leukocytes in AF but also point towards a potential novel avenue of treatment in AF.	[Friedrichs, Kai; Remane, Lisa; Mollenhauer, Martin; Rudolph, Volker; Rudolph, Tanja K.; Ravekes, Thorben; Baldus, Stephan; Klinke, Anna] Univ Cologne, Ctr Heart, D-50931 Cologne, Germany; [Friedrichs, Kai; Remane, Lisa; Mollenhauer, Martin; Rudolph, Volker; Rudolph, Tanja K.; Ravekes, Thorben; Baldus, Stephan; Klinke, Anna] Univ Cologne, Cologne Cardiovasc Res Ctr, D-50931 Cologne, Germany; [Adam, Matti; Deuschl, Florian] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Andrie, Rene P.; Stoeckigt, Florian; Schrickel, Jan W.; Nickenig, Georg] Univ Hosp Bonn, Dept Med Cardiol, Bonn, Germany; [Willems, Stephan] Univ Heart Ctr Hamburg, Dept Electrophysiol, Hamburg, Germany	University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Klinke, A (corresponding author), Univ Cologne, Ctr Heart, D-50931 Cologne, Germany.	anna.klinke@uk-koeln.de		Adam, Matti/0000-0002-6990-8135; Stockigt, Florian/0000-0002-0885-679X	Deutsche Forschungsgemeinschaft [DFG BA 1870/7-1, BA 1870/9-1, BA 1870/10-1, DFG KL 2516/1-1, DFG RU 1876/1-1]; Deutsches Zentrum fur Herz-Kreislaufforschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsches Zentrum fur Herz-Kreislaufforschung	This work was supported by the Deutsche Forschungsgemeinschaft, http://www.dfg.de/index.jsp (DFG BA 1870/7-1, BA 1870/9-1 and BA 1870/10-1 And DFG KL 2516/1-1 And DFG RU 1876/1-1) and the Deutsches Zentrum fur Herz-Kreislaufforschung, http://dzhk.de/(DZHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bapat A, 2012, AM J PHYSIOL-HEART C, V302, pH2331, DOI 10.1152/ajpheart.00094.2012; Bruins P, 1997, CIRCULATION, V96, P3542; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Conway DSG, 2004, AM HEART J, V148, P462, DOI 10.1016/j.ahj.2004.01.026; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Ding ZM, 1999, J IMMUNOL, V163, P5029; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Friedrichs K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00214; Friedrichs K, 2011, TRENDS MOL MED, V17, P556, DOI 10.1016/j.molmed.2011.05.007; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gao XP, 2005, PHYSIOL GENOMICS, V21, P230, DOI 10.1152/physiolgenomics.00291.2004; Goudis CA, 2012, EUROPACE, V14, P623, DOI 10.1093/europace/eur398; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Henningsen KMA, 2009, SCAND J CLIN LAB INV, V69, P425, DOI 10.1080/00365510802676848; Huang G, 2011, EUR J CLIN INVEST, V41, P719, DOI 10.1111/j.1365-2362.2010.02460.x; HUGHES BJ, 1992, J CLIN INVEST, V90, P1687, DOI 10.1172/JCI116041; Jerke U, 2013, J BIOL CHEM, V288, P12910, DOI 10.1074/jbc.M112.434613; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Khatib R, 2013, INT J CARDIOL, V165, P17, DOI 10.1016/j.ijcard.2012.02.009; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Lamm G, 2006, J CARDIOTHOR VASC AN, V20, P51, DOI 10.1053/j.jvca.2005.03.026; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Leftheriotis DI, 2009, INT J CARDIOL, V135, P361, DOI 10.1016/j.ijcard.2008.04.012; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Masson S, 2010, HEART, V96, P1909, DOI 10.1136/hrt.2009.191460; Mocsai A, 1999, J IMMUNOL, V162, P1120; Murdoch C, 2000, BLOOD, V95, P3032; Novo G, 2008, BRIT J CLIN PHARMACO, V66, P345, DOI 10.1111/j.1365-2125.2008.03234.x; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Psychari SN, 2005, AM J CARDIOL, V95, P764, DOI 10.1016/j.amjcard.2004.11.032; Ramlawi B, 2007, ANN THORAC SURG, V84, P1166, DOI 10.1016/j.athoracsur.2007.04.126; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Ross GD, 2002, IMMUNOL RES, V25, P219, DOI 10.1385/IR:25:3:219; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Soriano SG, 1999, STROKE, V30, P134, DOI 10.1161/01.STR.30.1.134; Sovari AA, 2008, REDOX REP, V13, P242, DOI 10.1179/135100008X309000; SPODICK DH, 1976, JAMA-J AM MED ASSOC, V235, P39, DOI 10.1001/jama.235.1.39; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	49	35	38	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89307	10.1371/journal.pone.0089307	http://dx.doi.org/10.1371/journal.pone.0089307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558493	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700139
J	Goryaynov, A; Yang, WD				Goryaynov, Alexander; Yang, Weidong			Role of Molecular Charge in Nucleocytoplasmic Transport	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; SINGLE-MOLECULE; IMPORTIN-BETA; PROTEIN IMPORT; TRANSLOCATION; NUCLEOPORINS; ARCHITECTURE; CELLS; HYDROPHOBICITY; SELECTIVITY	Transport of genetic materials and proteins between the nucleus and cytoplasm of eukaryotic cells is mediated by nuclear pore complexes (NPCs). A selective barrier formed by phenylalanine-glycine (FG) nucleoporins (Nups) with net positive charges in the NPC allows for passive diffusion of signal-independent small molecules and transport-receptor facilitated translocation of signal-dependent cargo molecules. Recently, negative surface charge was postulated to be another essential criterion for selective passage through the NPC. However, the charge-driven mechanism in determining the transport kinetics and spatial transport route for either passive diffusion or facilitated translocation remains obscure. Here we employed high-speed single-molecule fluorescence microscopy with an unprecedented spatiotemporal resolution of 9 nm and 400 ms to uncover these mechanistic fundamentals for nuclear transport of charged substrates through native NPCs. We found that electrostatic interaction between negative surface charges on transiting molecules and the positively charged FG Nups, although enhancing their probability of binding to the NPC, never plays a dominant role in determining their nuclear transport mode or spatial transport route. A 3D reconstruction of transport routes revealed that small signal-dependent endogenous cargo protein constructs with high positive surface charges that are destined to the nucleus, rather than repelled from the NPC as suggested in previous models, passively diffused through an axial central channel of the NPC in the absence of transport receptors. Finally, we postulated a comprehensive map of interactions between transiting molecules and FG Nups during nucleocytoplasmic transport by combining the effects of molecular size, signal and surface charge.	[Goryaynov, Alexander; Yang, Weidong] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Yang, WD (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	weidong.yang@temple.edu	Goryaynov, Alexander/I-4848-2015	Goryaynov, Alexander/0000-0001-8654-9042	National Institute of Health [NIH GM094041, GM097037]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094041, R01GM097037] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by grants from the National Institute of Health (NIH GM094041 & GM097037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Colwell LJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000747; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Golich D, 1995, NATURE, V377; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goryaynov A, 2012, INTEGR BIOL-UK, V4, P10, DOI 10.1039/c1ib00041a; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kapon R, 2010, NUCLEUS-PHILA, V1, P475, DOI 10.4161/nucl.1.6.13112; Kramer A, 2008, PFLUG ARCH EUR J PHY, V456, P155, DOI 10.1007/s00424-007-0396-y; Kumeta M, 2012, J CELL SCI, V125, P4979, DOI 10.1242/jcs.109520; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Naim B, 2009, EMBO J, V28, P2697, DOI 10.1038/emboj.2009.225; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers MA, 2012, CURR BIOL, V22, pR1006, DOI 10.1016/j.cub.2012.10.037; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Yang WD, 2013, NUCLEUS-AUSTIN, V4, P166, DOI 10.4161/nucl.24874; Yang WD, 2011, NUCLEUS-AUSTIN, V2, P10, DOI 10.4161/nucl.2.1.13818	52	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88792	10.1371/journal.pone.0088792	http://dx.doi.org/10.1371/journal.pone.0088792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558427	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700073
J	Mori, S; Nada, S; Kimura, H; Tajima, S; Takahashi, Y; Kitamura, A; Oneyama, C; Okada, M				Mori, Shunsuke; Nada, Shigeyuki; Kimura, Hironobu; Tajima, Shoji; Takahashi, Yusuke; Kitamura, Ayaka; Oneyama, Chitose; Okada, Masato			The mTOR Pathway Controls Cell Proliferation by Regulating the FoxO3a Transcription Factor via SGK1 Kinase	PLOS ONE			English	Article							PROTEIN-KINASE; BINDING PARTNER; RAG GTPASES; AKT; PHOSPHORYLATION; SERUM; ACTIVATION; EXPRESSION; COMPLEX; RICTOR	The mechanistic target of rapamycin (mTOR) functions as a component of two large complexes, mTORC1 and mTORC2, which play crucial roles in regulating cell growth and homeostasis. However, the molecular mechanisms by which mTOR controls cell proliferation remain elusive. Here we show that the FoxO3a transcription factor is coordinately regulated by mTORC1 and mTORC2, and plays a crucial role in controlling cell proliferation. To dissect mTOR signaling, mTORC1 was specifically inactivated by depleting p18, an essential anchor of mTORC1 on lysosomes. mTORC1 inactivation caused a marked retardation of cell proliferation, which was associated with upregulation of cyclin-dependent kinase inhibitors (CDKIs). Although Akt was activated by mTORC1 inactivation, FoxO3a was upregulated via an epigenetic mechanism and hypophosphorylated at Ser314, which resulted in its nuclear accumulation. Consistently, mTORC1 inactivation induced downregulation of serum- and glucocorticoid-inducible kinase 1 (SGK1), the kinase responsible for Ser314 phosphorylation. Expression of FoxO3a mutated at Ser314 suppressed cell proliferation by inducing CDKI expression. SGK1 overexpression suppressed CDKI expression in p18-deficient cells, whereas SGK1 knockdown induced CDKI expression in wild-type cells, resulting in the suppression of cell proliferation. These results suggest that mTORC1, in coordination with mTORC2, controls cell proliferation by regulating FoxO3a gene expression and SGK1-mediated phosphorylation of FoxO3a at Ser314.	[Mori, Shunsuke; Nada, Shigeyuki; Takahashi, Yusuke; Kitamura, Ayaka; Oneyama, Chitose; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Suita, Osaka 565, Japan; [Kimura, Hironobu; Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Suita, Osaka 565, Japan	Osaka University; Osaka University	Okada, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, 3-1 Yamadaoka, Suita, Osaka 565, Japan.	okadam@biken.osaka-u.ac.jp	Kimura, Hironobu/B-3731-2010	Mori, Shunsuke/0000-0001-6151-4425	Uehara Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22240088, 25117716]; Grants-in-Aid for Scientific Research [26640078, 25117716] Funding Source: KAKEN	Uehara Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Uehara Foundation and a Grant-in-Aid for scientific research (22240088 and 25117716) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-4; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bruhn Maressa A, 2013, Cancer Manag Res, V5, P281, DOI 10.2147/CMAR.S35178; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hales EC, 2013, CELLULAR SIGNALLING, V26, P149; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2011, BBA-MOL CELL RES, V1813, P1965, DOI 10.1016/j.bbamcr.2011.03.013; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Moniz Larissa S, 2013, Biochem J, V452, pe11, DOI 10.1042/BJ20130617; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Pozharny Y, 2010, MT SINAI J MED, V77, P225, DOI 10.1002/msj.20176; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Soma-Nagae T, 2013, J CELL SCI, V126, P3575, DOI 10.1242/jcs.121913; Sommer EM, 2013, BIOCHEM J, V452, P499, DOI 10.1042/BJ20130342; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Szmulewitz RZ, 2012, PROSTATE, V72, P157, DOI 10.1002/pros.21416; Takahashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P1151, DOI 10.1016/j.bbrc.2011.12.082; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Xie Q, 2012, EMBO REP, V13, P371, DOI 10.1038/embor.2012.25; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	55	65	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88891	10.1371/journal.pone.0088891	http://dx.doi.org/10.1371/journal.pone.0088891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558442	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700088
J	Orozovic, G; Orozovic, K; Jarhult, JD; Olsen, B				Orozovic, Goran; Orozovic, Kanita; Jarhult, Josef D.; Olsen, Bjorn			Study of Oseltamivir and Zanamivir Resistance-Related Mutations in Influenza Viruses Isolated from Wild Mallards in Sweden	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR RESISTANCE; A VIRUS; H1N1; SUSCEPTIBILITY; SURVEILLANCE; H5N1	Resistance to neuraminidase inhibitors (NAIs) is a growing problem in battle against influenza A virus. However, little is known about the resistance of viruses isolated from dabbling ducks, the natural reservoir of the influenza virus. To our knowledge, no low-pathogenic avian influenza (LPAI) virus resistant to NAIs has been detected. The aim of this study was to investigate mallard isolates of influenza A virus previously identified to carry oseltamivir carboxylate (OC) or zanamivir (ZA) resistance-related mutations. In this work, 21 viruses belonging to the N1, N3, N6 and N9 subtypes were analyzed using a colorimetric NA inhibition assay. The results of assay showed no NAIs-resistant phenotype for any of the viruses. The R118K mutation was the most recurrent, as it was observed in all subtypes except for N6. IC50 values confirmed the differences in sensitivity to OC or ZA observed in the N1 and N2 groups of NAs. Furthermore, both wild types (WTs) in the N6 and one WT in the N9 subtype were less sensitive to ZA than were genotypically related mutants with R152K and R118K change in the respective subtypes. This may indicate that these and probably even other NAIs resistance-related mutations found in our virus collection were not induced by NAIs residuals in the environment and that the impact of such mutations in an avian influenza could be dependent on subtype, strain and host species.	[Orozovic, Goran; Jarhult, Josef D.; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Orozovic, Kanita] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences	Orozovic, G (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	goran.orozovic@hotmail.com	Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council; Swedish Research Council Formas; EU network "New Flubird"	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); EU network "New Flubird"	This study was financially supported by the Swedish Research Council, the Swedish Research Council Formas and EU network "New Flubird". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Ferraris O, 2005, ANTIVIR RES, V68, P43, DOI 10.1016/j.antiviral.2005.07.004; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Gillman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071230; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Jarhult JD, 2012, INFECT ECOLOGY EPIDE, V2; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Khanna M, 2009, INDIAN J MICROBIOL, V49, P365, DOI 10.1007/s12088-009-0064-3; Kramarz P, 2009, EUROSURVEILLANCE, V14; Lee CW, 2009, COMP IMMUNOL MICROB, V32, P301, DOI 10.1016/j.cimid.2008.01.007; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nguyen HT, 2010, ANTIMICROB AGENTS CH, V54, P3671, DOI 10.1128/AAC.00581-10; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016028; Orozovic G, 2010, J VIROL METHODS, V170, P94, DOI 10.1016/j.jviromet.2010.09.006; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Richard M, 2008, J CLIN VIROL, V41, P20, DOI 10.1016/j.jcv.2007.10.021; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Singer AC, 2007, ENVIRON HEALTH PERSP, V115, P102, DOI 10.1289/ehp.9574; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Stoner TD, 2010, J VIROL, V84, P9800, DOI 10.1128/JVI.00296-10; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; WARREN L, 1959, J BIOL CHEM, V234, P1971; Webster R, 2002, WHOCDSCSRNCS20025, P40; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06	43	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89306	10.1371/journal.pone.0089306	http://dx.doi.org/10.1371/journal.pone.0089306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558492	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700138
J	Krieg, A; Mersch, S; Boeck, I; Dizdar, L; Weihe, E; Hilal, Z; Krausch, M; Mohlendick, B; Topp, SA; Piekorz, RP; Huckenbeck, W; Stoecklein, NH; Anlauf, M; Knoefel, WT				Krieg, Andreas; Mersch, Sabrina; Boeck, Inga; Dizdar, Levent; Weihe, Eberhard; Hilal, Zena; Krausch, Markus; Moehlendick, Birte; Topp, Stefan A.; Piekorz, Roland P.; Huckenbeck, Wolfgang; Stoecklein, Nikolas H.; Anlauf, Martin; Knoefel, Wolfram T.			New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell Lines	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; VESICULAR MONOAMINE TRANSPORTER; ENDOCRINE-CELLS; MOLECULAR-PATHOGENESIS; GENE-EXPRESSION; TUMORS; MIDGUT; CISPLATIN; NEOPLASMS; SYSTEM	Recently, a novel WHO-classification has been introduced that divided gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) according to their proliferation index into G1- or G2-neuroendocrine tumors (NET) and poorly differentiated small-cell or large-cell G3-neuroendocrine carcinomas (NEC). Our knowledge on primary NECs of the GEP-system is limited due to the rarity of these tumors and chemotherapeutic concepts of highly aggressive NEC do not provide convincing results. The aim of this study was to establish a reliable cell line model for NEC that could be helpful in identifying novel druggable molecular targets. Cell lines were established from liver (NEC-DUE1) or lymph node metastases (NEC-DUE2) from large cell NECs of the gastroesophageal junction and the large intestine, respectively. Morphological characteristics and expression of neuroendocrine markers were extensively analyzed. Chromosomal aberrations were mapped by array comparative genomic hybridization and DNA profiling was analyzed by DNA fingerprinting. In vitro and in vivo tumorigenicity was evaluated and the sensitivity against chemotherapeutic agents assessed. Both cell lines exhibited typical morphological and molecular features of large cell NEC. In vitro and in vivo experiments demonstrated that both cell lines retained their malignant properties. Whereas NEC-DUE1 and -DUE2 were resistant to chemotherapeutic drugs such as cisplatin, etoposide and oxaliplatin, a high sensitivity to 5-fluorouracil was observed for the NEC-DUE1 cell line. Taken together, we established and characterized the first GEP large-cell NEC cell lines that might serve as a helpful tool not only to understand the biology of these tumors, but also to establish novel targeted therapies in a preclinical setup.	[Krieg, Andreas; Mersch, Sabrina; Dizdar, Levent; Krausch, Markus; Moehlendick, Birte; Topp, Stefan A.; Stoecklein, Nikolas H.; Knoefel, Wolfram T.] Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany; [Krieg, Andreas; Mersch, Sabrina; Boeck, Inga; Dizdar, Levent; Hilal, Zena; Krausch, Markus; Moehlendick, Birte; Topp, Stefan A.; Huckenbeck, Wolfgang; Stoecklein, Nikolas H.; Anlauf, Martin; Knoefel, Wolfram T.] Univ Hosp Duesseldorf, Dusseldorf, Germany; [Boeck, Inga; Hilal, Zena; Anlauf, Martin] Univ Dusseldorf, Inst Pathol, Dusseldorf, Germany; [Weihe, Eberhard] Univ Marburg, Inst Anat & Cell Biol, Dept Mol Neurosci, Marburg, Germany; [Piekorz, Roland P.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Huckenbeck, Wolfgang] Univ Dusseldorf, Inst Forens Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Philipps University Marburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Krieg, A (corresponding author), Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany.	andreas.krieg@med.uni-duesseldorf.de		Mohlendick, Birte/0000-0001-9093-8585	Forschungskommission of the Medical Faculty, University Duesseldorf [41/09]; Deutsche Forschungsgemeinschaft [KR 3496/2-1]	Forschungskommission of the Medical Faculty, University Duesseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Forschungskommission of the Medical Faculty, University Duesseldorf (41/09 to AK) and by the Deutsche Forschungsgemeinschaft (KR 3496/2-1 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlman H, 2008, NEUROENDOCRINOLOGY, V87, P40, DOI 10.1159/000109976; Bajetta E, 2007, CANCER CHEMOTH PHARM, V59, P637, DOI 10.1007/s00280-006-0306-6; BISHOP AE, 1982, GASTROENTEROLOGY, V83, P902; Bosman F., 2010, WHO CLASSIFICATION T, V4th; BUFFA R, 1987, MOL CELL PROBE, V1, P367, DOI 10.1016/0890-8508(87)90018-1; Eissele R, 1999, DIGESTION, V60, P428, DOI 10.1159/000007688; Ellis LM, 2010, CLIN CANCER RES, V16, P5365, DOI 10.1158/1078-0432.CCR-10-2550; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Fazio N, 2013, CANCER TREAT REV, V39, P270, DOI 10.1016/j.ctrv.2012.06.009; Grozinsky-Glasberg S, 2012, NEUROENDOCRINOLOGY, V96, P173, DOI 10.1159/000338793; JAMES R, 1994, J BIOL CHEM, V269, P15229; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kloppel G, 2009, NEUROENDOCRINOLOGY, V90, P162, DOI 10.1159/000182196; Kolby L, 2001, AM J PATHOL, V158, P745, DOI 10.1016/S0002-9440(10)64017-5; Krausch M, 2013, ENDOCRINE; Lollgen RM, 2001, INT J CANCER, V92, P812, DOI 10.1002/ijc.1276; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; LUNDQVIST M, 1991, EUR J CANCER, V27, P1663, DOI 10.1016/0277-5379(91)90441-F; Mitry E, 1999, BRIT J CANCER, V81, P1351, DOI 10.1038/sj.bjc.6690325; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; MOERTEL CG, 1991, CANCER, V68, P227, DOI 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Nilsson O, 2006, NEUROENDOCRINOLOGY, V84, P212, DOI 10.1159/000098013; Oberg K, 2012, CURR OPIN ONCOL, V24, P433, DOI 10.1097/CCO.0b013e328353d7ba; Pape U, 2006, J CLIN ONCOL S18, P14074, DOI DOI 10.1200/JC0.2006.24.18_; Pavel M, 2012, NEUROENDOCRINOLOGY, V95, P157, DOI 10.1159/000335597; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Pfragner R, 1996, INT J ONCOL, V8, P513; Pfragner R, 2009, ANTICANCER RES, V29, P1951; Posorski N, 2011, CLIN EXP METASTAS, V28, P637, DOI 10.1007/s10585-011-9397-5; QUINN LA, 1979, CANCER RES, V39, P4914; Rindi G, 2005, BEST PRACT RES CL GA, V19, P519, DOI 10.1016/j.bpg.2005.03.005; RINDI G, 1986, HISTOCHEMISTRY, V85, P19, DOI 10.1007/BF00508649; ROCKWELL S, 1980, BRIT J CANCER, V41, P118; Schott M, 2011, DTSCH ARZTEBL INT, V108, P305, DOI 10.3238/arztebl.2011.0305; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Stilling GA, 2007, ENDOCR PATHOL, V18, P223, DOI 10.1007/s12022-007-9001-3; Takahashi Y, 2000, DIGESTION, V62, P262, DOI 10.1159/000007825; Terris B, 1998, GENE CHROMOSOME CANC, V22, P50, DOI 10.1002/(SICI)1098-2264(199805)22:1<50::AID-GCC7>3.0.CO;2-6; Tonnies H, 2001, GUT, V48, P536, DOI 10.1136/gut.48.4.536; Turner NC, 2010, BRIT J CANCER, V102, P1106, DOI 10.1038/sj.bjc.6605618; Van Buren G, 2007, CLIN CANCER RES, V13, P4704, DOI 10.1158/1078-0432.CCR-06-2723; WEIHE E, 1994, J MOL NEUROSCI, V5, P149, DOI 10.1007/BF02736730; Wiedenmann B, 1998, J MOL MED, V76, P637, DOI 10.1007/s001090050261; WILLIAMS ED, 1963, LANCET, V1, P238; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zhao CM, 1997, CELL TISSUE RES, V290, P539, DOI 10.1007/s004410050960; Zhao JM, 2000, AM J PATHOL, V157, P1431, DOI 10.1016/S0002-9440(10)64780-3	48	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88713	10.1371/journal.pone.0088713	http://dx.doi.org/10.1371/journal.pone.0088713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551139	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500055
J	Smeti, I; Watabe, I; Savary, E; Fontbonne, A; Zine, A				Smeti, Ibtihel; Watabe, Isabelle; Savary, Etienne; Fontbonne, Arnaud; Zine, Azel			HMGA2, the Architectural Transcription Factor High Mobility Group, Is Expressed in the Developing and Mature Mouse Cochlea	PLOS ONE			English	Article							INNER-EAR; HAIR CELL; SENSORY EPITHELIA; GENE-EXPRESSION; SELF-RENEWAL; SOX2; FATE; ORGAN; LET-7; DIFFERENTIATION	Hmga2 protein belongs to the non-histone chromosomal high-mobility group (HMG) protein family. HMG proteins have been shown to function as architectural transcription regulators, facilitating enhanceosome formation on a variety of mammalian promoters. Hmga2 are expressed at high levels in embryonic and transformed cells. Terminally differentiated cells, however, have been reported to express only minimal, if any, Hmga2. Our previous affymetrix array data showed that Hmga2 is expressed in the developing and adult mammalian cochleas. However, the spatio-temporal expression pattern of Hmga2 in the murine cochlea remained unknown. In this study, we report the expression of Hmga2 in developing and adult cochleas using immunohistochemistry and quantitative real time PCR analysis. Immunolabeling of Hmga2 in the embryonic, postnatal, and mature cochleas showed broad Hmga2 expression in embryonic cochlea (E14.5) at the level of the developing organ of Corti in differentiating hair cells, supporting cells, in addition to immature cells in the GER and LER areas. By postnatal stage (P0-P3), Hmga2 is predominantly expressed in the hair and supporting cells, in addition to cells in the LER area. By P12, Hmga2 immunolabeling is confined to the hair cells and supporting cells. In the adult ear, Hmga2 expression is maintained in the hair and supporting cell subtypes (i.e. Deiters' cells, Hensen cells, pillar cells, inner phalangeal and border cells) in the cochlear epithelium. Using quantitative real time PCR, we found a decrease in transcript level for Hmga2 comparable to other known inner ear developmental genes (Sox2, Atoh1, Jagged1 and Hes5) in the cochlear epithelium of the adult relative to postnatal ears. These data provide for the first time the tissue-specific expression and transcription level of Hmga2 during inner ear development and suggest its potential dual role in early differentiation and maintenance of both hair and supporting cell phenotypes.	[Smeti, Ibtihel; Watabe, Isabelle; Savary, Etienne; Fontbonne, Arnaud; Zine, Azel] CNRS UMR 7260 AMU, Marseille, France; [Smeti, Ibtihel; Zine, Azel] Univ Montpellier I, Fac Pharm, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier	Zine, A (corresponding author), CNRS UMR 7260 AMU, Marseille, France.	azel.zine@univ-amu.fr			ANR (Agence Nationale de Recherche) [ANR-2010-BLAN-1107-01-b]	ANR (Agence Nationale de Recherche)(French National Research Agency (ANR))	This study was funded by ANR (Agence Nationale de Recherche; ANR-2010-BLAN-1107-01-b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, DEVELOPMENT, V139, P1965, DOI 10.1242/dev.071670; Barald KF, 2004, DEVELOPMENT, V131, P4119, DOI 10.1242/dev.01339; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Chen P, 2002, DEVELOPMENT, V129, P2495; Cleynen I, 2008, INT J ONCOL, V32, P289; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fedele M, 2010, MOL CELL ENDOCRINOL, V326, P19, DOI 10.1016/j.mce.2010.03.019; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; HINOJOSA R, 1977, ACTA OTO-LARYNGOL, V84, P238, DOI 10.3109/00016487709123963; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Hume CR, 2007, GENE EXPR PATTERNS, V7, P798, DOI 10.1016/j.modgep.2007.05.002; Kelley MW, 2007, INT J DEV BIOL, V51, P571, DOI 10.1387/ijdb.072388mk; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kopecky BJ, 2012, J MICROSC-OXFORD, V248, P292, DOI 10.1111/j.1365-2818.2012.03673.x; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; Lim DJ, 1992, STRUCTURAL DEV COCHL, P33; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Malini E, 2011, BIOCHEMISTRY-US, V50, P3462, DOI 10.1021/bi200101f; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Morsli H, 1998, J NEUROSCI, V18, P3327; National Center for Biotechnology Information, GUID CAR US LAB AN; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; PUJOL R, 1973, ACTA OTO-LARYNGOL, V76, P1, DOI 10.3109/00016487309121476; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Seo E, 2011, MOL CELL BIOL, V31, P4593, DOI 10.1128/MCB.05798-11; Slattery EL, 2009, JARO-J ASSOC RES OTO, V10, P341, DOI 10.1007/s10162-009-0166-y; Smeti I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042987; Smeti I, 2011, GENE EXPR PATTERNS, V11, P22, DOI 10.1016/j.gep.2010.08.008; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tay Y, 2009, STEM CELL REV REP, V5, P328, DOI 10.1007/s12015-009-9095-8; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wong EYM, 2013, HEARING RES, V297, P13, DOI 10.1016/j.heares.2012.09.009; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229	46	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88757	10.1371/journal.pone.0088757	http://dx.doi.org/10.1371/journal.pone.0088757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551154	Green Published, gold			2022-12-25	WOS:000331271500065
J	Jiang, LZ; Liu, C; Tong, JB; Mao, RR; Chen, D; Wang, H; Huang, JF; Li, LJ				Jiang, Lizhu; Liu, Chen; Tong, Jianbin; Mao, Rongrong; Chen, Dan; Wang, Hui; Huang, Jufang; Li, Lingjiang			Fluoxetine Pretreatment Promotes Neuronal Survival and Maturation after Auditory Fear Conditioning in the Rat Amygdala	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; PROGENITOR-CELL PROLIFERATION; POSTTRAUMATIC-STRESS-DISORDER; DENTATE GYRUS; SYNAPTIC PLASTICITY; GRANULE CELLS; MEMORY; MICE; EXTINCTION; MECHANISMS	The amygdala is a critical brain region for auditory fear conditioning, which is a stressful condition for experimental rats. Adult neurogenesis in the dentate gyrus (DG) of the hippocampus, known to be sensitive to behavioral stress and treatment of the antidepressant fluoxetine (FLX), is involved in the formation of hippocampus-dependent memories. Here, we investigated whether neurogenesis also occurs in the amygdala and contributes to auditory fear memory. In rats showing persistent auditory fear memory following fear conditioning, we found that the survival of new-born cells and the number of new-born cells that differentiated into mature neurons labeled by BrdU and NeuN decreased in the amygdala, but the number of cells that developed into astrocytes labeled by BrdU and GFAP increased. Chronic pretreatment with FLX partially rescued the reduction in neurogenesis in the amygdala and slightly suppressed the maintenance of the long-lasting auditory fear memory 30 days after the fear conditioning. The present results suggest that adult neurogenesis in the amygdala is sensitive to antidepressant treatment and may weaken long-lasting auditory fear memory.	[Jiang, Lizhu; Li, Lingjiang] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Jiang, Lizhu; Li, Lingjiang] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Liu, Chen; Chen, Dan; Wang, Hui; Huang, Jufang] Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China; [Tong, Jianbin] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Mao, Rongrong] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Jiang, Lizhu] Dali Univ, Dept Neuropsychopathy, Sch Clin Med, Dali, Peoples R China	Central South University; Central South University; Central South University; Central South University; Chinese Academy of Sciences; Kunming Institute of Zoology; Dali University	Huang, JF (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	huangjufang@csu.edu.cn; llj2920@163.com	Chen, Dan/GRY-2691-2022; Jufang, Huang/AAW-1847-2020; Mao, Rong/Q-2595-2019	Chen, Dan/0000-0002-1570-9034; Jufang, Huang/0000-0002-9161-1055; Mao, Rong/0000-0002-0469-2281	National Natural Science Foundation of China [3086008, 31100786, 930830046, 81171286, 91232714]; National 973 Program of China [2009CB918303]; Program of the Chinese Ministry of Education [20090162110011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); Program of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (3086008 to Lizhu Jiang; 31100786 to Rongrong Mao; 930830046, 81171286, and 91232714 to Lingjiang Li), the National 973 Program of China (2009CB918303 to Lingjiang Li), and the Program of the Chinese Ministry of Education (20090162110011 to Lingjiang Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bekinschtein P, 2010, NEUROTOX RES, V18, P377, DOI 10.1007/s12640-010-9155-5; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Grillon C, 1996, MOL PSYCHIATR, V1, P278; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Keilhoff Gerburg, 2006, Neuropsychopharmacology, V31, P1165; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lieberwirth C, 2012, HORM BEHAV, V62, P357, DOI 10.1016/j.yhbeh.2012.03.005; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Okuda H, 2009, J NEUROSCI RES, V87, P3546, DOI 10.1002/jnr.22160; Pan YY, 2012, PLOS ONE, V7; Pham K, 2005, NEUROSCIENCE, V130, P17, DOI 10.1016/j.neuroscience.2004.09.015; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Tamaki K, 2008, J NEUROCHEM, V105, P1642, DOI 10.1111/j.1471-4159.2008.05253.x; Tong JB, 2013, EMBO J, V32, P1917, DOI 10.1038/emboj.2013.122; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	38	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89147	10.1371/journal.pone.0089147	http://dx.doi.org/10.1371/journal.pone.0089147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551236	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000108
J	Ma, HY; Jiang, W; Liu, P; Feng, NN; Ma, QQ; Ma, CY; Li, SJ; Liu, YX; Qiao, ZG; Ma, LB				Ma, Hongyu; Jiang, Wei; Liu, Ping; Feng, Nana; Ma, Qunqun; Ma, Chunyan; Li, Shujuan; Liu, Yuexing; Qiao, Zhenguo; Ma, Lingbo			Identification of Transcriptome-Derived Microsatellite Markers and Their Association with the Growth Performance of the Mud Crab (Scylla paramamosain)	PLOS ONE			English	Article							EXPLOITING EST DATABASES; SSR-MARKERS; GENE; POPULATION; TRAITS	Microsatellite markers from a transcriptome sequence library were initially isolated, and their genetic variation was characterized in a wild population of the mud crab (Scylla paramamosain). We then tested the association between these microsatellite markers and the growth performance of S. paramamosain. A total of 129 polymorphic microsatellite markers were identified, with an observed heterozygosity ranging from 0.19 to 1.00 per locus, an expected heterozygosity ranging from 0.23 to 0.96 per locus, and a polymorphism information content (PIC) ranging from 0.21 to 0.95 per locus. Of these microsatellite markers, 30 showed polymorphism in 96 full-sib individuals of a first generation family. Statistical analysis indicated that three microsatellite markers were significantly associated with 12 growth traits of S. paramamosain. Of these three markers, locus Scpa36 was significantly associated with eight growth traits, namely, carapace length, abdomen width (AW), body height (BH), fixed finger length of the claw, fixed finger width of the claw, fixed finger height of the claw, meropodite length of pereiopod 2, and meropodite length of pereiopod 3 (MLP3) (P<0.05). Locus Scpa75 was significantly associated with five growth traits, namely, internal carapace width, AW, carapace width at spine 8, distance between lateral spine 2 (DLS2), and MLP3 (P<0.05). Locus Spm30 was significantly associated with BH, DLS2, and body weight (P<0.05). Further analysis suggested a set of genotypes (BC at Scpa36, BC and BD at Scpa75, and AC at Spm30) that have great potential in the selection of S. paramamosain for growth traits. These findings will facilitate the development of population conservation genetics and molecular marker-assisted selective breeding of S. paramamosain and other closely related species.	[Ma, Hongyu; Jiang, Wei; Feng, Nana; Ma, Qunqun; Ma, Chunyan; Li, Shujuan; Liu, Yuexing; Qiao, Zhenguo; Ma, Lingbo] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Ma, Hongyu; Jiang, Wei; Feng, Nana; Ma, Qunqun; Ma, Chunyan; Li, Shujuan; Liu, Yuexing; Qiao, Zhenguo; Ma, Lingbo] Minist Agr, Key Lab East China Sea & Ocean Fishery Resources, Shanghai, Peoples R China; [Ma, Hongyu; Liu, Ping] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Ma, LB (corresponding author), Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China.	malingbo@vip.sina.com			National Natural Science Foundation of China [31001106]; National Non-Profit Institutes (East China Sea Fisheries Research Institute) [2011M05]; Fund of Key Laboratory of Sustainable Development of Marine Fisheries in Ministry of Agriculture of China (Yellow Sea Fisheries Research Institute) [2014]; Science and Technology Commission of Shanghai Municipality [10JC1418600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Non-Profit Institutes (East China Sea Fisheries Research Institute); Fund of Key Laboratory of Sustainable Development of Marine Fisheries in Ministry of Agriculture of China (Yellow Sea Fisheries Research Institute); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by the National Natural Science Foundation of China (grant number 31001106), the National Non-Profit Institutes (East China Sea Fisheries Research Institute, grant number 2011M05), the Fund of Key Laboratory of Sustainable Development of Marine Fisheries in Ministry of Agriculture of China (Yellow Sea Fisheries Research Institute, grant number 2014), and the Science and Technology Commission of Shanghai Municipality (grant number 10JC1418600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee R, 2010, BIOCHEM GENET, V48, P71, DOI 10.1007/s10528-009-9296-5; Chen Meng, 2009, Dalian Shuichan Xueyuan Xuebao, V24, P311; Cui Hai-yu, 2011, Marine Fisheries, V33, P274; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Dudaniec RY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014333; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Fishery Bureau of Ministry of Agriculture of China, 2012, MIN AGR CHIN CHIN FI; Fuji K, 2007, AQUACULTURE, V272, P291, DOI 10.1016/j.aquaculture.2007.07.210; [高保全 GAO Baoquan], 2008, [海洋水产研究, Marine Fisheries Research], V29, P44; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Jiang W, 2013, GENET MOL R IN PRESS; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Keenan C., 1999, ACAIR P; Keenan CP, 1998, RAFFLES B ZOOL, V46, P217; [李建林 LI Jian-lin], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P824; Li SJ, 2013, BIOTECHNOL B, V11, P123; Li XH, 2009, FISHERIES SCI, V75, P351, DOI 10.1007/s12562-008-0051-3; Liu Lei, 2012, Journal of Fisheries of China, V36, P1034; Ma HY, 2013, GENE, V519, P120, DOI 10.1016/j.gene.2013.01.028; Ma HY, 2012, J EXP BIOL, V215, P3120, DOI 10.1242/jeb.071654; Ma HY, 2011, BIOCHEM SYST ECOL, V39, P419, DOI 10.1016/j.bse.2011.05.024; Ma HY, 2011, BIOCHEM SYST ECOL, V39, P371, DOI 10.1016/j.bse.2011.05.007; Ma HY, 2011, J WORLD AQUACULT SOC, V42, P591, DOI 10.1111/j.1749-7345.2011.00503.x; Ma HY, 2011, MOL BIOL REP, V38, P4749, DOI 10.1007/s11033-010-0612-2; Ma HY, 2010, J CRUSTACEAN BIOL, V30, P441, DOI 10.1651/09-3263.1; Ma HongYu, 2009, Wuhan University Journal of Natural Sciences, V14, P267, DOI 10.1007/s11859-009-0315-5; Ma QQ, 2013, BIOCHEM SYST ECOL, V49, P62, DOI 10.1016/j.bse.2013.03.013; Mukherjee K, 2009, J WORLD AQUACULT SOC, V40, P274, DOI 10.1111/j.1749-7345.2009.00250.x; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Perrine D., 1979, MANGROVE CRAB PONAPE; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Takano M, 2005, MOL ECOL NOTES, V5, P794, DOI 10.1111/j.1471-8286.2005.01065.x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang YP, 2007, MAR BIOTECHNOL, V9, P500, DOI 10.1007/s10126-007-9011-7; Weller J.I., 1994, EC ASPECTS ANIMAL BR; Xu XJ, 2009, CONSERV GENET, V10, P1877, DOI 10.1007/s10592-009-9843-y; Yalin S., 1994, Naga, V17, P28; [杨晶 Yang Jing], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P721; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yu H, 2008, J HERED, V99, P208, DOI 10.1093/jhered/esm124; Yue GH, 2004, AQUACULTURE, V234, P85, DOI 10.1016/j.aquaculture.2003.12.021	43	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89134	10.1371/journal.pone.0089134	http://dx.doi.org/10.1371/journal.pone.0089134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551232	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000106
J	Mukherjee, S; Heithaus, MR; Trexler, JC; Ray-Mukherjee, J; Vaudo, J				Mukherjee, Shomen; Heithaus, Michael R.; Trexler, Joel C.; Ray-Mukherjee, Jayanti; Vaudo, Jeremy			Perceived Risk of Predation Affects Reproductive Life-History Traits in Gambusia holbrooki, but Not in Heterandria formosa	PLOS ONE			English	Article							MATERNAL CORTISOL EXPOSURE; FARMED ATLANTIC SALMON; LIVEBEARING FISH; INDUCED STRESS; CLUTCH SIZE; QUALITY; IMPACT; EVOLUTION; ECOLOGY; GROWTH	Key to predicting impacts of predation is understanding the mechanisms through which predators impact prey populations. While consumptive effects are well-known, non-consumptive predator effects (risk effects) are increasingly being recognized as important. Studies of risk effects, however, have focused largely on how trade-offs between food and safety affect fitness. Less documented, and appreciated, is the potential for predator presence to directly suppress prey reproduction and affect life-history characteristics. For the first time, we tested the effects of visual predator cues on reproduction of two prey species with different reproductive modes, lecithotrophy (i.e. embryonic development primarily fueled by yolk) and matrotrophy (i.e. energy for embryonic development directly supplied by the mother to the embryo through a vascular connection). Predation risk suppressed reproduction in the lecithotrophic prey (Gambusia holbrokii) but not the matrotroph (Heterandria formosa). Predator stress caused G. holbrooki to reduce clutch size by 43%, and to produce larger and heavier offspring compared to control females. H. formosa, however, did not show any such difference. In G. holbrooki we also found a significantly high percentage (14%) of stillbirths in predator-exposed treatments compared to controls (2%). To the best of our knowledge, this is the first direct empirical evidence of predation stress affecting stillbirths in prey. Our results suggest that matrotrophy, superfetation (clutch overlap), or both decrease the sensitivity of mothers to environmental fluctuation in resource (food) and stress (predation risk) levels compared to lecithotrophy. These mechanisms should be considered both when modeling consequences of perceived risk of predation on prey-predator population dynamics and when seeking to understand the evolution of reproductive modes.	[Mukherjee, Shomen; Heithaus, Michael R.; Trexler, Joel C.; Ray-Mukherjee, Jayanti; Vaudo, Jeremy] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [Mukherjee, Shomen; Ray-Mukherjee, Jayanti] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	State University System of Florida; Florida International University; University of Kwazulu Natal	Mukherjee, S (corresponding author), Florida Int Univ, Dept Biol Sci, North Miami, FL USA.	shomenm@gmail.com	Trexler, Joel C/I-5265-2012; Heithaus, Michael/AAF-9914-2020	Heithaus, Michael/0000-0002-3219-1003; Mukherjee, Shomen/0000-0002-2974-4447	School of Environment, Arts and Society; Florida International University Open Access Publishing Fund; Florida Coastal Everglades Long-Term Ecological Research program under National Science Foundation [DBI-0620409]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	School of Environment, Arts and Society; Florida International University Open Access Publishing Fund; Florida Coastal Everglades Long-Term Ecological Research program under National Science Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	SM was supported by School of Environment, Arts and Society. Publication of this article was funded in part by Florida International University Open Access Publishing Fund. This material was developed in collaboration with the Florida Coastal Everglades Long-Term Ecological Research program under National Science Foundation Grant No. DBI-0620409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banet AI, 2008, FUNCT ECOL, V22, P323, DOI 10.1111/j.1365-2435.2007.01367.x; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Clinchy M, 2004, P ROY SOC B-BIOL SCI, V271, P2473, DOI 10.1098/rspb.2004.2913; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Edwards TM, 2006, ENVIRON HEALTH PERSP, V114, P69, DOI 10.1289/ehp.8056; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eriksen MS, 2006, J FISH BIOL, V69, P114, DOI 10.1111/j.1095-8649.2006.01071.x; Espmark AM, 2008, APPL ANIM BEHAV SCI, V110, P404, DOI 10.1016/j.applanim.2007.04.003; Evans JP, 2007, BEHAV ECOL SOCIOBIOL, V61, P719, DOI 10.1007/s00265-006-0302-1; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Haake PW, 1983, SFRC8303; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Konnert TJ, 2002, THESIS; Leips J, 2009, EVOLUTION, V63, P1341, DOI 10.1111/j.1558-5646.2009.00631.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MARSH-MATTHEWS E., 2010, VIVIPAROUS FISHES, P255; McCormick MI, 1998, ECOLOGY, V79, P1873, DOI 10.1890/0012-9658(1998)079[1873:BIMSIA]2.0.CO;2; Norrdahl K, 2000, MAMMAL REV, V30, P147, DOI 10.1046/j.1365-2907.2000.00064.x; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; Pires Marcelo N., 2011, P28; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D, 1996, AM ZOOL, V36, P147; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Riesch R, 2013, AM NAT, V181, P78, DOI 10.1086/668597; Ruxton GD, 1997, P ROY SOC B-BIOL SCI, V264, P409, DOI 10.1098/rspb.1997.0058; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Schreck CB, 2001, AQUACULTURE, V197, P3, DOI 10.1016/S0044-8486(01)00580-4; Schurch R, 2005, BEHAVIOUR, V142, P265, DOI 10.1163/1568539053778274; SCRIMSHAW NS, 1945, BIOL BULL, V88, P233, DOI 10.2307/1538312; Sheriff MJ, 2013, ECOL LETT, V16, P271, DOI 10.1111/ele.12042; Sheriff MJ, 2010, ECOLOGY, V91, P2983, DOI 10.1890/09-1108.1; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Stearns S.C., 1992, pi; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; TRAVIS J, 1987, ECOLOGY, V68, P611, DOI 10.2307/1938466; Trexler JC, 1997, ECOLOGY, V78, P1370, DOI 10.1890/0012-9658(1997)078[1370:RAAPIO]2.0.CO;2; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; TREXLER JC, 1992, ECOLOGY, V73, P2224, DOI 10.2307/1941470; Trexler Joel C., 2011, P95; Turner CL, 1940, J MORPHOL, V67, P59, DOI 10.1002/jmor.1050670103; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; YLONER H, 1989, OIKOS, V55, P138, DOI 10.2307/3565886; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; Zuniga-Vega JJ, 2007, OIKOS, V116, P995, DOI 10.1111/j.2007.0030-1299.15763.x	58	29	29	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88832	10.1371/journal.pone.0088832	http://dx.doi.org/10.1371/journal.pone.0088832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551171	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000073
J	Yiengprugsawan, V; Berecki-Gisolf, J; McClure, R; Kelly, M; Seubsman, SA; Sleigh, AC				Yiengprugsawan, Vasoontara; Berecki-Gisolf, Janneke; McClure, Roderick; Kelly, Matthew; Seubsman, Sam-ang; Sleigh, Adrian C.		Cohort Study Team	The Effect of Injuries on Health Measured by Short Form 8 among a Large Cohort of Thai Adults	PLOS ONE			English	Article							ROAD TRAFFIC INJURIES; GLOBAL BURDEN; UNINTENTIONAL INJURY; HOUSEHOLD SURVEYS; OPEN-UNIVERSITY; RISK-FACTORS; LOW-INCOME; PREVENTION; QUALITY	Introduction: We investigate the links between health and injury in Thailand. This is important because of the high burden of injury in transitional countries and limited information for public health. Methods: We analyse 2005 baseline and 2009, 4-year follow-up data from distance learning students of Sukhothai Thammathirat Open University residing nationwide (n = 60569). Injury was reported for the past year in both periods. Medical Outcome Study Short-Form (SF-8 (TM)) health status was reported and Physical and Mental Component Summary Scores (PCS and MCS) were calculated. Analyses used covariate-adjusted multivariate linear regression. Results: In 2009, increasing numbers of traffic injuries (0, 1, 2, 3, 4+) associated with declining PCS scores (49.8, 48.4, 46.9, 46.2, 44.0), along with a similar monotonic decline for MCS scores (47.6, 46.0, 44.2, 42.7, 40.6). A similar (but smaller) dose-response gradient was found between non-traffic injuries and SF-8 scores. Longitudinal analyses showed those with incident injury (no injury 2005, injury 2009) had lower PCS and MCS scores compared to those with no injury in both periods. Individuals with reverting injury status (injury 2005, no injury 2009) reported improvement in PCS and MCS scores over the four-year period. Conclusion: We found significant and epidemiologically important associations between increasing injury frequency and worse health in the past year, especially traffic injuries. Longitudinal 2005-2009 results were supportive and revealed statistically significant adverse 4-year effects of incident injury on health. If injury reverted over four years, low initial scores improved greatly. Findings highlight the importance of injury prevention as a public health priority.	[Yiengprugsawan, Vasoontara; Kelly, Matthew; Seubsman, Sam-ang; Sleigh, Adrian C.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Berecki-Gisolf, Janneke; McClure, Roderick] Monash Univ, Monash Injury Res Inst, Melbourne, Vic 3004, Australia; [Seubsman, Sam-ang] Sukhothai Thammathirat Open Univ, Sch Human Ecol, Nonthaburi, Thailand	Australian National University; Monash University; Sukhothai Thammathirat Open University	Yiengprugsawan, V (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	vasoontara.yieng@anu.edu.au	Harley, David O/C-1326-2010; Yiengprugsawan, Vas Sbirakos/G-3176-2011; Yiengprugsawan, Vasoontara/N-7072-2013; Harley, David/B-4910-2017; Kelly, Matthew/ABC-1069-2020; sleigh, adrian/J-4540-2019	Yiengprugsawan, Vas Sbirakos/0000-0001-9101-4704; Yiengprugsawan, Vasoontara/0000-0001-9101-4704; Harley, David/0000-0001-6691-5420; Kelly, Matthew/0000-0001-7963-2139; sleigh, adrian/0000-0001-8443-7864; McClure, Roderick/0000-0002-9067-8282; Seubsman, Sam-ang/0000-0002-7451-3218	International Collaborative Research Grants Scheme; Wellcome Trust UK [GR071587MA]; Australian National Health and Medical Research Council -NHMRC [268055]; global health grant from the NHMRC [585426]	International Collaborative Research Grants Scheme; Wellcome Trust UK(Wellcome Trust); Australian National Health and Medical Research Council -NHMRC(National Health and Medical Research Council (NHMRC) of Australia); global health grant from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) and the Australian National Health and Medical Research Council -NHMRC (268055), and as a global health grant from the NHMRC (585426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Cameron CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-114; Chadbunchachai Witaya, 2012, J Med Assoc Thai, V95 Suppl 7, pS274; Cohen L, 2003, J SAFETY RES, V34, P473, DOI 10.1016/j.jsr.2003.03.005; Connor J, 2004, EPIDEMIOLOGY, V15, P337, DOI 10.1097/01.ede.0000120045.58295.86; Cunningham R, 2010, NEW ZEAL MED J, V123, P35; Ditsuwan V, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-2; Fingerhut LA, 2005, AM J PUBLIC HEALTH, V95, P1089, DOI 10.2105/AJPH.2005.064469; Fitzharris Michael, 2007, Traffic Inj Prev, V8, P309, DOI 10.1080/15389580701216533; Forchheimer M, 2004, AM J PHYS MED REHAB, V83, P390, DOI 10.1097/01.PHM.0000124441.78275.C9; Gamsiz Bilgin N, 2012, ACTA ORTHOP TRAUMATO, V46, P168, DOI 10.3944/AOTT.2012.2673; Ham OK, 2008, PUBLIC HEALTH NURS, V25, P37, DOI 10.1111/j.1525-1446.2008.00678.x; Heinen M, 2004, INJURY PREV, V10, P327, DOI 10.1136/ip.2004.005991; Herbert HK, 2011, INFECT DIS CLIN N AM, V25, P653, DOI 10.1016/j.idc.2011.06.004; Hong TT, 2009, HEALTH INF MANAG J, V38, P15, DOI 10.1177/183335830903800103; Johnston BD, 2008, INJURY PREV, V14, P145, DOI 10.1136/ip.2008.019265; Laursen B, 2012, DAN MED J, V59; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LIN KH, 2013, J OCCUP REHABIL; Littleton SM, 2012, INJURY, V43, P1586, DOI 10.1016/j.injury.2011.03.002; Lyons R, 2010, INJURY PREV, V16, P145, DOI 10.1136/ip.2009.025833; Nakahara S, 2006, J TRAUMA, V61, P768, DOI 10.1097/01.ta.0000236033.25861.aa; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; Palmer KT, 2008, OCCUP ENVIRON MED, V65, P757, DOI 10.1136/oem.2007.037440; Peden M, 2002, BRIT MED J, V324, P1153, DOI 10.1136/bmj.324.7346.1153; Petridou E, 2004, EPIDEMIOLOGY, V15, P428, DOI 10.1097/01.ede.0000129519.76945.0d; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Seubsman SA, 2012, ASEAN J OPEN DISTANC, V4, P58; Siriruttanapruk S, 2004, IND HEALTH, V42, P135, DOI 10.2486/indhealth.42.135; Sleet DA, 2004, AM J HEALTH BEHAV, V28, pS6; Sleigh AC, 2008, INT J EPIDEMIOL, V37, P266, DOI 10.1093/ije/dym161; Stephan K, 2011, ACCIDENT ANAL PREV, V43, P1062, DOI 10.1016/j.aap.2010.12.011; Stephan K, 2010, SE ASIAN J TROP MED, V41, P1220; Stevenson M, 2009, INJURY PREV, V15, P1, DOI 10.1136/ip.2008.020792; Tawatsupa B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001396; Tawatsupa B, 2013, IND HEALTH, V51, P34, DOI 10.2486/indhealth.2012-0138; Thepaksorn P, 2007, INT J OCCUP ENV HEAL, V13, P290, DOI 10.1179/oeh.2007.13.3.290; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Ware JE Jr, 2001, SCORE INTERPRET SING; Wibulpolprasert S., 2011, THAILAND HLTH PROFIL; Yiengprugsawan V, 2012, PUBLIC HEALTH, V126, P33, DOI 10.1016/j.puhe.2011.09.027; Yiengprugsawan V, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-172; Zaloshnja E, 2005, AM J PREV MED, V28, P88, DOI 10.1016/j.amepre.2004.09.016	45	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88903	10.1371/journal.pone.0088903	http://dx.doi.org/10.1371/journal.pone.0088903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551187	Green Published, gold			2022-12-25	WOS:000331266000081
J	Kamat, S; Yeola, S; Zhang, WY; Bianchi, L; Driscoll, M				Kamat, Shaunak; Yeola, Shrutika; Zhang, Wenying; Bianchi, Laura; Driscoll, Monica			NRA-2, a Nicalin Homolog, Regulates Neuronal Death by Controlling Surface Localization of Toxic Caenorhabditis elegans DEG/ENaC Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; ER Quality Control; Intracellular Trafficking; Ion Channels; Neurodegeneration; C; elegans; Nicalin; Quality Control; Trafficking	TOUCH RECEPTOR NEURONS; SENSING ION CHANNELS; CALCIUM; MEC-2; NECROSIS; COMPLEX; GENE; PROTEASES; STOMATIN; SUBUNIT	Background: Mechanisms that regulate plasma membrane expression of neuronally toxic DEG/ENaC channels are unclear. Results: Disruption of ER NRA-2, a Nicalin homolog, enhances C. elegans MEC-10(d) DEG/ENaC neurotoxicity. Immunocytochemistry, TIRF imaging, and electrophysiological assays support that NRA-2 controls relative MEC-10(d) distribution between ER and cell surface to regulate channel activity levels. Conclusion: NRA-2 regulates surface expression of a mutant DEG/ENaC channel. Significance: NRA-2 Nicalin can modulate DEG/ENaC pathophysiology. Hyperactivated DEG/ENaCs induce neuronal death through excessive cation influx and disruption of intracellular calcium homeostasis. Caenorhabditis elegans DEG/ENaC MEC-4 is hyperactivated by the (d) mutation and induces death of touch neurons. The analogous substitution in MEC-10 (MEC-10(d)) co-expressed in the same neurons is only mildly neurotoxic. We exploited the lower toxicity of MEC-10(d) to identify RNAi knockdowns that enhance neuronal death. We report here that knock-out of the C. elegans nicalin homolog NRA-2 enhances MEC-10(d)-induced neuronal death. Cell biological assays in C. elegans neurons show that NRA-2 controls the distribution of MEC-10(d) between the endoplasmic reticulum and the cell surface. Electrophysiological experiments in Xenopus oocytes support this notion and suggest that control of channel distribution by NRA-2 is dependent on the subunit composition. We propose that nicalin/NRA-2 functions in a quality control mechanism to retain mutant channels in the endoplasmic reticulum, influencing the extent of neuronal death. Mammalian nicalin may have a similar role in DEG/ENaC biology, therefore influencing pathological conditions like ischemia.	[Kamat, Shaunak; Yeola, Shrutika; Zhang, Wenying; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bianchi, Laura] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	Rutgers State University New Brunswick; University of Miami	Bianchi, L (corresponding author), Univ Miami, Dept Physiol & Biophys, Rm 5133,1600 NW 10th Ave, Miami, FL 33136 USA.	lbianchi@med.miami.edu; driscoll@dls.rutgers.edu			National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034435, R01NS070969] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Donald Winkelmann for help with TIRF microscopy and instrument sharing, Jian Xue and Helen Ushakov for generating the Ex221 transgenic nra-2 rescue strain, and Dr. Barth Grant and Dr. Anne Norris for help with immunofluorescence experiments. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440).	Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Alvarez de la Rosa Diego, 2013, Curr Mol Pharmacol, V6, P35; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bianchi Laura, 2006, WormBook, P1; BRENNER S, 1974, GENETICS, V77, P71; Brown AL, 2008, J GEN PHYSIOL, V131, P605, DOI 10.1085/jgp.200709910; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chai S, 2010, J BIOL CHEM, V285, P13002, DOI 10.1074/jbc.M109.086041; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Dettmer U, 2010, J BIOL CHEM, V285, P26174, DOI 10.1074/jbc.M110.132548; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gessmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012814; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Hobbs CA, 2013, J PHYSIOL-LONDON, V591, P4377, DOI 10.1113/jphysiol.2012.240861; Hong K, 2000, J NEUROSCI, V20, P2575; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Martin-Fernandez ML, 2013, J MICROSC-OXFORD, V252, P16, DOI 10.1111/jmi.12070; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Sangaletti R, 2013, JOVE-J VIS EXP, DOI 10.3791/50649; Sedensky MM, 2004, AM J PHYSIOL-CELL PH, V287, pC468, DOI 10.1152/ajpcell.00182.2003; Sendrowski K, 2013, PHARMACOL REP, V65, P730, DOI 10.1016/S1734-1140(13)71052-1; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHREFFLER W, 1995, GENETICS, V139, P1261; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Wang Y, 2013, J GEN PHYSIOL, V142, P157, DOI 10.1085/jgp.201310974; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhang W, 2008, CELL DEATH DIFFER, V15, P1794, DOI 10.1038/cdd.2008.114; Zhang W., 2008, THESIS RUTGERS U PIS	47	7	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11916	11926		10.1074/jbc.M113.533695	http://dx.doi.org/10.1074/jbc.M113.533695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24567339	Green Published, hybrid			2022-12-25	WOS:000335010600032
J	Kim, HS; Chen, QJ; Kim, SK; Nickoloff, JA; Hromas, R; Georgiadis, MM; Lee, SH				Kim, Hyun-Suk; Chen, Qiujia; Kim, Sung-Kyung; Nickoloff, Jac A.; Hromas, Robert; Georgiadis, Millie M.; Lee, Suk-Hee			The DDN Catalytic Motif Is Required for Metnase Functions in Non-homologous End Joining ( NHEJ) Repair and Replication Restart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Binding Protein; DNA Damage; DNA Enzymes; DNA Repair; DNA Replication	ENHANCES DNA-REPAIR; TRANSPOSASE DOMAIN; BIOCHEMICAL-CHARACTERIZATION; MARINER TRANSPOSON; CRYSTAL-STRUCTURE; SETMAR PROTEIN; MOS1; EVOLUTION; ELEMENT; HSMAR1	Background: Metnase, a transposase-containing DNA repair protein, retains DNA cleavage activity with a DDN motif. Results: Substitution with the ancestral transposase DDD/DDE catalytic motif results in a decrease in ssDNA binding and ss-overhang cleavage activities. Conclusion: The DDN motif is required for Metnase DNA repair activities. Significance: Understanding the requirements for catalytic activity provides insights on how Metnase functions as a DNA repair protein. Metnase (or SETMAR) arose from a chimeric fusion of the Hsmar1 transposase downstream of a protein methylase in anthropoid primates. Although the Metnase transposase domain has been largely conserved, its catalytic motif (DDN) differs from the DDD motif of related transposases, which may be important for its role as a DNA repair factor and its enzymatic activities. Here, we show that substitution of DDN610 with either DDD610 or DDE610 significantly reduced in vivo functions of Metnase in NHEJ repair and accelerated restart of replication forks. We next tested whether the DDD or DDE mutants cleave single-strand extensions and flaps in partial duplex DNA and pseudo-Tyr structures that mimic stalled replication forks. Neither substrate is cleaved by the DDD or DDE mutant, under the conditions where wild-type Metnase effectively cleaves ssDNA overhangs. We then characterized the ssDNA-binding activity of the Metnase transposase domain and found that the catalytic domain binds ssDNA but not dsDNA, whereas dsDNA binding activity resides in the helix-turn-helix DNA binding domain. Substitution of Asn-610 with either Asp or Glu within the transposase domain significantly reduces ssDNA binding activity. Collectively, our results suggest that a single mutation DDN610 DDD610, which restores the ancestral catalytic site, results in loss of function in Metnase.	[Kim, Hyun-Suk; Chen, Qiujia; Kim, Sung-Kyung; Georgiadis, Millie M.; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nickoloff, Jac A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Hromas, Robert] Shands Hlth Care Syst, Gainesville, FL 32610 USA; [Georgiadis, Millie M.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Colorado State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis	Lee, SH (corresponding author), Indiana Univ Sch Med, Indiana Univ, Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	slee@iu.edu			National Institutes of Health [R01 CA151367, R01 GM084020, R01 CA140422]; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA140422, R01CA151367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 CA151367 (to S.-H. L.), R01 GM084020 (to J. A. N.), R01 CA140422 (to R. H.), and the Indiana University Simon Cancer Center.	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Craig NL, 1997, ANNU REV BIOCHEM, V66, P437, DOI 10.1146/annurev.biochem.66.1.437; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Delauriere L, 2009, BIOCHEMISTRY-US, V48, P7279, DOI 10.1021/bi900609v; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Goodwin KD, 2010, BIOCHEMISTRY-US, V49, P5705, DOI 10.1021/bi100171x; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; Melek M, 1998, SCIENCE, V280, P301, DOI 10.1126/science.280.5361.301; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Richardson JM, 2006, EMBO J, V25, P1324, DOI 10.1038/sj.emboj.7601018; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Williamson EA, 2008, BIOCHIMIE, V90, P1422, DOI 10.1016/j.biochi.2008.05.010; Williamson EA, 2012, CANCER RES, V72, P6200, DOI 10.1158/0008-5472.CAN-12-0313; Wolkowicz UM, 2014, ACS CHEM BIOL, V9, P743, DOI 10.1021/cb400791u; Wray J, 2010, CANCER GENET CYTOGEN, V200, P184, DOI 10.1016/j.cancergencyto.2010.04.011; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	35	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10930	10938		10.1074/jbc.M113.533216	http://dx.doi.org/10.1074/jbc.M113.533216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573677	Green Published, hybrid			2022-12-25	WOS:000334226400060
J	Yu, WJ; Li, NN; Tan, EK; Cheng, L; Zhang, JH; Mao, XY; Chang, L; Zhao, DM; Liao, Q; Peng, R				Yu, Wen Juan; Li, Nan Nan; Tan, Eng King; Cheng, Lan; Zhang, Jin Hong; Mao, Xue Ye; Chang, Li; Zhao, Dong Mei; Liao, Qiao; Peng, Rong			No Association of Four Candidate Genetic Variants in MnSOD and SYNIII with Parkinson's Disease in Two Chinese Populations	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; SYNAPSIN-III; POLYMORPHISMS; EXPRESSION; RISK	Background: The manganese superoxide dismutase (MnSOD) gene, which encodes a chief reactive oxygen species (ROS) scavenging enzyme, has been reported to be associated with the risk of developing sporadic Parkinson's disease (PD) in some Asian races and the synapsin III (SYN3) gene with some neuropsychiatric diseases. Objective: To explore the associations between the MnSOD and SYN III variations and PD in two Chinese populations from mainland China and Singapore. Methods: We recruited 2342 subjects including 1200 sporadic PD patients and 1142 healthy controls from two independent Asian countries. Using a case-control methodology, we genotyped the single nucleotide polymorphisms (SNP) in MnSOD (rs4880) and SYN III (rs3788470, rs3827336, rs5998557) to explore the associations with risk of PD. Results: The results showed the genotype distributions and minor allele frequencies (MAF) of MnSOD (rs4880) and SYN III (rs3788470, rs3827336, rs5998557) were not significantly different between PD patients and healthy controls in mainland China and Singapore, as well as in merged populations. Conclusions: The variations of MnSOD (rs4880) and SYN III (rs3788470, rs3827336, rs5998557) were not major risk factors for PD among Chinese, at least in our study populations.	[Yu, Wen Juan; Li, Nan Nan; Cheng, Lan; Zhang, Jin Hong; Mao, Xue Ye; Chang, Li; Zhao, Dong Mei; Liao, Qiao; Peng, Rong] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Tan, Eng King] Duke NUS Grad Med Sch, Singapore, Singapore; [Tan, Eng King] Singapore Gen Hosp, Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Zhang, Jin Hong] Sichuan Univ, Wangjiang Hosp, Dept Internal Med, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; National University of Singapore; National Neuroscience Institute (NNI); Singapore General Hospital; Sichuan University	Peng, R (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan Provinc, Peoples R China.	qrpeng@hotmail.com			Science and Technology Support Program, Science and Technology Department of Sichuan province [2013SZ0003]	Science and Technology Support Program, Science and Technology Department of Sichuan province	This work was supported by the Science and Technology Support Program, Science and Technology Department of Sichuan province. The grant numbers are 2013SZ0003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Chen Q, 2009, NEUROSCI LETT, V465, P248, DOI 10.1016/j.neulet.2009.09.032; D'Alfonso S, 1999, EUR J HUM GENET, V7, P377, DOI 10.1038/sj.ejhg.5200301; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Farin FM, 2001, MOVEMENT DISORD, V16, P705, DOI 10.1002/mds.1153; Feng J, 2002, J NEUROSCI, V22, P4372, DOI 10.1523/JNEUROSCI.22-11-04372.2002; Ferreira A, 2000, J NEUROSCI, V20, P3736, DOI 10.1523/JNEUROSCI.20-10-03736.2000; Fong CS, 2007, CLIN CHIM ACTA, V378, P136, DOI 10.1016/j.cca.2006.11.006; Grasbon-Frodl EM, 1999, BIOCHEM BIOPH RES CO, V255, P749, DOI 10.1006/bbrc.1998.9998; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kile BM, 2010, J NEUROSCI, V30, P9762, DOI 10.1523/JNEUROSCI.2071-09.2010; Makkar R, 2007, PSYCHIAT GENET, V17, P109, DOI 10.1097/YPG.0b013e328012a0c6; Otaegui D, 2009, MULT SCLER J, V15, P124, DOI 10.1177/1352458508096682; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; PARBOOSINGH JS, 1995, ARCH NEUROL-CHICAGO, V52, P1160, DOI 10.1001/archneur.1995.00540360038013; Rajaraman P, 2008, NEURO-ONCOLOGY, V10, P709, DOI 10.1215/15228517-2008-037; ShimodaMatsubayashi S, 1997, NEUROLOGY, V49, P1257, DOI 10.1212/WNL.49.5.1257; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Vallada H, 1998, SCHIZOPHR RES, V32, P115; Warner TT, 2003, ANN NEUROL, V53, pS16, DOI 10.1002/ana.10487; Wiener HW, 2007, GENES BRAIN BEHAV, V6, P770, DOI 10.1111/j.1601-183X.2007.00308.x; Yoo MS, 2003, MOL BRAIN RES, V110, P76, DOI 10.1016/S0169-328X(02)00586-7; ZHANG P, 1994, NEUROSCIENCE, V61, P317, DOI 10.1016/0306-4522(94)90234-8; ZHANG P, 1993, NEUROSCIENCE, V55, P167, DOI 10.1016/0306-4522(93)90463-P	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88050	10.1371/journal.pone.0088050	http://dx.doi.org/10.1371/journal.pone.0088050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586301	Green Submitted, Green Published, gold			2022-12-25	WOS:000332389000007
J	Mupepele, AC; Muller, T; Dittrich, M; Floren, A				Mupepele, Anne-Christine; Mueller, Tobias; Dittrich, Marcus; Floren, Andreas			Are Temperate Canopy Spiders Tree-Species Specific?	PLOS ONE			English	Article							HABITAT STRUCTURE; PREY SELECTION; ARANEAE; FAUNA; DIVERSITY; FOREST; ASSEMBLAGES; ARANEIDAE; RICHNESS; WEB	Arboreal spiders in deciduous and coniferous trees were investigated on their distribution and diversity. Insecticidal knockdown was used to comprehensively sample spiders from 175 trees from 2001 to 2003 in the Bialowieza forest and three remote forests in Poland. We identified 140 species from 9273 adult spiders. Spider communities were distinguished between deciduous and coniferous trees. The richest fauna was collected from Quercus where beta diversity was also highest. A tree-species-specific pattern was clearly observed for Alnus, Carpinus, Picea and Pinus trees and also for those tree species that were fogged in only four or three replicates, namely Betula and Populus. This hitherto unrecognised association was mainly due to the community composition of common species identified in a Dufrene-Legendre indicator species analysis. It was not caused by spatial or temporal autocorrelation. Explaining tree-species specificity for generalist predators like spiders is difficult and has to involve physical and ecological tree parameters like linkage with the abundance of prey species. However, neither did we find a consistent correlation of prey group abundances with spiders nor could differences in spider guild composition explain the observed pattern. Our results hint towards the importance of deterministic mechanisms structuring communities of generalist canopy spiders although the casual relationship is not yet understood.	[Mupepele, Anne-Christine] Univ Freiburg, D-79106 Freiburg, Germany; [Mueller, Tobias; Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, D-97070 Wurzburg, Germany; [Floren, Andreas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	University of Freiburg; University of Wurzburg; University of Wurzburg	Floren, A (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany.	floren@biozentrum.uni-wuerzburg.de	Mupepele, Anne-Christine/J-3855-2014; Müller, Tobias/A-8952-2008	Mupepele, Anne-Christine/0000-0002-5671-0963; 	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blick T., 2004, CHECKLIST SPIDERS CE; Blick Theo, 2006, Fragmenta Faunistica (Warsaw), V49, P115; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Brierton BM, 2003, J ARACHNOL, V31, P350, DOI 10.1636/0161-8202(2003)031[0350:SFOSMA]2.0.CO;2; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Copley CR, 2010, CAN J FOREST RES, V40, P904, DOI 10.1139/X10-043; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Falinski J.B., 1986, VEGETATION DYNAMICS; Finch OD, 2008, BIODIVERS CONSERV, V17, P2849, DOI 10.1007/s10531-008-9400-x; Floren Andreas, 2010, Abc Taxa, V8, P158; Floren Andreas, 2008, P489; Floren Andreas, 2008, P279; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; Halaj J, 1998, J ARACHNOL, V26, P203; Horstmann Klaus, 2008, P469; Hsieh YL, 2011, BIODIVERS CONSERV, V20, P2953, DOI 10.1007/s10531-011-0158-1; Jedrzejewska B, 1998, ECOLOGICAL STUDIES P, P4; JENNINGS DT, 1986, J ARACHNOL, V14, P315; JOST L, 2009, ECOL ECON, V68, P925, DOI DOI 10.1016/J.ECOLECON.2008.10.015; Larrivee M, 2009, AGR FOREST ENTOMOL, V11, P225, DOI 10.1111/j.1461-9563.2008.00421.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Ludy C, 2007, AGR ECOSYST ENVIRON, V119, P368, DOI 10.1016/j.agee.2006.08.005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mestre L, 2011, ANIM BEHAV, V81, P741, DOI 10.1016/j.anbehav.2011.01.002; NENTWIG W, 1986, OECOLOGIA, V68, P595, DOI 10.1007/BF00378777; NENTWIG W, 1985, OECOLOGIA, V66, P580, DOI 10.1007/BF00379353; Nicolai Volker, 1993, Spixiana, V16, P61; Nyffeler M, 1999, J ARACHNOL, V27, P317; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Otto Stefan, 2007, Fragmenta Faunistica (Warsaw), V50, P57; Pateiro-Lopez B., 2009, ALPHAHULL GEN CONVEX; Pinzon J, 2011, ENVIRON ENTOMOL, V40, P797, DOI 10.1603/EN11081; Platen R, 1999, NATURSCHUTZ LANDSCHA, V8, P1; Prieto-Benitez S, 2011, BIOL CONSERV, V144, P683, DOI 10.1016/j.biocon.2010.11.024; R Core Team, 2012, R LANG ENV STAT COMP; Roberts DW., 2012, LABDSV ORDINATION MU; Schmidt JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049223; Schmidt JM, 2010, OECOLOGIA, V164, P899, DOI 10.1007/s00442-010-1785-z; Sorensen LL, 2004, BIODIVERS CONSERV, V13, P437, DOI 10.1023/B:BIOC.0000006510.49496.1e; SOUTHWOOD TRE, 1982, ECOL ENTOMOL, V7, P331, DOI 10.1111/j.1365-2311.1982.tb00674.x; Sprick Peter, 2008, P225; Uetz GW, 1999, J ARACHNOL, V27, P270; Wise DH, 1993, SPIDERS ECOLOGICAL W; Ziesche TM, 2008, FOREST ECOL MANAG, V255, P738, DOI 10.1016/j.foreco.2007.09.060	46	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e86571	10.1371/journal.pone.0086571	http://dx.doi.org/10.1371/journal.pone.0086571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586251	Green Published, gold			2022-12-25	WOS:000331714700004
J	Hayashi, K; Watanabe, B; Nakagawa, Y; Minami, S; Morita, T				Hayashi, Ken'ichiro; Watanabe, Bunta; Nakagawa, Yoshiaki; Minami, Saki; Morita, Tsuyoshi			RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; MEGAKARYOBLASTIC LEUKEMIA; NUCLEAR-LOCALIZATION; MRTF-A; MYOCARDIN; GENE; DIFFERENTIATION; EXPRESSION; CELLS	Epithelial-msenchymal transition (EMT) is closely associated with cancer and tissue fibrosis. The nuclear accumulation of myocardin-related transcription factor A (MRTF-A/MAL/MKL1) plays a vital role in EMT. In various cells treated with CCG-1423, a novel inhibitor of Rho signaling, the nuclear accumulation of MRTF-A is inhibited. However, the molecular target of this inhibitor has not yet been identified. In this study, we investigated the mechanism of this effect of CCG-1423. The interaction between MRTF-A and importin alpha/beta 1 was inhibited by CCG-1423, but monomeric G-actin binding to MRTF-A was not inhibited. We coupled Sepharose with CCG-1423 (CCG-1423 Sepharose) to investigate this mechanism. A pull-down assay using CCG-1423 Sepharose revealed the direct binding of CCG-1423 to MRTF-A. Furthermore, we found that the N-terminal basic domain (NB) of MRTF-A, which acts as a functional nuclear localization signal (NLS) of MRTF-A, was the binding site for CCG-1423. G-actin did not bind to CCG-1423 Sepharose, but the interaction between MRTF-A and CCG-1423 Sepharose was reduced in the presence of G-actin. We attribute this result to the high binding affinity of MRTF-A for G-actin and the proximity of NB to G-actin-binding sites (RPEL motifs). Therefore, when MRTF-A forms a complex with G-actin, the binding of CCG-1423 to NB is expected to be blocked. NF-E2 related factor 2, which contains three distinct basic amino acid-rich NLSs, did not bind to CCG-1423 Sepharose, but other RPEL-containing proteins such as MRTF-B, myocardin, and Phactr1 bound to CCG-1423 Sepharose. These results suggest that the specific binding of CCG-1423 to the NLSs of RPEL-containing proteins. Our proposal to explain the inhibitory action of CCG-1423 is as follows: When the G-actin pool is depleted, CCG-1423 binds specifically to the NLS of MRTF-A/B and prevents the interaction between MRTF-A/B and importin alpha/beta 1, resulting in inhibition of the nuclear import of MRTF-A/B.	[Hayashi, Ken'ichiro; Morita, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Osaka, Japan; [Watanabe, Bunta] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Nakagawa, Yoshiaki; Minami, Saki] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Kyoto, Japan	Osaka University; Kyoto University; Kyoto University	Hayashi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, Osaka, Japan.	khayashi@nbiochem.med.osaka-u.ac.jp		Watanabe, Bunta/0000-0003-3645-5712	Ministry of Education, Science, Sports and Culture of Japan [23590332]; Project MEET, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research [23590332] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project MEET, Osaka University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (23590332 to K. H.) and Project MEET, Osaka University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer PD, 2000, J CHEM SOC DALTON, P1805, DOI 10.1039/b000079p; Bell JL, 2013, BEILSTEIN J ORG CHEM, V9, P966, DOI 10.3762/bjoc.9.111; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hayashi K, 2013, J BIOL CHEM, V288, P5743, DOI 10.1074/jbc.M112.408120; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; MCINTYRE GD, 1983, BIOCHEM J, V211, P519, DOI 10.1042/bj2110519; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Scharenberg M. A., 2010, INT J BIOCHEM CELL B, V53, P8627; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wiezlak M, 2012, J CELL SCI, V125, P5860, DOI 10.1242/jcs.112078	29	65	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89016	10.1371/journal.pone.0089016	http://dx.doi.org/10.1371/journal.pone.0089016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558465	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700111
J	Ingrasciotta, Y; Sultana, J; Giorgianni, F; Caputi, AP; Arcoraci, V; Tari, DU; Linguiti, C; Perrotta, M; Nucita, A; Pellegrini, F; Fontana, A; Cavagna, L; Santoro, D; Trifiro, G				Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Caputi, Achille Patrizio; Arcoraci, Vincenzo; Tari, Daniele Ugo; Linguiti, Claudio; Perrotta, Margherita; Nucita, Andrea; Pellegrini, Fabio; Fontana, Andrea; Cavagna, Lorenzo; Santoro, Domenico; Trifiro, Gianluca			The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRESCRIBING PATTERN; GENERAL-PRACTICE; INTERACTION RISK; PREVALENCE; CARE; PROGRESSION; OUTCOMES; TRENDS	Background: The use of nephrotoxic drugs can further worsening renal function in chronic kidney disease (CKD) patients. It is therefore imperative to explore prescribing practices that can negatively affect CKD patients. Aim: To analyze the use of nephrotoxic drugs in CKD patients in a general population of Southern Italy during the years 2006-2011. Methods: The general practice "Arianna" database contains data from 158,510 persons, registered with 123 general practitioners (GPs) of Caserta. CKD patients were identified searching: CKD-related ICD-9 CM codes among causes of hospitalization; CKD-relevant procedures undergone in hospital (e.g. dialysis); drug prescriptions issued for a CKD-related indication. A list of nephrotoxic drugs was compiled and validated by pharmacologists and nephrologists. The summary of product characteristics was used to classify drugs as 'contraindicated' or 'to be used with caution' in renal diseases. Frequency of nephrotoxic drug use, overall, by drug class and single compounds, by GPs within one year prior or after first CKD diagnosis and within one year after dialysis entry was calculated. Results: Overall, 1,989 CKD patients and 112 dialysed patients were identified. Among CKD patients, 49.8% and 45.2% received at least one prescription for a contraindicated nephrotoxic drug within one year prior or after first CKD diagnosis, respectively. In detail, 1,119 CKD patients (56.3%) had at least one nonsteroidal anti-inflammatory drugs (NSAIDs) prescription between CKD diagnosis and end of follow-up. A large proportion of CKD patients (35.6%) were treated with NSAIDs for periods exceeding 90 days. Contraindicated nephrotoxic drugs were used commonly in CKD, with nimesulide (16.6%) and diclofenac (11.0%) being most frequently used. Conclusions: Contraindicated nephrotoxic drugs were highly prescribed in CKD patients from a general population of Southern Italy. CKD diagnosis did not seem to reduce significantly the prescription of nephrotoxic drugs, which may increase the risk of preventable renal function deterioration.	[Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Caputi, Achille Patrizio; Arcoraci, Vincenzo; Santoro, Domenico; Trifiro, Gianluca] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Tari, Daniele Ugo; Linguiti, Claudio; Perrotta, Margherita] Caserta Local Hlth Serv, Caserta, Italy; [Nucita, Andrea] Univ Messina, Dept Cognit Sci Educ & Cultural Studies CSECS, Messina, Italy; [Pellegrini, Fabio; Fontana, Andrea] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, FG, Italy; [Cavagna, Lorenzo] Univ Pavia, Div Rheumatol, I-27100 Pavia, Italy; [Cavagna, Lorenzo] IRCCS Fdn Policlin S Matteo, Pavia, Italy	University of Messina; University of Messina; IRCCS Casa Sollievo Della Sofferenza; University of Pavia; IRCCS Fondazione San Matteo	Trifiro, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	trifirog@unime.it	Fontana, Andrea/J-8584-2016; Arcoraci, Vincenzo/HGA-3713-2022; santoro, domenico/L-2482-2013; santoro, domenico/P-7902-2014; Sultana, Janet/Z-4817-2019; Nucita, Andrea/F-3826-2014; Trifiro, Gianluca/K-9744-2016; Tari, Daniele Ugo/AAY-8658-2021; Cavagna, Lorenzo/AAU-3943-2021	Fontana, Andrea/0000-0002-6660-5315; Arcoraci, Vincenzo/0000-0003-0061-0477; santoro, domenico/0000-0002-4279-6559; santoro, domenico/0000-0002-4279-6559; Trifiro, Gianluca/0000-0003-1147-7296; Tari, Daniele Ugo/0000-0002-7312-419X; Cavagna, Lorenzo/0000-0003-3292-1528; Perrotta, Margherita/0000-0001-8498-2838; Sultana, Janet/0000-0001-9622-169X; Giorgianni, Francesco/0000-0003-1779-0822; Nucita, Andrea/0000-0001-6257-5529				Adams RJ, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-70; Alacqua M, 2008, ARTHRIT RHEUM-ARTHR, V59, P568, DOI 10.1002/art.23526; Alacqua M, 2009, EPILEPSY RES, V85, P107, DOI 10.1016/j.eplepsyres.2009.03.002; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Broadbent A, 2003, PROG PALLIAT CARE, V11, P183; Cavagna L, 2013, INT J IMMUNOPATH PH, V26, P279, DOI 10.1177/039463201302600132; Cirillo M, 2006, KIDNEY INT, V70, P800, DOI 10.1038/sj.ki.5001641; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; De Berardis G, 2004, DIABETES CARE, V27, P398, DOI 10.2337/diacare.27.2.398; De Nicola L, 2011, CLIN J AM SOC NEPHRO, V6, P2421, DOI 10.2215/CJN.01180211; Delzell E, 1998, MEDICINE, V77, P102, DOI 10.1097/00005792-199803000-00003; Disney APS, 1998, NEPHROL DIAL TRANSPL, V13, P854, DOI 10.1093/ndt/13.4.854; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gooch K, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.02.015; Henry D, 1997, BRIT J CLIN PHARMACO, V44, P85, DOI 10.1046/j.1365-2125.1997.00631.x; Jardine MJ, 2010, J AM COLL CARDIOL, V56, P956, DOI 10.1016/j.jacc.2010.02.068; Khan S, 2008, J EVAL CLIN PRACT, V14, P422, DOI 10.1111/j.1365-2753.2007.00883.x; Kuo HW, 2010, PHARMACOEPIDEM DR S, V19, P743, DOI 10.1002/pds.1962; Montecucco C, 2009, EUR J PAIN SUPP, P105, DOI 10.1016/j.eujps.2009.07.006; Murtagh F, 2007, OPIOIDS CANC PAIN, P131; Nderitu P, 2013, FAM PRACT, V30, P247, DOI 10.1093/fampra/cms086; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Niscola Pasquale, 2011, G Ital Nefrol, V28, P269; Obrador GT, 2010, KIDNEY INT, V77, pS2, DOI 10.1038/ki.2009.540; Oteri A, 2010, BRIT J CLIN PHARMACO, V70, P514, DOI 10.1111/j.1365-2125.2010.03619.x; Ottawa V, 2001, DIALYSIS RENAL TRANS; Pannu N, 2008, CRIT CARE MED, V36, pS216, DOI 10.1097/CCM.0b013e318168e375; Piacentini N, 2005, EUR J CLIN PHARMACOL, V61, P615, DOI 10.1007/s00228-005-0972-z; Radulescu Daniela, 2009, J Med Life, V2, P199; Santoro Domenico, 2013, Clin Nephrol, V79 Suppl 1, pS2; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Singh AK, 2003, NEW ENGL J MED, V349, P2055, DOI 10.1056/NEJMcpc030028; Snively CS, 2004, AM FAM PHYSICIAN, V70, P1921; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS133; Trifiro G, 2008, EUR J CLIN PHARMACOL, V64, P619, DOI 10.1007/s00228-007-0459-1; Trifiro G, 2008, PARKINSONISM RELAT D, V14, P420, DOI 10.1016/j.parkreldis.2007.10.010; Trifiro G, 2006, BRIT J CLIN PHARMACO, V62, P582, DOI 10.1111/j.1365-2125.2006.02687.x; Usami T, 2002, CURR OPIN NEPHROL HY, V11, P343, DOI 10.1097/00041552-200205000-00012; Weigert AL, 1998, AM J MED SCI, V316, P94, DOI 10.1097/00000441-199808000-00005; WHELTON A, 1991, J CLIN PHARMACOL, V31, P588, DOI 10.1002/j.1552-4604.1991.tb03743.x; Zager RA, 1997, SEMIN NEPHROL, V17, P3	45	39	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89072	10.1371/journal.pone.0089072	http://dx.doi.org/10.1371/journal.pone.0089072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558471	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700117
J	Xiong, FF; Xia, LL; Wang, JF; Wu, B; Wang, DY; Yuan, LF; Cheng, YT; Zhu, HY; Che, XY; Zhang, QH; Zhao, GP; Wang, Y				Xiong, Feifei; Xia, Liliang; Wang, Jingfang; Wu, Biao; Wang, Dengyu; Yuan, Longfang; Cheng, Yating; Zhu, Hongying; Che, Xiaoyan; Zhang, Qinghua; Zhao, Guoping; Wang, Ying			A High-Affinity CDR-Grafted Antibody against Influenza A H5N1 Viruses Recognizes a Conserved Epitope of H5 Hemagglutinin	PLOS ONE			English	Article							T-CELL EPITOPES; COMPLEMENTARITY-DETERMINING REGIONS; MONOCLONAL-ANTIBODY; PATHOGENIC H5N1; ANTIGENIC VARIATION; MOLECULAR-DYNAMICS; DUAL-SPECIFICITY; BINDING; IDENTIFICATION; HUMANIZATION	Highly pathogenic avian influenza (HPAI) H5N1 virus infection is still a potential threat to public health worldwide. While vaccines and antiviral drugs are currently under development, neutralizing antibodies could offer an alternative strategy to prevent and treat H5N1 virus infection. In the present study, we had developed a humanized antibody against H5N1 viruses from mouse-derived hybridoma in order to minimize its immunogenicity for potential clinical application. The humanized antibody hH5M9 was generated by transferring the mouse complementarity determining region (CDR) residues together with four key framework region (FR) residues onto the FR of the human antibody. This humanized antibody exhibited high affinity and specificity comparable to the parental mouse or chimeric counterpart with broad and strong neutralization activity against all H5N1 clades and subclades except for Egypt clades investigated. Furthermore, through epitope mapping we identified a linear epitope on the top region of hemagglutinin (HA) that was H5N1 specific and conserved. Our results for the first time reported a humanized antibody against H5N1 viruses by CDR grafting method. With the expected lower immunogenicity, this humanized antibody was expected to be more efficacious than murine or human-mouse chimeric antibodies for future application in humans.	[Xiong, Feifei; Zhang, Qinghua] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Xiong, Feifei; Xia, Liliang; Wu, Biao; Wang, Dengyu; Yuan, Longfang; Cheng, Yating; Zhu, Hongying; Zhao, Guoping; Wang, Ying] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Wang, Jingfang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Che, Xiaoyan] Southern Med Univ, Cent Lab, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200030, Peoples R China	Tongji University; Shanghai Jiao Tong University; Southern Medical University - China; Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, Y (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	ywang@sibs.ac.cn	Wang, Jingfang/Q-2597-2018	Wang, Jingfang/0000-0002-1355-5481; Zhao, Guo-Ping/0000-0002-7621-6620	National High Technology Research and Development Program of China (863 Program) [2006AA 02A 252]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2011ZX09506-001]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported by National High Technology Research and Development Program of China (863 Program, Grant No. 2006AA 02A 252) http://www.863.gov.cn/; and National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant No. 2011ZX09506-001) http://www. nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; COLCHER D, 1990, JNCI-J NATL CANCER I, V82, P1191, DOI 10.1093/jnci/82.14.1191; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Cusick MF, 2009, J IMMUNOL, V183, P6432, DOI 10.4049/jimmunol.0901617; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 2000, PROTEINS, V40, P572; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huston James S., 2001, Human Antibodies, V10, P127; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Laisney IL, 1999, IMMUNOL LETT, V67, P185, DOI 10.1016/S0165-2478(99)00010-3; Li BH, 2007, BIOCHEM BIOPH RES CO, V357, P951, DOI 10.1016/j.bbrc.2007.04.039; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-80; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Mazor Y, 2005, MOL IMMUNOL, V42, P55, DOI 10.1016/j.molimm.2004.07.013; NAKATANI T, 1994, PROTEIN ENG, V7, P435, DOI 10.1093/protein/7.3.435; Ofran Y, 2008, J IMMUNOL, V181, P6230, DOI 10.4049/jimmunol.181.9.6230; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Paquet ME, 2005, METHODS, V35, P338, DOI 10.1016/j.ymeth.2004.10.005; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Sawyer LA, 2000, ANTIVIR RES, V47, P57, DOI 10.1016/S0166-3542(00)00111-X; SECCAMANI E, 1989, NUCL MED BIOL, V16, P167, DOI 10.1016/0883-2897(89)90191-8; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang SF, 2010, VIRAL IMMUNOL, V23, P585, DOI 10.1089/vim.2010.0058; Wang SF, 2009, BIOCHEM BIOPH RES CO, V382, P691, DOI 10.1016/j.bbrc.2009.03.119; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Workman CJ, 1998, J PROTEIN CHEM, V17, P599, DOI 10.1007/BF02780961; Workman CJ, 1997, J MOL RECOGNIT, V10, P225, DOI 10.1002/(SICI)1099-1352(199709/10)10:5<225::AID-JMR372>3.0.CO;2-1; World Health Organization, CUM NUMB CONF HUM CA; WRIGHT A, 1992, CRIT REV IMMUNOL, V12, P125; Yang JB, 2009, VACCINE, V27, P3862, DOI 10.1016/j.vaccine.2009.04.019; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zhu XY, 2013, J VIROL, V87, P12619, DOI 10.1128/JVI.01577-13	57	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88777	10.1371/journal.pone.0088777	http://dx.doi.org/10.1371/journal.pone.0088777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558425	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700071
J	Zhou, MZ; Yu, H; Yin, XH; Sabour, PM; Chen, W; Gong, J				Zhou, Mengzhou; Yu, Hai; Yin, Xianhua; Sabour, Parviz M.; Chen, Wei; Gong, Joshua			Lactobacillus zeae Protects Caenorhabditis elegans from Enterotoxigenic Escherichia coli-Caused Death by Inhibiting Enterotoxin Gene Expression of the Pathogen	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; POSTWEANING DIARRHEA; VIRULENCE GENES; HEAT-LABILE; MODEL HOST; PROBIOTICS; INFECTION; DEFENSE; SCREEN; CELLS	Background: The nematode Caenorhabditis elegans has become increasingly used for screening antimicrobials and probiotics for pathogen control. It also provides a useful tool for studying microbe-host interactions. This study has established a C. elegans life-span assay to preselect probiotic bacteria for controlling K88(+) enterotoxigenic Escherichia coli (ETEC), a pathogen causing pig diarrhea, and has determined a potential mechanism underlying the protection provided by Lactobacillus. Methodology/Principal Findings: Life-span of C. elegans was used to measure the response of worms to ETEC infection and protection provided by lactic acid-producing bacteria (LAB). Among 13 LAB isolates that varied in their ability to protect C. elegans from death induced by ETEC strain JG280, Lactobacillus zeae LB1 offered the highest level of protection (86%). The treatment with Lactobacillus did not reduce ETEC JG280 colonization in the nematode intestine. Feeding E. coli strain JFF4 (K88+ but lacking enterotoxin genes of estA, estB, and elt) did not cause death of worms. There was a significant increase in gene expression of estA, estB, and elt during ETEC JG280 infection, which was remarkably inhibited by isolate LB1. The clone with either estA or estB expressed in E. coli DH5 alpha was as effective as ETEC JG280 in killing the nematode. However, the elt clone killed only approximately 40% of worms. The killing by the clones could also be prevented by isolate LB1. The same isolate only partially inhibited the gene expression of enterotoxins in both ETEC JG280 and E. coli DH5a in-vitro. Conclusions/Significance: The established life-span assay can be used for studies of probiotics to control ETEC (for effective selection and mechanistic studies). Heat-stable enterotoxins appeared to be the main factors responsible for the death of C. elegans. Inhibition of ETEC enterotoxin production, rather than interference of its intestinal colonization, appears to be the mechanism of protection offered by Lactobacillus.	[Zhou, Mengzhou; Chen, Wei] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Zhou, Mengzhou; Yu, Hai; Yin, Xianhua; Sabour, Parviz M.; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada	Jiangnan University; Agriculture & Agri Food Canada	Chen, W (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.	chenwei66@jiangnan.edu.cn; joshua.gong@agr.gc.ca	Chen, Wei/GZK-7348-2022		Agriculture and Agri-Food Canada	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was funded by Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Anyanful A, 2009, CELL HOST MICROBE, V5, P450, DOI 10.1016/j.chom.2009.04.012; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Carey CM, 2008, J MICROBIOL METH, V73, P125, DOI 10.1016/j.mimet.2008.01.014; Daniel C, 2006, APPL ENVIRON MICROB, V72, P5799, DOI 10.1128/AEM.00109-06; Daudelin JF, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-69; De Mitchell I, 1976, J Appl Bacteriol, V41, P163; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Haesebrouck F, 2004, VET MICROBIOL, V100, P255, DOI 10.1016/j.vetmic.2004.03.002; HARVILLE BA, 1995, INFECT IMMUN, V63, P745, DOI 10.1128/IAI.63.3.745-750.1995; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Jin LZ, 2000, J SCI FOOD AGR, V80, P619, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;619::AID-JSFA583&gt;3.0.CO;2-7; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Nadeau E, 2011, US patent, Patent No. [20070218035 A1., 20070218035]; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nagy S, 1999, J CLIN MICROBIOL, V37, P1642, DOI 10.1128/JCM.37.5.1642-1645.1999; Nair GB, 1998, MICROB PATHOGENESIS, V24, P123, DOI 10.1006/mpat.1997.0177; Nemcova R, 2007, VET RES COMMUN, V31, P791, DOI 10.1007/s11259-007-0048-x; Noamani BN, 2003, VET MICROBIOL, V97, P87, DOI 10.1016/j.vetmic.2003.08.006; Paupard MC, 2001, J HISTOCHEM CYTOCHEM, V49, P949, DOI 10.1177/002215540104900803; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Roselli M, 2007, J NUTR, V137, P2709, DOI 10.1093/jn/137.12.2709; Roselli M, 2006, BRIT J NUTR, V95, P1177, DOI 10.1079/BJN20051681; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Si W, 2007, APPL ENVIRON MICROB, V73, P7110, DOI 10.1128/AEM.01108-07; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Stiernagle Theresa, 2006, WormBook, P1; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TURNBULL PCB, 1978, J APPL BACTERIOL, V45, P157, DOI 10.1111/j.1365-2672.1978.tb04211.x; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; Wang CY, 2011, J FOOD PROTECT, V74, P86, DOI 10.4315/0362-028X.JFP-10-155; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Zhang L, 2010, VET MICROBIOL, V141, P142, DOI 10.1016/j.vetmic.2009.09.003; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05; Zhu J, 2011, INFECT IMMUN, V79, P1688, DOI 10.1128/IAI.01281-10	44	39	40	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89004	10.1371/journal.pone.0089004	http://dx.doi.org/10.1371/journal.pone.0089004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558463	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700109
J	Zhu, ZF; Meng, K; Zhong, YC; Qi, L; Mao, XB; Yu, KW; Zhang, W; Zhu, PF; Ren, ZP; Wu, BW; Ji, QW; Wang, X; Zeng, QT				Zhu, Zheng-Feng; Meng, Kai; Zhong, Yu-Cheng; Qi, Liang; Mao, Xiao-Bo; Yu, Kun-Wu; Zhang, Wei; Zhu, Peng-Fei; Ren, Ze-Peng; Wu, Bang-Wei; Ji, Qin-Wei; Wang, Xiang; Zeng, Qiu-Tang			Impaired Circulating CD4(+)LAP(+) Regulatory T Cells in Patients with Acute Coronary Syndrome and Its Mechanistic Study	PLOS ONE			English	Article							LATENCY-ASSOCIATED PEPTIDE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TGF-BETA ACTIVATION; NERVOUS-SYSTEM; MYOCARDIAL-INFARCTION; AMELIORATES LUPUS; CUTTING EDGE; ATHEROSCLEROSIS; INFLAMMATION; GARP	Objective: CD4(+) latency-associated peptide (LAP)(+) regulatory T cells (Tregs) are a newly discovered T cell subset in humans and the role of these cells in patients with acute coronary syndrome (ACS) has not been explored. We designed to investigate whether circulating frequency and function of CD4(+)LAP(+) Tregs are defective in ACS. Methods: One hundred eleven ACS patients (acute myocardial infarction and unstable angina) and 117 control patients were enrolled in the study. The control patients consisted of chronic stable angina (CSA) and chest pain syndrome (CPS). The frequencies of circulating CD4(+)LAP(+) Tregs and the expression of the transmembrane protein glycoprotein-A repetitions predominant (GARP) on CD4(+) T cells were determined by flow cytometry. The function of CD4(+)LAP(+) Tregs was detected using thymidine uptake. Serum interleukin-10 (IL-10) and transforming growth factor-beta protein (TGF-beta) levels were detected using ELISA and expression of GARP mRNA in peripheral blood mononuclear cells (PBMCs) was measured by real time-polymerase chain reaction. Results: We found ACS patients had a significantly lower frequency of circulating CD4(+)LAP(+) Tregs, and the function of these cells was reduced compared to controls. The expression of GARP in CD4(+) T cells and the serum levels of TGF-b in ACS patients were lower than those of control patients. The serum levels of IL-10 were similar between the two cohorts. Conclusions: A novel regulatory T cell subset, defined as CD4(+)LAP(+) T cells is defective in ACS patients.	[Zhu, Zheng-Feng; Meng, Kai; Zhong, Yu-Cheng; Mao, Xiao-Bo; Yu, Kun-Wu; Zhang, Wei; Zhu, Peng-Fei; Ren, Ze-Peng; Wu, Bang-Wei; Wang, Xiang; Zeng, Qiu-Tang] Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol,Union Hosp, Minist Educ,Inst Cardiol,Tongji Med Coll, Wuhan 430074, Peoples R China; [Qi, Liang] Nanjing Med Univ, Affiliated Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Ji, Qin-Wei] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Cardiol, Nanning, Peoples R China	Huazhong University of Science & Technology; Nanjing Medical University	Wang, X (corresponding author), Huazhong Univ Sci & Technol, Key Lab Biol Targeted Therapy, Lab Cardiovasc Immunol,Union Hosp, Minist Educ,Inst Cardiol,Tongji Med Coll, Wuhan 430074, Peoples R China.	wxiang128@yahoo.com.cn; zengqiutang@gmail.com		Wu, Bangwei/0000-0002-2765-4640	National Natural Science Foundation of China [81070237, 81270354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two grants from the National Natural Science Foundation of China (number 81070237 and number 81270354 to QTZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Battaglia M, 2009, EUR J IMMUNOL, V39, P3296, DOI 10.1002/eji.200940117; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boswell S, 2011, IMMUNOLOGY, V133, P278, DOI 10.1111/j.1365-2567.2011.03425.x; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Duan W, 2011, J IMMUNOL, V187, P6499, DOI 10.4049/jimmunol.1101398; Erren M, 1999, ARTERIOSCL THROM VAS, V19, P2355, DOI 10.1161/01.ATV.19.10.2355; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Ganta CK, 2006, AM J PHYSIOL-REG I, V291, pR558, DOI 10.1152/ajpregu.00846.2005; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ishikawa H, 2007, DIABETES, V56, P2103, DOI 10.2337/db06-1632; Keski-Oja J, 2004, TRENDS CELL BIOL, V14, P657, DOI 10.1016/j.tcb.2004.10.003; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Nakamura-Wakatsuki T, 2012, EXP DERMATOL, V21, P189, DOI 10.1111/j.1600-0625.2011.01419.x; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Oida T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015523; OLLENDORFF V, 1994, CELL GROWTH DIFFER, V5, P213; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sardella G, 2007, THROMB RES, V120, P631, DOI 10.1016/j.thromres.2006.12.005; Sharabi A, 2006, P NATL ACAD SCI USA, V103, P8810, DOI 10.1073/pnas.0603201103; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Tang TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024272; Tang TT, 2010, CELL PHYSIOL BIOCHEM, V25, P451, DOI 10.1159/000303050; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; VIGLIETTA V, 2004, J EXP MED, V971, P9; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wu HY, 2009, LUPUS, V18, P586, DOI 10.1177/0961203308100511; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; YASUE H, 1986, CIRCULATION, V74, P955, DOI 10.1161/01.CIR.74.5.955; Zhang WC, 2012, J BIOL CHEM, V287, P34157, DOI 10.1074/jbc.M112.382978; Zhong YC, 2012, J CLIN IMMUNOL, V32, P1104, DOI 10.1007/s10875-012-9699-7	51	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88775	10.1371/journal.pone.0088775	http://dx.doi.org/10.1371/journal.pone.0088775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558424	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700070
J	Aoyama, J; Watanabe, S; Miller, MJ; Mochioka, N; Otake, T; Yoshinaga, T; Tsukamoto, K				Aoyama, Jun; Watanabe, Shun; Miller, Michael J.; Mochioka, Noritaka; Otake, Tsuguo; Yoshinaga, Tatsuki; Tsukamoto, Katsumi			Spawning Sites of the Japanese Eel in Relation to Oceanographic Structure and the West Mariana Ridge	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; FRESH-WATER EELS; REAL-TIME PCR; ANGUILLA-JAPONICA; EUROPEAN EEL; LARVAL TRANSPORT; SARGASSO SEA; SPECIES IDENTIFICATION; OCEANIC MIGRATION; ATLANTIC EELS	The Japanese eel, Anguilla japonica, spawns within the North Equatorial Current that bifurcates into both northward and southward flows in its westward region, so its spawning location and larval transport dynamics seem important for understanding fluctuations in its recruitment to East Asia. Intensive research efforts determined that Japanese eels spawn along the western side of the West Mariana Ridge during new moon periods, where all oceanic life history stages have been collected, including eggs and spawning adults. However, how the eels decide where to form spawning aggregations is unknown because spawning appears to have occurred at various latitudes. A salinity front formed from tropical rainfall was hypothesized to determine the latitude of its spawning locations, but an exact spawning site was only found once by collecting eggs in May 2009. This study reports on the collections of Japanese eel eggs and preleptocephali during three new moon periods in June 2011 and May and June 2012 at locations indicating that the distribution of lower salinity surface water or salinity fronts influence the latitude of spawning sites along the ridge. A distinct salinity front may concentrate spawning south of the front on the western side of the seamount ridge. It was also suggested that eels may spawn at various latitudes within low-salinity water when the salinity fronts appeared unclear. Eel eggs were distributed within the 150-180 m layer near the top of the thermocline, indicating shallow spawning depths. Using these landmarks for latitude (salinity front), longitude (seamount ridge), and depth (top of the thermocline) to guide the formation of spawning aggregations could facilitate finding mates and help synchronize their spawning.	[Aoyama, Jun; Watanabe, Shun; Miller, Michael J.; Otake, Tsuguo; Tsukamoto, Katsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Watanabe, Shun; Tsukamoto, Katsumi] Nihon Univ, Coll Bioresource Sci, Tokyo, Kanagawa, Japan; [Mochioka, Noritaka] Kyushu Univ, Fac Agr, Fukuoka 812, Japan; [Yoshinaga, Tatsuki] Kitasato Univ, Sch Marine Biosci, Tokyo, Kanagawa, Japan	University of Tokyo; Nihon University; Kyushu University; Kitasato University	Aoyama, J (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan.	jaoyama@aori.u-tokyo.ac.jp		Yoshinaga, Tatsuki/0000-0003-3920-0459	Grants-in-Aid for Scientific Research [21228005] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Ahn H, 2012, AQUACULTURE, V330, P100, DOI 10.1016/j.aquaculture.2011.12.020; Als TD, 2011, MOL ECOL, V20, P1333, DOI 10.1111/j.1365-294X.2011.05011.x; [Anonymous], 2003, FISHERIES, V28, P28; Aoyama J, 2012, FISHERIES SCI, V78, P1195, DOI 10.1007/s12562-012-0544-y; Aoyama Jun, 2009, Aqua-Bioscience Monographs, V2, P1; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Bonhommeau S, 2008, FISH OCEANOGR, V17, P32, DOI 10.1111/j.1365-2419.2007.00453.x; Chow S, 2009, FISHERIES SCI, V75, P257, DOI 10.1007/s12562-008-0017-5; Cote CL, 2013, MOL ECOL, V22, P1763, DOI 10.1111/mec.12142; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Dou SZ, 2007, AQUACULTURE, V266, P117, DOI 10.1016/j.aquaculture.2007.02.032; Dufour S, 2009, FISH FISHERIES SERIE, V30; Durif CMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059212; Durif CMF, 2011, P ROY SOC B-BIOL SCI, V278, P464, DOI 10.1098/rspb.2010.1547; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Gardner JV, 2010, GEOL SOC AM BULL, V122, P1378, DOI 10.1130/B30149.1; Han YS, 2010, MAR ECOL PROG SER, V401, P221, DOI 10.3354/meps08422; Ishikawa S, 2001, FISHERIES SCI, V67, P1097, DOI 10.1046/j.1444-2906.2001.00366.x; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Jellyman D, 2010, MAR ECOL PROG SER, V404, P241, DOI 10.3354/meps08468; Kaneko I, 1998, J GEOPHYS RES-OCEANS, V103, P12959, DOI 10.1029/97JC03761; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kim YY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002013; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; Kimura S, 1994, PRELIMINARY REPORT H, P9; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; KLECKNER RC, 1988, J MAR RES, V46, P647, DOI 10.1357/002224088785113469; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kurogi H, 2011, FISHERIES SCI, V77, P199, DOI 10.1007/s12562-010-0318-3; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; McCleave J.D., 1987, P102; McCleave J.D., 1985, Contributions in Marine Science, V27, P316; McCleave JD, 1987, AM FISH SOC S SERIES, V1, P286; Miller MJ, 2009, AM FISH S S, V69, P231; Minegishi Y, 2009, ICES J MAR SCI, V66, P1915, DOI 10.1093/icesjms/fsp158; Mochioka N, 1995, PRELIMINARY REPORT H, P33; Munk P, 2010, P ROY SOC B-BIOL SCI, V277, P3593, DOI 10.1098/rspb.2010.0900; Nishi T, 2005, J FISH BIOL, V67, P1213, DOI 10.1111/j.1095-8649.2005.00817.x; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; REVERDIN G, 1994, J GEOPHYS RES-OCEANS, V99, P20323, DOI 10.1029/94JC01477; ROBINS CR, 1979, B MAR SCI, V29, P401; Schabetsberger R, 2013, MAR ECOL PROG SER, V475, P177, DOI 10.3354/meps10254; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; SCHOTH M, 1982, HELGOLANDER MEERESUN, V35, P309, DOI 10.1007/BF02006139; Shinoda A, 2011, REV FISH BIOL FISHER, V21, P591, DOI 10.1007/s11160-010-9195-1; Tesch F.-W., 2003, EEL BIOL MANAGEMENT; Tsukamoto K, 2003, ENVIRON BIOL FISH, V66, P221, DOI 10.1023/A:1023926705906; Tsukamoto K, 2002, CAN J FISH AQUAT SCI, V59, P1989, DOI 10.1139/F02-165; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2013, FISHERIES SCI, V79, P407, DOI 10.1007/s12562-013-0611-z; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Tsukamoto Katsumi, 2009, P21; Tsukamoto K, 2009, MAR BIOL, V156, P835, DOI 10.1007/s00227-008-1123-8; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; Van Ginneken V, 2005, ANIM BIOL, V55, P203, DOI 10.1163/1570756054472791; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; Watanabe S, 2004, MAR BIOTECHNOL, V6, P566, DOI 10.1007/s10126-004-1000-5; Wirth T, 2003, P ROY SOC B-BIOL SCI, V270, P681, DOI 10.1098/rspb.2002.2301; Yoshinaga T, 2011, FISHERIES SCI, V77, P983, DOI 10.1007/s12562-011-0418-8; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x; Zenimoto K, 2012, PRELIMINARY REPORT H, P10	66	54	55	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88759	10.1371/journal.pone.0088759	http://dx.doi.org/10.1371/journal.pone.0088759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551155	gold, Green Submitted, Green Published			2022-12-25	WOS:000331266000063
J	Tashima, Y; Stanley, P				Tashima, Yuko; Stanley, Pamela			Antibodies That Detect O-Linked beta-D-N-Acetylglucosamine on the Extracellular Domain of Cell Surface Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Flow Cytometry; Mutant; O-GlcNAc; O-GlcNAcylation; CHO; GlcNAc-terminating N-Glycans; Lec1; Lec8	KIDNEY BHK CELLS; MONOCLONAL-ANTIBODIES; NOTCH RECEPTORS; GLCNAC; MUTANTS; FRINGE; NUCLEAR; GLYCOSYLTRANSFERASE; SWAINSONINE; MODULATION	Background: Seven antibodies that detect cytosolic and nuclear O-GlcNAc were examined for recognition of O-GlcNAc on cell surface glycoproteins. Results: Three antibodies recognized cell surface O-GlcNAc and also bound terminal -GlcNAc on N-glycans. Conclusion: With careful controls, cell surface O-GlcNAc can be detected using antibodies CTD110.6, 18B10.C7, and 9D1.E4. Significance: Antibodies to monitor cell surface O-GlcNAcylated proteins were characterized. The transfer of N-acetylglucosamine (GlcNAc) to Ser or Thr in cytoplasmic and nuclear proteins is a well known post-translational modification that is catalyzed by the O-GlcNAc transferase OGT. A more recently identified O-GlcNAc transferase, EOGT, functions in the secretory pathway and transfers O-GlcNAc to proteins with epidermal growth factor-like (EGF) repeats. A number of antibodies that detect O-GlcNAc in cytosolic and nuclear extracts have been described previously. Here we compare seven of these antibodies (CTD110.6, 10D8, RL2, HGAC85, 18B10.C7(#3), 9D1.E4(#10), and 1F5.D6 (#14) for detection of the O-GlcNAc modification on extracellular domains of membrane or secreted glycoproteins that may also carry various N- and O-glycans. We found that CTD110.6 binds not only to O-GlcNAc on proteins but also to terminal -GlcNAc on the complex N-glycans of Lec8 Chinese hamster ovary (CHO) cells that lack UDP-Gal transporter activity and express GlcNAc-terminating, complex N-glycans. We show that CTD110.6, #3, and #10 antibodies can be used to detect cell surface glycoproteins bearing O-GlcNAc. Cell surface glycoproteins recognized by CTD110.6 antibody included NOTCH1 that possesses many EGF repeats with a consensus site for EOGT. Knockdown of CHO Eogt reduced binding of CTD110.6 to Lec1 CHO cells, and expression of a human EOGT cDNA increased the O-GlcNAc signal on Lec1 cells and the extracellular domain of NOTCH1. Thus, with careful controls, antibodies CTD110.6 (IgM), #3 (IgG), and #10 (IgG) can be used to detect membrane and secreted proteins modified by O-GlcNAc on EGF repeats.	[Tashima, Yuko; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA	Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747	National Institutes of Health from the NCI [R01 CA095022]; National Institutes of Health from the NIGMS [R01 GM106417]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA095022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106417] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA095022 from the NCI and R01 GM106417 from the NIGMS (to P. S.).	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; FODDY L, 1986, CARBOHYD RES, V151, P293, DOI 10.1016/S0008-6215(00)90349-5; FODDY L, 1986, BIOCHEM J, V233, P697, DOI 10.1042/bj2330697; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hoffmann BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032762; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sakaidani Y, 2010, METHOD ENZYMOL, V480, P355, DOI 10.1016/S0076-6879(10)80016-3; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; TORRES CR, 1984, J BIOL CHEM, V259, P3308; TURNER JR, 1990, P NATL ACAD SCI USA, V87, P5608, DOI 10.1073/pnas.87.15.5608; Varki A., 2009, ESSENTIALS GLYCOBIOL; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989	32	41	42	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11132	11142		10.1074/jbc.M113.492512	http://dx.doi.org/10.1074/jbc.M113.492512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573683	Green Published, hybrid			2022-12-25	WOS:000334638500017
J	Burgess, RJ; Han, JH; Zhang, ZG				Burgess, Rebecca J.; Han, Junhong; Zhang, Zhiguo			The Ddc1-Mec3-Rad17 Sliding Clamp Regulates HistoneHistone Chaperone Interactions and DNA Replicationcoupled Nucleosome Assembly in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; Chromatin; Chromatin Regulation; DNA Damage Response; DNA Replication; Histone Chaperone; Histones; CAF-1; Rtt106; Nucleosome Assembly	DAMAGE CHECKPOINT; HISTONE-H3 LYSINE-56; FORK PROGRESSION; GENOME; ACETYLATION; RESPONSES; REPAIR; ASF1; RECOGNITION; INHERITANCE	Background: Genome stability is maintained in part by chromatin structure and checkpoint factors. Results: Yeast cells harboring mutations in the Ddc1-Mec3-Rad17 checkpoint complex exhibit synthetic phenotypes with histone chaperone mutants. Conclusion: The Ddc1-Mec3-Rad17 complex regulates nucleosome assembly. Significance: Checkpoint factors and histone chaperones coordinate to maintain genome integrity. The maintenance of genome integrity is regulated in part by chromatin structure and factors involved in the DNA damage response pathway. Nucleosome assembly is a highly regulated process that restores chromatin structure after DNA replication, DNA repair, and gene transcription. During S phase the histone chaperones Asf1, CAF-1, and Rtt106 coordinate to deposit newly synthesized histones H3-H4 onto replicated DNA in budding yeast. Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents. The DNA damage sensitivity of rad17 rtt106 cells depends on the function of Rtt106 in nucleosome assembly. Epistasis analysis reveals that 9-1-1 complex components interact with multiple DNA replication-coupled nucleosome assembly factors, including Rtt106, CAF-1, and lysine residues of H3-H4. Furthermore, rad17 cells exhibit defects in the deposition of newly synthesized H3-H4 onto replicated DNA. Finally, deletion of RAD17 results in increased association of Asf1 with checkpoint kinase Rad53, which may lead to the observed reduction in Asf1-H3 interaction in rad17 mutant cells. In addition, we observed that the interaction between histone H3-H4 with histone chaperone CAF-1 or Rtt106 increases in cells lacking Rad17. These results support the idea that the 9-1-1 checkpoint protein regulates DNA replication-coupled nucleosome assembly in part through regulating histone-histone chaperone interactions.	[Burgess, Rebecca J.; Han, Junhong; Zhang, Zhiguo] Mayo Clin, Coll Med, Ctr Individualized Med, Dept Biochem & Mol Biol,Epigen Translat Program, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu		Han, Junhong/0000-0002-3371-8698	National Institutes of Health [GM72719, GM81838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072719, R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM72719 and GM81838.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Burgess RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002846; Burgess RJ, 2010, PROTEIN CELL, V1, P607, DOI 10.1007/s13238-010-0086-y; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Fazly A, 2012, J BIOL CHEM, V287, P10753, DOI 10.1074/jbc.M112.347450; Fry RC, 2005, ANNU REV MICROBIOL, V59, P357, DOI 10.1146/annurev.micro.59.031805.133658; Gamper AM, 2012, J BIOL CHEM, V287, P12445, DOI 10.1074/jbc.M112.352310; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Guenole A, 2013, MOL CELL, V49, P346, DOI 10.1016/j.molcel.2012.11.023; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Karras GI, 2013, MOL CELL, V49, P536, DOI 10.1016/j.molcel.2012.11.016; Komata M, 2009, MOL CELL BIOL, V29, P5008, DOI 10.1128/MCB.01934-08; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Li Q, 2012, BBA-GENE REGUL MECH, V1819, P238, DOI 10.1016/j.bbagrm.2011.06.013; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rodriguez J, 2013, GENE DEV, V27, P74, DOI 10.1101/gad.202978.112; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sharp JA, 2005, GENETICS, V171, P885, DOI 10.1534/genetics.105.044719; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	2	2	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10518	10529		10.1074/jbc.M114.552463	http://dx.doi.org/10.1074/jbc.M114.552463			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573675	Green Published, hybrid			2022-12-25	WOS:000334226400025
J	Eresheim, C; Leeb, C; Buchegger, P; Nimpf, J				Eresheim, Christine; Leeb, Christian; Buchegger, Patricia; Nimpf, Johannes			Signaling by the Extracellular Matrix Protein Reelin Promotes Granulosa Cell Proliferation in the Chicken Follicle*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Lipoprotein Receptor; Molecular Cell Biology; Phosphotyrosine Signaling; Signal Transduction	DENSITY-LIPOPROTEIN RECEPTOR; LIGAND-BINDING REPEATS; VLDL RECEPTOR; TYROSINE PHOSPHORYLATION; NEURONAL MIGRATION; BRAIN-DEVELOPMENT; DOMINANT; MOUSE; DAB1; EXPRESSION	Background: The control of rapid proliferation of granulosa cells during chicken oocyte growth is unknown. Results: Reelin is expressed in theca cells and triggers disabled-1 phosphorylation in granulosa cells via ApoER2 and the VLDL receptor. Conclusion: The Reelin signaling pathway stimulates granulosa cell proliferation during folliculogenesis. Significance: This work demonstrates a novel function of Reelin. Chicken oocytes develop in follicles and reach an enormous size because of a massive uptake of yolk precursors such as very low density lipoprotein and vitellogenin. Oocyte growth is supported by theca cells and granulosa cells, which establish dynamic and highly organized cell layers surrounding the oocyte. The signaling processes orchestrating the development of these layered structures are largely unknown. Here we demonstrate that the Reelin pathway, which determines the development of layered neuronal structures in the brain, is also active in chicken follicles. Reelin, which is expressed in theca cells, triggers a signal in granulosa cells via apolipoprotein E receptor 2 and the very low density lipoprotein receptor, resulting in the phosphorylation of disabled-1 and consecutive activation of the phosphatidylinositol 3-kinase/Akt pathway. This signaling pathway supports the proliferation of differentiated granulosa cells to keep up with the demand of cells to cover the rapidly increasing surface of the giant germ cell.	[Eresheim, Christine; Leeb, Christian; Buchegger, Patricia; Nimpf, Johannes] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Nimpf, J (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	Johannes.Nimpf@meduniwien.ac.at		Nimpf, Johannes/0000-0002-9273-3492	Austrian Science Fund (FWF) [P 24767-B21]; Austrian Science Fund (FWF) [P 24767] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grant P 24767-B21 (to J. N.).	Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; BUJO H, 1995, J BIOL CHEM, V270, P23546, DOI 10.1074/jbc.270.40.23546; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Fayad T, 2007, BIOL REPROD, V76, P466, DOI 10.1095/biolreprod.106.057216; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Gao ZH, 2010, MOL CELL BIOL, V30, P4339, DOI 10.1128/MCB.00545-10; Hermann M, 1998, FASEB J, V12, P897, DOI 10.1096/fasebj.12.10.897; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; Hummel S, 2007, J BIOL CHEM, V282, P8011, DOI 10.1074/jbc.M606029200; JOHNSON A L, 1990, Critical Reviews in Poultry Biology, V2, P319; Jossin Yves, 2011, Small GTPases, V2, P322; Katyal S, 2004, EMBO J, V23, P1878, DOI 10.1038/sj.emboj.7600185; Kim D, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.109694; Kisliouk T, 2013, NEUROSCIENCE, V238, P114, DOI 10.1016/j.neuroscience.2013.02.020; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Nimpf J, 1998, ATHEROSCLEROSIS, V141, P191, DOI 10.1016/S0021-9150(98)00172-5; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; PERRY MM, 1978, J ANAT, V125, P481; Recheis B, 2000, J BIOL CHEM, V275, P35320, DOI 10.1074/jbc.M005025200; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Schmierer B, 2003, BIOL REPROD, V68, P620, DOI 10.1095/biolreprod.102.008714; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Schuster MK, 2004, BIOL REPROD, V70, P1493, DOI 10.1095/biolreprod.103.024331; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sisco B, 2003, ENDOCRINOLOGY, V144, P3904, DOI 10.1210/en.2003-0485; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Willnow TE, 1998, BIOL CHEM, V379, P1025	40	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10182	10191		10.1074/jbc.M113.533489	http://dx.doi.org/10.1074/jbc.M113.533489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24573679	Green Published, hybrid			2022-12-25	WOS:000333807000063
J	Joe, MK; Kwon, HS; Cojocaru, R; Tomarev, SI				Joe, Myung Kuk; Kwon, Heung Sun; Cojocaru, Radu; Tomarev, Stanislav I.			Myocilin Regulates Cell Proliferation and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Growth; Cell Proliferation; Cell Signaling; ERK; Mesenchymal Stem Cells	OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; PROTEIN COMPLEX; GASTRIC-CANCER; KINASE KINASE; NON-SECRETION; TUMOR-GROWTH; ER STRESS	Background: The physiological function(s) of myocilin, a glaucoma-associated protein, is poorly understood. Results: Myocilin enhances cell proliferation and survival together with the activation of the ERK signaling pathway. Myocilin-deficient mesenchymal stem cells demonstrate reduced proliferation and survival. Conclusion: Myocilin participates in the regulation of cell growth and survival. Significance: This study provides new insight into the role of myocilin in ocular and non-ocular tissues. Myocilin, a causative gene for open angle glaucoma, encodes a secreted glycoprotein with poorly understood functions. To gain insight into its functions, we produced a stably transfected HEK293 cell line expressing myocilin under an inducible promoter and compared gene expression profiles between myocilin-expressing and vector control cell lines by a microarray analysis. A significant fraction of differentially expressed genes in myocilin-expressing cells was associated with cell growth and cell death, suggesting that myocilin may have a role in the regulation of cell growth and survival. Increased proliferation of myocilin-expressing cells was demonstrated by the WST-1 proliferation assay, direct cell counting, and immunostaining with antibodies against Ki-67, a cellular proliferation marker. Myocilin-containing conditioned medium also increased proliferation of unmodified HEK293 cells. Myocilin-expressing cells were more resistant to serum starvation-induced apoptosis than control cells. TUNEL-positive apoptotic cells were dramatically decreased, and two apoptotic marker proteins, cleaved caspase 7 and cleaved poly(ADP-ribose) polymerase, were significantly reduced in myocilin-expressing cells as compared with control cells under apoptotic conditions. In addition, myocilin-deficient mesenchymal stem cells exhibited reduced proliferation and enhanced susceptibility to serum starvation-induced apoptosis as compared with wild-type mesenchymal stem cells. Phosphorylation of ERK1/2 and its upstream kinases, c-Raf and MEK, was increased in myocilin-expressing cells compared with control cells. Elevated phosphorylation of ERK1/2 was also observed in the trabecular meshwork of transgenic mice expressing 6-fold higher levels of myocilin when compared with their wild-type littermates. These results suggest that myocilin promotes cell proliferation and resistance to apoptosis via the ERK1/2 MAPK signaling pathway.	[Tomarev, Stanislav I.] NEI, SRGCB, LRCMB, NIH, Bethesda, MD 20892 USA; [Cojocaru, Radu] Elsevier Life Sci Solut, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Reed Elsevier; Elsevier	Tomarev, SI (corresponding author), NEI, SRGCB, LRCMB, NIH, Bldg 6,Rm 212,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov			National Institutes of Health, NEI, Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000318] Funding Source: NIH RePORTER	National Institutes of Health, NEI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, NEI, Intramural Research Program.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; GERDES J, 1984, J IMMUNOL, V133, P1710; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Johnson TV, 2014, BRAIN, V137, P503, DOI 10.1093/brain/awt292; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim KK, 2010, MOL CARCINOGEN, V49, P259, DOI 10.1002/mc.20596; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Koshida S, 2007, CANCER SCI, V98, P315, DOI 10.1111/j.1349-7006.2006.00383.x; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kurata H, 2000, EXP CELL RES, V254, P180, DOI 10.1006/excr.1999.4738; Kwon HS, 2013, J BIOL CHEM, V288, P26357, DOI 10.1074/jbc.M112.446138; Kwon HS, 2011, J CELL PHYSIOL, V226, P3392, DOI 10.1002/jcp.22701; Kwon HS, 2013, J BIOL CHEM, V288, P16882, DOI 10.1074/jbc.M112.422972; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; LUTJENDRECOLL E, 1981, INVEST OPHTH VIS SCI, V21, P563; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Marimuthu A, 2013, BBA-PROTEINS PROTEOM, V1834, P2308, DOI 10.1016/j.bbapap.2013.04.029; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Miljkovic-Licina M, 2012, MOL CANCER THER, V11, P2588, DOI 10.1158/1535-7163.MCT-12-0245; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shearer T, 2001, EXP EYE RES, V73, P25, DOI 10.1006/exer.2001.1007; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Starborg M, 1996, J CELL SCI, V109, P143; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sudbeck BD, 1999, BIOCHEM J, V339, P167, DOI 10.1042/0264-6021:3390167; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	76	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10155	10167		10.1074/jbc.M113.547091	http://dx.doi.org/10.1074/jbc.M113.547091			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563482	hybrid, Green Published			2022-12-25	WOS:000333807000061
J	Shih, PM; Zarzycki, J; Niyogi, KK; Kerfeld, CA				Shih, Patrick M.; Zarzycki, Jan; Niyogi, Krishna K.; Kerfeld, Cheryl A.			Introduction of a Synthetic CO2fixing Photorespiratory Bypass into a Cyanobacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Cyanobacteria; Metabolic Engineering; Photosynthesis; Rubisco; Synthetic Biology; 3-Hydroxypropionate Bi-cycle; Chloroflexus; Synechococcus	CHLOROFLEXUS-AURANTIACUS; 3-HYDROXYPROPIONATE CYCLE; KEY ENZYME; PHOTOSYNTHESIS; METABOLISM; OPTIMALITY; PATHWAYS; COLI	Background: Photorespiration limits carbon fixation. Results: Heterologous expression and functional activity of six enzymes from the 3-hydroxypropionate bi-cycle are demonstrated in cyanobacteria. Conclusion: A synthetic CO2-fixing photorespiratory bypass can be introduced into cyanobacteria. Significance: The results lay the foundation for expressing an alternative CO2 fixation pathway in cyanobacteria, algae, and plants. Global photosynthetic productivity is limited by the enzymatic assimilation of CO2 into organic carbon compounds. Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), the carboxylating enzyme of the Calvin-Benson cycle, poorly discriminates between CO2 and O-2, leading to photorespiration and the loss of fixed carbon and nitrogen. With the advent of synthetic biology, it is now feasible to design, synthesize, and introduce biochemical pathways in vivo. We engineered a synthetic photorespiratory bypass based on the 3-hydroxypropionate bi-cycle into the model cyanobacterium, Synechococcus elongatus sp. PCC 7942. The heterologously expressed cycle is designed to function as both a photorespiratory bypass and an additional CO2-fixing pathway, supplementing the Calvin-Benson cycle. We demonstrate the function of all six introduced enzymes and identify bottlenecks to be targeted in subsequent bioengineering. These results have implications for efforts to improve photosynthesis and for the green production of high value products of biotechnological interest.	[Shih, Patrick M.; Niyogi, Krishna K.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Shih, Patrick M.; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA; [Zarzycki, Jan; Kerfeld, Cheryl A.] Michigan State Univ, Dept Energy Plant, Res Labs, Dept Biochem & Mol Biol, E Lansing, MI USA; [Zarzycki, Jan; Niyogi, Krishna K.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Michigan State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Niyogi, KK (corresponding author), Univ Calif Berkeley, 111 Koshland Hall, Berkeley, CA 94720 USA.	niyogi@berkeley.edu; ckerfeld@lbl.gov		Zarzycki, Jan/0000-0002-6307-6497	National Science Foundation [MCB0851054]; Gordon and Betty Moore Foundation [GBMF3070]; United States Department of Energy [DE-AC02 05CH11231]	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); United States Department of Energy(United States Department of Energy (DOE))	Supported by National Science Foundation Grant MCB0851054 (to C. A. K.) and by Gordon and Betty Moore Foundation Grant GBMF3070 (to K. K. N.).; Supported by United States Department of Energy Contract DE-AC02 05CH11231.	Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Ducat DC, 2011, P NATL ACAD SCI USA, V108, P3941, DOI 10.1073/pnas.1016026108; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Hesselmann RPX, 1999, SYST APPL MICROBIOL, V22, P454, DOI 10.1016/S0723-2020(99)80055-1; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hu Z.-H., 2010, ENV ANAEROBIC TECHNO, P259; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kebeish R, 2007, NAT BIOTECHNOL, V25, P593, DOI 10.1038/nbt1299; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Lipscomb T. W., 2012, ENG COMPLEX PHENOTYP, P185, DOI [10.1002/9781118433034.ch7, DOI 10.1002/9781118433034.CH7]; Mackey Shannon R, 2007, Methods Mol Biol, V362, P115; Maier A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00038; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mattozzi MD, 2013, METAB ENG, V16, P130, DOI 10.1016/j.ymben.2013.01.005; Niederholtmeyer H, 2010, APPL ENVIRON MICROB, V76, P3462, DOI 10.1128/AEM.00202-10; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Pellicer MT, 1996, J BACTERIOL, V178, P2051, DOI 10.1128/jb.178.7.2051-2059.1996; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; SHARKEY TD, 1988, PHYSIOL PLANTARUM, V73, P147, DOI 10.1111/j.1399-3054.1988.tb09205.x; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Zarzycki J, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-28; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294; Zarzycki J, 2011, APPL ENVIRON MICROB, V77, P6181, DOI 10.1128/AEM.00705-11; Zarzycki J, 2009, P NATL ACAD SCI USA, V106, P21317, DOI 10.1073/pnas.0908356106	32	62	66	3	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9493	9500		10.1074/jbc.C113.543132	http://dx.doi.org/10.1074/jbc.C113.543132			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558040	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000333807000006
J	Faure, L; Nagarajan, S; Hwang, H; Montgomery, CL; Khan, BR; John, G; Koulen, P; Blancaflor, EB; Chapman, KD				Faure, Lionel; Nagarajan, Subbiah; Hwang, Hyeondo; Montgomery, Christa L.; Khan, Bibi Rafeiza; John, George; Koulen, Peter; Blancaflor, Elison B.; Chapman, Kent D.			Synthesis of Phenoxyacyl-Ethanolamides and Their Effects on Fatty Acid Amide Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Enzyme Kinetics; Lipids; Plant; Signaling; N-Acylethanolamines; Fatty Acid Amide Hydrolase; Synthetic Compounds	N-ACYLETHANOLAMINE; ANANDAMIDE; METABOLISM; OVEREXPRESSION; IDENTIFICATION; CONSTITUENT; HYDROLYSIS; INHIBITOR; PATHWAY; ANALOGS	Background: Fatty acid amide hydrolase (FAAH) belongs to the family of amidase signature proteins and is involved in N-acylethanolamine (NAE) metabolism. Results: New synthetic phenoxyacyl-ethanolamide compounds increased the amidohydrolase activity of FAAH. Conclusion: Phenoxyacyl-ethanolamide compounds increased the activity of the FAAH enzyme in plants and animals. Significance: New properties of FAAH proteins were revealed with these phenoxyacyl-ethanolamide compounds, and the potential for their applications in vivo was demonstrated. N-Acylethanolamines (NAEs) are involved in numerous biological activities in plant and animal systems. The metabolism of these lipids by fatty acid amide hydrolase (FAAH) is a key regulatory point in NAE signaling activity. Several active site-directed inhibitors of FAAH have been identified, but few compounds have been described that enhance FAAH activity. Here we synthesized two sets of phenoxyacyl-ethanolamides from natural products, 3-n-pentadecylphenolethanolamide and cardanolethanolamide, with structural similarity to NAEs and characterized their effects on the hydrolytic activity of FAAH. Both compounds increased the apparent V-max of recombinant FAAH proteins from both plant (Arabidopsis) and mammalian (Rattus) sources. These NAE-like compounds appeared to act by reducing the negative feedback regulation of FAAH activity by free ethanolamine. Both compounds added to seedlings relieved, in part, the negative growth effects of exogenous NAE12:0. Cardanolethanolamide reduced neuronal viability and exacerbated oxidative stress-mediated cell death in primary cultured neurons at nanomolar concentrations. This was reversed by FAAH inhibitors or exogenous NAE substrate. Collectively, our data suggest that these phenoxyacyl-ethanolamides act to enhance the activity of FAAH and may stimulate the turnover of NAEs in vivo. Hence, these compounds might be useful pharmacological tools for manipulating FAAH-mediated regulation of NAE signaling in plants or animals.	[Faure, Lionel; Koulen, Peter; Blancaflor, Elison B.; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Nagarajan, Subbiah; Hwang, Hyeondo; John, George] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Montgomery, Christa L.; Koulen, Peter] Univ Missouri, Vis Res Ctr, Dept Ophthalmol, Sch Med, Kansas City, MO 64108 USA; [Koulen, Peter] Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA; [Khan, Bibi Rafeiza; Blancaflor, Elison B.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	University of North Texas System; University of North Texas Denton; City University of New York (CUNY) System; City College of New York (CUNY); University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Noble Research Institute	Chapman, KD (corresponding author), Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, 1155 Union Circle,305220, Denton, TX 76203 USA.	chapman@unt.edu		Chapman, Kent/0000-0003-0489-3072; Faure, Lionel/0000-0002-7022-3934; Blancaflor, Elison/0000-0001-6115-9670; Subbiah, Nagarajan/0000-0003-2233-4872; Khan, Bibi/0000-0002-7661-0142	National Institutes of Health (NIH), NEI [EY022774]; NIH, NIA [AG010485, AG022550, AG027956]; NIH NCRR; NIH, NIGMS [RR027093]; United States Department of Energy, Office of Science, Division of Basic Energy Sciences [DE-FG02-05ER15647]; Research to Prevent Blindness; Felix and Carmen Sabates Missouri Endowed Chair in Vision Research; Vision Research Foundation of Kansas City; National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (Rapid) [1046099]; Gulf of Mexico Research Initiative (GoMRI) [SA 12-05/GoMRI-002, TUL-626-11/12]; Professional Staff Congress-City University of New York (PSC-CUNY) awards; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027093] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022550, P01AG027956, P01AG010485] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Division of Basic Energy Sciences(United States Department of Energy (DOE)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Felix and Carmen Sabates Missouri Endowed Chair in Vision Research; Vision Research Foundation of Kansas City; National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (Rapid); Gulf of Mexico Research Initiative (GoMRI); Professional Staff Congress-City University of New York (PSC-CUNY) awards; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grant EY022774; NIH, NIA, Grants AG010485, AG022550, and AG027956; the NIH NCRR; and NIH, NIGMS, Grant RR027093 (to P. K.). This work was also supported by the United States Department of Energy, Office of Science, Division of Basic Energy Sciences, Grant DE-FG02-05ER15647 (to K. D. C. and E. B. B.).; Supported by a Challenge Grant from Research to Prevent Blindness, the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research, and the Vision Research Foundation of Kansas City.; Supported in part by National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (Rapid) Grant 1046099, Gulf of Mexico Research Initiative (GoMRI) Grant SA 12-05/GoMRI-002 (subcontract TUL-626-11/12), and Professional Staff Congress-City University of New York (PSC-CUNY) awards.	Balachandran VS, 2010, ANGEW CHEM INT EDIT, V49, P9509, DOI 10.1002/anie.201002260; Balachandran VS, 2013, CHEM SOC REV, V42, P427, DOI 10.1039/c2cs35344j; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cota D, 2003, J ENDOCRINOL INVEST, V26, P1041, DOI 10.1007/BF03348205; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Cotter MQ, 2011, PLANT SIGNAL BEHAV, V6, P671, DOI 10.4161/psb.6.5.14704; Coulon D, 2012, PLANT SCI, V184, P129, DOI 10.1016/j.plantsci.2011.12.015; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Duncan RS, 2011, CLIN OPHTHALMOL, V5, P543, DOI 10.2147/OPTH.S18309; Duncan RS, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-50; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Garg P, 2011, NEUROSCI LETT, V492, P134, DOI 10.1016/j.neulet.2011.01.073; HILLARD CJ, 1995, BBA-LIPID LIPID MET, V1257, P249, DOI 10.1016/0005-2760(95)00087-S; Jonsson KO, 2001, BRIT J PHARMACOL, V133, P1263, DOI 10.1038/sj.bjp.0704199; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Katayama K, 1999, BBA-MOL CELL BIOL L, V1440, P205, DOI 10.1016/S1388-1981(99)00124-9; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim SC, 2009, J BIOL CHEM, V284, P34065, DOI 10.1074/jbc.M109.059022; Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o; Lang WS, 1999, J MED CHEM, V42, P1682, DOI 10.1021/jm990139o; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Patricelli MP, 1998, BIOORG MED CHEM LETT, V8, P613, DOI 10.1016/S0960-894X(98)00073-0; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Shrestha R, 2006, BBA-MOL CELL BIOL L, V1761, P324, DOI 10.1016/j.bbalip.2006.03.004; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; Teaster ND, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00032; Tripathy S, 1999, PLANT PHYSIOL, V121, P1299, DOI 10.1104/pp.121.4.1299; Trox J, 2010, J AGR FOOD CHEM, V58, P5341, DOI 10.1021/jf904580k; Vandevoorde S, 2005, BIOCHEM BIOPH RES CO, V337, P104, DOI 10.1016/j.bbrc.2005.09.015; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200	45	14	14	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9340	9351		10.1074/jbc.M113.533315	http://dx.doi.org/10.1074/jbc.M113.533315			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24558037	Green Published, hybrid			2022-12-25	WOS:000333472100050
J	Chen, KH; Chen, LR; Wang, YK				Chen, Kuo-Hu; Chen, Li-Ru; Wang, Ying-Kuan			Contamination of Medical Charts: An Important Source of Potential Infection in Hospitals	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; HAND HYGIENE; BACTERIAL-CONTAMINATION; PATHOGENS	Objective: This prospective study aims to identify and compare the incidence of bacterial contamination of hospital charts and the distribution of species responsible for chart contamination in different units of a tertiary hospital. Methods: All beds in medical, surgical, pediatric, and obstetric-gynecologic general wards (556) and those in corresponding special units (125) including medical, surgical, pediatric intensive care units (ICUs), the obstetric tocolytic unit and delivery room were surveyed for possible chart contamination. The outer surfaces of included charts were sampled by one experienced investigator with sterile cotton swabs rinsed with normal saline. Results: For general wards and special units, the overall sampling rates were 81.8% (455/556) and 85.6% (107/125) (p = 0.316); the incidence of chart contamination was 63.5% and 83.2%, respectively (p<0.001). Except for obstetric-gynecologic charts, the incidence was significantly higher in each and in all ICUs than in corresponding wards. Coagulase-negative staphylococci was the most common contaminant in general wards (40.0%) and special units (34.6%) (p>0.05). Special units had a significantly higher incidence of bacterial contamination due to Staphylococcus aureus (17.8%), Methicillin-resistant Staphylococcus aureus (9.3%), Streptococcus viridans (9.4%), Escherichia coli (11.2%), Klebsiella pneumoniae (7.5%), and Acinetobacter baumannii (7.5%). Logistic regression analysis revealed the incidence of chart contamination was 2- to 4-fold higher in special units than in general wards [odds ratios: 1.97-4.00]. Conclusions: Noting that most hospital charts are contaminated, our study confirms that a hospital chart is not only a medical record but also an important source of potential infection. The plastic cover of the medical chart can harbor potential pathogens, thus acting as a vector of bacteria. Additionally, chart contamination is more common in ICUs. These findings highlight the importance of effective hand-washing before and after handling medical charts. However, managers and clinical staff should pay more attention to the issue and may consider some interventions.	[Chen, Kuo-Hu] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Kuo-Hu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Li-Ru] Mackay Mem Hosp, Taipei, Taiwan; [Chen, Li-Ru] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan; [Wang, Ying-Kuan] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Nursing, Taipei, Taiwan	Tzu Chi University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Chen, KH (corresponding author), Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	alexgfctw@yahoo.com.tw			Buddhist Tzu-Chi General Hospital, Taipei Branch, Taiwan [TCRD-TPE-99-20]	Buddhist Tzu-Chi General Hospital, Taipei Branch, Taiwan	This research was supported by a grant from Buddhist Tzu-Chi General Hospital, Taipei Branch, Taiwan (TCRD-TPE-99-20); (http://www.tzuchi.com.tw/tzuchi_en/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Alothman A, 2003, J HOSP INFECT, V55, P304, DOI 10.1016/j.jhin.2003.08.003; Aragon D, 2005, AACN ADV CRIT CARE, V16, P121, DOI 10.1097/00044067-200504000-00002; Bebbington A, 2003, J HOSP INFECT, V55, P299, DOI 10.1016/j.jhin.2003.08.016; Brady RR, 2011, CLIN MICROBIOL INFEC, V17, P830, DOI 10.1111/j.1469-0691.2011.03493.x; Bures S, 2000, AM J INFECT CONTROL, V28, P465, DOI 10.1067/mic.2000.107267; Cohen SR, 2003, J HOSP INFECT, V55, P236, DOI 10.1016/S0195-6701(03)00297-4; Dancer SJ, 2004, J HOSP INFECT, V56, P10, DOI 10.1016/j.jhin.2003.09.017; Ducel G., 2002, WHOCDSCSREPH200212; Garcia-Vazquez E, 2011, CLIN MICROBIOL INFEC, V17, P894, DOI 10.1111/j.1469-0691.2010.03391.x; Halton K, 2011, CLIN MICROBIOL INFEC, V17, P868, DOI 10.1111/j.1469-0691.2011.03494.x; Hamza N, 2007, ANN ROY COLL SURG, V89, P665, DOI 10.1308/003588407X205341; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Jeans AR, 2010, J HOSP INFECT, V74, P16, DOI 10.1016/j.jhin.2009.06.032; Loh W, 2000, J HOSP INFECT, V45, P65, DOI 10.1053/jhin.1999.0702; Marinella MA, 2000, INFECT DIS CLIN PRAC, V9, P39, DOI 10.1097/00019048-200009010-00011; Panhotra BR, 2005, AM J INFECT CONTROL, V33, P398, DOI 10.1016/j.ajic.2004.12.009; Panhotra BR, 2016, BRIT J INFECT CONTRO, V5, P15, DOI [10.1177/14690446040050030401, DOI 10.1177/14690446040050030401]; Pittet D, 2011, J HOSP INFECT, V77, P299, DOI 10.1016/j.jhin.2010.10.013; Pittet D, 2001, LANCET, P9; Randle J, 2010, J HOSP INFECT, V76, P252, DOI 10.1016/j.jhin.2010.06.027; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; Scheithauer S, 2009, AM J INFECT CONTROL, V37, P835, DOI 10.1016/j.ajic.2009.06.005; Slekovec C, 2011, J HOSP INFECT, V78, P133, DOI 10.1016/j.jhin.2011.03.011; Tacconelli E, 2011, CLIN MICROBIOL INFEC, V17, P794, DOI 10.1111/j.1469-0691.2011.03499.x; Tekerekoglu MS, 2011, AM J INFECT CONTROL, V39, P379, DOI 10.1016/j.ajic.2010.10.026; Teng SO, 2009, J MICROBIOL IMMUNOL, V42, P86; World Health Organization, 2009, WHO GUID HAND HYG HL; Zimbudzi E, 2011, AUSTRALAS MED J, V4, P538, DOI 10.4066/AMJ.2011.726	29	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e78512	10.1371/journal.pone.0078512	http://dx.doi.org/10.1371/journal.pone.0078512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558355	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700001
J	Kim, GS; Cho, S; Nelson, JW; Zipfel, GJ; Han, BH				Kim, Gab Seok; Cho, Seongeun; Nelson, James W.; Zipfel, Gregory J.; Han, Byung Hee			TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; BRAIN-INJURY; AFFORDS NEUROPROTECTION; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; DOWN-REGULATION; BDNF PROTECTS; GRANULE CELLS; INFARCT SIZE	Perinatal hypoxic ischemia (H-I) causes brain damage and long-term neurological impairments, leading to motor dysfunctions and cerebral palsy. Many studies have demonstrated that the TrkB-ERK1/2 signaling pathway plays a key role in mediating the protective effect of brain-derived neurotrophic factor (BDNF) following perinatal H-I brain injury in experimental animals. In the present study, we explored the neuroprotective effects of the TrkB-specific agonist monoclonal antibody 29D7 on H-I brain injury in neonatal rats. First, we found that intracerebroventricular (icv) administration of 29D7 in normal P7 rats markedly increased the levels of phosphorylated ERK1/2 and phosphorylated AKT in neurons up to 24 h. Second, P7 rats received icv administration of 29D7 and subjected to H-I injury induced by unilateral carotid artery ligation and exposure to hypoxia (8% oxygen). We found that 29D7, to a similar extent to BDNF, significantly inhibited activation of caspase-3, a biochemical hallmark of apoptosis, following H-I injury. Third, we found that this 29D7-mediated neuroprotective action persisted at least up to 5 weeks post-H-I injury as assessed by brain tissue loss, implicating long-term neurotrophic effects rather than an acute delay of cell death. Moreover, the long-term neuroprotective effect of 29D7 was tightly correlated with sensorimotor functional recovery as assessed by a tape-removal test, while 29D7 did not significantly improve rotarod performance. Taken together, these findings demonstrate that pretreatment with the TrkB-selective agonist 29D7 significantly increases neuronal survival and behavioral recovery following neonatal hypoxicischemic brain injury.	[Kim, Gab Seok; Han, Byung Hee] Seoul Natl Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Cho, Seongeun] Wyeth Neurosci Discovery Res, Princeton, NJ USA; [Nelson, James W.; Zipfel, Gregory J.; Han, Byung Hee] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO USA; [Nelson, James W.; Zipfel, Gregory J.; Han, Byung Hee] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Zipfel, Gregory J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Seoul National University (SNU); Pfizer; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Han, BH (corresponding author), Seoul Natl Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea.	hanh@wudosis.wustl.edu			Brain Research Center of the 21st Century Frontier Research Program grant; Ministry of Science and Technology; Republic of Korea; Department of Neurological Surgery, Washington University in St. Louis, Missouri, United States of America	Brain Research Center of the 21st Century Frontier Research Program grant; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Republic of Korea; Department of Neurological Surgery, Washington University in St. Louis, Missouri, United States of America	This research was supported in part by the Brain Research Center of the 21st Century Frontier Research Program grant funded by the Ministry of Science and Technology, the Republic of Korea, and by the Department of Neurological Surgery, Washington University in St. Louis, Missouri, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsmeier M, 2007, RESUSCITATION, V74, P552, DOI 10.1016/j.resuscitation.2007.01.040; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Andsberg G, 2002, NEUROBIOL DIS, V9, P187, DOI 10.1006/nbdi.2001.0456; Balaratnasingam S, 2012, PHARMACOL THERAPEUT, V134, P116, DOI 10.1016/j.pharmthera.2012.01.006; Barnea A, 2004, BRAIN RES, V1020, P106, DOI 10.1016/j.brainres.2004.06.018; Beck M, 2005, AMYOTROPH LATERAL SC, V6, P100, DOI 10.1080/14660820510028412; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Cho S, 2003, BRAIN RES, V982, P146, DOI 10.1016/S0006-8993(03)02846-4; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Edwards AD, 1995, BIOCHEM BIOPH RES CO, V217, P1193, DOI 10.1006/bbrc.1995.2895; Ezquer ME, 2006, EXP NEUROL, V197, P391, DOI 10.1016/j.expneurol.2005.10.015; Fouad K, 2010, J NEUROTRAUMA; Gill MB, 2008, J NEUROSCI RES, V86, P3584, DOI 10.1002/jnr.21795; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Han BH, 2000, NEUROBIOL DIS, V7, P38; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Han BH, 2002, J BIOL CHEM, V277, P30128, DOI 10.1074/jbc.M202931200; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Han BH, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-86; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; La Torre A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.99; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; LEVINE S, 1960, AM J PATHOL, V36, P1; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; MacLellan CL, 2006, STROKE, V37, P1266, DOI 10.1161/01.STR.0000217268.81963.78; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Nurse S, 1996, J CEREBR BLOOD F MET, V16, P474, DOI 10.1097/00004647-199605000-00014; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; ORTIZ J, 1995, J NEUROSCI, V15, P1285; Park HY, 2012, ONCOL REP, V28, P353, DOI 10.3892/or.2012.1773; Paxinos G, 2005, RAT BRAIN STEROTAXIC, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Qian MD, 2006, J NEUROSCI, V26, P9394, DOI 10.1523/JNEUROSCI.1118-06.2006; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rosenblum K, 2002, J NEUROSCI, V22, P5432; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shin DH, 2006, J NEUROCHEM, V96, P561, DOI 10.1111/j.1471-4159.2005.03582.x; Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023; Suzuki K, 1997, MOL CHEM NEUROPATHOL, V30, P101, DOI 10.1007/BF02815153; Tang XN, 2010, AGEING RES REV, V9, P61, DOI 10.1016/j.arr.2009.10.002; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Tomimatsu T, 2001, NEUROSCI LETT, V312, P21, DOI 10.1016/S0304-3940(01)02178-4; Uluc K, 2013, CNS NEUROL DISORD-DR, V12, P360, DOI 10.2174/18715273113129990061; Yager JY, 2006, BEHAV BRAIN RES, V173, P171, DOI 10.1016/j.bbr.2006.06.019; Zhang Y, 2001, STROKE, V32, P1378, DOI 10.1161/01.STR.32.6.1378; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	69	19	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88962	10.1371/journal.pone.0088962	http://dx.doi.org/10.1371/journal.pone.0088962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551199	Green Submitted, Green Published, gold			2022-12-25	WOS:000331271500086
J	Echeverry-Galvis, MA; Peterson, JK; Sulo-Caceres, R				Angela Echeverry-Galvis, Maria; Peterson, Jennifer K.; Sulo-Caceres, Rajmonda			The Social Nestwork: Tree Structure Determines Nest Placement in Kenyan Weaverbird Colonies	PLOS ONE			English	Article							INFORMATION-CENTERS; SITE SELECTION; RANDOM FORESTS; EVOLUTION; BEHAVIOR; MICROCLIMATE; AGGREGATION; POPULATION; REPULSION; DYNAMICS	Group living is a life history strategy employed by many organisms. This strategy is often difficult to study because the exact boundaries of a group can be unclear. Weaverbirds present an ideal model for the study of group living, because their colonies occupy a space with discrete boundaries: a single tree. We examined one aspect of group living. nest placement, in three Kenyan weaverbird species: the Black-capped Weaver (Pseudonigrita cabanisi), Grey-capped Weaver (P. arnaudi) and White-browed Sparrow Weaver (Ploceropasser mahali). We asked which environmental, biological, and/or abiotic factors influenced their nest arrangement and location in a given tree. We used machine learning to analyze measurements taken from 16 trees and 516 nests outside the breeding season at the Mpala Research Station in Laikipia Kenya, along with climate data for the area. We found that tree architecture, number of nests per tree, and nest-specific characteristics were the main variables driving nest placement. Our results suggest that different Kenyan weaverbird species have similar priorities driving the selection of where a nest is placed within a given tree. Our work illustrates the advantage of using machine learning techniques to investigate biological questions.	[Angela Echeverry-Galvis, Maria; Peterson, Jennifer K.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Sulo-Caceres, Rajmonda] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA; [Angela Echeverry-Galvis, Maria] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia	Princeton University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pontificia Universidad Javeriana	Echeverry-Galvis, MA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	mayayito@gmail.com	Peterson, Jennifer K/ABC-6548-2020	Peterson, Jennifer K/0000-0002-0274-6143; Echeverry-Galvis, Maria Angela/0000-0002-5273-8694	Department of Ecology and Evolutionary Biology of Princeton University; Bert Kerstetter; Bill Unger; UIC College of Engineering; Department of Computer Science at UIC; UIC Women in Science and Engineering; National Science Foundation [IIS0705822]; NSF [III-CXT-0705311, IIS-0747369]	Department of Ecology and Evolutionary Biology of Princeton University; Bert Kerstetter; Bill Unger; UIC College of Engineering; Department of Computer Science at UIC; UIC Women in Science and Engineering; National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	Funding was provided by the Department of Ecology and Evolutionary Biology of Princeton University, Bert Kerstetter, Bill Unger, UIC College of Engineering, Department of Computer Science at UIC, UIC Women in Science and Engineering, National Science Foundation IIS0705822 (T. Berger-Wolf), NSF III-CXT-0705311 D.I. Rubenstein), Collaborative Research: Computational Methods for Understanding Social Interactions in Animal Populations (Berger-Wolf and Rubenstein) and NSF IIS-0747369, CAREER: Computational Tools for Population Biology (Berger-Wolf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Asokan S, 2008, J ENVIRON BIOL, V29, P393; Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Bijleveld AI, 2010, OIKOS, V119, P277, DOI 10.1111/j.1600-0706.2009.17892.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURGER J, 1985, CONDOR, V87, P364, DOI 10.2307/1367217; Chen Z, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002956; Collias N. E., 1964, University of California Publications in Zoology, V73, P1; COLLIAS NE, 1964, AM ZOOL, V4, P175; COLLIAS NE, 1977, AUK, V94, P50; COLLIAS NE, 1978, AUK, V95, P472; COLLIAS NE, 1980, AUK, V97, P213; Cordoba-Cordoba Sergio, 2010, Marine Ornithology, V38, P79; Couzin ID, 2003, SELF ORG COLLECTIVE; Craig A, 2004, BIRDS AFRICA, VVII; Crook J. H., 1956, British Journal of Animal Behaviour, V4, P76, DOI 10.1016/S0950-5601(56)80028-2; CROOK JOHN HURRELL, 1963, IBIS, V105, P238, DOI 10.1111/j.1474-919X.1963.tb02498.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DARLINGTON PJ, 1972, P NATL ACAD SCI USA, V69, P3151, DOI 10.1073/pnas.69.11.3151; Dray S., 2007, R NEWS, V7, P47; FERGUSON JWH, 1989, CONDOR, V91, P100, DOI 10.2307/1368152; Ferguson JWH, 2002, J COMP PHYSIOL B, V172, P137, DOI 10.1007/s00360-001-0236-x; Fry CH, 2004, BIRDS AFRICA; Giesselmann UC, 2008, AUSTRAL ECOL, V33, P607, DOI 10.1111/j.1442-9993.2007.01826.x; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; Hamer Keith C., 2002, P217; Hartman CA, 2003, CONDOR, V105, P158, DOI 10.1650/0010-5422(2003)105[158:OAMOHL]2.0.CO;2; Hatcher L., 1994, STEP BY STEP APPROAC; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; HOOGLAND JL, 1976, ECOL MONOGR, V46, P33, DOI 10.2307/1942393; HORN H S, 1970, Condor, V72, P15, DOI 10.2307/1366470; HORN H S, 1971, P144; HORN HS, 1968, ECOLOGY, V49, P682, DOI 10.2307/1935532; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jovani R, 2007, P ROY SOC B-BIOL SCI, V274, P2465, DOI 10.1098/rspb.2007.0527; Jovani R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001992; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Krause DJ, 2002, LIVING GROUPS; LEWIS DM, 1982, CONDOR, V84, P306, DOI 10.2307/1367373; Newell FL, 2011, FOREST ECOL MANAG, V262, P739, DOI 10.1016/j.foreco.2011.05.006; Oliveira S, 2012, FOREST ECOL MANAG, V275, P117, DOI 10.1016/j.foreco.2012.03.003; Pitman C, 1958, B BR ORNITHOL CLUB; Rubenstein D., 1978, SOCIAL BEHAV PERSPEC, P205, DOI [10.1007/978-1-4684-2901-5_9, DOI 10.1007/978-1-4684-2901-5_9]; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Rubenstein DR, 2011, P NATL ACAD SCI USA, V108, P10816, DOI 10.1073/pnas.1100303108; Schellinck J, 2011, ECOL MODEL, V222, P1897, DOI 10.1016/j.ecolmodel.2011.03.013; SCHNELL GD, 1973, IBIS, V115, P93, DOI 10.1111/j.1474-919X.1973.tb02626.x; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Sendova-Franks AB, 2010, ANIM BEHAV, V79, P473, DOI 10.1016/j.anbehav.2009.11.035; Sibbald AM, 2000, APPL ANIM BEHAV SCI, V70, P49, DOI 10.1016/S0168-1591(00)00145-3; Smit B, 2013, ECOLOGY, V94, P1142, DOI 10.1890/12-1511.1; Waltz E.C., 1983, Colonial Waterbirds, V6, P31, DOI 10.2307/1520964; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Yazid M., 2009, APPL MATH SCI, V3, P2085; YEOMANS KA, 1982, J ROY STAT SOC D-STA, V31, P221; Zhang GY, 2012, J APPL STAT, V39, P151, DOI 10.1080/02664763.2011.578621; Zimmerman D.A., 1996, BIRDS KENYA NO TANZA	58	6	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88761	10.1371/journal.pone.0088761	http://dx.doi.org/10.1371/journal.pone.0088761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551157	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000065
J	Chen, X; Shen, L; Chou, HH				Chen, Xi; Shen, Lu; Chou, Hui-Hsien			MicroRNA-Target Binding Structures Mimic MicroRNA Duplex Structures in Humans	PLOS ONE			English	Article							ARGONAUTE PROTEINS; SIRNA BIOGENESIS; MESSENGER-RNA; RECOGNITION; PREDICTION; EVOLUTION; GENES; RISC; MIRNAS; DETERMINANTS	Traditionally, researchers match a microRNA guide strand to mRNA sequences using sequence comparisons to predict its potential target genes. However, many of the predictions can be false positives due to limitations in sequence comparison alone. In this work, we consider the association of two related RNA structures that share a common guide strand: the microRNA duplex and the microRNA-target binding structure. We have analyzed thousands of such structure pairs and found many of them share high structural similarity. Therefore, we conclude that when predicting microRNA target genes, considering just the microRNA guide strand matches to gene sequences may not be sufficient - The microRNA duplex structure formed by the guide strand and its companion passenger strand must also be considered. We have developed software to translate RNA binding structure into encoded representations, and we have also created novel automatic comparison methods utilizing such encoded representations to determine RNA structure similarity. Our software and methods can be utilized in the other RNA secondary structure comparisons as well.	[Chen, Xi; Chou, Hui-Hsien] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Shen, Lu] Johns Hopkins Univ, Dept Biostat, Baltimore, MD USA; [Chou, Hui-Hsien] Iowa State Univ, Dept Comp Sci, Ames, IA USA	Iowa State University; Johns Hopkins University; Iowa State University	Chou, HH (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	hhchou@iastate.edu			National Science Foundataion [DBI-0850195]; Direct For Biological Sciences [0850195] Funding Source: National Science Foundation	National Science Foundataion; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundataion Grant DBI-0850195, (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 0850195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist.	Ahmed F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-105; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; BARBATO C, 2009, BIOMED RES INT; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Betancur Juan G., 2012, Frontiers in Genetics, V3, P127, DOI 10.3389/fgene.2012.00127; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dimitrov RA, 2004, BIOPHYS J, V87, P215, DOI 10.1529/biophysj.103.020743; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; DUECK A, 2012, NUCL ACIDS RES; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guerra-Assuncao JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-218; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hochsmann M, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P159, DOI 10.1109/CSB.2003.1227315; HOCHSMANN M, 2005, TREE ALIGNMENT MODEL; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Kaya E, 2012, SCIENCE, V336, P985, DOI 10.1126/science.1223549; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI N, 2013, NUCL ACIDS RES; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Witkos TM, 2011, CURR MOL MED, V11, P93; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhu Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-718	55	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88806	10.1371/journal.pone.0088806	http://dx.doi.org/10.1371/journal.pone.0088806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551166	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000070
J	Park, SH; Jang, SY; Kim, H; Lee, SW				Park, So Hyun; Jang, Shin Yi; Kim, Ho; Lee, Seung Wook			An Association Rule Mining-Based Framework for Understanding Lifestyle Risk Behaviors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PUBLIC-HEALTH; METAANALYSIS; PREVALENCE; PATTERNS; SLEEP; DISEASE; OBESITY; ADULTS; MASS	Objectives: This study investigated the prevalence and patterns of lifestyle risk behaviors in Korean adults. Methods: We utilized data from the Fourth Korea National Health and Nutrition Examination Survey for 14,833 adults (>20 years of age). We used association rule mining to analyze patterns of lifestyle risk behaviors by characterizing nonadherence to public health recommendations related to the Alameda 7 health behaviors. The study variables were current smoking, heavy drinking, physical inactivity, obesity, inadequate sleep, breakfast skipping, and frequent snacking. Results: Approximately 72% of Korean adults exhibited two or more lifestyle risk behaviors. Among women, current smoking, obesity, and breakfast skipping were associated with inadequate sleep. Among men, breakfast skipping with additional risk behaviors such as physical inactivity, obesity, and inadequate sleep was associated with current smoking. Current smoking with additional risk behaviors such as inadequate sleep or breakfast skipping was associated with physical inactivity. Conclusion: Lifestyle risk behaviors are intercorrelated in Korea. Information on patterns of lifestyle risk behaviors could assist in planning interventions targeted at multiple behaviors simultaneously.	[Park, So Hyun; Kim, Ho; Lee, Seung Wook] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Jang, Shin Yi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiovasc Imaging Ctr, Seoul, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, H (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.	hokim@snu.ac.kr; leeswook@snu.ac.kr	Kim, Ho/AAS-2402-2021	Kim, Ho/0000-0001-7472-3752; Jang, Shin Yi/0000-0003-4319-7029				Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Belloc N B, 1973, Prev Med, V2, P67, DOI 10.1016/0091-7435(73)90009-1; Berrigan D, 2003, PREV MED, V36, P615, DOI 10.1016/S0091-7435(02)00067-1; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Centers for Disease Controland Prevention, 2009, PREV TRENDS DAT NAT; Chou KL, 2008, J AGING HEALTH, V20, P788, DOI 10.1177/0898264308321082; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289; HALL SM, 1992, AM J PUBLIC HEALTH, V82, P799, DOI 10.2105/AJPH.82.6.799; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Imamura T, 2007, MED BIOL ENG COMPUT, V45, P51, DOI 10.1007/s11517-006-0121-6; Johansson SE, 1999, INT J EPIDEMIOL, V28, P1073, DOI 10.1093/ije/28.6.1073; Kang Kiwon, 2010, J Prev Med Public Health, V43, P73, DOI 10.3961/jpmph.2010.43.1.73; Katanoda K, 2008, J EPIDEMIOL, V18, P14; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Kool J, 2004, J REHABIL MED, V36, P49, DOI 10.1080/16501970310020104; Korea Centers for Disease Control and Prevention, 2007, 4 KOR NAT HLTH NUTR; Korea Institute for Health Social Affairs, 2006, DET HLTH KOR; Laaksonen M, 2001, EUR J PUBLIC HEALTH, V11, P294, DOI 10.1093/eurpub/11.3.294; Lee DG, 2013, J MED SYST, V37, DOI 10.1007/s10916-012-9896-1; LeMarchand L, 1997, CANCER RES, V57, P4787; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Mistry R, 2009, PREV MED, V48, P291, DOI 10.1016/j.ypmed.2008.12.013; Myers J, 2004, AM J MED, V117, P912, DOI 10.1016/j.amjmed.2004.06.047; Nahar J, 2011, J MED SYST, V35, P353, DOI 10.1007/s10916-009-9372-8; OECD, WHAT AR EQ SCAL; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Sakata K, 2001, Nihon Koshu Eisei Zasshi, V48, P837; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Tai YM, 2009, INT J MED INFORM, V78, pE75, DOI 10.1016/j.ijmedinf.2009.09.005; Tan PN, 2004, INFORM SYST, V29, P293, DOI 10.1016/S0306-4379(03)00072-3; Taylor AH, 2005, PSYCHOPHARMACOLOGY, V181, P1, DOI 10.1007/s00213-005-2216-4; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88859	10.1371/journal.pone.0088859	http://dx.doi.org/10.1371/journal.pone.0088859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551181	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000077
J	Kazi, A; Ozcan, S; Tecleab, A; Sun, Y; Lawrence, HR; Sebti, SM				Kazi, Aslamuzzaman; Ozcan, Sevil; Tecleab, Awet; Sun, Ying; Lawrence, Harshani R.; Sebti, Said M.			Discovery of PI-1840, a Novel Noncovalent and Rapidly Reversible Proteasome Inhibitor with Anti-tumor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Apoptosis; Bcl-2 Family Proteins; Cancer Therapy; Cell Proliferation; p53; Proteasome; CT-L; PI-1840; Noncovalent	PROTEIN-DEGRADATION; 20S PROTEASOME; P53 PATHWAY; UBIQUITIN; CANCER; CELL; TMC-95A; TARGET; IMMUNOPROTEASOME; LACTACYSTIN	Background: Food and Drug Administration-approved proteasome inhibitors act covalently, which hampers their safety. Results: Structure activity relationship (SAR) studies, mass spectrometry, and dialysis identified PI-1840 as a noncovalent proteasome inhibitor that sensitizes human cancer cells to p53 and Bcl2 antagonists. Conclusion: Noncovalent proteasome inhibitors suppress in vivo tumor growth with little toxicity in mouse xenografts. Significance: Discovery of noncovalent proteasome inhibitors warrants their development as anti-cancer drugs. The proteasome inhibitor bortezomib is effective in hematologic malignancies such as multiple myeloma but has little activity against solid tumors, acts covalently, and is associated with undesired side effects. Therefore, noncovalent inhibitors that are less toxic and more effective against solid tumors are desirable. Structure activity relationship studies led to the discovery of PI-1840, a potent and selective inhibitor for chymotrypsin-like (CT-L) (IC50 value = 27 +/- 0.14 nm) over trypsin-like and peptidylglutamyl peptide hydrolyzing (IC50 values >100 m) activities of the proteasome. Furthermore, PI-1840 is over 100-fold more selective for the constitutive proteasome over the immunoproteasome. Mass spectrometry and dialysis studies demonstrate that PI-1840 is a noncovalent and rapidly reversible CT-L inhibitor. In intact cancer cells, PI-1840 inhibits CT-L activity, induces the accumulation of proteasome substrates p27, Bax, and IB-, inhibits survival pathways and viability, and induces apoptosis. Furthermore, PI-1840 sensitizes human cancer cells to the mdm2/p53 disruptor, nutlin, and to the pan-Bcl-2 antagonist BH3-M6. Finally, in vivo, PI-1840 but not bortezomib suppresses the growth in nude mice of human breast tumor xenografts. These results warrant further evaluation of a noncovalent and rapidly reversible proteasome inhibitor as potential anticancer agents against solid tumors.	[Kazi, Aslamuzzaman; Ozcan, Sevil; Tecleab, Awet; Sun, Ying; Lawrence, Harshani R.; Sebti, Said M.] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Kazi, Aslamuzzaman; Lawrence, Harshani R.; Sebti, Said M.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Lawrence, Harshani R.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sebti, SM (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr, Tampa, FL 33612 USA.	said.sebti@moffitt.org			National Institutes of Health [P01-CA118210]; NATIONAL CANCER INSTITUTE [P30CA076292, P01CA118210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-CA118210.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bellavista E, 2013, CURR PHARM DESIGN, V19, P702, DOI 10.2174/138161213804581927; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Desvergne A, 2013, J MED CHEM, V56, P3367, DOI 10.1021/jm4002007; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x; Favrot M, 1998, GENE THER, V5, P728, DOI 10.1038/sj.gt.3300661; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Gallastegui N, 2012, ANGEW CHEM INT EDIT, V51, P247, DOI 10.1002/anie.201106010; Groll M, 2001, J MOL BIOL, V311, P543, DOI 10.1006/jmbi.2001.4869; Groll M, 2010, CHEMMEDCHEM, V5, P1701, DOI 10.1002/cmdc.201000293; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Hutter G, 2012, LEUKEMIA, V26, P2442, DOI 10.1038/leu.2012.118; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kazi A, 2009, CELL CYCLE, V8, P1940, DOI 10.4161/cc.8.12.8798; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kuhn DJ, 2012, SEMIN HEMATOL, V49, P258, DOI 10.1053/j.seminhematol.2012.04.003; Love I. M., 2013, METHOD MOL BIOL, V53, P63; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Ozcan S, 2013, J MED CHEM, V56, P3783, DOI 10.1021/jm400221d; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Satija YK, 2013, INT J CANCER, V133, P2759, DOI 10.1002/ijc.28129; Schwartz AL, 1999, ANNU REV MED, V50, P57; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	39	18	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11906	11915		10.1074/jbc.M113.533950	http://dx.doi.org/10.1074/jbc.M113.533950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24570003	hybrid, Green Published			2022-12-25	WOS:000335010600031
J	Vogel, S; Chatterjee, M; Metzger, K; Borst, O; Geisler, T; Seizer, P; Muller, I; Mack, A; Schumann, S; Buhring, HJ; Lang, F; Sorg, RV; Langer, H; Gawaz, M				Vogel, Sebastian; Chatterjee, Madhumita; Metzger, Katja; Borst, Oliver; Geisler, Tobias; Seizer, Peter; Mueller, Iris; Mack, Andreas; Schumann, Susanne; Buehring, Hans-Joerg; Lang, Florian; Sorg, Ruediger V.; Langer, Harald; Gawaz, Meinrad			Activated Platelets Interfere with Recruitment of Mesenchymal Stem Cells to Apoptotic Cardiac Cells via High Mobility Group Box 1/Toll-like Receptor 4-mediated Down-regulation of Hepatocyte Growth Factor Receptor MET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Mesenchymal Stem Cells; Myocardial Infarction; Platelets; Toll-like Receptors (TLR); HMGB1; Cardiac Repair and Regeneration	ACUTE MYOCARDIAL-INFARCTION; TOLL-LIKE RECEPTORS; ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; STROMAL CELLS; IN-VITRO; CLINICAL IMPLICATIONS; STERILE INFLAMMATION; PROTEIN; BONE	Background: Mesenchymal stem cells (MSC) contribute to cardiac repair after myocardial injury. Underlying molecular mechanisms remain unexplored. Results: Activated platelets inhibit recruitment of MSC to apoptotic cardiac myocytes and fibroblasts via HMGB1/TLR-4-mediated down-regulation of HGF receptor MET. Conclusion: We identify a novel mechanism by which platelets impair MSC migration to damaged cardiac cells. Significance: The cross-talk between platelets and MSC might be critical for myocardial repair. Recruitment of mesenchymal stem cells (MSC) following cardiac injury, such as myocardial infarction, plays a critical role in tissue repair and may contribute to myocardial recovery. However, the mechanisms that regulate migration of MSC to the site of tissue damage remain elusive. Here, we demonstrate in vitro that activated platelets substantially inhibit recruitment of MSC toward apoptotic cardiac myocytes and fibroblasts. The alarmin high mobility group box 1 (HMGB1) was released by platelets upon activation and mediated inhibition of the cell death-dependent migratory response through Toll-like receptor (TLR)-4 expressed on the MSC. Migration of MSC to apoptotic cardiac myocytes and fibroblasts was driven by hepatocyte growth factor (HGF), and platelet activation was followed by HMGB1/TLR-4-dependent down-regulation of HGF receptor MET on MSC, thereby impairing HGF-driven MSC recruitment. We identify a novel mechanism by which platelets, upon activation, interfere with MSC recruitment to apoptotic cardiac cells, a process that may be of particular relevance for myocardial repair and regeneration.	[Vogel, Sebastian; Chatterjee, Madhumita; Metzger, Katja; Borst, Oliver; Geisler, Tobias; Seizer, Peter; Mueller, Iris; Langer, Harald; Gawaz, Meinrad] Eberhard Karls Univ Tubingen, Dept Cardiol & Cardiovasc Dis, D-72076 Tubingen, Germany; [Mack, Andreas] Eberhard Karls Univ Tubingen, Inst Anat, D-72076 Tubingen, Germany; [Schumann, Susanne; Buehring, Hans-Joerg] Eberhard Karls Univ Tubingen, Dept Oncol Haematol Immunol Rheumatol & Pulmonol, D-72076 Tubingen, Germany; [Lang, Florian] Eberhard Karls Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [Sorg, Ruediger V.] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf	Gawaz, M (corresponding author), Univ Tubingen, Med Klin 3, Otfried Muller Str 10, D-72076 Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de	Chatterjee, Madhumita/AAJ-1802-2020; Geisler, Tobias/AAO-4472-2020	Chatterjee, Madhumita/0000-0002-3428-4107; Vogel, Sebastian/0000-0002-3284-0464; Mack, Andreas/0000-0001-7591-4374; Borst, Oliver/0000-0003-4002-4085	German Heart Foundation/German Foundation of Heart Research Grant [F/19/13]; Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe [KFO 274]	German Heart Foundation/German Foundation of Heart Research Grant; Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe(German Research Foundation (DFG))	This work was supported by German Heart Foundation/German Foundation of Heart Research Grant F/19/13 and the Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe KFO 274 "Platelets: Basic Mechanisms and Translational Implications."	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Borst O, 2012, CIRC RES, V111, P1297, DOI 10.1161/CIRCRESAHA.112.276444; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; Gawaz M, 2013, BLOOD, V122, P2550, DOI 10.1182/blood-2013-05-468694; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Kohno T, 2009, CARDIOVASC RES, V81, P565, DOI 10.1093/cvr/cvn291; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Langer HF, 2009, J MOL CELL CARDIOL, V47, P315, DOI 10.1016/j.yjmcc.2009.03.011; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Muller I, 2006, CYTOTHERAPY, V8, P437, DOI 10.1080/14653240600920782; Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nomura S, 2011, PLATELETS, V22, P396, DOI 10.3109/09537104.2011.553970; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rouhiainen A, 2000, THROMB HAEMOSTASIS, V84, P1087; Stellos K, 2010, J THROMB HAEMOST, V8, P205, DOI 10.1111/j.1538-7836.2009.03659.x; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vogel S, 2013, BIOCHEM BIOPH RES CO, V431, P428, DOI 10.1016/j.bbrc.2012.12.153; Vogel S, 2010, CELL MOL LIFE SCI, V67, P295, DOI 10.1007/s00018-009-0183-3; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; WILLERSON JT, 1989, CIRCULATION, V80, P198, DOI 10.1161/01.CIR.80.1.198; Wollert KC, 2005, CIRCULATION, V112, P151, DOI 10.1161/CIRCULATIONAHA.105.551895; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Zhu Y, 2000, HEART, V83, P450, DOI 10.1136/heart.83.4.450	59	31	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11068	11082		10.1074/jbc.M113.530287	http://dx.doi.org/10.1074/jbc.M113.530287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24567328	Green Published, hybrid			2022-12-25	WOS:000334638500012
J	Wang, AM; Midura, RJ; Vasanji, A; Wang, AJ; Hascall, VC				Wang, Aimin; Midura, Ronald J.; Vasanji, Amit; Wang, Andrew J.; Hascall, Vincent C.			Hyperglycemia Diverts Dividing Osteoblastic Precursor Cells to an Adipogenic Pathway and Induces Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Autophagy; Diabetes; ER Stress; Heparin; Inflammation; Stromal Cell; Monocyte Adhesive Hyaluronan Matrix; Osteogenesis; Osteopenia	SMOOTH-MUSCLE-CELLS; EXPERIMENTAL DIABETIC-NEPHROPATHY; ENDOPLASMIC-RETICULUM STRESS; MESENCHYMAL STEM-CELLS; BONE-MINERAL DENSITY; MESANGIAL CELLS; RESORBING CELLS; MURINE MODEL; CYCLIN D3; MELLITUS	Background: Adipocytes accumulate in diabetic bone marrow. Results: Bone marrow stromal cells that divide in hyperglycemia divert from the osteoblast lineage to pathological adipogenesis and produce an extensive monocyte-adhesive hyaluronan matrix with consequent demineralization of trabecular bone. Conclusion: This mechanism diminishes the stromal cell population with an accumulation of metabolically stressed adipocytes. Significance: This provides new insights into diabetic osteopenia. Isolated rat bone marrow stromal cells cultured in osteogenic medium in which the normal 5.6 mm glucose is changed to hyperglycemic 25.6 mm glucose greatly increase lipid formation between 21-31 days of culture that is associated with decreased biomineralization, up-regulate expression of cyclin D3 and two adipogenic markers (CCAAT/enhancer binding protein and peroxisome proliferator-activated receptor ) within 5 days of culture, increase neutral and polar lipid synthesis within 5 days of culture, and form a monocyte-adhesive hyaluronan matrix through an endoplasmic reticulum stress-induced autophagic mechanism. Evidence is also provided that, by 4 weeks after diabetes onset in the streptozotocin-induced diabetic rat model, there is a large loss of trabecular bone mineral density without apparent proportional changes in underlying collagen matrices, a large accumulation of a hyaluronan matrix within the trabecular bone marrow, and adipocytes and macrophages embedded in this hyaluronan matrix. These results support the hypothesis that hyperglycemia in bone marrow diverts dividing osteoblastic precursor cells (bone marrow stromal cells) to a metabolically stressed adipogenic pathway that induces synthesis of a hyaluronan matrix that recruits inflammatory cells and establishes a chronic inflammatory process that demineralizes trabecular cancellous bone.	[Wang, Aimin; Midura, Ronald J.; Vasanji, Amit; Wang, Andrew J.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Wang, AM (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44106 USA.	wanga@ccf.org			National Institutes of Health [R01 DK62934, P01 HL107147]; NHLBI, National Institutes of Health [P01 HL107147]; Mizutani Foundation [1000057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mizutani Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK62934 (to A. W.) and P01 HL107147 (to V. H. and A. W., Project 1) and by NHLBI, National Institutes of Health Grant P01 HL107147 (to Hyaluronan Matrices in Vascular Pathologies). This work was also supported by Mizutani Foundation Grant 1000057 (to V. H. and A. W.).	Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096, DOI 10.2106/00004623-199607000-00016; Botolin S, 2005, ENDOCRINOLOGY, V146, P3622, DOI 10.1210/en.2004-1677; Botolin S, 2007, ENDOCRINOLOGY, V148, P198, DOI 10.1210/en.2006-1006; BOUILLON R, 1995, J CLIN ENDOCR METAB, V80, P1194, DOI 10.1210/jc.80.4.1194; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CALABRO A, 2000, PROTEOGLYCANS STRUCT, P5; CALVO JC, 1993, ARCH BIOCHEM BIOPHYS, V302, P468, DOI 10.1006/abbi.1993.1241; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Folk JW, 1999, J ORTHOP TRAUMA, V13, P369, DOI 10.1097/00005131-199906000-00008; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hascall VC, 2000, GLYCOCONJUGATE J, V17, P607, DOI 10.1023/A:1011082728155; Herrero S, 1998, CALCIFIED TISSUE INT, V62, P260, DOI 10.1007/s002239900427; HERSKIND AM, 1992, DIABETES METAB, V18, P63; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; KLEIN DJ, 1986, DIABETES, V35, P1130, DOI 10.2337/diabetes.35.10.1130; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; Lassus J, 1998, CLIN ORTHOP RELAT R, P7; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LOCATTO ME, 1993, BONE MINER, V23, P129, DOI 10.1016/S0169-6009(08)80049-9; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Masson E, 2006, IUBMB LIFE, V58, P381, DOI 10.1080/15216540600755980; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; McCabe NP, 2011, NEOPLASIA, V13, P31, DOI 10.1593/neo.10998; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Miazgowski T, 1998, OSTEOPOROSIS INT, V8, P399, DOI 10.1007/s001980050082; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Motyl KJ, 2009, J CELL PHYSIOL, V218, P575, DOI 10.1002/jcp.21626; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quinn JMW, 1996, J PATHOL, V179, P106; Reddy G, 2001, DIABETES RES CLIN PR, V54, P1, DOI 10.1016/S0168-8227(01)00273-X; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosen ED, 2002, ANN ENDOCRINOL-PARIS, V63, P79; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Shyng YC, 2001, INT J ORAL MAX SURG, V30, P70, DOI 10.1054/ijom.2000.0004; TOOLE BP, 2000, PROTEOGLYCANS STRUCT, P61; Verhaeghe J, 2000, BONE, V27, P249, DOI 10.1016/S8756-3282(00)00308-2; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 2000, J BIOL CHEM, V275, P11082, DOI 10.1074/jbc.275.15.11082; Wang T, 2007, PATTERN RECOGN LETT, V28, P501, DOI 10.1016/j.patrec.2006.09.004; Ward DT, 2001, J AM SOC NEPHROL, V12, P779, DOI 10.1681/ASN.V124779; WAUD CE, 1994, CALCIFIED TISSUE INT, V54, P237, DOI 10.1007/BF00301685; White CB, 2003, CLIN ORTHOP RELAT R, P37, DOI 10.1097/01.blo.0000084402.53464.90; Yevdokimova NY, 2006, ACTA BIOCHIM POL, V53, P383; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139	72	46	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11410	11420		10.1074/jbc.M113.541458	http://dx.doi.org/10.1074/jbc.M113.541458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24569987	Green Published, hybrid			2022-12-25	WOS:000334638500042
J	Kumagai, K; Kawano-Kawada, M; Hanada, K				Kumagai, Keigo; Kawano-Kawada, Miyuki; Hanada, Kentaro			Phosphoregulation of the Ceramide Transport Protein CERT at Serine 315 in the Interaction with VAMP-associated Protein ( VAP) for Inter-organelle Trafficking of Ceramide in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Golgi; Lipid-binding Protein; Lipid Transport; Sphingolipid	PLECKSTRIN-HOMOLOGY-DOMAIN; NONVESICULAR TRAFFICKING; ENDOPLASMIC-RETICULUM; SPHINGOLIPID METABOLISM; MOLECULAR MACHINERY; SEMIINTACT CELLS; STRUCTURAL BASIS; BINDING PROTEIN; PHOSPHORYLATION; KINASE	Background: CERT transports ceramide from the ER to the Golgi apparatus and is supported by its FFAT motif-dependent binding to the ER membrane protein VAP. Results: CERT is phosphorylated at Ser-315 near the FFAT motif. Conclusion: The phosphorylation strengthens the CERT-VAP-A interaction to up-regulate ceramide trafficking. Significance: This provides new insights into molecular mechanisms underlying functional regulation of FFAT-containing proteins for the inter-organelle lipid trafficking. The ceramide transport protein CERT mediates the inter-organelle transport of ceramide for the synthesis of sphingomyelin, presumably through endoplasmic reticulum (ER)-Golgi membrane contact sites. CERT has a short peptide motif named FFAT, which associates with the ER-resident membrane protein VAP. We show that the phosphorylation of CERT at serine 315, which is adjacent to the FFAT motif, markedly enhanced the interaction of CERT with VAP. The phosphomimetic CERT S315E mutant exhibited higher activity to support the ER-to-Golgi transport of ceramide than the wild-type control in a semi-intact cell system, and this enhanced activity was abrogated when its FFAT motif was deleted. The level of phosphorylation of CERT at Ser-315 increased in HeLa cells treated with a sphingolipid biosynthesis inhibitor or exogenous sphingomyelinase. Expression of CERT S315E induced intracellular punctate structures, to which CERT and VAP were co-localized, and the occurrence of the structure was dependent on both phosphatidylinositol 4-monophosphate binding and VAP binding activities of CERT. Phosphorylation of another region (named a serine-rich motif) in CERT is known to down-regulate the activity of CERT. Analysis of various CERT mutant constructs showed that the de-phosphorylation of the serine-rich motif and the phosphorylation of Ser-315 likely have the additive contribution to enhance the activity of CERT. These results demonstrate that the phosphorylation of CERT at the FFAT motif-adjacent serine affected its affinity for VAP, which may regulate the inter-organelle trafficking of ceramide in response to the perturbation of cellular sphingomyelin and/or other sphingolipids.	[Kumagai, Keigo; Kawano-Kawada, Miyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hanak@nih.go.jp	Kumagai, Keigo/AAG-1385-2021	KAWANO-KAWADA, Miyuki/0000-0002-1168-9291; Kumagai, Keigo/0000-0002-1663-2905; Hanada, Kentaro/0000-0003-1383-2781	Japan Society for the Promotion of Science KAKENHI [23790118, 25460086, 22370054, 25670045]; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23790118 and 25460086 (to K. K.), 22370054 and 25670045 (to K. H.), and by the Takeda Science Foundation.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Charruyer A, 2008, J BIOL CHEM, V283, P16682, DOI 10.1074/jbc.M800799200; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Florin L, 2009, J BIOTECHNOL, V141, P84, DOI 10.1016/j.jbiotec.2009.02.014; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Guo J, 2010, CELL PHYSIOL BIOCHEM, V26, P717, DOI 10.1159/000322339; HANADA K, 1985, FEBS LETT, V191, P278, DOI 10.1016/0014-5793(85)80024-7; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2013, BIOCH BIOPH IN PRESS, DOI [10.1016/j.bbalip/2013.06.006, DOI 10.1016/J.BBALIP/2013.06.006]; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2012, METHOD CELL BIOL, V108, P117, DOI 10.1016/B978-0-12-386487-1.00006-7; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330	41	58	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10748	10760		10.1074/jbc.M113.528380	http://dx.doi.org/10.1074/jbc.M113.528380			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569996	hybrid, Green Published			2022-12-25	WOS:000334226400044
J	Nakano, S; Okazaki, S; Tokiwa, H; Asano, Y				Nakano, Shogo; Okazaki, Seiji; Tokiwa, Hiroaki; Asano, Yasuhisa			Binding of NAD(+) and L-Threonine Induces Stepwise Structural and Flexibility Changes in Cupriavidus necator L-Threonine Dehydrogenase*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Dehydrogenase; Enzyme Kinetics; Molecular Dynamics; NAD	ARCHAEON PYROCOCCUS-HORIKOSHII; MOLECULAR-DYNAMICS SIMULATIONS; LIVER ALCOHOL-DEHYDROGENASE; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; SUPERFAMILY; REFINEMENT; CATALYSIS; PROGRAM	Background: The structural changes in short chain dehydrogenase-like l-threonine dehydrogenase (SDR-like l-ThrDH) that occur during catalysis remain unknown. Results: Several analyses revealed dynamical changes in SDR-like l-ThrDH. Conclusion: NAD(+) and l-threonine binding induced changes in flexibility and structure. Significance: This report demonstrates that the dynamical structural changes of SDR-like l-ThrDH are important for the reactivity and specificity of the enzyme. Crystal structures of short chain dehydrogenase-like l-threonine dehydrogenase from Cupriavidus necator (CnThrDH) in the apo and holo forms were determined at 2.25 and 2.5 , respectively. Structural comparison between the apo and holo forms revealed that four regions of CnThrDH adopted flexible conformations when neither NAD(+) nor l-Thr were bound: residues 38-59, residues 77-87, residues 180-186, and the catalytic domain. Molecular dynamics simulations performed at the 50-ns time scale revealed that three of these regions remained flexible when NAD(+) was bound to CnThrDH: residues 80-87, residues 180-186, and the catalytic domain. Molecular dynamics simulations also indicated that the structure of CnThrDH changed from a closed form to an open form upon NAD(+) binding. The newly formed cleft in the open form may function as a conduit for substrate entry and product exit. These computational results led us to hypothesize that the CnThrDH reaction progresses by switching between the closed and open forms. Enzyme kinetics parameters of the L80G, G184A, and T186N variants also supported this prediction: the k(cat)/K-m,K- l-Thr value of the variants was >330-fold lower than that of the wild type; this decrease suggested that the variants mostly adopt the open form when l-Thr is bound to the active site. These results are summarized in a schematic model of the stepwise changes in flexibility and structure that occur in CnThrDH upon binding of NAD(+) and l-Thr. This demonstrates that the dynamical structural changes of short chain dehydrogenase-like l-threonine dehydrogenase are important for the reactivity and specificity of the enzyme.	[Nakano, Shogo; Okazaki, Seiji; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Nakano, Shogo; Okazaki, Seiji; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Tokiwa, Hiroaki] Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan; [Nakano, Shogo; Okazaki, Seiji; Tokiwa, Hiroaki; Asano, Yasuhisa] JST, ERATO, Asano Act Enzyme Mol Project, Imizu, Toyama 9390398, Japan	Toyama Prefectural University; Toyama Prefectural University; Rikkyo University; Japan Science & Technology Agency (JST)	Asano, Y (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	asano@pu-toyama.ac.jp	Asano, Yasuhisa/K-5898-2016; Nakano, Shogo/AAN-1455-2020	Asano, Yasuhisa/0000-0003-3645-3952; Nakano, Shogo/0000-0002-6614-7158	ERATO Asano Active Enzyme Molecule Project from the Japan Science and Technology Agency	ERATO Asano Active Enzyme Molecule Project from the Japan Science and Technology Agency	This work was supported by a grant from the ERATO Asano Active Enzyme Molecule Project from the Japan Science and Technology Agency.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; Bowyer A, 2009, J STRUCT BIOL, V168, P294, DOI 10.1016/j.jsb.2009.07.011; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Ebara S, 2001, BBA-GEN SUBJECTS, V1568, P111, DOI 10.1016/S0304-4165(01)00207-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EPPERLY BR, 1991, J BIOL CHEM, V266, P6086; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friedman AJ, 2012, CHEM BIOL DRUG DES, V80, P173, DOI 10.1111/j.1747-0285.2012.01392.x; Gil-Ortiz F, 2010, J MOL BIOL, V399, P476, DOI 10.1016/j.jmb.2010.04.025; Hayward S, 2006, BIOPHYS J, V91, P1823, DOI 10.1529/biophysj.106.085910; Higashi N, 2005, J BIOSCI BIOENG, V99, P175, DOI 10.1263/jbb.99.175; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; KAMIYA Y, 1995, INTERNAL MED, V34, P679, DOI 10.2169/internalmedicine.34.679; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kazuoka T, 2003, J BACTERIOL, V185, P4483, DOI 10.1128/JB.185.15.4483-4489.2003; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Millerioux Y, 2013, MOL MICROBIOL, V90, P114, DOI 10.1111/mmi.12351; MISONO H, 1987, AGR BIOL CHEM TOKYO, V51, P1467, DOI 10.1080/00021369.1987.10868209; MOE, 2012, MOL OP ENV; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagel ZD, 2012, BIOCHEMISTRY-US, V51, P4147, DOI 10.1021/bi3001352; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; Ramaswamy S, 1999, BIOCHEMISTRY-US, V38, P13951, DOI 10.1021/bi991731i; Sakuraba H, 2011, ARCH BIOCHEM BIOPHYS, V512, P126, DOI 10.1016/j.abb.2011.05.013; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Shimizu Y, 2005, EXTREMOPHILES, V9, P317, DOI 10.1007/s00792-005-0447-2; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Tsutsui Y, 2013, J BIOL CHEM, V288, P31963, DOI 10.1074/jbc.M113.509984; Ueatrongchit T, 2011, ANAL BIOCHEM, V410, P44, DOI 10.1016/j.ab.2010.11.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoneda K, 2012, J BIOL CHEM, V287, P12966, DOI 10.1074/jbc.M111.336958; Yoneda K, 2010, FEBS J, V277, P5124, DOI 10.1111/j.1742-4658.2010.07916.x	39	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10445	10454		10.1074/jbc.M113.540773	http://dx.doi.org/10.1074/jbc.M113.540773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558034	hybrid, Green Published			2022-12-25	WOS:000334226400018
J	Arif, E; Rathore, YS; Kumari, B; Ashish, F; Wong, HN; Holzman, LB; Nihalani, D				Arif, Ehtesham; Rathore, Yogendra S.; Kumari, Babita; Ashish, Fnu; Wong, Hetty N.; Holzman, Lawrence B.; Nihalani, Deepak			Slit Diaphragm Protein Neph1 and Its Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Signaling; Kidney; Phosphorylation; Podocytes; Neph1; Renal Injury	ISCHEMIC BRAIN-INJURY; FUSION PROTEIN; ACTIN CYTOSKELETON; PODOCYTE PROTEIN; IN-VIVO; DOMAIN; MECHANISMS; ZEBRAFISH; PEPTIDES; MODEL	Background: Neph1 is a podocyte protein that is critical for maintaining renal function. Results: Inhibiting Neph1 signaling preserves podocyte structure and function in response to glomerular injury-inducing agents. Conclusion: Maintaining a robust expression of Neph1 at the podocyte cell membrane protects podocytes from renal injury. Significance: This is the first report demonstrating that Neph1 signaling is a therapeutic target for preventing podocyte damage. Podocytes are specialized epithelial cells that are critical components of the glomerular filtration barrier, and their dysfunction leads to proteinuria and renal failure. Therefore, preserving podocyte function is therapeutically significant. In this study, we identified Neph1 signaling as a therapeutic target that upon inhibition prevented podocyte damage from a glomerular injury-inducing agent puromycin aminonucleoside (PAN). To specifically inhibit Neph1 signaling, we used a protein transduction approach, where the cytoplasmic domain of Neph1 (Neph1CD) tagged with a protein transduction domain trans-activator of transcription was transduced in cultured podocytes prior to treatment with PAN. The PAN-induced Neph1 phosphorylation was significantly reduced in Neph1CD-transduced cells; in addition, these cells were resistant to PAN-induced cytoskeletal damage. The biochemical analysis using subfractionation studies showed that unlike control cells Neph1 was retained in the lipid raft fractions in the transduced cells following treatment with PAN, indicating that transduction of Neph1CD in podocytes prevented PAN-induced mislocalization of Neph1. In accordance, the immunofluorescence analysis further suggested that Neph1CD-transduced cells had increased ability to retain endogenous Neph1 at the membrane in response to PAN-induced injury. Similar results were obtained when angiotensin was used as an injury-inducing agent. Consistent with these observations, maintaining high levels of Neph1 at the membrane using a podocyte cell line overexpressing chimeric Neph1 increased the ability of podocytes to resist PAN-induced injury and PAN-induced albumin leakage. Using a zebrafish in vivo PAN and adriamycin injury models, we further demonstrated the ability of transduced Neph1CD to preserve glomerular function. Collectively, these results support the conclusion that inhibiting Neph1 signaling is therapeutically significant in preventing podocyte damage from glomerular injury.	[Arif, Ehtesham; Rathore, Yogendra S.; Kumari, Babita; Wong, Hetty N.; Holzman, Lawrence B.; Nihalani, Deepak] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Rathore, Yogendra S.; Ashish, Fnu] Inst Microbial Technol, Ctr Sci & Ind Res, Chandigarh 160036, India	University of Pennsylvania; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arif, E (corresponding author), Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	ehtesham@mail.med.upenn.edu; deepakn@mail.med.upenn.edu	Arif, Ehtesham/AAV-8272-2020; nihalani, deepak/AAK-9453-2020	Holzman, Lawrence/0000-0002-8961-234X; Arif, Ehtesham/0000-0001-9638-3189	National Institutes of Health [P30 DK050306]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956, P30DK050306, R01DK080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The imaging core was supported by Center Grant P30 DK050306 from the National Institutes of Health.	Albarran B, 2005, PROTEIN ENG DES SEL, V18, P147, DOI 10.1093/protein/gzi014; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Arif E, 2013, KIDNEY INT, V84, P1154, DOI 10.1038/ki.2013.201; Cao GD, 2002, J NEUROSCI, V22, P5423; Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8; Donnini S, 2009, CELL CYCLE, V8, P1271, DOI 10.4161/cc.8.8.8301; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Durvasula RV, 2006, CURR OPIN NEPHROL HY, V15, P1, DOI 10.1097/01.mnh.0000199012.79670.0b; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Guan N, 2004, PATHOL INT, V54, P703, DOI 10.1111/j.1440-1827.2004.01683.x; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu HF, 2010, NEPHROLOGY, V15, P75, DOI 10.1111/j.1440-1797.2009.01146.x; Mallik L, 2012, J BIOL CHEM, V287, P9441, DOI 10.1074/jbc.M111.284927; Matsusaka T, 2010, HYPERTENSION, V55, P967, DOI 10.1161/HYPERTENSIONAHA.109.141994; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; Panchapakesan U, 2005, NAT CLIN PRACT NEPHR, V1, P33, DOI 10.1038/ncpneph0029; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sawant R, 2010, MOL BIOSYST, V6, P628, DOI 10.1039/b916297f; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Srivastava T, 2013, J CELL COMMUN SIGNAL, V7, P49, DOI 10.1007/s12079-012-0184-0; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vazquez J, 2003, HYPERTENSION, V41, P751, DOI 10.1161/01.HYP.0000047878.13793.41; Vega-Warner V, 2004, KIDNEY INT, V66, P1881, DOI 10.1111/j.1523-1755.2004.00962.x; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Zhang Chaojie, 2003, Curr Protoc Toxicol, VChapter 1, DOI 10.1002/0471140856.tx0107s17; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	56	34	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9502	9518		10.1074/jbc.M113.505743	http://dx.doi.org/10.1074/jbc.M113.505743			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554715	Green Published, hybrid			2022-12-25	WOS:000333807000008
J	Fan, KH; Lin, CY; Kang, CJ; Lee, LY; Huang, SF; Liao, CT; Chen, IH; Ng, SH; Wang, HM; Chang, JTC				Fan, Kang-Hsing; Lin, Chien-Yu; Kang, Chung-Jan; Lee, Li-Yu; Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How; Ng, Shu-Hang; Wang, Hung-Ming; Chang, Joseph Tung-Chieh			Postoperative Concomitant Chemoradiotherapy Improved Treatment Outcomes of Patients with Oral Cavity Cancer with Multiple-Node Metastases but No Other Major Risk Factors	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; INTENSITY-MODULATED RADIOTHERAPY; STAGE NASOPHARYNGEAL CARCINOMA; NECK-CANCER; RANDOMIZED-TRIAL; CISPLATIN; CHEMOTHERAPY; RADIATION	Purpose: To investigate the results of postoperative radiotherapy (PORT) for the treatment of pathologic N2b/c squamous cell carcinoma of the oral cavity (OSCC). Mterials and Methods: This study reviewed cancer registry data collected in our hospital from 1998 to 2009 with the following inclusion criteria: primary OSCC, treatment with radical surgery, and multiple nodal metastases. Patients who had extracapsular spreading of the lymph node metastases or positive resection margins or who refused to undergo PORT were excluded. The prescribed dose of PORT was 60-66 Gy. Concurrent chemotherapy was optional. Patient characteristics, treatment parameters and clinical outcome were recorded. The primary end point was overall survival, and the secondary endpoint was disease status. Results: There were 138 eligible cases, and the median follow-up period was 35 months. The 3-year overall survival rate was 56%. Univariate analysis revealed that pathologic T4 status (pT4), bone marrow invasion, and lymphatic invasion were significantly correlated with poor outcome (p < 0.05). Multivariate analysis showed that pT4, lymphatic invasion, and the no concurrent chemotherapy were independent poor prognostic factors (p < 0.05). Fifty-four patients had tumor recurrence. The 3-year recurrence-free survival rate was 59%. Skin invasion, pT4, and bone marrow invasion were correlated with poor prognosis in the univariate analysis (p < 0.05). Only pT4 (p, 0.01) and no concurrent chemotherapy (p = 0.03) were independently correlated with poor recurrence-free survival. Conclusion: For OSCC patients with multiple-node metastases without extracapsular spreading or positive resection margins, PORT without concurrent chemotherapy correlated to inferior outcome. Multiple lymph node metastases might be considered an indication for concurrent chemotherapy.	[Fan, Kang-Hsing; Lin, Chien-Yu; Chang, Joseph Tung-Chieh] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Hematol & Oncol, Tao Yuan, Taiwan; [Kang, Chung-Jan; Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How] Chang Gung Mem Hosp, Dept Head & Neck Surg, Tao Yuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Ng, Shu-Hang] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan; [Fan, Kang-Hsing; Lin, Chien-Yu; Huang, Shiang-Fu] Chang Gung Univ, Sch Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Ng, Shu-Hang; Chang, Joseph Tung-Chieh] Chang Gung Univ, Sch Med, Dept Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wang, HM (corresponding author), Chang Gung Mem Hosp, Dept Hematol & Oncol, Tao Yuan, Taiwan.	whm526@adm.cgmh.org.tw; cgmhnog@gmail.com	Fan, K/GXH-3734-2022; Li-yu, Lee/G-5055-2010	Fan, Kang-Hsing/0000-0002-0910-7803	Chang Gung Memorial Hospital in Taiwan [CMRPG 300061-2]	Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	This work was supported by grant CMRPG 300061-2 from the Chang Gung Memorial Hospital in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2001, INT J RADIAT ONCOL, V51, P571, DOI 10.1016/S0360-3016(01)01690-X; Bachaud JM, 1996, INT J RADIAT ONCOL, V36, P999, DOI 10.1016/S0360-3016(96)00430-0; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Edge SB, 2010, AJCC CANC STAGING MA; Fan KH, 2007, INT J RADIAT ONCOL, V67, P453, DOI 10.1016/j.ijrobp.2006.06.026; Fan KH, 2010, INT J RADIAT ONCOL, V77, P1024, DOI 10.1016/j.ijrobp.2009.06.064; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Ho KF, 2008, ACTA ONCOL, V47, P1513, DOI 10.1080/02841860701846160; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Koutcher L, 2011, INT J RADIAT ONCOL, V81, P915, DOI 10.1016/j.ijrobp.2010.07.008; Liao CT, 2007, CANCER, V110, P1501, DOI 10.1002/cncr.22959; Liao CT, 2007, CANCER, V110, P564, DOI 10.1002/cncr.22814; Lin CY, 2008, INT J RADIAT ONCOL, V70, P1373, DOI 10.1016/j.ijrobp.2007.08.022; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Osman N, 2013, EUR ARCH OTORHINOLAR; PETERS LJ, 1993, INT J RADIAT ONCOL, V26, P3, DOI 10.1016/0360-3016(93)90167-T; Porceddu SV, 2004, INT J RADIAT ONCOL, V60, P365, DOI 10.1016/j.ijrobp.2004.03.011; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Steinmann D, 2009, STRAHLENTHER ONKOL, V185, P682, DOI 10.1007/s00066-009-1989-5; Tsan DL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-215; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570	25	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e86922	10.1371/journal.pone.0086922	http://dx.doi.org/10.1371/journal.pone.0086922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586259	Green Published, Green Submitted, gold			2022-12-25	WOS:000331880700005
J	Illmer, P; Reitschuler, C; Wagner, AO; Schwarzenauer, T; Lins, P				Illmer, Paul; Reitschuler, Christoph; Wagner, Andreas Otto; Schwarzenauer, Thomas; Lins, Philipp			Microbial Succession during Thermophilic Digestion: The Potential of Methanosarcina sp.	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; ACETATE CONCENTRATIONS; ANAEROBIC-DIGESTION; START-UP; METHANE; COMMUNITY; GENES; METHANOGENESIS; TEMPERATURE; PATHWAYS	A distinct succession from a hydrolytic to a hydrogeno- and acetotrophic community was well documented by DGGE (denaturing gradient gel electrophoresis) and dHPLC (denaturing high performance liquid chromatography), and confirmed by qPCR (quantitative PCR) measurements and DNA sequence analyses. We could prove that Methanosarcina thermophila has been the most important key player during the investigated anaerobic digestion process. This organism was able to terminate a stagnation phase, most probable caused by a decreased pH and accumulated acetic acid following an initial hydrolytic stage. The lack in Methanosarcina sp. could not be compensated by high numbers of Methanothermobacter sp. or Methanoculleus sp., which were predominant during the initial or during the stagnation phase of the fermentation, respectively.	[Illmer, Paul; Reitschuler, Christoph; Wagner, Andreas Otto; Schwarzenauer, Thomas; Lins, Philipp] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria	University of Innsbruck	Illmer, P (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	Paul.Illmer@uibk.ac.at	Wagner, Andreas Otto/L-3082-2013	Wagner, Andreas Otto/0000-0002-6009-8498; Illmer, Paul/0000-0003-3368-3015				Beckmann S, 2011, APPL ENVIRON MICROB, V77, P3749, DOI 10.1128/AEM.02818-10; Chae KJ, 2008, BIORESOURCE TECHNOL, V99, P1, DOI 10.1016/j.biortech.2006.11.063; Chandra R, 2012, RENEW SUST ENERG REV, V16, P1462, DOI 10.1016/j.rser.2011.11.035; CLARENS M, 1990, APPL MICROBIOL BIOT, V33, P239, DOI 10.1007/BF00176532; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Esposito G, 2012, REV ENVIRON SCI BIO, V11, P325, DOI 10.1007/s11157-012-9277-8; FERGUSON TJ, 1983, APPL ENVIRON MICROB, V46, P348, DOI 10.1128/AEM.46.2.348-355.1983; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Hao LP, 2013, BIORESOURCE TECHNOL, V140, P319, DOI 10.1016/j.biortech.2013.04.113; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Illmer P, 2009, WASTE MANAGE, V29, P162, DOI 10.1016/j.wasman.2008.02.005; Illmer P, 2009, WASTE MANAGE, V29, P1838, DOI 10.1016/j.wasman.2009.02.003; Kulkarni G, 2009, P NATL ACAD SCI USA, V106, P15915, DOI 10.1073/pnas.0905914106; Lins P, 2009, MULL ABFALL, V12, P604; Lins P, 2014, BIORESOURCE TECHNOL, V152, P347, DOI 10.1016/j.biortech.2013.11.020; Lins P, 2012, BIORESOURCE TECHNOL, V110, P167, DOI 10.1016/j.biortech.2012.01.145; Lins P, 2010, FEMS MICROBIOL ECOL, V71, P469, DOI 10.1111/j.1574-6941.2009.00821.x; Lockhart RJ, 2006, APPL ENVIRON MICROB, V72, P5659, DOI 10.1128/AEM.01057-06; Lu F, 2013, WATER RES, V47, P2297, DOI 10.1016/j.watres.2013.01.049; Malin C, 2008, MICROBIOL RES, V163, P503, DOI 10.1016/j.micres.2007.07.004; Mountfort D., 1994, ANAEROBIC FUNGI BIOL, V1st Edn, DOI [10.1201/9781003067085, DOI 10.1201/9781003067085]; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nielsen HB, 2011, WATER SCI TECHNOL, V64, P1723, DOI 10.2166/wst.2011.654; Pereyra LP, 2010, APPL ENVIRON MICROB, V76, P2192, DOI 10.1128/AEM.01285-09; Reitschuler C, 2014, WORLD J MICROB BIOT, V30, P293, DOI 10.1007/s11274-013-1450-x; Schwarzenauer T, 2012, WORLD J MICROB BIOT, V28, P755, DOI 10.1007/s11274-011-0847-7; Sekiguchi H, 2001, BIOTECHNOL LETT, V23, P1205, DOI 10.1023/A:1010517117046; Shimada H, 2008, J BACTERIOL, V190, P5404, DOI 10.1128/JB.00415-08; Sonnichsen M, 1999, LIPIDS, V34, P1347, DOI 10.1007/s11745-999-0488-z; Supaphol S, 2011, BIORESOURCE TECHNOL, V102, P4021, DOI 10.1016/j.biortech.2010.11.124; Wagner AO, 2012, MICROBIOL RES, V167, P630, DOI 10.1016/j.micres.2011.11.007; Wagner AO, 2010, WASTE MANAGE, V30, P1822, DOI 10.1016/j.wasman.2010.05.013; Wagner AO, 2009, APPL ENVIRON MICROB, V75, P956, DOI 10.1128/AEM.01411-08; Watanabe T, 2004, FEMS MICROBIOL LETT, V232, P153, DOI 10.1016/S0378-1097(04)00045-X; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; WESTERMANN P, 1989, APPL ENVIRON MICROB, V55, P514, DOI 10.1128/AEM.55.2.514-515.1989; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	40	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e86967	10.1371/journal.pone.0086967	http://dx.doi.org/10.1371/journal.pone.0086967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586260	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900007
J	Morisaki, N; Belfort, MB; McCormick, MC; Mori, R; Noma, H; Kusuda, S; Fujimura, M				Morisaki, Naho; Belfort, Mandy B.; McCormick, Marie C.; Mori, Rintaro; Noma, Hisashi; Kusuda, Satoshi; Fujimura, Masanori		Neonatal Res Network Japan	Brief Parenteral Nutrition Accelerates Weight Gain, Head Growth Even in Healthy VLBWs	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; PREMATURE-INFANTS; PROTEIN-INTAKE; OUTCOMES; MORBIDITY; MORTALITY; JAPAN; AGE; SUPPLEMENTATION	Introduction:Whether parenteral nutrition benefits growth of very low birth weight (VLBW) preterm infants in the setting of rapid enteral feeding advancement is unclear. Our aim was to examine this issue using data from Japan, where enteral feeding typically advances at a rapid rate. Methods: We studied 4005 hospitalized VLBW, very preterm (23-32 weeks' gestation) infants who reached full enteral feeding (100 ml/kg/day) by day 14, from 75 institutions in the Neonatal Research Network Japan (2003-2007). Main outcomes were weight gain, head growth, and extra-uterine growth restriction (EUGR, measurement,10 th percentile for postmenstrual age) at discharge. Results: 40% of infants received parenteral nutrition. Adjusting for maternal, infant, and institutional characteristics, infants who received parenteral nutrition had greater weight gain [0.09 standard deviation (SD), 95% CI: 0.02, 0.16] and head growth (0.16 SD, 95% CI: 0.05, 0.28); lower odds of EUGR by head circumference (OR 0.66, 95% CI: 0.49, 0.88). No statistically significant difference was seen in the proportion of infants with EUGR at discharge. SGA infants and infants who took more than a week until full feeding had larger estimates. Discussion: Even in infants who are able to establish enteral nutrition within 2 weeks, deprivation of parenteral nutrition in the first weeks of life could lead to under nutrition, but infants who reached full feeding within one week benefit least. It is important to predict which infants are likely or not likely to advance on enteral feedings within a week and balance enteral and parenteral nutrition for these infants.	[Morisaki, Naho; Mori, Rintaro; Noma, Hisashi] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, Tokyo, Japan; [Morisaki, Naho] Univ Tokyo, Dept Pediat, Bunkyo Ku, Tokyo, Japan; [Belfort, Mandy B.] Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Belfort, Mandy B.] Harvard Univ, Sch Med, Boston, MA USA; [McCormick, Marie C.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; [McCormick, Marie C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Noma, Hisashi] Inst Stat Math, Dept Data Sci, Tachikawa, Tokyo, Japan; [Kusuda, Satoshi] Tokyo Womens Med Univ, Dept Neonatol, Maternal & Perinatal Ctr, Shinjuku Ku, Tokyo, Japan; [Fujimura, Masanori] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Neonatol, Osaka, Japan	National Center for Child Health & Development - Japan; University of Tokyo; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; Tokyo Women's Medical University	Morisaki, N (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Setagaya Ku, Tokyo, Japan.	naho0330@gmail.com	Belfort, Mandy/AAN-2024-2021	Morisaki, Naho/0000-0001-6151-4513; Mori, Rintaro/0000-0001-7656-6156; Noma, Hisashi/0000-0002-2520-9949	Ministry of Health, Labor and Welfare [H22-JISEDAI-IPPAN-006]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a Health Labor Sciences Research Grant by the Ministry of Health, Labor and Welfare, in 2004-2008(H22-JISEDAI-IPPAN-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor Amitha R, 2012, Sultan Qaboos Univ Med J, V12, P33; Belfort MB, 2013, NESTLE NUTR WORKS SE, V71, P171, DOI 10.1159/000342610; Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282; Blanco CL, 2012, J PEDIATR GASTR NUTR, V54, P601, DOI 10.1097/MPG.0b013e31824887a0; Blanco CL, 2008, J PEDIATR-US, V153, P535, DOI 10.1016/j.jpeds.2008.04.059; Bombell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000504.pub3; Dinerstein A, 2006, J PERINATOL, V26, P436, DOI 10.1038/sj.jp.7211539; Dusick AM, 2003, SEMIN PERINATOL, V27, P302, DOI 10.1016/S0146-0005(03)00044-2; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Ehrenkranz RA, 2007, SEMIN PERINATOL, V31, P48, DOI 10.1053/j.semperi.2007.02.001; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Ehrenkranz RA, 2010, EARLY HUM DEV, V86, pS21, DOI 10.1016/j.earlhumdev.2010.01.014; Higgins RD, 2012, J PEDIATR-US, V160, P511, DOI 10.1016/j.jpeds.2011.12.024; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; HUGHES CA, 1983, GUT, V24, P241, DOI 10.1136/gut.24.3.241; Isayama T, 2012, PEDIATRICS, V130, pE957, DOI 10.1542/peds.2012-0336; Janeiro P, 2010, EUR J PEDIATR, V169, P99, DOI 10.1007/s00431-009-0995-z; KENNEDY KA, 2000, COCHRANE DB SYST REV; Kono Y, 2008, PEDIATR INT, V50, P23, DOI 10.1111/j.1442-200X.2007.02516.x; Kono Y, 2011, PEDIATR INT, V53, P1051, DOI 10.1111/j.1442-200X.2011.03480.x; Kusuda S, 2006, PEDIATRICS, V118, pE1130, DOI 10.1542/peds.2005-2724; Kusuda S, 2012, PEDIATR RES, V72, P531, DOI 10.1038/pr.2012.114; Maggio L, 2007, J PEDIATR GASTR NUTR, V44, P124, DOI 10.1097/01.mpg.0000237927.00105.f7; Martin CR, 2009, PEDIATRICS, V124, P649, DOI 10.1542/peds.2008-3258; Moyses HE, 2013, AM J CLIN NUTR, V97, P816, DOI 10.3945/ajcn.112.042028; Poindexter BB, 2006, J PEDIATR-US, V148, P300, DOI 10.1016/j.jpeds.2005.10.038; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Trintis J, 2010, J PERINATOL, V30, P403, DOI 10.1038/jp.2009.173; Uehara R, 2011, J EPIDEMIOL, V21, P217, DOI 10.2188/jea.JE20100123; Uhing MR, 2009, CLIN PERINATOL, V36, P165, DOI 10.1016/j.clp.2008.09.010; Garcia LV, 2012, AN PEDIATR, V76, P127, DOI 10.1016/j.anpedi.2011.04.007; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88392	10.1371/journal.pone.0088392	http://dx.doi.org/10.1371/journal.pone.0088392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586323	Green Published, gold, Green Submitted			2022-12-25	WOS:000331711900027
J	Kolfschoten, NE; Marang-van de Mheen, PJ; Wouters, MWJM; Eddes, EH; Tollenaar, RAEM; Stijnen, T; Kievit, J				Kolfschoten, Nikki E.; Marang-van de Mheen, Perla J.; Wouters, Michel W. J. M.; Eddes, Eric-Hans; Tollenaar, Rob A. E. M.; Stijnen, Theo; Kievit, Job		Dutch Surgical Colorectal Audit	A Combined Measure of Procedural Volume and Outcome to Assess Hospital Quality of Colorectal Cancer Surgery, a Secondary Analysis of Clinical Audit Data	PLOS ONE			English	Article							AFFAIRS SURGICAL RISK; VETERANS-AFFAIRS; OF-CARE; MORTALITY; NETHERLANDS; ADJUSTMENT	Objective: To identify, on the basis of past performance, those hospitals that demonstrate good outcomes in sufficient numbers to make it likely that they will provide adequate quality of care in the future, using a combined measure of volume and outcome (CM-V&O). To compare this CM-V&O with measures using outcome-only (O-O) or volume-only (V-O), and verify 2010-quality of care assessment on 2011 data. Design: Secondary analysis of clinical audit data. Setting: The Dutch Surgical Colorectal Audit database of 2010 and 2011, the Netherlands. Participants: 8911 patients (test population, treated in 2010) and 9212 patients (verification population, treated in 2011) who underwent a resection of primary colorectal cancer in 89 Dutch hospitals. Main Outcome Measures: Outcome was measured by Observed/Expected (O/E) postoperative mortality and morbidity. CM-V&O states 2 criteria; 1) outcome is not significantly worse than average, and 2) outcome is significantly better than substandard, with 'substandard care' being defined as an unacceptably high O/E threshold for mortality and/or morbidity (which we set at 2 and 1.5 respectively). Results: Average mortality and morbidity in 2010 were 4.1 and 24.3% respectively. 84 (94%) hospitals performed 'not worse than average' for mortality, but only 21 (24%) of those were able to prove they were also 'better than substandard' (O/E, 2). For morbidity, 42 hospitals (47%) met the CM-V&O. Morbidity in 2011 was significantly lower in these hospitals (19.8 vs. 22.8% p<0.01). No relationship was found between hospitals' 2010 performance on O-O en V-O, and the quality of their care in 2011. Conclusion: CM-V&O for morbidity can be used to identify hospitals that provide adequate quality and is associated with better outcomes in the subsequent year.	[Kolfschoten, Nikki E.; Tollenaar, Rob A. E. M.; Kievit, Job] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Kolfschoten, Nikki E.; Marang-van de Mheen, Perla J.; Kievit, Job] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Wouters, Michel W. J. M.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands; [Eddes, Eric-Hans] Deventer Hosp, Dept Surg, Deventer, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Biostat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Deventer Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kievit, J (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	j.kievit@lumc.nl	de Mheen, Perla J. Marang-van/I-2783-2015; Rutten, Harm J/H-9595-2017; Meijerink, Wilhelmus JHJ/T-3619-2017; Wouters, Michel/B-5882-2019	de Mheen, Perla J. Marang-van/0000-0003-1439-0989; Meijerink, Wilhelmus JHJ/0000-0002-5402-0811; Wouters, Michel/0000-0001-6173-0662				Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLAMEY RW, 2006, EUROPEAN GUIDELINES, P343; Daley J, 1997, J AM COLL SURGEONS, V185, P328, DOI 10.1016/S1072-7515(01)00939-5; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Dimick JB, 2009, HEALTH AFFAIR, V28, P1189, DOI 10.1377/hlthaff.28.4.1189; Elferink M A G, 2010, Eur J Surg Oncol, V36 Suppl 1, pS74, DOI 10.1016/j.ejso.2010.06.028; Khuri SF, 1997, J AM COLL SURGEONS, V185, P315, DOI 10.1016/S1072-7515(01)00938-3; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; Kolfschoten NE, 2013, EJSO-EUR J SURG ONC, V39, P156, DOI 10.1016/j.ejso.2012.10.007; Kolfschoten NE, 2011, EJSO-EUR J SURG ONC, V37, P956, DOI 10.1016/j.ejso.2011.08.137; Medicine Io, 1990, MED STRAT QUAL ASS C, V1, P468; Simunovic M, ANN SURG ONCOL, V17, P2537; Sonnenday CJ, 2010, ANN SURG ONCOL, V17, P2535, DOI 10.1245/s10434-010-1117-x; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P869, DOI 10.1136/bmjqs.2010.048058; van Gijn W, 2010, Eur J Surg Oncol, V36 Suppl 1, pS55, DOI 10.1016/j.ejso.2010.06.027; Van Gijn W, 2009, J SURG ONCOL, V99, P491, DOI 10.1002/jso.21203; Van Leersum NJ, 2013, EUR J SURG ONCOL; Westaby S, 2007, BRIT MED J, V335, P759, DOI 10.1136/bmj.39318.644549.AE; Wouters MWJM, 2009, J SURG ONCOL, V99, P481, DOI 10.1002/jso.21191; Wouters M, 2008, J SURG ONCOL, V98, P307, DOI 10.1002/jso.21100	21	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88737	10.1371/journal.pone.0088737	http://dx.doi.org/10.1371/journal.pone.0088737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558418	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700064
J	Niitsu, S; Toga, K; Tomizuka, S; Maekawa, K; Machida, R; Kamito, T				Niitsu, Shuhei; Toga, Kouhei; Tomizuka, Shigekazu; Maekawa, Kiyoto; Machida, Ryuichiro; Kamito, Takehiko			Ecdysteroid-Induced Programmed Cell Death Is Essential for Sex-Specific Wing Degeneration of the Wingless-Female Winter Moth	PLOS ONE			English	Article							BAGWORM MOTH; LEPIDOPTERA; APOPTOSIS; FLIGHTLESSNESS; PUPAE; AUTOPHAGY; EVOLUTION; ECDYSONE; DIAPAUSE; DISCS	The winter moth, Nyssiodes lefuarius, has a unique life history in that adults appear during early spring after a long pupal diapause from summer to winter. The moth exhibits striking sexual dimorphism in wing form; males have functional wings of normal size, whereas females lack wings. We previously found that cell death of the pupal epithelium of females appears to display condensed chromatin within phagocytes. To provide additional detailed data for interpreting the role of cell death, we performed light microscopy, transmission electron microscopy, and TUNEL assay. We consequently detected two modes of cell death, i.e., dying cells showed both DNA fragmentation derived from epithelial nuclei and autophagic vacuole formation. To elucidate the switching mechanism of sex-specific wing degeneration in females of N. lefuarius, we tested the effects of the steroid hormone 20-hydroxyecdysone (20E) on pupal diapause termination and wing morphogenesis in both sexes. When 20E (5.4 mu g) was injected into both sexes within 2 days of pupation, wing degeneration started 4 days after 20E injection in females, whereas wing morphogenesis and scale formation started 6 days after 20E injection in males. We discuss two important findings: (1) degeneration of the pupal wing epithelium of females was not only due to apoptosis and phagocytotic activation but also to autophagy and epithelial cell shrinkage; and (2) 20E terminated the summer diapause of pupae, and triggered selective programmed cell death only of the female-pupal wing epithelium in the wingless female winter moth.	[Niitsu, Shuhei; Kamito, Takehiko] Int Christian Univ, Dept Life Sci, Tokyo, Japan; [Niitsu, Shuhei] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan; [Toga, Kouhei; Maekawa, Kiyoto] Toyama Univ, Grad Sch Sci & Engn, Toyama 930, Japan; [Tomizuka, Shigekazu] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tomizuka, Shigekazu; Machida, Ryuichiro] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano, Japan	International Christian University; Tokyo Metropolitan University; University of Toyama; University of Tsukuba; University of Tsukuba	Niitsu, S (corresponding author), Int Christian Univ, Dept Life Sci, Tokyo, Japan.	shu-30@aioros.ocn.ne.jp	Toga, Kouhei/AHC-4090-2022	Toga, Kouhei/0000-0001-7244-5920; Maekawa, Kiyoto/0000-0002-2354-1059				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Andersen Nils Moller, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P91; [Anonymous], 1998, TINEA; ARPAGAUS M, 1986, REPROD NUTR DEV, V26, P1305; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; BODNARYK RP, 1985, J INSECT PHYSIOL, V31, P53, DOI 10.1016/0022-1910(85)90042-3; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Common IFB, 1970, INSECTS AUSTR; Fedotov DM, 1939, CR ACAD SCI URSS, V24, P616; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fujiwara H, 2001, DEV GENES EVOL, V211, P118, DOI 10.1007/s004270000131; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HACKMAN WALTER, 1966, NOTULAE ENTOMOL, V46, P1; Hafez M., 1969, Bulletin de la Societe Entomologique d'Egypte, V53, P161; Hamilton WD, 1978, DIVERSITY INSECT FAU; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P11; Ishizuya-Oka A, 2010, APOPTOSIS, V15, P350, DOI 10.1007/s10495-009-0422-y; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIMURA T, 1977, Kontyu, V45, P97; KODAMA R, 1995, ROUX ARCH DEV BIOL, V204, P418, DOI 10.1007/BF00360849; Koenuma A, 1987, J FS SHINSHU U, V22, P67; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lobbia S, 2007, ARCH INSECT BIOCHEM, V65, P152, DOI 10.1002/arch.20192; Lobbia S, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.11; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Matsuda R., 1979, P137; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Montero JA, 2010, APOPTOSIS, V15, P365, DOI 10.1007/s10495-009-0444-5; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; NARDI JB, 1991, J MORPHOL, V209, P121, DOI 10.1002/jmor.1052090110; Niitsu S, 2003, J MORPHOL, V257, P164, DOI 10.1002/jmor.10116; Niitsu S, 2008, CELL TISSUE RES, V333, P169, DOI 10.1007/s00441-008-0615-7; Niitsu S, 2011, TISSUE CELL, V43, P143, DOI 10.1016/j.tice.2011.01.003; Niitsu Shuhei, 2001, Entomological Science, V4, P1; Niitsu S, 2008, EUR J ENTOMOL, V105, P697, DOI 10.14411/eje.2008.095; QUENNEDEY A, 1990, TISSUE CELL, V22, P721, DOI 10.1016/0040-8166(90)90067-J; Riddiford L.M., 1985, P37; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Sameshima SY, 2004, EVOL DEV, V6, P336, DOI 10.1111/j.1525-142X.2004.04041.x; SATO T, 1977, JPN J APPL ENTOMOL Z, V21, P6, DOI 10.1303/jjaez.21.6; Sattler K., 1991, Bulletin of the British Museum (Natural History) Entomology, V60, P243; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Suzuki D, 2009, DEV BIOL, V335, P396, DOI 10.1016/j.ydbio.2009.09.014; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; WILLIAMS CM, 1968, BIOL BULL, V134, P344, DOI 10.2307/1539610; Zuzarte-Luis V, 2002, INT J DEV BIOL, V46, P871	49	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89435	10.1371/journal.pone.0089435	http://dx.doi.org/10.1371/journal.pone.0089435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558499	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700145
J	Paquet, F; Delalande, O; Goffinont, S; Culard, F; Loth, K; Asseline, U; Castaing, B; Landon, C				Paquet, Francoise; Delalande, Olivier; Goffinont, Stephane; Culard, Francoise; Loth, Karine; Asseline, Ulysse; Castaing, Bertrand; Landon, Celine			Model of a DNA-Protein Complex of the Architectural Monomeric Protein MC1 from Euryarchaea	PLOS ONE			English	Article							INTEGRATION HOST FACTOR; CHROMOSOMAL-PROTEIN; MINOR-GROOVE; CRYSTAL-STRUCTURE; THERMOPLASMA-ACIDOPHILUM; TRANSCRIPTION FACTOR; WEB SERVER; BINDING; RECOGNITION; CHROMATIN	In Archaea the two major modes of DNA packaging are wrapping by histone proteins or bending by architectural nonhistone proteins. To supplement our knowledge about the binding mode of the different DNA-bending proteins observed across the three domains of life, we present here the first model of a complex in which the monomeric Methanogen Chromosomal protein 1 (MC1) from Euryarchaea binds to the concave side of a strongly bent DNA. In laboratory growth conditions MC1 is the most abundant architectural protein present in Methanosarcina thermophila CHTI55. Like most proteins that strongly bend DNA, MC1 is known to bind in the minor groove. Interaction areas for MC1 and DNA were mapped by Nuclear Magnetic Resonance (NMR) data. The polarity of protein binding was determined using paramagnetic probes attached to the DNA. The first structural model of the DNA-MC1 complex we propose here was obtained by two complementary docking approaches and is in good agreement with the experimental data previously provided by electron microscopy and biochemistry. Residues essential to DNA-binding and -bending were highlighted and confirmed by site-directed mutagenesis. It was found that the Arg25 side-chain was essential to neutralize the negative charge of two phosphates that come very close in response to a dramatic curvature of the DNA.	[Paquet, Francoise; Goffinont, Stephane; Culard, Francoise; Loth, Karine; Asseline, Ulysse; Castaing, Bertrand; Landon, Celine] Univ Orleans, CNRS, UPR 4301, Ctr Biophys Mol, Orleans, France; [Delalande, Olivier] Univ Rennes 1, CNRS, UMR 6290, Fac Sci Pharmaceut & Biol,Inst Genet & Dev Rennes, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Paquet, F (corresponding author), Univ Orleans, CNRS, UPR 4301, Ctr Biophys Mol, Orleans, France.	francoise.paquet@cnrs-orleans.fr		Castaing, Bertrand/0000-0001-5077-8978; PAQUET, Francoise/0000-0001-8838-3445	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	Funds result from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh AM, 2008, J THEOR BIOL, V252, P742, DOI 10.1016/j.jtbi.2008.02.033; Agback P, 1998, NAT STRUCT BIOL, V5, P579, DOI 10.1038/836; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bao QY, 2007, J MOL BIOL, V367, P731, DOI 10.1016/j.jmb.2006.09.082; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Blanchet C, 2011, NUCLEIC ACIDS RES, V39, pW68, DOI 10.1093/nar/gkr316; Bure C, 2008, J MOL BIOL, V376, P120, DOI 10.1016/j.jmb.2007.11.057; CHARTIER F, 1988, BIOCHIM BIOPHYS ACTA, V951, P149, DOI 10.1016/0167-4781(88)90035-8; Chen CY, 2005, NUCLEIC ACIDS RES, V33, P430, DOI 10.1093/nar/gki191; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cordeiro TN, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002380; Culard F, 2003, J MOL BIOL, V328, P1185, DOI 10.1016/S0022-2836(03)00361-9; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; De Vuyst G, 2005, BIOCHEMISTRY-US, V44, P10369, DOI 10.1021/bi0474416; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELANGE RJ, 1981, J BIOL CHEM, V256, P900; DELANGE RJ, 1981, J BIOL CHEM, V256, P905; DeLano W, 2002, PYMOL 0 99; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Ellenberger T, 1997, STRUCTURE, V5, P153, DOI 10.1016/S0969-2126(97)00174-3; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Feng YG, 2010, PROTEIN SCI, V19, P1253, DOI 10.1002/pro.385; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; Huber EM, 2012, STRUCTURE, V20, P1757, DOI 10.1016/j.str.2012.07.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Klass J, 2003, NUCLEIC ACIDS RES, V31, P2852, DOI 10.1093/nar/gkg389; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Le Cam E, 1999, J MOL BIOL, V285, P1011, DOI 10.1006/jmbi.1998.2321; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Mouw KW, 2007, MOL MICROBIOL, V63, P1319, DOI 10.1111/j.1365-2958.2007.05586.x; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paquet F, 2004, BIOCHEMISTRY-US, V43, P14971, DOI 10.1021/bi048382z; Paquet F, 2010, FEBS J, V277, P5133, DOI 10.1111/j.1742-4658.2010.07927.x; Paradinas C, 1998, EUR J BIOCHEM, V257, P372, DOI 10.1046/j.1432-1327.1998.2570372.x; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rubio-Cosials A, 2011, NAT STRUCT MOL BIOL, V18, P1281, DOI 10.1038/nsmb.2160; Saladin A, 2010, NUCLEIC ACIDS RES, V38, P6313, DOI 10.1093/nar/gkq459; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stratmann D, 2011, PROTEINS, V79, P2662, DOI 10.1002/prot.23090; Su SY, 2000, J MOL BIOL, V303, P395, DOI 10.1006/jmbi.2000.4112; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; TEYSSIER C, 1994, BIOCHEM J, V303, P567, DOI 10.1042/bj3030567; Teyssier C, 1996, BIOCHEMISTRY-US, V35, P7954, DOI 10.1021/bi952414o; Tolstorukov MY, 2007, J MOL BIOL, V371, P725, DOI 10.1016/j.jmb.2007.05.048; van Dijk M, 2010, NUCLEIC ACIDS RES, V38, P5634, DOI 10.1093/nar/gkq222; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Zhang ZF, 2010, MOL MICROBIOL, V76, P749, DOI 10.1111/j.1365-2958.2010.07136.x; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	67	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88809	10.1371/journal.pone.0088809	http://dx.doi.org/10.1371/journal.pone.0088809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558431	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700077
J	Santoro, M; Mattiucci, S; Cipriani, P; Bellisario, B; Romanelli, F; Cimmaruta, R; Nascetti, G				Santoro, Mario; Mattiucci, Simonetta; Cipriani, Paolo; Bellisario, Bruno; Romanelli, Francesco; Cimmaruta, Roberta; Nascetti, Giuseppe			Parasite Communities of Icefish (Chionodraco hamatus) in the Ross Sea (Antarctica): Influence of the Host Sex on the Helminth Infracommunity Structure	PLOS ONE			English	Article							SOUTH-SHETLAND ISLANDS; METAZOAN PARASITES; FISH; ACANTHOCEPHALA; SPECIFICITY; INFECTION; PATTERNS; NEMATODA; CYCLE; RANK	Parasite communities of Chionodraco hamatus were investigated from Terra Nova Bay (Ross Sea, Antarctica) during host spawning time. Special attention was given to helminth infracommunities and effect of host sex on its structure. A total of 21 taxa including 5 ecto-parasites and 16 endo-parasites were identified. The number of ecto and endo-parasite species per individual host ranged from 1 to 3 and 3 to 10, respectively, while the mean numbers of parasite specimens per individual host were 4.7 and 1309.7, respectively. The rich abundance of infection suggests a rich concentration of helminth intermediate/paratenic hosts in the coastal waters of Terra Nova Bay. Chionodraco hamatus serves as a definitive host for 10 helminth taxa, while it acts as an intermediate/paratenic host for 6 helminth taxa. Larvae of 6 helminth taxa for which C. hamatus serves as intermediate/paratenic host represented 98.7% of all specimens found. Of these, the tetraphyllidean and diphyllobothridean cestodes and the nematode Contracaecum osculatum s.l. were the most prevalent and abundant. 'Larval' infracommunities had significantly higher species richness, total abundance and diversity than 'adult' infracommunities, suggesting the important role of C. hamatus in supporting the life cycles of those parasites in the study area as a paratenic/intermediate host. Significant differences in the pattern of helminth infracommunities of larval forms between male and female fish were found. These differences could be caused by physiological, and most probably by behavioral differences between sexes suggesting that sex is an important factor influencing parasite burden in C. hamatus during reproductive season.	[Santoro, Mario; Mattiucci, Simonetta; Cipriani, Paolo] Univ Roma La Sapienza, Sect Parasitol, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Bellisario, Bruno; Cimmaruta, Roberta; Nascetti, Giuseppe] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Romanelli, Francesco] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Sapienza University Rome; Tuscia University; Sapienza University Rome	Santoro, M (corresponding author), Univ Roma La Sapienza, Sect Parasitol, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marisant@libero.it	Bellisario, Bruno/D-5766-2015; Cimmaruta, Roberta/AAC-9151-2020; Bellisario, Bruno/S-2651-2019; Romanelli, Francesco/A-7925-2012; Santoro, Mario/K-3251-2019; Mattiucci, Simonetta/K-5285-2018; Nascetti, Giuseppe/AAA-6396-2020	Bellisario, Bruno/0000-0002-5339-0757; cipriani, paolo/0000-0003-4599-7724; Cimmaruta, Roberta/0000-0002-1421-5155; Nascetti, Giuseppe/0000-0002-1159-8103	Italian Ministry of Education and Research (MIUR), Programma Nazionale di Ricerche in Antartide	Italian Ministry of Education and Research (MIUR), Programma Nazionale di Ricerche in Antartide(Ministry of Education, Universities and Research (MIUR))	This study was supported by Italian Ministry of Education and Research (MIUR), Programma Nazionale di Ricerche in Antartide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2006, 0607 CCAMLR; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ARDUINO P, 1995, SYST PARASITOL, V30, P1, DOI 10.1007/BF00009238; Bartoli P, 2000, J HELMINTHOL, V74, P289; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gaevskaya A.V., 1982, Nauchnye Doklady Vysshei Shkoly Biologicheskie Nauki, V1982, P27; Garcia A, 2008, J FISH BIOL, V73, P2274, DOI 10.1111/j.1095-8649.2008.02072.x; George-Nascimento M, 2004, ECOL LETT, V7, P527, DOI 10.1111/j.1461-0248.2004.00609.x; George-Nascimento M, 2002, REV CHIL HIST NAT, V75, P835; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Holmes J.C., 1986, P187; Klimpel S, 2003, PARASITOL RES, V91, P290, DOI 10.1007/s00436-003-0957-8; Klimpel S, 2006, MAR ECOL PROG SER, V315, P249, DOI 10.3354/meps315249; Kock KH, 2005, POLAR BIOL, V28, P897, DOI [10.1007/s00300-005-0019-z, 10.1007/s00300-005-0020-6]; KOCK KH, 1991, ANTARCT SCI, V3, P125, DOI 10.1017/S0954102091000172; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; La Mesa M, 2004, POLAR BIOL, V27, P321, DOI 10.1007/s00300-004-0599-z; Lagrue C, 2011, J FISH BIOL, V79, P466, DOI 10.1111/j.1095-8649.2011.03041.x; Laskowski Z, 2010, ACTA PARASITOL, V55, P161, DOI 10.2478/s11686-010-0022-6; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Marcogliese DJ, 2002, PARASITOLOGY, V124, pS83, DOI 10.1017/S003118200200149X; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; ORECCHIA P, 1994, INT J PARASITOL, V24, P367, DOI 10.1016/0020-7519(94)90084-1; Palm HW, 2007, POLAR BIOL, V30, P1513, DOI 10.1007/s00300-007-0312-0; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Rocka A, 2006, ACTA PARASITOL, V51, P26, DOI 10.2478/s11686-006-0003-y; Rocka Anna, 2003, Polish Polar Research, V24, P261; Rokicki Jerzy, 1992, Polish Polar Research, V13, P53; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Santoro M, 2013, J HELMINTHOL, V87, P277, DOI 10.1017/S0022149X12000338; Santoro M, 2013, DIS AQUAT ORGAN, V105, P139, DOI 10.3354/dao02626; Santoro M, 2010, PARASITOL INT, V59, P367, DOI 10.1016/j.parint.2010.04.009; SAWYER RT, 1986, LEECH BIOL BEHAV FEE; SIEGEL V, 1980, MEERESFORSCHUNG, V28, P146; Simkova A, 2005, PARASITOL RES, V95, P65, DOI 10.1007/s00436-004-1261-y; Sutton CP, 2008, CCAMLR SCI, V15, P139; Tompkins DM, 1999, PARASITOLOGY, V118, P417, DOI 10.1017/S0031182098003886; Wojciechowska Anna, 1993, Acta Parasitologica, V38, P15; Zdzitowiecki K., 1999, Parassitologia (Rome), V41, P575; Zdzitowiecki K, 2001, ACTA PARASITOL, V46, P202; ZDZITOWIECKI K, 1997, SYNOPSES ANTARCTIC B, V8; ZDZITOWIECKI K, 1991, SYNOPSES ANTARCTIC B, V3; Zdzitowiecki Krzysztof, 2001, Polish Polar Research, V22, P205; Zdzitowiecki Krzysztof, 1999, Polish Polar Research, V20, P59	49	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88876	10.1371/journal.pone.0088876	http://dx.doi.org/10.1371/journal.pone.0088876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558440	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700086
J	Hu, JJ; Lu, J; Lian, GW; Zhang, JP; Hecht, JL; Sheen, VL				Hu, Jianjun; Lu, Jie; Lian, Gewei; Zhang, Jingping; Hecht, Jonathan L.; Sheen, Volney L.			Filamin B Regulates Chondrocyte Proliferation and Differentiation through Cdk1 Signaling	PLOS ONE			English	Article							CELL-CYCLE; INDIAN-HEDGEHOG; SKELETAL DEVELOPMENT; BONE-GROWTH; STEM-CELLS; MUTATIONS; CARTILAGE; MITOSIS; BINDING; FLNB	Humans who harbor loss of function mutations in the actin-associated filamin B (FLNB) gene develop spondylocarpotarsal syndrome (SCT), a disorder characterized by dwarfism (delayed bone formation) and premature fusion of the vertebral, carpal and tarsal bones (premature differentiation). To better understand the cellular and molecular mechanisms governing these seemingly divergent processes, we generated and characterized FlnB knockdown ATDC5 cell lines. We found that FlnB knockdown led to reduced proliferation and enhanced differentiation in chondrocytes. Within the shortened growth plate of postnatal FlnB(-/-) mice long bone, we observed a similarly progressive decline in the number of rapidly proliferating chondrocytes and premature differentiation characterized by an enlarged prehypertrophic zone, a widened Col2a1(+)/Col10a1(+) overlapping region, but relatively reduced hypertrophic zone length. The reduced chondrocyte proliferation and premature differentiation were, in part, attributable to enhanced G2/M phase progression, where fewer FlnB deficient ATDC5 chondrocytes resided in the G2/M phase of the cell cycle. FlnB loss reduced Cdk1 phosphorylation (an inhibitor of G2/M phase progression) and Cdk1 inhibition in chondrocytes mimicked the null FlnB, premature differentiation phenotype, through a beta 1-integrin receptor-Pi3k/Akt (a key regulator of chondrocyte differentiation) mediated pathway. In this context, the early prehypertrophic differentiation provides an explanation for the premature differentiation seen in this disorder, whereas the progressive decline in proliferating chondrocytes would ultimately lead to reduced chondrocyte production and shortened bone length. These findings begin to define a role for filamin proteins in directing both cell proliferation and differentiation through indirect regulation of cell cycle associated proteins.	[Hu, Jianjun; Lu, Jie; Lian, Gewei; Zhang, Jingping; Sheen, Volney L.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Hu, Jianjun; Lu, Jie; Lian, Gewei; Zhang, Jingping; Hecht, Jonathan L.; Sheen, Volney L.] Harvard Univ, Sch Med, Boston, MA USA; [Hecht, Jonathan L.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Sheen, VL (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	vsheen@bidmc.harvard.edu	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617; Lu, Jie/0000-0001-6843-9720	National Institutes of Health [NS063997-01]; Empire State Stem Cell Fund [the New York State Department of Health] [C024324]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063997, R01NS092062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell Fund [the New York State Department of Health]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health [NS063997-01 to VLS]. This work was also supported in part by the Empire State Stem Cell Fund [the New York State Department of Health Contract # C024324 to VLS]. The opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani A, 1996, ANTICANCER RES, V16, P3585; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bicknell LS, 2007, J MED GENET, V44, P89, DOI 10.1136/jmg.2006.043687; Bicknell LS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029967; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Farrington-Rock C, 2006, HUM MUTAT, V27, P705, DOI 10.1002/humu.20348; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Irniger S, 2002, FEBS LETT, V532, P7, DOI 10.1016/S0014-5793(02)03657-8; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Leise WF, 2002, DEV BIOL, V249, P156, DOI 10.1006/dbio.2002.0743; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; Lunstrum GP, 1999, J HISTOCHEM CYTOCHEM, V47, P1, DOI 10.1177/002215549904700101; MacPherson M, 2010, AM J PHYSIOL-CELL PH, V298, pC206, DOI 10.1152/ajpcell.00505.2009; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; PINES J, 1991, CELL GROWTH DIFFER, V2, P305; Razinia Z, 2011, J CELL SCI, V124, P2631, DOI 10.1242/jcs.084343; REICHENBERGER E, 1991, DEV BIOL, V148, P562, DOI 10.1016/0012-1606(91)90274-7; Reichert H, 2011, RESULTS PROBL CELL D, V53, P529, DOI 10.1007/978-3-642-19065-0_21; SARTOR H, 1992, GENOMICS, V13, P911, DOI 10.1016/0888-7543(92)90190-4; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sebastian A, 2011, J ORTHOP RES, V29, P375, DOI 10.1002/jor.21262; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zheng L, 2007, J CELL BIOL, V178, P121, DOI 10.1083/jcb.200703113; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	43	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89352	10.1371/journal.pone.0089352	http://dx.doi.org/10.1371/journal.pone.0089352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551245	gold, Green Submitted, Green Published			2022-12-25	WOS:000331271500109
J	Lu, QY; Zhao, L; Li, DM; Hao, DQ; Zhan, Y; Li, WB				Lu, Qingyao; Zhao, Lin; Li, Dongmei; Hao, Diqiu; Zhan, Yong; Li, Wenbin			A GMRAV Ortholog Is Involved in Photoperiod and Sucrose Control of Flowering Time in Soybean	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LOCUS-T; SUGAR; GENE; EXPRESSION; MUTANTS; PHOTOSYNTHESIS; TRANSCRIPTION; SIGNALS; GLUCOSE	Photoperiod and sucrose levels play a key role in the control of flowering. GmRAV reflected a diurnal rhythm with the highest expression at 4 h after the beginning of a dark period in soybean leaves, and was highly up-regulated under shortday (SD) conditions, despite of not following a diurnal pattern under long-day (LD) conditions. GmRAV-i (GmRAV-inhibition) transgenic soybean exhibited early flowering phenotype. Two of the FT Arabidopsis homologs, GmFT2a and GmFT5a, were highly expressed in the leaves of soybeans with inhibition (-i) of GmRAV under SD conditions. Moreover, the transcript levels of the two FT homologs in GmRAV-i soybeans were more sensitive to SD conditions than LD conditions compared to the WT plant. GmRAV-i soybeans and Arabidopsis rav mutants showed more sensitive hypocotyl elongation responses when compared with wild-type seedlings, and GmRAV-ox overevpressed in tobacco revealed no sensitive changes in hypocotyl length. These indicated that GmRAV was a novel negative regulator of SD-mediated flowering and hypocotyl elongation. Although sucrose has been suggested to promote flowering induction in many plant species, high concentration of sucrose (4% [w/v]) applied into media defer flowering time in Arabidopsis wild-type and rav mutant. This delayed flowering stage might be caused by reduction of LEAFY expression. Furthermore, Arabidopsis rav mutants and GmRAV-i soybean plants were less sensitive to sucrose by the inhibition assays of hypocotyls and roots growth. In contrast, transgenic GmRAV overexpressing (-ox) tobacco plants displayed more sensitivity to sucrose. In conclusion, GmRAV was inferred to have a fundamental function in photoperiod, darkness, and sucrose signaling responses to regulate plant development and flowering induction.	[Lu, Qingyao; Zhao, Lin; Li, Dongmei; Hao, Diqiu; Li, Wenbin] Northeast Agr Univ, Key Lab Biol & Genet & Breeding Soybean Northeast, Minist Agr, Key Lab Soybean Biol,Chinese Educ Minist, Harbin, Peoples R China; [Zhan, Yong] Agr Acad Shi He Zi, Shihezi City, Xinjiang Provin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Zhao, L (corresponding author), Northeast Agr Univ, Key Lab Biol & Genet & Breeding Soybean Northeast, Minist Agr, Key Lab Soybean Biol,Chinese Educ Minist, Harbin, Peoples R China.	zhaolinneau@126.com; wenbinli@neau.edu.cn			National Core Soybean Genetic Engineering Project [2013ZX08004-1 003]; Chinese National Natural Science Foundation [31271748, 60932008, 31101169, 31201227]; National 973 Project [2012CB126311]; National 863 Project [2013AA102602, 2012AA101106-1-9]; Chinese Key Projects of Soybean Transformation [2013ZX08004-005]; Provincial/National Education Ministry project [1252G014, 1252-NCET-005, 20122325120012]; Provincial/National Education Ministry; Youth Backbone Research program of Provincial Education Department [1253G010]	National Core Soybean Genetic Engineering Project; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China); National 863 Project(National High Technology Research and Development Program of China); Chinese Key Projects of Soybean Transformation; Provincial/National Education Ministry project; Provincial/National Education Ministry; Youth Backbone Research program of Provincial Education Department	This study was conducted in the Key Laboratory of Soybean Biology of Chinese Education Ministry, Soybean Research & Development Center, CARS and the key Laboratory of Northeastern Soybean Biology and Breeding/Genetics of Chinese Agriculture Ministry, financially supported by National Core Soybean Genetic Engineering Project (Contract No. 2013ZX08004-1 003), Chinese National Natural Science Foundation (31271748, 60932008, 31101169, 31201227), National 973 Project (2012CB126311), National 863 Project (2013AA102602, 2012AA101106-1-9), Chinese Key Projects of Soybean Transformation (2013ZX08004-005), Provincial/National Education Ministry project (1252G014, 1252-NCET-005, 20122325120012), and Provincial/National Education Ministry for the team of soybean molecular design. Youth Backbone Research program of Provincial Education Department (1253G010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Amasino RM, 1996, CURR OPIN GENET DEV, V6, P480, DOI 10.1016/S0959-437X(96)80071-2; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Boxall SF, 1997, PLANT PHYSIOL, V114, pS247; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; CHEN MH, 1994, PLANT J, V6, P625, DOI 10.1046/j.1365-313X.1994.6050625.x; Corbesier L, 1998, PLANTA, V206, P131, DOI 10.1007/s004250050383; COUPLAND G, 1995, TRENDS GENET, V11, P393, DOI 10.1016/S0168-9525(00)89122-2; Dangl JL, 1995, CELL, V83, P1071, DOI 10.1016/0092-8674(95)90134-5; Destro D., 2001, Crop Breeding and Applied Biotechnology, V1, P72; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; HADLEY P, 1984, ANN BOT-LONDON, V53, P669, DOI 10.1093/oxfordjournals.aob.a086732; Heyer AG, 2004, PLANT J, V39, P161, DOI 10.1111/j.1365-313X.2004.02124.x; Hiraoka K, 2008, PLANT MORPHOL, V19, P3; Huang HR, 2012, NEW PHYTOL, V194, P676, DOI 10.1111/j.1469-8137.2012.04101.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; King RW, 2012, RUSS J PLANT PHYSL+, V59, P479, DOI 10.1134/S1021443712040061; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Koornneef M, 1998, GENETICS, V148, P885; Laby RJ, 2000, PLANT J, V23, P587, DOI 10.1046/j.1365-313x.2000.00833.x; Martin T, 1997, PLANT J, V11, P53, DOI 10.1046/j.1365-313X.1997.11010053.x; Mita S, 1997, PLANT J, V11, P841, DOI 10.1046/j.1365-313X.1997.11040841.x; Moreno-Cortes A, 2012, NEW PHYTOL, V194, P83, DOI 10.1111/j.1469-8137.2011.04023.x; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Pineiro M, 1998, PLANT PHYSIOL, V117, P1, DOI 10.1104/pp.117.1.1; PRIEM B, 1992, PLANT PHYSIOL, V98, P399, DOI 10.1104/pp.98.1.399; Roldan M, 1999, PLANT J, V20, P581, DOI 10.1046/j.1365-313X.1999.00632.x; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; SHEEN J, 1994, PHOTOSYNTH RES, V39, P427, DOI 10.1007/BF00014596; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stevenson CC, 2009, PLANT GROWTH REGUL, V59, P255, DOI 10.1007/s10725-009-9412-x; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; YORK WS, 1984, PLANT PHYSIOL, V75, P295, DOI 10.1104/pp.75.2.295; Zhang LX, 2001, AGRON J, V93, P944, DOI 10.2134/agronj2001.934944x; Zhao L, 2008, PLANTA, V227, P1389, DOI 10.1007/s00425-008-0711-7; Zhao L, 2012, J EXP BOT, V63, P3257, DOI 10.1093/jxb/ers056; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294	47	23	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89145	10.1371/journal.pone.0089145	http://dx.doi.org/10.1371/journal.pone.0089145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551235	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500101
J	Wilson, CB; Ebenezer, PJ; McLaughlin, LD; Francis, J				Wilson, C. Brad; Ebenezer, Philip J.; McLaughlin, Leslie D.; Francis, Joseph			Predator Exposure/Psychosocial Stress Animal Model of Post-Traumatic Stress Disorder Modulates Neurotransmitters in the Rat Hippocampus and Prefrontal Cortex	PLOS ONE			English	Article							TRAUMATIC MEMORY; SEROTONIN; DOPAMINE; NOREPINEPHRINE; PTSD; ANXIETY; SYMPTOMS; AMYGDALA; BINDING; PROTEIN	Post-Traumatic Stress Disorder (PTSD) can develop in response to a traumatic event involving a threat to life. To date, no diagnostic biomarkers have been identified for PTSD. Recent research points toward physiological abnormalities in the hypothalamic-pituitary-adrenal (HPA) axis, sympathoadrenal medullary and immune system that may be implicated in the disorder. The modulation of neurotransmitters is another possible mechanism, but their role in the progression of PTSD is poorly understood. Low serotonin (5-HT) may be a factor, but it may not be the only neurotransmitter affected as modulation affects levels of other neurotransmitters. In this study, we hypothesized the predator exposure/psychosocial stress rodent model of PTSD may alter levels of 5-HT and other neurotransmitters in the rat hippocampus and prefrontal cortex (PFC). Male Sprague-Dawley rats were used in this experiment. We induced PTSD via a predator exposure/psychosocial stress model, whereby rats were placed in a cage with a cat for 1 hour on days 1 and 11 of the 31-day experiment. Rats also received psychosocial stress via daily cage cohort changes. On day 32, the rats were sacrificed and the brains dissected to remove the hippocampus and PFC. Norepinephrine (NE), 5-Hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), dopamine (DA), and 3,4-Dihydroxyphenylacetic acid (DOPAC), and 5-HT levels in the hippocampus and PFC were measured with high-performance liquid chromatography (HPLC). In the hippocampus, 5-HT and HVA were lower, while NE and DOPAC were higher, in the PTSD group vs. controls. In the PFC, only 5-HT was lower, while NE, DA, and DOPAC were higher, in the PTSD group vs. controls. The rate limiting enzymes tyrosine hydroxylase and tryptophan hydroxylase were also examined and confirmed our findings. These results demonstrate that the predator exposure/psychosocial stress model of PTSD produces neurotransmitter changes similar to those seen in human patients and may cause a heightened noradrenergic response.	[Wilson, C. Brad; Ebenezer, Philip J.; McLaughlin, Leslie D.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	McLaughlin, LD (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	lmclaughlin@vetmed.lsu.edu; jfrancis@vetmed.lsu.edu			LSU SVM corps grant	LSU SVM corps grant	Funding provided via LSU SVM corps grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; ARORA RC, 1993, LIFE SCI, V53, P919, DOI 10.1016/0024-3205(93)90444-8; BLANCHARD RJ, 1975, J COMP PHYSIOL PSYCH, V88, P81, DOI 10.1037/h0076213; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Butts KA, 2011, P NATL ACAD SCI USA, V108, P18459, DOI 10.1073/pnas.1111746108; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Berumen LC, 2012, SCI WORLD J, DOI 10.1100/2012/823493; Dansie EJ, 2012, PSYCHOSOMATICS, V53, P250, DOI 10.1016/j.psym.2011.08.007; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1259, DOI 10.1016/S0006-3223(99)00044-X; Delamothe T, 2005, BRIT MED J, V331, P1489, DOI 10.1136/bmj.331.7531.1489; Deyama S, 2008, J NEUROSCI, V28, P7728, DOI 10.1523/JNEUROSCI.1480-08.2008; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; DUBOVSKY SL, 1994, J CLIN PSYCHIAT, V55, P34; Edmondson D, 2013, PROG CARDIOVASC DIS, V55, P548, DOI 10.1016/j.pcad.2013.03.004; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; Fisher PM, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-2; FRANCIS GS, 1993, CIRCULATION, V87, P40; GANGULY PK, 1986, CIRC RES, V59, P684, DOI 10.1161/01.RES.59.6.684; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; Geracioti TD, 2013, J PSYCHIATR RES, V47, P995, DOI 10.1016/j.jpsychires.2013.01.023; Glover DA, 2003, BEHAV BRAIN RES, V144, P137, DOI 10.1016/S0166-4328(03)00074-3; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Jurgens CWD, 2005, J PHARMACOL EXP THER, V314, P552, DOI 10.1124/jpet.105.085332; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130; Lukaschek K, 2013, J PSYCHOSOM RES, V74, P340, DOI 10.1016/j.jpsychores.2012.12.011; Muldoon MF, 2004, J CLIN ENDOCR METAB, V89, P266, DOI 10.1210/jc.2003-031295; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Peirson AR, 2000, PSYCHOL REP, V87, P707, DOI 10.2466/PR0.87.7.707-716; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sondergaard HP, 2004, CLIN CHIM ACTA, V342, P93, DOI 10.1016/j.cccn.2003.12.019; Southwick S M, 1999, Semin Clin Neuropsychiatry, V4, P242; Williams E, 2006, BIOL PSYCHOL, V71, P171, DOI 10.1016/j.biopsycho.2005.03.002; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613; Zoladz PR, 2013, PROG NEURO-PSYCHOPH, V44, P1, DOI 10.1016/j.pnpbp.2013.01.001	43	72	77	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89104	10.1371/journal.pone.0089104	http://dx.doi.org/10.1371/journal.pone.0089104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551226	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500098
J	Liao, JY; Hu, N; Zhou, NA; Lin, LB; Zhao, C; Yi, SX; Fan, TX; Bao, W; Liang, X; Chen, H; Xu, W; Chen, C; Cheng, Q; Zeng, YM; Si, WK; Yang, Z; Huang, W				Liao, Junyi; Hu, Ning; Zhou, Nian; Lin, Liangbo; Zhao, Chen; Yi, Shixiong; Fan, Tingxu; Bao, Wei; Liang, Xi; Chen, Hong; Xu, Wei; Chen, Cheng; Cheng, Qiang; Zeng, Yongming; Si, Weike; Yang, Zhong; Huang, Wei			Sox9 Potentiates BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic Differentiation (Publication with Expression of Concern. See vol. 16, 2021) (Publication with Expression of Concern. See vol. 16, 2021)	PLOS ONE			English	Article; Publication with Expression of Concern							MESENCHYMAL STEM-CELLS; MEDIATED GENE-TRANSFER; ENDOCHONDRAL OSSIFICATION; CARTILAGE DEVELOPMENT; TRANSCRIPTION FACTOR; BONE; GROWTH; RUNX2; CHONDROCYTES; EXPRESSION	Bone morphogenetic protein 2 (BMP2) is one of the key chondrogenic growth factors involved in the cartilage regeneration. However, it also exhibits osteogenic abilities and triggers endochondral ossification. Effective chondrogenesis and inhibition of BMP2-induced osteogenesis and endochondral ossification can be achieved by directing the mesenchymal stem cells (MSCs) towards chondrocyte lineage with chodrogenic factors, such as Sox9. Here we investigated the effects of Sox9 on BMP2-induced chondrogenic and osteogenic differentiation of MSCs. We found exogenous overexpression of Sox9 enhanced the BMP2-induced chondrogenic differentiation of MSCs in vitro. Also, it inhibited early and late osteogenic differentiation of MSCs in vitro. Subcutaneous stem cell implantation demonstrated Sox9 potentiated BMP2-induced cartilage formation and inhibited endochondral ossification. Mouse limb cultures indicated that BMP2 and Sox9 acted synergistically to stimulate chondrocytes proliferation, and Sox9 inhibited BMP2-induced chondrocytes hypertrophy and ossification. This study strongly suggests that Sox9 potentiates BMP2-induced MSCs chondrogenic differentiation and cartilage formation, and inhibits BMP2-induced MSCs osteogenic differentiation and endochondral ossification. Thus, exogenous overexpression of Sox9 in BMP2-induced mesenchymal stem cells differentiation may be a new strategy for cartilage tissue engineering.	[Liao, Junyi; Hu, Ning; Zhou, Nian; Lin, Liangbo; Zhao, Chen; Yi, Shixiong; Fan, Tingxu; Bao, Wei; Chen, Hong; Xu, Wei; Chen, Cheng; Cheng, Qiang; Huang, Wei] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China; [Zeng, Yongming] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Si, Weike; Yang, Zhong] Third Mil Med Univ, Dept Clin Hematol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Army Medical University	Huang, W (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing, Peoples R China.	huangwei68@263.net	Junyi, Liao/AAP-9076-2020; CHEN, Hong/AAC-7879-2019	CHEN, Hong/0000-0002-4152-624X; Cheng, Chen/0000-0002-8767-7895	National Natural Science Foundation of China [81371972, 31070875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant81371972 and 31070875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; An CH, 2010, ANN BIOMED ENG, V38, P1647, DOI 10.1007/s10439-009-9892-x; Augello A, 2010, EUR CELLS MATER, V20, P121; Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Benthien JP, 2011, KNEE SURG SPORT TR A, V19, P543, DOI 10.1007/s00167-010-1271-5; Cairns DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039642; Cao L, 2011, BIOMATERIALS, V32, P3910, DOI 10.1016/j.biomaterials.2011.02.014; Chen HM, 2009, J ORTHOP RES, V27, P1432, DOI 10.1002/jor.20905; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Cucchiarini M, 2012, J MOL MED; Cucchiarini M, 2011, TISSUE ENG PT A, V17, P1921, DOI [10.1089/ten.tea.2011.0018, 10.1089/ten.TEA.2011.0018]; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Dhinsa BS, 2012, CURR STEM CELL RES T, V7, P143; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Garza-Veloz I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4260; Guerit D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062582; Handorf AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022887; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534; Hu N, 2013, CELL PHYSIOL BIOCHEM, V32, P486, DOI 10.1159/000354453; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kao YJ, 2011, PHYSICIAN SPORTSMED, V39, P60, DOI 10.3810/psm.2011.11.1940; Kawato Y, 2011, BIOCHEM BIOPH RES CO, V416, P205, DOI 10.1016/j.bbrc.2011.11.026; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lin L, 2011, MOL THER, V19, P1426, DOI 10.1038/mt.2011.101; Longo UG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/168385; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090; Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669; Mi Z, 2003, ARTHRITIS RES THER, V5, pR132, DOI 10.1186/ar745; Nishimura R, 2012, FRONT BIOSCI-LANDMRK, V17, P2657, DOI 10.2741/4076; Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Park JS, 2011, BIOMATERIALS, V32, P3679, DOI 10.1016/j.biomaterials.2011.01.063; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rodriguez-Merchan EC, 2012, RHEUMATOL INT; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shintani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053086; Steinert AF, 2008, INJURY, V39, pS97, DOI 10.1016/j.injury.2008.01.034; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Venkatesan JK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt113; Wang JH, 2013, BONE, V57, P311, DOI 10.1016/j.bone.2013.08.015; Wang Y, 2013, DEV BIOL, V381, P301, DOI 10.1016/j.ydbio.2013.07.016; Woo EJ, 2013, CLIN ORTHOP RELAT R, V471, P1707, DOI 10.1007/s11999-012-2684-x; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang HN, 2011, BIOMATERIALS, V32, P7695, DOI 10.1016/j.biomaterials.2011.06.059; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu L, 2012, DEV BIOL, V372, P263, DOI 10.1016/j.ydbio.2012.09.021; Yu YY, 2010, BONE, V47, P65, DOI 10.1016/j.bone.2010.03.012	63	47	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89025	10.1371/journal.pone.0089025	http://dx.doi.org/10.1371/journal.pone.0089025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551211	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000092
J	Charitos, EI; Ziegler, PD; Stierle, U; Robinson, DR; Graf, B; Sievers, HH; Hanke, T				Charitos, Efstratios I.; Ziegler, Paul D.; Stierle, Ulrich; Robinson, Derek R.; Graf, Bernhard; Sievers, Hans-Hinrich; Hanke, Thorsten			How Often Should We Monitor for Reliable Detection of Atrial Fibrillation Recurrence? Efficiency Considerations and Implications for Study Design	PLOS ONE			English	Article							SURGICAL ABLATION; FOLLOW-UP; MANAGEMENT; CATHETER; TRIAL; ACCURACY; EPISODES; TIME	Objective: Although atrial fibrillation (AF) recurrence is unpredictable in terms of onset and duration, current intermittent rhythm monitoring (IRM) diagnostic modalities are short-termed and discontinuous. The aim of the present study was to investigate the necessary IRM frequency required to reliably detect recurrence of various AF recurrence patterns. Methods: The rhythm histories of 647 patients (mean AF burden: 12 +/- 22% of monitored time; 687 patient-years) with implantable continuous monitoring devices were reconstructed and analyzed. With the use of computationally intensive simulation, we evaluated the necessary IRM frequency to reliably detect AF recurrence of various AF phenotypes using IRM of various durations. Results: The IRM frequency required for reliable AF detection depends on the amount and temporal aggregation of the AF recurrence (p<0.0001) as well as the duration of the IRM (p<0.001). Reliable detection (>95% sensitivity) of AF recurrence required higher IRM frequencies (>12 24-hour; >6 7-day; >4 14-day; >3 30-day IRM per year; p<0.0001) than currently recommended. Lower IRM frequencies will under-detect AF recurrence and introduce significant bias in the evaluation of therapeutic interventions. More frequent but of shorter duration, IRMs (24-hour) are significantly more time effective (sensitivity per monitored time) than a fewer number of longer IRM durations (p<0.0001). Conclusions: Reliable AF recurrence detection requires higher IRM frequencies than currently recommended. Current IRM frequency recommendations will fail to diagnose a significant proportion of patients. Shorter duration but more frequent IRM strategies are significantly more efficient than longer IRM durations.	[Charitos, Efstratios I.; Stierle, Ulrich; Graf, Bernhard; Sievers, Hans-Hinrich; Hanke, Thorsten] Med Univ Lubeck, Dept Cardiac & Thorac Vasc Surg, D-23538 Lubeck, Germany; [Ziegler, Paul D.] Medtronic Inc, Minneapolis, MN USA; [Robinson, Derek R.] Univ Sussex, Sch Math & Phys Sci, Dept Math, Brighton, E Sussex, England	University of Lubeck; Medtronic; University of Sussex	Charitos, EI (corresponding author), Med Univ Lubeck, Dept Cardiac & Thorac Vasc Surg, D-23538 Lubeck, Germany.	efstratios.charitos@gmail.com	Charitos, Efstratios/AAG-2005-2020		AWS WA, USA (Education Coursework Grant) [EDU_Charitos_ULuebeckResearch_Fall2012]	AWS WA, USA (Education Coursework Grant)	The computational resources for this work were kindly provided by AWS WA, USA (Education Coursework Grant Award: EDU_Charitos_ULuebeckResearch_Fall2012). The grant donor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Calkins H, 2012, J INTERV CARD ELECTR, V33, P171, DOI 10.1007/s10840-012-9672-7; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Charitos EI, 2012, CIRCULATION, V126, P806, DOI 10.1161/CIRCULATIONAHA.112.098079; Charitos EI., 2013, ACP-APPL CARDIOPUL P, V17, P3; Crossley GH, 2011, J AM COLL CARDIOL, V57, P1181, DOI 10.1016/j.jacc.2010.12.012; Fusaro VA, 2013, CIRCULATION, V127, P517, DOI 10.1161/CIRCULATIONAHA.112.123034; Fusaro VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002147; Hanke T, 2009, CIRCULATION, V120, pS177, DOI 10.1161/CIRCULATIONAHA.108.838474; Henry L, 2010, INNOVATIONS, V5, P259, DOI 10.1097/IMI.0b013e3181ee5b42; Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852; Kaemmerer WF, 2001, J CARDIOVASC ELECTR, V12, P121, DOI 10.1046/j.1540-8167.2001.00121.x; Kamel H, 2013, STROKE, V44, P528, DOI 10.1161/STROKEAHA.112.679100; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Kottkamp H, 2004, J AM COLL CARDIOL, V44, P869, DOI 10.1016/j.jacc.2004.047.049; Passman RS, 2004, J CARDIOVASC ELECTR, V15, P773, DOI 10.1046/j.1540-8167.2004.03537.x; Purerfellner H, 2004, PACE, V27, P983, DOI 10.1111/j.1540-8159.2004.00569.x; Rosenberg MA, 2013, PACE, V36, P328, DOI 10.1111/pace.12053; Senatore G, 2005, J AM COLL CARDIOL, V45, P873, DOI 10.1016/j.jacc.2004.11.050; Strickberger SA, 2005, HEART RHYTHM, V2, P125, DOI 10.1016/j.hrthm.2004.10.042; Vasamreddy CR, 2006, J CARDIOVASC ELECTR, V17, P134, DOI 10.1111/j.1540-8167.2006.00359.x; Verma A, 2013, JAMA INTERN MED, V173, P149, DOI 10.1001/jamainternmed.2013.1561; Ziegler PD, 2006, HEART RHYTHM, V3, P1445, DOI 10.1016/j.hrthm.2006.07.030	23	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89022	10.1371/journal.pone.0089022	http://dx.doi.org/10.1371/journal.pone.0089022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563690	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000331262600128
J	Wang, X; Beitler, JJ; Wang, H; Lee, MJ; Huang, W; Koenig, L; Nannapaneni, S; Amin, ARMR; Bonner, M; Shin, HJC; Chen, ZG; Arbiser, JL; Shin, DM				Wang, Xu; Beitler, Jonathan J.; Wang, Hong; Lee, Michael J.; Huang, Wen; Koenig, Lydia; Nannapaneni, Sreenivas; Amin, A. R. M. Ruhul; Bonner, Michael; Shin, Hyung Ju C.; Chen, Zhuo Georgia; Arbiser, Jack L.; Shin, Dong M.			Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; KAPPA-B ACTIVATION; DRUG-RESISTANCE; DOWN-REGULATION; EXPRESSION; HEAD; INHIBITORS; SURVIVAL; PRODUCT	Resistance to chemotherapy remains a major obstacle in cancer therapy. This study aimed to evaluate the molecular mechanism and efficacy of honokiol in inducing apoptosis and enhancing paclitaxel chemotherapy in pre-clinical multi-drug resistant (MDR) cancer models, including lineage-derived human MDR (KB-8-5, KB-C1, KB-V1) and their parental drug sensitive KB-3-1 cancer cell lines. In vitro analyses demonstrated that honokiol effectively inhibited proliferation in KB-3-1 cells and the MDR derivatives (IC50 ranging 3.35 +/- 0.13 mu g/ml to 2.77 +/- 0.22 mu g/ml), despite their significant differences in response to paclitaxel (IC50 ranging 1.66 +/- 0.09 ng/ml to 6560.9 +/- 439.52 ng/ml). Honokiol induced mitochondria-dependent and death receptor-mediated apoptosis in MDR KB cells, which was associated with inhibition of EGFR-STAT3 signaling and downregulation of STAT3 target genes. Combined treatment with honokiol and paclitaxel synergistically augmented cytotoxicity in MDR KB cells, compared with treatment with either agent alone in vitro. Importantly, the combined treatment significantly inhibited in vivo growth of KB-8-5 tumors in a subcutaneous model. Tumor tissues from the combination group displayed a significant inhibition of Ki-67 expression and an increase in TUNEL-positive cells compared with the control group. These results suggest that targeting multidrug resistance using honokiol in combination with chemotherapy drugs may provide novel therapeutic opportunities.	[Wang, Xu; Koenig, Lydia; Nannapaneni, Sreenivas; Amin, A. R. M. Ruhul; Chen, Zhuo Georgia; Shin, Dong M.] Emory Univ Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA; [Beitler, Jonathan J.; Wang, Hong; Huang, Wen] Emory Univ Sch Med, Winship Canc Inst, Dept Radiat Oncol & Otolaryngol, Atlanta, GA USA; [Lee, Michael J.] Emory Coll Arts & Sci, Atlanta, GA USA; [Shin, Hyung Ju C.] Quest Diagnost, Atlanta, GA USA; [Bonner, Michael; Arbiser, Jack L.] Emory Univ Sch Med, Winship Canc Inst, Dept Dermatol, Atlanta, GA USA; [Bonner, Michael; Arbiser, Jack L.] Atlanta Vet Adm Med Ctr, Atlanta, GA USA	Emory University; Emory University; Emory University	Shin, DM (corresponding author), Emory Univ Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA.	dmshin@emory.edu	Bonner, Michael Yi/ABD-6756-2021; Shin, Dong Moon/G-9649-2013	Bonner, Michael Yi/0000-0002-8184-0954; Shin, Dong Moon/0000-0002-8245-4174; AMIN, ARM/0000-0001-9144-2960	National Cancer Institute (NCI) through a Head and Neck Cancer SPORE award [P50CA128613, P30 CA138292, AR47901]; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [P50CA128613, P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER	National Cancer Institute (NCI) through a Head and Neck Cancer SPORE award; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the National Cancer Institute (NCI) through a Head and Neck Cancer SPORE award (P50CA128613), P30 CA138292, and AR47901. D.M.S., J.J.B., and Z.G.C. would also like to acknowledge the Georgia Cancer Coalition for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2006, MOL CANCER RES, V4, P621, DOI 10.1158/1541-7786.MCR-06-0076; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Ang KK, 2002, CANCER RES, V62, P7350; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; DASSONVILLE O, 1993, J CLIN ONCOL, V11, P1873, DOI 10.1200/JCO.1993.11.10.1873; Gilbert J, 2012, CLIN CANC RES; Goldsmith KC, 2012, CANCER RES, V72, P2565, DOI 10.1158/0008-5472.CAN-11-3603; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Hahm ER, 2008, CLIN CANCER RES, V14, P1248, DOI 10.1158/1078-0432.CCR-07-1926; HORIO M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P106, DOI 10.1016/0005-2736(91)90274-C; Ishitsuka K, 2005, BLOOD, V106, P1794, DOI 10.1182/blood-2005-01-0346; Khan Z, 2010, CURR CANCER DRUG TAR, V10, P660, DOI 10.2174/156800910793605866; Knauer SK, 2012, HUM MUTAT; Leeman-Neill RJ, 2010, CLIN CANCER RES, V16, P2571, DOI 10.1158/1078-0432.CCR-10-0333; Li L, 2007, CANCER RES, V67, P4894, DOI 10.1158/0008-5472.CAN-06-3818; Nicholson KM, 1999, BRIT J CANCER, V81, P423, DOI 10.1038/sj.bjc.6690711; Park EJ, 2009, CANCER LETT, V277, P133, DOI 10.1016/j.canlet.2008.11.029; SANTINI J, 1991, HEAD NECK-J SCI SPEC, V13, P132, DOI 10.1002/hed.2880130209; Shigemura K, 2007, CANCER-AM CANCER SOC, V109, P1279, DOI 10.1002/cncr.22551; Sivapackiam J, 2010, DALTON T, V39, P5842, DOI 10.1039/c002361b; Sreekanth CN, 2011, ONCOGENE, V30, P3139, DOI 10.1038/onc.2011.23; Supino-Rosin L, 2000, J BIOL CHEM, V275, P21850, DOI 10.1074/jbc.M001834200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tse AKW, 2005, BIOCHEM PHARMACOL, V70, P1443, DOI 10.1016/j.bcp.2005.08.011; Wang X, 2011, ACS NANO, V5, P6184, DOI 10.1021/nn200739q; Wang X, 2009, ACS NANO, V3, P3165, DOI 10.1021/nn900649v; Xu D, 2006, CANCER LETT, V243, P274, DOI 10.1016/j.canlet.2005.11.031; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035	29	35	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e86369	10.1371/journal.pone.0086369	http://dx.doi.org/10.1371/journal.pone.0086369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586249	Green Published, gold, Green Submitted			2022-12-25	WOS:000332385900004
J	Volova, T; Kiselev, E; Vinogradova, O; Nikolaeva, E; Chistyakov, A; Sukovatiy, A; Shishatskaya, E				Volova, Tatiana; Kiselev, Evgeniy; Vinogradova, Olga; Nikolaeva, Elena; Chistyakov, Anton; Sukovatiy, Aleksey; Shishatskaya, Ekaterina			A Glucose-Utilizing Strain, Cupriavidus euthrophus B-10646: Growth Kinetics, Characterization and Synthesis of Multicomponent PHAs	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; POLYHYDROXYALKANOATE COPOLYMERS; MOLECULAR-WEIGHT; SURFACE-ENERGY; NORTH PACIFIC; TERPOLYESTER; BIOSYNTHESIS; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE-CO-3-HYDROXYHEXANOATE); BIOCOMPATIBILITY; TERPOLYMERS	This study investigates kinetic and production parameters of a glucose-utilizing bacterial strain, C. eutrophus B-10646, and its ability to synthesize PHA terpolymers. Optimization of a number of parameters of bacterial culture (cell concentration in the inoculum, physiological activity of the inoculum, determined by the initial intracellular polymer content, and glucose concentration in the culture medium during cultivation) provided cell concentrations and PHA yields reaching 110 g/L and 80%, respectively, under two-stage batch culture conditions. Addition of precursor substrates (valerate, hexanoate, propionate, c-butyrolactone) to the culture medium enabled synthesis of PHA terpolymers, P(3HB/3HV/4HB) and P(3HB/3HV/3HHx), with different composition and different molar fractions of 3HB, 3HV, 4HB, and 3HHx. Different types of PHA terpolymers synthesized by C. eutrophus B-10646 were used to prepare films, whose physicochemical and physicalmechanical properties were investigated. The properties of PHA terpolymers were significantly different from those of the P3HB homopolymer: they had much lower degrees of crystallinity and lower melting points and thermal decomposition temperatures, with the difference between these temperatures remaining practically unchanged. Films prepared from all PHA terpolymers had higher mechanical strength and elasticity than P3HB films. In spite of dissimilar surface structures, all films prepared from PHA terpolymers facilitated attachment and proliferation of mouse fibroblast NIH 3T3 cells more effectively than polystyrene and the highly crystalline P3HB.	[Volova, Tatiana; Kiselev, Evgeniy; Nikolaeva, Elena; Sukovatiy, Aleksey; Shishatskaya, Ekaterina] Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk, Russia; [Volova, Tatiana; Vinogradova, Olga; Shishatskaya, Ekaterina] Siberian Fed Univ, Krasnoyarsk, Russia; [Chistyakov, Anton] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Siberian Federal University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Volova, T (corresponding author), Russian Acad Sci, Inst Biophys, Siberian Branch, Krasnoyarsk, Russia.	volova45@mail.ru	Volova, Tatiana/P-3767-2015; Kiselev, Evgeniy G/Q-5365-2016; Kiselev, Evgeniy Pavlovich/GYQ-9325-2022; Zalygin, Anton/AAC-9031-2022; Shishatskaya, Ekaterina/I-8684-2014; Nikolaeva, Elena D/I-8679-2014; sukovatiy, aleksey/I-8992-2014; Shishatskaya, Ekaterina/ABC-8374-2021; Chistyakov, Anton/E-2509-2014	Kiselev, Evgeniy G/0000-0003-4472-7087; Zalygin, Anton/0000-0003-0132-0674; sukovatiy, aleksey/0000-0002-5412-8267; Nikolaeva, Elena/0000-0002-5298-828X; Shishatskaya, Ekaterina/0000-0001-7967-243X; Volova, Tatiana/0000-0001-9392-156X	Project "Biotechnologies of novel biomaterials: Innovative Biopolymers and Biomedicine Devices" [11.G34.31.0013]	Project "Biotechnologies of novel biomaterials: Innovative Biopolymers and Biomedicine Devices"	This study was financially supported by Project "Biotechnologies of novel biomaterials: Innovative Biopolymers and Biomedicine Devices" (Agreement No. 11.G34.31.0013 with Amendment No. 1 of 15 February 2013) in accordance with Resolution No. 220 of the Government of the Russian Federation of April 9, 2010, "On measures designed to attract leading scientists to the Russian institutions of higher learning." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Aziz N, 2012, J CHEM TECHNOL BIOT, V87, P1607, DOI 10.1002/jctb.3817; Agus J, 2010, POLYM DEGRAD STABIL, V95, P2250, DOI 10.1016/j.polymdegradstab.2010.09.009; Amirul AA, 2008, WORLD J MICROB BIOT, V24, P1327, DOI 10.1007/s11274-007-9605-2; Andrade JD., 1985, SURFACE INTERFACIAL, P15; [Anonymous], 1982, 4681982 ISO; Bengtsson S, 2010, J BIOTECHNOL, V147, P172, DOI 10.1016/j.jbiotec.2010.03.022; Bhubalan K, 2008, POLYM DEGRAD STABIL, V93, P17, DOI 10.1016/j.polymdegradstab.2007.11.004; Bhubalan K, 2010, POLYM DEGRAD STABIL, V95, P1436, DOI 10.1016/j.polymdegradstab.2009.12.018; Boskhomdzhiev AP, 2010, THESIS AN BACH I BIO; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Cavalheiro JMBT, 2012, BIORESOURCE TECHNOL, V111, P391, DOI 10.1016/j.biortech.2012.01.176; Chanprateep S, 2006, J BIOSCI BIOENG, V101, P51, DOI 10.1263/jbb.101.51; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chen GQ, 2010, MICROBIOL MONOGR, V14, P121, DOI 10.1007/978-3-642-03287_5_6; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; De Gennes PG, 1987, ADV PHYS SCI, V151, P619; Green PR, 2002, BIOMACROMOLECULES, V3, P208, DOI 10.1021/bm015620m; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Hasirci V., 2000, BIOMATERIALS BIOENGI, P141; Hu YJ, 2009, ACTA BIOMATER, V5, P1115, DOI 10.1016/j.actbio.2008.09.021; Ishizaki A, 2001, APPL MICROBIOL BIOT, V57, P6; Ji GZ, 2009, J BIOMAT SCI-POLYM E, V20, P325, DOI 10.1163/156856209X412191; Ji Y, 2008, BIOMATERIALS, V29, P3807, DOI 10.1016/j.biomaterials.2008.06.008; Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044; Khosravi-Darani K, 2013, APPL MICROBIOL BIOT, V97, P1407, DOI 10.1007/s00253-012-4649-0; Kijchavengkul T, 2008, POLYM INT, V57, P793, DOI 10.1002/pi.2420; Laycock B, 2013, PROG POLYM SCI, V38, P536, DOI 10.1016/j.progpolymsci.2012.06.003; Lee SY, 1996, TRENDS BIOTECHNOL, V14, P431, DOI 10.1016/0167-7799(96)10061-5; Li QA, 2011, NEW BIOTECHNOL, V28, P92, DOI 10.1016/j.nbt.2010.08.007; Liang YS, 2008, J BIOMED MATER RES A, V87A, P441, DOI 10.1002/jbm.a.31801; Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6; Liu Q, 2008, J BIOMAT SCI-POLYM E, V19, P1521, DOI 10.1163/156856208786140391; Lopez-Cuellar MR, 2011, INT J BIOL MACROMOL, V48, P74, DOI 10.1016/j.ijbiomac.2010.09.016; Madden LA, 2000, POLYMER, V41, P3499, DOI 10.1016/S0032-3861(99)00611-4; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Ou WF, 2011, BIOMATERIALS, V32, P3178, DOI 10.1016/j.biomaterials.2011.01.031; Ramachandran H, 2011, APPL BIOCHEM BIOTECH, V164, P867, DOI 10.1007/s12010-011-9180-8; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6; Sudesh K., 2010, PRACTICAL GUIDE MICR; Sun JA, 2010, BIOSCI BIOTECH BIOCH, V74, P1716, DOI 10.1271/bbb.100242; Tanabe S, 2004, ENVIRON SCI TECHNOL, V38, P403, DOI 10.1021/es034966x; Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8; Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0; VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508; Volova TG, 2006, APPL MICROBIOL BIOT, V73, P429, DOI 10.1007/s00253-006-0460-0; Volova TG, 2013, POLYM SCI SER A+, V55, P427, DOI 10.1134/S0965545X13070080; Volova T G, 2011, Prikl Biokhim Mikrobiol, V47, P544; Volova T.G., 2004, POLYHYDROXYALKANOATE; Volova T.G., 2013, DEGRADABLE POLYM PRO; Volova TG, 2008, MACROMOL SYMP, V269, P1, DOI 10.1002/masy.200850901; [Волова Т.Г. Volova Tatiana G.], 2012, [Журнал Сибирского федерального университета. Серия: Биология, Zhurnal Sibirskogo federal'nogo universiteta. Seriya: Biologiya], V5, P280; Volova TG, 1998, MICROBIOLOGY+, V67, P420; Volova TG, 2009, HYDROGEN-BASED BIOSYNTHESIS, P1; Volova TG, 2006, POLYOXYALKANOATES BI; Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053; Wei X, 2009, J BIOMED MATER RES A, V90A, P894, DOI 10.1002/jbm.a.32146; Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010; Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7; Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031; Zhang HF, 2009, BIOTECHNOL BIOENG, V104, P582, DOI 10.1002/bit.22409; Zhao W, 2007, PROCESS BIOCHEM, V42, P1342, DOI 10.1016/j.procbio.2007.07.006; Zhou J, 2010, BIOMATERIALS, V31, P7512, DOI 10.1016/j.biomaterials.2010.06.044	64	42	49	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e87551	10.1371/journal.pone.0087551	http://dx.doi.org/10.1371/journal.pone.0087551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586280	gold, Green Published, Green Submitted			2022-12-25	WOS:000331880700006
J	Wang, C; Zhang, N; Gao, CQ; Cui, ZY; Sun, D; Yang, CP; Wang, YC				Wang, Chao; Zhang, Nan; Gao, Caiqiu; Cui, Zhiyuan; Sun, Dan; Yang, Chuanping; Wang, Yucheng			Comprehensive Transcriptome Analysis of Developing Xylem Responding to Artificial Bending and Gravitational Stimuli in Betula platyphylla	PLOS ONE			English	Article							TENSION WOOD; ARABINOGALACTAN-PROTEINS; LIGNIN BIOSYNTHESIS; RNA-SEQ; CELLULOSE; GENES; ARABIDOPSIS; EXPRESSION; REGULATORS; TOOL	Betula platyphylla Suk (birch) is a fast-growing woody species that is important in pulp industries and the biofuels. However, as an important pulp species, few studies had been performed on its wood formation. In the present study, we investigated the molecular responses of birch xylem to artificial bending and gravitational stimuli. After trunks of birch trees were subjected to bending for 8 weeks, the cellulose content was significantly greater in tension wood (TW) than in opposite wood (OW) or normal wood (NW), whereas the lignin content in TW was significantly lower than that in OW and NW. In addition, TW grew more rapidly than OW and generated TW-specific fibers with an additional G-layer. Three transcriptome libraries were constructed from TW, OW and NW of B. platyphylla, respectively, after the plants were subjected to artificial bending. Overall, 80,909 nonredundant unigenes with a mean size of 768 nt were assembled. Expression profiles were generated, and 9,684 genes were found to be significantly differentially expressed among the TW, OW and NW libraries. These included genes involved in secondary cell wall structure, wood composition, and cellulose or lignin biosynthesis. Our study showed that during TW formation, genes involved in cellulose synthesis were induced, while the expression of lignin synthesis-related genes decreased, resulting in increased cellulose content and decreased lignin levels in TW. In addition, fasciclin-like arabinogalactan proteins play important role in TW formation. These findings may provide important insights into wood formation at the molecular level.	[Wang, Chao; Zhang, Nan; Gao, Caiqiu; Cui, Zhiyuan; Sun, Dan; Yang, Chuanping; Wang, Yucheng] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China	Northeast Forestry University - China	Yang, CP (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	yangchuanpingnefu@yahoo.com; ychngwang@yahoo.com			National High Technology Research and Development Program ("863" Program) of China [2011AA100202]; Fundamental Research Funds for the Central Universities [DL11EA02]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (2011AA100202), and the Fundamental Research Funds for the Central Universities (DL11EA02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Baba K, 2009, MOL PLANT, V2, P893, DOI 10.1093/mp/ssp054; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bowling AJ, 2008, AM J BOT, V95, P655, DOI 10.3732/ajb.2007368; Brereton NJB, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-13; Chung SK, 2012, BIORESOURCE TECHNOL, V110, P423, DOI 10.1016/j.biortech.2012.01.046; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuddapah S, 2009, COLD SPRING HARBOR P; Decou R, 2009, PHYTOCHEMISTRY, V70, P163, DOI 10.1016/j.phytochem.2008.12.019; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Du J, 2010, J INTEGR PLANT BIOL, V52, P17, DOI 10.1111/j.1744-7909.2010.00901.x; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hemm MR, 2001, TRENDS PLANT SCI, V6, P135, DOI 10.1016/S1360-1385(01)01915-X; Jin H, 2011, PLANTA, V234, P959, DOI 10.1007/s00425-011-1449-1; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; No EG, 2000, PHYSIOL PLANTARUM, V110, P524, DOI 10.1111/j.1399-3054.2000.1100415.x; Paux E, 2005, NEW PHYTOL, V167, P89, DOI 10.1111/j.1469-8137.2005.01396.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pilate G, 2004, CR BIOL, V327, P889, DOI 10.1016/j.crvi.2004.07.006; Qiu D, 2008, NEW PHYTOL, V179, P94, DOI 10.1111/j.1469-8137.2008.02439.x; Richet N, 2011, J EXP BOT, V62, P3575, DOI 10.1093/jxb/err047; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; TIMELL TE, 1973, WOOD SCI TECHNOL, V7, P1, DOI 10.1007/BF00353373; Wang GF, 2011, PLANT BIOTECHNOL J, V9, P486, DOI 10.1111/j.1467-7652.2010.00569.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Yamashita S, 2008, TREE PHYSIOL, V28, P1331, DOI 10.1093/treephys/28.9.1331; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zenoni S, 2004, PLANT CELL, V16, P295, DOI 10.1105/tpc.018705; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y	43	22	24	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87566	10.1371/journal.pone.0087566	http://dx.doi.org/10.1371/journal.pone.0087566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586282	gold, Green Published, Green Submitted			2022-12-25	WOS:000331714700006
J	Grondahl-Yli-Hannuksela, K; Vuononvirta, J; Peltola, V; Mertsola, J; He, QS				Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; Peltola, Ville; Mertsola, Jussi; He, Qiushui			Lack of Association between Mannose Binding Lectin and Antibody Responses after Acellular Pertussis Vaccinations	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BORDETELLA-PERTUSSIS; BOOSTER IMMUNIZATION; INNATE IMMUNITY; DEFICIENCY; GENE; VACCINE; PROTEIN; ADOLESCENCE; RESURGENCE	Background: Mannose-binding lectin (MBL) is one of the key molecules in innate immunity and its role in human vaccine responses is poorly known. This study aimed to investigate the possible association of MBL polymorphisms with antibody production after primary and booster vaccinations with acellular pertussis vaccines in infants and adolescents. Methodology/Principal Findings: Five hundred and sixty eight subjects were included in this study. In the adolescent cohort 355 subjects received a dose of diphtheria and tetanus toxoids and acellular pertussis (dTpa) vaccine ten years previously. Follow-up was performed at 3, 5 and 10 years. Infant cohort consisted of 213 subjects, who had received three primary doses of DTaP vaccine at 3, 5, and 12 months of age according to Finnish immunization program. Blood samples were collected before the vaccinations at 2,5 months of age and after the vaccinations at 13 months and 2 years of age. Concentrations of IgG antibodies to pertussis toxin, filamentous hemagglutinin, and pertactin and antibodies to diphtheria and tetanus toxoids were measured by standardized enzyme-linked immunosorbant assay. Single nucleotide polymorphisms of MBL2 gene exon1 (codons 52, 54, 57) were examined. MBL serum concentration was also measured from the adolescent cohort. No association was found with MBL2 exon 1 polymorphisms and antibody responses against vaccine antigens, after primary and booster dTpa vaccination. Conclusions: This study indicates that MBL polymorphisms do not affect the production and persistence of antibodies after acellular pertussis vaccination. Our finding also suggests that MBL might not be involved in modulating antibody responses to the vaccines made of purified bacterial proteins.	[Grondahl-Yli-Hannuksela, Kirsi; Vuononvirta, Juho; He, Qiushui] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Turku, Finland; [Peltola, Ville; Mertsola, Jussi] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	He, QS (corresponding author), Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Turku, Finland.	qiushui.he@thl.fi	Mertsola, Jussi/AAE-3460-2021		Academy of Finland [122833]; Special Governmental Fund for University Hospitals; Finnish Cultural Foundation the Varsinais-Suomi Regional Fund	Academy of Finland(Academy of Finland); Special Governmental Fund for University Hospitals; Finnish Cultural Foundation the Varsinais-Suomi Regional Fund	This work was supported by the Academy of Finland [grant no 122833], the Special Governmental Fund for University Hospitals, and Finnish Cultural Foundation the Varsinais-Suomi Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkoff AM, 2012, VACCINE, V30, P6897, DOI 10.1016/j.vaccine.2012.09.003; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Devyatyrova-Johnson M, 2000, INFECT IMMUN, V68, P3894, DOI 10.1128/IAI.68.7.3894-3899.2000; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Edelman K, 2007, CLIN INFECT DIS, V44, P1271, DOI 10.1086/514338; Edelman KJ, 2004, CLIN INFECT DIS, V39, P179, DOI 10.1086/421943; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461; Grondahl-Yli-Hannuksela K, 2013, APMIS, V121, P311, DOI 10.1111/apm.12000; Grondahl-Yli-Hannuksela K, 2012, J INFECT DIS, V205, P1214, DOI 10.1093/infdis/jis182; Guttormsen HK, 2009, CLIN IMMUNOL, V130, P264, DOI 10.1016/j.clim.2008.09.012; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Juul-Madsen HR, 2011, VACCINE, V29, P9499, DOI 10.1016/j.vaccine.2011.10.016; Kimman TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003665; Lagstrom H, 2013, INT J EPIDEMIOL, V42, P1273, DOI 10.1093/ije/dys150; Lipscombe R. J., 1992, Human Molecular Genetics, V1, P709, DOI 10.1093/hmg/1.9.709; MADSEN HO, 1995, J IMMUNOL, V155, P3013; MADSEN HO, 1994, IMMUNOGENETICS, V40, P37, DOI 10.1007/BF00163962; Mertsola J, 2010, CLIN INFECT DIS, V51, P656, DOI 10.1086/655825; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Minh NNT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e70; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; REIZENSTEIN E, 1995, J IMMUNOL METHODS, V183, P279, DOI 10.1016/0022-1759(95)00067-K; Roos A, 2006, J IMMUNOL METHODS, V309, P108, DOI 10.1016/j.jim.2005.11.017; Ruseva M, 2009, IMMUNOLOGY, V127, P279, DOI 10.1111/j.1365-2567.2008.03016.x; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Tang YW, 2007, J INFECT DIS, V196, P1021, DOI 10.1086/521370; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198; Xing D, 2011, J IMMUNOL METHODS, V372, P137, DOI 10.1016/j.jim.2011.07.005	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88919	10.1371/journal.pone.0088919	http://dx.doi.org/10.1371/journal.pone.0088919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558451	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700097
J	Jayasundar, JJ; Xing, J; Robinson, JM; Cheung, HC; Dong, WJ				Jayasundar, Jayant James; Xing, Jun; Robinson, John M.; Cheung, Herbert C.; Dong, Wen-Ji			Molecular Dynamics Simulations of the Cardiac Troponin Complex Performed with FRET Distances as Restraints	PLOS ONE			English	Article							C CENTRAL HELIX; REGULATORY DOMAIN; STRUCTURAL-CHANGES; INHIBITORY REGION; HYPERTROPHIC CARDIOMYOPATHY; CONFORMATIONAL TRANSITION; CONTAINING-FILAMENTS; TERMINAL DOMAIN; THIN FILAMENT; N-DOMAIN	Cardiac troponin (cTn) is the Ca2+-sensitive molecular switch that controls cardiac muscle activation and relaxation. However, the molecular detail of the switching mechanism and how the Ca2+ signal received at cardiac troponin C (cTnC) is communicated to cardiac troponin I (cTnI) are still elusive. To unravel the structural details of troponin switching, we performed ensemble Forster resonance energy transfer (FRET) measurements and molecular dynamic (MD) simulations of the cardiac troponin core domain complex. The distance distributions of forty five inter-residue pairs were obtained under Ca2+-free and saturating Ca2+ conditions from time-resolved FRET measurements. These distances were incorporated as restraints during the MD simulations of the cardiac troponin core domain. Compared to the Ca2+-saturated structure, the absence of regulatory Ca2+ perturbed the cTnC N-domain hydrophobic pocket which assumed a closed conformation. This event partially unfolded the cTnI regulatory region/switch. The absence of Ca2+, induced flexibility to the D/E linker and the cTnI inhibitory region, and rotated the cTnC N-domain with respect to rest of the troponin core domain. In the presence of saturating Ca2+ the above said phenomenon were absent. We postulate that the secondary structure perturbations experienced by the cTnI regulatory region held within the cTnC N-domain hydrophobic pocket, coupled with the rotation of the cTnC N-domain would control the cTnI mobile domain interaction with actin. Concomitantly the rotation of the cTnC N-domain and perturbation of the D/E linker rigidity would control the cTnI inhibitory region interaction with actin to effect muscle relaxation.	[Jayasundar, Jayant James; Xing, Jun; Dong, Wen-Ji] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Jayasundar, Jayant James; Xing, Jun; Dong, Wen-Ji] Washington State Univ, Dept Integrated Physiol & Neurosci, Pullman, WA 99164 USA; [Robinson, John M.] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Cheung, Herbert C.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	Washington State University; Washington State University; South Dakota State University; University of Alabama System; University of Alabama Birmingham	Dong, WJ (corresponding author), Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu		Jayasundar, Jayant James/0000-0001-9963-9629	National Institutes of Health [HL80186, HL52508]; M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186, R01HL052508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by National Institutes of Health Grant HL80186 (WJD), National Institutes of Health Grant HL52508 (HCC) and M. J. Murdock Charitable Trust (WJD). This work was supported in part by the research computing resources acquired and managed by UAB IT Research Computing. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; BABU A, 1993, J BIOL CHEM, V268, P19232; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Calvert MJ, 2000, J BIOL CHEM, V275, P32508, DOI 10.1074/jbc.M005764200; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Cordina NM, 2012, PROTEIN SCI, V21, P1376, DOI 10.1002/pro.2124; DOBROWOLSKI Z, 1991, J BIOL CHEM, V266, P5703; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Genchev GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058313; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; JIN JP, 1989, J BIOL CHEM, V264, P14471; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Manning EP, 2011, BIOCHEMISTRY-US, V50, P7405, DOI 10.1021/bi200506k; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ramakrishnan S, 1995, BIOCHEMISTRY-US, V34, P16789, DOI 10.1021/bi00051a029; Ritchie DW, 2005, J APPL CRYSTALLOGR, V38, P808, DOI 10.1107/S002188980502474X; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Sheldahl C, 2003, BIOPHYS J, V84, P1057, DOI 10.1016/S0006-3495(03)74922-4; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Varughese JF, 2010, J BIOMOL STRUCT DYN, V28, P159, DOI 10.1080/07391102.2010.10507350; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200	54	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87135	10.1371/journal.pone.0087135	http://dx.doi.org/10.1371/journal.pone.0087135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558365	Green Submitted, gold, Green Published			2022-12-25	WOS:000331706700011
J	Mondhe, M; Chessher, A; Goh, S; Good, L; Stach, JEM				Mondhe, Madhav; Chessher, Ashley; Goh, Shan; Good, Liam; Stach, James E. M.			Species-Selective Killing of Bacteria by Antimicrobial Peptide-PNAs	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; ANTIBIOTIC-RESISTANCE; NONCODING RNA; INHIBITION; GROWTH; SEQUENCE; TRANSLATION; DATABASE; CORE	Broad-spectrum antimicrobials kill indiscriminately, a property that can lead to negative clinical consequences and an increase in the incidence of resistance. Species-specific antimicrobials that could selectively kill pathogenic bacteria without targeting other species in the microbiome could limit these problems. The pathogen genome presents an excellent target for the development of such antimicrobials. In this study we report the design and evaluation of species-selective peptide nucleic acid (PNA) antibacterials. Selective growth inhibition of B. subtilis, E. coli, K. pnuemoniae and S. enterica serovar Typhimurium in axenic or mixed culture could be achieved with PNAs that exploit species differences in the translation initiation region of essential genes. An S. Typhimurium-specific PNA targeting ftsZ resulted in elongated cells that were not observed in E. coli, providing phenotypic evidence of the selectivity of PNA-based antimicrobials. Analysis of the genomes of E. coli and S. Typhimurium gave a conservative estimate of >150 PNA targets that could potentially discriminate between these two closely related species. This work provides a basis for the development of a new class of antimicrobial with a tuneable spectrum of activity.	[Mondhe, Madhav; Chessher, Ashley; Stach, James E. M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goh, Shan] Univ London, Royal Vet Coll, Dept Pathol & Infect Dis, London, England	Newcastle University - UK; University of London; University of London Royal Veterinary College	Stach, JEM (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jem.stach@ncl.ac.uk	Goh, Shan/A-7261-2010	Goh, Shan/0000-0002-9028-0303; Good, Liam/0000-0002-2798-8640; Stach, James/0000-0001-8787-2407	Nuffield Foundation [NAL/01166/G]	Nuffield Foundation	Nuffield Foundation (NAL/01166/G) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P29, DOI 10.1093/jac/48.suppl_1.29; Andrews JM, 2009, BSAC METHODS ANTIMIC; Casadevall A, 2009, EXPERT OPIN PHARMACO, V10, P1699, DOI 10.1517/14656560903066837; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Faridani OR, 2006, NUCLEIC ACIDS RES, V34, P5915, DOI 10.1093/nar/gkl750; Foliaki S, 2009, J ALLERGY CLIN IMMUN, V124, P982, DOI 10.1016/j.jaci.2009.08.017; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Ghosal A, 2013, ACS CHEM BIOL, V8, P360, DOI 10.1021/cb300434e; Giesen U, 1998, NUCLEIC ACIDS RES, V26, P5004, DOI 10.1093/nar/26.21.5004; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 2000, MICROBIOL-SGM, V146, P2665, DOI 10.1099/00221287-146-10-2665; Good L, 1998, P NATL ACAD SCI USA, V95, P2073, DOI 10.1073/pnas.95.5.2073; Good Liam, 2002, Methods Mol Biol, V208, P237; Hacek DM, 1999, J CLIN MICROBIOL, V37, P1881, DOI 10.1128/JCM.37.6.1881-1884.1999; Harth G, 2000, P NATL ACAD SCI USA, V97, P418, DOI 10.1073/pnas.97.1.418; Hatamoto M, 2009, APPL MICROBIOL BIOT, V84, P1161, DOI 10.1007/s00253-009-2099-0; Hoban Daryl J, 2003, Clin Cornerstone, VSuppl 3, pS12; Jayaraman R, 2009, CURR SCI INDIA, V96, P1475; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kurupati P, 2007, ANTIMICROB AGENTS CH, V51, P805, DOI 10.1128/AAC.00709-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Menossi M, 2000, BIOTECHNIQUES, V28, P424, DOI 10.2144/00283bm06; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shen N, 2009, P NATL ACAD SCI USA, V106, P8163, DOI 10.1073/pnas.0903491106; Tilley LD, 2006, ANTIMICROB AGENTS CH, V50, P2789, DOI 10.1128/AAC.01286-05; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; White DG, 1997, ANTIMICROB AGENTS CH, V41, P2699, DOI 10.1128/AAC.41.12.2699; Yates CM, 2006, BIOL LETT-UK, V2, P463, DOI 10.1098/rsbl.2006.0478; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	42	49	54	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89082	10.1371/journal.pone.0089082	http://dx.doi.org/10.1371/journal.pone.0089082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558473	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700119
J	Uda, A; Sekizuka, T; Tanabayashi, K; Fujita, O; Kuroda, M; Hotta, A; Sugiura, N; Sharma, N; Morikawa, S; Yamada, A				Uda, Akihiko; Sekizuka, Tsuyoshi; Tanabayashi, Kiyoshi; Fujita, Osamu; Kuroda, Makoto; Hotta, Akitoyo; Sugiura, Naoko; Sharma, Neekun; Morikawa, Shigeru; Yamada, Akio			Role of Pathogenicity Determinant Protein C (PdpC) in Determining the Virulence of the Francisella tularensis Subspecies tularensis SCHU	PLOS ONE			English	Article							INTRAMACROPHAGE GROWTH; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; CELLS; MACROPHAGES; TULAREMIA; INFECTION; STRAIN; GENES; MICE	Francisella tularensis subspecies tularensis, the etiological agent of tularemia, is highly pathogenic to humans and animals. However, the SCHU strain of F. tularensis SCHU P0 maintained by passaging in artificial media has been found to be attenuated. To better understand the molecular mechanisms behind the pathogenicity of F. tularensis SCHU, we attempted to isolate virulent bacteria by serial passages in mice. SCHU P5 obtained after 5th passages in mice remained avirulent, while SCHU P9 obtained after 9th passages was completely virulent in mice. Moreover, SCHU P9 grew more efficiently in J774.1 murine macrophages compared with that in the less pathogenic SCHU P0 and P5. Comparison of the nucleotide sequences of the whole genomes of SCHU P0, P5, and P9 revealed only 1 nucleotide difference among P0, P5 and P9 in 1 of the 2 copies of pathogenicity determinant protein C (pdpC) gene. An adenine residue deletion was observed in the pdpC1 gene of SCHU P0, P5, and P9 and in the pdpC2 gene of SCHU P0, and P5, while P9 was characterized by the wild type pdpC2 gene. Thus, SCHU P0 and P5 expressed only truncated forms of PdpC protein, while SCHU P9 expressed both wild type and truncated versions. To validate the pathogenicity of PdpC, both copies of the pdpC gene in SCHU P9 have been inactivated by Targetron mutagenesis. SCHU P9 mutants with inactivated pdpC gene showed low intracellular growth in J774.1 cells and did not induce severe disease in experimentally infected mice, while virulence of the mutants was restored by complementation with expression of the intact PdpC. These results demonstrate that PdpC is crucial in determining the virulence of F. tularensis SCHU.	[Uda, Akihiko; Tanabayashi, Kiyoshi; Fujita, Osamu; Hotta, Akitoyo; Sugiura, Naoko; Sharma, Neekun; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Sugiura, Naoko; Sharma, Neekun] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Yamada, Akio] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Publ Hlth, Bunkyo Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Gifu University; University of Tokyo	Tanabayashi, K (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo, Japan.	ktana@nih.go.jp		MORIKAWA, SHIGERU/0000-0001-6249-6716; Sekizuka, Tsuyoshi/0000-0002-1302-5472; Sharma, Neekun/0000-0002-4456-8074	Ministry of Health, Labour and Welfare of Japan [H22-Shinkou-Ippan-010]; Japan Society for the Promotion of Science [23790489]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by the Health Science Research Grants from the Ministry of Health, Labour and Welfare of Japan (H22-Shinkou-Ippan-010; http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/) and Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (23790489; http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlund MK, 2010, INFECT IMMUN, V78, P3118, DOI 10.1128/IAI.00146-10; Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cheung KKM, 2007, THESIS U VICTORIA; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Eliasson H, 2007, SCAND J INFECT DIS, V39, P880, DOI 10.1080/00365540701402970; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Fortier A H, 1994, Immunol Ser, V60, P349; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; FUJITA H, 1993, MICROBIOL IMMUNOL, V37, P837, DOI 10.1111/j.1348-0421.1993.tb01713.x; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; He YQ, 2007, COMPARATIVE MED, V57, P18; HESSELBROCK W, 1945, J BACTERIOL, V49, P209, DOI 10.1128/JB.49.3.209-231.1945; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Lindgren M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-20; Long ME, 2012, INFECT IMMUN; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Pomerantsev AP, 2001, PLASMID, V46, P86, DOI 10.1006/plas.2001.1538; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Russo BC, 2011, INFECT IMMUN, V79, P3665, DOI 10.1128/IAI.00135-11; SATO KYUZO, 1960, JAPANESE JOUR BACT, V15, P51; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sjodin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011556; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; THORPE BD, 1964, J IMMUNOL, V93, P558; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070; Zaide G, 2011, APPL ENVIRON MICROB, V77, P1608, DOI 10.1128/AEM.01862-10	47	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89075	10.1371/journal.pone.0089075	http://dx.doi.org/10.1371/journal.pone.0089075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558472	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700118
J	Vanneste, S; Joos, K; Langguth, B; To, WT; De Ridder, D				Vanneste, Sven; Joos, Kathleen; Langguth, Berthold; To, Wing Ting; De Ridder, Dirk			Neuronal Correlates of Maladaptive Coping: An EEG-Study in Tinnitus Patients	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DEFAULT-MODE NETWORK; ALPHA OSCILLATIONS; PREFRONTAL CORTEX; BRAIN; PERCEPTION; DEPRESSION; SEVERITY; PAIN; DYSREGULATION	Here we aimed to investigate the neuronal correlates of different coping styles in patients suffering from chronic tinnitus. Adaptive and maladaptive coping styles were determined in 85 tinnitus patients. Based on resting state EEG recordings, coping related differences in brain activity and connectivity were found. Maladaptive coping behavior was related to increases in subjective tinnitus loudness and distress, higher tinnitus severity and higher depression scores. EEG recordings demonstrated increased alpha activity over the left dorsolateral prefrontal cortex (DLPFC) and subgenual anterior cingulate cortex (sgACC) as well as increased connectivity in the default (i.e. resting state) network in tinnitus patients with a maladaptive coping style. Correlation analysis revealed that the changes in the DLPFC correlate primarily with maladaptive coping behavior, whereas the changes in the sgACC correlate with tinnitus severity and depression. Our findings are in line with previous research in the field of depression that during resting state a alpha band hyperconnectivity exists within the default network for patients who use a maladaptive coping style, with the sgACC as the dysfunctional node and that the strength of the connectivity is related to focusing on negative mood and catastrophizing about the consequences of tinnitus.	[Vanneste, Sven; Joos, Kathleen] Univ Antwerp, Dept Translat Neurosci, Fac Med, B-2020 Antwerp, Belgium; [Vanneste, Sven] Univ Texas Richardson, Sch Behav & Brain Sci, Richardson, TX USA; [Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [To, Wing Ting] Univ Coll Ghent, Fac Social Work & Welf Studies, Ghent, Belgium; [De Ridder, Dirk] Univ Otago, Dunedin Sch Med, Dept Surg Sci, Dunedin, New Zealand; [De Ridder, Dirk] Sint Augustinus Hosp, BRAI2N, Antwerp, Belgium	University of Antwerp; University of Texas System; University of Texas Dallas; University of Regensburg; HOGENT University College of Applied Sciences & Arts; University of Otago	Vanneste, S (corresponding author), Univ Antwerp, Dept Translat Neurosci, Fac Med, B-2020 Antwerp, Belgium.	sven.vanneste@utdallas.edu	Langguth, Berthold/AAP-2638-2021	Vanneste, Sven/0000-0003-1513-5752				Abler B, 2008, NEUROREPORT, V19, P21, DOI 10.1097/WNR.0b013e3282f3adeb; Andolina D, 2013, NEUROPSYCHOPHARMACOL, V38, P2057, DOI 10.1038/npp.2013.107; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Berman M.G., 2010, SOC COGN AFFECT NEUR; Bijttebier P, 1997, PERS INDIV DIFFER, V23, P157, DOI 10.1016/S0191-8869(97)00012-3; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; BOUMAN TK, 1985, GEDRAG GEZOND, V13, P13; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budd RJ, 1995, J PSYCHOSOM RES, V39, P1015, DOI 10.1016/0022-3999(95)00512-9; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cohen J., 2003, APPL MULTIPLE REGRES; Congedo M., 2002, EUREKA VERSION 3 0 C; Congedo M, 2010, BRAIN TOPOGR, V23, P134, DOI 10.1007/s10548-009-0113-6; Cooney RE, 2010, COGN AFFECT BEHAV NE, V10, P470, DOI 10.3758/CABN.10.4.470; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Faber M, 2011, BRAIN STIMUL; Fletcher K, 2013, COMPR PSYCHIAT; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frank E., 2011, J NEUROL; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Freund W, 2007, SOMATOSENS MOT RES, V24, P203, DOI 10.1080/08990220701723636; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; GOEBEL G, 1994, HNO, V42, P166; Green MJ, 2011, ACTA PSYCHIAT SCAND, V124, P307, DOI 10.1111/j.1600-0447.2011.01718.x; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hamilton JP, 2011, BIOL PSYCHIAT; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kirschner A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00139; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Knyazev GG, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00348; Knyazev GG, 2012, NEUROSCI BIOBEHAV R, V36, P677, DOI 10.1016/j.neubiorev.2011.10.002; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Kross E, 2009, BIOL PSYCHIAT, V65, P361, DOI 10.1016/j.biopsych.2008.10.019; Landgrebe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005026; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; MARRIAGE J, 1995, J LARYNGOL OTOL, V109, P915, DOI 10.1017/S0022215100131676; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Meeus O, 2007, B-ENT, P11; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mo J, 2013, NEUROIMAGE, V68, P112, DOI 10.1016/j.neuroimage.2012.11.058; Moisset X, 2007, NEUROIMAGE, V37, pS80, DOI 10.1016/j.neuroimage.2007.03.054; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Piccirillo JF, 2013, JAMA OTOLARYNGOL, V139, P388, DOI 10.1001/jamaoto.2013.233; Plazier M., 2011, BRAIN STIMUL; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Schacter Daniel L, 2012, Dialogues Clin Neurosci, V14, P7; Schwarzer R, 1995, HDB COPING THEORY RE; Scott B, 2000, PSYCHOSOMATICS, V41, P347, DOI 10.1176/appi.psy.41.4.347; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Simpson JJ, 2000, HEARING RES, V145, P1, DOI 10.1016/S0378-5955(00)00093-9; Vanneste S, 2013, CEREB CORTEX; Vanneste S, 2012, BRAIN TOPOGR, V25, P97, DOI 10.1007/s10548-011-0191-0; Vanneste S, 2011, BRAIN STIMUL, V4, P242, DOI 10.1016/j.brs.2010.12.001; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; von Leupoldt A, 2009, NEUROIMAGE, V48, P200, DOI 10.1016/j.neuroimage.2009.06.015; Weisz N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00073	81	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88253	10.1371/journal.pone.0088253	http://dx.doi.org/10.1371/journal.pone.0088253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558383	Green Submitted, gold, Green Published			2022-12-25	WOS:000331706700029
J	Polanska, E; Pospisilova, S; Stros, M				Polanska, Eva; Pospisilova, Sarka; Stros, Michal			Binding of Histone H1 to DNA Is Differentially Modulated by Redox State of HMGB1	PLOS ONE			English	Article							CHROMOSOMAL-PROTEIN HMG1; LINKER HISTONES; CHROMATIN; DOMAINS; ASSOCIATION; CYTOKINE; B4	HMGB1 is an architectural protein in chromatin, acting also as a signaling molecule outside the cell. Recent reports from several laboratories provided evidence that a number of both the intracellular and extracellular functions of HMGB1 may depend on redox-sensitive cysteine residues of the protein. In this study we demonstrate that redox state of HMGB1 can significantly modulate the ability of the protein to bind and bend DNA, as well as to promote DNA end-joining. We also report a high affinity binding of histone H1 to hemicatenated DNA loops and DNA minicircles. Finally, we show that reduced HMGB1 can readily displace histone H1 from DNA, while oxidized HMGB1 has limited capacity for H1 displacement. Our results suggested a novel mechanism for the HMGB1-mediated modulation of histone H1 binding to DNA. Possible biological consequences of linker histones H1 replacement by HMGB1 for the functioning of chromatin are discussed.	[Polanska, Eva; Stros, Michal] Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Prot, CS-61265 Brno, Czech Republic; [Pospisilova, Sarka; Stros, Michal] Masaryk Univ, Ctr Mol Med, Cent European Inst Technol CEITEC, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno	Stros, M (corresponding author), Acad Sci Czech Republ, Inst Biophys, Lab Anal Chromosomal Prot, Kralovopolska 135, CS-61265 Brno, Czech Republic.	stros@ibp.cz	Pospisilova, Sarka/D-7200-2012	Pospisilova, Sarka/0000-0001-7136-2680	Grant Agency of the Czech Republic [P305/12/2475]; EU [286154-SYLICA]; European Regional Development Fund [CEITEC CZ. 1.05/1.1.00/02.0068]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); EU(European Commission); European Regional Development Fund(European Commission)	Financial support was provided through the Grant Agency of the Czech Republic (Grant P305/12/2475 awarded to MS.). The research was also supported by the EU 7th Framework program under the "Capacities'' specific program (contract No. 286154-SYLICA) and by European Regional Development Fund CEITEC CZ. 1.05/1.1.00/02.0068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BILLINGS PC, 1992, BIOCHEM BIOPH RES CO, V188, P1286, DOI 10.1016/0006-291X(92)91371-V; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; CARBALLO M, 1983, EMBO J, V2, P1759, DOI 10.1002/j.1460-2075.1983.tb01654.x; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Grabarz A, 2012, AM J CANCER RES, V2, P249; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; JACKSON JB, 1979, BIOCHEMISTRY-US, V18, P3739, DOI 10.1021/bi00584a015; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Li GQ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00068; Lu X, 2004, J BIOL CHEM, V279, P8701, DOI 10.1074/jbc.M311348200; Lyubchenko YL, 2002, NUCLEIC ACIDS RES, V30, P4902, DOI 10.1093/nar/gkf626; Nagaki S, 1998, BIOCHEM BIOPH RES CO, V246, P137, DOI 10.1006/bbrc.1998.8589; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Nightingale K, 1996, EMBO J, V15, P548, DOI 10.1002/j.1460-2075.1996.tb00387.x; OGAWA Y, 1995, J BIOL CHEM, V270, P9272, DOI 10.1074/jbc.270.16.9272; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x; STROS M, 1990, INT J BIOL MACROMOL, V12, P282, DOI 10.1016/0141-8130(90)90014-2; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; STROS M, 1994, FEBS LETT, V344, P201, DOI 10.1016/0014-5793(94)00364-5; Stros M, 2000, EUR J BIOCHEM, V267, P4088, DOI 10.1046/j.1432-1327.2000.01450.x; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tang DL, 2012, MOL MED, V18, P1360, DOI 10.2119/molmed.2012.00314; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; VARGAWEISZ P, 1993, J BIOL CHEM, V268, P20699; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Villar-Garea A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001553; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Yaneva J, 1997, P NATL ACAD SCI USA, V94, P13448, DOI 10.1073/pnas.94.25.13448; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	41	20	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89070	10.1371/journal.pone.0089070	http://dx.doi.org/10.1371/journal.pone.0089070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551219	Green Submitted, gold, Green Published			2022-12-25	WOS:000331266000098
J	Solano, E; Taylor, PJ; Rautenbach, A; Ropiquet, A; Castiglia, R				Solano, Emanuela; Taylor, Peter J.; Rautenbach, Anita; Ropiquet, Anne; Castiglia, Riccardo			Cryptic Speciation and Chromosomal Repatterning in the South African Climbing Mice Dendromus (Rodentia, Nesomyidae)	PLOS ONE			English	Article							MUROID RODENTS; EVOLUTION; DIVERGENCE; PHYLOGENY; AUTOSOME; TRANSLOCATIONS; PHYLOGEOGRAPHY; DIVERSITY; PATTERNS; MAMMALS	We evaluate the intra-and interspecific diversity in the four South African rodent species of the genus Dendromus. The molecular phylogenetic analysis on twenty-three individuals have been conducted on a combined dataset of nuclear and mitochondrial markers. Moreover, the extent and processes underlying chromosomal variation, have been investigated on three species by mean of G-, C-bands, NORs and Zoo-FISH analysis. The molecular analysis shows the presence of six monophyletic lineages corresponding to D. mesomelas, D. mystacalis and four lineages within D. cfr. melanotis with high divergence values (ranges: 10.6% - 18.3%) that raises the question of the possible presence of cryptic species. The first description of the karyotype for D. mesomelas and D. mystacalis and C-and G-banding for one lineage of D. cfr. melanotis are reported highlighting an extended karyotype reorganization in the genus. Furthermore, the G-banding and Zoo-FISH evidenced an autosome-sex chromosome translocation characterizing all the species and our timing estimates this mutation date back 7.4 mya (Late Miocene). Finally, the molecular clock suggests that cladogenesis took place since the end of Miocene to Plio-Pleistocene, probably due to ecological factors, isolation in refugia followed by differential adaptation to the mesic or dry habitat.	[Solano, Emanuela; Castiglia, Riccardo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Taylor, Peter J.] Sch Environm Sci, Dept Ecol & Resource Management, Thohoyandou, South Africa; [Taylor, Peter J.; Rautenbach, Anita] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Ropiquet, Anne] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England	Sapienza University Rome; University of Kwazulu Natal; Imperial College London	Solano, E (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	emanuela.solano@uniroma1.it	Taylor, Peter/E-8655-2011; Ropiquet, Anne/E-6154-2011; Taylor, Peter John/N-3172-2019; Ropiquet, Anne/AAC-5042-2021	Taylor, Peter/0000-0001-9048-7366; Ropiquet, Anne/0000-0003-3755-5467; Castiglia, Riccardo/0000-0002-9011-302X; solano, emanuela/0000-0001-8482-9243	University of Stellenbosch; South African National Research Foundation	University of Stellenbosch; South African National Research Foundation(National Research Foundation - South Africa)	Part of this study was carried out during the post-doctoral fellowship of E. Solano at the University of Stellenbosch and the work was supported by the South African National Research Foundation and the University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley T, 2002, CYTOGENET GENOME RES, V96, P33, DOI 10.1159/000063030; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Castiglia R, 2006, J ZOOL SYST EVOL RES, V44, P223, DOI 10.1111/j.1439-0469.2006.00356.x; Castiglia R, 2014, MAMMAL REV, V44, P1, DOI 10.1111/mam.12009; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; CONROY GC, 1992, NATURE, V356, P144, DOI 10.1038/356144a0; Denys C, 2012, MAMMALIA, V76, P295, DOI 10.1515/mammalia-2011-0012; Deuve JL, 2008, CHROMOSOMA, V117, P211, DOI 10.1007/s00412-007-0140-6; Deuve JL, 2006, CHROMOSOME RES, V14, P681, DOI 10.1007/s10577-006-1080-3; Dippenaar N. J., 1983, ANN MUS ROY AFR, V237, P1; Dobigny G, 2002, CYTOGENET GENOME RES, V98, P75, DOI 10.1159/000068541; Dobigny G, 2002, CYTOGENET GENOME RES, V96, P117, DOI 10.1159/000063044; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; ELLERY WN, 1991, S AFR J SCI, V87, P499; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; GRAVES JAM, 1994, INT REV CYTOL, V154, P191; GU X, 1995, MOL BIOL EVOL, V12, P546; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; JAEGER JJ, 1986, CR ACAD SCI II, V302, P917; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MATTHEY R, 1970, Mammalia, V34, P459, DOI 10.1515/mamm.1970.34.3.459; MATTHEY ROBERT, 1967, MAMMALIA, V31, P281, DOI 10.1515/mamm.1967.31.2.281; McKenna MC, 1997, CLASSIFICATION MAMMA; Meester JAJ, 1986, TRANSVAAL MUS MONOGR, V5, P1; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; NESBITT MN, 1973, CHROMOSOMA, V41, P145, DOI 10.1007/BF00319691; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rambau RV, 2003, MOL PHYLOGENET EVOL, V28, P564, DOI 10.1016/S1055-7903(03)00058-7; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Rens W, 2006, NAT PROTOC, V1, P783, DOI 10.1038/nprot.2006.91; SEABRIGH.M, 1971, LANCET, V2, P971; SEARLE JB, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P309; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Solano E, 2011, J ZOOL, V285, P110, DOI 10.1111/j.1469-7998.2011.00820.x; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor P., 1998, SMALLER MAMMALS KWAZ; Taylor PJ, 2009, J ZOOL, V277, P317, DOI 10.1111/j.1469-7998.2008.00542.x; Taylor PJ, 2000, J MAMMAL, V81, P317, DOI 10.1644/1545-1542(2000)081<0317:POCVIS>2.0.CO;2; Tougard C, 2013, BIOL J LINN SOC, V108, P434, DOI 10.1111/j.1095-8312.2012.02034.x; Veyrunes F, 2004, CHROMOSOME RES, V12, P369, DOI 10.1023/B:CHRO.0000034098.09885.e6; Wilson D. E., 2005, MAMMAL SPECIES WORLD	51	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88799	10.1371/journal.pone.0088799	http://dx.doi.org/10.1371/journal.pone.0088799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551165	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000331266000069
J	Herva, ME; Zibaee, S; Fraser, G; Barker, RA; Goedert, M; Spillantini, MG				Herva, Maria Eugenia; Zibaee, Shahin; Fraser, Graham; Barker, Roger A.; Goedert, Michel; Spillantini, Maria Grazia			Anti-amyloid Compounds Inhibit alpha- Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification ( PMCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Amyloid; Cell Therapy; Drug Screening; Protein Aggregation; PMCA	TO-NEURON TRANSMISSION; PARKINSONS-DISEASE; PRION PROTEIN; CONGO RED; LEWY BODIES; FIBRILS; INCLUSIONS; SCRAPIE; BETA; FLUORESCENCE	Background: -Synuclein filaments can be formed in vitro, but the process is slow and unreliable, unsuitable for high throughput screening. Results: Protein misfolding cyclic amplification (PMCA) rapidly assembles -synuclein into filaments that form aggregates in cell culture and whose formation is inhibited by anti-amyloid compounds. Conclusion: Anti-amyloid compounds affect PMCA cell-transmissible -synuclein fibril formation. Significance: -Synuclein PMCA is useful for the screening of anti-aggregation compounds as treatments for -synucleinopathies. Filaments made of -synuclein form the characteristic Lewy pathology in Parkinson and other diseases. The formation of -synuclein filaments can be reproduced in vitro by incubation of recombinant protein, but the filament growth is very slow and highly variable and so unsuitable for fast high throughput anti-aggregation drug screening. To overcome this obstacle we have investigated whether the protein misfolding cyclic amplification (PMCA) technique, used for fast amplification of prion protein aggregates, could be adapted for growing -synuclein aggregates and thus suitable for screening of drugs to affect -synuclein aggregation for the treatment of the yet incurable -synucleinopathies. Circular dichroism, electron microscopy, and native and SDS-polyacrylamide gels were used to demonstrate -synuclein aggregate formation by PMCA, and the strain imprint of the -synuclein fibrils was studied by proteinase K digestion. We also demonstrated that -synuclein fibrils are able to seed new -synuclein PMCA reactions and to enter and aggregate in cells in culture. In particular, we have generated a line of chronically infected cells, which transmit -synuclein aggregates even after multiple passages. To evaluate the sensitivity of the PMCA system as an -synuclein anti-aggregating drug screening assay a panel of 10 drugs was tested. Anti-amyloid compounds proved efficient in inhibiting -synuclein fibril formation induced by PMCA. Our results show that -synuclein PMCA is a fast and reproducible system that could be used as a high throughput screening method for finding new -synuclein anti-aggregating compounds.	[Herva, Maria Eugenia; Barker, Roger A.; Spillantini, Maria Grazia] John Van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Zibaee, Shahin; Fraser, Graham; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Spillantini, MG (corresponding author), John Van Geest Brain Repair Ctr, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	mgs11@cam.ac.uk	zibaee, shahin/AAK-9497-2021	Barker, Roger Alistair/0000-0001-8843-7730	Parkinson's UK; UK Medical Research Council; NC3Rs fellowship; Parkinson&quot;s UK [G-1102, K-1012] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NC3Rs fellowship; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by a grant from the Parkinson's UK (to R. A. B., M. G. S., and M. E. H.) and by funding from the UK Medical Research Council (to M. G., S. Z., and G. F.).; Recipient of a NC3Rs fellowship. To whom the correspondence may be addressed: John Van Geest Brain Repair Centre, Forvie Site, Robinson way, Cambridge CB2 0PY, UK. E-mail: meh67@cam.ac.uk.	Ahn JS, 2007, ANAL BIOCHEM, V367, P259, DOI 10.1016/j.ab.2007.05.023; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Grelle G, 2011, BIOCHEMISTRY-US, V50, P10624, DOI 10.1021/bi2012383; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hirohata M, 2008, CURR PHARM DESIGN, V14, P3280, DOI 10.2174/138161208786404173; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Locke CJ, 2008, NEUROSCI LETT, V439, P129, DOI 10.1016/j.neulet.2008.05.003; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P631, DOI 10.1021/bi201435d; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; O'Hare E, 2010, BEHAV BRAIN RES, V208, P274, DOI 10.1016/j.bbr.2009.11.027; Ono K, 2007, J NEUROSCI RES, V85, P1547, DOI 10.1002/jnr.21271; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Pienaar IS, 2012, MOL NEUROBIOL, V45, P126, DOI 10.1007/s12035-011-8226-9; Pinotsi D, 2013, CHEMBIOCHEM, V14, P846, DOI 10.1002/cbic.201300103; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008454.pub2; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Rudyk H, 2000, J GEN VIROL, V81, P1155, DOI 10.1099/0022-1317-81-4-1155; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sahay S, 2014, BIOCHEMISTRY-US, V53, P807, DOI 10.1021/bi401543z; Samii A, 2009, DRUG AGING, V26, P769, DOI 10.2165/11316780-000000000-00000; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a	43	62	68	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11897	11905		10.1074/jbc.M113.542340	http://dx.doi.org/10.1074/jbc.M113.542340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24584936	hybrid, Green Published			2022-12-25	WOS:000335010600030
J	Bullen, JW; Balsbaugh, JL; Chanda, D; Shabanowitz, J; Hunt, DF; Neumann, D; Hart, GW				Bullen, John W.; Balsbaugh, Jeremy L.; Chanda, Dipanjan; Shabanowitz, Jeffrey; Hunt, Donald F.; Neumann, Dietbert; Hart, Gerald W.			Cross-talk between Two Essential Nutrient-sensitive Enzymes O-GlcNAc TRANSFERASE ( OGT) AND AMP-ACTIVATED PROTEIN KINASE ( AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Histones; Nuclear Translocation; O-GlcNAc; O-GlcNAcylation; Skeletal Muscle; O-GlcNAc Transferase; Nutrient Sensing	MASS-SPECTROMETRY; PHOSPHORYLATION; GLCNACYLATION; GLYCOSYLATION; COEXPRESSION; METABOLISM; INHIBITOR; MECHANISM; DYNAMICS; INSIGHTS	Background: OGT and AMPK collectively target hundreds of intracellular signaling processes, but no study has addressed whether they regulate each other. Results: AMPK activity mediates the substrate selectivity of OGT, and O-GlcNAcylation modulates the activity of AMPK. Conclusion: There is significant cross-talk between the O-GlcNAc and AMPK systems. Significance: OGT and AMPK may synergistically regulate numerous nutrient-sensitive processes essential for life. Nutrient-sensitive pathways regulate both O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK), cooperatively connecting metabolic homeostasis to regulation of numerous intracellular processes essential for life. Similar to phosphorylation, catalyzed by kinases such as AMPK, O-GlcNAcylation is a highly dynamic Ser/Thr-specific post-translational modification of nuclear, cytoplasmic, and mitochondrial proteins catalyzed exclusively by OGT. OGT and AMPK target a multitude of intracellular proteins, with the net effect to protect cells from the damaging effects of metabolic stress. Despite hundreds of studies demonstrating significant overlap in upstream and downstream signaling processes, no study has investigated if OGT and AMPK can directly regulate each other. We show acute activation of AMPK alters the substrate selectivity of OGT in several cell lines and nuclear localization of OGT in C2C12 skeletal muscle myotubes. Nuclear localization of OGT affects O-GlcNAcylation of numerous nuclear proteins and acetylation of Lys-9 on histone 3 in myotubes. AMPK phosphorylates Thr-444 on OGT in vitro; phosphorylation of Thr-444 is tightly associated with AMPK activity and nuclear localization of OGT in myotubes, and phospho-mimetic T444E-OGT exhibits altered substrate selectivity. Conversely, the - and -subunits of AMPK are O-GlcNAcylated, O-GlcNAcylation of the 1-subunit increases with AMPK activity, and acute inhibition of O-GlcNAc cycling disrupts activation of AMPK. We have demonstrated significant cross-talk between the O-GlcNAc and AMPK systems, suggesting OGT and AMPK may cooperatively regulate nutrient-sensitive intracellular processes that mediate cellular metabolism, growth, proliferation, and/or tissue function.	[Bullen, John W.; Hart, Gerald W.] Johns Hopkins Univ Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Chanda, Dipanjan; Neumann, Dietbert] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands	Johns Hopkins University; University of Virginia; University of Virginia; Maastricht University	Hart, GW (corresponding author), Johns Hopkins Univ Sch Med, Dept Biol Chem, 725 North Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Chanda, Dipanjan/AAU-3996-2021	Chanda, Dipanjan/0000-0003-0685-187X; Hart, Gerald/0000-0001-7812-4351; Neumann, Dietbert/0000-0002-4316-684X; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health [R01CA42486, R01DK61671, GM037537, N01-HV-00240, P01HL107153, R24DK084949]; Netherlands Organization for Scientific Research VIDI Grant [864.10.007]; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK084949, R01DK061671, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research VIDI Grant; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part, by National Institutes of Health Grants R01CA42486, R01DK61671, GM037537; N01-HV-00240; P01HL107153, R24DK084949, The Netherlands Organization for Scientific Research VIDI Grant (864.10.007), and the Patrick C. Walsh Prostate Cancer Research Fund.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Graham DRM, 2005, PROTEOMICS, V5, P2309, DOI 10.1002/pmic.200401249; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hall EH, 2010, MOL CELL PROTEOMICS, V9, P2853, DOI 10.1074/mcp.M110.003665; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2000, METH MOL B, V99, P63; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941	32	119	120	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10592	10606		10.1074/jbc.M113.523068	http://dx.doi.org/10.1074/jbc.M113.523068			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563466	hybrid, Green Published			2022-12-25	WOS:000334226400031
J	Jamal, MS; Parveen, S; Beg, MA; Suhail, M; Chaudhary, AGA; Damanhouri, GA; Abuzenadah, AM; Rehan, M				Jamal, Mohammad S.; Parveen, Shadma; Beg, Mohd A.; Suhail, Mohd; Chaudhary, Adeel G. A.; Damanhouri, Ghazi A.; Abuzenadah, Adel M.; Rehan, Mohd			Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches	PLOS ONE			English	Article							NF-KAPPA-B; PAN-ACTIVE INHIBITORS; CELL-CYCLE ARREST; BCL-2 FAMILY; CANCER CELLS; INDUCED APOPTOSIS; SCORING FUNCTIONS; IN-VITRO; PROTEIN; STAT3	Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) is a naphthoquinone derivative from the roots of plant Plumbago zeylanica and belongs to one of the largest and diverse groups of plant metabolites. The anticancer and antiproliferative activities of plumbagin have been observed in animal models as well as in cell cultures. Plumbagin exerts inhibitory effects on multiple cancer-signaling proteins, however, the binding mode and the molecular interactions have not yet been elucidated for most of these protein targets. The present study is the first attempt to provide structural insights into the binding mode of plumbagin to five cancer signaling proteins viz. PI3K gamma, AKT1/PKB alpha, Bcl-2, NF-kappa B, and Stat3 using molecular docking and (un) binding simulation analysis. We validated plumbagin docking to these targets with previously known important residues. The study also identified and characterized various novel interacting residues of these targets which mediate the binding of plumbagin. Moreover, the exact modes of inhibition when multiple mode of inhibition existed was also shown. Results indicated that the engaging of these important interacting residues in plumbagin binding leads to inhibition of these cancer-signaling proteins which are key players in the pathogenesis of cancer and thereby ceases the progression of the disease.	[Jamal, Mohammad S.; Beg, Mohd A.; Suhail, Mohd; Chaudhary, Adeel G. A.; Damanhouri, Ghazi A.; Rehan, Mohd] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Parveen, Shadma] MJP Rohilkhand Univ, Bareilly Coll, Bareilly, UP, India; [Abuzenadah, Adel M.] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia	King Abdulaziz University; Mahatma Jyotiba Phule Rohilkhand University; King Abdulaziz University	Rehan, M (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	mrehan786@gmail.com	Suhail, Mohd/K-2086-2014; Rehan, Mohd/H-9835-2012; Beg, Mohd A/K-3366-2013; Damanhouri, Ghazi/Q-7901-2019; Suhail, Mohd/H-9626-2012	Suhail, Mohd/0000-0002-1641-4633; Beg, Mohd A/0000-0002-8495-4738; Rehan, Mohd/0000-0003-4898-6043	King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia	King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia	The work presented in the research paper was financially supported by the King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2008, BIOCHEMISTRY-US, V47, P7838, DOI 10.1021/bi800730q; ACS, 2008, GLOB CANC FACTS FIG, P1; Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Baell JB, 2002, BIOCHEM PHARMACOL, V64, P851, DOI 10.1016/S0006-2952(02)01148-6; Bajwa N, 2012, EXPERT OPIN THER PAT, V22, P37, DOI 10.1517/13543776.2012.644274; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Chen CA, 2009, PANCREATOLOGY, V9, P797, DOI 10.1159/000210028; Cheng HM, 2013, ACS MED CHEM LETT, V4, P91, DOI 10.1021/ml300309h; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cortes J, 2005, BIOINFORMATICS, V21, pI116, DOI 10.1093/bioinformatics/bti1017; Dandawate P, 2012, BIOORG MED CHEM LETT, V22, P3104, DOI 10.1016/j.bmcl.2012.03.060; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Demma J, 2009, TOXICOL IN VITRO, V23, P266, DOI 10.1016/j.tiv.2008.12.007; Devaurs D, 2013, NUCLEIC ACIDS RES, V41, pW297, DOI 10.1093/nar/gkt380; Dewson G, 2010, CELL HEALTH CYTOSKEL, V2, P9; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Hazra B, 2002, PHYTOTHER RES, V16, P133, DOI 10.1002/ptr.867; He JX, 2012, J BIOSCIENCES, V37, P243, DOI 10.1007/s12038-012-9202-x; Hsu YL, 2006, J PHARMACOL EXP THER, V318, P484, DOI 10.1124/jpet.105.098863; Hubbard S. J., 1993, TECHNICAL REPORT; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Klasa RJ, 2002, ANTISENSE NUCLEIC A, V12, P193, DOI 10.1089/108729002760220798; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; KRISHNASWAMY M, 1980, INDIAN J EXP BIOL, V18, P876; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lindsley CW, 2007, CURR TOP MED CHEM, V7, P1349; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loercher A, 2004, CANCER RES, V64, P6511, DOI 10.1158/0008-5472.CAN-04-0852; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Naresh RAR, 1996, J PHARM PHARMACOL, V48, P1128, DOI 10.1111/j.2042-7158.1996.tb03907.x; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nazeem S, 2009, MUTAGENESIS, V24, P413, DOI 10.1093/mutage/gep023; PARIMALA R, 1993, MOL CELL BIOCHEM, V125, P59, DOI 10.1007/BF00926835; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reed JC, 1997, J NATL CANCER I, V89, P988, DOI 10.1093/jnci/89.14.988; Robe PA, 2004, CLIN CANCER RES, V10, P5595, DOI 10.1158/1078-0432.CCR-03-0392; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Sakamoto S, 2009, BIOL PHARM BULL, V32, P434, DOI 10.1248/bpb.32.434; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sandur SK, 2010, MOL CANCER RES, V8, P107, DOI 10.1158/1541-7786.MCR-09-0257; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Shukla S, 2007, MOL CANCER THER, V6, P3279, DOI 10.1158/1535-7163.MCT-07-0564; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Singh U. V., 1997, Indian Journal of Physiology and Pharmacology, V41, P171; Souissi I, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-12; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Sugie S, 1998, CANCER LETT, V127, P177, DOI 10.1016/S0304-3835(98)00035-4; Thasni KA, 2008, ANN ONCOL, V19, P696, DOI 10.1093/annonc/mdm557; Thasni KA, 2013, MOL CARCINOGEN, V52, P392, DOI 10.1002/mc.21877; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang CCC, 2008, CANCER LETT, V259, P82, DOI 10.1016/j.canlet.2007.10.005; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wei J, 2010, J MED CHEM, V53, P8000, DOI 10.1021/jm100746q; Wei J, 2009, J MED CHEM, V52, P4511, DOI 10.1021/jm900472s; Ye KQ, 2005, J CELL BIOCHEM, V96, P463, DOI 10.1002/jcb.20549; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhao Yan-Li, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P208	91	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e87309	10.1371/journal.pone.0087309	http://dx.doi.org/10.1371/journal.pone.0087309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586269	Green Published, Green Submitted, gold			2022-12-25	WOS:000332390800003
J	Harper, M; Gronenberg, L; Liao, J; Lee, C				Harper, Marc; Gronenberg, Luisa; Liao, James; Lee, Christopher			Comprehensive Detection of Genes Causing a Phenotype Using Phenotype Sequencing and Pathway Analysis	PLOS ONE			English	Article							NITRO-N-NITROSOGUANIDINE; COLI K-12 MG1655; ESCHERICHIA-COLI; PHOSPHOENOLPYRUVATE CARBOXYKINASE; SUCCINATE PRODUCTION; METABOLIC EVOLUTION; ADAPTIVE EVOLUTION; MUTATION; OVEREXPRESSION; FERMENTATION	Discovering all the genetic causes of a phenotype is an important goal in functional genomics. We combine an experimental design for detecting independent genetic causes of a phenotype with a high-throughput sequencing analysis that maximizes sensitivity for comprehensively identifying them. Testing this approach on a set of 24 mutant strains generated for a metabolic phenotype with many known genetic causes, we show that this pathway-based phenotype sequencing analysis greatly improves sensitivity of detection compared with previous methods, and reveals a wide range of pathways that can cause this phenotype. We demonstrate our approach on a metabolic re-engineering phenotype, the PEP/OAA metabolic node in E. coli, which is crucial to a substantial number of metabolic pathways and under renewed interest for biofuel research. Out of 2157 mutations in these strains, pathway-phenoseq discriminated just five gene groups (12 genes) as statistically significant causes of the phenotype. Experimentally, these five gene groups, and the next two high-scoring pathway-phenoseq groups, either have a clear connection to the PEP metabolite level or offer an alternative path of producing oxaloacetate (OAA), and thus clearly explain the phenotype. These high-scoring gene groups also show strong evidence of positive selection pressure, compared with strictly neutral selection in the rest of the genome.	[Harper, Marc; Liao, James; Lee, Christopher] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Lee, Christopher] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Gronenberg, Luisa; Liao, James] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Harper, M (corresponding author), Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA.	marcharper@ucla.edu		Liao, James/0000-0002-4580-7276	Oce of Science (BER), U. S. Department of Energy [DE-FC02-02ER63421]	Oce of Science (BER), U. S. Department of Energy	This research was supported by the Oce of Science (BER), U. S. Department of Energy, Cooperative Agreement No. DE-FC02-02ER63421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.98; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; CHAO YP, 1993, APPL ENVIRON MICROB, V59, P4261, DOI 10.1128/AEM.59.12.4261-4265.1993; Chatterjee R, 2001, APPL ENVIRON MICROB, V67, P148, DOI 10.1128/AEM.67.1.148-154.2001; Chen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012397; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P132, DOI 10.1159/000089642; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Ewens WJ., 2004, MATH POPULATION GENE, V27; Fong NL, 2013, FEMS MICROBIOLOGY LE; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Harper M, 2012, MUTAT RES-FUND MOL M, V731, P64, DOI 10.1016/j.mrfmmm.2011.10.011; Harper MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016517; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; HUCHO F, 1975, ANGEW CHEM INT EDIT, V14, P591, DOI 10.1002/anie.197505911; Jantama K, 2008, BIOTECHNOL BIOENG, V99, P1140, DOI 10.1002/bit.21694; Jones E., 2001, SCIPY OPEN SOURCE SC; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kim HJ, 2012, APPL MICROBIOL BIOT, V94, P1079, DOI 10.1007/s00253-011-3779-0; Kim P, 2004, APPL ENVIRON MICROB, V70, P1238, DOI 10.1128/AEM.70.2.1238-1241.2004; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; Lee C, 2009, SCIPY, V8, P62; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lee J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIAO JC, 1994, ANN NY ACAD SCI, V745, P21; Liu RM, 2012, APPL MICROBIOL BIOT, V94, P959, DOI 10.1007/s00253-012-3896-4; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller J.H., 1972, EXPT MOL GENETICS, V60; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Ohnishi J, 2008, MUTAT RES-GEN TOX EN, V649, P239, DOI 10.1016/j.mrgentox.2007.10.003; Park S, 2013, BIOPROC BIOSYST ENG, V36, P127, DOI [10.1007/s00449-012-0759-4, 10.1007/s00449-012-0821-2]; Peng L, 2006, FEMS MICROBIOLOGY LE, V235, P17; Peng L, 2004, APPL MICROBIOLOGY BI; Peng LF, 2004, FEMS MICROBIOL LETT, V235, P17, DOI 10.1016/j.femsle.2004.04.003; R Core Team, 2012, R LANG ENV STAT COMP; Raineri E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-239; Reyes LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017678; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; Silhavy T.J., 1984, EXPT GENE FUSIONS; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Umland TC, 2012, MBIO, V3, DOI 10.1128/mBio.00113-12; Velicer GJ, 2006, P NATL ACAD SCI USA, V103, P8107, DOI 10.1073/pnas.0510740103; Waegeman H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-70; Zhang B, 2012, METAB ENG; Zhang X, 2009, APPL ENVIRON MICROB, V75, P7807, DOI 10.1128/AEM.01758-09; Zhang XL, 2009, P NATL ACAD SCI USA, V106, P20180, DOI 10.1073/pnas.0905396106; Zhu Y, 2012, GENETICS, V192, P139, DOI 10.1534/genetics.112.141986	60	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88072	10.1371/journal.pone.0088072	http://dx.doi.org/10.1371/journal.pone.0088072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586303	Green Submitted, Green Published, gold			2022-12-25	WOS:000332389000008
J	Liegl, R; Koenig, S; Siedlecki, J; Haritoglou, C; Kampik, A; Kernt, M				Liegl, Raffael; Koenig, Susanna; Siedlecki, Jakob; Haritoglou, Christos; Kampik, Anselm; Kernt, Marcus			Temsirolimus Inhibits Proliferation and Migration in Retinal Pigment Epithelial and Endothelial Cells via mTOR Inhibition and Decreases VEGF and PDGF Expression	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; GROWTH-FACTOR; MAMMALIAN TARGET; HYPOXIC REGULATION; DEGENERATION; ANGIOGENESIS; RAPAMYCIN; EFFICACY; RANIBIZUMAB; SAFETY	Due to their high prevalence, retinal vascular diseases including age related macular degeneration (AMD), retinal vein occlusions (RVO), diabetic retinopathy (DR) and diabetic macular edema have been major therapeutic targets over the last years. The pathogenesis of these diseases is complex and yet not fully understood. However, increased proliferation, migration and angiogenesis are characteristic cellular features in almost every retinal vascular disease. The introduction of vascular endothelial growth factor (VEGF) binding intravitreal treatment strategies has led to great advances in the therapy of these diseases. While the predominant part of affected patients benefits from the specific binding of VEGF by administering an anti-VEGF antibody into the vitreous cavity, a small number of non-responders exist and alternative or additional therapeutic strategies should therefore be evaluated. The mammalian target of rapamycin (mTOR) is a central signaling pathway that eventually triggers up-regulation of cellular proliferation, migration and survival and has been identified to play a key role in angiogenesis. In the present study we were able to show that both retinal pigment epithelial (RPE) cells as wells as human umbilical vein endothelial cells (HUVEC) are inhibited in proliferating and migrating after treatment with temsirolimus in non-toxic concentrations. Previous studies suggest that the production of VEGF, platelet derived growth factor (PDGF) and other important cytokines is not only triggered by hypoxia but also by mTOR itself. Our results indicate that temsirolimus decreases VEGF and PDGF expression on RNA and protein levels significantly. We therefore believe that the mTOR inhibitor temsirolimus might be a promising drug in the future and it seems worthwhile to evaluate complementary therapeutic effects with anti-VEGF drugs for patients not profiting from mono anti-VEGF therapy alone.	[Liegl, Raffael; Koenig, Susanna; Siedlecki, Jakob; Haritoglou, Christos; Kampik, Anselm; Kernt, Marcus] Univ Munich, Dept Ophthalmol, Munich, Germany	University of Munich	Liegl, R (corresponding author), Univ Munich, Dept Ophthalmol, Munich, Germany.	Raffael.Liegl@med.uni-muenchen.de						AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Borders EB, 2010, AM J HEALTH-SYST PH, V67, P2095, DOI 10.2146/ajhp100020; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Browning DJ, 2012, AM J OPHTHALMOL, V154, P222, DOI 10.1016/j.ajo.2012.04.020; Bukowski RM, 2012, EXPERT OPIN DRUG SAF, V11, P861, DOI 10.1517/14740338.2012.713344; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; Cheung L. K, 2013, AGE RELATED MACULAR; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Cohen SY, 2012, RETINA-J RET VIT DIS, V32, P1480, DOI 10.1097/IAE.0b013e318240a516; Cohen SY, 2013, GRAEFES ARCH CLIN EX; Danesi R, 2013, CANC TREAT REV; Deming DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060709; Ding J, 2012, CURR DIABETES REP, V12, P346, DOI 10.1007/s11892-012-0283-6; Eshleman JS, 2002, CANCER RES, V62, P7291; Feng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068149; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Frey T, 2011, ANTIOXID REDOX SIGN, V15, P1271, DOI 10.1089/ars.2011.3906; Frost P, 2013, J ONCOL, V2013, DOI 10.1155/2013/897025; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Ho AC, 2012, OPHTHALMOLOGY, V119, P2179, DOI 10.1016/j.ophtha.2012.07.058; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kehler AK, 2012, CURR EYE RES, V37, P500, DOI 10.3109/02713683.2012.663855; Kernt M, 2010, BRIT J OPHTHALMOL, V94, P1533, DOI 10.1136/bjo.2010.182162; Kernt M, BR J OPHTHALMOL, V94, P1533; Kernt M, 2012, GROWTH FACTORS, V30, P49, DOI 10.3109/08977194.2011.639300; Kernt M, 2009, J CATARACT REFR SURG, V35, P354, DOI 10.1016/j.jcrs.2008.10.052; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; Kuhn JG, 2007, CLIN CANCER RES, V13, P7401, DOI 10.1158/1078-0432.CCR-07-0781; Kwon YS, 2005, INVEST OPHTH VIS SCI, V46, P454, DOI 10.1167/iovs.04-0753; Lee WJ, 2012, BRIT J OPHTHALMOL, V96, P1426, DOI 10.1136/bjophthalmol-2012-301913; Li SY, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/426769; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lin CH, 2013, BRIT J PHARMACOL, V168, P920, DOI 10.1111/j.1476-5381.2012.02227.x; LoRusso PM, 2013, ONCOLOGY-BASEL, V84, P43, DOI 10.1159/000343063; Maity A, 2000, CANCER RES, V60, P5879; Martin LA, 2013, CANC TREAT REV; Massacesi C, 2013, ANN NY ACAD SCI, V1280, P19, DOI 10.1111/nyas.12060; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muether PS, 2013, RETINA; Negrier S, 2011, LANCET ONCOL, V12, P673, DOI 10.1016/S1470-2045(11)70124-3; Nguyen QD, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-32; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmucker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042701; Semenza GL, 2001, J CLIN INVEST, V108, P39, DOI 10.1172/JCI13374; Sheri A, 2010, CLIN BREAST CANCER, V10, pS79, DOI 10.3816/CBC.2010.s.016; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Spunt SL, 2011, J CLIN ONCOL, V29, P2933, DOI 10.1200/JCO.2010.33.4649; Stewart MW, 2012, CURR DIABETES REV, V8, P237, DOI 10.2174/157339912800840488; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Sun Y, 2012, JPN J CLIN ONCOL, V42, P836, DOI 10.1093/jjco/hys110; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Wan XL, 2006, NEOPLASIA, V8, P394, DOI 10.1593/neo.05820; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Yuan TL, 2008, P NATL ACAD SCI USA, V105, P9739, DOI 10.1073/pnas.0804123105; Zask A, 2011, EXPERT OPIN THER PAT, V21, P1109, DOI 10.1517/13543776.2011.584871; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zheng YF, 2012, INDIAN J OPHTHALMOL, V60, P428, DOI 10.4103/0301-4738.100542; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	67	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88203	10.1371/journal.pone.0088203	http://dx.doi.org/10.1371/journal.pone.0088203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586308	Green Published, Green Submitted, gold			2022-12-25	WOS:000332389000009
J	Hartfield, EM; Yamasaki-Mann, M; Fernandes, HJR; Vowles, J; James, WS; Cowley, SA; Wade-Martins, R				Hartfield, Elizabeth M.; Yamasaki-Mann, Michiko; Fernandes, Hugo J. Ribeiro; Vowles, Jane; James, William S.; Cowley, Sally A.; Wade-Martins, Richard			Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; HUMAN ES; HIGHLY EFFICIENT; GENE-EXPRESSION; ALPHA-SYNUCLEIN; CALCIUM; VULNERABILITY; DIFFERENTIATION	Human induced pluripotent stem cells (hiPSCs) offer the potential to study otherwise inaccessible cell types. Critical to this is the directed differentiation of hiPSCs into functional cell lineages. This is of particular relevance to research into neurological disease, such as Parkinson's disease (PD), in which midbrain dopaminergic neurons degenerate during disease progression but are unobtainable until post-mortem. Here we report a detailed study into the physiological maturation over time of human dopaminergic neurons in vitro. We first generated and differentiated hiPSC lines into midbrain dopaminergic neurons and performed a comprehensive characterisation to confirm dopaminergic functionality by demonstrating dopamine synthesis, release, and re-uptake. The neuronal cultures include cells positive for both tyrosine hydroxylase (TH) and G protein-activated inward rectifier potassium channel 2 (Kir3.2, henceforth referred to as GIRK2), representative of the A9 population of substantia nigra pars compacta (SNc) neurons vulnerable in PD. We observed for the first time the maturation of the slow autonomous pace-making (<10 Hz) and spontaneous synaptic activity typical of mature SNc dopaminergic neurons using a combination of calcium imaging and electrophysiology. hiPSC-derived neurons exhibited inositol tri-phosphate (IP3) receptor-dependent release of intracellular calcium from the endoplasmic reticulum in neuronal processes as calcium waves propagating from apical and distal dendrites, and in the soma. Finally, neurons were susceptible to the dopamine neuron-specific toxin 1-methyl-4-phenylpyridinium (MPP+) which reduced mitochondrial membrane potential and altered mitochondrial morphology. Mature hiPSC-derived dopaminergic neurons provide a neurophysiologically-defined model of previously inaccessible vulnerable SNc dopaminergic neurons to bridge the gap between clinical PD and animal models.	[Hartfield, Elizabeth M.; Yamasaki-Mann, Michiko; Fernandes, Hugo J. Ribeiro; Vowles, Jane; James, William S.; Cowley, Sally A.; Wade-Martins, Richard] Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England; [Hartfield, Elizabeth M.; Yamasaki-Mann, Michiko; Fernandes, Hugo J. Ribeiro; Wade-Martins, Richard] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Vowles, Jane; James, William S.; Cowley, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, James Martin Stem Cell Facil, Oxford OX1 3RE, England	University of Oxford; University of Oxford; University of Oxford	Wade-Martins, R (corresponding author), Univ Oxford, Oxford Parkinsons Dis Ctr, Oxford, England.	richard.wade-martins@dpag.ox.ac.uk	james, william/H-4289-2013; Fernandes, Hugo/G-5309-2015	james, william/0000-0002-2506-1198; Fernandes, Hugo/0000-0002-1404-5045; Wade-Martins, Richard/0000-0001-6691-580X; Cowley, Sally/0000-0003-0297-6675	Monument Trust Discovery Award from Parkinson's UK; Oxford James Martin Stem Cell Facility; James Martin Research Fellowship; Wellcome Trust Career Re-Entry Fellowship [WT082260/Z/07/Z]; Parkinson&quot;s UK [J-0901] Funding Source: researchfish	Monument Trust Discovery Award from Parkinson's UK; Oxford James Martin Stem Cell Facility; James Martin Research Fellowship; Wellcome Trust Career Re-Entry Fellowship(Wellcome Trust); Parkinson&quot;s UK(Parkinson&apos;s UK)	The work was supported by the Monument Trust Discovery Award from Parkinson's UK and The Oxford James Martin Stem Cell Facility. MYM holds a James Martin Research Fellowship, and SC holds a Wellcome Trust Career Re-Entry Fellowship (WT082260/Z/07/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini B, 1999, J NEUROPHYSIOL, V82, P2249, DOI 10.1152/jn.1999.82.5.2249; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cooper O., 2012, SCI TRANSL MED, V4; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hernandez Felix, 2008, Curr Aging Sci, V1, P56; HEYER EJ, 1984, BRAIN RES, V310, P142, DOI 10.1016/0006-8993(84)90018-0; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Iovino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013947; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; KANG Y, 1993, NEUROSCI RES, V18, P195, DOI 10.1016/0168-0102(93)90055-U; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Moralli D, 2011, STEM CELL REV REP, V7, P471, DOI 10.1007/s12015-010-9224-4; Morikawa H, 2000, J NEUROSCI, V20, part. no.; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Patani R, 2012, J NEUROCHEM, V122, P738, DOI 10.1111/j.1471-4159.2012.07825.x; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Reyes S, 2012, J COMP NEUROL, V520, P2591, DOI 10.1002/cne.23051; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; STROMBERG I, 1991, EXP NEUROL, V112, P140, DOI 10.1016/0014-4886(91)90064-J; Sundberg M, 2013, STEM CELLS, V31, P1548, DOI 10.1002/stem.1415; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Surmeier DJ, 2013, J BIOL CHEM, V288, P10736, DOI 10.1074/jbc.R112.410530; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TEPPER JM, 1990, DEV BRAIN RES, V54, P21, DOI 10.1016/0165-3806(90)90061-3; Tian LP, 2012, BIOTECHNOL LETT, V34, P1167, DOI 10.1007/s10529-012-0888-5; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018271	63	97	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87388	10.1371/journal.pone.0087388	http://dx.doi.org/10.1371/journal.pone.0087388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586273	Green Submitted, Green Published, gold			2022-12-25	WOS:000331717900009
J	Ryu, S; Chang, Y; Zhang, YY; Woo, HY; Kwon, MJ; Park, H; Lee, KB; Son, HJ; Cho, J; Guallar, E				Ryu, Seungho; Chang, Yoosoo; Zhang, Yiyi; Woo, Hee-Yeon; Kwon, Min-Jung; Park, Hyosoon; Lee, Kyu-Beck; Son, Hee Jung; Cho, Juhee; Guallar, Eliseo			Higher Serum Direct Bilirubin Levels Were Associated with a Lower Risk of Incident Chronic Kidney Disease in Middle Aged Korean Men	PLOS ONE			English	Article							RACE-RELATED DIFFERENCES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INVERSE RELATIONSHIP; INSULIN-RESISTANCE; METABOLIC SYNDROME; NATIONAL-HEALTH; BILE-PIGMENTS; RENAL-DISEASE; UNITED-STATES	Background: The association between serum bilirubin levels and incident chronic kidney disease (CKD) in the general population is unknown. We aimed to examine the association between serum bilirubin concentration (total, direct, and indirect) and the risk of incident CKD. Methods and Findings: Longitudinal cohort study of 12,823 Korean male workers 30 to 59 years old without CKD or proteinuria at baseline participating in medical health checkup program in a large worksite. Study participants were followed for incident CKD from 2002 through 2011. Estimated glomerular filtration rate (eGFR) was estimated by using the CKD-EPI equation. CKD was defined as eGFR <60 mL/min per 1.73 m(2). Parametric Cox models and pooled logistic regression models were used to estimate adjusted hazard ratios for incident CKD. We observed 238 incident cases of CKD during 70,515.8 person-years of follow-up. In age-adjusted models, the hazard ratios for CKD comparing quartiles 2-4 vs. quartile 1 of serum direct bilirubin were 0.93 (95% CI 0.67-1.28), 0.88 (0.60-1.27) and 0.60 (0.42-0.88), respectively. In multivariable models, the adjusted hazard ratio for CKD comparing the highest to the lowest quartile of serum direct bilirubin levels was 0.60 (95% CI 0.41-0.87; P trend = 0.01). Neither serum total nor indirect bilirubin levels were significantly associated with the incidence of CKD. Conclusions: Higher serum direct bilirubin levels were significantly associated with a lower risk of developing CKD, even adjusting for a variety of cardiometabolic parameters. Further research is needed to elucidate the mechanisms underlying this association and to establish the role of serum direct bilirubin as a marker for CKD risk.	[Ryu, Seungho; Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Ryu, Seungho; Chang, Yoosoo; Zhang, Yiyi; Son, Hee Jung; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Ryu, Seungho; Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Zhang, Yiyi; Cho, Juhee; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Woo, Hee-Yeon; Kwon, Min-Jung; Park, Hyosoon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Lab Med, Seoul, South Korea; [Lee, Kyu-Beck] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea; [Son, Hee Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Comprehens Canc Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center	Guallar, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	eguallar@jhsph.edu	zhang, yiyi/J-2592-2012; Cho, Juhee/ABD-2280-2021	Chang, Yoosoo/0000-0002-6945-9050; Ryu, Seungho/0000-0002-3927-8646	Kangbuk Samsung Hospital	Kangbuk Samsung Hospital(Samsung)	This study was funded by the Kangbuk Samsung Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin CA, 2005, AM J PHYSIOL-RENAL, V288, pF778, DOI 10.1152/ajprenal.00215.2004; Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Chang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037241; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Chin HJ, 2009, J KOREAN MED SCI, V24, pS22, DOI 10.3346/jkms.2009.24.S1.S22; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins AJ, 2003, KIDNEY INT, V64, pS24, DOI 10.1046/j.1523-1755.64.s87.5.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Djousse L, 2003, AM J CARDIOL, V91, P485, DOI 10.1016/S0002-9149(02)03256-3; Erdogan D, 2006, ATHEROSCLEROSIS, V184, P431, DOI 10.1016/j.atherosclerosis.2005.05.011; Farrera J A, 1994, Bioorg Med Chem, V2, P181, DOI 10.1016/S0968-0896(00)82013-1; FISCHER AF, 1988, J PEDIATR GASTR NUTR, V7, P27, DOI 10.1097/00005176-198801000-00007; Franchini M, 2010, ADV CLIN CHEM, V50, P47, DOI 10.1016/S0065-2423(10)50003-9; Fried L, 2004, J AM SOC NEPHROL, V15, P3184, DOI 10.1097/01.ASN.0000146422.45434.35; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Han SS, 2010, TOHOKU J EXP MED, V221, P133, DOI 10.1620/tjem.221.133; Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250, DOI 10.1161/01.ATV.16.2.250; Huang SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042594; Hwang HJ, 2010, CLIN CHIM ACTA, V411, P1496, DOI 10.1016/j.cca.2010.06.003; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; Kotal P, 1996, GASTROENTEROLOGY, V111, P217, DOI 10.1053/gast.1996.v111.pm8698202; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Leung N, 2001, KIDNEY INT, V60, P1047, DOI 10.1046/j.1523-1755.2001.0600031047.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lin LY, 2009, ATHEROSCLEROSIS, V203, P563, DOI 10.1016/j.atherosclerosis.2008.07.021; Maines MD, 1999, J PHARMACOL EXP THER, V291, P911; MANOLIO TA, 1992, CLIN CHEM, V38, P1853; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Rodrigues C, 2012, AM J MED SCI, V343, P114, DOI 10.1097/MAJ.0b013e318223460f; ROSENTHAL P, 1984, CLIN CHEM, V30, P1380; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; SCHACHTER D, 1957, SCIENCE, V126, P507, DOI 10.1126/science.126.3272.507-a; Schnackenberg CG, 2000, AM J PHYSIOL-RENAL, V279, pF302, DOI 10.1152/ajprenal.2000.279.2.F302; Setia S, 2002, ARCH PEDIAT ADOL MED, V156, P276, DOI 10.1001/archpedi.156.3.276; Shin HS, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-29; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Taaffe DR, 2003, ANN HUM BIOL, V30, P329, DOI 10.1080/0301446031000089588; Tapan S, 2009, CLIN BIOCHEM, V42, P791, DOI 10.1016/j.clinbiochem.2009.02.005; Targher G, 2009, CLIN CHEM LAB MED, V47, P1055, DOI 10.1515/CCLM.2009.244; Targher G, 2009, KIDNEY INT, V75, P863, DOI 10.1038/ki.2008.677; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Thorp Micah L, 2006, Dis Manag, V9, P115, DOI 10.1089/dis.2006.9.115; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; YAMAUCHI Y, 1989, Acta Paediatrica Japonica, V31, P65; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Zou AP, 2001, HYPERTENSION, V37, P547, DOI 10.1161/01.HYP.37.2.547	57	25	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e75178	10.1371/journal.pone.0075178	http://dx.doi.org/10.1371/journal.pone.0075178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586219	gold, Green Published, Green Submitted			2022-12-25	WOS:000331714700001
J	Preston, J; Smith, AD; Schofield, EJ; Chadwick, AV; Jones, MA; Watts, JEM				Preston, Joanne; Smith, Andrew D.; Schofield, Eleanor J.; Chadwick, Alan V.; Jones, Mark A.; Watts, Joy E. M.			The Effects of Mary Rose Conservation Treatment on Iron Oxidation Processes and Microbial Communities Contributing to Acid Production in Marine Archaeological Timbers	PLOS ONE			English	Article							SULFUR ACCUMULATION; FERROUS IRON; BACTERIA; WOOD	The Tudor warship the Mary Rose has reached an important transition point in her conservation. The 19 year long process of spraying with polyethylene glycol (PEG) has been completed (April 29th 2013) and the hull is air drying under tightly controlled conditions. Acidophilic bacteria capable of oxidising iron and sulfur have been previously identified and enriched from unpreserved timbers of the Mary Rose, demonstrating that biological pathways of iron and sulfur oxidization existed potentially in this wood, before preservation with PEG. This study was designed to establish if the recycled PEG spray system was a reservoir of microorganisms capable of iron and sulfur oxidization during preservation of the Mary Rose. Microbial enrichments derived from PEG impregnated biofilm collected from underneath the Mary Rose hull, were examined to better understand the processes of cycling of iron. X-ray absorption spectroscopy was utilised to demonstrate the biological contribution to production of sulfuric acid in the wood. Using molecular microbiological techniques to examine these enrichment cultures, PEG was found to mediate a shift in the microbial community from a co-culture of Stenotrophomonas and Brevunidimonas sp, to a co-culture of Stenotrophomonas and the iron oxidising Alicyclobacillus sp. Evidence is presented that PEG is not an inert substance in relation to the redox cycling of iron. This is the first demonstration that solutions of PEG used in the conservation of the Mary Rose are promoting the oxidation of ferrous iron in acidic solutions, in which spontaneous abiotic oxidation does not occur in water. Critically, these results suggest PEG mediated redox cycling of iron between valence states in solutions of 75% PEG 200 and 50% PEG 2000 (v/v) at pH 3.0, with serious implications for the future use of PEG as a conservation material of iron rich wooden archaeological artefacts.	[Preston, Joanne; Watts, Joy E. M.] Univ Portsmouth, Portsmouth, Hants, England; [Smith, Andrew D.] STFC Daresbury Lab, Warrington, Cheshire, England; [Schofield, Eleanor J.; Jones, Mark A.] Mary Rose Trust, HM Naval Base, Portsmouth, Hants, England; [Chadwick, Alan V.] Univ Kent, Sch Phys Sci, Canterbury, Kent, England	University of Portsmouth; STFC Daresbury Laboratory; University of Kent	Watts, JEM (corresponding author), Univ Portsmouth, Portsmouth, Hants, England.	joy.watts@port.ac.uk		Chadwick, Alan/0000-0002-6485-9207; Watts, Joy/0000-0001-9595-0540; Preston, Joanne/0000-0002-2268-4998	Mary Rose Trust; University of Portsmouth; EU Marie Curie [FP7-RG 276948]	Mary Rose Trust; University of Portsmouth; EU Marie Curie(European Commission)	Funding to support this work was obtained from the Mary Rose Trust, and the University of Portsmouth. JEMW was supported by a EU Marie Curie (FP7-RG 276948) award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amouric A, 2011, MICROBIOL-SGM, V157, P111, DOI 10.1099/mic.0.044537-0; Benz M, 1998, ARCH MICROBIOL, V169, P159, DOI 10.1007/s002030050555; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Bruckner CG, 2008, APPL ENVIRON MICROB, V74, P7740, DOI 10.1128/AEM.01399-08; Christensen M, 2006, J RAMAN SPECTROSC, V37, P1171, DOI 10.1002/jrs.1589; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Fors Y, 2008, INT BIODETER BIODEGR, V62, P336, DOI 10.1016/j.ibiod.2007.11.008; Guilminot E, 2002, CORROS SCI, V44, P2199, DOI 10.1016/S0010-938X(02)00010-0; Hafors B., 2001, CONSERVATION SWEDISH; Hoffmann P, 2004, HOLZFORSCHUNG, V58, P211, DOI 10.1515/HF.2004.033; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jones M, 2003, ARCHAEOLOGY MARY ROS; Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2; Krausova VI, 2006, HYDROBIOLOGIA, V559, P77, DOI 10.1007/s10750-004-0571-5; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Marsden P., 2003, SEALED TIME LOSS REC; Mosselmans JFW, 2009, J SYNCHROTRON RADIAT, V16, P818, DOI 10.1107/S0909049509032282; Pearson C, 1979, USE POLYETHYLENE GLY, p[24, 51]; Preston J, 2012, APPL ENV MICROBIOLOG; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Rimstidt JD, 2003, GEOCHIM COSMOCHIM AC, V67, P873, DOI 10.1016/S0016-7037(02)01165-1; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sandstrom M, 2005, P NATL ACAD SCI USA, V102, P14165, DOI 10.1073/pnas.0504490102; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wetherall KM, 2008, J ARCHAEOL SCI, V35, P1317, DOI 10.1016/j.jas.2007.09.007	31	23	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e84169	10.1371/journal.pone.0084169	http://dx.doi.org/10.1371/journal.pone.0084169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586230	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000331711900003
J	Huang, XJ; Sun, K; Zhao, YDD; Vogel, SM; Song, YL; Mahmud, N; Zhao, YY				Huang, Xiaojia; Sun, Kai; Zhao, Yidan D.; Vogel, Stephen M.; Song, Yuanling; Mahmud, Nadim; Zhao, You-Yang			Human CD34(+) Progenitor Cells Freshly Isolated from Umbilical Cord Blood Attenuate Inflammatory Lung Injury following LPS Challenge	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; ENDOTHELIAL-CELLS; LONG-TERM; MICE; NEOVASCULARIZATION; TRANSPLANTATION	Adult stem cell-based therapy is a promising novel approach for treatment of acute lung injury. Here we investigated the therapeutic potential of freshly isolated human umbilical cord blood CD34(+) progenitor cells (fCB-CD34(+) cells) in a mouse model of acute lung injury. At 3 h post-lipopolysaccharide (LPS) challenge, fCB-CD34(+) cells were transplanted i.v. to mice while CD34(-) cells or PBS were administered as controls in separate cohorts of mice. We observed that fCB-CD34(+) cell treatment inhibited lung vascular injury evident by decreased lung vascular permeability. In contrast, CD34(-) cells had no effects on lung vascular injury. Lung inflammation determined by myeloperoxidase activity, neutrophil sequestration and expression of pro-inflammatory mediators was attenuated in fCB-CD34(+) cell-treated mice at 26 h post-LPS challenge compared to PBS or CD34(-) cell-treated controls. Importantly, lung inflammation in fCB-CD34(+) cell-treated mice was returned to normal levels as seen in basal mice at 52 h post-LPS challenge whereas PBS or CD34(-) cell-treated control mice exhibited persistent lung inflammation. Accordingly, fCB-CD34(+) cell-treated mice exhibited a marked increase of survival rate. Employing in vivo 5-bromo-2'-deoxyuridine incorporation assay, we found a drastic induction of lung endothelial proliferation in fCB-CD34(+) cell-treated mice at 52 h post-LPS compared to PBS or CD34(-) cell-treated controls, which contributed to restoration of vascular integrity and thereby inhibition of lung inflammation. Taken together, these data have demonstrated the protective effects of fCB-CD34(+) cell on acute lung injury induced by LPS challenge, suggesting fCB-CD34(+) cells are an important source of stem cells for the treatment of acute lung injury.	[Huang, Xiaojia; Sun, Kai; Zhao, Yidan D.; Vogel, Stephen M.; Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA; [Huang, Xiaojia; Sun, Kai; Zhao, Yidan D.; Vogel, Stephen M.; Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA; [Huang, Xiaojia] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Pharmacol, Zhenjiang, Peoples R China; [Song, Yuanling] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Mahmud, Nadim] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Jiangsu University; Fudan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, YY (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	yyzhao@uic.edu		ZHAO, YOU-YANG/0000-0002-0041-0339	NIH [R01HL085462, R56HL085462, P01HL077806]; National Center for Research Resources [UL1RR029879]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL085462, R01HL085462, P01HL077806] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part through NIH grants R01HL085462, R56HL085462, and P01HL077806 to YYZ; The National Center for Research Resources grant UL1RR029879 to the UIC Center for Clinical & Translational Science. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RG, 1986, BLOOD, V67, P842; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; CIVIN CI, 1984, J IMMUNOL, V133, P157; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; De Paepe ME, 2011, AM J PATHOL, V178, P1329, DOI 10.1016/j.ajpath.2010.11.062; Dreher L, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0051; Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895; Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gotts JE, 2011, CRIT CARE CLIN, V27, P719, DOI 10.1016/j.ccc.2011.04.004; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Huang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050094; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; ITO A, 1995, LAB INVEST, V72, P532; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kim ES, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-108; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lee JW, 2013, AM J RESP CRIT CARE, V187, P751, DOI 10.1164/rccm.201206-0990OC; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Losordo DW, 2012, CIRC-CARDIOVASC INTE, V5, P821, DOI 10.1161/CIRCINTERVENTIONS.112.968321; Mao QF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-37; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; O'Reilly MA, 2001, AM J PHYSIOL-LUNG C, V281, pL291, DOI 10.1152/ajplung.2001.281.2.L291; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubio D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001398; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; SIMMONS DL, 1992, J IMMUNOL, V148, P267; SOLIGO D, 1991, LEUKEMIA, V5, P1026; SUBRAMANIAM M, 1995, J EXP MED, V181, P2277, DOI 10.1084/jem.181.6.2277; Sullivan MJ, 2008, NAT REV CANCER, V8, P554, DOI 10.1038/nrc2418; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiss Daniel J, 2008, Proc Am Thorac Soc, V5, P637, DOI 10.1513/pats.200804-037DW; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Zhao YD, 2010, AM J PHYSIOL-LUNG C, V298, pL36, DOI 10.1152/ajplung.00064.2009; Zhao YDD, 2009, CIRC RES, V105, P696, DOI 10.1161/CIRCRESAHA.109.199778; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	52	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88814	10.1371/journal.pone.0088814	http://dx.doi.org/10.1371/journal.pone.0088814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558433	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700079
J	Huang, XP; Wang, X; Lv, YH; Xu, LL; Lin, JS; Diao, Y				Huang, Xiaoping; Wang, Xiao; Lv, Yinghui; Xu, Luli; Lin, Junsheng; Diao, Yong			Protection Effect of Kallistatin on Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Antioxidative Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; ANGIOGENESIS; INFLAMMATION; INJURY; INHIBITION; EXPRESSION	Prolonged inflammation and oxidative stress are emerging as key causes of pathological wound healing and the development of liver fibrosis. We have investigated the effects of recombinant human kallistatin, produced in Pichia. pastoris, on preventing carbon tetrachloride (CCl4)-induced liver fibrosis in rats. Daily administration of kallistatin prevented development of CCl4-induced liver fibrosis, which was evidenced by histological study. In all kallistatin treated rats, activation of hepatic stellate cells (HSC) as assessed by s-smooth muscle actin staining was attenuated, TGF- beta 1 expression was inhibited, class I serum biomarkers associated with the process of fibrogenesis, such as hyaluronic acid, laminin, and procollagen III, were lowered, compared with that in the model control group. Furthermore, residual hepatic functional reserve was improved by kallistatin treatment. CCl4 induced elevation of malondialdehyde level and reduced superoxide dismutase activity in the liver, while kallistatin reduced these oxidative parameters. We also investigated the effects of kallistatin on rat primary HSC and LX-2, the human HSC cell line. Kallistatin scavenged H2O2-induced ROS in the LX-2 cells, and suppressed the activation of primary HSC. These results suggest recombinant human kallistatin might be a promising drug candidate for therapeutic intervention of liver fibrosis.	[Huang, Xiaoping; Wang, Xiao; Lv, Yinghui; Xu, Luli; Lin, Junsheng; Diao, Yong] Huaqiao Univ, Inst Mol Med, Quanzhou, Peoples R China	Huaqiao University	Lin, JS (corresponding author), Huaqiao Univ, Inst Mol Med, Quanzhou, Peoples R China.	junshenglin@hqu.edu.cn; diaoyong@hqu.edu.cn			National Natural Science Foundation of China [81271691, 81201183, 81270734]; Program for International S&T Cooperation Projects of China [2011DFG33320]; Key Science & Technology Project of the Fujian Province in China [2013N5007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for International S&T Cooperation Projects of China; Key Science & Technology Project of the Fujian Province in China	This research is funded by National Natural Science Foundation of China (81271691, 81201183, 81270734); Program for International S&T Cooperation Projects of China (No. 2011DFG33320); Key Science & Technology Project of the Fujian Province in China (No. 2013N5007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao J, 2006, HUM GENE THER, V17, P1201, DOI 10.1089/hum.2006.17.1201; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Diao Y, 2007, WORLD J GASTROENTERO, V13, P4615, DOI 10.3748/wjg.v13.i34.4615; Diao Y, 2011, WORLD J GASTROENTERO, V17, P111, DOI 10.3748/wjg.v17.i1.111; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Gao L, 2008, LAB INVEST, V88, P1157, DOI 10.1038/labinvest.2008.85; Guillaume M, 2013, J HEPATOL, V58, P240, DOI 10.1016/j.jhep.2012.09.010; Hsieh JL, 2009, HUM GENE THER, V20, P147, DOI 10.1089/hum.2008.096; Huang Xiaoping, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P249; Itoh A, 2010, BIOL PHARM BULL, V33, P983, DOI 10.1248/bpb.33.983; Iwaisako K, 2012, P NATL ACAD SCI USA, V109, pE1369, DOI 10.1073/pnas.1202464109; Kim HJ, 2008, FOOD CHEM TOXICOL, V46, P3407, DOI 10.1016/j.fct.2008.08.012; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Liu YY, 2012, AM J PHYSIOL-RENAL, V303, pF1230, DOI 10.1152/ajprenal.00257.2012; Luo QL, 2007, AM J PHYSIOL-GASTR L, V292, pG1272, DOI 10.1152/ajpgi.00474.2006; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Pellicoro A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S26; Shaker ME, 2011, FUND CLIN PHARMACOL, V25, P248, DOI 10.1111/j.1472-8206.2010.00824.x; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Valva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023218; Wang CR, 2007, J RHEUMATOL, V34, P2171; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Yin H, 2010, HYPERTENSION, V56, P260, DOI 10.1161/HYPERTENSIONAHA.110.152330; Zhu H, 2012, METABOLISM	27	37	43	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88498	10.1371/journal.pone.0088498	http://dx.doi.org/10.1371/journal.pone.0088498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558397	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700043
J	Piai, V; Roelofs, A; Jensen, O; Schoffelen, JM; Bonnefond, M				Piai, Vitoria; Roelofs, Ardi; Jensen, Ole; Schoffelen, Jan-Mathijs; Bonnefond, Mathilde			Distinct Patterns of Brain Activity Characterise Lexical Activation and Competition in Spoken Word Production	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC INTERFERENCE; TIME-COURSE; DISTRACTOR FREQUENCY; LANGUAGE PRODUCTION; SELECTIVE ATTENTION; TEMPORAL SIGNATURES; PREFRONTAL CORTEX; SPEECH PRODUCTION; TASK	According to a prominent theory of language production, concepts activate multiple associated words in memory, which enter into competition for selection. However, only a few electrophysiological studies have identified brain responses reflecting competition. Here, we report a magnetoencephalography study in which the activation of competing words was manipulated by presenting pictures (e.g., dog) with distractor words. The distractor and picture name were semantically related (cat), unrelated (pin), or identical (dog). Related distractors are stronger competitors to the picture name because they receive additional activation from the picture relative to other distractors. Picture naming times were longer with related than unrelated and identical distractors. Phase-locked and non-phase-locked activity were distinct but temporally related. Phase-locked activity in left temporal cortex, peaking at 400 ms, was larger on unrelated than related and identical trials, suggesting differential activation of alternative words by the picture-word stimuli. Non-phase-locked activity between roughly 350-650 ms (4-10 Hz) in left superior frontal gyrus was larger on related than unrelated and identical trials, suggesting differential resolution of the competition among the alternatives, as reflected in the naming times. These findings characterise distinct patterns of activity associated with lexical activation and competition, supporting the theory that words are selected by competition.	[Piai, Vitoria; Roelofs, Ardi; Jensen, Ole; Schoffelen, Jan-Mathijs; Bonnefond, Mathilde] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Piai, Vitoria] Max Planck Inst Psycholinguist, Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Schoffelen, Jan-Mathijs] Max Planck Inst Psycholinguist, Neurobiol Language Dept, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Max Planck Society	Piai, V (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	v.piai@donders.ru.nl	Jensenq, Ole/D-2120-2010; Schoffelen, Jan-Mathijs/D-3716-2009; Roelofs, Ardi/A-5311-2010; Bonnefond, Mathilde/J-7572-2012; Piai, Vitória/D-5777-2012	Jensenq, Ole/0000-0001-8193-8348; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Piai, Vitória/0000-0002-4860-5952	Netherlands Organization for Scientific Research [MaGW 400-09-138, VICI 453-09-002, 056-14-011]; Fyssen Funding Scheme	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Fyssen Funding Scheme	This research was supported by grants from the Netherlands Organization for Scientific Research under grant number MaGW 400-09-138 (to A.R.), and VICI 453-09-002 and 056-14-011 (to O.J.), and by a grant from the Fyssen Funding Scheme (to M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2009, NEUROPSYCHOLOGIA, V47, P2089, DOI 10.1016/j.neuropsychologia.2009.03.019; Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Bastiaansen MCM, 2000, CLIN NEUROPHYSIOL, V111, P1300, DOI 10.1016/S1388-2457(00)00272-8; Belke E, 2013, Q J EXP PSYCHOL, V66, P2135, DOI 10.1080/17470218.2013.775318; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; Chen CC, 2012, NEUROIMAGE, V59, P340, DOI 10.1016/j.neuroimage.2011.07.066; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Zubicaray GI, 2002, NEUROIMAGE, V16, P1084, DOI 10.1006/nimg.2002.1135; de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054; de Zubicaray GI, 2013, J EXP PSYCHOL GEN, V142, P131, DOI 10.1037/a0028717; de Zubicaray GI, 2009, COGN AFFECT BEHAV NE, V9, P260, DOI 10.3758/CABN.9.3.260; Dell'Acqua R, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00177; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dhooge E, 2010, J EXP PSYCHOL LEARN, V36, P878, DOI 10.1037/a0019128; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Ewald A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00166; Finkbeiner M, 2006, CORTEX, V42, P790, DOI 10.1016/S0010-9452(08)70419-2; Finkbeiner M, 2006, CORTEX, V42, P1032, DOI 10.1016/S0010-9452(08)70210-7; GLASER WR, 1984, J EXP PSYCHOL HUMAN, V10, P640, DOI 10.1037/0096-1523.10.5.640; Greenham SL, 2000, BIOL PSYCHOL, V55, P79, DOI 10.1016/S0301-0511(00)00070-3; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hantsch A, 2013, LANG COGNITIVE PROC, V28, P684, DOI 10.1080/01690965.2011.595725; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hirschfeld G, 2008, NEUROREPORT, V19, P1227, DOI 10.1097/WNR.0b013e328309ecd1; Hutson J, 2013, LANG COGNITIVE PROC, V28, P615, DOI 10.1080/01690965.2011.605599; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Janssen N, 2008, J EXP PSYCHOL LEARN, V34, P249, DOI 10.1037/0278-7393.34.1.249; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LA HEIJ W, 1990, BRIT J PSYCHOL, V81, P511; La Heij W, 2006, CORTEX, V42, P1028; Laaksonen H, 2012, NEUROIMAGE, V60, P29, DOI 10.1016/j.neuroimage.2011.11.087; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 2001, P NATL ACAD SCI USA, V98, P13464, DOI 10.1073/pnas.231459498; Liljestrom M, 2005, NEUROIMAGE, V25, P734, DOI 10.1016/j.neuroimage.2004.11.034; LUPKER SJ, 1979, MEM COGNITION, V7, P485, DOI 10.3758/BF03198265; Madebach A, 2011, J EXP PSYCHOL LEARN, V37, P522, DOI 10.1037/a0021970; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mulatti C, 2013, CORTEX, DOI [10.1016/j.cortex.2013.08.018, DOI 10.1016/J.C0RTEX.2013.08.018]; Mulatti C, 2012, CORTEX, V48, P363, DOI 10.1016/j.cortex.2011.04.025; Neumann O., 1986, 1111986 U BIEL; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oppenheim GM, 2010, COGNITION, V114, P227, DOI 10.1016/j.cognition.2009.09.007; Piai V, 2012, MEM COGNITION, V40, P614, DOI 10.3758/s13421-011-0171-3; Piai V, 2012, BRAIN RES, V1450, P87, DOI 10.1016/j.brainres.2012.02.050; Piai V, 2011, J MEM LANG, V64, P404, DOI 10.1016/j.jml.2011.01.004; Rahman RA, 2010, PSYCHON B REV, V17, P657, DOI 10.3758/PBR.17.5.657; Rahman RA, 2009, LANG COGNITIVE PROC, V24, P713, DOI 10.1080/01690960802597250; Rahman RA, 2009, LANG COGNITIVE PROC, V24, P749, DOI 10.1080/01690960802648491; ROELOFS A, 1992, COGNITION, V42, P107, DOI 10.1016/0010-0277(92)90041-F; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Roelofs A, 2002, COGNITIVE BRAIN RES, V15, P85, DOI 10.1016/S0926-6410(02)00218-5; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Roelofs A, 2013, LANG COGNITIVE PROC, V28, P655, DOI 10.1080/01690965.2011.615663; Roelofs A, 2013, CORTEX, V49, P1767, DOI 10.1016/j.cortex.2013.03.001; Roelofs A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00307; Roelofs A, 2011, J EXP PSYCHOL LEARN, V37, P1032, DOI 10.1037/a0023328; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; Schnur TT, 2009, P NATL ACAD SCI USA, V106, P322, DOI 10.1073/pnas.0805874106; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Spalek K, 2008, BRAIN LANG, V107, P220, DOI 10.1016/j.bandl.2008.05.005; Starreveld PA, 1996, J EXP PSYCHOL LEARN, V22, P896, DOI 10.1037/0278-7393.22.4.896; Starreveld PA, 2013, LANG COGNITIVE PROC, V28, P633, DOI 10.1080/01690965.2011.608026; Stolk A, 2013, NEUROIMAGE, V68, P39, DOI 10.1016/j.neuroimage.2012.11.047; Strijkers K, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00356; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tse CY, 2007, P NATL ACAD SCI USA, V104, P17157, DOI 10.1073/pnas.0707901104; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang L, 2012, HUM BRAIN MAPP, V33, P2898, DOI 10.1002/hbm.21410	86	66	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88674	10.1371/journal.pone.0088674	http://dx.doi.org/10.1371/journal.pone.0088674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558410	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700056
J	Yang, EJ; Lee, J; Lee, SY; Kim, EK; Moon, YM; Jung, YO; Park, SH; Cho, ML				Yang, Eun-Ji; Lee, Jennifer; Lee, Seon-Young; Kim, Eun-Kyung; Moon, Young-Mee; Jung, Young Ok; Park, Sung-Hwan; Cho, Mi-La			EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1 alpha with Th17/Treg Control	PLOS ONE			English	Article							GREEN TEA; RHEUMATOID-ARTHRITIS; TNF-ALPHA; CELLS; EPIGALLOCATECHIN-3-GALLATE; PATHWAY; MICE; DIFFERENTIATION; MECHANISMS; EXPRESSION	Epigallocatechin-3-gallate (EGCG) is a green tea polyphenol exerting potent anti-oxidant and anti-inflammatory effects by inhibiting signaling and gene expression. The objective of the study was to evaluate the effect of EGCG on interleukin (IL)-1 receptor antagonist knockout (IL-1RaKO) autoimmune arthritis models. IL-1RaKO arthritis models were injected intraperitoneally with EGCG three times per week after the first immunization. EGCG decreased the arthritis index and showed protective effects against joint destruction in the IL-1RaKO arthritis models. The expression of pro-inflammatory cytokines, oxidative stress proteins, and p-STAT3 (Y705) and p-STAT3 (S727), mTOR and HIF-1 alpha were significantly lower in mice treated with EGCG. EGCG reduced osteoclast markers in vivo and in vitro along with anti-osteoclastic activity was observed in EGCG-treated IL-1RaKO mice. The proportion of Foxp3(+) Treg cells increased in the spleens of mice treated with EGCG, whereas the proportion of Th17 cells reduced. In vitro, p-STAT3 (Y705) and p-STAT3 (S727), HIF1 alpha and glycolytic pathway molecules were decreased by EGCG. EGCG suppressed the activation of mTOR and subsequently HIF-1 alpha, which is considered as a metabolic check point of Th17/Treg differentiation supporting the therapeutic potential of EGCG in autoimmune arthritis.	[Yang, Eun-Ji; Lee, Seon-Young; Kim, Eun-Kyung; Moon, Young-Mee; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea; [Lee, Jennifer; Park, Sung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Ctr Rheumat Dis,Div Rheumatol, Seoul, South Korea; [Yang, Eun-Ji; Lee, Seon-Young; Kim, Eun-Kyung; Moon, Young-Mee; Cho, Mi-La] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Lab Immune Network,Conversant Res Consortium Immu, Seoul, South Korea; [Jung, Young Ok] Hallym Univ, Kang Nam Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Hallym University	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, Seoul, South Korea.	iammila@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0081791]; Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092258]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (grant number 2009-0081791) and by a grant of the Korea Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (grant number A092258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Aktas O, 2004, J IMMUNOL, V173, P5794, DOI 10.4049/jimmunol.173.9.5794; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Coccia M, 2012, J EXP MED; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Domingo DS, 2010, INT J CLIN EXP PATHO, V3, P706; Dryden GW, 2013, INFLAMM BOWEL DIS, V19, P1904, DOI 10.1097/MIB.0b013e31828f5198; Haqqi TM, 1999, P NATL ACAD SCI USA, V96, P4524, DOI 10.1073/pnas.96.8.4524; Hoffmann J, 2011, BIOCHEM PHARMACOL, V82, P1153, DOI 10.1016/j.bcp.2011.07.063; Kim HR, 2008, J NUTR, V138, P2111, DOI 10.3945/jn.108.089912; Lin SK, 2008, ARCH OTOLARYNGOL, V134, P522, DOI 10.1001/archotol.134.5.522; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Morinobu A, 2008, ARTHRITIS RHEUM, V58, P2012, DOI 10.1002/art.23594; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Oz HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00132; Riegsecker S, 2013, LIFE SCI, V93, P307, DOI 10.1016/j.lfs.2013.07.006; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Van Aller GS, 2011, BIOCHEM BIOPH RES CO, V406, P194, DOI 10.1016/j.bbrc.2011.02.010; Wu DY, 2012, MOL ASPECTS MED, V33, P107, DOI 10.1016/j.mam.2011.10.001; Zhou F, 2005, ARTHRITIS RHEUM-US, V52, P3731, DOI 10.1002/art.21481	24	76	81	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e86062	10.1371/journal.pone.0086062	http://dx.doi.org/10.1371/journal.pone.0086062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558360	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700006
J	Yazawa, S; Yokobori, T; Ueta, G; Ide, M; Altan, B; Thongprachum, A; Nishimura, T; Nakajima, T; Kominato, Y; Asao, T; Saniabadi, AR; Furukawa, K; Kuwano, H; Le Pendu, J; Ushijima, H				Yazawa, Shin; Yokobori, Takehiko; Ueta, Gen; Ide, Munenori; Altan, Bolag; Thongprachum, Aksara; Nishimura, Toyo; Nakajima, Tamiko; Kominato, Yoshihiko; Asao, Takayuki; Saniabadi, Abby R.; Furukawa, Kiyoshi; Kuwano, Hiroyuki; Le Pendu, Jacques; Ushijima, Hiroshi			Blood Group Substances as Potential Therapeutic Agents for the Prevention and Treatment of Infection with Noroviruses Proving Novel Binding Patterns in Human Tissues	PLOS ONE			English	Article							NORWALK VIRUS-INFECTION; SIALYL-LEWIS-X; GROUP ANTIGENS; GENETIC-ANALYSIS; GENOGROUP-II; GROUP-A; VIRAL GASTROENTERITIS; MONOCLONAL-ANTIBODY; GII-4 NOROVIRUS; GASTRIC MUCIN	Blood group-related glycans determining ABO and Lewis blood groups are known to function as attachment factors for most of the norovirus (NoV) strains. To identify binding specificity of each NoV, recombinant norovirus-like particles (VLPs) and human saliva samples with different ABO, Lewis phenotypes and secretor status have been commonly applied. When binding specificities of VLPs prepared from 16 different genotypes of NoVs in GI and GII genogroups were characterized in samples of human gastric mucosa compared to human saliva based on blood group phenotypes, considerable differences were observed for several strains. Novel binding specificities determined by an ELISA using preparations from human gastric mucosa were also ascertained by immunohistochemical analyses using human jejunal mucosa, widely believed to be susceptible to NoV infection. Further, A, B and O(H) blood group substances prepared from porcine and squid tissues were found to be effective for preventing ABO blood group-specific binding of VLPs to both saliva and mucosa samples. Therefore, these blood group substances might have potential for the prevention and treatment of NoV infection.	[Yazawa, Shin; Yokobori, Takehiko; Altan, Bolag; Asao, Takayuki; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan; [Yazawa, Shin; Nishimura, Toyo] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima, Japan; [Ueta, Gen; Furukawa, Kiyoshi] Nagaoka Univ Technol, Dept Bioengn, Lab Glycobiol, Nagaoka, Niigata 94021, Japan; [Ide, Munenori] Gunma Univ, Grad Sch Med, Dept Diagnost Pathol, Maebashi, Gunma 371, Japan; [Thongprachum, Aksara; Ushijima, Hiroshi] Univ Tokyo, Dept Dev Med Sci, Sch Int Hlth, Grad Sch Med, Tokyo, Japan; [Thongprachum, Aksara; Ushijima, Hiroshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo, Japan; [Nakajima, Tamiko; Kominato, Yoshihiko] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gunma 371, Japan; [Saniabadi, Abby R.] JIMRO Co Ltd, Tokyo, Japan; [Le Pendu, Jacques] Univ Nantes, INSERM, UMR892, CNRS,UMR 6299, Nantes, France	Gunma University; Otsuka Pharmaceutical; Nagaoka University of Technology; Gunma University; University of Tokyo; Nihon University; Gunma University; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Yazawa, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 371, Japan.	syazawa@titan.ocn.ne.jp	Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387				Asao T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/834790; BENDICH A, 1946, J EXP MED, V83, P485, DOI 10.1084/jem.83.6.485; BENDICH A, 1947, J AM CHEM SOC, V69, P2163, DOI 10.1021/ja01201a031; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; CHADWICK DW, 1949, NATURE, V164, P61, DOI 10.1038/164061a0; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Cheetham S, 2007, J VIROL, V81, P3535, DOI 10.1128/JVI.01306-06; Chen YT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002152; Daniels G, 1995, HUMAN BLOOD GROUPS, P8; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508; Estes MK, 2003, MICROBIAL PATHOGENESIS AND THE INTESTINAL EPITHELIAL CELL, P525; Frenck R, 2012, J INFECT DIS, V206, P1386, DOI 10.1093/infdis/jis514; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Green F R, 1988, Subcell Biochem, V12, P119; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Horowitz MI, 1977, GLYCOCONJUGATES, V1, P189; Huang PW, 2009, GLYCOCONJUGATE J, V26, P1085, DOI 10.1007/s10719-009-9229-x; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Huang PW, 2003, J INFECT DIS, V188, P19, DOI 10.1086/375742; Hutson AM, 2005, J MED VIROL, V77, P116, DOI 10.1002/jmv.20423; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; Iseki S, 1956, P JAPAN ACAD, V32, P201; Iseki S, 1977, HUMAN BLOOD GROUPS, P126; Iseki S, 1951, P JAPAN ACAD, V27, P455; Issa S, 2010, GLYCOBIOLOGY, V20, P1046, DOI 10.1093/glycob/cwq066; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Koda Y, 1996, AM J HUM GENET, V59, P343; Kubota T, 2012, J VIROL, V86, P11138, DOI 10.1128/JVI.00278-12; Kudo T, 1996, J BIOL CHEM, V271, P9830, DOI 10.1074/jbc.271.16.9830; Le Pendu J, 2006, SEMIN IMMUNOL, V18, P375, DOI 10.1016/j.smim.2006.07.009; LEVY AG, 1976, GASTROENTEROLOGY, V70, P321; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Marionneau S, 2005, J INFECT DIS, V192, P1071, DOI 10.1086/432546; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; MOLLICONE R, 1985, LAB INVEST, V53, P219; Morgan WTJ, 1943, BIOCHEM J, V37, P640, DOI 10.1042/bj0370640; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Nasir W, 2012, GLYCOBIOLOGY, V22, P1163, DOI 10.1093/glycob/cws084; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Okada M, 2005, J CLIN MICROBIOL, V43, P4391, DOI 10.1128/JCM.43.9.4391-4401.2005; Okame M, 2007, J MED VIROL, V79, P1180, DOI 10.1002/jmv.20906; Okame M, 2006, J MED VIROL, V78, P1318, DOI 10.1002/jmv.20696; Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Schenkel-Brunner H, 1995, HUMAN BLOOD GROUPS; SCHREIBER DS, 1973, NEW ENGL J MED, V288, P1318, DOI 10.1056/NEJM197306212882503; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; SLOMIANY BL, 1978, EUR J BIOCHEM, V90, P39, DOI 10.1111/j.1432-1033.1978.tb12572.x; Tan M, 2005, TRENDS MICROBIOL, V13, P285, DOI 10.1016/j.tim.2005.04.004; Tan M, 2008, VIROLOGY, V379, P324, DOI 10.1016/j.virol.2008.06.041; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Thomsson KA, 2005, GLYCOBIOLOGY, V15, P791, DOI 10.1093/glycob/cwi059; Tian P, 2005, LETT APPL MICROBIOL, V41, P315, DOI 10.1111/j.1472-765X.2005.01775.x; Tian P, 2007, RES VET SCI, V83, P410, DOI 10.1016/j.rvsc.2007.01.017; Tsuboi K, 2007, ANN SURG ONCOL, V14, P1880, DOI 10.1245/s10434-007-9363-2; Varki A, 1999, ESSENTIALS GLYCOBIOL, P429; Watkins W.M., 1995, GLYCOPROTEINS, P313; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Yazawa S, 2002, GLYCOBIOLOGY, V12, P545, DOI 10.1093/glycob/cwf070; YAZAWA S, 1984, J BIOCHEM-TOKYO, V96, P1737, DOI 10.1093/oxfordjournals.jbchem.a135006; YAZAWA S, 1983, J IMMUNOGENET, V10, P349; YAZAWA S, 1995, CANCER RES, V55, P1473; Yazawa S, 1996, TRANSFUSION, V36, P286, DOI 10.1046/j.1537-2995.1996.36396182149.x; YAZAWA S, 1990, IMMUNOL INVEST, V19, P319, DOI 10.3109/08820139009050773; YAZAWA S, 1993, JPN J CANCER RES, V84, P641, DOI 10.1111/j.1349-7006.1993.tb02024.x; Yazawa S, 2008, Protection against norovirus infection or removal of norovirus by using substance associated with blood type, Patent No. [WO2010/010948 A1, PCT/JP2009/063273, 2010010948]; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	80	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89071	10.1371/journal.pone.0089071	http://dx.doi.org/10.1371/journal.pone.0089071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558470	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700116
J	Abolhasani, MM; Naebe, M; Jalali-Arani, A; Guo, QP				Abolhasani, Mohammad Mahdi; Naebe, Minoo; Jalali-Arani, Azam; Guo, Qipeng			Influence of Miscibility Phenomenon on Crystalline Polymorph Transition in Poly(Vinylidene Fluoride)/Acrylic Rubber/Clay Nanocomposite Hybrid	PLOS ONE			English	Article							FLUORIDE)/CLAY NANOCOMPOSITES; INTERCALATION; RHEOLOGY; BEHAVIOR	In this paper, intercalation of nanoclay in the miscible polymer blend of poly(vinylidene fluoride) (PVDF) and acrylic rubber(ACM) was studied. X-ray diffraction was used to investigate the formation of nanoscale polymer blend/clay hybrid. Infrared spectroscopy and X-ray analysis revealed the coexistence of beta and gamma crystalline forms in PVDF/Clay nanocomposite while alpha crystalline form was found to be dominant in PVDF/ACM/Clay miscible hybrids. Flory-Huggins interaction parameter (B) was used to further explain the miscibility phenomenon observed. The B parameter was determined by combining the melting point depression and the binary interaction model. The estimated B values for the ternary PVDF/ACM/Clay and PVDF/ACM pairs were all negative, showing both proper intercalation of the polymer melt into the nanoclay galleries and the good miscibility of PVDF and ACM blend. The B value for the PVDF/ACM blend was almost the same as that measured for the PVDF/ACM/Clay hybrid, suggesting that PVDF chains in nanocomposite hybrids interact with ACM chains and that nanoclay in hybrid systems is wrapped by ACM molecules.	[Abolhasani, Mohammad Mahdi] Kashan Univ, Dept Chem Engn, Kashan, Iran; [Naebe, Minoo; Guo, Qipeng] Deakin Univ, Inst Frontier Mat, Geelong, Vic 3217, Australia; [Jalali-Arani, Azam] Amirkabir Univ Technol, Dept Polymer Engn & Color Technol, Tehran, Iran	University Kashan; Deakin University; Amirkabir University of Technology	Abolhasani, MM (corresponding author), Kashan Univ, Dept Chem Engn, Kashan, Iran.	abolhasani@kashanu.ac.ir	Guo, Qipeng/A-8140-2013; Abolhasani, Mohammadmahdi/GPK-0655-2022; Jalali-Arani, Azam/I-3816-2018	Jalali-Arani, Azam/0000-0002-3805-8916; Naebe, Minoo/0000-0002-0607-6327; Guo, Qipeng/0000-0001-7113-651X; Abolhasani, Mohammad Mahdi/0000-0002-4605-3648				Abolhasani MM, 2013, POLYMER, V54, P4686, DOI 10.1016/j.polymer.2013.06.044; Abolhasani MM, NEW APPROACH M UNPUB; Abolhasani MM, FOLD SURFACE F UNPUB; Abolhasani MM, 2013, J APPL POLYM SCI, V130, P1247, DOI 10.1002/app.39213; AKELAH A, 1994, NANOSTRUCT MATER, V4, P965; Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7; Asai K, 2008, POLYMER, V49, P5186, DOI 10.1016/j.polymer.2008.09.061; Asai K, 2008, POLYMER, V49, P4298, DOI 10.1016/j.polymer.2008.07.037; Buckley J, 2006, POLYMER, V47, P2411, DOI 10.1016/j.polymer.2006.02.012; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; Hoffmann B, 2000, MACROMOL RAPID COMM, V21, P57, DOI 10.1002/(SICI)1521-3927(20000101)21:1<57::AID-MARC57>3.3.CO;2-5; Hyun YH, 2001, MACROMOLECULES, V34, P8084, DOI 10.1021/ma002191w; Krishnamoorti R, 1996, CHEM MATER, V8, P1728, DOI 10.1021/cm960127g; LeBaron PC, 1999, APPL CLAY SCI, V15, P11, DOI 10.1016/S0169-1317(99)00017-4; Li Y, 2008, MACROMOLECULES, V41, P3396, DOI 10.1021/ma800148x; Li YJ, 2008, MACROMOLECULES, V41, P3120, DOI 10.1021/ma7027402; Li YJ, 2006, POLYMER, V47, P3946, DOI 10.1016/j.polymer.2006.03.075; Li YJ, 2006, MACROMOLECULES, V39, P4195, DOI 10.1021/ma060181a; Lim SK, 2002, CHEM MATER, V14, P1989, DOI 10.1021/cm010498j; NISHI T, 1975, MACROMOLECULES, V8, P909, DOI 10.1021/ma60048a040; Priya L, 2003, J APPL POLYM SCI, V89, P2036, DOI 10.1002/app.12346; Priya L, 2003, J POLYM SCI POL PHYS, V41, P31, DOI 10.1002/polb.10355; Priya L, 2002, J POLYM SCI POL PHYS, V40, P1682, DOI 10.1002/polb.10223; Ramasundaram S, 2008, J POLYM SCI POL PHYS, V46, P2173, DOI 10.1002/polb.21550; RIEDL B, 1984, POLYM ENG SCI, V24, P1291, DOI 10.1002/pen.760241705; Shah D, 2004, ADV MATER, V16, P1173, DOI 10.1002/adma.200306355; VAIA RA, 1993, CHEM MATER, V5, P1694, DOI 10.1021/cm00036a004; Vaia RA, 1996, CHEM MATER, V8, P2628, DOI 10.1021/cm960102h; VAIA RA, 1995, MACROMOLECULES, V28, P8080, DOI 10.1021/ma00128a016; Zare Y, 2012, J APPL POLYM SCI, V124, P1225, DOI 10.1002/app.35134	30	23	23	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88715	10.1371/journal.pone.0088715	http://dx.doi.org/10.1371/journal.pone.0088715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551141	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500057
J	Mishra, SR; Joshi, MP; Khanal, V				Mishra, Shiva Raj; Joshi, Mahesh Prasad; Khanal, Vishnu			Family Planning Knowledge and Practice among People Living with HIV in Nepal	PLOS ONE			English	Article							HARD-TO-REACH; CONTRACEPTIVE USE; POSITIVE MEN; UNSAFE SEX; INTENTIONS; FERTILITY; PREGNANCY; SUPERINFECTION; PREVALENCE; PREVENTION	Unsafe sexual behavior is common among the HIV infected. This exposes them to the risks of unintended pregnancy, HIV transmission to uninfected partners and super-infection. Studies on the use of family planning measures among People Living with HIV (PLHIV) are scarce in Nepal. The aim of this study was to explore the knowledge and practice of family planning (FP) in PLHIV. A cross sectional survey was conducted during July-December 2012 in Kaski district of Nepal. A total of 120 PLHIVs were recruited using snowball sampling from three HIV clinics within the Pokhara sub-metropolitan city area. This study found that nine in ten PLHIV had heard about family planning. Two thirds of respondents were using at least one FP method. The majority (65.8%) used condoms and had received FP counseling (67.5%). Less than one percent used condoms in addition to another contraceptive. Being single, being female and having received the counselling sessions were associated with the use of FP. The individuals who received FP counseling were more likely [OR 4.522; 95% CI (1.410-14.504)] to use FP. Females were more likely [OR 4.808; 95% CI (1.396-16.556)] to use FP than males. The individuals who were single/de-facto widowed were more likely [OR 7.330; 95% CI (2.064-26.028)] to use FP than the married individuals. Our findings suggest that there is a need to focus on FP counseling if the HIV prevention program is to increase FP use among the PLHIV population. Use of dual contraceptives need to be promoted through counseling sessions and other health promotion programs focusing in HIV prevention.	[Mishra, Shiva Raj] Inst Med, Kathmandu, Nepal; [Joshi, Mahesh Prasad] Naulo Ghumti Nepal, Kaski, Nepal; [Khanal, Vishnu] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia	Curtin University	Mishra, SR (corresponding author), Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal.	shivarajmishra@gmail.com	Khanal, Vishnu/AAE-5948-2020; Mishra, Shiva Raj/C-4172-2014	Mishra, Shiva Raj/0000-0002-2993-3504; Khanal, Vishnu/0000-0002-3863-9913				[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Boler T, 2006, SOUND SILENCE DIFFIC; Botnick MR, 2000, J HOMOSEXUAL, V38, P77, DOI 10.1300/J082v38n04_04; Bouhnik AD, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000255086.54599.23; Cates W, 2002, SEX TRANSM DIS, V29, P168, DOI 10.1097/00007435-200203000-00007; Central Bureau of Statistics (CBS), 2011, AR POP; Ceylan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-20; Chakrapani V, 2011, INFECT DIS OBSTET GY, V2011; Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Day J., 2012, SAIL WORLD AUSTR FIS; Dia A, 2010, SEX TRANSM INFECT, V86, P148, DOI 10.1136/sti.2008.035147; District AIDS Coordination Committee (DACC), 2011, GLIMPS KASK DISTR DA; DoHS, 2010, ANN REPORT; Elul B, 2009, AIDS, V23, pS19, DOI 10.1097/01.aids.0000363774.91376.dc; Family Health International (FHI), 2010, 5 COUNTR STUD FAM PL; Family Health International (FHI), 2010, PREV MOTH TO CHILD H; Family Planning Association of Nepal (FPAN), 2011, PEOPL LIV HIV STIGM; Hailemariam TG, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-900; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Jha SM, 2009, KNOWLEDGE CONDOMS AD; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, REP GLOB AIDS EP; Josheph EJ, 2010, UTILIZATION FAMILY P; Kalichman SC, 2007, SEX TRANSM INFECT, V83, P371, DOI 10.1136/sti.2006.023630; Khanal V, 2013, J COMMUNITY HLTH; Khanal V, 2013, BREASTFEED MED; Loubiere S, 2009, SOC SCI MED, V69, P885, DOI 10.1016/j.socscimed.2009.05.044; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; MARSTON C, 2004, EFFECTS CONTRACEPTIO; Ministry of Health & Population NE ICF Macro USAID, 2006, NEP DEM HLTH SURV 20; Ministry of Health & Population NE ICF Macro USAID, 2012, NEP DEM HLTH SURV 20; Mishra SR, 2013, OPPORTUNITIES INTEGR; National Centre for AIDS and STD Control (NCASC), 2003, NAT GUID VOL HIV AID; Nattabi Barbara, 2011, Confl Health, V5, P18, DOI 10.1186/1752-1505-5-18; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Neupane D, 2012, J Nepal Health Res Counc, V10, P136; Peipert JF, 2011, CONTRACEPTION, V84, P252, DOI 10.1016/j.contraception.2011.01.023; Pokharel S, 2006, REPROD HEALTH MATTER, V14, P156, DOI 10.1016/S0968-8080(06)28255-7; Poudel KC, 2011, J HEALTH POPUL NUTR, V29, P191, DOI 10.3329/jhpn.v29i3.7866; Poudel KC, 2009, AIDS BEHAV, V13, P1143, DOI 10.1007/s10461-008-9454-5; Sadler GR, 2010, NURS HEALTH SCI, V12, P369, DOI 10.1111/j.1442-2018.2010.00541.x; Shrestha D R, 2012, J Nepal Health Res Counc, V10, P108; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Soto Mas F, 1997, Rev Esp Salud Publica, V71, P335; US Food and Administration (FDA), COND COULD SAV YOUR; USAID Acquire Project, 2008, COUNS EFF US FAM PLA; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; WHO Medica Center, 2009, COND HIV PREV; WHO UNFPA, 2006, GLION CONS STRENGTH; Zodpey S P, 2004, Indian J Dermatol Venereol Leprol, V70, P123	50	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88663	10.1371/journal.pone.0088663	http://dx.doi.org/10.1371/journal.pone.0088663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551132	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000052
J	Gibbs, PEM; Lerner-Marmarosh, N; Poulin, A; Farah, E; Maines, MD				Gibbs, Peter E. M.; Lerner-Marmarosh, Nicole; Poulin, Amelia; Farah, Elie; Maines, Mahin D.			Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor	FASEB JOURNAL			English	Article						diabetes; heme metabolism; protein kinases	SIGNAL-TRANSDUCTION PATHWAY; IX-ALPHA REDUCTASE; CRYSTAL-STRUCTURE; TYROSINE KINASE; GENE-EXPRESSION; ISOFORM-A; KAPPA-B; IGF-II; PROTEIN; SUBSTRATE	Insulin binding changes conformation of the insulin receptor kinase (IRK) domain and initiates glucose uptake through the insulin, IGF-1, phosphatidyl inositol 3-kinase (PI3K), and MAPK pathways; human biliverdin reductase (hBVR) is an IRK substrate and pathway effector. This is the first report on hBVR peptide-mediated IRK activation and conformational change. (KYCCSRK)-K-290, which increased IRK V-max without changing K-m, stimulated glucose uptake and potentiated insulin and IGF-1 stimulation in 4 cell lines. KYCCSRK in native hBVR was necessary for the hBVR and IRK cross-activation. Peptide treatment also activated PI3K downstream effectors, Akt and ERK, phosphorylation, and Elk transcriptional activity. In cells transfected with CMV-regulated EGFP-VP-peptide plasmid, C-292 -> A mutant did not stimulate glucose uptake; K-296 -> A decreased uptake and kinase activity. KEDQYMKMTV, corresponding to hBVR's SH2-binding domain, was a potent inhibitor of glucose uptake and IRK. The mechanism of action of peptides was examined using cells expressing IRK (aa 988-1263) activated by coexpressed KYCCSRK. Three active cysmutants of IRK, with fluorophore coupled to cysteines, C-1056, C-1138, or C-1234, were examined for changes in fluorescence emission spectra in the presence of peptides. KYCCSRK and KEDQYMKMTV bound to different sites in IRK. The findings identify novel agents for activating or inhibiting insulin signaling and offer a new approach for treatment of type 2 diabetes and hypoglycemia.	[Gibbs, Peter E. M.; Lerner-Marmarosh, Nicole; Poulin, Amelia; Farah, Elie; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu			U.S. National Institutes of Health [ES004066]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004066] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by U.S. National Institutes of Health grant ES004066. The authors thank Dr. Tihomir Miralem for his assistance with the Akt activation analyses.	Baer K, 2001, BIOCHEMISTRY-US, V40, P14268, DOI 10.1021/bi015588g; Ciaraldi TP, 2002, METABOLISM, V51, P1171, DOI 10.1053/meta.2002.34050; COBB MH, 1989, J BIOL CHEM, V264, P18701; Ding VDH, 2002, BIOCHEM J, V367, P301, DOI 10.1042/BJ20020708; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Gibbs PEM, 2012, J BIOL CHEM, V287, P1066, DOI 10.1074/jbc.M111.279612; Gogg S, 2009, DIABETES, V58, P2238, DOI 10.2337/db08-0961; Hickerson R, 2005, J MOL BIOL, V354, P459, DOI 10.1016/j.jmb.2005.09.010; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Li M, 2001, DIABETES, V50, P2323, DOI 10.2337/diabetes.50.10.2323; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Qureshi SA, 2000, J BIOL CHEM, V275, P36590, DOI 10.1074/jbc.M006287200; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Trabuco LG, 2012, NUCLEIC ACIDS RES, V40, pW423, DOI 10.1093/nar/gks398; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Won JS, 2003, J NEUROSCI, V23, P7470; Wu JH, 2008, NAT STRUCT MOL BIOL, V15, P251, DOI 10.1038/nsmb.1388	41	32	33	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2478	2491		10.1096/fj.13-247015	http://dx.doi.org/10.1096/fj.13-247015			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24568842	Green Published			2022-12-25	WOS:000339883600009
J	Leddy, HA; McNulty, AL; Lee, SH; Rothfusz, NE; Gloss, B; Kirby, ML; Hutson, MR; Cohn, DH; Guilak, F; Liedtke, W				Leddy, Holly A.; McNulty, Amy L.; Lee, Suk Hee; Rothfusz, Nicole E.; Gloss, Bernd; Kirby, Margaret L.; Hutson, Mary R.; Cohn, Daniel H.; Guilak, Farshid; Liedtke, Wolfgang			Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations	FASEB JOURNAL			English	Article						cartilage; calcium signaling; growth plate; bone morphogenetic protein	SENSITIVE ION-CHANNEL; POTENTIAL VANILLOID 4; CATION CHANNEL; VR-OAC; BONE; RECOMBINATION; EXPRESSION; MUTATIONS; ACTIVIN; MICE	Point mutations in the calcium-permeable TRPV4 ion channel have been identified as the cause of autosomal-dominant human motor neuropathies, arthropathies, and skeletal malformations of varying severity. The objective of this study was to determine the mechanism by which TRPV4 channelopathy mutations cause skeletal dysplasia. The human TRPV4(V620I) channelopathy mutation was transfected into primary porcine chondrocytes and caused significant (2.6-fold) up-regulation of follistatin (FST) expression levels. Pore altering mutations that prevent calcium influx through the channel prevented significant FST up-regulation (1.1-fold). We generated a mouse model of the TRPV4(V620I) mutation, and found significant skeletal deformities (e. g., shortening of tibiae and digits, similar to the human disease brachyolmia) and increases in Fst/TRPV4 mRNA levels (2.8-fold). FST was significantly up-regulated in primary chondrocytes transfected with 3 different dysplasia-causing TRPV4 mutations (2- to 2.3-fold), but was not affected by an arthropathy mutation (1.1-fold). Furthermore, FST-loaded microbeads decreased bone ossification in developing chick femora (6%) and tibiae (11%). FST gene and protein levels were also increased 4-fold in human chondrocytes from an individual natively expressing the TRPV4(T89I) mutation. Taken together, these data strongly support that up-regulation of FST in chondrocytes by skeletal dysplasia-inducing TRPV4 mutations contributes to disease pathogenesis.	[Leddy, Holly A.; McNulty, Amy L.; Rothfusz, Nicole E.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed, Durham, NC USA; [Lee, Suk Hee; Liedtke, Wolfgang] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Gloss, Bernd] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC USA; [Kirby, Margaret L.; Hutson, Mary R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC USA; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Duke Univ Clin Pain & Palliat Care, Durham, NC USA; [Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Cohn, Daniel H.] Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Dept Orthopaed Surg, Los Angeles, CA USA	Duke University; Duke University; Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Guilak, F (corresponding author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, Box 3093, Durham, NC 27710 USA.	guilak@duke.edu; wolfgang@neuro.duke.edu	Liedtke, Wolfgang/GNH-1878-2022; Guilak, Farshid/AAF-8558-2020	Guilak, Farshid/0000-0001-7380-0330; Leddy, Holly/0000-0002-1604-2876	U.S. National Institutes of Health (NIH) [AR48182, AR48852, AG15768, AR50245, AG46927, DE018549, HD022657, AR062651]; Arthritis Foundation; NIH [P41RR11823-03]; NIH-National Institute of Neurological Disorders and Stroke Center Core grant [5P30NS061789]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062651, R01AR048182, P01AR050245, R01AR048852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046927, R01AG015768] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Institute of Neurological Disorders and Stroke Center Core grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Stephen Johnson and Daniel Stapor for technical assistance, and Michele Yeo for assistance with Fig. 6C. The authors also thank Dr. Brian Johnstone and his laboratory for providing the ATDC5 cells. This work is supported by U.S. National Institutes of Health (NIH) grants AR48182 (F.G.), AR48852 (F.G.), AG15768 (F.G.), AR50245 (F.G.), AG46927 (F.G.), DE018549 (W.L.), HD022657 (D.C.), and AR062651 (D.C.), and by the Arthritis Foundation. Venus plasmid (pBES2) was obtained from the Yeast Resource Center (University of Washington, Seattle, WA. USA) funded under NIH grant P41RR11823-03. Recombineering and zygote injections were performed by the Duke Neurotransgenic Laboratory, supported with funding from NIH-National Institute of Neurological Disorders and Stroke Center Core grant 5P30NS061789.	Abe Y, 2004, J BONE MINER RES, V19, P1302, DOI 10.1359/JBMR.040408; Blount AL, 2008, J BIOL CHEM, V283, P7016, DOI 10.1074/jbc.M709502200; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Camacho N, 2010, AM J MED GENET A, V152A, P1169, DOI 10.1002/ajmg.a.33392; Chao PHG, 2006, AM J PHYSIOL-CELL PH, V291, pC718, DOI 10.1152/ajpcell.00127.2005; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; Eleswarapu SV, 2013, ACTA BIOMATER, V9, P5554, DOI 10.1016/j.actbio.2012.10.031; Funaba M, 1996, ENDOCRINOLOGY, V137, P4250, DOI 10.1210/en.137.10.4250; Furman BD, 2007, J ORTHOP RES, V25, P578, DOI 10.1002/jor.20331; Gajos-Michniewicz A, 2012, J BONE MINER METAB, V30, P426, DOI 10.1007/s00774-011-0347-8; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hurd L. M., 2013, TRANS ORTHOP RES SOC, V59; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamande SR, 2011, NAT GENET, V43, P1142, DOI 10.1038/ng.945; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Liedtke WB, 2011, P NATL ACAD SCI USA, V108, P12509, DOI 10.1073/pnas.1109199108; Liedtke Wolfgang B., 2007, P303; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Merino R, 1999, DEVELOPMENT, V126, P2161; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Mutai H, 2003, CELL CALCIUM, V33, P471, DOI 10.1016/S0143-4160(03)00062-9; Muyrers J P, 2000, Genet Eng (N Y), V22, P77; Nagy A., 2003, MANIPULATING THE MOU; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B, 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; O'Conor CJ, 2013, ANN RHEUM DIS, V72, P300, DOI 10.1136/annrheumdis-2012-202272; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Rosen V, 2006, ANN NY ACAD SCI, V1068, P19, DOI 10.1196/annals.1346.005; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Yamazaki Y, 2011, BIOTECH HISTOCHEM, V86, P351, DOI 10.3109/10520295.2010.506158; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	49	27	28	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2525	2537		10.1096/fj.13-245936	http://dx.doi.org/10.1096/fj.13-245936			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24577120	Green Published			2022-12-25	WOS:000339883600013
J	Cushing, L; Stochaj, W; Siegel, M; Czerwinski, R; Dower, K; Wright, Q; Hirschfield, M; Casanova, JL; Picard, C; Puel, A; Lin, LL; Rao, VR				Cushing, Leah; Stochaj, Wayne; Siegel, Marshall; Czerwinski, Robert; Dower, Ken; Wright, Quentin; Hirschfield, Margaret; Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne; Lin, Lih-Ling; Rao, Vikram R.			Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Innate Immunity; Interleukin Receptor-associated Kinase (IRAK); Protein Kinases; Protein Phosphorylation; Toll-like Receptors (TLR); Interleukin 1 (IL-1); Interleukin Receptor-associated Kinase 4 (IRAK4)	PYOGENIC BACTERIAL-INFECTIONS; DEPENDENT PROTEIN-KINASE; MYD88 DEFICIENCY; IRAK-4 KINASE; PHOSPHORYLATION; REDUNDANT; COMPLEX; LOOP; FEATURES; IMMUNITY	Background: IRAK4 is a central kinase in IL-1R/TLR signaling. Results: IRAK4 is activated by autophosphorylation, and its inhibition reduces cytokine induction in human monocytes but not dermal fibroblasts. Conclusion: IL-1R/TLR-induced autophosphorylation activates IRAK4 and controls cytokine induction in a cell type-specific manner. Significance: Our data provide the mechanism of IRAK4 activation and role in cytokine induction in human cells. IRAK4 is a central kinase in innate immunity, but the role of its kinase activity is controversial. The mechanism of activation for IRAK4 is currently unknown, and little is known about the role of IRAK4 kinase in cytokine production, particularly in different human cell types. We show IRAK4 autophosphorylation occurs by an intermolecular reaction and that autophosphorylation is required for full catalytic activity of the kinase. Phosphorylation of any two of the residues Thr-342, Thr-345, and Ser-346 is required for full activity, and the death domain regulates the activation of IRAK4. Using antibodies against activated IRAK4, we demonstrate that IRAK4 becomes phosphorylated in human cells following stimulation by IL-1R and Toll-like receptor agonists, which can be blocked pharmacologically by a dual inhibitor of IRAK4 and IRAK1. Interestingly, in dermal fibroblasts, although complete inhibition of IRAK4 kinase activity does not inhibit IL-1-induced IL-6 production, NF-B, or MAPK activation, there is complete ablation of these processes in IRAK4-deficient cells. In contrast, the inhibition of IRAK kinase activity in primary human monocytes reduces R848-induced IL-6 production with minimal effect on NF-B or MAPK activation. Taken together, these studies define the mechanism of IRAK4 activation and highlight the differential role of IRAK4 kinase activity in different human cell types as well as the distinct roles IRAK4 scaffolding and kinase functions play.	[Cushing, Leah; Czerwinski, Robert; Dower, Ken; Wright, Quentin; Hirschfield, Margaret; Lin, Lih-Ling; Rao, Vikram R.] Pfizer Res, Inflammat & Remodeling Res Unit, Cambridge, MA 02140 USA; [Stochaj, Wayne] Pfizer Res, Global Biol Technol, Cambridge, MA 02140 USA; [Siegel, Marshall] Pfizer Chem Technol Sect, Pearl River, NY 10965 USA; [Casanova, Jean-Laurent; Puel, Anne] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Imagine Inst, Lab Human Genet Infect Dis, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Study Ctr Primary Immunodeficiencies, F-75015 Paris, France; [Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Univ Paris 05, F-75006 Paris, France	Pfizer; Pfizer; Pfizer; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lin, LL (corresponding author), Pfizer, Inflammat & Remodeling Res Unit, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	Lih-Ling.Lin@pfizer.com; Vikram.Rao@pfizer.com	Puel, Anne/H-7305-2017; Picard, Capucine/H-3914-2017; Casanova, Jean-Laurent/I-3418-2017	Puel, Anne/0000-0003-2603-0323; Picard, Capucine/0000-0001-8788-5056; Wright, Quentin/0000-0001-9628-0200; Casanova, Jean-Laurent/0000-0002-7782-4169				Cameron B, 2012, J NEUROSCI, V32, P15112, DOI 10.1523/JNEUROSCI.1729-12.2012; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Chiang EY, 2011, J IMMUNOL, V186, P1279, DOI 10.4049/jimmunol.1002821; Czerwinski R, 2005, BIOCHEMISTRY-US, V44, P9563, DOI 10.1021/bi050608q; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim TW, 2011, J IMMUNOL, V186, P2871, DOI 10.4049/jimmunol.1002242; Koziczak-Holbro M, 2009, ARTHRITIS RHEUM-US, V60, P1661, DOI 10.1002/art.24552; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Shen BH, 2002, DEVELOPMENT, V129, P1925; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Tuazon PT, 1998, BIOCHEMISTRY-US, V37, P17024, DOI 10.1021/bi982103o; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	33	36	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10865	10875		10.1074/jbc.M113.544809	http://dx.doi.org/10.1074/jbc.M113.544809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567333	Green Published, hybrid			2022-12-25	WOS:000334226400054
J	Vild, CJ; Xu, ZH				Vild, Cody J.; Xu, Zhaohui			Vfa1 Binds to the N-terminal Microtubule-interacting and Trafficking ( MIT) Domain of Vps4 and Stimulates Its ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Crystal Structure; Endosomes; Membrane Trafficking; Protein-Protein Interactions; ESCRT; MVB; Vfa1; Vps4	ESCRT-III CHMP3; STRUCTURAL BASIS; AAA-ATPASE; PROTEIN; MACHINERY; COMPLEX; CYTOKINESIS; RECOGNITION; PATHWAY; BIOGENESIS	Background: Vfa1 was recently identified as a Vps4-binding protein, yet its function was unknown. Results: Vfa1 potently stimulates Vps4 ATPase activity, and Vps4-Vfa1 interaction consists of a binding mechanism previously seen in other Vps4 regulator structures. Conclusion: Biochemical and biophysical studies show that Vfa1 is a novel regulator of Vps4 in the multivesicular body pathway. Significance: Vps4-Vfa1 interaction further expands the complexity of Vps4 regulation. The endosomal sorting complexes required for transport (ESCRT) are responsible for multivesicular body biogenesis, membrane abscission during cytokinesis, and retroviral budding. They function as transiently assembled molecular complexes on the membrane, and their disassembly requires the action of the AAA-ATPase Vps4. Vps4 is regulated by a multitude of ESCRT and ESCRT-related proteins. Binding of these proteins to Vps4 is often mediated via the microtubule-interacting and trafficking (MIT) domain of Vps4. Recently, a new Vps4-binding protein Vfa1 was identified in a yeast genetic screen, where overexpression of Vfa1 caused defects in vacuolar morphology. However, the function of Vfa1 and its role in vacuolar biology were largely unknown. Here, we provide the first detailed biochemical and biophysical study of Vps4-Vfa1 interaction. The MIT domain of Vps4 binds to the C-terminal 17 residues of Vfa1. This interaction is of high affinity and greatly stimulates the ATPase activity of Vps4. The crystal structure of the Vps4-Vfa1 complex shows that Vfa1 adopts a canonical MIT-interacting motif 2 structure that has been observed previously in other Vps4-ESCRT interactions. These findings suggest that Vfa1 is a novel positive regulator of Vps4 function.	[Xu, Zhaohui] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, ZH (corresponding author), Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA.	zhaohui@umich.edu			National Institutes of Health [GM095769]; Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095769 (to Z. X.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Arlt H, 2011, TRAFFIC, V12, P1592, DOI 10.1111/j.1600-0854.2011.01252.x; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rozycki B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002736; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	52	11	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10378	10386		10.1074/jbc.M113.532960	http://dx.doi.org/10.1074/jbc.M113.532960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567329	Green Published, hybrid			2022-12-25	WOS:000334226400012
J	Semeniuk, A; Sohlenkamp, C; Duda, K; Holzl, G				Semeniuk, Adrian; Sohlenkamp, Christian; Duda, Katarzyna; Hoelzl, Georg			A Bifunctional Glycosyltransferase from Agrobacterium tumefaciens Synthesizes Monoglucosyl and Glucuronosyl Diacylglycerol under Phosphate Deprivation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Chromatography; Glycolipids; Glycosyltransferases; Membrane Bilayer; Gram-negative; Q-TOF; Bifunctional; Glucuronic Acid	ACHOLEPLASMA-LAIDLAWII MEMBRANES; UDP-GLUCOSE 4-EPIMERASE; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-MELILOTI; DIGLUCOSYLDIACYLGLYCEROL SYNTHASE; SUCCINOGLYCAN BIOSYNTHESIS; PHOSPHORUS LIMITATION; PSEUDOMONAS-DIMINUTA; ARABIDOPSIS-THALIANA; FAMILY RHIZOBIACEAE	Background: Despite the high diversity of glycolipids found in many organisms, only a few glycosyltransferases have been isolated. Results: A bifunctional glycosyltransferase, synthesizing glucuronosyl or monoglucosyl diacylglycerol, was isolated from Agrobacterium. Conclusion: Glycolipids and other nonphospholipids can mutually replace each other, enhancing the ability to adapt to changing environments. Significance: This is the first report on the isolation of a glucuronosyl diacylglycerol synthase. Glycolipids are mainly found in phototrophic organisms (like plants and cyanobacteria), in Gram-positive bacteria, and a few other bacterial phyla. Besides the function as bulk membrane lipids, they often play a role under phosphate deprivation as surrogates for phospholipids. The Gram-negative Agrobacterium tumefaciens accumulates four different glycolipids under phosphate deficiency, including digalactosyl diacylglycerol and glucosylgalactosyl diacylglycerol synthesized by a processive glycosyltransferase. The other two glycolipids have now been identified by mass spectrometry and nuclear magnetic resonance spectroscopy as monoglucosyl diacylglycerol and glucuronosyl diacylglycerol. These two lipids are synthesized by a single promiscuous glycosyltransferase encoded by the ORF atu2297, with UDP-glucose or UDP-glucuronic acid as sugar donors. The transfer of sugars differing in their chemistry is a novel feature not observed before for lipid glycosyltransferases. Furthermore, this enzyme is the first glucuronosyl diacylglycerol synthase isolated. Deletion mutants of Agrobacterium lacking monoglucosyl diacylglycerol and glucuronosyl diacylglycerol or all glycolipids are not impaired in growth or virulence during infection of tobacco leaf discs. Our data suggest that the four glycolipids and the nonphospholipid diacylglyceryl trimethylhomoserine can mutually replace each other during phosphate deprivation. This redundancy of different nonphospholipids may represent an adaptation mechanism to enhance the competitiveness in nature.	[Semeniuk, Adrian; Hoelzl, Georg] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53113 Bonn, Germany; [Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico; [Duda, Katarzyna] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, D-23845 Borstel, Germany	University of Bonn; Universidad Nacional Autonoma de Mexico; Forschungszentrum Borstel	Holzl, G (corresponding author), Univ Bonn, Inst Mol Physiol & Biotechnol Plants, Karlrobert Kreiten Str 13, D-53115 Bonn, Germany.	hoelzl@uni-bonn.de	Sohlenkamp, Christian/C-6219-2018	Sohlenkamp, Christian/0000-0002-9962-2859; Semeniuk, Adrian David/0000-0002-5751-8068	Deutsche Forschungsgemeinschaft [Ho 3870/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Ho 3870/1-3 (to G. H.). Part of this work was presented at the FEBS Workshop on Microbial Lipids: Diversity in Structure and Formation, May 16-19, 2013, Bern, Switzerland (BALI-009).	Abraham WR, 2004, INT J SYST EVOL MICR, V54, P1227, DOI 10.1099/ijs.0.02943-0; Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Andres E, 2011, J BIOL CHEM, V286, P35367, DOI 10.1074/jbc.M110.214148; Vences-Guzman MA, 2013, ENVIRON MICROBIOL, V15, P895, DOI 10.1111/j.1462-2920.2012.02867.x; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Batrakov SG, 1997, BBA-LIPID LIPID MET, V1347, P127, DOI 10.1016/S0005-2760(97)00060-X; BATRAKOV SG, 1978, CHEM PHYS LIPIDS, V21, P1, DOI 10.1016/0009-3084(78)90052-X; Batrakov SG, 1996, BBA-LIPID LIPID MET, V1302, P167, DOI 10.1016/0005-2760(96)00060-4; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; BUENDIA AM, 1991, MOL MICROBIOL, V5, P1519, DOI 10.1111/j.1365-2958.1991.tb00799.x; CANGELOSI GA, 1987, J BACTERIOL, V169, P2086, DOI 10.1128/jb.169.5.2086-2091.1987; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CEDERGREN RA, 1994, J LIPID RES, V35, P1452; CREMERS HCJC, 1990, J BIOL CHEM, V265, P21122; Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004; De Castro C, 2008, CARBOHYD RES, V343, P1924, DOI 10.1016/j.carres.2008.01.036; Devers EA, 2011, J BACTERIOL, V193, P1377, DOI 10.1128/JB.00768-10; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Geske T, 2013, GLYCOBIOLOGY, V23, P69, DOI 10.1093/glycob/cws124; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7045, DOI 10.1128/jb.175.21.7045-7055.1993; Hoelzl G, 2007, PROG LIPID RES, V46, P225, DOI 10.1016/j.plipres.2007.05.001; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Jorasch P, 2000, EUR J BIOCHEM, V267, P3770, DOI 10.1046/j.1432-1327.2000.01414.x; Karlsson OP, 1996, BIOCHEMISTRY-US, V35, P10094, DOI 10.1021/bi9602876; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Kereszt A, 1998, J BACTERIOL, V180, P5426, DOI 10.1128/JB.180.20.5426-5431.1998; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; KOYNOVA RD, 1993, BIOCHEMISTRY-US, V32, P12437, DOI 10.1021/bi00097a023; Linscheid M, 1997, BBA-LIPID LIPID MET, V1347, P151, DOI 10.1016/S0005-2760(97)00065-9; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; MINNIKIN DE, 1974, NATURE, V249, P268, DOI 10.1038/249268a0; MINNIKIN DE, 1971, BIOCHIM BIOPHYS ACTA, V249, P651, DOI 10.1016/0005-2736(71)90148-9; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Okazaki Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2512; Ostberg Y, 2007, FEMS MICROBIOL LETT, V272, P22, DOI 10.1111/j.1574-6968.2007.00728.x; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SEGERS P, 1994, INT J SYST BACTERIOL, V44, P499, DOI 10.1099/00207713-44-3-499; STERN N, 1971, FEBS LETT, V19, P217, DOI 10.1016/0014-5793(71)80517-3; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Vikstrom S, 2000, J BIOL CHEM, V275, P9296, DOI 10.1074/jbc.275.13.9296; Weissenmayer B, 2000, MOL PLANT MICROBE IN, V13, P666, DOI 10.1094/MPMI.2000.13.6.666; Wieslander A, 1997, CURR TOP MEMBR, V44, P517; WOLUCKA BA, 1993, BIOCHIM BIOPHYS ACTA, V1170, P131, DOI 10.1016/0005-2760(93)90062-E; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107	57	18	18	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10104	10114		10.1074/jbc.M113.519298	http://dx.doi.org/10.1074/jbc.M113.519298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558041	Green Published, hybrid			2022-12-25	WOS:000333807000057
J	Redjadj, C; Darmon, G; Maillard, D; Chevrier, T; Bastianelli, D; Verheyden, H; Loison, A; Said, S				Redjadj, Claire; Darmon, Gaelle; Maillard, Daniel; Chevrier, Thierry; Bastianelli, Denis; Verheyden, Helene; Loison, Anne; Said, Sonia			Intra- and Interspecific Differences in Diet Quality and Composition in a Large Herbivore Community	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; NEAR-INFRARED SPECTROSCOPY; RED-DEER; ROE DEER; BODY-MASS; POPULATION-DENSITY; GUT FILL; RUMINANTS; PATTERNS; FOREST	Species diversity in large herbivore communities is often explained by niche segregation allowed by differences in body mass and digestive morphophysiological features. Based on large number of gut samples in fall and winter, we analysed the temporal dynamics of diet composition, quality and interspecific overlap of 4 coexisting mountain herbivores. We tested whether the relative consumption of grass and browse differed among species of different rumen types (moose-type and intermediate-type), whether diet was of lower quality for the largest species, whether we could identify plant species which determined diet quality, and whether these plants, which could be "key-food-resources'' were similar for all herbivores. Our analyses revealed that (1) body mass and rumen types were overall poor predictors of diet composition and quality, although the roe deer, a species with a moose-type rumen was confirmed as an "obligatory non grazer'', while red deer, the largest species, had the most lignified diet; (2) diet overlap among herbivores was well predicted by rumen type (high among species of intermediate types only), when measured over broad plant groups, (3) the relationship between diet composition and quality differed among herbivore species, and the actual plant species used during winter which determined the diet quality, was herbivore species-specific. Even if diets overlapped to a great extent, the species-specific relationships between diet composition and quality suggest that herbivores may select different plant species within similar plant group types, or different plant parts and that this, along with other behavioural mechanisms of ecological niche segregation, may contribute to the coexistence of large herbivores of relatively similar body mass, as observed in mountain ecosystems.	[Redjadj, Claire; Darmon, Gaelle; Loison, Anne] Univ Savoie, CNRS, Lab Ecol Alpine, Le Bourget Du Lac, France; [Redjadj, Claire; Maillard, Daniel; Chevrier, Thierry; Said, Sonia] Ctr Natl Etud & Rech Appl Faune Montagne & Cervid, Off Natl Chasse & Faune Sauvage, Le Perray En Yvelines, France; [Darmon, Gaelle] Univ Laval, Dept Biol, Chaire Rech Ind Prod Forestiers Anticosti, Quebec City, PQ G1K 7P4, Canada; [Bastianelli, Denis] Ctr Cooperat Int Rech Agron Dev, Montpellier, France; [Verheyden, Helene] INRA, Comportement & Ecol Faune Sauvage, Castanet Tolosan, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Laval University; CIRAD; INRAE	Loison, A (corresponding author), Univ Savoie, CNRS, Lab Ecol Alpine, Le Bourget Du Lac, France.	anne.loison@univ-savoie.fr	Bastianelli, Denis/A-5572-2011	Bastianelli, Denis/0000-0002-6394-5920; SAID, Sonia/0000-0003-1485-8297	Centre National de la Recherche Scientifique (CNRS)-ATIP fund; Office National de la Chasse et de la Faune Sauvage (ONCFS)	Centre National de la Recherche Scientifique (CNRS)-ATIP fund; Office National de la Chasse et de la Faune Sauvage (ONCFS)	This project was funded by a Centre National de la Recherche Scientifique (CNRS)-ATIP fund and by the Office National de la Chasse et de la Faune Sauvage (ONCFS). CNRS was involved as a funder only. ONCFS was involved in study design, data collection, decision to publish and the preparation of the manuscript.	Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; ABRAMS P, 1980, ECOLOGY, V61, P44, DOI 10.2307/1937153; Behrend A, 2004, ACTA THERIOL, V49, P503, DOI 10.1007/BF03192594; Bell R.H.V., 1970, ANIMAL POPULATIONS R, P111; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; Bertolino S, 2009, J ZOOL, V277, P63, DOI 10.1111/j.1469-7998.2008.00512.x; Boissier J, 2005, CONSERVATOIRE BOT NA, P140; Bonenfant C, 2002, ECOGRAPHY, V25, P446, DOI 10.1034/j.1600-0587.2002.250407.x; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; CHAMRAD ALBERT D., 1964, J WILDL MAGMT, V28, P473, DOI 10.2307/3798199; Chessel D., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Clauss M, 2006, EUR J WILDLIFE RES, V52, P88, DOI 10.1007/s10344-005-0024-0; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; Clauss M, 2010, ANIMAL, V4, P979, DOI 10.1017/S1751731110000388; Clauss M, 2010, J ZOOL, V281, P26, DOI 10.1111/j.1469-7998.2009.00675.x; Clauss M, 2008, OECOLOGIA, V157, P377, DOI 10.1007/s00442-008-1093-z; Clauss M, 2009, ZOOLOGY, V112, P195, DOI 10.1016/j.zool.2008.08.001; Clauss M, 2009, COMP BIOCHEM PHYS A, V152, P398, DOI 10.1016/j.cbpa.2008.11.009; Codron D, 2007, J ZOOL, V273, P21, DOI 10.1111/j.1469-7998.2007.00292.x; Codron D, 2008, OIKOS, V117, P344, DOI 10.1111/j.2007.0030-1299.16387.x; Codron D, 2007, EUR J WILDLIFE RES, V53, P100, DOI 10.1007/s10344-006-0071-1; Codron D, 2010, CAN J ZOOL, V88, P1129, DOI 10.1139/Z10-077; Cransac N, 1997, REV ECOL-TERRE VIE, V52, P21; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; Darmon G, 2007, CAN J ZOOL, V85, P634, DOI 10.1139/Z07-040; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; de Iongh HH, 2011, J TROP ECOL, V27, P503, DOI 10.1017/S0266467411000307; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; DOLEDEC S, 1987, ACTA OECOL-OEC GEN, V8, P403; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Duncan Alan J., 2008, V195, P89, DOI 10.1007/978-3-540-72422-3_4; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Fritz Herve, 2006, Conservation Biology Series (Cambridge), V11, P19; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; GarciaGonzalez R, 1996, FOREST ECOL MANAG, V88, P15, DOI 10.1016/S0378-1127(96)03805-4; Garel M, 2007, ECOL APPL, V17, P1607, DOI 10.1890/06-0898.1; Gebert C, 2001, MAMMAL REV, V31, P189, DOI 10.1046/j.1365-2907.2001.00090.x; Gonzalez G, 2001, CAN J ZOOL, V79, P2072, DOI 10.1139/cjz-79-11-2072; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Gross J, 2006, MORTEST TESTS NORMAL; HANSKI I, 1978, ECOLOGY, V59, P168, DOI 10.2307/1936644; Heroldova M, 1996, FOREST ECOL MANAG, V88, P139, DOI 10.1016/S0378-1127(96)03819-4; HOBBS NT, 1990, J WILDLIFE MANAGE, V54, P515, DOI 10.2307/3809344; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Homolka M, 2001, FOLIA ZOOL, V50, P89; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Illius Andrew W., 2006, Conservation Biology Series (Cambridge), V11, P71; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kamler J, 2001, SMALL RUMINANT RES, V41, P101, DOI 10.1016/S0921-4488(01)00206-1; Kleynhans EJ, 2011, OIKOS, V120, P591, DOI 10.1111/j.1600-0706.2010.18712.x; Loison A., 2003, Ecological Studies, V167, P351; Marchand P, 2013, MAMMAL REV, V43, P275, DOI 10.1111/mam.12000; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Pettorelli N, 2002, P ROY SOC B-BIOL SCI, V269, P747, DOI 10.1098/rspb.2001.1791; Pinheiro JC, 2000, LINEAR MIXED EFFECTS; Prins Herbert H. T., 2008, V195, P179, DOI 10.1007/978-3-540-72422-3_7; Prins HHT, 2006, AFR J ECOL, V44, P186, DOI 10.1111/j.1365-2028.2006.00619.x; Putman R. J., 1996, COMPETITION RESOURCE; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Relyea RA, 2000, J WILDLIFE MANAGE, V64, P146, DOI 10.2307/3802984; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schroder J, 1984, ACTA ZOOL FENN; Storms D, 2008, WILDLIFE BIOL, V14, P237, DOI 10.2981/0909-6396(2008)14[237:SVIDCA]2.0.CO;2; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; Tenenhaus M., 1995, REV STAT APPLIQUEE, V43, P7; Thuries L, 2005, J NEAR INFRARED SPEC, V13, P187, DOI 10.1255/jnirs.537; Tixier H, 1996, REV ECOL-TERRE VIE, V51, P3; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van Wieren SE, 1996, THESIS U WAGENINGEN; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Verheyden-Tixier H, 2008, OECOLOGIA, V156, P715, DOI 10.1007/s00442-008-1020-3; Yoccoz NG, 2011, REV GEOGR ALP, V98, DOI [10.4000/rga.1279, DOI 10.4000/RGA.1279]; Zuur Alain F., 2009, P1	82	41	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e84756	10.1371/journal.pone.0084756	http://dx.doi.org/10.1371/journal.pone.0084756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586233	gold, Green Submitted, Green Published			2022-12-25	WOS:000331880700003
J	Dotu, I; Mechery, V; Clote, P				Dotu, Ivan; Mechery, Vinodh; Clote, Peter			Energy Parameters and Novel Algorithms for an Extended Nearest Neighbor Energy Model of RNA	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; NUCLEIC-ACID OLIGOMERS; THERMODYNAMIC PARAMETERS; PARTITION-FUNCTION; WEB SERVER; SEQUENCES; TRANSITION; DERIVATION; COMMON; HELIX	We describe the first algorithm and software, RNAenn, to compute the partition function and minimum free energy secondary structure for RNA with respect to an extended nearest neighbor energy model. Our next-nearest-neighbor triplet energy model appears to lead to somewhat more cooperative folding than does the nearest neighbor energy model, as judged by melting curves computed with RNAenn and with two popular software implementations for the nearestneighbor energy model.	[Dotu, Ivan; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Mechery, Vinodh] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA	Boston College; Hofstra University; Northwell Health	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	clote@bc.edu		Dotu, Ivan/0000-0002-0438-9557	NSF [DMS-1016618, DBI-1262439]; Direct For Biological Sciences [1262439] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by NSF (http://www.nsf.gov) grant DMS-1016618, entitled "Energy parameters and novel algorithms for an extended nearest neighbor energy model of RNA'', as well as NSF DBI-1262439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronescu M, 2007, BIOINFORMATICS, V23, pI19, DOI 10.1093/bioinformatics/btm223; BAUMGARTNER A, 1979, J CHEM PHYS, V70, P429, DOI 10.1063/1.437206; Bekaert M, 2003, BIOINFORMATICS, V19, P327, DOI 10.1093/bioinformatics/btf868; Binder H, 2004, J PHYS CHEM B, V108, P18015, DOI 10.1021/jp049592o; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Bon M, 2009, THESIS ECOLE POLYTEC; Brown D. T., 1959, INFORM CONTROL, V4, P386, DOI DOI 10.1016/S0019-9958(59)80016-4; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chiu WLAK, 2003, NUCLEIC ACIDS RES, V31, P483, DOI 10.1093/nar/gkg114; Clote Peter, 2009, Journal of Bioinformatics and Computational Biology, V7, P869, DOI 10.1142/S0219720009004333; Dill KA, 2002, MOL DRIVING FORCES S; Ding Y, 2004, NUCL ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gray DM, 1997, BIOPOLYMERS, V42, P795, DOI 10.1002/(SICI)1097-0282(199712)42:7<795::AID-BIP5>3.0.CO;2-O; Gray DM, 1997, BIOPOLYMERS, V42, P783, DOI 10.1002/(SICI)1097-0282(199712)42:7<783::AID-BIP4>3.0.CO;2-P; Gray DM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-252; Gutell R., 2005, CURR OPIN STRUC BIOL, V12, P301; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 1998, DISCRETE APPL MATH, V88, P207, DOI 10.1016/S0166-218X(98)00073-0; IRELAND CT, 1968, BIOMETRIKA, V55, P179; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Kazan H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000832; Kihara D, 2001, P NATL ACAD SCI USA, V98, P10125, DOI 10.1073/pnas.181328398; Kiryu H, 2007, BIOINFORMATICS, V23, P434, DOI 10.1093/bioinformatics/btl636; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lyngso RB, 1999, BIOINFORMATICS, V15, P440, DOI 10.1093/bioinformatics/15.6.440; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Mikulecky PJ, 2004, NUCLEIC ACIDS RES, V32, P3967, DOI 10.1093/nar/gkh723; Najafabadi HS, 2006, J THEOR BIOL, V238, P657, DOI 10.1016/j.jtbi.2005.06.014; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Serganov A, 2005, NAT STRUCT MOL BIOL, V12, P218, DOI 10.1038/nsmb906; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Turner D. H., 2009, NUCL ACIDS RES, V0; Vashishta A, 2007, INT J ONCOL, V30, P1223; Wakeman CA, 2007, TRENDS BIOCHEM SCI, V32, P415, DOI 10.1016/j.tibs.2007.08.005; Waldispuhl J, 2007, J COMPUT BIOL, V14, P190, DOI 10.1089/cmb.2006.0012; Waldminghaus T, 2008, BIOL CHEM, V389, P1319, DOI 10.1515/BC.2008.150; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	57	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85412	10.1371/journal.pone.0085412	http://dx.doi.org/10.1371/journal.pone.0085412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586240	Green Published, Green Submitted, gold			2022-12-25	WOS:000331717900004
J	Evangeli, M; Newell, ML; Richter, L; McGrath, N				Evangeli, Michael; Newell, Marie-Louise; Richter, Linda; McGrath, Nuala			The Association between Self-Reported Stigma and Loss-to-Follow Up in Treatment Eligible HIV Positive Adults in Rural Kwazulu-Natal, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT PROGRAM; TREATMENT COHORT; THERAPY; RISK; CARE; MORTALITY; PEOPLE; INITIATION; RETENTION; OUTCOMES	Background: The relationship between loss-to-follow-up (LTFU) in HIV treatment and care programmes and psychosocial factors, including self-reported stigma, is important to understand. This prospective cohort study explored stigma and LTFU in treatment eligible adults who had yet not started antiretroviral therapy (ART). Methods: Psychosocial, clinical and demographic data were collected at a baseline interview. Self-reported stigma was measured with a multi-item scale. LTFU was defined as not attending clinic in the 90 days since last appointment or before death. Data was collected between January 2009 and January 2013 and analysed using Cox Regression. Results: 380 individuals were recruited (median time in study 3.35 years, total time at risk 1065.81 person-years). 203 were retained (53.4%), 109 were LTFU (28.7%), 48 had died and were not LTFU at death (12.6%) and 20 had transferred out (5.3%). The LTFU rate was 10.65 per 100 person-years (95% CI: 8.48-12.34). 362 individuals (95.3%) started ART. Stigma total score (categorised in quartiles) was not significantly associated with LTFU in either univariable or multivariable analysis (adjusting for other variables in the final model): second quartile aHR 0.77 (95% CI: 0.41-1.46), third quartile aHR 1.20(95% CI: 0.721-2.04), fourth quartile aHR 0.62 (95% CI: 0.35-1.11). In the final multivariable model, higher LTFU rates were associated with male gender, increased openness with friends/family and believing that community problems would be solved at higher levels. Lower LTFU rates were independently associated with increased year of age, greater reliance on family/friends, and having children. Conclusions: Demographic and other psychosocial factors were more closely related to LTFU than self-reported stigma. This may be consistent with high levels of social exposure to HIV and ART and with stigma affecting LTFU less than other stages of care. Research and clinical implications are discussed.	[Evangeli, Michael] Royal Holloway Univ London, Dept Psychol, London, England; [Newell, Marie-Louise; McGrath, Nuala] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Newell, Marie-Louise] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Richter, Linda] Human Sci Res Council, Durban, South Africa; [McGrath, Nuala] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McGrath, Nuala] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England	University of London; Royal Holloway University London; University of Kwazulu Natal; University of Southampton; Human Sciences Research Council-South Africa; University of Southampton; University of Southampton	Evangeli, M (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	michael.evangeli@rhul.ac.uk	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [WT083495MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	Nuala McGrath was supported by a Wellcome Trust fellowship grant (# WT083495MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2011, J HEALTH PSYCHOL, V16, P1071, DOI 10.1177/1359105311398727; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Bor J, 2011, TROP MED INT HEALTH, V16, P988, DOI 10.1111/j.1365-3156.2011.02795.x; Braitstein P, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-7; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; De Silva MJ, 2006, SOC SCI MED, V62, P941, DOI 10.1016/j.socscimed.2005.06.050; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Elford J, 2007, AIDS, V21, pS63, DOI 10.1097/01.aids.0000255087.62223.ff; Fatti G, 2012, INT AIDS C WASH DC U; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Health Do, 2010, S AFR ANT TREATM GUI; Health Do, 2004, NAT ANT TREATM GUID; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Hills M, 2009, SHORT INTRO STATA BI; Holzemer WL, 2007, J ADV NURS, V58, P541, DOI 10.1111/j.1365-2648.2007.04244.x; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kunutsor S, 2010, AIDS BEHAV, V14, P1347, DOI 10.1007/s10461-010-9780-2; McGrath N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-121; McMahon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056047; Mutevedzi PC, LOSS FOLLOW UP UNPUB; Mutevedzi PC, 2013, TROP MED INT HEALTH, V18, P934, DOI 10.1111/tmi.12135; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peoples A, 2008, 3 ANN GLOB HLTH S; Plazy M, 2013, RETENTION CARE ART I; Pronyk PM, 2008, SOC SCI MED, V66, P1999, DOI 10.1016/j.socscimed.2008.01.023; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; (SANAC) SANAC, 2011, M S AFR NAT AIDS COU; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Shisana O, 2013, S AFR AIDS C DURB S; Somi G, 2012, TROP MED INT HEALTH, V17, P497, DOI 10.1111/j.1365-3156.2011.02952.x; StataCorp, 2019, STATA STAT SOFTWARE; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tayler-Smith K, 2011, TROP MED INT HEALTH, V16, P579, DOI 10.1111/j.1365-3156.2011.02740.x; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; UNAIDS, 2009, S AFR COUNTR SIT; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; Wills TA., 1991, PROSOCIAL BEHAV, P265; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010; Zaidi J, 2013, DRAMATIC INCREASES H	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88235	10.1371/journal.pone.0088235	http://dx.doi.org/10.1371/journal.pone.0088235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586310	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000331714700010
J	Thumbi, SM; Bronsvoort, BMD; Poole, EJ; Kiara, H; Toye, PG; Mbole-Kariuki, MN; Conradie, I; Jennings, A; Handel, IG; Coetzer, JAW; Steyl, JCA; Hanotte, O; Woolhouse, MEJ				Thumbi, Samuel M.; Bronsvoort, Barend Mark de Clare; Poole, Elizabeth Jane; Kiara, Henry; Toye, Philip G.; Mbole-Kariuki, Mary Ndila; Conradie, Ilana; Jennings, Amy; Handel, Ian Graham; Coetzer, Jacobus Andries Wynand; Steyl, Johan C. A.; Hanotte, Olivier; Woolhouse, Mark E. J.			Parasite Co-Infections and Their Impact on Survival of Indigenous Cattle	PLOS ONE			English	Article							HELMINTH COINFECTION; MALARIA; INFECTIONS; EPIDEMIOLOGY; DISEASES; WORMS; POPULATIONS; DYNAMICS; ANEMIA; RISK	In natural populations, individuals may be infected with multiple distinct pathogens at a time. These pathogens may act independently or interact with each other and the host through various mechanisms, with resultant varying outcomes on host health and survival. To study effects of pathogens and their interactions on host survival, we followed 548 zebu cattle during their first year of life, determining their infection and clinical status every 5 weeks. Using a combination of clinical signs observed before death, laboratory diagnostic test results, gross-lesions on post-mortem examination, histo-pathology results and survival analysis statistical techniques, cause-specific aetiology for each death case were determined, and effect of co-infections in observed mortality patterns. East Coast fever (ECF) caused by protozoan parasite Theileria parva and haemonchosis were the most important diseases associated with calf mortality, together accounting for over half (52%) of all deaths due to infectious diseases. Co-infection with Trypanosoma species increased the hazard for ECF death by 6 times (1.4-25; 95% CI). In addition, the hazard for ECF death was increased in the presence of Strongyle eggs, and this was burden dependent. An increase by 1000 Strongyle eggs per gram of faeces count was associated with a 1.5 times (1.4-1.6; 95% CI) increase in the hazard for ECF mortality. Deaths due to haemonchosis were burden dependent, with a 70% increase in hazard for death for every increase in strongyle eggs per gram count of 1000. These findings have important implications for disease control strategies, suggesting a need to consider co-infections in epidemiological studies as opposed to singlepathogen focus, and benefits of an integrated approach to helminths and East Coast fever disease control.	[Thumbi, Samuel M.; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh, Midlothian, Scotland; [Bronsvoort, Barend Mark de Clare; Jennings, Amy; Handel, Ian Graham] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Bronsvoort, Barend Mark de Clare; Jennings, Amy; Handel, Ian Graham] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Poole, Elizabeth Jane; Kiara, Henry; Toye, Philip G.; Mbole-Kariuki, Mary Ndila] Int Livestock Res Inst, Nairobi, Kenya; [Hanotte, Olivier] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Conradie, Ilana; Coetzer, Jacobus Andries Wynand] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Onderstepoort, South Africa; [Steyl, Johan C. A.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0110 Onderstepoort, South Africa	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; CGIAR; International Livestock Research Institute (ILRI); University of Nottingham; University of Pretoria; University of Pretoria	Thumbi, SM (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	samthumbi@gmail.com	Mwangi, Thumbi/L-2216-2019	Mwangi, Thumbi/0000-0002-5754-0556; Bronsvoort, Mark/0000-0002-3271-8485; Steyl, Johan/0000-0002-5940-6799; Hanotte, Olivier/0000-0002-2877-4767; Poole, Elizabeth Jane/0000-0002-8570-794X	Wellcome Trust [079445]; BBSRC [BBS/E/D/05191133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to thank the Wellcome Trust (grant No. 079445) for the financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Adegnika AA, 2012, CURR OPIN HIV AIDS, V7, P221, DOI 10.1097/COH.0b013e3283524d90; Alizon S, 2008, AM NAT, V172, pE150, DOI 10.1086/590958; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Bronsvoort BMD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-171; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Craig BH, 2008, PARASITOLOGY, V135, P433, DOI 10.1017/S0031182008004137; Drake L. J., 2001, Parasitology, V122, pS73, DOI 10.1017/S0031182000017662; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Ezeamama AE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000245; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Harms G, 2002, TROP MED INT HEALTH, V7, P479, DOI 10.1046/j.1365-3156.2002.00893.x; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; King D., 2006, NECROPSY BOOK GUIDE, V4th; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perry B, 2007, SCIENCE, V315, P333, DOI 10.1126/science.1138614; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; R Core Team, 2016, R FDN STAT COMP; Rich KM, 2011, PREV VET MED, V101, P133, DOI 10.1016/j.prevetmed.2010.08.002; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; Thumbi SM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-175	33	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e76324	10.1371/journal.pone.0076324	http://dx.doi.org/10.1371/journal.pone.0076324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586220	Green Published, Green Submitted, gold			2022-12-25	WOS:000331714700002
J	Warren, IA; Vera, JC; Johns, A; Zinna, R; Marden, JH; Emlen, DJ; Dworkin, I; Lavine, LC				Warren, Ian A.; Vera, J. Cristobal; Johns, Annika; Zinna, Robert; Marden, James H.; Emlen, Douglas J.; Dworkin, Ian; Lavine, Laura C.			Insights into the Development and Evolution of Exaggerated Traits Using De Novo Transcriptomes of Two Species of Horned Scarab Beetles	PLOS ONE			English	Article							LENGTH DIMORPHISM; COLEOPTERA; SIZE; RNA; DIVERSITY; SELECTION; GENES; DIVERSIFICATION; SEPTENTRIONALIS; SCARABAEOIDEA	Scarab beetles exhibit an astonishing variety of rigid exo-skeletal outgrowths, known as "horns". These traits are often sexually dimorphic and vary dramatically across species in size, shape, location, and allometry with body size. In many species, the horn exhibits disproportionate growth resulting in an exaggerated allometric relationship with body size, as compared to other traits, such as wings, that grow proportionately with body size. Depending on the species, the smallest males either do not produce a horn at all, or they produce a disproportionately small horn for their body size. While the diversity of horn shapes and their behavioural ecology have been reasonably well studied, we know far less about the proximate mechanisms that regulate horn growth. Thus, using 454 pyrosequencing, we generated transcriptome profiles, during horn growth and development, in two different scarab beetle species: the Asian rhinoceros beetle, Trypoxylus dichotomus, and the dung beetle, Onthophagus nigriventris. We obtained over half a million reads for each species that were assembled into over 6,000 and 16,000 contigs respectively. We combined these data with previously published studies to look for signatures of molecular evolution. We found a small subset of genes with horn-biased expression showing evidence for recent positive selection, as is expected with sexual selection on horn size. We also found evidence of relaxed selection present in genes that demonstrated biased expression between horned and horn-less morphs, consistent with the theory of developmental decoupling of phenotypically plastic traits.	[Warren, Ian A.; Zinna, Robert; Lavine, Laura C.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Warren, Ian A.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Vera, J. Cristobal; Marden, James H.] Penn State Univ, Dept Biol, State Coll, PA USA; [Johns, Annika; Emlen, Douglas J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	Washington State University; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Montana System; University of Montana; Michigan State University; Michigan State University	Warren, IA (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	ianawarren.work@gmail.com		Lavine, Laura/0000-0002-0262-359X; Dworkin, Ian/0000-0002-2874-287X	National Science Foundation [IOS-0919781, IOS-0919730, IOS-0920142, IOS- 0950416]	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation (IOS-0919781, IOS-0919730, IOS-0920142, IOS- 0950416) provided funding for this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Andersson Malte, 1994; [Anonymous], 2010, GS FLX TITANIUM SERI; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arrow G.J., 1951, HORNED BEETLES; Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Carvalho RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-695; Choi JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-703; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cotton S, 2004, J EVOLUTION BIOL, V17, P1310, DOI 10.1111/j.1420-9101.2004.00754.x; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Darwin G., 1871, P423; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Eberhard, 1978, PSYCHE, V83, P292; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Emlen DJ, 2005, EVOLUTION, V59, P1060; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Enrodi S., 1985, DYNASTINAE WORLD; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; HALFFTNER G, 1982, NESTING BEHAV DUNG B; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hongo Y, 2012, ACTA ETHOL, V15, P195, DOI 10.1007/s10211-012-0128-y; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Iguchi Y, 1998, ANN ENTOMOL SOC AM, V91, P845, DOI 10.1093/aesa/91.6.845; Karino K, 2004, ECOL RES, V19, P663, DOI 10.1111/j.1440-1703.2004.00681.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kijimoto T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-504; Krell FT, 2000, INVERTEBR TAXON, V14, P871, DOI 10.1071/IT00031; Kusui Y., 1976, Entomological Rev Japan, V29, P51; Lai J, 2008, LOVE RHINOCEROS STAG; Lavine LC, 2013, ARCH INSECT BIOCHEM, V82, P43, DOI 10.1002/arch.21072; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Markusson E, 1997, OECOLOGIA, V110, P501, DOI 10.1007/s004420050186; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Moczek AP, 2002, EVOL ECOL RES, V4, P587; Moczek AP, 1999, J EVOLUTION BIOL, V12, P27, DOI 10.1046/j.1420-9101.1999.00004.x; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Muller GB, 2005, J EXP ZOOL PART B, V304B, P487, DOI 10.1002/jez.b.21081; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohlsson T, 2002, P ROY SOC B-BIOL SCI, V269, P21, DOI 10.1098/rspb.2001.1848; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pitchers W, 2013, EVOLUTION, V67, P438, DOI 10.1111/j.1558-5646.2012.01774.x; Plaistow SJ, 2005, ECOL ENTOMOL, V30, P692, DOI 10.1111/j.0307-6946.2005.00740.x; Quinlan AR, 2008, NAT METHODS, V5, P454; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Snell-Rood EC, 2013, J EXP ZOOL PART B, V320B, P22, DOI 10.1002/jez.b.22479; Snell-Rood EC, 2011, EVOLUTION, V65, P231, DOI 10.1111/j.1558-5646.2010.01106.x; Snell-Rood EC, 2010, BIOESSAYS, V32, P71, DOI 10.1002/bies.200900132; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tyndale-Briscoe M, 1990, COMMON DUNG BEETLES; Vanhooydonck B, 2005, BEHAV ECOL SOCIOBIOL, V59, P157, DOI 10.1007/s00265-005-0022-y; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vera JC, 2012, FUNCTIONAL TRANSCRIP; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wasik BR, 2012, GENESIS, V50, P404, DOI 10.1002/dvg.20814; West-Eberhard M.J., 1984, Symposia of the Royal Entomological Society of London, V12, P283; West-Eberhard Mary Jane, 2003, pi; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	74	14	14	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88364	10.1371/journal.pone.0088364	http://dx.doi.org/10.1371/journal.pone.0088364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586317	Green Published, Green Submitted, gold			2022-12-25	WOS:000331714700015
J	Wang, LM; Tang, WF; Chen, SC; Sun, YY; Fan, Y; Shi, YJ; Zhu, JF; Wang, X; Zheng, L; Shao, AZ; Ding, GW; Liu, C; Liu, RP; Yin, J; Gu, HY				Wang, Liming; Tang, Weifeng; Chen, Suocheng; Sun, Yangyong; Fan, Yu; Shi, Yijun; Zhu, Jingfeng; Wang, Xu; Zheng, Liang; Shao, Aizhong; Ding, Guowen; Liu, Chao; Liu, Ruiping; Yin, Jun; Gu, Haiyong			N-acetyltransferase 2 Polymorphisms and Risk of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENETIC POLYMORPHISMS; SUSCEPTIBILITY; NAT2; ASSOCIATION	Esophageal cancer was the fifth most commonly diagnosed cancer and the fourth leading cause of cancer-related death in China in 2009. Genetic factors might play an important role in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). We conducted a hospital-based case-control study to evaluate ten NAT2 tagging single nucleotide polymorphisms (SNPs) on the risk of ESCC. Six hundred and twenty-nine ESCC cases and 686 controls were recruited. Their genotypes were determined using the ligation detection reaction method. In the single locus analyses, there was a borderline statistically significant difference in genotype frequencies of NAT2 rs1565684 T>C SNP between the cases and the controls (p = 0.057). The NAT2 rs1565684 CC genotype was associated with a borderline significantly increased risk for ESCC (CC vs. TT: adjusted OR = 1.77, 95% Cl = 0.97-3.21, p = 0.063 and CC vs. TT/TC: adjusted OR = 1.68, 95% Cl = 0.93-3.04, p = 0.085). The association was evident among older patients and patients who never drunk. After the Bonferroni correction, in all comparison models, NAT2 rs1565684 T>C SNP was not associated with ESCC risk (p>0.05). For the other nine NAT2 SNPs, after Bonferroni correction, in all comparison models, the nine SNPs were also not associated with ESCC risk (p>0.05). Thus, nine NAT2 tagging SNPs were not associated with risk of ESCC. NAT2 rs1565684 T>C SNP might play a slight role in ESCC etiology. Additional, larger studies and tissue-specific biological characterization are required to confirm the current findings.	[Wang, Liming; Fan, Yu] Jiangsu Univ, Affiliated Peoples Hosp, Dept Chemotherapy, Inst Canc, Zhenjiang, Jiangsu, Peoples R China; [Tang, Weifeng; Chen, Suocheng; Sun, Yangyong; Shi, Yijun; Zhu, Jingfeng; Wang, Xu; Shao, Aizhong; Ding, Guowen; Liu, Chao; Yin, Jun; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Zheng, Liang] Suzhou Univ, Peoples Hosp Changzhou 1, Dept Cardiothorac Surg, Changzhou, Peoples R China; [Zheng, Liang] Suzhou Univ, Affiliated Hosp 3, Changzhou, Peoples R China; [Liu, Ruiping] Nanjing Med Univ, Changzhou Second Peoples Hosp, Affiliated Hosp, Dept Orthoped, Changzhou, Peoples R China	Jiangsu University; Jiangsu University; Nanjing Medical University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	yin912@126.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81370001, 81371927, 81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau [QN201102]; Affiliated People's Hospital of Jiangsu University fund [Y200913]; Jiangsu University Clinical medicine science and technology development fund [JLY20120004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and ScienceTechnology Foundation of Health Bureau; Affiliated People's Hospital of Jiangsu University fund; Jiangsu University Clinical medicine science and technology development fund	This study was supported in part by National Natural Science Foundation of China (81370001, 81371927, 81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017), Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102), Affiliated People's Hospital of Jiangsu University fund (Y200913) and Jiangsu University Clinical medicine science and technology development fund (JLY20120004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM M, 1990, DNA CELL BIOL, V9, P193, DOI 10.1089/dna.1990.9.193; Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Cui D, 2011, LUNG CANCER, V73, P153, DOI 10.1016/j.lungcan.2010.12.012; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; Gong CM, 2011, MED ONCOL, V28, P365, DOI 10.1007/s12032-010-9423-5; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Jain M, 2007, CANCER INVEST, V25, P340, DOI 10.1080/07357900701358074; LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.39; Lee JM, 2000, INT J CANCER, V89, P458, DOI 10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R; Liao G., 2013, ORAL DIS; Liu L, 2009, CHEM RES TOXICOL, V22, P1962, DOI 10.1021/tx9002676; Malik MA, 2009, ARCH MED RES, V40, P416, DOI 10.1016/j.arcmed.2009.06.009; MANABE S, 1991, CARCINOGENESIS, V12, P1945, DOI 10.1093/carcin/12.10.1945; Morita S, 1998, INT J CANCER, V79, P517, DOI 10.1002/(SICI)1097-0215(19981023)79:5<517::AID-IJC12>3.0.CO;2-Z; Walker K, 2009, J TOXICOL ENV HEAL B, V12, P440, DOI 10.1080/10937400903158383; Wei JS, 2013, HUM IMMUNOL, V74, P1199, DOI 10.1016/j.humimm.2013.06.012; Yin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076294; Zhang J, 2010, BREAST CANCER RES TR, V123, P877, DOI 10.1007/s10549-010-0807-1; Zhong X, 2010, ARCH MED RES, V41, P275, DOI 10.1016/j.arcmed.2010.06.001	20	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87783	10.1371/journal.pone.0087783	http://dx.doi.org/10.1371/journal.pone.0087783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586291	Green Submitted, Green Published, gold			2022-12-25	WOS:000331711900017
J	Ormond, DR; Shannon, C; Oppenheim, J; Zeman, R; Das, K; Murali, R; Jhanwar-Uniyal, M				Ormond, D. Ryan; Shannon, Craig; Oppenheim, Julius; Zeman, Richard; Das, Kaushik; Murali, Raj; Jhanwar-Uniyal, Meena			Stem Cell Therapy and Curcumin Synergistically Enhance Recovery from Spinal Cord Injury	PLOS ONE			English	Article							NF-KAPPA-B; NEURAL STEM/PROGENITOR CELLS; FUNCTIONAL RECOVERY; PROGENITOR-CELLS; ISCHEMIA/REPERFUSION INJURY; HISTOLOGICAL OUTCOMES; IMPROVES LOCOMOTOR; BODY-WEIGHT; IN-VIVO; PROLIFERATION	Acute traumatic spinal cord injury (SCI) is marked by the enhanced production of local cytokines and pro-inflammatory substances that induce gliosis and prevent reinnervation. The transplantation of stem cells is a promising treatment strategy for SCI. In order to facilitate functional recovery, we employed stem cell therapy alone or in combination with curcumin, a naturally-occurring anti-inflammatory component of turmeric (Curcuma longa), which potently inhibits NF-kappa B. Spinal cord contusion following laminectomy (T9-10) was performed using a weight drop apparatus (10 g over a 12.5 or 25 mm distance, representing moderate or severe SCI, respectively) in Sprague-Dawley rats. Neural stem cells (NSC) were isolated from subventricular zone (SVZ) and transplanted at the site of injury with or without curcumin treatment. Functional recovery was assessed by BBB score and body weight gain measured up to 6 weeks following SCI. At the conclusion of the study, the mass of soleus muscle was correlated with BBB score and body weight. Stem cell therapy improved recovery from moderate SCI, however, it had a limited effect on recovery after severe SCI. Curcumin stimulated NSC proliferation in vitro, and in combination with stem cell therapy, induced profound recovery from severe SCI as evidenced by improved functional locomotor recovery, increased body weight, and soleus muscle mass. These findings demonstrate that curcumin in conjunction with stem cell therapy synergistically improves recovery from severe SCI. Furthermore, our results indicate that the effect of curcumin extends beyond its known anti-inflammatory properties to the regulation of stem cell proliferation.	[Ormond, D. Ryan; Shannon, Craig; Oppenheim, Julius; Das, Kaushik; Murali, Raj; Jhanwar-Uniyal, Meena] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; [Zeman, Richard] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Jhanwar-Uniyal, M (corresponding author), New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA.	meena_jhanwar@nymc.edu	Ormond, David R/R-4847-2017; Oppenheim, Julius/AAP-9428-2020	Ormond, David R/0000-0001-7027-2915; Oppenheim, Julius/0000-0002-5988-0677	American Association of Neurological Surgeons NREF/Medtronic Research Fellowship grant	American Association of Neurological Surgeons NREF/Medtronic Research Fellowship grant	This work was funded from the American Association of Neurological Surgeons NREF/Medtronic Research Fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; [Anonymous], 2009, ON DEGR SEP PAR SPIN; Avci G, 2012, J SURG RES, V172, pE39, DOI 10.1016/j.jss.2011.08.021; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Bernardo A, 2003, J NEUROPATH EXP NEUR, V62, P509, DOI 10.1093/jnen/62.5.509; Bottai D, 2008, MOL MED, V14, P634, DOI 10.2119/2008-00077.Bottai; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; Dolgun H, 2010, J CLIN NEUROSCI, V17, P486, DOI 10.1016/j.jocn.2009.07.108; Dupont-Versteegden EE, 1998, AM J PHYSIOL-CELL PH, V275, pC1124, DOI 10.1152/ajpcell.1998.275.4.C1124; Fansa I, 2009, J INT MED RES, V37, P520, DOI 10.1177/147323000903700228; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; GANESHAIAH KN, 1980, INDIAN J EXP BIOL, V18, P700; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Holly LT, 2012, J NEUROSURG-SPINE, V17, P134, DOI 10.3171/2012.5.SPINE1216; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; JHANWARUNIYAL M, 1993, BRAIN RES, V631, P97, DOI 10.1016/0006-8993(93)91192-U; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kavakli HS, 2011, ULUS TRAVMA ACIL CER, V17, P14, DOI 10.5505/tjtes.2011.31391; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kuo CP, 2011, ANESTHESIOLOGY, V115, P1229, DOI 10.1097/ALN.0b013e31823306f0; Landry E, 2004, J NEUROTRAUM, V21, P1008, DOI 10.1089/0897715041651060; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee YS, 2007, J APPL PHYSIOL, V103, P1808, DOI 10.1152/japplphysiol.00588.2007; Lin MS, 2011, J NEUROTRAUM, V28, P1259, DOI 10.1089/neu.2011.1768; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Liu M, 2006, EUR J APPL PHYSIOL, V97, P355, DOI 10.1007/s00421-006-0199-4; Liu M, 2010, EUR J APPL PHYSIOL, V109, P709, DOI 10.1007/s00421-010-1392-z; Marshall Gregory P. II, 2008, V438, P135, DOI 10.1007/978-1-59745-133-8_12; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Miller RH, 2012, NEUROSCI LETT, V519, P87, DOI 10.1016/j.neulet.2012.01.043; Morell Pierre, 1999, P69; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Ormond DR, 2012, J NEUROSURG-SPINE, V16, P497, DOI 10.3171/2012.1.SPINE11769; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Parr AM, 2008, SURG NEUROL, V70, P600, DOI 10.1016/j.surneu.2007.09.043; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; Pogue AI, 2011, J INORG BIOCHEM, V105, P1434, DOI 10.1016/j.jinorgbio.2011.05.012; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Rafati DS, 2008, J NEUROSCI RES, V86, P566, DOI 10.1002/jnr.21508; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Ruff CA, 2012, EXP NEUROL, V235, P78, DOI 10.1016/j.expneurol.2011.02.010; Saito T, 2011, ANESTH ANALG, V113, P565, DOI 10.1213/ANE.0b013e318224ac35; SATOSKAR RR, 1986, INT J CLIN PHARM TH, V24, P651; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Singh A, 2011, J NEUROTRAUM, V28, P2405, DOI 10.1089/neu.2010.1660; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Weiss S, 1996, J NEUROSCI, V16, P7599; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Zeman RJ, 2006, J NEUROTRAUM, V23, P170, DOI 10.1089/neu.2006.23.170; Zeman RJ, 2001, EXP NEUROL, V172, P228, DOI 10.1006/exnr.2001.7803; Zeman RJ, 1999, EXP NEUROL, V159, P267, DOI 10.1006/exnr.1999.7146; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	76	48	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88916	10.1371/journal.pone.0088916	http://dx.doi.org/10.1371/journal.pone.0088916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558450	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700096
J	Staud, R; Weyl, EE; Riley, JL; Fillingim, RB				Staud, Roland; Weyl, Elizabeth E.; Riley, Joseph L., III; Fillingim, Roger B.			Slow Temporal Summation of Pain for Assessment of Central Pain Sensitivity and Clinical Pain of Fibromyalgia Patients	PLOS ONE			English	Article							C-FIBER REFLEX; 2ND PAIN; CENTRAL SENSITIZATION; CENTRAL MODULATION; WIDESPREAD PAIN; HEAT PAIN; WIND-UP; RESPONSES; CONTACT; HYPERSENSITIVITY	Background: In healthy individuals slow temporal summation of pain or wind-up (WU) can be evoked by repetitive heat-pulses at frequencies of >.33 Hz. Previous WU studies have used various stimulus frequencies and intensities to characterize central sensitization of human subjects including fibromyalgia (FM) patients. However, many trials demonstrated considerable WU-variability including zero WU or even wind-down (WD) at stimulus intensities sufficient for activating C-nociceptors. Additionally, few WU-protocols have controlled for contributions of individual pain sensitivity to WU-magnitude, which is critical for WU-comparisons. We hypothesized that integration of 3 different WU-trains into a single WU-response function (WU-RF) would not only control for individuals' pain sensitivity but also better characterize their central pain responding including WU and WD. Methods: 33 normal controls (NC) and 38 FM patients participated in a study of heat-WU. We systematically varied stimulus intensities of. 4 Hz heat-pulse trains applied to the hands. Pain summation was calculated as difference scores of 1st and 5th heat-pulse ratings. WU-difference (WU-D) scores related to 3 heat-pulse trains (44 degrees C, 46 degrees C, 48 degrees C) were integrated into WU-response functions whose slopes were used to assess group differences in central pain sensitivity. WU-aftersensations (WU-AS) at 15 s and 30 s were used to predict clinical FM pain intensity. Results: WU-D scores linearly accelerated with increasing stimulus intensity (p,. 001) in both groups of subjects (FM. NC) from WD to WU. Slope of WU-RF, which is representative of central pain sensitivity, was significantly steeper in FM patients than NC (p,. 003). WU-AS predicted clinical FM pain intensity (Pearson's r=.4; p<.04). Conclusions: Compared to single WU series, WU-RFs integrate individuals' pain sensitivity as well as WU and WD. Slope of WU-RFs was significantly different between FM patients and NC. Therefore WU-RF may be useful for assessing central sensitization of chronic pain patients in research and clinical practice.	[Staud, Roland; Weyl, Elizabeth E.] Univ Florida, Dept Med, Gainesville, FL 32611 USA; [Riley, Joseph L., III; Fillingim, Roger B.] Univ Florida, Dept Community Dent & Behav Sci, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Staud, R (corresponding author), Univ Florida, Dept Med, Gainesville, FL 32611 USA.	staudr@ufl.edu	Fillingim, Roger/K-3569-2019; Staud, Roland/A-8442-2008	Fillingim, Roger/0000-0002-7699-8183	NIH [AR053541, NR014049]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The work was funded by NIH grants AR053541 and NR014049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2013, EUR J PAIN, V17, P67, DOI 10.1002/j.1532-2149.2012.00190.x; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; BEYDOUN A, 1993, ELECTROEN CLIN NEURO, V88, P173, DOI 10.1016/0168-5597(93)90002-7; Chen L, 2009, PAIN, V143, P65, DOI 10.1016/j.pain.2009.01.022; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; DICKENSON AH, 1991, PAIN, V46, P344, DOI 10.1016/0304-3959(91)90118-H; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; FIELDS HL, 1984, AM J MED, V77, P2, DOI 10.1016/S0002-9343(84)80097-2; Fillingim RB, 2005, BIOL PSYCHOL, V69, P97, DOI 10.1016/j.biopsycho.2004.11.008; George SZ, 2007, J PAIN, V8, P2, DOI 10.1016/j.jpain.2006.05.009; Gozariu M, 2000, EUR J PHARMACOL, V394, P75, DOI 10.1016/S0014-2999(00)00114-X; Gozariu M, 1998, BRAIN RES, V792, P168, DOI 10.1016/S0006-8993(98)00214-5; Gozariu M, 1997, J NEUROPHYSIOL, V78, P3165, DOI 10.1152/jn.1997.78.6.3165; Granot M, 2003, EUR J PAIN, V7, P139, DOI 10.1016/S1090-3801(02)00087-3; Granot M, 2006, PAIN, V122, P295, DOI 10.1016/j.pain.2006.02.003; Greenspan JD, 2011, J PAIN, V12, pT61, DOI 10.1016/j.jpain.2011.08.006; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Mason P, 2005, J NEUROPHYSIOL, V94, P1659, DOI 10.1152/jn.00249.2005; Mason P, 2006, HAND CLINIC, V81, P211, DOI 10.1016/S0072-9752(06)80019-9; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Nielsen J, 1998, SOMATOSENS MOT RES, V15, P220, DOI 10.1080/08990229870781; Oaklander AL, 2013, PEDIATRICS, V131, pE1091, DOI 10.1542/peds.2012-2597; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; PRICE DD, 1972, EXP NEUROL, V37, P371, DOI 10.1016/0014-4886(72)90081-7; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; PRICE DD, 1994, PROG PAIN RES MANAG, V1, P61; PRICE DD, 1978, J NEUROPHYSIOL, V41, P933, DOI 10.1152/jn.1978.41.4.933; Price DD, 1992, HDB PAIN ASSESSMENT, P114; Raphael KG, 2009, J OROFAC PAIN, V23, P54; Staud R, 2005, J PAIN, V6, P323, DOI 10.1016/j.jpain.2005.01.357; Staud R, 2004, PAIN, V110, P689, DOI 10.1016/j.pain.2004.05.009; Staud R, 2003, PAIN, V102, P87, DOI 10.1016/s0304-3959(02)00344-5; Staud R, 2003, PAIN, V105, P215, DOI 10.1016/S0304-3959(03)00208-2; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2008, PAIN, V139, P315, DOI 10.1016/j.pain.2008.04.024; Staud R, 2008, EUR J PAIN, V12, P1078, DOI 10.1016/j.ejpain.2008.02.002; Staud R, 2007, J PAIN, V8, P893, DOI 10.1016/j.jpain.2007.06.006; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Staud Roland, 2005, Curr Pain Headache Rep, V9, P316, DOI 10.1007/s11916-005-0006-7; Staud R, 2006, J PAIN, V7, P575, DOI 10.1016/j.jpain.2006.02.005; TOREBJORK HE, 1974, J NEUROL NEUROSUR PS, V37, P653, DOI 10.1136/jnnp.37.6.653; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Vera-Portocarrero LP, 2006, NEUROSCIENCE, V140, P1311, DOI 10.1016/j.neuroscience.2006.03.016; Vierck CJ, 2013, PAIN, V154, P334, DOI 10.1016/j.pain.2012.10.021; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Wade JB, 1996, PAIN, V68, P157, DOI 10.1016/S0304-3959(96)03162-4; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zhou QQ, 2011, J PAIN, V12, P297, DOI 10.1016/j.jpain.2010.09.002	59	66	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89086	10.1371/journal.pone.0089086	http://dx.doi.org/10.1371/journal.pone.0089086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558475	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700121
J	Wu, GG; Li, WH; He, WG; Jiang, N; Zhang, GX; Chen, W; Yang, HF; Liu, QL; Huang, YN; Zhang, L; Zhang, T; Zeng, XC				Wu, Geng-Gang; Li, Wen-Hong; He, Wen-Guang; Jiang, Nan; Zhang, Guang-Xian; Chen, Wei; Yang, Hai-Feng; Liu, Qi-Long; Huang, Yan-Nian; Zhang, Lei; Zhang, Tong; Zeng, Xian-Cheng			Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MICRORNAS; CANCER; BIOGENESIS; ONCOMIRS; GENOMICS; PROSTATE; MODEL	Hepatocellular carcinoma (HCC) is one of the most common human malignancies and the third leading cause of cancer mortality worldwide. The development and progression of HCC is a complicated process, involving the deregulation of multiple genes that are essential to cell biological processes. Recently, microRNAs (miRNAs) have been suggested to be closely associated with tumorigenesis. Our study showed that miR-184 is upregulated in HCC cell lines and tissues. Overexpression of miR-184 in HCC cells increased cell proliferation, tumorigenicity, and cell cycle progression, whereas inhibition of miR-184 reduced cell proliferation, tumorigenicity, and cell cycle progression. Additionally, we identified SOX7 as a direct target of miR-184. Ectopic expression of miR-184 led to downregulation of the SOX7 protein, resulting in upregulation of c-Myc, Cyclin D1, and phosphorylation of Rb. Our findings suggested that miR-184 represents a potential onco-miR and plays an important role in HCC progression by suppressing SOX7 expression.	[Wu, Geng-Gang; Li, Wen-Hong; He, Wen-Guang; Liu, Qi-Long; Huang, Yan-Nian; Zeng, Xian-Cheng] Sun Yat Sen Univ, BoJi Affiliated Hosp, Zengcheng Peoples Hosp, Dept Gen Surg, Zengcheng, Peoples R China; [Jiang, Nan; Zhang, Tong] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Guang-Xian] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Hai-Feng] Guangzhou Univ Chinese Med, Guangdong Prov Hosp TCM, Affiliated Hosp 2, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Lei; Zeng, Xian-Cheng] Sun Yat Sen Univ, BoJi Affiliated Hosp, Zengcheng Peoples Hosp, Dept Clin Lab, Zengcheng, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Zhejiang University; Guangzhou University of Chinese Medicine; Sun Yat Sen University	Zhang, T (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhjeff72@sina.com; zxcheng1974@163.com	JIANG, NAN/AHB-1945-2022		Guangdong Natural Science Foundation [10451130001004472, S2013010016023]; Science and Technology Programme of Guangzhou Municipal Government [2013J4100081]; Supported Foundation of Science and Technology Innovation of Zengcheng [ZC201004]; National Natural Science Foundation of China [81000959]; Science and Technology Planning Project of Guangdong Province, China [2009B030801007]; Fundamental Research Funds for the Central Universities [12ykpy47]; National 12th Five-Year Science and Technology Plan Major Projects of China [2012ZX10002017-005]; National Science Foundation of China [81201781]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Programme of Guangzhou Municipal Government; Supported Foundation of Science and Technology Innovation of Zengcheng; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National 12th Five-Year Science and Technology Plan Major Projects of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported as follows: Study design, data collection and analysis-Guangdong Natural Science Foundation(No. 10451130001004472, No. S2013010016023), Science and Technology Programme of Guangzhou Municipal Government(No. 2013J4100081), and the Supported Foundation of Science and Technology Innovation of Zengcheng (No. ZC201004); decision to publish, or preparation of the manuscript-National Natural Science Foundation of China (No. 81000959), Science and Technology Planning Project of Guangdong Province, China (No. 2009B030801007), The Fundamental Research Funds for the Central Universities(No. 12ykpy47), National 12th Five-Year Science and Technology Plan Major Projects of China (No. 2012ZX10002017-005), and the Youth Project of National Science Foundation of China (No. 81201781).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chan DW, 2012, ONCOTARGET, V3, P1546; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Gao B, 2013, BIOMED PHAR IN PRESS; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Katoh M, 2002, INT J MOL MED, V9, P363; Katoh Y, 2005, ONCOL REP, V14, P797; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lei JY, 2012, J GASTROINTEST SURG, V16, P2120, DOI 10.1007/s11605-012-2019-y; Li B, 2012, PATHOL ONCOL RES, V18, P1039, DOI 10.1007/s12253-012-9542-8; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Markou A, 2011, CLIN CHEM LAB MED, V49, P1591, DOI 10.1515/CCLM.2011.661; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Takayama T, 2011, JPN J CLIN ONCOL, V41, P447, DOI 10.1093/jjco/hyr016; Tivnan A, 2010, ANTICANCER RES, V30, P4391; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Willatt JM, 2012, CANCER IMAGING, V12, P79, DOI 10.1102/1470-7330.2012.0011; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xu Y, 2013, PLOS ONE, V8; Zhang Y, 2009, CANCER LETT, V277, P29, DOI 10.1016/j.canlet.2008.11.014	36	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88796	10.1371/journal.pone.0088796	http://dx.doi.org/10.1371/journal.pone.0088796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558429	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700075
J	Marshall, JM; Flechtner, AD; La Perle, KM; Gunn, JS				Marshall, Joanna M.; Flechtner, Alan D.; La Perle, Krista M.; Gunn, John S.			Visualization of Extracellular Matrix Components within Sectioned Salmonella Biofilms on the Surface of Human Gallstones	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; O-ANTIGEN CAPSULE; COMMON BILE-DUCT; ELECTRON-MICROSCOPY; PIGMENT GALLSTONES; ESCHERICHIA-COLI; CHOLESTEROL STONES; TYPHOID-FEVER; CARRIER STATE; IDENTIFICATION	Chronic carriage of Salmonella Typhi is mediated primarily through the formation of bacterial biofilms on the surface of cholesterol gallstones. Biofilms, by definition, involve the formation of a bacterial community encased within a protective macromolecular matrix. Previous work has demonstrated the composition of the biofilm matrix to be complex and highly variable in response to altered environmental conditions. Although known to play an important role in bacterial persistence in a variety of contexts, the Salmonella biofilm matrix remains largely uncharacterized under physiological conditions. Initial attempts to study matrix components and architecture of the biofilm matrix on gallstone surfaces were hindered by the auto-fluorescence of cholesterol. In this work we describe a method for sectioning and direct visualization of extracellular matrix components of the Salmonella biofilm on the surface of human cholesterol gallstones and provide a description of the major matrix components observed therein. Confocal micrographs revealed robust biofilm formation, characterized by abundant but highly heterogeneous expression of polysaccharides such as LPS, Vi and O-antigen capsule. CsgA was not observed in the biofilm matrix and flagellar expression was tightly restricted to the biofilm-cholesterol interface. Images also revealed the presence of preexisting Enterobacteriaceae encased within the structure of the gallstone. These results demonstrate the use and feasibility of this method while highlighting the importance of studying the native architecture of the gallstone biofilm. A better understanding of the contribution of individual matrix components to the overall biofilm structure will facilitate the development of more effective and specific methods to disrupt these bacterial communities.	[Marshall, Joanna M.; Gunn, John S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Flechtner, Alan D.; La Perle, Krista M.] Ohio State Univ, Dept Vet Biosci Comparat Pathol & Mouse Phenotypi, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gunn, JS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	gunn.43@osu.edu	La Perle, Krista Marie DuBray/B-3099-2015	Marshall, Joanna/0000-0002-5829-9688	NIH T32 Graduate Research Fellowship [AI65411-5]; US National Institutes of Health [AI066208, P30 CA016058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066208, R56AI109002, T32AI065411] Funding Source: NIH RePORTER	NIH T32 Graduate Research Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an NIH T32 Graduate Research Fellowship (AI65411-5 to JMM) and grants from the US National Institutes of Health (AI066208 to JSG and P30 CA016058 to KML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson EK, 2013, CHEM BIOL, V20, P5, DOI 10.1016/j.chembiol.2013.01.004; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Bhutta ZA, 2009, JAMA-J AM MED ASSOC, V302, P898, DOI 10.1001/jama.2009.1259; Brandstetter KA, 2013, LARYNGOSCOPE; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; CETTA F, 1995, DIGEST DIS SCI, V40, P2189, DOI 10.1007/BF02209004; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Csendes A, 1996, ARCH SURG-CHICAGO, V131, P389; DIEHL AK, 1995, AM J GASTROENTEROL, V90, P967; DOLGIN SM, 1981, NEW ENGL J MED, V304, P808, DOI 10.1056/NEJM198104023041402; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Giannella R, 2010, SLEISENGER FORTRANS; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hazrah P, 2004, HPB (Oxford), V6, P28, DOI 10.1080/13651820310025192; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; KAUFMAN HS, 1989, ANN SURG, V209, P584, DOI 10.1097/00000658-198905000-00011; Kawai M, 2002, AM J GASTROENTEROL, V97, P83; Kim IS, 2003, YONSEI MED J, V44, P561, DOI 10.3349/ymj.2003.44.4.561; Kurtin W E, 2000, Int J Surg Investig, V2, P299; LAI CW, 1992, AM J GASTROENTEROL, V87, P1198; Lambou-Gianoukos S, 2008, SURG CLIN N AM, V88, P1175, DOI 10.1016/j.suc.2008.07.009; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; LEUNG JWC, 1989, J CLIN MICROBIOL, V27, P915, DOI 10.1128/JCM.27.5.915-921.1989; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Maurer KJ, 2009, GASTROENTEROLOGY, V136, P425, DOI 10.1053/j.gastro.2008.12.031; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; MERSELIS JG, 1964, AM J TROP MED HYG, V13, P425, DOI 10.4269/ajtmh.1964.13.425; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Morosini MI, 2010, J ANTIMICROB CHEMOTH, V65, P1545, DOI 10.1093/jac/dkq168; Parry CM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-107; Prouty AM, 2004, FEMS IMMUNOL MED MIC, V41, P177, DOI 10.1016/j.femsim.2004.03.002; Prouty AM, 2003, INFECT IMMUN, V71, P7154, DOI 10.1128/IAI.71.12.7154-7158.2003; Prouty AM, 2002, J BACTERIOL, V184, P1270, DOI 10.1128/JB.184.5.1270-1276.2002; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Qiao T, 2013, MICROSC RES TECHNIQ, V76, P443, DOI 10.1002/jemt.22185; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; Ristori C, 1982, Bull Pan Am Health Organ, V16, P361; Romling U, 1998, MOL MICROBIOL, V28, P249, DOI 10.1046/j.1365-2958.1998.00791.x; Romling U, 1998, J BACTERIOL, V180, P722; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546; Speranza B, 2011, J FOOD SCI, V76, pM12, DOI 10.1111/j.1750-3841.2010.01936.x; STEWART L, 1987, ANN SURG, V206, P242, DOI 10.1097/00000658-198709000-00002; Stewart L, 2002, J GASTROINTEST SURG, V6, P891, DOI 10.1016/S1091-255X(02)00035-5; Stewart L, 2007, J GASTROINTEST SURG, V11, P977, DOI 10.1007/s11605-007-0168-1; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; SWIDSINSKI A, 1995, GASTROENTEROLOGY, V108, P860, DOI 10.1016/0016-5085(95)90461-1; Vanhoof R, 2012, EUR J CLIN MICROBIOL, V31, P491, DOI 10.1007/s10096-011-1336-5; Venneman NG, 2010, GASTROENTEROL CLIN N, V39, P171, DOI 10.1016/j.gtc.2010.02.010; Villarreal JV, 2013, J MICROBIOL METH, V94, P161, DOI 10.1016/j.mimet.2013.06.009; Wang SW, 2013, ENVIRON MICROBIOL, V15, P2238, DOI 10.1111/1462-2920.12095; White AP, 2003, J BACTERIOL, V185, P5398, DOI 10.1128/JB.185.18.5398-5407.2003; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	63	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89243	10.1371/journal.pone.0089243	http://dx.doi.org/10.1371/journal.pone.0089243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551241	gold, Green Submitted, Green Published			2022-12-25	WOS:000331271500106
J	Quesada-Moraga, E; Lopez-Diaz, C; Landa, BB				Quesada-Moraga, Enrique; Lopez-Diaz, Cristina; Beatriz Landa, Blanca			The Hidden Habit of the Entomopathogenic Fungus Beauveria bassiana: First Demonstration of Vertical Plant Transmission	PLOS ONE			English	Article							ENDOPHYTES; PATHOGENS; DIVERSITY; STRAIN	Beauveria bassiana strain 04/01-Tip, obtained from a larva of the opium poppy stem gall wasp Iraella luteipes (Hymenoptera; Cynipidae), endophytically colonizes opium poppy (Papaver somniferum L.) plants and protects them against this pest. The goal of this study was to monitor the dynamics of endophytic colonization of opium poppy by B. bassiana after the fungus was applied to the seed and to ascertain whether the fungus is transmitted vertically via seeds. Using a species-specific nested PCR protocol and DNA extracted from surface-sterilised leaf pieces or seeds of B. bassiana-inoculated opium poppy plants, the fungus was detected within the plant beginning at the growth stage of rosette building and them throughout the entire plant growth cycle (about 120-140 days after sowing). The fungus was also detected in seeds from 50% of the capsules sampled. Seeds that showed positive amplification for B. bassiana were planted in sterile soil and the endophyte was again detected in more than 42% of the plants sampled during all plant growth stages. Beauveria bassiana was transmitted to seeds in 25% of the plants from the second generation that formed a mature capsule. These results demonstrate for the first time the vertical transmission of an entomopathogenic fungus from endophytically colonised maternal plants. This information is crucial to better understand the ecological role of entomopathogenic fungi as plant endophytes and may allow development of a sustainable and cost effective strategy for I. luteipes management in P. somniferum.	[Quesada-Moraga, Enrique; Lopez-Diaz, Cristina] Univ Cordoba, Agr & Forestry Engn Sch, Dept Agr & Forest Sci & Resources, Cordoba, Spain; [Beatriz Landa, Blanca] Spanish Natl Res Council, Inst Sustainable Agr, Cordoba, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Quesada-Moraga, E (corresponding author), Univ Cordoba, Agr & Forestry Engn Sch, Dept Agr & Forest Sci & Resources, Cordoba, Spain.	equesada@uco.es	QUESADA-MORAGA, ENRIQUE/K-3419-2014; Landa, Blanca B/K-9629-2014	QUESADA-MORAGA, ENRIQUE/0000-0003-4021-3900; Landa, Blanca B/0000-0002-9511-3731; Lopez- Diaz, Cristina/0000-0002-7532-163X	Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia, Spain [AGR-7681]	Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia, Spain(Junta de Andalucia)	This research was supported by project AGR-7681 from the Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia, Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; Giordano L, 2013, MYCOL PROG, V12, P127, DOI 10.1007/s11557-012-0822-1; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Landa BB, 2013, J INVERTEBR PATHOL, V114, P128, DOI 10.1016/j.jip.2013.06.007; Landa BB, 2007, PHYTOPATHOLOGY, V97, P1380, DOI 10.1094/PHYTO-97-11-1380; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Quesada-Moraga E, 2006, MYCOPATHOLOGIA, V161, P323, DOI 10.1007/s11046-006-0014-0; Quesada-Moraga E, 2009, ENVIRON ENTOMOL, V38, P723, DOI 10.1603/022.038.0324; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zabalgogeazcoa I, 2008, SPAN J AGRIC RES, V6, P138, DOI 10.5424/sjar/200806S1-382	15	62	68	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89278	10.1371/journal.pone.0089278	http://dx.doi.org/10.1371/journal.pone.0089278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551242	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500107
J	Ruther, J; McCaw, J; Bocher, L; Pothmann, D; Putz, I				Ruther, Joachim; McCaw, Jennifer; Boecher, Lisa; Pothmann, Daniela; Putz, Irina			Pheromone Diversification and Age-Dependent Behavioural Plasticity Decrease Interspecific Mating Costs in Nasonia	PLOS ONE			English	Article							LOCAL MATE COMPETITION; MALE SEX-PHEROMONE; JEWEL WASP NASONIA; PARASITIC WASP; VITRIPENNIS HYMENOPTERA; NATURAL-POPULATIONS; NORTH-AMERICA; RATIO; PTEROMALIDAE; FEMALES	Interspecific mating can cause severe fitness costs due to the fact that hybrids are often non-viable or less fit. Thus, theory predicts the selection of traits that lessen reproductive interactions between closely related sympatric species. Males of the parasitic wasp Nasonia vitripennis differ from all other Nasonia species by an additional sex pheromone component, but the ecological selective forces underlying this pheromone diversification are unknown. Here we present data from lab experiments suggesting that costly interspecific sexual interactions with the sympatric species N. giraulti might have been responsible for the pheromone evolution and some courtship-related behavioural adaptations in N. vitripennis. Most N. giraulti females are inseminated already within the host, but N. giraulti males still invest in costly sex pheromones after emergence. Furthermore, they do not discriminate between N. vitripennis females and conspecifics during courtship. Therefore, N. vitripennis females, most of which emerge as virgins, face the risk of mating with N. giraulti resulting in costly all-male broods due to Wolbachia-induced cytoplasmic incompatibility. As a counter adaptation, young N. vitripennis females discriminate against N. giraulti males using the more complex conspecific sex pheromone and reject most of them during courtship. With increasing age, however, N. vitripennis females become less choosy, but often compensate mating errors by re-mating with a conspecific. By doing so, they can principally avoid suboptimal offspring sex ratios, but a microcosm experiment suggests that under more natural conditions N. vitripennis females cannot completely avoid fitness costs due to heterospecific mating. Our study provides support for the hypothesis that communication interference of closely related sympatric species using similar sexual signals can generate selective pressures that lead to their divergence.	[Ruther, Joachim; McCaw, Jennifer; Boecher, Lisa; Pothmann, Daniela; Putz, Irina] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany	University of Regensburg	Ruther, J (corresponding author), Univ Regensburg, Inst Zool, Univ Str 31, D-93053 Regensburg, Germany.	joachim.ruther@biologie.uni-regensburg.de	Ruther, Joachim/AAE-3568-2019	Ruther, Joachim/0000-0002-1295-347X	Deutsch Forschungsgemeinschaft (DFG);  [RU 717/10-2]	Deutsch Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	This research was funded by the Deutsch Forschungsgemeinschaft (DFG) (http://www.dfg.de/); grant RU 717/10-2 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bordenstein SR, 1998, GENETICS, V148, P1833; Bordenstein SR, 2000, EVOLUTION, V54, P567, DOI 10.1111/j.0014-3820.2000.tb00059.x; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; Buellesbach J, 2013, J EVOLUTION BIOL, V26, P2467, DOI 10.1111/jeb.12242; Burton-Chellew MN, 2008, AM NAT, V172, P393, DOI 10.1086/589895; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; DARLING DC, 1990, ANN ENTOMOL SOC AM, V83, P352, DOI 10.1093/aesa/83.3.352; Drapeau MD, 1999, EVOL ECOL RES, V1, P223; ElSayed A.M., 2013, PHEROBASE DATABASE P; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; Grillenberger BK, 2009, J EVOLUTION BIOL, V22, P460, DOI 10.1111/j.1420-9101.2008.01677.x; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; KING B, 1993, J INSECT BEHAV, V6, P313, DOI 10.1007/BF01048112; King BH, 2000, ENVIRON ENTOMOL, V29, P927, DOI 10.1603/0046-225X-29.5.927; Klein AL, 2012, J ARACHNOL, V40, P138, DOI 10.1636/H11-31.1; Marshall JL, 2002, TRENDS ECOL EVOL, V17, P558, DOI 10.1016/S0169-5347(02)02636-8; Mautz BS, 2008, J INSECT BEHAV, V21, P203, DOI 10.1007/s10905-008-9120-9; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; Niehuis O, 2013, NATURE, V494, P345, DOI 10.1038/nature11838; Raychoudhury R, 2010, HEREDITY, V104, P278, DOI 10.1038/hdy.2009.147; Raychoudhury R, 2010, HEREDITY, V104, P318, DOI 10.1038/hdy.2009.160; Ruther J., 2013, CHEM ECOLOGY INSECT, P112; Ruther J, 2008, J CHEM ECOL, V34, P99, DOI 10.1007/s10886-007-9411-1; Ruther J, 2007, J EXP BIOL, V210, P2163, DOI 10.1242/jeb.02789; Ruther J, 2010, ANIM BEHAV, V80, P1035, DOI 10.1016/j.anbehav.2010.09.008; Ruther J, 2009, P ROY SOC B-BIOL SCI, V276, P3303, DOI 10.1098/rspb.2009.0738; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shuker DM, 2004, P NATL ACAD SCI USA, V101, P10363, DOI 10.1073/pnas.0308034101; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Steiger S, 2010, P ROY SOC LOND B BIO, P970, DOI DOI 10.1098/RSPB.2010.2285; Steiner S, 2006, J CHEM ECOL, V32, P1687, DOI 10.1007/s10886-006-9102-3; Steiner S, 2009, BEHAV ECOL, V20, P570, DOI 10.1093/beheco/arp033; Tanner ME, 2002, ACCOUNTS CHEM RES, V35, P237, DOI 10.1021/ar000056y; Tinghitella RM, 2013, ECOL EVOL, V3, P2820, DOI 10.1002/ece3.666; van de Zande L, 2014, MOL ECOL RESOUR, V14, P578, DOI 10.1111/1755-0998.12201; VANDENASSEM J, 1980, BEHAVIOUR, V75, P301, DOI 10.1163/156853980X00456; VANDENASSEM J, 1980, NETH J ZOOL, V30, P208, DOI 10.1163/002829679X00386; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; WERREN JH, 1983, EVOLUTION, V37, P116, DOI 10.1111/j.1558-5646.1983.tb05520.x; WERREN JH, 1980, SCIENCE, V208, P1157, DOI 10.1126/science.208.4448.1157; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028	44	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89214	10.1371/journal.pone.0089214	http://dx.doi.org/10.1371/journal.pone.0089214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551238	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500103
J	Tafuma, TA; Burnett, RJ; in 't Veld, DH				Tafuma, Taurayi A.; Burnett, Rosemary J.; in 't Veld, Diana Huis			National Guidelines Not Always Followed When Diagnosing Smear-Negative Pulmonary Tuberculosis in Patients with HIV in Botswana	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; MICROSCOPY; INFECTION; SETTINGS	Background: Diagnosis of smear negative pulmonary tuberculosis (SNPTB) is challenging, especially in patients with HIV. The Botswana National Tuberculosis Program (BNTP) guidelines give guidance in diagnosing and treating SNPTB. Patients with chronic cough should be screened for TB by 3 sputum smear investigations. If negative, a chest x-ray (CXR) should be performed. If negative for TB, antimicrobial treatment for other infections should be started. We investigated the clinicians' use of the guidelines in clinical practice. Methods: Data regarding the medical history (coughing period), requested and conducted investigations concerning tuberculosis diagnosis (sputum smear or culture or CXR) or alternative diagnoses (sputum microscopy or blood or sputum culture for diagnosis of other organisms), in SNPTB HIV-positive patients (outpatients and admitted patients) from 2006-2009 in a district hospital in Botswana were extracted from all available hospital medical records. Additionally, a survey was done in all doctors diagnosing SNPTB in this hospital using a self-administered questionnaire with questions regarding the application of the BNTP guidelines in practice. Descriptive analyses of collected data were performed to test the compliance to the guidelines. Results: Data from medical records showed that in 47.0% (132/281) of patients, TB treatment was started without microbiological results from sputum smears. Other methods to rule out or confirm PTB were used in 2.1% (6/281); and 99.6% (280/281) of SNPTB patients had received a CXR. The survey in 7 clinicians found that all always used CXR, and all clinicians requested three sputum results only sometimes. Six out of 7 clinicians started antibiotics before starting TB treatment. Reasons clinicians gave for difficulties in following the guidelines included inability of patients to produce sputum; and laboratory delays in releasing sputum results. Conclusion: Between 2006 and 2009 a high proportion of SNPTB diagnoses in a district hospital in Botswana were not supported by laboratory investigation.	[Tafuma, Taurayi A.] Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana; [Burnett, Rosemary J.] Univ Limpopo, Dept Publ Hlth, Pretoria, South Africa; [in 't Veld, Diana Huis] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [in 't Veld, Diana Huis] FWO Res Fdn Flanders, Brussels, Belgium	University of Limpopo; University of Antwerp	Tafuma, TA (corresponding author), Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana.	tauadd@gmail.com		Burnett, Rosemary/0000-0003-1346-1570				Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Central Statistics Office, 2008, BOTSW AIDS IMP SURV; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Gearing RE, 2006, J CAN ACAD CHILD ADO, V15, P126; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Harries AD, 1998, B WORLD HEALTH ORGAN, V76, P651; Huebner RE, 1997, INT J TUBERC LUNG D, V1, P333; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Matee M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-68; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; MESFIN MM, 2003, ETHIOP J HEALTH DEV, V19, P13; Morse M, 2008, INT J TUBERC LUNG D, V12, P1279; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; 2007, BOTSWANA NATL TB PRO	17	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88654	10.1371/journal.pone.0088654	http://dx.doi.org/10.1371/journal.pone.0088654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551128	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500053
J	Chen, HJ; Chen, CY				Chen, Hwajiun; Chen, Chun-Yao			Starvation Induces Phenotypic Diversification and Convergent Evolution in Vibrio vulnificus	PLOS ONE			English	Article							LONG-TERM SURVIVAL; STATIONARY-PHASE; GROWTH ADVANTAGE; ESCHERICHIA-COLI; NONCULTURABLE STATE; REGULATORY MUTATIONS; RESUSCITATION; TEMPERATURE; CULTURES; PATHOGEN	Starvation is a common stress experienced by bacteria living in natural environments and the ability to adapt to and survive intense stress is of paramount importance for any bacterial population. A series of starvation experiments were conducted using V. vulnificus 93U204 in phosphate-buffered saline and seawater. The starved population entered the death phase during the first week and approximately 1% of cells survived. After that the population entered a long-term stationary phase, and could survive for years. Starvation-induced diversification (SID) of phenotypes was observed in starved populations and phenotypic variants (PVs) appeared in less than 8 days. The cell density, rather than the population size, had a major effect on the extent of SID. SID was also observed in strain YJ016, where it evolved at a faster pace. PVs appeared to emerge in a fixed order: PV with reduced motility, PV with reduced proteolytic activity, and PV with reduced hemolytic activity. All of the tested PVs had growth advantages in the stationary phase phenotypes and increased fitness compared with 93U204 cells in co-culture competition experiments, which indicates that they had adapted to starvation. We also found that SID occurred in natural seawater with a salinity of 1%-3%, so this mechanism may facilitate bacterial adaptation in natural environments.	[Chen, Hwajiun; Chen, Chun-Yao] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chen, Hwajiun; Chen, Chun-Yao] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	Tzu Chi University; Tzu Chi University	Chen, CY (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	cychen@mail.tcu.edu.tw		Chen, Chun-Yao/0000-0002-5028-8319	National Science Council [NSC96-2311-B-320-004]; Tzu Chi University [TCIRP96003-01]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University	National Science Council grant NSC96-2311-B-320-004, (http://web1.nsc.gov.tw/). Tzu Chi University grant TCIRP96003-01, (http://www.tcu.edu.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel BKN, 2008, MICROBIOL RES, V163, P323, DOI 10.1016/j.micres.2006.06.006; AMY PS, 1983, APPL ENVIRON MICROB, V45, P1109, DOI 10.1128/AEM.45.3.1109-1115.1983; Arias CR, 1998, APPL ENVIRON MICROB, V64, P3403; Bacun-Druzina V, 2007, FEMS MICROBIOL LETT, V266, P119, DOI 10.1111/j.1574-6968.2006.00515.x; Biosca EG, 1996, APPL ENVIRON MICROB, V62, P450, DOI 10.1128/AEM.62.2.450-455.1996; Chen C, 2005, THESIS CHUNG SHAN ME; Chen CY, 2006, J WORLD AQUACULT SOC, V37, P82, DOI 10.1111/j.1749-7345.2006.00010.x; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Chen SY, 2009, INT J FOOD MICROBIOL, V129, P157, DOI 10.1016/j.ijfoodmicro.2008.11.009; Dalsgaard I, 1999, DIS AQUAT ORGAN, V35, P187, DOI 10.3354/dao035187; Daniels NA, 2011, CLIN INFECT DIS, V52, P788, DOI 10.1093/cid/ciq251; DEATH A, 1993, J BACTERIOL, V175, P1475, DOI 10.1128/JB.175.5.1475-1483.1993; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Fouz B, 2006, J FISH DIS, V29, P285, DOI 10.1111/j.1365-2761.2006.00719.x; Gonzalez C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000208; Gonzalez-Escalona N, 2006, ENVIRON MICROBIOL, V8, P658, DOI 10.1111/j.1462-2920.2005.00943.x; Gopal S, 2005, INT J FOOD MICROBIOL, V102, P151, DOI 10.1016/j.ijfoodmicro.2004.12.011; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Helmus RA, 2012, FEMS MICROBIOL ECOL, V79, P218, DOI 10.1111/j.1574-6941.2011.01211.x; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; HILL WE, 1991, APPL ENVIRON MICROB, V57, P707, DOI 10.1128/AEM.57.3.707-711.1991; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kim SM, 2012, MICROBIOL-SGM, V158, P2017, DOI 10.1099/mic.0.059071-0; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Mahmud ZH, 2010, APPL ENVIRON MICROB, V76, P4890, DOI 10.1128/AEM.00636-10; Marco-Noales E, 1999, APPL ENVIRON MICROB, V65, P1117; Martinez-Rodriguez A, 2004, INT J FOOD MICROBIOL, V90, P321, DOI 10.1016/S0168-1605(03)00325-8; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Notley-McRobb L, 2000, GENETICS, V156, P1493; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Notley-McRobb L, 2003, P ROY SOC B-BIOL SCI, V270, P843, DOI 10.1098/rspb.2002.2295; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2620, DOI 10.1128/AEM.61.7.2620-2623.1995; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2624, DOI 10.1128/AEM.61.7.2624-2630.1995; OSTLING J, 1995, J BACTERIOL, V177, P6978, DOI 10.1128/jb.177.23.6978-6982.1995; Park KJ, 2004, J BACTERIOL, V186, P3304, DOI 10.1128/JB.186.11.3304-3312.2004; Paul K, 2004, INFECT IMMUN, V72, P5478, DOI 10.1128/IAI.72.9.5478-5482.2004; Petrun B, 2013, CAN J MICROBIOL, V59, P130, DOI 10.1139/cjm-2012-0439; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Silby MW, 2005, APPL ENVIRON MICROB, V71, P569, DOI 10.1128/AEM.71.1.569-573.2005; Smith B, 2006, APPL ENVIRON MICROB, V72, P1445, DOI 10.1128/AEM.72.2.1445-1451.2006; Stretton S, 1997, FEMS MICROBIOL LETT, V146, P23, DOI 10.1016/S0378-1097(96)00387-4; Tark M, 2005, J BACTERIOL, V187, P5203, DOI 10.1128/JB.187.15.5203-5213.2005; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Vattakaven T, 2006, APPL ENVIRON MICROB, V72, P6508, DOI 10.1128/AEM.00798-06; Wei XM, 1998, APPL ENVIRON MICROB, V64, P1708; Wong HC, 2005, J FOOD PROTECT, V68, P154, DOI 10.4315/0362-028X-68.1.154; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x	57	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88658	10.1371/journal.pone.0088658	http://dx.doi.org/10.1371/journal.pone.0088658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551129	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000049
J	Hosokawa, T; Nikoh, N; Fukatsu, T				Hosokawa, Takahiro; Nikoh, Naruo; Fukatsu, Takema			Fine-Scale Geographical Origin of an Insect Pest Invading North America	PLOS ONE			English	Article							HEMIPTERA HETEROPTERA PLATASPIDAE	Invasive species may rapidly spread throughout new areas once introduced, which may potentially lead to serious damage to local fauna and flora. Information on geographical origins, introduction routes, and biology in native regions of such invasive species is of critical importance in identifying means of transport, preventing reintroduction, and establishing control/eradication methods. The plataspid stinkbug Megacopta cribraria, known as kudzu bug, recently invaded North America and now has become not only an agricultural pest of soybean but also a nuisance pest. Here we investigate the geographical origin of the invasive M. cribraria populations. Phylogeographical analyses based on 8.7 kb mitochondrial DNA sequences of the introduced and East Asian native Megacopta populations identified a well-supported clade consisting of the introduced populations and M. punctatissima populations in the Kyushu region of Japan, which strongly suggests that the invading M. cribraria populations are derived from a M. punctatissima population in the Kyushu region. Therefore, the region is proposed as a promising source of natural enemies for biological control of the invasive pest. Based on the phylogenetic information, relationship and treatment of the two Megacopta species are discussed.	[Hosokawa, Takahiro; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hosokawa, T (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 90301, Japan.	h133053@comb.u-ryukyu.ac.jp		Hosokawa, Takahiro/0000-0001-7618-1774	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	This study was financially supported by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AMV, 2014, MOL ECOL, V23, P1516, DOI 10.1111/mec.12366; Eger J.E. Jr., 2010, Insecta Mundi, V0121, P1; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Gardner WA, 2013, J ENTOMOL SCI, V48, P118; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Ishikawa T, 2012, TERRESTRIAL HETEROPT, V3; Jenkins Tracie M., 2011, Insects, V2, P264, DOI 10.3390/insects2030264; Jenkins TM, 2010, J ENTOMOL SCI, V45, P62, DOI 10.18474/0749-8004-45.1.62; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Montandon A. L., 1896, Annales de la Societe Entomologique de Belgique, Vxl, P86; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruberson JR, 2013, APPL ENTOMOL ZOOL, V48, P3, DOI 10.1007/s13355-012-0146-2; Sax D. F., 2005, SPECIES INVASIONS IN; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suiter DR, 2010, J INTEGR PEST MANAG, V1, DOI 10.1603/IPM10009; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tomokuni M, 1993, FIELD GUIDE JAPANESE; YANG WE-I, 1934, BULL FAN MEM INST BIOL [ZOOL], V5, P137	20	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89107	10.1371/journal.pone.0089107	http://dx.doi.org/10.1371/journal.pone.0089107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551228	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000102
J	DiDonato, JA; Aulak, K; Huang, Y; Wagner, M; Gerstenecker, G; Topbas, C; Gogonea, V; DiDonato, AJ; Tang, WHW; Mehl, RA; Fox, PL; Plow, EF; Smith, JD; Fisher, EA; Hazen, SL				DiDonato, Joseph A.; Aulak, Kulwant; Huang, Ying; Wagner, Matthew; Gerstenecker, Gary; Topbas, Celalettin; Gogonea, Valentin; DiDonato, Anthony J.; Tang, W. H. Wilson; Mehl, Ryan A.; Fox, Paul L.; Plow, Edward F.; Smith, Jonathan D.; Fisher, Edward A.; Hazen, Stanley L.			Site-specific Nitration of Apolipoprotein A-I at Tyrosine 166 Is Both Abundant within Human Atherosclerotic Plaque and Dysfunctional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl-tRNA Synthetase; Apolipoproteins; Atherosclerosis; Peroxidase; Post-translational Modification; Dysfunctional HDL; Nitrotyrosine; Orthogonal Amino Acid; Protein Nitration; Unnatural Amino Acid (uAA)	HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; MYELOPEROXIDASE-CATALYZED OXIDATION; RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; ESCHERICHIA-COLI; STATIN THERAPY; HUMAN ATHEROMA; HEART-DISEASE	Background: The functional importance of apolipoprotein A-I (apoA-I) nitration at tyrosine 166 (Tyr(166)) in vivo is controversial. Results: Nitrotyrosine 166-apoA-I accounts for 8% of apoA-I within human atheroma, is not HDL-associated, and is functionally impaired. Conclusion: Buoyant density ultracentrifugation of HDL can lead to erroneous results, particularly with modified apoA-I forms. Significance: Detection and quantification of nitrotyrosine 166-apoA-I may provide insights into a pathophysiological process within the artery wall. We reported previously that apolipoprotein A-I (apoA-I) is oxidatively modified in the artery wall at tyrosine 166 (Tyr(166)), serving as a preferred site for post-translational modification through nitration. Recent studies, however, question the extent and functional importance of apoA-I Tyr(166) nitration based upon studies of HDL-like particles recovered from atherosclerotic lesions. We developed a monoclonal antibody (mAb 4G11.2) that recognizes, in both free and HDL-bound forms, apoA-I harboring a 3-nitrotyrosine at position 166 apoA-I (NO2-Tyr(166)-apoA-I) to investigate the presence, distribution, and function of this modified apoA-I form in atherosclerotic and normal artery wall. We also developed recombinant apoA-I with site-specific 3-nitrotyrosine incorporation only at position 166 using an evolved orthogonal nitro-Tyr-aminoacyl-tRNA synthetase/tRNA(CUA) pair for functional studies. Studies with mAb 4G11.2 showed that NO2-Tyr(166)-apoA-I was easily detected in atherosclerotic human coronary arteries and accounted for approximate to 8% of total apoA-I within the artery wall but was nearly undetectable (>100-fold less) in normal coronary arteries. Buoyant density ultracentrifugation analyses showed that NO2-Tyr(166)-apoA-I existed as a lipid-poor lipoprotein with <3% recovered within the HDL-like fraction (d = 1.063-1.21). NO2-Tyr(166)-apoA-I in plasma showed a similar distribution. Recovery of NO2-Tyr(166)-apoA-I using immobilized mAb 4G11.2 showed an apoA-I form with 88.1 +/- 8.5% reduction in lecithin-cholesterol acyltransferase activity, a finding corroborated using a recombinant apoA-I specifically designed to include the unnatural amino acid exclusively at position 166. Thus, site-specific nitration of apoA-I at Tyr(166) is an abundant modification within the artery wall that results in selective functional impairments. Plasma levels of this modified apoA-I form may provide insights into a pathophysiological process within the diseased artery wall.	[DiDonato, Joseph A.; Aulak, Kulwant; Huang, Ying; Wagner, Matthew; Gerstenecker, Gary; Topbas, Celalettin; Gogonea, Valentin; DiDonato, Anthony J.; Tang, W. H. Wilson; Fox, Paul L.; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Tang, W. H. Wilson; Plow, Edward F.; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [DiDonato, Joseph A.; Huang, Ying; Tang, W. H. Wilson; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Gerstenecker, Gary; Topbas, Celalettin; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44118 USA; [DiDonato, Anthony J.] John Carroll Univ, Dept Psychol, University Hts, OH 44118 USA; [Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Fisher, Edward A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; John Carroll University; Oregon State University; New York University; New York University	DiDonato, JA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	didonaj@ccf.org; hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Fisher, Edward/ABE-7469-2020; Tang, Wai Hong Wilson/I-1238-2013; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Tang, W. H. Wilson/0000-0002-8335-735X; Fisher, Edward/0000-0001-9802-143X	AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL103931, P01HL076491, R01HL017964] Funding Source: NIH RePORTER	AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mass spectrometry studies were performed within the Lerner Research Institute mass spectrometry facility, which is partially supported through a Center of Innovation award by AB SCIEX.	BADIMON JJ, 1989, LAB INVEST, V60, P455; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hewing B., 2014, ARTERIOSCLER THROMB, DOI [10.1161/ATVBAHA.113.303044, DOI 10.1161/ATVBAHA. 113. 303044]; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Hughes SD, 1997, ARTERIOSCL THROM VAS, V17, P1725, DOI 10.1161/01.ATV.17.9.1725; Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Navab M, 2002, CURR OPIN LIPIDOL, V13, P363, DOI 10.1097/00041433-200208000-00003; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Parks JS, 1999, METH MOL B, V109, P123; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Samuelson J. C., 2013, ENZYME ENG, P93; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; Viera L, 1999, METHOD ENZYMOL, V301, P373; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	59	75	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10276	10292		10.1074/jbc.M114.556506	http://dx.doi.org/10.1074/jbc.M114.556506			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558038	Green Published, hybrid			2022-12-25	WOS:000334226400005
J	Sterner, E; Masuko, S; Li, GY; Li, LY; Green, DE; Otto, NJ; Xu, YM; DeAngelis, PL; Liu, J; Dordick, JS; Linhardt, RJ				Sterner, Eric; Masuko, Sayaka; Li, Guoyun; Li, Lingyun; Green, Dixy E.; Otto, Nigel J.; Xu, Yongmei; DeAngelis, Paul L.; Liu, Jian; Dordick, Jonathan S.; Linhardt, Robert J.			Fibroblast Growth Factor-based Signaling through Synthetic Heparan Sulfate Blocks Copolymers Studied Using High Cell Density Three-dimensional Cell Printing*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Glycosaminoglycan; Heparan Sulfate; Polysaccharide; Three-dimensional Cellular Printing; Block Copolymers; Fibroblast Growth Factors; Signaling Complex	CHEMOENZYMATIC SYNTHESIS; HEPARIN/HEPARAN SULFATE; RECEPTOR SPECIFICITY; HEPAROSAN SYNTHASES; TERNARY COMPLEXES; CRYSTAL-STRUCTURE; FACTOR FAMILY; FGF; OLIGOSACCHARIDES; BIOSYNTHESIS	Background: Fibroblast growth factor-receptor-heparan sulfate (FGF-HS-FGFR) signals cell proliferation. Results: HS synthesized with sulfated domains at its non-reducing ends actively promotes cellular proliferation in a three-dimensional cell microarray. Conclusion: A symmetric 2:2:2 FGF-HS-FGFR complex is preferred over an asymmetric 2:1:2 model by these data. Significance: This paper suggests a preference for symmetry in the signal transduction complex having two FGF-FGFR on the non-reducing end of two HS chains. Four well-defined heparan sulfate (HS) block copolymers containing S-domains (high sulfo group content) placed adjacent to N-domains (low sulfo group content) were chemoenzymatically synthesized and characterized. The domain lengths in these HS block co-polymers were approximate to 40 saccharide units. Microtiter 96-well and three-dimensional cell-based microarray assays utilizing murine immortalized bone marrow (BaF3) cells were developed to evaluate the activity of these HS block co-polymers. Each recombinant BaF3 cell line expresses only a single type of fibroblast growth factor receptor (FGFR) but produces neither HS nor fibroblast growth factors (FGFs). In the presence of different FGFs, BaF3 cell proliferation showed clear differences for the four HS block co-polymers examined. These data were used to examine the two proposed signaling models, the symmetric FGF(2)-HS2-FGFR(2) ternary complex model and the asymmetric FGF(2)-HS1-FGFR(2) ternary complex model. In the symmetric FGF(2)-HS2-FGFR(2) model, two acidic HS chains bind in a basic canyon located on the top face of the FGF(2)-FGFR(2) protein complex. In this model the S-domains at the non-reducing ends of the two HS proteoglycan chains are proposed to interact with the FGF(2)-FGFR(2) protein complex. In contrast, in the asymmetric FGF(2)-HS1-FGFR(2) model, a single HS chain interacts with the FGF(2)-FGFR(2) protein complex through a single S-domain that can be located at any position within an HS chain. Our data comparing a series of synthetically prepared HS block copolymers support a preference for the symmetric FGF(2)-HS2-FGFR(2) ternary complex model.	[Sterner, Eric; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Masuko, Sayaka; Li, Guoyun; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Mat Sci, Troy, NY 12180 USA; [Green, Dixy E.; Otto, Nigel J.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73126 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	linhar@rpi.edu			National Institutes of Health [HL62244, GM38060, HL096972, ES 020903, ES 018022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972, R01HL094463, R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020903, R41ES018022, R42ES018022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060, U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62244, GM38060, HL096972, ES 020903, and ES 018022.	Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; DeAngelis Paul L, 2013, Methods Mol Biol, V1022, P215, DOI 10.1007/978-1-62703-465-4_17; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661; GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; Hileman RE, 1997, GLYCOBIOLOGY, V7, P231; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Kusche-Gullberg M, 2012, J BIOL CHEM, V287, P21950, DOI 10.1074/jbc.M112.350389; Li GY, 2013, BIOPOLYMERS, V99, P675, DOI 10.1002/bip.22263; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu J, 2012, CURR OPIN STRUC BIOL, V22, P550, DOI 10.1016/j.sbi.2012.07.004; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Ly M, 2010, OMICS, V14, P389, DOI 10.1089/omi.2009.0123; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Masuko S, 2012, J ORG CHEM, V77, P1449, DOI 10.1021/jo202322k; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Meli L, 2012, BIOMATERIALS, V33, P9087, DOI 10.1016/j.biomaterials.2012.08.065; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Otto NJ, 2012, J BIOL CHEM, V287, P7203, DOI 10.1074/jbc.M111.311704; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Powell AK, 2002, J BIOL CHEM, V277, P28554, DOI 10.1074/jbc.M111754200; Puvirajesinghe TM, 2012, CHEM BIOL, V19, P553, DOI 10.1016/j.chembiol.2012.03.011; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; ROSENBERG RD, 1978, P NATL ACAD SCI USA, V75, P3065, DOI 10.1073/pnas.75.7.3065; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sterner E, 2013, BIOCHEMISTRY-US, V52, P9009, DOI 10.1021/bi401284r; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu YM, 2012, J BIOL CHEM, V287, P29054, DOI 10.1074/jbc.M112.358523; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	61	22	23	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9754	9765		10.1074/jbc.M113.546937	http://dx.doi.org/10.1074/jbc.M113.546937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563485	Green Published, hybrid			2022-12-25	WOS:000333807000027
J	Choudhury, BI; Khan, ML; Dayanandan, S				Choudhury, Baharul Islam; Khan, Mohammed Latif; Dayanandan, Selvadurai			Functional Androdioecy in Critically Endangered Gymnocladus assamicus (Leguminosae) in the Eastern Himalayan Region of Northeast India	PLOS ONE			English	Article							SEX-RATIOS; EVOLUTION; DIOECY; MAINTENANCE; POPULATIONS; GYNODIOECY; SYSTEMS	Gymnocladus assamicus is a critically endangered tree species endemic to Northeast India, and shows sexual dimorphism with male and hermaphrodite flowers on separate trees. We studied phenology, reproductive biology and mating system of the species. The flowers are small, tubular, odorless and last for about 96 hours. Pollen grains in both morphs were viable and capable of fertilization leading to fruit and seed set. Scanning electron micrographs revealed morphologically similar pollen in both male and hermaphrodite flowers. The fruit set in open pollinated flowers was 43.61 percent, while controlled autogamous and geitonogamous pollinations yielded 76.81 and 65.58 percent fruit set respectively. Xenogamous pollinations between male and hermaphrodite flowers resulted in 56.85 percent fruit set and pollinations between hermaphrodite flowers yielded 67.90 percent fruit set. This indicates a functionally androdioecious mating system and pollination limited fruit set in G. assamicus. Phylogenetic analyses of Gymnocladus and the sister genus Gleditsia are needed to assess if the androdioecious mating system in G. assamicus evolved from dioecy as a result of selection for hermaphrodites for reproductive assurance during colonization of pollination limited high altitude ecosystems.	[Choudhury, Baharul Islam; Dayanandan, Selvadurai] Concordia Univ, Forest & Evolutionary Genom Lab, Quebec City, PQ, Canada; [Choudhury, Baharul Islam; Dayanandan, Selvadurai] Concordia Univ, Ctr Struct & Funct Genom, Dept Biol, Quebec City, PQ, Canada; [Choudhury, Baharul Islam; Dayanandan, Selvadurai] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Choudhury, Baharul Islam; Khan, Mohammed Latif] North Eastern Reg Inst Sci & Technol, Dept Forestry, Nirjuli, Arunachal Prade, India	Concordia University - Canada; Concordia University - Canada; North Eastern Regional Institute of Science & Technology (NERIST)	Choudhury, BI (corresponding author), Concordia Univ, Forest & Evolutionary Genom Lab, Quebec City, PQ, Canada.	baharulchoudhury@gmail.com	KHAN, MOHAMMED LATIF/Q-7641-2019; Choudhury, Baharul I/AAU-9440-2020	KHAN, MOHAMMED LATIF/0000-0001-6849-0307; Choudhury, Baharul/0000-0002-6624-6439	Department of Science and Technology, New Delhi [SR/SO/PS-16/2002]; FRQNT; NSERC	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); FRQNT; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Department of Science and Technology, New Delhi (Sanction no. SR/SO/PS-16/2002) to M.L.K. Partial support of FRQNT and NSERC to BC and SD is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto J, 1999, AM J BOT, V86, P880, DOI 10.2307/2656708; Astrop TI, 2012, PALAEONTOL ELECTRON, V15; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 1998, TRENDS PLANT SCI, V3, P335, DOI 10.1016/S1360-1385(98)01299-0; Bawa K.S., 1983, P394; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; BAWA KS, 1981, ANN MO BOT GARD, V68, P254, DOI 10.2307/2398798; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Carlson JE, 2007, AM J BOT, V94, P674, DOI 10.3732/ajb.94.4.674; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; CHARLESWORTH D, 1984, BIOL J LINN SOC, V22, P333, DOI 10.1111/j.1095-8312.1984.tb01683.x; Chasnov JR, 2010, J EVOLUTION BIOL, V23, P539, DOI 10.1111/j.1420-9101.2009.01919.x; Choudhury B. I., 2007, Research Letters in Ecology, V2007, P59282, DOI 10.1155/2007/59282; Dafni A., 1992, POLLINATION ECOLOGY; Dai C, 2012, NEW PHYTOL, V193, P787, DOI 10.1111/j.1469-8137.2011.03966.x; Darwin C, 1877, EFFECTS CROSS SELF F; Delannay X, 1978, NATURALISTES BELGES, V99, P169; Dezhao C, 2010, FLORA CHINA, V10, P36; Dixon KW, 2009, SCIENCE, V325, P571, DOI 10.1126/science.1176295; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; FEINSINGER P, 1978, ECOL MONOGR, V48, P269, DOI 10.2307/2937231; FRITSCH P, 1992, NATURE, V359, P633, DOI 10.1038/359633a0; Heilbuth JC, 2000, AM NAT, V156, P221, DOI 10.1086/303389; Herendeen PS, 2003, INT J PLANT SCI, V164, pS393, DOI 10.1086/376881; LEE YT, 1976, J ARNOLD ARBORETUM, V57, P91, DOI 10.5962/bhl.part.28162; LISTON A, 1990, NATURE, V343, P641, DOI 10.1038/343641a0; LLOYD DG, 1975, GENETICA, V45, P325, DOI 10.1007/BF01508307; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; Matsuyama S, 2009, PLANT SPEC BIOL, V24, P215, DOI 10.1111/j.1442-1984.2009.00258.x; MAYER SS, 1991, TRENDS ECOL EVOL, V6, P320, DOI 10.1016/0169-5347(91)90039-Z; Menon Shaily, 2010, Endangered Species Research, V11, P175, DOI 10.3354/esr00275; MUENCHOW GE, 1987, AM J BOT, V74, P287, DOI 10.2307/2444031; Nishide Masato, 2009, APG Acta Phytotaxonomica et Geobotanica, V60, P61; OPLER PA, 1980, BIOTROPICA, V12, P40, DOI 10.2307/2388155; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Pannell J, 1997, J ECOL, V85, P57, DOI 10.2307/2960627; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; Pannell JR, 2002, FUNCT ECOL, V16, P862, DOI 10.1046/j.1365-2435.2002.06893.x; Philbrick C. Thomas, 1994, Plant Species Biology, V9, P43, DOI 10.1111/j.1442-1984.1994.tb00081.x; RIESEBERG LH, 1992, SYST BOT, V17, P324, DOI 10.2307/2419526; Roskov Y., 2005, ILDIS WORLD DATABASE; Sanjappa M, 2002, ADV LEGUME RES INDIA, P27; Schnabel A, 2003, AM J BOT, V90, P310, DOI 10.3732/ajb.90.2.310; Shivanna K.R., 1992, POLLEN BIOL LAB MANU; Stephenson A.G., 1983, POLLINATION BIOL, P109; TURNER BJ, 1992, P NATL ACAD SCI USA, V89, P10643, DOI 10.1073/pnas.89.22.10643; Watson L., 1993, GENERA LEGUMINOSAE C; Weeks SC, 2008, INVERTEBR BIOL, V127, P336, DOI 10.1111/j.1744-7410.2008.00130.x; Weeks SC, 2006, INTEGR COMP BIOL, V46, P449, DOI 10.1093/icb/icj048; Weeks SC, 2012, EVOLUTION, V66, P3670, DOI 10.1111/j.1558-5646.2012.01714.x; Wolf DE, 2004, AM NAT, V163, P122, DOI 10.1086/380493; Wolf DE, 2001, GENETICS, V159, P1243; Yampolsky C., 1922, BIBL GENET, V3, P4; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161	54	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e87287	10.1371/journal.pone.0087287	http://dx.doi.org/10.1371/journal.pone.0087287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586267	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000332396200012
J	Nielsen, S; Akerstrom, T; Rinnov, A; Yfanti, C; Scheele, C; Pedersen, BK; Laye, MJ				Nielsen, Soren; Akerstrom, Thorbjorn; Rinnov, Anders; Yfanti, Christina; Scheele, Camilla; Pedersen, Bente K.; Laye, Matthew J.			The miRNA Plasma Signature in Response to Acute Aerobic Exercise and Endurance Training	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IMPAIRS GLUCOSE-METABOLISM; MICRORNA EXPRESSION; GENE-EXPRESSION; CIRCULATING MICRORNAS; RESISTANCE EXERCISE; CARDIAC-HYPERTROPHY; MICROARRAY ANALYSIS; MESSENGER-RNAS; BIOMARKERS	MiRNAs are potent intracellular posttranscriptional regulators and are also selectively secreted into the circulation in a cellspecific fashion. Global changes in miRNA expression in skeletal muscle in response to endurance exercise training have been reported. Therefore, our aim was to establish the miRNA signature in human plasma in response to acute exercise and chronic endurance training by utilizing a novel methodological approach. RNA was isolated from human plasma collected from young healthy men before and after an acute endurance exercise bout and following 12 weeks of endurance training. Global miRNA (742 miRNAs) measurements were performed as a screening to identify detectable miRNAs in plasma. Using customized qPCR panels we quantified the expression levels of miRNAs detected in the screening procedure (188 miRNAs). We demonstrate a dynamic regulation of circulating miRNA (ci-miRNA) levels following 0 hour (miR-106a, miR-221, miR-30b, miR-151-5p, let-7i, miR-146, miR-652 and miR-151-3p), 1 hour (miR-338-3p, miR-330-3p, miR-223, miR-139-5p and miR-143) and 3 hours (miR-1) after an acute exercise bout (P<0.00032). Where ci-miRNAs were all downregulated immediately after an acute exercise bout (0 hour) the 1 and 3 hour post exercise timepoints were followed by upregulations. In response to chronic training, we identified seven ci-miRNAs with decreased levels in plasma (miR-342-3p, let-7d, miR-766, miR-25, miR148a, miR-185 and miR-21) and two miRNAs that were present at higher levels after the training period (miR-103 and miR-107) (P<0.00032). In conclusion, acute exercise and chronic endurance training, likely through specific mechanisms unique to each stimulus, robustly modify the miRNA signature of human plasma.	[Nielsen, Soren; Akerstrom, Thorbjorn; Rinnov, Anders; Yfanti, Christina; Scheele, Camilla; Pedersen, Bente K.; Laye, Matthew J.] Univ Copenhagen, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark; [Nielsen, Soren; Akerstrom, Thorbjorn; Rinnov, Anders; Yfanti, Christina; Scheele, Camilla; Pedersen, Bente K.; Laye, Matthew J.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, CMRC, Copenhagen, Denmark; [Laye, Matthew J.] Buck Inst Res Aging, Novato, CA USA; [Akerstrom, Thorbjorn] Univ Copenhagen, Fac Sci, August Krogh Ctr, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Buck Institute for Research on Aging; University of Copenhagen	Nielsen, S (corresponding author), Univ Copenhagen, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark.	soren_nielsen@inflammation-metabolism.dk	Åkerström, Thorbjörn CA/D-9884-2015; Yfanti, Christina/AHB-7627-2022; Scheele, Camilla/S-6401-2017; Nielsen, Søren/AAC-2325-2020; Laye, Matthew J/AAQ-1897-2020; Scheele, Camilla/AAA-3599-2020; Pedersen, Bente Klarlund/AGR-3217-2022	Åkerström, Thorbjörn CA/0000-0002-7330-1723; Yfanti, Christina/0000-0002-5656-8370; Scheele, Camilla/0000-0002-6055-9709; Nielsen, Søren/0000-0002-3119-750X; Laye, Matthew J/0000-0003-3214-3113; Scheele, Camilla/0000-0002-6055-9709; Pedersen, Bente Klarlund/0000-0001-6508-6288; Rinnov, Anders Rasmussen/0000-0003-3859-3289	Danish National Research Foundation [DNRF55]; Danish Council for Independent Research - Medical Sciences; Lundbeck Foundation [R67-A6473]; Danish Ministry of Science, Technology, and Innovation; Capital Region of Denmark; CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research) [09-067009, 09-075724]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Science, Technology, and Innovation; Capital Region of Denmark; CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research)	The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (DNRF55). This study was further supported by the Danish Council for Independent Research - Medical Sciences and by grants from the Lundbeck Foundation (grant no. R67-A6473). CIM is part of the UNIK Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology, and Innovation. CIM is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Copenhagen Muscle Research Centre is supported by a grant from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002360; Colombo M, 2005, METABOLISM, V54, P1571, DOI 10.1016/j.metabol.2005.06.003; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Drummond MJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1333, DOI 10.1152/ajpendo.90562.2008; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Alvarez-Lopez MJ, 2013, J ALZHEIMERS DIS, V33, P1177, DOI 10.3233/JAD-121264; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee KY, 2006, OBESITY, V14, P1294, DOI 10.1038/oby.2006.147; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lira FS, 2009, EUR J APPL PHYSIOL, V107, P203, DOI 10.1007/s00421-009-1115-5; Listowski MA, 2013, CELL MOL BIOL LETT, V18, P34, DOI 10.2478/s11658-012-0038-z; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Merlet E, 2013, CARDIOVASC RES; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yfanti C, 2012, J APPL PHYSIOL, V112, P990, DOI 10.1152/japplphysiol.01027.2010	50	198	203	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87308	10.1371/journal.pone.0087308	http://dx.doi.org/10.1371/journal.pone.0087308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586268	Green Submitted, Green Published, gold			2022-12-25	WOS:000331711900010
J	Li, Q; Nan, WZ; Wang, K; Liu, X				Li, Qi; Nan, Weizhi; Wang, Kai; Liu, Xun			Independent Processing of Stimulus-Stimulus and Stimulus-Response Conflicts	PLOS ONE			English	Article							COGNITIVE CONTROL MECHANISMS; DIMENSIONAL OVERLAP; ATTENTIONAL CONTROL; HUMAN BRAIN; STROOP-LIKE; SIMON; COMPATIBILITY; MODEL; TASK; INTERFERENCE	The dimensional overlap (DO) model proposes distinct mechanisms for stimulus-stimulus (S-S) and stimulus-response (S-R) conflict effects. Many studies have examined the independence of S-S and S-R conflict effects in the color-word Stroop and Simon tasks. However, confounds exist between the distinction of DO (i.e., S-S dimensional overlap compared with S-R dimensional overlap) and the distinction of stimulus attributes (e.g., color compared with spatial location; semantic compared with nonsemantic information), which may hinder interpretation of the independence of S-S and S-R conflicts. A spatial Stroop (word) task and a spatial Stroop (arrow) task were combined with a Simon task in Experiments 1 and 2, respectively to eliminate these confounds of stimulus attributes. The results showed that S-S and S-R conflicts affected performance additively. There was no significant correlation across participants. These findings lend further support to independent processing of S-S and S-R conflicts as it is outlined in the taxonomy of DO.	[Li, Qi; Nan, Weizhi; Wang, Kai; Liu, Xun] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Nan, Weizhi; Wang, Kai] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Q (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	liqi@psych.ac.cn; liux@psych.ac.cn	Liu, Xun/C-2400-2009; qi, li/GWV-7143-2022; WANG, KAI/W-3057-2019	Liu, Xun/0000-0003-1366-8926; WANG, KAI/0000-0002-0392-9275	National Natural Science Foundation of China [31200782, 31271194, 31070987]; Beijing Natural Science Foundation [7133250]; Young Scientists Fund of the Institute of Psychology [Y1CX242005]; National Key Technologies R&D Program of China [2012BAI36B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Young Scientists Fund of the Institute of Psychology; National Key Technologies R&D Program of China(National Key Technology R&D Program)	This research was supported by National Natural Science Foundation of China (Grants 31200782, 31271194, 31070987), Beijing Natural Science Foundation (Grant 7133250), Young Scientists Fund of the Institute of Psychology (Grant Y1CX242005), and National Key Technologies R&D Program of China (Grant 2012BAI36B01). Experimental data of this study may be requested via email. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2011, PSYCHON B REV, V18, P505, DOI 10.3758/s13423-011-0084-y; Augustinova M, 2010, PSYCHON B REV, V17, P827, DOI 10.3758/PBR.17.6.827; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Funes MJ, 2010, COGNITION, V114, P338, DOI 10.1016/j.cognition.2009.10.007; Funes MJ, 2010, J EXP PSYCHOL HUMAN, V36, P147, DOI 10.1037/a0017598; Jiang J, 2013, CEREBRAL CO IN PRESS; Kerzel D, 2012, PSYCHON B REV, V19, P456, DOI 10.3758/s13423-012-0246-6; Kim C, 2012, BRAIN RES, V1444, P55, DOI 10.1016/j.brainres.2012.01.023; Kim C, 2011, HUM BRAIN MAPP, V32, P304, DOI 10.1002/hbm.21020; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Kornblum S, 1999, J EXP PSYCHOL HUMAN, V25, P688, DOI 10.1037/0096-1523.25.3.688; KORNBLUM S, 1994, PSYCHOL RES-PSYCH FO, V56, P130, DOI 10.1007/BF00419699; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Liu X, 2010, ATTEN PERCEPT PSYCHO, V72, P1710, DOI 10.3758/APP.72.6.1710; Luo CR, 1999, PSYCHOL SCI, V10, P35, DOI 10.1111/1467-9280.00103; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Proctor R. W., 1990, STIMULUS RESPONSE CO; SIMON JR, 1990, ACTA PSYCHOL, V73, P159, DOI 10.1016/0001-6918(90)90077-S; SIMON JR, 1969, J APPL PSYCHOL, V53, P433, DOI 10.1037/h0028034; Simon JR., 1990, STIMULUS RESPONSE CO; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturz BR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00842; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Torres-Quesada M, 2013, ACTA PSYCHOL, V142, P203, DOI 10.1016/j.actpsy.2012.11.015; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Wang HB, 2007, J COGNITIVE NEUROSCI, V19, P1678, DOI 10.1162/jocn.2007.19.10.1678; Wang K, 2010, NEUROSCIENCE, V165, P101, DOI 10.1016/j.neuroscience.2009.09.070; Wang K, 2013, NEUROIMAGE IN PRESS; Yamaguchi M, 2012, PSYCHOL REV, V119, P272, DOI 10.1037/a0026620	39	18	21	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89249	10.1371/journal.pone.0089249	http://dx.doi.org/10.1371/journal.pone.0089249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558489	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700135
J	Priest, JR; Nead, KT; Wehner, MR; Cooke, JP; Leeper, NJ				Priest, James R.; Nead, Kevin T.; Wehner, Mackenzie R.; Cooke, John P.; Leeper, Nicholas J.			Self-Reported History of Childhood Smoking Is Associated with an Increased Risk for Peripheral Arterial Disease Independent of Lifetime Smoking Burden	PLOS ONE			English	Article							PREDICTION	Atherosclerotic disorders are well known to be associated with obesity, lipid profile, smoking, hypertension and other medical comorbidities, and large cohort studies have explored the childhood correlates to these adult risk factors. However, there has been little investigation into the childhood risk factors for peripheral arterial disease (PAD). We endeavored to better understand the role of smoking in childhood in the risk for PAD in a well described cohort of 1,537 adults at high risk for cardiovascular disease. In a multivariate regression model, we observed an increased risk of PAD among those who reported a history of smoking during childhood (OR = 2.86; 95% CI, 1.99-4.11; P<0.001), which remained statistically significant after controlling for lifetime smoking burden (OR = 1.55; 95% CI, 1.00-2.41; P = 0.049). Our novel observation of disproportionate risk of PAD conferred by a history of childhood smoking may reflect an unrecognized biological mechanism such as a unique susceptibility to vascular injury or an unaccounted for covariate such as secondhand smoke exposure in childhood. This observation suggests further investigation is required into the pathophysiology of smoking in the developing vasculature and the need for detailed clinical data about patterns of childhood smoking and smoke exposure.	[Priest, James R.] Stanford Univ, Sch Med, Div Pediat Cardiol, Stanford, CA 94305 USA; [Nead, Kevin T.] Stanford Univ, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Wehner, Mackenzie R.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Cooke, John P.] Methodist DeBakey Heart & Vasc Ctr, Ctr Cardiovasc Regenerat, Houston, TX USA; [Priest, James R.; Cooke, John P.; Leeper, Nicholas J.] Stanford Univ, Sch Med, Cardiovasc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Stanford University	Leeper, NJ (corresponding author), Stanford Univ, Sch Med, Div Vasc Surg, Stanford, CA 94305 USA.	nleeper@stanford.edu		Wehner, Mackenzie/0000-0002-5579-2282; Cooke, John/0000-0003-0033-9138	National Institutes of Health [K12HD000850, K12HL087746, K08HL10360501A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010360, K12HL087746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (K12HD000850 to Dr. Priest, K12HL087746 to Dr Cooke, and K08HL10360501A1 to Dr. Leeper). There are no relevant relationships with industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Galal W, 2008, CHEST, V134, P925, DOI 10.1378/chest.08-0418; Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959; Leeper NJ, 2012, CIRCULATION, V125, P3220, DOI 10.1161/CIRCULATIONAHA.111.033878; Nead KT, 2013, J AM COLL CARDIOL, V62, P553, DOI 10.1016/j.jacc.2013.04.061; Nead KT, 2013, CIRC-CARDIOVASC QUAL, V6, P255, DOI 10.1161/CIRCOUTCOMES.111.000070; Nead KT, 2013, AM J CARDIOL, V111, P851, DOI 10.1016/j.amjcard.2012.11.055; Rafie AHS, 2010, VASC MED, V15, P443, DOI 10.1177/1358863X10388345; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tynan Michael A., 2012, Morbidity and Mortality Weekly Report, V61, P565	9	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88972	10.1371/journal.pone.0088972	http://dx.doi.org/10.1371/journal.pone.0088972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558458	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700104
J	Ye, AY; Liu, QR; Li, CY; Zhao, M; Qu, H				Ye, Adam Y.; Liu, Qing-Rong; Li, Chuan-Yun; Zhao, Min; Qu, Hong			Human Transporter Database: Comprehensive Knowledge and Discovery Tools in the Human Transporter Genes	PLOS ONE			English	Article							MEMBRANE TRANSPORTERS; METABOLIC PATHWAYS; RESOURCE; SYSTEMS; SERVER	Transporters are essential in homeostatic exchange of endogenous and exogenous substances at the systematic, organic, cellular, and subcellular levels. Gene mutations of transporters are often related to pharmacogenetics traits. Recent developments in high throughput technologies on genomics, transcriptomics and proteomics allow in depth studies of transporter genes in normal cellular processes and diverse disease conditions. The flood of high throughput data have resulted in urgent need for an updated knowledgebase with curated, organized, and annotated human transporters in an easily accessible way. Using a pipeline with the combination of automated keywords query, sequence similarity search and manual curation on transporters, we collected 1,555 human non-redundant transporter genes to develop the Human Transporter Database (HTD) (http://htd.cbi.pku.edu.cn). Based on the extensive annotations, global properties of the transporter genes were illustrated, such as expression patterns and polymorphisms in relationships with their ligands. We noted that the human transporters were enriched in many fundamental biological processes such as oxidative phosphorylation and cardiac muscle contraction, and significantly associated with Mendelian and complex diseases such as epilepsy and sudden infant death syndrome. Overall, HTD provides a well-organized interface to facilitate research communities to search detailed molecular and genetic information of transporters for development of personalized medicine.	[Ye, Adam Y.; Zhao, Min; Qu, Hong] Peking Univ, Coll Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Qing-Rong] NIDA, Behav Neurosci Res Branch, NIH, IRP, Baltimore, MD USA; [Li, Chuan-Yun] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Ye, Adam Y.] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Peking University; Peking University	Zhao, M (corresponding author), Peking Univ, Coll Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	zhaomin.2006@gmail.com; quh@mail.cbi.pku.edu.cn	Zhao, Min/J-6588-2019; Ye, Yongxin/AAR-4486-2020; Liu, Qing-Rong/A-3059-2012	Zhao, Min/0000-0001-5498-3434; Ye, Yongxin/0000-0002-1542-0740; Liu, Qing-Rong/0000-0001-8477-6452	National Natural Science Foundation of China [31171270]; National Basic Research Program of China [2011CB518000]; NIDA-NIH	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NIDA-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by the National Natural Science Foundation of China [grant number 31171270] and the National Basic Research Program of China [grant number 2011CB518000]. QL is supported by the intramural research program of NIDA-NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Burge S., 2012, DATABASE OXFORD, V2012; Cardoso AR, 2010, BBA-BIOENERGETICS, V1797, P832, DOI 10.1016/j.bbabio.2009.12.017; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Fichant G, 2006, FEMS MICROBIOL LETT, V256, P333, DOI 10.1111/j.1574-6968.2006.00139.x; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Huang Y, 2007, CANCER METAST REV, V26, P183, DOI 10.1007/s10555-007-9050-6; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Kalyana-Sundaram S, 2012, CELL, V149, P1622, DOI 10.1016/j.cell.2012.04.041; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kong L, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat063; Li CY, 2007, CELL RES, V17, P357, DOI 10.1038/cr.2007.27; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Longo N, 2011, AM J MED GENET C, V157C, P72, DOI 10.1002/ajmg.c.30292; Miao ZY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-60; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oshiro C, 2010, PHARMACOGENET GENOM, V20, P211, DOI 10.1097/FPC.0b013e328333b99c; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Relling MV, 2011, CLIN PHARMACOL THER, V89, P387, DOI 10.1038/clpt.2010.320; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Takahashi N, 2010, J HUM GENET, V55, P731, DOI 10.1038/jhg.2010.98; Ueda K, 2011, BIOSCI BIOTECH BIOCH, V75, P401, DOI 10.1271/bbb.100816; van Veen HW, 2010, NATURE, V467, P926, DOI 10.1038/467926a; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ware JA, 2006, MOL PHARMACEUT, V3, P1, DOI 10.1021/mp058084b; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yan Q, 2000, AAPS PHARMSCI, V2, part. no.; Yan Q, 2010, METHODS MOL BIOL, V637, P1, DOI 10.1007/978-1-60761-700-6_1; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zhao M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S10; Zhao M, 2011, SCI CHINA LIFE SCI, V54, P60, DOI 10.1007/s11427-010-4125-y; Zhao M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S13; Zhao M, 2009, CELL RES, V19, P793, DOI 10.1038/cr.2009.61; Zhao Min, 2009, BMC Genomics, V10 Suppl 3, pS31, DOI 10.1186/1471-2164-10-S3-S31	50	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88883	10.1371/journal.pone.0088883	http://dx.doi.org/10.1371/journal.pone.0088883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558441	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700087
J	Kopp, R; Bauer, I; Ramalingam, A; Egg, M; Schwerte, T				Kopp, Renate; Bauer, Ines; Ramalingam, Anil; Egg, Margit; Schwerte, Thorsten			Prolonged Hypoxia Increases Survival Even in Zebrafish (Danio rerio) Showing Cardiac Arrhythmia	PLOS ONE			English	Article							GENE-EXPRESSION; LARVAL ZEBRAFISH; MITOCHONDRIAL BIOGENESIS; OXYGEN-TRANSPORT; SKELETAL-MUSCLE; CHANNEL PROTEIN; ANDEAN NATIVES; MESSENGER-RNA; FISHES; HERG	Tolerance towards hypoxia is highly pronounced in zebrafish. In this study even beneficial effects of hypoxia, specifically enhanced survival of zebrafish larvae, could be demonstrated. This effect was actually more pronounced in breakdance mutants, which phenotypically show cardiac arrhythmia. Breakdance mutants (bre) are characterized by chronically reduced cardiac output. Despite an about 50% heart rate reduction, they become adults, but survival rate significantly drops to 40%. Normoxic bre animals demonstrate increased hypoxia inducible factor 1 a (Hif-1 alpha) expression, which indicates an activated hypoxic signaling pathway. Consequently, cardiovascular acclimation, like cardiac hypertrophy and increased erythrocyte concentration, occurs. Thus, it was hypothesized, that under hypoxic conditions survival might be even more reduced. When bre mutants were exposed to hypoxic conditions, they surprisingly showed higher survival rates than under normoxic conditions and even reached wildtype values. In hypoxic wildtype zebrafish, survival yet exceeded normoxic control values. To specify physiological acclimation, cardiovascular and metabolic parameters were measured before hypoxia started (3 dpf), when the first differences in survival rate occurred (7 dpf) and when survival rate plateaued (15 dpf). Hypoxic animals expectedly demonstrated Hif-1 alpha accumulation and consequently enhanced convective oxygen carrying capacity. Moreover, bre animals showed a significantly enhanced heart rate under hypoxic conditions, which reached normoxic wildtype values. This improvement in convective oxygen transport ensured a sufficient oxygen and nutrient supply and was also reflected in the significantly higher mitochondrial activity. The highly optimized energy metabolism observed in hypoxic zebrafish larvae might be decisive for periods of higher energy demand due to organ development, growth and increased activity. However, hypoxia increased survival only during a short period of development and starting hypoxia before or after this phase reduced survival, particularly in bre animals. Thus, the physiological plasticity, which enables zebrafish larvae to benefit from a hypoxia, occurs only within a narrow developmental window.	[Kopp, Renate] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; Univ Innsbruck, Ctr Mol Biol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck	Kopp, R (corresponding author), Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria.	Renate.Kopp@uibk.ac.at	Schwerte, Thorsten/K-6549-2019; Schwerte, Thorsten/A-6088-2009	Schwerte, Thorsten/0000-0002-6330-8817				Achard-Joris M, 2006, BIOMETALS, V19, P237, DOI 10.1007/s10534-005-5671-9; Allen RG, 1999, J CELL PHYSIOL, V180, P114, DOI 10.1002/(SICI)1097-4652(199907)180:1<114::AID-JCP13>3.0.CO;2-0; Bagatto B, 2001, J EXP BIOL, V204, P4335; Barrionuevo WR, 1999, O2 CONSUMPTION HEART; Bennett MR, 2001, CIRC RES, V88, P648, DOI 10.1161/hh0701.089955; Burggren WW, 2011, RESP PHYSIOL NEUROBI, V178, P13, DOI 10.1016/j.resp.2011.05.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crockett EL, 1999, J EXP ZOOL, V284, P276, DOI 10.1002/(SICI)1097-010X(19990801)284:3<276::AID-JEZ5>3.0.CO;2-N; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Egg M, 2013, CHRONOBIOL INT, V30, P510, DOI 10.3109/07420528.2012.754447; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; GORDON GB, 1977, AM J PATHOL, V88, P663; Grillitsch S, 2005, J EXP BIOL, V208, P309, DOI 10.1242/jeb.01410; He LP, 2004, ACTA OBSTET GYN SCAN, V83, P144, DOI 10.1111/j.0001-6349.2004.00345.x; HOCHACHKA PW, 1991, J APPL PHYSIOL, V70, P1720, DOI 10.1152/jappl.1991.70.4.1720; Isomoto S, 1997, J CARDIOVASC ELECTR, V8, P1431, DOI 10.1111/j.1540-8167.1997.tb01040.x; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; JOSE AD, 1969, CIRC RES, V25, P53, DOI 10.1161/01.RES.25.1.53; Kopp R, 2005, J EXP BIOL, V208, P2123, DOI 10.1242/jeb.01620; Kopp R, 2011, PHYSIOL GENOMICS, V43, P506, DOI 10.1152/physiolgenomics.00250.2010; Kopp R, 2010, PHYSIOL GENOMICS, V42A, P8, DOI 10.1152/physiolgenomics.00052.2010; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liu HP, 2002, BIOCHEM PHARMACOL, V64, P1745, DOI 10.1016/S0006-2952(02)01456-9; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; MATHESON GO, 1991, J APPL PHYSIOL, V70, P1963, DOI 10.1152/jappl.1991.70.5.1963; McMullen DC, 2008, INSECT BIOCHEM MOLEC, V38, P367, DOI 10.1016/j.ibmb.2007.12.003; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Milkiewicz M, 2005, AM J PHYSIOL-HEART C, V289, pH336, DOI 10.1152/ajpheart.01105.2004; Nanduri J, 2008, BIOCHEM BIOPH RES CO, V373, P309, DOI 10.1016/j.bbrc.2008.06.028; Nanduri J, 2009, BIOCHEM BIOPH RES CO, V388, P212, DOI 10.1016/j.bbrc.2009.07.149; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; O'Brien KM, 2011, J EXP BIOL, V214, P275, DOI 10.1242/jeb.046854; O'Connor EA, 2011, FISH PHYSIOL BIOCHEM, V37, P461, DOI 10.1007/s10695-010-9447-y; Padilla PA, 2001, P NATL ACAD SCI USA, V98, P7331, DOI 10.1073/pnas.131213198; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Richards JG, 2008, AM J PHYSIOL-REG I, V295, pR979, DOI 10.1152/ajpregu.00192.2008; Rombough P, 2009, J EXP BIOL, V212, P778, DOI 10.1242/jeb.026575; Tadolini B, 2000, FREE RADICAL RES, V33, P105, DOI 10.1080/10715760000300661; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tingaud-Sequeira A, 2011, J LIPID RES, V52, P1765, DOI 10.1194/jlr.D017012; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; van der Meer DLM, 2005, AM J PHYSIOL-REG I, V289, pR1512, DOI 10.1152/ajpregu.00089.2005; van der Velden YU, 2011, P NATL ACAD SCI USA, V108, P4358, DOI 10.1073/pnas.1010210108; Vidal-Puig AJ, 2000, NAT GENET, V26, P387, DOI 10.1038/82489; Yaqoob N, 2010, COMP BIOCHEM PHYS A, V156, P475, DOI 10.1016/j.cbpa.2010.03.033	49	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89099	10.1371/journal.pone.0089099	http://dx.doi.org/10.1371/journal.pone.0089099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551224	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500096
J	Rosenthal, M; Aiello, AE; Chenoweth, C; Goldberg, D; Larson, E; Gloor, G; Foxman, B				Rosenthal, Mariana; Aiello, Allison E.; Chenoweth, Carol; Goldberg, Deborah; Larson, Elaine; Gloor, Gregory; Foxman, Betsy			Impact of Technical Sources of Variation on the Hand Microbiome Dynamics of Healthcare Workers	PLOS ONE			English	Article							SEQUENCING PLATFORMS; DIVERSITY	We assessed the dynamics of hand microbial community structure of 34 healthcare workers from a single surgical intensive care unit over a short (3 week) time period, whilst taking into account the technical sources of variability introduced by specimen collection, DNA extraction, and sequencing. Sample collection took place at 3 different time points. Only the sampling collection method appeared to have a significant impact on the observed hand microbial community structure among the healthcare workers. Analysis of samples collected using glove-juice showed a slightly more similar microbial composition within individual hand samples over time than between the hands of different individuals over time. This was not true for samples collected using a swab, where samples from a single individual were no more similar to each other over time than those among other individuals over time, suggesting they were essentially independent. DNA extraction techniques (lysozyme only versus enzyme cocktail) and sequencing (replicate set 1 versus 2) using Ion Torrent Personal Genome Machine, were not influential to the microbial community structures. Glove-juice sample collection may likely be the method of choice in hand hygiene studies in the healthcare setting.	[Rosenthal, Mariana; Aiello, Allison E.; Chenoweth, Carol; Foxman, Betsy] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Goldberg, Deborah] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Larson, Elaine] Columbia Univ, Sch Nursing, New York, NY USA; [Larson, Elaine] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Gloor, Gregory] Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Columbia University	Rosenthal, M (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	rosenbr@umich.edu; bfoxman@umich.edu	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380; Foxman, Betsy/0000-0001-6682-238X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health Interdisciplinary Program in Infectious Diseases Training Grant [T32 AI049816]; Robert Wood Johnson Foundation Health & Society Scholars (RWJF HSS) Small Grants Program [N012550-399789]; University of Michigan Rackham Graduate Student Research Grant; University of Michigan School of Public Health Department of Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049816] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health Interdisciplinary Program in Infectious Diseases Training Grant; Robert Wood Johnson Foundation Health & Society Scholars (RWJF HSS) Small Grants Program; University of Michigan Rackham Graduate Student Research Grant(University of Michigan System); University of Michigan School of Public Health Department of Epidemiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding support was provided by The National Institute of Allergy and Infectious Diseases of the National Institutes of Health funded Interdisciplinary Program in Infectious Diseases Training Grant (T32 AI049816), the Robert Wood Johnson Foundation Health & Society Scholars (RWJF HSS) Small Grants Program (#N012550-399789), The University of Michigan Rackham Graduate Student Research Grant, and The University of Michigan School of Public Health Department of Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Vercoe E, 2012, CAN J GASTROENTEROL, V26, P457, DOI 10.1155/2012/213828; Banfield KR, 2005, J HOSP INFECT, V61, P183, DOI 10.1016/j.jhin.2005.03.016; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rosenthal M, 2014, PATHOGENS, V3, P1, DOI 10.3390/pathogens3010001; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Salazar O, 2007, BIOTECHNOL LETT, V29, P985, DOI 10.1007/s10529-007-9345-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Scholz MB, 2012, CURR OPIN BIOTECH, V23, P9, DOI 10.1016/j.copbio.2011.11.013; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865	27	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88999	10.1371/journal.pone.0088999	http://dx.doi.org/10.1371/journal.pone.0088999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551205	Green Published, Green Submitted			2022-12-25	WOS:000331271500091
J	Novoyatleva, T; Sajjad, A; Pogoryelov, D; Patra, C; Schermuly, RT; Engel, FB				Novoyatleva, Tatyana; Sajjad, Amna; Pogoryelov, Denys; Patra, Chinmoy; Schermuly, Ralph T.; Engel, Felix B.			FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14	FASEB JOURNAL			English	Article						heart; signaling; TWEAK	FIBROBLAST-GROWTH-FACTOR; FACTOR-KAPPA-B; HEART DEVELOPMENT; FACTOR RECEPTOR-1; DNA-SYNTHESIS; WEAK INDUCER; MYOCYTE PROLIFERATION; ADULT CARDIOMYOCYTES; CARDIAC REGENERATION; ENDOTHELIAL-CELLS	Fibroblast growth factors (FGFs) signal through FGF receptors (FGFRs) mediating a broad range of cellular functions during embryonic development, as well as disease and regeneration during adulthood. Thus, it is important to understand the underlying molecular mechanisms that modulate this system. Here, we show that FGFR-1 can interact with the TNF receptor superfamily member fibroblast growth factor-inducible molecule 14 (Fn14) resulting in cardiomyocyte cell cycle reentry. FGF1-induced cell cycle reentry in neonatal cardiomyocytes could be blocked by Fn14 inhibition, while TWEAK-induced cell cycle activation was inhibited by blocking FGFR-1 signaling. In addition, costimulation experiments revealed a synergistic effect of FGF1 and TWEAK in regard to cardiomyocyte cell cycle induction via PI3K/Akt signaling. Overexpression of Fn14 with either FGFR-1 long [FGFR-1(L)] or FGFR-1 short [FGFR-1(S)] isoforms resulted after FGF1/TWEAK stimulation in cell cycle reentry of >40% adult cardiomyocytes. Finally, coimmunoprecipitation and proximity ligation assays indicated that endogenous FGFR-1 and Fn14 interact with each other in cardiomyocytes. This interaction was strongly enhanced in the presence of their corresponding ligands, FGF1 and TWEAK. Taken together, our data suggest that FGFR-1/Fn14 interaction may represent a novel endogenous mechanism to modulate the action of these receptors and their ligands and to control cardiomyocyte cell cycle reentry.	[Novoyatleva, Tatyana; Sajjad, Amna; Patra, Chinmoy; Engel, Felix B.] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany; [Sajjad, Amna] Univ Faisalabad, Govt Coll, Faisalabad, Pakistan; [Pogoryelov, Denys] Goethe Univ Frankfurt, Inst Biochem, Membrane Transport Machineries Grp, Frankfurt, Germany; [Schermuly, Ralph T.] Univ Giessen, Dept Pulm Pharmacotherapy, D-35390 Giessen, Germany; [Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, D-91054 Erlangen, Germany	Max Planck Society; Government College University Faisalabad; Goethe University Frankfurt; Justus Liebig University Giessen; University of Erlangen Nuremberg	Engel, FB (corresponding author), Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Univ Str 22, D-91054 Erlangen, Germany.	tatyana.novoyatleva@innnere.med.uni-giessen.de; felix.engel@uk-erlangen.de	Engel, Felix/A-1767-2008	Engel, Felix/0000-0003-2605-3429; Schermuly, Ralph/0000-0002-5167-6970; Patra, Chinmoy/0000-0003-3849-5187; Sajjad, Amna/0000-0001-8478-8138	Alexander von Humboldt Foundation; Behrens-Weise-Stiftung; Emerging Fields Initiative Cell Cycle in Disease and Regeneration (CYDER) of the Friedrich Alexander University (Erlangen-Nurnberg, Germany)	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Behrens-Weise-Stiftung; Emerging Fields Initiative Cell Cycle in Disease and Regeneration (CYDER) of the Friedrich Alexander University (Erlangen-Nurnberg, Germany)	The authors thank Michael Berens (Translational Genomics Research Institute, Phoenix, AZ, USA), Ken Walsh (Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA), and Thomas Braun (Max Planck Institute for Heart and Lung Research) for adenoviral constructs and David Zebrowski for critical reading of the manuscript. The authors are grateful to Petra Freund and Stefanie Viehmann for technical assistance and Miriam Damm for the technical suggestions regarding the PLA assay. This work was supported by the Alexander von Humboldt Foundation (Sofja Kovalevskaja Award to F.B.E.), the Behrens-Weise-Stiftung, and the Emerging Fields Initiative Cell Cycle in Disease and Regeneration (CYDER) of the Friedrich Alexander University (Erlangen-Nurnberg, Germany).	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Borroto-Escuela DO, 2012, J NEUROSCI, V32, P6295, DOI 10.1523/JNEUROSCI.4203-11.2012; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Carey DJ, 1997, BIOCHEM J, V327, P1; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Cuevas P, 1997, GROWTH FACTORS, V15, P29, DOI 10.3109/08977199709002110; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 1999, CIRC RES, V85, P294, DOI 10.1161/01.RES.85.3.294; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; ENGELMANN GL, 1993, CIRC RES, V72, P7, DOI 10.1161/01.RES.72.1.7; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Faraone D, 2006, BLOOD, V107, P1896, DOI 10.1182/blood-2005-04-1524; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gargano N, 1997, J NEUROSCI RES, V50, P1; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Graves Lee M, 2002, Mol Interv, V2, P208, DOI 10.1124/mi.2.4.208; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; JIN Y, 1994, J MOL CELL CARDIOL, V26, P1449, DOI 10.1006/jmcc.1994.1164; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; KARDAMI E, 1990, MOL CELL BIOCHEM, V92, P129; LIU L, 1995, AM J PHYSIOL-HEART C, V268, pH1927, DOI 10.1152/ajpheart.1995.268.5.H1927; Lu SY, 2008, BIOCHEM BIOPH RES CO, V373, P270, DOI 10.1016/j.bbrc.2008.06.029; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Mustonen E, 2010, ACTA PHYSIOL, V199, P11, DOI 10.1111/j.1748-1716.2010.02080.x; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pellieux C, 2001, J CLIN INVEST, V108, P1843, DOI 10.1172/JCI200113627; Poling J, 2011, ARTERIOSCL THROM VAS, V31, P2297, DOI 10.1161/ATVBAHA.111.232835; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sheikh F, 1999, CARDIOVASC RES, V42, P696, DOI 10.1016/S0008-6363(99)00008-5; Smyth LA, 2005, HYPERTENSION, V46, P100, DOI 10.1161/01.HYP.0000167991.82153.16; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; SPEIR E, 1992, CIRC RES, V71, P251, DOI 10.1161/01.RES.71.2.251; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Steiling H, 2003, CURR OPIN BIOTECH, V14, P533, DOI 10.1016/j.copbio.2003.08.003; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; Wajant H, 2013, BRIT J PHARMACOL, V170, P748, DOI 10.1111/bph.12337; WANAKA A, 1991, DEVELOPMENT, V111, P455; Weinberg JM, 2011, KIDNEY INT, V79, P151, DOI 10.1038/ki.2010.435; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6; Zebrowski DC, 2013, REV PHYSIOL BIOCH P, V165, P67, DOI 10.1007/112_2013_12	66	16	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2492	2503		10.1096/fj.13-243576	http://dx.doi.org/10.1096/fj.13-243576			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24571920				2022-12-25	WOS:000339883600010
J	Ishida, M; Arai, SP; Ohbayashi, N; Fukuda, M				Ishida, Morie; Arai, Saki P.; Ohbayashi, Norihiko; Fukuda, Mitsunori			The GTPase-deficient Rab27A( Q78L) Mutant Inhibits Melanosome Transport in Melanocytes through Trapping of Rab27A Effector Protein Slac2-a/Melanophilin in Their Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Low Molecular Weight G Proteins; Melanogenesis; Membrane Trafficking; Protein Targeting; Rab; Small GTPases; Subcellular Organelles	REGULATES AMYLASE RELEASE; PAROTID ACINAR-CELLS; MYOSIN-VA; GRISCELLI-SYNDROME; ACTIVATING PROTEIN; HOMOLOGY DOMAIN; BINDING DOMAIN; MEMBRANE; IDENTIFICATION; SIGNALS	Background: A GTPase-deficient Rab27A(Q78L) mutation caused perinuclear melanosome aggregation by an unknown mechanism. Results: Forcible targeting of Rab27A(Q78L) to melanosomes by a novel melanosome-targeting tag restored peripheral melanosome distribution in Rab27A-deficient cells. Conclusion: The GTPase activity of Rab27A is required for its melanosome localization, not for melanosome transport. Significance: These findings provide new insights into the mechanism underlying the spatiotemporal regulation of Rab27A activity. The small GTPase Rab27A is a crucial regulator of actin-based melanosome transport in melanocytes, and functionally defective Rab27A causes human Griscelli syndrome type 2, which is characterized by silvery hair. A GTPase-deficient, constitutively active Rab27A(Q78L) mutant has been shown to act as an inhibitor of melanosome transport and to induce perinuclear aggregation of melanosomes, but the molecular mechanism by which Rab27A(Q78L) inhibits melanosome transport remained to be determined. In this study, we attempted to identify the primary cause of the perinuclear melanosome aggregation induced by Rab27A(Q78L). The results showed that Rab27A(Q78L) is unable to localize on mature melanosomes and that its inhibitory activity on melanosome transport is completely dependent on its binding to the Rab27A effector Slac2-a/melanophilin. When we forcibly expressed Rab27A(Q78L) on mature melanosomes by using a novel melanosome-targeting tag that we developed in this study and named the MST tag, the MST-Rab27A(Q78L) fusion protein behaved in the same manner as wild-type Rab27A. It localized on mature melanosomes without inducing melanosome aggregation and restored normal peripheral melanosome distribution in Rab27A-deficient cells. These findings indicate that the GTPase activity of Rab27A is required for its melanosome localization but is not required for melanosome transport.	[Ishida, Morie; Arai, Saki P.; Ohbayashi, Norihiko; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Tokyo Biochemical Research Foundation; International Advanced Research and Education Organization of Tohoku University; Grants-in-Aid for Scientific Research [24570206] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; International Advanced Research and Education Organization of Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to N. O. and M. F.); by a grant from the Tokyo Biochemical Research Foundation (to M. F.); and by the International Advanced Research and Education Organization of Tohoku University (to M. I.).	Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Calvo PA, 1999, J BIOL CHEM, V274, P12780, DOI 10.1074/jbc.274.18.12780; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Fukuda M, 2010, HISTOL HISTOPATHOL, V25, P1473, DOI 10.14670/HH-25.1473; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2011, J BIOL CHEM, V286, P33854, DOI 10.1074/jbc.M111.281394; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Ohbayashi N, 2010, PIGM CELL MELANOMA R, V23, P365, DOI 10.1111/j.1755-148X.2010.00705.x; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Piccirillo R, 2006, J CELL SCI, V119, P2003, DOI 10.1242/jcs.02930; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tarafder AK, 2011, TRAFFIC, V12, P1056, DOI 10.1111/j.1600-0854.2011.01216.x; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XS, 2012, BIOCHEM BIOPH RES CO, V426, P209, DOI 10.1016/j.bbrc.2012.08.064; Wu XFS, 2012, P NATL ACAD SCI USA, V109, pE2101, DOI 10.1073/pnas.1209397109	49	9	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11059	11067		10.1074/jbc.M114.552281	http://dx.doi.org/10.1074/jbc.M114.552281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584932	hybrid, Green Published			2022-12-25	WOS:000334638500011
J	Harvey, MC; Fleet, A; Okolowsky, N; Hamel, PA				Harvey, Malcolm C.; Fleet, Andrew; Okolowsky, Nadia; Hamel, Paul A.			Distinct Effects of the mesenchymal dysplasia Gene Variant of Murine Patched-1 Protein on Canonical and Non-canonical Hedgehog Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Hedgehog; Receptor Modification; Receptor Regulation; SH3 Domains; Patched-1; Sonic Hedgehog; c-src	MAMMARY-GLAND MORPHOGENESIS; CELL-CYCLE PROGRESSION; SONIC HEDGEHOG; HUMAN HOMOLOG; NEURAL-TUBE; SRC; MICE; EXPRESSION; MOUSE; CDO	Background: Patched-1 is the primary ligand receptor in both canonical and non-canonical Hedgehog signaling. Results: Truncation of the Patched-1 C terminus impairs regulation of Patched-1-mediated c-src activation and elevates the expression of Hedgehog target genes. Conclusion: The Ptch1 C terminus is required for mediation of both canonical and non-canonical Hedgehog signaling. Significance: A mutant of Ptch1 differentially regulates canonical and non-canonical Hh signaling pathways. Hedgehog (Hh) signaling requires regulation of the receptor Patched-1 (Ptch1), which, in turn, regulates Smoothened activity (canonical Hh signaling) as well as other non-canonical signaling pathways. The mutant Ptch1 allele mesenchymal dysplasia (mes), which truncates the Ptch1 C terminus, produces a limited spectrum of developmental defects in mice as well as deregulation of canonical Hh signaling in some, but not all, affected tissues. Paradoxically, mes suppresses canonical Hh signaling and binds to Hh ligands with an affinity similar to wild-type mouse Ptch1 (mPtch1). We characterized the distinct activities of the mes variant of mPtch1 mediating Hh signaling through both canonical and non-canonical pathways. We demonstrated that mPtch1 bound c-src in an Hh-regulated manner. Stimulation with Sonic Hedgehog (Shh) of primary mammary mesenchymal cells from wild-type and mes animals activated Erk1/2. Although Shh activated c-src in wild-type cells, c-src was constitutively activated in mes mesenchymal cells. Transient assays showed that wild-type mPtch1, mes, or mPtch1 lacking the C terminus repressed Hh signaling in Ptch1-deficient mouse embryo fibroblasts and that repression was reversed by Shh, revealing that the C terminus was dispensable for mPtch1-dependent regulation of canonical Hh signaling. In contrast to these transient assays, constitutively high levels of mGli1 but not mPtch1 were present in primary mammary mesenchymal cells from mes mice, whereas the expression of mPtch1 was similarly induced in both mes and wild-type cells. These data define a novel signal transduction pathway involving c-src that is activated by the Hh ligands and reveals the requirement for the C terminus of Ptch in regulation of canonical and non-canonical Hh signaling pathways.	[Harvey, Malcolm C.; Fleet, Andrew; Okolowsky, Nadia; Hamel, Paul A.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Hamel, PA (corresponding author), Univ Toronto, Rm 6318,Med Sci Bldg,1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	paul.hamel@utoronto.ca			Canadian Institutes of Health Research Grant [MOP-97929]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This project was funded by Canadian Institutes of Health Research Grant MOP-97929 (to P. A. H.).	Aboulkassim TO, 2003, ONCOGENE, V22, P2967, DOI 10.1038/sj.onc.1206513; Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Blair SS, 1997, DEVELOPMENT, V124, P4053; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang H, 2012, DEV BIOL, V370, P187, DOI 10.1016/j.ydbio.2012.07.027; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chatzizacharias NA, 2012, HISTOL HISTOPATHOL, V27, P677, DOI 10.14670/HH-27.677; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hepker J, 1997, DEVELOPMENT, V124, P549; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jenkins D, 2007, J ANAT, V211, P620, DOI 10.1111/j.1469-7580.2007.00808.x; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Z, 2008, INT J BIOL SCI, V4, P29; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marigo V, 1996, DEVELOPMENT, V122, P1225; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Moraes RC, 2009, DEVELOPMENT, V136, P1423, DOI 10.1242/dev.023994; MULLER WJ, 1991, CANCER METAST REV, V10, P217, DOI 10.1007/BF00050793; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pietsch T, 1997, CANCER RES, V57, P2085; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Sweet HO, 1996, J HERED, V87, P87, DOI 10.1093/oxfordjournals.jhered.a022981; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; WEBSTER MA, 1995, P NATL ACAD SCI USA, V92, P7849, DOI 10.1073/pnas.92.17.7849; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	46	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10939	10949		10.1074/jbc.M113.514844	http://dx.doi.org/10.1074/jbc.M113.514844			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570001	hybrid, Green Published			2022-12-25	WOS:000334226400061
J	Yi, F; Wang, H; Chai, Q; Wang, XL; Shen, WK; Willis, MS; Lee, HC; Lu, T				Yi, Fu; Wang, Huan; Chai, Qiang; Wang, Xiaoli; Shen, Win-Kuang; Willis, Monte S.; Lee, Hon-Chi; Lu, Tong			Regulation of Large Conductance Ca2+ -activated K+ ( BK) Channel beta 1 Subunit Expression by Muscle RING Finger Protein 1 in Diabetic Vessels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Potassium Channels; Protein Degradation; Ubiquitin Ligase; Vascular Smooth Muscle Cells	ARTERIAL SMOOTH-MUSCLE; NF-KAPPA-B; POTASSIUM CHANNELS; UBIQUITIN LIGASE; IN-VIVO; MYOCARDIAL-INFARCTION; ACUTE HYPERGLYCEMIA; SPARKLET ACTIVITY; DOWN-REGULATION; CELLS	Background: Impaired BK channel function in diabetic vessels is associated with decreased BK channel 1 subunit (BK-1) expression. Results: Muscle RING finger protein 1 (MuRF1) physically interacts with BK-1 and accelerates BK-1 proteolysis. Conclusion: Increased MuRF1 expression is a novel mechanism underlying diabetic BK channelopathy and vasculopathy. Significance: MuRF1 is a potential therapeutic target of BK channel dysfunction and vascular complications in diabetes. The large conductance Ca2+-activated K+ (BK) channel, expressed abundantly in vascular smooth muscle cells (SMCs), is a key determinant of vascular tone. BK channel activity is tightly regulated by its accessory 1 subunit (BK-1). However, BK channel function is impaired in diabetic vessels by increased ubiquitin/proteasome-dependent BK-1 protein degradation. Muscle RING finger protein 1 (MuRF1), a muscle-specific ubiquitin ligase, is implicated in many cardiac and skeletal muscle diseases. However, the role of MuRF1 in the regulation of vascular BK channel and coronary function has not been examined. In this study, we hypothesized that MuRF1 participated in BK-1 proteolysis, leading to the down-regulation of BK channel activation and impaired coronary function in diabetes. Combining patch clamp and molecular biological approaches, we found that MuRF1 expression was enhanced, accompanied by reduced BK-1 expression, in high glucose-cultured human coronary SMCs and in diabetic vessels. Knockdown of MuRF1 by siRNA in cultured human SMCs attenuated BK-1 ubiquitination and increased BK-1 expression, whereas adenoviral expression of MuRF1 in mouse coronary arteries reduced BK-1 expression and diminished BK channel-mediated vasodilation. Physical interaction between the N terminus of BK-1 and the coiled-coil domain of MuRF1 was demonstrated by pulldown assay. Moreover, MuRF1 expression was regulated by NF-B. Most importantly, pharmacological inhibition of proteasome and NF-B activities preserved BK-1 expression and BK-channel-mediated coronary vasodilation in diabetic mice. Hence, our results provide the first evidence that the up-regulation of NF-B-dependent MuRF1 expression is a novel mechanism that leads to BK channelopathy and vasculopathy in diabetes.	[Yi, Fu; Wang, Huan; Chai, Qiang; Wang, Xiaoli; Lee, Hon-Chi; Lu, Tong] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Yi, Fu] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Shen, Win-Kuang] Mayo Clin, Dept Internal Med, Scottsdale, AZ 85259 USA; [Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Mayo Clinic; Air Force Military Medical University; Mayo Clinic; Mayo Clinic Phoenix; University of North Carolina; University of North Carolina Chapel Hill	Lu, T (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	lu.tong@mayo.edu	Willis, Monte S/J-9994-2015; yi, fu/HGE-6093-2022; Lu, Tong/A-7745-2009	Willis, Monte S/0000-0002-0769-5816; Lu, Tong/0000-0002-2393-7643	National Institutes of Health Grants [HL-74180, HL-080118]; American Diabetes Association Grants [ADA-JFA-07-39, 1-12-BS-119]; National Natural Science Foundation of the People's Republic of China [81000686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080118, R01HL074180, R56HL074180, R01HL104129] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grants(American Diabetes Association); National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74180 and HL-080118. This work was also supported by American Diabetes Association Grants ADA-JFA-07-39 and 1-12-BS-119).; Supported by National Natural Science Foundation of the People's Republic of China Grant 81000686.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; BENHAM CD, 1986, J PHYSIOL-LONDON, V381, P385, DOI 10.1113/jphysiol.1986.sp016333; Bjarnegard N, 2009, DIABETES VASC DIS RE, V6, P25, DOI 10.3132/dvdr.2009.005; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Bruno RM, 2013, DIABETOLOGIA, V56, P2107, DOI 10.1007/s00125-013-3008-8; Chai Q, 2013, CARDIOVASC RES, V100, P151, DOI 10.1093/cvr/cvt157; Chen SN, 2012, CIRC RES, V111, P907, DOI 10.1161/CIRCRESAHA.112.270207; Chen YQ, 2010, AM J NEPHROL, V32, P414, DOI 10.1159/000320131; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Dick GM, 2001, J BIOL CHEM, V276, P44835, DOI 10.1074/jbc.M106851200; Dunn KM, 2010, AM J PHYSIOL-CELL PH, V298, pC203, DOI 10.1152/ajpcell.00499.2009; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fang J, 2006, DIABETES, V55, P768, DOI 10.2337/diabetes.55.03.06.db05-1196; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Kawano N, 2012, J ATHEROSCLER THROMB, V19, P276, DOI 10.5551/jat.10629; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Li M, 2013, J BIOL CHEM, V288, P3668, DOI 10.1074/jbc.M112.426585; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Lu T, 2005, J BIOL CHEM, V280, P19097, DOI 10.1074/jbc.M414065200; Lu T, 2001, J PHYSIOL-LONDON, V534, P651, DOI 10.1111/j.1469-7793.2001.t01-1-00651.x; Lu T, 2008, BIOPHYS J, V95, P5165, DOI 10.1529/biophysj.108.138339; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1996, FEBS LETT, V385, P127; Mori A, 2011, BIOL PHARM BULL, V34, P150, DOI 10.1248/bpb.34.150; Mrosek M, 2008, BIOCHEMISTRY-US, V47, P10722, DOI 10.1021/bi800733z; Nagar D, 2005, AM J PHYSIOL-HEART C, V289, pH1417, DOI 10.1152/ajpheart.01174.2004; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Norhammar A, 2007, HEART, V93, P1577, DOI 10.1136/hrt.2006.097956; Popov Doina, 2008, Archives of Physiology and Biochemistry, V114, P150, DOI [10.1080/13813450802033990, 10.1080/13813450802033990 ]; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Rueda A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053321; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Velmurugan GV, 2012, AM J PHYSIOL-HEART C, V302, pH124, DOI 10.1152/ajpheart.00218.2011; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wan E, 2013, FASEB J, V27, P1859, DOI 10.1096/fj.12-223511; Wang RX, 2012, CHINESE MED J-PEKING, V125, P2548, DOI 10.3760/cma.j.issn.0366-6999.2012.14.028; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang Y, 2013, HYPERTENSION, V61, P519, DOI 10.1161/HYPERTENSIONAHA.111.00211; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361	64	29	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10853	10864		10.1074/jbc.M113.520940	http://dx.doi.org/10.1074/jbc.M113.520940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570002	hybrid, Green Published			2022-12-25	WOS:000334226400053
J	Ning, LL; Guo, JJ; Bai, QF; Jin, NZ; Liu, HX; Yao, XJ				Ning, Lulu; Guo, Jingjing; Bai, Qifeng; Jin, Nengzhi; Liu, Huanxiang; Yao, Xiaojun			Structural Diversity and Initial Oligomerization of PrP106-126 Studied by Replica-Exchange and Conventional Molecular Dynamics Simulations	PLOS ONE			English	Article							PRION PROTEIN-FRAGMENT; SECONDARY STRUCTURE; NMR STRUCTURE; CONFORMATIONAL POLYMORPHISM; PEPTIDE OLIGOMERIZATION; AMYLOID OLIGOMERS; ENERGY LANDSCAPE; AQUEOUS-SOLUTION; BETA-OLIGOMERS; SCRAPIE PRION	Prion diseases are marked by cerebral accumulation of the abnormal isoform of the prion protein. A fragment of prion protein composed of residues 106-126 (PrP106-126) exhibits similar properties to full length prion and plays a key role in the conformational conversion from cellular prion to its pathogenic pattern. Soluble oligomers of PrP106-126 have been proposed to be responsible for neurotoxicity. However, the monomeric conformational space and initial oligomerization of PrP106-126 are still obscure, which are very important for understanding the conformational conversion of PrP106-126. In this study, replica exchange molecular dynamics simulations were performed to investigate monomeric and dimeric states of PrP106-126 in implicit solvent. The structural diversity of PrP106-126 was observed and this peptide did not acquire stable structure. The dimeric PrP106-126 also displayed structural diversity and hydrophobic interaction drove the dimerization. To further study initial oligomerization of PrP106-126, 1 mu s conventional molecular dynamics simulations of trimer and tetramer formation were carried out in implicit solvent. We have observed the spontaneous formation of several basic oligomers and stable oligomers with high beta-sheet contents were sampled in the simulations of trimer and tetramer formation. The beta-hairpin formed in hydrophobic tail of PrP106-126 with residues 118-120 in turn may stabilize these oligomers and seed the formation oligomers. This study can provide insight into the detailed information about the structure of PrP106-126 and the dynamics of aggregation of monomeric PrP106-126 into oligomers in atomic level.	[Ning, Lulu; Guo, Jingjing; Bai, Qifeng; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Ning, Lulu; Guo, Jingjing; Bai, Qifeng; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Jin, Nengzhi] Gansu Comp Ctr, Lanzhou, Peoples R China; [Guo, Jingjing; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Liu, HX (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn; xjyao@lzu.edu.cn	Guo, Jingjing/GZL-0645-2022; Bai, Qifeng/A-2950-2019	Guo, Jingjing/0000-0002-4632-4364; Bai, Qifeng/0000-0001-7296-6187; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21103075, 20905033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos: 21103075 and 20905033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; [Anonymous], 2008, AMBER 10; Baumketner A, 2007, J MOL BIOL, V366, P275, DOI 10.1016/j.jmb.2006.11.015; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown DR, 2000, MOL CELL NEUROSCI, V15, P66, DOI 10.1006/mcne.1999.0796; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chebaro Y, 2009, J PHYS CHEM B, V113, P6942, DOI 10.1021/jp900334s; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cote S, 2012, J PHYS CHEM B, V116, P4043, DOI 10.1021/jp2126366; Daidone I, 2011, BIOPHYS J, V100, P3000, DOI 10.1016/j.bpj.2011.04.053; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Derreumaux P, 2001, BIOPHYS J, V81, P1657, DOI 10.1016/S0006-3495(01)75819-5; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Frishman D, 2004, PROTEIN-STRUCT FUNCT, V23, P566; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Higo J, 2001, PROTEIN SCI, V10, P1160, DOI 10.1110/ps.44901; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1529/biophysj.106.090993; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jobling MF, 1999, J NEUROCHEM, V73, P1557, DOI 10.1046/j.1471-4159.1999.0731557.x; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Laghaei R, 2011, J PHYS CHEM B, V115, P3146, DOI 10.1021/jp108870q; Levy Y, 2001, PROTEINS, V45, P382, DOI 10.1002/prot.1157; Lin MX, 1997, J BIOL CHEM, V272, P44; Lu Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4732761; Lu Y, 2011, J PHYS CHEM B, V115, P1282, DOI 10.1021/jp110269a; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Melquiond A, 2006, PROTEINS, V65, P180, DOI 10.1002/prot.21100; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ragg E, 1999, EUR J BIOCHEM, V266, P1192, DOI 10.1046/j.1432-1327.1999.00985.x; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santini S, 2004, J AM CHEM SOC, V126, P11509, DOI 10.1021/ja047286i; Santini S, 2004, CELL MOL LIFE SCI, V61, P951, DOI 10.1007/s00018-003-3455-3; Santini S, 2003, PROTEINS, V51, P258, DOI 10.1002/prot.10348; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Song W, 2008, J PHYS CHEM B, V112, P4410, DOI 10.1021/jp710592v; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tsai HH, 2005, P NATL ACAD SCI USA, V102, P8174, DOI 10.1073/pnas.0408653102; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; van der Kamp MW, 2011, TOP CURR CHEM, V305, P169, DOI 10.1007/128_2011_158; Villa A, 2006, J PHYS CHEM B, V110, P1423, DOI 10.1021/jp052722o; Walsh P, 2010, J AM CHEM SOC, V132, P7684, DOI 10.1021/ja100431q; Walsh P, 2009, BIOCHEMISTRY-US, V48, P5779, DOI 10.1021/bi9007319; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang L, 1999, PROTEIN SCI, V8, P1292, DOI 10.1110/ps.8.6.1292; Wang YL, 2011, INORG CHEM, V50, P4340, DOI 10.1021/ic102331x; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang ZQ, 2007, BIOPHYS J, V93, P1484, DOI 10.1529/biophysj.106.100537; Zhu XX, 2012, J PHYS CHEM B, V116, P4405, DOI 10.1021/jp210019h	81	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87266	10.1371/journal.pone.0087266	http://dx.doi.org/10.1371/journal.pone.0087266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586266	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900009
J	Lesser, IA; Gasevic, D; Lear, SA				Lesser, Iris A.; Gasevic, Danijela; Lear, Scott A.			The Association between Acculturation and Dietary Patterns of South Asian Immigrants	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; FOOD-HABITS; HEALTH; CHINESE; CONSUMPTION; PREVALENCE; MIGRATION; RESIDENCE	Dietary acculturation, specifically the adoption of western dietary habits, may result in adverse health effects such as obesity and type 2 diabetes. Therefore, it is necessary to explore the role of acculturation in dietary patterns as well as awareness and knowledge of healthy nutrition among South Asian immigrants. This is an especially important population to target as South Asians have higher prevalence rates of type 2 diabetes and cardiovascular disease, which may be magnified with immigration. The current investigation is a sub-study of the Multi-Cultural Community Health Assessment Trial (M-CHAT). There were 207 participants of South Asian origin included in the initial study, 129 were born outside of Canada and had immigrated after the age of 18. The length of residence in Canada was used as a marker for acculturation. A questionnaire addressing perceived changes in dietary patterns, food preparation, and nutrition knowledge and awareness since immigration was used to assess dietary practices. The association between length of residence and variables related to perceived changes in dietary patterns was explored with Spearman correlation and significant associations were subsequently analyzed with ordinal logistic regression analysis adjusted for age, sex, education and body mass index. South Asian immigrants in Canada reported a variety of positive dietary practices, including an increased consumption of fruits and vegetables and an improvement in food preparation (including an increase in grilling and a decrease in deep frying when cooking). However, there was a reported increase in the consumption of convenience foods, sugar-sweetened beverages, red meat and in dining out. South Asian immigrants in Canada reported a variety of positive dietary practices including an improvement in food preparation. Future health promotion strategies should encourage cultural sensitivity in efforts to reduce the consumption of sugar-sweetened beverage, convenience foods and to encourage eating at home rather than dining out.	[Lesser, Iris A.; Gasevic, Danijela; Lear, Scott A.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada	Simon Fraser University; Simon Fraser University	Lear, SA (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada.	slear@providencehealth.bc.ca		Gasevic, Danijela/0000-0001-5976-4011	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; El Hassan DA, 2012, CAN J DIET PRACT RES, V73, P143, DOI 10.3148/73.3.2012.143; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Holmboe-Ottesen G, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.18891; Jasti S, 2011, AM J HEALTH BEHAV, V35, P734; Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182; Ko GTC, 2007, ASIA PAC J CLIN NUTR, V16, P757; Koya DL, 2007, J GEN INTERN MED, V22, P841, DOI 10.1007/s11606-007-0163-y; Lassetter JH, 2009, J TRANSCULT NURS, V20, P93, DOI 10.1177/1043659608325841; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Lear SA, 2006, ETHNIC DIS, V16, P96; LEE MM, 1994, INT J EPIDEMIOL, V23, P984, DOI 10.1093/ije/23.5.984; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Mellin-Olsen T, 2005, ETHNIC HEALTH, V10, P311, DOI 10.1080/13557850500145238; National Asian Pacific American Community Development Data Center, 2005, S AS DEM AN; Pais P, 1996, LANCET, V348, P358, DOI 10.1016/S0140-6736(96)02507-X; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Raj S, 1999, J AM DIET ASSOC, V99, P1106, DOI 10.1016/S0002-8223(99)00266-7; Regev-Tobias H, 2012, NUTRITION, V28, P30, DOI 10.1016/j.nut.2011.02.010; Rosenmoller DL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-42; Roville-Sausse FN, 2005, PUBLIC HEALTH, V119, P726, DOI 10.1016/j.puhe.2004.10.021; Statistics Canada, 2010, STUD PROJ DIV CAN PO; Tami SH, 2012, ETHNIC DIS, V22, P192; Tremblay Mark S, 2005, Health Rep, V16, P23; U.S. Census Bureau, 2012, ACSBR1106 US CENS BU; Varghese S, 2002, CAN J DIET PRACT RES, V63, P72, DOI 10.3148/63.2.2002.72; Wandel M, 2008, APPETITE, V50, P376, DOI 10.1016/j.appet.2007.09.003	28	97	98	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88495	10.1371/journal.pone.0088495	http://dx.doi.org/10.1371/journal.pone.0088495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558396	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700042
J	Zheng, J; Li, J; Xu, LN; Xie, GY; Wen, QY; Luo, JD; Li, D; Huang, DH; Fan, SQ				Zheng, Jun; Li, Jiao; Xu, Lina; Xie, Guiyuan; Wen, Qiuyuan; Luo, Jiadi; Li, Duo; Huang, Donghai; Fan, Songqing			Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CAP-BINDING PROTEIN; TRANSLATIONAL CONTROL; CELL-PROLIFERATION; SIGNALING PATHWAY; UP-REGULATION; CANCER; EXPRESSION; EIF-4E; TUMORIGENESIS; PROGRESSION	Nasopharyngeal carcinoma (NPC) is a head and neck malignant tumor rare throughout most of the world but common in Southeast Asia, especially in Southern China. The phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) by MAP kinase-interacting kinases (Mnk) on Ser-209 promotes cellular proliferation, survival, malignant transformation and metastasis. However, whether the alterations of the expression of p-eIF4E and p-Mnk1 protein are associated with clinicopathologic/prognostic implication for NPC has not been reported. The purposes of the present study are to examine the expression of p-eIF4E and p-Mnk1 protein in NPC and non-cancerous nasopharyngeal epithelial tissues by immunohistochemistry and evaluate the association between the expression of p-eIF4E and p-Mnk1 protein and clinicopathological characteristics of NPC. The results showed that the positive percentage of p-Mnk1 and p-eIF4E proteins expression in NPC (83.5% and 75.4%, respectively) was significantly higher than that in non-cancerous nasopharyngeal epithelium (40.0% and 32.9%, respectively). The positive expression of p-eIF4E and p-Mnk1 in the NPC with cervical lymph node metastasis was significantly higher than those without lymph node metastasis. Additionally, p-eIF4E expression was more pronouncedly increased in metastatic NPC than the matched primary NPC. Increase of p-eIF4E and p-Mnk1 expression was significantly correlated inversely with overall survival. Spearman's rank correlation test further showed that expression of p-Mnk1 was strongly positive correlated with expression of p-eIF4E in NPC. The expression of p-Mnk1 and p-eIF4E in NPC was proved to be the independent prognostic factors regardless of lymph node metastasis, clinical stages and combination of radiotherapy and chemotherapy, histological type, age and gender by multivariate analysis. Taken together, high expression of p-Mnk1 and p-eIF4E might be novel valuable biomarkers to predict poor prognosis of NPC and therapeutic targets for developing the valid treatment strategies.	[Zheng, Jun; Li, Jiao; Xu, Lina; Wen, Qiuyuan; Luo, Jiadi; Li, Duo; Fan, Songqing] Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent South Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China; [Huang, Donghai] Cent South Univ, Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China; [Zheng, Jun] Changzhi Med Coll, Dept Biochem, Changzhi, Shanxi, Peoples R China	Central South University; Central South University; Central South University; Changzhi Medical College	Fan, SQ (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	fansongqing2003@hotmail.com	xu, li/GNH-3667-2022		National Natural Sciences Foundations of China [81071820, 81272566]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Sciences Foundations of China (NO: 81071820; 81272566) http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astanehe A, 2012, ONCOGENE, V31, P4434, DOI 10.1038/onc.2011.617; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chou J, 2008, HEAD NECK-J SCI SPEC, V30, P946, DOI 10.1002/hed.20833; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Farias TP, 2003, ARCH OTOLARYNGOL, V129, P794, DOI 10.1001/archotol.129.7.794; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Hou JQ, 2012, ONCOTARGET, V3, P118; Khoury T, 2009, CLIN LUNG CANCER, V10, P58, DOI 10.3816/CLC.2009.n.009; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Lee CC, 2008, CLIN OTOLARYNGOL, V33, P442, DOI 10.1111/j.1749-4486.2008.01770.x; Liang S, 2013, ONCOL REP, V29, P2422, DOI 10.3892/or.2013.2397; Mahalingam M, 2001, PROG MOLEC, V27, P131; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Muta D, 2011, J NEURO-ONCOL, V101, P33, DOI 10.1007/s11060-010-0233-6; Nathan CAO, 1999, LARYNGOSCOPE, V109, P1253, DOI 10.1097/00005537-199908000-00013; Pan CC, 2012, EXP THER MED, V4, P334, DOI 10.3892/etm.2012.584; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Razak ARA, 2010, EUR J CANCER, V46, P1967, DOI 10.1016/j.ejca.2010.04.004; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Rosenwald IB, 2001, THROMB HAEMOSTASIS, V85, P142; Segrelles C, 2004, CARCINOGENESIS, V25, P1137, DOI 10.1093/carcin/bgh132; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Tao Qian, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000312; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang ST, 1999, AM J PATHOL, V155, P247, DOI 10.1016/S0002-9440(10)65118-8; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wei WI, 2010, CLIN EXP OTORHINOLAR, V3, P1, DOI 10.3342/ceo.2010.3.1.1; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Wu MY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0400-z; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Zimmer SG, 2000, ANTICANCER RES, V20, P1343	39	35	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89220	10.1371/journal.pone.0089220	http://dx.doi.org/10.1371/journal.pone.0089220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551240	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500105
J	Boltz, KA; Jasti, M; Townley, JM; Shippen, DE				Boltz, Kara A.; Jasti, Madhu; Townley, Jennifer M.; Shippen, Dorothy E.			Analysis of Poly(ADP-Ribose) Polymerases in Arabidopsis Telomere Biology	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; CHROMOSOME END PROTECTION; MAMMALIAN TELOMERES; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTION; EMBRYONIC-DEVELOPMENT; CHROMATIN-STRUCTURE; CELL-SURVIVAL; DAMAGE	Maintaining the length of the telomere tract at chromosome ends is a complex process vital to normal cell division. Telomere length is controlled through the action of telomerase as well as a cadre of telomere-associated proteins that facilitate replication of the chromosome end and protect it from eliciting a DNA damage response. In vertebrates, multiple poly(ADP-ribose) polymerases (PARPs) have been implicated in the regulation of telomere length, telomerase activity and chromosome end protection. Here we investigate the role of PARPs in plant telomere biology. We analyzed Arabidopsis thaliana mutants null for PARP1 and PARP2 as well as plants treated with the PARP competitive inhibitor 3-AB. Plants deficient in PARP were hypersensitive to genotoxic stress, and expression of PARP1 and PARP2 mRNA was elevated in response to MMS or zeocin treatment or by the loss of telomerase. Additionally, PARP1 mRNA was induced in parp2 mutants, and conversely, PARP2 mRNA was induced in parp1 mutants. PARP3 mRNA, by contrast, was elevated in both parp1 and parp2 mutants, but not in seedlings treated with 3-AB or zeocin. PARP mutants and 3-AB treated plants displayed robust telomerase activity, no significant changes in telomere length, and no end-to-end chromosome fusions. Although there remains a possibility that PARPs play a role in Arabidopsis telomere biology, these findings argue that the contribution is a minor one.	[Boltz, Kara A.; Jasti, Madhu; Townley, Jennifer M.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dshippen@tamu.edu			National Institutes of Health [GM065383]; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (GM065383) to D. E. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Adams-Phillips L, 2008, MOL PLANT MICROBE IN, V21, P646, DOI 10.1094/MPMI-21-5-0646; Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Amiard S, 2011, PLANT CELL, V23, P4254, DOI 10.1105/tpc.111.092387; Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Balestrazzi A, 2011, PLANT CELL REP, V30, P287, DOI 10.1007/s00299-010-0975-9; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Boltz KA, 2012, MOL BIOL CELL, V23, P1558, DOI 10.1091/mbc.E11-12-1002; Brown EJ, 2000, GENE DEV, V14, P397; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Cao Y, 2002, ONCOGENE, V21, P3130, DOI 10.1038/sj.onc.1205419; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Cifuentes-Rojas C, 2012, GENE DEV, V26, P2512, DOI 10.1101/gad.202960.112; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; De Block M, 2005, PLANT J, V41, P95, DOI 10.1111/j.1365-313X.2004.02277.x; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; di Fagagna FD, 1999, NAT GENET, V23, P76; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Ghosh U, 2005, FEBS J, V272, P4237, DOI 10.1111/j.1742-4658.2005.04837.x; Ghosh U, 2007, MUTAT RES-FUND MOL M, V615, P66, DOI 10.1016/j.mrfmmm.2006.10.002; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Heacock ML, 2007, NUCLEIC ACIDS RES, V35, P6490, DOI 10.1093/nar/gkm472; Hefner E, 2006, DNA REPAIR, V5, P102, DOI 10.1016/j.dnarep.2005.08.013; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Hwang MG, 2007, NUCLEIC ACIDS RES, V35, P1333, DOI 10.1093/nar/gkm043; Ishikawa K, 2009, PLANT PHYSIOL, V151, P741, DOI 10.1104/pp.109.140442; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jia Q, 2013, PLANT MOL BIOL, V82, P339, DOI 10.1007/s11103-013-0065-9; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kannan K, 2008, MOL CELL BIOL, V28, P2332, DOI 10.1128/MCB.01490-07; Karamysheva ZN, 2004, J BIOL CHEM, V279, P47799, DOI 10.1074/jbc.M407938200; Kazda A, 2012, GENE DEV, V26, P1703, DOI 10.1101/gad.194944.112; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lamb RS, 2012, CELL MOL LIFE SCI, V69, P175, DOI 10.1007/s00018-011-0793-4; Leehy KA, 2013, PLANT CELL, V25, P1343, DOI 10.1105/tpc.112.107425; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nakaoka H, 2012, J BIOL CHEM, V287, P619, DOI 10.1074/jbc.M111.263723; NOSSERI C, 1994, EXP CELL RES, V212, P367, DOI 10.1006/excr.1994.1156; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Riha K, 2001, SCIENCE, V291, P1797, DOI 10.1126/science.1057110; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schulz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037287; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Ting NSY, 2005, NUCLEIC ACIDS RES, V33, P2090, DOI 10.1093/nar/gki342; Tong WM, 2001, MOL CELL BIOL, V21, P4046, DOI 10.1128/MCB.21.12.4046-4054.2001; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Vanderauwera S, 2007, P NATL ACAD SCI USA, V104, P15150, DOI 10.1073/pnas.0706668104; Vespa L, 2005, GENE DEV, V19, P2111, DOI 10.1101/gad.1333805; Yamazaki H, 2012, GENE DEV, V26, P241, DOI 10.1101/gad.177873.111; Yoshiyama K, 2009, P NATL ACAD SCI USA, V106, P12843, DOI 10.1073/pnas.0810304106; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	101	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88872	10.1371/journal.pone.0088872	http://dx.doi.org/10.1371/journal.pone.0088872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551184	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000079
J	Kannurpatti, SS; Motes, MA; Biswal, BB; Rypma, B				Kannurpatti, Sridhar S.; Motes, Michael A.; Biswal, Bharat B.; Rypma, Bart			Assessment of Unconstrained Cerebrovascular Reactivity Marker for Large Age-Range fMRI Studies	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; BOLD FMRI; FUNCTIONAL CONNECTIVITY; HYPERCAPNIC NORMALIZATION; VARIABILITY; ACTIVATION; AMPLITUDE; SIGNAL; MRI; CO2	Breath hold (BH), a commonly used task to measure cerebrovascular reactivity (CVR) in fMRI studies varies in outcome among individuals due to subject-physiology and/or BH-inspiration/expiration differences (i.e., performance). In prior age-related fMRI studies, smaller task-related BOLD response variability is observed among younger than older individuals. Also, a linear CVR versus task relationship exists in younger individuals which maybe useful to test the accuracy of CVR responses in older groups. Hence we hypothesized that subject-related physiological and/or BH differences, if present, may compromise CVR versus task linearity in older individuals. To test the hypothesis, empirical BH versus task relationships from motor and cognitive areas were obtained in younger (mean age = 26 years) and older (mean age = 58 years) human subjects. BH versus task linearity was observed only in the younger group, confirming our hypothesis. Further analysis indicated BH responses and its variability to be similar in both younger and older groups, suggesting that BH may not accurately represent CVR in a large age range. Using the resting state fluctuation of amplitude (RSFA) as an unconstrained alternative to BH, subject-wise correspondence between BH and RSFA was tested. Correlation between BH versus RSFA was significant within the motor but was not significant in the cognitive areas in the younger and was completely disrupted in both areas in the older subjects indicating that BH responses are constrained by subject-related physiology and/or performance-related differences. Contrasting BH to task, RSFA-task relationships were independent of age accompanied by age-related increases in CVR variability as measured by RSFA, not observed with BH. Together the results obtained indicate that RSFA accurately represents CVR in any age range avoiding multiple and yet unknown physiologic and task-related pitfalls of BH.	[Kannurpatti, Sridhar S.; Biswal, Bharat B.] RUTGERS New Jersey Med Sch, Dept Radiol, Newark, NJ 07102 USA; [Motes, Michael A.; Rypma, Bart] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Biswal, Bharat B.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Texas System; University of Texas Dallas; New Jersey Institute of Technology	Kannurpatti, SS (corresponding author), RUTGERS New Jersey Med Sch, Dept Radiol, Newark, NJ 07102 USA.	kannursr@njms.rutgers.edu; bart.rypma@utd.edu		Motes, Michael/0000-0001-6635-6948	National Institute of Health [AG029523-02, AG032088-02]; American Heart Association [0930132N]; NATIONAL INSTITUTE ON AGING [R01AG029523, R01AG032088] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Health through the grants AG029523-02 (BR), AG032088-02 (BB) and American Heart Association grant 0930132N (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2007, MAGN RESON IMAGING, V25, P1358, DOI 10.1016/j.mri.2007.03.022; Cohen ER, 2004, NEUROIMAGE, V23, P613, DOI 10.1016/j.neuroimage.2004.06.021; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Di X., 2012, CEREB CORTEX; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Handwerker DA, 2007, HUM BRAIN MAPP, V28, P846, DOI 10.1002/hbm.20307; HONG SK, 1971, J APPL PHYSIOL, V30, P540, DOI 10.1152/jappl.1971.30.4.540; Huettel SA, 2001, NEUROIMAGE, V13, P161, DOI 10.1006/nimg.2000.0675; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1567, DOI 10.1016/j.neuroimage.2007.09.040; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kannurpatti SS, 2011, HUM BRAIN MAPP, V32, P1125, DOI 10.1002/hbm.21097; Kannurpatti SS, 2011, MAGN RESON IMAGING, V29, P140, DOI 10.1016/j.mri.2010.07.006; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kannurpatti SS, 2002, MAGN RESON MED, V47, P864, DOI 10.1002/mrm.10131; Kastrup A, 1998, STROKE, V29, P2641, DOI 10.1161/01.STR.29.12.2641; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; Leoni RF, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/268483; Liau J, 2009, NEUROIMAGE, V45, P420, DOI 10.1016/j.neuroimage.2008.11.032; Liu P, 2012, HUM BRAIN MAPP; Liu TT, 2013, NEUROIMAGE; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lythgoe DJ, 1999, MAGN RESON IMAGING, V17, P495, DOI 10.1016/S0730-725X(98)00211-2; Mandell DM, 2008, STROKE, V39, P2021, DOI 10.1161/STROKEAHA.107.506709; Mennes M., 2012, CEREB CORTEX; Motes MA, 2011, COGN NEUROSCI-UK, V2, P1, DOI 10.1080/17588928.2010.512974; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ratnatunga C, 1990, Eur J Vasc Surg, V4, P519, DOI 10.1016/S0950-821X(05)80795-9; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Roberts P, 2009, COMP BREATH HOLDING, P1532; ROSTRUP E, 1994, NMR BIOMED, V7, P29, DOI 10.1002/nbm.1940070106; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; STEVENS CD, 1946, J CLIN INVEST, V25, P723, DOI 10.1172/JCI101755; Tancredi FB, 2013, J CEREBR BLOOD F MET, V33, P1066, DOI 10.1038/jcbfm.2013.48; Thomason ME, 2005, NEUROIMAGE, V25, P824, DOI 10.1016/j.neuroimage.2004.12.026; Thomason ME, 2008, NEUROIMAGE, V39, P206, DOI 10.1016/j.neuroimage.2007.08.014; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	47	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88751	10.1371/journal.pone.0088751	http://dx.doi.org/10.1371/journal.pone.0088751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551151	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000061
J	Margry, B; Kersemakers, SCW; Hoek, A; Arkesteijn, GJA; Wieland, WH; van Eden, W; Broere, F				Margry, Bram; Kersemakers, Saskia C. W.; Hoek, Aad; Arkesteijn, Ger J. A.; Wieland, Willemien H.; van Eden, Willem; Broere, Femke			Activated Peritoneal Cavity B-1a Cells Possess Regulatory B Cell Properties	PLOS ONE			English	Article							B10 CELLS; INDUCTION; RESPONSES; MICE; AUTOIMMUNITY; INFLAMMATION; SUPPRESSION; EXPRESSION; DEPLETION; DISEASE	Previous studies have suggested that murine peritoneal cavity-derived B-1a cells possess similarities with described regulatory B cell subsets. The aim of the current study was to examine the potential immunoregulatory function of peritoneal cavity-derived B(-1a) cells. In vitro activation of peritoneal cavity-derived B-and B-1a cells shows that activation of these B cells with anti-CD40 and LPS induces these cells to secrete more IL-10, IL-6 and IgM as compared to splenic B cells. In a suppression assay, CD40/TLR4-activated peritoneal cavity B cells possess regulatory B cell functions as they inhibit the capacity of CD4(+) T cells to produce both tumor necrosis factor-a and interferon-c. Splenic B cells did not show this, whereas non-activated peritoneal cavity B cells augmented the capacity of CD4(+) T cells to produce tumor necrosis factor-alpha, while the ability to produce interferon-c was not altered. The current paper compares splenic B cells to peritoneal cavity B(-1a) cells in an in vitro activation-and an suppression-assay and concludes that peritoneal cavity B(-1a) cells possess properties that appear similar to splenic autoimmune-suppressive regulatory B cell subsets described in the literature.	[Margry, Bram; Kersemakers, Saskia C. W.; Hoek, Aad; Arkesteijn, Ger J. A.; Wieland, Willemien H.; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands	Utrecht University	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl		Broere, Femke/0000-0001-9343-0111; Arkesteijn, Ger/0000-0001-7739-582X; van Eden, Willem/0000-0003-1272-704X	TI Pharma [T1-214-1]	TI Pharma	This work was supported by TI Pharma T1-214-1 (www.tipharma.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gray D, 2007, EUR J IMMUNOL, V37, P3304, DOI 10.1002/eji.200737728; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Koni PA, 2013, J IMMUNOL, V190, P3189, DOI 10.4049/jimmunol.1203364; Kretschmer B, 2011, IMMUNOL LETT, V136, P221, DOI 10.1016/j.imlet.2011.01.013; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Margry B, 2013, EUR J IMMUNOL, V43, P2317, DOI 10.1002/eji.201343418; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Mohan C, 1998, ARTHRITIS RHEUM-US, V41, P1652, DOI 10.1002/1529-0131(199809)41:9<1652::AID-ART17>3.0.CO;2-W; Nakashima H, 2010, J IMMUNOL, V184, P4637, DOI 10.4049/jimmunol.0901719; O'Neill SK, 2007, J IMMUNOL, V179, P5109, DOI 10.4049/jimmunol.179.8.5109; Palos MC, 2012, INFLAMM RES, V61, P1187, DOI 10.1007/s00011-012-0514-y; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Silverman GJ, 2013, NAT REV RHEUMATOL, V9, P291, DOI 10.1038/nrrheum.2013.30; Sindhava VJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00372; Suzuki K, 2010, IMMUNOL REV, V237, P180, DOI 10.1111/j.1600-065X.2010.00941.x; van dV, 2012, PLOS ONE, V7; Velupillai P, 1997, J IMMUNOL, V158, P338; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang M, 2010, J IMMUNOL, V184, P3321, DOI 10.4049/jimmunol.0902551; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	42	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88869	10.1371/journal.pone.0088869	http://dx.doi.org/10.1371/journal.pone.0088869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551182	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000078
J	Xiao, TT; Wang, YY; Zhang, Y; Bai, CH; Shen, XC				Xiao, Ting-Ting; Wang, Yuan-Yuan; Zhang, Yan; Bai, Cong-Hui; Shen, Xiang-Chun			Similar to Spironolactone, Oxymatrine Is Protective in Aldosterone-Induced Cardiomyocyte Injury via Inhibition of Calpain and Apoptosis-Inducing Factor Signaling	PLOS ONE			English	Article							CELL-DEATH; MYOCYTE APOPTOSIS; HEART-FAILURE; MECHANISMS; CALCIUM; ACTIVATION; PATHWAYS; SURVIVAL; DISEASE; SYSTEM	Accumulating evidence indicates that oxymatrine (OMT) possesses variously pharmacological properties, especially on the cardiovascular system. We previously demonstrated that activated calpain/apoptosis-inducing factor (AIF)-mediated pathway was the key molecular mechanism in aldosterone (ALD) induces cardiomyocytes apoptosis. In the present study, we extended the experimentation by investigating the effect of OMT on cardiomyocytes exposed to ALD, as compared to spironolactone (Spiro), a classical ALD receptor antagonist. Cardiomyocytes were pre-incubated with OMT, Spiro or vehicle for 1 h, and then, cardiomyocytes were exposed to ALD 24 h. The cell injury was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay and lactate dehydrogenase (LDH) leakage ratio. Apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, annexin V/PI staining, and relative caspase-3 activity assay. Furthermore, expression of pro-apoptotic proteins including truncated Bid (tBid), calpain and AIF were evaluated by western blot analysis. ALD stimulation increased cardiomyocytes apoptosis, caspase-3 activity and protein expression of calpain, tBid and AIF in the cytosol (p<0.05). Pre-incubated with cardiomyocytes injury and increased caspase-3 activity were significantly attenuated (p<0.05). Furthermore, OMT suppressed ALD-induced high expression of calpain and AIF. And these effects of OMT could be comparable to Spiro. These findings indicated that OMT might be a potential cardioprotective-agent against excessive ALD-induced cardiotoxicity, at least in part, mediated through inhibition of calpain/AIF signaling.	[Xiao, Ting-Ting; Zhang, Yan; Bai, Cong-Hui; Shen, Xiang-Chun] Guiyang Med Univ, Res Div Pharmacol, Guiyang, Peoples R China; [Xiao, Ting-Ting] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China; [Wang, Yuan-Yuan] Guiyang Med Univ, Res Div Pathophysiol, Guiyang, Peoples R China; [Shen, Xiang-Chun] Zhejiang Sci Tech Univ, Sch Life Sci, Hangzhou, Zhejiang, Peoples R China	Guizhou Medical University; Hong Kong Baptist University; Guizhou Medical University; Zhejiang Sci-Tech University	Shen, XC (corresponding author), Guiyang Med Univ, Res Div Pharmacol, Guiyang, Peoples R China.	shengxiangchun@126.com	Lv, Yuanjie/AER-0767-2022		National Natural Science Foundation of China [81173586]; Provincial Key Technologies R&D Program of Guizhou [SY-2011-3010]; Program for New Century Excellent Talents in University [NCET -13-0747]; Excellent Scientific and Technological & Educational Talents of Governor' Specal Funds in Guizhou Province [2011-28]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Key Technologies R&D Program of Guizhou; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Excellent Scientific and Technological & Educational Talents of Governor' Specal Funds in Guizhou Province	This study was supported by the National Natural Science Foundation of China (No.81173586), the Provincial Key Technologies R&D Program of Guizhou (No. SY-2011-3010), the Program for New Century Excellent Talents in University (NCET -13-0747), and the Excellent Scientific and Technological & Educational Talents of Governor' Specal Funds in Guizhou Province (No.2011-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 2008, EXP CELL RES, V314, P1237, DOI 10.1016/j.yexcr.2007.12.028; Alves AJ, 2010, WORLD J CARDIOL, V2, P187, DOI 10.4330/wjc.v2.i7.187; Armstrong PW, 2011, NEW ENGL J MED, V364, P79, DOI 10.1056/NEJMe1012547; Burniston JG, 2005, J MOL CELL CARDIOL, V39, P395, DOI 10.1016/j.yjmcc.2005.04.001; Callera GE, 2011, CARDIOVASC RES, V91, P720, DOI 10.1093/cvr/cvr131; Dooley R, 2011, FRONT BIOSCI-LANDMRK, V16, P440, DOI 10.2741/3697; Ferron L, 2011, CARDIOVASC RES, V90, P105, DOI 10.1093/cvr/cvq379; Gan RT, 2011, PLANTA MED, V77, P226, DOI 10.1055/s-0030-1250256; Hayashi H, 2008, HYPERTENS RES, V31, P363, DOI 10.1291/hypres.31.363; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Hong-Li S, 2008, PHYTOTHER RES, V22, P985, DOI 10.1002/ptr.2452; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Husi H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-110; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Leal J., 2012, EUROPEAN CARDIOVASCU, P116; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Manrique C, 2009, MED CLIN N AM, V93, P569, DOI 10.1016/j.mcna.2009.02.014; Manrique Camila, 2007, V139, P163; McMurray JJV, 2004, NEW ENGL J MED, V351, P526, DOI 10.1056/NEJMp048144; Mihailidou AS, 2009, HYPERTENSION, V54, P1306, DOI 10.1161/HYPERTENSIONAHA.109.136242; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Shahbaz AU, 2011, J CARDIOVASC PHARM, V57, P37, DOI 10.1097/FJC.0b013e3181fe1250; Shen XC, 2011, J ASIAN NAT PROD RES, V13, P215, DOI 10.1080/10286020.2010.550883; Soberman Judith, 2002, Curr Opin Investig Drugs, V3, P1024; Tirard M, 2004, J MOL ENDOCRINOL, V32, P825, DOI 10.1677/jme.0.0320825; Tokarska-Schlattner M, 2006, J MOL CELL CARDIOL, V41, P389, DOI 10.1016/j.yjmcc.2006.06.009; Rueda JOV, 2012, J APPL PHYSIOL, V112, P2110, DOI 10.1152/japplphysiol.01383.2011; Vijayaraghavan K, 2011, CARDIOL CLIN, V29, P137, DOI 10.1016/j.ccl.2010.11.003; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; Xiao TT, 2013, FOOD CHEM TOXICOL, V53, P364, DOI 10.1016/j.fct.2012.12.022; Yogi A, 2013, CELL SIGNAL, V25, P2163, DOI 10.1016/j.cellsig.2013.07.002; Yong-Gang C, 2010, PHYTOTHER RES, V24, P1844, DOI 10.1002/ptr.3206; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49; Zhao J, 2010, BRIT J PHARMACOL, V159, P1584, DOI 10.1111/j.1476-5381.2009.00551.x; Zhao JP, 2008, SURG TODAY, V38, P931, DOI 10.1007/s00595-008-3785-8; Zhao YG, 2003, GASTROENTEROLOGY, V125, P854, DOI 10.1016/S0016-5085(03)01066-7; 杨钰萍, 2009, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V29, P405	42	28	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88856	10.1371/journal.pone.0088856	http://dx.doi.org/10.1371/journal.pone.0088856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551180	gold, Green Submitted, Green Published			2022-12-25	WOS:000331266000076
J	Hosono, Y; Abe, T; Higuchi, M; Kajii, K; Sakuraba, S; Tada, S; Enomoto, T; Seki, M				Hosono, Yoshifumi; Abe, Takuya; Higuchi, Masato; Kajii, Kosa; Sakuraba, Shuichi; Tada, Shusuke; Enomoto, Takemi; Seki, Masayuki			Tipin Functions in the Protection against Topoisomerase I Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; DNA Repair; DNA Replication; DNA Topoisomerase; Molecular Cell Biology; Camptothecin; DT40; Replication Fork; Tipin; Top1	SISTER-CHROMATID COHESION; XENOPUS EGG EXTRACTS; DNA-REPLICATION; S-PHASE; HOMOLOGOUS RECOMBINATION; GENOME STABILITY; SACCHAROMYCES-CEREVISIAE; TUMOR-CELLS; COMPLEX; CHECKPOINT	Background: The Tim-Tipin complex is a component of the DNA replication machinery that is conserved across eukaryotes. Results:TIPIN gene knock-out cells showed hypersensitivity to the topoisomerase I inhibitor camptothecin, decreased DNA synthesizing activity, and Top1 degradation. Conclusion: The Tim-Tipin complex destabilizes the Top1 cleavage complex. Significance: The Tim-Tipin complex could be a potential drug target in cancer chemotherapy. The replication fork temporarily stalls when encountering an obstacle on the DNA, and replication resumes after the barrier is removed. Simultaneously, activation of the replication checkpoint delays the progression of S phase and inhibits late origin firing. Camptothecin (CPT), a topoisomerase I (Top1) inhibitor, acts as a DNA replication barrier by inducing the covalent retention of Top1 on DNA. The Timeless-Tipin complex, a component of the replication fork machinery, plays a role in replication checkpoint activation and stabilization of the replication fork. However, the role of the Timeless-Tipin complex in overcoming the CPT-induced replication block remains elusive. Here, we generated viable TIPIN gene knock-out (KO) DT40 cells showing delayed S phase progression and increased cell death. TIPIN KO cells were hypersensitive to CPT. However, homologous recombination and replication checkpoint were activated normally, whereas DNA synthesis activity was markedly decreased in CPT-treated TIPIN KO cells. Proteasome-dependent degradation of chromatin-bound Top1 was induced in TIPIN KO cells upon CPT treatment, and pretreatment with aphidicolin, a DNA polymerase inhibitor, suppressed both CPT sensitivity and Top1 degradation. Taken together, our data indicate that replication forks formed without Tipin may collide at a high rate with Top1 retained on DNA by CPT treatment, leading to CPT hypersensitivity and Top1 degradation in TIPIN KO cells.	[Hosono, Yoshifumi; Higuchi, Masato; Sakuraba, Shuichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Abe, Takuya] Fdn Italiana Ric Canc FIRC Inst Mol Oncol Fdn, Inst FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Kajii, Kosa; Seki, Masayuki] Tohoku Pharmaceut Univ, Dept Biochem, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Tada, Shusuke] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Enomoto, Takemi] Musashino Univ, Pharmaceut Sci Res Inst, Mol Cell Biol Lab, Fac Pharm, Tokyo 2028585, Japan	Tohoku University; IFOM - FIRC Institute of Molecular Oncology; Tohoku Medical & Pharmaceutical University	Seki, M (corresponding author), Tohoku Pharmaceut Univ, Dept Biochem, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	seki@tohoku-pharm.ac.jp	ABE, TAKUYA/A-2861-2015	ABE, TAKUYA/0000-0001-5298-082X	Ministry of Education, Culture, Sports, Science and Technology of Japan (NEXT KAKENHI) [22131002, 24590089]; Grants-in-Aid for Scientific Research [12J07075] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (NEXT KAKENHI); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (NEXT KAKENHI Grants 22131002 and 24590089).	Abe T, 2008, CELL SIGNAL, V20, P1978, DOI 10.1016/j.cellsig.2008.07.006; Aria V, 2013, J BIOL CHEM, V288, P12742, DOI 10.1074/jbc.M112.398073; Arnaudeau C, 2000, MUTAT RES-DNA REPAIR, V461, P221, DOI 10.1016/S0921-8777(00)00052-5; Aze A, 2013, CHROMOSOMA, V122, P401, DOI 10.1007/s00412-013-0411-3; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Errico A, 2010, EMBO REP, V11, P270, DOI 10.1038/embor.2010.27; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hosono Y, 2011, BIOCHEM BIOPH RES CO, V410, P568, DOI 10.1016/j.bbrc.2011.06.027; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kobayashi M, 2004, GENES CELLS, V9, P291, DOI 10.1111/j.1356-9597.2004.00728.x; Leman AR, 2012, CELL CYCLE, V11, P3945, DOI 10.4161/cc.21989; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lin CP, 2009, J BIOL CHEM, V284, P28084, DOI 10.1074/jbc.M109.030601; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Rapp JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013379; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Roseaulin LC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003213; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Yoshimura A, 2011, BIOCHEM BIOPH RES CO, V414, P298, DOI 10.1016/j.bbrc.2011.09.037; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858	52	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11374	11384		10.1074/jbc.M113.531707	http://dx.doi.org/10.1074/jbc.M113.531707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573676	Green Published, hybrid			2022-12-25	WOS:000334638500039
J	Akhter, R; Sanphui, P; Biswas, SC				Akhter, Rumana; Sanphui, Priyankar; Biswas, Subhas Chandra			The Essential Role of p53-up-regulated Modulator of Apoptosis ( Puma) and Its Regulation by FoxO3a Transcription Factor in beta- Amyloid- induced Neuron Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Bcl-2 Family Proteins; Cell Death; Foxo; Neurodegeneration; Neurons; siRNA; Bim; Puma	NERVE GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; PLAY REQUIRED ROLES; CELL-DEATH; ALZHEIMERS-DISEASE; BH3-ONLY PROTEIN; PROAPOPTOTIC ACTIVITY; FACTOR DEPRIVATION; PROMOTE APOPTOSIS; CORTICAL-NEURONS	Background: -Amyloid-induced neuron death and degeneration is considered to be central to the pathogenesis of Alzheimer disease. Results: p53-up-regulated modulator of apoptosis (Puma), a protein of the B-cell lymphoma-2 family, is induced by transcription factor FoxO3a and participates in neuron death in response to -amyloid. Conclusion: -Amyloid-induced neuron death requires induction of Puma. Significance: Puma could be a potential target for disease therapeutics. Neurodegeneration underlies the pathology of Alzheimer disease (AD). The molecules responsible for such neurodegeneration in AD brain are mostly unknown. Recent findings indicate that the BH3-only proteins of the Bcl-2 family play an essential role in various cell death paradigms, including neurodegeneration. Here we report that Puma (p53-up-regulated modulator of apoptosis), an important member of the BH3-only protein family, is up-regulated in neurons upon toxic -amyloid 1-42 (A(1-42)) exposure both in vitro and in vivo. Down-regulation of Puma by specific siRNA provides significant protection against neuron death induced by A(1-42). We further demonstrate that the activation of p53 and inhibition of PI3K/Akt pathways induce Puma. The transcription factor FoxO3a, which is activated when PI3K/Akt signaling is inhibited, directly binds with the Puma gene and induces its expression upon exposure of neurons to oligomeric A(1-42). Moreover, Puma cooperates with another BH3-only protein, Bim, which is already implicated in AD. Our results thus suggest that Puma is activated by both p53 and PI3K/Akt/FoxO3a pathways and cooperates with Bim to induce neuron death in response to A(1-42).	[Akhter, Rumana; Sanphui, Priyankar; Biswas, Subhas Chandra] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Biswas, SC (corresponding author), Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	biswassc@gmail.com			Department of Biotechnology, Government of India [BT/PR14383/MED/12/475/2010]; CSIR-Supra Institutional Project BenD [BSC0206]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR-Supra Institutional Project BenD	This work is supported in part by the Department of Biotechnology, Government of India, Project BT/PR14383/MED/12/475/2010 and CSIR-Supra Institutional Project BenD BSC0206.	Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Biswas SC, 2005, NEUROCHEM RES, V30, P839, DOI 10.1007/s11064-005-6877-5; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Biswas SC, 2010, J NEUROSCI, V30, P3973, DOI 10.1523/JNEUROSCI.6421-09.2010; Bock FJ, 2011, MOL CELL, V42, P555, DOI 10.1016/j.molcel.2011.05.022; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Estus S, 1997, J NEUROSCI, V17, P7736; Fogarty MP, 2010, NEUROBIOL AGING, V31, P1774, DOI 10.1016/j.neurobiolaging.2008.09.018; Fogarty MP, 2003, BIOCHEM J, V371, P789, DOI 10.1042/BJ20021660; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Futami T, 2005, J BIOL CHEM, V280, P826, DOI 10.1074/jbc.M409948200; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niizuma K, 2009, STROKE, V40, P618, DOI 10.1161/STROKEAHA.108.524447; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rideout HJ, 2003, J NEUROSCI, V23, P1237, DOI 10.1523/JNEUROSCI.23-04-01237.2003; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Selznick LA, 2000, J NEUROPATH EXP NEUR, V59, P271, DOI 10.1093/jnen/59.4.271; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Troy CM, 2000, J NEUROSCI, V20, P1386; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	59	74	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10812	10822		10.1074/jbc.M113.519355	http://dx.doi.org/10.1074/jbc.M113.519355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567336	hybrid, Green Published			2022-12-25	WOS:000334226400049
J	Chatani, E; Imamura, H; Yamamoto, N; Kato, M				Chatani, Eri; Imamura, Hiroshi; Yamamoto, Naoki; Kato, Minoru			Stepwise Organization of the beta- Structure Identifies Key Regions Essential for the Propagation and Cytotoxicity of Insulin Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Insulin; Protein Aggregation; Protein Misfolding; Protein Structure; Cytotoxicity; Prefibrillar Intermediate; Propagation	ELECTRON-MICROSCOPY; HYDROGEN-EXCHANGE; HUMAN-DISEASE; OLIGOMERS; MECHANISM; FIBRILLATION; BETA(2)-MICROGLOBULIN; TOXICITY; KINETICS; PROTOFIBRILS	Background: Oligomers and protofibrils have been observed in the early stages of fibrillation. Results: Fibrillation of insulin at a high salt concentration identified a new species of prefibrillar intermediate. Conclusion: Structural comparison of the intermediate and mature fibrils suggested regions responsible for self-propagation and cytotoxicity. Significance: The trapping of intermediate is an effective way of revealing molecular details of the organization of fibril structure. Amyloid fibrils are supramolecular assemblies, the deposition of which is associated with many serious diseases including Alzheimer, prion, and Huntington diseases. Several smaller aggregates such as oligomers and protofibrils have been proposed to play a role in early stages of the fibrillation process; however, little is known about how these species contribute to the formation of mature amyloid fibrils with a rigid cross- structure. Here, we identified a new pathway for the formation of insulin amyloid fibrils at a high concentration of salt in which mature fibrils were formed in a stepwise manner via a prefibrillar intermediate: minute prefibrillar species initially accumulated, followed by the subsequent formation of thicker amyloid fibrils. Fourier transform infrared spectra suggested the sequential formation of two types of -sheets with different strength hydrogen bonds, one of which was developed concomitantly with the mutual assembly of the prefibrillar intermediate to form mature fibrils. Interestingly, fibril propagation and cellular toxicity appeared only after the later step of structural organization, and a comparison of -sheet regions between the prefibrillar intermediate and mature fibrils using proteolysis led to the proposal of specific regions essential for manifestation of these properties.	[Chatani, Eri] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Imamura, Hiroshi; Yamamoto, Naoki; Kato, Minoru] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga 5258577, Japan	Kobe University; Ritsumeikan University	Chatani, E (corresponding author), 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	chatani@crystal.kobe-u.ac.jp; kato-m@ph.ritsumei.ac.jp	Imamura, Hiroshi/P-5916-2018	Imamura, Hiroshi/0000-0001-8924-747X	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant [23770188]; Astellas Foundation for Research into Metabolic Disorders; Hayashi Memorial Foundation for Female Natural Scientists; Tomizawa Foundation; Ritsumeikan Global Innovation Research Organization (R-GIRO); Grants-in-Aid for Scientific Research [25440071] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant; Astellas Foundation for Research into Metabolic Disorders(Astellas Pharmaceuticals); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Tomizawa Foundation; Ritsumeikan Global Innovation Research Organization (R-GIRO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant 23770188, and grants from the Astellas Foundation for Research into Metabolic Disorders, Hayashi Memorial Foundation for Female Natural Scientists, and Tomizawa Foundation (to E. C.), and the Ritsumeikan Global Innovation Research Organization (R-GIRO) (to M. K.).	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fodera V, 2009, J PHYS CHEM B, V113, P10830, DOI 10.1021/jp810972y; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Grudzielanek S, 2006, J MOL BIOL, V356, P497, DOI 10.1016/j.jmb.2005.11.075; He XL, 2010, J MOL BIOL, V395, P134, DOI 10.1016/j.jmb.2009.10.019; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jansen R, 2005, BIOPHYS J, V88, P1344, DOI 10.1529/biophysj.104.048843; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Konuma T, 2011, J MOL BIOL, V405, P851, DOI 10.1016/j.jmb.2010.11.029; Manno M, 2010, LANGMUIR, V26, P1424, DOI 10.1021/la903340v; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Muzaffar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027906; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, J PHARM SCI-US, V90, P29, DOI 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106; Relini A, 2010, BIOPHYS J, V98, P1277, DOI 10.1016/j.bpj.2009.11.052; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yanagi K, 2012, J MOL BIOL, V422, P390, DOI 10.1016/j.jmb.2012.05.034; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; ZHU YF, 1995, RAPID COMMUN MASS SP, V9, P1315, DOI 10.1002/rcm.1290091318	59	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10399	10410		10.1074/jbc.M113.520874	http://dx.doi.org/10.1074/jbc.M113.520874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569992	Green Published, hybrid			2022-12-25	WOS:000334226400014
J	Hang, LE; Lopez, CR; Liu, XP; Williams, JM; Chung, I; Wei, L; Bertuch, AA; Zhao, XL				Hang, Lisa E.; Lopez, Christopher R.; Liu, Xianpeng; Williams, Jaime M.; Chung, Inn; Wei, Lei; Bertuch, Alison A.; Zhao, Xiaolan			Regulation of Ku-DNA Association by Yku70 C-terminal Tail and SUMO Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Molecular Genetics; Sumoylation; Telomeres; Yeast; Ku Complex	DOUBLE-STRAND BREAKS; END-JOINING REPAIR; SACCHAROMYCES-CEREVISIAE; TELOMERE MAINTENANCE; BUDDING YEAST; CELL-CYCLE; HETERODIMER; COMPLEX; BINDING; SUMOYLATION	Background: The Ku70-Ku80 ring encloses DNA ends to enable telomere protection and DNA repair. Results: Conditional sumoylation of Ku70 is reduced by mutating C-terminal lysines and this mutant shows decreased DNA interaction, shortened telomeres, and altered DNA repair. Conclusion: Our analyses suggest that sumoylation modulates Ku function by enhancing its DNA association. Significance: Ku is regulated by Ku70 C-terminal lysines and SUMO modification. The Ku70-Ku80 ring complex encloses DNA ends to facilitate telomere maintenance and DNA break repair. Many studies focus on the ring-forming regions of subunits Ku70 and Ku80. Less is known about the Ku70 C-terminal tail, which lies outside the ring. Our results suggest that this region is responsible for dynamic sumoylation of Yku70 upon DNA association in budding yeast. Mutating a cluster of five lysines in this region largely eliminates Yku70 sumoylation. Chromatin immunoprecipitation analyses show that yku70 mutants with these lysines replaced by arginines exhibit reduced Ku-DNA association at both telomeres and internal DNA breaks. Consistent with this physical evidence, Yku70 sumoylation deficiency is associated with impaired ability to block DNA end resection and suppression of multiple defects caused by inefficient resection. Correlating with these, yku70 mutants with reduced sumoylation levels exhibit shorter telomeres, increased G overhang levels, and altered levels of non-homologous end joining. We also show that diminution of sumoylation does not affect Yku70 protein levels or its interactions with protein and RNA partners. These results suggest a model whereby Yku70 sumoylation upon DNA association strengthens Ku-DNA interaction to promote multiple functions of Ku.	[Hang, Lisa E.; Liu, Xianpeng; Chung, Inn; Wei, Lei; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Hang, Lisa E.; Zhao, Xiaolan] Cornell Univ, Weill Grad Sch Med Sci, Program Biochem, New York, NY 10065 USA; [Hang, Lisa E.; Zhao, Xiaolan] Cornell Univ, Weill Grad Sch Med Sci, Program Cell, New York, NY 10065 USA; [Hang, Lisa E.; Zhao, Xiaolan] Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10065 USA; [Wei, Lei; Zhao, Xiaolan] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Lopez, Christopher R.; Bertuch, Alison A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Williams, Jaime M.; Bertuch, Alison A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	zhaox1@mskcc.org		Nagy, Jaime/0000-0002-7945-4050; Bertuch, Alison/0000-0003-1864-8502; Zhao, Xiaolan/0000-0002-8302-6905	National Institutes of Health [GM080670, GM077509, GM008307]; American Cancer Society [RSG-12-013-01-CCG]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077509, T32GM008307, R01GM080670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080670, American Cancer Society Grant RSG-12-013-01-CCG, and Leukemia and Lymphoma Society Scholar Award (to X. Z.), National Institutes of Health Grant GM077509 (to A. B.), and GM008307 (T32 trainee J. M. W.).	Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Driller L, 2000, J BIOL CHEM, V275, P24921, DOI 10.1074/jbc.M002588200; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Hang LE, 2011, NAT STRUCT MOL BIOL, V18, P920, DOI 10.1038/nsmb.2100; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Palmbos PL, 2005, MOL CELL BIOL, V25, P10782, DOI 10.1128/MCB.25.24.10782-10790.2005; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	39	23	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10308	10317		10.1074/jbc.M113.526178	http://dx.doi.org/10.1074/jbc.M113.526178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567323	Green Published, hybrid			2022-12-25	WOS:000334226400007
J	Lebbe, EKM; Peigneur, S; Maiti, M; Devi, P; Ravichandran, S; Lescrinier, E; Ulens, C; Waelkens, E; D'Souza, L; Herdewijn, P; Tytgat, J				Lebbe, Eline K. M.; Peigneur, Steve; Maiti, Mohitosh; Devi, Prabha; Ravichandran, Samuthirapandian; Lescrinier, Eveline; Ulens, Chris; Waelkens, Etienne; D'Souza, Lisette; Herdewijn, Piet; Tytgat, Jan			Structure-Function Elucidation of a New alpha-Conotoxin, Lo1a, from Conus longurionis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Electrophysiology; Nicotinic Acetylcholine Receptors; NMR; Protein Engineering; Schizophrenia; Conotoxin; Conotoxin Structure-Function Relationship	NICOTINIC ACETYLCHOLINE-RECEPTORS; NACHR SUBTYPE SELECTIVITY; MOLECULAR DISSECTION; SUBUNIT INTERFACES; CRYSTAL-STRUCTURE; SOLUTION CONFORMATION; PEPTIDE ANTAGONIST; BINDING PROTEIN; LIGAND-BINDING; IDENTIFICATION	Background: -Conotoxins are small toxins produced by cone snails and antagonists of nicotinic acetylcholine receptors. Results: Two mutants were created to investigate the unusual C terminus of a novel -conotoxin from Conus longurionis. Conclusion: We characterized an important residue for discrimination between neuronal and muscle subtype nicotinic acetylcholine receptors. Significance: This opens perspectives for designing new ligands to affect brain disorders. -Conotoxins are peptide toxins found in the venom of marine cone snails and potent antagonists of various subtypes of nicotinic acetylcholine receptors (nAChRs). nAChRs are cholinergic receptors forming ligand-gated ion channels in the plasma membranes of certain neurons and the neuromuscular junction. Because nAChRs have an important role in regulating transmitter release, cell excitability, and neuronal integration, nAChR dysfunctions have been implicated in a variety of severe pathologies such as epilepsy, myasthenic syndromes, schizophrenia, Parkinson disease, and Alzheimer disease. To expand the knowledge concerning cone snail toxins, we examined the venom of Conus longurionis. We isolated an 18-amino acid peptide named -conotoxin Lo1a, which is active on nAChRs. To the best of our knowledge, this is the first characterization of a conotoxin from this species. The peptide was characterized by electrophysiological screening against several types of cloned nAChRs expressed in Xenopus laevis oocytes. The three-dimensional solution structure of the -conotoxin Lo1a was determined by NMR spectroscopy. Lo1a, a member of the 4/7 family, blocks the response to acetylcholine in oocytes expressing (7) nAChRs with an IC50 of 3.24 +/- 0.7 m. Furthermore, Lo1a shows a high selectivity for neuronal versus muscle subtype nAChRs. Because Lo1a has an unusual C terminus, we designed two mutants, Lo1a-D and Lo1a-RRR, to investigate the influence of the C-terminal residue. Lo1a-D has a C-terminal Asp deletion, whereas in Lo1a-RRR, a triple-Arg tail replaces the Asp. They blocked the neuronal nAChR (7) with a lower IC50 value, but remarkably, both adopted affinity for the muscle subtype E-11.	[Lebbe, Eline K. M.; Peigneur, Steve; Tytgat, Jan] Univ Leuven KU Leuven, B-3000 Louvain, Belgium; [Maiti, Mohitosh; Lescrinier, Eveline; Herdewijn, Piet] Univ Leuven KU Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Devi, Prabha; D'Souza, Lisette] Natl Inst Oceanog, Council Sci & Ind Res CSIR, Panaji 403004, Goa, India; [Ravichandran, Samuthirapandian] Annamalai Univ, Ctr Adv Study Marine Biol, Parangipettai 608502, Tamil Nadu, India; [Ulens, Chris] Univ Leuven KU Leuven, Lab Struct Neurobiol, B-3000 Louvain, Belgium; [Waelkens, Etienne] Univ Leuven KU Leuven, Lab Prot Phosphorylat & Prote, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Annamalai University; KU Leuven; KU Leuven	Tytgat, J (corresponding author), Katholieke Univ Leuven, Herestr 49, B-3000 Louvain, Belgium.	jan.tytgat@pharm.kuleuven.be	Lescrinier, Eveline/G-9339-2016; Samuthirapandiyan, Ravichandran/AAI-6658-2020	Lescrinier, Eveline/0000-0001-7066-4329; Samuthirapandiyan, Ravichandran/0000-0002-8632-5062; Herdewijn, Piet/0000-0003-3589-8503; Lebbe, Eline/0000-0001-8523-1518; Peigneur, Steve/0000-0003-0504-5702	F.W.O. Vlaanderen [G.0939.11, G.0762.13, G.0433.12, G.A071.10N, G.0257.08]; EU-FP7-MAREX; Inter-University Attraction Poles Program (Belgian State, Belgian Science Policy) [IUAP 7/10, IUAP 7/24]; University of Leuven [T/12/081, GOA12/016]; Academische Stichting Leuven [2013/146]	F.W.O. Vlaanderen(FWO); EU-FP7-MAREX; Inter-University Attraction Poles Program (Belgian State, Belgian Science Policy)(Belgian Federal Science Policy Office); University of Leuven(KU Leuven); Academische Stichting Leuven	Supported by Grants G.0939.11 and G.0762.13 (F.W.O. Vlaanderen).; Supported by Grants G.0433.12, G.A071.10N, and G.0257.08 from F.W.O. Vlaanderen; EU-FP7-MAREX, IUAP 7/10, and IUAP 7/24 from the Inter-University Attraction Poles Program (Belgian State, Belgian Science Policy); OT/12/081 and GOA12/016 from the University of Leuven; and 2013/146 from Academische Stichting Leuven. To whom correspondence should be addressed: Toxicology and Pharmacology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-32-34-04; Fax: 32-16-32-34-05; E-mail: jan.tytgat@pharm.kuleuven.be.	Alberola-Die A, 2011, J NEUROCHEM, V117, P1009, DOI 10.1111/j.1471-4159.2011.07271.x; Arias HR, 2000, INT J BIOCHEM CELL B, V32, P1017, DOI 10.1016/S1357-2725(00)00051-0; Armishaw C, 2009, J BIOL CHEM, V284, P9498, DOI 10.1074/jbc.M806136200; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; Chi SW, 2004, BIOCHEM J, V380, P347, DOI 10.1042/BJ20031792; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Everhart D, 2004, BIOCHEMISTRY-US, V43, P2732, DOI 10.1021/bi036180h; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gold AB, 2012, HUM GENET, V131, P857, DOI 10.1007/s00439-012-1143-9; Gotti C, 1997, PROG NEUROBIOL, V53, P199, DOI 10.1016/S0301-0082(97)00034-8; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; GROEBE DR, 1995, MOL PHARMACOL, V48, P105; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Jin AH, 2014, BIOCHEMISTRY-US, V53, P1, DOI 10.1021/bi400882s; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Keller Martin, 2004, Tech Hand Up Extrem Surg, V8, P212, DOI 10.1097/00130911-200412000-00003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lluisma AO, 2008, TOXICON, V51, P174, DOI 10.1016/j.toxicon.2007.07.009; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; MARTINEZ JS, 1995, BIOCHEMISTRY-US, V34, P14519, DOI 10.1021/bi00044a030; Marx UC, 2006, MAGN RESON CHEM, V44, pS41, DOI 10.1002/mrc.1821; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Park KH, 2001, J BIOL CHEM, V276, P49028, DOI 10.1074/jbc.M107798200; Peng C, 2008, PEPTIDES, V29, P1700, DOI 10.1016/j.peptides.2008.05.028; Peng C, 2010, ACTA BIOCH BIOPH SIN, V42, P745, DOI 10.1093/abbs/gmq074; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Quinton L, 2013, ANAL BIOANAL CHEM, V405, P5341, DOI 10.1007/s00216-013-6926-x; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; RUBBOLI F, 1994, EUR J NEUROSCI, V6, P1596, DOI 10.1111/j.1460-9568.1994.tb00550.x; Sacco KA, 2004, J PSYCHOPHARMACOL, V18, P457, DOI 10.1177/0269881104047273; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Steinlein OK, 2010, PFLUG ARCH EUR J PHY, V460, P495, DOI 10.1007/s00424-009-0766-8; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Teichert RW, 2005, J NEUROSCI, V25, P732, DOI 10.1523/JNEUROSCI.4065-04.2005; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Tucker JK, 2009, SYSTEMATIC CLASSIFIC; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; WEVERS A, 1994, MOL BRAIN RES, V25, P122, DOI 10.1016/0169-328X(94)90286-0; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan DD, 2007, TOXICON, V49, P1135, DOI 10.1016/j.toxicon.2007.02.011	77	18	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9573	9583		10.1074/jbc.M114.556175	http://dx.doi.org/10.1074/jbc.M114.556175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567324	Green Published, hybrid			2022-12-25	WOS:000333807000013
J	Voyvodic, PL; Min, D; Liu, R; Williams, E; Chitalia, V; Dunn, AK; Baker, AB				Voyvodic, Peter L.; Min, Daniel; Liu, Robert; Williams, Evan; Chitalia, Vipul; Dunn, Andrew K.; Baker, Aaron B.			Loss of Syndecan-1 Induces a Pro-inflammatory Phenotype in Endothelial Cells with a Dysregulated Response to Atheroprotective Flow*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Inflammation; Leukocyte; Mechanotransduction; Shear Stress; Atheroprotective Flow; Flow; Glycocalyx; Syndecan-1	FLUID SHEAR-STRESS; HEPARAN-SULFATE PROTEOGLYCANS; IN-VITRO; GROWTH-FACTOR; NITRIC-OXIDE; GLYCOCALYX; MECHANOTRANSDUCTION; ACTIVATION; MICE; ATHEROSCLEROSIS	Background: The endothelial glycocalyx extends into the arterial lumen and experiences shear forces from blood flow. Results: The loss of syndecan-1 results in a pro-inflammatory phenotype in endothelial cells with an altered response to atheroprotective flow. Conclusion: Syndecan-1 plays an important role in maintaining healthy endothelial phenotype. Significance: Therapies that retain syndecan-1 on endothelial cells may have the potential to reduce the progression of vascular disease. Fluid shear stresses are potent regulators of vascular homeostasis and powerful determinants of vascular disease progression. The glycocalyx is a layer of glycoaminoglycans, proteoglycans, and glycoproteins that lines the luminal surface of arteries. The glycocalyx interacts directly with hemodynamic forces from blood flow and, consequently, is a prime candidate for the mechanosensing of fluidic shear stresses. Here, we investigated the role of the glycocalyx component syndecan-1 (sdc-1) in controlling the shear stress-induced signaling and flow-mediated phenotypic modulation in endothelial cells. We found that knock-out of sdc-1 abolished several key early signaling events of endothelial cells in response to shear stress including the phosphorylation of Akt, the formation of a spatial gradient in paxillin phosphorylation, and the activation of RhoA. After exposure to atheroprotective flow, we found that sdc-1 knock-out endothelial cells had a phenotypic shift to an inflammatory/pro-atherosclerotic phenotype in contrast to the atheroprotective phenotype of wild type cells. Consistent with these findings, we found increased leukocyte adhesion to sdc-1 knock-out endothelial cells in vitro that was reduced by re-expression of sdc-1. In vivo, we found increased leukocyte recruitment and vascular permeability/inflammation in sdc-1 knock-out mice. Taken together, our studies support a key role for sdc-1 in endothelial mechanosensing and regulation of endothelial phenotype.	[Voyvodic, Peter L.; Min, Daniel; Liu, Robert; Williams, Evan; Dunn, Andrew K.; Baker, Aaron B.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Chitalia, Vipul] Boston Univ, Sch Med, Boston Med Ctr, Renal Sect,Dept Med, Boston, MA 02118 USA	University of Texas System; University of Texas Austin; Boston Medical Center; Boston University	Baker, AB (corresponding author), Univ Texas Austin, Dept Biomed Engn, 107 West Dean Keeton St,BME 5-202D,C0800, Austin, TX 78712 USA.	abbaker1@gmail.com	Baker, Aaron/AAT-4635-2020; Dunn, Andrew/I-9527-2014	Voyvodic, Peter/0000-0001-6578-8837	National Institutes of Health [DP2 OD008716-01]; American Heart Association [10SDG2630139]; NATIONAL CANCER INSTITUTE [R01CA175382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080946] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Grant DP2 OD008716-01 (to A. B. B.). This work was also supported by American Heart Association Grant 10SDG2630139.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Baker AB, 2010, ATHEROSCLEROSIS, V213, P436, DOI 10.1016/j.atherosclerosis.2010.09.003; Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Das S, 2014, BIOMATERIALS, V35, P196, DOI 10.1016/j.biomaterials.2013.09.105; Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; HECKER M, 1993, AM J PHYSIOL, V265, pH828, DOI 10.1152/ajpheart.1993.265.3.H828; Hennig T, 2011, J VASC RES, V48, P453, DOI 10.1159/000327009; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Hoshino Y, 2000, CIRCULATION, V102, P2528, DOI 10.1161/01.CIR.102.20.2528; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Hutcheson IR, 1996, BRIT J PHARMACOL, V118, P720, DOI 10.1111/j.1476-5381.1996.tb15459.x; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Koskinas KC, 2010, CIRCULATION, V121, P2092, DOI 10.1161/CIRCULATIONAHA.109.901678; Kumagai R, 2009, FREE RADICAL BIO MED, V47, P600, DOI 10.1016/j.freeradbiomed.2009.05.034; Kumekawa M, 2008, BIOL PHARM BULL, V31, P1609, DOI 10.1248/bpb.31.1609; Malek AM, 1999, J MOL CELL CARDIOL, V31, P387, DOI 10.1006/jmcc.1998.0873; Mobine HR, 2009, CIRC-HEART FAIL, V2, P121, DOI 10.1161/CIRCHEARTFAILURE.108.813261; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nam EJ, 2012, METHODS MOL BIOL, V836, P291, DOI 10.1007/978-1-61779-498-8_19; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pohl U., 1991, AM J PHYSIOL, V261, pH2016; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Ramani VC, 2013, FEBS J, V280, P2294, DOI 10.1111/febs.12168; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Roper JA, 2012, CURR OPIN STRUC BIOL, V22, P583, DOI 10.1016/j.sbi.2012.07.003; Savery MD, 2013, MICROVASC RES, V87, P83, DOI 10.1016/j.mvr.2013.02.001; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Voyvodic PL, 2012, LAB CHIP, V12, P3322, DOI 10.1039/c2lc40526a; Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100; Yang BH, 2011, ARTERIOSCL THROM VAS, V31, P376, DOI 10.1161/ATVBAHA.110.217794; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	60	82	85	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9547	9559		10.1074/jbc.M113.541573	http://dx.doi.org/10.1074/jbc.M113.541573			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554698	Green Published, hybrid			2022-12-25	WOS:000333807000011
J	Sitaras, I; Kalthoff, D; Beer, M; Peeters, B; de Jong, MCM				Sitaras, Ioannis; Kalthoff, Donata; Beer, Martin; Peeters, Ben; de Jong, Mart C. M.			Immune Escape Mutants of Highly Pathogenic Avian Influenza H5N1 Selected Using Polyclonal Sera: Identification of Key Amino Acids in the HA Protein	PLOS ONE			English	Article							A VIRUSES; HEMAGGLUTININ MOLECULE; ANTIGENIC SITES; EVOLUTION; POULTRY; NEUTRALIZATION; TRANSMISSION; VACCINATION; OUTBREAKS; VACCINES	Evolution of Avian Influenza (AI) viruses - sespecially of the Highly Pathogenic Avian Influenza (HPAI) H5N1 subtype - is a major issue for the poultry industry. HPAI H5N1 epidemics are associated with huge economic losses and are sometimes connected to human morbidity and mortality. Vaccination (either as a preventive measure or as a means to control outbreaks) is an approach that splits the scientific community, due to the risk of it being a potential driving force in HPAI evolution through the selection of mutants able to escape vaccination-induced immunity. It is therefore essential to study how mutations are selected due to immune pressure. To this effect, we performed an in vitro selection of mutants from HPAI A/turkey/Turkey/1/05 (H5N1), using immune pressure from homologous polyclonal sera. After 42 rounds of selection, we identified 5 amino acid substitutions in the Haemagglutinin (HA) protein, most of which were located in areas of antigenic importance and suspected to be prone to selection pressure. We report that most of the mutations took place early in the selection process. Finally, our antigenic cartography studies showed that the antigenic distance between the selected isolates and their parent strain increased with passage number.	[Sitaras, Ioannis; de Jong, Mart C. M.] Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands; [Sitaras, Ioannis; Peeters, Ben] Univ Wageningen & Res Ctr, Cent Vet Inst, Dept Virol, Lelystad, Netherlands; [Kalthoff, Donata; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Riems, Germany	Wageningen University & Research; Wageningen University & Research; Friedrich Loeffler Institute	de Jong, MCM (corresponding author), Wageningen Univ, Dept Anim Sci, NL-6700 AP Wageningen, Netherlands.	mart.dejong@wur.nl	de Jong, Mart C.M./GQQ-0825-2022	de Jong, Mart C.M./0000-0002-5339-1995; Sitaras, Ioannis/0000-0003-0161-8024; Hoffmann, Donata/0000-0003-4552-031X	Impulse Veterinary Avian Influenza Research in the Netherlands program of the Economic Structure Enhancement Fund	Impulse Veterinary Avian Influenza Research in the Netherlands program of the Economic Structure Enhancement Fund	This research was funded by the Impulse Veterinary Avian Influenza Research in the Netherlands program of the Economic Structure Enhancement Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2012, VIRUS GENES, V45, P14, DOI 10.1007/s11262-012-0758-1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Arafa A, 2012, ARCH VIROL, V157, P1931, DOI 10.1007/s00705-012-1385-9; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P181, DOI 10.1007/s00430-007-0042-5; Dapat IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036455; Domingo E, 1997, BIOL TRACE ELEM RES, V56, P23, DOI 10.1007/BF02778981; DONALD HB, 1954, J GEN MICROBIOL, V10, P457, DOI 10.1099/00221287-10-3-457; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Duvvuri Venkata R. S. K., 2009, Genomics Proteomics & Bioinformatics, V7, P47, DOI 10.1016/S1672-0229(08)60032-7; ECDC, 2011, SURV REP INFL VIR CH; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fouchier RAM, 2010, AVIAN DIS, V54, P220, DOI 10.1637/8740-032509-ResNote.1; GERHARD W, 1978, J EXP MED, V148, P383, DOI 10.1084/jem.148.2.383; Ginting TE, 2012, J VIROL, V86, P121, DOI 10.1128/JVI.06085-11; GITELMAN AK, 1986, J GEN VIROL, V67, P2247, DOI 10.1099/0022-1317-67-10-2247; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Hafez MH, 2010, POULTRY SCI, V89, P1609, DOI 10.3382/ps.2010-00708; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoper D, 2012, J VIROL, V86, P1394, DOI 10.1128/JVI.00797-11; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Ilyushina NA, 2012, J VIROL, V86, P4724, DOI 10.1128/JVI.06774-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jiang WM, 2010, J GEN VIROL, V91, P2491, DOI 10.1099/vir.0.023168-0; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nishiura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055358; Park KJ, 2011, J GEN VIROL, V92, P36, DOI 10.1099/vir.0.024992-0; Pavade G, 2011, REV SCI TECH OIE, V30, P661; PHILPOTT M, 1989, J VIROL, V63, P3453, DOI 10.1128/JVI.63.8.3453-3458.1989; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Portuguese Laboratory Network for the Diagnosis of Influenza I, 2012, EURO SURVEILL, V17; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Siddique N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-300; Smith Derek J, 2004, Discov Med, V4, P371; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 2004, PLOS COMPUT BIOL, V4, P371; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022844; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Swayne DE, 2012, EXPERT REV VACCINES, V11, P877, DOI 10.1586/ERV.12.60; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tsuchiya E, 2002, J GEN VIROL, V83, P1137, DOI 10.1099/0022-1317-83-5-1137; Ubol S, 2011, J GEN VIROL, V92, P307, DOI 10.1099/vir.0.025973-0; UN FAO, 2012, H5N1 HPAI GLOB OV JA; UN OIE, 2012, MAN DIAGN TESTS VACC; Van Borm S, 2010, AVIAN DIS, V54, P558, DOI 10.1637/8756-033109-ResNote.1; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Watanabe Y, 2012, J GEN VIROL, V93, P2215, DOI 10.1099/vir.0.044032-0; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization (WHO), 2011, AV INFL FACT SHEET; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; YEWDELL JW, 1986, J VIROL, V57, P623, DOI 10.1128/JVI.57.2.623-628.1986	77	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e84628	10.1371/journal.pone.0084628	http://dx.doi.org/10.1371/journal.pone.0084628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586231	Green Published, gold, Green Submitted			2022-12-25	WOS:000332385900001
J	Skefos, J; Cummings, C; Enzer, K; Holiday, J; Weed, K; Levy, E; Yuce, T; Kemper, T; Bauman, M				Skefos, Jerry; Cummings, Christopher; Enzer, Katelyn; Holiday, Jarrod; Weed, Katrina; Levy, Ezra; Yuce, Tarik; Kemper, Thomas; Bauman, Margaret			Regional Alterations in Purkinje Cell Density in Patients with Autism	PLOS ONE			English	Article							CEREBELLAR CONTRIBUTIONS; ALZHEIMERS-DISEASE; VESTIBULAR NUCLEI; NEURONAL DENSITY; LOBULE-VII; PROJECTIONS; BRAIN; INDIVIDUALS; VERMIS; CONNECTIVITY	Neuropathological studies, using a variety of techniques, have reported a decrease in Purkinje cell (PC) density in the cerebellum in autism. We have used a systematic sampling technique that significantly reduces experimenter bias and variance to estimate PC densities in the postmortem brains of eight clinically well-documented individuals with autism, and eight age-and gender-matched controls. Four cerebellar regions were analyzed: a sensorimotor area comprised of hemispheric lobules IV-VI, crus I & II of the posterior lobe, and lobule X of the flocculonodular lobe. Overall PC density was thus estimated using data from all three cerebellar lobes and was found to be lower in the cases with autism as compared to controls, an effect that was most prominent in crus I and II (p < 0.05). Lobule X demonstrated a trend towards lower PC density in only the males with autism (p = 0.05). Brain weight, a correlate of tissue volume, was found to significantly contribute to the lower lobule X PC density observed in males with autism, but not to the finding of lower PC density in crus I & II. Therefore, lower crus I & II PC density in autism is more likely due to a lower number of PCs. The PC density in lobule X was found to correlate with the ADI-R measure of the patient's use of social eye contact (R 2 = 20.75, p = 0.012). These findings support the hypothesis that abnormal PC density may contribute to selected clinical features of the autism phenotype.	[Skefos, Jerry; Cummings, Christopher; Enzer, Katelyn; Holiday, Jarrod; Weed, Katrina; Levy, Ezra; Yuce, Tarik; Kemper, Thomas; Bauman, Margaret] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA	Boston University	Skefos, J (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.	skefos@gmail.com			Autism Research Foundation	Autism Research Foundation	This work was supported by The Autism Research Foundation (http://www.theautismresearchfoundation.org) and Autism Speaks File Number 1391 (http://www.autismspeaks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashiwala RM, 2008, BRAIN RES, V1236, P73, DOI 10.1016/j.brainres.2008.07.119; ALTMAN J, 1996, DEV CEREBELLAR SYSTE; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; Angevine J, 1961, HUMAN CEREBELLUM ATL; Junior EA, 2007, J MATERN-FETAL NEO M, V20, P581, DOI 10.1080/14767050701482928; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Balaban CD, 2004, BRAIN RES, V996, P126, DOI 10.1016/j.brainres.2003.10.026; Balsters JH, 2010, NEUROIMAGE, V49, P2045, DOI 10.1016/j.neuroimage.2009.10.045; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BRAUTH SE, 1977, EXP BRAIN RES, V28, P73; Christ SE, 2011, NEUROPSYCHOLOGY, V25, P690, DOI 10.1037/a0024256; Cohen B, 1999, J VESTIBUL RES-EQUIL, V9, P163; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Danielsson S, 2005, EPILEPSIA, V46, P918, DOI 10.1111/j.1528-1167.2005.57504.x; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; Fehlow P, 1993, Padiatr Grenzgeb, V31, P259; Fukutani Y, 1996, NEUROSCI LETT, V214, P33; Guerin P, 1996, DEV MED CHILD NEUROL, V38, P203; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Heinsen H, 2000, J CHEM NEUROANAT, V20, P49, DOI 10.1016/S0891-0618(00)00067-3; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Holdnack J, 2011, ASSESSMENT, V18, P192, DOI 10.1177/1073191110394771; Ito M., 2012, CEREBELLUM BRAIN IMP; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; KARHUNEN PJ, 1994, BRIT MED J, V308, P1663, DOI 10.1136/bmj.308.6945.1663; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; KUME A, 1991, J NEUROL SCI, V101, P178, DOI 10.1016/0022-510X(91)90043-7; Larsell O, 1941, J COMP NEUROL, V75, P315, DOI 10.1002/cne.900750208; LARSELL O, 1958, ANAT REC, V130, P329; Lee M, 2002, BRAIN, V125, P1483, DOI 10.1093/brain/awf160; Limperopoulos C, 2005, PEDIATRICS, V115, P688, DOI 10.1542/peds.2004-1169; LOHR JB, 1986, BIOL PSYCHIAT, V21, P865, DOI 10.1016/0006-3223(86)90259-3; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Matsumoto R, 1998, ACTA NEUROPATHOL, V95, P149, DOI 10.1007/s004010050779; Mouton P.R., 2001, PRINCIPLES PRACTICES; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; ORNITZ EM, 1968, ARCH GEN PSYCHIAT, V19, P22; Ozol K, 1999, J COMP NEUROL, V412, P95; Pakan JMP, 2008, J COMP NEUROL, V508, P402, DOI 10.1002/cne.21623; Pakan JMP, 2010, J COMP NEUROL, V518, P175, DOI 10.1002/cne.22192; PHILLIPS SC, 1987, BRAIN, V110, P301, DOI 10.1093/brain/110.2.301; Poirier M, 2011, J ABNORM PSYCHOL, V120, P247, DOI 10.1037/a0022298; Ptak R., 2011, NEUROSCIENTIST REV J; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; Rogers JH, 1999, MECH DEVELOP, V87, P119, DOI 10.1016/S0925-4773(99)00154-9; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Saksena S, 2008, INT J DEV NEUROSCI, V26, P705, DOI 10.1016/j.ijdevneu.2008.07.007; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Sjobeck M, 2001, DEMENT GERIATR COGN, V12, P211, DOI 10.1159/000051260; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Straka H, 2006, J NEUROPHYSIOL, V96, P1963, DOI 10.1152/jn.00334.2006; Taylor MJ, 2012, NEUROPHYSIOL CLIN, V42, P19, DOI 10.1016/j.neucli.2011.08.002; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; TORVIK A, 1986, J NEUROL SCI, V76, P283, DOI 10.1016/0022-510X(86)90176-0; Van Kooij BJM, 2011, DEV MED CHILD NEUROL; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vastagh C, 2005, ANAT EMBRYOL, V209, P471, DOI 10.1007/s00429-005-0458-x; Wall DP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.10; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7; Wegiel J, 2013, BRAIN RES, V1512, P106, DOI 10.1016/j.brainres.2013.03.037; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Whitney ER, 2008, CEREBELLUM, V7, P406, DOI 10.1007/s12311-008-0043-y; Whitney ER, 2009, J NEUROSCI RES, V87, P2245, DOI 10.1002/jnr.22056; WILLIAMS RS, 1980, ARCH NEUROL-CHICAGO, V37, P749, DOI 10.1001/archneur.1980.00500610029003; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696; Xiong GX, 2002, NEUROSCI LETT, V322, P173, DOI 10.1016/S0304-3940(02)00108-8; Yerys BE, 2011, CHILD NEUROPSYCHOL, V17, P391, DOI 10.1080/09297049.2010.547462	80	98	99	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e81255	10.1371/journal.pone.0081255	http://dx.doi.org/10.1371/journal.pone.0081255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586223	Green Published, gold, Green Submitted			2022-12-25	WOS:000331880700001
J	Kayashima, Y; Tomita, H; Zhilicheva, S; Kim, S; Kim, HS; Bennett, BJ; Maeda, N				Kayashima, Yukako; Tomita, Hirofumi; Zhilicheva, Svetlana; Kim, Shinja; Kim, Hyung-Suk; Bennett, Brian J.; Maeda, Nobuyo			Quantitative Trait Loci Affecting Atherosclerosis at the Aortic Root Identified in an Intercross between DBA2J and 129S6 Apolipoprotein E-Null Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; GENETIC-LOCI; QTL GENE; MOUSE; SUSCEPTIBILITY; EXPRESSION; CHOLESTEROL; STRAINS	Apolipoprotein E-null mice on a DBA/2J genetic background (DBA-apoE) are highly susceptible to atherosclerosis in the aortic root area compared with those on a 129S6 background (129-apoE). To explore atherosclerosis-responsible genetic regions, we performed a quantitative trait locus (QTL) analysis using 172 male and 137 female F2 derived from an intercross between DBA-apoE and 129-apoE mice. A genome-wide scan identified two significant QTL for the size of lesions at the root: one is Ath44 on Chromosome (Chr) 1 at 158 Mb, and the other Ath45 on Chr 2 at 162 Mb. Ath44 co-localizes with but appears to be independent of a previously reported QTL, Ath1, while Ath45 is a novel QTL. DBA alleles of both Ath44 and Ath45 confer atherosclerosis-susceptibility. In addition, a QTL on Chr 14 at 73 Mb was found significant only in males, and 129 allele conferring susceptibility. Further analysis detected female-specific interactions between a second QTL on Chr 1 at 73 Mb and a QTL on Chr 3 at 21 Mb, and between Chr 7 at 84 Mb and Chr 12 at 77 Mb. These loci for the root atherosclerosis were independent of QTLs for plasma total cholesterol and QTLs for triglycerides, but a QTL for HDL (Chr 1 at 126 Mb) overlapped with the Ath44. Notably, haplotype analysis among 129S6, DBA/2J and C57BL/6 genomes and their gene expression data narrowed the candidate regions for Ath44 and Ath45 to less than 5 Mb intervals where multiple genome wide associations with cardiovascular phenotypes have also been reported in humans. SNPs in or near Fmo3, Sele and Selp for Ath44, and Lbp and Pkig for Ath45 were suggested for further investigation as potential candidates underlying the atherosclerosis susceptibility.	[Kayashima, Yukako; Tomita, Hirofumi; Zhilicheva, Svetlana; Kim, Shinja; Kim, Hyung-Suk; Maeda, Nobuyo] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA; [Bennett, Brian J.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	nobuyo@med.unc.edu		bennett, brian/0000-0002-0766-3195	NIH [HL042630]; American Heart Association Fellowship [09POST2250823]; Uehara Memorial Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, R37HL042630] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); Uehara Memorial Foundation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by an NIH grant HL042630 to NM (http://www.nih.gov/), an American Heart Association Fellowship Award 09POST2250823 to HT (http://www.heart.org/HEARTORG/), and an Uehara Memorial Foundation Fellowship (http://www.ueharazaidan.or.jp/) to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Bennett BJ, 2012, ARTERIOSCL THROM VAS, V32, P1790, DOI 10.1161/ATVBAHA.112.253864; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burkhardt R, 2011, ARTERIOSCL THROM VAS, V31, P775, DOI 10.1161/ATVBAHA.110.213843; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Dansky HM, 2002, GENETICS, V160, P1599; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hau J, 2011, 2011 HDB LAB ANIMAL, VI; Holdt LM, 2008, ARTERIOSCL THROM VAS, V28, P1097, DOI 10.1161/ATVBAHA.108.165654; Hsu J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005421; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KATSUDA S, 1992, AM J PATHOL, V140, P907; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lepper PM, 2007, J AM COLL CARDIOL, V50, P25, DOI 10.1016/j.jacc.2007.02.070; Lum H, 2002, AM J PHYSIOL-CELL PH, V282, pC59, DOI 10.1152/ajpcell.00256.2001; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; Manichaikul A, 2011, AM J PHYSIOL-HEART C, V301, pH1056, DOI 10.1152/ajpheart.00366.2011; O'Donnell CJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S4; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; Peyot ML, 2000, CIRC RES, V86, P76, DOI 10.1161/01.RES.86.1.76; Prins BP, 2012, ATHEROSCLEROSIS, V225, P1, DOI 10.1016/j.atherosclerosis.2012.05.015; Rodriguez JM, 2013, CIRC RES, V113, P1054, DOI 10.1161/CIRCRESAHA.113.302052; Safranow K, 2007, CARDIOLOGY, V108, P275, DOI 10.1159/000099096; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Srivastava U, 2012, ARTERIOSCL THROM VAS, V32, P2380, DOI 10.1161/ATVBAHA.112.255703; STEWARTPHILLIPS JL, 1989, CLIN INVEST MED, V12, P121; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Su ZG, 2009, J LIPID RES, V50, P2083, DOI 10.1194/jlr.M900076-JLR200; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; WARNICK GR, 1985, CLIN CHEM, V31, P217; Wolfrum S, 2010, ARTERIOSCL THROM VAS, V30, P1583, DOI 10.1161/ATVBAHA.110.205757; Yuan ZB, 2009, CIRC-CARDIOVASC GENE, V2, P220, DOI 10.1161/CIRCGENETICS.108.792499; Zhang ZM, 2012, CIRC-CARDIOVASC GENE, V5, P190, DOI 10.1161/CIRCGENETICS.111.961649; Zheng LH, 2000, BIOCHEM J, V349, P403, DOI 10.1042/0264-6021:3490403	49	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88274	10.1371/journal.pone.0088274	http://dx.doi.org/10.1371/journal.pone.0088274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586312	Green Published, gold, Green Submitted			2022-12-25	WOS:000331714700012
J	Ayers, S; Switnicki, MP; Angajala, A; Lammel, J; Arumanayagam, AS; Webb, P				Ayers, Stephen; Switnicki, Michal Piotr; Angajala, Anusha; Lammel, Jan; Arumanayagam, Anithachristy S.; Webb, Paul			Genome-Wide Binding Patterns of Thyroid Hormone Receptor Beta	PLOS ONE			English	Article							DEPENDENT NEGATIVE REGULATION; TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; RETINOIC ACID; RESPONSE ELEMENTS; DNA-BINDING; CHIP-SEQ; MECHANISM; REVEALS; DEFINES	Thyroid hormone (TH) receptors (TRs) play central roles in metabolism and are major targets for pharmaceutical intervention. Presently, however, there is limited information about genome wide localizations of TR binding sites. Thus, complexities of TR genomic distribution and links between TR beta binding events and gene regulation are not fully appreciated. Here, we employ a BioChIP approach to capture TR genome-wide binding events in a liver cell line (HepG2). Like other NRs, TR beta appears widely distributed throughout the genome. Nevertheless, there is striking enrichment of TR beta binding sites immediately 5' and 3' of transcribed genes and TR beta can be detected near 50% of T3 induced genes. In contrast, no significant enrichment of TR beta is seen at negatively regulated genes or genes that respond to unliganded TRs in this system. Canonical TRE half-sites are present in more than 90% of TR beta peaks and classical TREs are also greatly enriched, but individual TRE organization appears highly variable with diverse half-site orientation and spacing. There is also significant enrichment of binding sites for TR associated transcription factors, including AP-1 and CTCF, near TR peaks. We conclude that T3-dependent gene induction commonly involves proximal TR beta binding events but that far-distant binding events are needed for T3 induction of some genes and that distinct, indirect, mechanisms are often at play in negative regulation and unliganded TR actions. Better understanding of genomic context of TR binding sites will help us determine why TR regulates genes in different ways and determine possibilities for selective modulation of TR action.	[Ayers, Stephen; Switnicki, Michal Piotr; Angajala, Anusha; Lammel, Jan; Arumanayagam, Anithachristy S.; Webb, Paul] Methodist Hosp, Res Inst, Genom Med Program, Houston, TX 77030 USA; [Lammel, Jan] Tecnol Monterrey Sch Med, Monterrey, NL, Mexico	The Methodist Hospital System; The Methodist Hospital - Houston; Tecnologico de Monterrey	Webb, P (corresponding author), Methodist Hosp, Res Inst, Genom Med Program, 6535 Fannin, Houston, TX 77030 USA.	pwebb@tmhs.org	Ayers, Stephen D/O-4535-2014; Arumanayagam, Anithachristy/S-5750-2018	Ayers, Stephen D/0000-0003-1390-8969; Lammel Lindemann, Jan Antonio/0000-0002-3555-9571; Switnicki, Michal/0000-0003-0619-9375	American Thyroid Association; National Institutes of Health [RC4 DK090849]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090849] Funding Source: NIH RePORTER	American Thyroid Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a grant from the American Thyroid Association and the National Institutes of Health (RC4 DK090849). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bhat MK, 1997, J BIOL CHEM, V272, P28989, DOI 10.1074/jbc.272.46.28989; BRENT G A, 1989, New Biologist, V1, P329; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; CARR FE, 1992, J BIOL CHEM, V267, P18689; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chatonnet F, 2013, P NATL ACAD SCI USA, V110, pE766, DOI 10.1073/pnas.1210626110; Choi KC, 2008, BIOCHEM J, V411, P19, DOI 10.1042/BJ20071393; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; Diekman MJM, 2000, J CLIN ENDOCR METAB, V85, P1857, DOI 10.1210/jc.85.5.1857; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; FORMAN BM, 1992, MOL ENDOCRINOL, V6, P429, DOI 10.1210/me.6.3.429; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Isumi Y, 1998, ENDOCRINOLOGY, V139, P838, DOI 10.1210/en.139.3.838; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; KATZ RW, 1994, J BIOL CHEM, V269, P18915; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim SW, 2005, J BIOL CHEM, V280, P14545, DOI 10.1074/jbc.M411517200; Kim SW, 2004, MOL ENDOCRINOL, V18, P2924, DOI 10.1210/me.2004-0255; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LOPEZ G, 1993, MOL CELL BIOL, V13, P3042, DOI 10.1128/MCB.13.5.3042; Lupien M, 2009, MOL CELL BIOL, V29, P3413, DOI 10.1128/MCB.00020-09; Lutz M, 2003, EMBO J, V22, P1579, DOI 10.1093/emboj/cdg147; Malo MS, 2004, MOL ENDOCRINOL, V18, P1941, DOI 10.1210/me.2003-0351; Matsukawa T, 1996, J BIOCHEM-TOKYO, V119, P934; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Figueira ACM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012628; Murakami Y, 1998, LIFE SCI, V63, pPL337, DOI 10.1016/S0024-3205(98)00503-7; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; Qi JS, 1997, MOL CELL BIOL, V17, P7195, DOI 10.1128/MCB.17.12.7195; Ribeiro RCJ, 2001, J BIOL CHEM, V276, P14987, DOI 10.1074/jbc.M010195200; SAMUELS HH, 1989, ANNU REV PHYSIOL, V51, P623, DOI 10.1146/annurev.ph.51.030189.003203; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; SPINDLER BJ, 1975, J BIOL CHEM, V250, P4113; SUGAWARA A, 1993, ENDOCRINOLOGY, V133, P965, DOI 10.1210/en.133.3.965; Suh JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070097; Taniyama M, 1996, EUR J CLIN INVEST, V26, P454, DOI 10.1046/j.1365-2362.1996.155307.x; Taniyama M, 1997, CLIN ENDOCRINOL, V46, P271, DOI 10.1046/j.1365-2265.1997.1220934.x; Tsai CC, 2004, VITAM HORM, V68, P93; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Weth O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010119; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; Wu YF, 2001, J BIOL CHEM, V276, P3929, DOI 10.1074/jbc.M006743200; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325	69	42	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e81186	10.1371/journal.pone.0081186	http://dx.doi.org/10.1371/journal.pone.0081186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558356	Green Submitted, gold, Green Published			2022-12-25	WOS:000331706700002
J	Diffendorfer, JE; Compton, RW				Diffendorfer, Jay E.; Compton, Roger W.			Land Cover and Topography Affect the Land Transformation Caused by Wind Facilities	PLOS ONE			English	Article							ENERGY	Land transformation (ha of surface disturbance/MW) associated with wind facilities shows wide variation in its reported values. In addition, no studies have attempted to explain the variation across facilities. We digitized land transformation at 39 wind facilities using high resolution aerial imagery. We then modeled the effects of turbine size, configuration, land cover, and topography on the levels of land transformation at three spatial scales. The scales included strings (turbines with intervening roads only), sites (strings with roads connecting them, buried cables and other infrastructure), and entire facilities (sites and the roads or transmission lines connecting them to existing infrastructure). An information theoretic modeling approach indicated land cover and topography were well-supported variables affecting land transformation, but not turbine size or configuration. Tilled landscapes, despite larger distances between turbines, had lower average land transformation, while facilities in forested landscapes generally had the highest land transformation. At site and string scales, flat topographies had the lowest land transformation, while facilities on mesas had the largest. The results indicate the landscape in which the facilities are placed affects the levels of land transformation associated with wind energy. This creates opportunities for optimizing wind energy production while minimizing land cover change. In addition, the results indicate forecasting the impacts of wind energy on land transformation should include the geographic variables affecting land transformation reported here.	[Diffendorfer, Jay E.; Compton, Roger W.] US Geol Survey, Geosci & Environm Change Sci Ctr, Denver Fed Ctr, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey	Diffendorfer, JE (corresponding author), US Geol Survey, Geosci & Environm Change Sci Ctr, Denver Fed Ctr, Denver, CO 80225 USA.	jediffendorfer@usgs.gov		Diffendorfer, Jay/0000-0003-1093-6948	Land Change Science Program at the United States Geological Survey	Land Change Science Program at the United States Geological Survey	This research was funded by the Land Change Science Program at the United States Geological Survey. http://www.usgs.gov/climate_landuse/lcs/. Program managers had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Bureau of Land Management, 2005, FES0511 BUR LAND MAN; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BURNHAM KP, 1992, WILDLIFE 2001 : POPULATIONS, P16; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Denholm P., 2009, NATL RENEWABLE ENERG; *DOE, 2008, DOEGO1020082567; Elliot DL, 1991, PNL7789; Elliott LP, 2007, BIOSCIENCE, V57, P608, DOI 10.1641/B570708; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; Fthenakis V, 2009, RENEW SUST ENERG REV, V13, P1465, DOI 10.1016/j.rser.2008.09.017; Greenblatt J., 2009, CLEAN ENERGY 2030 GO; Hand M., 2012, EXPLORATION HIGH PEN, V1; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; MacKay D., 2008, SUSTAINABLE ENERGY H; McCullagh P, 1989, GEN LINEAR MODELS; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; OSMOSYS, 2009, CONTR OSMOSYS FOR; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pimentel D, 2002, BIOSCIENCE, V52, P1111, DOI 10.1641/0006-3568(2002)052[1111:RECAPI]2.0.CO;2; *R DEV COR TEAM, 2013, R LANG ENV STAT COMP; Siler-Evans K, 2013, P NATL ACAD SCI; Snyder B, 2009, RENEW ENERG, V34, P1567, DOI 10.1016/j.renene.2008.11.015	26	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88914	10.1371/journal.pone.0088914	http://dx.doi.org/10.1371/journal.pone.0088914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558449	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700095
J	Edlow, AG; Vora, NL; Hui, L; Wick, HC; Cowan, JM; Bianchi, DW				Edlow, Andrea G.; Vora, Neeta L.; Hui, Lisa; Wick, Heather C.; Cowan, Janet M.; Bianchi, Diana W.			Maternal Obesity Affects Fetal Neurodevelopmental and Metabolic Gene Expression: A Pilot Study	PLOS ONE			English	Article							BODY-MASS INDEX; APOLIPOPROTEIN-D EXPRESSION; FREE MESSENGER-RNA; CELL-FREE DNA; AMNIOTIC-FLUID; PREFRONTAL CORTEX; OXIDATIVE STRESS; NERVOUS-SYSTEM; PREGNANCY; DISEASE	Objective: One in three pregnant women in the United States is obese. Their offspring are at increased risk for neurodevelopmental and metabolic morbidity. Underlying molecular mechanisms are poorly understood. We performed a global gene expression analysis of mid-trimester amniotic fluid cell-free fetal RNA in obese versus lean pregnant women. Methods: This prospective pilot study included eight obese (BMI >= 30) and eight lean (BMI<25) women undergoing clinically indicated mid-trimester genetic amniocentesis. Subjects were matched for gestational age and fetal sex. Fetuses with abnormal karyotype or structural anomalies were excluded. Cell-free fetal RNA was extracted from amniotic fluid and hybridized to whole genome expression arrays. Genes significantly differentially regulated in 8/8 obese-lean pairs were identified using paired t-tests with the Benjamini-Hochberg correction (false discovery rate of <0.05). Biological interpretation was performed with Ingenuity Pathway Analysis and the BioGPS gene expression atlas. Results: In fetuses of obese pregnant women, 205 genes were significantly differentially regulated. Apolipoprotein D, a gene highly expressed in the central nervous system and integral to lipid regulation, was the most up-regulated gene (9-fold). Apoptotic cell death was significantly down-regulated, particularly within nervous system pathways involving the cerebral cortex. Activation of the transcriptional regulators estrogen receptor, FOS, and STAT3 was predicted in fetuses of obese women, suggesting a pro-estrogenic, pro-inflammatory milieu. Conclusion: Maternal obesity affects fetal neurodevelopmental and metabolic gene expression as early as the second trimester. These findings may have implications for postnatal neurodevelopmental and metabolic abnormalities described in the offspring of obese women.	[Edlow, Andrea G.; Vora, Neeta L.; Hui, Lisa; Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA; [Wick, Heather C.] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Cowan, Janet M.] Tufts Med Ctr, Dept Pathol & Lab Med, Boston, MA USA	Tufts Medical Center; Tufts University; Tufts Medical Center	Edlow, AG (corresponding author), Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA.	aedlow@tuftsmedicalcenter.org	Hui, Lisa/H-7109-2019	Hui, Lisa/0000-0002-9720-3562; Vora, Neeta/0000-0002-2504-9455; Edlow, Andrea/0000-0003-2915-5949	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD42053-10, R01 HD058880]; EPSRC [EP/F009429/2, EP/J016934/1, EP/F009429/1, EP/J016934/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053, R01HD058880] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awards R01 HD42053-10 and R01 HD058880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2012, NA33 REL HG U133 PLU; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; BAKER WA, 1994, DIABETIC MED, V11, P947, DOI 10.1111/j.1464-5491.1994.tb00252.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi DW, 2001, CLIN CHEM, V47, P1867; Blaschke AJ, 1998, J COMP NEUROL, V396, P39, DOI 10.1002/(SICI)1096-9861(19980622)396:1<39::AID-CNE4>3.0.CO;2-J; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Crespo PS, 2007, PUBLIC HEALTH NUTR, V10, P1121, DOI 10.1017/S1368980007000596; Dietz JA, 2011, PRENATAL DIAG, V31, P598, DOI 10.1002/pd.2732; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Edlow AG, 2012, BBA-MOL BASIS DIS, V1822, P1970, DOI 10.1016/j.bbadis.2012.04.005; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flori E, 2004, HUM REPROD, V19, P723, DOI 10.1093/humrep/deh117; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Guibert J, 2003, HUM REPROD, V18, P1733, DOI 10.1093/humrep/deg320; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; He X, 2009, NEUROSCI LETT, V455, P183, DOI 10.1016/j.neulet.2009.03.038; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Heikura U, 2008, AM J EPIDEMIOL, V167, P169, DOI 10.1093/aje/kwm291; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hinkle SN, 2012, INT J OBESITY, V36, P1312, DOI 10.1038/ijo.2012.143; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hui L, 2013, PRENAT DIAGN; Hui L, 2013, OBSTET GYNECOL, V121, P1248, DOI 10.1097/AOG.0b013e318293d70b; Hui LS, 2012, HUM GENET, V131, P1751, DOI 10.1007/s00439-012-1195-x; Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150; IPA website, 2013, CALC INT P VAL FUNCT; IPA website, 2013, ING UPSTR REG AN WHI; Jolliffee I.T., 2002, PRINCIPAL COMPONENT; Khan MM, 2003, J NEUROCHEM, V86, P1089, DOI 10.1046/j.1471-4159.2003.01866.x; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Koide K, 2011, HUM GENET, V129, P295, DOI 10.1007/s00439-010-0923-3; Kosacka J, 2009, NEUROSCIENCE, V162, P282, DOI 10.1016/j.neuroscience.2009.04.073; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Lapaire O, 2007, CLIN CHEM, V53, P405, DOI 10.1373/clinchem.2006.076083; Larrabee PB, 2005, JAMA-J AM MED ASSOC, V293, P836, DOI 10.1001/jama.293.7.836; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Liu ZT, 2001, FASEB J, V15, P1329, DOI 10.1096/fj.00-0530fje; Lun FMF, 2007, CLIN CHEM, V53, P796, DOI 10.1373/clinchem.2006.084350; Mahadik SP, 2002, SCHIZOPHR RES, V58, P55, DOI 10.1016/S0920-9964(01)00378-4; Makrydimas G, 2008, ULTRASOUND OBST GYN, V32, P594, DOI 10.1002/uog.6117; Massingham LJ, 2011, J MOL DIAGN, V13, P565, DOI 10.1016/j.jmoldx.2011.05.008; Masuzaki H, 2004, J MED GENET, V41, P289, DOI 10.1136/jmg.2003.015784; Min W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-8; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Newbold RR, 2011, AM J CLIN NUTR, V94, p1939S, DOI 10.3945/ajcn.110.001057; Niculescu MD, 2009, INT J DEV NEUROSCI, V27, P627, DOI 10.1016/j.ijdevneu.2009.08.005; Olson N Eric, 2006, NeuroRx, V3, P373; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Patel MP, 2009, CURR OPIN ONCOL, V21, P516, DOI 10.1097/CCO.0b013e328331a7a4; Pavlidis P, 2003, BIOINFORMATICS, V19, P1620, DOI 10.1093/bioinformatics/btg227; Pennings JLA, 2011, PRENATAL DIAG, V31, P1153, DOI 10.1002/pd.2850; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Peter I, 2008, DIAGN MOL PATHOL, V17, P185, DOI 10.1097/PDM.0b013e31815bcdb6; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Romero R, 2006, AM J OBSTET GYNECOL, V195, P360, DOI 10.1016/j.ajog.2006.06.077; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Stachowiak EK, 2013, NUTR NEUROSCI, V16, P96, DOI 10.1179/1476830512Y.0000000035; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanda R, 2013, MATERN CHILD HLTH J, V17, P222, DOI 10.1007/s10995-012-0964-4; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; VIJAYARAGHAVAN S, 1994, J CLIN ENDOCR METAB, V79, P568, DOI 10.1210/jc.79.2.568; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Hristoskova Sashka, 2006, Archives of Gynecology and Obstetrics, V274, P25, DOI 10.1007/s00404-005-0109-8	77	51	51	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88661	10.1371/journal.pone.0088661	http://dx.doi.org/10.1371/journal.pone.0088661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558408	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700054
J	Muise, ES; Zhu, YH; Verras, A; Karanam, BV; Gorski, J; Weingarth, D; Lin, HV; Hwa, J; Thompson, JR; Hu, GH; Liu, J; He, SW; DeVita, RJ; Shen, DM; Pinto, S				Muise, Eric S.; Zhu, Yonghua; Verras, Andreas; Karanam, Bindhu V.; Gorski, Judith; Weingarth, Drew; Lin, Hua V.; Hwa, Joyce; Thompson, John R.; Hu, Guanghui; Liu, Jian; He, Shuwen; DeVita, Robert J.; Shen, Dong-Ming; Pinto, Shirly			Identification and Characterization of Sebaceous Gland Atrophy-Sparing DGAT1 Inhibitors	PLOS ONE			English	Article							COA-DIACYLGLYCEROL ACYLTRANSFERASE; SKIN; DEFICIENCY; MECHANISM; GENE	Inhibition of Diacylglycerol O-acyltransferase 1 (DGAT1) has been a mechanism of interest for metabolic disorders. DGAT1 inhibition has been shown to be a key regulator in an array of metabolic pathways; however, based on the DGAT1 KO mouse phenotype the anticipation is that pharmacological inhibition of DGAT1 could potentially lead to skin related adverse effects. One of the aims in developing small molecule DGAT1 inhibitors that target key metabolic tissues is to avoid activity on skin-localized DGAT1 enzyme. In this report we describe a modeling-based approach to identify molecules with physical properties leading to differential exposure distribution. In addition, we demonstrate histological and RNA based biomarker approaches that can detect sebaceous gland atrophy pre-clinically that could be used as potential biomarkers in a clinical setting.	[Muise, Eric S.; Zhu, Yonghua; Verras, Andreas; Karanam, Bindhu V.; Gorski, Judith; Weingarth, Drew; Lin, Hua V.; Hwa, Joyce; Thompson, John R.; Hu, Guanghui; Liu, Jian; He, Shuwen; DeVita, Robert J.; Shen, Dong-Ming; Pinto, Shirly] Merck Res Labs, Discovery & Preclin Sci, Whithouse Stn, NJ 08889 USA	Merck & Company	Pinto, S (corresponding author), Merck Res Labs, Discovery & Preclin Sci, Whithouse Stn, NJ 08889 USA.	shirly_pinto@merck.com		Lin, Hua/0000-0001-5001-5567; Muise, Eric/0000-0002-1238-5118	Merck	Merck(Merck & Company)	Merck provided all funds for this work. All authors are current or former employees of Merck and may own stock or hold stock options in Merck. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Birch AM, 2010, CURR OPIN DRUG DISC, V13, P489; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, ENDOCRINOLOGY, V143, P2893, DOI 10.1210/en.143.8.2893; Denison H, 2013, DIABETES OBES METAB, V15, P136, DOI 10.1111/dom.12002; Denison H, 2013, DIABETES OBES METAB, DOI [10.1111/dom.12221, DOI 10.1111/D0M.12221]; DeVita RJ, 2013, J MED CHEM, V56, P9820, DOI 10.1021/jm4007033; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Hinde E, 2013, EXP DERMATOL, V22, P631, DOI 10.1111/exd.12207; Liao CZ, 2009, J CHEM INF MODEL, V49, P2801, DOI 10.1021/ci900289x; Lin HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054480; Liu JQ, 2013, OBESITY, V21, P1406, DOI 10.1002/oby.20193; STEWART ME, 1991, ADV LIPID RES, V24, P263; Terao M, 2009, MOL CELL BIOL, V29, P357, DOI 10.1128/MCB.01385-08; Thiboutot D, 1998, J INVEST DERMATOL, V111, P390, DOI 10.1046/j.1523-1747.1998.00322.x; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Zheng Y, 2001, GENOMICS, V71, P182, DOI 10.1006/geno.2000.6429	18	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88908	10.1371/journal.pone.0088908	http://dx.doi.org/10.1371/journal.pone.0088908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558447	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700093
J	Ong'ang'o, JR; Mwachari, C; Kipruto, H; Karanja, S				Ong'ang'o, Jane Rahedi; Mwachari, Christina; Kipruto, Hillary; Karanja, Simon			The Effects on Tuberculosis Treatment Adherence from Utilising Community Health Workers: A Comparison of Selected Rural and Urban Settings in Kenya	PLOS ONE			English	Article							DOT; DECENTRALIZATION; DISTRICT; PROGRAM; CARE	Introduction: Community Health Workers (CHWs) have been utilised for various primary health care activities in different settings especially in developing countries. Usually when utilised in well defined terms, they have a positive impact. To support Kenya's policy on engagement of CHWs for tuberculosis (TB) control, there is need to demonstrate effects of utilising them. Objectives: This study assessed TB treatment adherence among patients who utilised CHWs in management of their illness in comparison to those who did not in urban and rural settings. Methods: A retrospective cohort study was conducted in selected health facilities using standard clinical records for each TB patient registered for treatment between 2005 to 2011. Qualitative data was collected from CHWs and health care providers. Results: The study assessed 2778 tuberculosis patients and among them 1499 (54%) utilized CHWs for their TB treatment. The urban setting in comparison with the rural setting contributed 70% of patients utilising the CHWs (p<0.001). Overall treatment adherence of the cohort was 79%. Categorizing by use of CHWs, adherence among patients who had utilized CHWs was 83% versus 68% among those that had not (p<0.001). In comparison between the rural and urban settings adherence was 76% and 81.5% (p<0.001) respectively and when categorized by use of CHWs it was 73% and 90% (p<0.001) for the rural and urban set ups respectively. Utilisation of CHWs remained significant in enhancing treatment adherence in the cohort with unadjusted and adjusted ORs; OR 2.25, (95% 1.86-2.73) p<0.001 and OR 1.98 (95% 1.51-2.5) p<0.001 respectively. It was most effective in the urban set-up, OR 2.65 (95% 2.02-3.48, p<0.001) in comparison to the rural set up, OR 0.74 (95% 0.56-0.97) p = 0.032. Conclusion: Utilisation of CHWs enhanced TB treatment adherence and the best effects were in the urban set-up.	[Ong'ang'o, Jane Rahedi; Mwachari, Christina] Kenya Med Res Inst KEMRI, Ctr Resp Dis Res, Nairobi, Kenya; [Kipruto, Hillary] World Hlth Org WHO, Kenya Country Off, Nairobi, Kenya; [Karanja, Simon] Jomo Kenyatta Univ Agr & Technol JKUAT, Coll Hlth Sci, Nairobi, Kenya	Kenya Medical Research Institute; World Health Organization; Jomo Kenyatta University of Agriculture & Technology	Ong'ang'o, JR (corresponding author), Kenya Med Res Inst KEMRI, Ctr Resp Dis Res, Nairobi, Kenya.	jrnabongo@gmail.com	Kipruto, Hillary/ABB-7126-2021; Amboko, Rashidi/D-9046-2015		Pan African Thoracic Society	Pan African Thoracic Society	This work was supported by Pan African Thoracic Society (www.africanthoracic.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adatu F, 2003, INT J TUBERC LUNG D, V7, pS63; [Anonymous], 2003, ADHERENCE LONG TERM; Bagchi S, 2010, INT J PREVENTIVE MED, V1, P223; Brownstein JN, 2005, AM J PREV MED, V29, P128, DOI 10.1016/j.amepre.2005.07.024; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544; Clarke M, 2005, INT J TUBERC LUNG D, V9, P673; Daniel O, 2004, 15 INT AIDS C BANGK; Delacollette C, 1996, B WORLD HEALTH ORGAN, V74, P423; Dick J, 1996, TUBERCLE LUNG DIS, V77, P274, DOI 10.1016/S0962-8479(96)90013-1; Dick J, 1997, S AFR MED J, V87, P1042; Dick J, 2005, OPERATIONS RES RESUL; Egwaga S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-80; Friedman I, 2002, SEED TRUST HLTH PROG, V9, P176; Hill RC, 2005, INT J TUBERC LUNG D, V9, P1349; Kahssay HM., 1998, COMMUNITY HLTH WORKE; Kalyango JN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-282; Kangangi JK, 2003, INT J TUBERC LUNG D, V7, pS5; Kironde S, 2002, INT J TUBERC LUNG D, V6, P104; Kironde Samson, 2002, Afr Health Sci, V2, P73; Lariosa Theresita R., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P30; Lehmann U, 2004, 41 HUM RES HLTH DEV; Love MB, 1992, EMERGING ROLE COMMUN; Macq JCM, 2003, INT J TUBERC LUNG D, V7, P103; Maher D, 1999, INT J TUBERC LUNG D, V3, P762; MENON A, 1991, J TROP MED HYG, V94, P268; MENZIES R, 1993, TUBERCLE LUNG DIS, V74, P32, DOI 10.1016/0962-8479(93)90066-7; Ministry of Public Health and Sanitation Kenya, 2011, DIV LEPR TUB LUNG DI; Mkopi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051828; Nackers F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032140; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Nyirenda TE, 2003, INT J TUBERC LUNG D, V7, pS21; NYONATOR FK, 2003, GHANA COMMUNITY HLTH; Okanurak K, 1996, ACTA TROP, V61, P157, DOI 10.1016/0001-706X(95)00115-U; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Snider, 1982, B INT UNION TUBERC, V57, P247; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; World Health Organization, 1989, WHO TECHN SER, V780; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization, 1994, WHOTB94179; Zvavamwe Z, 2009, INT J NURS STUD, V46, P302, DOI 10.1016/j.ijnurstu.2008.09.013	42	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88937	10.1371/journal.pone.0088937	http://dx.doi.org/10.1371/journal.pone.0088937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558452	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700098
J	Siu, KL; Miao, XN; Cai, H				Siu, Kin Lung; Miao, Xiao Niu; Cai, Hua			Recoupling of eNOS with Folic Acid Prevents Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E Null Mice	PLOS ONE			English	Article							ACCELERATED ATHEROSCLEROSIS; OXIDATIVE STRESS; VITAMIN-E; INFILTRATION; PATHOGENESIS; INHIBITION	We have previously shown that eNOS uncoupling mediates abdominal aortic aneurysm (AAA) formation in hph-1 mice. In the present study we examined whether recoupling of eNOS prevents AAA formation in a well-established model of Angiotensin II-infused apolipoprotein E (apoE) null mice by targeting some common pathologies of AAA. Infusion of Ang II resulted in a 92% incidence rate of AAA in the apoE null animals. In a separate group, animals were treated orally with folic acid (FA), which is known to recouple eNOS through augmentation of dihydrofolate reductase (DHFR) function. This resulted in a reduction of AAA rate to 19.5%. Imaging with ultrasound showed that FA markedly inhibited expansion of abdominal aorta. FA also abolished elastin breakdown and macrophage infiltration in the AAA animals. The eNOS uncoupling activity, assessed by L-NAME-sensitive superoxide production, was minimal at baseline but greatly exaggerated with Ang II infusion, which was completely attenuated by FA. This was accompanied by markedly improved tetrahydrobiopterin and nitric oxide bioavailability. Furthermore, the expression and activity of DHFR was decreased in Ang II-infused apoE null mice specifically in the endothelial cells, while FA administration resulted in its recovery. Taken together, these data further establish a significant role of uncoupled eNOS in mediating AAA formation, and a universal efficacy of FA in preventing AAA formation via restoration of DHFR to restore eNOS function.	[Cai, Hua] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Anesthesiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Cardiol,Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Div Mol Med,Dept Anesthesiol, Los Angeles, CA 90095 USA.	hcai@mednet.ucla.edu			National Institute of Health National Heart, Lung and Blood Institute (NHLBI) [HL077440, HL088975, HL108701, HL009968]; American Heart Association (AHA) [12EIA8990025]; AHA [11POST7140041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108701, R01HL119968, R01HL088975, R01HL077440] Funding Source: NIH RePORTER	National Institute of Health National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institute of Health National Heart, Lung and Blood Institute (NHLBI) Grants HL077440 (HC), HL088975 (HC), HL108701 (HC, DGH), HL009968 (HC), an American Heart Association (AHA) Established Investigator Award (EIA) 12EIA8990025 (HC), and an AHA Postdoctoral Fellowship Award 11POST7140041 (KLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cafueri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035312; Centers for Disease Control and Prevention National Center for Health Statistics, 2013, DAT COMP COMPR MORT, V2P; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chen JQ, 2001, CIRCULATION, V104, P2391, DOI 10.1161/hc4501.099729; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; DUBICK MA, 1987, P SOC EXP BIOL MED, V184, P138; Dubick MA, 1999, P SOC EXP BIOL MED, V220, P39, DOI 10.1046/j.1525-1373.1999.d01-6.x; Fatini C, 2005, J VASC SURG, V42, P415, DOI 10.1016/j.jvs.2005.05.044; Gao L, 2012, HYPERTENSION, V59, P158, DOI 10.1161/HYPERTENSIONAHA.111.181644; Gao L, 2009, J MOL CELL CARDIOL, V47, P752, DOI 10.1016/j.yjmcc.2009.07.025; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Grigoryants V, 2005, J VASC SURG, V41, P108, DOI 10.1016/j.jvs.2004.09.033; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Johanning JM, 2001, J VASC SURG, V33, P579, DOI 10.1067/mva.2001.111805; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; Qadura M, 2013, J VASC SURG, V57, P1676, DOI 10.1016/j.jvs.2013.02.013; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Tamarat R, 2002, HYPERTENSION, V39, P830, DOI 10.1161/hy0302.104671; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Tornwall ME, 2001, ATHEROSCLEROSIS, V157, P167, DOI 10.1016/S0021-9150(00)00694-8; Tsuruda T, 2008, CIRC RES, V102, P1368, DOI 10.1161/CIRCRESAHA.108.173682; Turner GH, 2009, J MAGN RESON IMAGING, V30, P455, DOI 10.1002/jmri.21843; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Yayama K, 2006, HYPERTENSION, V48, P958, DOI 10.1161/01.HYP.0000244108.30909.27	29	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88899	10.1371/journal.pone.0088899	http://dx.doi.org/10.1371/journal.pone.0088899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558445	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700091
J	Tseliou, E; de Couto, G; Terrovitis, J; Sun, BM; Liu, WX; Marban, L; Marban, E				Tseliou, Eleni; de Couto, Geoffrey; Terrovitis, John; Sun, Baiming; Liu Weixin; Marban, Linda; Marban, Eduardo			Angiogenesis, Cardiomyocyte Proliferation and Anti-Fibrotic Effects Underlie Structural Preservation Post-Infarction by Intramyocardially-Injected Cardiospheres	PLOS ONE			English	Article							CARDIAC STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR ENLARGEMENT; PROGENITOR CELLS; HEART; COLLAGEN; REGENERATION; THERAPY; REPAIR; DIFFERENTIATION	Objective: We sought to understand the cellular and tissue-level changes underlying the attenuation of adverse remodeling by cardiosphere transplantation in acute myocardial infarction (MI). Background: Cardiospheres (CSps) are heart-derived multicellular clusters rich in stemness and capable of multilineage differentiation. Post-MI CSp transplantation improves left ventricular (LV) function and attenuates remodeling in both small and large animal studies. However, the mechanisms of benefit have not yet been fully elucidated. Methods: Four groups were studied: 1) "Sham'' (Wistar Kyoto rats with thoracotomy and ligature without infarction); 2) "MI'' (proximal LAD ligation with peri-infarct injection of vehicle); 3) "MI+CSp'' (MI with cardiospheres injected in the peri-infarct area); 4) "Small MI'' (mid-LAD ligation only). Results: In vivo 1 week after CSp transplantation, LV functional improvement was associated with an increase in cardiomyocyte proliferation. By 3 weeks, microvessel formation was enhanced, while cardiomyocyte hypertrophy and regional fibrosis were attenuated. Collagen deposition was reduced, collagen degradation was enhanced, and MMPs were upregulated. The beneficial effects of CSp transplantation were not observed in the Small MI group, indicating that the effects are not solely due to CSp-induced cardioprotection. In vitro, CSp-conditioned media reduced collagen production in coculture with fibroblasts and triggered neoangiogenesis in an ex vivo aortic ring assay. Conclusion: Cardiospheres enhance cardiomyocyte proliferation and angiogenesis, and attenuate hypertrophy and fibrosis, in the ischemic myocardium. These synergistic effects underlie the attenuation of adverse remodeling by cardiospheres.	[Tseliou, Eleni; de Couto, Geoffrey; Sun, Baiming; Liu Weixin; Marban, Linda; Marban, Eduardo] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Terrovitis, John] Univ Athens, Dept Cardiol 3, Athens, Greece	Cedars Sinai Medical Center; National & Kapodistrian University of Athens	Marban, E (corresponding author), Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA.	Eduardo.Marban@csmc.edu	Marban, Eduardo/GWC-8514-2022	de Couto, Geoffrey/0000-0002-1158-0560	California Institute of Regenerative Medicine	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Barile L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/354605; Bartosh TJ, 2008, J CELL BIOCHEM, V105, P612, DOI 10.1002/jcb.21862; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Braunwald E, 2013, J CLIN INVEST, V123, P6, DOI 10.1172/JCI67541; Chande M, 2001, LANCET, V357, P1099, DOI 10.1016/S0140-6736(00)04314-2; Chen LJ, 2012, STEM CELLS DEV, V21, P2122, DOI 10.1089/scd.2011.0463; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Costa EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070072; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Davis DR, 2010, STEM CELLS, V28, P903, DOI 10.1002/stem.413; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Duan Y, 2011, J CARDIOVASC TRANSL, V4, P605, DOI 10.1007/s12265-011-9304-0; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Eschenhagen T, 2011, CIRC RES, V109, P1, DOI 10.1161/CIRCRESAHA.111.248039; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gaetani R, 2010, J CELL MOL MED, V14, P1071, DOI 10.1111/j.1582-4934.2010.01078.x; Gersh BJ, 2009, MAYO CLIN PROC, V84, P876, DOI 10.1016/S0025-6196(11)60505-3; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; Ibrahim AG, 2012, AHA SCI SESSIONS; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kanazawa H, 2011, CIRCULATION, V124; KLONER RA, 1980, CIRCULATION, V62, P945, DOI 10.1161/01.CIR.62.5.945; Kshitiz, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003002; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Lauden L, 2013, CIRC RES, V112, P451, DOI 10.1161/CIRCRESAHA.112.276501; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Lipinski MJ, 2007, J AM COLL CARDIOL, V50, P1761, DOI 10.1016/j.jacc.2007.07.041; Lopez B, 2005, J HYPERTENS, V23, P1445, DOI 10.1097/01.hjh.0000173780.67308.f1; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Mukherjee R, 2010, FASEB J, V24, P3819, DOI 10.1096/fj.10-155531; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Schwartz RS, 2002, NEW ENGL J MED, V346, P2, DOI 10.1056/NEJM200201033460102; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Spinale FG, 2011, CIRCULATION, V124, P2052, DOI 10.1161/CIRCULATIONAHA.111.064071; Sutton MS, 1997, CIRCULATION, V96, P3294; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Ye JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030329; Yee K, 2011, AHA SCI SESSIONS; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	61	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88590	10.1371/journal.pone.0088590	http://dx.doi.org/10.1371/journal.pone.0088590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558402	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700048
J	Zhao, YL; Zhang, J; Yuan, TJ; Shen, T; Li, W; Yang, SH; Hou, Y; Wang, YZ; Jin, H				Zhao, Yanli; Zhang, Ji; Yuan, Tianjun; Shen, Tao; Li, Wei; Yang, Shihua; Hou, Ying; Wang, Yuanzhong; Jin, Hang			Discrimination of Wild Paris Based on Near Infrared Spectroscopy and High Performance Liquid Chromatography Combined with Multivariate Analysis	PLOS ONE			English	Article							L.; LEAF	Different geographical origins and species of Paris obtained from southwestern China were discriminated by near infrared (NIR) spectroscopy and high performance liquid chromatography (HPLC) combined with multivariate analysis. The NIR parameter settings were scanning (64 times), resolution (4 cm(-1)), scanning range (10000 cm(-1)similar to 4000 cm(-1)) and parallel collection (3 times). NIR spectrum was optimized by TQ 8.6 software, and the ranges 7455 similar to 6852 cm(-1) and 5973 similar to 4007 cm(-1) were selected according to the spectrum standard deviation. The contents of polyphyllin I, polyphyllin II, polyphyllin VI, and polyphyllin VII and total steroid saponins were detected by HPLC. The contents of chemical components data matrix and spectrum data matrix were integrated and analyzed by partial least squares discriminant analysis (PLS-DA). From the PLS-DA model of NIR spectrum, Paris samples were separated into three groups according to the different geographical origins. The (RX)-X-2 and Q(2)Y described accumulative contribution rates were 99.50% and 94.03% of the total variance, respectively. The PLS-DA model according to 12 species of Paris described 99.62% of the variation in X and predicted 95.23% in Y. The results of the contents of chemical components described differences among collections quantitatively. A multivariate statistical model of PLS-DA showed geographical origins of Paris had a much greater influence on Paris compared with species. NIR and HPLC combined with multivariate analysis could discriminate different geographical origins and different species. The quality of Paris showed regional dependence.	[Zhao, Yanli; Zhang, Ji; Wang, Yuanzhong; Jin, Hang] Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China; [Yuan, Tianjun; Li, Wei; Yang, Shihua; Hou, Ying] Yunnan Reascend Tobacco Technol Grp Co Ltd, Kunming, Yunnan, Peoples R China; [Shen, Tao] Yuxi Normal Univ, Coll Resources & Environm, Yuxi, Yunnan, Peoples R China	Yunnan Academy of Agricultural Sciences; China National Tobacco Corporation; Yuxi Normal University	Wang, YZ (corresponding author), Yunnan Acad Agr Sci, Inst Med Plants, Kunming, Yunnan, Peoples R China.	boletus@126.com; jinhang2009@126.com	Zhang, Ji/B-2830-2013; zhao, yan/GWC-9174-2022; Lv, Yuanjie/AER-0767-2022	Zhang, Ji/0000-0002-7737-0785; 	National Natural Science Foundation of China [81260608, 81260610]; Special Fund for Agro-Scientific Research in the Public Interest [201303117]; Yunnan Provincial Natural Science Foundation [2013FD066, 2013FZ150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest; Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province)	This work was supported by grants from National Natural Science Foundation of China (81260608 and 81260610), the Special Fund for Agro-Scientific Research in the Public Interest (201303117), the Yunnan Provincial Natural Science Foundation (2013FD066, 2013FZ150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2013, J PHARMACEUT BIOMED, V85, P295, DOI 10.1016/j.jpba.2013.07.005; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen QS, 2009, FOOD CHEM, V113, P1272, DOI 10.1016/j.foodchem.2008.08.042; [程建刚 CHENG Jiangang], 2009, [地理科学进展, Progress in Geography], V28, P18; Drasar P, 2004, J CHROMATOGR B, V812, P3, DOI 10.1016/j.jchromb.2004.09.037; Huck CW, 2005, ANAL CHIM ACTA, V538, P195, DOI 10.1016/j.aca.2005.01.064; Jiang Y, 2007, J PHARMACEUT BIOMED, V43, P341, DOI 10.1016/j.jpba.2006.06.030; Lee MS, 2005, CANCER BIOL THER, V4, P1248, DOI 10.4161/cbt.4.11.2136; Li H., 1986, BULL BOT RES, V6, P109; [李蒙 Li Meng], 2010, [中国农业气象, Chinese Journal of Agrometeorology], V31, P442; Li XD, 2012, EVID-BASED COMPL ALT, V12, P1; Louw ED, 2010, POSTHARVEST BIOL TEC, V58, P176, DOI 10.1016/j.postharvbio.2010.07.001; Man SL, 2009, ANAL BIOANAL CHEM, V395, P495, DOI 10.1007/s00216-009-2987-2; Manukyan A., 2011, MED AROMATIC PLANT S, V5, P119; Ong RCY, 2008, CANCER LETT, V261, P158, DOI 10.1016/j.canlet.2007.11.005; Otsuka M, 2001, ANALYST, V126, P1578, DOI 10.1039/b103498g; Qi LW, 2006, J CHROMATOGR A, V1134, P162, DOI 10.1016/j.chroma.2006.08.085; Siu FM, 2008, PROTEOMICS, V8, P3105, DOI 10.1002/pmic.200700829; [苏文华 Su Wenhua], 2003, [云南大学学报. 自然科学版, Journal of Yunnan University (Natural Science)], V25, P545; Suberu J, 2013, J PHARMACEUT BIOMED, V84, P269, DOI 10.1016/j.jpba.2013.06.025; Wu D, 2012, FOOD CHEM, V135, P2147, DOI 10.1016/j.foodchem.2012.07.011; [谢彩香 Xie Caixiang], 2011, [生态学报, Acta Ecologica Sinica], V31, P7551; Xie LJ, 2007, J FOOD ENG, V82, P395, DOI 10.1016/j.jfoodeng.2007.02.062; Yip PY, 2007, CHIN MED, V2, P1; Yu HY, 2009, FOOD CHEM, V113, P291, DOI 10.1016/j.foodchem.2008.06.083; Zhang JY, 2011, J ASIAN NAT PROD RES, V13, P670, DOI 10.1080/10286020.2011.578247; Zhang JinYu, 2012, African Journal of Pharmacy and Pharmacology, V6, P2802; Zhang L, 2013, J AGR FOOD CHEM, V61, P2597, DOI 10.1021/jf400428t; Zhao JL, 2010, MOLECULES, V15, P7961, DOI 10.3390/molecules15117961	29	44	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89100	10.1371/journal.pone.0089100	http://dx.doi.org/10.1371/journal.pone.0089100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558477	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700123
J	Tu, LH; Hu, HL; Chen, G; Peng, Y; Xiao, YL; Hu, TX; Zhang, J; Li, XW; Liu, L; Tang, Y				Tu, Li-hua; Hu, Hong-ling; Chen, Gang; Peng, Yong; Xiao, Yin-long; Hu, Ting-xing; Zhang, Jian; Li, Xian-wei; Liu, Li; Tang, Yi			Nitrogen Addition Significantly Affects Forest Litter Decomposition under High Levels of Ambient Nitrogen Deposition	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; PHOSPHORUS DYNAMICS; FOLIAR LITTER; RAINY AREA; CARBON; PATTERNS; RATES; PLANTATION; RELEASE; STORAGE	Background: Forest litter decomposition is a major component of the global carbon (C) budget, and is greatly affected by the atmospheric nitrogen (N) deposition observed globally. However, the effects of N addition on forest litter decomposition, in ecosystems receiving increasingly higher levels of ambient N deposition, are poorly understood. Methodology/Principal Findings: We conducted a two-year field experiment in five forests along the western edge of the Sichuan Basin in China, where atmospheric N deposition was up to 82-114 kg N ha(-1) in the study sites. Four levels of N treatments were applied: (1) control (no N added), (2) low-N (50 kg N ha(-1) year(-1)), (3) medium-N (150 kg N ha(-1) year(-1)), and (4) high-N (300 kg N ha(-1) year(-1)), N additions ranging from 40% to 370% of ambient N deposition. The decomposition processes of ten types of forest litters were then studied. Nitrogen additions significantly decreased the decomposition rates of six types of forest litters. N additions decreased forest litter decomposition, and the mass of residual litter was closely correlated to residual lignin during the decomposition process over the study period. The inhibitory effect of N addition on litter decomposition can be primarily explained by the inhibition of lignin decomposition by exogenous inorganic N. The overall decomposition rate of ten investigated substrates exhibited a significant negative linear relationship with initial tissue C/N and lignin/N, and significant positive relationships with initial tissue K and N concentrations; these relationships exhibited linear and logarithmic curves, respectively. Conclusions/Significance: This study suggests that the expected progressive increases in N deposition may have a potential important impact on forest litter decomposition in the study area in the presence of high levels of ambient N deposition.	[Tu, Li-hua; Hu, Hong-ling; Chen, Gang; Peng, Yong; Xiao, Yin-long; Hu, Ting-xing; Zhang, Jian; Li, Xian-wei] Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China; [Liu, Li] Sichuan Agr Univ, Maize Res Inst, Chengdu, Sichuan, Peoples R China; [Liu, Li] Sichuan Agr Univ, Personnel Dept, Chengdu, Sichuan, Peoples R China; [Tang, Yi] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Hu, TX (corresponding author), Sichuan Agr Univ, Coll Forestry, Yaan, Sichuan, Peoples R China.	hutx001@163.com			National Natural Science Foundation, China [31300522]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20125103120018]; Scientific Research Fund of Sichuan Provincial Education Department, China [12ZA118]; National Key Technology R&D Program of China [2011BAC09B05]; Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Fund of Sichuan Provincial Education Department, China; National Key Technology R&D Program of China(National Key Technology R&D Program); Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University	This study was funded by the National Natural Science Foundation, China (No. 31300522), Specialized Research Fund for the Doctoral Program of Higher Education, China (No. 20125103120018), Scientific Research Fund of Sichuan Provincial Education Department, China (No. 12ZA118), National Key Technology R&D Program of China (No. 2011BAC09B05), and Program for Creative Group Construction in "211 Project'' of Sichuan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Berg B, 1986, SCAND J FOREST RES, V1, P359, DOI 10.1080/02827588609382428; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Didham RK, 1998, OECOLOGIA, V116, P397, DOI 10.1007/s004420050603; Fang YT, 2011, J FOREST RES-JPN, V16, P341, DOI 10.1007/s10310-011-0267-4; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobbie SE, 2012, ECOL MONOGR, V82, P389, DOI 10.1890/11-1600.1; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Hogberg P, 2007, NATURE, V447, P781, DOI 10.1038/447781a; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Hu ZY, 2007, PEDOSPHERE, V17, P360, DOI 10.1016/S1002-0160(07)60043-5; JACKSON M. L., 1958, Soil Chemical Analysis.; Jia GD, 2010, ATMOS ENVIRON, V44, P2309, DOI 10.1016/j.atmosenv.2010.03.041; Jones J. B., 1990, SOIL TESTING PLANT A, P390; KEYSER P, 1978, J BACTERIOL, V135, P790, DOI 10.1128/JB.135.3.790-797.1978; Knops JMH, 2007, GLOBAL CHANGE BIOL, V13, P1960, DOI 10.1111/j.1365-2486.2007.01405.x; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; KRUG FJ, 1979, ANALYST, V104, P47, DOI 10.1039/an9790400047; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Moore TR, 2006, ECOSYSTEMS, V9, P46, DOI 10.1007/s10021-004-0026-x; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Swift M. J., 1979, Decomposition in terrestrial ecosystems.; Ti CP, 2012, BIOGEOCHEMISTRY, V108, P381, DOI 10.1007/s10533-011-9606-y; Tu LH, 2013, PEDOSPHERE IN PRESS; Tu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075862; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Tu Li-hua, 2012, Yingyong Shengtai Xuebao, V23, P2129; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; Vestgarden LS, 2001, SOIL BIOL BIOCHEM, V33, P465, DOI 10.1016/S0038-0717(00)00187-5; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; [肖银龙 Xiao Yinlong], 2013, [生态学报, Acta Ecologica Sinica], V33, P7355; Xu ZF, 2013, ENVIRON POLLUT, V177, P201, DOI 10.1016/j.envpol.2012.12.031; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zhuang Ping, 2002, Shengwu Duoyangxing, V10, P339	54	39	43	14	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88752	10.1371/journal.pone.0088752	http://dx.doi.org/10.1371/journal.pone.0088752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551152	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500064
J	Zhao, J; Kelnar, K; Bader, AG				Zhao, Jane; Kelnar, Kevin; Bader, Andreas G.			In-Depth Analysis Shows Synergy between Erlotinib and miR-34a	PLOS ONE			English	Article							CELL LUNG-CANCER; FACTOR RECEPTOR INHIBITORS; DRUG-COMBINATION; HIGH EXPRESSION; PHASE-II; GROWTH; RESISTANCE; GEFITINIB; EGFR; SENSITIVITY	Tyrosine kinase inhibitors directed against epidermal growth factor receptor (EGFR-TKI), such as erlotinib, are effective in a limited fraction of non-small cell lung cancer (NSCLC). However, the majority of NSCLC and other cancer types remain resistant. Therapeutic miRNA mimics modeled after endogenous tumor suppressor miRNAs inhibit tumor growth by repressing multiple oncogenes at once and, therefore, may be used to augment drug sensitivity. Here, we investigated the relationship of miR-34a and erlotinib and determined the therapeutic activity of the combination in NSCLC cells with primary and acquired erlotinib resistance. The drug combination was also tested in a panel of hepatocellular carcinoma cells (HCC), a cancer type known to be refractory to erlotinib. Using multiple analytical approaches, drug-induced inhibition of cancer cell proliferation was determined to reveal additive, antagonistic or synergistic effects. Our data show a strong synergistic interaction between erlotinib and miR-34a mimics in all cancer cells tested. Synergy was observed across a range of different dose levels and drug ratios, reducing IC50 dose requirements for erlotinib and miR-34a by up to 46-fold and 13-fold, respectively. Maximal synergy was detected at dosages that provide a high level of cancer cell inhibition beyond the one that is induced by the single agents alone and, thus, is of clinical relevance. The data suggest that a majority of NSCLC and other cancers previously not suited for erlotinib may prove sensitive to the drug when used in combination with a miR-34a-based therapy.	[Zhao, Jane; Kelnar, Kevin; Bader, Andreas G.] Mirna Therapeut Inc, Austin, TX 78744 USA		Bader, AG (corresponding author), Mirna Therapeut Inc, Austin, TX 78744 USA.	abader@mirnarx.com			National Institutes of Health [1R43CA134071, 1R43CA137939]; Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE [R43CA137939, R43CA134071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (1R43CA134071, 1R43CA137939, A.G.B.) and a commercialization grant from the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; American Cancer Society, 2013, CANC FACTS FIG 2013; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Giles KM, 2013, MOL CANC THER; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Ono M, 2004, MOL CANCER THER, V3, P465; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Philip PA, 2005, J CLIN ONCOL, V23, P6657, DOI 10.1200/JCO.2005.14.696; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Van Schaeybroeck S, 2006, MOL CANCER THER, V5, P1154, DOI 10.1158/1535-7163.MCT-05-0446; Vinall RL, 2012, INT J CANCER, V130, P2526, DOI 10.1002/ijc.26256; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhao J, 2013, MOL THER, V21, P1678, DOI 10.1038/mt.2013.148; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86; Zhu AX, 2012, 37 ANN EUR SOC MED O	44	45	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89105	10.1371/journal.pone.0089105	http://dx.doi.org/10.1371/journal.pone.0089105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551227	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500099
J	Aring;ogren, J; Finn, M; Bengtsson, B; Segerman, B				Aogren, Joakim; Finn, Maria; Bengtsson, Bjorn; Segerman, Bo			Microevolution during an Anthrax Outbreak Leading to Clonal Heterogeneity and Penicillin Resistance	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; MYCOBACTERIUM-TUBERCULOSIS; SEQUENCE; PATIENT	Anthrax is a bacterial disease primarily affecting grazing animals but it can also cause severe disease in humans. We have used genomic epidemiology to study microevolution of the bacterium in a confined outbreak in cattle which involved emergence of an antibiotic-resistant phenotype. At the time of death, the animals contained a heterogeneous population of Single Nucleotide Variants (SNVs), some being clonal but most being subclonal. We found that independent isolates from the same carcass had similar levels of SNV differences as isolates from different animals. Furthermore the relative levels of subclonal populations were different in different locations in the same carcass. The heterogeneity appeared to be derived in part from heterogeneity in the infectious dose. The resistance phenotype was linked to clonal mutations in an anti-sigma factor gene and in one case was preceded by an acquisition of a hypermutator phenotype. In another animal, small subclonal populations were observed with counteracting mutations that had turned off the resistance genes. In summary, this study shows the importance of accounting for both acquired and inherited heterogeneity when doing high-resolution infection tracing and when estimating the risks associated with penicillin treatment.	[Aogren, Joakim; Segerman, Bo] Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden; [Finn, Maria; Bengtsson, Bjorn] Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Aogren, Joakim] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	National Veterinary Institute SVA; National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Segerman, B (corresponding author), Natl Vet Inst SVA, Dept Bacteriol, Uppsala, Sweden.	bo.segerman@sva.se			EU-project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union; European Commission-Directorate General Home Affairs; Swedish Civil Contingencies Agency (MSB)	EU-project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union; European Commission-Directorate General Home Affairs; Swedish Civil Contingencies Agency (MSB)	This work was supported by/executed in the framework of the EU-project AniBioThreat (grant agreement: Home/2009/ISEC/AG/191) with the financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs. This publication reflects the views only of the author, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. This work was also supported by the Swedish Civil Contingencies Agency (MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athamna A, 2004, J ANTIMICROB CHEMOTH, V54, P424, DOI 10.1093/jac/dkh258; BARNES JM, 1947, J PATHOL BACTERIOL, V59, P113, DOI 10.1002/path.1700590113; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cavallo JD, 2002, ANTIMICROB AGENTS CH, V46, P2307, DOI 10.1128/AAC.46.7.2307-2309.2002; Chun JH, 2012, J BACTERIOL, V194, P4116, DOI 10.1128/JB.00159-12; *CLSI, 2010, A45A2 CLSI; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kupferschmidt K, 2011, SCIENCE, V333, P1818, DOI 10.1126/science.333.6051.1818; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Liu Y., 2007, ELECT DNA ARRAYS DET; Luna VA, 2009, J MICROBIOL METH, V79, P301, DOI 10.1016/j.mimet.2009.09.023; Mayer TA, 2001, JAMA-J AM MED ASSOC, V286, P2549, DOI 10.1001/jama.286.20.2549; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Patra G, 2002, RES MICROBIOL, V153, P139, DOI 10.1016/S0923-2508(02)01299-8; PEREZLAGO L, 2013, J INFECT DIS; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Ringertz SH, 2000, LANCET, V356, P1574, DOI 10.1016/S0140-6736(00)03133-0; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Ross CL, 2009, J BACTERIOL, V191, P6683, DOI 10.1128/JB.00691-09; Sanchez H, 2007, MOL MICROBIOL, V65, P920, DOI 10.1111/j.1365-2958.2007.05835.x; STERN EJ, 2008, EMERGING INFECT DIS, V14; STOBER MG, 1979, CLIN EXAMINATION CAT; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; Turnbull PCB, 2008, ANTHRAX HUMANS ANIMA; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vogler AJ, 2002, ANTIMICROB AGENTS CH, V46, P511, DOI 10.1128/AAC.46.2.511-513.2002; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3	37	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89112	10.1371/journal.pone.0089112	http://dx.doi.org/10.1371/journal.pone.0089112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551231	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000105
J	Wadood, A; Riaz, M; Uddin, R; ul-Haq, Z				Wadood, Abdul; Riaz, Muhammad; Uddin, Reaz; ul-Haq, Zaheer			In Silico Identification and Evaluation of Leads for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease Using Complex Based Pharmacophore Mapping and Virtual Screening	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG DISCOVERY; PLUS RIBAVIRIN; PROTEINASE; NS4A; DOCKING; DESIGN; DOMAIN; MODEL	Hepatitis C virus (HCV) infection is an alarming and growing threat to public health. The present treatment gives limited efficacy and is poorly tolerated, recommending the urgent medical demand for novel therapeutics. NS3/4A protease is a significant emerging target for the treatment of HCV infection. This work reports the complex-based pharmacophore modeling to find out the important pharmacophoric features essential for the inhibition of both protease and helicase activity of NS3/4A protein of HCV. A seven featured pharmacophore model of HCV NS3/4A protease was developed from the crystal structure of NS3/4A protease in complex with a macrocyclic inhibitor interacting with both protease and helicase sites residues via MOE pharmacophore constructing tool. It consists of four hydrogen bond acceptors (Acc), one hydrophobic (Hyd), one for lone pair or active hydrogen (Atom L) and a heavy atom feature (Atom Q). The generated pharmacophore model was validated by a test database of seventy known inhibitors containing 55 active and 15 inactive/least active compounds. The validated pharmacophore model was used to virtually screen the ChemBridge database. As a result of screening 1009 hits were retrieved and were subjected to filtering by Lipinski's rule of five on the basis of which 786 hits were selected for further assessment using molecular docking studies. Finally, 15 hits of different scaffolds having interactions with important active site residues were predicted as lead candidates. These candidates having unique scaffolds have a strong likelihood to act as further starting points in the development of novel and potent NS3/4A protease inhibitors.	[Wadood, Abdul; Riaz, Muhammad] Abdul Wali Khan Univ Mardan, Dept Biochem, Computat Med Chem Lab, Mardan, Khyber Pakhthun, Pakistan; [Uddin, Reaz; ul-Haq, Zaheer] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Karach, Sindh, Pakistan		Wadood, A (corresponding author), Abdul Wali Khan Univ Mardan, Dept Biochem, Computat Med Chem Lab, Mardan, Khyber Pakhthun, Pakistan.	awadood2001@yahoo.com	Uddin, Reaz/I-5673-2017; Wadood, Abdul/ABG-2789-2021; Ul-Haq, Zaheer/E-3061-2010	Uddin, Reaz/0000-0002-9928-4482; Ul-Haq, Zaheer/0000-0002-8530-8711				Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Chen KX, 2009, CURR OPIN INVEST DR, V10, P821; Clarke MO, 2011, BIOORG MED CHEM; Colvin HM, 2010, HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, P1; Debnath AK, 2003, J MED CHEM, V46, P4501, DOI 10.1021/jm030265z; Flisiak R, 2010, EXPERT OPIN INV DRUG, V19, P63, DOI 10.1517/13543780903431034; Fried M, 2002, AM POETRY REV, V31, P36; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Glunz PW, 2003, BIOORG MED CHEM LETT, V13, P785, DOI 10.1016/S0960-894X(03)00022-2; Hamid S., 2004, JPMA Journal of the Pakistan Medical Association, V54, P146; Han W, 2003, BIOORG MED CHEM LETT, V13, P1111, DOI 10.1016/S0960-894X(03)00031-3; Huang M, 2006, PROTEASES IN GASTROINTESTINAL TISSUES, P153; Ismail NSM, 2011, BIOORGAN MED CHEM, V19, P374, DOI 10.1016/j.bmc.2010.11.017; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Koch JO, 1996, VIROLOGY, V221, P54, DOI 10.1006/viro.1996.0352; Kurogi Y, 2001, CURR MED CHEM, V8, P1035, DOI 10.2174/0929867013372481; Kwong AD, 2008, CURR OPIN PHARMACOL, V8, P522, DOI 10.1016/j.coph.2008.09.007; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Li XF, 2011, BIOORG MED CHEM LETT, V21, P2048, DOI 10.1016/j.bmcl.2011.02.006; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; Nizi E, 2004, BIOORG MED CHEM LETT, V14, P2151, DOI 10.1016/j.bmcl.2004.02.032; Reiser M, 2009, EXPERT REV ANTI-INFE, V7, P537, DOI 10.1586/ERI.09.30; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; SATOH S, 1995, J VIROL, V69, P4255, DOI 10.1128/JVI.69.7.4255-4260.1995; Schiering N, 2011, P NATL ACAD SCI USA, V108, P21052, DOI 10.1073/pnas.1110534108; TANJI Y, 1994, J VIROL, V68, P8418, DOI 10.1128/JVI.68.12.8418-8422.1994; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Wadood A, 2013, BIOINFORMATION, V9, P309, DOI 10.6026/97320630009309; Wadood A, 2012, CHEM BIOL DRUG DES, V79, P431, DOI 10.1111/j.1747-0285.2011.01281.x; Wands JR, 2004, NEW ENGL J MED, V351, P1567, DOI 10.1056/NEJMe048237; Wei J, 2007, J CHEM INF MODEL, V47, P613, DOI 10.1021/ci600410m; Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013	44	23	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89109	10.1371/journal.pone.0089109	http://dx.doi.org/10.1371/journal.pone.0089109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551230	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000104
J	Kannan, S; Zacharias, M				Kannan, Srinivasaraghavan; Zacharias, Martin			Role of Tryptophan Side Chain Dynamics on the Trp-Cage Mini-Protein Folding Studied by Molecular Dynamics Simulations	PLOS ONE			English	Article							REPLICA-EXCHANGE SIMULATIONS; FREE-ENERGY LANDSCAPE; EXPLICIT SOLVENT; UNFOLDED STATE; FORCE-FIELD; MINIPROTEIN; WATER; RESOLUTION; COOPERATIVITY; INTERMEDIATE	The 20 residue Trp-cage mini-protein is one of smallest proteins that adopt a stable folded structure containing also well-defined secondary structure elements. The hydrophobic core is arranged around a single central Trp residue. Despite several experimental and simulation studies the detailed folding mechanism of the Trp-cage protein is still not completely understood. Starting from fully extended as well as from partially folded Trp-cage structures a series of molecular dynamics simulations in explicit solvent and using four different force fields was performed. All simulations resulted in rapid collapse of the protein to on average relatively compact states. The simulations indicate a significant dependence of the speed of folding to near-native states on the side chain rotamer state of the central Trp residue. Whereas the majority of intermediate start structures with the central Trp side chain in a near-native rotameric state folded successfully within less than 100 ns only a fraction of start structures reached near-native folded states with an initially non-native Trp side chain rotamer state. Weak restraining of the Trp side chain dihedral angles to the state in the folded protein resulted in significant acceleration of the folding both starting from fully extended or intermediate conformations. The results indicate that the side chain conformation of the central Trp residue can create a significant barrier for controlling transitions to a near native folded structure. Similar mechanisms might be of importance for the folding of other protein structures.	[Kannan, Srinivasaraghavan] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Kannan, Srinivasaraghavan] Agcy Sci Technol & Res, Ctr Expt Therapeut, Singapore, Singapore; [Zacharias, Martin] Tech Univ Munich, Phys Dept T38, Garching, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Technical University of Munich	Kannan, S (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	raghavk@bii.a-star.edu.sg; Martin.Zacharias@ph.tum.de			DFG (Center of Integrated Protein Science Munich: CIPSM); European Union (PRACE-0 project) [pr89tu]; Joint Council Office (JCO) [11/03/FG/07/05]; Agency for Science, Technology and Research (A*STAR), Singapore	DFG (Center of Integrated Protein Science Munich: CIPSM); European Union (PRACE-0 project); Joint Council Office (JCO); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	We thank the DFG (Center of Integrated Protein Science Munich: CIPSM), European Union (PRACE-0 project pr89tu) and Joint Council Office (JCO) (11/03/FG/07/05), Agency for Science, Technology and Research (A*STAR), Singapore, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Barua B, 2001, LETT PEPT SCI, V8, P221, DOI 10.1007/BF02446520; Barua B, 2008, PROTEIN ENG DES SEL, V21, P171, DOI 10.1093/protein/gzm082; Beck DAC, 2007, J STRUCT BIOL, V157, P514, DOI 10.1016/j.jsb.2006.10.002; Case D, 2010, AMBER, V11; Chowdhury S, 2004, J PHYS CHEM B, V108, P13855, DOI 10.1021/jp0478920; Chowdhury S, 2003, J MOL BIOL, V327, P711, DOI 10.1016/S0022-2836(03)00177-3; Culik RM, 2011, ANGEW CHEM INT EDIT, V50, P10884, DOI 10.1002/anie.201104085; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2010, PROTEINS, V78, P1889, DOI 10.1002/prot.22702; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng NJ, 2013, J PHYS CHEM B, V117, P12787, DOI 10.1021/jp401962k; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Halabis A, 2012, J PHYS CHEM B, V116, P6898, DOI 10.1021/jp212630y; Han W, 2013, J PHYS CHEM B, V117, P13367, DOI 10.1021/jp404331d; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu ZH, 2008, ARCH BIOCHEM BIOPHYS, V475, P140, DOI 10.1016/j.abb.2008.04.024; Hudaky P, 2008, BIOCHEMISTRY-US, V47, P1007, DOI 10.1021/bi701371x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Juraszek J, 2006, P NATL ACAD SCI USA, V103, P15859, DOI 10.1073/pnas.0606692103; Kannan S, 2007, PROTEINS, V66, P697, DOI 10.1002/prot.21258; Kannan S, 2009, INT J MOL SCI, V10, P1121, DOI 10.3390/ijms10031121; Kannan S, 2009, PROTEINS, V76, P448, DOI 10.1002/prot.22359; Lai ZZ, 2013, J PHYS CHEM B, V117, P4661, DOI 10.1021/jp309122b; Li DW, 2010, ANGEW CHEM INT EDIT, V49, P6778, DOI 10.1002/anie.201001898; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marinelli F, 2013, BIOPHYS J, V105, P1236, DOI 10.1016/j.bpj.2013.07.046; Marinelli F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000452; Meuzelaar H, 2013, J PHYS CHEM B, V117, P11490, DOI 10.1021/jp404714c; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; Ota M, 2004, P NATL ACAD SCI USA, V101, P17658, DOI 10.1073/pnas.0407015102; Paschek D, 2007, J STRUCT BIOL, V157, P524, DOI 10.1016/j.jsb.2006.10.031; Paschek D, 2008, P NATL ACAD SCI USA, V105, P17754, DOI 10.1073/pnas.0804775105; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Rovo P, 2011, J PEPT SCI, V17, P610, DOI 10.1002/psc.1377; Scian M, 2012, P NATL ACAD SCI USA, V109, P12521, DOI 10.1073/pnas.1121421109; Shao Q, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754656; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Snow CD, 2002, J AM CHEM SOC, V124, P14548, DOI 10.1021/ja028604l; Williams DV, 2011, BIOCHEMISTRY-US, V50, P1143, DOI 10.1021/bi101555y; Xu WX, 2008, BIOPHYS CHEM, V137, P116, DOI 10.1016/j.bpc.2008.08.002; Yao XQ, 2008, BIOCHEM BIOPH RES CO, V373, P64, DOI 10.1016/j.bbrc.2008.05.179; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	50	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88383	10.1371/journal.pone.0088383	http://dx.doi.org/10.1371/journal.pone.0088383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24563686	gold, Green Submitted, Green Published			2022-12-25	WOS:000330834400064
J	Fujita, N; Hirose, Y; Tran, CM; Chiba, K; Miyamoto, T; Toyama, Y; Shapiro, IM; Risbud, MV				Fujita, Nobuyuki; Hirose, Yuichiro; Tran, Cassie M.; Chiba, Kazuhiro; Miyamoto, Takeshi; Toyama, Yoshiaki; Shapiro, Irving M.; Risbud, Makarand V.			HIF-1-PHD2 axis controls expression of syndecan 4 in nucleus pulposus cells	FASEB JOURNAL			English	Article						cartilage; hypoxia; intervertebral disc	HUMAN INTERVERTEBRAL DISC; HEPARAN-SULFATE; TNF-ALPHA; FACTOR (HIF)-1-ALPHA; GENE-EXPRESSION; AGGRECAN GENE; GROWTH-FACTOR; HYPOXIA; HIF-1-ALPHA; DIFFERENTIATION	Intervertebral disc degeneration is the leading cause of chronic back pain. Recent studies show that raised level of SDC4, a cell-surface heparan sulfate (HS) proteoglycan, plays a role in pathogenesis of disc degeneration. However, in nucleus pulposus (NP) cells of the healthy intervertebral disc, the mechanisms that control expression of SDC4 and its physiological function are unknown. Hypoxia induced SDC4 mRNA and protein expression by similar to 2.4- and 4.4-fold (P<0.05), respectively, in NP cells. While the activity of the SDC4 promoter containing hypoxia response element (HRE) was induced 2-fold (P<0.05), the HRE mutation decreased the activity by 40% in hypoxia. Transfections with plasmids coding prolyl-4-hydroxylase domain protein 2 (PHD2) and ShPHD2 show that hypoxic expression of SDC4 mRNA and protein is regulated by PHD2 through controlling hypoxia-inducible factor 1 alpha (HIF-1 alpha) levels. Although overexpression of HIF-1 alpha significantly increased SDC4 protein levels, stable suppression of HIF-1 alpha and HIF-1 beta decreased SDC4 expression by 50% in human NP cells. Finally, suppression of SDC4 expression, as well as HS function, resulted in an similar to 2-fold increase in sex-determining region Y (SRY)-box 9 (Sox9) mRNA, and protein (P<0.05) and simultaneous increase in Sox9 transcriptional activity and target gene expression. Taken together, our findings suggest that in healthy discs, SDC4, through its HS side chains, contributes to maintenance of the hypoxic tissue niche by controlling baseline expression of Sox9.	[Fujita, Nobuyuki; Hirose, Yuichiro; Tran, Cassie M.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Hirose, Yuichiro; Tran, Cassie M.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki; Hirose, Yuichiro; Miyamoto, Takeshi; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; [Chiba, Kazuhiro] Kitasato Univ, Kitasato Inst Hosp, Dept Orthopaed Surg, Tokyo, Japan	Jefferson University; Jefferson University; Keio University; Kitasato University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR050087, R01-AR055655]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055655, R01AR050087] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR050087 and R01-AR055655). The authors report no conflicts of interest.	Adluri RS, 2011, ANTIOXID REDOX SIGN, V15, P1789, DOI 10.1089/ars.2010.3769; Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Cully Megan, 2013, Nat Rev Rheumatol, V9, P136, DOI 10.1038/nrrheum.2013.22; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540; Huegel J, 2013, DEV BIOL, V377, P100, DOI 10.1016/j.ydbio.2013.02.008; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; O'Connell MP, 2009, J BIOL CHEM, V284, P28704, DOI 10.1074/jbc.M109.028498; Okuyama E, 2013, J BIOCHEM, V154, P41, DOI 10.1093/jb/mvt024; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; RUDERT M, 1993, ACTA ORTHOP SCAND, V64, P37, DOI 10.3109/17453679308994524; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Smith MF, 2006, GLYCOBIOLOGY, V16, P221, DOI 10.1093/glycob/cwj061; Sowter HM, 2003, CANCER RES, V63, P6130; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tran CM, 2013, J BIOL CHEM, V288, P12654, DOI 10.1074/jbc.M112.448860; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Yeramian A, 2011, LAB INVEST, V91, P859, DOI 10.1038/labinvest.2011.58; Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620	43	27	29	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2455	2465		10.1096/fj.13-243741	http://dx.doi.org/10.1096/fj.13-243741			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24558194	Green Published			2022-12-25	WOS:000339883600007
J	Hayashi, Y; Tsurumizu, R; Tsukahara, J; Takeda, K; Narita, S; Mori, M; Miki, K; Tokuda, H				Hayashi, Yumi; Tsurumizu, Ryoji; Tsukahara, Jun; Takeda, Kazuki; Narita, Shin-ichiro; Mori, Makiko; Miki, Kunio; Tokuda, Hajime			Roles of the Protruding Loop of Factor B Essential for the Localization of Lipoproteins ( LolB) in the Anchoring of Bacterial Triacylated Proteins to the Outer Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Escherichia coli; Lipoprotein; Membrane Proteins; Protein Export; Protein Sorting; Protein Structure; LolB; Bacterial Lipoprotein; Periplasm	ESCHERICHIA-COLI LIPOPROTEINS; OVEREXPRESSION; MECHANISM; CLEAVAGE; DELETION; MODEL	Background: LolB accepts lipoproteins from LolA and anchors them to the inner leaflet of outer membranes. Results: Membrane targeting of lipoproteins is defective in several mutants with substitutions of Leu-68 of LolB. Conclusion: The protruding loop of LolB plays critical roles in the membrane anchoring activity. Significance: A possible mechanism for the last step of lipoprotein sorting is proposed. The Lol system comprising five Lol proteins, LolA through LolE, sorts Escherichia coli lipoproteins to outer membranes. The LolCDE complex, an ATP binding cassette transporter in inner membranes, releases outer membrane-specific lipoproteins in an ATP-dependent manner, causing formation of the LolA-lipoprotein complex in the periplasm. LolA transports lipoproteins through the periplasm to LolB on outer membranes. LolB is itself a lipoprotein anchored to outer membranes, although the membrane anchor is functionally dispensable. LolB then localizes lipoproteins to outer membranes through largely unknown mechanisms. The crystal structure of LolB is similar to that of LolA, and it possesses a hydrophobic cavity that accommodates acyl chains of lipoproteins. To elucidate the molecular function of LolB, a periplasmic version of LolB, mLolB, was mutagenized at various conserved residues. Despite the lack of acyl chains, most defective mutants were insoluble. However, a derivative with glutamate in place of leucine 68 was soluble and unable to localize lipoproteins to outer membranes. This leucine is present in a loop protruding from mLolB into an aqueous environment, and no analogous loop is present in LolA. Thus, leucine 68 was replaced with other residues. Replacement by acidic, but not hydrophobic, residues generated for the first time mLolB derivatives that can accept but cannot localize lipoproteins to outer membranes. Moreover, deletion of the leucine with neighboring residues impaired the lipoprotein receptor activity. Based on these observations, the roles of the protruding loop of LolB in the last step of lipoprotein sorting are discussed.	[Hayashi, Yumi; Tsurumizu, Ryoji; Tsukahara, Jun] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Narita, Shin-ichiro; Mori, Makiko; Tokuda, Hajime] Univ Morioka, Dept Nutr Sci, Takizawa, Iwate, Japan	University of Tokyo; Kyoto University	Tokuda, H (corresponding author), Univ Morioka, Dept Nutr Sci, 808 Sunakomi, Takizawa, Iwate, Japan.	htokuda@morioka-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Narita, Shin-ichiro/0000-0001-9425-2943; Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24570152] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan grants (to H. T.) and the Target Protein Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. M.).	BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; HIROTA Y, 1977, P NATL ACAD SCI USA, V74, P1417, DOI 10.1073/pnas.74.4.1417; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; MIZUSHIMA S, 1984, MOL CELL BIOCHEM, V60, P5; Nakada S, 2009, J BIOL CHEM, V284, P24634, DOI 10.1074/jbc.M109.001149; Narita S, 2011, J BACTERIOL, V193, P4832, DOI 10.1128/JB.05013-11; Okuda S, 2008, FEBS LETT, V582, P2247, DOI 10.1016/j.febslet.2008.05.022; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Sambrook J., 1989, MOL CLONING LAB MANU; Sugai R, 2001, J BACTERIOL, V183, P5523, DOI 10.1128/JB.183.19.5523-5528.2001; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Takeda K, 2003, ACTA CRYSTALLOGR D, V59, P1224, DOI 10.1107/S0907444903008709; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Tokuda H., 2014, BACTERIAL MEMBRANES, P133; Tsukahara J, 2009, FEBS J, V276, P4496, DOI 10.1111/j.1742-4658.2009.07156.x; Wada R, 2004, BIOCHEM BIOPH RES CO, V323, P1069, DOI 10.1016/j.bbrc.2004.08.200; Watanabe S, 2007, PROTEIN SCI, V16, P2741, DOI 10.1110/ps.073101307; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997; YAMADA H, 1989, J BIOL CHEM, V264, P18577; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	27	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10530	10539		10.1074/jbc.M113.539270	http://dx.doi.org/10.1074/jbc.M113.539270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569999	Green Published, hybrid			2022-12-25	WOS:000334226400026
J	Walsh, P; Vanderlee, G; Yau, J; Campeau, J; Sim, VL; Yip, CM; Sharpe, S				Walsh, Patrick; Vanderlee, Gillian; Yau, Jason; Campeau, Jody; Sim, Valerie L.; Yip, Christopher M.; Sharpe, Simon			The Mechanism of Membrane Disruption by Cytotoxic Amyloid Oligomers Formed by Prion Protein(106-126) Is Dependent on Bilayer Composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Atomic Force Microscopy; Membrane Bilayer; Peptides; Solid State NMR; Amyloid Oligomers; Cytotoxicity; Membrane Disruption; TIRF	SUPPORTED LIPID-BILAYERS; PROTEIN-FRAGMENT 106-126; APOPTOTIC CELL-DEATH; SOLID-STATE NMR; CALCIUM-CHANNEL ACTIVITY; ANTIMICROBIAL PEPTIDE; TRANSMEMBRANE DOMAIN; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; ALPHA-SYNUCLEIN	Background: Nonfibrillar amyloid oligomers are cytotoxic and may act through physical disruption of cell membranes. Results: Cytotoxic oligomers of the amyloid peptide PrP(106-126) disrupt membranes through distinct mechanisms, depending on lipid composition. Conclusion: Cytotoxicity of PrP(106-126) oligomers can occur through at least two different physical processes. Significance: Mechanisms for the membrane disruption of amyloid oligomers are proposed, providing new insight into their cytotoxicity. The formation of fibrillar aggregates has long been associated with neurodegenerative disorders such as Alzheimer and Parkinson diseases. Although fibrils are still considered important to the pathology of these disorders, it is now widely understood that smaller amyloid oligomers are the toxic entities along the misfolding pathway. One characteristic shared by the majority of amyloid oligomers is the ability to disrupt membranes, a commonality proposed to be responsible for their toxicity, although the mechanisms linking this to cell death are poorly understood. Here, we describe the physical basis for the cytotoxicity of oligomers formed by the prion protein (PrP)-derived amyloid peptide PrP(106-126). We show that oligomers of this peptide kill several mammalian cells lines, as well as mouse cerebellar organotypic cultures, and we also show that they exhibit antimicrobial activity. Physical perturbation of model membranes mimicking bacterial or mammalian cells was investigated using atomic force microscopy, polarized total internal reflection fluorescence microscopy, and NMR spectroscopy. Disruption of anionic membranes proceeds through a carpet or detergent model as proposed for other antimicrobial peptides. By contrast, when added to zwitterionic membranes containing cholesterol-rich ordered domains, PrP(106-126) oligomers induce a loss of domain separation and decreased membrane disorder. Loss of raft-like domains may lead to activation of apoptotic pathways, resulting in cell death. This work sheds new light on the physical mechanisms of amyloid cytotoxicity and is the first to clearly show membrane type-specific modes of action for a cytotoxic peptide.	[Walsh, Patrick; Yau, Jason; Sharpe, Simon] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Walsh, Patrick; Yau, Jason; Yip, Christopher M.; Sharpe, Simon] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Vanderlee, Gillian; Yip, Christopher M.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Campeau, Jody; Sim, Valerie L.] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB T6G 2G3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Alberta	Sharpe, S (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ssharpe@sickkids.ca	Sim, Valerie/C-4137-2013; Walsh, Patrick/ABG-2479-2020	Sim, Valerie/0000-0002-0088-8666; Yip, Christopher/0000-0003-4507-556X; Walsh, Patrick/0000-0003-4597-0396	Natural Sciences and Engineering Council of Canada [RGPIN 342069, Yip-RGPIN 194435]; PrioNet Canada; Alberta Prion Research Institute; Ontario graduate scholarship; Restracomp (The Hospital for Sick Children)	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); PrioNet Canada; Alberta Prion Research Institute; Ontario graduate scholarship(Ontario Graduate Scholarship); Restracomp (The Hospital for Sick Children)	This work was supported in part by the Natural Sciences and Engineering Council of Canada Discovery Grants RGPIN 342069 (to S. S.) and Yip-RGPIN 194435 (to C. M.) and an operating grant from PrioNet Canada and the Alberta Prion Research Institute (to V. S. and S. S.).; Supported by an Ontario graduate scholarship and a partial studentship from Restracomp (The Hospital for Sick Children).	Axelrod D, 1989, FLUORESCENCE POLARIZ, V30, P333; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1998, J NEUROSCI RES, V54, P331; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Castro BM, 2011, BIOPHYS J, V101, P1632, DOI 10.1016/j.bpj.2011.08.022; Cecchi C, 2009, BBA-BIOMEMBRANES, V1788, P2204, DOI 10.1016/j.bbamem.2009.07.019; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Domingues TM, 2010, LANGMUIR, V26, P11077, DOI 10.1021/la100662a; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Feigenson GW, 2006, NAT CHEM BIOL, V2, P560, DOI 10.1038/nchembio1106-560; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gajate C, 2009, BIOCHEM BIOPH RES CO, V380, P780, DOI 10.1016/j.bbrc.2009.01.147; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; KENDALL DA, 1982, J BIOL CHEM, V257, P3892; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Kourie JI, 2001, J NEUROSCI RES, V66, P214, DOI 10.1002/jnr.1213; Kuerka N., 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI DOI 10.1016/J.BBAMEM.2011.07.022; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Lin MX, 1997, J BIOL CHEM, V272, P44; Lu JX, 2011, BIOPHYS J, V100, P711, DOI 10.1016/j.bpj.2010.12.3696; Malchiodi-Albedi F., 2011, INT J ALZHEIMERS DIS, DOI [10.4061/2011/906964, DOI 10.4061/2011/906964]; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Miret S, 2006, J BIOMOL SCREEN, V11, P184, DOI 10.1177/1087057105283787; Moore A, 1998, METHOD CELL BIOL, V57, P265; MOR A, 1991, BIOCHEMISTRY-US, V30, P8824, DOI 10.1021/bi00100a014; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Oreopoulos J, 2009, J STRUCT BIOL, V168, P21, DOI 10.1016/j.jsb.2009.02.011; Oreopoulos J, 2009, BIOPHYS J, V96, P1970, DOI 10.1016/j.bpj.2008.11.041; Owen DM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2273; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Pollard HB, 1995, CELL MOL NEUROBIOL, V15, P513, DOI 10.1007/BF02071314; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Russell AL, 2010, CHEM PHYS LIPIDS, V163, P488, DOI 10.1016/j.chemphyslip.2010.03.009; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Salmona M, 1997, NEUROBIOL DIS, V4, P47, DOI 10.1006/nbdi.1997.0133; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Silei V, 1999, BRAIN RES, V818, P168, DOI 10.1016/S0006-8993(98)01272-4; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SPINK CH, 1990, BIOCHIM BIOPHYS ACTA, V1023, P25, DOI 10.1016/0005-2736(90)90005-9; TAYLOR MG, 1982, CHEM PHYS LIPIDS, V31, P359, DOI 10.1016/0009-3084(82)90072-X; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; TIMBS MM, 1990, BIOPHYS J, V58, P413, DOI 10.1016/S0006-3495(90)82387-0; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walsh P, 2010, J AM CHEM SOC, V132, P7684, DOI 10.1021/ja100431q; Walsh P, 2009, BIOCHEMISTRY-US, V48, P5779, DOI 10.1021/bi9007319; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Williamson R, 2011, CURR ALZHEIMER RES, V8, P213, DOI 10.2174/156720511795256008; Wood WG, 2002, NEUROBIOL AGING, V23, P685, DOI 10.1016/S0197-4580(02)00018-0; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhong J, 2007, BBA-BIOMEMBRANES, V1768, P1420, DOI 10.1016/j.bbamem.2007.03.003	82	47	48	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10419	10430		10.1074/jbc.M113.515866	http://dx.doi.org/10.1074/jbc.M113.515866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24554723	hybrid, Green Published			2022-12-25	WOS:000334226400016
J	Sato, K; Sugiyama, T; Nagase, T; Kitade, Y; Ueda, H				Sato, Katsuya; Sugiyama, Tsuyoshi; Nagase, Takahiro; Kitade, Yukio; Ueda, Hiroshi			Threonine 680 Phosphorylation of FLJ00018/PLEKHG2, a Rho Family-specific Guanine Nucleotide Exchange Factor, by Epidermal Growth Factor Receptor Signaling Regulates Cell Morphology of Neuro-2a Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Guanine Nucleotide Exchange Factor (GEF); Neurite Outgrowth; Protein phosphorylation; Rho GTPases	PROTEIN-KINASE-C; HETEROTRIMERIC G-PROTEINS; TAG SDS-PAGE; EGF RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; NEURITE OUTGROWTH; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; BREAST-CANCER	Background: RhoGEFs play important roles in regulation of the actin cytoskeleton. Results: The FLJ00018/PLEKHG2 was phosphorylated, and activated by EGF signaling might be interpreted as a direct effect on its GEF activity (which is not established). Conclusion: The phosphorylation of FLJ00018 was involved in the regulation of cell morphology. Significance: This study suggests that FLJ00018 receives and integrates different stimuli as a relay point in cell signaling. FLJ00018/PLEKHG2 is a guanine nucleotide exchange factor for the small GTPases Rac and Cdc42 and has been shown to mediate the signaling pathways leading to actin cytoskeleton reorganization. The function of FLJ00018 is regulated by the interaction of heterotrimeric GTP-binding protein G subunits or cytosolic actin. However, the details underlying the molecular mechanisms of FLJ00018 activation have yet to be elucidated. In the present study we show that FLJ00018 is phosphorylated and activated by (1)-adrenergic receptor stimulation-induced EGF receptor (EGFR) transactivation in addition to G signaling. FLJ00018 is also phosphorylated and activated by direct EGFR stimulation. The phosphorylation of FLJ00018 by EGFR stimulation is mediated by the Ras/mitogen-activated protein kinase (MAPK) pathway. Through deletion and site-directed mutagenesis studies, we have identified Thr-680 as the major site of phosphorylation by EGFR stimulation. FLJ00018 T680A, in which the phosphorylation site is replaced by alanine, showed a limited response of the Neuro-2a cell morphology to EGF stimulation. Our results provide evidence that stimulation of the Ras/MAPK pathway by EGFR results in FLJ00018 phosphorylation at Thr-680, which in turn controls changes in cell shape.	[Sato, Katsuya; Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Fac Engn, Gifu 5011193, Japan; [Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Sugiyama, Tsuyoshi] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Microbiol Lab, Gifu 5011196, Japan; [Nagase, Takahiro] Kazusa DNA Res Inst, Dept Biotechnol Res, Kisarazu 2920818, Japan	Gifu University; Gifu University; Gifu Pharmaceutical University; Kazusa DNA Research Institute	Ueda, H (corresponding author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Yanagido 1-1, Gifu 5011193, Japan.	hueda@gifu-u.ac.jp		Sato, Katsuya/0000-0002-5573-746X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for Scientific Research (C) from Japan Society for the Promotion of Science.	Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Giguere PM, 2012, J BIOL CHEM, V287, P31270, DOI 10.1074/jbc.M112.394379; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinoshita E, 2009, PROTEOMICS, V9, P4098, DOI 10.1002/pmic.200900020; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Nakajima D, 2002, DNA RES, V9, P99, DOI 10.1093/dnares/9.3.99; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sato K, 2013, CELL SIGNAL, V25, P41, DOI 10.1016/j.cellsig.2012.09.015; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200	46	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10045	10056		10.1074/jbc.M113.521880	http://dx.doi.org/10.1074/jbc.M113.521880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554703	Green Published, hybrid			2022-12-25	WOS:000333807000052
J	Shojaie, A; Jauhiainen, A; Kallitsis, M; Michailidis, G				Shojaie, Ali; Jauhiainen, Alexandra; Kallitsis, Michael; Michailidis, George			Inferring Regulatory Networks by Combining Perturbation Screens and Steady State Gene Expression Profiles	PLOS ONE			English	Article							MODELS; CAUSALITY; SYSTEMS; RECONSTRUCTION; DISCOVERY	Reconstructing transcriptional regulatory networks is an important task in functional genomics. Data obtained from experiments that perturb genes by knockouts or RNA interference contain useful information for addressing this reconstruction problem. However, such data can be limited in size and/or are expensive to acquire. On the other hand, observational data of the organism in steady state (e.g., wild-type) are more readily available, but their informational content is inadequate for the task at hand. We develop a computational approach to appropriately utilize both data sources for estimating a regulatory network. The proposed approach is based on a three-step algorithm to estimate the underlying directed but cyclic network, that uses as input both perturbation screens and steady state gene expression data. In the first step, the algorithm determines causal orderings of the genes that are consistent with the perturbation data, by combining an exhaustive search method with a fast heuristic that in turn couples a Monte Carlo technique with a fast search algorithm. In the second step, for each obtained causal ordering, a regulatory network is estimated using a penalized likelihood based method, while in the third step a consensus network is constructed from the highest scored ones. Extensive computational experiments show that the algorithm performs well in reconstructing the underlying network and clearly outperforms competing approaches that rely only on a single data source. Further, it is established that the algorithm produces a consistent estimate of the regulatory network.	[Shojaie, Ali] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Jauhiainen, Alexandra] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kallitsis, Michael; Michailidis, George] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	University of Washington; University of Washington Seattle; Karolinska Institutet; University of Michigan System; University of Michigan	Michailidis, G (corresponding author), Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA.	gmichail@umich.edu		Kallitsis, Michael/0000-0001-8086-499X	National Institutes of Health [1RC1CA145444-01, 1R21GM101719-01A1]; NATIONAL CANCER INSTITUTE [RC1CA145444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM101719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grants 1RC1CA145444-01 to GM and 1R21GM101719-01A1 to GM and AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchang B, 2009, P NATL ACAD SCI USA, V106, P6447, DOI 10.1073/pnas.0809822106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Csardi N., 2006, INT J COMP SYST, V1695, P1; Dasgupta S, 2008, ALGORITHMS; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Frohlich H, 2010, BIOINFORMATICS, P238, DOI [10.1093/bioinformatics/btq631, DOI 10.1093/BI0INF0RMATICS/BTQ631]; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Guo JA, 2011, BIOMETRIKA, V98, P1, DOI 10.1093/biomet/asq060; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Kalisch M, 2012, J STAT SOFTW, V47, P1; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klamt S, 2010, BIOINFORMATICS, V26, P2160, DOI 10.1093/bioinformatics/btq342; Knuth D. E., 1974, Information Processing Letters, V2, P153, DOI 10.1016/0020-0190(74)90001-5; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Michailidis G, 2013, MATH BIOSCI, V246, P326, DOI 10.1016/j.mbs.2013.10.003; Mukhopadhyay ND, 2007, BIOINFORMATICS, V23, P442, DOI 10.1093/bioinformatics/btl598; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Ong Irene M, 2002, Bioinformatics, V18 Suppl 1, pS241; Opgen-Rhein R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S3; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Reimand J, 2010, NUCLEIC ACIDS RES, V38, P4768, DOI 10.1093/nar/gkq232; Shojaie A, 2012, STAT BIOSCI, V4, P66, DOI 10.1007/s12561-011-9050-5; Shojaie A, 2010, BIOINFORMATICS, V26, pi517, DOI 10.1093/bioinformatics/btq377; Shojaie A, 2010, BIOMETRIKA, V97, P519, DOI 10.1093/biomet/asq038; Shojaie A, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1483; Shojaie A, 2009, J COMPUT BIOL, V16, P407, DOI 10.1089/cmb.2008.0081; Song L, 2009, BIOINFORMATICS, V25, pI128, DOI 10.1093/bioinformatics/btp192; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; Tresch A, 2008, STAT APPL GENET MOL, V7; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Yamaguchi R, 2007, IEEE SIGNAL PROC MAG, V24, P37, DOI 10.1109/MSP.2007.273053	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e82393	10.1371/journal.pone.0082393	http://dx.doi.org/10.1371/journal.pone.0082393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586224	gold, Green Published, Green Submitted			2022-12-25	WOS:000332396200003
J	Stewart, IB; Stewart, KL; Worringham, CJ; Costello, JT				Stewart, Ian B.; Stewart, Kelly L.; Worringham, Charles J.; Costello, Joseph T.			Physiological Tolerance Times while Wearing Explosive Ordnance Disposal Protective Clothing in Simulated Environmental Extremes	PLOS ONE			English	Article							UNCOMPENSABLE HEAT-STRESS; FLUID REPLACEMENT; TEMPERATURE; PERFORMANCE; EXERCISE; STRAIN; SENSOR	Explosive ordnance disposal (EOD) technicians are required to wear protective clothing to protect themselves from the threat of overpressure, fragmentation, impact and heat. The engineering requirements to minimise these threats results in an extremely heavy and cumbersome clothing ensemble that increases the internal heat generation of the wearer, while the clothing's thermal properties reduce heat dissipation. This study aimed to evaluate the heat strain encountered wearing EOD protective clothing in simulated environmental extremes across a range of differing work intensities. Eight healthy males [age 25 +/- 6 years (mean +/- sd), height 180 +/- 7 cm, body mass 79 +/- 9 kg, V. O-2max 57 +/- 6 ml. kg(-1) min(-1)] undertook nine trials while wearing an EOD9 suit (weighing 33.4 kg). The trials involved walking on a treadmill at 2.5, 4 and 5.5 km center dot h(-1) at each of the following environmental conditions, 21, 30 and 37 degrees C wet bulb globe temperature (WBGT) in a randomised controlled crossover design. The trials were ceased if the participants' core temperature reached 39 degrees C, if heart rate exceeded 90% of maximum, if walking time reached 60 minutes or due to fatigue/nausea. Tolerance times ranged from 10-60 minutes and were significantly reduced in the higher walking speeds and environmental conditions. In a total of 15 trials (21%) participants completed 60 minutes of walking; however, this was predominantly at the slower walking speeds in the 21 degrees C WBGT environment. Of the remaining 57 trials, 50 were ceased, due to attainment of 90% maximal heart rate. These near maximal heart rates resulted in moderate-high levels of physiological strain in all trials, despite core temperature only reaching 39 degrees C in one of the 72 trials.	[Stewart, Ian B.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Stewart, IB (corresponding author), Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia.	i.stewart@qut.edu.au	Stewart, Ian B/I-9927-2012; Costello, Joseph/AAW-8764-2020; Costello, Joseph/J-1374-2012; Costello, Joseph/G-6294-2011	Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Costello, Joseph/0000-0001-9510-7932; Stewart, Kelly/0000-0002-3386-7001; Stewart, Ian/0000-0003-1741-718X	Australian Government; National Security Science & Technology Centre within the Defence Science & Technology Organisation; US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	Australian Government(Australian GovernmentCGIAR); National Security Science & Technology Centre within the Defence Science & Technology Organisation; US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	This project is financially supported by the Australian Government, managed by the National Security Science & Technology Centre within the Defence Science & Technology Organisation, and the US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office. This support does not represent an endorsement of the contents or conclusions of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	10.1520/F2668-07, 2011, F266807 ASTM INT, DOI DOI 10.1520/F2668-07; Byrne C, 2007, BRIT J SPORT MED, V41, P126, DOI 10.1136/bjsm.2006.026344; Cheung S.S., 2010, ADV ENV EXERCISE PHY; Cheung SS, 1998, EUR J APPL PHYSIOL O, V77, P139; Cheung SS, 1998, J APPL PHYSIOL, V84, P1731, DOI 10.1152/jappl.1998.84.5.1731; DUBOIS D, 1989, NUTRITION, V5, P303; Goodman DA, 2009, MED SCI SPORT EXER, V41, P597, DOI 10.1249/MSS.0b013e31818a0eef; Hunt AP, 2012, EUR J APPL PHYSIOL, V112, P1963, DOI 10.1007/s00421-011-2143-5; ISO, 2004, ISO98862004; Kenefick RW, 2009, MED SCI SPORT EXER, V41, P1311, DOI 10.1249/MSS.0b013e3181988c14; Larsen B, 2011, MIL MED, V176, P1265, DOI 10.7205/MILMED-D-10-00470; MCLELLAN TM, 1993, AVIAT SPACE ENVIR MD, V64, P587; McLellan TM, 2013, COMPR PHYSIOL, V3, P1363, DOI 10.1002/cphy.c130002; MONTAIN SJ, 1994, J APPL PHYSIOL, V77, P216, DOI 10.1152/jappl.1994.77.1.216; Moran DS, 1998, AM J PHYSIOL-REG I, V275, pR129, DOI 10.1152/ajpregu.1998.275.1.R129; Morris A, 1992, EVALUATION PERSONAL, P1; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Roeder RA, 2010, J CRANIOFAC SURG, V21, P971, DOI 10.1097/SCS.0b013e3181e1e802; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Sleivert GG, 2007, INTJ SPORT PHYSIOL, V2, P98, DOI 10.1123/ijspp.2.1.98; Stewart IB, 2011, MIL MED, V176, P959, DOI 10.7205/MILMED-D-11-00052; Stewart IB, 2013, J ERGONOM S, VS2; STOLWIJK JA, 1966, PFLUG ARCH GES PHYS, V291, P129, DOI 10.1007/BF00412787; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P3227, DOI 10.1007/s00421-011-2299-z; Thake C, 2009, P 13 INT ENV ERG C B; Townshend AD, 2010, MED SCI SPORT EXER, V42, P160, DOI 10.1249/MSS.0b013e3181af21e2; WHITE MK, 1991, ERGONOMICS, V34, P445	27	30	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e83740	10.1371/journal.pone.0083740	http://dx.doi.org/10.1371/journal.pone.0083740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586228	gold, Green Published, Green Submitted			2022-12-25	WOS:000331717900001
J	Amaya, M; Voss, K; Sampey, G; Senina, S; de la Fuente, C; Mueller, C; Calvert, V; Kehn-Hall, K; Carpenter, C; Kashanchi, F; Bailey, C; Mogelsvang, S; Petricoin, E; Narayanan, A				Amaya, Moushimi; Voss, Kelsey; Sampey, Gavin; Senina, Svetlana; de la Fuente, Cynthia; Mueller, Claudius; Calvert, Valerie; Kehn-Hall, Kylene; Carpenter, Calvin; Kashanchi, Fatah; Bailey, Charles; Mogelsvang, Soren; Petricoin, Emanuel; Narayanan, Aarthi			The Role of IKK beta in Venezuelan Equine Encephalitis Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE; KINASE IKK; OLD-WORLD; INHIBITION; PATHWAY; PHOSPHORYLATION; REPLICATION; MODULATION; APOPTOSIS	Venezuelan equine encephalitis virus (VEEV) belongs to the genus Alphavirus, family Togaviridae. VEEV infection is characterized by extensive inflammation and studies from other laboratories implicated an involvement of the NF-kappa B cascade in the in vivo pathology. Initial studies indicated that at early time points of VEEV infection, the NF-kappa B complex was activated in cells infected with the TC-83 strain of VEEV. One upstream kinase that contributes to the phosphorylation of p65 is the IKK beta component of the IKK complex. Our previous studies with Rift valley fever virus, which exhibited early activation of the NF-kappa B cascade in infected cells, had indicated that the IKK beta component underwent macromolecular reorganization to form a novel low molecular weight form unique to infected cells. This prompted us to investigate if the IKK complex undergoes a comparable macromolecular reorganization in VEEV infection. Size-fractionated VEEV infected cell extracts indicated a macromolecular reorganization of IKK beta in VEEV infected cells that resulted in formation of lower molecular weight complexes. Well-documented inhibitors of IKK beta function, BAY-11-7082, BAY-11-7085 and IKK2 compound IV, were employed to determine whether IKK beta function was required for the production of infectious progeny virus. A decrease in infectious viral particles and viral RNA copies was observed with inhibitor treatment in the attenuated and virulent strains of VEEV infection. In order to further validate the requirement of IKK beta for VEEV replication, we overexpressed IKK beta in cells and observed an increase in viral titers. In contrast, studies carried out using IKK beta(-/-) cells demonstrated a decrease in VEEV replication. In vivo studies demonstrated that inhibitor treatment of TC-83 infected mice increased their survival. Finally, proteomics studies have revealed that IKK beta may interact with the viral protein nsP3. In conclusion, our studies have revealed that the host IKK beta protein may be critically involved in VEEV replication.	[Amaya, Moushimi; Voss, Kelsey; Sampey, Gavin; Senina, Svetlana; de la Fuente, Cynthia; Kehn-Hall, Kylene; Carpenter, Calvin; Kashanchi, Fatah; Bailey, Charles; Narayanan, Aarthi] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Mueller, Claudius; Calvert, Valerie; Petricoin, Emanuel] George Mason Univ, Ctr Appl Prote & Personalized Med, Manassas, VA USA; [Mogelsvang, Soren] Serpin Pharma LLC, Manassas, VA USA	George Mason University; George Mason University	Narayanan, A (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.	anaraya1@gmu.edu	Mueller, Claudius/A-4459-2012; Kehn-Hall, Kylene/I-5752-2013	Mueller, Claudius/0000-0003-4499-4724; Voss, Kelsey/0000-0003-1732-2682; Kehn-Hall, Kylene/0000-0001-8036-7213	George Mason University; US Department of Energy [DE-SC0001599]; George Mason University Libraries Open Access Publishing Fund; College of Science to the Center for Applied Proteomics and Molecular Medicine	George Mason University; US Department of Energy(United States Department of Energy (DOE)); George Mason University Libraries Open Access Publishing Fund; College of Science to the Center for Applied Proteomics and Molecular Medicine	This work was supported by George Mason University start-up funds to AN, the US Department of Energy grant (DE-SC0001599) to CB and FK, and the generous support of the College of Science to the Center for Applied Proteomics and Molecular Medicine. Publication of this article was funded in part by the George Mason University Libraries Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634; Charles PC, 2001, VIROLOGY, V284, P190, DOI 10.1006/viro.2001.0878; Foy NJ, 2013, J VIROL, V87, P1997, DOI 10.1128/JVI.02853-12; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; Garcia MG, 2005, LEUKEMIA RES, V29, P1425, DOI 10.1016/j.leukres.2005.05.004; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Hai T, 2006, J VIROL, V80, P4227, DOI 10.1128/JVI.80.9.4227-4241.2006; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jeong SJ, 2005, J BIOL CHEM, V280, P10326, DOI 10.1074/jbc.M412643200; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Kehn-Hall K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034761; Keller SA, 2000, BLOOD, V96, P2537; Kim DY, 2013, J VIROL; Lamb K, 2010, VIROLOGY, V406, P261, DOI 10.1016/j.virol.2010.07.009; Le Negrate G, 2012, CELL MICROBIOL, V14, P168, DOI 10.1111/j.1462-5822.2011.01720.x; Lee J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/416036; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Narayanan A, 2012, J BIOL CHEM, V287, P33198, DOI 10.1074/jbc.M112.356535; Narayanan A, 2012, VIROLOGY, V432, P219, DOI 10.1016/j.virol.2012.06.007; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Sharma A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-289; Sharma A, 2009, J GEN VIROL, V90, P1836, DOI 10.1099/vir.0.010280-0; Shifera AS, 2010, BIOCHEM BIOPH RES CO, V396, P585, DOI 10.1016/j.bbrc.2010.05.012; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2004, ANNU REV ENTOMOL, V49, P141, DOI 10.1146/annurev.ento.49.061802.123422; Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1; Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023	34	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e86745	10.1371/journal.pone.0086745	http://dx.doi.org/10.1371/journal.pone.0086745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586253	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900005
J	Koduvayur, SP; Gussin, HA; Parthasarathy, R; Hao, ZG; Kay, BK; Pepperberg, DR				Koduvayur, Sujatha P.; Gussin, Helene A.; Parthasarathy, Rajni; Hao, Zengping; Kay, Brian K.; Pepperberg, David R.			Generation of Recombinant Antibodies to Rat GABA(A) Receptor Subunits by Affinity Selection on Synthetic Peptides	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC ACIDA; PHAGE-DISPLAY; ALLOSTERIC MODULATION; DIRECTED EVOLUTION; GLUTAMATE-RECEPTOR; GLYCINE RECEPTORS; MEMBRANE-PROTEIN; HIGH AVIDITY; A-RECEPTORS; FRAGMENTS	The abundance and physiological importance of GABA(A) receptors in the central nervous system make this neurotransmitter receptor an attractive target for localizing diagnostic and therapeutic biomolecules. GABA(A) receptors are expressed within the retina and mediate synaptic signaling at multiple stages of the visual process. To generate monoclonal affinity reagents that can specifically recognize GABA(A) receptor subunits, we screened two bacteriophage M13 libraries, which displayed human scFvs, by affinity selection with synthetic peptides predicted to correspond to extracellular regions of the rat alpha 1 and beta 2 GABA(A) subunits. We isolated three anti-beta 2 and one anti-alpha 1 subunit specific scFvs. Fluorescence polarization measurements revealed all four scFvs to have low micromolar affinities with their cognate peptide targets. The scFvs were capable of detecting fully folded GABA(A) receptors heterologously expressed by Xenopus laevis oocytes, while preserving ligand-gated channel activity. Moreover, A10, the anti-alpha 1 subunit-specific scFv, was capable of detecting native GABA(A) receptors in the mouse retina, as observed by immunofluorescence staining. In order to improve their apparent affinity via avidity, we dimerized the A10 scFv by fusing it to the Fc portion of the IgG. The resulting scFv-Fc construct had a K-d of similar to 26 nM, which corresponds to an approximately 135-fold improvement in binding, and a lower detection limit in dot blots, compared to the monomeric scFv. These results strongly support the use of peptides as targets for generating affinity reagents to membrane proteins and encourage investigation of molecular conjugates that use scFvs as anchoring components to localize reagents of interest at GABA(A) receptors of retina and other neural tissues, for studies of receptor activation and subunit structure.	[Koduvayur, Sujatha P.; Hao, Zengping; Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Gussin, Helene A.; Parthasarathy, Rajni; Pepperberg, David R.] Univ Illinois, Dept Ophthalmol & Visual Sci, Illinois Eye & Ear Infirm, Lions Illinois Eye Res Inst, Chicago, IL USA; [Parthasarathy, Rajni; Pepperberg, David R.] Univ Illinois, Dept Bioengn, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koduvayur, SP (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	skoduvay@uic.edu	Parthasarathy, Rajni/AAF-8425-2020		NIH [EY016094, EY001792]; National Institute of General Medical Sciences (NIGMS) [1R01GM079096]; Daniel F. Rice Foundation and Ada L. Rice Foundation; BrightFocus Foundation; University of Illinois at Chicago Center for Clinical and Translational Sciences (CCTS) [UL1RR029879]; National Eye Institute; Zebrafish Protein Antibody Core [1R01GM079096]; NATIONAL EYE INSTITUTE [P30EY001792, R01EY016094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Daniel F. Rice Foundation and Ada L. Rice Foundation; BrightFocus Foundation(BrightFocus Foundation); University of Illinois at Chicago Center for Clinical and Translational Sciences (CCTS); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Zebrafish Protein Antibody Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (http://grants.nih.gov/grants/oer.htm) grants EY016094 and EY001792 from the National Eye Institute (http://www.nei.nih.gov/funding/); National Institute of General Medical Sciences (NIGMS, http://www. nigms. nih. gov/Research/), Zebrafish Protein & Antibody Core (http://www.bio.anl.gov/molecular_and_systems_biology/zebrafish1. html) grant 1R01GM079096; the Daniel F. and Ada L. Rice Foundation (Skokie, IL); Hope for Vision (http:// hopeforvision.org/, Washington, D.C.), the BrightFocus Foundation (http://www. brightfocus. org/, formerly, the American Health Assistance Foundation) (Clarksburg, MD); Research to Prevent Blindness (http://www. rpbusa. org/rpb/, New York, NY); and University of Illinois at Chicago Center for Clinical and Translational Sciences (CCTS, http://www.uic.edu/depts/mcam/CCTS/) award UL1RR029879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi L, 2010, CURR MED CHEM, V17, P1730, DOI 10.2174/092986710791111215; Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Albrecht H, 2007, Q J NUCL MED MOL IM, V51, P304; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Blazek D, 2003, FOLIA MICROBIOL, V48, P687, DOI 10.1007/BF02993480; Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604; Duan Z, 2010, COMB CHEM HIGH T SCR, V13, P818, DOI 10.2174/138620710792927376; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Eisenhardt SU, 2007, NAT PROTOC, V2, P3063, DOI 10.1038/nprot.2007.455; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; Feigenspan A, 2004, J NEUROPHYSIOL, V92, P2789, DOI 10.1152/jn.00284.2004; Feigenspan A, 1998, PROG RETIN EYE RES, V17, P99, DOI 10.1016/S1350-9462(97)00008-6; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; GREFERATH U, 1993, VISUAL NEUROSCI, V10, P551, DOI 10.1017/S0952523800004764; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; GRUNERT U, 1993, J COMP NEUROL, V335, P523, DOI 10.1002/cne.903350405; Gussin HA, 2006, J AM CHEM SOC, V128, P15701, DOI 10.1021/ja064324k; Gussin HA, 2013, ACS CHEM NEUROSCI, V4, P435, DOI 10.1021/cn300144v; Haidaris CG, 2001, J IMMUNOL METHODS, V257, P185, DOI 10.1016/S0022-1759(01)00463-X; Hawlisch H, 2001, ANAL BIOCHEM, V293, P142, DOI 10.1006/abio.2001.5120; Heeres JT, 2009, J AM CHEM SOC, V131, P18202, DOI 10.1021/ja907066r; Hotzel I, 2011, PROTEIN ENG DES SEL, V24, P679, DOI 10.1093/protein/gzr039; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; Hust M, 2002, J VIROL METHODS, V106, P225, DOI 10.1016/S0166-0934(02)00166-0; Janovjak H, 2010, NAT NEUROSCI, V13, P1027, DOI 10.1038/nn.2589; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kasturirangan S, 2010, CURR ALZHEIMER RES, V7, P214, DOI 10.2174/156720510791050876; Kortt AA, 2001, BIOMOL ENG, V18, P95, DOI 10.1016/S1389-0344(01)00090-9; Koulen P, 1996, J NEUROSCI, V16, P2127; Li YH, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-23; Luginbuhl B, 2006, J MOL BIOL, V363, P75, DOI 10.1016/j.jmb.2006.07.027; Lukasiewicz PD, 1998, SEMIN CELL DEV BIOL, V9, P293, DOI 10.1006/scdb.1998.0238; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mao YJ, 2011, ANAL BIOCHEM, V415, P21, DOI 10.1016/j.ab.2011.04.004; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; Milovnik P, 2009, PROTEIN ENG DES SEL, V22, P357, DOI 10.1093/protein/gzp011; Moghaddam A, 2003, J IMMUNOL METHODS, V280, P139, DOI 10.1016/S0022-1759(03)00109-1; MOHLER H, 1990, NEUROCHEM RES, V15, P199, DOI 10.1007/BF00972210; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; PACK P, 1992, BIOCHEMISTRY-US, V31, P1579, DOI 10.1021/bi00121a001; Papanastasiou D, 1999, J NEUROIMMUNOL, V94, P182, DOI 10.1016/S0165-5728(98)00249-5; Pershad K, 2011, ANAL BIOCHEM, V412, P210, DOI 10.1016/j.ab.2011.02.006; Peter JC, 2003, J BIOL CHEM, V278, P36740, DOI 10.1074/jbc.M306877200; Pini A, 2000, CURR PROTEIN PEPT SC, V1, P155, DOI 10.2174/1389203003381397; Qtaishat NM, 2013, ANAL BIOCHEM, V432, P49, DOI 10.1016/j.ab.2012.08.031; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; SEEBURG PH, 1990, COLD SH Q B, V55, P29; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1988, J NEUROSCI, V8, P289; Smith SM, 2011, METHODS MOL BIOL, V681, P485, DOI 10.1007/978-1-60761-913-0_29; Souriau C, 2004, GROWTH FACTORS, V22, P185, DOI 10.1080/08977190412331279872; Stein M, 2012, ANGEW CHEM INT EDIT, V51, P10500, DOI 10.1002/anie.201205475; Steinmeyer DE, 2008, DRUG DISCOV TODAY, V13, P613, DOI 10.1016/j.drudis.2008.04.005; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Ta HT, 2011, CIRC RES, V109, P365, DOI 10.1161/CIRCRESAHA.111.249375; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Tipps ME, 2010, J BIOL CHEM, V285, P22838, DOI 10.1074/jbc.M110.130815; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Vu TQ, 2005, BIOMATERIALS, V26, P1895, DOI 10.1016/j.biomaterials.2004.06.007; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; WOODWARD RM, 1993, MOL PHARMACOL, V43, P609; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yip GM, 2013, NAT CHEM BIOL; Yue L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2094; Zucker CL, 1998, J COMP NEUROL, V393, P309, DOI 10.1002/(SICI)1096-9861(19980413)393:3<309::AID-CNE4>3.0.CO;2-5	77	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87964	10.1371/journal.pone.0087964	http://dx.doi.org/10.1371/journal.pone.0087964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586298	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900020
J	Alberti, CF; Horowitz, T; Bronstad, PM; Bowers, AR				Alberti, Concetta F.; Horowitz, Todd; Bronstad, P. Matthew; Bowers, Alex R.			Visual Attention Measures Predict Pedestrian Detection in Central Field Loss: A Pilot Study	PLOS ONE			English	Article							OF-VIEW TEST; MOBILITY PERFORMANCE; VISION; HEMIANOPIA; OCCLUSION; MULTIPLE; TRACKING; DRIVERS; RISK	Purpose: The ability of visually impaired people to deploy attention effectively to maximize use of their residual vision in dynamic situations is fundamental to safe mobility. We conducted a pilot study to evaluate whether tests of dynamic attention (multiple object tracking; MOT) and static attention (Useful Field of View; UFOV) were predictive of the ability of people with central field loss (CFL) to detect pedestrian hazards in simulated driving. Methods: 11 people with bilateral CFL (visual acuity 20/30-20/200) and 11 age-similar normally-sighted drivers participated. Dynamic and static attention were evaluated with brief, computer-based MOT and UFOV tasks, respectively. Dependent variables were the log speed threshold for 60% correct identification of targets (MOT) and the increase in the presentation duration for 75% correct identification of a central target when a concurrent peripheral task was added (UFOV divided and selective attention subtests). Participants drove in a simulator and pressed the horn whenever they detected pedestrians that walked or ran toward the road. The dependent variable was the proportion of timely reactions (could have stopped in time to avoid a collision). Results: UFOV and MOT performance of CFL participants was poorer than that of controls, and the proportion of timely reactions was also lower (worse) (84% and 97%, respectively; p = 0.001). For CFL participants, higher proportions of timely reactions correlated significantly with higher (better) MOT speed thresholds (r = 0.73, p = 0.01), with better performance on the UFOV divided and selective attention subtests (r = -0.66 and -0.62, respectively, p < 0.04), with better contrast sensitivity scores (r = 0.54, p = 0.08) and smaller scotomas (r = -0.60, p = 0.05). Conclusions: Our results suggest that brief laboratory-based tests of visual attention may provide useful measures of functional visual ability of individuals with CFL relevant to more complex mobility tasks.	[Alberti, Concetta F.; Bronstad, P. Matthew; Bowers, Alex R.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA; [Horowitz, Todd] NCI, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Div Canc Control & Populat Sci, Rockville, MD USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bowers, AR (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA.	alex_bowers@meei.harvard.edu		Horowitz, Todd/0000-0001-5571-6266; Bowers, Alex/0000-0002-6038-0178	National Institutes of Health [EY018680, EY12890, 2P30EY003790]; Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH) [1 UL1 RR 025758-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY003790, R01EY012890, R00EY018680, R24EY012890, K99EY018680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health grants EY018680, EY12890 and 2P30EY003790 (www.nei.nih.gov). Development of the brief MOT test was supported by a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Grant #1 UL1 RR 025758-02) www.nih.gov; catalyst.harvard.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of State Highway and Transportation Officials, 2004, POL GEOM DES HIGHW S; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bowers A., 2011, PROC 6 INT DRIV S HU, P307; Bowers AR, 2010, INVEST OPHTH VIS SCI, V51, P6605, DOI 10.1167/iovs.10-5310; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Bronstad PM, 2013, JAMA OPHTHALMOL, V131, P303, DOI 10.1001/jamaophthalmol.2013.1443; Bronstad PM, 2009, P 5 INT DRIV S HUM F, P320; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Coeckelbergh TRM, 2004, HUM FACTORS, V46, P748, DOI 10.1518/hfes.46.4.748.56818; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; Dickinson, 1998, LOW VISION PRINCIPLE; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; Evans L., 2004, TRAFFIC SAFETY; Flombaum JI, 2008, COGNITION, V107, P904, DOI 10.1016/j.cognition.2007.12.015; Goldberg JL, 2013, JAMA OPHTHALMOL, V131, P1563, DOI 10.1001/jamaophthalmol.2013.5747; Hassan SE, 2002, OPTOMETRY VISION SCI, V79, P697, DOI 10.1097/00006324-200211000-00007; Hassell JB, 2006, BRIT J OPHTHALMOL, V90, P593, DOI 10.1136/bjo.2005.086595; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hogg RE, 2006, PROG RETIN EYE RES, V25, P249, DOI 10.1016/j.preteyeres.2005.11.002; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; Kuyk T, 1999, J REHABIL RES DEV, V36, P303; Leat SJ, 2008, OPTOMETRY VISION SCI, V85, P1049, DOI 10.1097/OPX.0b013e31818b949d; Matthew Bronstad P, 2011, J Clin Exp Ophthalmol, V2011, P1; Owsley C, 2004, J AM GERIATR SOC, V52, P1901, DOI 10.1111/j.1532-5415.2004.52516.x; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Patel RD, 2011, SEMIN OPHTHALMOL, V26, P372, DOI 10.3109/08820538.2011.570845; Peli E, 2005, TRANSPORT RES REC, P128; Peli E., 2002, DRIVING CONFIDENCE P; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Scholl BJ, 1999, COGNITIVE PSYCHOL, V38, P259, DOI 10.1006/cogp.1998.0698; TIMBERLAKE GT, 1987, INVEST OPHTH VIS SCI, V28, P1268; To L, 2013, VISION RES, V90, P15, DOI 10.1016/j.visres.2013.04.011; Verezen CA, 2011, OPTOMETRY VISION SCI, V88, P1164, DOI 10.1097/OPX.0b013e31822891e0; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Winer B.J., 1991, STAT PRINCIPLES EXPT; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015	39	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89381	10.1371/journal.pone.0089381	http://dx.doi.org/10.1371/journal.pone.0089381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558495	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700141
J	Ju, CR; Chen, RC				Ju, Chunrong; Chen, Rongchang			Factors Associated with Impairment of Quadriceps Muscle Function in Chinese Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VASTUS LATERALIS MUSCLE; FAT-FREE MASS; SKELETAL-MUSCLE; PHYSICAL-ACTIVITY; COPD; STRENGTH; EXERCISE; ENDURANCE; QUESTIONNAIRE; STIMULATION	Background: Quadriceps muscle dysfunction is well confirmed in chronic obstructive pulmonary disease (COPD) and reported to be related to a higher risk of mortality. Factors contributing to quadriceps dysfunction have been postulated, while not one alone could fully explain it and there are few reports on it in China. This study was aimed to investigate the severity of quadriceps dysfunction in patients with COPD, and to compare quadriceps muscle function in COPD and the healthy elderly. Methods: Quadriceps strength and endurance capabilities were investigated in 71 COPD patients and 60 age-matched controls; predicted values for quadriceps strength and endurance were calculated using regression equations (incorporating age, gender, anthropometric measurements and physical activities), based on the data from controls. Potential parameters related to quadriceps dysfunction in COPD were identified by stepwise regression analysis. Results: Mean values of quadriceps strength was 46% and endurance was 38% lower, in patients with COPD relative to controls. Gender, physical activities and anthropometric measurements were predictors to quadriceps function in the controls. While in COPD, forced expiratory volume in 1 second percentage of predicted value (FEV1% pred), nutritional depletion, gender and physical inactivity were identified as independent factors to quadriceps strength (R-2 = 0.72); FEV1%pred, thigh muscle mass, serum levels of tumor necrosis factor-alpha (TNF-alpha) and gender were correlated to quadriceps endurance variance, with each p<0.05. Conclusion: Quadriceps strength and endurance capabilities are both substantially impaired in Chinese COPD patients, with strength most affected. For the controls, physical activity is most important for quadriceps function. While for COPD patients, quadriceps dysfunction is related to multiple factors, with airflow limitation, malnutrition and muscle disuse being the main ones.	[Ju, Chunrong; Chen, Rongchang] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	chenrongchang2013@126.com			National Institute of Health [81100034]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by the National Institute of Health [Grant 81100034]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Caron MA, 2009, J APPL PHYSIOL, V107, P952, DOI 10.1152/japplphysiol.00194.2009; Coronell C, 2004, EUR RESPIR J, V24, P129, DOI 10.1183/09031936.04.00079603; Degens H, 2005, ACTA PHYSIOL SCAND, V184, P235, DOI 10.1111/j.1365-201X.2005.01447.x; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Donaldson AV, 2012, INT J CHRONIC OBSTR, V7, P523, DOI 10.2147/COPD.S28247; EDWARDS RHT, 1977, CLIN SCI MOL MED, V52, P283, DOI 10.1042/cs0520283; Engelen MPKJ, 2000, AM J CLIN NUTR, V71, P733, DOI 10.1093/ajcn/71.3.733; Gosker HR, 2007, EUR RESPIR J, V30, P73, DOI 10.1183/09031936.00146906; Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980; Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803; Gosker HR, 2003, CHEST, V123, P1416, DOI 10.1378/chest.123.5.1416; Hacievliyagil SS, 2013, NIGER J CLIN PRACT, V16, P76, DOI 10.4103/1119-3077.106771; Hernandes NA, 2009, J BRAS PNEUMOL, V35, P949, DOI 10.1590/S1806-37132009001000002; Hopkinson NS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-25; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Ju CR, 2011, CHINESE MED J-PEKING, V124, P2309, DOI 10.3760/cma.j.issn.0366-6999.2011.15.012; Kobayashi A, 2000, LUNG, V178, P119, DOI 10.1007/s004080000014; LAABAN JP, 1993, CHEST, V103, P1362, DOI 10.1378/chest.103.5.1362; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Maltais F, 2000, THORAX, V55, P848, DOI 10.1136/thorax.55.10.848; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; O'Shea SD, 2009, CHEST, V136, P1269, DOI 10.1378/chest.09-0029; Rabinovich RA, 2010, CURR OPIN PULM MED, V16, P123, DOI 10.1097/MCP.0b013e328336438d; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Sandland C J, 2005, J Cardiopulm Rehabil, V25, P181, DOI 10.1097/00008483-200505000-00011; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Serres I, 1998, CHEST, V113, P900, DOI 10.1378/chest.113.4.900; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Sugawara K, 2010, RESP MED, V104, P1883, DOI 10.1016/j.rmed.2010.05.008; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Tan WC, 2005, RESPIROLOGY, V10, P9; van't Hul A, 2004, MUSCLE NERVE, V29, P267, DOI 10.1002/mus.10552; Vivodtzev I, 2006, CHEST, V129, P1540, DOI 10.1378/chest.129.6.1540; VOORRIPS LE, 1991, MED SCI SPORT EXER, V23, P974, DOI 10.1249/00005768-199108000-00015; Warwick G, 2013, RESPIROLOGY, V18, P874, DOI 10.1111/resp.12089; Whittom F, 1998, MED SCI SPORT EXER, V30, P1467, DOI 10.1097/00005768-199810000-00001; ZATTARAHARTMANN MC, 1995, MUSCLE NERVE, V18, P495, DOI 10.1002/mus.880180504	42	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e84167	10.1371/journal.pone.0084167	http://dx.doi.org/10.1371/journal.pone.0084167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558357	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700003
J	Kato, Y; Miyauchi, T; Abe, Y; Kojic, D; Tanaka, M; Chikazawa, N; Nakatake, Y; Ko, SBH; Kobayashi, D; Hazama, A; Fujiwara, S; Uchida, T; Yasui, M				Kato, Yasuhiro; Miyauchi, Takayuki; Abe, Youichiro; Kojic, Dusan; Tanaka, Manami; Chikazawa, Nana; Nakatake, Yuhki; Ko, Shigeru B. H.; Kobayashi, Daisuke; Hazama, Akihiro; Fujiwara, Shoko; Uchida, Tatsuya; Yasui, Masato			Unprecedented Cell-Selection Using Ultra-Quick Freezing Combined with Aquaporin Expression	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; WATER PERMEABILITY; CRYOPRESERVATION; TOLERANCE; MICROORGANISMS; SACCHAROMYCES; TEMPERATURE; INHIBITION; VIABILITY; NETWORKS	Freezing is usually used for preservation and storage of biological samples; however, this process may have some adverse effects such as cell membrane damage. Aquaporin (AQP), a water channel protein, has been suggested to play some roles for cryopreservation although its molecular mechanism remains unclear. Here we show that membrane damage caused by ultra-quick freezing is rescued by the expression of AQP4. We next examine if the expression of AQP combined with ultra-quick freezing can be used to select cells efficiently under freezing conditions where most cells are died. CHO cells stably expressing AQP4 were exclusively selected from mixed cell cultures. Having identified the increased expression of AQP4 during ES cell differentiation into neuro-ectoderm using bioinformatics, we confirmed the improved survival of differentiated ES cells with AQP4 expression. Finally we show that CHO cells transiently transfected with Endothelin receptor A and Aqp4 were also selected and concentrated by multiple cycles of freezing/thawing, which was confirmed with calcium imaging in response to endothelin. Furthermore, we found that the expression of AQP enables a reduction in the amount of cryoprotectants for freezing, thereby decreasing osmotic stress and cellular toxicity. Taken together, we propose that this simple but efficient and safe method may be applicable to the selection of mammalian cells for applications in regenerative medicine as well as cell-based functional assays or drug screening protocols.	[Kato, Yasuhiro; Miyauchi, Takayuki; Abe, Youichiro; Kojic, Dusan; Tanaka, Manami; Yasui, Masato] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 160, Japan; [Chikazawa, Nana; Nakatake, Yuhki; Ko, Shigeru B. H.] Keio Univ, Sch Med, Dept Syst Med, Sakaguchi Lab, Tokyo, Japan; [Kobayashi, Daisuke; Hazama, Akihiro] Fukushima Med Univ, Sch Med, Dept Physiol, Fukushima, Japan; [Fujiwara, Shoko; Uchida, Tatsuya] Tokyo Univ Pharm & Life Sci, Dept Life Sci, Tokyo, Japan	Keio University; Keio University; Fukushima Medical University; Tokyo University of Pharmacy & Life Sciences	Yasui, M (corresponding author), Keio Univ, Sch Med, Dept Pharmacol, Tokyo 160, Japan.	myasui@a3.keio.jp	Nakatake, Yuhki/K-5405-2013; Abe, Yoichiro/J-5576-2013; Kojic, Dusan/AAO-9651-2021; Kobayashi, Daisuke/ABB-5208-2021; Abe, Yoichiro/AAN-8801-2020	Abe, Yoichiro/0000-0001-6163-8794; Kobayashi, Daisuke/0000-0003-2141-9444; Abe, Yoichiro/0000-0001-6163-8794; Kojic, Dusan/0000-0002-7199-0203	MEXT of Japan [22791938, 24792152]; Strategic International Research Cooperative Program; Japan Science and Technology Agency (JST); Keio Gijuku Academic Development Funds; Keio University	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Research Cooperative Program; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Keio Gijuku Academic Development Funds; Keio University	This work was supported by Grant-in-Aid for Young Scientists (B) of MEXT of Japan (22791938 and 24792152), Strategic International Research Cooperative Program, Japan Science and Technology Agency (JST), Keio Gijuku Academic Development Funds and Keio University Special Grant-in-Aid for Innovative Collaborative Research Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF463; Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; ANCHORDOGUY TJ, 1992, BIOCHIM BIOPHYS ACTA, V1104, P117, DOI 10.1016/0005-2736(92)90139-D; Bonhivers M, 1998, J BIOL CHEM, V273, P27565, DOI 10.1074/jbc.273.42.27565; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; Claassen DA, 2009, MOL REPROD DEV, V76, P722, DOI 10.1002/mrd.21021; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Dumont F, 2004, APPL ENVIRON MICROB, V70, P268, DOI 10.1128/AEM.70.1.268-272.2004; Edashige K, 2003, BIOL REPROD, V68, P87, DOI 10.1095/biolreprod.101.002394; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Ibata K, 2011, BIOPHYS J, V101, P2277, DOI 10.1016/j.bpj.2011.08.045; Ikeshima-Kataoka H, 2013, MOL CELL NEUROSCI, V56, P65, DOI 10.1016/j.mcn.2013.02.002; Ismail M, 2009, BRIT J CANCER, V100, P1889, DOI 10.1038/sj.bjc.6605093; Katkov II, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/981606; La Porta CAM, 2006, BIOL CELL, V98, P89, DOI 10.1042/BC20040153; Malmersjo S, 2013, P NATL ACAD SCI USA, V110, pE1524, DOI 10.1073/pnas.1220179110; MAZUR P, 1968, CRYOBIOLOGY, V5, P1, DOI 10.1016/S0011-2240(68)80138-5; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Miyazaki K, 2013, J NEUROIMMUNOL, V260, P107, DOI 10.1016/j.jneuroim.2013.03.003; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; TAKIGAWA M, 1995, EUR J BIOCHEM, V228, P102, DOI 10.1111/j.1432-1033.1995.0102o.x; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Tanghe A, 2005, APPL ENVIRON MICROB, V71, P6434, DOI 10.1128/AEM.71.10.6434-6437.2005; Tanghe A, 2004, APPL ENVIRON MICROB, V70, P3377, DOI 10.1128/AEM.70.6.3377-3382.2004; Tanghe A, 2003, ADV APPL MICROBIOL, V53, P129, DOI 10.1016/S0065-2164(03)53004-0; Xu X, 2010, BIOTECHNOL PROGR, V26, P827, DOI 10.1002/btpr.368	33	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87644	10.1371/journal.pone.0087644	http://dx.doi.org/10.1371/journal.pone.0087644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558371	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700017
J	Nachar, W; Busseuil, D; Shi, YF; Mihalache-Avram, T; Mecteau, M; Rheaume, E; Tardif, JC				Nachar, Walid; Busseuil, David; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Rheaume, Eric; Tardif, Jean-Claude			Optimisation of Reference Genes for Gene-Expression Analysis in a Rabbit Model of Left Ventricular Diastolic Dysfunction	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; HEART-FAILURE; PCR DATA; NORMALIZATION; FIBROSIS; HYPERCHOLESTEROLEMIA; ECHOCARDIOGRAPHY; SELECTION; VELOCITY; PEPTIDE	Left ventricular diastolic dysfunction (LVDD) is characterized by the disturbance of ventricle's performance due to its abnormal relaxation or to its increased stiffness during the diastolic phase. The molecular mechanisms underlying LVDD remain unknown. We aimed to identify normalization genes for accurate gene-expression analysis of LVDD using quantitative real-time PCR (RT-PCR) in a new rabbit model of LVDD. Eighteen rabbits were fed with a normal diet (n = 7) or a 0.5% cholesterol-enriched diet supplemented with vitamin D2 (n = 11) for an average of 14.5 weeks. We validated the presence of LVDD in this model using echocardiography for diastolic function assessment. RT-PCR was performed using cDNA derived from left ventricle samples to measure the stability of 10 genes as candidate reference genes (Gapdh, Hprt1, Ppia, Sdha, Rpl5, Actb, Eef1e1, Ywhaz, Pgk1, and G6pd). Using geNorm analysis, we report that Sdha, Gapdh and Hprt1 genes had the highest stability (M<0.2). By contrast, Hprt1 and Rpl5 genes were found to represent the best combination for normalization when using the Normfinder algorithm (stability value of 0.042). Comparison of both normalization strategies highlighted an increase of natriuretic peptides (Bnp and Anp), monocytes chemotactic protein-1 (Mcp-1) and NADPH oxidase subunit (Nox-2) mRNA expressions in ventricle samples of the hypercholesterolemic rabbits compared to controls (P<0.05). This increase correlates with LVDD echocardiographic parameters and most importantly it molecularly validates the presence of the disease in our model. This is the first study emphasizing the selection of stable reference genes for RTPCR normalization in a rabbit model of LVDD.	[Nachar, Walid; Busseuil, David; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Rheaume, Eric; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Nachar, Walid; Busseuil, David; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Rheaume, Eric; Tardif, Jean-Claude] Univ Montreal, Montreal, PQ, Canada; [Rheaume, Eric; Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Tardif, JC (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.	jean-claude.tardif@icm-mhi.org	Rheaume, Eric/ABA-4918-2021	Rheaume, Eric/0000-0002-0554-0984	Canada Research Chair in translational and personalized medicine [950-227725]	Canada Research Chair in translational and personalized medicine	Dr. Jean-Claude Tardif is the principal investigator of this article and he provided the funding from his Canada Research Chair in translational and personalized medicine #950-227725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Jacob, 2009, Heart Fail Clin, V5, P191, DOI 10.1016/j.hfc.2008.11.002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bauersachs J, 2006, CARDIOVASC RES, V72, P438, DOI 10.1016/j.cardiores.2006.08.014; Borlaug BA, 2006, TRENDS CARDIOVAS MED, V16, P273, DOI 10.1016/j.tcm.2006.05.003; Busseuil D, 2008, BRIT J PHARMACOL, V154, P765, DOI 10.1038/bjp.2008.122; Busseuil D, 2010, CARDIOLOGY, V117, P234, DOI 10.1159/000322905; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caradec J, 2010, BRIT J CANCER, V103, P1475, DOI 10.1038/sj.bjc.6605851; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Dubi S, 2010, CARDIOVASC PATHOL, V19, P147, DOI 10.1016/j.carpath.2008.12.008; Fatima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041533; Gan LM, 2004, ECHOCARDIOGR-J CARD, V21, P313, DOI 10.1111/j.0742-2822.2004.03111.x; Haugen E, 2007, INT J CARDIOL, V115, P24, DOI 10.1016/j.ijcard.2006.01.031; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Irzmanski R, 2012, CLIN EXP HYPERTENS, V34, P530, DOI 10.3109/10641963.2012.702831; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Khouri SJ, 2004, J AM SOC ECHOCARDIOG, V17, P290, DOI 10.1016/j.echo.2003.08.012; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Luchner A, 2001, CARDIOVASC RES, V51, P601, DOI 10.1016/S0008-6363(01)00316-9; Luo TY, 2004, J BIOMED SCI, V11, P829, DOI [10.1159/000081830, 10.1007/BF02254368]; Mamo S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-67; Martino A, 2011, J BIOTECHNOL, V153, P92, DOI 10.1016/j.jbiotec.2011.04.002; Mohamed BA, 2012, J MOL CELL CARDIOL, V53, P459, DOI 10.1016/j.yjmcc.2012.07.014; Murase T, 2012, HYPERTENS RES, V35, P186, DOI 10.1038/hr.2011.157; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Shi YF, 2006, J THORAC CARDIOV SUR, V131, P1080, DOI 10.1016/j.jtcvs.2006.01.015; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; Talini E, 2008, ATHEROSCLEROSIS, V197, P346, DOI 10.1016/j.atherosclerosis.2007.05.024; Vandesompele, 2009, REAL TIME PCR CURREN; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Xu Z, 2008, J CARDIOVASC PHARM, V51, P62, DOI 10.1097/FJC.0b013e31815bb629; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	38	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89331	10.1371/journal.pone.0089331	http://dx.doi.org/10.1371/journal.pone.0089331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558494	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700140
J	Sherwani, S; Farleigh, L; Agarwal, N; Loveless, S; Robertson, N; Hadaschik, E; Schnitzler, P; Bugert, JJ				Sherwani, Subuhi; Farleigh, Laura; Agarwal, Nidhi; Loveless, Samantha; Robertson, Neil; Hadaschik, Eva; Schnitzler, Paul; Bugert, Joachim Jakob			Seroprevalence of Molluscum contagiosum Virus in German and UK Populations	PLOS ONE			English	Article							ANTIBODIES; LESIONS; CELLS	Molluscum contagiosum virus (MCV) is a significant but underreported skin pathogen for children and adults. Seroprevalence studies can help establish burden of disease. Enzyme linked immunosorbent assay (ELISA) based studies have been published for Australian and Japanese populations and the results indicate seroprevalences between 6 and 22 percent in healthy individuals, respectively. To investigate seroprevalence in Europe, we have developed a recombinant ELISA using a truncated MCV virion surface protein MC084 (V123-R230) expressed in E. coli. The ELISA was found to be sensitive and specific, with low inter-and intra-assay variability. Sera from 289 German adults and children aged 0-40 years (median age 21 years) were analysed for antibodies against MC084 by direct binding ELISA. The overall seropositivity rate was found to be 14.8%. The seropositivity rate was low in children below the age of one (4.5%), peaked in children aged 210 years (25%), and fell again in older populations (11-40 years; 12.5%). Ten out of 33 healthy UK individuals (30.3%; median age 27 years) had detectable MC084 antibodies. MCV seroconversion was more common in dermatological and autoimmune disorders, than in immunocompromised patients or in patients with multiple sclerosis. Overall MCV seroprevalence is 2.1 fold higher in females than in males in a UK serum collection. German seroprevalences determined in the MC084 ELISA (14.8%) are at least three times higher than incidence of MC in a comparable Swiss population (4.9%). While results are not strictly comparable, this is lower than Australian seroprevalence in a virion based ELISA (n = 357; 23%; 1999), but higher than the seroprevalence reported in a Japanese study using an N-terminal truncation of MC133 (n = 108, 6%; 2000. We report the first large scale serological survey of MC in Europe (n = 393) and the first MCV ELISA based on viral antigen expressed in E. coli.	[Sherwani, Subuhi; Farleigh, Laura; Bugert, Joachim Jakob] Cardiff Univ, Sch Med, Inst Infect & Immun Med Microbiol, Cardiff CF10 3AX, S Glam, Wales; [Agarwal, Nidhi] Dr PN Behl Skin Inst & Sch Dermatol, New Delhi, India; [Loveless, Samantha; Robertson, Neil] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Hadaschik, Eva] Heidelberg Univ, Hautklin, Heidelberg, Germany; [Schnitzler, Paul] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany	Cardiff University; Cardiff University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bugert, JJ (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun Med Microbiol, Cardiff CF10 3AX, S Glam, Wales.	bugertjj@cf.ac.uk	Bugert, Joachim/AAK-6459-2021; Sherwani, Subuhi/AAR-4495-2021; Bugert, Joachim Jakob/D-1705-2012	Sherwani, Subuhi/0000-0002-0631-708X; Bugert, Joachim Jakob/0000-0002-0556-3211	Wellcome Trust [WT 092488]; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Subuhi Sherwani is self funded. Consumables expenses were partially supported by a Wellcome Trust grant to Bernhard Moser (grant Number WT 092488). Wellcome Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birthistle K, 1997, J INFECTION, V34, P21, DOI 10.1016/S0163-4453(97)80005-9; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; BREMAN JG, 1980, NEW ENGL J MED, V303, P1263, DOI 10.1056/NEJM198011273032204; BROWN S T, 1974, Journal of the American Venereal Disease Association, V1, P35; Buckley R, 1999, ARCH DERMATOL, V135, P1167, DOI 10.1001/archderm.135.10.1167; Bugert J.J., 2008, ENCY VIROLOGY, P319; BULLER RML, 1995, VIROLOGY, V213, P655, DOI 10.1006/viro.1995.0037; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; BURNETT JW, 1966, J INVEST DERMATOL, V46, P76, DOI 10.1038/jid.1966.12; BURNETT JW, 1968, J INVEST DERMATOL, V50, P67, DOI 10.1038/jid.1968.10; Butala N, 2013, PEDIATRICS, V131, pE1650, DOI 10.1542/peds.2012-2933; Chen XY, 2013, LANCET INFECT DIS, V13, P877, DOI 10.1016/S1473-3099(13)70109-9; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Esposito JJ, 1991, ARCH VIROL         S, V2, P91; Fife KH, 1996, VIROLOGY, V226, P95, DOI 10.1006/viro.1996.0631; GOTTLIEB SL, 1994, INT J DERMATOL, V33, P453, DOI 10.1111/j.1365-4362.1994.tb02853.x; Konya J, 1999, J INFECT DIS, V179, P701, DOI 10.1086/314620; KONYA J, 1992, J VIROL METHODS, V40, P183, DOI 10.1016/0166-0934(92)90067-N; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MITCHELL JC, 1953, BRIT J EXP PATHOL, V34, P44; POSTLETH.R, 1970, ARCH ENVIRON HEALTH, V21, P432, DOI 10.1080/00039896.1970.10667262; Reynolds MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005255; Senkevich TG, 1996, SCIENCE, V273, P813, DOI 10.1126/science.273.5276.813; Sherwani Subuhi, 2012, Methods Mol Biol, V890, P135, DOI 10.1007/978-1-61779-876-4_8; SHIRODARIA PV, 1979, BRIT J DERMATOL, V101, P133, DOI 10.1111/j.1365-2133.1979.tb05597.x; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Watanabe T, 1998, J INFECT DIS, V177, P284, DOI 10.1086/514197; Watanabe T, 2000, ARCH DERMATOL, V136, P1518, DOI 10.1001/archderm.136.12.1518; Wenk C, 2003, PEDIATR DERMATOL, V20, P482, DOI 10.1111/j.1525-1470.2003.20605.x	30	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88734	10.1371/journal.pone.0088734	http://dx.doi.org/10.1371/journal.pone.0088734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558417	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700063
J	Singh, SA; Goldberg, TA; Henson, AL; Husain-Krautter, S; Nihrane, A; Blanc, L; Ellis, SR; Lipton, JM; Liu, JM				Singh, Sharon A.; Goldberg, Tracie A.; Henson, Adrianna L.; Husain-Krautter, Sehba; Nihrane, Abdallah; Blanc, Lionel; Ellis, Steven R.; Lipton, Jeffrey M.; Liu, Johnson M.			p53-Independent Cell Cycle and Erythroid Differentiation Defects in Murine Embryonic Stem Cells Haploinsufficient for Diamond Blackfan Anemia-Proteins: RPS19 versus RPL5	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; S19 DEFICIENCY; HEMATOPOIETIC DEFECTS; ZEBRAFISH MODEL; MUTATIONS; ERYTHROPOIESIS; ACTIVATION; FAILURE; LEADS; PROLIFERATION	Diamond Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome caused by ribosomal protein haploinsufficiency. DBA exhibits marked phenotypic variability, commonly presenting with erythroid hypoplasia, less consistently with non-erythroid features. The p53 pathway, activated by abortive ribosome assembly, is hypothesized to contribute to the erythroid failure of DBA. We studied murine embryonic stem (ES) cell lines harboring a gene trap mutation in a ribosomal protein gene, either Rps19 or Rpl5. Both mutants exhibited ribosomal protein haploinsufficiency and polysome defects. Rps19 mutant ES cells showed significant increase in p53 protein expression, however, there was no similar increase in the Rpl5 mutant cells. Embryoid body formation was diminished in both mutants but nonspecifically rescued by knockdown of p53. When embryoid bodies were further differentiated to primitive erythroid colonies, both mutants exhibited a marked reduction in colony formation, which was again nonspecifically rescued by p53 inhibition. Cell cycle analyses were normal in Rps19 mutant ES cells, but there was a significant delay in the G2/M phase in the Rpl5 mutant cells, which was unaffected by p53 knockdown. Concordantly, Rpl5 mutant ES cells had a more pronounced growth defect in liquid culture compared to the Rps19 mutant cells. We conclude that the defects in our RPS19 and RPL5 haploinsufficient mouse ES cells are not adequately explained by p53 stabilization, as p53 knockdown appears to increase the growth and differentiation potential of both parental and mutant cells. Our studies demonstrate that gene trap mouse ES cells are useful tools to study the pathogenesis of DBA.	[Singh, Sharon A.; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Hofstra North Shore LIJ Sch Med, Dept Mol Med, Hempstead, NY 11549 USA; [Singh, Sharon A.; Goldberg, Tracie A.; Husain-Krautter, Sehba; Nihrane, Abdallah; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Feinstein Inst Med Res, Manhasset, NY USA; [Singh, Sharon A.; Goldberg, Tracie A.; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Steven & Alexandra Cohen Childrens Med Ctr New Yo, Div Hematol Oncol, New Hyde Pk, NY USA; [Henson, Adrianna L.; Ellis, Steven R.] Univ Louisville, Dept Biochem, Louisville, KY 40292 USA; [Singh, Sharon A.; Blanc, Lionel; Lipton, Jeffrey M.; Liu, Johnson M.] Hofstra North Shore LIJ Sch Med, Dept Pediat, Hempstead, NY USA	Hofstra University; Northwell Health; Northwell Health; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; University of Louisville; Hofstra University; Northwell Health	Singh, SA (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Mol Med, Hempstead, NY 11549 USA.	ssingh1@nshs.edu		Blanc, Lionel/0000-0002-0185-6260; Husain-Krautter, Sehba/0000-0001-6002-8046	National Institutes of Health [R01HL079571]; Diamond-Blackfan Anemia Foundation; Daniela Maria Arturi Foundation; Pediatric Cancer Foundation; Saint Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diamond-Blackfan Anemia Foundation; Daniela Maria Arturi Foundation; Pediatric Cancer Foundation; Saint Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (R01HL079571 to J.M. Lipton), the Diamond-Blackfan Anemia Foundation, the Daniela Maria Arturi Foundation, the Pediatric Cancer Foundation, and the Saint Baldrick's Foundation (to S. A. Singh and J.M. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badhai J, 2009, BBA-MOL BASIS DIS, V1792, P1036, DOI 10.1016/j.bbadis.2009.08.002; Chan Rebecca J., 2006, V330, P123; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Choi K, 1998, BIOCHEM CELL BIOL, V76, P947, DOI 10.1139/bcb-76-6-947; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Devlin EE, 2010, BLOOD, V116, P2826, DOI 10.1182/blood-2010-03-275776; Dianzani I, 2008, HAEMATOL-HEMATOL J, V93, P1601, DOI 10.3324/haematol.2008.000513; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ellis SR, 2011, SEMIN HEMATOL, V48, P89, DOI 10.1053/j.seminhematol.2011.02.005; Farrar JE, 2011, BLOOD, V118, P6943, DOI 10.1182/blood-2011-08-375170; Forrai A, 2005, EXP HEMATOL, V33, P845, DOI 10.1016/j.exphem.2005.03.016; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Ganguli G, 2002, EMBO REP, V3, P569, DOI 10.1093/embo-reports/kvf114; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gazda HT, 2004, BRIT J HAEMATOL, V127, P105, DOI 10.1111/j.1365-2141.2004.05152.x; HARVEY M, 1993, ONCOGENE, V8, P2457; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jaako P, 2011, BLOOD, V118, P6087, DOI 10.1182/blood-2011-08-371963; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kuramitsu M, 2008, BRIT J HAEMATOL, V140, P348, DOI 10.1111/j.1365-2141.2007.06930.x; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McGowan KA, 2011, SEMIN HEMATOL, V48, P106, DOI 10.1053/j.seminhematol.2011.02.001; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; Montel-Hagen A, 2008, BLOOD, V112, P4729, DOI 10.1182/blood-2008-05-159269; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Palis J, 2008, CURR OPIN HEMATOL, V15, P155, DOI 10.1097/MOH.0b013e3282f97ae1; PERDAHL EB, 1994, BLOOD, V83, P645; Quarello P, 2010, HAEMATOL-HEMATOL J, V95, P206, DOI 10.3324/haematol.2009.011783; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Taylor AM, 2012, EXP HEMATOL, V40, P228, DOI [10.1016/j.exphem.2011.11.007, 10.1016/j.exphem.2011.11.007.]; Teng T, 2013, MOL CELL BIOL, V33, P4660, DOI 10.1128/MCB.01174-13; Torihara H, 2011, BRIT J HAEMATOL, V152, P648, DOI 10.1111/j.1365-2141.2010.08535.x; Uechi T, 2008, HUM MOL GENET, V17, P3204, DOI 10.1093/hmg/ddn216; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vlachos A, 2012, BLOOD, V119, P3815, DOI 10.1182/blood-2011-08-375972; Weiss MJ, 2012, J CLIN INVEST, V122, P2346, DOI 10.1172/JCI63989; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; WILES MV, 1991, DEVELOPMENT, V111, P259; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	48	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89098	10.1371/journal.pone.0089098	http://dx.doi.org/10.1371/journal.pone.0089098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558476	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700122
J	Yamazaki, F; Kim, HH; Lau, P; Hwang, CK; Iuvone, PM; Klein, D; Clokie, SJH				Yamazaki, Fumiyoshi; Kim, Hyun Hee; Lau, Pierre; Hwang, Christopher K.; Iuvone, P. Michael; Klein, David; Clokie, Samuel J. H.			pY RNA1-s2: A Highly Retina-Enriched Small RNA That Selectively Binds to Matrin 3 (Matr3)	PLOS ONE			English	Article							Y-RNAS; RECOGNITION MOTIF; LINEAGE ANALYSIS; PROTEIN; IDENTIFICATION; MICRORNAS; DEGRADATION; EVOLUTION; ABUNDANCE; SIRNAS	The purpose of this study was to expand our knowledge of small RNAs, which are known to function within protein complexes to modulate the transcriptional output of the cell. Here we describe two previously unrecognized, small RNAs, termed pY RNA1-s1 and pY RNA1-s2 (processed Y RNA1-stem -1 and -2), thereby expanding the list of known small RNAs. pY RNA1-s1 and pY RNA1-s2 were discovered by RNA sequencing and found to be 20-fold more abundant in the retina than in 14 other rat tissues. Retinal expression of pY RNAs is highly conserved, including expression in the human retina, and occurs in all retinal cell layers. Mass spectrometric analysis of pY RNA1-S2 binding proteins in retina indicates that pY RNA1-s2 selectively binds the nuclear matrix protein Matrin 3 (Matr3) and to a lesser degree to hnrpul1 (heterogeneous nuclear ribonucleoprotein U-like protein). In contrast, pY RNA1-s1 does not bind these proteins. Accordingly, the molecular mechanism of action of pY RNA1-s2 is likely be through an action involving Matr3; this 95 kDa protein has two RNA recognition motifs (RRMs) and is implicated in transcription and RNA-editing. The high affinity binding of pY RNA1-s2 to Matr3 is strongly dependent on the sequence of the RNA and both RRMs of Matr3. Related studies also indicate that elements outside of the RRM region contribute to binding specificity and that phosphorylation enhances pY RNA-s2/Matr3 binding. These observations are of significance because they reveal that a previously unrecognized small RNA, pY RNA1-s2, binds selectively to Matr3. Hypothetically, pY RNA1-S2 might act to modulate cellular function through this molecular mechanism. The retinal enrichment of pY RNA1-s2 provides reason to suspect that the pY RNA1-s2/Matr3 interaction could play a role in vision.	[Yamazaki, Fumiyoshi; Kim, Hyun Hee; Klein, David; Clokie, Samuel J. H.] Eunice Shriver Kennedy Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Lau, Pierre] NINDS, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Hwang, Christopher K.; Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Hwang, Christopher K.; Iuvone, P. Michael] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Emory University; Emory University	Klein, D (corresponding author), Eunice Shriver Kennedy Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	kleind@mail.nih.gov		Klein, David/0000-0002-1792-5806; Clokie, Samuel/0000-0002-0025-3652	Intramural Research Program of the NICHD/NIH; NIH [R01 EY004864, P30 EY006360, T32 EY007092]; Research to Prevent Blindness, Inc. (RPB); RPB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836, ZIAHD008838, ZIAHD008837] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007092, P30EY006360, R01EY004864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	Intramural Research Program of the NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc. (RPB)(Research to Prevent Blindness (RPB)); RPB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by the Intramural Research Program of the NICHD/NIH, by NIH grants R01 EY004864, P30 EY006360, T32 EY007092, and by an unrestricted departmental grant from Research to Prevent Blindness, Inc. (RPB). PMI is a recipient of a Senior Scientific Investigator Award from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; BELGRADER P, 1991, J BIOL CHEM, V266, P9893; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Boria I, 2010, J MOL EVOL, V70, P346, DOI 10.1007/s00239-010-9332-4; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen XG, 2000, GENE DEV, V14, P777; Christov CP, 2006, MOL CELL BIOL, V26, P6993, DOI 10.1128/MCB.01060-06; Clokie SJ, 2012, J BIOL CHEM; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Giordano G, 2005, J NEUROCHEM, V94, P808, DOI 10.1111/j.1471-4159.2005.03235.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hibino Y, 2006, BBA-GENE STRUCT EXPR, V1759, P195, DOI 10.1016/j.bbaexp.2006.04.010; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Inagaki H, 1996, J BIOL CHEM, V271, P12525, DOI 10.1074/jbc.271.21.12525; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; LIVAK KJ, 1990, GENETICS, V124, P303; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mosig A, 2007, THEOR BIOSCI, V126, P9, DOI 10.1007/s12064-007-0003-y; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Nicolas FE, 2012, FEBS LETT, V586, P1226, DOI 10.1016/j.febslet.2012.03.026; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PRUIJN GJM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P395, DOI 10.1016/0167-4781(93)90006-Y; Przygodzka P, 2011, EXP CELL RES, V317, P802, DOI 10.1016/j.yexcr.2010.12.009; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Salton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023882; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Smalheiser NR, 2011, RNA, V17, P166, DOI 10.1261/rna.2123811; VANGELDER CWG, 1994, NUCLEIC ACIDS RES, V22, P2498, DOI 10.1093/nar/22.13.2498; VANHORN DJ, 1995, RNA, V1, P293	47	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88217	10.1371/journal.pone.0088217	http://dx.doi.org/10.1371/journal.pone.0088217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558381	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700027
J	Clegg, CH; Roque, R; Perrone, LA; Rininger, JA; Bowen, R; Reed, SG				Clegg, Christopher H.; Roque, Richard; Perrone, Lucy A.; Rininger, Joseph A.; Bowen, Richard; Reed, Steven G.			GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza	PLOS ONE			English	Article							VIRUS; TRANSMISSION; NARCOLEPSY; ANTIBODIES; MEMORY; CELLS; MF59	The ongoing threat from Influenza necessitates the development of new vaccine and adjuvant technologies that can maximize vaccine immunogenicity, shorten production cycles, and increase global vaccine supply. Currently, the most successful adjuvants for Influenza vaccines are squalene-based oil-in-water emulsions. These adjuvants enhance seroprotective antibody titers to homologous and heterologous strains of virus, and augment a significant dose sparing activity that could improve vaccine manufacturing capacity. As an alternative to an emulsion, we tested a simple lipid-based aqueous formulation containing a synthetic TLR4 ligand (GLA-AF) for its ability to enhance protection against H5N1 infection. GLA-AF was very effective in adjuvanting recombinant H5 hemagglutinin antigen (rH5) in mice and was as potent as the stable emulsion, SE. Both adjuvants induced similar antibody titers using a sub-microgram dose of rH5, and both conferred complete protection against a highly pathogenic H5N1 challenge. However, GLA-AF was the superior adjuvant in ferrets. GLA-AF stimulated a broader antibody response than SE after both the prime and boost immunization with rH5, and ferrets were better protected against homologous and heterologous strains of H5N1 virus. Thus, GLA-AF is a potent emulsion-free adjuvant that warrants consideration for pandemic influenza vaccine development.	[Clegg, Christopher H.; Roque, Richard; Perrone, Lucy A.] TRIA Biosci Corp, Seattle, WA USA; [Rininger, Joseph A.] CaroGen Corp, Hamden, CT USA; [Bowen, Richard] Colorado State Univ, Ft Collins, CO 80523 USA; [Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA	Colorado State University	Clegg, CH (corresponding author), TRIA Biosci Corp, Seattle, WA USA.	cclegg@triabio.com		PERRONE. MSPH, PhD, LUCY A./0000-0003-2185-688X	National Institutes of Health [R44AI081383]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI081383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health grant R44AI081383. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002302; Anderson RC, 2010, COLLOID SURFACE B, V75, P123, DOI 10.1016/j.colsurfb.2009.08.022; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Clegg CH, 2013, EXPERT REV VACCINES, V12, P767, DOI 10.1586/14760584.2013.811178; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Fox CB, 2013, VACCINE, V31, P1633, DOI 10.1016/j.vaccine.2012.10.048; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Hagen SR, 1997, J CHROMATOGR A, V767, P53, DOI 10.1016/S0021-9673(97)00041-1; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kothare SV, 2013, NEUROLOGY, V80, P1276, DOI 10.1212/WNL.0b013e31828ab382; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Lippi G, 2010, EUR J INTERN MED, V21, P70, DOI 10.1016/j.ejim.2009.12.001; McKeage K, 2011, DRUGS, V71, P465, DOI [10.2165/11206820-000000000-00000, 10.2165/11208090-000000000-00000]; McKinstry KK, 2011, J INTERN MED, V269, P507, DOI 10.1111/j.1365-2796.2011.02367.x; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; Orr MT, 2013, J CONTROL RELEASE, V172, P190, DOI 10.1016/j.jconrel.2013.07.030; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Vesikari T, 2010, PEDIATRICS, V126, pE762, DOI 10.1542/peds.2009-2628; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532	33	29	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88979	10.1371/journal.pone.0088979	http://dx.doi.org/10.1371/journal.pone.0088979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551202	Green Submitted, gold, Green Published			2022-12-25	WOS:000331271500088
J	Montero-Marin, J; Prado-Abril, J; Demarzo, MMP; Gascon, S; Garcia-Campayo, J				Montero-Marin, Jesus; Prado-Abril, Javier; Piva Demarzo, Marcelo Marcos; Gascon, Santiago; Garcia-Campayo, Javier			Coping with Stress and Types of Burnout: Explanatory Power of Different Coping Strategies	PLOS ONE			English	Article							EFFORT-REWARD-IMBALANCE; JOB STRESS; SOCIAL SUPPORT; QUESTIONNAIRE; NURSES; MINDFULNESS; ACCEPTANCE; DEFINITION; SETTINGS; TEACHERS	Background: Burnout occurs when professionals use ineffective coping strategies to try to protect themselves from work-related stress. The dimensions of 'overload', 'lack of development' and 'neglect', belonging to the 'frenetic', 'under-challenged' and 'worn-out' subtypes, respectively, comprise a brief typological definition of burnout. The aim of the present study was to estimate the explanatory power of the different coping strategies on the development of burnout subtypes. Methods: This was a cross-sectional survey with a random sample of university employees, stratified by occupation (n = 429). Multivariate linear regression models were constructed between the 'Burnout Clinical Subtypes Questionnaire', with its three dimensions - overload, lack of development and neglect-as dependent variables, and the 'Coping Orientation for Problem Experiences', with its fifteen dimensions, as independent variables. Adjusted multiple determination coefficients and beta coefficients were calculated to evaluate and compare the explanatory capacity of the different coping strategies. Results: The 'Coping Orientation for Problem Experiences' subscales together explained 15% of the 'overload' (p<0.001), 9% of the 'lack of development' (p<0.001), and 21% of the 'neglect' (p<0.001). 'Overload' was mainly explained by 'venting of emotions' (Beta = 0.34; p, 0.001); 'lack of development' by 'cognitive avoidance' (Beta = 0.21; p, 0.001); and 'neglect' by 'behavioural disengagement' (Beta = 0.40; p<0.001). Other interesting associations were observed. Conclusions: These findings further our understanding of the way in which the effectiveness of interventions for burnout may be improved, by influencing new treatments and preventive programmes using features of the strategies for handling stress in the workplace.	[Montero-Marin, Jesus] Univ Zaragoza, Fac Hlth Sci & Sports, Huesca, Spain; [Montero-Marin, Jesus; Garcia-Campayo, Javier] Univ Zaragoza, Dept Psychiat, Zaragoza, Spain; [Prado-Abril, Javier; Garcia-Campayo, Javier] Miguel Servet Univ Hosp, Psychiat Serv, Zaragoza, Spain; [Piva Demarzo, Marcelo Marcos] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Gascon, Santiago] Univ Zaragoza, Dept Psychol, Teruel, Spain; [Montero-Marin, Jesus; Gascon, Santiago; Garcia-Campayo, Javier] REDIAPP Red Invest Actividades Prevent & Promoc S, Zaragoza, Spain	University of Zaragoza; University of Zaragoza; Miguel Servet University Hospital; Universidade Federal de Sao Paulo (UNIFESP); University of Zaragoza	Montero-Marin, J (corresponding author), Univ Zaragoza, Fac Hlth Sci & Sports, Huesca, Spain.	jmontero@unizar.es	Demarzo, Marcelo/A-7021-2010; Montero-Marin, Jesus/ABG-8919-2020; Prado-Abril, Javier/AAA-3600-2020	Demarzo, Marcelo/0000-0002-7447-1839; Montero-Marin, Jesus/0000-0001-5677-1662; Prado-Abril, Javier/0000-0002-7286-9034; Gascon, Santiago/0000-0002-3723-0673; Garcia-Campayo, Javier/0000-0002-3797-4218	Research Network on Preventative Activities and Health Promotion [RD06/0018/0017]; Health Sciences Institute of Aragon (IACS); CNPq - Brazilian National Council for Research and Technology Development	Research Network on Preventative Activities and Health Promotion; Health Sciences Institute of Aragon (IACS); CNPq - Brazilian National Council for Research and Technology Development	This study was possible as a result of the support received from the Research Network on Preventative Activities and Health Promotion (RD06/0018/0017) and the Health Sciences Institute of Aragon (IACS). MMPD is grateful to the CNPq - Brazilian National Council for Research and Technology Development for a postdoctoral fellowship (Science without Borders Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, SUEZ COMPL UN WAT RE; AUERBACH SM, 1976, J CONSULT CLIN PSYCH, V44, P809, DOI 10.1037/0022-006X.44.5.809; Bakker AB, 2001, J SOC CLIN PSYCHOL, V20, P82, DOI 10.1521/jscp.20.1.82.22251; Bandura A, 1997, SELF EFFICACY EXERCI; Beutler L.E., 1990, SYSTEMATIC TREATMENT; Brinkborg H, 2011, BEHAV RES THER, V49, P389, DOI 10.1016/j.brat.2011.03.009; Buunk BP., 1999, EUR REV SOC PSYCHOL, V10, P259, DOI [DOI 10.1080/14792779943000080, 10.1080/14792779943000080]; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chapman LK, 2010, DEPRESS ANXIETY, V27, P316, DOI 10.1002/da.20510; Chen MJ, 2008, WORK STRESS, V22, P327, DOI 10.1080/02678370802573992; Crespo M., 1997, ANALISIS MODIFICACIO, V23, P797, DOI DOI 10.6018/ANALESPS.29.1.124531; Delaney-Black V, 2010, PEDIATRICS, V126, P887, DOI 10.1542/peds.2009-3059; Etxeberria J, 2007, MULTIPLE REGRESSION; Farber B.A, 1990, PSYCHOTHERAPY PRIVAT, V8, P35, DOI [DOI 10.1300/J294V08N01_07, 10.1300/J294v08n01_07]; Farber BA, 2000, J CLIN PSYCHOL, V56, P675, DOI 10.1002/(SICI)1097-4679(200005)56:5<675::AID-JCLP8>3.0.CO;2-D; Farber BA, 2000, J CLIN PSYCHOL, V56, P589, DOI 10.1002/(SICI)1097-4679(200005)56:5<589::AID-JCLP1>3.0.CO;2-S; Gerzina HA, 2012, TEACH LEARN MED, V24, P309, DOI 10.1080/10401334.2012.715255; Gibbons C, 2010, INT J NURS STUD, V47, P1299, DOI 10.1016/j.ijnurstu.2010.02.015; Gil-Monte P. R, 2007, SINDROME QUEMARSE TR; Gil-Monte P.R., 2005, SINDROME QUEMARSE TR; Griffith J, 1999, BRIT J EDUC PSYCHOL, V69, P517, DOI 10.1348/000709999157879; Guerrero E, 2003, ANAL PSICOL, V10, P145; Haberthur AK, 2009, J CLIN PSYCHOL, V65, P1039, DOI 10.1002/jclp.20606; Heiervang E, 2011, SOC PSYCH PSYCH EPID, V46, P69, DOI 10.1007/s00127-009-0171-9; Herbert JD, 2008, COGNITIVE BEHAV THER, P4; HOFER MA, 1972, PSYCHOSOM MED, V34, P481, DOI 10.1097/00006842-197211000-00001; Huberman A, 1999, UNDERSTANDING PREVEN, P159, DOI DOI 10.1017/CBO9780511527784.009; iD'Souza RM, 2003, J EPIDEMIOL COMMUNIT, V57, P849; Isaksson KE, 2013, BMC PUBLIC HEALTH, V10, P213; Kaplowitz MD, 2004, PUBLIC OPIN QUART, V68, P94, DOI 10.1093/poq/nfh006; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; Koenig HG, 2001, ANN PHARMACOTHER, V35, P352, DOI 10.1345/aph.10215; Lazarus R., 1984, STRESS APPRAISAL COP; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; LAZARUS RS, 1993, ANNU REV PSYCHOL, V44, P1, DOI 10.1146/annurev.ps.44.020193.000245; Lloyd J, 2013, WORK STRESS, V27, P181, DOI 10.1080/02678373.2013.782157; Losa Iglesias ME, 2010, INT J NURS STUD, V47, P30, DOI 10.1016/j.ijnurstu.2009.06.014; Asuero AM, 2013, GAC SANIT, V27, P521, DOI 10.1016/j.gaceta.2013.04.007; Martinez-Gonzalez M, 2006, BIOESTADISTICA AMIGA, P851; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; McCracken LM, 2010, PAIN, V148, P141, DOI 10.1016/j.pain.2009.10.034; Montero-Marin J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1240; Montero-Marin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-922; Montero-Marin Jesus, 2011, BMC Med Educ, V11, P103, DOI 10.1186/1472-6920-11-103; Montero-Marin J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-74; Montero-Marin J, 2011, BMC MED EDUC, V11, DOI [10.1186/1472-6920-11-103, 10.1186/1471-244X-11-49]; Montero-Marin J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-302; Montero-Marin Jesus, 2009, J Occup Med Toxicol, V4, P31, DOI 10.1186/1745-6673-4-31; Ohue T, 2011, JPN J NURS SCI, V8, P76, DOI 10.1111/j.1742-7924.2010.00161.x; Paris M, 2010, J BEHAV HEALTH SER R, V37, P519, DOI 10.1007/s11414-009-9202-2; Paul HA, 2006, CHILD FAM BEHAV THER, V28, P73; Pejuskovic B, 2011, PSYCHIAT DANUB, V23, P389; Pisanti R, 2012, MED LAV, V103, P466; Demarzo MMP, 2012, INT J PREVENTIVE MED, V3, P670; Prati G, 2009, ANXIETY STRESS COPIN, V23, P1; Rodero B, 2012, J PSYCHOSOM RES, V73, P86, DOI 10.1016/j.jpsychores.2012.05.011; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Salanova M, 2005, PSICOTHEMA, V17, P390; Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x; Schulz M, 2009, J PSYCHIATR MENT HLT, V16, P225, DOI 10.1111/j.1365-2850.2008.01355.x; Sobczak LR, 2013, COGN BEHAV PRACT, V20, P13, DOI 10.1016/j.cbpra.2011.08.005; Tyrell Z, 2010, COG BEHAV THER, V3, P18; Unger JB, 1998, J ADOLESCENT RES, V13, P134, DOI 10.1177/0743554898132003; Unterbrink T, 2007, INT ARCH OCC ENV HEA, V80, P433, DOI 10.1007/s00420-007-0169-0; Vilardaga R, 2011, J SUBST ABUSE TREAT, V40, P323, DOI 10.1016/j.jsat.2010.11.015; Volker R, 2010, STRESS HEALTH, V26, P149, DOI 10.1002/smi.1276; Wallace SL, 2010, J EMPLOYMENT COUNS, V47, P111, DOI 10.1002/j.2161-1920.2010.tb00096.x; WEINBERGER DA, 1979, J ABNORM PSYCHOL, V88, P369, DOI 10.1037/0021-843X.88.4.369; Zeller JM, 2013, WORKPLACE HEALTH SAF, V61, P86, DOI 10.3928/21650799-20130116-67	70	47	48	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89090	10.1371/journal.pone.0089090	http://dx.doi.org/10.1371/journal.pone.0089090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551223	gold, Green Submitted, Green Published			2022-12-25	WOS:000331266000101
J	Snell, CE; Turley, H; McIntyre, A; Li, DM; Masiero, M; Schofield, CJ; Gatter, KC; Harris, AL; Pezzella, F				Snell, Cameron E.; Turley, Helen; McIntyre, Alan; Li, Demin; Masiero, Massimo; Schofield, Christopher J.; Gatter, Kevin C.; Harris, Adrian L.; Pezzella, Francesco			Proline-Hydroxylated Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) Upregulation in Human Tumours	PLOS ONE			English	Article							PROLYL HYDROXYLATION; FACTOR (HIF)-1-ALPHA; CANCER-CELLS; HIF-ALPHA; FACTOR-I; OXYGEN; EXPRESSION; HIF-2-ALPHA; PROTEIN; TARGET	The stabilisation of HIF-alpha is central to the transcriptional response of animals to hypoxia, regulating the expression of hundreds of genes including those involved in angiogenesis, metabolism and metastasis. HIF-alpha is degraded under normoxic conditions by proline hydroxylation, which allows for recognition and ubiquitination by the von-Hippel-Lindau (VHL) E3 ligase complex. The aim of our study was to investigate the posttranslational modification of HIF-1 alpha in tumours, to assess whether there are additional mechanisms besides reduced hydroxylation leading to stability. To this end we optimised antibodies against the proline-hydroxylated forms of HIF-1 alpha for use in formalin fixed paraffin embedded (FFPE) immunohistochemistry to assess effects in tumour cells in vivo. We found that HIF-1 alpha proline-hydroxylated at both VHL binding sites (Pro402 and Pro564), was present in hypoxic regions of a wide range of tumours, tumour xenografts and in moderately hypoxic cells in vitro. Staining for hydroxylated HIF-1 alpha can identify a subset of breast cancer patients with poorer prognosis and may be a better marker than total HIF-1 alpha levels. The expression of unhydroxylated HIF-1 alpha positively correlates with VHL in breast cancer suggesting that VHL may be rate-limiting for HIF degradation. Our conclusions are that the degradation of proline-hydroxylated HIF-1 alpha may be rate-limited in tumours and therefore provides new insights into mechanisms of HIF upregulation. Persistence of proline-hydroxylated HIF-1 alpha in perinecrotic areas suggests there is adequate oxygen to support prolyl hydroxylase domain (PHD) activity and proline-hydroxylated HIF-1 alpha may be the predominant form associated with the poorer prognosis that higher levels of HIF-1 alpha confer.	[Snell, Cameron E.; Turley, Helen; Gatter, Kevin C.; Pezzella, Francesco] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Tumour Pathol Grp, Oxford, England; [McIntyre, Alan; Harris, Adrian L.] Univ Oxford, Weatherall Inst Mol Med, Dept Med Oncol, Mol Oncol Labs, Oxford, England; [Li, Demin; Masiero, Massimo] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Haematooncol Grp, Oxford, England; [Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Snell, CE (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Tumour Pathol Grp, Oxford, England.	Cameron.snell@gmail.com	Harris, Adrian L/ABA-3343-2020; Li, Demin/O-4065-2019; Snell, Cameron/M-7413-2015	Harris, Adrian L/0000-0003-1376-8409; Li, Demin/0000-0002-7118-3401; McIntyre, Alan/0000-0002-4791-7292; Schofield, Christopher/0000-0002-0290-6565; Snell, Cameron/0000-0001-7847-3041	Nuffield Medical Fellowship; British Heart Foundation [PG/12/33/29546] Funding Source: researchfish; Cancer Research UK [11359, 10702] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Nuffield Medical Fellowship; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	CS is supported by a Nuffield Medical Fellowship (http://www.admin.ox.ac.uk/councilsec/gov/linkedcharitiesoftheuniversityofoxford/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Beasley NJP, 2002, CANCER RES, V62, P2493; Beitner-Johnson D, 2001, CELL SIGNAL, V13, P23, DOI 10.1016/S0898-6568(00)00128-5; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Cai QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009720; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Couvelard A, 2005, HISTOPATHOLOGY, V46, P668, DOI 10.1111/j.1365-2559.2005.02160.x; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Evans SM, 2004, CANCER RES, V64, P1886, DOI 10.1158/0008-5472.CAN-03-2424; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Hutchison GJ, 2004, CLIN CANCER RES, V10, P8405, DOI 10.1158/1078-0432.CCR-03-0135; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Knowles HJ, 2003, CANCER RES, V63, P1764; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Masson N, 2012, EMBO REP, V13, P251, DOI 10.1038/embor.2012.9; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818	38	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e88955	10.1371/journal.pone.0088955	http://dx.doi.org/10.1371/journal.pone.0088955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563687	Green Submitted, gold, Green Published			2022-12-25	WOS:000331262600121
J	Song, Y; Gong, K; Yan, H; Hong, W; Wang, L; Wu, YL; Li, WH; Li, WX; Cao, ZJ				Song, Yu; Gong, Ke; Yan, Hong; Hong, Wei; Wang, Le; Wu, Yingliang; Li, Wenhua; Li, Wenxin; Cao, Zhijian			Sj7170, a Unique Dual-function Peptide with a Specific alpha- Chymotrypsin Inhibitory Activity and a Potent Tumoractivating Effect from Scorpion Venom*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glioblastoma; Metastasis; Peptides; Proliferation; Protease Inhibitor	EPITHELIAL-MESENCHYMAL TRANSITION; ASCARIS TRYPSIN-INHIBITOR; PROTEINASE-INHIBITORS; PROTEASE INHIBITORS; TUMOR PROGRESSION; CELL INVASION; CANCER; GLIOMA; SUPERFAMILY; EVOLUTION	Background: Sj7170 is a new peptide from scorpion venom. Results: Sj7170 specifically inhibits the activity of -chymotrypsin. Sj7170 promotes glioblastoma tumorigenesis and metastasis by up-regulating cyclin D1 and Snail. Conclusion: Sj7170 not only specifically inhibits -chymotrypsin activity but also promotes the tumorigenesis and metastasis of glioblastoma. Significance: Sj7170 is a unique dual-function peptide with a protease inhibitory activity and a potent tumor-activating effect. A new peptide precursor, termed Sj7170, was characterized from the venomous gland cDNA library of the scorpion Scorpiops jendeki. Sj7170 was deduced to be a 62-amino acid peptide cross-linked by five disulfide bridges. The recombinant Sj7170 peptide (rSj7170) with chromatographic purity was produced by a prokaryotic expression system. Enzyme inhibition assay in vitro and in vivo showed that rSj7170 specifically inhibited the activity of -chymotrypsin at micromole concentrations. In addition, Sj7170 not only promoted cell proliferation and colony formation by up-regulating the expression of cyclin D1 in vitro but also enhanced tumor growth in nude mice. Finally, Sj7170 accelerated cellular migration and invasion by increasing the expression of the transcription factor Snail and then inducing the epithelial-mesenchymal transition. Moreover, Sj7170 changed cell morphology and cytoskeleton of U87 cells by the GTPase pathway. Taken together, Sj7170 is a unique dual-function peptide, i.e. a specific -chymotrypsin inhibitor and a potent tumorigenesis/metastasis activator. Our work not only opens an avenue of developing new modulators of tumorigenesis/metastasis from serine protease inhibitors but also strengthens the functional link between protease inhibitors and tumor activators.	[Song, Yu; Yan, Hong; Hong, Wei; Wang, Le; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Song, Yu; Gong, Ke; Yan, Hong; Hong, Wei; Wang, Le; Wu, Yingliang; Li, Wenhua; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Li, WH (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	whli@whu.edu.cn; liwxlab@whu.edu.cn; zjcao@whu.edu.cn	Hong, Wei/AAJ-6912-2020	Hong, Wei/0000-0001-7410-4679	National Key Basic Research Program [2010CB529800, 2010CB530100]; China Specific Project for Developing New Drugs Grant [2011ZX09401-302]; Fundamental Research Funds for the Central Universities in China; National Nature Science Foundation of China [81273540]	National Key Basic Research Program(National Basic Research Program of China); China Specific Project for Developing New Drugs Grant; Fundamental Research Funds for the Central Universities in China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grants 2010CB529800 and 2010CB530100, China Specific Project for Developing New Drugs Grant 2011ZX09401-302, Fundamental Research Funds for the Central Universities in China and the National Nature Science Foundation of China Grant 81273540.	Arbiser JL, 2007, BLOOD, V109, P560, DOI 10.1182/blood-2006-06-029934; BABIN DR, 1984, ARCH BIOCHEM BIOPHYS, V232, P143, DOI 10.1016/0003-9861(84)90530-7; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Chen ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057529; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Gessler F, 2011, NEUROSCI LETT, V497, P49, DOI 10.1016/j.neulet.2011.04.027; Goel A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.141; GRASBERGER BL, 1994, STRUCTURE, V2, P669, DOI 10.1016/S0969-2126(00)00067-8; GRONENBORN AM, 1990, BIOCHEMISTRY-US, V29, P183, DOI 10.1021/bi00453a025; Heinen TE, 2011, TOXICON, V57, P497, DOI 10.1016/j.toxicon.2011.01.002; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kataoka H, 2002, PATHOL INT, V52, P89, DOI 10.1046/j.1440-1827.2002.01320.x; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lee HC, 2005, J CELL BIOCHEM, V94, P597, DOI 10.1002/jcb.20312; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Mamelak AN, 2007, EXPERT OPIN DRUG DEL, V4, P175, DOI 10.1517/17425247.4.2.175; Mignogna G, 1996, PROTEIN SCI, V5, P357; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Saini SS, 1999, TOXICON, V37, P1605, DOI 10.1016/S0041-0101(99)00110-5; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Wang ZW, 2010, CURR STEM CELL RES T, V5, P74, DOI 10.2174/157488810790442813; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zeng XC, 2000, TOXICON, V38, P893, DOI 10.1016/S0041-0101(99)00192-0	30	12	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11667	11680		10.1074/jbc.M113.540419	http://dx.doi.org/10.1074/jbc.M113.540419			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24584937	Green Published, hybrid			2022-12-25	WOS:000335010600010
J	Chen, XJ; Sun, WY; Gianaris, NG; Riley, AM; Cummins, TR; Fehrenbacher, JC; Obukhov, AG				Chen, Xingjuan; Sun, Weiyang; Gianaris, Nicholas G.; Riley, Ashley M.; Cummins, Theodore R.; Fehrenbacher, Jill C.; Obukhov, Alexander G.			Furanocoumarins Are a Novel Class of Modulators for the Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channel*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Imaging; Calcium Signaling; Ion Channels; TRP Channels	ANGELICA-DAHURICA; SODIUM-CHANNELS; FORMALIN TEST; IMPERATORIN; CAPSAICIN; BINDING; PAIN; IDENTIFICATION; SUPPRESSION; RELEASE	Background: Furanocoumarin imperatorin is a major active component of Angelica dahurica root extracts exhibiting analgesic properties. Results: Imperatorin inhibited formalin- and capsaicin-induced nocifensive responses, facilitated TRPV1 desensitization, and sensitized TRPV1 to acid activation. Conclusion: Furanocoumarins represent a novel class of TRPV1 partial agonists exhibiting analgesic potential. Significance: Imperatorin is a lead compound for drug discovery aimed at developing new analgesics. Furanocoumarin imperatorin is the major active component of Angelica dahurica root extracts, widely used in traditional medicine to treat headache, toothache, and orbital eye pain. In this study, we investigated the mechanisms that may underlie the pain-relieving effects of the compound. We found that imperatorin significantly inhibited formalin- and capsaicin-induced nocifensive responses but did not alter baseline thermal withdrawal thresholds in the rat. We established that imperatorin is a weak agonist of TRPV1, a channel implicated in detecting several noxious stimuli, exhibiting a 50% effective concentration (EC50) of 12.6 +/- 3.2 m. A specific TRPV1 antagonist, JNJ-17203212 (0.5 m), potently inhibited imperatorin-induced TRPV1 activation. Site-directed mutagenesis studies revealed that imperatorin most likely acted via a site adjacent to or overlapping with the TRPV1 capsaicin-binding site. TRPV1 recovery from desensitization was delayed in the presence of imperatorin. Conversely, imperatorin sensitized TRPV1 to acid activation but did not affect the current amplitude and/or the activation-inactivation properties of Na(v)1.7, a channel important for transmission of nociceptive information. Thus, our data indicate that furanocoumarins represent a novel group of TRPV1 modulators that may become important lead compounds in the drug discovery process aimed at developing new treatments for pain management.	[Chen, Xingjuan; Sun, Weiyang; Gianaris, Nicholas G.; Riley, Ashley M.; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Cummins, Theodore R.; Fehrenbacher, Jill C.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Cummins, Theodore R.; Fehrenbacher, Jill C.; Obukhov, Alexander G.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Sun, Weiyang] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan 250355, Shandong, Peoples R China	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Shandong University of Traditional Chinese Medicine	Obukhov, AG (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr,MS360A, Indianapolis, IN 46202 USA.	aobukhov@iupui.edu	Obukhov, Alexander G/C-7246-2008; chen, xingjuan/V-4064-2019	Obukhov, Alexander G/0000-0002-3862-6004; chen, xingjuan/0000-0002-7380-8399	National Institutes of Health [R01HL083381, R01HL115140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083381, R01HL115140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL083381 and R01HL115140 (to A. G. O.).	[Anonymous], 2011, MED LETT DRUGS THER, V53, P42; Ban HS, 2003, PLANTA MED, V69, P408, DOI 10.1055/s-2003-39702; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Btesh J, 2013, J NEUROSCI, V33, P9184, DOI 10.1523/JNEUROSCI.4991-12.2013; Chakraborty S, 2011, J PHARMACOL EXP THER, V339, P329, DOI 10.1124/jpet.111.183673; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Farazifard R, 2005, BRAIN RES PROTOC, V16, P44, DOI 10.1016/j.brainresprot.2005.10.003; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang GJ, 2012, J AGR FOOD CHEM, V60, P1673, DOI 10.1021/jf204297e; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kumar S, 2012, J CELL PHYSIOL, V227, P1408, DOI 10.1002/jcp.22855; Liu RM, 2004, J CHROMATOGR A, V1052, P223, DOI 10.1016/j.chroma.2004.08.127; Lu H. C., 2005, CHINESE NATURAL CURE; Lu W, 2013, MED CHEM, V9, P993, DOI 10.2174/1573406411309070013; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Luszczki JJ, 2009, EPILEPSY RES, V85, P293, DOI 10.1016/j.eplepsyres.2009.03.027; Mathie A, 2010, J PHARM PHARMACOL, V62, P1089, DOI 10.1111/j.2042-7158.2010.01131.x; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Planells-Cases R, 2011, ADV EXP MED BIOL, V704, P491, DOI 10.1007/978-94-007-0265-3_27; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reilly RM, 2012, J PHARMACOL EXP THER, V342, P416, DOI 10.1124/jpet.111.190314; Rohacs Tibor, 2013, Advances in Biological Regulation, V53, P341, DOI 10.1016/j.jbior.2013.07.004; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Salat K, 2013, CURR MED CHEM, V20, P1409, DOI 10.2174/09298673113209990107; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; SZOLCSANYI J, 1975, ARZNEIMITTEL-FORSCH, V25, P1877; Wu KC, 2013, EUR J PHARMACOL, V721, P49, DOI 10.1016/j.ejphar.2013.09.056; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Zhang H, 2009, RAPID COMMUN MASS SP, V23, P2167, DOI 10.1002/rcm.4123	44	29	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9600	9610		10.1074/jbc.M113.536862	http://dx.doi.org/10.1074/jbc.M113.536862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569998	hybrid, Green Published			2022-12-25	WOS:000333807000015
J	Fraga, H; Bech-Serra, JJ; Canals, F; Ortega, G; Millet, O; Ventura, S				Fraga, Hugo; Bech-Serra, Joan-Josep; Canals, Francesc; Ortega, Gabriel; Millet, Oscar; Ventura, Salvador			The Mitochondrial Intermembrane Space Oxireductase Mia40 Funnels the Oxidative Folding Pathway of the Cytochrome c Oxidase Assembly Protein Cox19*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Disulfide; Mitochondria; Oxidation-Reduction; Protein Folding; Protein Translocation; Cox19; Mia40; Protein Oxidative Folding	DISULFIDE BOND FORMATION; SMALL TIM PROTEINS; SECONDARY STRUCTURE; RELAY SYSTEM; IMPORT; SIGNAL; BIOGENESIS; CYSTEINES; COX19	Background: Mia40 accelerates Cox19 folding through the specific recognition of the third Cys in the second CX9C motif. Results: The chaperone catalysis renders a native-like intermediate that oxidizes in a slow uncatalyzed reaction into native Cox19. Conclusion: The role of Mia40 is funnelling an already sequentially encoded, but rough, substrate folding landscape. Significance: These results provide a rationale for the substrate promiscuity of the chaperone Mia40. Mia40-catalyzed disulfide formation drives the import of many proteins into the mitochondria. Here we characterize the oxidative folding of Cox19, a twin CX9C Mia40 substrate. Cox19 oxidation is extremely slow, explaining the persistence of import-competent reduced species in the cytosol. Mia40 accelerates Cox19 folding through the specific recognition of the third Cys in the second helical CX9C motif and the subsequent oxidation of the inner disulfide bond. This renders a native-like intermediate that oxidizes in a slow uncatalyzed reaction into native Cox19. The same intermediate dominates the pathway in the absence of Mia40, and chemical induction of an -helical structure by trifluoroethanol suffices to accelerate productive folding and mimic the Mia40 folding template mechanism. The Mia40 role is to funnel a rough folding landscape, skipping the accumulation of kinetic traps, providing a rationale for the promiscuity of Mia40.	[Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Bech-Serra, Joan-Josep; Canals, Francesc] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona 08135, Spain; [Ortega, Gabriel; Millet, Oscar] CIC BioGUNE, Struct Biol Unit, Metab & Dis Program, Derio 48160, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); CIC bioGUNE	Fraga, H (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	hugofraga@gmail.com; salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Bech-Serra, Joan Josep/AAA-2330-2020; Quintanilla, Gabriel Ortega/C-7850-2018; Ventura, Salvador/AAY-3170-2021; Quintanilla, Gabriel Ortega/AAC-6618-2021; Fraga, Hugo/X-4850-2019; Millet, Oscar/F-9696-2011	Ventura, Salvador/0000-0002-9652-6351; Bech-Serra, Joan Josep/0000-0003-3486-781X; Quintanilla, Gabriel Ortega/0000-0002-7126-9096; Ventura, Salvador/0000-0002-9652-6351; Quintanilla, Gabriel Ortega/0000-0002-7126-9096; Fraga, Hugo/0000-0001-7677-4086; Millet, Oscar/0000-0001-8748-4105	Ministerio de Ciencia e Innovacion, Spain [BFU2010-14901]; Generalitat de Catalunya [2009-SGR-760]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/ 87148/2012]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Grants BFU2010-14901 (Ministerio de Ciencia e Innovacion, Spain) and 2009-SGR-760 (Generalitat de Catalunya) grants.; Supported by Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BPD/ 87148/2012). To whom correspondence may be addressed. Tel.: 34-93-5812154; Fax: 34-93-5811264; E-mail: hugofraga@gmail.com.	Arolas JL, 2006, J BIOL CHEM, V281, P22906, DOI 10.1074/jbc.M602301200; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bourens M, 2012, J BIOL CHEM, V287, P31258, DOI 10.1074/jbc.M112.383562; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chiti F, 1999, NAT STRUCT BIOL, V6, P380; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Fischer M, 2013, MOL BIOL CELL, V24, P2160, DOI 10.1091/mbc.E12-12-0862; Harrison P., 2008, PLOS COMPUT BIOL, V4; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Leary SC, 2013, MOL BIOL CELL, V24, P683, DOI 10.1091/mbc.E12-09-0705; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Riemer J, 2011, BBA-BIOMEMBRANES, V1808, P981, DOI 10.1016/j.bbamem.2010.06.003; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rigby K, 2007, J BIOL CHEM, V282, P10233, DOI 10.1074/jbc.M610082200; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062; Ventura S, 2011, PROTEIN REV, V14, P1, DOI 10.1007/978-1-4419-7273-6_1; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	32	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9852	9864		10.1074/jbc.M114.553479	http://dx.doi.org/10.1074/jbc.M114.553479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569988	hybrid, Green Published			2022-12-25	WOS:000333807000035
J	Wei, BX; Xu, XM; Jin, ZY; Tian, YQ				Wei, Benxi; Xu, Xueming; Jin, Zhengyu; Tian, Yaoqi			Surface Chemical Compositions and Dispersity of Starch Nanocrystals Formed by Sulfuric and Hydrochloric Acid Hydrolysis	PLOS ONE			English	Article							FTIR; DEGRADATION; ADSORPTION; CELLULOSE; AMYLOSE; LIPIDS; PH	Surface chemical compositions of starch nanocrystals (SNC) prepared using sulfuric acid (H2SO4) and hydrochloric acid (HCl) hydrolysis were analyzed by X-ray photoelectron spectroscopy (XPS) and FT-IR. The results showed that carboxyl groups and sulfate esters were presented in SNC after hydrolysis with H2SO4, while no sulfate esters were detected in SNC during HCl-hydrolysis. TEM results showed that, compared to H2SO4-hydrolyzed sample, a wider size distribution of SNC prepared by HCl-hydrolysis were observed. Zeta-potentials were -23.1 and -5.02 mV for H2SO4- and HCl-hydrolyzed SNC suspensions at pH 6.5, respectively. Nevertheless, the zeta-potential values decreased to -32.3 and -10.2 mV as the dispersion pH was adjusted to 10.6. After placed 48 h at pH 10.6, zeta-potential increased to -24.1 mV for H2SO4-hydrolyzed SNC, while no change was detected for HCl-hydrolyzed one. The higher zeta-potential and relative small particle distribution of SNC caused more stable suspensions compared to HCl-hydrolyzed sample.	[Wei, Benxi; Xu, Xueming; Jin, Zhengyu; Tian, Yaoqi] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Wei, Benxi; Xu, Xueming; Jin, Zhengyu; Tian, Yaoqi] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University; Jiangnan University	Jin, ZY (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	jinlab2008@yahoo.com; yqtian@jiangnan.edu.cn	Tian, Yaoqi/E-7493-2010	Tian, Yaoqi/0000-0001-5693-8872	Natural Science Foundation of China [31201288]; Natural Science Foundation of Jiangsu Province [BK2012115]; Project of State Key Laboratory of Food Science and Technology, Jiangnan University [SKLF-ZZB-201206]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Project of State Key Laboratory of Food Science and Technology, Jiangnan University	This study was financially supported by Natural Science Foundation of China (No. 31201288), Natural Science Foundation of Jiangsu Province (No. BK2012115), and the Project of State Key Laboratory of Food Science and Technology, Jiangnan University (No. SKLF-ZZB-201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angellier H, 2005, MACROMOL SYMP, V221, P95, DOI 10.1002/masy.200550310; Angellier H, 2005, LANGMUIR, V21, P2425, DOI 10.1021/la047530j; Angellier H, 2004, BIOMACROMOLECULES, V5, P1545, DOI 10.1021/bm049914u; Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X; Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j; Chen GJ, 2008, POLYMER, V49, P1860, DOI 10.1016/j.polymer.2008.02.020; COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014; Dorris G.M., 1978, CELLUL CHEM TECHNOL, V12, P9; Dufresne A, 2008, CAN J CHEM, V86, P484, DOI 10.1139/V07-152; Ibrahim M, 2005, INDIAN J PURE AP PHY, V43, P911; Kim HY, 2012, STARCH-STARKE, V64, P367, DOI 10.1002/star.201100105; Koshy KM, 1997, CARBOHYD RES, V297, P93, DOI 10.1016/S0008-6215(96)00254-6; Le Corre D, 2010, BIOMACROMOLECULES, V11, P1139, DOI 10.1021/bm901428y; Li C, 2012, STARCH-STARKE, V64, P497, DOI 10.1002/star.201100178; Lin N, 2012, NANOSCALE, V4, P3274, DOI 10.1039/c2nr30260h; Liu BJ, 2009, COLLOID SURFACE A, V339, P185, DOI 10.1016/j.colsurfa.2009.02.020; Liu DG, 2009, J COLLOID INTERF SCI, V339, P117, DOI 10.1016/j.jcis.2009.07.035; MARSH RA, 1982, STARKE, V34, P149, DOI 10.1002/star.19820340502; MEDNICK ML, 1962, J ORG CHEM, V27, P398, DOI 10.1021/jo01049a013; MILLAR GJ, 1995, J CATAL, V155, P52, DOI 10.1006/jcat.1995.1187; Mjorberg P. J., 1981, CELL CHEM TECHNOL, V15, P481; MORRISON WR, 1981, STARKE, V33, P408, DOI 10.1002/star.19810331203; MORRISON WR, 1988, J CEREAL SCI, V8, P1, DOI [10.1016/S0733-5210(88)80044-4, 10.1006/jcrs.1997.0181]; Mosier NS, 2002, BIOTECHNOL BIOENG, V79, P610, DOI 10.1002/bit.10316; Namazi H, 2010, CARBOHYD POLYM, V79, P731, DOI 10.1016/j.carbpol.2009.09.033; Putseys JA, 2010, J CEREAL SCI, V51, P238, DOI 10.1016/j.jcs.2010.01.011; Ren LL, 2012, CARBOHYD POLYM, V87, P1874, DOI 10.1016/j.carbpol.2011.08.070; Rindlav-Westling A, 2003, BIOMACROMOLECULES, V4, P166, DOI 10.1021/bm0256810; Rivero S, 2012, J AGR FOOD CHEM, V60, P492, DOI 10.1021/jf204077k; Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+; Singh V, 2008, INT J FOOD PROP, V11, P495, DOI 10.1080/10942910802083774; Singh V, 2000, CARBOHYD POLYM, V41, P191, DOI 10.1016/S0144-8617(99)00086-7; Sugama T, 1997, J MATER SCI, V32, P3995, DOI 10.1023/A:1018681203069; Yang F, 2007, J COLLOID INTERF SCI, V306, P285, DOI 10.1016/j.jcis.2006.10.062	34	41	42	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e86024	10.1371/journal.pone.0086024	http://dx.doi.org/10.1371/journal.pone.0086024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586246	gold, Green Published, Green Submitted			2022-12-25	WOS:000332390800001
J	Mercadal, L; Metzger, M; Haymann, JP; Thervet, E; Boffa, JJ; Flamant, M; Vrtovsnik, FO; Gauci, C; Froissart, M; Stengel, B				Mercadal, Lucile; Metzger, Marie; Haymann, Jean Philippe; Thervet, Eric; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, Francois; Gauci, Cedric; Froissart, Marc; Stengel, Benedicte		NephroTest Study Grp	A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; NATIONAL-HEALTH; HEPCIDIN EXPRESSION; TRANSFERRIN; DEFICIENCY; DIAGNOSIS	Background: Iron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia. Methods: We studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding capacity (TIBC<50 mu mol/L) in 1011 outpatients with non-dialysis CKD participating in the Nephrotest study. All had glomerular filtration rates measured (mGFR) by Cr-51-EDTA renal clearance; 199 also had hepcidin measures. Results: The TSAT-TIBC-ferritin index explained Hb variation better than indexes combining TSAT-TIBC or ferritin-TSAT. It showed hypotransferrinaemia and non-inflammatory functional iron deficiency (ID) to be more common than either absolute or inflammatory ID: 20%, 19%, 6%, and 2%, respectively. Hb was lower in all abnormal, compared with normal, iron profiles, and decreased more when mGFR was below 30 mL/min/1.73 m(2) (interaction p<0.0001). In patients with mGFR<30 mL/min/1.73 m(2), the Hb decreases associated with hypotransferrinaemia, non-inflammatory functional ID, and absolute ID were 0.83 +/- 0.16 g/dL, 0.51 +/- 0.18 and 0.89 +/- 0.29, respectively. Compared with normal iron profiles, hepcidin was severely depressed in absolute ID but higher in hypotransferrinaemia. Conclusions: The combined TSAT-TIBC-ferritin index identifies hypotransferrinaemia and non-inflammatory functional ID as the major mechanisms of iron disorders in CKD anaemia. Both disorders were associated with a greater decrease in Hb when mGFR was <30 mL/min/1.73 m(2). Taking these iron profiles into account may be useful in stratifying patients in clinical trials of CKD anaemia and might improve the management of iron therapy.	[Mercadal, Lucile; Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France; [Mercadal, Lucile] Hop La Pitie Salpetriere, AP HP, Dept Nephrol, Paris, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, UMRS 1018, Villejuif, France; [Haymann, Jean Philippe] Univ Paris 06, Hop Tenon, AP HP, Dept Physiol & Nephrol, Paris, France; [Haymann, Jean Philippe; Boffa, Jean-Jacques] INSERM, U702, Paris, France; [Thervet, Eric] Univ Paris 05, Hop Europeen G Pompidou, AP HP, Dept Nephrol, Paris, France; [Thervet, Eric] INSERM, UMR S775, Paris, France; [Boffa, Jean-Jacques] Univ Paris 06, Hop Tenon, AP HP, Dept Nephrol, Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Dept Physiol, F-75877 Paris, France; [Flamant, Martin; Vrtovsnik, Francois] Univ Paris Diderot, INSERM, U699, Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Dept Nephrol, F-75877 Paris, France; [Gauci, Cedric; Froissart, Marc] Univ Paris 05, Hop Europeen G Pompidou, AP HP, Dept Physiol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Mercadal, L (corresponding author), INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Kidney Dis Team, Villejuif, France.	lucile.mercadal@psl.aphp.fr	Stengel, Benedicte/G-5730-2015; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Stengel, Benedicte/0000-0001-9469-0804; Froissart, Marc/0000-0002-4010-3173; Vrtovsnik, Francois/0000-0003-1554-314X; Metzger, Marie/0000-0003-3597-5409; DAUGAS, Eric/0000-0001-7256-7979	INSERM GISIReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]; F. Hoffman-La Roche Ltd.; Amgen [20119011]	INSERM GISIReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); F. Hoffman-La Roche Ltd.; Amgen(Amgen)	The NephroTest CKD cohort study is supported by the following grants: INSERM GISIReSP AO 8113LS TGIR (BS), French Ministry of Health AOM 09114 (MF), INSERM AO 8022LS (BS), Agence de la Biomedecine R0 8156LL (BS), AURA (MF), and Roche 2009-152-447G (MF). The NephroTest initiative was also sponsored by unrestricted grants from F. Hoffman-La Roche Ltd (LM). BS benefits from an Investigator Sponsored Study from Amgen (20119011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby DR, 2009, KIDNEY INT, V75, P976, DOI 10.1038/ki.2009.21; Bartnikas TB, 2011, BLOOD, V117, P630, DOI 10.1182/blood-2010-05-287359; BEGUIN Y, 1993, BLOOD, V81, P1067; Bermejo F, 2009, WORLD J GASTROENTERO, V15, P4638, DOI 10.3748/wjg.15.4638; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fernandez-Rodriguez AM, 1999, AM J KIDNEY DIS, V34, P508, DOI 10.1016/S0272-6386(99)70079-X; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Fraenkel PG, 2009, BLOOD, V113, P2843, DOI 10.1182/blood-2008-06-165340; GOYA N, 1972, BLOOD-J HEMATOL, V40, P239, DOI 10.1182/blood.V40.2.239.239; Herzog CA, 2004, J CARD FAIL, V10, P467, DOI 10.1016/j.cardfail.2004.03.003; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; HUGGENVIK JI, 1989, BLOOD, V74, P482; Kalantar-Zadeh K, 1998, AM J KIDNEY DIS, V31, P263, DOI 10.1053/ajkd.1998.v31.pm9469497; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Lipschitz D A, 1992, Nutrition, V8, P443; McFarlane SI, 2008, AM J KIDNEY DIS, V51, pS46, DOI 10.1053/j.ajkd.2007.12.019; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Prinsen BHCMT, 2001, J AM SOC NEPHROL, V12, P1017, DOI 10.1681/ASN.V1251017; Rawat R, 2009, EUR J CLIN NUTR, V63, P787, DOI 10.1038/ejcn.2008.33; Sawhney MS, 2007, AM J GASTROENTEROL, V102, P82, DOI 10.1111/j.1572-0241.2006.00908.x; Stancu S, 2010, AM J KIDNEY DIS, V55, P639, DOI 10.1053/j.ajkd.2009.10.043; Trombini P, 2007, HAEMATOLOGICA, V92, P1407, DOI 10.3324/haematol.11377; WITTE DL, 1991, CLIN CHEM, V37, P484; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	26	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e84144	10.1371/journal.pone.0084144	http://dx.doi.org/10.1371/journal.pone.0084144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586229	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900002
J	Daly, B; Long, WC				Daly, Benjamin; Long, W. Christopher			Inter-Cohort Cannibalism of Early Benthic Phase Blue King Crabs (Paralithodes platypus): Alternate Foraging Strategies in Different Habitats Lead to Different Functional Responses	PLOS ONE			English	Article							DENSITY-DEPENDENT PREDATION; BODY-SIZE; CAMTSCHATICUS TILESIUS; CANCER-MAGISTER; CHESAPEAKE-BAY; DUNGENESS CRAB; RED; PREY; TEMPERATURE; SURVIVAL	Blue king crabs (Paralithodes platypus) are commercially and ecologically important in Alaska, USA, but population abundances have fluctuated over the past several decades likely resulting from a combination of environmental and biological factors, including recruitment variability. Cannibalism between cohorts may be a source of mortality limiting recruitment success in the wild, but the degree of inter-cohort cannibalism is unknown for early benthic phase blue king crabs. In laboratory experiments, we evaluated the effects of habitat type (sand and shell) on the predator functional response and foraging behavior of year-1 blue king crabs as predators of year-0 conspecifics and examined the effects of predator presence on crypsis of prey crabs. In sand, consumption rates increased with predator size and prey density until satiation, while predation rates in shell were low regardless of predator size or prey density. These differential predation rates yielded a type III functional response in sand but a type I functional response in shell habitat. Crypsis of prey crabs was generally high and did not change in the presence of predators. Predator foraging activity was reduced in shell and may be an adaptive behavior to balance foraging efficiency and susceptibility to larger predators. Our results demonstrate that early benthic phase blue king crabs are cannibalistic between cohorts in the laboratory and that shell material is extremely effective for reducing encounter rates with conspecific predators. The distribution and abundance of such habitat may be important for recruitment success in some populations. Future studies should compare benthic habitat and species assemblages in areas with variable abundances, such as the Pribilof Islands and Saint Matthew Island in the eastern Bering Sea, to better understand possible mechanisms for recruitment variability.	[Daly, Benjamin; Long, W. Christopher] NOAA, Kodiak Lab, Resource Assessment & Conservat Engn Div, Alaska Fisheries Sci Ctr,Natl Marine Fisheries Se, Kodiak, AK USA	National Oceanic Atmospheric Admin (NOAA) - USA	Daly, B (corresponding author), NOAA, Kodiak Lab, Resource Assessment & Conservat Engn Div, Alaska Fisheries Sci Ctr,Natl Marine Fisheries Se, Kodiak, AK USA.	ben.daly@noaa.gov	Long, William C/C-7074-2009	Long, William C/0000-0002-7095-1245	NOAA, National Marine Fisheries Service	NOAA, National Marine Fisheries Service(National Oceanic Atmospheric Admin (NOAA) - USA)	Funding was supplied by NOAA, National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2013, J EXP MAR BIOL ECOL, V439, P92, DOI 10.1016/j.jembe.2012.10.006; Alexander ME, 2012, MAR ECOL PROG SER, V468, P191, DOI 10.3354/meps09978; Andresen H, 2010, J EXP MAR BIOL ECOL, V390, P31, DOI 10.1016/j.jembe.2010.04.027; Armstrong D.A., 1985, EARLY LIFE HIST JUVE, P211; Armstrong D.A., 1987, DISTRIBUTION ABUNDAN; Bolker B, 2008, ECOLOGICAL MODELS DA; Borisov RR, 2007, RUSS J MAR BIOL +, V33, P227, DOI 10.1134/S1063074007040049; BOTSFORD LW, 1978, J FISH RES BOARD CAN, V35, P833, DOI 10.1139/f78-134; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chuchukalo VI, 2011, RUSS J MAR BIOL+, V37, P558, DOI 10.1134/S1063074011070029; Daly B, 2013, 2013 E BER IN PRESS; Daly B, 2014, J EXP MAR BIOL ECOL, V451, P98, DOI 10.1016/j.jembe.2013.11.011; Daly B, 2013, AQUACULTURE, V416, P196, DOI 10.1016/j.aquaculture.2013.09.024; Daly B, 2012, AQUACULTURE, V364, P206, DOI 10.1016/j.aquaculture.2012.08.034; Daly B, 2012, J EXP MAR BIOL ECOL, V429, P47, DOI 10.1016/j.jembe.2012.06.010; Daly B, 2009, AQUACULTURE, V293, P68, DOI 10.1016/j.aquaculture.2009.04.010; DEW CB, 1990, CAN J FISH AQUAT SCI, V47, P1944, DOI 10.1139/f90-219; Dittel AI, 1995, B MAR SCI, V57, P902; Downes S, 2001, ECOLOGY, V82, P2870, DOI 10.2307/2679967; FERNANDEZ M, 1993, CAN J FISH AQUAT SCI, V50, P2100, DOI 10.1139/f93-234; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; HASSELL MP, 1977, J ANIM ECOL, V46, P249, DOI 10.2307/3959; Heck KL, 2001, MAR ECOL PROG SER, V222, P163, DOI 10.3354/meps222163; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; Hines AH, 2009, MAR ECOL PROG SER, V385, P127, DOI 10.3354/meps08055; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Januario SM, 2013, J EXP MAR BIOL ECOL, V446, P36, DOI 10.1016/j.jembe.2013.04.017; Kolts JM, 2013, MAR ECOL PROG SER, V483, P209, DOI 10.3354/meps10292; KURIHARA Y, 1987, MAR ECOL PROG SER, V41, P123, DOI 10.3354/meps041123; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; Long WC, 2012, J EXP MAR BIOL ECOL, V422, P101, DOI 10.1016/j.jembe.2012.04.019; Long WC, 2012, MAR ECOL PROG SER, V456, P139, DOI 10.3354/meps09702; Long WC, 2013, J EXP MAR BIOL ECOL, V449, P142, DOI 10.1016/j.jembe.2013.09.004; Long WC, 2012, J EXP MAR BIOL ECOL, V413, P50, DOI 10.1016/j.jembe.2011.11.015; Lovrich GA, 1997, J EXP MAR BIOL ECOL, V211, P225, DOI 10.1016/S0022-0981(96)02715-3; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MANSOUR RA, 1991, MAR ECOL PROG SER, V72, P239, DOI 10.3354/meps072239; Marshall S, 2005, APPL ANIM BEHAV SCI, V90, P65, DOI 10.1016/j.applanim.2004.07.007; Moksnes PO, 1997, J EXP MAR BIOL ECOL, V215, P157, DOI 10.1016/S0022-0981(97)00052-X; Morse DH, 2006, BEHAV ECOL, V17, P405, DOI 10.1093/beheco/arj053; NPFMC (North Pacific Fishery Management Council), 2011, STOCK ASS FISH EV RE; Palacios R, 1985, COMMUNITY ANAL APPL, P193; Pirtle JL, 2012, MAR ECOL PROG SER, V465, P169, DOI 10.3354/meps09883; Pirtle JL, 2010, J EXP MAR BIOL ECOL, V393, P130, DOI 10.1016/j.jembe.2010.07.012; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Seitz RD, 2001, ECOLOGY, V82, P2435, DOI 10.1890/0012-9658(2001)082[2435:DDPHVA]2.0.CO;2; Shafir S, 1988, BEHAV ECOLOGY, V9, P74; SIH A, 1982, ECOLOGY, V63, P786, DOI 10.2307/1936799; Stevens BG, 2005, J EXP MAR BIOL ECOL, V321, P1, DOI 10.1016/j.jembe.2004.12.026; Stevens BG, 2008, AQUAC RES, V39, P390, DOI 10.1111/j.1365-2109.2007.01798.x; Stoner AW, 2013, J EXP MAR BIOL ECOL, V442, P10, DOI 10.1016/j.jembe.2013.02.002; Stoner AW, 2010, J SHELLFISH RES, V29, P1005, DOI 10.2983/035.029.0401; Sullivan ME, 2008, DEEP-SEA RES PT II, V55, P1729, DOI 10.1016/j.dsr2.2008.03.004; Swiney KM, 2013, AQUAC RES, V44, P1007, DOI 10.1111/j.1365-2109.2012.03105.x; Swingle JS, 2013, AQUACULTURE, V384, P13, DOI 10.1016/j.aquaculture.2012.12.015; Tapella F, 2009, J EXP MAR BIOL ECOL, V372, P31, DOI 10.1016/j.jembe.2009.02.003; Tschanz B, 2007, ECOLOGY, V88, P1300, DOI 10.1890/06-1512; WAHLE RA, 1992, OIKOS, V65, P52, DOI 10.2307/3544887	59	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88694	10.1371/journal.pone.0088694	http://dx.doi.org/10.1371/journal.pone.0088694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558414	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700060
J	Feng, YL; Huang, W; Wani, M; Yu, XY; Ashraf, M				Feng, Yuliang; Huang, Wei; Wani, Mashhood; Yu, Xiyong; Ashraf, Muhammad			Ischemic Preconditioning Potentiates the Protective Effect of Stem Cells through Secretion of Exosomes by Targeting Mecp2 via miR-22	PLOS ONE			English	Article							INFARCTED HEART; SURVIVAL; TRANSPLANTATION; EXPRESSION; REPAIR	Mesenchymal stem cells (MSCs) have potential application for the treatment of ischemic heart diseases. Besides differentiation properties, MSCs protect ischemic cardiomyocytes by secretion of paracrine factors. In this study, we found exosomes enriched with miR-22 were secreted by MSCs following ischemic preconditioning (Exo(IPC)) and mobilized to cardiomyocytes where they reduced their apoptosis due to ischemia. Interestingly, by time-lapse imaging, we for the first time captured the dynamic shedding of miR-22 loaded exosomes from cytosol to extracellular space. Furthermore, the antiapoptotic effect of miR-22 was mediated by direct targeting of methyl CpG binding protein 2 (Mecp2). In vivo data showed that delivery of Exo(IPC) significantly reduced cardiac fibrosis. Our data identified a significant benefit of Exo(IPC) for the treatment of cardiac diseases by targeting Mecp2 via miR-22.	[Feng, Yuliang; Yu, Xiyong] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Med Res Ctr,Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Feng, Yuliang; Huang, Wei; Wani, Mashhood; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University System of Ohio; University of Cincinnati	Yu, XY (corresponding author), Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Cardiovasc Inst, Med Res Ctr,Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China.	yuxycn@hotmail.com; ashrafm251@gmail.com	Ashraf, Muhammad/ABB-3463-2021; HUANG, WEI/A-4639-2013	Huang, Wei/0000-0003-3046-4220	National Institutes of Health [R37-HL-074272, HL-095375, HL-087246]; National Natural Science Foundation of China [81120108003]; National Key Basic Research Program of China [2012CB526602]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095375, R01HL087246, R37HL074272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R37-HL-074272, HL-095375, HL-087246 (to M. Ashraf) and National Natural Science Foundation of China (No. 81120108003), National Key Basic Research Program of China (No. 2012CB526602) (to X.Y. Yu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra M, 2010, HUM MOL GENET, V19, P2177, DOI 10.1093/hmg/ddq096; Buccini S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0301-5; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Katare R, 2011, CIRC RES, V109, P894, DOI 10.1161/CIRCRESAHA.111.251546; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596	19	299	332	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88685	10.1371/journal.pone.0088685	http://dx.doi.org/10.1371/journal.pone.0088685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558412	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700058
J	Kuwabara, T; Mori, K; Kasahara, M; Yokoi, H; Imamaki, H; Ishii, A; Koga, K; Sugawara, A; Yasuno, S; Ueshima, K; Morikawa, T; Konishi, Y; Imanishi, M; Nishiyama, A; Nakao, K; Mukoyama, M				Kuwabara, Takashige; Mori, Kiyoshi; Kasahara, Masato; Yokoi, Hideki; Imamaki, Hirotaka; Ishii, Akira; Koga, Kenichi; Sugawara, Akira; Yasuno, Shinji; Ueshima, Kenji; Morikawa, Takashi; Konishi, Yoshio; Imanishi, Masahito; Nishiyama, Akira; Nakao, Kazuwa; Mukoyama, Masashi			Predictive Significance of Kidney Myeloid-Related Protein 8 Expression in Patients with Obesity- or Type 2 Diabetes-Associated Kidney Diseases	PLOS ONE			English	Article							IGA NEPHROPATHY; BLOOD-PRESSURE; MACROPHAGES; MICE; ANGIOTENSINOGEN; HYPERGLYCEMIA; CALPROTECTIN; PROGRESSION; PODOCYTES; CHILDREN	Background and Objective: We have reported that toll-like receptor 4 (TLR4) and one of its endogenous ligands, myeloid-related protein 8 (MRP8 or S100A8), play an important role in the progression of diabetic nephropathy in mice. The aim of this study was to evaluate significance of kidney MRP8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases. Methods: In diabetic, obese or control subjects, MRP8 mRNA and protein expression levels in renal biopsy samples were determined by real-time RT-PCR and immunohistochemistry (n = 28 and 65, respectively), and their associations with baseline and prognostic parameters were analyzed. Effects of MRP8 upon pro-inflammatory gene expressions were examined using macrophages. Results: Kidney MRP8 gene and protein expression levels were elevated in obese or diabetic groups compared to control group. Among all subjects, by univariate linear regression analysis, glomerular MRP8-positive cell count and tubulointerstitial MRP8-positive area at baseline were both, respectively, correlated not only with various known risk factors for diabetic nephropathy (such as systolic blood pressure, proteinuria and serum creatinine) but also with extent of glomerulosclerosis and tubulointerstitial fibrosis. Independent factors predicting urinary protein levels a year later were examined by multivariate analysis, and they included glomerular MRP8-positive cell count (beta = 0.59, P < 0.001), proteinuria (beta = 0.37, P = 0.002) and systolic blood pressure (beta = 0.21, P = 0.04) at baseline, after adjustment for known risk factors. MRP8 protein expression was observed in CD68-positive macrophages and atrophic tubules. In cultured mouse macrophages, MRP8 protein induced proinflammatory cytokine expressions and also triggered auto-induction of MRP8 in a TLR4-dependent manner. Conclusions: Glomerular MRP8 expression appears to be associated with progression of proteinuria in obese or type 2 diabetic patients, possibly by inducing inflammatory changes in macrophages through TLR4 signaling.	[Kuwabara, Takashige; Mori, Kiyoshi; Kasahara, Masato; Yokoi, Hideki; Imamaki, Hirotaka; Ishii, Akira; Koga, Kenichi; Nakao, Kazuwa; Mukoyama, Masashi] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Mori, Kiyoshi; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Kasahara, Masato; Yasuno, Shinji; Ueshima, Kenji] Kyoto Univ Hosp, Dept EBM Res, Inst Adv Clin & Translat Sci, Kyoto 606, Japan; [Sugawara, Akira] Osaka Red Cross Hosp, Dept Nephrol, Osaka, Japan; [Morikawa, Takashi; Konishi, Yoshio; Imanishi, Masahito] Osaka City Gen Hosp, Div Nephrol & Hypertens, Osaka, Japan; [Nishiyama, Akira] Kagawa Univ, Sch Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan	Kyoto University; Kyoto University; Kyoto University; Osaka Red Cross Hospital; Osaka City General Hospital; Kagawa University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan.	keyem@kuhp.kyoto-u.ac.jp	Yokoi, Hideki/AAV-9038-2021; Yokoi, Hideki/R-1289-2016; Mori, Kiyoshi/N-1267-2014	Yokoi, Hideki/0000-0001-8343-9737; Yokoi, Hideki/0000-0001-8343-9737; Mori, Kiyoshi/0000-0002-7285-8351; Kuwabara, Takashige/0000-0003-3507-4328; Nishiyama, Akira/0000-0001-5971-820X	Ministry of Health, Labour and Welfare of Japan; Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Foundation for Applied Enzymology; Smoking Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Smoking Research Foundation	This work was supported in part by Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan (to KM), research grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to TK, KM, and MM), from the Japan Foundation for Applied Enzymology (to TK) and from the Smoking Research Foundation (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jin Y, 2013, DIABETES CARE; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kawasaki Y, 2005, AM J KIDNEY DIS, V45, P510, DOI 10.1053/j.ajkd.2004.11.019; Kawasaki Y, 2009, TOHOKU J EXP MED, V218, P49, DOI 10.1620/tjem.218.49; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Mortensen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007419; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nishiyama A, 2011, NEPHROL DIAL TRANSPL, V26, P170, DOI 10.1093/ndt/gfq371; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Pepper RJ, 2013, KIDNEY INT, V83, P1150, DOI 10.1038/ki.2013.2; Praga M, 2006, CURR OPIN NEPHROL HY, V15, P481, DOI 10.1097/01.mnh.0000242172.06459.7c; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Ruggenenti P, 1998, J AM SOC NEPHROL, V9, P2157; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; TAFT JL, 1994, DIABETES, V43, P1046, DOI 10.2337/diabetes.43.8.1046; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88942	10.1371/journal.pone.0088942	http://dx.doi.org/10.1371/journal.pone.0088942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558454	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700100
J	Liu, BY; Campo, EM; Bossing, T				Liu, Boyin; Campo, Eva M.; Bossing, Torsten			Drosophila Embryos as Model to Assess Cellular and Developmental Toxicity of Multi-Walled Carbon Nanotubes (MWCNT) in Living Organisms	PLOS ONE			English	Article							NERVOUS-SYSTEM LINEAGES; GENE-EXPRESSION; NANOMATERIALS; CYTOTOXICITY; MELANOGASTER; MECHANISMS; FATE	Different toxicity tests for carbon nanotubes (CNT) have been developed to assess their impact on human health and on aquatic and terrestrial animal and plant life. We present a new model, the fruit fly Drosophila embryo offering the opportunity for rapid, inexpensive and detailed analysis of CNTs toxicity during embryonic development. We show that injected Dil labelled multi-walled carbon nanotubes (MWCNTs) become incorporated into cells in early Drosophila embryos, allowing the study of the consequences of cellular uptake of CNTs on cell communication, tissue and organ formation in living embryos. Fluorescently labelled subcellular structures showed that MWCNTs remained cytoplasmic and were excluded from the nucleus. Analysis of developing ectodermal and neural stem cells in MWCNTs injected embryos revealed normal division patterns and differentiation capacity. However, an increase in cell death of ectodermal but not of neural stem cells was observed, indicating stem cell-specific vulnerability to MWCNT exposure. The ease of CNT embryo injections, the possibility of detailed morphological and genomic analysis and the low costs make Drosophila embryos a system of choice to assess potential developmental and cellular effects of CNTs and test their use in future CNT based new therapies including drug delivery.	[Liu, Boyin; Bossing, Torsten] Univ Bangor, Sch Biol Sci, Bangor, Gwynedd, Wales; [Campo, Eva M.] Univ Bangor, Sch Elect Engn, Bangor, Gwynedd, Wales	Bangor University; Bangor University	Bossing, T (corresponding author), Univ Plymouth, Sch Biomed & Healthcare Related Sci, Plymouth PL4 8AA, Devon, England.	torsten.bossing@plymouth.ac.uk	Campo, Eva/GQP-2694-2022; Liu, Boyin/HHS-3981-2022	Bossing, Torsten/0000-0002-3277-9130	Royal Society	Royal Society(Royal Society of London)	Royal Society Research Grant awarded to Torsten Bossing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Bashaw GJ, 2010, COLD SPRING HARB PRO; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CAMPOSORTEGA JA, 1995, MOL NEUROBIOL, V10, P75, DOI 10.1007/BF02740668; Chen PH, 2013, BIOMATERIALS, V34, P5661, DOI 10.1016/j.biomaterials.2013.03.093; Cheng JP, 2012, INT J NANOMED, V7, P3731, DOI 10.2147/IJN.S30459; Cheng JP, 2009, TOXICOL APPL PHARM, V235, P216, DOI 10.1016/j.taap.2008.12.006; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; da Rocha AM, 2013, COMP BIOCHEM PHYS A, V165, P460, DOI 10.1016/j.cbpa.2013.03.025; De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453; Dresselhaus MS, 2004, PHILOS T R SOC A, V362, P2065, DOI 10.1098/rsta.2004.1430; Frenz LM, 1996, J CELL SCI, V109, P2649; Furrer MP, 2004, NEUROSIGNALS, V13, P37, DOI 10.1159/000076157; Galloway T, 2010, ENVIRON POLLUT, V158, P1748, DOI 10.1016/j.envpol.2009.11.013; Gilbert S.F., 2010, DEV BIOL; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Hacker U, 1997, DEVELOPMENT, V124, P3565; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; Juillerat-Jeanneret L, 2013, NANOTOXICOLOGY; Kasai Y, 2012, PER MED, V7, P621; Kounatidis I, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120075; Lanone S, 2013, ADV DRUG DELIV REV; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Liu Y, 2012, ACC CHEM RES; Manning L, 2012, CELL REP, V2, P1002, DOI 10.1016/j.celrep.2012.09.009; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Philbrook NA, 2011, REPROD TOXICOL, V32, P442, DOI 10.1016/j.reprotox.2011.09.002; Prakash R, 2003, APPL PHYS LETT, V83, P1219, DOI 10.1063/1.1599042; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; TECHNAU GM, 1987, DEVELOPMENT, V100, P1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thorley AJ, 2013, PHARM THER; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	49	22	22	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88681	10.1371/journal.pone.0088681	http://dx.doi.org/10.1371/journal.pone.0088681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558411	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700057
J	Proietti, MC; Reisser, J; Marins, LF; Rodriguez-Zarate, C; Marcovaldi, MA; Monteiro, DS; Pattiaratchi, C; Secchi, ER				Proietti, Maira C.; Reisser, Julia; Marins, Luis Fernando; Rodriguez-Zarate, Clara; Marcovaldi, Maria A.; Monteiro, Danielle S.; Pattiaratchi, Charitha; Secchi, Eduardo R.			Genetic Structure and Natal Origins of Immature Hawksbill Turtles (Eretmochelys imbricata) in Brazilian Waters	PLOS ONE			English	Article							SEA-TURTLES; MARINE TURTLES; POPULATION-STRUCTURE; CHELONIA-MYDAS; MIGRATORY BEHAVIOR; MIXED STOCKS; WEST-INDIES; ATLANTIC; DISPERSAL; INCREASE	Understanding the connections between sea turtle populations is fundamental for their effective conservation. Brazil hosts important hawksbill feeding areas, but few studies have focused on how they connect with nesting populations in the Atlantic. Here, we (1) characterized mitochondrial DNA control region haplotypes of immature hawksbills feeding along the coast of Brazil (five areas ranging from equatorial to temperate latitudes, 157 skin samples), (2) analyzed genetic structure among Atlantic hawksbill feeding populations, and (3) inferred natal origins of hawksbills in Brazilian waters using genetic, oceanographic, and population size information. We report ten haplotypes for the sampled Brazilian sites, most of which were previously observed at other Atlantic feeding grounds and rookeries. Genetic profiles of Brazilian feeding areas were significantly different from those in other regions (Caribbean and Africa), and a significant structure was observed between Brazilian feeding grounds grouped into areas influenced by the South Equatorial/North Brazil Current and those influenced by the Brazil Current. Our genetic analysis estimates that the studied Brazilian feeding aggregations are mostly composed of animals originating from the domestic rookeries Bahia and Pipa, but some contributions from African and Caribbean rookeries were also observed. Oceanographic data corroborated the local origins, but showed higher connection with West Africa and none with the Caribbean. High correlation was observed between origins estimated through genetics/rookery size and oceanographic/rookery size data, demonstrating that ocean currents and population sizes influence haplotype distribution of Brazil's hawksbill populations. The information presented here highlights the importance of national conservation strategies and international cooperation for the recovery of endangered hawksbill turtle populations.	[Proietti, Maira C.; Monteiro, Danielle S.; Secchi, Eduardo R.] Univ Fed Rio Grande, Inst Oceanog, Rio Grande, RS, Brazil; [Reisser, Julia; Pattiaratchi, Charitha] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Reisser, Julia; Pattiaratchi, Charitha] Univ Western Australia, Sch Civil Environm & Min Engn, Perth, WA 6009, Australia; [Reisser, Julia] CSIRO, Wealth Oceans Flagship, Floreat, WA, Australia; [Marins, Luis Fernando] Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande, RS, Brazil; [Rodriguez-Zarate, Clara] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Marcovaldi, Maria A.] Fundacao Pro Tamar, Praia Do Forte, BA, Brazil; [Monteiro, Danielle S.] Nucleo Educ & Monitoramento Ambiental, Rio Grande, RS, Brazil	Universidade Federal do Rio Grande; University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Federal do Rio Grande; Flinders University South Australia	Proietti, MC (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Rio Grande, RS, Brazil.	mairaproietti@gmail.com	Marins, Luis Fernando/L-1333-2014; Pattiaratchi, Charitha/E-6916-2011; Secchi, Eduardo R./ABF-1191-2020; Secchi, Eduardo/D-5038-2013; Reisser, Julia/K-2065-2013	Pattiaratchi, Charitha/0000-0003-2229-6183; Secchi, Eduardo R./0000-0001-9087-9909; Secchi, Eduardo/0000-0001-9087-9909; Proietti, Maira/0000-0002-5504-5770; Reisser, Julia/0000-0002-1785-1042; Marins, Luis/0000-0002-7219-5295	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Rufford Foundation [8110-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rufford Foundation	Scholorship and travel funds were provided to MCP by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/. Fieldwork and analyses were funded by The Rufford Foundation, http://www.rufford.org/, Grant #8110-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois FA, 2006, P 26 ANN S SEA TURTL, P179; Allen CD, 2013, MAR ECOL PROG SER, V472, P275, DOI 10.3354/meps10023; Amorocho DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031486; Avise JC, 2007, CONSERV GENET, P295; Balazs G, 1999, MARINE TURTLE SPECIA, V4, P101; Bass AL, 1996, MOL ECOL, V5, P321; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bellini C., 1996, MAR TURT NEWSL, V74, P12; Bellini Claudio, 2000, Marine Turtle Newsletter, V87, P11; Bjorndal KA, 2010, MAR BIOL, V157, P135, DOI 10.1007/s00227-009-1304-0; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Blumenthal JM, 2009, CHELONIAN CONSERV BI, V8, P1, DOI 10.2744/CCB-0758.1; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 2003, CRC MAR BIOL SER, P243; Bolten Alan B., 1999, P110; BOULON RH, 1994, COPEIA, P811; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2007, MOL ECOL, V16, P3514, DOI 10.1111/j.1365-294X.2007.03431.x; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen BW, 1996, ECOL APPL, V6, P566, DOI 10.2307/2269392; Browne DC, 2010, CONSERV GENET, V11, P1541, DOI 10.1007/s10592-009-9883-3; Carreras C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066037; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz-Fernandez Rogelio, 1999, Chelonian Conservation and Biology, V3, P296; Diez CE, 2011, MONA MONITO ISLAND; Ehrhart Llewellyn M., 1999, P61; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Gallo B, 2000, P 18 INT SEA TURTL S, P150; Garduno-Andrade M, 2000, DINAMICA POBLACION T; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Godfrey MH, 2007, MOL ECOL, V16, P3511, DOI 10.1111/j.1365-294X.2007.03356.x; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Grossman A, 2007, MAR TURT NEWSL, V116, P2; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M, 2011, ECOL MODEL, V222, P1515, DOI 10.1016/j.ecolmodel.2011.02.003; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Hillis David M., 1996, P321; IUCN, 2022, IUCN RED LIST THREAT; Kamel SJ, 2009, J HERPETOL, V43, P367, DOI 10.1670/07-231R2.1; Lara-Ruiz P, 2006, CONSERV GENET, V7, P773, DOI 10.1007/s10592-005-9102-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leon Yolanda M., 1999, Chelonian Conservation and Biology, V3, P230; Leroux RA, 2012, J HERED, V103, P806, DOI 10.1093/jhered/ess055; Lima Eduardo H. S. M., 2008, Marine Turtle Newsletter, P14; Lopez-Castro MC, 2013, MAR ECOL PROG SER, V490, P233, DOI 10.3354/meps10433; Lumpkin R, 2007, LAGRANGIAN ANALYSIS AND PREDICTION OF COASTAL AND OCEAN DYNAMICS, P39, DOI 10.1017/CBO9780511535901.003; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Marcovaldi MA, 1999, BIOL CONSERV, V91, P35, DOI 10.1016/S0006-3207(99)00043-9; Marcovaldi MA, 2007, CHELONIAN CONSERV BI, V6, P223, DOI 10.2744/1071-8443(2007)6[223:FYOHST]2.0.CO;2; Marcovaldi Maria Angela, 2006, Marine Turtle Newsletter, P4; Meylan PA, 2011, B AM MUSEUM NAT HIST, V357; Moncada FG, 2012, BIOL CONSERV, V148, P191, DOI 10.1016/j.biocon.2012.01.011; Monzon-Arguello C, 2011, J EXP MAR BIOL ECOL, V407, P345, DOI 10.1016/j.jembe.2011.07.017; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Monzon-Arguello C, 2010, J EXP MAR BIOL ECOL, V387, P9, DOI 10.1016/j.jembe.2010.03.004; Mortimer JA, 2008, HAWKSBILL TURTLE ERE, DOI [10.2307/1564433, DOI 10.2307/1564433]; Mortimer JA, 2007, MOL ECOL, V16, P17, DOI 10.1111/j.1365-294X.2006.03252.x; Musick JA, 1996, BIOL SEA TURTLES, V1, P137; Naro-Maciel E, 2007, J HERED, V98, P29, DOI 10.1093/jhered/esl050; Oksanen AJ, 2013, VEGAN COMMUNITY ECOL; Pella J, 2001, FISH B-NOAA, V99, P151; Proietti M, 2013, FIGSHARE; Proietti M, 2013, HAWKSBILL 10 LOGGERH; Proietti MC, 2012, MAR ECOL PROG SER, V447, P195, DOI 10.3354/meps09477; Proietti Maira Carneiro, 2012, Marine Turtle Newsletter, P4; Putman NF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1468; R Core Team, 2021, R LANG ENV STAT COMP; Revuelta O, 2012, ORYX, V46, P348, DOI 10.1017/S0030605311001529; Richardson JI, 2006, ANIM CONSERV, V9, P302, DOI 10.1111/j.1469-1795.2006.00036.x; Richardson PB, 2009, CHELONIAN CONSERV BI, V8, P192, DOI 10.2744/CCB-0871.1; Santos AJB, 2013, ENDANGER SPECIES RES, V21, P25, DOI 10.3354/esr00505; Schuyler Q, 2014, CONSERV BIOL, V28, P129, DOI 10.1111/cobi.12126; Scott R, 2012, MAR BIOL, V159, P481, DOI 10.1007/s00227-011-1825-1; Shamblin BM, 2012, MAR ECOL PROG SER, V469, P145, DOI 10.3354/meps09980; Troeng S, 2005, ECOGRAPHY, V28, P394, DOI 10.1111/j.0906-7590.2005.04110.x; van Dam RP, 1998, J EXP MAR BIOL ECOL, V220, P15, DOI 10.1016/S0022-0981(97)00080-4; Vaske Jr T, 2006, PESCA ARQUIPELAGO SA, P152; Velez-Zuazo X, 2008, MOL ECOL, V17, P839, DOI 10.1111/j.1365-294X.2007.03635.x; Vilaca ST, 2013, J EXP MAR BIOL ECOL, V446, P334, DOI 10.1016/j.jembe.2013.06.004; Wood LD, 2013, HERPETOL CONSERV BIO, V8, P258; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	83	24	24	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88746	10.1371/journal.pone.0088746	http://dx.doi.org/10.1371/journal.pone.0088746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558419	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700065
J	Sharif, S; Abbasi, BH; Khurshid, A; Alam, MM; Shaukat, S; Angez, M; Rana, MS; Zaidi, SSZ				Sharif, Salmaan; Abbasi, Bilal Haider; Khurshid, Adnan; Alam, Muhammad Masroor; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Zaidi, Syed Sohail Zahoor			Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses in Nad Ali District of Southern Afghanistan during June 2009-February 2011	PLOS ONE			English	Article							MOLECULAR EVOLUTION; WILD POLIOVIRUS; OUTBREAK; ERADICATION; STRAINS	Oral polio vaccine has been used successfully as a powerful tool to control the spread of wild polioviruses throughout the world; however, during replication in under immunized children, some vaccine viruses revert and acquire the neurovirulent phenotypic properties. In this study, we describe the evolution and circulation of Vaccine-Derived Polioviruses (VDPVs) in Helmand province of Afghanistan. We investigated 2646 AFP cases of Afghan children from June 2009-February 2011 and isolated 103 (04%) vaccine viruses, 45(1.7%) wild type polioviruses and six (0.22%) type 2 circulating vaccine-derived polioviruses (cVDPVs). These cVDPVs showed 97.7%-98.2% nucleotide and 98%-98.7% amino acid homology in VP1 region on comparison with Sabin type 2 reference strain. All these cVDPVs had two signature mutations of neurovirulent phenotypes and 12 additional mutations in P1 capsid region that might also have contributed to increase neurovirulence and replication. Phylogenetic analysis revealed that all these viruses were closely related and originated from previously reported Sabin like 2 virus from Pakistan which did not conform to the standard definition of VDPVs at that time. It was also observed that initial OPV dose was administered approximately 9 months prior to the collection of first stool specimen of index case. Our findings support that suboptimal surveillance and low routine immunization coverage have contributed to the emergence and spread of these viruses in Afghanistan. We therefore recommend high quality immunization campaigns not only in affected district Nad Ali but also in the bordering areas between Pakistan and Afghanistan to prevent the spread of cVDPVs.	[Sharif, Salmaan; Khurshid, Adnan; Alam, Muhammad Masroor; Shaukat, Shahzad; Angez, Mehar; Rana, Muhammad Suleman; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Sharif, Salmaan; Abbasi, Bilal Haider] Quaid i Azam Univ, Dept Biotechnol, Islamabad, Pakistan	Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Angez, Mehar/J-3792-2015; Zaidi, Syed Sohail Zahoor/F-7432-2015; Shaukat, Shahzad/HHZ-1088-2022; Rana, Dr. Muhammad Suleman/HCH-1540-2022; Abbasi, Bilal Haider/J-1810-2019	Abbasi, Bilal Haider/0000-0002-6529-2134				Afghanistan W, 2011, REP VACC DER POL VIR; Agol VI, 2006, CURR TOP MICROBIOL, V299, P211; Alexander JP, 2009, J INFECT DIS, V199, P391, DOI 10.1086/596052; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P996; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1093; [Anonymous], 2000, WKLY EPIDEMIOL REC, V77, P133; [Anonymous], MMWR MORB MORTAL WKL, V55, P1093; Avellon A, 2008, EMERG INFECT DIS, V14, P1807, DOI 10.3201/eid1411.080517; Bellmunt A, 1999, VIROLOGY, V265, P178, DOI 10.1006/viro.1999.0003; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P846; DOMINGO E, 1985, GENE, V40, P1, DOI 10.1016/0378-1119(85)90017-4; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Friedrich F, 2000, ACTA VIROL, V44, P109; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; Guillot S, 2000, J VIROL, V74, P8434, DOI 10.1128/JVI.74.18.8434-8443.2000; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis I, 2005, J GEN VIROL, V86, P3137, DOI 10.1099/vir.0.80823-0; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KEW OM, 1984, REV INFECT DIS, V6, pS499; Kilpatrick DR, 2005, J VIROL, V79, P12623; KINNUNEN L, 1990, J GEN VIROL, V71, P317, DOI 10.1099/0022-1317-71-2-317; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Polio laboratory manual - World Health Organization, 2004, WHOIVB04104; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Razafindratsimandresy R, 2013, EMERGING INFECT DIS, V19; Rousset D, 2003, EMERGING INFECT DIS, V9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zurbriggen S, 2008, APPL ENVIRON MICROB, V74, P5608, DOI 10.1128/AEM.02764-07; 2008, WKLY EPIDEMIOL REC, V84, P77	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88442	10.1371/journal.pone.0088442	http://dx.doi.org/10.1371/journal.pone.0088442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558390	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700036
J	Smith, RCG; Price, SR				Smith, Rosanna C. G.; Price, Stephen R.			Modelling of Human Low Frequency Sound Localization Acuity Demonstrates Dominance of Spatial Variation of Interaural Time Difference and Suggests Uniform Just-Noticeable Differences in Interaural Time Difference	PLOS ONE			English	Article							AUDITORY-NERVE DATA; OWL TYTO-ALBA; BARN OWL; BRAIN-STEM; LATERAL POSITION; ACOUSTICAL CUES; TONES; LOCATION; HEAD; DISCRIMINATION	Sound source localization is critical to animal survival and for identification of auditory objects. We investigated the acuity with which humans localize low frequency, pure tone sounds using timing differences between the ears. These small differences in time, known as interaural time differences or ITDs, are identified in a manner that allows localization acuity of around 1 degrees at the midline. Acuity, a relative measure of localization ability, displays a non-linear variation as sound sources are positioned more laterally. All species studied localize sounds best at the midline and progressively worse as the sound is located out towards the side. To understand why sound localization displays this variation with azimuthal angle, we took a first-principles, systemic, analytical approach to model localization acuity. We calculated how ITDs vary with sound frequency, head size and sound source location for humans. This allowed us to model ITD variation for previously published experimental acuity data and determine the distribution of just-noticeable differences in ITD. Our results suggest that the best-fit model is one whereby just-noticeable differences in ITDs are identified with uniform or close to uniform sensitivity across the physiological range. We discuss how our results have several implications for neural ITD processing in different species as well as development of the auditory system.	[Smith, Rosanna C. G.; Price, Stephen R.] UCL, Dept Cell & Dev Biol, London, England; [Smith, Rosanna C. G.] UCL, Ctr Math Phys & Engn Life Sci & Expt Biol CoMPLEX, London, England	University of London; University College London; University of London; University College London	Smith, RCG (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	r.c.smith@ucl.ac.uk		Smith, Rosanna/0000-0002-4058-1263; Price, Stephen/0000-0001-7804-9849	EPSRC; BBSRC; MRC; Wellcome Trust [094399/B/10/Z]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the EPSRC (www.epsrc.ac.uk), BBSRC (www.bbsrc.ac.uk) and MRC (www.mrc.ac.uk) (doctoral training funding to RCGS) and the Wellcome Trust, www.wellcome.ac.uk (Grant 094399/B/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Bala ADS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000675; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bernstein LR, 2001, J NEUROSCI RES, V66, P1035, DOI 10.1002/jnr.10103; Blauert J., 1997, SPATIAL HEARING PSYC; Brughera A, 2013, J ACOUST SOC AM, V133, P2839, DOI 10.1121/1.4795778; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; CARR CE, 1990, J NEUROSCI, V10, P3227; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; DAVENPORT CHARLES BENEDICT, 1940, PROC AMER PHIL SOC, V83, P1; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; Duda RO, 1998, J ACOUST SOC AM, V104, P3048, DOI 10.1121/1.423886; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HAFTER ER, 1975, J ACOUST SOC AM, V57, P181, DOI 10.1121/1.380412; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hartley RVL, 1921, PHYS REV, V18, P431, DOI 10.1103/PhysRev.18.431; Hausmann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007721; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hillenbrand JM, 2009, ATTEN PERCEPT PSYCHO, V71, P1150, DOI 10.3758/APP.71.5.1150; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Jones HG, 2011, JARO-J ASSOC RES OTO, V12, P127, DOI 10.1007/s10162-010-0242-3; JOSEPH AW, 1993, J NEUROPHYSIOL, V69, P1197, DOI 10.1152/jn.1993.69.4.1197; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; Koka K, 2008, J ACOUST SOC AM, V123, P4297, DOI 10.1121/1.2916587; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; KUHN GF, 1977, J ACOUST SOC AM, V62, P157, DOI 10.1121/1.381498; Kuhn GF, 1987, DIRECTIONAL HEARING; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Macpherson EA, 2002, J ACOUST SOC AM, V111, P2219, DOI 10.1121/1.1471898; MAKOUS JC, 1990, J ACOUST SOC AM, V87, P2188, DOI 10.1121/1.399186; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Moore JM, 2008, HEARING RES, V238, P94, DOI 10.1016/j.heares.2007.11.006; Mossop JE, 1998, J ACOUST SOC AM, V104, P1574, DOI 10.1121/1.424369; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; Overholt M, 1992, J NEUROSCI, V12, P1698; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; Perrott D, 1984, J ACOUST SOC AM, P1201; Peterson GE, 1952, J ACOUST SOC AM, V24; Phillips DP, 2012, NEUROSCI BIOBEHAV R, V36, P889, DOI 10.1016/j.neubiorev.2011.11.003; RABINOWITZ WM, 1993, PRESENCE, V2, P125; Ramon y Cajal S, 1904, HISTOLOGY NERVOUS SY, VI; Rayleigh L, 1876, NATURE, V14, P32, DOI DOI 10.1038/014032A0; Recanzone GH, 1998, J ACOUST SOC AM, V103, P1085, DOI 10.1121/1.421222; Rschevkin S, 1963, COURSE LECT THEORY S; SANDEL TT, 1955, J ACOUST SOC AM, V27, P842, DOI 10.1121/1.1908052; SAYERS BM, 1964, J ACOUST SOC AM, V36, P923, DOI 10.1121/1.1919121; SCHMIDT PH, 1953, ACTA PHYSIOL PHARM N, V3, P2; Schnupp JWH, 2003, J ACOUST SOC AM, V113, P2021, DOI 10.1121/1.1547460; SIMON HJ, 1994, J ACOUST SOC AM, V95, P1534, DOI 10.1121/1.408541; Stem RM, 1996, J ACOUST SOC AM, V100, P2278, DOI 10.1121/1.417937; STERN RM, 1978, J ACOUST SOC AM, V64, P127, DOI 10.1121/1.381978; STERN RM, 1988, J ACOUST SOC AM, V84, P156, DOI 10.1121/1.396982; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; Tollin DJ, 2009, J ACOUST SOC AM, V126, P3125, DOI 10.1121/1.3257234; TRAHIOTIS C, 1986, J ACOUST SOC AM, V79, P1950, DOI 10.1121/1.393202; WHO (World Health Organization), 2013, WHO CHILD GROWTH STA; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	65	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89033	10.1371/journal.pone.0089033	http://dx.doi.org/10.1371/journal.pone.0089033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558468	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700114
J	Wentzell, JS; Cassar, M; Kretzschmar, D				Wentzell, Jill S.; Cassar, Marlene; Kretzschmar, Doris			Organophosphate-Induced Changes in the PKA Regulatory Function of Swiss Cheese/NTE Lead to Behavioral Deficits and Neurodegeneration	PLOS ONE			English	Article							NEUROPATHY TARGET ESTERASE; ORTHO-CRESYL PHOSPHATE; DELAYED NEUROTOXICITY; DROSOPHILA; PROTEIN; EXPRESSION; NEURONS; BRAIN; GENE; HOMEOSTASIS	Organophosphate-induced delayed neuropathy (OPIDN) is a Wallerian-type axonopathy that occurs weeks after exposure to certain organophosphates (OPs). OPs have been shown to bind to Neuropathy Target Esterase (NTE), thereby inhibiting its enzymatic activity. However, only OPs that also induce the so-called aging reaction cause OPIDN. This reaction results in the release and possible transfer of a side group from the bound OP to NTE and it has been suggested that this induces an unknown toxic function of NTE. To further investigate the mechanisms of aging OPs, we used Drosophila, which expresses a functionally conserved orthologue of NTE named Swiss Cheese (SWS). Treating flies with the organophosporous compound tri-ortho-cresyl phosphate (TOCP) resulted in behavioral deficits and neurodegeneration two weeks after exposure, symptoms similar to the delayed effects observed in other models. In addition, we found that primary neurons showed signs of axonal degeneration within an hour after treatment. Surprisingly, increasing the levels of SWS, and thereby its enzymatic activity after exposure, did not ameliorate these phenotypes. In contrast, reducing SWS levels protected from TOCP-induced degeneration and behavioral deficits but did not affect the axonopathy observed in cell culture. Besides its enzymatic activity as a phospholipase, SWS also acts as regulatory PKA subunit, binding and inhibiting the C3 catalytic subunit. Measuring PKA activity in TOCP treated flies revealed a significant decrease that was also confirmed in treated rat hippocampal neurons. Flies expressing additional PKA-C3 were protected from the behavioral and degenerative phenotypes caused by TOCP exposure whereas primary neurons were not. In addition, knocking-down PKA-C3 caused similar behavioral and degenerative phenotypes as TOCP treatment. We therefore propose a model in which OP-modified SWS cannot release PKA-C3 and that the resulting loss of PKA-C3 activity plays a crucial role in developing the delayed symptoms of OPIDN but not in the acute toxicity.	[Wentzell, Jill S.; Cassar, Marlene; Kretzschmar, Doris] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University	Kretzschmar, D (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	kretzsch@ohsu.edu		Cassar, Marlene/0000-0003-1500-8868; kretzschmar, doris/0000-0002-0519-2377	National Institutes of Health [NS047663-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health, grant number NS047663-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDONIA MB, 1981, ANNU REV PHARMACOL, V21, P511, DOI 10.1146/annurev.pa.21.040181.002455; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; CARRINGTON CD, 1983, TOXICOL LETT, V18, P251, DOI 10.1016/0378-4274(83)90102-9; CHAPIN RE, 1991, TOXICOL APPL PHARM, V108, P194, DOI 10.1016/0041-008X(91)90110-Z; da Cruz AB, 2008, J NEUROSCI, V28, P10885, DOI 10.1523/JNEUROSCI.3015-08.2008; FUNK KA, 1994, ARCH TOXICOL, V68, P308, DOI 10.1007/s002040050074; Hein ND, 2010, TOXICOL LETT, V199, P1, DOI 10.1016/j.toxlet.2010.06.020; INUI K, 1993, FUND APPL TOXICOL, V20, P111, DOI 10.1006/faat.1993.1013; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; JOHNSON MK, 1990, TOXICOL APPL PHARM, V102, P385, DOI 10.1016/0041-008X(90)90036-T; JOHNSON MK, 1980, TOXICOL LETT, V5, P95, DOI 10.1016/0378-4274(80)90154-X; JOHNSON MK, 1974, J NEUROCHEM, V23, P785, DOI 10.1111/j.1471-4159.1974.tb04404.x; Johnson MK, 1982, TARGET INITIATION DE; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kraft R, 1998, J NEUROSCI, V18, P8886; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Krishnan N, 2012, NEUROBIOL DIS; Lahiri DK, 2002, ANN NY ACAD SCI, V965, P324; LOTTI M, 1992, CRIT REV TOXICOL, V21, P465, DOI 10.3109/10408449209089884; Lotti M, 2000, ORGANOPHOSPHORUS COM; Lush MJ, 1998, BIOCHEM J, V332, P1; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Petroianu G, 2001, J APPL TOXICOL, V21, P263, DOI 10.1002/jat.752; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Read DJ, 2007, TOXICOL APPL PHARM, V219, P190, DOI 10.1016/j.taap.2006.08.002; Read DJ, 2009, J NEUROSCI, V29, P11594, DOI 10.1523/JNEUROSCI.3007-09.2009; Schuh RA, 2002, TOXICOL APPL PHARM, V182, P176, DOI 10.1006/taap.2002.9445; SMITH HV, 1959, LANCET, V2, P1019; Smith MI, 1930, PUBLIC HEALTH REP, V45, P2509, DOI 10.2307/4579816; SRIVASTAVA AK, 1990, FOOD CHEM TOXICOL, V28, P303, DOI 10.1016/0278-6915(90)90047-Q; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Wang L, 2009, NEUROTOXICOLOGY, V30, P1084, DOI 10.1016/j.neuro.2009.06.006; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Zaccheo O, 2004, J BIOL CHEM; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	40	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87526	10.1371/journal.pone.0087526	http://dx.doi.org/10.1371/journal.pone.0087526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558370	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700016
J	Lehmann, S; Relano-Gines, A; Resina, S; Brillaud, E; Casanova, D; Vincent, C; Hamela, C; Poupeau, S; Laffont, M; Gabelle, A; Delaby, C; Belondrade, M; Arnaud, JD; Alvarez, MT; Maurel, JC; Maurel, P; Crozet, C				Lehmann, Sylvain; Relano-Gines, Aroa; Resina, Sarah; Brillaud, Elsa; Casanova, Danielle; Vincent, Charles; Hamela, Claire; Poupeau, Sophie; Laffont, Mathieu; Gabelle, Audrey; Delaby, Constance; Belondrade, Maxime; Arnaud, Jacques-Damien; Alvarez, Maria-Teresa; Maurel, Jean-Claude; Maurel, Patrick; Crozet, Carole			Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology in Prion Disorder	PLOS ONE			English	Article							MOUSE MODEL; THERAPY; DISEASE; MICE; DYSFUNCTION; GENE; RNAI; PRP	One of the main challenges for neurodegenerative disorders that are principally incurable is the development of new therapeutic strategies, which raises important medical, scientific and societal issues. Creutzfeldt-Jakob diseases are rare neurodegenerative fatal disorders which today remain incurable. The objective of this study was to evaluate the efficacy of the down-regulation of the prion protein (PrP) expression using siRNA delivered by, a water-in-oil microemulsion, as a therapeutic candidate in a preclinical study. After 12 days rectal mucosa administration of Aonys/PrP-siRNA in mice, we observed a decrease of about 28% of the brain PrPC level. The effect of Aonys/PrP-siRNA was then evaluated on prion infected mice. Several mice presented a delay in the incubation and survival time compared to the control groups and a significant impact was observed on astrocyte reaction and neuronal survival in the PrP-siRNA treated groups. These results suggest that a new therapeutic scheme based an innovative delivery system of PrP-siRNA can be envisioned in prion disorders.	[Lehmann, Sylvain; Gabelle, Audrey; Delaby, Constance; Crozet, Carole] Univ Montpellier I, Ctr Hosp Univ Montpellier U1040, INSERM, IMRB, Montpellier, France; [Lehmann, Sylvain; Relano-Gines, Aroa; Casanova, Danielle; Hamela, Claire; Belondrade, Maxime; Crozet, Carole] CNRS, UPR1142, Inst Genet Humaine, Montpellier, France; [Resina, Sarah; Brillaud, Elsa; Vincent, Charles; Poupeau, Sophie; Laffont, Mathieu; Maurel, Jean-Claude; Maurel, Patrick] Medesis Pharma SA, Baillargues, France; [Arnaud, Jacques-Damien; Alvarez, Maria-Teresa] Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Lehmann, S (corresponding author), Univ Montpellier I, Ctr Hosp Univ Montpellier U1040, INSERM, IMRB, Montpellier, France.	s-lehmann@chu-montpellier.fr	GABELLE, Audrey/X-9172-2019; Lehmann, Sylvain/P-1301-2017; Alvarez, Maria/GZH-1345-2022; crozet, carole/ABB-5877-2021	GABELLE, Audrey/0000-0002-7648-9194; Lehmann, Sylvain/0000-0001-6117-562X; Crozet, Carole/0000-0002-7292-7046; DELABY, Constance/0000-0002-8606-6814; RELANO GINES, AROA/0000-0002-3906-6360	Medesis Pharma	Medesis Pharma	This work was supported by Medesis Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown P, 2009, CNS NEUROL DISORD-DR, V8, P316, DOI 10.2174/187152709789541989; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Mallucci G, 2005, NAT REV NEUROSCI, V6, P23, DOI 10.1038/nrn1584; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Parchi P, 2012, FOLIA NEUROPATHOL, V50, P20; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Pouladi MA, 2012, NEUROBIOL DIS, V48, P282, DOI 10.1016/j.nbd.2012.06.026; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pulford B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011085; Relano-Gines A., 2009, Infectious Disorders - Drug Targets, V9, P58; Relano-Gines A, 2011, J INFECT DIS, V204, P1038, DOI 10.1093/infdis/jir484; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Sikorska Beata, 2012, Subcell Biochem, V65, P457, DOI 10.1007/978-94-007-5416-4_17; Toupet K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002773; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; White MD, 2009, CNS NEUROL DISORD-DR, V8, P342, DOI 10.2174/187152709789541934; White MD, 2009, PRION, V3, P121, DOI 10.4161/pri.3.3.9289; Wroblewska M, 2011, ACTA BIOCHIM POL, V58, P275; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	22	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88797	10.1371/journal.pone.0088797	http://dx.doi.org/10.1371/journal.pone.0088797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551164	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500069
J	Zhao, Y; Quigg, A				Zhao, Yan; Quigg, Antonietta			Nutrient Limitation in Northern Gulf of Mexico (NGOM): Phytoplankton Communities and Photosynthesis Respond to Nutrient Pulse	PLOS ONE			English	Article							MISSISSIPPI RIVER PLUME; PHOSPHORUS LIMITATION; SEASONAL DYNAMICS; FUNCTIONAL TRAITS; COASTAL WATERS; NITROGEN; GROWTH; EUTROPHICATION; PRODUCTIVITY; HYPOXIA	Although the Mississippi-Atchafalaya River system exports large amounts of nutrients to the Northern Gulf of Mexico annually, nutrient limitation of primary productivity still occurs offshore, acting as one of the major factors controlling local phytoplankton biomass and community structure. Bioassays were conducted for 48 hrs at two stations adjacent to the river plumes in April and August 2012. High Performance of Liquid Chromatography (HPLC) combined with ChemTax and a Fluorescence Induction and Relaxation (FIRe) system were combined to observe changes in the phytoplankton community structure and photosynthetic activity. Major fluorescence parameters (F-o, F-v/F-m) performed well to reveal the stimulating effect of the treatments with nitrogen (N-nitrate) and with nitrogen plus phosphate (+NPi). HPLC/ChemTax results showed that phytoplankton community structure shifted with nitrate addition: we observed an increase in the proportion of diatoms and prasinophytes and a decrease in cyanobacteria and prymnesiophytes. These findings are consistent with predictions from trait-based analysis which predict that phytoplankton groups with high maximum growth rates (mu(max)) and high nutrient uptake rates (V-max) readily take advantage of the addition of limiting nutrients. Changes in phytoplankton community structure, if persistent, could trigger changes of particular organic matter fluxes and alter the micro-food web cycles and bottom oxygen consumption.	[Zhao, Yan; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Zhao, Y (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	claire.zhy@tamu.edu			National Oceanographic and Atmospheric Administration (NOAA) CSCOR [NOS-NCCOS-2009-2001466]	National Oceanographic and Atmospheric Administration (NOAA) CSCOR(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by National Oceanographic and Atmospheric Administration (NOAA) CSCOR Grant number NOS-NCCOS-2009-2001466. This is a contribution of the NOAA NGOMEX research program. http://www.noaa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf JE, 2006, ESTUAR COAST SHELF S, V67, P108, DOI 10.1016/j.ecss.2005.11.030; AKSNES DL, 1991, MAR ECOL PROG SER, V70, P65, DOI 10.3354/meps070065; Cermeno P, 2011, MAR ECOL PROG SER, V429, P19, DOI 10.3354/meps09088; Cullen J.J., 2003, LIMNOL OCEANOGR B, V12, P29, DOI [10.1002/lob.200413229, DOI 10.1002/LOB.200413229, DOI 10.1002/L0B.200312229]; Dagg MJ, 2007, ESTUAR COAST, V30, P735, DOI 10.1007/BF02841331; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; Edwards KF, 2013, ECOL LETT, V16, P56, DOI 10.1111/ele.12012; Edwards KF, 2011, ECOLOGY, V92, P2085, DOI 10.1890/11-0395.1; Eldridge PM, 2010, ECOL MODEL, V221, P1028, DOI 10.1016/j.ecolmodel.2009.04.054; Fennel K., 2013, J GEOPHYS RES-OCEANS, P1; FISHER TR, 1992, MAR ECOL PROG SER, V82, P51, DOI 10.3354/meps082051; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; Grover JP, 2006, J PLANKTON RES, V28, P1, DOI 10.1093/plankt/fbi095; GROVER JP, 1991, J PHYCOL, V27, P70, DOI 10.1111/j.0022-3646.1991.00070.x; Habib OA, 1997, HYDROBIOLOGIA, V350, P63, DOI 10.1023/A:1003037012226; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Kuipers BR, 1999, MAR ECOL PROG SER, V180, P93, DOI 10.3354/meps180093; Lambert CD, 1999, CONT SHELF RES, V19, P1, DOI 10.1016/S0278-4343(98)00075-2; Laurent A, 2012, BIOGEOSCIENCES, V9, P4707, DOI 10.5194/bg-9-4707-2012; Laza-Martinez A, 2007, J PLANKTON RES, V29, P913, DOI 10.1093/plankt/fbm069; Lewitus AJ, 2005, ESTUARIES, V28, P160, DOI 10.1007/BF02732761; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lohrenz SE, 1999, CONT SHELF RES, V19, P1113, DOI 10.1016/S0278-4343(99)00012-6; Lugus A., 2004, J PLANKTON RES, V26, P291; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Mahaffey C, 2012, MAR ECOL PROG SER, V460, P13, DOI 10.3354/meps09699; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Paerl HW, 2009, ESTUAR COAST, V32, P593, DOI 10.1007/s12237-009-9158-8; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pinckney JL, 1996, J PLANKTON RES, V18, P1867, DOI 10.1093/plankt/18.10.1867; Qian YR, 2003, CONT SHELF RES, V23, P1, DOI 10.1016/S0278-4343(02)00173-5; Quigg A, 2013, CONT SHELF RES, V60, P1, DOI 10.1016/j.csr.2013.04.015; Quigg A, 2011, AQUAT GEOCHEM, V17, P519, DOI 10.1007/s10498-011-9134-3; Raateoja M, 2004, LIMNOL OCEANOGR, V49, P1006, DOI 10.4319/lo.2004.49.4.1006; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2002, HYDROBIOLOGIA, V475, P39, DOI 10.1023/A:1020388503274; Schaeffer BA, 2012, MAR POLLUT BULL, V64, P1705, DOI 10.1016/j.marpolbul.2012.03.017; Schluter L, 2000, MAR ECOL PROG SER, V192, P49, DOI 10.3354/meps192049; SMITH SM, 1994, ESTUARIES, V17, P740, DOI 10.2307/1352744; Sommer U, 1995, LIMNOL OCEANOGR, V40, P1271, DOI 10.4319/lo.1995.40.7.1271; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strom SL, 1996, MAR ECOL PROG SER, V130, P229, DOI 10.3354/meps130229; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P227, DOI 10.3354/ame01357; Sylvan JB, 2007, LIMNOL OCEANOGR, V52, P2679, DOI 10.4319/lo.2007.52.6.2679; Sylvan JB, 2006, ENVIRON SCI TECHNOL, V40, P7548, DOI 10.1021/es061417t; Sylvan JB, 2011, ESTUAR COAST, V34, P1220, DOI 10.1007/s12237-011-9415-5; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Tomas CR, 1997, IDENTIFYING MARINE P; Turner RE, 2013, AQUAT MICROB ECOL, V68, P159, DOI 10.3354/ame01607; TURNER RE, 1991, BIOSCIENCE, V41, P140, DOI 10.2307/1311453; Turner RE, 2006, MAR POLLUT BULL, V52, P139, DOI 10.1016/j.marpolbul.2005.08.012; Walker ND, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023716; Wawrik B, 2003, MAR ECOL PROG SER, V251, P87, DOI 10.3354/meps251087	60	12	12	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88732	10.1371/journal.pone.0088732	http://dx.doi.org/10.1371/journal.pone.0088732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551144	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500059
J	Fang, HW; Chiang, PH; Huang, YC				Fang, Hsin-Wei; Chiang, Po-Hsing; Huang, Yhu-Chering			Livestock-Associated Methicillin-Resistant Staphylococcus aureus ST9 in Pigs and Related Personnel in Taiwan	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; RAPID IDENTIFICATION; ST398; PREVALENCE; ANIMALS; INFECTIONS; CHILDREN; CLONES; ORIGIN; SWINE	Background: A livestock-associated (LA) methicillin-resistant Staphylococcus aureus (MRSA) strain sequence type 398 (ST398) is found related to animals and humans in Europe and North America. To evaluate the nasal carriage of MRSA among pigs and related workers in Taiwan, we conducted this study. Methods: From June 25 to October 1 2012, a total of 641 and 100 nasal swabs were obtained from pigs and related workers, respectively, from 22 pig farms nationwide and 2 pig auction markets in Taiwan. All MRSA isolates were molecularly characterized. Results: Overall, the nasal carriage rate of MRSA was 14.4% for pigs and 13% for humans. The carriage rate for pigs younger than 3 months was significantly higher than those older than 3 months (25.4% vs. 5.8%, p < .001). Percentage of MRSA-positive pig farms was 59.1% (13/22). The carriage rate for pigs in large-scale herds (>= 10000 pigs) was significantly higher than that in small-scale (34.3% vs. 7.0%, p < .001) and that in auction markets (3.8%). The carriage rate was 19.2% (10/52) for pig farm workers, and the rate in large-scale farms was significantly higher than that in small-scale (36.8% vs. 9.1%, p = .014). Except for 3 isolates from humans, the other 99 isolates belonged to sequence type (ST) 9. 83 of 89 isolates from pigs shared a common pulsotype, which was also shared by 6 isolates from humans. Conclusion: More than 10% of pigs and related workers in Taiwan carried LA-MRSA ST9 in nares and cross-species transmission of LA-MRSA was documented by molecular methods.	[Fang, Hsin-Wei; Chiang, Po-Hsing; Huang, Yhu-Chering] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp Linkou, Dept Pediat, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Sch Med, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw		Chiang, Po-Hsing/0000-0001-6026-8410	Medical Foundation in Memory of Dr. Deh-Lin Cheng and Nation Science Council of Executive Yuan, Taiwan [NSC 102-2628-B-182A-010]; Chang g Gung Memorial Hospital [BMRP236]	Medical Foundation in Memory of Dr. Deh-Lin Cheng and Nation Science Council of Executive Yuan, Taiwan; Chang g Gung Memorial Hospital(Chang Gung Memorial Hospital)	This research was supported by Medical Foundation in Memory of Dr. Deh-Lin Cheng and Nation Science Council of Executive Yuan, Taiwan (NSC 102-2628-B-182A-010) and from Chang g Gung Memorial Hospital (BMRP236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Baba K, 2010, INT J ANTIMICROB AG, V36, P352, DOI 10.1016/j.ijantimicag.2010.06.040; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; CLSI, 2018, PERF STAND ANT SUSC, P1; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgerald JR, 2012, TRENDS MICROBIOL, V20, P192, DOI 10.1016/j.tim.2012.01.006; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2012, J CLIN MICROBIOL, V50, P3735, DOI 10.1128/JCM.02053-12; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Ip M, 2005, J CLIN MICROBIOL, V43, P5069, DOI 10.1128/JCM.43.10.5069-5073.2005; Kang YC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-284; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Larsen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031245; Lim SK, 2012, VET MICROBIOL, V155, P88, DOI 10.1016/j.vetmic.2011.08.011; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lo YP, 2012, COMP IMMUNOL MICROB, V35, P513, DOI 10.1016/j.cimid.2012.05.001; Lu SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018620; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otter JA, 2012, J HOSP INFECT, V81, P143, DOI 10.1016/j.jhin.2012.04.009; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Tsai HY, 2012, INT J ANTIMICROB AG, V39, P449, DOI 10.1016/j.ijantimicag.2012.02.001; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; Wan MT, 2013, VET MICROBIOL, V162, P779, DOI 10.1016/j.vetmic.2012.10.003; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MW, 2008, EURO SURVEILLANCE, V13; Yu F, 2008, CLIN MICROBIOL INFEC, V14, P381, DOI 10.1111/j.1469-0691.2007.01927.x; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	47	38	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88826	10.1371/journal.pone.0088826	http://dx.doi.org/10.1371/journal.pone.0088826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551168	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000072
J	Liu, ME; Huang, CC; Yang, AC; Tu, PC; Yeh, HL; Hong, CJ; Liou, YJ; Chen, JF; Chou, KH; Lin, CP; Tsai, SJ				Liu, Mu-En; Huang, Chu-Chung; Yang, Albert C.; Tu, Pei-Chi; Yeh, Heng-Liang; Hong, Chen-Jee; Liou, Ying-Jay; Chen, Jin-Fan; Chou, Kun-Hsien; Lin, Ching-Po; Tsai, Shih-Jen			Catechol-O-Methyltransferase Val158Met Polymorphism on the Relationship between White Matter Hyperintensity and Cognition in Healthy People	PLOS ONE			English	Article							PREFRONTAL CORTEX; HUMAN BRAIN; NEUROBIOLOGICAL CHANGES; COMT GENOTYPE; DOPAMINE; IMPAIRMENT; AGE; LESIONS; MECHANISMS; EXPRESSION	Background: White matter lesions can be easily observed on T2-weighted MR images, and are termed white matter hyperintensities (WMH). Their presence may be correlated with cognitive impairment; however, the relationship between regional WMH volume and catechol-O-methyltransferase (COMT) Val158Met polymorphism in healthy populations remains unclear. Methods: We recruited 315 ethnic Chinese adults with a mean age of 54.9 +/- 21.8 years (range: 21-89 y) to examine the genetic effect of COMT on regional WMH and the manner in which they interact to affect cognitive function in a healthy adult population. Cognitive tests, structural MRI scans, and genotyping of COMT were conducted for each participant. Results: Negative correlations between the Digit Span Forward (DSF) score and frontal WMH volumes (r = -.123, P=.032, uncorrected) were noted. For the genetic effect of COMT, no significant difference in cognitive performance was observed among 3 genotypic groups. However, differences in WMH volumes over the subcortical region (P = .016, uncorrected), whole brain (P = .047, uncorrected), and a trend over the frontal region (P = .050, uncorrected) were observed among 3 COMT genotypic groups. Met homozygotes and Met/Val heterozygotes exhibited larger WMH volumes in these brain regions than the Val homozygotes. Furthermore, a correlation between the DSF and regional WMH volume was observed only in Met homozygotes. The effect size (cohen's f) revealed a small effect. Conclusions: The results indicate that COMT might modulate WMH volumes and the effects of WMH on cognition.	[Liu, Mu-En; Yang, Albert C.; Tu, Pei-Chi; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Mu-En; Lin, Ching-Po] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Albert C.; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yeh, Heng-Liang] Hlth Care Grp, Taipei, Taiwan; [Chen, Jin-Fan] Tao Yuan Vet Hosp, Dept Pathol, Tao Yuan, Taiwan; [Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Sch Life Sci, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lin, CP (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	chingpolin@gmail.com; tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Huang, Chu-Chung/0000-0002-9096-9610; Yang, Albert Chih-Chieh/0000-0003-2794-9649	Taipei Veterans General Hospital, Taiwan [V101C-006, VGHUST101-G1-1-1, VGHUST102- G1-2-1]; National Science Council Grant, Taiwan [NSC 102-2314-B-075B-001, NSC 101-2321-B-010 -026 -, NSC 101-2911-I-008-001, NSC 101-2314-B-075 -040]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); National Science Council Grant, Taiwan	This work was supported by grants V101C-006, VGHUST101-G1-1-1, VGHUST102- G1-2-1 from Taipei Veterans General Hospital, Taiwan, grants NSC 102-2314-B-075B-001, NSC 101-2321-B-010 -026 -, NSC 101-2911-I-008-001, NSC 101-2314-B-075 -040, and NSC 101-2911-I-008-001 from National Science Council Grant, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, NEUROPSYCHOLOGIA, V49, P3931, DOI 10.1016/j.neuropsychologia.2011.10.010; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Berman S, 2008, ANN NY ACAD SCI, V1141, P195, DOI 10.1196/annals.1441.031; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Bunce D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013567; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Duncan, 2000, Am J Ophthalmol, V130, P687, DOI 10.1016/S0002-9394(00)00752-2; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Fernstrom JD, 2000, AM J CLIN NUTR, V71, p1669S, DOI 10.1093/ajcn/71.6.1669S; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kohama SG, 2012, AGE, V34, P1093, DOI 10.1007/s11357-011-9357-7; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LARUE A, 1987, INT J AGING HUM DEV, V25, P79, DOI 10.2190/DV3R-PBJQ-E0FT-7W2B; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Liu B, 2010, NEUROIMAGE, V50, P243, DOI 10.1016/j.neuroimage.2009.12.020; LUNDSTROM K, 1995, BBA-PROTEIN STRUCT M, V1251, P1, DOI 10.1016/0167-4838(95)00071-2; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Muangpaisan Weerasak, 2010, Journal of the Medical Association of Thailand, V93, P224; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Ota M, 2009, INT J GERIATR PSYCH, V24, P1463, DOI 10.1002/gps.2289; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seger D, 2010, CLIN TOXICOL, V48, P695, DOI 10.3109/15563650.2010.516263; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shin J, 2012, J NEUROL NEUROSUR PS, V83, P315, DOI 10.1136/jnnp-2011-300872; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Sonohara K, 2008, GERIATR GERONTOL INT, V8, P93, DOI 10.1111/j.1447-0594.2008.00454.x; Thomason ME, 2010, NEUROIMAGE, V53, P926, DOI 10.1016/j.neuroimage.2010.01.033; Tomimoto H, 2003, ACTA NEUROPATHOL, V106, P527, DOI 10.1007/s00401-003-0749-3; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; van Amelsvoort T, 2008, PSYCHOL MED, V38, P89, DOI 10.1017/S0033291707000700; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Wang YQ, 2001, AM J PHYSIOL-REG I, V280, pR248, DOI 10.1152/ajpregu.2001.280.1.R248; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Xu HY, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00008; Xu HY, 2009, BEHAV NEUROSCI, V123, P418, DOI 10.1037/a0014477; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zinkstok J, 2006, NEUROSCI LETT, V405, P34, DOI 10.1016/j.neulet.2006.06.034	57	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88749	10.1371/journal.pone.0088749	http://dx.doi.org/10.1371/journal.pone.0088749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551149	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000060
J	Christiansen, MT; Kaas, RS; Chaudhuri, RR; Holmes, MA; Hasman, H; Aarestrup, FM				Christiansen, Mette T.; Kaas, Rolf S.; Chaudhuri, Roy R.; Holmes, Mark A.; Hasman, Henrik; Aarestrup, Frank M.			Genome-Wide High-Throughput Screening to Investigate Essential Genes Involved in Methicillin-Resistant Staphylococcus aureus Sequence Type 398 Survival	PLOS ONE			English	Article							STATIONARY-PHASE; VIRULENCE GENES; MUTAGENESIS; EXPRESSION; PEPTIDOGLYCAN; STRAINS; PROTEIN; IDENTIFICATION; GROWTH; ACID	Livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) Sequence Type 398 (ST398) is an opportunistic pathogen that is able to colonize and cause disease in several animal species including humans. To better understand the adaptation, evolution, transmission and pathogenic capacity, further investigations into the importance of the different genes harboured by LA-MRSA ST398 are required. In this study we generated a genome-wide transposon mutant library in an LA-MRSA ST398 isolate to evaluate genes important for bacterial survival in laboratory and host-specific environments. The transposon mutant library consisted of approximately 1 million mutants with around 140,000 unique insertion sites and an average number of unique inserts per gene of 44.8. We identified LA-MRSA ST398 essential genes comparable to other high-throughput S. aureus essential gene studies. As ST398 is the most common MRSA isolated from pigs, the transposon mutant library was screened in whole porcine blood. Twenty-four genes were specifically identified as important for bacterial survival in porcine blood. Mutations in 23 of these genes resulted in attenuated bacterial fitness. Seven of the 23 genes were of unknown function, whereas 16 genes were annotated with functions predominantly related to carbon metabolism, pH shock and a variety of regulations and only indirectly to virulence factors. Mutations in one gene of unknown function resulted in a hypercompetitive mutant. Further evaluation of these genes is required to determine their specific relevance in blood survival.	[Christiansen, Mette T.; Kaas, Rolf S.; Hasman, Henrik; Aarestrup, Frank M.] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Chaudhuri, Roy R.; Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge, England	Technical University of Denmark; University of Cambridge	Christiansen, MT (corresponding author), UCL, London, England.	m.christiansen@ucl.ac.uk; fmaa@food.dtu.dk	Chaudhuri, Roy/E-3774-2014	Chaudhuri, Roy/0000-0001-5037-2695; Aarestrup, Frank/0000-0002-7116-2723; Kaas, Rolf Sommer/0000-0002-5050-8668; Hasman, Henrik/0000-0001-6314-2709; Holmes, Mark/0000-0002-5454-1625	Danish Ministry of Food, Agriculture and Fisheries [3304-FVFP-09-F-002-1]; Technical University of Denmark; MRC [G1001787] Funding Source: UKRI; Medical Research Council [G1001787] Funding Source: researchfish	Danish Ministry of Food, Agriculture and Fisheries; Technical University of Denmark; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in part by the Danish Ministry of Food, Agriculture and Fisheries (Grant no. 3304-FVFP-09-F-002-1) and The Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KL, 2010, FEMS IMMUNOL MED MIC, V60, P208, DOI 10.1111/j.1574-695X.2010.00736.x; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; DEVRIESE LA, 1972, ZENTRALB VET RIEHE B, V19, P598; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; Hughes JD, 2007, TRANSFUSION, V47, P2050, DOI 10.1111/j.1537-2995.2007.01429.x; Khatiwara A, 2012, APPL ENVIRON MICROB, V78, P3098, DOI 10.1128/AEM.06865-11; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Pickard D, 2013, J BACTERIOL, V195, P1320, DOI 10.1128/JB.01632-12; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Prasad UV, 2013, APPL BIOCHEM BIOTECH, V169, P862, DOI 10.1007/s12010-012-0027-8; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saunders Nicholas A., 2007, V391, P71; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Sun F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015703; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Verkade E, 2013, INFECT GENETICS EVOL; Wakeman CA, 2012, MOL MICROBIOL, V86, P1376, DOI 10.1111/mmi.12063	50	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e89018	10.1371/journal.pone.0089018	http://dx.doi.org/10.1371/journal.pone.0089018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24563689	Green Accepted, Green Published, gold			2022-12-25	WOS:000331262600127
J	Young, BE; Cooper, EM; McIntyre, AW; Kent, T; Witter, F; Harris, ZL; O'Brien, KO				Young, Bridget E.; Cooper, Elizabeth M.; McIntyre, Allison W.; Kent, Tera; Witter, Frank; Harris, Z. Leah; O'Brien, Kimberly O.			Placental vitamin D receptor (VDR) expression is related to neonatal vitamin D status, placental calcium transfer, and fetal bone length in pregnant adolescents	FASEB JOURNAL			English	Article						25(OH)D; 1; 25(OH)2D; gestation; calcidiol	PARATHYROID-HORMONE; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; BIRTH-WEIGHT; IN-UTERO; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; TRANSPORTER; METABOLISM; LACTATION	The purpose of the study was to identify determinants of placental vitamin D receptor (VDR) expression and placental calcium (Ca) transfer among pregnant adolescents. Placental tissue was obtained in 94 adolescents (18 yr) at term. In 12 of these teens, stable Ca isotopes were given intravenously (Ca-42) and orally (Ca-44) early in labor. Placental VDR expression was assessed via Western blot and validated by RT-PCR. Maternal-to-fetal Ca transfer was calculated as the enrichment in cord blood at delivery relative to maternal serum enrichment 2 h postdosing. Isotopic study outcomes were examined in relation to fetal long bone length, placental VDR, serum 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)(2)D], and parathyroid hormone (PTH) in maternal circulation and cord blood at delivery. Placental VDR expression was inversely associated with neonatal 25(OH)D (P=0.012) and positively with neonatal 1,25(OH)(2)D (P=0.006). Placental VDR was a positive predictor of fetal femur length Z score (P=0.018; R-2=0.06) and was positively correlated with maternal-to-fetal transfer of intravenous Ca-42 (P=0.004; R-2=0.62). The fetus may regulate placental VDR expression given the significant associations with neonatal vitamin D metabolites. The association between placental VDR and fetal long bone length may indicate a role for VDR in fetal bone development, potentially by mediating transplacental Ca transfer.Young, B. E., Cooper, E. M., McIntyre, A. W., Kent, T., Witter, F., Harris, Z. L., O'Brien, K. O. Placental vitamin D receptor (VDR) expression is related to neonatal vitamin D status, placental calcium transfer, and fetal bone length in pregnant adolescents.	[Young, Bridget E.; Kent, Tera; O'Brien, Kimberly O.] Cornell Univ, Dept Nutr Sci, Ithaca, NY 14853 USA; [Cooper, Elizabeth M.; McIntyre, Allison W.] Univ Rochester, Sch Med, Rochester, NY USA; [Witter, Frank; Harris, Z. Leah] Johns Hopkins Sch Med, Baltimore, MD USA	Cornell University; University of Rochester; Johns Hopkins University; Johns Hopkins Medicine	O'Brien, KO (corresponding author), Cornell Univ, Dept Nutr Sci, 230 Savage Hall, Ithaca, NY 14853 USA.	koo4@cornell.edu		Harris, Zena Leah/0000-0003-0110-8438				ABRAMS SA, 1992, J BONE MINER RES, V7, P287, DOI 10.1002/jbmr.5650070307; Belkacemi L, 2005, MOL CELL ENDOCRINOL, V236, P31, DOI 10.1016/j.mce.2005.03.002; Bond H, 2008, J PHYSIOL-LONDON, V586, P2015, DOI 10.1113/jphysiol.2007.149104; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Chang SC, 2003, AM J CLIN NUTR, V77, P1248, DOI 10.1093/ajcn/77.5.1248; CHEN TC, 1990, J NUTR BIOCHEM, V1, P320, DOI 10.1016/0955-2863(90)90068-V; Dilworth MR, 2010, P NATL ACAD SCI USA, V107, P3894, DOI 10.1073/pnas.0911710107; Essley B, 2011, J DEV ORIG HLTH DIS, V2, P272, DOI 10.1017/S2040174411000511; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Fischer D, 2007, CLIN EXP OBSTET GYN, V34, P80; GERTNER JM, 1980, J PEDIATR-US, V97, P637, DOI 10.1016/S0022-3476(80)80029-1; Halhali A, 2010, J STEROID BIOCHEM, V121, P448, DOI 10.1016/j.jsbmb.2010.03.008; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jaacks LM, 2011, J NUTR, V141, P1267, DOI 10.3945/jn.110.135798; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Karras SN, 2014, OSTEOPOROSIS INT, V25, P795, DOI 10.1007/s00198-013-2468-5; Kato S, 2002, HORM RES, V57, P73, DOI 10.1159/000057955; Kovacs CS, 2012, ANNU REV NUTR, V32, P97, DOI 10.1146/annurev-nutr-071811-150742; Kovacs CS, 2005, AM J PHYSIOL-ENDOC M, V289, pE133, DOI 10.1152/ajpendo.00354.2004; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lewis S, 2010, MOL NUTR FOOD RES, V54, P1092, DOI 10.1002/mnfr.201000044; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Mahon P, 2010, J BONE MINER RES, V25, P14, DOI 10.1359/jbmr.090701; MARKESTAD T, 1984, AM J CLIN NUTR, V40, P1057, DOI 10.1093/ajcn/40.5.1057; Martin R, 2007, BONE, V40, P1203, DOI 10.1016/j.bone.2006.12.060; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; MOORE ES, 1985, PEDIATR RES, V19, P566, DOI 10.1203/00006450-198506000-00013; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Morley R, 2009, EUR J CLIN NUTR, V63, P802, DOI 10.1038/ejcn.2008.55; Namgung R, 2000, P NUTR SOC, V59, P55, DOI 10.1017/S0029665100000070; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; O'Brien KO, 2014, J CLIN ENDOCR METAB, V99, P1348, DOI 10.1210/jc.2013-1366; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Rummens K, 2003, PEDIATR RES, V54, P466, DOI 10.1203/01.PDR.0000081302.06915.D3; SHANY S, 1984, AM J CLIN NUTR, V40, P1290, DOI 10.1093/ajcn/40.6.1290; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Strid H, 2003, PLACENTA, V24, P445, DOI 10.1053/plac.2002.0941; Suzuki Y, 2008, J BONE MINER RES, V23, P1249, DOI [10.1359/jbmr.080314, 10.1359/JBMR.080314]; TUAN RS, 1991, J CELL SCI, V98, P333; Wagner CL, 2012, NUTRIENTS, V4, P208, DOI 10.3390/nu4030208; YERGEY AL, 1987, BIOMED ENVIRON MASS, V14, P603, DOI 10.1002/bms.1200141105; Young BE, 2012, AM J CLIN NUTR, V95, P1103, DOI 10.3945/ajcn.111.023861; Young BE, 2012, J BONE MINER RES, V27, P177, DOI 10.1002/jbmr.526; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4	48	25	26	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2029	2037		10.1096/fj.13-246736	http://dx.doi.org/10.1096/fj.13-246736			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24558197				2022-12-25	WOS:000335336000008
J	Wallez, Y; Riedl, SJ; Pasquale, EB				Wallez, Yann; Riedl, Stefan J.; Pasquale, Elena B.			Association of the Breast Cancer Antiestrogen Resistance Protein 1 ( BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Breast Cancer; Cancer; Drug Resistance; MAP Kinases (MAPKs); Protein-Protein Interactions; ERK1; 2; NSP3; PEA15; Mesenchymal Phenotype	SRC-TRANSFORMED CELLS; GDP EXCHANGE FACTOR; CAS FAMILY-MEMBERS; CYCLIN D1 PROMOTER; TYROSINE PHOSPHORYLATION; TAMOXIFEN RESISTANCE; SUBSTRATE DOMAIN; BCAR1/P130CAS PROTEIN; ADAPTER PROTEINS; DEPENDENT MANNER	Background: BCAR1 (breast cancer antiestrogen resistance protein 1) and BCAR3 promote antiestrogen resistance and malignancy in breast cancer. Results: Mutations preventing the tight BCAR1-BCAR3 association disrupt downstream signaling events required for antiestrogen resistance, including ERK1/2 activation. Conclusion: Complex formation is critical for BCAR1-BCAR3 oncogenic activities. Significance: The BCAR1-BCAR3 complex and associated signaling events represent promising therapeutic targets in breast cancer. Most breast cancers are estrogen receptor-positive and treated with antiestrogens, but aberrant signaling networks can induce drug resistance. One of these networks involves the scaffolding protein BCAR1/p130CAS, which regulates cell growth and migration/invasion. A less investigated scaffolding protein that also confers antiestrogen resistance is the SH2 domain-containing protein BCAR3. BCAR1 and BCAR3 bind tightly to each other through their C-terminal domains, thus potentially connecting their associated signaling networks. However, recent studies using BCAR1 and BCAR3 interaction mutants concluded that association between the two proteins is not critical for many of their interrelated activities regulating breast cancer malignancy. We report that these previously used BCAR mutations fail to cause adequate loss-of-function of the complex. By using structure-based BCAR1 and BCAR3 mutants that lack the ability to interact, we show that BCAR3-induced antiestrogen resistance in MCF7 breast cancer cells critically depends on its ability to bind BCAR1. Interaction with BCAR3 increases the levels of phosphorylated BCAR1, ultimately potentiating BCAR1-dependent antiestrogen resistance. Furthermore, antiestrogen resistance in cells overexpressing BCAR1/BCAR3 correlates with increased ERK1/2 activity. Inhibiting ERK1/2 through overexpression of the regulatory protein PEA15 negates the resistance, revealing a key role for ERK1/2 in BCAR1/BCAR3-induced antiestrogen resistance. Reverse-phase protein array data show that PEA15 levels in invasive breast cancers correlate with patient survival, suggesting that PEA15 can override ERK1/2 activation by BCAR1/BCAR3 and other upstream regulators. We further uncovered that the BCAR3-related NSP3 can also promote antiestrogen resistance. Thus, strategies to disrupt BCAR1-BCAR3/NSP3 complexes and associated signaling networks could ultimately lead to new breast cancer therapies.	[Wallez, Yann; Riedl, Stefan J.; Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@sanfordburnham.org		Wallez, Yann/0000-0001-9654-6187	National Institutes of Health [R01CA160457]; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA160457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA160457.	Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Bartholomeusz C, 2010, CLIN CANCER RES, V16, P1802, DOI 10.1158/1078-0432.CCR-09-1456; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Brinkman A, 2010, BREAST CANCER RES TR, V120, P401, DOI 10.1007/s10549-009-0403-4; Browne CD, 2010, P NATL ACAD SCI USA, V107, P18944, DOI 10.1073/pnas.1007558107; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Cai DP, 1999, J IMMUNOL, V163, P2104; Cai DP, 2003, CANCER RES, V63, P6802; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Cunningham-Edmondson AC, 2009, BREAST CANCER-TARGET, V1, P39; Dail M, 2004, J BIOL CHEM, V279, P41892, DOI 10.1074/jbc.M402929200; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Dorssers LCJ, 2004, CLIN CANCER RES, V10, P6194, DOI 10.1158/1078-0432.CCR-04-0444; Felekkis KN, 2005, MOL CANCER RES, V3, P32; Felekkis K, 2006, METHOD ENZYMOL, V407, P55, DOI 10.1016/S0076-6879(05)07006-0; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Hiscox S, 2004, CLIN EXP METASTAS, V21, P201, DOI 10.1023/B:CLIN.0000037697.76011.1d; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kumbrink J, 2012, NEOPLASIA, V14, P108, DOI 10.1593/neo.111760; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Makkinje A, 2012, J BIOL CHEM, V287, P27703, DOI 10.1074/jbc.M112.389981; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Regelmann AG, 2006, IMMUNITY, V25, P907, DOI 10.1016/j.immuni.2006.09.014; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Roselli S, 2010, CELL SIGNAL, V22, P1745, DOI 10.1016/j.cellsig.2010.06.015; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sakakibara A, 2000, J BIOL CHEM, V275, P6404, DOI 10.1074/jbc.275.9.6404; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; Shah AN, 2007, ANTI-CANCER DRUG, V18, P371, DOI 10.1097/CAD.0b013e32801265d7; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; Stassi G, 2005, CANCER RES, V65, P6668, DOI 10.1158/0008-5472.CAN-04-4009; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tornillo G, 2013, STEM CELLS, V31, P1422, DOI 10.1002/stem.1403; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; van Agthoven T, 2012, INT J CANCER, V131, P1998, DOI 10.1002/ijc.27489; van der Flier S, 2000, INT J CANCER, V89, P465, DOI 10.1002/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; van der Flier S, 2001, INT J BIOL MARKER, V16, P172, DOI 10.1177/172460080101600303; Vervoort VS, 2007, GENE, V391, P161, DOI 10.1016/j.gene.2006.12.016; Wallez Yann, 2012, Genes Cancer, V3, P382, DOI 10.1177/1947601912460050; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Wilson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065678; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	72	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10431	10444		10.1074/jbc.M113.541839	http://dx.doi.org/10.1074/jbc.M113.541839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24584939	Green Published, hybrid			2022-12-25	WOS:000334226400017
J	Gurung, B; Muhammad, AB; Hua, XX				Gurung, Buddha; Muhammad, Abdul Bari; Hua, Xianxin			Menin Is Required for Optimal Processing of the MicroRNA let-7a*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Cancer Biology; MicroRNA; Pancreas; Pancreatic Islets; Tumor Suppressor Gene; IRS2; Menin; let-7a	ENDOCRINE-NEOPLASIA TYPE-1; HISTONE METHYLTRANSFERASE COMPLEX; JUND-ACTIVATED TRANSCRIPTION; PANCREATIC BETA-CELLS; RECEPTOR SUBSTRATE 2; RNA-INTERFERENCE; MOLECULAR-GENETICS; MICROPROCESSOR COMPLEX; INSULIN SENSITIVITY; MTOR PATHWAY	Background: Menin represses pancreatic beta cell proliferation. Results: Menin promotes processing of let-7a, whose target IRS2 plays an important role in insulin signaling and beta cell proliferation. Conclusion: Menin represses beta cell proliferation partly via regulation of miRNA biogenesis. Significance: Understanding how menin represses beta cell proliferation will aid toward improving therapies targeting endocrine tumors and metabolic diseases including diabetes. Multiple endocrine neoplasia type I (MEN1) is an inherited syndrome that includes susceptibility to pancreatic islet hyperplasia. This syndrome results from mutations in the MEN1 gene, which encodes menin protein. Menin interacts with several transcription factors, including JunD, and inhibits their activities. However, the precise mechanism by which menin suppresses gene expression is not well understood. Here, we show that menin interacts with arsenite-resistant protein 2 (ARS2), a component of the nuclear RNA CAP-binding complex that is crucial for biogenesis of certain miRNAs including let-7a. The levels of primary-let-7a (pri-let-7a) are not affected by menin; however, the levels of mature let-7a are substantially decreased upon Men1 excision. Let-7a targets, including Insr and Irs2, pro-proliferative genes that are crucial for insulin-mediated signaling, are up-regulated in Men1-excised cells. Inhibition of let-7a using anti-miRNA in wild type cells is sufficient to enhance the expression of insulin receptor substrate 2 (IRS2) to levels observed in Men1-excised cells. Depletion of menin does not affect the expression of Drosha and CBP80, but substantially impairs the processing of pri-miRNA to pre-miRNA. Ars2 knockdown decreased let-7a processing in menin-expressing cells but had little impact on let-7a levels in menin-excised cells. As IRS2 is known to mediate insulin signaling and insulin/mitogen-induced cell proliferation, these findings collectively unravel a novel mechanism whereby menin suppresses cell proliferation, at least partly by promoting the processing of certain miRNAs, including let-7a, leading to suppression of Irs2 expression and insulin signaling.	[Gurung, Buddha; Muhammad, Abdul Bari; Hua, Xianxin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Hua, XX (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, 421 Curie Blvd,420 BRB II-III, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu			National Institutes of Health [R01-CA-113962, R01-DK085121]; Caring for Carcinoid Foundation-AACR Grant Care for Carcinoid Foundation [11-60-33XH]; Institute for Translational Medicine and Therapeutics [400-4130-2-0.4001]; Juvenile Diabetes Research Foundation [5-2012-221]; NATIONAL CANCER INSTITUTE [R01CA113962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085121, R01DK097555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caring for Carcinoid Foundation-AACR Grant Care for Carcinoid Foundation; Institute for Translational Medicine and Therapeutics; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA-113962 and R01-DK085121 (to X. H.). This work was also supported by Caring for Carcinoid Foundation-AACR Grant Care for Carcinoid Foundation 11-60-33XH, Institute for Translational Medicine and Therapeutics Grant 400-4130-2-0.4001, and Juvenile Diabetes Research Foundation Grant 5-2012-221.	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Burgess JR, 2000, CLIN ENDOCRINOL, V53, P205, DOI 10.1046/j.1365-2265.2000.01032.x; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Gurung B, 2013, CANCER RES, V73, P2650, DOI 10.1158/0008-5472.CAN-12-3158; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Huang J, 2012, NATURE, V482, P542, DOI 10.1038/nature10806; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jin SH, 2003, CANCER RES, V63, P4204; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Libe R, 2005, EUR J ENDOCRINOL, V153, P477, DOI 10.1530/eje.1.02004; Luzi E, 2012, NUCLEIC ACID THER, V22, P103, DOI 10.1089/nat.2012.0344; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Perren A, 2004, ANN NY ACAD SCI, V1014, P199, DOI 10.1196/annals.1294.021; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stalberg P, 2004, J CLIN ENDOCR METAB, V89, P2326, DOI 10.1210/jc.2003-031228; Thiel AT, 2013, HAEMATOLOGICA, V98, P918, DOI 10.3324/haematol.2012.074195; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wuescher L, 2011, AM J PHYSIOL-ENDOC M, V301, pE474, DOI 10.1152/ajpendo.00022.2011; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	56	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9902	9908		10.1074/jbc.M113.520692	http://dx.doi.org/10.1074/jbc.M113.520692			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563463	Green Published, hybrid			2022-12-25	WOS:000333807000039
J	Imamura, K; Maeda, S; Kawamura, I; Matsuyama, K; Shinohara, N; Yahiro, Y; Nagano, S; Setoguchi, T; Yokouchi, M; Ishidou, Y; Komiya, S				Imamura, Katsuyuki; Maeda, Shingo; Kawamura, Ichiro; Matsuyama, Kanehiro; Shinohara, Naohiro; Yahiro, Yuhei; Nagano, Satoshi; Setoguchi, Takao; Yokouchi, Masahiro; Ishidou, Yasuhiro; Komiya, Setsuro			Human Immunodeficiency Virus Type 1 Enhancer-binding Protein 3 Is Essential for the Expression of Asparagine-linked Glycosylation 2 in the Regulation of Osteoblast and Chondrocyte Differentiation*.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Chondrogenesis; Endoplasmic Reticulum Stress; Endoplasmic Reticulum (ER); Osteoblasts; Alg2; Hivep3; runx2	BONE-FORMATION; CLEIDOCRANIAL DYSPLASIA; CONGENITAL DISORDERS; GROWTH-PLATE; FACTOR CBFA1; GENE; MICE; SCHNURRI-3; TRANSCRIPTION; PATHWAY	Background: The mechanisms by which Hivep3 regulates the osteochondrogenesis remain elusive. Results: Knockdown of Hivep3 down-regulated Alg2 expression. Alg2 suppressed osteoblast differentiation by inhibiting the activity of Runx2. Alg2 silencing suppressed the expression of Creb3l2 and chondrogenesis. Conclusion: Alg2 may be a modulator of osteochondrogenesis. Significance: This is the first report to describe the association of an Alg gene with osteochondrogenesis. Human immunodeficiency virus type 1 enhancer-binding protein 3 (Hivep3) suppresses osteoblast differentiation by inducing proteasomal degradation of the osteogenesis master regulator Runx2. In this study, we tested the possibility of cooperation of Hivep1, Hivep2, and Hivep3 in osteoblast and/or chondrocyte differentiation. Microarray analyses with ST-2 bone stroma cells demonstrated that expression of any known osteochondrogenesis-related genes was not commonly affected by the three Hivep siRNAs. Only Hivep3 siRNA promoted osteoblast differentiation in ST-2 cells, whereas all three siRNAs cooperatively suppressed differentiation in ATDC5 chondrocytes. We further used microarray analysis to identify genes commonly down-regulated in both MC3T3-E1 osteoblasts and ST-2 cells upon knockdown of Hivep3 and identified asparagine-linked glycosylation 2 (Alg2), which encodes a mannosyltransferase residing on the endoplasmic reticulum. The Hivep3 siRNA-mediated promotion of osteoblast differentiation was negated by forced Alg2 expression. Alg2 suppressed osteoblast differentiation and bone formation in cultured calvarial bone. Alg2 was immunoprecipitated with Runx2, whereas the combined transfection of Runx2 and Alg2 interfered with Runx2 nuclear localization, which resulted in suppression of Runx2 activity. Chondrocyte differentiation was promoted by Hivep3 overexpression, in concert with increased expression of Creb3l2, whose gene product is the endoplasmic reticulum stress transducer crucial for chondrogenesis. Alg2 silencing suppressed Creb3l2 expression and chondrogenesis of ATDC5 cells, whereas infection of Alg2-expressing virus promoted chondrocyte maturation in cultured cartilage rudiments. Thus, Alg2, as a downstream mediator of Hivep3, suppresses osteogenesis, whereas it promotes chondrogenesis. To our knowledge, this study is the first to link a mannosyltransferase gene to osteochondrogenesis.	[Imamura, Katsuyuki; Maeda, Shingo; Kawamura, Ichiro; Matsuyama, Kanehiro; Shinohara, Naohiro; Ishidou, Yasuhiro; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, Kagoshima 8908544, Japan; [Imamura, Katsuyuki; Kawamura, Ichiro; Matsuyama, Kanehiro; Shinohara, Naohiro; Yahiro, Yuhei; Nagano, Satoshi; Yokouchi, Masahiro; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 8908544, Japan; [Setoguchi, Takao; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Near Future Locomotor Organ Med Creat Course, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Maeda, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	maeda-s@umin.ac.jp		Nagano, Satoshi/0000-0003-2015-1730	Japan Society for the Promotion of Science KAKENHI [23592221, 23592222]; Cell Science Research Foundation; Hip Joint Foundation of Japan; Grants-in-Aid for Scientific Research [23592222] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Hip Joint Foundation of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23592221 (to S. M.) and 23592222 (to Y. I.), a grant from the Cell Science Research Foundation (to S. M.), and a grant from the Hip Joint Foundation of Japan (to S. M.).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bobick BE, 2004, J BIOL CHEM, V279, P4588, DOI 10.1074/jbc.M309805200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Coman D, 2008, CLIN GENET, V73, P507, DOI 10.1111/j.1399-0004.2008.01015.x; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017161; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Shim JH, 2013, J CLIN INVEST, V123, P4010, DOI 10.1172/JCI69443; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Udagawa Y, 2000, GENES CELLS, V5, P359, DOI 10.1046/j.1365-2443.2000.00328.x; Wein MN, 2012, P NATL ACAD SCI USA, V109, P8173, DOI 10.1073/pnas.1205848109; Wu LC, 2002, GENE EXPRESSION, V10, P137, DOI 10.3727/000000002783992479; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	43	11	12	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9865	9879		10.1074/jbc.M113.520585	http://dx.doi.org/10.1074/jbc.M113.520585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563464	hybrid, Green Published			2022-12-25	WOS:000333807000036
J	Kerner, J; Minkler, P; Lesnefsky, E; Hoppel, C				Kerner, Janos; Minkler, Paul; Lesnefsky, Edward; Hoppel, Charles			Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation	FASEB JOURNAL			English	Meeting Abstract	Experimental Biology Meeting	APR 26-30, 2014	San Diego, CA	Cenveo, LI COR, Wiley, Mead Johnson Pediat Nutr Inst, IPRECIO, F1000 Res, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut					[Kerner, Janos; Minkler, Paul; Hoppel, Charles] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lesnefsky, Edward] Louis Stokes VA Med Ctr, Cleveland, OH USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center					NIA NIH HHS [P01 AG015885, P01 AG15885] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	1		S		758.2								1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AX0MP	24558043	hybrid, Green Published			2022-12-25	WOS:000346646704152
J	Bitter, K; Glaser, C; Neumann, K; Blunck, U; Frankenberger, R				Bitter, Kerstin; Glaeser, Christin; Neumann, Konrad; Blunck, Uwe; Frankenberger, Roland			Analysis of Resin-Dentin Interface Morphology and Bond Strength Evaluation of Core Materials for One Stage Post-Endodontic Restorations	PLOS ONE			English	Article							ROOT-CANAL DENTIN; REINFORCED COMPOSITE POSTS; PULP CHAMBER DENTIN; PUSH-OUT TESTS; FIBER POSTS; SMEAR LAYER; LUTING AGENT; ADHESIVE; SYSTEMS; TAGS	Purpose: Restoration of endodontically treated teeth using fiber posts in a one-stage procedure gains more popularity and aims to create a secondary monoblock. Data of detailed analyses of so called "post-and-core-systems" with respect to morphological characteristics of the resin-dentin interface in combination with bond strength measurements of fiber posts luted with these materials are scarce. The present study aimed to analyze four different post-and-core-systems with two different adhesive approaches (self-etch and etch-and-rinse). Materials and Methods: Human anterior teeth (n = 80) were endodontically treated and post space preparations and post placement were performed using the following systems: Rebilda Post/Rebilda DC/Futurabond DC (Voco) (RB), Luxapost/Luxacore Z/Luxabond Prebond and Luxabond A+B (DMG) (LC), X Post/Core X Flow/XP Bond and Self Cure Activator (Dentsply DeTrey) (CX), FRC Postec/MultiCore Flow/AdheSE DC (Ivoclar Vivadent) (MC). Adhesive systems and core materials of 10 specimens per group were labeled using fluorescent dyes and resin-dentin interfaces were analyzed using Confocal Laser Scanning Microscopy (CLSM). Bond strengths were evaluated using a push-out test. Data were analyzed using repeated measurement ANOVA and following post-hoc test. Results: CLSM analyses revealed significant differences between groups with respect to the factors hybrid layer thickness (p<0.0005) and number of resin tags (p = 0.02; ANOVA). Bond strength was significantly affected by core material (p = 0.001), location inside the root canal (p<0.0005) and incorporation of fluorescent dyes (p = 0.036; ANOVA). CX [7.7 (4.4) MPa] demonstrated significantly lower bond strength compared to LC [14.2 (8.7) MPa] and RB [13.3 (3.7) MPa] (p<0.05; Tukey HSD) but did not differ significantly from MC [11.5 (3.5) MPa]. Conclusion: It can be concluded that bond strengths inside the root canal were not affected by the adhesive approach of the post-and-core-system. All systems demonstrated homogenous hybrid layer formation and penetration into the dentinal tubules in spite of the complicating conditions for adhesion inside the root canal.	[Bitter, Kerstin; Glaeser, Christin; Blunck, Uwe] Charite, ChariteCtr 3, Univ Sch Dent Med, Dept Operat & Prevent Dent, D-13353 Berlin, Germany; [Neumann, Konrad] Charite, ChariteCtr 3, Dept Med Informat Biometry & Epidemiol, D-13353 Berlin, Germany; [Frankenberger, Roland] Univ Marburg, Dept Operat Dent & Endodontol, Marburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg	Bitter, K (corresponding author), Charite, ChariteCtr 3, Univ Sch Dent Med, Dept Operat & Prevent Dent, D-13353 Berlin, Germany.	kerstin.bitter@charite.de	Frankenberger, Roland/J-8198-2012; Blunck, Uwe/AAG-3093-2020	Frankenberger, Roland/0000-0002-5112-4463; Blunck, Uwe/0000-0001-6428-4987	VOCO; Dentsply DeTrey; Ivoclar Vivadent; DMG	VOCO; Dentsply DeTrey; Ivoclar Vivadent; DMG	This study was supported by VOCO, Dentsply DeTrey, Ivoclar Vivadent, and DMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTER D, 1992, J DENT RES, V71, P1619, DOI 10.1177/00220345920710091401; Arrais CAG, 2007, J PROSTHET DENT, V97, P99, DOI 10.1016/j.prosdent.2006.12.007; Arrais CAG, 2009, J ADHES DENT, V11, P15; Arrais CAG, 2009, J DENT, V37, P219, DOI 10.1016/j.jdent.2008.11.016; Bitter K, 2006, INT ENDOD J, V39, P809, DOI 10.1111/j.1365-2591.2006.01155.x; Bitter K, 2012, INT ENDOD J, V45, P1116, DOI 10.1111/j.1365-2591.2012.02081.x; Bitter K, 2012, OPER DENT, V37, P397, DOI 10.2341/11-066-L; Bitter K, 2004, INT ENDOD J, V37, P840, DOI 10.1111/j.1365-2591.2004.00888.x; Bitter K, 2008, J ENDODONT, V34, P306, DOI 10.1016/j.joen.2007.12.011; Bitter K, 2009, J ENDODONT, V35, P1477, DOI 10.1016/j.joen.2009.07.026; Bitter K, 2009, J ADHES DENT, V11, P7; Bitter K, 2009, EUR J ORAL SCI, V117, P326, DOI 10.1111/j.1600-0722.2009.00623.x; Cagidiaco MC, 2008, INT J PROSTHODONT, V21, P328; CZONSTKOWSKY M, 1990, DENT CLIN N AM, V34, P13; D'Alpino PHP, 2006, J DENT, V34, P623, DOI 10.1016/j.jdent.2005.12.004; D'Alpino PHP, 2006, J ADHES DENT, V8, P285; Fawzi EM, 2010, J ADHES DENT, V12, P63, DOI 10.3290/j.jad.a17594; Ferrari M, 2000, INT ENDOD J, V33, P397, DOI 10.1046/j.1365-2591.2000.00310.x; Ferrari M, 2009, J DENT RES, V88, P951, DOI 10.1177/0022034509342851; Ferrari M, 2000, AM J DENT, V13, P255; Goracci C, 2008, J DENT RES, V87, P1122, DOI 10.1177/154405910808701208; Goracci C, 2007, J DENT, V35, P827, DOI 10.1016/j.jdent.2007.07.009; Gu XH, 2009, EUR J ORAL SCI, V117, P597, DOI 10.1111/j.1600-0722.2009.00661.x; Kenshima S, 2006, J DENT, V34, P775, DOI 10.1016/j.jdent.2006.03.001; Kurtz JS, 2003, AM J DENT, V16, p31A; Lohbauer U, 2008, J ADHES DENT, V10, P97; Malyk Y, 2010, INT ENDOD J, V43, P47, DOI 10.1111/j.1365-2591.2009.01631.x; Mazzoni A, 2009, EUR J ORAL SCI, V117, P447, DOI 10.1111/j.1600-0722.2009.00656.x; Mjor IA, 2001, INT ENDOD J, V34, P346, DOI 10.1046/j.1365-2591.2001.00393.x; Naumann M, 2012, J ENDODONT, V38, P432, DOI 10.1016/j.joen.2012.01.003; Perdigao J, 2007, PRACT PROCED AESTHET, V19, P365; Perdigao Jorge, 2007, J Prosthodont, V16, P154, DOI 10.1111/j.1532-849X.2006.00166.x; Perdigao Jorge, 2007, Pract Proced Aesthet Dent, V19, P359; Pest LB, 2002, DENT MATER, V18, P596, DOI 10.1016/S0109-5641(02)00003-9; Radovic I, 2008, EUR J ORAL SCI, V116, P557, DOI 10.1111/j.1600-0722.2008.00577.x; Rodig T, 2010, J ADHES DENT, V12, P197, DOI 10.3290/j.jad.a18441; Santos JN, 2006, J ENDODONT, V32, P1088, DOI 10.1016/j.joen.2006.07.001; Sarkis-Onofre R, 2013, OPER DENT; Sattabanasuk V, 2007, J DENT, V35, P467, DOI 10.1016/j.jdent.2007.01.002; Schmage P, 2009, J PROSTHET DENT, V102, P368, DOI 10.1016/S0022-3913(09)60196-7; Soares CJ, 2008, DENT MATER, V24, P1405, DOI 10.1016/j.dental.2008.03.004; Sterzenbach G, 2012, J ENDODONT, V38, P1557, DOI 10.1016/j.joen.2012.08.015; Sterzenbach G, 2012, ACTA ODONTOL SCAND, V70, P368, DOI 10.3109/00016357.2011.603702; Tay FR, 2005, J ENDODONT, V31, P584, DOI 10.1097/01.don.0000168891.23486.de; Tay FR, 2007, J ENDODONT, V33, P391, DOI 10.1016/j.joen.2006.10.009; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023; Watson T F, 1997, Adv Dent Res, V11, P433; Watzke R, 2008, DENT MATER, V24, P1512, DOI 10.1016/j.dental.2008.03.022; Zhang L, 2008, EUR J ORAL SCI, V116, P280, DOI 10.1111/j.1600-0722.2008.00536.x; Zicari F, 2008, DENT MATER, V24, P967, DOI 10.1016/j.dental.2007.11.011	51	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e86294	10.1371/journal.pone.0086294	http://dx.doi.org/10.1371/journal.pone.0086294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586248	Green Published, Green Submitted, gold			2022-12-25	WOS:000332396200008
J	Baca, M; Laderach, P; Haggar, J; Schroth, G; Ovalle, O				Baca, Maria; Laederach, Peter; Haggar, Jeremy; Schroth, Gotz; Ovalle, Oriana			An Integrated Framework for Assessing Vulnerability to Climate Change and Developing Adaptation Strategies for Coffee Growing Families in Mesoamerica	PLOS ONE			English	Article								The Mesoamerican region is considered to be one of the areas in the world most vulnerable to climate change. We developed a framework for quantifying the vulnerability of the livelihoods of coffee growers in Mesoamerica at regional and local levels and identify adaptation strategies. Following the Intergovernmental Panel on Climate Change (IPCC) concepts, vulnerability was defined as the combination of exposure, sensitivity and adaptive capacity. To quantify exposure, changes in the climatic suitability for coffee and other crops were predicted through niche modelling based on historical climate data and locations of coffee growing areas from Mexico, Guatemala, El Salvador and Nicaragua. Future climate projections were generated from 19 Global Circulation Models. Focus groups were used to identify nine indicators of sensitivity and eleven indicators of adaptive capacity, which were evaluated through semi-structured interviews with 558 coffee producers. Exposure, sensitivity and adaptive capacity were then condensed into an index of vulnerability, and adaptation strategies were identified in participatory workshops. Models predict that all target countries will experience a decrease in climatic suitability for growing Arabica coffee, with highest suitability loss for El Salvador and lowest loss for Mexico. High vulnerability resulted from loss in climatic suitability for coffee production and high sensitivity through variability of yields and out-migration of the work force. This was combined with low adaptation capacity as evidenced by poor post harvest infrastructure and in some cases poor access to credit and low levels of social organization. Nevertheless, the specific contributors to vulnerability varied strongly among countries, municipalities and families making general trends difficult to identify. Flexible strategies for adaption are therefore needed. Families need the support of government and institutions specialized in impacts of climate change and strengthening of farmer organizations to enable the adjustment of adaptation strategies to local needs and conditions.	[Baca, Maria; Laederach, Peter] Int Ctr Trop Agr CIAT, Managua, Nicaragua; [Haggar, Jeremy] Univ Greenwich, NRI, Chatham, Kent, England; [Schroth, Gotz] Rainforest Alliance, Wageningen, Netherlands; [Ovalle, Oriana] Int Ctr Trop Agr CIAT, Cali, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; University of Greenwich; Alliance; International Center for Tropical Agriculture - CIAT	Baca, M (corresponding author), Int Ctr Trop Agr CIAT, Managua, Nicaragua.	magubago@gmail.com		Laderach, Peter/0000-0001-8708-6318	Green Mountain Coffee Roasters (GMCR); Natural Environment Research Council [NE/K501402/1] Funding Source: researchfish; NERC [NE/K501402/1] Funding Source: UKRI	Green Mountain Coffee Roasters (GMCR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was conducted under the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) in collaboration with Catholic Relief Services (CRS) and additional funding from Green Mountain Coffee Roasters (GMCR). Funds were used for employment and development of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no further patents, products in development or marketed products to declare.	Adger W.N., 1999, MITIG ADAPT STRAT GL, P253, DOI DOI 10.1023/A:1009601904210; Adger WN, 2003, ECON GEOGR, V79, P387; Altieri M.A., 2009, LEISA REV AGROECOLOG, V14, P5; Baker P, 2007, GLOBAL WARMING IMPAC; Castro F, 2004, 23 WORLD BANK LAT AM; CEPAL (Comision Economica Para America Latina y el Caribe), 2002, CENTR IMP CAID PREC; Cutter SL, 1996, PROG HUM GEOG, V20, P529, DOI 10.1177/030913259602000407; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; DFID (Departament for Internacional Development UK), 1999, HOJ OR MED VID SOST; Di Rienzo JA., 2008, INFOSTAT VERSION 200; Diaz R, 2009, REV IBEROAMERICANA R, V10, P61; Eakin H, 2011, ENVIRON MANAGE, V47, P352, DOI 10.1007/s00267-010-9603-2; ESCAMILLA E, 2005, MANEJO INTEGRADO PLA, V76, P5; Fabio Suarez, 1999, FUNDAMENTOS ESTADIST; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Geilfus Frans, 1997, 80 HERRAMIENTAS DESA; Haggar J, 2013, ENVIRON MANAGE, V51, P811, DOI 10.1007/s00267-013-0019-7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IPCC Grupo Gubernamental de Expertos sobre el Cambio climatico, 2008, CAMB CLIM AG; Ipcc (Intergovernmental Panel on Climate Change), 2001, CLIM CHANG 2001 WORK; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Laderach P, 2012, SPECIALTY COFFEE MAN, P39; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ramirez J., 2010, DISAGGREGATION GLOBA; Schroth G, 2013, AGRONOMY SU IN PRESS; Smit B, 1996, CLIMATIC CHANGE, V33, P7, DOI 10.1007/BF00140511; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tucker CM, 2010, GLOBAL ENVIRON CHANG, V20, P23, DOI 10.1016/j.gloenvcha.2009.07.006; Yohe G., 2006, SYNTHETIC ASSESSMENT	31	103	106	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88463	10.1371/journal.pone.0088463	http://dx.doi.org/10.1371/journal.pone.0088463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586328	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000332389000010
J	Wang, C; Huang, CC; Qian, J; Xiao, J; Li, H; Wen, YL; He, XH; Ran, W; Shen, QR; Yu, GH				Wang, Chang; Huang, Chichao; Qian, Jian; Xiao, Jian; Li, Huan; Wen, Yongli; He, Xinhua; Ran, Wei; Shen, Qirong; Yu, Guanghui			Rapid and Accurate Evaluation of the Quality of Commercial Organic Fertilizers Using Near Infrared Spectroscopy	PLOS ONE			English	Article							REFLECTANCE SPECTROSCOPY; PIG MANURE; COMPOST; MATTER; STABILITY; PREDICT	The composting industry has been growing rapidly in China because of a boom in the animal industry. Therefore, a rapid and accurate assessment of the quality of commercial organic fertilizers is of the utmost importance. In this study, a novel technique that combines near infrared (NIR) spectroscopy with partial least squares (PLS) analysis is developed for rapidly and accurately assessing commercial organic fertilizers quality. A total of 104 commercial organic fertilizers were collected from full-scale compost factories in Jiangsu Province, east China. In general, the NIR-PLS technique showed accurate predictions of the total organic matter, water soluble organic nitrogen, pH, and germination index; less accurate results of the moisture, total nitrogen, and electrical conductivity; and the least accurate results for water soluble organic carbon. Our results suggested the combined NIR-PLS technique could be applied as a valuable tool to rapidly and accurately assess the quality of commercial organic fertilizers.	[Wang, Chang; Huang, Chichao; Qian, Jian; Xiao, Jian; Li, Huan; Wen, Yongli; Ran, Wei; Shen, Qirong; Yu, Guanghui] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China; [He, Xinhua] Univ Western Australia, Sch Plant Biol, Crawley, Australia	Nanjing Agricultural University; University of Western Australia	Yu, GH (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing, Jiangsu, Peoples R China.	yuguanghui@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Yu, Guanghui/H-4968-2013; Wang, Chang/E-5303-2019; He, Xinhua/B-8047-2015	Yu, Guanghui/0000-0002-5699-779X; Wang, Chang/0000-0003-2217-5445; He, Xinhua/0000-0002-5570-3454	National Natural Science Foundation of China [41371248, 41371299]; National Basic Research Program of China [2011CB100503]; Natural Science Foundation of Jiangsu Province of China [BK20131321]; 111 Project [B12009]; Qing Lan Project, Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project); Qing Lan Project, Innovative Research Team Development Plan of the Ministry of Education of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Natural Science Foundation of China (41371248 and 41371299), the National Basic Research Program of China (2011CB100503), the Natural Science Foundation of Jiangsu Province of China (BK20131321), the 111 Project (B12009), Qing Lan Project, Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht R, 2009, ENVIRON SCI TECHNOL, V43, P804, DOI 10.1021/es802064u; Albrecht R, 2008, BIORESOURCE TECHNOL, V99, P448, DOI 10.1016/j.biortech.2006.12.019; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Chang CW, 2001, SOIL SCI SOC AM J, V65, P480, DOI 10.2136/sssaj2001.652480x; Cozzolino D, 2003, J AGR SCI-CAMBRIDGE, V140, P65, DOI 10.1017/S0021859602002836; Fidencio PH, 2002, COMMUN SOIL SCI PLAN, V33, P1607, DOI 10.1081/CSS-120004302; Fluckiger M, 2011, FOOD CHEM, V126, P1817, DOI 10.1016/j.foodchem.2010.12.078; Francou U, 2005, COMPOST SCI UTIL, V13, P72; Fujiwara T, 2007, SOIL SCI PLANT NUTR, V53, P102, DOI 10.1111/j.1747-0765.2007.00109.x; Gajalakshmi S, 2008, CRIT REV ENV SCI TEC, V38, P311, DOI 10.1080/10643380701413633; Hayes DJM, 2012, BIORESOURCE TECHNOL, V119, P393, DOI 10.1016/j.biortech.2012.05.137; Huang G, 2007, J NEAR INFRARED SPEC, V15, P387, DOI 10.1255/jnirs.745; Lu W. Z., 2000, MODERN NEAR INFRARED; Malley DF, 2005, COMMUN SOIL SCI PLAN, V36, P455, DOI 10.1081/CSS-200043187; Meissl K, 2008, APPL SPECTROSC, V62, P873, DOI 10.1366/000370208785284277; Moral R, 2009, BIORESOURCE TECHNOL, V100, P5454, DOI 10.1016/j.biortech.2008.12.007; Moral R, 2007, P INT C ENV MAN ENG, P1683; Peltre C, 2011, SOIL BIOL BIOCHEM, V43, P197, DOI 10.1016/j.soilbio.2010.09.036; Saeys W, 2005, BIOSYST ENG, V91, P393, DOI 10.1016/j.biosystemseng.2005.05.001; Saeys W, 2004, J NEAR INFRARED SPEC, V12, P299, DOI 10.1255/jnirs.438; Said-Pullicino D, 2007, BIORESOURCE TECHNOL, V98, P1822, DOI 10.1016/j.biortech.2006.06.018; Soriano-Disla JM, 2010, GEODERMA, V158, P93, DOI 10.1016/j.geoderma.2009.12.022; Tang Z, 2011, CHEMOSPHERE, V82, P1202, DOI 10.1016/j.chemosphere.2010.11.032; Vernoux A, 2009, SCI TOTAL ENVIRON, V407, P2390, DOI 10.1016/j.scitotenv.2008.12.033; Xing L, 2008, POULTRY SCI, V87, P1281, DOI 10.3382/ps.2007-00464; Yang ZL, 2006, J NEAR INFRARED SPEC, V14, P261, DOI 10.1255/jnirs.643; Yu GH, 2011, WASTE MANAGE, V31, P1729, DOI 10.1016/j.wasman.2010.10.031; Yu GH, 2010, BIORESOURCE TECHNOL, V101, P8244, DOI 10.1016/j.biortech.2010.06.007	28	15	16	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88279	10.1371/journal.pone.0088279	http://dx.doi.org/10.1371/journal.pone.0088279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586313	Green Published, Green Submitted, gold			2022-12-25	WOS:000332385900009
J	Xue, WW; Yang, Y; Wang, XT; Liu, HX; Yao, XJ				Xue, Weiwei; Yang, Ying; Wang, Xiaoting; Liu, Huanxiang; Yao, Xiaojun			Computational Study on the Inhibitor Binding Mode and Allosteric Regulation Mechanism in Hepatitis C Virus NS3/4A Protein	PLOS ONE			English	Article							FREE-ENERGY CALCULATION; MOLECULAR-DYNAMICS; RESP METHODOLOGY; MM-PBSA; HCV NS3; DERIVATIVES; NETWORKS; COMMUNICATION; SIMULATIONS; RESISTANCE	HCV NS3/4A protein is an attractive therapeutic target responsible for harboring serine protease and RNA helicase activities during the viral replication. Small molecules binding at the interface between the protease and helicase domains can stabilize the closed conformation of the protein and thus block the catalytic function of HCV NS3/4A protein via an allosteric regulation mechanism. But the detailed mechanism remains elusive. Here, we aimed to provide some insight into the inhibitor binding mode and allosteric regulation mechanism of HCV NS3/4A protein by using computational methods. Four simulation systems were investigated. They include: apo state of HCV NS3/4A protein, HCV NS3/4A protein in complex with an allosteric inhibitor and the truncated form of the above two systems. The molecular dynamics simulation results indicate HCV NS3/4A protein in complex with the allosteric inhibitor 4VA adopts a closed conformation (inactive state), while the truncated apo protein adopts an open conformation (active state). Further residue interaction network analysis suggests the communication of the domain-domain interface play an important role in the transition from closed to open conformation of HCV NS3/4A protein. However, the inhibitor stabilizes the closed conformation through interaction with several key residues from both the protease and helicase domains, including His57, Asp79, Asp81, Asp168, Met485, Cys525 and Asp527, which blocks the information communication between the functional domains interface. Finally, a dynamic model about the allosteric regulation and conformational changes of HCV NS3/4A protein was proposed and could provide fundamental insights into the allosteric mechanism of HCV NS3/4A protein function regulation and design of new potent inhibitors.	[Xue, Weiwei; Wang, Xiaoting; Yao, Xiaojun] Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Yang, Ying] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Yang, Ying] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China	Lanzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Lanzhou University; Macau University of Science & Technology	Yao, XJ (corresponding author), Lanzhou Univ, Dept Chem, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	Xue, Weiwei/C-7461-2016	Xue, Weiwei/0000-0002-3285-0574; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21175063]; program for Changjiang Scholars and Innovative Research Team in University [PCSIRT: IRT1137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant No. 21175063) and the program for Changjiang Scholars and Innovative Research Team in University (PCSIRT: IRT1137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; [Anonymous], 2008, AMBER 10; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Chiappori F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002844; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding SC, 2011, J VIROL, V85, P4343, DOI 10.1128/JVI.02130-10; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Graham B, 2011, HEP DART 2011 KAUAI; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huo SH, 2002, J MED CHEM, V45, P1412, DOI 10.1021/jm010338j; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klibanov OM, 2012, PHARMACOTHERAPY, V32, P173, DOI 10.1002/PHAR.1046; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2005, J MED CHEM, V48, P4040, DOI 10.1021/jm049081q; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Li LW, 2007, J AM CHEM SOC, V129, P15668, DOI 10.1021/ja076046a; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matthews SJ, 2012, CLIN THER, V34, P1857, DOI 10.1016/j.clinthera.2012.07.011; Melnikova I, 2011, NAT REV DRUG DISCOV, V10, P93, DOI 10.1038/nrd3361; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Piggot TJ, 2012, BIOCHEMISTRY-US, V51, P1707, DOI 10.1021/bi201237a; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saalau-Bethell SM, 2011, LIV M SAN FRANC CA U; Saalau-Bethell SM, 2012, NAT CHEM BIOL, V8, P920, DOI [10.1038/NCHEMBIO.1081, 10.1038/nchembio.1081]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen MY, 2013, MOL BIOSYST, V9, P2435, DOI 10.1039/c3mb70168a; Shen MY, 2013, MOL BIOSYST, V9, P361, DOI 10.1039/c2mb25408e; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tan S. L, 2006, HEPATITIS C VIRUSES, P163; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; vanAalten DMF, 1995, PROTEIN ENG, V8, P1129; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035159; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wright DW, 2012, J AM CHEM SOC, V134, P12885, DOI 10.1021/ja301565k; Xu L, 2013, MOL BIOSYST, V9, P2107, DOI 10.1039/c3mb70120d; Xue WW, 2012, MOL BIOSYST, V8, P2753, DOI 10.1039/c2mb25157d; Xue WW, 2012, J COMPUT CHEM, V33, P527, DOI 10.1002/jcc.22887; Yang Y, 2011, J CHEM INF MODEL, V51, P3235, DOI 10.1021/ci200159g; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8	63	20	20	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e87077	10.1371/journal.pone.0087077	http://dx.doi.org/10.1371/journal.pone.0087077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586263	Green Published, Green Submitted, gold			2022-12-25	WOS:000332385900006
J	Fushing, H; Chen, SC; Hwang, CR				Fushing, Hsieh; Chen, Shu-Chun; Hwang, Chii-Ruey			Single Stock Dynamics on High-Frequency Data: From a Compressed Coding Perspective	PLOS ONE			English	Article							VOLUME; VOLATILITY; PHASES	High-frequency return, trading volume and transaction number are digitally coded via a nonparametric computing algorithm, called hierarchical factor segmentation (HFS), and then are coupled together to reveal a single stock dynamics without global state-space structural assumptions. The base-8 digital coding sequence, which is capable of revealing contrasting aggregation against sparsity of extreme events, is further compressed into a shortened sequence of state transitions. This compressed digital code sequence vividly demonstrates that the aggregation of large absolute returns is the primary driving force for stimulating both the aggregations of large trading volumes and transaction numbers. The state of system-wise synchrony is manifested with very frequent recurrence in the stock dynamics. And this data-driven dynamic mechanism is seen to correspondingly vary as the global market transiting in and out of contraction-expansion cycles. These results not only elaborate the stock dynamics of interest to a fuller extent, but also contradict some classical theories in finance. Overall this version of stock dynamics is potentially more coherent and realistic, especially when the current financial market is increasingly powered by high-frequency trading via computer algorithms, rather than by individual investors.	[Fushing, Hsieh] Univ Calif Davis, Davis, CA 95616 USA; [Chen, Shu-Chun; Hwang, Chii-Ruey] Acad Sinica, Inst Math, Taipei, Taiwan	University of California System; University of California Davis; Academia Sinica - Taiwan	Fushing, H (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	fhsieh@ucdavis.edu	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137	NSF [DMS 1007219]	NSF(National Science Foundation (NSF))	This research was supported by NSF under grant DMS 1007219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane T, 2000, J FINANC, V55, P2259, DOI 10.1111/0022-1082.00286; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Chang LB, 2013, BULL INST MATH ACAD, V8, P31; Chang LB, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022116; Clark Carol, 2010, CHICAGO FED LETT, V272; Fushing H, 2006, J THEOR BIOL, V238, P805, DOI 10.1016/j.jtbi.2005.06.031; Fushing H, 2010, PSYCHOMETRIKA, V75, P351; Fushing H, 2009, INT J BIOSTATISTICS, V5; Fushing H, 2010, STAT BIOSCI, V2, P18, DOI 10.1007/s12561-010-9019-9; Fushing H, 2012, QUANT FINANC, V12, P213, DOI 10.1080/14697681003743040; Fushing H, 2010, J COMPUT GRAPH STAT, V19, P221, DOI 10.1198/jcgs.2009.07141; Fushing H, 2009, COMPUTATION STAT, V24, P409, DOI 10.1007/s00180-008-0134-8; GALLANT AR, 1992, REV FINANC STUD, V5, P199, DOI 10.1093/rfs/5.2.199; JONES CM, 1994, REV FINANC STUD, V7, P631, DOI 10.1093/rfs/7.4.631; KARPOFF JM, 1987, J FINANC QUANT ANAL, V22, P109, DOI 10.2307/2330874; TAUCHEN GE, 1983, ECONOMETRICA, V51, P485, DOI 10.2307/1912002	16	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e85018	10.1371/journal.pone.0085018	http://dx.doi.org/10.1371/journal.pone.0085018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586235	gold, Green Published, Green Submitted			2022-12-25	WOS:000331717900002
J	Byrd, DT; Knobel, K; Affeldt, K; Crittenden, SL; Kimble, J				Byrd, Dana T.; Knobel, Karla; Affeldt, Katharyn; Crittenden, Sarah L.; Kimble, Judith			A DTC Niche Plexus Surrounds the Germline Stem Cell Pool in Caenorhabditis elegans	PLOS ONE			English	Article							RNA-BINDING PROTEIN; C-ELEGANS; MITOTIC REGION; SIGNALING LIGAND; LINE; GLP-1; GLD-1; DIFFERENTIATION; DECISION; PROGRESSION	The mesenchymal distal tip cell (DTC) provides the niche for Caenorhabditis elegans germline stem cells (GSCs). The DTC has a complex cellular architecture: its cell body caps the distal gonadal end and contacts germ cells extensively, but it also includes multiple cellular processes that extend along the germline tube and intercalate between germ cells. Here we use the lag-2 DTC promoter to drive expression of myristoylated GFP, which highlights DTC membranes and permits a more detailed view of DTC architecture. We find that short processes intercalating between germ cells contact more germ cells than seen previously. We define this region of extensive niche contact with germ cells as the DTC plexus. The extent of the DTC plexus corresponds well with the previously determined extent of the GSC pool. Moreover, expression of a differentiation marker increases as germ cells move out of the plexus. Maintenance of this DTC plexus depends on the presence of undifferentiated germ cells, suggesting that germ cell state can influence niche architecture. The roles of this DTC architecture remain an open question. One idea is that the DTC plexus delivers Notch signaling to the cluster of germ cells comprising the GSC pool; another idea is that the plexus anchors GSCs at the distal end.	[Byrd, Dana T.; Crittenden, Sarah L.; Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Byrd, Dana T.; Knobel, Karla; Affeldt, Katharyn; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Kimble, Judith] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kimble, Judith] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	jekimble@wisc.edu			National Institute of Health postdoctoral fellowship [F32 GM072126]; National Institutes of Health [R01 GM069454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072126, R01GM069454] Funding Source: NIH RePORTER	National Institute of Health postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DTB was supported by National Institute of Health postdoctoral fellowship F32 GM072126. JK is supported by National Institutes of Health grant R01 GM069454 and is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2011, SCIENCE, V332, P312, DOI 10.1126/science.1205971; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Bachorik JL, 2005, P NATL ACAD SCI USA, V102, P10893, DOI 10.1073/pnas.0504593102; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; BRENNER S, 1974, GENETICS, V77, P71; Byrd DT, 2009, SEMIN CELL DEV BIOL, V20, P1107, DOI 10.1016/j.semcdb.2009.09.005; Chen SY, 2011, CURR OPIN GENET DEV, V21, P684, DOI 10.1016/j.gde.2011.07.008; Cinquin O, 2010, P NATL ACAD SCI USA, V107, P2048, DOI 10.1073/pnas.0912704107; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Eckmann CR, 2002, DEV CELL, V3, P697, DOI 10.1016/S1534-5807(02)00322-2; Finger FP, 2003, DEV BIOL, V261, P220, DOI 10.1016/S0012-1606(03)00296-3; Fitzgerald K, 1995, DEVELOPMENT, V121, P4275; Fox PM, 2011, DEVELOPMENT, V138, P2223, DOI 10.1242/dev.059535; FRANCIS R, 1995, GENETICS, V139, P579; Gradilla AC, 2013, CELL TISSUE RES, V352, P59, DOI 10.1007/s00441-013-1578-x; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hansen D, 2004, DEVELOPMENT, V131, P93, DOI 10.1242/dev.00916; Henderson ST, 1997, MOL BIOL CELL, V8, P1751, DOI 10.1091/mbc.8.9.1751; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; HODGKIN J, 1979, GENETICS, V91, P67; Hubbard EJA, 2007, DEV DYNAM, V236, P3343, DOI 10.1002/dvdy.21335; Jones AR, 1996, DEV BIOL, V180, P165, DOI 10.1006/dbio.1996.0293; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kershner A, 2013, ADV EXP MED BIOL, V786, P29, DOI 10.1007/978-94-007-6621-1_3; Kim HS, 2011, DEVELOPMENT, V138, P4013, DOI 10.1242/dev.059568; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Lander AD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-19; Lehmann R, 2012, CELL STEM CELL, V10, P729, DOI 10.1016/j.stem.2012.05.016; Lints R., 2009, REPROD SYSTEM SOMATI; Morgan DE, 2010, DEV BIOL, V346, P204, DOI 10.1016/j.ydbio.2010.07.022; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Peters EC, 2013, G3-GENES GENOM GENET, V3, P181, DOI 10.1534/g3.112.004416; Rasband W., 2006, IMAGEJ; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025; Voronina E, 2012, DEVELOPMENT, V139, P3732, DOI 10.1242/dev.083980; Wong BG, 2013, INTEGR BIOL-UK, V5, P976, DOI 10.1039/c3ib20291g; Wong MC, 2012, WIRES DEV BIOL, V1, P519, DOI 10.1002/wdev.45; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	54	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88372	10.1371/journal.pone.0088372	http://dx.doi.org/10.1371/journal.pone.0088372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586318	Green Published, gold, Green Submitted			2022-12-25	WOS:000331711900026
J	Kim, YY; Moon, JS; Kwon, MC; Shin, J; Im, SK; Kim, HA; Han, JK; Kong, YY				Kim, Yoon-Young; Moon, Jin-Sook; Kwon, Min-chul; Shin, Juhee; Im, Sun-Kyoung; Kim, Hyun-A; Han, Jin-Kwan; Kong, Young-Yun			Meteorin Regulates Mesendoderm Development by Enhancing Nodal Expression	PLOS ONE			English	Article							RIGHT ASYMMETRIC EXPRESSION; ANTERIOR VISCERAL ENDODERM; EMBRYONIC STEM-CELLS; MESODERM FORMATION; PROMOTES DIFFERENTIATION; MOUSE; ANTAGONISTS; INDUCTION; EPIBLAST; ACTIVIN	During gastrulation, distinct lineage specification into three germ layers, the mesoderm, endoderm and ectoderm, occurs through an elaborate harmony between signaling molecules along the embryonic proximo-distal and anterior-posterior axes, and Nodal signaling plays a key role in the early embryonic development governing embryonic axis formation, mesoderm and endoderm specification, and left-right asymmetry determination. However, the mechanism by which Nodal expression is regulated is largely unknown. Here, we show that Meteorin regulates Nodal expression and is required for mesendoderm development. It is highly expressed in the inner cell mass of blastocysts and further in the epiblast and extra-embryonic ectoderm during gastrulation. Genetic ablation of the Meteorin gene resulted in early embryonic lethality, presumably due to impaired lineage allocation and subsequent cell accumulation. Embryoid body culture using Meteorin-null embryonic stem (ES) cells showed reduced Nodal expression and concomitant impairment of mesendoderm specification. Meteorin-null embryos displayed reduced levels of Nodal transcripts before the gastrulation stage, and impaired expression of Goosecoid, a definitive endoderm marker, during gastrulation, while the proximo-distal and anterior-posterior axes and primitive streak formation were preserved. Our results show that Meteorin is a novel regulator of Nodal transcription and is required to maintain sufficient Nodal levels for endoderm formation, thereby providing new insights in the regulation of mesendoderm allocation.	[Kim, Yoon-Young; Shin, Juhee; Im, Sun-Kyoung; Kim, Hyun-A; Kong, Young-Yun] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Yoon-Young; Moon, Jin-Sook; Kwon, Min-chul; Shin, Juhee; Im, Sun-Kyoung; Han, Jin-Kwan] POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH)	Kong, YY (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	ykong@snu.ac.kr		Moon, Jin-Sook/0000-0002-7231-328X	National Research Foundation of Korea (RND) [2013003731]; National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND) [0920310]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) (RND) [2013037841]; Global Frontier Project grant (RND) of the National Research Foundation [2013045940]; Ministry of Education, Science and Technology of Korea	National Research Foundation of Korea (RND)(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND); Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST) (RND)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Global Frontier Project grant (RND) of the National Research Foundation(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (RND no. 2013003731); National R&D Program for Cancer Control, Ministry of Health & Welfare, the Republic of Korea (RND no. 0920310); Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (RND no. 2013037841); and a Global Frontier Project grant (RND no. 2013045940) of the National Research Foundation funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1999, GENE DEV, V13, P1589, DOI 10.1101/gad.13.12.1589; Agius E, 2000, DEVELOPMENT, V127, P1173; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Jorgensen JR, 2012, EXP NEUROL, V237, P260, DOI 10.1016/j.expneurol.2012.06.027; Jorgensen JR, 2011, NEUROBIOL DIS, V41, P160, DOI 10.1016/j.nbd.2010.09.003; Jorgensen JR, 2009, J MOL NEUROSCI, V39, P104, DOI 10.1007/s12031-009-9189-4; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lawson KA, 1999, INT J DEV BIOL, V43, P773; Lee HS, 2010, J CELL SCI, V123, P1959, DOI 10.1242/jcs.063784; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Nagi A, 2003, MANIPULATING MOUSE E; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Pfendler KC, 2005, STEM CELLS DEV, V14, P162, DOI 10.1089/scd.2005.14.162; Rodriguez TA, 2005, DEVELOPMENT, V132, P2513, DOI 10.1242/dev.01847; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takenaga M, 2007, J CELL SCI, V120, P2078, DOI 10.1242/jcs.004127; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Varlet I, 1997, DEVELOPMENT, V124, P1033; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yasuo H, 1999, CURR BIOL, V9, P869, DOI 10.1016/S0960-9822(99)80391-1; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88811	10.1371/journal.pone.0088811	http://dx.doi.org/10.1371/journal.pone.0088811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558432	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700078
J	Silberbush, A; Tsurim, I; Rosen, R; Margalith, Y; Ovadia, O				Silberbush, Alon; Tsurim, Ido; Rosen, Ran; Margalith, Yoel; Ovadia, Ofer			Species-Specific Non-Physical Interference Competition among Mosquito Larvae	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; INTRASPECIFIC COMPETITION; CULISETA-LONGIAREOLATA; DEVELOPMENT TIME; DENSITY; CULICIDAE; SIZE; VECTOR; GROWTH; DISPLACEMENT	Individuals of different sex, size or developmental stage can compete differently and hence contribute distinctively to population dynamics. In species with complex life cycles such as insects, competitive ability is often positively correlated with larval developmental stage. Yet, little is known on how the development and survival of early-instars is influenced by interference from late-instar larvae, especially at low densities when exploitative competition is expected to be negligible. Furthermore, the specificity and mechanisms by which interference competition operates are largely unknown. We performed two complementary experiments aiming to quantify the competitive effects of late instar Ochlerotatus caspius on early instar larvae at low densities and under high resource supply rate. The first experiment examined the net effect of interference by 4th on 1st instar O. caspius larvae, relative to the effect of 1st instars on themselves. The second experiment examined the effect of species-specific, non-physical interference competition (i.e., cage larvae) by 4th on 1st instar O. caspius larvae at low or high densities. Specifically, we compared the responses of O. caspius larvae raised in the presence of caged con-or hetero-specific, Culiseta longiareolata, with that of larvae in the empty-cage control group. As expected, interference from late instar larvae had a net negative effect on the development rate of first instars. In contrast, the presence of caged con-specifics (non-physical interference) accelerated the development rate of O. caspius, however, this pattern was only evident at the low density. Notably, no such pattern was detected in the presence of caged hetero-specifics. These results strongly suggest the existence of species-specific growth regulating semiochemicals.	[Silberbush, Alon; Tsurim, Ido; Margalith, Yoel; Ovadia, Ofer] Ben Gurion Univ Negev, Dept Life Sci, Ctr Biol Control, IL-84105 Beer Sheva, Israel; [Tsurim, Ido] Achva Acad Coll, Dept Life Sci, Arugot, Israel; [Rosen, Ran] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel	Ben Gurion University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Silberbush, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Ctr Biol Control, IL-84105 Beer Sheva, Israel.	alonsil@gmail.com	Silberbush, Alon/AAD-3650-2021; Silberbush, Alon/GPP-6599-2022	Silberbush, Alon/0000-0002-8762-6836; Ovadia, Ofer/0000-0002-4941-4947; Tsurim, Ido/0000-0002-8510-3089				Alto BW, 2009, J ANIM ECOL, V78, P928, DOI 10.1111/j.1365-2656.2009.01558.x; Amr ZS, 1997, J AM MOSQUITO CONTR, V13, P375; BARBOSA P, 1973, ENTOMOL EXP APPL, V16, P146, DOI 10.1007/BF00290687; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; BLAUSTEIN L, 1993, ECOL ENTOMOL, V18, P104, DOI 10.1111/j.1365-2311.1993.tb01190.x; BLAUSTEIN L, 1994, J ANIM ECOL, V63, P841, DOI 10.2307/5261; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bradshaw WE, 1997, ECOLOGY, V78, P969, DOI 10.1890/0012-9658(1997)078[0969:HODTAP]2.0.CO;2; BROADIE KS, 1991, ECOL ENTOMOL, V16, P145, DOI 10.1111/j.1365-2311.1991.tb00203.x; Carron A., 2007, European Mosquito Bulletin, P4; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583; Crossland MR, 2012, BIOL LETTERS, V8, P226, DOI 10.1098/rsbl.2011.0794; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Dieng H, 2002, MED VET ENTOMOL, V16, P285, DOI 10.1046/j.1365-2915.2002.00377.x; EDGERLY JS, 1992, J ANIM ECOL, V61, P139, DOI 10.2307/5517; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; Gleiser RM, 2000, ENTOMOL EXP APPL, V95, P135, DOI 10.1023/A:1003994321769; Grether GF, 2009, BIOL REV, V84, P617, DOI 10.1111/j.1469-185X.2009.00089.x; Gross EM, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P196; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611; Keddy P., 2001, COMPETITION; Lack D.L., 1971, ECOLOGICAL ISOLATION; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lurling M, 2003, J PLANKTON RES, V25, P967, DOI 10.1093/plankt/25.8.967; Maciá Arnaldo, 2009, Rev. Soc. Entomol. Argent., V68, P107; Mahmood F, 1997, J VECTOR ECOL, V22, P90; MARGALIT J, 1973, ISRAEL J ZOOL, V22, P27; Miller TX, 2011, TRENDS ECOL EVOL, V26, P183; Moll JD, 2008, AM NAT, V171, P839, DOI 10.1086/587517; MOORE CG, 1969, ANN ENTOMOL SOC AM, V62, P1325, DOI 10.1093/aesa/62.6.1325; MORI A, 1979, Tropical Medicine, V21, P85; Morin P., 1999, COMMUNITY ECOL; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Muturi EJ, 2010, ACTA TROP, V116, P141, DOI 10.1016/j.actatropica.2010.07.003; Ng'habi KR, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-49; Persson L, 1998, THEOR POPUL BIOL, V54, P270, DOI 10.1006/tpbi.1998.1380; PETERS TM, 1969, MOSQ NEWS, V29, P667; RAJAGOPALAN PK, 1976, INDIAN J MED RES, V64, P688; Rasband WS, 2011, IMAGEJ; REISEN WK, 1975, MOSQ NEWS, V35, P473; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; RENSHAW M, 1993, ECOL ENTOMOL, V18, P223, DOI 10.1111/j.1365-2311.1993.tb01094.x; Roberts D, 1998, J MED ENTOMOL, V35, P665, DOI 10.1093/jmedent/35.5.665; Roberts D, 2010, ENTOMOL EXP APPL, V135, P271, DOI 10.1111/j.1570-7458.2010.00993.x; Roiz D, 2007, J VECTOR ECOL, V32, P10, DOI 10.3376/1081-1710(2007)32[10:ASOMBI]2.0.CO;2; Royama T., 1992, ANAL POPULATION ECOL; Shaalan E. A., 2012, Journal of Entomology, V9, P183, DOI 10.3923/je.2012.183.186; Shalaby A.M., 1972, Bulletin Soc Ent Egypte, V56, P301; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; SIDDIQUI T F, 1976, Tropical Medicine, V18, P195; Sokal RR, 1995, BIOMETRY PRINCIPLES; Suleman Mohammad, 1993, Pakistan Journal of Zoology, V25, P321; Telang A, 2007, J EXP BIOL, V210, P854, DOI 10.1242/jeb.02715; Tseng M, 2004, P ROY SOC B-BIOL SCI, V271, pS186, DOI 10.1098/rsbl.2003.0139; Tsurim I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057875; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	61	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88650	10.1371/journal.pone.0088650	http://dx.doi.org/10.1371/journal.pone.0088650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558406	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700052
J	Zhu, XM; Deng, XP; Huang, GY; Wang, J; Yang, JW; Chen, S; Ma, X; Wang, BB				Zhu, Xiaomei; Deng, Xiaopeng; Huang, Guangying; Wang, Jing; Yang, Jingwen; Chen, Si; Ma, Xu; Wang, Binbin			A Novel Mutation of Hyaluronan Synthase 2 Gene in Chinese Children with Ventricular Septal Defect	PLOS ONE			English	Article							CARDIAC-VALVE FORMATION; TO-MESENCHYMAL TRANSITION; MOUSE HYALURONAN SYNTHASE; CONGENITAL HEART-DEFECTS; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; MORPHOGENESIS; RECEPTOR; EXPRESSION	As a major product of extracellular matrix (ECM), Hyaluronic acid (HA) is involved in early cardiac development and mainly synthesized by Hyaluronan synthase 2 (HAS2) during embryogenesis. Targeted deletion of HAS2 gene in mice led to obvious cardiac and vascular defects. To clarify the potential association of the mutation in HAS2 with the development of congenital heart disease (CHD), in this study, we sequenced the coding region of HAS2 and identified a novel non-synonymous variant c. A1496T (p.Glu499Val) in one of 100 non-syndromic Ventricular Septal Defect (VSD) patients. The variant was not observed in 250 controls. In addition, to determine the contribution of HAS2 variant in VSD, we compared HA content in supernatant using HA quantitative analysis and found that the mutation obviously affected the HA synthetic activity of HAS2. To our knowledge, this is the first time that the mutation in HAS2 was found in Chinese VSD patients, which suggested that HAS2 may be involved in the etiology of non-syndromic VSD and have the vital function in the development of heart septum.	[Zhu, Xiaomei; Ma, Xu; Wang, Binbin] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhu, Xiaomei; Yang, Jingwen; Chen, Si; Ma, Xu; Wang, Binbin] Natl Res Inst Family Planning, Beijing, Peoples R China; [Deng, Xiaopeng] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Ma, Xu] World Hlth Org Collaborating Ctr Res Human Reprod, Beijing, Peoples R China; [Huang, Guangying] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Wang, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; China Medical University; World Health Organization; Fudan University; Capital Medical University	Ma, X (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	NICGR@263.net; wbbahu@163.com		Wang, Binbin/0000-0002-1597-5930	National Basic Research Program of China [2010CB5295040]; National Natural Science Foundation of China [81300131]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2010CB5295040, http://www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (81300131, http://www.nsfc.gov.cn/publish/portal0/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BALDWIN HS, 1994, CIRC RES, V74, P244, DOI 10.1161/01.RES.74.2.244; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Hanson KP, 2013, TISSUE ENG PT A, V19, P1132, DOI [10.1089/ten.tea.2012.0316, 10.1089/ten.TEA.2012.0316]; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; KRUG EL, 1985, DEV BIOL, V112, P414, DOI 10.1016/0012-1606(85)90414-2; Lagendijk AK, 2013, TRENDS CARDIOVAS MED, V23, P135, DOI 10.1016/j.tcm.2012.10.002; Lagendijk AK, 2010, TRENDS CARDIOVAS MED, V20, P124, DOI 10.1016/j.tcm.2010.10.003; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; MOLLER JH, 1995, PEDIATR CARDIOL, V16, P216, DOI 10.1007/BF00795710; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Penny DJ, 2011, LANCET, V377, P1103, DOI 10.1016/S0140-6736(10)61339-6; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rodgers LS, 2006, CIRC RES, V99, P583, DOI 10.1161/01.RES.0000242561.95978.43; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Spicer AP, 1997, GENOMICS, V41, P493, DOI 10.1006/geno.1997.4696; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stevens MV, 2008, CIRC RES, V103, P1430, DOI 10.1161/CIRCRESAHA.108.180752; Sullivan KE, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024349; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wang DZ, 2010, PEDIATR CARDIOL, V31, P357, DOI 10.1007/s00246-010-9641-9; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	46	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87437	10.1371/journal.pone.0087437	http://dx.doi.org/10.1371/journal.pone.0087437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558368	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700014
J	Ceccarelli, M; Galluzzi, L; Migliazzo, A; Magnani, M				Ceccarelli, Marcello; Galluzzi, Luca; Migliazzo, Antonella; Magnani, Mauro			Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CANINE LEISHMANIASIS; VISCERAL LEISHMANIASIS; PERIPHERAL-BLOOD; ASSAY; DIAGNOSIS; DOGS; QUANTIFICATION; AMPLIFICATION; AGENTS	Leishmaniasis is a neglected disease with a broad clinical spectrum which includes asymptomatic infection. A thorough diagnosis, able to distinguish and quantify Leishmania parasites in a clinical sample, constitutes a key step in choosing an appropriate therapy, making an accurate prognosis and performing epidemiological studies. Several molecular techniques have been shown to be effective in the diagnosis of leishmaniasis. In particular, a number of PCR methods have been developed on various target DNA sequences including kinetoplast minicircle constant regions. The first aim of this study was to develop a SYBR green-based qPCR assay for Leishmania (Leishmania) infantum detection and quantification, using kinetoplast minicircle constant region as target. To this end, two assays were compared: the first used previously published primer pairs (qPCR1), whereas the second used a nested primer pairs generating a shorter PCR product (qPCR2). The second aim of this study was to evaluate the possibility to discriminate among subgenera Leishmania (Leishmania) and Leishmania (Viannia) using the qPCR2 assay followed by melting or High Resolution Melt (HRM) analysis. Both assays used in this study showed good sensitivity and specificity, and a good correlation with standard IFAT methods in 62 canine clinical samples. However, the qPCR2 assay allowed to discriminate between Leishmania (Leishmania) and Leishmania (Viannia) subgenera through melting or HRM analysis. In addition to developing assays, we investigated the number and genetic variability of kinetoplast minicircles in the Leishmania (L.) infantum WHO international reference strain (MHOM/TN/80/IPT1), highlighting the presence of minicircle subclasses and sequence heterogeneity. Specifically, the kinetoplast minicircle number per cell was estimated to be 26,566 +/- 1,192, while the subclass of minicircles amplifiable by qPCR2 was estimated to be 1,263 +/- 115. This heterogeneity, also observed in canine clinical samples, must be taken into account in quantitative PCR-based applications; however, it might also be used to differentiate between Leishmania subgenera.	[Ceccarelli, Marcello; Galluzzi, Luca; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy; [Migliazzo, Antonella] Ist Zooprofilatt Sperimentale Sicilia, Palermo, PA, Italy	University of Urbino; IZS Sicilia	Galluzzi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Fano, PU, Italy.	luca.galluzzi@uniurb.it	Galluzzi, Luca/G-3969-2012; Magnani, Mauro/A-1919-2008; Migliazzo, Antonella/R-4756-2017	Galluzzi, Luca/0000-0002-1747-526X; Migliazzo, Antonella/0000-0002-8341-1125; Magnani, Mauro/0000-0001-6456-6626; Ceccarelli, Marcello/0000-0003-1647-6284				Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aoun O, 2009, VET PARASITOL, V166, P27, DOI 10.1016/j.vetpar.2009.08.006; Cabral M, 1998, VET PARASITOL, V76, P173, DOI 10.1016/S0304-4017(97)00208-2; Cruz I, 2013, EXP PARASITOL, V134, P281, DOI 10.1016/j.exppara.2013.03.026; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Galluzzi L, 2010, J APPL PHYCOL, V22, P1, DOI 10.1007/s10811-009-9411-3; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; Gradoni L, 2004, 0412 ISTISAN I SUP S; Gradoni L, 2000, LEISHMANIASIS OIE MA, P802; Gramiccia M, 2010, VET PARASITOL, V171, P223, DOI 10.1016/j.vetpar.2010.03.025; Harris E, 1998, J CLIN MICROBIOL, V36, P1989, DOI 10.1128/JCM.36.7.1989-1995.1998; Iniesta L, 2002, CLIN DIAGN LAB IMMUN, V9, P1137, DOI 10.1128/CDLI.9.5.1137-1141.2002; Lachaud L, 2002, J CLIN MICROBIOL, V40, P210, DOI 10.1128/JCM.40.1.210-215.2002; Lachaud L, 2001, J CLIN MICROBIOL, V39, P613, DOI 10.1128/JCM.39.2.613-617.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Manna L, 2008, VET J, V177, P279, DOI 10.1016/j.tvjl.2007.04.013; Martin-Ezquerra G, 2009, BRIT J DERMATOL, V161, P320, DOI 10.1111/j.1365-2133.2009.09282.x; MARTY P, 1992, T ROY SOC TROP MED H, V86, P249, DOI 10.1016/0035-9203(92)90295-N; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Pita-Pereira D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-15; Pornprasert S, 2008, EUR J HAEMATOL, V80, P510, DOI 10.1111/j.1600-0609.2008.01055.x; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Schulz A, 2003, J CLIN MICROBIOL, V41, P1529, DOI 10.1128/JCM.41.4.1529-1535.2003; SEMIAOSANTOS SJ, 1995, PARASITOL RES, V81, P235; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Sideris V, 1999, EUR J EPIDEMIOL, V15, P271, DOI 10.1023/A:1007526401175; SIMPSON L, 1986, INT REV CYTOL, V99, P119; Simpson L, 1997, MOL BIOCHEM PARASIT, V86, P133, DOI 10.1016/S0166-6851(97)00037-6; SIMPSON L, 1971, J MOL BIOL, V56, P443, DOI 10.1016/0022-2836(71)90394-9; Sudarshan M, 2011, J ANTIMICROB CHEMOTH, V66, P1751, DOI 10.1093/jac/dkr185; Tsukayama P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001956; Tupperwar N, 2008, DIAGN MICR INFEC DIS, V61, P23, DOI 10.1016/j.diagmicrobio.2007.12.013; Vergel C, 2005, AM J TROP MED HYG, V72, P423, DOI 10.4269/ajtmh.2005.72.423; White H, 2006, TECHNOLOGY ASSESSMEN	40	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88845	10.1371/journal.pone.0088845	http://dx.doi.org/10.1371/journal.pone.0088845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551178	gold, Green Submitted, Green Published			2022-12-25	WOS:000331266000075
J	Chung, KM; Hsu, SC; Chu, YR; Lin, MY; Jiaang, WT; Chen, RH; Chen, X				Chung, Kuei-Min; Hsu, Shu-Ching; Chu, Yue-Ru; Lin, Mei-Yao; Jiaang, Weir-Tong; Chen, Ruey-Hwa; Chen, Xin			Fibroblast Activation Protein (FAP) Is Essential for the Migration of Bone Marrow Mesenchymal Stem Cells through RhoA Activation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; STROMAL CELLS; SERINE-PROTEASE; TUMOR-GROWTH; IN-VITRO; DIFFERENTIAL EXPRESSION; ACTIN CYTOSKELETON; CLEAVING ENZYME; BREAST-CANCER; SEPRASE	Background: The ability of human bone marrow mesenchymal stem cells (BM-MSCs) to migrate and localize specifically to injured tissues is central in developing therapeutic strategies for tissue repair and regeneration. Fibroblast activation protein (FAP) is a cell surface serine protease expressed at sites of tissue remodeling during embryonic development. It is also expressed in BM-MSCs, but not in normal tissues or cells. The function of FAP in BM-MSCs is not known. Principal Findings: We found that depletion of FAP proteins significantly inhibited the migration of BM-MSCs in a transwell chemotaxis assay. Such impaired migration ability of BM-MSCs could be rescued by re-expressing FAP in these cells. We then demonstrated that depletion of FAP activated intracellular RhoA GTPase. Consistently, inhibition of RhoA activity using a RhoA inhibitor rescued its migration ability. Inhibition of FAP activity with an FAP-specific inhibitor did not affect the activation of RhoA or the migration of BM-MSCs. Furthermore, the inflammatory cytokines interleukin-1beta (IL-1 beta) and transforming growth factor-beta (TGF-beta) upregulated FAP expression, which coincided with better BM-MSC migration. Conclusions: Our results indicate FAP plays an important role in the migration of BM-MSCs through modulation of RhoA GTPase activity. The peptidase activity of FAP is not essential for such migration. Cytokines IL-1 beta and TGF-beta upregulate the expression level of FAP and thus enhance BM-MSC migration.	[Chung, Kuei-Min; Chu, Yue-Ru; Jiaang, Weir-Tong; Chen, Xin] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Hsu, Shu-Ching] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Miaoli, Taiwan; [Lin, Mei-Yao; Chen, Ruey-Hwa] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Chen, Xin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan	Chung, KM (corresponding author), Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan.	970304@nhri.org.tw; xchen@nhri.org.tw	Chen, Ruey-Hwa/G-6121-2019; Jiaang, Weir-Torn/D-2072-2010; Hsu, Shu-Ching/E-3869-2010	Chen, Ruey-Hwa/0000-0001-8124-5832; 	National Science Council, Taiwan [NSC 98-3112-B-400-013]; National Health Research Institutes, Taiwan;  [NRPGMNRPGM-98LC009]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); 	The work was supported by (NRPGMNRPGM-98LC009), National Science Council (NSC 98-3112-B-400-013), Taiwan and National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Artym VV, 2002, CARCINOGENESIS, V23, P1593, DOI 10.1093/carcin/23.10.1593; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chen H, 2009, EXP MOL PATHOL, V87, P189, DOI 10.1016/j.yexmp.2009.09.001; Chen HW, 2013, J IMMUNOL, V190, P5065, DOI 10.4049/jimmunol.1202775; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chen WT, 2003, ADV EXP MED BIOL, V524, P197; Chen WT, 2003, CANCER METAST REV, V22, P259, DOI 10.1023/A:1023055600919; Cheng JD, 2002, CANCER RES, V62, P4767; Christiansen VJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P177, DOI 10.1016/j.abb.2006.11.006; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Gout SP, 2001, MOL BIOL CELL, V12, P3268, DOI 10.1091/mbc.12.10.3268; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang Y, 2004, CANCER RES, V64, P2712, DOI 10.1158/0008-5472.CAN-03-3184; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Huber MA, 2003, J INVEST DERMATOL, V120, P182, DOI 10.1046/j.1523-1747.2003.12035.x; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Lee KN, 2004, BLOOD, V103, P3783, DOI 10.1182/blood-2003-12-4240; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; MONSKY WL, 1994, CANCER RES, V54, P5702; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Niggli V, 1999, FEBS LETT, V445, P69, DOI 10.1016/S0014-5793(99)00098-8; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; Ohnuma K, 2007, J BIOL CHEM, V282, P10117, DOI 10.1074/jbc.M609157200; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Poplawski SE, 2013, J MED CHEM, V56, P3467, DOI 10.1021/jm400351a; Ramirez-Montagut T, 2004, ONCOGENE, V23, P5435, DOI 10.1038/sj.onc.1207730; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; RIES C, 1994, BLOOD, V83, P3638; RIES C, 1995, BIOL CHEM H-S, V376, P345; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Ruster B, 2005, STEM CELLS DEV, V14, P231, DOI 10.1089/scd.2005.14.231; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tran E, 2013, J EXP MED, V210, P1125, DOI 10.1084/jem.20130110; Tsai TY, 2010, J MED CHEM, V53, P6572, DOI 10.1021/jm1002556; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wicki A, 2001, INT J CANCER, V91, P763, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1128>3.0.CO;2-B; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987	66	48	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88772	10.1371/journal.pone.0088772	http://dx.doi.org/10.1371/journal.pone.0088772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551161	Green Submitted, gold, Green Published			2022-12-25	WOS:000331266000067
J	Jagadeeshan, S; Krishnamoorthy, YR; Singhal, M; Subramanian, A; Mavuluri, J; Lakshmi, A; Roshini, A; Baskar, G; Ravi, M; Joseph, LD; Sadasivan, K; Krishnan, A; Nair, AS; Venkatraman, G; Rayala, SK				Jagadeeshan, S.; Krishnamoorthy, Y. R.; Singhal, M.; Subramanian, A.; Mavuluri, J.; Lakshmi, A.; Roshini, A.; Baskar, G.; Ravi, M.; Joseph, L. D.; Sadasivan, K.; Krishnan, A.; Nair, A. S.; Venkatraman, G.; Rayala, S. K.			Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis	ONCOGENE			English	Article						Pak1; fibronectin; PDAC; NF-kappa B-p65; KRAS intact model	NF-KAPPA-B; DUCTAL ADENOCARCINOMA; CANCER; EXPRESSION; PAK1; PATHWAY; RAS; LOCALIZATION; TARGETS; BIOLOGY	Pancreatic ductal adenocarcinoma (PDAC) is the eighth largest cause of cancer-related mortality across the world, with a median 5-year survival rate of less than 3.5%. This is partly because the molecules and the molecular mechanisms that contribute to PDAC are not well understood. Our goal is to understand the role of p21-activated kinase 1 (Pak1) signaling axis in the progression of PDAC. Pak1, a serine/threonine kinase, is a well-known regulator of cytoskeletal remodeling, cell motility, cell proliferation and cell survival. Recent reports suggest that Pak1 by itself can have an oncogenic role in a wide variety of cancers. In this study, we analyzed the expression of Pak1 in human pancreatic cancer tissues and found that Pak1 levels are significantly upregulated in PDAC samples as compared with adjacent normals. Further, to study the functional role of Pak1 in pancreatic cancer model systems, we developed stable overexpression and lentiviral short hairpin RNA-mediated knockdown (KD) clones of Pak1 and studied the changes in transforming properties of the cells. We also observed that Pak1 KD clones failed to form tumors in nude mice. By adopting a quantitative PCR array-based approach, we identified fibronectin, a component of the extracellular matrix and a mesenchymal marker, as a transcriptional target of Pak1 signaling. The underlying molecular mechanism of Pak1-mediated transformation includes its nuclear import and recruitment to the fibronectin promoter via interaction with nuclear factor-kappa B (NF-kappa B)-p65 complex. To our knowledge, this is the first study illustrating Pak1-NF-kappa B-p65-mediated fibronectin regulation as a potent tumor-promoting mechanism in KRAS intact model.	[Jagadeeshan, S.; Krishnamoorthy, Y. R.; Singhal, M.; Subramanian, A.; Mavuluri, J.; Lakshmi, A.; Roshini, A.; Rayala, S. K.] IIT Madras, Dept Biotechnol, Chennai 600036, Tamil Nadu, India; [Baskar, G.; Ravi, M.] Sri Ramachandra Univ, Dept Human Genet, Chennai 600116, Tamil Nadu, India; [Joseph, L. D.] Sri Ramachandra Univ, Dept Pathol, Chennai 600116, Tamil Nadu, India; [Sadasivan, K.] Govt Med Coll, Dept Plast & Reconstruct Surg, Thiruvananthapuram, Kerala, India; [Nair, A. S.] RGCB, Thiruvananthapuram 695014, Kerala, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Rayala, SK (corresponding author), IIT Madras, Dept Biotechnol, Chennai 600036, Tamil Nadu, India.	sasha@rgcb.res.in; ganeshv@sriramachandra.edu.in; rayala@iitm.ac.in	Krishnan, Anand/H-1314-2016; Singhal, Mahak/V-4017-2019; Mavuluri, Jayadev/AAW-6724-2021; JAGADEESHAN, SANKAR/S-8384-2019; Venkatraman, Ganesh/AAB-1467-2020; Joseph, Leena Dennis/AAS-9420-2020; Arivazhagan, Lakshmi/AAD-8613-2020	Singhal, Mahak/0000-0002-7303-9585; JAGADEESHAN, SANKAR/0000-0002-3778-8757; Venkatraman, Ganesh/0000-0003-0179-9785; Arivazhagan, Lakshmi/0000-0002-3713-442X; Muralikrishnan, Anirudh Subramanian/0000-0001-7102-9968; Rayala, Suresh/0000-0003-4394-4450	Department of Biotechnology (DBT), Government of India [BT/PR13559/Med/30/283/2010]; Indian Institute of Technology Madras (IITM)	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Indian Institute of Technology Madras (IITM)	We thank Silpa for help in mutagenesis and cloning and Swarnalatha for help with Pak1 lentiviral clones. Thanks to Sekar Sathiya, Rohan Prasad, Hemadev and the entire team of the Centre for Toxicology and Developmental Research (CEFT), Sri Ramachandra University, Chennai, for help with animal experiments. We thank the Department of Biotechnology (DBT), Government of India for the financial support to SKR (grant no.: BT/PR13559/Med/30/283/2010) and Indian Institute of Technology Madras (IITM) for all other facilities.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Costello E, 2012, NAT REV GASTRO HEPAT, V9, P435, DOI 10.1038/nrgastro.2012.119; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; Falasca M, 2011, ANTI-CANCER AGENT ME, V11, P455, DOI 10.2174/187152011795677382; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; Hidalgo M, 2012, CLIN CANCER RES, V18, P4249, DOI 10.1158/1078-0432.CCR-12-1327; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Krautz C, 2011, ANTI-CANCER AGENT ME, V11, P411, DOI 10.2174/187152011795677409; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Linder S, 2001, HEPATO-GASTROENTEROL, V48, P1321; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; Menard RE, 2003, CELL SIGNAL, V15, P1099, DOI 10.1016/S0898-6568(03)00087-1; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Ong CC, 2011, ONCOTARGET, V2, P491; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Sanchez-Solana B, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404061; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; World Cancer Research Fund/ American Institute for Cancer Research, 2012, CONT UPD PROJ SUMM F; Wu R, 2010, INT J CANCER, V127, P2230, DOI 10.1002/ijc.25226; Ye Diana Zi, 2012, Cell Logist, V2, P105; Yeh JJ, 2007, EXPERT OPIN THER TAR, V11, P673, DOI 10.1517/14728222.11.5.673	34	37	38	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 22	2015	34	4					455	464		10.1038/onc.2013.576	http://dx.doi.org/10.1038/onc.2013.576			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AZ8FU	24561527				2022-12-25	WOS:000348451300006
J	Noda, K; Nakao, S; Zandi, S; Sun, DW; Hayes, KC; Hafezi-Moghadam, A				Noda, Kousuke; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hayes, K. C.; Hafezi-Moghadam, Ali			Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm	FASEB JOURNAL			English	Article						adhesion molecules; adipokines; Nile grass rat	ADHESION MOLECULE-1; HYPERGLYCEMIC RAT; HUMAN RETINA; NILE RAT; CELLS; MICE; COMPLICATIONS; PERMEABILITY; LEUKOSTASIS; EXPRESSION	The pathogenesis of diabetic retinopathy (DR) in metabolic syndrome (MetS) and type 2 diabetes (T2D) is not well studied, partly because an appropriate model has not been developed. Recently, we introduced a novel model of spontaneous T2D and MetS that replicates the relevant features of the human disease. In the current study, we investigated the retinal vascular changes in these animals. Experimental DR in streptozotocin (STZ)-injected rodents is described as an inflammatory disease, in which intercellular adhesion molecule 1 (ICAM-1) plays a key role. In comparison, advanced diabetes (HbA1c>10%) in the Nile grass rat (NGR) was associated with lower ICAM-1 protein expression when compared with that in normal or moderately diabetic animals. Vascular cell adhesion molecule 1 (VCAM-1) expression, however, was unaffected by the disease state. As opposed to the STZ-induced model of DR, in diabetic NGRs, most leukocytes accumulated in the retinal arteries. Consistent with the ICAM-1 reduction, leukocyte accumulation was significantly reduced in advanced disease. Similarly, leukocyte adhesions were significantly lower, with elevated plasma triglycerides (>200 mg/dl), and cholesterol (>240 mg/dl). However, these adhesions were significantly higher in animals with higher plasma insulin (>5 IU/ml) and leptin (>20 ng/ml), suggesting a role for these hormones in diabetic retinal leukostasis. Diabetic NGRs showed substantial retinal endothelial injury, primarily in the microvessels, including vascular tortuosity, obliterated acellular capillaries, and pericyte ghosts. The NGR provides a convenient and realistic model for investigation of retinal changes in MetS/T2D with convincing advantages over the commonly used STZ-induced T1D. Noda, K., Nakao, S., Zandi, S., Sun, D., Hayes, K. C., Hafezi-Moghadam, A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm.	[Noda, Kousuke; Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Ctr Excellence Funct & Mol Imaging, Boston, MA 02115 USA; [Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Noda, Kousuke] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 812, Japan; [Sun, Dawei] Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 2, Harbin, Peoples R China; [Hayes, K. C.] Brandeis Univ, Dept Biol, Foster Biomed Res Lab, Waltham, MA 02254 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Hokkaido University; Kyushu University; Harbin Medical University; Brandeis University	Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, 221 Longwood Ave, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Hafezi-Moghadam, Ali/0000-0002-5336-0697; Zandi, Souska/0000-0001-9351-4278	U.S. National Institutes of Health (NIH) DiaComp award; Bausch & Lomb (Rochester, NY, USA); Japanese Eye Bank Association; Tear Film and Ocular Surface Society Young Investigator fellowship; Malaysian Palm Oil Board; Bright Focus Foundation	U.S. National Institutes of Health (NIH) DiaComp award; Bausch & Lomb (Rochester, NY, USA); Japanese Eye Bank Association; Tear Film and Ocular Surface Society Young Investigator fellowship; Malaysian Palm Oil Board; Bright Focus Foundation(BrightFocus Foundation)	The authors thank A. Schering, F. Xie, A. Auerbach, J. Bolsinger, and A. Pronczuk for technical assistance, and R. Garland for help with manuscript preparation. This work was supported by the U.S. National Institutes of Health (NIH) DiaComp award (to A.H.-M.), overseas research fellowship awards from Bausch & Lomb (Rochester, NY, USA; to K.N. and S.N.), a fellowship award from the Japanese Eye Bank Association (to K.N. and S.N.), a Tear Film and Ocular Surface Society Young Investigator fellowship (to S.N. under the mentorship of A.H.-M.), and by the Malaysian Palm Oil Board and the Bright Focus Foundation.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bolsinger J, 2013, J NUTR BIOCHEM, V24, P1945, DOI 10.1016/j.jnutbio.2013.06.004; Chaabo F, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-29; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen WQ, 2003, INVEST OPHTH VIS SCI, V44, P5016, DOI 10.1167/iovs.03-0418; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; COLEMAN DL, 1974, DIABETOLOGIA, V10, P607, DOI 10.1007/BF01221993; DULIN WE, 1970, DIABETOLOGIA, V6, P317, DOI 10.1007/BF01212245; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hafezi-Moghadam A, 2007, FASEB J, V21, P464, DOI 10.1096/fj.06-6390com; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hughes JM, 2004, BRIT J OPHTHALMOL, V88, P566, DOI 10.1136/bjo.2003.021204; IKEDA H, 1981, DIABETES, V30, P1045, DOI 10.2337/diabetes.30.12.1045; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Jariyapongskul A, 2003, CLIN HEMORHEOL MICRO, V29, P331; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; MASUDA M, 1990, DIABETES, V39, P466, DOI 10.2337/diabetes.39.4.466; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miyahara S, 2004, AM J PATHOL, V164, P1697, DOI 10.1016/S0002-9440(10)63728-5; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 1998, INVEST OPHTH VIS SCI, V39, P2190; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Nguyen TT, 2009, CURR DIABETES REP, V9, P277, DOI 10.1007/s11892-009-0043-4; Noda K, 2010, FASEB J, V24, P2443, DOI 10.1096/fj.09-152678; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; ROBERTSON RP, 1973, J CLIN INVEST, V52, P1620, DOI 10.1172/JCI107340; Sasase T, 2006, DIABETES OBES METAB, V8, P501, DOI 10.1111/j.1463-1326.2005.00535.x; Sasongko MB, 2011, DIABETOLOGIA, V54, P2409, DOI 10.1007/s00125-011-2200-y; SCHRODER S, 1991, AM J PATHOL, V139, P81; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Skondra D, 2008, INVEST OPHTH VIS SCI, V49, P726, DOI 10.1167/iovs.07-0405; TAYLOR PD, 1994, BRIT J PHARMACOL, V111, P42, DOI 10.1111/j.1476-5381.1994.tb14021.x	40	38	43	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2014	28	5					2038	2046		10.1096/fj.12-215715	http://dx.doi.org/10.1096/fj.12-215715			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3RA	24571922	Green Published			2022-12-25	WOS:000335336000009
J	Kabekkodu, SP; Bhat, S; Radhakrishnan, R; Aithal, A; Mascarenhas, R; Pandey, D; Rai, L; Kushtagi, P; Mundyat, GP; Satyamoorthy, K				Kabekkodu, Shama Prasada; Bhat, Samatha; Radhakrishnan, Raghu; Aithal, Abhijit; Mascarenhas, Roshan; Pandey, Deeksha; Rai, Lavanya; Kushtagi, Pralhad; Mundyat, Gopinath Puthiya; Satyamoorthy, Kapaettu			DNA Promoter Methylation-dependent Transcription of the Double C2-like Domain beta( DOC2B) Gene Regulates Tumor Growth in Human Cervical Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Cell Growth; Cell Invasion; Cell Motility; ERK; DNA Promoter Methylation; DOC2B; Human Papillomavirus; Actin Remodeling; Cervical Cancer	ACTIVATED PROTEIN-KINASE; CELL MOTILITY; ACTIN ORGANIZATION; EPIGENETIC THERAPY; SUPPRESSOR GENE; FASCIN; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; FILOPODIA	Background:DOC2B promoter hypermethylation is an early and frequent event in cervical cancer. Results:DOC2B hypermethylation induces transcriptional repression, reactivated by demethylation; ectopic expression increases Ca2+ flux and inhibits key characteristics of tumorigenesis including proliferation, motility, and invasion. Conclusion:DOC2B gene is epigenetically regulated and inhibits cervical cancer growth. Significance: DNA methylation regulates DOC2B gene expression in cervical cancer. Double C2-like domain (DOC2B) gene encodes for a calcium-binding protein, which is involved in neurotransmitter release, sorting, and exocytosis. We have identified the promoter region of the DOC2B gene as hypermethylated in pre-malignant, malignant cervical tissues, and cervical cancer cell lines by methylation-sensitive dimethyl sulfoxide-polymerase chain reaction and bisulfite genome sequencing; whereas, it was unmethylated in normal cervical tissues (p < 0.05). The promoter hypermethylation was inversely associated with mRNA expression in SiHa, CaSki, and HeLa cells and treatment with demethylating agent 5-aza-2-deoxycytidine restored DOC2B expression. The region -630 to +25 bp of the DOC2B gene showed robust promoter activity by a luciferase reporter assay and was inhibited by in vitro artificial methylation with Sss1 methylase prior to transient transfections. Overexpression of the DOC2B gene in SiHa cells when compared with controls showed significantly reduced colony formation, cell proliferation, induced cell cycle arrest, and repressed cell migration and invasion (p < 0.05). Ectopic expression of DOC2B resulted in anoikis-mediated cell death and repressed tumor growth in a nude mice xenograft model (p < 0.05). DOC2B expressing cells showed a significant increase in intracellular calcium level (p < 0.05), impaired AKT1 and ERK1/2 signaling, and induced actin cytoskeleton remodeling. Our results show that promoter hypermethylation and silencing of the DOC2B gene is an early and frequent event during cervical carcinogenesis and whose reduced expression due to DNA promoter methylation may lead to selective cervical tumor growth.	[Kabekkodu, Shama Prasada; Bhat, Samatha; Radhakrishnan, Raghu; Aithal, Abhijit; Mascarenhas, Roshan; Mundyat, Gopinath Puthiya; Satyamoorthy, Kapaettu] Manipal Univ, Manipal Life Sci Ctr, Div Biotechnol, Manipal 576104, Karnataka, India; [Pandey, Deeksha; Rai, Lavanya] Manipal Univ, Kasturba Med Coll, Dept OBGYN, Manipal 576104, Karnataka, India; [Kushtagi, Pralhad] Manipal Univ, Dept OBGYN, Kasturba Med Coll, Mangalore 575001, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Satyamoorthy, K (corresponding author), Manipal Univ, Manipal Life Sci Ctr, Div Biotechnol, Manipal 576104, Karnataka, India.	ksatyamoorthy@manipal.edu	Kabekkodu, Shama Prasada/AAD-2947-2021; Radhakrishnan, Raghu/P-1685-2015; Aithal, Abhijit/AAR-9856-2021; kabekkodu, Shama Prasada/Q-2810-2018; Satyamoorthy, Kapaettu/H-3254-2015	Kabekkodu, Shama Prasada/0000-0002-4158-3893; Radhakrishnan, Raghu/0000-0003-0088-4777; Satyamoorthy, Kapaettu/0000-0002-2368-5490; rai, lavanya/0000-0003-3912-584X; Aithal, Abhijit/0000-0001-9035-7529; Kushtagi, Pralhad/0000-0002-5815-9001	TIFAC-CORE, Government of India; Indian Council of Medical Research, Government of India; Manipal University	TIFAC-CORE, Government of India; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Manipal University	This work was supported by grants from TIFAC-CORE, Government of India, the Indian Council of Medical Research, Government of India, and the Manipal University.	Balanathan P, 2004, J MOL ENDOCRINOL, V32, P55, DOI 10.1677/jme.0.0320055; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Duenas-Gonzalez A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-38; Duncan RR, 2000, BIOCHIMIE, V82, P421, DOI 10.1016/S0300-9084(00)00214-5; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Estecio MRH, 2006, ONCOGENE, V25, P5018, DOI 10.1038/sj.onc.1209509; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Evans MF, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-10; Flanagan JM, 2007, BRIT J CANCER, V96, P183, DOI 10.1038/sj.bjc.6603516; Fukuda N, 2009, DIABETES, V58, P377, DOI 10.2337/db08-0303; Gonzalgo ML, 1997, CANCER RES, V57, P594; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Guenin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042704; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Hu XT, 2013, J PATHOL, V229, P62, DOI 10.1002/path.4093; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; June Carl H, 2004, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0505s64; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kholod N, 2007, J MOL DIAGN, V9, P574, DOI 10.2353/jmoldx.2007.070025; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; Malkinson G, 2006, CELL CALCIUM, V39, P85, DOI 10.1016/j.ceca.2005.10.007; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370; Zanet J, 2012, J CELL BIOL, V197, P477, DOI 10.1083/jcb.201110135	39	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10637	10649		10.1074/jbc.M113.491506	http://dx.doi.org/10.1074/jbc.M113.491506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570007	Green Published, hybrid			2022-12-25	WOS:000334226400034
J	Mori, Y; Saito, T; Chang, SH; Kobayashi, H; Ladel, CH; Guehring, H; Chung, UI; Kawaguchi, H				Mori, Yoshifumi; Saito, Taku; Chang, Song Ho; Kobayashi, Hiroshi; Ladel, Christoph H.; Guehring, Hans; Chung, Ung-il; Kawaguchi, Hiroshi			Identification of Fibroblast Growth Factor-18 as a Molecule to Protect Adult Articular Cartilage by Gene Expression Profiling*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Chondrocytes; Fibroblast Growth Factor (FGF); Microarray; Osteoarthritis; Regeneration	CELL-SPECIFIC MOLECULE-1; MATRIX METALLOPROTEINASE-13; OSTEOGENIC PROTEIN-1; TISSUE INHIBITORS; FACTOR (FGF)-18; REPAIR; CHONDROCYTES; DEFECTS; CHONDROGENESIS; FIBROBLAST-GROWTH-FACTOR-18	Background: Prevention of adult articular cartilage and treatment of its lesions are essential. Results: Microarray analyses identified Fgf18, which inhibits aggrecan release from cartilage and enhances proliferation of chondrocytes. The intra-articular injection of rhFGF18 prevented cartilage degeneration in a rat osteoarthritis model. Conclusion: Fgf18 protects adult articular cartilage through Timp1 expression. Significance: Fgf18 may represent a therapeutic agent for osteoarthritis. To identify genes that maintain the homeostasis of adult articular cartilage and regenerate its lesions, we initially compared four types of chondrocytes: articular (AA) versus growth plate (AG) cartilage chondrocytes in adult rats, and superficial layer (IS) versus deep layer (ID) chondrocytes of epiphyseal cartilage in infant rats. Microarray analyses revealed that 40 and 186 genes had 10-fold higher expression ratios of AA/AG and IS/ID, respectively, and 16 genes showed 10-fold of both AA/AG and IS/ID ratios. The results were validated by real-time RT-PCR analysis. Among them, Hoxd1, Fgf18, and Esm1 were expressed more strongly in AA than in IS. Fgf18 was the extracellular and secreted factor that decreased glycosaminoglycan release and depletion from the cartilage, and enhanced proliferation of articular chondrocytes. Fgf18 was strongly expressed in the articular cartilage chondrocytes of adult rats. In a surgical rat osteoarthritis model, a once-weekly injection of recombinant human FGF18 (rhFGF18) given 3 weeks after surgery prevented cartilage degeneration in a dose-dependent manner at 6 and 9 weeks after surgery, with significant effect at 10 g/week of rhFGF18. As the underlying mechanism, rhFGF18 strongly up-regulated Timp1 expression in the cell and organ cultures, and inhibition of aggrecan release by rhFGF18 was restored by addition of an antibody to Timp1. In conclusion, we have identified Fgf18 as a molecule that protects articular cartilage by gene expression profiling, and the anticatabolic effects may at least partially be mediated by the Timp1 expression.	[Mori, Yoshifumi; Saito, Taku; Chang, Song Ho; Kobayashi, Hiroshi; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ladel, Christoph H.; Guehring, Hans] Merck KGaA, Merck Serono Res, D-64293 Darmstadt, Germany	University of Tokyo; University of Tokyo; Merck KGaA; EMD Serono Inc.	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kawaguchi0126@gmail.com	Ladel, Christoph/ABG-3165-2021	Ladel, Christoph/0000-0001-8657-6219	Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 23689065]; Merck Serono S.A.; Geneva, Switzerland; Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Merck Serono S.A.; Geneva, Switzerland; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The gene expression profiling study was supported by Grants-in-aid for Scientific Research 19109007 and 23689065 from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The rat osteoarthritis study was sponsored by Merck Serono S.A., Geneva, Switzerland (a branch of Merck Serono S.A., Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany). rhFGF18 (INN: sprifermin) is in clinical development and is not currently approved by any regulatory authority, including the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA). C. H. L. and H. G. are employees of Merck KGaA.	Agah A., 2002, AM J PATHOL, V161, P831; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Church V, 2005, ANAT EMBRYOL, V209, P461, DOI 10.1007/s00429-005-0464-z; CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8; Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Farr J, 2011, CLIN ORTHOP RELAT R, V469, P2696, DOI 10.1007/s11999-010-1764-z; Frenkel SR, 2000, PLAST RECONSTR SURG, V105, P980, DOI 10.1097/00006534-200003000-00022; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Jelic M, 2001, GROWTH FACTORS, V19, P101, DOI 10.3109/08977190109001079; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Louwerse RT, 2000, J BIOMED MATER RES, V49, P506, DOI 10.1002/(SICI)1097-4636(20000315)49:4<506::AID-JBM9>3.0.CO;2-A; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Tanaka H, 2004, TISSUE ENG, V10, P633, DOI 10.1089/107632704323061988; Wakitani S, 1997, ACTA ORTHOP SCAND, V68, P474, DOI 10.3109/17453679708996266; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Yamane S, 2007, TISSUE ENG, V13, P2163, DOI 10.1089/ten.2006.0431; Yan D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3441	42	44	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10192	10200		10.1074/jbc.M113.524090	http://dx.doi.org/10.1074/jbc.M113.524090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24577103	Green Published, hybrid			2022-12-25	WOS:000333807000064
J	Lung, RI; Chira, C; Andreica, A				Lung, Rodica Ioana; Chira, Camelia; Andreica, Anca			Game Theory and Extremal Optimization for Community Detection in Complex Dynamic Networks	PLOS ONE			English	Article								The detection of evolving communities in dynamic complex networks is a challenging problem that recently received attention from the research community. Dynamics clearly add another complexity dimension to the difficult task of community detection. Methods should be able to detect changes in the network structure and produce a set of community structures corresponding to different timestamps and reflecting the evolution in time of network data. We propose a novel approach based on game theory elements and extremal optimization to address dynamic communities detection. Thus, the problem is formulated as a mathematical game in which nodes take the role of players that seek to choose a community that maximizes their profit viewed as a fitness function. Numerical results obtained for both synthetic and real-world networks illustrate the competitive performance of this game theoretical approach.	[Lung, Rodica Ioana] Univ Babes Bolyai, Dept Stat Forecasting & Math, R-3400 Cluj Napoca, Romania; [Chira, Camelia; Andreica, Anca] Univ Babes Bolyai, Dept Comp Sci, R-3400 Cluj Napoca, Romania	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj	Lung, RI (corresponding author), Univ Babes Bolyai, Dept Stat Forecasting & Math, R-3400 Cluj Napoca, Romania.	rodica.lung@econ.ubbcluj.ro	lung, rodica ioana I/C-4716-2011; Chira, Camelia/B-5566-2015; Chira, Camelia/AAO-7860-2020; Andreica, Anca M./C-4082-2011	Chira, Camelia/0000-0002-1949-1298; Andreica, Anca/0000-0003-2363-5757; Lung, Rodica Ioana/0000-0002-5572-8141	CNCS Romania; OPEN-RES Academic Writing project [PN-II-PT-PCCA-2011-3.1-0682];  [PN II TE 320]	CNCS Romania(Consiliul National al Cercetarii Stiintifice (CNCS)); OPEN-RES Academic Writing project; 	This research is supported by Grant PN II TE 320, "Emergence, auto-organization and evolution: New computational models in the study of complex systems," funded by CNCS Romania (http://uefiscdi.gov.ro/articole/1966/Proiecte-de-cercetare-pentru-stimularea-constituirii-de-tinere-echipe-de-cercetareindependente-ti.html). The first author would like to acknowledge the support received within the PN-II-PT-PCCA-2011-3.1-0682 OPEN-RES Academic Writing project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], CSNE0209030 CORR; [Anonymous], [No title captured]; Asur S, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P913; Boettcher S, 2001, PHYS REV LETT, V86, P5211, DOI 10.1103/PhysRevLett.86.5211; Chi Y, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P153; Chira C, 2011, LECT NOTES ARTIF INT, V6678, P380, DOI 10.1007/978-3-642-21219-2_48; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Folino F, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P256, DOI 10.1109/ASONAM.2010.23; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gong MG, 2012, J COMPUT SCI TECH-CH, V27, P455, DOI 10.1007/s11390-012-1235-y; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Kim MS, 2009, PROC VLDB ENDOW, V2; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lin Y.R., 2008, P 17 INT C WORLD WID, P685, DOI [10.1145/1367497.1367590, DOI 10.1145/1367497.1367590]; Lung RI, 2008, INT J COMPUT COMMUN, V3, P364; Lung RI, 2011, STUD COMPUT INTELL, V387, P195; McKelvey R.D., 1996, HDB COMPUTATIONAL EC, V1, P87, DOI DOI 10.1016/S1574-0021(96)01004-0; Mitchell M., 2009, COMPLEXITY GUIDED TO; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; PAPPI FU, 1993, CONTEMP SOCIOL, V22, P128, DOI 10.2307/2075047; Pizzuti C, 2008, LECT NOTES COMPUT SC, V5199, P1081, DOI 10.1007/978-3-540-87700-4_107; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Tang L., 2008, P 14 ACM SIGKDD INT, P677, DOI [10.1145/1401890.1401972, DOI 10.1145/1401890.1401972]; Tasgin M., 2006, COMMUNITY DETECTION; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WATTS DJ, 2003, 6 DEGREES SCI CONNEC	38	15	15	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e86891	10.1371/journal.pone.0086891	http://dx.doi.org/10.1371/journal.pone.0086891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586257	Green Published, gold			2022-12-25	WOS:000332389000005
J	Anderson, EM; Jenkins, AC; Caudle, RM; Neubert, JK				Anderson, Ethan M.; Jenkins, Alan C.; Caudle, Robert M.; Neubert, John K.			The Effects of a Co-Application of Menthol and Capsaicin on Nociceptive Behaviors of the Rat on the Operant Orofacial Pain Assessment Device	PLOS ONE			English	Article							INTRADERMAL INJECTION; THERMAL PREFERENCE; TRPA1 CONTRIBUTES; INDUCED ANALGESIA; RECEPTOR; TRPM8; ASSAY; HYPERALGESIA; CHANNELS; SENSITIVITY	Background: Transient receptor potential (TRP) cation channels are involved in the perception of hot and cold pain and are targets for pain relief in humans. We hypothesized that agonists of TRPV1 and TRPM8/TRPA1, capsaicin and menthol, would alter nociceptive behaviors in the rat, but their opposite effects on temperature detection would attenuate one another if combined. Methods: Rats were tested on the Orofacial Pain Assessment Device (OPAD, Stoelting Co.) at three temperatures within a 17 min behavioral session (33 degrees C, 21 degrees C, 45 degrees C). Results: The lick/face ratio (L/F: reward licking events divided by the number of stimulus contacts. Each time there is a licking event a contact is being made.) is a measure of nociception on the OPAD and this was equally reduced at 45 degrees C and 21 degrees C suggesting they are both nociceptive and/or aversive to rats. However, rats consumed (licks) equal amounts at 33 degrees C and 21 degrees C but less at 45 degrees C suggesting that heat is more nociceptive than cold at these temperatures in the orofacial pain model. When menthol and capsaicin were applied alone they both induced nociceptive behaviors like lower L/F ratios and licks. When applied together though, the licks at 21 degrees C were equal to those at 33 degrees C and both were significantly higher than at 45 degrees C. Conclusions: This suggests that the cool temperature is less nociceptive when TRPM8/TRPA1 and TRPV1 are co-activated. These results suggest that co-activation of TRP channels can reduce certain nociceptive behaviors. These data demonstrate that the motivational aspects of nociception can be influenced selectively by TRP channel modulation and that certain aspects of pain can be dissociated and therefore targeted selectively in the clinic.	[Anderson, Ethan M.; Caudle, Robert M.] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA; [Anderson, Ethan M.; Caudle, Robert M.] Univ Florida, Coll Med, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Jenkins, Alan C.; Neubert, John K.] Univ Florida, Dept Orthodont, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Anderson, EM (corresponding author), Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32611 USA.	ethan241@gmail.com		Caudle, Robert/0000-0002-2394-4114	NIH [5R44DA026220-03]; NATIONAL INSTITUTE ON DRUG ABUSE [R44DA026220] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the NIH grant 5R44DA026220-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Albin KC, 2008, CHEM SENSES, V33, P3, DOI 10.1093/chemse/bjm056; Anderson EM, 2012, NEUROSCIENCE, V223, P45, DOI 10.1016/j.neuroscience.2012.07.037; Anderson EM, 2012, NEUROSCIENCE, V214, P14, DOI 10.1016/j.neuroscience.2012.04.032; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Caspani O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007383; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cliff MA, 1996, PHYSIOL BEHAV, V59, P487, DOI 10.1016/0031-9384(95)02089-6; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dunham JP, 2010, NEUROSCIENCE, V165, P1412, DOI 10.1016/j.neuroscience.2009.11.065; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Farco JA, 2013, MINI-REV MED CHEM, V13, P124; Fluhr K, 2009, CLIN J PAIN, V25, P128, DOI 10.1097/AJP.0b013e3181817aa2; Frederick J, 2007, BIOCHEM BIOPH RES CO, V358, P1058, DOI 10.1016/j.bbrc.2007.05.029; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Green BG, 2005, CHEM SENSES, V30, pI201, DOI 10.1093/chemse/bjh184; Green BG, 2000, PHYSIOL BEHAV, V68, P631, DOI 10.1016/S0031-9384(99)00221-8; Guimaraes M.Z.P., 2007, TRPA1 SENSORY CHANNE; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Liu BY, 2013, PAIN, V154, P2169, DOI 10.1016/j.pain.2013.06.043; McKemy D., 2007, TRPM8 COLD MENTHOL R; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2013, ACS CHEM NEUROSCI, V4, P238, DOI 10.1021/cn300193h; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Neubert JK, 2006, BEHAV BRAIN RES, V170, P308, DOI 10.1016/j.bbr.2006.03.008; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; Neubert JK, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-49; Neubert JK, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-43; Nolan TA, 2012, PAIN; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; Nolan TA, 2011, BEHAV BRAIN RES, V216, P723, DOI 10.1016/j.bbr.2010.08.023; Pan R, 2012, J PHARMACOL EXP THER, V343, P661, DOI 10.1124/jpet.112.196717; Patil MJ, 2010, NEUROSCIENCE, V171, P1109, DOI 10.1016/j.neuroscience.2010.09.031; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Roberts K, 2011, J CLIN NEUROSCI, V18, P926, DOI 10.1016/j.jocn.2010.11.015; Rossi HL, 2012, NEUROSCIENCE, V224, P294, DOI 10.1016/j.neuroscience.2012.08.015; Rossi HL, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-37; Rossi HL, 2008, BEHAV BRAIN RES, V187, P478, DOI 10.1016/j.bbr.2007.09.021; Rossi HL, 2009, J PAIN, V10, P646, DOI 10.1016/j.jpain.2009.01.002; Rossi HL, 2009, BEHAV BRAIN RES, V203, P240, DOI 10.1016/j.bbr.2009.05.009; Sang CN, 1996, ANESTHESIOLOGY, V85, P491, DOI 10.1097/00000542-199609000-00007; SIDELL N, 1990, J CELL PHYSIOL, V142, P410, DOI 10.1002/jcp.1041420226; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; Sluka KA, 1997, PAIN, V71, P157, DOI 10.1016/S0304-3959(97)03354-X; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Staruschenko A, 2010, J BIOL CHEM, V285, P15167, DOI 10.1074/jbc.M110.106153; SWANDULLA D, 1987, PFLUG ARCH EUR J PHY, V409, P52, DOI 10.1007/BF00584749; SWANDULLA D, 1986, NEUROSCI LETT, V68, P23, DOI 10.1016/0304-3940(86)90223-5; Szallasi A, 2007, COMPLEX REGULATION T; Zhao M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-55	58	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89137	10.1371/journal.pone.0089137	http://dx.doi.org/10.1371/journal.pone.0089137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558480	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700126
J	Cavalcanti, E; Vadrucci, E; Delvecchio, FR; Addabbo, F; Bettini, S; Liou, R; Monsurro, V; Huang, AYC; Pizarro, TT; Santino, A; Chieppa, M				Cavalcanti, Elisabetta; Vadrucci, Elisa; Delvecchio, Francesca Romana; Addabbo, Francesco; Bettini, Simona; Liou, Rachel; Monsurro, Vladia; Huang, Alex Yee-Chen; Pizarro, Theresa Torres; Santino, Angelo; Chieppa, Marcello			Administration of Reconstituted Polyphenol Oil Bodies Efficiently Suppresses Dendritic Cell Inflammatory Pathways and Acute Intestinal Inflammation	PLOS ONE			English	Article							EPITHELIAL-CELLS; QUERCETIN GLUCURONIDES; BOWEL DISEASES; COLITIS; DIFFERENTIATION; BIOAVAILABILITY; STABILIZATION; ACTIVATION; QUERCITRIN; MECHANISM	Polyphenols are natural compounds capable of interfering with the inflammatory pathways of several in vitro model systems. In this study, we developed a stable and effective strategy to administer polyphenols to treat in vivo models of acute intestinal inflammation. The in vitro suppressive properties of several polyphenols were first tested and compared for dendritic cells (DCs) production of inflammatory cytokines. A combination of the polyphenols, quercetin and piperine, were then encapsulated into reconstituted oil bodies (OBs) in order to increase their stability. Our results showed that administration of low dose reconstituted polyphenol OBs inhibited LPS-mediated inflammatory cytokine secretion, including IL-6, IL-23, and IL-12, while increasing IL-10 and IL-1R alpha production. Mice treated with the polyphenol-containing reconstituted OBs (ROBs) were partially protected from dextran sodium sulfate (DSS)-induced colitis and associated weight loss, while mortality and inflammatory scores revealed an overall anti-inflammatory effect that was likely mediated by impaired DC immune responses. Our study indicates that the administration of reconstituted quercetin and piperine-containing OBs may represent an effective and potent anti-inflammatory strategy to treat acute intestinal inflammation.	[Cavalcanti, Elisabetta; Vadrucci, Elisa; Addabbo, Francesco; Chieppa, Marcello] IRCCS de Bellis, Lab Expt Immunopathol, Castellana Grotte, BA, Italy; [Vadrucci, Elisa; Delvecchio, Francesca Romana; Chieppa, Marcello] Mario Negri South, Lab Mucosal Immunol, Santa Maria Imbaro, CH, Italy; [Delvecchio, Francesca Romana; Chieppa, Marcello] ARCHES, Lab Translat Med, Castellana Grotte, BA, Italy; [Bettini, Simona] Univ Salento, Dept Engn Innovat, Lecce, Italy; [Liou, Rachel; Huang, Alex Yee-Chen] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Monsurro, Vladia] Univ Verona, Sch Med, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Pizarro, Theresa Torres] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Santino, Angelo] CNR, Inst Sci Food Prod, Lecce, Italy	IRCCS Saverio de Bellis; University of Salento; Case Western Reserve University; University of Verona; Case Western Reserve University; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Chieppa, M (corresponding author), IRCCS de Bellis, Lab Expt Immunopathol, Castellana Grotte, BA, Italy.	transmed@irccsdebellis.it	Chieppa, Marcello/I-8447-2018; Santino, Angelo/AAD-5735-2020; Huang, Alex/R-4662-2017; Huang, Alex Y./ABG-8182-2021; Chieppa, Marcello/AAG-9835-2019	Chieppa, Marcello/0000-0001-9819-0823; Santino, Angelo/0000-0002-3348-0747; Huang, Alex/0000-0002-5701-4521; Huang, Alex Y./0000-0002-5701-4521; Chieppa, Marcello/0000-0001-9819-0823; Bettini, Simona/0000-0002-5506-5413; Delvecchio, Francesca Romana/0000-0002-3661-1212	"My First AIRC Grant Italian Cancer Association'' Milano Italy [MFAG 10684]; Italian Ministry of Health; Fondazione Cassa di Risparmio di Puglia [GR2009]; "Pro.Ali.Fun'' (ARCHES, Castellana Grotte, Bari) [PON02_00186_2937475]; NIH [R01 CA154656, P01 DK091222]; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [R01CA154656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222] Funding Source: NIH RePORTER	"My First AIRC Grant Italian Cancer Association'' Milano Italy; Italian Ministry of Health(Ministry of Health, Italy); Fondazione Cassa di Risparmio di Puglia; "Pro.Ali.Fun'' (ARCHES, Castellana Grotte, Bari); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by "My First AIRC Grant (MFAG 10684) Italian Cancer Association" Via Corridoni, 7 20122 Milano Italy; the Italian Ministry of Health, "GR2009" the Fondazione Cassa di Risparmio di Puglia, PON02_00186_2937475 "Pro.Ali.Fun" and 5 per mille 2010 (ARCHES, Castellana Grotte, Bari); A.Y.H. is supported by NIH R01 CA154656 and the St. Baldrick's Foundation; T. T. P is supported by NIH P01 DK091222. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036262; Bettini S, 2013, RSC ADV, V3, P5422, DOI 10.1039/c3ra40552d; BURN PL, 1992, J CHEM SOC CHEM COMM, P32, DOI 10.1039/c39920000032; Cai X, 2013, CURR MED CHEM, V20, P2572, DOI 10.2174/09298673113209990120; Chen MCM, 2004, J AGR FOOD CHEM, V52, P3982, DOI 10.1021/jf035533g; Chen X, 2006, CELL MOL IMMUNOL, V3, P401; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; COOPER HS, 1993, LAB INVEST, V69, P238; D'Introno A, 2009, PLANT BIOTECHNOL J, V7, P422, DOI 10.1111/j.1467-7652.2009.00409.x; Dall'Acqua S, 2012, MOLECULES, V17, P8898, DOI 10.3390/molecules17088898; de Baey A, 2003, J IMMUNOL, V170, P5089, DOI 10.4049/jimmunol.170.10.5089; de Medina FS, 2002, LIFE SCI, V70, P3097, DOI 10.1016/S0024-3205(02)01568-0; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Kasimsetty SG, 2009, J AGR FOOD CHEM, V57, P10636, DOI 10.1021/jf902716r; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Kesarwani Kritika, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P253, DOI 10.1016/S2221-1691(13)60060-X; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Manjeet R, 1999, INT J IMMUNOPHARMACO, V21, P435, DOI 10.1016/S0192-0561(99)00024-7; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Middel P, 2006, GUT, V55, P220, DOI 10.1136/gut.2004.063008; Naito Y, 2004, INFLAMM RES, V53, P462, DOI 10.1007/s00011-004-1281-1; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; Rescigno M, 2005, NAT MED, V11, P254, DOI 10.1038/nm0305-254; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Romier B, 2008, BRIT J NUTR, V100, P542, DOI 10.1017/S0007114508966666; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; Ruiz PA, 2007, J NUTR, V137, P1208, DOI 10.1093/jn/137.5.1208; Shirai M, 2001, J AGR FOOD CHEM, V49, P5602, DOI 10.1021/jf010713g; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tzen JTC, 1998, J BIOCHEM-TOKYO, V123, P318, DOI 10.1093/oxfordjournals.jbchem.a021939; Yang JH, 2006, DRUG METAB DISPOS, V34, P296, DOI 10.1124/dmd.105.005280	43	36	37	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88898	10.1371/journal.pone.0088898	http://dx.doi.org/10.1371/journal.pone.0088898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558444	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700090
J	Hill, DB; Vasquez, PA; Mellnik, J; McKinley, SA; Vose, A; Mu, F; Henderson, AG; Donaldson, SH; Alexis, NE; Boucher, RC; Forest, MG				Hill, David B.; Vasquez, Paula A.; Mellnik, John; McKinley, Scott A.; Vose, Aaron; Mu, Frank; Henderson, Ashley G.; Donaldson, Scott H.; Alexis, Neil E.; Boucher, Richard C.; Forest, M. Gregory			A Biophysical Basis for Mucus Solids Concentration as a Candidate Biomarker for Airways Disease	PLOS ONE			English	Article							CYSTIC-FIBROSIS; RHEOLOGICAL PROPERTIES; PULMONARY SECRETIONS; VISCOELASTIC MODULI; RESPIRATORY MUCUS; SPUTUM; MUCIN; BRONCHIECTASIS; PENETRATION; DIFFUSION	In human airways diseases, including cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), host defense is compromised and airways inflammation and infection often result. Mucus clearance and trapping of inhaled pathogens constitute key elements of host defense. Clearance rates are governed by mucus viscous and elastic moduli at physiological driving frequencies, whereas transport of trapped pathogens in mucus layers is governed by diffusivity. There is a clear need for simple and effective clinical biomarkers of airways disease that correlate with these properties. We tested the hypothesis that mucus solids concentration, indexed as weight percent solids (wt%), is such a biomarker. Passive microbead rheology was employed to determine both diffusive and viscoelastic properties of mucus harvested from human bronchial epithelial (HBE) cultures. Guided by sputum from healthy (1.5-2.5 wt%) and diseased (COPD, CF; 5 wt%) subjects, mucus samples were generated in vitro to mimic in vivo physiology, including intermediate range wt% to represent disease progression. Analyses of microbead datasets showed mucus diffusive properties and viscoelastic moduli scale robustly with wt%. Importantly, prominent changes in both biophysical properties arose at similar to 4 wt%, consistent with a gel transition (from a more viscous-dominated solution to a more elastic-dominated gel). These findings have significant implications for: (1) penetration of cilia into the mucus layer and effectiveness of mucus transport; and (2) diffusion vs. immobilization of micro-scale particles relevant to mucus barrier properties. These data provide compelling evidence for mucus solids concentration as a baseline clinical biomarker of mucus barrier and clearance functions.	[Hill, David B.; Vose, Aaron; Mu, Frank; Henderson, Ashley G.; Donaldson, Scott H.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27514 USA; [Hill, David B.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC USA; [Vasquez, Paula A.; Mellnik, John; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC USA; [Vasquez, Paula A.; Mellnik, John; Forest, M. Gregory] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [McKinley, Scott A.] Univ Florida, Dept Math, Gainesville, FL 32611 USA; [Henderson, Ashley G.] Univ N Carolina, Dept Med, Div Pulm & Crit Care, Chapel Hill, NC USA; [Alexis, Neil E.] Univ N Carolina, Dept Pediat, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hill, DB (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27514 USA.	dbhill@med.unc.edu	Donaldson, Scott H./ABG-5157-2021	Donaldson, Scott H./0000-0003-4802-0388	National Science Foundation [DMS-1100281, DMR-1122483]; National Institutes of Health [NIH/NHLBI 1 P01 HL 108808-01A1, NIH/NHLBI 5 R01 HL 077546-05]; Simons Foundation [245653]; Cystic Fibrosis Foundation [HILL08I0, BUTTON07XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077546, P01HL108808] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by National Science Foundation grants DMS-1100281, DMR-1122483, National Institutes of Health grants NIH/NHLBI 1 P01 HL 108808-01A1, NIH/NHLBI 5 R01 HL 077546-05, a Simons Foundation Collaboration Grant Number 245653, and the Cystic Fibrosis Foundation (HILL08I0, BUTTON07XX0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Bhat PG, 1996, J PHARM SCI, V85, P624, DOI 10.1021/js950381s; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Deng WH, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011112; Didier G, 2012, J TIME SER ANAL, V33, P724, DOI 10.1111/j.1467-9892.2012.00792.x; Ernst D, 2012, SOFT MATTER, V8, P4886, DOI 10.1039/c2sm25220a; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Georgiades P, 2013, BIOPOLYMERS; Hill DB, 2012, ESTABLISHMENT RESP A; Jeffery PK, 1998, THORAX, V53, P129, DOI 10.1136/thx.53.2.129; Kater A, 2007, ANN NY ACAD SCI, V1112, P140, DOI 10.1196/annals.1415.006; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kirch J, 2012, P NATL ACAD SCI USA, V109, P18355, DOI 10.1073/pnas.1214066109; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001; Livraghi-Butrico A, 2012, MUCOSAL IMMUNOL, V5, P397, DOI 10.1038/mi.2012.17; Loughlin CE, 2010, RESP MED, V104, P29, DOI 10.1016/j.rmed.2009.07.002; Macierzanka A, 2011, SOFT MATTER, V7, P8077, DOI 10.1039/c1sm05888f; MacKintosh FC, 1999, CURR OPIN COLLOID IN, V4, P300, DOI 10.1016/S1359-0294(99)90010-9; Magdziarz M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011129; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mason TG, 2000, RHEOL ACTA, V39, P371, DOI 10.1007/s003970000094; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Matsui H, 2005, J IMMUNOL, V175, P1090, DOI 10.4049/jimmunol.175.2.1090; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; MATTHEWS LW, 1963, AM REV RESPIR DIS, V88, P199; O'Malley D, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/L01001; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; POTTER JL, 1967, AM REV RESPIR DIS, V96, P83; PUCHELLE E, 1984, BIORHEOLOGY, V21, P265; Quraishi MS, 1998, CLIN OTOLARYNGOL, V23, P403, DOI 10.1046/j.1365-2273.1998.00172.x; ROBERTS GP, 1976, ARCH BIOCHEM BIOPHYS, V173, P528, DOI 10.1016/0003-9861(76)90289-7; Rubin BK, 2007, PAEDIATR RESPIR REV, V8, P4, DOI 10.1016/j.prrv.2007.02.004; Sackner M A, 1987, Eur J Respir Dis Suppl, V153, P159; Saito DM, 2010, AM J RHINOL ALLERGY, V24, P1, DOI 10.2500/ajra.2010.24.3420; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Schuster BS, 2013, BIOMATERIALS, V34, P3439, DOI 10.1016/j.biomaterials.2013.01.064; SILBERBERG A, 1982, ADV EXP MED BIOL, V144, P53; TAM PY, 1980, BIORHEOLOGY, V17, P465; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; Thornton DJ, 1997, J BIOL CHEM, V272, P9561; Waigh TA, 2005, REP PROG PHYS, V68, P685, DOI 10.1088/0034-4885/68/3/R04; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w	54	113	113	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87681	10.1371/journal.pone.0087681	http://dx.doi.org/10.1371/journal.pone.0087681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558372	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700018
J	Ismail, SA; Ghazoul, J; Ravikanth, G; Kushalappa, CG; Shaanker, RU; Kettle, CJ				Ismail, Sascha A.; Ghazoul, Jaboury; Ravikanth, Gudasalamani; Kushalappa, Cheppudira G.; Shaanker, Ramanan Uma; Kettle, Chris J.			Forest Trees in Human Modified Landscapes: Ecological and Genetic Drivers of Recruitment Failure in Dysoxylum malabaricum (Meliaceae)	PLOS ONE			English	Article							WESTERN-GHATS; BIODIVERSITY CONSERVATION; INBREEDING DEPRESSION; HABITAT FRAGMENTATION; SEED DISPERSAL; SACRED GROVES; SYNERGISMS; POLLEN; METAANALYSIS; DISTURBANCE	Tropical agro-forest landscapes are global priority areas for biodiversity conservation. Little is known about the ability of these landscapes to sustain large late successional forest trees upon which much forest biodiversity depends. These landscapes are subject to fragmentation and additional habitat degradation which may limit tree recruitment and thus compromise numerous ecosystem services including carbon storage and timber production. Dysoxylum malabaricum is a large canopy tree species in the Meliaceae, a family including many important tropical timber trees. This species is found in highly fragmented forest patches within a complex agro-forest landscape of the Western Ghats biodiversity hot spot, South India. In this paper we combined a molecular assessment of inbreeding with ecological and demographic data to explore the multiple threats to recruitment of this tree species. An evaluation of inbreeding, using eleven microsatellite loci in 297 nursery-reared seedlings collected form low and high density forest patches embedded in an agro-forest matrix, shows that mating between related individuals in low density patches leads to reduced seedling performance. By quantifying habitat degradation and tree recruitment within these forest patches we show that increasing canopy openness and the increased abundance of pioneer tree species lead to a general decline in the suitability of forest patches for the recruitment of D. malabaricum. We conclude that elevated inbreeding due to reduced adult tree density coupled with increased degradation of forest patches, limit the recruitment of this rare late successional tree species. Management strategies which maintain canopy cover and enhance local densities of adult trees in agro-forest mosaics will be required to ensure D. malabaricum persists in these landscapes. Our study highlights the need for a holistic understanding of the incipient processes that threaten populations of many important and rare tropical tree species in human dominated agro-forest landscapes.	[Ismail, Sascha A.; Ghazoul, Jaboury; Kettle, Chris J.] Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland; [Ravikanth, Gudasalamani; Shaanker, Ramanan Uma] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India; [Kushalappa, Cheppudira G.] Univ Agr Sci Bangalore, Coll Forestry, Ponnampet, Karnataka, India; [Shaanker, Ramanan Uma] Univ Agr Sci, Dept Crop Physiol, Bangalore, Karnataka, India; [Shaanker, Ramanan Uma] Univ Agr Sci, Sch Ecol & Conservat, Bangalore, Karnataka, India	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore; University of Agricultural Sciences Bangalore	Ismail, SA (corresponding author), Swiss Fed Inst Technol, Inst Terr Ecosyst, Zurich, Switzerland.	sascha.ismail@env.ethz.ch	Ismail, Sascha A./AAU-6260-2020; G, Ravikanth/AAI-5668-2020; Ghazoul, Jaboury/B-2121-2018; Kushalappa, Cheppudira/AAY-8491-2020	G, Ravikanth/0000-0002-9399-8580; Ismail, Sascha Asif/0000-0003-2883-0666; Uma Shaanker, Ramanan/0000-0003-3100-7654	ETH Zurich [ETH-22 08-2]	ETH Zurich(ETH Zurich)	This research was funded by ETH Zurich under the grant number ETH-22 08-2 (http://www.vpf.ethz.ch/researchfunding/index_EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves WD, 2011, NEOTROP ENTOMOL, V40, P39, DOI 10.1590/S1519-566X2011000100006; Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; [Anonymous], 1952, WEALTH INDIA RAW MAT; Benitez-Malvido J, 2003, BIOTROPICA, V35, P530, DOI 10.1111/j.1744-7429.2003.tb00609.x; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Bhagwat SA, 2005, ECOL SOC, V10; Bhagwat SA, 2005, CONSERV BIOL, V19, P1853, DOI 10.1111/j.1523-1739.2005.00248.x; Breed MF, 2012, MOL ECOL, V21, P5955, DOI 10.1111/mec.12056; Breed MF, 2012, ECOL LETT, V15, P444, DOI 10.1111/j.1461-0248.2012.01752.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Cascante A, 2002, CONSERV BIOL, V16, P137, DOI 10.1046/j.1523-1739.2002.00317.x; Chandrakanth MG, 2004, NAT RESOUR FORUM, V28, P102, DOI 10.1111/j.1477-8947.2004.00077.x; Chandran MDS, 1997, CURR SCI INDIA, V73, P146; CHANDRASHEKARA UM, 1994, J TROP ECOL, V10, P337, DOI 10.1017/S0266467400008014; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Ganesh T, 2001, CURR SCI INDIA, V80, P394; Garcia C., 2006, ECOLOGICAL NATL NATU, P199; Garcia CA, 2010, CONSERV BIOL, V24, P479, DOI 10.1111/j.1523-1739.2009.01386.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hobbs RJ, 2001, CONSERV BIOL, V15, P1522, DOI 10.1046/j.1523-1739.2001.01092.x; Ismail SA, 2012, MOL ECOL, V21, P5484, DOI 10.1111/mec.12054; Jones DT, 2003, J APPL ECOL, V40, P380, DOI 10.1046/j.1365-2664.2003.00794.x; Kettle CJ, 2007, MOL ECOL, V16, P3581, DOI 10.1111/j.1365-294X.2007.03419.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Kumar R, 2000, 100 RED LISTED MED P; Kushalappa C. G., 2001, FOREST GENETIC RESOU, P21; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; LEE K. E., 1971, Termites and Soils.; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; R Core Team, 2021, R LANG ENV STAT COMP; Raman TRS, 2003, BIRD CONSERV INT, V13, P199, DOI 10.1017/S0959270903003162; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Scariot A, 2000, BIOTROPICA, V32, P662, DOI 10.1646/0006-3606(2000)032[0662:SMBLIA]2.0.CO;2; Tabarelli M, 2004, BIODIVERS CONSERV, V13, P1419, DOI 10.1023/B:BIOC.0000019398.36045.1b; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Uriarte M, 2010, ECOLOGY, V91, P1317, DOI 10.1890/09-0785.1; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x	49	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89437	10.1371/journal.pone.0089437	http://dx.doi.org/10.1371/journal.pone.0089437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558500	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700146
J	Kessler, R; Hegenscheid, K; Fleck, S; Khaw, A; Kirsch, M; Hosten, N; Langner, S				Kessler, Rebecca; Hegenscheid, Katrin; Fleck, Steffen; Khaw, Alexander; Kirsch, Michael; Hosten, Norbert; Langner, Soenke			Patient Body Weight-Tailored Contrast Medium Injection Protocol for the Craniocervical Vessels: A Prospective Computed Tomography Study	PLOS ONE			English	Article							MULTIDETECTOR CT; HEPATIC ENHANCEMENT; ARTERIAL PHASE; BOLUS-TRACKING; MASS INDEX; HELICAL CT; ANGIOGRAPHY; DURATION; LIVER; UNIFORMITY	Objectives: To evaluate body weight-tailored contrast medium (CM) administration for computed tomography angiography (CTA) of the craniocervical vessels. Methods: Institutional review board approval was obtained, and all patients gave written informed consent. Sixty patients were consecutively assigned to one of three dose groups (20 patients per group) with CM doses of Visipaque 270 (R) (iodixanol 270 mg/ml) tailored to body weight at doses of 1.5, 1.0, or 0.5 ml/kg. Region-of-interest (ROI) analysis of maximum enhancement (ME) was conducted, and signal-to-noise-ratios (SNR) and contrast-to-noise-ratios (CNR) were calculated. Retrospective comparison was performed with three matched control groups examined with a standard CM dose (80 ml of Visipaque 270 (R)). Image quality was rated by two neuroradiologists blinded to the CM dose used. Interrater reliability was calculated using kappa statistics. Results: Body weight/BMI and ME were inversely correlated in the three control groups receiving the standard dose (r = -0.544/-0.597/-0.542/r = -0.358/r = -0.424/r = -0.280). Compared to standard dose, 1.5 ml/kg produced higher ME, SNR, and CNR in the anterior circulation (p <= 0.038), 1.0 ml/kg had higher ME in cervical and medium-sized cerebral arteries (p <= 0.034), and 0.5 ml/kg had lower ME, SNR and CNR for medium-sized cerebral arteries (p <= 0.049). ME, SNR, and CNR were the same for 1.5 ml/kg and 1.0 ml/kg (p >= 0.24), and both had higher values compared to 0.5 ml/kg (p <= 0.043/p <= 0.028). In patients with BMI>25, 1.5 ml/kg and 1.0 ml/kg produced higher ME than standard dose (p<0.001/p = 0.008), but ME in patients with BMI>25 did not differ between group 1 and group 2 (p = 0.673). In patients with BMI <= 25, 1.5 ml/kg and 1.0 ml/kg produced ME comparable to standard dose (p = 0.132/p = 0.403). Regardless of patient weight, 0.5 ml/kg yielded lower ME than standard dose (p = 0.019/0.002). Conclusions: Craniocervical CTA with a body weight-tailored CM dose of 1.0 ml/kg (270 mg iodine/ml) reduces iodine load in patients weighing <80 kg while producing ME similar to standard dose and improves ME in patients with BMI>25.	[Kessler, Rebecca; Hegenscheid, Katrin; Kirsch, Michael; Hosten, Norbert; Langner, Soenke] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Fleck, Steffen] Univ Med Greifswald, Dept Neurosurg, Greifswald, Germany; [Khaw, Alexander] Univ Med Greifswald, Dept Neurol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kessler, R (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany.	rebecca.seipel@uni-greifswald.de	Langner, Soenke/ABB-6744-2021	Langner, Soenke/0000-0001-7241-1173				Angermaier A, 2011, CEREBROVASC DIS, V31, P177, DOI 10.1159/000321868; Arakawa H, 2007, AM J ROENTGENOL, V189, P156, DOI 10.2214/AJR.06.1240; Arana E, 2009, EUR J RADIOL, V70, P507, DOI 10.1016/j.ejrad.2008.01.048; Awai K, 2004, RADIOLOGY, V230, P142, DOI 10.1148/radiol.2301021008; Bae KT, 1998, RADIOLOGY, V207, P647, DOI 10.1148/radiology.207.3.9609886; Bae KT, 2008, AM J ROENTGENOL, V190, P777, DOI 10.2214/AJR.07.2765; Bae KT, 2007, RADIOLOGY, V242, P582, DOI 10.1148/radiol.2422052132; Byrt T, 1996, EPIDEMIOLOGY, V7, P561, DOI 10.1097/00001648-199609000-00030; Fleischmann D, 2000, RADIOLOGY, V214, P363, DOI 10.1148/radiology.214.2.r00fe18363; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Herman S, 2004, J COMPUT ASSIST TOMO, V28, pS7, DOI 10.1097/01.rct.0000120855.80935.2f; Ho LM, 2007, RADIOLOGY, V243, P431, DOI 10.1148/radiol.2432060390; Ichikawa T, 2006, EUR J RADIOL, V58, P165, DOI 10.1016/j.ejrad.2005.11.037; Kalra MK, 2003, KOREAN J RADIOL, V4, P234, DOI 10.3348/kjr.2003.4.4.234; Katzberg RW, 2007, RADIOLOGY, V243, P622, DOI 10.1148/radiol.2433061411; Kondo H, 2010, RADIOLOGY, V254, P163, DOI 10.1148/radiol.09090369; Kondo H, 2008, RADIOLOGY, V249, P872, DOI 10.1148/radiol.2492080033; KORMANO M, 1983, INVEST RADIOL, V18, P364, DOI 10.1097/00004424-198307000-00013; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Nakaura T, 2008, INVEST RADIOL, V43, P512, DOI 10.1097/RLI.0b013e3181727505; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Roggenland D, 2008, AM J ROENTGENOL, V190, pW351, DOI 10.2214/AJR.07.3402; Sandstede JJW, 2001, EUR RADIOL, V11, P1396, DOI 10.1007/s003300000816; Schoellnast H, 2006, AM J ROENTGENOL, V187, P1074, DOI 10.2214/AJR.05.0714; Seifarth H, 2009, EUR RADIOL, V19, P2373, DOI 10.1007/s00330-009-1421-7; Shimizu T, 2000, J COMPUT ASSIST TOMO, V24, P219, DOI 10.1097/00004728-200003000-00006; Tan IYL, 2009, AM J NEURORADIOL, V30, P525, DOI 10.3174/ajnr.A1408; Tatsugami F, 2010, ACAD RADIOL, V17, P207, DOI 10.1016/j.acra.2009.09.010; U.S. National Library of Medicine National Institutes of Health, 2009, VISIPAQUE IOD INJ SO; Yamashita Y, 2000, RADIOLOGY, V216, P718, DOI 10.1148/radiology.216.3.r00se26718; Yanaga Y, 2007, RADIOLOGY, V245, P475, DOI 10.1148/radiol.2452061749	31	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88867	10.1371/journal.pone.0088867	http://dx.doi.org/10.1371/journal.pone.0088867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558438	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700084
J	Murray, AD; McNeil, CJ; Salarirad, S; Whalley, LJ; Staff, RT				Murray, Alison D.; McNeil, Christopher J.; Salarirad, Sima; Whalley, Lawrence J.; Staff, Roger T.			Early Life Socioeconomic Circumstance and Late Life Brain Hyperintensities - A Population Based Cohort Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; LIVING-CONDITIONS; ADULT MORTALITY; HEART-DISEASE; CHILDHOOD; RISK; BIRTH; ORIGINS; EXPOSURE; STROKE	Context: There have been many reports confirming the association between lower childhood socioeconomic circumstance and cardiovascular disease but evidence for links with cerebrovascular disease is contradictory. Hyperintensities on brain magnetic resonance imaging are associated with vascular risk factors, cognitive decline, dementia and death. However, the relationship between childhood socioeconomic circumstance and these lesions is unclear. Objective: To test the hypothesis that childhood socioeconomic circumstance is associated with late life hyperintensity burden and that neither adult socioeconomic circumstance nor change in socioeconomic circumstance during life influence this effect. Design: Cohort study Setting: Community Participants: 227 community dwelling members of the 1936 Aberdeen Birth Cohort aged 68 years, who were free from dementia. Main Outcome Measures: Relationship between early life socioeconomic circumstance (paternal occupation) and abundance of late life brain hyperintensities. Results: We find significant negative correlations between childhood socioeconomic circumstance and white matter hyperintensities (rho = -0.18, P<0.01), and periventricular hyperintensities (rho = -0.15, P<0.05), between educational attainment and white matter hyperintensities (rho = -0.15, P<0.05) and periventricular hyperintensities (rho = -0.17, P<0.05), and between childhood intelligence and periventricular hyperintensities (rho = -0.14, P<0.05). The relationship is strongest for childhood socioeconomic circumstance and regional white matter hyperintensities, where there is a step change in increased burden from paternal occupation grades equivalent to a shift from "white collar" to "blue collar" paternal occupation. Significant correlations were also found between hypertension and hyperintensity burden in all brain regions (rho = 0.15-0.24, P<0.05). In models that include hypertension, the magnitude of the effect of childhood socioeconomic circumstance is similar to and independent from that of hypertension. Conclusions: Childhood socioeconomic circumstance predicts the burden of brain white matter hyperintensities aged 68 years. The mechanism underlying this effect is unknown, but may act through fetal and/or early life programming of cerebrovascular disease. Future work to understand this vulnerability will inform strategies to reduce dementia and stroke.	[Murray, Alison D.; McNeil, Christopher J.; Salarirad, Sima; Whalley, Lawrence J.; Staff, Roger T.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland; [Staff, Roger T.] NHS Grampian, Dept Nucl Med, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Murray, AD (corresponding author), Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen, Scotland.	a.d.murray@abdn.ac.uk	Murray, Alison/H-6250-2017; Staff, Roger T/G-1826-2011; whalley, lawrence j/E-9019-2011	Murray, Alison/0000-0003-4915-4847; Staff, Roger T/0000-0003-0620-8673; McNeil, Chris/0000-0001-7846-1083	Alzheimer's Research UK	Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	Image acquisition and image analysis for this study was funded by the Alzheimer's Research Trust (now Alzheimer's Research UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker DJP, 2001, BMJ-BRIT MED J, V323, P1273, DOI 10.1136/bmj.323.7324.1273; Benisty S, 2009, J NEUROL NEUROSUR PS, V80, P478, DOI 10.1136/jnnp.2008.160440; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Black R, 1980, INEQUALITIES HLTH; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DELAMOTHE T, 1991, BRIT MED J, V303, P1046, DOI 10.1136/bmj.303.6809.1046; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FORSDAHL A, 1978, J EPIDEMIOL COMMUN H, V32, P34, DOI 10.1136/jech.32.1.34; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gianaros PJ, 2011, CEREB CORTEX, V21, P896, DOI 10.1093/cercor/bhq160; Gianaros PJ, 2012, CEREB CORTEX; GLIKSMAN MD, 1995, J EPIDEMIOL COMMUN H, V49, P10, DOI 10.1136/jech.49.1.10; Great Britain Office of Population Censuses and Surveys, 1990, STAND OCC CLASS COD; Grimaud O, 2011, AGE AGEING, V40, P116, DOI 10.1093/ageing/afq142; Hart CL, 2003, J EPIDEMIOL COMMUN H, V57, P385, DOI 10.1136/jech.57.5.385; Hoyle R.H., 1995, STRUCTURAL EQUATION, P158; Joreskog KG, 1984, LISREL 6 USERS GUID; Meier IB, 2012, J INT NEUROPSYCH SOC, V18, P414, DOI 10.1017/S1355617712000227; Murray AD, 2011, BRAIN, V134, P3684, DOI 10.1093/brain/awr259; Murray AD, 2012, AGE, V34, P451, DOI 10.1007/s11357-011-9233-5; Naess O, 2004, J EPIDEMIOL COMMUN H, V58, P597, DOI 10.1136/jech.2003.012229; Pickett R. Wilkinson, 2010, SPIRIT LEVEL WHY EQU; Power C, 2005, AM J PUBLIC HEALTH, V95, P1396, DOI 10.2105/AJPH.2004.047340; Salarirad S, 2011, AGE AGEING, V40, P562, DOI 10.1093/ageing/afr065; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Scottish Council for Research in Education, 1933, INT SCOTT SCH CHILDR; Seidler A, 2007, OCCUP ENVIRON MED, V64, P108, DOI 10.1136/oem.2005.024190; Shenkin SD, 2009, STROKE, V40, P1225, DOI 10.1161/STROKEAHA.108.527259; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2006, NUTR REV, V64, pS44, DOI 10.1301/nr.2006.may.S44-S49; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Soderlund H, 2006, NEUROBIOL AGING, V27, P16, DOI 10.1016/j.neurobiolaging.2004.12.008; Sposato LA, 2011, J STROKE CEREBROVASC; Staff RT, 2012, ANN NEUROL, V71, P653, DOI 10.1002/ana.22631; Wamala SP, 2001, INT J EPIDEMIOL, V30, P275, DOI 10.1093/ije/30.2.275; Whalley LJ, 2011, MATURITAS, V69, P365, DOI 10.1016/j.maturitas.2011.05.010; Wright CB, 2005, STROKE, V36, P1207, DOI 10.1161/01.STR.0000165923.02318.22	42	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88969	10.1371/journal.pone.0088969	http://dx.doi.org/10.1371/journal.pone.0088969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558456	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700102
J	Utsunomiya, YT; Carmo, AS; Neves, HHR; Carvalheiro, R; Matos, MC; Zavarez, LB; Ito, PKRK; O'Brien, AMP; Solkner, J; Porto-Neto, LR; Schenkel, FS; McEwan, J; Cole, JB; da Silva, MVGB; Van Tassell, CP; Sonstegard, TS; Garcia, JF				Utsunomiya, Yuri T.; Carmo, Adriana S.; Neves, Haroldo H. R.; Carvalheiro, Roberto; Matos, Marcia C.; Zavarez, Ludmilla B.; Ito, Pier K. R. K.; O'Brien, Ana M. Perez; Soelkner, Johann; Porto-Neto, Laercio R.; Schenkel, Flavio S.; McEwan, John; Cole, John B.; da Silva, Marcos V. G. B.; Van Tassell, Curtis P.; Sonstegard, Tad S.; Garcia, Jose Fernando			Genome-Wide Mapping of Loci Explaining Variance in Scrotal Circumference in Nellore Cattle	PLOS ONE			English	Article							ADDITIVE GENETIC-RELATIONSHIPS; REPRODUCTIVE TRAITS; BINDING-PROTEINS; HEIFER PREGNANCY; GROWTH; ASSOCIATION; SELECTION; CLONING; FAMILY; SP4	The reproductive performance of bulls has a high impact on the beef cattle industry. Scrotal circumference (SC) is the most recorded reproductive trait in beef herds, and is used as a major selection criterion to improve precocity and fertility. The characterization of genomic regions affecting SC can contribute to the identification of diagnostic markers for reproductive performance and uncover molecular mechanisms underlying complex aspects of bovine reproductive biology. In this paper, we report a genome-wide scan for chromosome segments explaining differences in SC, using data of 861 Nellore bulls (Bos indicus) genotyped for over 777,000 single nucleotide polymorphisms. Loci that excel from the genome background were identified on chromosomes 4, 6, 7, 10, 14, 18 and 21. The majority of these regions were previously found to be associated with reproductive and body size traits in cattle. The signal on chromosome 14 replicates the pleiotropic quantitative trait locus encompassing PLAG1 that affects male fertility in cattle and stature in several species. Based on intensive literature mining, SP4, MAGEL2, SH3RF2, PDE5A and SNAI2 are proposed as novel candidate genes for SC, as they affect growth and testicular size in other animal models. These findings contribute to linking reproductive phenotypes to gene functions, and may offer new insights on the molecular biology of male fertility.	[Utsunomiya, Yuri T.; Carmo, Adriana S.; Matos, Marcia C.; Zavarez, Ludmilla B.; Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil; [Neves, Haroldo H. R.; Carvalheiro, Roberto] UNESP Univ Estadual Paulista, Dept Zootecnia, Sao Paulo, Brazil; [Carvalheiro, Roberto] GenSys Consultores Associados, Porto Alegre, RS, Brazil; [Ito, Pier K. R. K.; Garcia, Jose Fernando] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil; [Soelkner, Johann] BOKU Univ Nat Resources & Life Sci, Div Livestock Sci, Dept Sustainable Agr Syst, Vienna, Austria; [Porto-Neto, Laercio R.] CSIRO Commonwealth Sci & Ind Res Org, Food Futures Flagship, Brisbane, Qld, Australia; [Schenkel, Flavio S.] Univ Guelph, Ctr Genet Improvement Livestock, Guelph, ON N1G 2W1, Canada; [McEwan, John] AgResearch, Ctr Reprod & Genom, Mosgiel, Otago, New Zealand; [Cole, John B.] ARS, Anim Improvement Programs Lab, USDA, Beltsville, MD USA; [da Silva, Marcos V. G. B.] Embrapa Dairy Cattle, Bioinformat & Anim Genom Lab, Juiz De Fora, MG, Brazil; [Sonstegard, Tad S.] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Natural Resources & Life Sciences, Vienna; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Guelph; AgResearch - New Zealand; United States Department of Agriculture (USDA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA)	Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil.	jfgarcia@fmva.unesp.br	de Rezende Neves, Haroldo Henrique/F-9521-2012; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Andreia/D-8603-2012; Carvalheiro, Roberto/I-2239-2013; Carvalheiro, Roberto/AAG-2222-2020; Schenkel, Flavio/ABG-1842-2021; Cole, John B./J-8571-2014; Van Tassell, Curtis P./O-4247-2019; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020; Carmo, Adriana S/E-4342-2016; McEwan, John/A-1143-2008; Porto-Neto, Laercio R/D-2594-2012	Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carvalheiro, Roberto/0000-0002-4506-0555; Carvalheiro, Roberto/0000-0002-4506-0555; Cole, John B./0000-0003-1242-4401; Van Tassell, Curtis P./0000-0002-8416-2087; Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; Carmo, Adriana S/0000-0002-2712-4789; McEwan, John/0000-0003-4801-6207; Porto-Neto, Laercio R/0000-0002-3536-8265; Perez O'Brien, Ana Maria/0000-0002-2077-8421; Schenkel, Flavio/0000-0001-8700-0633; Solkner, Johann/0000-0002-1517-5829	National Counsel of Technological and Scientific Development (CNPq) [560922/2010-8, 483590/2010-0]; Sao Paulo Research Foundation (FAPESP) [2011/16643-2, 2010/52030-2]; ARS [ARS-0423740] Funding Source: Federal RePORTER	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by: National Counsel of Technological and Scientific Development (CNPq - http://www.cnpq.br/) (process 560922/2010-8 and 483590/2010-0); and Sao Paulo Research Foundation (FAPESP - http://www.fapesp.br/) (process 2011/16643-2 and 2010/52030-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alianca, 2012, SUM TOUR 2012 AL NEL; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Ball L, 1983, J SOC THERIO; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; BOURDON RM, 1986, J ANIM SCI, V62, P958, DOI 10.2527/jas1986.624958x; Brown PR, 2003, BIOL REPROD, V68, P2241, DOI 10.1095/biolreprod.102.013466; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Dias LT, 2003, REV BRAS ZOOTECN, V32, P1878, DOI 10.1590/S1516-35982003000800011; Evans JL, 1999, J ANIM SCI, V77, P2621; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Fortes MRS, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101089; French CA, 2003, CANCER RES, V63, P304; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; HUGGINS C, 1948, J EXP MED, V88, P169, DOI 10.1084/jem.88.2.169; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kinsella RJ, 2011, ENSEMBL BIOMARTS HUB; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Langer C, 2002, BIOCHEM BIOPH RES CO, V296, P1051, DOI 10.1016/S0006-291X(02)02038-7; MARTIN LC, 1992, J ANIM SCI, V70, P4006, DOI 10.2527/1992.70124006x; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; Neto MH, 1996, ARQ BRAS MED VET ZOO, V48, P755; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2022, R LANG ENV STAT COMP; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; Stefan M, 2005, GENOMICS, V85, P630, DOI 10.1016/j.ygeno.2005.02.004; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; TOELLE VD, 1985, J ANIM SCI, V60, P89, DOI 10.2527/jas1985.60189x; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Van Melis MH, 2010, J ANIM SCI, V88, P3809, DOI 10.2527/jas.2009-2127; Vezzosi D, 2011, EUR J ENDOCRINOL, V165, P177, DOI 10.1530/EJE-10-1123; YAN BF, 1995, ARCH BIOCHEM BIOPHYS, V316, P899, DOI 10.1006/abbi.1995.1121; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	43	32	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88561	10.1371/journal.pone.0088561	http://dx.doi.org/10.1371/journal.pone.0088561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558400	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700046
J	Llop-Guevara, A; Chu, DK; Walker, TD; Goncharova, S; Fattouh, R; Silver, JS; Moore, CL; Xie, JL; O'Byrne, PM; Coyle, AJ; Kolbeck, R; Humbles, AA; Stampfli, MR; Jordana, M				Llop-Guevara, Alba; Chu, Derek K.; Walker, Tina D.; Goncharova, Susanna; Fattouh, Ramzi; Silver, Jonathan S.; Moore, Cheryl Lynn; Xie, Juliana L.; O'Byrne, Paul M.; Coyle, Anthony J.; Kolbeck, Roland; Humbles, Alison A.; Staempfli, Martin R.; Jordana, Manel			A GM-CSF/IL-33 Pathway Facilitates Allergic Airway Responses to Sub-Threshold House Dust Mite Exposure	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; GM-CSF; TRANSGENE EXPRESSION; MURINE MODEL; IL-33; CYTOKINE; ASTHMA; RECEPTOR; INFLAMMATION; LUNG	Allergic asthma is a chronic immune-inflammatory disease of the airways. Despite aeroallergen exposure being universal, allergic asthma affects only a fraction of individuals. This is likely related, at least in part, to the extent of allergen exposure. Regarding house dust mite (HDM), we previously identified the threshold required to elicit allergic responses in BALB/c mice. Here, we investigated the impact of an initial immune perturbation on the response to sub-threshold HDM exposure. We show that transient GM-CSF expression in the lung facilitated robust eosinophilic inflammation, long-lasting antigen-specific Th2 responses, mucus production and airway hyperresponsiveness. This was associated with increased IL-33 levels and activated CD11b(+) DCs expressing OX40L. GM-CSF-driven allergic responses were significantly blunted in IL-33-deficient mice. IL-33 was localized on alveolar type II cells and in vitro stimulation of human epithelial cells with GM-CSF enhanced intracellular IL-33 independently of IL-1 alpha. Likewise, GM-CSF administration in vivo resulted in increased levels of IL-33 but not IL-1 alpha. These findings suggest that exposures to environmental agents associated with GM-CSF production, including airway infections and pollutants, may decrease the threshold of allergen responsiveness and, hence, increase the susceptibility to develop allergic asthma through a GM-CSF/IL-33/OX40L pathway.	[Llop-Guevara, Alba; Chu, Derek K.; Walker, Tina D.; Goncharova, Susanna; Fattouh, Ramzi; Moore, Cheryl Lynn; Xie, Juliana L.; Coyle, Anthony J.; Staempfli, Martin R.; Jordana, Manel] McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Silver, Jonathan S.; Kolbeck, Roland; Humbles, Alison A.] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [O'Byrne, Paul M.; Staempfli, Martin R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Coyle, Anthony J.] Pfizer, Cambridge, MA USA	McMaster University; AstraZeneca; Medimmune; McMaster University; Pfizer	Jordana, M (corresponding author), McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.	jordanam@mcmaster.ca	T, E/HII-8943-2022	Stampfli, Martin/0000-0003-4918-5889; Llop-Guevara, Alba/0000-0002-7913-9472; O'Byrne, Paul/0000-0003-0979-281X; Fattouh, Ramzi/0000-0001-6573-6367; Chu, Derek/0000-0001-8269-4496	Canadian Institute of Health Research (CIHR) [87517]; LaCaixa-ICCS scholarship; Fundacion Caja Madrid doctoral scholarship (Spain); CIHR Vanier scholar	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); LaCaixa-ICCS scholarship; Fundacion Caja Madrid doctoral scholarship (Spain); CIHR Vanier scholar(Canadian Institutes of Health Research (CIHR))	This work was partially supported by a grant from the Canadian Institute of Health Research (CIHR, grant number 87517). AL-G was initially supported by a LaCaixa-ICCS scholarship and then a Fundacion Caja Madrid doctoral scholarship (Spain); DKC is a CIHR Vanier scholar; and MJ holds a Senior Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; DeMaio L, 2009, AM J PHYSIOL-LUNG C, V296, pL1051, DOI 10.1152/ajplung.00021.2009; Fattouh Ramzi, 2008, Inflammation & Allergy Drug Targets, V7, P224, DOI 10.2174/187152808786848388; Fattouh R, 2008, AM J RESP CRIT CARE, V177, P593, DOI 10.1164/rccm.200706-958OC; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; He JQ, 2003, CHEST, V123, p438S, DOI 10.1378/chest.123.3_suppl.438S; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Johnson JR, 2007, AM J PHYSIOL-LUNG C, V293, pL730, DOI 10.1152/ajplung.00056.2007; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kabesch M, 2007, ALLERGY, V62, P423, DOI 10.1111/j.1398-9995.2006.01300.x; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kube D, 2001, AM J PHYSIOL-LUNG C, V280, pL493, DOI 10.1152/ajplung.2001.280.3.L493; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Lei XF, 1998, CLIN EXP IMMUNOL, V113, P157; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Llop-Guevara A, 2011, INFLAMMATION AND ALLERGY DRUG DESIGN, P187; Llop-Guevara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002426; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nelson MP, 2011, J IMMUNOL, V186, P2372, DOI 10.4049/jimmunol.1002558; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Prefontaine D, 2010, J ALLERGY CLIN IMMUN, V125, P752, DOI 10.1016/j.jaci.2009.12.935; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Stampfli MR, 1998, J CLIN INVEST, V102, P1704, DOI 10.1172/JCI4160; Sunyer J, 2004, J ALLERGY CLIN IMMUN, V114, P1033, DOI 10.1016/j.jaci.2004.05.072; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trimble NJ, 2009, AM J RESP CELL MOL, V40, P38, DOI 10.1165/rcmb.2008-0107OC; Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Xiang ZG, 2010, IMMUNOL LETT, V131, P159, DOI 10.1016/j.imlet.2010.04.005; Yamaya M, 2012, PULM MED, V2012, DOI 10.1155/2012/834826; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109	45	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88714	10.1371/journal.pone.0088714	http://dx.doi.org/10.1371/journal.pone.0088714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551140	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500056
J	Restivo, A; Degano, I; Ribechini, E; Colombini, MP				Restivo, Annalaura; Degano, Ilaria; Ribechini, Erika; Colombini, Maria Perla			Development and Optimisation of an HPLC-DAD-ESI-Q-ToF Method for the Determination of Phenolic Acids and Derivatives	PLOS ONE			English	Article							MASS-SPECTROMETRY; CHROMATOGRAPHY; ANTIOXIDANTS	A method for the HPLC-MS/MS analysis of phenols, including phenolic acids and naphtoquinones, using an amideembedded phase column was developed and compared to the literature methods based on classical C18 stationary phase columns. RP-Amide is a recently developed polar embedded stationary phase, whose wetting properties mean that up to 100% water can be used as an eluent. The increased retention and selectivity for polar compounds and the possibility of working in 100% water conditions make this column particularly interesting for the HPLC analysis of phenolic acids and derivatives. In this study, the chromatographic separation was optimised on an HPLC-DAD, and was used to separate 13 standard phenolic acids and derivatives. The method was validated on an HPLC-ESI-Q-ToF. The acquisition was performed in negative polarity and MS/MS target mode. Ionisation conditions and acquisition parameters for the Q-ToF detector were investigated by working on collision energies and fragmentor potentials. The performance of the method was fully evaluated on standards. Moreover, several raw materials containing phenols were analysed: walnut, gall, wine, malbec grape, French oak, red henna and propolis. Our method allowed us to characterize the phenolic composition in a wide range of matrices and to highlight possible matrix effects.	[Restivo, Annalaura; Degano, Ilaria; Ribechini, Erika; Colombini, Maria Perla] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy	University of Pisa	Degano, I (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	ilaria.degano@unipi.it	Degano, Ilaria/F-9184-2012; Ribechini, Erika/M-7210-2014; Ribechini, Erika/AAH-3769-2020	Degano, Ilaria/0000-0002-3585-8555; Ribechini, Erika/0000-0002-4978-2782; Ribechini, Erika/0000-0002-4978-2782; colombini, maria perla/0000-0002-1666-8596	PAR-FAS Regione Toscana; VAT project	PAR-FAS Regione Toscana(Regione Toscana); VAT project	The authors gratefully acknowledge the VAT project ("La vita breve del tannino'', founded by PAR-FAS 2007-2013 Regione Toscana) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Reidah IM, 2013, FOOD RES INT, V51, P354, DOI 10.1016/j.foodres.2012.12.033; Benhaim D, 2010, J CHROMATOGR A, V1217, P65, DOI 10.1016/j.chroma.2009.11.013; Benmeddour Z, 2013, J FUNCT FOODS, V5, P346, DOI 10.1016/j.jff.2012.11.005; Cannon J, 1994, DYE PLANTS DYEING; Chen LL, 2009, J PHARMACEUT BIOMED, V50, P127, DOI 10.1016/j.jpba.2009.03.039; Chocholous P, 2013, TALANTA, V103, P221, DOI 10.1016/j.talanta.2012.10.036; Degano I, 2009, APPL SPECTROSC REV, V44, P363, DOI 10.1080/05704920902937876; Degano I, 2009, THESIS; Rodriguez-Hernandez MD, 2012, J FOOD SCI, V77, pC1058, DOI 10.1111/j.1750-3841.2012.02886.x; Dugo P, 2009, J CHROMATOGR A, V1216, P7213, DOI 10.1016/j.chroma.2009.08.030; Francisco MLD, 2009, FOOD CHEM, V117, P356, DOI 10.1016/j.foodchem.2009.03.110; Ghafoor A. O., 2012, Journal of Chemical and Pharmaceutical Research, V4, P3158; Ghasemzadeh A, 2011, J MED PLANTS RES, V5, P6697, DOI 10.5897/JMPR11.1404; Hawryl MA, 2012, JPC-J PLANAR CHROMAT, V25, P394, DOI 10.1556/JPC.25.2012.5.2; Hofenk De Graaff J.H., 2004, COLOURFUL; Inbaraj BS, 2010, J PHARMACEUT BIOMED, V51, P549, DOI 10.1016/j.jpba.2009.09.006; Iswaldi I, 2011, ANAL BIOANAL CHEM, V400, P3643, DOI 10.1007/s00216-011-4998-z; Kale A., 2010, INT J PHARM BIOSCIEN, V1, P1; Khoddami A, 2013, MOLECULES, V18, P2328, DOI 10.3390/molecules18022328; McGachy NT, 2009, J SEP SCI, V32, P4101, DOI 10.1002/jssc.200900551; Motilva MJ, 2013, J CHROMATOGR A, V1292, P66, DOI 10.1016/j.chroma.2013.01.012; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; Saxena M., 2012, INT J PHARM SCI REV, V16, P130, DOI DOI 10.5897/JMPR11.1404; Taylor PJ, 2005, CLIN BIOCHEM, V38, P328, DOI 10.1016/j.clinbiochem.2004.11.007	24	17	17	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88762	10.1371/journal.pone.0088762	http://dx.doi.org/10.1371/journal.pone.0088762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551158	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500066
J	Ochi, A; Mori, K; Emoto, M; Nakatani, S; Morioka, T; Motoyama, K; Fukumoto, S; Imanishi, Y; Koyama, H; Ishimura, E; Inaba, M				Ochi, Akinobu; Mori, Katsuhito; Emoto, Masanori; Nakatani, Shinya; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Koyama, Hidenori; Ishimura, Eiji; Inaba, Masaaki			Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; TYPE-2 DIABETES-MELLITUS; FATTY LIVER; GLYCOPROTEIN/FETUIN-A; RECEPTOR; ASSOCIATION; ADIPONECTIN; STEATOSIS; DISEASE; HUMANS	Fetuin-A, a circulating glycoprotein synthesized in the liver, is involved in insulin resistance and type 2 diabetes. However, regulation of fetuin-A synthesis has remained obscure. We previously reported that pioglitazone treatment significantly reduced serum fetuin-A levels in patients with type 2 diabetes. To clarify whether pioglitazone can directory inhibit hepatic fetuin-A synthesis, we investigated the effects of pioglitazone on fetuin-A expression both in vitro and in vivo. Pioglitazone treatment suppressed mRNA and protein expression of fetuin-A in Fao hepatoma cells. Interestingly, rosiglitazone but not metformin, also inhibited fetuin-A expression. In addition, GW 9662, an inhibitor of peroxisome proliferator-activated receptor (PPAR) gamma, reversed pioglitazone-induced suppression of fetuin-A, suggesting that thiazolidinedione derivatives may have common characteristics with regard to fetuin-A suppression, possibly through PPAR gamma activation. Finally, oral administration of pioglitazone to mice for 8 weeks resulted in suppression of hepatic fetuin-A mRNA. These findings suggest that pioglitazone may partially ameliorate insulin resistance through its direct inhibitory effects on fetuin-A expression in the liver.	[Ochi, Akinobu; Mori, Katsuhito; Emoto, Masanori; Nakatani, Shinya; Morioka, Tomoaki; Motoyama, Koka; Fukumoto, Shinya; Imanishi, Yasuo; Ishimura, Eiji; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan; [Koyama, Hidenori] Hyogo Coll Med, Div Endocrinol & Metab, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Osaka Metropolitan University; Hyogo College of Medicine	Mori, K (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 558, Japan.	ktmori@med.osaka-cu.ac.jp	Koyama, Hidenori/AAU-2346-2020; Ochi, Akinobu/K-5380-2019	Koyama, Hidenori/0000-0001-7930-2228; OCHI, AKINOBU/0000-0001-6809-8399	Japan Society for the Promotion of Science [25461250]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by a Grant-in-Aid for Scientific Research (C) (No.25461250) from the Japan Society for the Promotion of Science (to Mori). No additional funding was received for this study. The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; BACKER JM, 1989, J BIOL CHEM, V264, P1694; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Derosa G, 2010, DRUGS, V70, P1945, DOI 10.2165/11538100-000000000-00000; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Haukeland JW, 2012, EUR J ENDOCRINOL, V166, P503, DOI 10.1530/EJE-11-0864; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Jiang QJ, 2010, J INVEST DERMATOL, V130, P1288, DOI 10.1038/jid.2009.423; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Monden M, 2013, DIABETES, V62, P478, DOI 10.2337/db11-1116; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Mori K, 2005, MOL CELL ENDOCRINOL, V230, P39, DOI 10.1016/j.mce.2004.11.004; Mori K, 2008, METABOLISM, V57, P1248, DOI 10.1016/j.metabol.2008.04.019; Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8; Mori K, 2011, RECENT PATENTS ENDOC, V5, P124, DOI 10.2174/187221411799015372; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Stefan N, 2013, NAT MED, V19, P394, DOI 10.1038/nm.3116; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Takata H, 2009, J ATHEROSCLER THROMB, V16, P448, DOI 10.5551/jat.No950; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797	28	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88704	10.1371/journal.pone.0088704	http://dx.doi.org/10.1371/journal.pone.0088704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551137	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000056
J	Rienth, M; Torregrosa, L; Kelly, MT; Luchaire, N; Pellegrino, A; Grimplet, J; Romieu, C				Rienth, Markus; Torregrosa, Laurent; Kelly, Mary T.; Luchaire, Nathalie; Pellegrino, Anne; Grimplet, Jerome; Romieu, Charles			Is Transcriptomic Regulation of Berry Development More Important at Night than During the Day?	PLOS ONE			English	Article							GRAPE BERRY; GENE-EXPRESSION; ORGANIC-ACIDS; OXIDATIVE STRESS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; FUNCTIONAL-CHARACTERIZATION; ANTHOCYANIN BIOSYNTHESIS; PROLINE ACCUMULATION; AROMATIC COMPOSITION	Diurnal changes in gene expression occur in all living organisms and have been studied on model plants such as Arabidopsis thaliana. To our knowledge the impact of the nycthemeral cycle on the genetic program of fleshly fruit development has been hitherto overlooked. In order to circumvent environmental changes throughout fruit development, young and ripening berries were sampled simultaneously on continuously flowering microvines acclimated to controlled circadian light and temperature changes. Gene expression profiles along fruit development were monitored during both day and night with whole genome microarrays (Nimblegen (R) vitis 12x), yielding a total number of 9273 developmentally modulated probesets. All day-detected transcripts were modulated at night, whereas 1843 genes were night-specific. Very similar developmental patterns of gene expression were observed using independent hierarchical clustering of day and night data, whereas functional categories of allocated transcripts varied according to time of day. Many transcripts within pathways, known to be up-regulated during ripening, in particular those linked to secondary metabolism exhibited a clearer developmental regulation at night than during the day. Functional enrichment analysis also indicated that diurnally modulated genes considerably varied during fruit development, with a shift from cellular organization and photosynthesis in green berries to secondary metabolism and stress-related genes in ripening berries. These results reveal critical changes in gene expression during night development that differ from daytime development, which have not been observed in other transcriptomic studies on fruit development thus far.	[Rienth, Markus] Fdn Jean Poupelain, Javrezac, France; [Rienth, Markus; Torregrosa, Laurent; Luchaire, Nathalie] INRA SupAgro, UMR AGAP, Montpellier, France; [Kelly, Mary T.] Fac Pharm Montpellier, Lab Oenol, UMR1083, F-34060 Montpellier, France; [Luchaire, Nathalie; Pellegrino, Anne] INRA, UMR LEPSE, F-34060 Montpellier, France; [Grimplet, Jerome] Univ La Rioja, CSIC, ICVV, Logrono, Spain; [Romieu, Charles] INRA, UMR AGAP, F-34060 Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier; INRAE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-CAR-UR - Instituto de Ciencias de la Vid y del Vino (ICVV); Universidad de La Rioja; INRAE; Universite de Montpellier	Romieu, C (corresponding author), INRA, UMR AGAP, F-34060 Montpellier, France.	romieu@supagro.inra.fr	Rienth, Markus/AAK-3241-2021; Grimplet, Jerome/A-3422-2011; Rienth, Markus/AAI-5448-2021; Grimplet, Jérôme/M-4589-2019; romieu, charles/C-2115-2015	Rienth, Markus/0000-0002-6302-6297; Grimplet, Jerome/0000-0002-3265-4012; Grimplet, Jérôme/0000-0002-3265-4012; Luchaire, Nathalie/0000-0001-5566-7644; romieu, charles/0000-0003-2607-8335	ANR (Agence national de la recherche) -Genopole project [ANR-2010-GENM-004-01]; Jean Poupelain foundation (30 Rue Gate Chien, 16100 Javrezac, France)	ANR (Agence national de la recherche) -Genopole project(French National Research Agency (ANR)); Jean Poupelain foundation (30 Rue Gate Chien, 16100 Javrezac, France)	This work is part of the DURAVITIS program which is financially supported by the ANR (Agence national de la recherche) -Genopole (project ANR-2010-GENM-004-01) and the Jean Poupelain foundation (30 Rue Gate Chien, 16100 Javrezac, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DO, 2006, AM J ENOL VITICULT, V57, P249; Aharoni A, 2002, PLANT PHYSIOL, V129, P1019, DOI 10.1104/pp.003558; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Bai Y, 2012, MOL GENET GENOMICS, V287, P663, DOI 10.1007/s00438-012-0707-7; BELY M, 1990, J FERMENT BIOENG, V70, P246, DOI 10.1016/0922-338X(90)90057-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Beruter J, 2004, J PLANT PHYSIOL, V161, P1011, DOI 10.1016/j.jplph.2003.12.008; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Boss P.K., 2009, GRAPEVINE MOL PHYSL, P263, DOI DOI 10.1007/978-90-481-2305-6_10; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Bouloumpasi E, 2002, VITIS, V41, P195; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Brillouet JM, 2013, ANN BOT-LONDON, V112, P1003, DOI 10.1093/aob/mct168; Broderick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035537; Broderick R, 2009, BIOCHEM SOC T, V37, P926, DOI 10.1042/BST0370926; Burkle L, 2003, PLANT J, V34, P13, DOI 10.1046/j.1365-313X.2003.01700.x; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chaib J, 2010, PLANT J, V62, P1083, DOI 10.1111/j.1365-313X.2010.04219.x; Chen FX, 2009, FOOD CHEM, V114, P657, DOI 10.1016/j.foodchem.2008.10.003; Chen LS, 1997, PLANT PHYSIOL, V115, P1127, DOI 10.1104/pp.115.3.1127; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Chow BY, 2013, SEMIN CELL DEV BIOL, V24, P383, DOI 10.1016/j.semcdb.2013.02.005; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; COOMBE BG, 1973, PLANT PHYSIOL, V51, P629, DOI 10.1104/pp.51.4.629; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; CREASY GL, 1993, AM J ENOL VITICULT, V44, P187; Cruz-Rus E, 2010, J PLANT PHYSIOL, V167, P739, DOI 10.1016/j.jplph.2009.12.017; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Davies C., 2009, GRAPEVINE MOL PHYSL, P229, DOI [10.1007/978-90-481-2305-6_9, DOI 10.1007/978-90-481-2305-6_9]; DeBolt S, 2006, P NATL ACAD SCI USA, V103, P5608, DOI 10.1073/pnas.0510864103; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deytieux-Belleau C, 2007, J INT SCI VIGNE VIN, V41, P141; Diakou P, 2000, AUST J PLANT PHYSIOL, V27, P221; DROUET AG, 1977, PHYTOCHEMISTRY, V16, P505, DOI 10.1016/0031-9422(77)80002-2; Du H, 2010, PLANT PHYSIOL, V154, P1304, DOI 10.1104/pp.110.163741; El-Kereamy A, 2003, PHYSIOL PLANTARUM, V119, P175, DOI 10.1034/j.1399-3054.2003.00165.x; Emmerlich V, 2003, P NATL ACAD SCI USA, V100, P11122, DOI 10.1073/pnas.1832002100; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Eyeghe-Bickong HA, 2012, J CHROMATOGR B, V885, P43, DOI 10.1016/j.jchromb.2011.12.011; Famiani F, 2000, J EXP BOT, V51, P675, DOI 10.1093/jexbot/51.345.675; Fasoli M, 2012, PLANT CELL, V24, P3489, DOI 10.1105/tpc.112.100230; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; FINDLAY N, 1987, J EXP BOT, V38, P668, DOI 10.1093/jxb/38.4.668; Ford C. M., 1998, Australian Journal of Grape and Wine Research, V4, P48, DOI 10.1111/j.1755-0238.1998.tb00134.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fortes AM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-149; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; GEIGENBERGER P, 1993, PLANTA, V189, P329, DOI 10.1007/BF00194429; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; GREENSPAN MD, 1994, PLANT CELL ENVIRON, V17, P811, DOI 10.1111/j.1365-3040.1994.tb00175.x; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Grimplet Jerome, 2012, BMC Res Notes, V5, P213, DOI 10.1186/1756-0500-5-213; Grimplet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008365; Guillaumie S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-165; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; HALE CR, 1962, NATURE, V195, P917, DOI 10.1038/195917a0; HAMILTON AJ, 1991, P NATL ACAD SCI USA, V88, P7434, DOI 10.1073/pnas.88.16.7434; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; He F, 2010, MOLECULES, V15, P9057, DOI 10.3390/molecules15129057; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hernandez-Orte P, 2005, FOOD CHEM, V89, P163, DOI 10.1016/j.foodchem.2004.02.021; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Ichihashi Y, 2010, PLANT CELL PHYSIOL, V51, P252, DOI 10.1093/pcp/pcp184; International Organisation of Vine and Wine, 2012, STAT REP WORLD VIT; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; JOHNSON RW, 1992, PLANT CELL ENVIRON, V15, P947, DOI 10.1111/j.1365-3040.1992.tb01027.x; Kelly MT, 2010, J CHROMATOGR A, V1217, P7385, DOI 10.1016/j.chroma.2010.09.047; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P5348, DOI 10.1021/jf010758h; Kennedy JA, 2006, AM J ENOL VITICULT, V57, P239; Kim Y, 2012, MOL PLANT, V5, P678, DOI 10.1093/mp/sss005; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; Kovermann P, 2007, PLANT J, V52, P1169, DOI 10.1111/j.1365-313X.2007.03367.x; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; LAKSO AN, 1975, PLANT PHYSIOL, V56, P370, DOI 10.1104/pp.56.3.370; Lei M, 2001, J CELL SCI, V114, P1447; Li J, 2012, PROTOPLASMA, V249, P95, DOI 10.1007/s00709-011-0357-3; Lijavetzky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039547; Lobit P, 2006, J EXP BOT, V57, P1471, DOI 10.1093/jxb/erj128; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Lu S, 2002, PLANT PHYSIOL, V130, P477, DOI 10.1104/pp.006544; Luchaire N, 2013, GIESCO 2013, P788; Lucker J, 2004, PHYTOCHEMISTRY, V65, P2649, DOI 10.1016/j.phytochem.2004.08.017; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Martinez-Andujar C, 2011, P NATL ACAD SCI USA, V108, P17225, DOI 10.1073/pnas.1112151108; Mateo JJ, 2000, J CHROMATOGR A, V881, P557, DOI 10.1016/S0021-9673(99)01342-4; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; Mchedlishvili N, 2012, J CELL SCI, V125, P906, DOI 10.1242/jcs.091967; McWatters HG, 2011, FEBS LETT, V585, P1474, DOI 10.1016/j.febslet.2011.03.051; Melino VJ, 2011, J SCI FOOD AGR, V91, P1712, DOI 10.1002/jsfa.4376; Mendes-Pinto MM, 2009, ARCH BIOCHEM BIOPHYS, V483, P236, DOI 10.1016/j.abb.2009.01.008; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Moing A, 2000, PHYSIOL PLANTARUM, V108, P1, DOI 10.1034/j.1399-3054.2000.108001001.x; Monagas M, 2005, CRIT REV FOOD SCI, V45, P85, DOI 10.1080/10408690490911710; Munoz-Robredo PR, 2011, CHILEAN J AGR RES, V71; Narsai R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-93; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Nunan KJ, 1998, PLANT PHYSIOL, V118, P783, DOI 10.1104/pp.118.3.783; Nunan KJ, 2001, PLANTA, V214, P257, DOI 10.1007/s004250100609; Ojeda H, 1999, VITIS, V38, P145; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Ollat N, 2002, J INT SCI VIGNE VIN, V36, P109; PARK SK, 1993, ACS SYM SER, V536, P98; Pereira HS, 2005, THEOR APPL GENET, V111, P871, DOI 10.1007/s00122-005-0009-0; Pilati S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-428; Pillet J, 2012, PLANT CELL PHYSIOL, V53, P1776, DOI 10.1093/pcp/pcs121; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Possner D., 1983, ACTA HORT, V139, P117, DOI [10.17660/ActaHortic.1983.139.16, DOI 10.17660/ACTAHORTIC.1983.139.16]; POSSNER DRE, 1985, VITIS, V24, P229; Ramassamy S, 1998, J EXP BOT, V49, P1909, DOI 10.1093/jexbot/49.329.1909; RAZUNGLES A, 1993, SCI ALIMENT, V13, P59; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rienth M, 2012, VITIS, V51, P167; Rienth M, 2013, P 18 INT S GIESCO, P412; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; Rotter A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-104; RUFFNER HP, 1982, VITIS, V21, P247; RUFFNER HP, 1976, PHYTOCHEMISTRY, V15, P1877, DOI 10.1016/S0031-9422(00)88835-4; Ryona I, 2010, J AGR FOOD CHEM, V58, P9723, DOI 10.1021/jf102072w; Sanmartin M, 2007, PLANTA, V225, P873, DOI 10.1007/s00425-006-0399-5; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; SCHMALSTIG JG, 1987, PLANT PHYSIOL, V85, P407, DOI 10.1104/pp.85.2.407; Schmulling T, 2002, J PLANT GROWTH REGUL, V21, P40, DOI 10.1007/s003440010046; SCHNEIDER A, 1987, AM J ENOL VITICULT, V38, P151; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; Shelp BJ, 2012, BOTANY, V90, P651, DOI [10.1139/B2012-030, 10.1139/b2012-030]; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Singsaas E, 2001, NEW PHTYOLOGIST, V145, P39; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soufleros E, 1998, AM J ENOL VITICULT, V49, P266; Steffan H., 1975, Vitis, V14, P181; Stines A. P., 2000, Australian Journal of Grape and Wine Research, V6, P150, DOI 10.1111/j.1755-0238.2000.tb00174.x; Stines AP, 1999, PLANT PHYSIOL, V120, P923, DOI 10.1104/pp.120.3.923; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Suzuki N, 2011, PLANT J, V66, P844, DOI 10.1111/j.1365-313X.2011.04550.x; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Terrier N, 2001, MOLECULAR BIOLOGY & BIOTECHNOLOGY OF THE GRAPEVINE, P35; Terrier N, 2001, PLANTA, V213, P20, DOI 10.1007/s004250000472; TESNIERE CM, 1993, AM J ENOL VITICULT, V44, P445; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang JF, 2010, BIOSCI BIOTECH BIOCH, V74, P1583, DOI 10.1271/bbb.100175; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Williams C. A., 1994, FLAVONOIDS ADV RES 1, P337; WILSON B, 1984, J AGR FOOD CHEM, V32, P919, DOI 10.1021/jf00124a054; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang Y, 2012, APPL ENVIRON MICROB, V78, P5845, DOI 10.1128/AEM.00218-12; Yao YX, 2009, SCI HORTIC-AMSTERDAM, V122, P404, DOI 10.1016/j.scienta.2009.05.033; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zhang XY, 2006, PLANT PHYSIOL, V142, P220, DOI 10.1104/pp.106.081430; Zhang XR, 2003, J AM SOC HORTIC SCI, V128, P316, DOI 10.21273/JASHS.128.3.0316	172	34	34	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88844	10.1371/journal.pone.0088844	http://dx.doi.org/10.1371/journal.pone.0088844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551177	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000074
J	Zeng, FG; Tang, Q; Lu, T				Zeng, Fan-Gang; Tang, Qing; Lu, Thomas			Abnormal Pitch Perception Produced by Cochlear Implant Stimulation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; AUDITORY-NERVE; FREQUENCY DISCRIMINATION; IMPAIRED LISTENERS; SPEECH RECOGNITION; MELODY RECOGNITION; MUSIC PERCEPTION; NORMAL-HEARING; TEMPORAL CUES; ELECTRODE	Contemporary cochlear implants with multiple electrode stimulation can produce good speech perception but poor music perception. Hindered by the lack of a gold standard to quantify electric pitch, relatively little is known about the nature and extent of the electric pitch abnormalities and their impact on cochlear implant performance. Here we overcame this obstacle by comparing acoustic and electric pitch perception in 3 unilateral cochlear-implant subjects who had functionally usable acoustic hearing throughout the audiometric frequency range in the non-implant ear. First, to establish a baseline, we measured and found slightly impaired pure tone frequency discrimination and nearly perfect melody recognition in all 3 subjects' acoustic ear. Second, using pure tones in the acoustic ear to match electric pitch induced by an intra-cochlear electrode, we found that the frequency-electrode function was not only 1-2 octaves lower, but also 2 times more compressed in frequency range than the normal cochlear frequency-place function. Third, we derived frequency difference limens in electric pitch and found that the equivalent electric frequency discrimination was 24 times worse than normal-hearing controls. These 3 abnormalities are likely a result of a combination of broad electric field, distant intra-cochlear electrode placement, and non-uniform spiral ganglion cell distribution and survival, all of which are inherent to the electrode-nerve interface in contemporary cochlear implants. Previous studies emphasized on the "mean'' shape of the frequency-electrode function, but the present study indicates that the large "variance'' of this function, reflecting poor electric pitch discriminability, is the main factor limiting contemporary cochlear implant performance.	[Zeng, Fan-Gang] Univ Calif Irvine, Dept Anat & Neurobiol, Ctr Hearing Res, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Biomed Engn, Ctr Hearing Res, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Cognit Sci, Ctr Hearing Res, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Otolaryngol Head & Neck Surg, Ctr Hearing Res, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Zeng, FG (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Ctr Hearing Res, Irvine, CA 92717 USA.	fzeng@uci.edu			National Institutes of Health [RO1-DC008858, P30-DC008369]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC008369, R01DC008858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (RO1-DC008858 and P30-DC008369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASA, 1994, S111994 ASA ANSI; Baumann U, 2006, HEARING RES, V213, P34, DOI 10.1016/j.heares.2005.12.010; BEKESY GEORG v., 1952, ACTA OTO LARYNGOL, V42, P197, DOI 10.3109/00016485209120346; Blamey PJ, 1996, HEARING RES, V99, P139, DOI 10.1016/S0378-5955(96)00095-0; Boex C, 2006, JARO-J ASSOC RES OTO, V7, P110, DOI 10.1007/s10162-005-0027-2; Bonham BH, 2008, HEARING RES, V242, P141, DOI 10.1016/j.heares.2008.03.006; Carlyon RP, 2010, JARO-J ASSOC RES OTO, V11, P625, DOI 10.1007/s10162-010-0222-7; Collins LM, 1997, J ACOUST SOC AM, V101, P440, DOI 10.1121/1.417989; de Cheveigne A, 1998, J ACOUST SOC AM, V103, P1261, DOI 10.1121/1.423232; Dorman MF, 2007, JARO-J ASSOC RES OTO, V8, P234, DOI 10.1007/s10162-007-0071-1; DYNES SBC, 1992, HEARING RES, V58, P79, DOI 10.1016/0378-5955(92)90011-B; Eddington D K, 1978, Ann Otol Rhinol Laryngol, V87, P1; FREYMAN RL, 1991, J SPEECH HEAR RES, V34, P1371, DOI 10.1044/jshr.3406.1371; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; Green T, 2012, INT J AUDIOL, V51, P389, DOI 10.3109/14992027.2011.642010; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARTMANN R, 1990, ACTA OTO-LARYNGOL, P128; Izzo AD, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714296; JESTEADT W, 1980, PERCEPT PSYCHOPHYS, V28, P85, DOI 10.3758/BF03204321; Kang R, 2009, EAR HEARING, V30, P411, DOI 10.1097/AUD.0b013e3181a61bc0; Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LICKLIDER JCR, 1951, EXPERIENTIA, V7, P128, DOI 10.1007/BF02156143; McDermott HJ, 1997, J ACOUST SOC AM, V101, P1622, DOI 10.1121/1.418177; McDermott H, 2009, AUDIOL NEURO-OTOL, V14, P2, DOI 10.1159/000206489; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; McKay CM, 1996, J ACOUST SOC AM, V99, P1079, DOI 10.1121/1.414594; Meddis R, 1997, J ACOUST SOC AM, V102, P1811, DOI 10.1121/1.420088; Middlebrooks JC, 2008, HEARING RES, V242, P52, DOI 10.1016/j.heares.2008.04.001; Middlebrooks JC, 2010, J NEUROSCI, V30, P1937, DOI 10.1523/JNEUROSCI.4949-09.2010; NELSON DA, 1995, J ACOUST SOC AM, V98, P1987, DOI 10.1121/1.413317; Oxenham AJ, 2004, P NATL ACAD SCI USA, V101, P1421, DOI 10.1073/pnas.0306958101; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; PIJL S, 1995, HEARING RES, V89, P203, DOI 10.1016/0378-5955(95)00138-9; Reiss LAJ, 2007, JARO-J ASSOC RES OTO, V8, P241, DOI 10.1007/s10162-007-0077-8; SCHOUTEN JF, 1962, J ACOUST SOC AM, V34, P517, DOI 10.1121/1.1918160; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shower EG, 1931, J ACOUST SOC AM, V3, P275, DOI 10.1121/1.1915561; Singh S, 2009, EAR HEARING, V30, P160, DOI 10.1097/AUD.0b013e31819342b9; Spahr AJ, 2008, J SPEECH LANG HEAR R, V51, P1599, DOI 10.1044/1092-4388(2008/07-0254); Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Tang Q, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046029; VANDENHONERT C, 1987, HEARING RES, V29, P195, DOI 10.1016/0378-5955(87)90167-5; Vermeire K, 2013, HEARING RES, V306, P29, DOI 10.1016/j.heares.2013.09.004; Vermeire K, 2008, HEARING RES, V245, P98, DOI 10.1016/j.heares.2008.09.003; Vollmer M, 2007, J NEUROPHYSIOL, V98, P2588, DOI 10.1152/jn.00011.2007; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315; Xu J, 2000, AM J OTOL, V21, P49, DOI 10.1016/S0196-0709(00)80112-X; Zeng FG, 2011, HEARING RES, V277, P61, DOI 10.1016/j.heares.2011.03.010; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250; ZENG FG, 1991, Q J EXP PSYCHOL-A, V43, P565, DOI 10.1080/14640749108400987; Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zeng FG, 2002, HEARING RES, V174, P101, DOI 10.1016/S0378-5955(02)00644-5; Zeng FG, 2004, COCHLEAR IMPLANTS AU; ZWICKER E, 1961, J ACOUST SOC AM, V33, P248, DOI 10.1121/1.1908630	57	51	53	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88662	10.1371/journal.pone.0088662	http://dx.doi.org/10.1371/journal.pone.0088662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551131	Green Published, gold			2022-12-25	WOS:000331266000051
J	Akbari, P; Braber, S; Gremmels, H; Koelink, PJ; Verheijden, KAT; Garssen, J; Fink-Gremmels, J				Akbari, Peyman; Braber, Saskia; Gremmels, Hendrik; Koelink, Pim J.; Verheijden, Kim A. T.; Garssen, Johan; Fink-Gremmels, Johanna			Deoxynivalenol: a trigger for intestinal integrity breakdown	FASEB JOURNAL			English	Article						Caco-2 cells; TEER; tight junction proteins	TIGHT JUNCTION PROTEINS; BARRIER FUNCTION; SUBCELLULAR-LOCALIZATION; EPITHELIAL-CELLS; CROHNS-DISEASE; PREGNANT-WOMEN; IN-VITRO; PERMEABILITY; EXPRESSION; CLAUDIN-4	Disintegration of the colonic epithelial barrier is considered a key event in the initiation and progression of inflammatory bowel and celiac disease. As the primary etiology of these diseases remains unknown, we hypothesized that the trichothecene deoxynivalenol (DON), a fungal metabolite found in grain-based human diets, might be one of the triggers resulting in an impairment of the intestinal tight junction network preceding an inflammatory response. Using horizontal impedance measurements, we demonstrate that DON disintegrates a human Caco-2 cell monolayer within <1 h after exposure to concentrations as low as 1.39 mu M. This initial trigger is followed by a decrease in transepithelial resistance and an increased permeability of marker molecules, such as lucifer yellow and FITC-labeled dextran. In parallel, the increase in paracellular transport of FITC-dextran is demonstrated in vivo in B6C3F(1) mice, challenged orally with DON. In vitro claudin protein levels are decreased and correlated with a displacement within the cells in vitro and in vivo, accompanied by a compensatory up-regulation of mRNA levels of claudins and their binding partner ZO-1. In treated mice, alterations in villus architecture in the entire intestinal tract resemble the disintegration of the epithelial barrier, a characteristic of chronic inflammatory bowel disease.	[Akbari, Peyman; Braber, Saskia; Fink-Gremmels, Johanna] Univ Utrecht, Div Vet Pharm Pharmacol & Toxicol, NL-3508 TC Utrecht, Netherlands; [Koelink, Pim J.; Verheijden, Kim A. T.; Garssen, Johan] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, NL-3508 TC Utrecht, Netherlands; [Gremmels, Hendrik] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Garssen, Johan] Nutricia Res, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Danone Nutricia	Braber, S (corresponding author), Univ Utrecht, Yalelaan 104, NL-3584 CM Utrecht, Netherlands.	s.braber@uu.nl	garssen, johan/I-7159-2016; Verheijden, Kim/K-4088-2017; Fink-Gremmels, Johanna/G-3707-2012; Gremmels, Hendrik/G-3185-2012	Verheijden, Kim/0000-0003-4622-4299; Gremmels, Hendrik/0000-0002-7818-620X	European Union, European Regional Development Fund; Netherlands Ministry of Economic Affairs, Agriculture, and Innovation; European Commission Peaks in the Delta in East Netherlands program; Municipality of Groningen (The Netherlands); Provinces of Groningen (The Netherlands); Provinces of Fryslan (The Netherlands); Provinces of Drenthe (The Netherlands); Netherlands Carbohydrate Competence Center (CCC) [WP25]; Nutricia Research (Utrecht, The Netherlands); FrieslandCampina (Amersfoort, The Netherlands)	European Union, European Regional Development Fund; Netherlands Ministry of Economic Affairs, Agriculture, and Innovation(Ministry of Economic Affairs, Netherlands); European Commission Peaks in the Delta in East Netherlands program; Municipality of Groningen (The Netherlands)(Netherlands Government); Provinces of Groningen (The Netherlands); Provinces of Fryslan (The Netherlands); Provinces of Drenthe (The Netherlands); Netherlands Carbohydrate Competence Center (CCC); Nutricia Research (Utrecht, The Netherlands); FrieslandCampina (Amersfoort, The Netherlands)	This project is jointly financed by the European Union, European Regional Development Fund; The Netherlands Ministry of Economic Affairs, Agriculture, and Innovation; the European Commission Peaks in the Delta in East Netherlands program; the Municipality of Groningen (The Netherlands); the Provinces of Groningen, Fryslan, and Drenthe (The Netherlands); The Netherlands Carbohydrate Competence Center (CCC; WP25; http://www.cccresearch.nl); Nutricia Research (Utrecht, The Netherlands); and FrieslandCampina (Amersfoort, The Netherlands). The authors thank Rob Bleumink (Center for Cell Imaging, Faculty of Veterinary Medicine, Utrecht University) for his help with the fluorescent imaging.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; AZCONAOLIVERA JI, 1995, TOXICOL APPL PHARM, V133, P109, DOI 10.1006/taap.1995.1132; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; CANIL C, 1993, INFECT IMMUN, V61, P2755, DOI 10.1128/IAI.61.7.2755-2762.1993; Danicke S, 2004, ARCH ANIM NUTR, V58, P169, DOI 10.1080/00039420410001667548; DeMeo MT, 2002, J CLIN GASTROENTEROL, V34, P385, DOI 10.1097/00004836-200204000-00003; Dombrink-Kurtzman MA, 2010, J FOOD PROTECT, V73, P1073, DOI 10.4315/0362-028X-73.6.1073; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; He KY, 2012, TOXICOL APPL PHARM, V265, P10, DOI 10.1016/j.taap.2012.09.017; Hepworth SJ, 2012, FOOD ADDIT CONTAM A, V29, P269, DOI 10.1080/19440049.2010.551301; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Ivanov AI, 2004, NOVART FDN SYMP, V263, P124; IVANOV AI, 2004, NOVART FDN SYMP, V263, P211; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; Kasuga F, 1998, MYCOPATHOLOGIA, V142, P161, DOI 10.1023/A:1006923808748; KIRKLAND SC, 1985, CANCER RES, V45, P3790; Kolf-Clauw M, 2009, TOXICOL IN VITRO, V23, P1580, DOI 10.1016/j.tiv.2009.07.015; Lutz KL, 1997, J PHARM SCI, V86, P977, DOI 10.1021/js970134j; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; McLaughlin J, 2004, AM J PHYSIOL-CELL PH, V287, pC1412, DOI 10.1152/ajpcell.00007.2004; Menard S, 2010, MUCOSAL IMMUNOL, V3, P247, DOI 10.1038/mi.2010.5; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mutch DM, 2004, PHYSIOL GENOMICS, V17, P11, DOI 10.1152/physiolgenomics.00150.2003; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pestka JJ, 2010, TOXINS, V2, P1300, DOI 10.3390/toxins2061300; Pinton P, 2012, TOXICOL SCI, V130, P180, DOI 10.1093/toxsci/kfs239; Pinton P, 2010, J NUTR, V140, P1956, DOI 10.3945/jn.110.123919; Pinton P, 2009, TOXICOL APPL PHARM, V237, P41, DOI 10.1016/j.taap.2009.03.003; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; PRELUSKY DB, 1988, FUND APPL TOXICOL, V10, P276, DOI 10.1016/0272-0590(88)90312-0; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reeves PG, 1997, J NUTR, V127, pS838; Sarkanj B, 2013, FOOD CHEM TOXICOL, V62, P231, DOI 10.1016/j.fct.2013.08.043; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Sergent T, 2006, TOXICOL LETT, V164, P167, DOI 10.1016/j.toxlet.2005.12.006; Sun MJ, 2012, ANAL BIOCHEM, V425, P96, DOI 10.1016/j.ab.2012.03.010; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tamagawa H, 2003, LAB INVEST, V83, P1045, DOI 10.1097/01.LAB.0000078741.55670.6E; Turner PC, 2011, FOOD ADDIT CONTAM A, V28, P1220, DOI 10.1080/19440049.2011.584070; Urcan E, 2010, DENT MATER, V26, P51, DOI 10.1016/j.dental.2009.08.007; Van de Walle J, 2010, TOXICOL APPL PHARM, V245, P291, DOI 10.1016/j.taap.2010.03.012; Videmann B, 2007, FOOD CHEM TOXICOL, V45, P1938, DOI 10.1016/j.fct.2007.04.011; Warth B, 2012, TOXICOL LETT, V211, P85, DOI 10.1016/j.toxlet.2012.02.023; Will C, 2008, PERITON DIALYSIS INT, V28, P577; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	56	97	106	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2414	2429		10.1096/fj.13-238717	http://dx.doi.org/10.1096/fj.13-238717			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24568843				2022-12-25	WOS:000339883600004
J	Williams, SM; Chandran, AV; Vijayabaskar, MS; Roy, S; Balaram, H; Vishveshwara, S; Vijayan, M; Chatterji, D				Williams, Sunanda Margrett; Chandran, Anu V.; Vijayabaskar, Mahalingam S.; Roy, Sourav; Balaram, Hemalatha; Vishveshwara, Saraswathi; Vijayan, Mamannamana; Chatterji, Dipankar			A Histidine Aspartate Ionic Lock Gates the Iron Passage in Miniferritins from Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Ion Channels; Iron; Mycobacterium; X-ray Crystallography; Mycobacterium smegmatis; Ionic Cluster; Iron Oxidation	DNA-BINDING PROTEIN; COLI RNA-POLYMERASE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CARBON NANOTUBES; DPS PROTEIN; FERRITIN; MECHANISM; IDENTIFICATION	Background: DNA-binding protein from starved cells (Dps) are nano-compartments that can oxidize and store iron rendering protection from free radicals. Results: A histidine-aspartate ionic cluster in mycobaterial Dps2 modulates the rate of iron entry and exit in these proteins. Conclusion: Substitutions that disrupt the cluster interface alter the iron uptake/release properties with localized structural changes. Significance: Identifying important gating residues can help in designing nano-delivery vehicles. Dps (DNA-binding protein from starved cells) are dodecameric assemblies belonging to the ferritin family that can bind DNA, carry out ferroxidation, and store iron in their shells. The ferritin-like trimeric pore harbors the channel for the entry and exit of iron. By representing the structure of Dps as a network we have identified a charge-driven interface formed by a histidine aspartate cluster at the pore interface unique to Mycobacterium smegmatis Dps protein, MsDps2. Site-directed mutagenesis was employed to generate mutants to disrupt the charged interactions. Kinetics of iron uptake/release of the wild type and mutants were compared. Crystal structures were solved at a resolution of 1.8-2.2 for the various mutants to compare structural alterations vis a vis the wild type protein. The substitutions at the pore interface resulted in alterations in the side chain conformations leading to an overall weakening of the interface network, especially in cases of substitutions that alter the charge at the pore interface. Contrary to earlier findings where conserved aspartate residues were found crucial for iron release, we propose here that in the case of MsDps2, it is the interplay of negative-positive potentials at the pore that enables proper functioning of the protein. In similar studies in ferritins, negative and positive patches near the iron exit pore were found to be important in iron uptake/release kinetics. The unique ionic cluster in MsDps2 makes it a suitable candidate to act as nano-delivery vehicle, as these gated pores can be manipulated to exhibit conformations allowing for slow or fast rates of iron release.	[Williams, Sunanda Margrett; Chandran, Anu V.; Vishveshwara, Saraswathi; Vijayan, Mamannamana; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vijayabaskar, Mahalingam S.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Roy, Sourav; Balaram, Hemalatha; Chatterji, Dipankar] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; University of Leeds; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Chatterji, D (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in	ROY, SOURAV/AAI-2678-2021	ROY, SOURAV/0000-0002-3927-571X; Vijayabaskar, MS/0000-0002-5559-9394; Chatterji, Dipankar/0000-0002-9985-0632	Department of Biotechnology (DBT); Council of Scientific and Industrial Research	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant from the Department of Biotechnology (DBT) infrastructure program for basic biological research.; Supported by senior research fellowships from the Council of Scientific and Industrial Research.	Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Benjamin JAM, 2010, CAN J PHYSIOL PHARM, V88, P264, DOI 10.1139/Y10-014; Bevers Loes E, 2011, Prog Mol Subcell Biol, V52, P29, DOI 10.1007/978-3-642-21230-7_2; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brentjens RJ, 1996, J BACTERIOL, V178, P808, DOI 10.1128/jb.178.3.808-816.1996; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Ceci P, 2011, J BIOL INORG CHEM, V16, P869, DOI 10.1007/s00775-011-0784-9; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Chowdhury RP, 2007, J BACTERIOL, V189, P8973, DOI 10.1128/JB.01222-07; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Ghatak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016019; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; Jeong GH, 2007, CARBON, V45, P978, DOI 10.1016/j.carbon.2006.12.032; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Jolley CC, 2010, BIOPHYS J, V99, P3385, DOI 10.1016/j.bpj.2010.09.001; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Kannan N, 2001, PROTEIN SCI, V10, P46, DOI 10.1110/ps.26201; Kauko A, 2004, J MOL BIOL, V338, P547, DOI 10.1016/j.jmb.2004.03.009; Kim HJ, 2011, CARBON, V49, P3717, DOI 10.1016/j.carbon.2011.04.037; Kim SG, 2006, J MOL BIOL, V361, P105, DOI 10.1016/j.jmb.2006.06.010; Konagurthu AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010048; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEONG LM, 1992, ANAL BIOCHEM, V207, P317, DOI 10.1016/0003-2697(92)90018-3; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; LILLIE RD, 1974, HISTOCHEM J, V6, P679, DOI 10.1007/BF01011507; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nicodeme M, 2004, CURR MICROBIOL, V48, P51, DOI 10.1007/s00284-003-4116-3; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Sabareesh V, 2010, ANALYST, V135, P2723, DOI 10.1039/c0an00130a; Saraswathi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008017; Simonian Michael H, 2002, Curr Protoc Cell Biol, VAppendix 3, p3B, DOI 10.1002/0471143030.cba03bs15; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Thumiger A, 2006, PROTEINS, V62, P827, DOI 10.1002/prot.20828; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tosha T, 2012, J BIOL CHEM, V287, P13016, DOI 10.1074/jbc.M111.332734; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; WATT GD, 1988, P NATL ACAD SCI USA, V85, P7457, DOI 10.1073/pnas.85.20.7457; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yoshimura H, 2006, COLLOID SURFACE A, V282, P464, DOI 10.1016/j.colsurfa.2006.01.037; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	66	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11042	11058		10.1074/jbc.M113.524421	http://dx.doi.org/10.1074/jbc.M113.524421			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573673	Green Published, hybrid			2022-12-25	WOS:000334638500010
J	Mazzitelli, LR; Adamo, HP				Mazzitelli, Luciana R.; Adamo, Hugo P.			Hyperactivation of the Human Plasma Membrane Ca2(+) Pump PMCA h4xb by Mutation of Glu99 to Lys	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Calcium ATPase; Calcium Transport; Enzymes; Transporters	CALMODULIN-BINDING DOMAIN; CA2+ PUMP; CALCIUM-PUMP; CA-2+ PUMP; ISOFORM 4B; CA2+-ATPASE; ATPASE; PROTEINS; SITE; AUTOINHIBITION	Background: The calmodulin-stimulated human plasma membrane Ca2+ pump is regulated by autoinhibition. Results: The E99K mutation deregulates the pump increasing its maximal activity at saturating concentrations of Ca2+. Conclusion: The cytosolic portion of the M1 transmembrane segment is critical for inhibition by the extreme C-terminal autoinhibitory domain. Significance: This work presents new insights into the structure and the mechanism of human PMCA autoinhibition. The transport of calcium to the extracellular space carried out by plasma membrane Ca2+ pumps (PMCAs) is essential for maintaining low Ca2+ concentrations in the cytosol of eukaryotic cells. The activity of PMCAs is controlled by autoinhibition. Autoinhibition is relieved by the binding of Ca2+-calmodulin to the calmodulin-binding autoinhibitory sequence, which in the human PMCA is located in the C-terminal segment and results in a PMCA of high maximal velocity of transport and high affinity for Ca2+. Autoinhibition involves the intramolecular interaction between the autoinhibitory domain and a not well defined region of the molecule near the catalytic site. Here we show that the fusion of GFP to the C terminus of the h4xb PMCA causes partial loss of autoinhibition by specifically increasing the V-max. Mutation of residue Glu(99) to Lys in the cytosolic portion of the M1 transmembrane helix at the other end of the molecule brought the V-max of the h4xb PMCA to near that of the calmodulin-activated enzyme without increasing the apparent affinity for Ca2+. Altogether, the results suggest that the autoinhibitory interaction of the extreme C-terminal segment of the h4 PMCA is disturbed by changes of negatively charged residues of the N-terminal region. This would be consistent with a recently proposed model of an autoinhibited form of the plant ACA8 pump, although some differences are noted.	[Mazzitelli, Luciana R.; Adamo, Hugo P.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), UBA, Fac Farm & Bioquim, IQUIFIB, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049	Universidad de Buenos Aires [UBACYT 20020100100800]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2022]; Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo [BID 2134]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo	This work was supported by Grants UBACYT 20020100100800 from Universidad de Buenos Aires, PIP 2022 from Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo BID 2134.	Adamo HP, 1998, BIOCHEM J, V331, P763, DOI 10.1042/bj3310763; ADAMO HP, 1992, J BIOL CHEM, V267, P14244; Bauer A, 1996, YEAST, V12, P965, DOI 10.1002/(SICI)1097-0061(199608)12:10<965::AID-YEA999>3.0.CO;2-Q; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cura CI, 2008, BBA-BIOMEMBRANES, V1778, P2757, DOI 10.1016/j.bbamem.2008.08.020; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Curry MC, 2012, J BIOL CHEM, V287, P28598, DOI 10.1074/jbc.M112.364737; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ENYEDI A, 1991, J BIOL CHEM, V266, P8952; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; JAMES P, 1988, J BIOL CHEM, V263, P2905; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; NIGGLI V, 1981, J BIOL CHEM, V256, P395; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paszty K, 2005, BIOCHEM J, V391, P687, DOI 10.1042/BJ20051012; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VERMA AK, 1994, J BIOL CHEM, V269, P1687; VORHERR T, 1992, BIOCHEMISTRY-US, V31, P8245, DOI 10.1021/bi00150a018	42	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10761	10768		10.1074/jbc.M113.535583	http://dx.doi.org/10.1074/jbc.M113.535583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24584935	hybrid, Green Published			2022-12-25	WOS:000334226400045
J	Tsukagoshi, H; Nakamura, A; Ishida, T; Touhara, KK; Otagiri, M; Moriya, S; Samejima, M; Igarashi, K; Fushinobu, S; Kitamoto, K; Arioka, M				Tsukagoshi, Hikaru; Nakamura, Akihiko; Ishida, Takuya; Touhara, Kouki K.; Otagiri, Masato; Moriya, Shigeharu; Samejima, Masahiro; Igarashi, Kiyohiko; Fushinobu, Shinya; Kitamoto, Katsuhiko; Arioka, Manabu			Structural and Biochemical Analyses of Glycoside Hydrolase Family 26 beta-Mannanase from a Symbiotic Protist of the Termite Reticulitermes speratus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Glycoside Hydrolases; Plant Cell Wall; Polysaccharide; Symbiosis; Mannanase; Symbiotic Protist; Termite	CRYSTAL-STRUCTURE; EXPRESSION; BINDING; SYSTEMS	Background: Symbiotic protists of the termite gut contribute to lignocellulosic biomass degradation. Results: A novel protistan -mannanase efficiently degrades glucomannan and displays glucose/mannose binding properties when complexed with gluco-manno-oligosaccharide. Conclusion: Specific recognition and accommodation of glucose at the distal - subsites provides the structural basis for activity against glucomannan. Significance: The mechanism underlying heteropolysaccharide recognition by mannanase has been clarified. Termites and their symbiotic protists have established a prominent dual lignocellulolytic system, which can be applied to the biorefinery process. One of the major components of lignocellulose from conifers is glucomannan, which comprises a heterogeneous combination of -1,4-linked mannose and glucose. Mannanases are known to hydrolyze the internal linkage of the glucomannan backbone, but the specific mechanism by which they recognize and accommodate heteropolysaccharides is currently unclear. Here, we report biochemical and structural analyses of glycoside hydrolase family 26 mannanase C (RsMan26C) from a symbiotic protist of the termite Reticulitermes speratus. RsMan26C was characterized based on its catalytic efficiency toward glucomannan, compared with pure mannan. The crystal structure of RsMan26C complexed with gluco-manno-oligosaccharide(s) explained its specificities for glucose and mannose at subsites -5 and -2, respectively, in addition to accommodation of both glucose and mannose at subsites -3 and -4. RsMan26C has a long open cleft with a hydrophobic platform of Trp(94) at subsite -5, facilitating enzyme binding to polysaccharides. Notably, a unique oxidized Met(85) specifically interacts with the equatorial O-2 of glucose at subsite -3. Our results collectively indicate that specific recognition and accommodation of glucose at the distal negative subsites confers efficient degradation of the heteropolysaccharide by mannanase.	[Tsukagoshi, Hikaru; Touhara, Kouki K.; Fushinobu, Shinya; Kitamoto, Katsuhiko; Arioka, Manabu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo 1138657, Japan; [Nakamura, Akihiko; Ishida, Takuya; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Otagiri, Masato] RIKEN, Biomass Engn Program Cooperat Div, Yokohama, Kanagawa 2300045, Japan; [Moriya, Shigeharu] Yokohama City Univ, Lab Environm Mol Biol, Grad Sch, Yokohama, Kanagawa 2300045, Japan; [Moriya, Shigeharu] RIKEN Adv Sci Inst, Mol & Informat Life Sci Unit, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; University of Tokyo; RIKEN; Yokohama City University; RIKEN	Arioka, M (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	arioka@mail.ecc.u-tokyo.ac.jp	Nakamura, Akihiko/U-1988-2019; Moriya, Shigeharu/F-4604-2014; Moriya, Shigeharu/AGY-8351-2022; Igarashi, Kiyohiko/E-6799-2016; Fushinobu, Shinya/E-4987-2011	Nakamura, Akihiko/0000-0003-0409-5759; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874; Igarashi, Kiyohiko/0000-0001-5152-7177; Fushinobu, Shinya/0000-0003-1346-6435; Touhara, Kouki/0000-0003-3167-9784	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114001, 24114008]; Grants-in-Aid for Scientific Research [24114008] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) (to M. A.) and by a Grant-in-Aid for Innovative Areas 24114001 and 24114008 (to K. I.) from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT).	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Breznak J. A., 1994, ACETOGENESIS CARBON, P551; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Hungate RE, 1938, ECOLOGY, V19, P1, DOI 10.2307/1930363; Inoue T, 2005, GENE, V349, P67, DOI 10.1016/j.gene.2004.11.048; Inoue T, 1997, J INSECT PHYSIOL, V43, P235, DOI 10.1016/S0022-1910(96)00097-2; JUE CK, 1985, J BIOCHEM BIOPH METH, V11, P109, DOI 10.1016/0165-022X(85)90046-6; Kulcinskaja E, 2013, APPL ENVIRON MICROB, V79, P133, DOI 10.1128/AEM.02118-12; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Songsiriritthigul C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-20; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x; Uchima CA, 2012, BIOSCI BIOTECH BIOCH, V76, P368, DOI 10.1271/bbb.110628; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; YAMAOKA I, 1977, Zoological Magazine (Tokyo), V86, P34; YAMAOKA I, 1975, Zoological Magazine (Tokyo), V84, P23; Yan XX, 2008, J MOL BIOL, V379, P535, DOI 10.1016/j.jmb.2008.03.068	38	19	19	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10843	10852		10.1074/jbc.M114.555383	http://dx.doi.org/10.1074/jbc.M114.555383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570006	hybrid, Green Published			2022-12-25	WOS:000334226400052
J	De Marchi, U; Thevenet, J; Hermant, A; Dioum, E; Wiederkehr, A				De Marchi, Umberto; Thevenet, Jonathan; Hermant, Aurelie; Dioum, Elhadji; Wiederkehr, Andreas			Calcium Co-regulates Oxidative Metabolism and ATP Synthase-dependent Respiration in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Energy Metabolism; Insulin; Islet; Mitochondria; NAD	STIMULATED INSULIN-SECRETION; ISOLATED RAT ISLETS; PYRUVATE-DEHYDROGENASE; MATRIX ALKALINIZATION; MITOCHONDRIAL CA2+; OXYGEN-CONSUMPTION; CYTOPLASMIC CA2+; CYTOSOLIC CA2+; GLUCOSE; ATP/ADP	Background: Nutrients stimulate calcium dependent activation of energy metabolism, in pancreatic beta cells. Results: Glucose-induced ATP synthase-dependent respiration is strictly calcium-dependent, with little or no effect of calcium on the NAD(P)H response. Conclusion: Calcium coordinates oxidative metabolism and respiration in pancreatic beta cells. Significance: Calcium has novel mitochondrial targets downstream of mitochondrial dehydrogenases. Mitochondrial energy metabolism is essential for glucose-induced calcium signaling and, therefore, insulin granule exocytosis in pancreatic beta cells. Calcium signals are sensed by mitochondria acting in concert with mitochondrial substrates for the full activation of the organelle. Here we have studied glucose-induced calcium signaling and energy metabolism in INS-1E insulinoma cells and human islet beta cells. In insulin secreting cells a surprisingly large fraction of total respiration under resting conditions is ATP synthase-independent. We observe that ATP synthase-dependent respiration is markedly increased after glucose stimulation. Glucose also causes a very rapid elevation of oxidative metabolism as was followed by NAD(P)H autofluorescence. However, neither the rate of the glucose-induced increase nor the new steady-state NAD(P)H levels are significantly affected by calcium. Our findings challenge the current view, which has focused mainly on calcium-sensitive dehydrogenases as the target for the activation of mitochondrial energy metabolism. We propose a model of tight calcium-dependent regulation of oxidative metabolism and ATP synthase-dependent respiration in beta cell mitochondria. Coordinated activation of matrix dehydrogenases and respiratory chain activity by calcium allows the respiratory rate to change severalfold with only small or no alterations of the NAD(P)H/NAD(P)(+) ratio.	[De Marchi, Umberto; Thevenet, Jonathan; Hermant, Aurelie; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, CH-1015 Lausanne, Switzerland; [Dioum, Elhadji] Nestle Inst Hlth Sci, Diabet & Metab Hlth, CH-1015 Lausanne, Switzerland	Nestle SA; Nestle SA	Wiederkehr, A (corresponding author), Nestle Inst Hlth Sci, Quartier Innovat Batiment G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com		De Marchi, Umberto/0000-0002-6011-5446				Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Akhmedov D, 2012, BBA-MOL CELL RES, V1823, P1815, DOI 10.1016/j.bbamcr.2012.07.005; Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; DAS AM, 1989, FEBS LETT, V256, P97, DOI 10.1016/0014-5793(89)81725-9; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; Doliba NM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1507, DOI 10.1152/ajpendo.00282.2006; Doliba NM, 2003, DIABETES, V52, P394, DOI 10.2337/diabetes.52.2.394; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; GILON P, 1992, J BIOL CHEM, V267, P20713; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HELLMAN B, 1974, BIOCHEM J, V138, P33, DOI 10.1042/bj1380033; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MEGLASSON MD, 1989, METABOLISM, V38, P1188, DOI 10.1016/0026-0495(89)90158-3; MORENOSANCHEZ R, 1990, BIOCHEM J, V268, P421, DOI 10.1042/bj2680421; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nicholls LI, 2002, BIOCHEM BIOPH RES CO, V291, P1081, DOI 10.1006/bbrc.2002.6567; OHTA M, 1990, J BIOL CHEM, V265, P17525; OHTA M, 1993, J PHARMACOL EXP THER, V264, P35; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Park KS, 2012, KOREAN J PHYSIOL PHA, V16, P71, DOI 10.4196/kjpp.2012.16.1.71; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Samper E, 2009, FREE RADICAL BIO MED, V46, P387, DOI 10.1016/j.freeradbiomed.2008.10.036; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, ISLETS, V1, P154, DOI 10.4161/isl.1.2.9058; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006	46	55	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9182	9194		10.1074/jbc.M113.513184	http://dx.doi.org/10.1074/jbc.M113.513184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554722	Green Published, hybrid			2022-12-25	WOS:000333472100037
J	Joshi, PM; Sutor, SL; Huntoon, CJ; Karnitz, LM				Joshi, Poorval M.; Sutor, Shari L.; Huntoon, Catherine J.; Karnitz, Larry M.			Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; CDK (Cyclin-dependent Kinase); DNA Damage; Homologous Recombination; Ovarian Cancer; CDK12; Cisplatin; Poly(ADP)-ribose Polymerase; RAD51; Veliparib	CYCLIN K/CDK12 COMPLEX; DNA-DAMAGE; BRCA1; PHOSPHORYLATION; MAINTENANCE; DEFICIENCY; EXPRESSION; THERAPY; RAD51; CELLS	Background: CDK12 mutations occur in ovarian cancer. Results: These mutations impaired CDK12 kinase activity. Additionally, disabling CDK12 in ovarian cancer cells reduced BRCA1 levels and disrupted homologous recombination repair. Conclusion: CDK12 mutations that impair kinase activity likely disrupt homologous recombination. Significance: Defects in homologous recombination caused by CDK12 mutations may predict sensitivity to chemotherapy agents, including poly(ADP-ribose) polymerase inhibitors. Mutations in the tumor suppressors BRCA1 and BRCA2, which encode proteins that are key participants in homologous recombination (HR) repair, occur in approximate to 20% of high grade serous ovarian cancers. Although only 20% of these tumors have mutations in BRCA1 and BRCA2, nearly 50% of these tumors have defects in HR. Notably, however, the underlying genetic defects that give rise to HR defects in the absence of BRCA1 and BRCA2 mutations have not been fully elucidated. Here we show that the recurrent somatic CDK12 mutations identified in ovarian cancers impair the catalytic activity of this kinase, which is involved in the transcription of a subset of genes, including BRCA1 and other DNA repair genes. Furthermore, we show that disabling CDK12 function in ovarian cancer cells reduces BRCA1 levels, disrupts HR repair, and sensitizes these cells to the cross-linking agents melphalan and cisplatin and to the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888). Taken together, these findings suggest that many CDK12 mutations are an unrecognized cause of HR defects in ovarian cancers.	[Joshi, Poorval M.; Karnitz, Larry M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Sutor, Shari L.; Huntoon, Catherine J.; Karnitz, Larry M.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin, Div Oncol Res, 200 First St SW, Rochester, MN 55905 USA.	karnitz.larry@mayo.edu		Joshi, Poorval/0000-0001-7886-9994	Mayo Clinic Ovarian Cancer SPORE Grant (through the National Institutes of Health) [P50 CA136393]; Mayo Clinic Pobanz Family Predoctoral Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA136393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	Mayo Clinic Ovarian Cancer SPORE Grant (through the National Institutes of Health); Mayo Clinic Pobanz Family Predoctoral Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Mayo Clinic Ovarian Cancer SPORE Grant P50 CA136393 (through the National Institutes of Health) and Mayo Clinic Pobanz Family Predoctoral Research Fellowship (to P. M. J.).	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blazek D, 2012, CELL CYCLE, V11, P1049, DOI 10.4161/cc.11.6.19678; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Huehls AM, 2012, MOL PHARMACOL, V82, P767, DOI 10.1124/mol.112.080614; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Nakada S, 2012, CANCER RES, V72, P4974, DOI 10.1158/0008-5472.CAN-12-1057; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ratner ES, 2012, CURR OPIN ONCOL, V24, P564, DOI 10.1097/CCO.0b013e3283564230; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Stordal B, 2013, MOL ONCOL, V7, P567, DOI 10.1016/j.molonc.2012.12.007; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200	34	125	145	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9247	9253		10.1074/jbc.M114.551143	http://dx.doi.org/10.1074/jbc.M114.551143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554720	hybrid, Green Published			2022-12-25	WOS:000333472100042
J	Insetta, ER; Soriano, AJ; Totanes, FIG; Macatangay, BJC; Belizario, VY				Insetta, Emily R.; Soriano, Alex J.; Totanes, Francis Isidore G.; Macatangay, Bernard J. C.; Belizario, Vicente Y., Jr.			Fear of Birth Defects Is a Major Barrier to Soil-Transmitted Helminth Treatment (STH) for Pregnant Women in the Philippines	PLOS ONE			English	Article							MEBENDAZOLE; THERAPY	The World Health Organization recommends anthelminthic treatment for pregnant women after the first trimester in soil-transmitted helminth (STH) endemic regions to prevent adverse maternal-fetal consequences. Although studies have shown the high prevalence of infection in the Philippines, no research has evaluated deworming practices. We hypothesized that pregnant women are not receiving deworming treatment and we aimed to identify barriers to World Health Organization guideline implementation. We conducted key informant interviews with local Department of Health (DOH) administrators, focus group discussions with nurses, midwives, and health care workers, and knowledge, attitudes, and practices surveys with women of reproductive age to elicit perspectives about deworming during pregnancy. Key informant interviews revealed that healthcare workers were not deworming pregnant women due to inadequate drug supply, infrastructure and personnel as well as fear of teratogenicity. Focus group discussions showed that healthcare workers similarly had not implemented guidelines due to infrastructure challenges and concerns for fetal malformations. The majority of local women believed that STH treatment causes side effects (74.8%) as well as maternal harm (67.3%) and fetal harm (77.9%). Women who were willing to take anthelminthics while pregnant had significantly greater knowledge as demonstrated by higher Treatment Scores (mean rank 146.92 versus 103.1, z = -4.40, p<0.001) and higher Birth Defect Scores (mean rank 128.09 versus 108.65, z = -2.43, p = 0.015). This study concludes that World Health Organization guidelines are not being implemented in the Philippines. Infrastructure, specific protocols, and education for providers and patients regarding anthelminthic treatment are necessary for the successful prevention of STH morbidity and mortality among pregnant women.	[Insetta, Emily R.; Soriano, Alex J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Totanes, Francis Isidore G.; Belizario, Vicente Y., Jr.] Univ Philippines, NIH, Manila, Philippines; [Totanes, Francis Isidore G.; Belizario, Vicente Y., Jr.] Univ Philippines, Coll Publ Hlth, Manila, Philippines; [Macatangay, Bernard J. C.] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Soriano, AJ (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	soriano.alex@medstudent.pitt.edu		Macatangay, Bernard/0000-0002-0405-0991	University of Pittsburgh School of Medicine Dean's Summer Research Program	University of Pittsburgh School of Medicine Dean's Summer Research Program	The source of funding for this paper was the University of Pittsburgh School of Medicine Dean's Summer Research Program which awards medical students with trainee funds to complete clinic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; Belizario VY, 2009, ASIA-PAC J PUBLIC HE, V21, P26, DOI 10.1177/1010539508327245; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; Christian M.S., 1987, REV DEV TOXICI UNPUB; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; Diav-Citrin O, 2003, AM J OBSTET GYNECOL, V188, P282, DOI 10.1067/mob.2003.79; Duque FT, 2006, INTEGRATED HELMINTH; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Larocque R, 2006, TROP MED INT HEALTH, V11, P1485, DOI 10.1111/j.1365-3156.2006.01706.x; Monse B, 2010, INT DENT J, V60, P85, DOI 10.1922/IDJ_2420Monse09; Nandha B, 2012, HEALTH EDUC RES, V27, P585, DOI 10.1093/her/cyr045; Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Torlesse H, 2001, T ROY SOC TROP MED H, V95, P195, DOI 10.1016/S0035-9203(01)90164-6; Urbani C, 2001, TROP MED INT HEALTH, V6, P935, DOI 10.1046/j.1365-3156.2001.00820.x; WHO Expert Committee on the Control of Schistosomiasis, 2001, 912 WHO EXP COMM CON	17	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e85992	10.1371/journal.pone.0085992	http://dx.doi.org/10.1371/journal.pone.0085992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586245	Green Published, gold			2022-12-25	WOS:000332389000003
J	Morita, T; Koike, H; Hagiwara, H; Ito, E; Machida, M; Sato, S; Habe, H; Kitamoto, D				Morita, Tomotake; Koike, Hideaki; Hagiwara, Hiroko; Ito, Emi; Machida, Masayuki; Sato, Shun; Habe, Hiroshi; Kitamoto, Dai			Genome and Transcriptome Analysis of the Basidiomycetous Yeast Pseudozyma antarctica Producing Extracellular Glycolipids, Mannosylerythritol Lipids	PLOS ONE			English	Article							CYTOSOLIC ACETYL-COENZYME; ATP-CITRATE LYASE; CANDIDA-ANTARCTICA; USTILAGINOMYCETOUS YEAST; SP NOV.; OPEN SOFTWARE; GENE-CLUSTER; BIOSURFACTANTS; BIOSYNTHESIS; IDENTIFICATION	Pseudozyma antarctica is a non-pathogenic phyllosphere yeast known as an excellent producer of mannosylerythritol lipids (MELs), multi-functional extracellular glycolipids, from vegetable oils. To clarify the genetic characteristics of P. antarctica, we analyzed the 18 Mb genome of P. antarctica T-34. On the basis of KOG analysis, the number of genes (219 genes) categorized into lipid transport and metabolism classification in P. antarctica was one and a half times larger than that of yeast Saccharomyces cerevisiae (140 genes). The gene encoding an ATP/citrate lyase (ACL) related to acetyl-CoA synthesis conserved in oleaginous strains was found in P. antarctica genome: the single ACL gene possesses the four domains identical to that of the human gene, whereas the other oleaginous ascomycetous species have the two genes covering the four domains. P. antarctica genome exhibited a remarkable degree of synteny to U. maydis genome, however, the comparison of the gene expression profiles under the culture on the two carbon sources, glucose and soybean oil, by the DNA microarray method revealed that transcriptomes between the two species were significantly different. In P. antarctica, expression of the gene sets relating fatty acid metabolism were markedly up-regulated under the oily conditions compared with glucose. Additionally, MEL biosynthesis cluster of P. antarctica was highly expressed regardless of the carbon source as compared to U. maydis. These results strongly indicate that P. antarctica has an oleaginous nature which is relevant to its non-pathogenic and MEL-overproducing characteristics. The analysis and dataset contribute to stimulate the development of improved strains with customized properties for high yield production of functional bio-based materials.	[Morita, Tomotake; Ito, Emi; Sato, Shun; Habe, Hiroshi; Kitamoto, Dai] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan; [Koike, Hideaki; Hagiwara, Hiroko; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Morita, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba Cent 5-2,1-1-1 Higashi, Tsukuba, Ibaraki, Japan.	morita-tomotake@aist.go.jp	kitamoto, dai/R-4905-2018; Morita, Tomotake/L-7073-2018; Habe, Hiroshi/L-8939-2018; Sato, Shun/M-5355-2016	kitamoto, dai/0000-0002-6859-8892; Morita, Tomotake/0000-0001-6956-3096; Habe, Hiroshi/0000-0001-8721-2206; Sato, Shun/0000-0002-0117-9984				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blank K, 2006, J BIOTECHNOL, V125, P474, DOI 10.1016/j.jbiotec.2006.04.004; BOEKHOUT T, 1995, J GEN APPL MICROBIOL, V41, P359, DOI 10.2323/jgam.41.359; Boekhout T., 1998, P790, DOI 10.1016/B978-044481312-1/50108-8; BOOTHROYD B, 1956, CAN J BIOCHEM PHYS, V34, P10; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dean RA, 2007, NAT BIOTECHNOL, V25, P67, DOI 10.1038/nbt0107-67; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; FLUHARTY AL, 1969, BIOCHEMISTRY-US, V8, P2627, DOI 10.1021/bi00834a056; Fukuoka T, 2007, APPL MICROBIOL BIOT, V76, P801, DOI 10.1007/s00253-007-1051-4; Fukuoka T, 2007, BIOTECHNOL LETT, V29, P1111, DOI 10.1007/s10529-007-9363-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golubev Wladyslav, 2007, Mycoscience, V48, P29, DOI 10.1007/s10267-006-0324-6; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Hewald S, 2006, APPL ENVIRON MICROB, V72, P5469, DOI 10.1128/AEM.00506-06; Hynes MJ, 2010, EUKARYOT CELL, V9, P1039, DOI 10.1128/EC.00080-10; Imura T, 2007, LANGMUIR, V23, P1659, DOI 10.1021/la0620814; Ito S, 2007, COLLOID SURFACE B, V58, P165, DOI 10.1016/j.colsurfb.2007.03.003; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kitamoto D, 1998, BIOTECHNOL LETT, V20, P813, DOI 10.1023/A:1005347022247; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P37, DOI 10.1080/00021369.1990.10869919; Kitamoto D, 2001, BIOTECHNOL LETT, V23, P1709, DOI 10.1023/A:1012464717259; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; Koitabashi M, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-40; Konishi M, 2007, APPL MICROBIOL BIOT, V75, P521, DOI 10.1007/s00253-007-0853-8; Konishi M, 2011, J BIOSCI BIOENG, V111, P702, DOI 10.1016/j.jbiosc.2011.02.004; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kose O, 2002, BIORESOURCE TECHNOL, V83, P125, DOI 10.1016/S0960-8524(01)00203-6; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Morita T, 2007, FEMS YEAST RES, V7, P286, DOI 10.1111/j.1567-1364.2006.00154.x; Morita T, 2006, APPL MICROBIOL BIOT, V73, P305, DOI 10.1007/s00253-006-0466-7; Morita T, 2006, YEAST, V23, P661, DOI 10.1002/yea.1386; Morita T, 2013, APPL MICROBIOL BIOT, V97, P4691, DOI 10.1007/s00253-013-4858-1; Morita T, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00064-13; Morita T, 2011, J BIOSCI BIOENG, V112, P137, DOI 10.1016/j.jbiosc.2011.04.008; Morita T, 2010, YEAST, V27, P905, DOI 10.1002/yea.1794; Morita T, 2009, BIOTECHNOL APPL BIOC, V53, P39, DOI 10.1042/BA20090033; R Core Team, 2021, R LANG ENV STAT COMP; Rau U, 2005, APPL MICROBIOL BIOT, V68, P607, DOI 10.1007/s00253-005-1906-5; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Schmid Rolf D, 1998, Angew Chem Int Ed Engl, V37, P1608, DOI 10.1002/(SICI)1521-3773(19980703)37:12<1608::AID-ANIE1608>3.0.CO;2-V; Seo HS, 2007, FEMS YEAST RES, V7, P1035, DOI 10.1111/j.1567-1364.2007.00251.x; Spoeckner S, 1999, APPL MICROBIOL BIOT, V51, P33, DOI 10.1007/s002530051359; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamano K, 2008, FUNGAL GENET BIOL, V45, P139, DOI 10.1016/j.fgb.2007.09.005; Tamano K, 2013, APPL MICROBIOL BIOT, V97, P269, DOI 10.1007/s00253-012-4193-y; Teichmann B, 2007, MOL MICROBIOL, V66, P525, DOI 10.1111/j.1365-2958.2007.05941.x; Vorapreeda T, 2012, MICROBIOL-SGM, V158, P217, DOI 10.1099/mic.0.051946-0; Wang QM, 2006, INT J SYST EVOL MICR, V56, P289, DOI 10.1099/ijs.0.63827-0; Yang YH, 2005, STAT BIOL HEALTH, P49	59	28	29	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e86490	10.1371/journal.pone.0086490	http://dx.doi.org/10.1371/journal.pone.0086490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586250	Green Submitted, Green Published, gold			2022-12-25	WOS:000331880700004
J	Ayyadurai, S; Charania, MA; Xiao, B; Viennois, E; Zhang, YC; Merlin, D				Ayyadurai, Saravanan; Charania, Moiz A.; Xiao, Bo; Viennois, Emilie; Zhang, Yuchen; Merlin, Didier			Colonic miRNA Expression/Secretion, Regulated by Intestinal Epithelial PepT1, Plays an Important Role in Cell-to-Cell Communication during Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTERCELLULAR COMMUNICATION; ULCERATIVE-COLITIS; MICRORNA TARGETS; MESSENGER-RNAS; C-ELEGANS; IN-VIVO; CANCER; GENE; MECHANISM	PepT1 is a member of the proton-oligopeptide cotransporter family SLC15, which mediates the transport of di/tripeptides from intestinal lumen into epithelial cells. MicroRNAs (miRNAs), a small noncoding RNAs (21-23 nucleotides), post-transcriptionally regulate gene expression by binding to the 3'-untranslated regions (UTRs) of their target mRNAs. Although the role of most miRNAs remains elusive, they have been implicated in vital cellular functions such as intestinal epithelial cells differentiation, proliferation, and apoptosis. In the present study, we investigated the effect of intestinal epithelial PepT1 expression on microRNA (miRNA) expression/secretion in the colons of control mice and in mice with experimentally induced colonic inflammation (colitis). The colonic miRNA expression was deregulated in both colitis and control mice but the deregulation of miRNA expression/secretion was specific to colonic tissue and did not affect other tissues such as spleen and liver. Intestinal epithelial PepT1-dependent deregulation of colonic miRNA expression not only affects epithelial cells but also other cell types, such as intestinal macrophages. Importantly, we found the miRNA 23b which was known to be involved in inflammatory bowel disease was secreted and transported between cells to impose a gene-silencing effect on recipient intestinal macrophages. Based on our data, we may conclude that the expression of a specific protein, PepT1, in the intestine affects local miRNA expression/secretion in the colon on a tissue specific manner and may play an important role during the induction and progression of colitis. Colonic miRNA expression/secretion, regulated by intestinal epithelial PepT1, could play a crucial role in cell-to-cell communication during colitis.	[Ayyadurai, Saravanan; Charania, Moiz A.; Xiao, Bo; Viennois, Emilie; Zhang, Yuchen; Merlin, Didier] Georgia State Univ, Ctr Diagnost & Therapeut, Dept Biol & Chem, Atlanta, GA 30303 USA; [Viennois, Emilie; Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ayyadurai, S (corresponding author), Georgia State Univ, Ctr Diagnost & Therapeut, Dept Biol & Chem, Atlanta, GA 30303 USA.	sayyadurai@gsu.edu	Zhang, Yuchen/GYI-8858-2022; Xiao, Bo/G-8200-2012	Viennois, Emilie/0000-0002-3104-620X	department of veteran's affairs	department of veteran's affairs(US Department of Veterans Affairs)	This work was supported by the department of veteran's affairs (Didier Merlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2010, ANN BIOL CLIN-PARIS, V68, P263, DOI 10.1684/abc.2010.0429; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27; Buyse M, 2003, AM J PATHOL, V163, P1969, DOI 10.1016/S0002-9440(10)63555-9; Buyse M, 2002, AM J PHYSIOL-CELL PH, V283, pC1795, DOI 10.1152/ajpcell.00186.2002; Charania MA, 2013, INFECT IMMUN, V81, P923, DOI 10.1128/IAI.01388-12; Charania MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1282, DOI 10.1152/ajpgi.00401.2011; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Dalmasso G, 2008, GASTROENTEROLOGY, V134, P166, DOI 10.1053/j.gastro.2007.10.026; Dalmasso G, 2011, GASTROENTEROLOGY, V141, P1334, DOI 10.1053/j.gastro.2011.06.080; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Dalmasso G, 2010, AM J PHYSIOL-GASTR L, V299, pG687, DOI 10.1152/ajpgi.00527.2009; Dame MK, 2010, IN VITRO CELL DEV-AN, V46, P114, DOI 10.1007/s11626-009-9247-9; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Ehnfors J, 2009, CELL DEATH DIFFER, V16, P749, DOI 10.1038/cdd.2009.7; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; Furuta K, 2012, CURR OPIN CELL BIOL, V24, P211, DOI 10.1016/j.ceb.2011.12.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003; Lasser Cecilia, 2013, Methods Mol Biol, V1024, P109, DOI 10.1007/978-1-62703-453-1_9; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nguyen HTT, 2009, GASTROENTEROLOGY, V137, P1435, DOI 10.1053/j.gastro.2009.06.043; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Saban Ricardo, 2007, BMC Physiology, V7, P3, DOI 10.1186/1472-6793-7-3; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Wang J, 2007, CLIN EXP METASTAS, V24, P411, DOI 10.1007/s10585-007-9078-6; Wang P, 2013, J IMMUNOL, V191, P1413, DOI 10.4049/jimmunol.1202598; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Ziegler TR, 2002, AM J CLIN NUTR, V75, P922, DOI 10.1093/ajcn/75.5.922; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	67	27	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87614	10.1371/journal.pone.0087614	http://dx.doi.org/10.1371/journal.pone.0087614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586284	Green Published, Green Submitted, gold			2022-12-25	WOS:000331711900014
J	Mohawk, KL; Poly, F; Sahl, JW; Rasko, DA; Guerry, P				Mohawk, Krystle L.; Poly, Frederic; Sahl, Jason W.; Rasko, David A.; Guerry, Patricia			High Frequency, Spontaneous motA Mutations in Campylobacter jejuni Strain 81-176	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GENOME SEQUENCE; EPITHELIAL-CELLS; FLAGELLAR MOTOR; GENE-EXPRESSION; PHASE VARIATION; NCTC 11168; INFECTION; VIRULENCE; COLONIZATION	Campylobacter jejuni is an important cause of bacterial diarrhea worldwide. The pathogenesis of C. jejuni is poorly understood and complicated by phase variation of multiple surface structures including lipooligosaccharide, capsule, and flagellum. When C. jejuni strain 81-176 was plated on blood agar for single colonies, the presence of translucent, non-motile colonial variants was noted among the majority of opaque, motile colonies. High-throughput genomic sequencing of two flagellated translucent and two opaque variants as well as the parent strain revealed multiple genetic changes compared to the published genome. However, the only mutated open reading frame common between the two translucent variants and absent from the opaque variants and the parent was motA, encoding a flagellar motor protein. A total of 18 spontaneous motA mutations were found that mapped to four distinct sites in the gene, with only one class of mutation present in a phase variable region. This study exemplifies the mutative/adaptive properties of C. jejuni and demonstrates additional variability in C. jejuni beyond phase variation.	[Mohawk, Krystle L.; Poly, Frederic; Guerry, Patricia] Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA; [Sahl, Jason W.; Rasko, David A.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA	Naval Medical Research Center (NMRC); University System of Maryland; University of Maryland Baltimore	Guerry, P (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Silver Spring, MD 20910 USA.	patricia.guerry@med.navy.mil		, Jason/0000-0002-2497-0138; David, Rasko/0000-0002-7337-7154	Military Infectious Diseases Research Program [6000.RAD1.DA3.A0308]	Military Infectious Diseases Research Program	This work was supported by the Military Infectious Diseases Research Program, Work unit no. 6000.RAD1.DA3.A0308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Barrero-Tobon AM, 2012, MOL MICROBIOL, V84, P352, DOI 10.1111/j.1365-2958.2012.08027.x; Bayliss CD, 2012, NUCLEIC ACIDS RES, V40, P5876, DOI 10.1093/nar/gks246; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; BUCK GE, 1981, J CLIN MICROBIOL, V14, P585, DOI 10.1128/JCM.14.5.585-586.1981; CALDWELL MB, 1985, INFECT IMMUN, V50, P941, DOI 10.1128/IAI.50.3.941-943.1985; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; CBS, 2007, TMHMM SERV V 2 0; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Gaasbeek EJ, 2009, J BACTERIOL, V191, P3785, DOI 10.1128/JB.01817-08; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Hendrixson DR, 2008, MOL MICROBIOL, V70, P519, DOI 10.1111/j.1365-2958.2008.06428.x; Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Jones FR, 2006, INFECT IMMUN, V74, P790, DOI 10.1128/IAI.74.1.790-793.2006; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Linton D, 2001, CURR OPIN MICROBIOL, V4, P35, DOI 10.1016/S1369-5274(00)00161-2; Marshall JK, 2009, KIDNEY INT, V75, pS42, DOI 10.1038/ki.2008.618; Nachamkin I, 2001, J INFECT DIS, V184, P221, DOI 10.1086/322008; Novik V, 2010, INFECT IMMUN, V78, P3540, DOI 10.1128/IAI.00109-10; Obara M, 2008, J BACTERIOL, V190, P3565, DOI 10.1128/JB.00849-07; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Park SF, 2000, J BACTERIOL, V182, P207, DOI 10.1128/JB.182.1.207-210.2000; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PETERSON MC, 1994, WESTERN J MED, V161, P148; Pimentel M, 2008, DIGEST DIS SCI, V53, P982, DOI 10.1007/s10620-007-9977-z; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Prunier AL, 2005, J BACTERIOL, V187, P3455, DOI 10.1128/JB.187.10.3455-3464.2005; Revez J, 2013, INFECT GENET EVOL, V16, P305, DOI 10.1016/j.meegid.2013.03.009; Revez J, 2012, J BACTERIOL, V194, P6298, DOI 10.1128/JB.01385-12; Rozen S, 2000, Methods Mol Biol, V132, P365; RUSSELL RG, 1989, INFECT IMMUN, V57, P1438, DOI 10.1128/IAI.57.5.1438-1444.1989; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; SKIRROW MB, 1980, J HYG-CAMBRIDGE, V85, P427, DOI 10.1017/S0022172400063506; Song YC, 2004, MOL MICROBIOL, V53, P541, DOI 10.1111/j.1365-2958.2004.04175.x; Spiller RC, 2007, J GASTROENTEROL, V42, P41, DOI 10.1007/s00535-006-1925-8; SUERBAUM S, 1993, J BACTERIOL, V175, P3278, DOI 10.1128/jb.175.11.3278-3288.1993; Tribble DR, 2010, INFECT IMMUN, V78, P1750, DOI 10.1128/IAI.01021-09; Turrientes MC, 2009, 19 EUR SOC CLIN MICR; van den Broek D, 2005, MICROBIOL-SGM, V151, P1403, DOI 10.1099/mic.0.27777-0; Verdu EF, 2007, CAN J GASTROENTEROL, V21, P453, DOI 10.1155/2007/169591; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Zhou JD, 1997, J MOL BIOL, V273, P428, DOI 10.1006/jmbi.1997.1316	57	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88043	10.1371/journal.pone.0088043	http://dx.doi.org/10.1371/journal.pone.0088043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558375	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700021
J	Peitsch, WK; Doerflinger, Y; Fischer-Colbrie, R; Huck, V; Bauer, AT; Utikal, J; Goerdt, S; Schneider, SW				Peitsch, Wiebke K.; Doerflinger, Yvette; Fischer-Colbrie, Reiner; Huck, Volker; Bauer, Alexander T.; Utikal, Jochen; Goerdt, Sergij; Schneider, Stefan W.			Desmoglein 2 Depletion Leads to Increased Migration and Upregulation of the Chemoattractant Secretoneurin in Melanoma Cells	PLOS ONE			English	Article							OPENER JO-1 IMPROVES; E-CADHERIN; TRANSENDOTHELIAL MIGRATION; NEUROPEPTIDE SECRETONEURIN; HUMAN MONOCYTES; MUSCLE-CELLS; IN-VITRO; EXPRESSION; ADHESION; PROLIFERATION	During development and progression of malignant melanoma, an important role has been attributed to alterations of cell-cell adhesions, in particular, to a "cadherin switch" from E-to N-cadherin. We have previously shown that a subtype of melanoma cells express the desmosomal cadherin desmoglein 2 as non-junction-bound cell surface protein in addition to classical cadherins. To study the role of desmoglein 2 in melanoma cells, melanoma lines containing high endogenous amounts of desmoglein 2 were depleted of the protein by RNA interference. Transwell migration and scratch wounding assays showed markedly increased migration upon desmoglein 2 suppression whereas proliferation and viability remained unaltered. In gene expression profiles, desmoglein 2 depletion was associated with overexpression of migration-related genes. Strongest overexpression was found for secretogranin II which has not been reported in melanoma cells before. The bioactive peptide derived from secretogranin II, secretoneurin, is known to exert chemoattractive functions and was demonstrated here to stimulate melanoma cell migration. In summary, we show that desmoglein 2 expression attenuates migration of melanoma cells. The mechanism of desmoglein 2 impaired cell migration is mediated by downregulation of secretogranin II. Loss of desmoglein 2 increases expression of secretogranin II, followed by an enhanced migratory activity of melanoma cells. Our data add a new pathway of regulating melanoma cell migration related to a desmoglein 2 - secretogranin II axis.	[Peitsch, Wiebke K.; Doerflinger, Yvette; Huck, Volker; Bauer, Alexander T.; Utikal, Jochen; Goerdt, Sergij; Schneider, Stefan W.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany; [Peitsch, Wiebke K.; Doerflinger, Yvette] German Canc Res Ctr, Helmholtz Grp Cell Biol, Heidelberg, Germany; [Fischer-Colbrie, Reiner] Med Univ Innsbruck, Dept Pharmacol, A-6020 Innsbruck, Austria; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Helmholtz Association; German Cancer Research Center (DKFZ)	Peitsch, WK (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany.	w.peitsch@dkfz-heidelberg.de	Huck, Volker/B-5627-2011	Huck, Volker/0000-0001-8988-1091; Utikal, Jochen/0000-0001-5316-0241	Deutsche Krebshilfe [108626, 109312]; Deutsche Forschungsgemeinschaft (DFG) [SFB/TR23]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Krebshilfe to WK Peitsch (project no. 108626) and to JU (project no. 109312) and a grant from the Deutsche Forschungsgemeinschaft (DFG) to SWS (SFB/TR23, project A9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Beyer I, 2012, CLIN CANCER RES, V18, P3340, DOI 10.1158/1078-0432.CCR-11-3213; Beyer I, 2011, CANCER RES, V71, P7080, DOI 10.1158/0008-5472.CAN-11-2009; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bosserhoff AK, 2013, MOL CARCINOG, DOI [10.1002/mc.22018, DOI 10.1002/MC.22018.[]; Brandner JM, 2013, PATHOLOGY, V45, P443, DOI 10.1097/PAT.0b013e328363b3bd; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Cirillo N, 2008, J CELL BIOCHEM, V103, P598, DOI 10.1002/jcb.21431; Dunzendorfer S, 1998, BLOOD, V91, P1527, DOI 10.1182/blood.V91.5.1527.1527_1527_1532; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; Helle KB, 2010, REGUL PEPTIDES, V165, P45, DOI 10.1016/j.regpep.2009.09.009; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; Kahler CM, 1996, EUR J PHARMACOL, V304, P135, DOI 10.1016/0014-2999(96)00135-5; Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P2029, DOI 10.1161/01.ATV.17.10.2029; Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P932, DOI 10.1161/01.ATV.17.5.932; Kahler CM, 2002, REGUL PEPTIDES, V105, P35, DOI 10.1016/S0167-0115(01)00379-2; Kirchmair R, 2004, CIRCULATION, V110, P1121, DOI 10.1161/01.CIR.0000139884.81390.56; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; Kuphal S, 2004, ONCOGENE, V23, P8509, DOI 10.1038/sj.onc.1207831; Kuphal S, 2012, ARCH BIOCHEM BIOPHYS, V524, P43, DOI 10.1016/j.abb.2011.10.020; Kuphal S, 2009, PIGM CELL MELANOMA R, V22, P296, DOI 10.1111/j.1755-148X.2009.00568.x; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Li G, 2004, EXP CELL RES, V297, P142, DOI 10.1016/j.yexcr.2004.03.012; Li G, 2001, CANCER RES, V61, P3819; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; Ludwig T, 2002, AM J PHYSIOL-RENAL, V283, pF319, DOI 10.1152/ajprenal.00327.2001; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Peitsch WK, 1999, EUR J CELL BIOL, V78, P767, DOI 10.1016/S0171-9335(99)80027-2; Pieperhoff S, 2007, EUR J CELL BIOL, V86, P377, DOI 10.1016/j.ejcb.2007.04.001; Pieperhoff S, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/139167; Qi JF, 2006, MOL BIOL CELL, V17, P1261, DOI 10.1091/mbc.E05-10-0927; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; REINISCH N, 1993, FEBS LETT, V334, P41, DOI 10.1016/0014-5793(93)81676-Q; Rickelt S, 2008, CELL TISSUE RES, V334, P401, DOI 10.1007/s00441-008-0704-7; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Schratzberger P, 1996, NEUROSCI LETT, V214, P208, DOI 10.1016/0304-3940(96)12947-5; Seftor REB, 2012, AM J PATHOL, V181, P1115, DOI 10.1016/j.ajpath.2012.07.013; Spangler B, 2011, PIGM CELL MELANOMA R, V24, P148, DOI 10.1111/j.1755-148X.2010.00787.x; TANG A, 1994, J CELL SCI, V107, P983; Trojan L, 2005, ANTICANCER RES, V25, P183; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Yan SY, 2006, SURGERY, V140, P243, DOI 10.1016/j.surg.2006.04.001; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Zak J, 2000, PFLUG ARCH EUR J PHY, V440, P179, DOI 10.1007/s004240000282; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	67	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89491	10.1371/journal.pone.0089491	http://dx.doi.org/10.1371/journal.pone.0089491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558503	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700149
J	Roje, DM				Roje, Dawn M.			Evaluating the Effects of Non-Neutral Molecular Markers on Phylogeny Inference	PLOS ONE			English	Article							EVOLUTIONARY; TELEOSTEI; ALIGNMENT; GOBIES; CLADES; ORDER	Nucleotide substitution models used in molecular phylogenetics do not account for nucleotide sequences evolving under selection, yet selection is rarely tested for. If non-neutral markers violate these models (i.e. non-independence of sites), it is expected that their reconstructed topologies be incongruent with those inferred from neutral ones and conclusions made from those phylogenies should be reexamined. Using rhodopsin as a phylogenetic marker has recently been called into question for exactly this reason. Rhodopsin is assumed to have evolved under strong positive selection for organisms that inhabit similar aquatic environments, making it unsuitable for the phylogenetics of aquatic organisms, but it is unclear what the effects of non-neutrality on phylogeny estimation are. To evaluate potential incongruence of neutral versus non-neutral markers, and the notion that rhodopsin should not be used in the molecular phylogenetics of fishes, a molecular dataset of 78 acanthomorph taxa and sequences from four nuclear, protein coding loci (including rhodopsin), were examined. Only one marker was found to be neutral while the remaining tests, for all other loci, rejected the null hypothesis of neutrality. To evaluate the possible effect(s) of positively versus negatively selected sites, the three non-neutral markers were analyzed to determine the presence of positively and negatively selected codons. To determine congruence in topology among ML trees inferred by individual neutral and non-neutral markers, as well as the combined (concatenated) dataset, tree, comparisons of distances among trees and hypothesis (topology) testing were carried out. Results of the tree distance metrics and topology testing support the notion that neutrality alone does not determine congruence in topology, and those data that are inferred to have evolved under selection should not necessarily be excluded. In addition, the number of sites inferred to have evolved under positive selection does not predict congruence with other markers or the topology inferred with the concatenated dataset.	Amer Museum Nat Hist, Dept Ichthyol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Roje, DM (corresponding author), Amer Museum Nat Hist, Dept Ichthyol, New York, NY 10024 USA.	droje@amnh.org						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff PA, 2008, CLADISTICS, V24, P591, DOI 10.1111/j.1096-0031.2007.00189.x; Hagstrom GI, 2004, ARTIF LIFE, V10, P157, DOI 10.1162/106454604773563586; Hang DH, 2003, LECT NOTES COMPUT SC, V2723, P13; Jobb G, 2008, TREEFINDER VERSION O; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Larmuseau MHD, 2010, MOL PHYLOGENET EVOL, V55, P689, DOI 10.1016/j.ympev.2009.10.007; Li B, 2009, MOL PHYLOGENET EVOL, V50, P345, DOI 10.1016/j.ympev.2008.11.013; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MS, 2005, EVOLUTION, V59, P374; Tornabene L, 2013, SYST BIODIVERS, V11, P345, DOI 10.1080/14772000.2013.818589	24	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87428	10.1371/journal.pone.0087428	http://dx.doi.org/10.1371/journal.pone.0087428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558367	Green Submitted, gold, Green Published			2022-12-25	WOS:000331706700013
J	Takebayashi, A; Kimura, F; Kishi, Y; Ishida, M; Takahashi, A; Yamanaka, A; Takahashi, K; Suginami, H; Murakami, T				Takebayashi, Akie; Kimura, Fuminori; Kishi, Yohei; Ishida, Mitsuaki; Takahashi, Akimasa; Yamanaka, Akiyoshi; Takahashi, Kentaro; Suginami, Hiroshi; Murakami, Takashi			The Association between Endometriosis and Chronic Endometritis	PLOS ONE			English	Article							PLASMA-CELLS; EXPRESSION; WOMEN; ACTIVATION	Objective: To evaluate the association between endometriosis and chronic endometritis. Methods: Endometrial specimens were obtained from 71 patients, 34 with endometriosis (endometriosis group) and 37 without endometriosis (non-endometriosis group), who underwent hysterectomy, and the specimens were immunostained for the plasmacyte marker CD138. The rate of chronic endometritis was compared between the endometriosis group and the non-endometriosis group. Furthermore, the 71 patients were also divided into two groups, 28 with chronic endometritis (chronic endometritis group) and 43 without chronic endometritis (non-chronic endometritis group). Logistic regression analysis was performed with variables including age, body mass index (BMI), gravidity and parity, and diagnoses of leiomyoma, adenomyosis, and endometriosis on pathology to examine the independent effect of each variable on chronic endometritis. Patients suffering from cervical invasive carcinoma, endometrial carcinoma, and endometrial polyps or treated with gonadotropin-releasing hormone agonists, progestins, or oral contraceptives before surgery were excluded. Results: Chronic endometritis was identified in 52.94% of the endometriosis group and 27.02% of the non-endometriosis group (p<0.05). Logistic regression analysis revealed that endometriosis was associated with chronic endometritis. Conclusions: This result suggests a strong association between endometriosis and chronic endometritis.	[Takebayashi, Akie; Kimura, Fuminori; Takahashi, Akimasa; Yamanaka, Akiyoshi; Murakami, Takashi] Shiga Univ Med Sci, Dept Obstet & Gynecol, Otsu, Shiga 52021, Japan; [Kishi, Yohei; Suginami, Hiroshi] Takanohara Cent Hosp, Dept Obstet & Gynecol, Nara, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ishida, Mitsuaki] Shiga Univ Med Sci, Div Diagnost Pathol, Otsu, Shiga 52021, Japan; [Takahashi, Kentaro] Shiga Univ Med Sci, Dept Community Perinatal Med, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Takebayashi, A (corresponding author), Shiga Univ Med Sci, Dept Obstet & Gynecol, Seta Tsukinowa Cho, Otsu, Shiga 52021, Japan.	akiie21@belle.shiga-med.ac.jp	Kimura, Fuminori/AAZ-7380-2020; Takahashi, Akimasa/AAD-4753-2019	Takahashi, Akimasa/0000-0001-5698-553X; Takahashi, Akimasa/0000-0002-2585-9271	Japan Society for the Promotion of Science [24659729, 23592400]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science, Grant Number 24659729 and 23592400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer-Garner IB, 2001, MODERN PATHOL, V14, P877, DOI 10.1038/modpathol.3880405; Berbic M, 2009, HUM REPROD, V24, P325, DOI 10.1093/humrep/den393; Braun DP, 1998, CURR OPIN OBSTET GYN, V10, P365, DOI 10.1097/00001703-199810000-00003; Canis M, 1997, FERTIL STERIL, V67, P817; Cicinelli E, 2005, J MINIM INVAS GYN L, V12, P514, DOI 10.1016/j.jmig.2005.07.394; CRUM CP, 1983, AM J OBSTET GYNECOL, V147, P812, DOI 10.1016/0002-9378(83)90045-5; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; Feghali J, 2003, Gynecol Obstet Fertil, V31, P127, DOI 10.1016/S1297-9589(03)00007-9; Garcia-Velasco JA, 2003, SEMIN REPROD MED, V21, P165; Gazvani R, 2002, FERTIL STERIL, V77, P62, DOI 10.1016/S0015-0282(01)02954-5; GREENWOOD SM, 1981, OBSTET GYNECOL, V58, P176; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Hever A, 2007, P NATL ACAD SCI USA, V104, P12451, DOI 10.1073/pnas.0703451104; Johnston-MacAnanny EB, 2010, FERTIL STERIL, V93, P437, DOI 10.1016/j.fertnstert.2008.12.131; Jones RK, 1998, HUM REPROD UPDATE, V4, P702, DOI 10.1093/humupd/4.5.702; Kasius JC, 2012, HUM REPROD, V27, P153, DOI 10.1093/humrep/der341; Khan KN, 2004, FERTIL STERIL, V81, P652, DOI 10.1016/j.fertnstert.2003.07.037; Kitaya K, 2011, AM J REPROD IMMUNOL, V66, P410, DOI 10.1111/j.1600-0897.2011.01051.x; Kitaya K, 2011, FERTIL STERIL, V95, P1156, DOI 10.1016/j.fertnstert.2010.09.061; Kyama Cleophas M, 2003, Reprod Biol Endocrinol, V1, P123, DOI 10.1186/1477-7827-1-123; Lebovic DI, 2002, IMMUNOL ALLERGY CLIN, V22, P585, DOI 10.1016/S0889-8561(02)00007-3; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matalliotakis IM, 2003, INT IMMUNOPHARMACOL, V3, P81, DOI 10.1016/S1567-5769(02)00216-3; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OOSTERLYNCK DJ, 1993, ARCH GYNECOL OBSTET, V253, P197, DOI 10.1007/BF02766646; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Polisseni F, 2003, GYNECOL OBSTET INVES, V55, P205, DOI 10.1159/000072075; Porta C, 2011, CANCER LETT, V305, P250, DOI 10.1016/j.canlet.2010.10.012; Siristatidis C, 2006, J OBSTET GYNAECOL RE, V32, P162, DOI 10.1111/j.1447-0756.2006.00373.x; Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328; Taylor RN, 1997, ANN NY ACAD SCI, V828, P194, DOI 10.1111/j.1749-6632.1997.tb48540.x; Taylor RN, 2002, ANN NY ACAD SCI, V955, P89, DOI 10.1111/j.1749-6632.2002.tb02769.x; Uo M, 2012, GUT IN PRESS; Vinatier D, 1996, HUM REPROD UPDATE, V2, P371, DOI 10.1093/humupd/2.5.371; WOOD GM, 1986, GUT, V27, P1151, DOI 10.1136/gut.27.10.1151; Wu MY, 2003, AM J REPROD IMMUNOL, V49, P285, DOI 10.1034/j.1600-0897.2003.01207.x	36	56	74	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88354	10.1371/journal.pone.0088354	http://dx.doi.org/10.1371/journal.pone.0088354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558386	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700032
J	Bruckbauer, A; Zemel, MB				Bruckbauer, Antje; Zemel, Michael B.			Synergistic Effects of Polyphenols and Methylxanthines with Leucine on AMPK/Sirtuin-Mediated Metabolism in Muscle Cells and Adipocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENERGY-METABOLISM; SIRT1 ACTIVATION; NITRIC-OXIDE; IN-VIVO; RESVERATROL; AMPK	The AMPK-Sirt1 pathway is an important regulator of energy metabolism and therefore a potential target for prevention and therapy of metabolic diseases. We recently demonstrated leucine and its metabolite beta-hydroxy-beta-methylbutyrate (HMB) to synergize with low-dose resveratrol (200 nM) to activate sirtuin signaling and stimulate energy metabolism. Here we show that leucine exerts a direct effect on Sirt1 kinetics, reducing its Km for NAD(+) by.50% and enabling low doses of resveratrol to further activate the enzyme (p = 0.012). To test which structure elements of resveratrol are necessary for synergy, we assessed potential synergy of structurally similar and dissimilar polyphenols as well as other compounds converging on the same pathways with leucine using fatty acid oxidation (FAO) as screening tool. Dose-response curves for FAO were constructed and the highest non-effective dose (typically 1-10 nM) was used with either leucine (0.5 mM) or HMB (5 mM) to treat adipocytes and myotubes for 24 h. Significant synergy was detected for stilbenes with FAO increase in adipocytes by 60-70% (p<0.05) and in myotubes.2000% (p<0.01). Sirt1 and AMPK activities were stimulated by similar to 65% (p<0.001) and similar to 50% (p<0.03), respectively. Similarly, hydroxycinnamic acids and derivatives (chlorogenic, cinnamic, and ferulic acids) combined with leucine/HMB increased FAO (300-1300%, p<0.01), AMPK activity (50-150%, p<0.01), and Sirt1 activity (similar to 70%, p<0.001). In contrast, more complex polyphenol structures, such as ellagic acid and epigallocatechin gallate required higher concentrations (> 1 mM) and exhibited little or no synergy. Thus, the six-carbon ring structure bound to a carboxylic group seems to be a necessary element for leucine/HMB synergy with other stilbenes and hydroxycinnamic acids to stimulate AMPK/Sirt1 dependent FAO; these effects occur at concentrations that produce no independent effects and are readily achievable via oral administration.	[Bruckbauer, Antje; Zemel, Michael B.] NuSirt Sci Inc, Res & Dev, Knoxville, TN 37931 USA		Bruckbauer, A (corresponding author), NuSirt Sci Inc, Res & Dev, Knoxville, TN 37931 USA.	abruckbauer@nusirt.com		Zemel, Michael/0000-0003-4104-5750	NuSirt Sciences, Inc.	NuSirt Sciences, Inc.	This project was internally funded by NuSirt Sciences, Inc. No external sponsors or funders were involved. The funder NuSirt Sciences Inc. played no role in study design, data collection and analysis, and the preparation of the manuscript. The funder approved the publication of the manuscript.	ARNER P, 1993, J LIPID RES, V34, P1737; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; Baraldi PG, 2008, CHEM REV, V108, P238, DOI 10.1021/cr0682195; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Boswell-Smith V, 2006, J ALLERGY CLIN IMMUN, V117, P1237, DOI 10.1016/j.jaci.2006.02.045; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Brenmoehl J, 2013, MITOCHONDRION, DOI 10.1016/j.mito.2013.04.002; Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Bruckbauer A, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-91; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Cho SJ, 2012, BRIT J NUTR, V108, P2166, DOI 10.1017/S0007114512000347; D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321; De Toni L, 2011, J ENDOCRINOL INVEST, V34, P738, DOI 10.1007/BF03346724; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Huang B, 2011, J AGR FOOD CHEM, V59, P3666, DOI 10.1021/jf104814t; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang W, 2012, METABOLISM, V61, P424, DOI 10.1016/j.metabol.2011.08.003; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Robich MP, 2011, EUR J PHARMACOL, V664, P45, DOI 10.1016/j.ejphar.2011.04.059; Sabatini S, 2011, ACTA BIOCHIM POL, V58, P237; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang R, 2009, ENDOCRINOLOGY, V150, P3076, DOI 10.1210/en.2009-0108	40	61	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89166	10.1371/journal.pone.0089166	http://dx.doi.org/10.1371/journal.pone.0089166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551237	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500102
J	de Pinho, JR; Grilo, C; Boone, RB; Galvin, KA; Snodgrass, JG				de Pinho, Joana Roque; Grilo, Clara; Boone, Randall B.; Galvin, Kathleen A.; Snodgrass, Jeffrey G.			Influence of Aesthetic Appreciation of Wildlife Species on Attitudes towards Their Conservation in Kenyan Agropastoralist Communities	PLOS ONE			English	Article							AMBOSELI-NATIONAL-PARK; PROTECTED AREAS; LOCAL PEOPLE; FEAR; BENEFITS; RESERVE; MAASAI; PREFERENCES; MANAGEMENT; ORGANISMS	The influence of human aesthetic appreciation of animal species on public attitudes towards their conservation and related decision-making has been studied in industrialized countries but remains underexplored in developing countries. Working in three agropastoralist communities around Amboseli National Park, southern Kenya, we investigated the relative strength of human aesthetic appreciation on local attitudes towards the conservation of wildlife species. Using semi-structured interviewing and free listing (n = 191) as part of a mixed methods approach, we first characterized local aesthetic judgments of wildlife species. With a Generalized Linear Mixed Models (GLMM) approach, we then determined the influence of perceiving four species as beautiful on local support for their protection ("rescuing them"), and of perceiving four other species as ugly on support for their removal from the area, while controlling for informant personal and household socioeconomic attributes. Perceiving giraffe, gazelles and eland as beautiful is the strongest variable explaining support for rescuing them. Ugliness is the strongest variable influencing support for the removal of buffalo, hyena, and elephant (but not lion). Both our qualitative and quantitative results suggest that perceptions of ugly species could become more positive through direct exposure to those species. We propose that protected areas in developing countries facilitate visitation by local residents to increase their familiarity with species they rarely see or most frequently see in conflict with human interests. Since valuing a species for its beauty requires seeing it, protected areas in developing countries should connect the people who live around them with the animals they protect. Our results also show that aesthetic appreciation of biodiversity is not restricted to the industrialized world.	[de Pinho, Joana Roque; Boone, Randall B.; Galvin, Kathleen A.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [de Pinho, Joana Roque] Univ Lisbon, Ctr Adm & Polit Publ, Inst Super Ciencias Sociais & Polit, P-1699 Lisbon, Portugal; [Grilo, Clara] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Grilo, Clara] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Grilo, Clara] Univ Aveiro, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [Boone, Randall B.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Galvin, Kathleen A.; Snodgrass, Jeffrey G.] Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA	Colorado State University; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Aveiro; Universidade de Aveiro; Colorado State University; Colorado State University	de Pinho, JR (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	roquedepinho.joana@gmail.com	Boone, Randall B/N-6566-2013; Grilo, Clara/H-2002-2012; De Pinho, Joana Roque/L-2441-2014	Boone, Randall B/0000-0003-3362-2976; Grilo, Clara/0000-0001-9870-3115; De Pinho, Joana Roque/0000-0002-4659-2684	Fundacao para a Ciencia e a Tecnologia (FCT) [PRAXIS XXI/BD/19669/99, SFRH/BPD/43242/2008]; Fulbright Program in Portugal; Calouste Gulbenkian Foundation; Fundacao Luso-Americana para o Desenvolvimento; Global Livestock-Collaborative Research Support Program (USAID); Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/64205/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fulbright Program in Portugal; Calouste Gulbenkian Foundation; Fundacao Luso-Americana para o Desenvolvimento; Global Livestock-Collaborative Research Support Program (USAID)(United States Agency for International Development (USAID)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was possible thanks to grants from the Fundacao para a Ciencia e a Tecnologia (FCT) (PRAXIS XXI/BD/19669/99; SFRH/BPD/43242/2008), the Fulbright Program in Portugal, the Calouste Gulbenkian Foundation, the Fundacao Luso-Americana para o Desenvolvimento and the Global Livestock-Collaborative Research Support Program (USAID) to JRP; and a Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/64205/2009) grant to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballouard JM, 2012, J HERPETOL, V46, P423, DOI 10.1670/11-118; BARRETT CB, 1995, WORLD DEV, V23, P1073, DOI 10.1016/0305-750X(95)00031-7; Bates D, 2011, IME4 LINEAR MIXED EF; Bernard H.R., 2002, RES METHODS ANTHR QU, V3rd; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; Bjornstad O., 2009, NCF SPATIAL NONPARAM; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Brostrom G., 2011, GLMMML GEN LINEAR MO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BurnSilver S., 2007, FRAGMENTATION SEMIAR, P225; Collett DP, 1987, CONSERVATION AFRICA, P149; Coote J., 1992, ANTHR ART AESTHETICS, P245; Czech B, 1998, CONSERV BIOL, V12, P1103, DOI 10.1046/j.1523-1739.1998.97253.x; de Pinho J. R., 2009, STAYING TOGETHER PEO; Dollar L, 2012, EXPLORERS J STO 0719; Drury R, 2011, ANIM CONSERV, V14, P18, DOI 10.1111/j.1469-1795.2010.00375.x; Estren M. J., 2012, Journal of Animal Ethics, V2, P6; FINCH VA, 1977, ECOLOGY, V58, P1384, DOI 10.2307/1935090; Frynta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063110; Frynta D, 2011, HUM ECOL, V39, P829, DOI 10.1007/s10745-011-9447-2; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; Gillingham S, 1999, ENVIRON CONSERV, V26, P218, DOI 10.1017/S0376892999000302; Goldman M, 2007, ENVIRON PLANN D, V25, P307, DOI 10.1068/d0505; Goldman MJ, 2013, ORYX, V47, P490, DOI 10.1017/S0030605312000907; Goldman Mara J., 2010, Human Dimensions of Wildlife, V15, P332, DOI 10.1080/10871209.2010.506671; Groom R, 2008, ENVIRON CONSERV, V35, P242, DOI 10.1017/S037689290800489X; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Heberlein TA, 2012, CONSERV BIOL, V26, P583, DOI 10.1111/j.1523-1739.2012.01892.x; Hill CM, 1998, ENVIRON CONSERV, V25, P244, DOI 10.1017/S0376892998000307; Huddy L, 2000, POLIT PSYCHOL, V21, P745, DOI 10.1111/0162-895X.00215; Infield M, 2001, CONSERV BIOL, V15, P800, DOI 10.1046/j.1523-1739.2001.015003800.x; Infield M., 2003, NAMES ANKOLE COWS; IUCN, 2011, IUCN 2011 IUCN RED L; Jackman B, 2012, ELEPHANTS KILLED MAA; Jacobson SK, 2012, CONSERV BIOL, V26, P171, DOI 10.1111/j.1523-1739.2011.01750.x; KALLAND A, 1993, ARCTIC, V46, P124; Kaltenborn B., 2010, HUM DIMENS WILDL, V11, P397; Kaltenborn BP, 2006, BIODIVERS CONSERV, V15, P4633, DOI 10.1007/s10531-005-6196-9; Klumpp D, 1993, BEING MAASAI ETHNICI, P195; Knegtering E, 2002, ENVIRON BEHAV, V34, P378, DOI 10.1177/0013916502034003006; Knight AJ, 2008, J ENVIRON PSYCHOL, V28, P94, DOI 10.1016/j.jenvp.2007.10.001; Kuriyan R, 2002, SOC NATUR RESOUR, V15, P949, DOI 10.1080/08941920290107675; Landova E, 2012, J ENVIRON PSYCHOL, V32, P69, DOI 10.1016/j.jenvp.2011.10.005; Lawson H, 2013, DAILY MAIL; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Maresova J, 2008, ECOL ECON, V64, P554, DOI 10.1016/j.ecolecon.2007.03.012; Maresova J, 2009, THEOR BIOSCI, V128, P227, DOI 10.1007/s12064-009-0075-y; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; Mol F., 1996, MAASAI LANGUAGE CULT; Montgomery CA, 2002, J ENVIRON MANAGE, V65, P313, DOI 10.1006/jema.2002.0553; Moss CJ., 2011, AMBOSELI ELEPHANTS; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; Ole Kesoi E, 2012, LIONESS KILLED INSID; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Prokop P, 2013, ANIM CONSERV, V16, P458, DOI 10.1111/acv.12014; Prokop P, 2010, ANN ZOOL FENN, V47, P417, DOI 10.5735/086.047.0606; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Randler C, 2012, SOC ANIM, V20, P61, DOI 10.1163/156853012X614369; Reid R, 2004, LUCID WORKING PAPER; Revkin A. C., 2012, NY TIMES; Robinson LW, 2012, HUM ECOL, V40, P571, DOI 10.1007/s10745-012-9502-7; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Sachedina H, 2010, ORYX, V44, P390, DOI 10.1017/S0030605310000499; Somjee S., 1993, MAT CULTURE KENYA; Stern MJ, 2008, SOC NATUR RESOUR, V21, P859, DOI 10.1080/08941920801973763; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; TURTON D, 1980, MAN, V15, P320, DOI 10.2307/2801674; Wangui EE, 2008, AGR HUM VALUES, V25, P365, DOI 10.1007/s10460-007-9111-z; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; WELLER SC, 1988, SYSTEMATIC DATA COLL; WESTERN D, 1994, NATURAL CONNECTIONS, P15; WESTERN D, 1982, AMBIO, V11, P302; Western D., 1972, East African Wildlife Journal, V10, P43; WESTERN D, 1979, HUM ECOL, V7, P75, DOI 10.1007/BF00889353; Western D, 2009, BIOL CONSERV, V142, P2538, DOI 10.1016/j.biocon.2009.05.025; Wildlife Connection, 2013, WILDL CONN BRIDG GAP; Woods B., 2000, J TOURISM STUDIES, V11, P25; Zuur Alain F., 2009, P1	85	59	61	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88842	10.1371/journal.pone.0088842	http://dx.doi.org/10.1371/journal.pone.0088842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7IR	24551176	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500076
J	Fraser, MD; Moorby, JM; Vale, JE; Evans, DM				Fraser, Mariecia D.; Moorby, Jon M.; Vale, James E.; Evans, Darren M.			Mixed Grazing Systems Benefit both Upland Biodiversity and Livestock Production	PLOS ONE			English	Article							WATER-SOLUBLE CARBOHYDRATE; LOLIUM-PERENNE L.; NITROUS-OXIDE; PERFORMANCE; BRITAIN; DIET; GRASSLANDS; MANAGEMENT; EMISSIONS; PASTURE	Background: With world food demand expected to double by 2050, identifying farming systems that benefit both agricultural production and biodiversity is a fundamentally important challenge for the 21st century, but this has to be achieved in a sustainable way. Livestock grazing management directly influences both economic outputs and biodiversity on upland farms while contributing to potentially damaging greenhouse gas emissions, yet no study has attempted to address these impacts simultaneously. Methods: Using a replicated, landscape-scale field experiment consisting of five management 'systems' we tested the effects of progressively altering elements within an upland farming system, viz i) incorporating cattle grazing into an upland sheep system, ii) integrating grazing of semi-natural rough grazing into a mixed grazing system based on improved pasture, iii) altering the stocking ratio within a mixed grazing system, and iv) replacing modern crossbred cattle with a traditional breed. We quantified the impacts on livestock productivity and numbers of birds and butterflies over four years. Results, Conclusion and Significance: We found that management systems incorporating mixed grazing with cattle improve livestock productivity and reduce methane emissions relative to sheep only systems. Systems that also included semi-natural rough grazing consistently supported more species of birds and butterflies, and it was possible to incorporate bouts of summer grazing of these pastures by cattle to meet habitat management prescriptions without compromising cattle performance overall. We found no evidence that the system incorporating a cattle breed popular as a conservation grazer was any better for bird and butterfly species richness than those based on a mainstream breed, yet methane emissions from such a system were predicted to be higher. We have demonstrated that mixed upland grazing systems not only improve livestock production, but also benefit biodiversity, suggesting a 'win-win' solution for farmers and conservationists.	[Fraser, Mariecia D.; Moorby, Jon M.; Vale, James E.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Evans, Darren M.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Hull	Fraser, MD (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	mariecia.fraser@aber.ac.uk	Fraser, Mariecia/W-7321-2019; Evans, Darren Mark/J-9782-2012; Moorby, Jon/L-4586-2018	Moorby, Jon/0000-0002-4449-8432; Evans, Darren/0000-0003-4061-6726; Fraser, Mariecia/0000-0003-3999-1270	UK Department for Environment, Food and Rural Affairs [LS3407]	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	The work was funded by the the UK Department for Environment, Food and Rural Affairs (project no. LS3407): https://www.gov.uk/government/ organisations/department-for-environment-food-rural-affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs S, 2010, LAND USE POLICY, V27, P550, DOI 10.1016/j.landusepol.2009.07.009; Alderman G., 1993, EN PROT REQ RUM ADV; [Anonymous], 1994, NATURE FARMING LOW I; Bussink DW, 1998, NUTR CYCL AGROECOSYS, V51, P19, DOI 10.1023/A:1009747109538; Carey PD, 2002, BIOL CONSERV, V108, P183, DOI 10.1016/S0006-3207(02)00105-2; Clothier L, 2010, 20 DEFR AGR CHANG EN; DAVIES DA, 1984, GRASS FORAGE SCI, V39, P229, DOI 10.1111/j.1365-2494.1984.tb01687.x; DEFRA, 2012, AGR STAT CLIM CHANG; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Dong H., 2006, GUIDELINES NATL GREE, V4; Eckard RJ, 2010, LIVEST SCI, V130, P47, DOI 10.1016/j.livsci.2010.02.010; Evans DM, 2006, BIOL LETTERS, V2, P636, DOI 10.1098/rsbl.2006.0543; Evans DM, 2005, BIOL LETTERS, V1, P322, DOI 10.1098/rsbl.2005.0335; Fraser MD, 2013, AGR ECOSYST ENVIRON, V175, P8, DOI 10.1016/j.agee.2013.05.002; Fraser MD, 2009, LIVEST SCI, V123, P70, DOI 10.1016/j.livsci.2008.10.008; Fuller RJ, 1999, BIOL CONSERV, V91, P73, DOI 10.1016/S0006-3207(99)00039-7; Furness R. W., 1993, BIRDS MONITORS ENV C; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GRANT SA, 1985, J ECOL, V73, P987, DOI 10.2307/2260163; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Li DJ, 2013, J ENVIRON MANAGE, V128, P893, DOI 10.1016/j.jenvman.2013.06.026; Marchant J., 1990, POPULATION TRENDS BR; McAllister TA, 1996, CAN J ANIM SCI, V76, P231, DOI 10.4141/cjas96-035; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller LA, 2001, GRASS FORAGE SCI, V56, P383, DOI 10.1046/j.1365-2494.2001.00288.x; *MLC, 2000, SHEEP MAN MATT, V8; Moorby JM, 2006, GRASS FORAGE SCI, V61, P52, DOI 10.1111/j.1365-2494.2006.00507.x; Nolan T., 1992, Natural resource development and utilization: future research and technology management in soil-plant-animal-human systems: Proceedings of the Commission of European Communities Coordination Workshop, Wageningen, Netherlands, June 29-July 2, 1992., P12; Oenema O, 1997, SOIL USE MANAGE, V13, P288, DOI 10.1111/j.1475-2743.1997.tb00600.x; Oostermeijer JGB, 1998, BIOL CONSERV, V86, P271, DOI 10.1016/S0006-3207(98)00040-8; R Development Core Team, 2011, R LANG ENV STAT COMP; Reynal SM, 2005, J DAIRY SCI, V88, P4045, DOI 10.3168/jds.S0022-0302(05)73090-3; Sydes C., 1988, Special Publication of the British Ecological Society, V7, P323; Taylor K, 2001, J ECOL, V89, P126, DOI 10.1046/j.1365-2745.2001.00534.x; THOMPSON DBA, 1995, BIOL CONSERV, V71, P163, DOI 10.1016/0006-3207(94)00043-P; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Todd RW, 2006, J ENVIRON QUAL, V35, P404, DOI 10.2134/jeq2005.0045; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Whitehead A., 2002, METAANALYSIS CONTROL; Wright IA, 2006, ANIM SCI, V82, P271, DOI 10.1079/ASC200517	40	51	51	4	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89054	10.1371/journal.pone.0089054	http://dx.doi.org/10.1371/journal.pone.0089054			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551216	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000095
J	Kim, HJ; Baek, MJ; Kim, S				Kim, Hyun Jung; Baek, Min Jae; Kim, SangYun			Alternative Type of the Trail Making Test in Nonnative English-Speakers: The Trail Making Test-Black & White	PLOS ONE			English	Article							RATING-SCALE SUM; NORMATIVE DATA; PART-B; VALIDATION; EDUCATION; NORMS; AGE	Objective: The Trail Making Test (TMT) has its limitations when applied to Eastern cultures due to its reliance on the alphabet. We looked for an alternative tool that is reliable and distinguishable like the TMT and devised the Trail Making Test Black & White (TMT-B&W) as a new variant. This study identifies the applicability of the TMT-B&W as a useful neuropsychological tool and determines whether the TMT-B&W could play an equivalent role as the TMT. Methods: The TMT-B&W uses numbers encircled by black or white circles as stimuli, instead of using the alphabet. A total of 138 participants were including containing groups of 31 cognitively normal controls (NC), 55 mild cognitive impairment (MCI), and 52 people with Alzheimer's disease (AD). Along with the TMT-B&W, the TMT and other neuropsychological tests were administered to all subjects. Results: A considerably low dropout rate for TMT B&W demonstrates that all participants were more willingly engaged in the TMT B&W than the TMT. In particular, subjects with cognitive impairments or lower levels of education performed better on the TMT-B&W than the TMT. The difference in time-to-completion of the TMT-B&W was significant according to the level of cognitive impairment. The TMT-B&W revealed a high correlation with the TMT and frontal lobe function test. Conclusion: The TMT-B&W is as reliable and effective as the TMT. It is worth developing a new variant of the TMT.	[Kim, Hyun Jung; Baek, Min Jae; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Inst, Seoungnam Si, Kyeonggi Do, South Korea; [Kim, SangYun] Seol Natl Univ, Bundang Hosp, Dept Neurol, Seoungnam Si, Kyeonggi Do, South Korea	Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Inst, Seoungnam Si, Kyeonggi Do, South Korea.	neuroksy@snu.ac.kr			Ministry of Knowledge Economy; Korea Evaluation Institute of Industrial Technology [Assessment Technology of Cognitive Ability in the Elderly] [10035434]	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Evaluation Institute of Industrial Technology [Assessment Technology of Cognitive Ability in the Elderly]	The study was supported by the Ministry of Knowledge Economy and the Korea Evaluation Institute of Industrial Technology [10035434, Assessment Technology of Cognitive Ability in the Elderly]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; Boucugnani LL, 1989, ARCH CLIN NEUROPSYCH, V4, P161, DOI DOI 10.1093/ARCLIN/4.2.161; Christensen K. J., 1991, PSYCHOL ASSESSMENT J, V3, P168; D'Elia L.F., 1996, COLOR TRAILS TEST; Fernandez AL, 2008, SCAND J PSYCHOL, V49, P239, DOI 10.1111/j.1467-9450.2008.00637.x; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Horton A. M. J, 1979, CLIN NEUROPSYCHOLOGY, V1, P20; Kang SJ., 2002, J KOREAN NEUROL ASS, V20, P8; Kang SJ, 1997, J KOREAN NEUROL ASS, V24, P300; Kim Hyun Jung, 2011, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V10, P95; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Leitan LA, 1994, NEUROPSYCHOL REV, V4, P161; Lezak MD, 1995, NEUROPSYCHOLOGICAL A, V3; Lu Lei, 2002, Appl Neuropsychol, V9, P219, DOI 10.1207/S15324826AN0904_4; Marshall GA, 2006, ALZ DIS ASSOC DIS, V20, P56, DOI 10.1097/01.wad.0000201852.60330.16; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P746, DOI 10.1001/archneurol.2010.115; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Park Jaeseol, 2007, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V6, P12; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; SHUTE GE, 1990, DEV NEUROPSYCHOL, V6, P1, DOI 10.1080/87565649009540445; Spreen O, 1998, COMPENDIUM NEUROPSYC; WALDMANN BW, 1992, J CLIN PSYCHOL, V48, P360, DOI 10.1002/1097-4679(199205)48:3<360::AID-JCLP2270480314>3.0.CO;2-P; WIEDERHOLT WC, 1993, J AM GERIATR SOC, V41, P639, DOI 10.1111/j.1532-5415.1993.tb06738.x	30	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89078	10.1371/journal.pone.0089078	http://dx.doi.org/10.1371/journal.pone.0089078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7GP	24551221	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000100
J	Popp, AW; Buffat, H; Eberli, U; Lippuner, K; Ernst, M; Richards, RG; Stadelmann, VA; Windolf, M				Popp, Albrecht W.; Buffat, Helene; Eberli, Ursula; Lippuner, Kurt; Ernst, Manuela; Richards, R. Geoff; Stadelmann, Vincent A.; Windolf, Markus			Microstructural Parameters of Bone Evaluated Using HR-pQCT Correlate with the DXA-Derived Cortical Index and the Trabecular Bone Score in a Cohort of Randomly Selected Premenopausal Women	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; X-RAY ABSORPTIOMETRY; IN-VIVO ASSESSMENT; DISTAL RADIUS; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; PRIMARY HYPERPARATHYROIDISM; OSTEOPOROTIC FRACTURES; MICROARCHITECTURE; TIBIA	Background: Areal bone mineral density is predictive for fracture risk. Microstructural bone parameters evaluated at the appendicular skeleton by high-resolution peripheral quantitative computed tomography (HR-pQCT) display differences between healthy patients and fracture patients. With the simple geometry of the cortex at the distal tibial diaphysis, a cortical index of the tibia combining material and mechanical properties correlated highly with bone strength ex vivo. The trabecular bone score derived from the scan of the lumbar spine by dual-energy X-ray absorptiometry (DXA) correlated ex vivo with the micro architectural parameters. It is unknown if these microstructural correlations could be made in healthy premenopausal women. Methods: Randomly selected women between 20-40 years of age were examined by DXA and HR-pQCT at the standard regions of interest and at customized sub regions to focus on cortical and trabecular parameters of strength separately. For cortical strength, at the distal tibia the volumetric cortical index was calculated directly from HR-pQCT and the areal cortical index was derived from the DXA scan using a Canny threshold-based tool. For trabecular strength, the trabecular bone score was calculated based on the DXA scan of the lumbar spine and was compared with the corresponding parameters derived from the HR-pQCT measurements at radius and tibia. Results: Seventy-two healthy women were included (average age 33.8 years, average BMI 23.2 kg/m(2)). The areal cortical index correlated highly with the volumetric cortical index at the distal tibia (R = 0.798). The trabecular bone score correlated moderately with the microstructural parameters of the trabecular bone. Conclusion: This study in randomly selected premenopausal women demonstrated that microstructural parameters of the bone evaluated by HR-pQCT correlated with the DXA derived parameters of skeletal regions containing predominantly cortical or cancellous bone. Whether these indexes are suitable for better predictions of the fracture risk deserves further investigation.	[Popp, Albrecht W.; Buffat, Helene; Lippuner, Kurt] Univ Hosp Bern, Dept Osteoporosis, Inselspital, CH-3010 Bern, Switzerland; [Popp, Albrecht W.; Buffat, Helene; Lippuner, Kurt] Univ Bern, Bern, Switzerland; [Eberli, Ursula; Ernst, Manuela; Richards, R. Geoff; Stadelmann, Vincent A.; Windolf, Markus] AO Res Inst Davos, Davos, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Popp, AW (corresponding author), Univ Hosp Bern, Dept Osteoporosis, Inselspital, CH-3010 Bern, Switzerland.	albrecht.popp@insel.ch	Stadelmann, Vincent A./X-1543-2018; Richards, Robert G/I-8235-2015	Richards, Robert G/0000-0002-7778-2480; Windolf, Markus/0000-0001-8077-6914; Stadelmann, Vincent/0000-0002-8741-2184; Lippuner, Kurt/0000-0002-7195-3779; Popp, Albrecht/0000-0002-5954-7495; Perrelet, Romain/0000-0003-2925-6117	AO Research program	AO Research program	This study was funded by the AO Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; BLACK DM, 1992, J BONE MINER RES, V7, P633; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Boutroy S, 2012, OSTEOPOROS INT; Burghardt AJ, 2010, BONE, V47, P519, DOI 10.1016/j.bone.2010.05.034; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; CASEZ JP, 1994, J BONE MINER RES, V9, P1851; Cohen A, 2009, J CLIN ENDOCR METAB, V94, P4351, DOI 10.1210/jc.2009-0996; CORDEY J, 1992, J BONE MINER RES, V7, pS437, DOI 10.1002/jbmr.5650071414; Hans D, 2011, J BONE MINER RES, V26, P2762, DOI 10.1002/jbmr.499; Hans D, 2011, J CLIN DENSITOM, V14, P302, DOI 10.1016/j.jocd.2011.05.005; Hernandez CJ, 2006, J BONE MINER RES, V21, P1248, DOI 10.1359/JBMR.060514; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Khosla S, 2006, J BONE MINER RES, V21, P124, DOI 10.1359/JBMR.050916; Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8; Liu XS, 2010, J BONE MINER RES, V25, P746, DOI 10.1359/jbmr.090822; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Nishiyama KK, 2012, OSTEOPOROS INT; Nishiyama KK, 2010, J BONE MINER RES, V25, P882, DOI 10.1359/jbmr.091020; Popp AW, 2009, OSTEOPOROSIS INT, V20, P1393, DOI 10.1007/s00198-008-0808-7; Popp AW, 2013, J BONE MINER RES, V28, P449, DOI 10.1002/jbmr.1775; Popp AW, 2012, BONE, V50, P296, DOI 10.1016/j.bone.2011.10.033; Pothuaud L, 2008, BONE, V42, P775, DOI 10.1016/j.bone.2007.11.018; Seeman E, 2003, J APPL PHYSIOL, V95, P2142, DOI 10.1152/japplphysiol.00564.2003; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Silva BC, 2013, J CLIN DENSITOM, V16, P554, DOI 10.1016/j.jocd.2013.07.001; Silva BC, 2013, J CLIN ENDOCR METAB, V98, P1963, DOI 10.1210/jc.2012-4255; Sode M, 2011, BONE, V48, P1291, DOI 10.1016/j.bone.2011.03.755; Sode M, 2010, BONE, V46, P1652, DOI 10.1016/j.bone.2010.02.021; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; Stein EM, 2010, J BONE MINER RES, V25, P2296, DOI 10.1002/jbmr.152; Vico L, 2008, J BONE MINER RES, V23, P1741, DOI 10.1359/JBMR.080704; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	34	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88946	10.1371/journal.pone.0088946	http://dx.doi.org/10.1371/journal.pone.0088946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551194	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000084
J	Acharya, S; Safaie, BM; Wongkongkathep, P; Ivanova, MI; Attar, A; Klarner, FG; Schrader, T; Loo, JA; Bitan, G; Lapidus, LJ				Acharya, Srabasti; Safaie, Brian M.; Wongkongkathep, Piriya; Ivanova, Magdalena I.; Attar, Aida; Klaerner, Frank-Gerrit; Schrader, Thomas; Loo, Joseph A.; Bitan, Gal; Lapidus, Lisa J.			Molecular Basis for Preventing alpha-Synuclein Aggregation by a Molecular Tweezer*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Mass Spectrometry (MS); Parkinson's Disease; Protein Aggregation; Spectroscopy; Inhibitor; Intramolecular Diffusion	INTRINSICALLY DISORDERED PROTEINS; PHOTOCHEMICAL CROSS-LINKING; MASS-SPECTROMETRY; UNMODIFIED PROTEINS; DIFFUSION; OLIGOMERIZATION; INHIBITORS; TETRAMER; PEPTIDE; BINDING	Background: The molecular tweezer, CLR01, binds to Lys and prevents aggregation of -synuclein. Results: CLR01 binds directly to monomeric -synuclein near the N terminus and changes the charge distribution in the sequence, swelling the chain, and increasing the protein reconfiguration rate. Conclusion: Aggregation is inhibited by making the protein more diffusive. Significance: The most effective aggregation inhibitors may change monomer dynamics rather than structure. Recent work on -synuclein has shown that aggregation is controlled kinetically by the rate of reconfiguration of the unstructured chain, such that the faster the reconfiguration, the slower the aggregation. In this work we investigate this relationship by examining -synuclein in the presence of a small molecular tweezer, CLR01, which binds selectively to Lys side chains. We find strong binding to multiple Lys within the chain as measured by fluorescence and mass-spectrometry and a linear increase in the reconfiguration rate with concentration of the inhibitor. Top-down mass-spectrometric analysis shows that the main binding of CLR01 to -synuclein occurs at the N-terminal Lys-10/Lys-12. Photo-induced cross-linking of unmodified proteins (PICUP) analysis shows that under the conditions used for the fluorescence analysis, -synuclein is predominantly monomeric. The results can be successfully modeled using a kinetic scheme in which two aggregation-prone monomers can form an encounter complex that leads to further oligomerization but can also dissociate back to monomers if the reconfiguration rate is sufficiently high. Taken together, the data provide important insights into the preferred binding site of CLR01 on -synuclein and the mechanism by which the molecular tweezer prevents self-assembly into neurotoxic aggregates by -synuclein and presumably other amyloidogenic proteins.	[Acharya, Srabasti; Lapidus, Lisa J.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Safaie, Brian M.; Attar, Aida; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Wongkongkathep, Piriya; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Ivanova, Magdalena I.; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Attar, Aida; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Loo, Joseph A.; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Inst Organ Chem, D-45117 Essen, Germany; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany	Michigan State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Duisburg Essen; University of Duisburg Essen	Lapidus, LJ (corresponding author), Michigan State Univ, Dept Phys & Astron, 567 Wilson Rd Rm 4227, E Lansing, MI 48824 USA.	lapidus@msu.edu	Wongkongkathep, Piriya/E-7139-2011; Bitan, Gal/U-2204-2019	Wongkongkathep, Piriya/0000-0003-0751-8622; Bitan, Gal/0000-0001-7046-3754	National Institutes of Health [R01 GM103479]; NIH High-End Shared Instrumentation Program [S10 RR028893]; NIH [R01 GM100908]; University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation Grant [20095024]; Team Parkinson/Parkinson Alliance Grant; NSF [MCB-0825001]; Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103479, R01GM100908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH High-End Shared Instrumentation Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation Grant; Team Parkinson/Parkinson Alliance Grant; NSF(National Science Foundation (NSF)); Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by National Institutes of Health Grants R01 GM103479 (to J. A. L.); NIH High-End Shared Instrumentation Program S10 RR028893 (to J. A. L.); NIH R01 GM100908 (to L. J. L.); University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development (to G. B.); RJG Foundation Grant 20095024 (to G. B.); Team Parkinson/Parkinson Alliance Grant (to G. B.); NSF MCB-0825001 (to L. J. L.); and Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government (to P. W.).	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bier D, 2013, NAT CHEM, V5, P234, DOI [10.1038/NCHEM.1570, 10.1038/nchem.1570]; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; Chen YJ, 2010, J PHYS CHEM B, V114, P15969, DOI 10.1021/jp104746g; Cho MK, 2009, PROTEIN SCI, V18, P1840, DOI 10.1002/pro.194; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Dutt S, 2013, J ORG CHEM, V78, P6721, DOI 10.1021/jo4009673; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Lapidus L. J., 2001, PHYS REV LETT, V87, P4; Lapidus LJ, 2002, J MOL BIOL, V319, P19, DOI 10.1016/S0022-2836(02)00193-6; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lopes DHJ, 2012, METHODS MOL BIOL, V849, P11, DOI 10.1007/978-1-61779-551-0_2; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1; Singh VR, 2007, BIOCHEMISTRY-US, V46, P10046, DOI 10.1021/bi700270j; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Xie YM, 2006, J AM CHEM SOC, V128, P14432, DOI 10.1021/ja063197p; Yin S, 2011, INT J MASS SPECTROM, V300, P118, DOI 10.1016/j.ijms.2010.06.032; Yin S, 2010, J AM SOC MASS SPECTR, V21, P899, DOI 10.1016/j.jasms.2010.01.002	32	71	71	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10727	10737		10.1074/jbc.M113.524520	http://dx.doi.org/10.1074/jbc.M113.524520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567327	hybrid, Green Published			2022-12-25	WOS:000334226400042
J	Herrmann, J; Ravilious, GE; McKinney, SE; Westfall, CS; Lee, SG; Baraniecka, P; Giovannetti, M; Kopriva, S; Krishnan, HB; Jez, JM				Herrmann, Jonathan; Ravilious, Geoffrey E.; McKinney, Samuel E.; Westfall, Corey S.; Lee, Soon Goo; Baraniecka, Patrycja; Giovannetti, Marco; Kopriva, Stanislav; Krishnan, Hari B.; Jez, Joseph M.			Structure and Mechanism of Soybean ATP Sulfurylase and the Committed Step in Plant Sulfur Assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Enzyme Structure; Plant; Plant Biochemistry; Protein Structure	CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; SULFATE ASSIMILATION; NUCLEOTIDE-BINDING; ADENOSINE-5'-PHOSPHOSULFATE KINASE; 5'-ADENYLYLSULFATE REDUCTASE; FUNCTIONAL EXPRESSION; SECONDARY METABOLISM; ESCHERICHIA-COLI; CLONING	Background: ATP sulfurylase catalyzes the energetically unfavorable formation of adenosine 5-phosphosulfate in plant sulfur assimilation. Results: Structural and kinetic analyses identifies key active site residues. Conclusion: A reaction mechanism involving distortion of nucleotide conformation and stabilizing interactions is proposed. Significance: These results provide the first molecular insights on a plant ATP sulfurylase and the committed step of plant sulfur assimilation. Enzymes of the sulfur assimilation pathway are potential targets for improving nutrient content and environmental stress responses in plants. The committed step in this pathway is catalyzed by ATP sulfurylase, which synthesizes adenosine 5-phosphosulfate (APS) from sulfate and ATP. To better understand the molecular basis of this energetically unfavorable reaction, the x-ray crystal structure of ATP sulfurylase isoform 1 from soybean (Glycine max ATP sulfurylase) in complex with APS was determined. This structure revealed several highly conserved substrate-binding motifs in the active site and a distinct dimerization interface compared with other ATP sulfurylases but was similar to mammalian 3-phosphoadenosine 5-phosphosulfate synthetase. Steady-state kinetic analysis of 20 G. max ATP sulfurylase point mutants suggests a reaction mechanism in which nucleophilic attack by sulfate on the -phosphate of ATP involves transition state stabilization by Arg-248, Asn-249, His-255, and Arg-349. The structure and kinetic analysis suggest that ATP sulfurylase overcomes the energetic barrier of APS synthesis by distorting nucleotide structure and identifies critical residues for catalysis. Mutations that alter sulfate assimilation in Arabidopsis were mapped to the structure, which provides a molecular basis for understanding their effects on the sulfur assimilation pathway.	[Herrmann, Jonathan; Ravilious, Geoffrey E.; McKinney, Samuel E.; Westfall, Corey S.; Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Baraniecka, Patrycja; Giovannetti, Marco; Kopriva, Stanislav] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Giovannetti, Marco] Univ Turin, Dept Life Sci & Syst Biol, I-10125 Turin, Italy; [Krishnan, Hari B.] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA	Washington University (WUSTL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Turin; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), Washington Univ, Dept Biol, One Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Kopriva, Stanislav/C-7401-2013; Giovannetti, Marco/AGR-6494-2022; Giovannetti, Marco/AAK-4589-2020	Kopriva, Stanislav/0000-0002-7416-6551; Giovannetti, Marco/0000-0003-4637-9880; Giovannetti, Marco/0000-0003-4637-9880; Lee, Soon Goo/0000-0002-1541-8587	Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; ARS [ARS-0424526] Funding Source: Federal RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research and supported by Grant DE-AC02-06CH11357. Product names are necessary to report factually on available data; however, the United States Department of Agriculture neither guarantees nor warrants the standard of product, and the use of the name by the United States Department of Agriculture implies no approval of the product to the exclusion of others that may be suitable.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aharoni A, 2011, CURR OPIN BIOTECH, V22, P239, DOI 10.1016/j.copbio.2010.11.004; ASAHI T, 1964, BIOCHIM BIOPHYS ACTA, V82, P58, DOI 10.1016/0304-4165(64)90007-8; Beynon JD, 2001, BIOCHEMISTRY-US, V40, P14509, DOI 10.1021/bi015643l; Bradley ME, 2009, J MOL EVOL, V68, P1, DOI 10.1007/s00239-008-9181-6; BRUNOLD C, 1984, PLANT PHYSIOL, V76, P579, DOI 10.1104/pp.76.3.579; CACCO G, 1977, PLANT PHYSIOL, V60, P582, DOI 10.1104/pp.60.4.582; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deyrup AT, 1999, J BIOL CHEM, V274, P28929, DOI 10.1074/jbc.274.41.28929; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Hatzfeld Y, 2000, GENE, V248, P51, DOI 10.1016/S0378-1119(00)00132-3; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Heiss S, 1999, PLANT MOL BIOL, V39, P847, DOI 10.1023/A:1006169717355; Hofgen R, 2001, AMINO ACIDS, V20, P291, DOI 10.1007/s007260170045; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; KLONUS D, 1994, PLANT J, V6, P105, DOI 10.1046/j.1365-313X.1994.6010105.x; KLONUS D, 1995, PLANT PHYSIOL, V107, P653, DOI 10.1104/pp.107.2.653; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Koprivova A, 2013, PLANT PHYSIOL, V163, P1133, DOI 10.1104/pp.113.225748; Krishnan HB, 2005, CROP SCI, V45, P454, DOI 10.2135/cropsci2005.0454; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; LEUSTEK T, 1994, PLANT PHYSIOL, V105, P897, DOI 10.1104/pp.105.3.897; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Logan HM, 1996, J BIOL CHEM, V271, P12227, DOI 10.1074/jbc.271.21.12227; MacRae IJ, 2002, NAT STRUCT BIOL, V9, P945, DOI 10.1038/nsb868; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; MURILLO M, 1995, ARCH BIOCHEM BIOPHYS, V323, P195, DOI 10.1006/abbi.1995.0026; Ohkama-Ohtsu N, 2010, PLANT CELL PHYSIOL, V51, P1255, DOI 10.1093/pcp/pcq095; OSSLUND T, 1982, PLANT PHYSIOL, V70, P39, DOI 10.1104/pp.70.1.39; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parey K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074707; Parey K, 2013, METALLOMICS, V5, P302, DOI 10.1039/c2mt20225e; Park YS, 1997, J BIOL CHEM, V272, P15161, DOI 10.1074/jbc.272.24.15161; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Ravilious GE, 2013, BIOSCIENCE REP, V33, P585, DOI 10.1042/BSR20130073; Ravilious GE, 2013, J BIOL CHEM, V288, P6107, DOI 10.1074/jbc.M112.439414; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1993, ARCH BIOCHEM BIOPHYS, V307, P272, DOI 10.1006/abbi.1993.1590; Rotte C, 2000, PLANT PHYSIOL, V124, P715, DOI 10.1104/pp.124.2.715; Shin R, 2011, FEBS LETT, V585, P143, DOI 10.1016/j.febslet.2010.11.025; Taguchi Y, 2004, BIOCHEMISTRY-US, V43, P4111, DOI 10.1021/bi036052t; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ullrich TC, 2001, J MOL BIOL, V313, P1117, DOI 10.1006/jmbi.2001.5098; Ullrich TC, 2001, EMBO J, V20, P316, DOI 10.1093/emboj/20.3.316; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Venkatachalam KV, 1999, J BIOL CHEM, V274, P2601, DOI 10.1074/jbc.274.5.2601; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522; Zhu L, 2008, PLANT PHYSIOL BIOCH, V46, P731, DOI 10.1016/j.plaphy.2007.03.029	69	33	34	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10919	10929		10.1074/jbc.M113.540401	http://dx.doi.org/10.1074/jbc.M113.540401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24584934	hybrid, Green Published			2022-12-25	WOS:000334226400059
J	Rodrigues, JR; Couto, A; Cabezas, A; Pinto, RM; Ribeiro, JM; Canales, J; Costas, MJ; Cameselle, JC				Rui Rodrigues, Joaquim; Couto, Ana; Cabezas, Alicia; Maria Pinto, Rosa; Meireles Ribeiro, Joao; Canales, Jose; Jesus Costas, Maria; Carlos Cameselle, Jose			Bifunctional Homodimeric Triokinase/FMN Cyclase CONTRIBUTION OF PROTEIN DOMAINS TO THE ACTIVITIES OF THE HUMAN ENZYME AND MOLECULAR DYNAMICS SIMULATION OF DOMAIN MOVEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FAD; Fructose Metabolism; Molecular Docking; Molecular Dynamics; Mutagenesis; Site-specific; Bifunctional Kinase; Cyclase; Cyclic FMN; DAK Gene; Dihydroxyacetone Phosphorylation; Glyceraldehyde Phosphorylation	COLI DIHYDROXYACETONE KINASE; COVALENT SUBSTRATE-BINDING; RIBOFLAVIN 4',5'-CYCLIC PHOSPHATE; ISOLATED RAT HEPATOCYTES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CITROBACTER-FREUNDII; FRUCTOSE METABOLISM; NEGATIVE REGULATION; HUMAN ERYTHROCYTES	Background: Triokinase, which phosphorylates dihydroxyacetone and fructose-derived glyceraldehyde, remains molecularly unidentified. Results: Human DAK gene encodes homodimeric triokinase/FMN cyclase formed by two-domain subunits. Although kinase activity requires intact homodimers, cyclase requires only a truncated, single domain subunit. Conclusion: Triokinase/FMN cyclase identity and bifunctionality are established. Significance: This study molecularly dissects a bifunctional enzyme of unusual specificity and finishes the molecular identification of fructose pathway enzymes. Mammalian triokinase, which phosphorylates exogenous dihydroxyacetone and fructose-derived glyceraldehyde, is neither molecularly identified nor firmly associated to an encoding gene. Human FMN cyclase, which splits FAD and other ribonucleoside diphosphate-X compounds to ribonucleoside monophosphate and cyclic X-phosphodiester, is identical to a DAK-encoded dihydroxyacetone kinase. This bifunctional protein was identified as triokinase. It was modeled as a homodimer of two-domain (K and L) subunits. Active centers lie between K1 and L2 or K2 and L1: dihydroxyacetone binds K and ATP binds L in different subunits too distant (approximate to 14 ) for phosphoryl transfer. FAD docked to the ATP site with ribityl 4-OH in a possible near-attack conformation for cyclase activity. Reciprocal inhibition between kinase and cyclase reactants confirmed substrate site locations. The differential roles of protein domains were supported by their individual expression: K was inactive, and L displayed cyclase but not kinase activity. The importance of domain mobility for the kinase activity of dimeric triokinase was highlighted by molecular dynamics simulations: ATP approached dihydroxyacetone at distances below 5 in near-attack conformation. Based upon structure, docking, and molecular dynamics simulations, relevant residues were mutated to alanine, and k(cat) and K-m were assayed whenever kinase and/or cyclase activity was conserved. The results supported the roles of Thr(112) (hydrogen bonding of ATP adenine to K in the closed active center), His(221) (covalent anchoring of dihydroxyacetone to K), Asp(401) and Asp(403) (metal coordination to L), and Asp(556) (hydrogen bonding of ATP or FAD ribose to L domain). Interestingly, the His(221) point mutant acted specifically as a cyclase without kinase activity.	[Rui Rodrigues, Joaquim; Couto, Ana; Cabezas, Alicia; Maria Pinto, Rosa; Meireles Ribeiro, Joao; Canales, Jose; Jesus Costas, Maria; Carlos Cameselle, Jose] Univ Extremadura, Fac Med, Dept Bioquim & Biol Mol & Genet, Grp Enzimol, E-06006 Badajoz, Spain; [Rui Rodrigues, Joaquim] Inst Politecn Leiria, Escola Super Tecnol & Gestao, P-2411901 Leiria, Portugal	Universidad de Extremadura; Polytechnic Institute of Leiria; Polytechnic Institute of Porto	Cameselle, JC (corresponding author), Univ Extremadura, Fac Med, Dept Bioquim & Biol Mol & Genet, Av Elvas S-N,Apartado 108, E-06006 Badajoz, Spain.	camselle@unex.es	Costas, Maria Jesus/K-7394-2014; Rodrigues, Joaquim Rui/L-4137-2014; Cabezas, Alicia/K-6564-2014; Cameselle, Jose Carlos/K-6421-2014; Ribeiro, João Meireles/K-6555-2014; Pinto, Rosa M/K-6560-2014; Canales, Jose/K-8793-2014	Costas, Maria Jesus/0000-0001-8815-1839; Rodrigues, Joaquim Rui/0000-0002-9756-1124; Cabezas, Alicia/0000-0002-2908-9147; Cameselle, Jose Carlos/0000-0003-0005-081X; Ribeiro, João Meireles/0000-0002-6548-1402; Pinto, Rosa M/0000-0003-4594-8113; Canales, Jose/0000-0002-7897-9832	Ministerio de Educacion y Ciencia or Ministerio de Ciencia e Innovacion del Gobierno de Espana [BFU2006-510, BFU2009-07296]; Junta de Extremadura or Gobierno de Extremadura [GRU08043, GRU09135, GR10133]; Fondo Europeo de Desarrollo Regional; Fondo Social Europeo	Ministerio de Educacion y Ciencia or Ministerio de Ciencia e Innovacion del Gobierno de Espana; Junta de Extremadura or Gobierno de Extremadura; Fondo Europeo de Desarrollo Regional(European Commission); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The work was supported in part by Ministerio de Educacion y Ciencia or Ministerio de Ciencia e Innovacion del Gobierno de Espana Grants BFU2006-510 and BFU2009-07296) and Junta de Extremadura or Gobierno de Extremadura Grants GRU08043, GRU09135, and GR10133 cofinanced by Fondo Europeo de Desarrollo Regional and Fondo Social Europeo.	ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Bachler C, 2005, J BIOL CHEM, V280, P18321, DOI 10.1074/jbc.M500279200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BEUTLER E, 1973, BLOOD, V41, P559, DOI 10.1182/blood.V41.4.559.559; BONTHRON DT, 1994, HUM MOL GENET, V3, P1627, DOI 10.1093/hmg/3.9.1627; Burns SP, 2000, BIOCHEM J, V349, P539, DOI 10.1042/0264-6021:3490539; Cabezas A, 2005, BIOCHEM BIOPH RES CO, V338, P1682, DOI 10.1016/j.bbrc.2005.10.142; Cabezas A, 2001, BIOCHEMISTRY-US, V40, P13710, DOI 10.1021/bi0157159; Canales J, 2005, ANAL BIOCHEM, V341, P214, DOI 10.1016/j.ab.2005.01.060; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P268; CROSS NCP, 1990, LANCET, V335, P306, DOI 10.1016/0140-6736(90)90603-3; DANIEL R, 1995, J BACTERIOL, V177, P4392, DOI 10.1128/jb.177.15.4392-4401.1995; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Dong F, 2002, SCIENCE, V298, P1227, DOI 10.1126/science.1076947; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fontes R, 2000, ACTA BIOCHIM POL, V47, P233, DOI 10.18388/abp.2000_4082; Fraiz FJ, 1998, BIOCHEM J, V330, P881, DOI 10.1042/bj3300881; FRANDSEN EK, 1971, EUR J BIOCHEM, V23, P588, DOI 10.1111/j.1432-1033.1971.tb01658.x; GANCEDO C, 1986, EUR J BIOCHEM, V159, P171, DOI 10.1111/j.1432-1033.1986.tb09848.x; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Golaz O, 1996, ELECTROPHORESIS, V17, P573, DOI 10.1002/elps.1150170328; Harrison J., 1976, P1; HAYASHI SI, 1967, J BIOL CHEM, V242, P1030; HERS HG, 1953, BIOCHIM BIOPHYS ACTA, V11, P427, DOI 10.1016/0006-3002(53)90062-6; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOFMANN KH, 1981, Z ALLG MIKROBIOL, V21, P219, DOI 10.1002/jobm.3630210307; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Ivy JL, 1998, MED SCI SPORT EXER, V30, P837, DOI 10.1097/00005768-199806000-00010; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Luisi B, 1998, J MOL BIOL, V279, P1123, DOI 10.1006/jmbi.1998.1833; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V270, P15, DOI 10.1016/0003-9861(89)90002-7; Madero M, 2011, CURR HYPERTENS REP, V13, P29, DOI 10.1007/s11906-010-0163-x; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; MIWA I, 1994, PREP BIOCHEM, V24, P203, DOI 10.1080/10826069408010094; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Oberholzer AE, 2006, J MOL BIOL, V359, P539, DOI 10.1016/j.jmb.2006.03.057; Pavlovic-Djuranovic S, 2006, BBA-BIOMEMBRANES, V1758, P1012, DOI 10.1016/j.bbamem.2005.12.002; Perdomo AB, 2012, J PROTEOME RES, V11, P717, DOI 10.1021/pr2006445; Petersen AB, 2004, MUTAT RES-GEN TOX EN, V560, P173, DOI 10.1016/j.mrgentox.2004.03.002; PILKIS SJ, 1976, J BIOL CHEM, V251, P7841; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Sanchez-Moreno I, 2009, CHEMBIOCHEM, V10, P225, DOI 10.1002/cbic.200800573; Sanner MF, 2005, STRUCTURE, V13, P447, DOI 10.1016/j.str.2005.01.010; Schomburg D., 2007, SPRINGER HDB ENZYMES, V35, P351; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Siebold C, 2003, P NATL ACAD SCI USA, V100, P8188, DOI 10.1073/pnas.0932787100; Sievenpiper JL, 2009, DIABETES CARE, V32, P1930, DOI 10.2337/dc09-0619; SILLERO MAG, 1969, EUR J BIOCHEM, V10, P345, DOI 10.1111/j.1432-1033.1969.tb00696.x; Steinmann B, 2001, METABOLIC MOL BASES, P1489; Taguchi T, 2002, CELL BIOCHEM FUNCT, V20, P223, DOI 10.1002/cbf.952; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tolan DR, 2007, CEREBELLUM, V6, P130, DOI 10.1080/14734220601064759; Uzcategui NL, 2007, AUTOPHAGY, V3, P626, DOI 10.4161/auto.4907; Uzcategui NL, 2007, ANTIMICROB AGENTS CH, V51, P3960, DOI 10.1128/AAC.00423-07; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WARNETTEHAMMOND ME, 1985, J BIOL CHEM, V260, P2647; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yamano K, 1996, Z NATURFORSCH C, V51, P155; Zierkiewicz W, 2008, J PHYS CHEM B, V112, P16734, DOI 10.1021/jp8058118; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	85	14	15	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10620	10636		10.1074/jbc.M113.525626	http://dx.doi.org/10.1074/jbc.M113.525626			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569995	Green Published, hybrid			2022-12-25	WOS:000334226400033
J	Boroughs, LK; Antonyak, MA; Cerione, RA				Boroughs, Lindsey K.; Antonyak, Marc A.; Cerione, Richard A.			A Novel Mechanism by Which Tissue Transglutaminase Activates Signaling Events That Promote Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; PI3-kinase (PI3K); Src; Transformation; Cell Survival; p70 S6-kinase; Tissue Transglutaminase	BREAST-CANCER CELLS; MIDDLE T-ANTIGEN; FACTOR-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; INDUCED APOPTOSIS; DRUG-RESISTANCE; EXPRESSION; BINDING; TRANSFORMATION	Background: Tissue transglutaminase (tTG) promotes various aspects of oncogenesis, including cell survival. Results: Ectopically expressed tTG in non-transformed cells triggers a survival response that involves c-Src and PI3-kinase. Conclusion: tTG promotes survival by activating PI3-kinase through a c-Src-dependent mechanism. Significance: These findings demonstrate that tTG has an intrinsic capability to promote cell survival and explains how it contributes to oncogenesis. Tissue transglutaminase (tTG) functions as a GTPase and an acyl transferase that catalyzes the formation of protein cross-links. tTG expression is frequently up-regulated in human cancer, where it has been implicated in various aspects of cancer progression, including cell survival and chemo-resistance. However, the extent to which tTG cooperates with other proteins within the context of a cancer cell, versus its intrinsic ability to confer transformed characteristics to cells, is poorly understood. To address this question, we asked what effect the ectopic expression of tTG in a non-transformed cellular background would have on the behavior of the cells. Using NIH3T3 fibroblasts stably expressing a Myc-tagged form of tTG, we found that tTG strongly protected these cells from serum starvation-induced apoptosis and triggered the activation of the PI3-kinase/mTOR Complex 1 (mTORC1)/p70 S6-kinase pathway. We determined that tTG forms a complex with the non-receptor tyrosine kinase c-Src and PI3-kinase, and that treating cells with inhibitors to block tTG function (monodansylcadaverine; MDC) or c-Src kinase activity (PP2) disrupted the formation of this complex, and prevented tTG from activating the PI3-kinase pathway. Moreover, treatment of fibroblasts over-expressing tTG with PP2, or with inhibitors that inactivate components of the PI3-kinase pathway, including PI3-kinase (LY294002) and mTORC1 (rapamycin), ablated the tTG-promoted survival of the cells. These findings demonstrate that tTG has an intrinsic capability to stimulate cell survival through a novel mechanism that activates PI3-kinase signaling events, thus highlighting tTG as a potential target for the treatment of human cancer.	[Boroughs, Lindsey K.; Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NIGMS NIH HHS [R01 GM040654, P41 GM103485] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, P41GM103485] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Antonyak MA, 2001, J BIOL CHEM, V276, P33582, DOI 10.1074/jbc.M105318200; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; AUGER KR, 1992, J BIOL CHEM, V267, P5408; Boroughs LK, 2011, J BIOL CHEM, V286, P37094, DOI 10.1074/jbc.M111.242438; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HAEFNER B, 1995, J BIOL CHEM, V270, P7937, DOI 10.1074/jbc.270.14.7937; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; LING LE, 1992, J VIROL, V66, P1702, DOI 10.1128/JVI.66.3.1702-1708.1992; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; MEHTA K, 1986, CANCER RES, V46, P1388; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; SERUNIAN LA, 1990, J VIROL, V64, P4718, DOI 10.1128/JVI.64.10.4718-4725.1990; SINGH US, 1995, BIOCHEMISTRY-US, V34, P15863, DOI 10.1021/bi00048a032; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; von Willebrand M, 1998, J BIOL CHEM, V273, P3994, DOI 10.1074/jbc.273.7.3994; Wang JB, CANC CELL, V18, P207; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021; Zhang RL, 2003, GLIA, V42, P194, DOI 10.1002/glia.10222	40	34	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10115	10125		10.1074/jbc.M113.464693	http://dx.doi.org/10.1074/jbc.M113.464693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569994	hybrid, Green Published			2022-12-25	WOS:000333807000058
J	Emery, AC; Eiden, MV; Eiden, LE				Emery, Andrew C.; Eiden, Maribeth V.; Eiden, Lee E.			Separate Cyclic AMP Sensors for Neuritogenesis, Growth Arrest, and Survival of Neuroendocrine Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic AMP (cAMP); ERK; Guanine Nucleotide Exchange Factor (GEF); p38 MAPK; Protein Kinase A (PKA); Epac; NCS; Rapgef2	CYCLASE-ACTIVATING POLYPEPTIDE; DEPENDENT PROTEIN-KINASE; PC12 CELLS; ADENYLATE-CYCLASE; NEURITE OUTGROWTH; NEURONAL DIFFERENTIATION; SIGNALING PATHWAY; FARNESYLTHIOSALICYLIC ACID; NEUROTROPHIN RECEPTOR; SUSTAINED ACTIVATION	Background: Three cAMP sensors (PKA, Epac1/2, and NCS/Rapgef2) coexist in neuroendocrine cells. Their roles in differentiation require elucidation. Results: Epac2, PKA, and NCS/Rapgef2 independently gate signaling for growth arrest, cell survival, and neuritogenesis after GPCR-G(s) engagement in PC12 cells. Conclusion: Parallel, insulated pathways effect cAMP-dependent neuroendocrine cell differentiation. Significance: Assays for parcellated cAMP signaling in neuroendocrine cells have a broad application for CNS drug discovery. Dividing neuroendocrine cells differentiate into a neuronal-like phenotype in response to ligands activating G protein-coupled receptors, leading to the elevation of the second messenger cAMP. Growth factors that act at receptor tyrosine kinases, such as nerve growth factor, also cause differentiation. We report here that two aspects of cAMP-induced differentiation, neurite extension and growth arrest, are dissociable at the level of the sensors conveying the cAMP signal in PC12 and NS-1 cells. Following cAMP elevation, neuritogenic cyclic AMP sensor/Rapgef2 is activated for signaling to ERK to mediate neuritogenesis, whereas Epac2 is activated for signaling to the MAP kinase p38 to mediate growth arrest. Neither action of cAMP requires transactivation of TrkA, the receptor for NGF. In fact, the differentiating effects of NGF do not require activation of any of the cAMP sensors protein kinase A, Epac, or neuritogenic cyclic AMP sensor/Rapgef2 but, rather, depend on ERK and p38 activation via completely independent signaling pathways. Hence, cAMP- and NGF-dependent signaling for differentiation are also completely insulated from each other. Cyclic AMP and NGF also protect NS-1 cells from serum withdrawal-induced cell death, again by two wholly separate signaling mechanisms, PKA-dependent for cAMP and PKA-independent for NGF.	[Emery, Andrew C.; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Intramural Res Program, Bethesda, MD 20892 USA; [Eiden, Maribeth V.] NIMH, Sect Directed Gene Transfer, Lab Cellular & Mol Regulat, Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Intramural Res Program, 9000 Rockville Pike,Bldg 49,Rm 5A38, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov		Emery, Andrew/0000-0002-6760-2570; Eiden, Lee/0000-0001-7524-944X	National Institute of Mental Health Intramural Research Program [1ZIAMH002386, 1ZIAMH002592]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002592, ZIAMH002386] Funding Source: NIH RePORTER	National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Mental Health Intramural Research Program Projects 1ZIAMH002386 (to L. E. E.) and 1ZIAMH002592 (to M. V. E.).	BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Emery AC, 2013, MOL PHARMACOL, V83, P95, DOI 10.1124/mol.112.081760; Emery AC, 2012, FASEB J, V26, P3199, DOI 10.1096/fj.11-203042; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hughes AL, 2000, J BIOL CHEM, V275, P37829, DOI 10.1074/jbc.M003146200; Hughes AL, 2001, J NEUROSCI RES, V63, P10, DOI 10.1002/1097-4547(20010101)63:1<10::AID-JNR2>3.0.CO;2-R; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Ji HF, 2013, HEPATOLOGY, V57, P1225, DOI 10.1002/hep.25802; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; KOIZUMI S, 1988, J NEUROSCI, V8, P715; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Liu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018072; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; Mor A, 2011, J INVEST DERMATOL, V131, P2040, DOI 10.1038/jid.2011.152; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Racz B, 2008, REGUL PEPTIDES, V145, P105, DOI 10.1016/j.regpep.2007.09.015; Racz B, 2007, NEUROTOX RES, V12, P95, DOI 10.1007/BF03033918; RAUSCH DM, 1988, MOL ENDOCRINOL, V2, P921, DOI 10.1210/mend-2-10-921; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tanaka K, 2001, PROG NEUROBIOL, V65, P173, DOI 10.1016/S0301-0082(01)00002-8; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	58	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10126	10139		10.1074/jbc.M113.529321	http://dx.doi.org/10.1074/jbc.M113.529321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567337	Green Published, hybrid			2022-12-25	WOS:000333807000059
J	Martinez-Gutierrez, M; Correa-Londono, LA; Castellanos, JE; Gallego-Gomez, JC; Osorio, JE				Martinez-Gutierrez, Marlen; Correa-Londono, Luis A.; Castellanos, Jaime E.; Gallego-Gomez, Juan C.; Osorio, Jorge E.			Lovastatin Delays Infection and Increases Survival Rates in AG129 Mice Infected with Dengue Virus Serotype 2	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; ANTIBODY-RESPONSE; CONTROLLED-TRIAL; ANIMAL-MODELS; MOUSE MODEL; IN-VIVO; INHIBITOR; STATINS; PROTEIN; REPLICATION	Background: It has been reported that treatment of DENV-infected cultures with Lovastatin (LOV), can affect viral assembly. The objective of this study was to evaluate the effect of LOV on the survival rate and viremia levels of DENV-2-infected AG129 mice. Methodology/Principal Findings: Mice were inoculated with 1x10(6) plaque-forming units (PFU/ml) of DENV-2 and treated with LOV (200 mg/kg/day). Pre-treatment with one or three doses of LOV increased the survival rate compared to untreated mice (7.3 and 7.1 days, respectively, compared to 4.8 days). Viremia levels also decreased by 21.8% compared to untreated mice, but only in the group administered three doses prior to inoculation. When LOV was administered after viral inoculation, the survival rate increased (7.3 days in the group treated at 24 hpi, 6.8 days in the group treated at 48 hpi and 6.5 days in the group treated with two doses) compared to the untreated group (4.8 days). Interestingly, the serum viral titer increased by 24.6% in mice treated at 48 hpi with a single dose of LOV and by 21.7% in mice treated with two doses (at 24 and 48 hpi) of LOV compared to untreated mice. Finally histopathological changes in the liver and spleen in infected and untreated mice included massive extramedullary erythropoiesis foci and inflammatory filtration, and these characteristics were decreased or absent in LOV-treated mice. Conclusions/Significance: Our results suggest that the effect of LOV on viremia depends on the timing of treatment and on the number of doses administered. We observed a significant increase in the survival rate in both schemes due to a delay in the progression of the disease. However, the results obtained in the post-treatment scheme must be handled carefully because this treatment scheme increases viremia and we do not know how this increase could affect disease progression in humans.	[Martinez-Gutierrez, Marlen] Univ Antioquia, Programa Estudio & Cotrol Enfermdades Trop, Medellin, Colombia; [Correa-Londono, Luis A.] Univ Antioquia, Fac Med, Medellin, Colombia; [Correa-Londono, Luis A.] Congregac Mariana, Lab Patol, Medellin, Colombia; [Castellanos, Jaime E.] Univ El Bosque, Grp Virol, Bogota, Colombia; [Gallego-Gomez, Juan C.] Univ Antioquia, Mol & Translat Med Grp, Viral Vector Core & Gene Therapy Neurosci Grp Ant, Medellin, Colombia; [Gallego-Gomez, Juan C.] Univ Antioquia, Mol & Translat Med Grp, Medellin, Colombia; [Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	Universidad de Antioquia; Universidad de Antioquia; Universidad El Bosque; Universidad de Antioquia; Universidad de Antioquia; University of Wisconsin System; University of Wisconsin Madison	Martinez-Gutierrez, M (corresponding author), Univ Antioquia, Programa Estudio & Cotrol Enfermdades Trop, Medellin, Colombia.	mmartinezg@udea.edu.co	Gallegomez, Juantxo/AAX-1633-2020; Castellanos, Jaime/W-2635-2019	Gallegomez, Juantxo/0000-0001-7453-2569; Castellanos, Jaime/0000-0003-1596-8383; Martinez-Gutierrez, Marlen/0000-0002-9429-0058	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) [111549326092]; COLCIENCIAS [1308-489-25267]	COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by COLCIENCIAS (Departamento Administrativo de Ciencia, Tecnologia e Innovacion) grant No. 111549326092. M.M.G. received a Ph.D. Fellowship (1308-489-25267) from COLCIENCIAS (http://www.colciencias.gov.co/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Brewoo JN, 2012, VACCINE, V30, P1513, DOI 10.1016/j.vaccine.2011.11.072; Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12; Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045; Chang JH, 2011, ANTIVIR RES, V92, P369, DOI 10.1016/j.antiviral.2011.08.003; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805; Isusi E, 2000, ATHEROSCLEROSIS, V153, P283, DOI 10.1016/S0021-9150(00)00407-X; Jasinska M, 2007, PHARMACOL REP, V59, P483; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Julander Justin G., 2011, Antiviral Chemistry & Chemotherapy, V21, P105, DOI 10.3851/IMP1690; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lee E, 2006, J GEN VIROL, V87, P2791, DOI 10.1099/vir.0.82164-0; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lin CY, 2013, J FORMOS MED ASSOC, V112, P61, DOI 10.1016/j.jfma.2012.06.005; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12; Mueck AO, 2001, EXP CLIN ENDOCR DIAB, V109, P181, DOI 10.1055/s-2001-14843; Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470; Oishi Kazunori, 2007, Journal of Infection and Chemotherapy, V13, P125, DOI 10.1007/s10156-007-0516-9; Organization PAH, 2011, NUMB REP CAS DENG FI; Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0; Palaniswamy C, 2010, AM J THER, V17, P75, DOI 10.1097/MJT.0b013e31819cdc86; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Stanislaus R, 2001, J NEUROSCI RES, V66, P155, DOI 10.1002/jnr.1207; Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P14, DOI 10.1179/2046904712Z.00000000046; Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11; Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203; Xu XF, 2008, INTERVIROLOGY, V51, P182, DOI 10.1159/000151531; Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062	49	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87412	10.1371/journal.pone.0087412	http://dx.doi.org/10.1371/journal.pone.0087412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586275	Green Published, gold, Green Submitted			2022-12-25	WOS:000331717900010
J	Fischer, R; Xygalatas, D; Mitkidis, P; Reddish, P; Tok, P; Konvalinka, I; Bulbulia, J				Fischer, Ronald; Xygalatas, Dimitris; Mitkidis, Panagiotis; Reddish, Paul; Tok, Penny; Konvalinka, Ivana; Bulbulia, Joseph			The Fire-Walker's High: Affect and Physiological Responses in an Extreme Collective Ritual	PLOS ONE			English	Article							PAIN	How do people feel during extreme collective rituals? Despite longstanding speculation, few studies have attempted to quantify ritual experiences. Using a novel pre/post design, we quantified physiological fluctuations (heart rates) and self-reported affective states from a collective fire-walking ritual in a Mauritian Hindu community. Specifically, we compared changes in levels of happiness, fatigue, and heart rate reactivity among high-ordeal participants (fire-walkers), low-ordeal participants (non-fire-walking participants with familial bonds to fire-walkers) and spectators (unrelated/unknown to the fire-walkers). We observed that fire-walkers experienced the highest increase in heart rate and reported greater happiness post-ritual compared to low-ordeal participants and spectators. Low-ordeal participants reported increased fatigue after the ritual compared to both fire-walkers and spectators, suggesting empathetic identification effects. Thus, witnessing the ritualistic suffering of loved ones may be more exhausting than experiencing suffering oneself. The findings demonstrate that the level of ritual involvement is important for shaping affective responses to collective rituals. Enduring a ritual ordeal is associated with greater happiness, whereas observing a loved-one endure a ritual ordeal is associated with greater fatigue post-ritual.	[Fischer, Ronald] Victoria Univ Wellington, Ctr Appl Cross Cultural Res, Wellington, New Zealand; [Fischer, Ronald] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand; [Fischer, Ronald; Xygalatas, Dimitris; Reddish, Paul; Tok, Penny; Bulbulia, Joseph] Masaryk Univ, LEVYNA Lab Expt Res Relig, Brno, Czech Republic; [Xygalatas, Dimitris; Mitkidis, Panagiotis] Aarhus Univ, Interact Minds Ctr IMC, Dept Culture & Soc, Aarhus, Denmark; [Mitkidis, Panagiotis] Duke Univ, Social Sci Res Inst, Ctr Adv Hindsight, Durham, NC USA; [Mitkidis, Panagiotis] Aarhus Univ, Sch Business & Social Sci, Interdisciplinary Ctr Org Architecture, Aarhus, Denmark; [Konvalinka, Ivana] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Konvalinka, Ivana] Cent European Univ, Dept Cognit Sci, Budapest, Hungary; [Bulbulia, Joseph] Victoria Univ Wellington, Fac Humanities & Social Studies, Wellington, New Zealand	Victoria University Wellington; Victoria University Wellington; Masaryk University Brno; Aarhus University; Duke University; Aarhus University; Technical University of Denmark; Central European University; Victoria University Wellington	Fischer, R (corresponding author), Victoria Univ Wellington, Ctr Appl Cross Cultural Res, Wellington, New Zealand.	ronald.fischer@vuw.ac.nz	Xygalatas, Dimitris/P-3376-2019; Xygalatas, Dimitris/C-1956-2014; Fischer, Ronald/G-6447-2017; Konvalinka, Ivana/AAC-3418-2022	Xygalatas, Dimitris/0000-0003-1561-9327; Xygalatas, Dimitris/0000-0003-1561-9327; Fischer, Ronald/0000-0002-3055-3955; Konvalinka, Ivana/0000-0003-3405-6291; Bulbulia, Joseph/0000-0002-5861-2056	University Research Funding Grant from Victoria University of Wellington (URF Grant) [8-3046-108855]; "Technologies of the Mind" project; Velux Foundation; Interactive Minds Centre at Aarhus University, Denmark; Laboratory for the Experimental Research of Religion at Masaryk University, (LEVYNA) [CZ.1.07/2.3.00/20.0048]; European Social Fund; state budget of the Czech Republic; Canadian Social Sciences and Humanities Research Council (SSHRC); Economic and Social Research Council [ES/I005455/1] Funding Source: researchfish; ESRC [ES/I005455/1] Funding Source: UKRI	University Research Funding Grant from Victoria University of Wellington (URF Grant); "Technologies of the Mind" project; Velux Foundation(Velux Fonden); Interactive Minds Centre at Aarhus University, Denmark; Laboratory for the Experimental Research of Religion at Masaryk University, (LEVYNA); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Canadian Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was supported by a University Research Funding Grant from Victoria University of Wellington (URF Grant 8-3046-108855); the "Technologies of the Mind" project, financed by the Velux Foundation; the Interactive Minds Centre at Aarhus University, Denmark; the Laboratory for the Experimental Research of Religion at Masaryk University, (LEVYNA, CZ.1.07/2.3.00/20.0048), co-financed by the European Social Fund and the state budget of the Czech Republic; and the Canadian Social Sciences and Humanities Research Council (SSHRC) project "The Evolution of Religion and Morality." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta CS, 2005, HUM NATURE-INT BIOS, V16, P323, DOI 10.1007/s12110-005-1014-3; Atkinson QD, 2011, EVOL HUM BEHAV, V32, P50, DOI 10.1016/j.evolhumbehav.2010.09.002; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Barrett LF, 1998, J PERS SOC PSYCHOL, V74, P967, DOI 10.1037/0022-3514.74.4.967; Bastian B, 2011, PSYCHOL SCI, V22, P334, DOI 10.1177/0956797610397058; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Durkheim Emile, 1912, FORMES ELEMENTAIRES; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Franklin JC, 2013, PSYCHOL SCI, V24, P521, DOI 10.1177/0956797612458805; Franklin JC, 2010, J ABNORM PSYCHOL, V119, P850, DOI 10.1037/a0020896; Gibson AS, 2003, SPORTS MED, V33, P167; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2008, J LEGAL STUD, V37, pS133, DOI 10.1086/529447; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; McNeill W. H., 1995, KEEPING TOGETHER TIM; Olivola CY, 2013, J BEHAV DECIS MAKING, V26, P91, DOI 10.1002/bdm.767; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reddish P, 2014, RELIG BRAIN BEHAV, V4, P3, DOI 10.1080/2153599X.2013.764545; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Taves Ann, 1999, FITS TRANCES VISIONS; Tewari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047291; Turner Victor, 1969, RITUAL PROCESS STRUC; WARD C, 1984, ETHOS, V12, P307, DOI 10.1525/eth.1984.12.4.02a00020; Whitehouse H., 2000, ARGUMENTS ICONS DIVE; Whitehouse Harvey, 2004, MODES RELIGIOSITY CO; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Xygalatas D., 2012, BURNING SAINTS COGNI; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910	32	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88355	10.1371/journal.pone.0088355	http://dx.doi.org/10.1371/journal.pone.0088355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586315	Green Published, gold, Green Submitted			2022-12-25	WOS:000331714700014
J	Lee, GH; Lee, MR; Lee, HY; Kim, SH; Kim, HK; Kim, HR; Chae, HJ				Lee, Geum-Hwa; Lee, Mi-Rin; Lee, Hwa-Young; Kim, Seung Hyun; Kim, Hye-Kyung; Kim, Hyung-Ryong; Chae, Han-Jung			Eucommia ulmoides Cortex, Geniposide and Aucubin Regulate Lipotoxicity through the Inhibition of Lysosomal BAX	PLOS ONE			English	Article							MEMBRANE PERMEABILIZATION; HEPATIC LIPOTOXICITY; ANTIOXIDANT ACTIVITY; HYPOLIPIDEMIC ACTION; OLIV. LEAVES; CELL-DEATH; APOPTOSIS; EXTRACT; INVOLVEMENT; EXPRESSION	In this study we examined the inhibition of hepatic dyslipidemia by Eucommia ulmoides extract (EUE). Using a screening assay for BAX inhibition we determined that EUE regulates BAX-induced cell death. Among various cell death stimuli tested EUE regulated palmitate-induced cell death, which involves lysosomal BAX translocation. EUE rescued palmitate-induced inhibition of lysosomal V-ATPase, alpha-galactosidase, alpha-mannosidase, and acid phosphatase, and this effect was reversed by bafilomycin, a lysosomal V-ATPase inhibitor. The active components of EUE, aucubin and geniposide, showed similar inhibition of palmitate-induced cell death to that of EUE through enhancement of lysosome activity. Consistent with these in vitro findings, EUE inhibited the dyslipidemic condition in a high-fat diet animal model by regulating the lysosomal localization of BAX. This study demonstrates that EUE regulates lipotoxicity through a novel mechanism of enhanced lysosomal activity leading to the regulation of lysosomal BAX activation and cell death. Our findings further indicate that geniposide and aucubin, active components of EUE, may be therapeutic candidates for non-alcoholic fatty liver disease.	[Lee, Geum-Hwa; Lee, Mi-Rin; Lee, Hwa-Young; Kim, Hye-Kyung; Chae, Han-Jung] Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju, South Korea; [Lee, Geum-Hwa; Lee, Mi-Rin; Lee, Hwa-Young; Kim, Hye-Kyung; Chae, Han-Jung] Chonbuk Natl Univ, Sch Med, Cardiovasc Res Inst, Jeonju, South Korea; [Kim, Seung Hyun] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Wonkwang Dent Res Inst, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University; Yonsei University; Wonkwang University; Wonkwang University	Chae, HJ (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju, South Korea.	hjchae@chonbuk.ac.kr		Chae, Han-Jung/0000-0003-4190-9889	National Research Foundation [2012R1A2A1A03001907, 2008-0062279]	National Research Foundation	This study was supported by the National Research Foundation (2012R1A2A1A03001907 and 2008-0062279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Harish R, 2010, J PHARM BIOALLIED SC, V2, P341, DOI 10.4103/0975-7406.72137; Hung MY, 2006, FOOD CHEM TOXICOL, V44, P1424, DOI 10.1016/j.fct.2006.03.009; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Kim BH, 2009, J MED FOOD, V12, P764, DOI 10.1089/jmf.2008.1239; Kim HY, 2004, J ETHNOPHARMACOL, V93, P227, DOI 10.1016/j.jep.2004.03.047; Lee GH, 2012, INT J BIOCHEM CELL B, V44, P600, DOI 10.1016/j.biocel.2011.12.017; Lee GH, 2011, J BIOL CHEM, V286, P24743, DOI 10.1074/jbc.M110.167734; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; Li H, 2004, PHYTOCHEM ANALYSIS, V15, P306, DOI 10.1002/pca.783; Li H, 2009, J AOAC INT, V92, P103; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Luo JY, 2009, J ENZYM INHIB MED CH, V24, P1280, DOI 10.3109/14756360902829741; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Park SA, 2006, J MED FOOD, V9, P474, DOI 10.1089/jmf.2006.9.474; Park SA, 2006, J ETHNOPHARMACOL, V107, P412, DOI 10.1016/j.jep.2006.03.034; Peng MJ, 2013, J CHROMATOGR B, V940, P86, DOI 10.1016/j.jchromb.2013.09.032; Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Trivedi NS, 2000, PHOTOCHEM PHOTOBIOL, V71, P634, DOI 10.1562/0031-8655(2000)071<0634:QAOPLI>2.0.CO;2; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Yamasaki M, 2005, BBA-MOL CELL BIOL L, V1735, P176, DOI 10.1016/j.bbalip.2005.05.010; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	32	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88017	10.1371/journal.pone.0088017	http://dx.doi.org/10.1371/journal.pone.0088017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586300	gold, Green Published, Green Submitted			2022-12-25	WOS:000331711900022
J	Chan, JYL; Wang, KH; Fang, CL; Chen, WY				Chan, Jung-Yi Lisa; Wang, Kuo-Hsien; Fang, Chia-Lang; Chen, Wei-Yu			Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?	PLOS ONE			English	Article							GIANT-CELL ASTROCYTOMAS; FACIAL ANGIOFIBROMA; MTOR PATHWAY; ANGIOMYOLIPOMA; GENE; TSC2; LYMPHANGIOLEIOMYOMATOSIS; HAMARTOMAS; SIROLIMUS; TUMOR	Fibrous papules of the face are hamartomas characterized by stellate-shaped stromal cells, multinucleated giant cells, and proliferative blood vessels in the dermis. The pathogenesis of fibrous papules remains unclear. There is a striking microscopic resemblance between fibrous papules and tuberous sclerosis complex (TSC)-associated angiofibromas. A germline mutation of the TSC1 or TSC2 gene, leading to activation of the mammalian target of rapamycin (mTOR) pathway, accounts for the pathogenesis of TSC-associated angiofibromas. Activated mTOR subsequently activates p70 ribosomal protein S6 kinase (p70S6K) and ribosomal protein S6 (S6) by phosphorylation. Rapamycin, a mTOR inhibitor, is effective in treating TSC-associated angiofibromas. The aim of this study was to understand whether the mTOR pathway is activated in fibrous papules. We studied immunoexpressions of phosphorylated (p-) mTOR effectors in fibrous papules, TSC-associated angiofibromas, and normal skin controls. P-mTOR, p-p70S6K and p-S6 were highly expressed in dermal stromal cells and epidermal keratinocytes in fibrous papules and TSC-associated angiofibromas but not in fibroblasts and epidermal keratinocytes of normal skin controls (p<0.001). The results suggest topical rapamycin may be a novel treatment option for fibrous papules.	[Chan, Jung-Yi Lisa] Cathay Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Wang, Kuo-Hsien] Taipei Med Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Wang, Kuo-Hsien] Taipei Med Univ, Coll Med, Sch Med, Dept Dermatol, Taipei, Taiwan; [Fang, Chia-Lang; Chen, Wei-Yu] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang; Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan	Cathay General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, WY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan.	1047@tmu.edu.tw			Cathay General Hospital, Taipei, Taiwan [98CGH-TMU-06]	Cathay General Hospital, Taipei, Taiwan	This study was supported by the grant from Cathay General Hospital (98CGH-TMU-06), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal C, 2005, J CUTAN PATHOL, V32, P424, DOI 10.1111/j.0303-6987.2005.00362.x; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bittencourt RCA, 2001, J AM ACAD DERMATOL, V45, P731, DOI 10.1067/mjd.2001.116223; Budde K, 2012, AM J KIDNEY DIS, V59, P276, DOI 10.1053/j.ajkd.2011.10.013; Calonje E, 2010, ROOKS TXB DERMATOLOG, DOI [10.1002/9781444317633.ch56, DOI 10.1002/9781444317633.CH56]; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; Fackler I, 2003, J CUTAN PATHOL, V30, P174, DOI 10.1034/j.1600-0560.2003.2o066.x; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; GRAHAM JH, 1965, J INVEST DERMATOL, V45, P194, DOI 10.1038/jid.1965.118; Grieb S, 2008, HAUTARZT, V59, P774, DOI 10.1007/s00105-008-1633-9; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; GUITART J, 1991, J CUTAN PATHOL, V18, P284, DOI 10.1111/j.1600-0560.1991.tb01237.x; Haemel AK, 2010, ARCH DERMATOL, V146, P715, DOI 10.1001/archdermatol.2010.125; Hofbauer GFL, 2008, BRIT J DERMATOL, V159, P473, DOI 10.1111/j.1365-2133.2008.08677.x; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kenerson H, 2007, HUM PATHOL, V38, P1361, DOI 10.1016/j.humpath.2007.01.028; Kenerson HL, 2002, CANCER RES, V62, P5645; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kucher C, 2007, J CUTAN PATHOL, V34, P571, DOI 10.1111/j.1600-0560.2006.00667.x; Li SW, 2008, P NATL ACAD SCI USA, V105, P3539, DOI 10.1073/pnas.0712397105; Li SW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1236; McNamara EK, 2012, J DERMATOL TREAT, V23, P46, DOI 10.3109/09546634.2010.489598; Meigel W N, 1979, Am J Dermatopathol, V1, P329; Mutizwa MM, 2011, BRIT J DERMATOL, V165, P922, DOI 10.1111/j.1365-2133.2011.10476.x; NELLIST M, 1993, CELL, V75, P1305; NEMETH AJ, 1988, J AM ACAD DERMATOL, V19, P1102, DOI 10.1016/S0190-9622(88)70279-0; NICKEL WR, 1962, ARCH DERMATOL, V85, P209, DOI 10.1001/archderm.1962.01590020049006; Pan CC, 2008, J PATHOL, V214, P387, DOI 10.1002/path.2289; Plank TL, 1998, CANCER RES, V58, P4766; Ragaz A, 1979, Am J Dermatopathol, V1, P353, DOI 10.1097/00000372-197900140-00012; Robb VA, 2006, MODERN PATHOL, V19, P839, DOI 10.1038/modpathol.3800610; Rose C, 2000, AM J DERMATOPATH, V22, P563, DOI 10.1097/00000372-200012000-00018; Salido R, 2012, J EUR ACAD DERMATOL, V26, P1315, DOI 10.1111/j.1468-3083.2011.04212.x; SAYLAN T, 1971, BRIT J DERMATOL, V85, P111; Sepp T, 1996, J MED GENET, V33, P962, DOI 10.1136/jmg.33.11.962; SPIEGEL J, 1983, J AM ACAD DERMATOL, V9, P360, DOI 10.1016/S0190-9622(83)70142-8; Tyburczy ME, 2013, HUM MOL GEN IN PRESS; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Wataya-Kaneda M, 2011, BRIT J DERMATOL, V165, P912, DOI 10.1111/j.1365-2133.2011.10471.x; Yeung RS, 2003, GENE CHROMOSOME CANC, V38, P368, DOI 10.1002/gcc.10256	45	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89467	10.1371/journal.pone.0089467	http://dx.doi.org/10.1371/journal.pone.0089467			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558502	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700148
J	Deng, H; Zhang, XT; Wang, ML; Zheng, HY; Liu, LJ; Wang, ZY				Deng, Hao; Zhang, Xin-Tian; Wang, Mo-Lin; Zheng, Hong-Yan; Liu, Li-Jiang; Wang, Zhao-Yi			ER-alpha 36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells	PLOS ONE			English	Article							MAMMARY STEM-CELLS; RECEPTOR-ALPHA; EXPRESSION; VARIANT; GLAND; GATA-3; POPULATION; RESISTANCE; DIFFERENTIATION; IDENTIFICATION	The breast cancer stem cells (BCSC) play important roles in breast cancer occurrence, recurrence and metastasis. However, the role of estrogen signaling, a signaling pathway important in development and progression of breast cancer, in regulation of BCSC has not been well established. Previously, we identified and cloned a variant of estrogen receptor alpha, ER-alpha 36, with a molecular weight of 36 kDa. ER-alpha 36 lacks both transactivation domains AF-1 and AF-2 of the 66 kDa full-length ER-alpha (ER-alpha 66) and mediates rapid estrogen signaling to promote proliferation of breast cancer cells. In this study, we aim to investigate the function and the underlying mechanism of ER-alpha 36-mediated rapid estrogen signaling in growth regulation of the ER-positive breast cancer stem/progenitor cells. ER-positive breast cancer cells MCF7 and T47D as well as the variants with different levels of ER-alpha 36 expression were used. The effects of estrogen on BCSC's abilities of growth, self-renewal, differentiation and tumor-seeding were examined using tumorsphere formation, flow cytometry, indirect immunofluorence staining and in vivo xenograft assays. The underlying mechanisms were also studied with Western-blot analysis. We found that 17-beta-estradiol (E2 beta) treatment increased the population of ER-positive breast cancer stem/progenitor cells while failed to do so in the cells with knocked-down levels of ER-alpha 36 expression. Cells with forced expression of recombinant ER-alpha 36, however, responded strongly to E2 beta treatment by increasing growth in vitro and tumor-seeding efficiency in vivo. The rapid estrogen signaling via the AKT/GSK3 beta pathway is involved in estrogen-stimulated growth of ER-positive breast cancer stem/progenitor cells. We concluded that ER-alpha 36-mediated rapid estrogen signaling plays an important role in regulation and maintenance of ER-positive breast cancer stem/progenitor cells.	[Deng, Hao; Zhang, Xin-Tian; Wang, Mo-Lin; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol, Omaha, NE 68178 USA; [Deng, Hao; Zhang, Xin-Tian; Wang, Mo-Lin; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Immunol, Omaha, NE 68178 USA; [Deng, Hao; Zheng, Hong-Yan; Liu, Li-Jiang] Jianghan Univ, Jiangda Pathol Ctr, Wuhan, Hubei, Peoples R China; [Wang, Mo-Lin] Shandong Univ, Sch Med, Inst Med Genet, Jinan 250100, Shandong, Peoples R China	Creighton University; Creighton University; Jianghan University; Shandong University	Wang, ZY (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol, Omaha, NE 68178 USA.	zywang@creighton.edu			Nebraska Tobacco Settlement Biomedical Research Program [LB-606 (Stem Cell 2011-03), LB595]; Department of Defense [DAMD 11-1-0497]	Nebraska Tobacco Settlement Biomedical Research Program; Department of Defense(United States Department of Defense)	This work was supported by the Nebraska Tobacco Settlement Biomedical Research Program Awards LB-606 (Stem Cell 2011-03) and LB595, and Department of Defense grant DAMD 11-1-0497. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Han JS, 2009, INT J ONCOL, V34, P1449, DOI 10.3892/ijo_00000273; Kang LG, 2011, J STEROID BIOCHEM, V127, P262, DOI 10.1016/j.jsbmb.2011.08.011; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Oliveira LR, 2010, HISTOL HISTOPATHOL, V25, P371, DOI 10.14670/HH-25.371; Pelekanou V, 2012, STEROIDS, V77, P928, DOI 10.1016/j.steroids.2011.12.016; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Voduc D, 2008, CANCER EPIDEM BIOMAR, V17, P365, DOI 10.1158/1055-9965.EPI-06-1090; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhang XT, 2013, ENDOCRINOLOGY, V154, P1990, DOI 10.1210/en.2013-1116	41	52	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88034	10.1371/journal.pone.0088034	http://dx.doi.org/10.1371/journal.pone.0088034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558373	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700019
J	Sun, YG; Myers, CJ; Dicker, AP; Lu, B				Sun, Yunguang; Myers, Carey Jeanne; Dicker, Adam Paul; Lu, Bo			A Novel Radiation-Induced p53 Mutation Is Not Implicated in Radiation Resistance via a Dominant-Negative Effect	PLOS ONE			English	Article							CELL LUNG-CANCER; WILD-TYPE P53; TUMOR-SUPPRESSOR GENE; NON-HODGKINS-LYMPHOMA; DNA-BINDING DOMAIN; NF-KAPPA-B; MUTANT P53; PROSTATE-CANCER; 2ND CANCERS; TRANSCRIPTIONAL ACTIVATION	Understanding the mutations that confer radiation resistance is crucial to developing mechanisms to subvert this resistance. Here we describe the creation of a radiation resistant cell line and characterization of a novel p53 mutation. Treatment with 20 Gy radiation was used to induce mutations in the H460 lung cancer cell line; radiation resistance was confirmed by clonogenic assay. Limited sequencing was performed on the resistant cells created and compared to the parent cell line, leading to the identification of a novel mutation (del) at the end of the DNA binding domain of p53. Levels of p53, phosphop-53, p21, total caspase 3 and cleaved caspase 3 in radiation resistant cells and the radiation susceptible (parent) line were compared, all of which were found to be similar. These patterns held true after analysis of p53 overexpression in H460 cells; however, H1299 cells transfected with mutant p53 did not express p21, whereas those given WT p53 produced a significant amount, as expected. A luciferase assay demonstrated the inability of mutant p53 to bind its consensus elements. An MTS assay using H460 and H1299 cells transfected with WT or mutant p53 showed that the novel mutation did not improve cell survival. In summary, functional characterization of a radiation-induced p53 mutation in the H460 lung cancer cell line does not implicate it in the development of radiation resistance.	[Sun, Yunguang; Dicker, Adam Paul; Lu, Bo] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Myers, Carey Jeanne] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Lu, B (corresponding author), Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA.	bo.lu@jeffersonhospital.org		Dicker, Adam/0000-0003-0733-3337; Sun, Yunguang/0000-0003-4004-9514	Pennsylvania CURE grant [4100054872]; Kimmel Cancer Center Core Grant [-5 P30 CA056036-14]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER	Pennsylvania CURE grant; Kimmel Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by Pennsylvania CURE grant 4100054872 and Kimmel Cancer Center Core Grant -5 P30 CA056036-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizti P, 2000, MOL CELL BIOL, V20, P7450, DOI 10.1128/MCB.20.20.7450-7459.2000; Armstrong MB, 2006, NEOPLASIA, V8, P967, DOI 10.1593/neo.06574; Aylon Y, 2011, CURR OPIN GENET DEV, V21, P86, DOI 10.1016/j.gde.2010.10.002; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Benchimol S, 2001, CELL DEATH DIFFER; Berkson RG, 2005, INT J CANCER, V115, P701, DOI 10.1002/ijc.20968; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Bostrom PJ, 2007, EUR UROL, V52, P973, DOI 10.1016/j.eururo.2007.07.002; BRACHMAN DG, 1991, CANCER RES, V51, P6393; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brown LM, 2007, BREAST CANCER RES TR, V106, P439, DOI 10.1007/s10549-007-9509-8; Chaturvedi AK, 2007, JNCI-J NATL CANCER I, V99, P1634, DOI 10.1093/jnci/djm201; Chene P, 1998, J MOL BIOL, V281, P205, DOI 10.1006/jmbi.1998.1897; Chene P, 1999, J MOL BIOL, V286, P1269, DOI 10.1006/jmbi.1999.2563; Chene P, 2000, BIOTECHNIQUES, V28, P240; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Chene P, 1997, J MOL BIOL, V273, P873, DOI 10.1006/jmbi.1997.1360; CHIBA I, 1990, ONCOGENE, V5, P1603; De Luca P, 2013, PROSTATE CANCER P D, V16, P233, DOI 10.1038/pcan.2013.12; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; DeBenedetti VMG, 1996, CANCER EPIDEM BIOMAR, V5, P93; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Elbendary AA, 1996, CLIN CANCER RES, V2, P1571; Ettinger DS, 2013, J NATL COMPR CANC NE, V11, P645, DOI 10.6004/jnccn.2013.0084; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; Fogelfeld L, 1996, J CLIN ENDOCR METAB, V81, P3039, DOI 10.1210/jc.81.8.3039; Gao WM, 2003, LUNG CANCER-J IASLC, V40, P141, DOI 10.1016/S0169-5002(03)00035-7; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hemminki K, 2008, J CLIN ONCOL, V26, P1850, DOI 10.1200/JCO.2007.14.6068; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang C, 2012, PROTEIN PHOSPHORYLAT; Huang S, 2011, CANCER RES, V71, P7071, DOI 10.1158/0008-5472.CAN-11-0128; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Jung IL, 2010, INT J MOL MED, V25, P517, DOI 10.3892/ijmm_00000372; Ko JL, 2000, INT J CANCER, V89, P265, DOI 10.1002/1097-0215(20000520)89:3<265::AID-IJC9>3.0.CO;2-N; Kozaki K, 2000, CANCER RES, V60, P2535; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kumar P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003027; Lee YS, 2010, INT J RADIAT ONCOL, V77, P858, DOI 10.1016/j.ijrobp.2009.12.076; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; Levine AJ, 1995, ANN NY ACAD SCI, V768, P111, DOI 10.1111/j.1749-6632.1995.tb12115.x; Levine AJ, 2008, BLOOD, V112, P2997, DOI 10.1182/blood-2008-07-167718; Lubin DJ, 2010, J MOL BIOL, V395, P705, DOI 10.1016/j.jmb.2009.11.013; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Mudie NY, 2006, J CLIN ONCOL, V24, P1568, DOI 10.1200/JCO.2005.04.2200; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nagai W, 2012, BIOCHEM BIOPH RES CO, V421, P15, DOI 10.1016/j.bbrc.2012.03.091; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Nieder AM, 2008, J UROLOGY, V180, P2005, DOI 10.1016/j.juro.2008.07.038; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pinto EM, 2011, PITUITARY, V14, P400, DOI 10.1007/s11102-009-0194-y; Richiardi L, 2007, INT J CANCER, V120, P623, DOI 10.1002/ijc.22345; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SANG BC, 1994, ONCOGENE, V9, P853; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; SHAULIAN E, 1993, EMBO J, V12, P2789, DOI 10.1002/j.1460-2075.1993.tb05940.x; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Shieh SY, 2000, GENE DEV, V14, P289; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; STENGER JE, 1994, EMBO J, V13, P6011, DOI 10.1002/j.1460-2075.1994.tb06947.x; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Travis LB, 2005, JNCI-J NATL CANCER I, V97, P1354, DOI 10.1093/jnci/dji278; Tward JD, 2006, CANCER-AM CANCER SOC, V107, P108, DOI 10.1002/cncr.21971; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; van Baardwijk A, 2008, INT J RADIAT ONCOL, V71, P1103, DOI 10.1016/j.ijrobp.2007.11.028; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WANG X, 1995, CANCER EPIDEM BIOMAR, V4, P543; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zhang H, 1991, ONCOGENE, V16, P1713	88	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e87492	10.1371/journal.pone.0087492	http://dx.doi.org/10.1371/journal.pone.0087492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558369	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700015
J	Wack, DS; Polak, P; Furuyama, J; Burkard, RF				Wack, David S.; Polak, Paul; Furuyama, Jon; Burkard, Robert F.			Masking Level Differences - A Diffusion Tensor Imaging and Functional MRI Study	PLOS ONE			English	Article							AUDITORY-CORTEX; INFERIOR COLLICULUS; NOISE; RESPONSES; THALAMUS; LANGUAGE; HUMANS; SYSTEM; PITCH; TONES	In our previous study we investigated Masking Level Differences (MLD) using functional Magnetic Resonance Imaging (fMRI), but were unable to confirm neural correlations for the MLD within the auditory cortex and inferior colliculus. Here we have duplicated conditions from our previous study, but have included more participants and changed the study site to a new location with a newer scanner and presentation system. Additionally, Diffusion Tensor Imaging (DTI) is included to allow investigation of fiber tracts that may be involved with MLDs. Twenty participants were included and underwent audiometric testing and MRI scanning. The current study revealed regions of increased and decreased activity within the auditory cortex when comparing the combined noise and signal of the dichotic MLD stimuli (N0S pi and N pi S0) with N0S0. Furthermore, we found evidence of inferior colliculus involvement. Our DTI findings show strong correlations between DTI measures within the brainstem and signal detection threshold levels. Patterns of correlation when the signal was presented only to the right ear showed an extensive network in the left hemisphere; however, the opposite was not true for the signal presented only to the left ear. Our current study was able to confirm what we had previously hypothesized using fMRI, while extending our investigation of MLDs to include the characteristics of connecting neural pathways.	[Wack, David S.] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA; [Polak, Paul] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY 14260 USA; [Furuyama, Jon] Toshiba Amer Med Syst Inc, Tustin, CA USA; [Burkard, Robert F.] SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Toshiba Corporation; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wack, DS (corresponding author), SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA.	dswack@buffalo.edu		Polak, Paul/0000-0002-7719-7572	Toshiba America Medical Systems	Toshiba America Medical Systems	This project received funding from Toshiba America Medical Systems. Dr. Furuyama is an employee of Toshiba America Medical Systems. The scanner used was a Toshiba scanner. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ashburner J., 1997, CLIN MRI DEV MR, V7, P26; Badgaiyan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028075; Barker D, 2012, CEREB CORTEX, V22, P745, DOI 10.1093/cercor/bhr065; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Budd TW, 2003, NEUROIMAGE, V20, P1783, DOI 10.1016/j.neuroimage.2003.07.026; Buxton R. B., 2009, INTRO FUNCTIONAL MAG; Chait M, 2006, CEREB CORTEX, V16, P835, DOI 10.1093/cercor/bhj027; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Ernst SMA, 2008, NEUROIMAGE, V43, P321, DOI 10.1016/j.neuroimage.2008.07.046; Ernst SMA, 2010, NEUROIMAGE, V49, P835, DOI 10.1016/j.neuroimage.2009.07.014; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; Fowler C G, 1995, J Am Acad Audiol, V6, P399; Fowler C G, 1996, J Am Acad Audiol, V7, P23; FOWLER CG, 1992, J SPEECH HEAR RES, V35, P216, DOI 10.1044/jshr.3501.216; Friston K., 2007, STAT PARAMETRIC MAPP, DOI [10.1016/B978-0-12-372560-8.X5000-1, DOI 10.1016/B978-0-12-372560-8.X5000-1]; Guo YQ, 2003, HEARING RES, V178, P12, DOI 10.1016/S0378-5955(03)00023-6; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hall DA, 2007, NEUROREPORT, V18, P323, DOI 10.1097/WNR.0b013e32802b70ce; Hall DA, 2009, CEREB CORTEX, V19, P576, DOI 10.1093/cercor/bhn108; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; HUGDAHL K, 1990, BRAIN LANG, V39, P1, DOI 10.1016/0093-934X(90)90001-W; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; Karbe H, 1998, J CEREBR BLOOD F MET, V18, P1157, DOI 10.1097/00004647-199810000-00012; Katsunuma A, 2002, MAGN RESON MATER PHY, V13, P139, DOI 10.1016/S1352-8661(01)00142-9; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; Kim S, 2006, SPEECH COMMUN, V48, P855, DOI 10.1016/j.specom.2006.03.004; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; Leon A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036203; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Lin Y, 2008, J MAGN RESON IMAGING, V28, P598, DOI 10.1002/jmri.21464; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Mai J.K., 1997, ATLAS HUMAN BRAIN; Musiek FE, 2011, BRAIN COGNITION, V76, P225, DOI 10.1016/j.bandc.2011.03.011; OJEMANN GA, 1975, BRAIN LANG, V2, P101, DOI 10.1016/S0093-934X(75)80057-5; Palmer AR, 2000, J NEUROPHYSIOL, V84, P844, DOI 10.1152/jn.2000.84.2.844; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Schmithorst VJ, 2013, NEUROIMAGE CLIN; Seok JH, 2007, PSYCHIAT RES-NEUROIM, V156, P93, DOI 10.1016/j.pscychresns.2007.02.002; SHANKWEILER D, 1967, Q J EXP PSYCHOL, V19, P59, DOI 10.1080/14640746708400069; Smalt CJ, 2012, FUNCTIONAL MAGNETIC; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Stracke H, 2009, CEREB CORTEX, V19, P1440, DOI 10.1093/cercor/bhn183; SUGISHITA M, 1995, BRAIN, V118, P417, DOI 10.1093/brain/118.2.417; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Wack DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041263; Wack DS, 2010, LOCALIZATION BINAURA; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64	54	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88466	10.1371/journal.pone.0088466	http://dx.doi.org/10.1371/journal.pone.0088466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558392	Green Published, gold			2022-12-25	WOS:000331706700038
J	Webb, LE; Jensen, MB; Engel, B; van Reenen, CG; Gerrits, WJJ; de Boer, IJM; Bokkers, EAM				Webb, Laura E.; Jensen, Margit Bak; Engel, Bas; van Reenen, Cornelis G.; Gerrits, Walter J. J.; de Boer, Imke J. M.; Bokkers, Eddie A. M.			Chopped or Long Roughage: What Do Calves Prefer? Using Cross Point Analysis of Double Demand Functions	PLOS ONE			English	Article							DIFFERENT ROOTING MATERIALS; AFFECTING DIET SELECTION; VEAL CALVES; RUMEN DEVELOPMENT; CHEWING ACTIVITY; PARTICLE LENGTH; FOOD PREFERENCE; ANIMAL-WELFARE; FEED; BEHAVIOR	The present study aimed to quantify calves'(Bos taurus) preference for long versus chopped hay and straw, and hay versus straw, using cross point analysis of double demand functions, in a context where energy intake was not a limiting factor. Nine calves, fed milk replacer and concentrate, were trained to work for roughage rewards from two simultaneously available panels. The cost (number of muzzle presses) required on the panels varied in each session (left panel/right panel): 7/35, 14/28, 21/21, 28/14, 35/7. Demand functions were estimated from the proportion of rewards achieved on one panel relative to the total number of rewards achieved in one session. Cross points (cp) were calculated as the cost at which an equal number of rewards was achieved from both panels. The deviation of the cp from the midpoint (here 21) indicates the strength of the preference. Calves showed a preference for long versus chopped hay (cp = 14.5; P = 0.004), and for hay versus straw (cp = 38.9; P = 0.004), both of which improve rumen function. Long hay may stimulate chewing more than chopped hay, and the preference for hay versus straw could be related to hedonic characteristics. No preference was found for chopped versus long straw (cp = 20.8; P = 0.910). These results could be used to improve the welfare of calves in production systems; for example, in systems where calves are fed hay along with high energy concentrate, providing long hay instead of chopped could promote roughage intake, rumen development, and rumination.	[Webb, Laura E.; de Boer, Imke J. M.; Bokkers, Eddie A. M.] Wageningen Univ, Anim Prod Syst Grp, NL-6700 AP Wageningen, Netherlands; [Jensen, Margit Bak] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Engel, Bas] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [van Reenen, Cornelis G.] Univ Wageningen & Res Ctr, Lelystad, Netherlands; [Gerrits, Walter J. J.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Aarhus University; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Webb, LE (corresponding author), Wageningen Univ, Anim Prod Syst Grp, NL-6700 AP Wageningen, Netherlands.	laura.webb@wur.nl	Bokkers, Eddie/A-9073-2015; de Boer, Imke/P-7107-2014	Bokkers, Eddie/0000-0002-2000-7600; de Boer, Imke/0000-0002-0675-7528; , Laura/0000-0002-4943-4294; Jensen, Margit Bak/0000-0001-7982-582X	Division for Earth and Life Sciences (ALW) of the Netherlands Organisation for Scientific Research (NWO); Product Board Animal Feed; UFAW	Division for Earth and Life Sciences (ALW) of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Product Board Animal Feed; UFAW	This work was supported by the Division for Earth and Life Sciences (ALW) of the Netherlands Organisation for Scientific Research (NWO), and the Product Board Animal Feed. Travelling between The Netherlands and Denmark was supported by UFAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saiady MY, 2010, ASIAN AUSTRAL J ANIM, V23, P475, DOI 10.5713/ajas.2010.90364; Bach A, 2013, J DAIRY SCI, V96, P4634, DOI 10.3168/jds.2012-6196; Berends H, 2012, J DAIRY SCI, V95, P3190, DOI 10.3168/jds.2011-4643; Breukink HJ, 1991, EAAP PUBLICATION, V52, P118; Brscic M, 2011, J DAIRY SCI, V94, P853, DOI 10.3168/jds.2010-3480; COOPER SDB, 1995, BRIT J NUTR, V74, P39, DOI 10.1079/BJN19950105; Cooper SDB, 1996, J ANIM SCI, V74, P1240; DEBOEVER JL, 1990, ANIM FEED SCI TECH, V27, P281, DOI 10.1016/0377-8401(90)90143-V; FORKMAN B, 1991, BEHAVIOUR, V117, P243, DOI 10.1163/156853991X00553; Gonzalez LA, 2012, ANIM FEED SCI TECH, V172, P66, DOI 10.1016/j.anifeedsci.2011.12.009; Heinrichs J, 2005, ADV DAIRY TECHNOL, V17, P179; Holm L, 2007, APPL ANIM BEHAV SCI, V107, P133, DOI 10.1016/j.applanim.2006.09.021; HUGHES BO, 1988, ANIM BEHAV, V36, P1696, DOI 10.1016/S0003-3472(88)80110-6; HURSH SR, 1993, DRUG ALCOHOL DEPEN, V33, P165, DOI 10.1016/0376-8716(93)90058-X; Inglis IR, 1997, ANIM BEHAV, V53, P1171, DOI 10.1006/anbe.1996.0320; Inglis IR, 2000, BEHAVIOUR, V137, P1567, DOI 10.1163/156853900502727; Inglis IR, 2001, ANIM BEHAV, V62, P543, DOI 10.1006/anbe.2001.1780; Jensen MB, 2007, APPL ANIM BEHAV SCI, V108, P31, DOI 10.1016/j.applanim.2006.10.014; Kammes KL, 2012, J DAIRY SCI, V95, P807, DOI 10.3168/jds.2011-4588; KENNEY PA, 1984, AUST J AGR RES, V35, P831, DOI 10.1071/AR9840831; KENNEY PA, 1984, AUST J AGR RES, V35, P551, DOI 10.1071/AR9840551; Krause KM, 2002, J DAIRY SCI, V85, P1947, DOI 10.3168/jds.S0022-0302(02)74271-9; Kyriazakis I, 1998, BRIT J NUTR, V79, P55, DOI 10.1079/BJN19980009; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MATTHEWS LR, 1979, J EXP ANAL BEHAV, V32, P245, DOI 10.1901/jeab.1979.32-245; Mattiello S, 2002, J ANIM SCI, V80, P367; MCADIE TM, 1993, APPL ANIM BEHAV SCI, V37, P223, DOI 10.1016/0168-1591(93)90113-4; McCullagh P, 1989, GEN LINEAR MODELS; Morisse JP, 1999, ANIM WELFARE, V8, P43; OSBORNE SR, 1977, ANIM LEARN BEHAV, V5, P221, DOI 10.3758/BF03209232; Pedersen LJ, 2005, APPL ANIM BEHAV SCI, V94, P31, DOI 10.1016/j.applanim.2004.11.023; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; Provenza FD, 1996, J ANIM SCI, V74, P2355; Redbo I, 1997, APPL ANIM BEHAV SCI, V53, P193, DOI 10.1016/S0168-1591(96)01145-8; REDBO I, 1990, APPL ANIM BEHAV SCI, V26, P57, DOI 10.1016/0168-1591(90)90087-T; SAS Institute, 2014, STAT AN SYST 9 2; Sorensen DB, 2004, ANIM BEHAV, V68, P949, DOI 10.1016/j.anbehav.2003.12.017; Sorensen DB, 2001, APPL ANIM BEHAV SCI, V74, P281, DOI 10.1016/S0168-1591(01)00166-6; Suarez BJ, 2007, J DAIRY SCI, V90, P2390, DOI 10.3168/jds.2006-524; Suarez BJ, 2006, J DAIRY SCI, V89, P4376, DOI 10.3168/jds.S0022-0302(06)72484-5; Veissier I, 1998, APPL ANIM BEHAV SCI, V57, P35, DOI 10.1016/S0168-1591(97)00108-1; Vicari T, 2008, DOMEST ANIM ENDOCRIN, V34, P74, DOI 10.1016/j.domaniend.2006.11.002; VSN International, 2012, GENSTAT WIND; Webb LE, 2013, J DAIRY SCI, V96, P7765, DOI 10.3168/jds.2012-6135; Webb LE, 2012, APPL ANIM BEHAV SCI, V136, P108, DOI 10.1016/j.applanim.2011.12.004; WELCH JG, 1982, J ANIM SCI, V54, P885, DOI 10.2527/jas1982.544885x; Welfare Quality<(R)>, 2009, WELF QUAL ASS PROT C; Wilson JR, 1996, AUST J AGR RES, V47, P199, DOI 10.1071/AR9960199	48	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88778	10.1371/journal.pone.0088778	http://dx.doi.org/10.1371/journal.pone.0088778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558426	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700072
J	Deshpande, G; Willis, E; Chatterjee, S; Fernandez, R; Dias, K; Schedl, P				Deshpande, Girish; Willis, Elinor; Chatterjee, Sandip; Fernandez, Robert; Dias, Kristen; Schedl, Paul			BMP Signaling and the Maintenance of Primordial Germ Cell Identity in Drosophila Embryos	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; SEX DETERMINATION; MOUSE EMBRYO; OVARY; MIGRATION; NICHE; SPECIFICATION; EMBRYOGENESIS; MELANOGASTER	The specification of primordial germ cells (PGCs) and subsequent maintenance of germ-line identity in Drosophila embryos has long been thought to occur solely under the control of cell-autonomous factors deposited in the posterior pole plasm during oogenesis. However, here we document a novel role for somatic BMP signaling in the maintenance of PGC fate during the period leading up to embryonic gonad coalescence. We find that PGCs fail to maintain their germline identity when BMP signaling is compromised. They initiate but are unable to properly assemble the germline stem cell-specific organelle, the spectrosome, and they lose expression of the germline-specific gene Vasa. BMP signaling must, however, be finely tuned as there are deleterious consequences to PGCs when the pathway is excessively active. We show that one mechanism used to calibrate the effects of BMP signals is dependent on the Ubc9 homolog Lesswright (Lwr).	[Deshpande, Girish; Willis, Elinor; Chatterjee, Sandip; Fernandez, Robert; Dias, Kristen; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Schedl, Paul] RAS, Inst Gene Biol, Moscow 117901, Russia	Princeton University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Schedl, P (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	pschedl@princeton.edu		Fernandez, Robert/0000-0002-7187-3138	NIH [GM043432]; Gene Biology Institute by the Russian Federation Ministry of Education and Science [14.B25.31.0022]; BSF (US-Israel Binational Science Foundation) [2009439]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gene Biology Institute by the Russian Federation Ministry of Education and Science; BSF (US-Israel Binational Science Foundation)	The authors would like to acknowledge the support provided by NIH (GM043432), by a grant to the Gene Biology Institute by the Russian Federation Ministry of Education and Science (14.B25.31.0022) and by a grant from the BSF (US-Israel Binational Science Foundation) 2009439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Casper A, 2006, DEVELOPMENT, V133, P2783, DOI 10.1242/dev.02415; Casper AL, 2009, DEVELOPMENT, V22, P722; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Chou TB, 1996, GENETICS, V144, P1673; DESHPANDE G, 1995, MOL CELL BIOL, V15, P4430; Dorfman R, 2001, DEVELOPMENT, V128, P965; Durcova-Hills G, 2008, CURR TOP DEV BIOL, V83, P185, DOI [10.1016/S0070-2153(08)00406-7, 10.1016/S0070-2153(09)00406-7]; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FOE VE, 1983, J CELL SCI, V61, P31; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gilboa L, 2004, CURR BIOL, V145, P871; Hashiyama K, 2011, SCIENCE, V333, P885, DOI 10.1126/science.1208146; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; ILLMENSEE K, 1974, P NATL ACAD SCI USA, V71, P1016, DOI 10.1073/pnas.71.4.1016; Janzer B, 2001, MECH DEVELOP, V100, P3, DOI 10.1016/S0925-4773(00)00529-3; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lin H, 1995, DEV GENET, V1, P6; Lin H, 1994, DEVELOPMENT, V4, P947; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Maezawa T, 2009, DEV GROWTH DIFFER, V51, P453, DOI 10.1111/j.1440-169X.2009.01108.x; Mahowald AP, 2001, INT REV CYTOL, V203, P187; Miles WO, 2008, GENE DEV, V22, P2578, DOI 10.1101/gad.494808; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Sato T, 2010, ZOOL SCI, V27, P804, DOI 10.2108/zsj.27.804; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Van Doren M, 1998, CURR BIOL, V8, P243; Waterbury JA, 2000, GENETICS, V155, P1741; Wawersik M, 2005, DEV DYNAM, V234, P22, DOI 10.1002/dvdy.20503; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5	41	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88847	10.1371/journal.pone.0088847	http://dx.doi.org/10.1371/journal.pone.0088847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551179	Green Published, gold, Green Submitted			2022-12-25	WOS:000331271500077
J	Mitome-Mishima, Y; Yamamoto, M; Yatomi, K; Nonaka, S; Miyamoto, N; Urabe, T; Arai, H; Oishi, H				Mitome-Mishima, Yumiko; Yamamoto, Munetaka; Yatomi, Kenji; Nonaka, Senshu; Miyamoto, Nobukazu; Urabe, Takao; Arai, Hajime; Oishi, Hidenori			Endothelial Cell Proliferation in Swine Experimental Aneurysm after Coil Embolization	PLOS ONE			English	Article							GUGLIELMI DETACHABLE COIL; RUPTURED INTRACRANIAL ANEURYSMS; CAROTID-ARTERY ANEURYSMS; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; SACCULAR ANEURYSMS; PLATINUM COILS; TRIAL ISAT; PART I; MODEL	After coil embolization, recanalization in cerebral aneurysms adversely influences long-term prognosis. Proliferation of endothelial cells on the coil surface may reduce the incidence of recanalization and further improve outcomes after coil embolization. We aimed to map the expression of proliferating tissue over the aneurysmal orifice and define the temporal profile of tissue growth in a swine experimental aneurysm model. We compared the outcomes after spontaneous thrombosis with those of coil embolization using histological and morphological techniques. In aneurysms that we not coiled, spontaneous thrombosis was observed, and weak, easily detachable proliferating tissue was evident in the aneurysmal neck. In contrast, in the coil embolization group, histological analysis showed endothelial-like cells lining the aneurysmal opening. Moreover, immunohistochemical and morphological analysis suggested that these cells were immature endothelial cells. Our results indicated the existence of endothelial cell proliferation 1 week after coil embolization and showed immature endothelial cells in septal tissue between the systemic circulation and the aneurysm. These findings suggest that endothelial cells are lead to and proliferate in the former aneurysmal orifice. This is the first examination to evaluate the temporal change of proliferating tissue in a swine experimental aneurysm model.	[Mitome-Mishima, Yumiko; Yamamoto, Munetaka; Yatomi, Kenji; Arai, Hajime; Oishi, Hidenori] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan; [Oishi, Hidenori] Juntendo Univ, Sch Med, Dept Neuroendovasc Therapy, Tokyo, Japan; [Nonaka, Senshu] Juntendo Univ, Urayasu Hosp, Dept Neurosurg, Chiba, Japan; [Miyamoto, Nobukazu; Urabe, Takao] Juntendo Univ, Urayasu Hosp, Dept Neurol, Chiba, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Mitome-Mishima, Y (corresponding author), Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo 113, Japan.	ymishima@juntendo.ac.jp		Mitome-Mishima, Yumiko/0000-0001-8545-616X				Bouzeghrane F, 2010, AM J NEURORADIOL, V31, P418, DOI 10.3174/ajnr.A1853; Byrne JV, 1997, AM J NEURORADIOL, V18, P29; DAWSON RC, 1995, NEUROSURGERY, V36, P133, DOI 10.1227/00006123-199501000-00017; Dawson RC, 1996, AM J NEURORADIOL, V17, P853; Gallas S, 2009, AM J NEURORADIOL, V30, P1986, DOI 10.3174/ajnr.A1744; GERMAN WJ, 1954, NEW ENGL J MED, V250, P104, DOI 10.1056/NEJM195401212500303; GRAVES VB, 1992, AM J NEURORADIOL, V13, P189; GRAVES VB, 1993, AM J NEURORADIOL, V14, P787; GRAVES VB, 1990, AM J NEURORADIOL, V11, P249; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; Hayakawa M, 2000, J NEUROSURG, V93, P561, DOI 10.3171/jns.2000.93.4.0561; Ishihara S, 2002, AJNR AM J NEURORADIO, V23; Johnston SC, 2001, STROKE, V32, P597, DOI 10.1161/01.STR.32.3.597; Kadirvel R, 2007, AM J NEURORADIOL, V28, P849; Lee D, 2007, J NEUROSURG, V107, P94, DOI 10.3171/JNS-07/07/0094; MASSOUD TF, 1994, NEURORADIOLOGY, V36, P537, DOI 10.1007/BF00593517; MAWAD ME, 1995, AM J NEURORADIOL, V16, P7; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Murayama Y, 1999, AM J NEURORADIOL, V20, P1986; Murayama Y, 1999, AM J NEURORADIOL, V20, P1992; Murayama Y, 1997, NEUROSURGERY, V40, P1233, DOI 10.1097/00006123-199706000-00024; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Szikora I, 1997, AM J NEURORADIOL, V18, P667; Tajiri N, 2012, CURR PHARM DESIGN, V18, P3663, DOI 10.2174/138161212802002724; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Walberer Maureen, 2010, Exp Transl Stroke Med, V2, P22, DOI 10.1186/2040-7378-2-22; Xia WL, 2010, CLIN EXP PHARMACOL P, V37, P253, DOI 10.1111/j.1440-1681.2009.05279.x; Yatomi K, 2012, J NEUROL SURG PART A, V73, P397, DOI 10.1055/s-0032-1322592	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89047	10.1371/journal.pone.0089047	http://dx.doi.org/10.1371/journal.pone.0089047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551215	Green Published, Green Submitted, gold			2022-12-25	WOS:000331271500094
J	Wu, XJ; Zhang, HL; Liu, HY; Xing, YQ; Liu, KD				Wu, Xiujuan; Zhang, Hongliang; Liu, Haiyu; Xing, Yingqi; Liu, Kangding			Microembolic Signals Detected with Transcranial Doppler Sonography Differ between Symptomatic and Asymptomatic Middle Cerebral Artery Stenoses in Northeast China	PLOS ONE			English	Article							ACUTE STROKE PATIENTS; ATHEROSCLEROTIC STENOSIS; OCCLUSIVE DISEASE; ANGIOGRAPHY; ULTRASOUND; EMBOLI	Although microembolus monitoring has been widely used for ischemic cerebrovascular disease, the clinical significance of microembolic signal (MES) in asymptomatic middle cerebral artery (MCA) stenosis remains unclear. We aim to investigate the frequency of MES and the value of MES in predicting ischemic stroke secondary to asymptomatic MCA stenosis. From June 2011 to December 2012, microembolus monitoring was performed in 83 asymptomatic and 126 symptomatic subjects. By comparing the demographics and risk factors between the symptomatic and asymptomatic subjects, we found that the ratio of male sexuality and smoking history differed (101/126 vs 43/83, and 88/126 vs 38/83, respectively, p<0.01). The frequency of MES was significantly higher in the symptomatic group than in the asymptomatic group (49/126 vs 2/108, p<0.01). Specifically, the frequency of MES in the symptomatic and asymptomatic groups with mild stenosis, moderate stenosis, severe stenosis and occlusion groups was 4/18 (22.22%) vs 0/30 (0), 13/31 (41.94%) vs 1/28 (3.57%), 30/62 (48.39%) vs 1/39 (2.56%), 2/15 (13.33%) vs 0/11 (0), respectively. Except for the occlusive group, the frequency of MES is correlated with stenosis degree and symptom. Two patients in the asymptomatic group were found positive for MES, and the MES number was 1 for both. During the one-year follow-up, neither of them developed ischemic stroke. In conclusion, MES detected with TCD differs between symptomatic and asymptomatic MCA stenoses. Due to the low frequency, the value of MES as a predictor of subsequent ischemic stroke in patients with asymptomatic MCA stenosis might be limited.	[Wu, Xiujuan; Zhang, Hongliang; Liu, Haiyu; Xing, Yingqi; Liu, Kangding] Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China	Jilin University	Xing, YQ (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China.	xingyq@sina.com; kangdingliu@163.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559; Xing, Yingqi/0000-0002-7403-5789				Gao S, 2004, STROKE, V35, P2832, DOI 10.1161/01.STR.0000147035.31297.b6; Hao Q, 2010, CEREBROVASC DIS, V29, P424, DOI 10.1159/000289345; Komotar RJ, 2010, WORLD J RADIOL, V2, P166, DOI 10.4329/wjr.v2.i5.166; Kremer C, 2004, J NEUROL NEUROSUR PS, V75, P1300, DOI 10.1136/jnnp.2003.017863; Li ML, 2009, ATHEROSCLEROSIS, V204, P447, DOI 10.1016/j.atherosclerosis.2008.10.019; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Mok VCT, 2009, CEREBROVASC DIS, V28, P18, DOI 10.1159/000215939; Ni J, 2011, J NEUROL SCI, V301, P63, DOI 10.1016/j.jns.2010.10.029; Ritter MA, 2008, J NEUROL, V255, P953, DOI 10.1007/s00415-008-0638-8; ROTHER J, 1994, CEREBROVASC DIS, V4, P273, DOI 10.1159/000108494; Shan G, 2003, J NEUROIMAGING, V13, P124, DOI 10.1177/1051228403251190; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; SPENCER MP, 1990, STROKE, V21, P415, DOI 10.1161/01.STR.21.3.415; Tan TY, 2008, J CLIN ULTRASOUND, V36, P422, DOI 10.1002/jcu.20515; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250; Wong KS, 2001, J NEUROIMAGING, V11, P137, DOI 10.1111/j.1552-6569.2001.tb00023.x; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Wu XJ, 2013, CHINESE MED J-PEKING, V126, P1355, DOI 10.3760/cma.j.issn.0366-6999.20121659; [邢英琦 XING YingQi], 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P1906; Xu WH, 2010, ATHEROSCLEROSIS, V212, P507, DOI 10.1016/j.atherosclerosis.2010.06.035; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899	22	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88986	10.1371/journal.pone.0088986	http://dx.doi.org/10.1371/journal.pone.0088986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551204	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500090
J	Reeksting, BJ; Coetzer, N; Mahomed, W; Engelbrecht, J; van den Berg, N				Reeksting, Bianca J.; Coetzer, Nanette; Mahomed, Waheed; Engelbrecht, Juanita; van den Berg, Noelani			De Novo Sequencing, Assembly, and Analysis of the Root Transcriptome of Persea americana (Mill.) in Response to Phytophthora cinnamomi and Flooding	PLOS ONE			English	Article							HYDROXYPROLINE-RICH GLYCOPROTEINS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; LOW-OXYGEN; SIGNALING PATHWAYS; DIFFERENTIAL EXPRESSION; DEFENSE RESPONSES; MOLECULAR-BIOLOGY; HEMOGLOBIN GENE	Avocado is a diploid angiosperm containing 24 chromosomes with a genome estimated to be around 920 Mb. It is an important fruit crop worldwide but is susceptible to a root rot caused by the ubiquitous oomycete Phytophthora cinnamomi. Phytophthora root rot (PRR) causes damage to the feeder roots of trees, causing necrosis. This leads to branch-dieback and eventual tree death, resulting in severe losses in production. Control strategies are limited and at present an integrated approach involving the use of phosphite, tolerant rootstocks, and proper nursery management has shown the best results. Disease progression of PRR is accelerated under high soil moisture or flooding conditions. In addition, avocado is highly susceptible to flooding, with even short periods of flooding causing significant losses. Despite the commercial importance of avocado, limited genomic resources are available. Next generation sequencing has provided the means to generate sequence data at a relatively low cost, making this an attractive option for non-model organisms such as avocado. The aims of this study were to generate sequence data for the avocado root transcriptome and identify stress-related genes. Tissue was isolated from avocado infected with P. cinnamomi, avocado exposed to flooding and avocado exposed to a combination of these two stresses. Three separate sequencing runs were performed on the Roche 454 platform and produced approximately 124 Mb of data. This was assembled into 7685 contigs, with 106 448 sequences remaining as singletons. Genes involved in defence pathways such as the salicylic acid and jasmonic acid pathways as well as genes associated with the response to low oxygen caused by flooding, were identified. This is the most comprehensive study of transcripts derived from root tissue of avocado to date and will provide a useful resource for future studies.	[Reeksting, Bianca J.; Mahomed, Waheed; van den Berg, Noelani] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Coetzer, Nanette] Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa; [Reeksting, Bianca J.; Coetzer, Nanette; Mahomed, Waheed; Engelbrecht, Juanita; van den Berg, Noelani] Univ Pretoria, Forestry & Agr Biotechnol Inst, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria; University of Pretoria	Reeksting, BJ (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	bjreeksting@gmail.com	van den Berg, Noelani/B-9598-2008; Engelbrecht, Juanita/ABE-2891-2021; Reeksting, Bianca/ABF-8312-2020	van den Berg, Noelani/0000-0001-9574-7331; Engelbrecht, Juanita/0000-0002-4439-1205; Reeksting, Bianca/0000-0003-1219-9574	Technology and Human Resources Programme (THRIP) [TP2011060300010]; National Research Foundation (NRF); Hans Merensky Foundation; Genomics research institute (GRI) at the University of Pretoria	Technology and Human Resources Programme (THRIP); National Research Foundation (NRF); Hans Merensky Foundation; Genomics research institute (GRI) at the University of Pretoria	This work was supported by the Technology and Human Resources Programme (THRIP, grant number TP2011060300010) as an initiative of the National Research Foundation (NRF), the Hans Merensky Foundation, and the Genomics research institute (GRI) at the University of Pretoria. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Acosta-Muniz CH, 2012, PHYSIOL PLANTARUM, V144, P59, DOI 10.1111/j.1399-3054.2011.01522.x; Agarwal S, 2006, CRIT REV PLANT SCI, V25, P1, DOI 10.1080/07352680500365232; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Ben-Ya'acov A., 1995, Horticultural Reviews, V17, P381, DOI 10.1002/9780470650585.ch11; BIALE JB, 1946, AM J BOT, V33, P363, DOI 10.2307/2437124; Bond DM, 2009, PLANT J, V59, P576, DOI 10.1111/j.1365-313X.2009.03891.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen WQJ, 2004, TRENDS PLANT SCI, V9, P591, DOI 10.1016/j.tplants.2004.10.007; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Curtis RHC, 2013, MOL PLANT MICROBE IN, V26, P36, DOI 10.1094/MPMI-05-12-0135-FI; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; DARVAS JM, 1984, PLANT DIS, V68, P691, DOI 10.1094/PD-69-691; de Carvalho JF, 2013, HEREDITY, V110, P181, DOI 10.1038/hdy.2012.76; Deepak S, 2010, J PHYTOPATHOL, V158, P585, DOI 10.1111/j.1439-0434.2010.01669.x; DEMPSEY DA, 1995, B I PASTEUR, V93, P167, DOI 10.1016/0020-2452(96)81488-6; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Dobrowolski MP, 2008, PLANT PATHOL, V57, P928, DOI 10.1111/j.1365-3059.2008.01883.x; Duvenhage J. A., 1994, Yearbook - South African Avocado Growers' Association, V17, P35; Ender F, 2002, PLANT CELL, V14, P1147, DOI 10.1105/tpc.000711; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Garcia-Pineda E, 2010, PLANT SOIL, V331, P45, DOI 10.1007/s11104-009-0225-5; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Halim VA, 2006, PLANT BIOLOGY, V8, P307, DOI 10.1055/s-2006-924025; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Huitema E, 2003, MOL PLANT PATHOL, V4, P487, DOI [10.1046/j.1364-3703.2003.00195.x, 10.1046/J.1364-3703.2003.00195.X]; Hutcheson SW, 1998, ANNU REV PHYTOPATHOL, V36, P59, DOI 10.1146/annurev.phyto.36.1.59; Jacobs KA, 1997, 19 USDA FOR SERV; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; KANELLIS AK, 1989, PLANT PHYSIOL, V90, P259, DOI 10.1104/pp.90.1.259; KANELLIS AK, 1989, PLANT CELL PHYSIOL, V30, P817, DOI 10.1093/oxfordjournals.pcp.a077811; KANELLIS AK, 1991, PLANT PHYSIOL, V96, P269, DOI 10.1104/pp.96.1.269; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Kong P, 2003, PLANT PATHOL, V52, P681, DOI 10.1111/j.1365-3059.2003.00935.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Licausi F, 2011, NEW PHYTOL, V190, P550, DOI 10.1111/j.1469-8137.2010.03562.x; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Loulakakis CA, 2006, POSTHARVEST BIOL TEC, V39, P29, DOI 10.1016/j.postharvbio.2005.09.005; Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nie XZ, 1997, PLANT PHYSIOL, V114, P835, DOI 10.1104/pp.114.3.835; Niggeweg R, 2000, PLANT MOL BIOL, V42, P775, DOI 10.1023/A:1006319113205; O'Kennedy MM, 2011, S AFR J BOT, V77, P335, DOI 10.1016/j.sajb.2010.09.016; Peterson MP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-305; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Prabhu SA, 2012, ACTA BIOCH BIOPH SIN, V44, P415, DOI 10.1093/abbs/gms015; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Robinson LH, 2003, AUSTRALAS PLANT PATH, V32, P53, DOI 10.1071/AP02064; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rookes JE, 2008, PHYSIOL MOL PLANT P, V72, P151, DOI 10.1016/j.pmpp.2008.08.005; Sachs MM, 1996, J EXP BOT, V47, P1, DOI 10.1093/jxb/47.1.1; SIMMONS CR, 1994, CRIT REV PLANT SCI, V13, P325, DOI 10.1080/07352680490484569; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; TAYLOR ER, 1994, PLANT MOL BIOL, V24, P853, DOI 10.1007/BF00014440; Thanseem I, 2005, TREE PHYSIOL, V25, P1361, DOI 10.1093/treephys/25.11.1361; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; VICK BA, 1984, PLANT PHYSIOL, V75, P458, DOI 10.1104/pp.75.2.458; Visser EJW, 2003, ANN BOT-LONDON, V91, P107, DOI 10.1093/aob/mcg014; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; WESTE G, 1983, PHYTOPATHOL Z, V106, P163; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Zentmyer G.A., 1980, PHYTOPHTHORA CINNAMO; ZENTMYER GA, 1984, TROP PEST MANAGE, V30, P388, DOI 10.1080/09670878409370915; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zou XL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-189	79	29	32	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e86399	10.1371/journal.pone.0086399	http://dx.doi.org/10.1371/journal.pone.0086399			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24563685	Green Submitted, Green Published, gold			2022-12-25	WOS:000331254600010
J	Storch, A; Kassubek, J; Tumani, H; Vladimirtsev, VA; Hermann, A; Osakovsky, VL; Baranov, VA; Krivoshapkin, VG; Ludolph, AC				Storch, Alexander; Kassubek, Jan; Tumani, Hayrettin; Vladimirtsev, Vsevolod A.; Hermann, Andreas; Osakovsky, Vladimir L.; Baranov, Vladimir A.; Krivoshapkin, Vadim G.; Ludolph, Albert C.			Communicating Hydrocephalus Following Eosinophilic Meningitis Is Pathogenic for Chronic Viliuisk Encephalomyelitis in Northeastern Siberia	PLOS ONE			English	Article							TOXOCARA-CANIS	Background: Viliuisk encephalomyelitis (VE) is an endemic neurological disease in Northeast Siberia and generally considered to be a chronic encephalomyelitis of unknown origin actually spreading in the Sakha (Yakutian) Republic. Methodology and Principle Findings: In search for the pathophysiology and causative agent of VE, we performed a cross-sectional study on clinical, serological and neuroimaging data on chronic VE patients during two medical expeditions to three villages within the Viliuiski river basin in the Republic of Sakha in 2000 and to the capital Yakutsk in 2006. The severity of the core clinical picture with predominant sensory ataxia, gait apraxia, lower limb spasticity, cognitive impairment and bladder dysfunction correlated with the degree of MRI findings showing enlargement of inner ventricular spaces as in communicating hydrocephalus. Laboratory studies revealed transient eosinophilia during the preceding acute meningitis-like phase, but no ongoing inflammatory process in the CSF. We found immune reactions against Toxocara canis in the majority of chronic VE patients but rarely in controls (P = 0.025; Fisher's exact test). Histological analysis of subacute to subchronic VE brain samples showed eosinophilic infiltrations with no signs of persistent Toxocara canis infection. Conclusions and Significance: Our data showed that pressure by the communicating hydrocephalus as a mechanical factor is the major pathogenic mechanism in chronic VE, most likely triggered by eosinophilic meningitis. There are no signs for an ongoing inflammatory process in chronic VE. The past eosinophilic reaction in VE might be caused by Toxocara ssp. infection and might therefore represent the first hint for an initial cause leading to the development of chronic VE. Our data provide a framework for future studies and potential therapeutic interventions for this enigmatic epidemic neurological disease potentially spreading in Sakha Republic.	[Storch, Alexander; Hermann, Andreas] Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, Dresden, Germany; [Storch, Alexander] German Ctr Neurodegenerat Dis DZNE Dresden, Dresden, Germany; [Kassubek, Jan; Tumani, Hayrettin; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Vladimirtsev, Vsevolod A.; Osakovsky, Vladimir L.; Krivoshapkin, Vadim G.] NEFU, Sci Res Inst Hlth, Yakutsk, Russia; [Baranov, Vladimir A.] Natl Med Ctr Yakutia, Dept Radiol, Yakutsk, Russia	Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Ulm University	Storch, A (corresponding author), Tech Univ Dresden, Dept Neurol, Div Neurodegenerat Dis, Dresden, Germany.	alexander.storch@neuro.med.tu-dresden.de; albert.ludolph@uni-ulm.de	Hermann, Andreas/D-4213-2017; Vladimirtsev, Vsevolod/H-1470-2019; Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/F-2774-2015; Kassubek, Jan/O-1740-2019; Osakovskij, Vladimir L./A-7843-2014; Krivoshapkin, Vadim/AAX-9511-2021	Hermann, Andreas/0000-0002-7364-7791; Vladimirtsev, Vsevolod/0000-0002-5480-3592; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Osakovskij, Vladimir L./0000-0001-9529-2488; Krivoshapkin, Vadim/0000-0002-8960-3283	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) to AS and ACL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartschi E, 2004, INFECTION, V32, P116, DOI 10.1007/s15010-004-3028-x; Ceianu C, 2008, CLIN VACCINE IMMUNOL, V15, P1749, DOI 10.1128/CVI.00275-08; Fillaux J, 2013, VET PARASITOL, V193, P327, DOI 10.1016/j.vetpar.2012.12.028; Finsterer Josef, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P279, DOI 10.1590/S0036-46652007000500002; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Goffette S, 2000, EUR J NEUROL, V7, P703, DOI 10.1046/j.1468-1331.2000.00123.x; Goldfarb LG, 2009, FOLIA NEUROPATHOL, V47, P171; GOLDFARB LG, 1992, BRAIN, V115, P961, DOI 10.1093/brain/115.4.961; Green AJE, 2003, J NEUROL SCI, V212, P69, DOI 10.1016/S0022-510X(03)00107-2; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lee HS, 2010, EPIDEMIOLOGY, V21, P24, DOI 10.1097/EDE.0b013e3181c30fd2; Lemieux L, 1998, Med Image Anal, V2, P227, DOI 10.1016/S1361-8415(98)80021-2; Lo Re III V, 2003, AM J MED, V114, P217, DOI 10.1016/S0002-9343(02)01495-X; Maak RL, 1887, VILIUISK AREA IAKUTS; Magnaval JF, 2011, VECTOR-BORNE ZOONOT, V11, P157, DOI 10.1089/vbz.2009.0105; McLean CA, 1997, NEUROPATH APPL NEURO, V23, P212, DOI 10.1046/j.1365-2990.1997.9098090.x; Moreira-Silva Sandra F., 2004, Rev. Soc. Bras. Med. Trop., V37, P169, DOI 10.1590/S0037-86822004000200011; Ota S, 1994, Rinsho Shinkeigaku, V34, P1148; Pinelli E, 2013, VET PARASITOL, V193, P337, DOI 10.1016/j.vetpar.2012.12.029; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Smith RR, 2000, NEUROIMAGING, P585; Stone R, 2002, SCIENCE, V296, P642, DOI 10.1126/science.296.5568.642; Storch A, 2008, NEUROL SCI, V29, P11, DOI 10.1007/s10072-008-0852-2; Taslowa R, 1982, PSYCHOL DISORDERS TY; Vidal JE, 2003, AM J TROP MED HYG, V69, P341, DOI 10.4269/ajtmh.2003.69.341; Xinou E, 2003, AM J NEURORADIOL, V24, P714	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e84670	10.1371/journal.pone.0084670	http://dx.doi.org/10.1371/journal.pone.0084670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586232	Green Published, Green Submitted, gold			2022-12-25	WOS:000332396200005
J	Cheng, Y; Liu, Y; Wu, B; Zhang, JZ; Gu, J; Liao, YL; Wang, FK; Mao, XH; Yu, XJ				Cheng, Yan; Liu, Yan; Wu, Bin; Zhang, Jian-zhi; Gu, Jiang; Liao, Ya-ling; Wang, Fu-kun; Mao, Xu-hu; Yu, Xue-jie			Proteomic Analysis of the Ehrlichia chaffeensis Phagosome in Cultured DH82 Cells	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; MYCOBACTERIUM-TUBERCULOSIS; LEGIONELLA-PNEUMOPHILA; ENDOPLASMIC-RETICULUM; CROSS-PRESENTATION; MEMBRANE-PROTEINS; APOPTOTIC CELLS; VACUOLAR SYSTEM; MATURATION; MACROPHAGES	Ehrlichia chaffeensis is an obligately intracellular bacterium that resides and multiplies within cytoplasmic vacuoles of phagocytes. The Ehrlichia-containing vacuole (ECV) does not fuse with lysosomes, an essential condition for Ehrlichia to survive inside phagocytes, but the mechanism of inhibiting the fusion of the phagosome with lysosomes is not clear. Understanding the ECV molecular composition may decipher the mechanism by which Ehrlichia inhibits phagosomelysosome fusion. In this study, we obtained highly purified ECVs from E. chaffeensis-infected DH82 cells by sucrose density gradient centrifugation and analyzed their composition by mass spectrometry-based proteomics. The ECV composition was compared with that of phagolysosomes containing latex beads. Lysosomal proteins such as cathepsin D, cathepsin S, and lysosomal acid phosphatase were not detected in E. chaffeensis phagosome preparations. Some small GTPases, involved in membrane dynamics and phagocytic trafficking, were detected in ECVs. A notable finding was that Rab7, a late endosomal marker, was consistently detected in E. chaffeensis phagosomes by mass spectrometry. Confocal microscopy confirmed that E. chaffeensis phagosomes contained Rab7 and were acidified at approximately pH 5.2, suggesting that the E. chaffeensis vacuole was an acidified late endosomal compartment. Our results also demonstrated by mass spectrometry and immunofluorescence analysis that Ehrlichia morulae were not associated with the autophagic pathway. Ehrlichia chaffeensis did not inhibit phagosomes containing latex beads from fusing with lysosomes in infected cells. We concluded that the E. chaffeensis vacuole was a late endosome and E. chaffeensis might inhibit phagosome-lysosome fusion by modifying its vacuolar membrane composition, rather than by regulating the expression of host genes involved in trafficking.	[Cheng, Yan; Gu, Jiang; Liao, Ya-ling; Mao, Xu-hu] Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Cheng, Yan; Liu, Yan; Wu, Bin; Yu, Xue-jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Cheng, Yan; Wang, Fu-kun] Bethune Int Peace Hosp, Shijiazhuang, Peoples R China; [Liu, Yan] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wu, Bin] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Zhang, Jian-zhi] Univ Texas Med Branch, Sch Hlth Profess, Galveston, TX 77555 USA; [Yu, Xue-jie] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China	Army Medical University; University of Texas System; University of Texas Medical Branch Galveston; Jiangsu Provincial Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston; Shandong University	Mao, XH (corresponding author), Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.	maoxh2012@hotmail.com; xuyu@UTMB.EDU	Gu, Jiang/AAT-2432-2021; Yu, Xuejie/AAP-9246-2021	Gu, Jiang/0000-0001-8035-4551; 	National Institute of Allergy and Infectious Disease [AI31431]; Natural Science Foundation of China [31200142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI031431, R01AI031431] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institute of Allergy and Infectious Disease (AI31431) and by a grant from Natural Science Foundation of China (31200142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Barnewall RE, 1997, INFECT IMMUN, V65, P1455, DOI 10.1128/IAI.65.4.1455-1461.1997; Bottger G, 1996, J BIOL CHEM, V271, P29191, DOI 10.1074/jbc.271.46.29191; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cardoso CM, TRAFFIC, V11, P221; Chong A, 2009, INFECT IMMUN, V77, P4724, DOI 10.1128/IAI.00150-09; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000; Defacque H, 2000, EMBO J, V19, P199, DOI 10.1093/emboj/19.2.199; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Giodini A, 2009, P NATL ACAD SCI USA, V106, P3324, DOI 10.1073/pnas.0813305106; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Lee BY, MOL CELL PROTEOMICS, V9, P32; Liu Y, 2011, MICROBES INFECT, V13, P232, DOI 10.1016/j.micinf.2010.10.021; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; May RC, 2001, J CELL SCI, V114, P1061; Mott J, 1999, INFECT IMMUN, V67, P1368, DOI 10.1128/IAI.67.3.1368-1378.1999; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; MULLER WA, 1980, J CELL BIOL, V86, P292, DOI 10.1083/jcb.86.1.292; MULLER WA, 1980, J CELL BIOL, V86, P304, DOI 10.1083/jcb.86.1.304; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; PIZON V, 1994, J CELL SCI, V107, P1661; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Robinson MS, 1996, CELL, V84, P13, DOI 10.1016/S0092-8674(00)80988-5; Rupper Adam, 2008, V445, P339, DOI 10.1007/978-1-59745-157-4_22; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; Tisdale EJ, 1999, MOL BIOL CELL, V10, P1837, DOI 10.1091/mbc.10.6.1837; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Walker DH, 1997, LAB INVEST, V76, P129	55	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88461	10.1371/journal.pone.0088461	http://dx.doi.org/10.1371/journal.pone.0088461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558391	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700037
J	Ippolito, JE; Piwnica-Worms, D				Ippolito, Joseph E.; Piwnica-Worms, David			A Fluorescence-Coupled Assay for Gamma Aminobutyric Acid (GABA) Reveals Metabolic Stress-Induced Modulation of GABA Content in Neuroendocrine Cancer	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; INTRACELLULAR PH; EXTRACELLULAR PH; SKELETAL-MUSCLE; L-GLUTAMATE; PROSTATE; DIFFERENTIATION; EXPRESSION; GROWTH; QUANTIFICATION	Pathways involved in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA) have been implicated in the pathogenesis of high grade neuroendocrine (NE) neoplasms as well as neoplasms from a non-NE lineage. Using The Cancer Genome Atlas, overexpression of the GABA synthetic enzyme, glutamate decarboxylase 1 (GAD1), was found to be associated with decreased disease free-survival in prostate adenocarcinoma and decreased overall survival in clear cell renal cell carcinomas. Furthermore, GAD1 was found to be expressed in castrate-resistant prostate cancer cell lines, but not androgen-responsive cell lines. Using a novel fluorescence-coupled enzymatic microplate assay for GABA mediated through reduction of resazurin in a prostate neuroendocrine carcinoma (PNEC) cell line, acid microenvironment-induced stress increased GABA levels while alkaline microenvironment-induced stress decreased GABA through modulation of GAD1 and glutamine synthetase (GLUL) activities. Moreover, glutamine but not glucose deprivation decreased GABA through modulation of GLUL. Consistent with evidence in prokaryotic and eukaryotic organisms that GABA synthesis mediated through GAD1 may play a crucial role in surviving stress, GABA may be an important mediator of stress survival in neoplasms. These findings identify GABA synthesis and metabolism as a potentially important pathway for regulating cancer cell stress response as well as a potential target for therapeutic strategies.	[Ippolito, Joseph E.; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO USA; [Ippolito, Joseph E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Ippolito, JE (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.	ippolitoj@mir.wustl.edu; dpiwnica-worms@mdanderson.org			Radiological Society of North America [RR1031]; National Institutes of Health [P50 CA94056]; Siteman Cancer Center [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842, P50CA094056] Funding Source: NIH RePORTER	Radiological Society of North America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the Radiological Society of North America (RR1031; http://www.rsna.org) and the National Institutes of Health (P50 CA94056). The HTS core is supported in part by a grant to the Siteman Cancer Center (P30 CA091842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, PROSTATE, V39, P135, DOI 10.1002/(SICI)1097-0045(19990501)39:2<135::AID-PROS9>3.0.CO;2-S; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Azuma H, 2003, CANCER RES, V63, P8090; Babin E, 2006, J LARYNGOL OTOL, V120, P289, DOI 10.1017/S0022215106000594; Bacac M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000032; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P109, DOI 10.1677/erc.1.00876; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman J, 1999, ANAL CHIM ACTA, V402, P47, DOI 10.1016/S0003-2670(99)00533-4; Cheville JC, 2002, CANCER-AM CANCER SOC, V95, P1028, DOI 10.1002/cncr.10788; CORREA JG, 1993, FREE RADICAL RES COM, V19, P303, DOI 10.3109/10715769309056519; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLellis R A, 2001, Am J Clin Pathol, V115 Suppl, pS5; Demellawy Dina El, 2006, Ann Diagn Pathol, V10, P162, DOI 10.1016/j.anndiagpath.2005.09.008; diSantAgnese PA, 1996, CANCER, V78, P357, DOI 10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U; DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287; Edwards LJ, 1998, MOL REPROD DEV, V50, P434, DOI 10.1002/(SICI)1098-2795(199808)50:4<434::AID-MRD7>3.3.CO;2-S; Feehily C, 2012, J APPL MICROBIOL; Feehily C, 2012, APPL ENV MICROBIOL; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gillies R. J., 2013, CANC RES; Hashim AI, 2011, CLIN EXP METASTAS, V28, P841, DOI 10.1007/s10585-011-9415-7; Hausler RE, 2000, ANAL BIOCHEM, V281, P1, DOI 10.1006/abio.2000.4556; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Hu Y, 2002, J BIOL CHEM, V11, P11; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Ippolito JE, 2006, P NATL ACAD SCI USA, V103, P12505, DOI 10.1073/pnas.0605207103; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; Kobayashi S, 2001, J NEUROCHEM, V76, P1935, DOI 10.1046/j.1471-4159.2001.00214.x; KOVACEVIC Z, 1971, BIOCHEM J, V125, P757, DOI 10.1042/bj1250757; Kwan YW, 1996, BRIT J PHARMACOL, V118, P755, DOI 10.1111/j.1476-5381.1996.tb15464.x; Liu Y, 2008, WORLD J GASTROENTERO, V14, P7175, DOI 10.3748/wjg.14.7175; LOSCHER W, 1980, N-S ARCH PHARMACOL, V315, P119, DOI 10.1007/BF00499254; Madry C, 2008, P NATL ACAD SCI USA, V105, P12563, DOI 10.1073/pnas.0805624105; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; MILLER RE, 1978, P NATL ACAD SCI USA, V75, P1418, DOI 10.1073/pnas.75.3.1418; Montie JE, 2006, J UROLOGY, V175, P2070; Naves T, 2013, BIOCH PHARM; O'Byrne CP, 2011, J MICROBIOL METH, V84, P137, DOI 10.1016/j.mimet.2010.10.017; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PASSONEAU JV, 1993, ENZYMATIC ANAL PRACT; PUSATERI ME, 1984, J NEUROCHEM, V42, P1269, DOI 10.1111/j.1471-4159.1984.tb02782.x; Quek ML, 2006, UROLOGY, V67, P1247, DOI 10.1016/j.urology.2005.12.009; Roberts SS, 2009, PATHOL ONCOL RES, V15, P645, DOI 10.1007/s12253-009-9165-x; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Saxena S, 2012, TOXICOL APPL PHARM, V264, P324, DOI 10.1016/j.taap.2012.08.033; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; Shinji S, 2006, INT J ONCOL, V29, P357; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Sorensen Morten, 1998, Current Opinion in Oncology, V10, P133, DOI 10.1097/00001622-199803000-00009; Takayama N, 2012, ANAL BIOCHEM, V425, P114, DOI 10.1016/j.ab.2012.03.011; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tretter L, 2000, J NEUROSCI, V20, P8972; Tsunoda S, 2005, INT J GYNECOL CANCER, V15, P295, DOI 10.1111/j.1525-1438.2005.15219.x; Valero E, 2004, BIOPHYS J, V86, P3598, DOI 10.1529/biophysj.103.035956; Vermeir S, 2007, J AGR FOOD CHEM, V55, P3240, DOI 10.1021/jf0637022; Wafa LA, 2007, HUM PATHOL, V38, P161, DOI 10.1016/j.humpath.2006.07.003; Wick MR, 2000, AM J CLIN PATHOL, V113, P331, DOI 10.1309/ETJ3-QBUK-13QD-J8FP; WICK MR, 2002, CURR DIAGN PATHOL, V8, P102, DOI DOI 10.1054/CDIP.2001.0102; WOLF R, 1991, ANAL BIOCHEM, V192, P78, DOI 10.1016/0003-2697(91)90187-X; Xue QW, 2013, CHEM COMMUN, V49, P2640, DOI 10.1039/c3cc39064k; Yamamoto N, 2006, ANAL BIOCHEM, V351, P139, DOI 10.1016/j.ab.2005.12.011; Yao JL, 2006, AM J SURG PATHOL, V30, P705, DOI 10.1097/00000478-200606000-00005; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009; Zhu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047584	79	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88667	10.1371/journal.pone.0088667	http://dx.doi.org/10.1371/journal.pone.0088667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551133	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000053
J	Proenca-Ferreira, R; Brugnerotto, AF; Garrido, VT; Dominical, VM; Vital, DM; Ribeiro, MDR; dos Santos, ME; Traina, F; Olalla-Saad, ST; Costa, FF; Conran, N				Proenca-Ferreira, Renata; Brugnerotto, Ana Flavia; Garrido, Vanessa Tonin; Dominical, Venina Marcela; Vital, Daiana Morelli; Reis Ribeiro, Marilene de Fatima; dos Santos, Melissa Ercolin; Traina, Fabiola; Olalla-Saad, Sara T.; Costa, Fernando Ferreira; Conran, Nicola			Endothelial Activation by Platelets from Sickle Cell Anemia Patients	PLOS ONE			English	Article							KAPPA-B; POTENTIAL ROLE; STEADY-STATE; DISEASE; MONOCYTES; PLASMA; PATHOPHYSIOLOGY; VASOOCCLUSION; EPTIFIBATIDE; COAGULATION	Sickle cell anemia (SCA) is associated with a hypercoagulable state. Increased platelet activation is reported in SCA and SCA platelets may present augmented adhesion to the vascular endothelium, potentially contributing to the vaso-occlusive process. We sought to observe the effects of platelets (PLTs) from healthy control (CON) individuals and SCA individuals on endothelial activation, in vitro. Human umbilical vein endothelial cells (HUVEC) were cultured, in the presence, or not, of washed PLTs from CON or steady-state SCA individuals. Supernatants were reserved for cytokine quantification, and endothelial adhesion molecules (EAM) were analyzed by flow cytometry; gene expressions of ICAM1 and genes of the NF-kappa B pathway were analyzed by qPCR. SCA PLTs were found to be more inflammatory, displaying increased adhesive properties, an increased production of IL-1 beta and a tendency towards elevated expressions of P-selectin and activated alpha(IIbb)beta(3). Following culture in the presence of SCA PLTs, HUVEC presented significant augmentations in the expressions of the EAM, ICAM-1 and E-selectin, as well as increased IL-8 production and increased ICAM1 and NFKB1 (encodes p50 subunit of NF-kappa B) gene expressions. Interestingly, transwell inserts abolished the effects of SCA PLTs on EAM expression. Furthermore, an inhibitor of the NF-kappa B pathway, BAY 11-7082, also prevented the induction of EAM expression on the HUVEC surface by SCA PLTs. In conclusion, we find further evidence to indicate that platelets circulate in an activated state in sickle cell disease and are capable of stimulating endothelial cell activation. This effect appears to be mediated by direct contact, or even adhesion, between the platelets and endothelial cells and via NF kappa B-dependent signaling. As such, activated platelets in SCD may contribute to endothelial activation and, therefore, to the vaso-occlusive process. Results provide further evidence to support the use of anti-platelet approaches in association with other therapies for SCD.	[Proenca-Ferreira, Renata; Brugnerotto, Ana Flavia; Garrido, Vanessa Tonin; Dominical, Venina Marcela; Vital, Daiana Morelli; Traina, Fabiola; Olalla-Saad, Sara T.; Costa, Fernando Ferreira; Conran, Nicola] Univ Campinas UNICAMP, Sch Med, INCT Sangue, Haematol & Haemotherapy Ctr, Campinas, SP, Brazil; [Reis Ribeiro, Marilene de Fatima; dos Santos, Melissa Ercolin] Childrens Ctr Hematol Invest, Campinas, SP, Brazil; [Traina, Fabiola] Univ Sao Paulo, Riberao Preto Med Sch, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Conran, N (corresponding author), Univ Campinas UNICAMP, Sch Med, INCT Sangue, Haematol & Haemotherapy Ctr, Campinas, SP, Brazil.	conran@unicamp.br	Conran, Nicola/B-8961-2012; Costa, Fernando F/D-1566-2012; Traina, Fabiola/U-1451-2019; Traina, Fabiola/L-3809-2014; CTC USP, CEPID 13 18/J-8951-2014	Conran, Nicola/0000-0001-5726-7919; Costa, Fernando F/0000-0002-4632-572X; Traina, Fabiola/0000-0003-4258-289X; Traina, Fabiola/0000-0003-4258-289X; CTC USP, CEPID 13 18/0000-0002-7123-9524	FAPESP [2008/57441-0, 2009/54279-0]; CNPq; INCT do Sangue	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT do Sangue	This work was supported by FAPESP (grants 2008/57441-0 and 2009/54279-0), CNPq, and INCT do Sangue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Browne PV, 1996, AM J HEMATOL, V51, P296, DOI 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R; CHAPLIN H, 1980, THROMB HAEMOSTASIS, V43, P218; CHAPLIN H JR, 1989, East African Medical Journal, V66, P574; Charneski L, 2010, AM J HEALTH-SYST PH, V67, P895, DOI 10.2146/ajhp090229; Colella MP, 2012, J THROMB HAEMOST, V10, P1967, DOI 10.1111/j.1538-7836.2012.04861.x; Conran N, 2009, HEMOGLOBIN, V33, P1, DOI 10.1080/03630260802625709; Desai PC, 2013, THROMB RES, V132, P341, DOI 10.1016/j.thromres.2013.08.002; Epinat JC, 1999, ONCOGENE, V18, P6896, DOI 10.1038/sj.onc.1203218; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; FRANCIS RB, 1989, HAEMOSTASIS, V19, P105; Garrido VT, 2012, BRIT J HAEMATOL, V158, P788, DOI 10.1111/j.1365-2141.2012.09218.x; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Jakubowski JA, 2013, BRIT J CLIN PHARMACO, V75, P1433, DOI 10.1111/bcp.12042; KENNY MW, 1980, J CLIN PATHOL, V33, P622, DOI 10.1136/jcp.33.7.622; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Lee SP, 2007, BRIT J HAEMATOL, V139, P612, DOI 10.1111/j.1365-2141.2007.06787.x; Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2; MEHTA P, 1980, J PEDIATR-US, V96, P209, DOI 10.1016/S0022-3476(80)80804-3; Noubouossie DC, 2013, EUR J HAEMATOL; Novelli EM, 2012, AM J HEMATOL, V87, P326, DOI 10.1002/ajh.22274; OSAMO NO, 1981, ACTA HAEMATOL-BASEL, V66, P102, DOI 10.1159/000207105; PETERS M, 1994, THROMB HAEMOSTASIS, V71, P169; Polanowska-Grabowska R, 2010, ARTERIOSCL THROM VAS, V30, P2392, DOI 10.1161/ATVBAHA.110.211615; Proenca-Ferreira R, 2010, BRIT J HAEMATOL, V149, P280, DOI 10.1111/j.1365-2141.2010.08087.x; Sakamoto TM, 2013, CLIN BIOCH; Setty BNY, 2012, BRIT J HAEMATOL, V157, P370, DOI 10.1111/j.1365-2141.2012.09065.x; Setty BNY, 2001, BLOOD, V98, P3228, DOI 10.1182/blood.V98.12.3228; Setty BNY, 2000, BLOOD, V96, P1119, DOI 10.1182/blood.V96.3.1119; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; Sparkenbaugh E, 2013, BR J HAEMATOL; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Stuart MJ, 2001, PEDIATR PATHOL MOL M, V20, P27, DOI 10.1080/15513810109168816; Tomer A, 2004, J BIOL REG HOMEOS AG, V18, P172; Tomer A, 2001, J LAB CLIN MED, V137, P398, DOI 10.1067/mlc.2001.115450; TRIADOU P, 1990, NOUV REV FR HEMATOL, V32, P137; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Wun T, 1997, J LAB CLIN MED, V129, P507, DOI 10.1016/S0022-2143(97)90005-6; Wun T, 1998, BRIT J HAEMATOL, V100, P741, DOI 10.1046/j.1365-2141.1998.00627.x; Wun T, 2002, CLIN LAB HAEMATOL, V24, P81; Wun T, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-17	43	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89012	10.1371/journal.pone.0089012	http://dx.doi.org/10.1371/journal.pone.0089012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551209	Green Published, gold, Green Submitted			2022-12-25	WOS:000331266000090
J	Wu, L; Fu, ZH; Zhou, SJ; Gong, JP; Liu, CA; Qiao, ZR; Li, SW				Wu, Lun; Fu, Zhihao; Zhou, Shiji; Gong, Jianping; Liu, Chang An; Qiao, Zhengrong; Li, Shengwei			HIF-1 alpha and HIF-2 alpha: Siblings in Promoting Angiogenesis of Residual Hepatocellular Carcinoma after High-Intensity Focused Ultrasound Ablation	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; RADIOFREQUENCY ABLATION; VASCULOGENIC MIMICRY; EPHA2 OVEREXPRESSION; TUMOR ANGIOGENESIS; HYPOXIA; EXPRESSION; MECHANISMS; VEGF	Background: High-intensity focused ultrasound (HIFU) is a widely applied to treatment for unresectable hepatocellular carcinoma. However, insufficient HIFU can result in rapid progression of the residual tumor. The mechanism of such rapid growth of the residual tumor after HIFU ablation is poorly understood. Objective: The aim of this study was to investigate the dynamic angiogenesis of residual tumor, and the temporal effect and mechanism of the HIF-1, 2 alpha in the residual tumor angiogenesis. Methods: Xenograft tumors of HepG2 cells were created by subcutaneously inoculating nude mice (athymic BALB/c nu/nu mice) with hepatoma cells. About thirty days after inoculation, all mice (except control group) were treated by HIFU and assigned randomly to 7 groups according to various time intervals (1st, 3rd, 5th day (d) and 1st, 2nd, 3rd, 4th week (w)). The residual tumor tissues were obtained from the experimental groups at various time points. Protein levels of HIF-1 alpha, HIF-2 alpha, VEGF-A, and EphA2 were quantified by immunohistochemistry analysis and Western Blot assays, and mRNA levels measured by Q-PCR. Microvascular density was calculated with counting of CD31 positive vascular endothelial cells by immunohistochemical staining. Results: Compared with the control group, protein and mRNA levels of HIF-1 alpha reached their highest levels on the 3rd day (P<0.01), then decreased (P<0.05). HIF-2 alpha expression reached its highest level on the 2nd week compared with control group (P<0.01), then decreased (2w-4w) (P<0.05). The protein and mRNA levels of VEGF-A and EphA2 in the residual tumor tissues group that received HIFU were significantly decreased until 1 week compared with the control group (P<0.01). However, the levels increased compared to controls in 2-4 weeks (P<0.05). Similar results were obtained for MVD expression (P<0.05). Conclusion: Insufficient HIFU ablation promotes the angiogenesis in residual carcinoma tissue over time. The data indicate that the HIF-1, 2 alpha/VEGFA/EphA2 pathway is involved.	[Wu, Lun; Fu, Zhihao; Gong, Jianping; Liu, Chang An; Li, Shengwei] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing Key Lab Hepatobiliary Surg, Chongqing, Peoples R China; [Zhou, Shiji] Chongqing Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Qiao, Zhengrong] Peoples Five Hosp Chongqing, Dept Gen Surg, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Li, SW (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Chongqing Key Lab Hepatobiliary Surg, Chongqing, Peoples R China.	lishengwei11@163.com	周, 世骥/AIA-4309-2022		National Natural Scientific Foundation of China [81272570]; Municipal Health Burean Science Foundation of Chongqing [2012-1-040, 2010-1-68]; National Natural Science Fund for Young [81301975]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Health Burean Science Foundation of Chongqing; National Natural Science Fund for Young	This research was supported by National Natural Scientific Foundation of China (No. 81272570), Municipal Health Burean Science Foundation of Chongqing (2012-1-040, 2010-1-68), and National Natural Science Fund for Young (81301975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2012, J BIOL CHEM, V287, P1962, DOI 10.1074/jbc.M111.305615; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chan ACY, 2013, ANN SURG, V257, P686, DOI 10.1097/SLA.0b013e3182822c02; Chen DL, 2003, J BIOL CHEM, V278, P13595, DOI 10.1074/jbc.C200694200; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheng N, 2003, NEOPLASIA, V5, P445, DOI 10.1016/S1476-5586(03)80047-7; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fan YZ, 2010, WORLD J GASTRO SURG, V2, P117, DOI 10.4240/wjgs.v2.i4.117; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He CJ, 2012, CANCER SCI, V103, P528, DOI 10.1111/j.1349-7006.2011.02177.x; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Jin-Lu M, 2011, BIOCHEM BIOPH RES CO, V408, P686, DOI 10.1016/j.bbrc.2011.04.089; Kaseb AO, 2009, CANCER-AM CANCER SOC, V115, P4895, DOI 10.1002/cncr.24537; Ke S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-73; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kong J, 2012, PLOS ONE, V7; Lu C, 2008, CANCER BIOL THER, V7, P1098, DOI 10.4161/cbt.7.7.6168; Merritt WM, 2010, CANCER BIOL THER, V10, P1306, DOI 10.4161/cbt.10.12.13582; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pan Y, 2004, ONCOGENE, V23, P4975, DOI 10.1038/sj.onc.1207657; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Sun BC, 2007, CANCER LETT, V249, P188, DOI 10.1016/j.canlet.2006.08.016; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; VECCHIETTI V, 1979, FARMACO-ED SCI, V34, P829; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; [王璐 Wang Lu], 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P314; Xiang ZL, 2011, CLIN CANCER RES, V17, P5463, DOI 10.1158/1078-0432.CCR-10-3096; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhou HB, 2011, JPN J RADIOL, V29, P615, DOI 10.1007/s11604-011-0603-9; Zhou JW, 2010, J OBSTET GYNAECOL RE, V36, P232, DOI 10.1111/j.1447-0756.2010.01196.x; Zhu GQ, 2010, CLIN CANCER RES, V16, P4732, DOI 10.1158/1078-0432.CCR-10-1408; Zhu H, 2011, CANCER BIOL THER, V11, P981, DOI 10.4161/cbt.11.11.15707	46	20	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88913	10.1371/journal.pone.0088913	http://dx.doi.org/10.1371/journal.pone.0088913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551189	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000082
J	Siller, M; Goyal, S; Yoshimoto, FK; Xiao, Y; Wei, SZ; Guengerich, FP				Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K.; Xiao, Yi; Wei, Shouzou; Guengerich, F. Peter			Oxidation of Endogenous N-Arachidonoylserotonin by Human Cytochrome P450 2U1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Cytochrome P450; Eicosanoid; Lipid Oxidation; Mass Spectrometry (MS)	FATTY-ACID HYDROXYLATION; MASS-SPECTROMETRY DATA; OMEGA-HYDROXYLATION; DRUG-METABOLISM; IDENTIFICATION; ENZYMES; PROTEINS; EXPRESSION; PURIFICATION; ELUCIDATION	Background: Cytochrome P450 (P450, CYP) 2U1 is an orphan enzyme, only reported to catalyze some fatty acid oxidations. Results: Metabolomic screening led to the identification of N-arachidonoylserotonin as a substrate. Conclusion: P450 2U1 catalyzes oxygenation at C-2 of the indole ring. Significance: The localization of P450 2U1 and its metabolism of an inhibitor of fatty acid amide hydrolase may indicate a function in brain. Cytochrome P450 (P450) 2U1 has been shown to be expressed, at the mRNA level, in human thymus, brain, and several other tissues. Recombinant P450 2U1 was purified and used as a reagent in a metabolomic search for substrates in bovine brain. In addition to fatty acid oxidation reactions, an oxidation of endogenous N-arachidonoylserotonin was characterized. Subsequent NMR and mass spectrometry and chemical synthesis showed that the main product was the result of C-2 oxidation of the indole ring, in contrast to other human P450s that generated different products. N-Arachidonoylserotonin, first synthesized chemically and described as an inhibitor of fatty acid amide hydrolase, had previously been found in porcine and mouse intestine; we demonstrated its presence in bovine and human brain samples. The product (2-oxo) was 4-fold less active than N-arachidonoylserotonin in inhibiting fatty acid amide hydrolase. The rate of oxidation of N-arachidonoylserotonin was similar to that of arachidonic acid, one of the previously identified fatty acid substrates of P450 2U1. The demonstration of the oxidation of N-arachidonoylserotonin by P450 2U1 suggests a possible role in human brain and possibly other sites.	[Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K.; Xiao, Yi; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K.; Xiao, Yi; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Siller, Michal] Palacky Univ, Inst Mol & Translat Med, Div Pharmacol & Toxicol, Olomouc 77515, Czech Republic	Vanderbilt University; Vanderbilt University; Palacky University Olomouc	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	GOYAL, SANDEEP/I-2773-2019	GOYAL, SANDEEP/0000-0002-7011-8886; Yoshimoto, Francis/0000-0002-2308-2999	United States Public Health Service [R37 CA090426, P30 ES000267]; Czech Republic [CZ.1.05/2.1.00/01.0030, CZ.1.07/2.4.00/17.0015]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Czech Republic(Czech Republic Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by United States Public Health Service Grants R37 CA090426 and P30 ES000267 and Czech Republic Projects CZ.1.05/2.1.00/01.0030 (Biomedicine for Development and Human Resources) and CZ.1.07/2.4.00/17.0015 (TransMedChem).	Bisogno T, 1998, BIOCHEM BIOPH RES CO, V248, P515, DOI 10.1006/bbrc.1998.8874; BODDUPALLI SS, 1992, ARCH BIOCHEM BIOPHYS, V292, P20, DOI 10.1016/0003-9861(92)90045-X; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Dierks EA, 1998, J BIOL CHEM, V273, P23055, DOI 10.1074/jbc.273.36.23055; Dong MS, 1996, ARCH BIOCHEM BIOPHYS, V327, P11, DOI 10.1006/abbi.1996.0086; Dong MS, 1996, BIOCHEMISTRY-US, V35, P10031, DOI 10.1021/bi960873z; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Gilmore AJ, 2012, BRIT J PHARMACOL, V167, P1076, DOI 10.1111/j.1476-5381.2012.02047.x; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; Guengerich FP, 2010, MOL INTERV, V10, P153, DOI 10.1124/mi.10.3.6; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1978, BIOCHEMISTRY-US, V17, P3633, DOI 10.1021/bi00610a033; Guengerich FP, 1996, CRIT REV TOXICOL, V26, P551, DOI 10.3109/10408449609037477; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jakoby W. B., 1980, ENZYMATIC BASIS DETO, V1, P1; Jarrar YB, 2013, PROSTAG LEUKOTR ESS, V89, P227, DOI 10.1016/j.plefa.2013.06.008; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; JONES P, 1968, BIOCHEM J, V110, P617, DOI 10.1042/bj1100617; Karlgren M, 2004, BIOCHEM BIOPH RES CO, V315, P679, DOI 10.1016/j.bbrc.2004.01.110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; LU AYH, 1968, J BIOL CHEM, V243, P1331; Ma XC, 2005, DRUG METAB DISPOS, V33, P489, DOI 10.1124/dmd.104.002410; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; MEINNEL T, 1993, BIOCHIMIE, V75, P1061, DOI 10.1016/0300-9084(93)90005-D; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanchez-Ponce R, 2007, ANAL CHEM, V79, P3355, DOI 10.1021/ac0622781; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tang ZM, 2009, ANAL CHEM, V81, P3071, DOI 10.1021/ac900021a; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Verhoeckx KCM, 2011, BBA-MOL CELL BIOL L, V1811, P578, DOI 10.1016/j.bbalip.2011.07.008; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; Wu ZL, 2009, BIOTECHNOL LETT, V31, P1589, DOI 10.1007/s10529-009-0059-5; Xiao Y, 2012, J LIPID RES, V53, P1610, DOI 10.1194/jlr.M027185; Yoo JM, 2013, INT IMMUNOPHARMACOL, V17, P123, DOI 10.1016/j.intimp.2013.05.013	61	22	24	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10476	10487		10.1074/jbc.M114.550004	http://dx.doi.org/10.1074/jbc.M114.550004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563460	Green Published, hybrid			2022-12-25	WOS:000334226400021
J	Simon, C; Klose, T; Herbst, S; Han, BG; Sinz, A; Glaeser, RM; Stubbs, MT; Lilie, H				Simon, Claudia; Klose, Thomas; Herbst, Sabine; Han, Bong Gyoon; Sinz, Andrea; Glaeser, Robert M.; Stubbs, Milton T.; Lilie, Hauke			Disulfide Linkage and Structure of Highly Stable Yeastderived Virus-like Particles of Murine Polyomavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Self-assembly; Protein Stability; Viral Protein; Virus Assembly; Yeast	MAJOR CAPSID PROTEIN; HIGH-LEVEL EXPRESSION; SIMIAN-VIRUS-40 VP1; INSECT CELLS; YEAST-CELLS; RESOLUTION; SOFTWARE; COMPLEX	Background: Polyoma virus-like particles produced in vivo (yVLPs) are more stable than those assembled in vitro. Results: yVLPs exhibit higher disulfide connectivity and additional N-terminal structural features in VP1. Conclusion: An ordered network of cystine-bridged VP1 N-terminal peptides contributes to polyoma virus capsid stability. Significance: These results suggest a role for intracellular components in optimizing capsid assembly. VP1 is the major coat protein of murine polyomavirus and forms virus-like particles (VLPs) in vitro. VLPs consist of 72 pentameric VP1 subunits held together by a terminal clamp structure that is further stabilized by disulfide bonds and chelation of calcium ions. Yeast-derived VLPs (yVLPs) assemble intracellularly in vivo during recombinant protein production. These in vivo assembled yVLPs differ in several properties from VLPs assembled in vitro from bacterially produced pentamers. We found several intermolecular disulfide linkages in yVLPs involving 5 of the 6 cysteines of VP1 (Cys(115)-Cys(20), Cys(12)-Cys(20), Cys(16)-Cys(16), Cys(12)/ Cys(16)-Cys(115), and Cys(274)-Cys(274)), indicating a highly coordinated disulfide network within the in vivo assembled particles involving the N-terminal region of VP1. Cryoelectron microscopy revealed structured termini not resolved in the published crystal structure of the bacterially expressed VLP that appear to clamp the pentameric subunits together. These structural features are probably the reason for the observed higher stability of in vivo assembled yVLPs compared with in vitro assembled bacterially expressed VLPs as monitored by increased thermal stability, higher resistance to trypsin cleavage, and a higher activation enthalpy of the disassembly reaction. This high stability is decreased following disassembly of yVLPs and subsequent in vitro reassembly, suggesting a role for cellular components in optimal assembly.	[Simon, Claudia; Stubbs, Milton T.; Lilie, Hauke] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Klose, Thomas] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Herbst, Sabine; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany; [Han, Bong Gyoon; Glaeser, Robert M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Martin Luther University Halle Wittenberg; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Martin Luther University Halle Wittenberg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lilie, H (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 03, D-06120 Halle, Germany.	hauke.lilie@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013; Simon, Claudia/0000-0003-1976-5305	Deutsche Forschungsgemeinschaft [GRK 1026]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK 1026.	Ashcroft AE, 2005, J NANOSCI NANOTECHNO, V5, P2034, DOI 10.1166/jnn.2005.507; Bird G, 2008, J VIROL, V82, P9848, DOI 10.1128/JVI.01221-08; Bundy BC, 2011, J BIOTECHNOL, V154, P230, DOI 10.1016/j.jbiotec.2011.04.011; Chang DC, 1997, J GEN VIROL, V78, P1435, DOI 10.1099/0022-1317-78-6-1435; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; CRIPE TP, 1995, J VIROL, V69, P7807, DOI 10.1128/JVI.69.12.7807-7813.1995; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Erickson KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002630; Frank J, 2006, 3 DIMENSIONAL ELECT, P71; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Inoue T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002037; Jao CC, 1999, J GEN VIROL, V80, P2481, DOI 10.1099/0022-1317-80-9-2481; LEAVITT AD, 1985, J BIOL CHEM, V260, P2803; Li PP, 2000, J VIROL, V74, P11388, DOI 10.1128/JVI.74.23.11388-11393.2000; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Liew MWO, 2010, J BIOTECHNOL, V150, P224, DOI 10.1016/j.jbiotec.2010.08.010; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; MONTROSS L, 1991, J VIROL, V65, P4991, DOI 10.1128/JVI.65.9.4991-4998.1991; Palkova Z, 2000, FEBS LETT, V478, P281, DOI 10.1016/S0014-5793(00)01787-7; Palkova Z, 2000, FEBS LETT, V467, P359, DOI 10.1016/S0014-5793(00)01170-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Sasnauskas K, 1999, BIOL CHEM, V380, P381, DOI 10.1515/BC.1999.050; Sasnauskas K, 2002, INTERVIROLOGY, V45, P308, DOI 10.1159/000067922; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Schmidt U, 2000, J VIROL, V74, P1658, DOI 10.1128/JVI.74.4.1658-1662.2000; Simon C, 2013, PREP BIOCHEM BIOTECH, V43, P217, DOI 10.1080/10826068.2012.750613; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; Typke D, 2005, J STRUCT BIOL, V149, P17, DOI 10.1016/j.jsb.2004.09.003; Walczak CP, 2011, J VIROL, V85, P2386, DOI 10.1128/JVI.01855-10	34	14	14	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10411	10418		10.1074/jbc.M113.484162	http://dx.doi.org/10.1074/jbc.M113.484162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567335	Green Published, hybrid			2022-12-25	WOS:000334226400015
J	VanLeeuwen, JE; Rafalovich, I; Sellers, K; Jones, KA; Griffith, TN; Huda, R; Miller, RJ; Srivastava, DP; Penzes, P				VanLeeuwen, Jon-Eric; Rafalovich, Igor; Sellers, Katherine; Jones, Kelly A.; Griffith, Theanne N.; Huda, Rafiq; Miller, Richard J.; Srivastava, Deepak P.; Penzes, Peter			Coordinated Nuclear and Synaptic Shuttling of Afadin Promotes Spine Plasticity and Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Chromatin Histone Modification; Neurobiology; Nucleus; Signaling; Synapses; Synaptic Plasticity; AF-6; Dendritic Spine; Small GTPase	PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; STIMULI; NEURONS; PROTEIN; AF-6	Background: Coordinated synaptic and nuclear signaling is required for long lasting changes in neuronal morphology. Results: Afadin undergoes activity-dependent bi-directional shuttling to synapses and the nucleus resulting in dendritic spine remodeling and histone modifications. Conclusion: Afadin is required for coordinated signaling at synapses and the nucleus. Significance: Bi-directional trafficking of afadin is required for coordinated synaptic and nuclear signaling in response to activity-dependent stimulation. The ability of a neuron to transduce extracellular signals into long lasting changes in neuronal morphology is central to its normal function. Increasing evidence shows that coordinated regulation of synaptic and nuclear signaling in response to NMDA receptor activation is crucial for long term memory, synaptic tagging, and epigenetic signaling. Although mechanisms have been proposed for synapse-to-nuclear communication, it is unclear how signaling is coordinated at both subcompartments. Here, we show that activation of NMDA receptors induces the bi-directional and concomitant shuttling of the scaffold protein afadin from the cytosol to the nucleus and synapses. Activity-dependent afadin nuclear translocation peaked 2 h post-stimulation, was independent of protein synthesis, and occurred concurrently with dendritic spine remodeling. Moreover, activity-dependent afadin nuclear translocation coincides with phosphorylation of histone H3 at serine 10 (H3S10p), a marker of epigenetic modification. Critically, blocking afadin nuclear accumulation attenuated activity-dependent dendritic spine remodeling and H3 phosphorylation. Collectively, these data support a novel model of neuronal nuclear signaling whereby dual-residency proteins undergo activity-dependent bi-directional shuttling from the cytosol to synapses and the nucleus, coordinately regulating dendritic spine remodeling and histone modifications.	[VanLeeuwen, Jon-Eric; Rafalovich, Igor; Jones, Kelly A.; Griffith, Theanne N.; Huda, Rafiq; Srivastava, Deepak P.; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Miller, Richard J.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Sellers, Katherine; Srivastava, Deepak P.] Kings Coll London, Inst Psychiat, Dept Neurosci, James Black Ctr, London SE5 8AF, England; [Sellers, Katherine; Srivastava, Deepak P.] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 8AF, England	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of London; King's College London; University of London; King's College London	Srivastava, DP (corresponding author), 125 Coldharbour Lane, London SE5 9NU, England.	deepak.srivsatava@kcl.ac.uk; p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016; Griffith, Theanne/AAF-8560-2021	Penzes, Peter/0000-0001-5449-1640; Huda, Rafiq/0000-0002-6814-9966; Sellers, Katherine/0000-0003-0125-657X; Srivastava, Deepak Prakash/0000-0001-6512-9065	National Institutes of Health [DA013141-11A1]; NIMH [MH071316, MH097216]; Ruth L. Kirschstein NRSA [1F31MH087043, 1F31MH085362, 1F31NS076201]; Royal Society United Kingdom; Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association; National Science Foundation Grant [DGE-0824162]; Autism Speaks; NARSAD; Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071316, F31MH087043, F31MH085362, R01MH097216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society United Kingdom(Royal Society of London); Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association(American Heart Association); National Science Foundation Grant(National Science Foundation (NSF)); Autism Speaks; NARSAD(NARSAD); Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA013141-11A1 (to R. J. M.), Grants MH071316 and MH097216 from NIMH (to P. P.), and Ruth L. Kirschstein NRSA 1F31MH087043 (to J. E. V.), 1F31MH085362 (to K. A. J.), and 1F31NS076201 (to R. H.). This work was also supported by grants from the Royal Society United Kingdom, Brain and Behavior Foundation (formally National Alliance for Research on Schizophrenia and Depression (NARSAD)), Psychiatric Research Trust, and American Heart Association (to D. P. S.), National Science Foundation Grant DGE-0824162 (to I. R.), and Autism Speaks, NARSAD, Brain Research Foundation.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Brami-Cherrier K, 2007, J NEUROCHEM, V101, P697, DOI 10.1111/j.1471-4159.2006.04352.x; Buchert M, 2007, J CELL PHYSIOL, V210, P212, DOI 10.1002/jcp.20853; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Maze I, 2013, NEUROPSYCHOPHARMACOL, V38, P3, DOI 10.1038/npp.2012.124; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; Srivastava DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2794; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622	31	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10831	10842		10.1074/jbc.M113.536391	http://dx.doi.org/10.1074/jbc.M113.536391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567331	Green Published, hybrid			2022-12-25	WOS:000334226400051
J	Hakim, F; Kaitsuka, T; Raeed, JM; Wei, FY; Shiraki, N; Akagi, T; Yokota, T; Kume, S; Tomizawa, K				Hakim, Farzana; Kaitsuka, Taku; Raeed, Jamiruddin Mohd; Wei, Fan-Yan; Shiraki, Nobuaki; Akagi, Tadayuki; Yokota, Takashi; Kume, Shoen; Tomizawa, Kazuhito			High Oxygen Condition Facilitates the Differentiation of Mouse and Human Pluripotent Stem Cells into Pancreatic Progenitors and Insulin-producing Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Embryonic Stem Cell; Hypoxia-inducible Factor; Induced Pluripotent Stem Cells; Regenerative Medicine	HYPOXIA-INDUCIBLE FACTOR-1; BETA-CELL; EMBRYONIC-DEVELOPMENT; DEFINITIVE ENDODERM; SELF-RENEWAL; EFFICIENT DIFFERENTIATION; ENDOCRINE-CELLS; GENE-EXPRESSION; IN-VITRO; WNT	Background: Oxygen plays a key role in organ development, including pancreatic -cells. Results: High oxygen conditions increase Ngn3-positive and insulin-positive cells from both mouse and human pluripotent stem cells. Conclusion: Culturing under high oxygen conditions has a facilitative effect on pancreatic differentiation. Significance: This new technique provides an efficient method to utilize patient-specific iPS cells for the treatment of diabetes. Pluripotent stem cells have potential applications in regenerative medicine for diabetes. Differentiation of stem cells into insulin-producing cells has been achieved using various protocols. However, both the efficiency of the method and potency of differentiated cells are insufficient. Oxygen tension, the partial pressure of oxygen, has been shown to regulate the embryonic development of several organs, including pancreatic -cells. In this study, we tried to establish an effective method for the differentiation of induced pluripotent stem cells (iPSCs) into insulin-producing cells by culturing under high oxygen (O-2) conditions. Treatment with a high O-2 condition in the early stage of differentiation increased insulin-positive cells at the terminus of differentiation. We found that a high O-2 condition repressed Notch-dependent gene Hes1 expression and increased Ngn3 expression at the stage of pancreatic progenitors. This effect was caused by inhibition of hypoxia-inducible factor-1 protein level. Moreover, a high O-2 condition activated Wnt signaling. Optimal stage-specific treatment with a high O-2 condition resulted in a significant increase in insulin production in both mouse embryonic stem cells and human iPSCs and yielded populations containing up to 10% C-peptide-positive cells in human iPSCs. These results suggest that culturing in a high O-2 condition at a specific stage is useful for the efficient generation of insulin-producing cells.	[Hakim, Farzana; Kaitsuka, Taku; Raeed, Jamiruddin Mohd; Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Hakim, Farzana; Akagi, Tadayuki; Yokota, Takashi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Shiraki, Nobuaki; Kume, Shoen] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Stem Cell Biol, Chuo Ku, Kumamoto 8600811, Japan; [Shiraki, Nobuaki; Kume, Shoen] Kumamoto Univ, Global Centers Excellence, Chuo Ku, Kumamoto 8600811, Japan	Kumamoto University; Kanazawa University; Kumamoto University; Kumamoto University	Tomizawa, K (corresponding author), Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tomikt@kumamoto-u.ac.jp	Yokota, Takashi/J-8483-2015; Wei, Fan-Yan/AAD-8461-2021; Tomizawa, Kazuhito/F-2405-2015; Kume, Shoen/M-4356-2016; Jamiruddin, Mohd. Raeed/ABA-3747-2020; Akagi, Tadayuki/E-1078-2011	Tomizawa, Kazuhito/0000-0002-5663-2627; Kume, Shoen/0000-0002-4292-205X; Jamiruddin, Mohd. Raeed/0000-0003-0495-4808; Akagi, Tadayuki/0000-0002-1733-9452; shiraki, nobuaki/0000-0001-6708-9976; Wei, Fan-Yan/0000-0002-4843-724X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science through its "Funding Program for Next Generation World-leading Researchers"; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26253059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science through its "Funding Program for Next Generation World-leading Researchers"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Japan Society for the Promotion of Science through its "Funding Program for Next Generation World-leading Researchers," by the Uehara Memorial Foundation, and by the Takeda Science Foundation.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Fraker CA, 2007, STEM CELLS, V25, P3155, DOI 10.1634/stemcells.2007-0445; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Heinis M, 2012, FASEB J, V26, P2734, DOI 10.1096/fj.11-199224; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kaitsuka T, 2014, STEM CELL TRANSL MED, V3, P114, DOI 10.5966/sctm.2013-0075; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakano D, 2014, NAT CHEM BIOL, V10, P141, DOI 10.1038/nchembio.1410; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shah SR, 2011, DEV BIOL, V349, P342, DOI 10.1016/j.ydbio.2010.10.033; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	59	30	34	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9623	9638		10.1074/jbc.M113.524363	http://dx.doi.org/10.1074/jbc.M113.524363			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554704	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000333807000017
J	Santhoshkumar, P; Xie, L; Raju, M; Reneker, L; Sharma, KK				Santhoshkumar, Puttur; Xie, Leike; Raju, Murugesan; Reneker, Lixing; Sharma, K. Krishna			Lens Crystallin Modifications and Cataract in Transgenic Mice Overexpressing Acylpeptide Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cataract; Lens; Peptides; Protease; Protein Degradation; Transgenic Mice; Crystallins; Acylpeptide Hydrolase	ALPHA-A-CRYSTALLIN; TRYPSIN-MODIFIED BOVINE; AGE-RELATED-CHANGES; HIV-1 PROTEASE; PROTEOMIC ANALYSIS; MOUSE LENS; RAT LENS; PROTEOLYSIS; IDENTIFICATION; DEGRADATION	Background: Acylpeptide hydrolase (APH) in the lens may have an integral role in cataract formation. Results: Transgenic overexpression of APH results in crystallin cleavage, impaired lens development, and cataract. Conclusion: APH may be involved in the generation of peptides that have the potential to induce protein aggregation. Significance: The transgenic APH mouse model could help us understand the role of crystallin fragments in cataractogenesis. The accumulation of crystallin fragments in vivo and their subsequent interaction with crystallins are responsible, in part, for protein aggregation in cataracts. Transgenic mice overexpressing acylpeptide hydrolase (APH) specifically in the lens were prepared to test the role of protease in the generation and accumulation of peptides. Cataract development was seen at various postnatal days in the majority of mice expressing active APH (wt-APH). Cataract onset and severity of the cataracts correlated with the APH protein levels. Lens opacity occurred when APH protein levels were >2.6% of the total lens protein and the specific activity, assayed using Ac-Ala-p-nitroanilide substrate, was >1 unit. Transgenic mice carrying inactive APH (mt-APH) did not develop cataract. Cataract development also correlated with N-terminal cleavage of the APH to generate a 57-kDa protein, along with an increased accumulation of low molecular weight (LMW) peptides, similar to those found in aging human and cataract lenses. Nontransgenic mouse lens proteins incubated with purified wt-APH in vitro resulted in a >20% increase in LMW peptides. Crystallin modifications and cleavage were quite dramatic in transgenic mouse lenses with mature cataract. Affected lenses showed capsule rupture at the posterior pole, with expulsion of the lens nucleus and degenerating fiber cells. Our study suggests that the cleaved APH fragment might exert catalytic activity against crystallins, resulting in the accumulation of distinct LMW peptides that promote protein aggregation in lenses expressing wt-APH. The APH transgenic model we developed will enable in vivo testing of the roles of crystallin fragments in protein aggregation.	[Santhoshkumar, Puttur; Xie, Leike; Raju, Murugesan; Reneker, Lixing; Sharma, K. Krishna] Univ Missouri, Dept Ophthalmol, Columbia, MO 65212 USA; [Sharma, K. Krishna] Univ Missouri, Dept Biochem, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Dept Ophthalmol, Columbia, MO 65212 USA.	Sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278	National Institutes of Health [EY019878]; University of Missouri Research Board; NATIONAL EYE INSTITUTE [R01EY019878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri Research Board; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY019878. This work was also supported by an award from the University of Missouri Research Board.	Alapure BV, 2008, J CATARACT REFR SURG, V34, P2063, DOI 10.1016/j.jcrs.2008.08.016; Asomugha CO, 2010, MOL VIS, V16, P476; Azuma M, 2003, BIOCHEM BIOPH RES CO, V307, P558, DOI 10.1016/S0006-291X(03)01194-X; AZUMA M, 1990, EXP EYE RES, V51, P393, DOI 10.1016/0014-4835(90)90151-J; Bettelheim FA, 1997, EXP EYE RES, V64, P667, DOI 10.1006/exer.1996.0233; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; Burgess D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-13; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CARMICHAEL PL, 1989, MECH AGEING DEV, V50, P37, DOI 10.1016/0047-6374(89)90057-2; Chauhan BK, 2002, GENES CELLS, V7, P1267, DOI 10.1046/j.1365-2443.2002.00602.x; Chongcharoen K, 1998, BIOCHEM BIOPH RES CO, V247, P136, DOI 10.1006/bbrc.1998.8747; Clement S, 1998, J BIOL CHEM, V273, P7604, DOI 10.1074/jbc.273.13.7604; David L L, 1989, Lens Eye Toxic Res, V6, P725; DAVIES KJA, 1990, ADV EXP MED BIOL, V264, P503; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Faurobert Mireille, 2007, V355, P9; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Friedrich MG, 2012, J BIOL CHEM, V287, P39012, DOI 10.1074/jbc.M112.391565; Fujino T, 1998, BBA-BIOMEMBRANES, V1374, P47, DOI 10.1016/S0005-2736(98)00131-X; GARBER AT, 1984, J BIOL CHEM, V259, P376; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Hariharapura R, 2013, EXP EYE RES, V109, P51, DOI 10.1016/j.exer.2013.01.016; Harrington V, 2007, MOL VIS, V13, P1680; Hoehenwarter W, 2006, AMINO ACIDS, V30, P369, DOI 10.1007/s00726-005-0283-9; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Inomata M, 1997, BBA-MOL BASIS DIS, V1362, P11, DOI 10.1016/S0925-4439(97)00050-1; Inomata M, 2002, CURR EYE RES, V25, P207, DOI 10.1076/ceyr.25.4.207.13486; IWASAKI N, 1995, INVEST OPHTH VIS SCI, V36, P502; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Mitta M, 1998, J BIOCHEM-TOKYO, V123, P924; Mitton KP, 1996, J BIOL CHEM, V271, P31803, DOI 10.1074/jbc.271.50.31803; Mou LS, 2010, INVEST OPHTH VIS SCI, V51, P396, DOI 10.1167/iovs.09-3772; MURAKAMI K, 1990, FREE RADICAL BIO MED, V8, P217, DOI 10.1016/0891-5849(90)90066-R; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; Reddy VN, 1997, OPHTHALMOLOGICA, V211, P192, DOI 10.1159/000310788; Reneker LW, 2011, INVEST OPHTH VIS SCI, V52, P2100, DOI 10.1167/iovs.10-5650; Reneker LW, 2004, INVEST OPHTH VIS SCI, V45, P4083, DOI 10.1167/iovs.03-1270; Robertson LJG, 2008, INVEST OPHTH VIS SCI, V49, P1016, DOI 10.1167/iovs.07-0792; Sakamoto-Mizutani K, 2002, EXP EYE RES, V75, P611, DOI 10.1006/exer.2002.2065; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Senthilkumar R, 2002, J BIOL CHEM, V277, P39136, DOI 10.1074/jbc.M204684200; Senthilkumar R, 2001, EXP EYE RES, V72, P301, DOI 10.1006/exer.2000.0955; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1996, CURR EYE RES, V15, P363, DOI 10.3109/02713689608995826; SHARMA KK, 1992, EXP EYE RES, V54, P1005, DOI 10.1016/0014-4835(92)90165-O; SHARMA KK, 1993, EUR J BIOCHEM, V216, P631, DOI 10.1111/j.1432-1033.1993.tb18183.x; Shearer TR, 1998, CURR EYE RES, V17, P1037, DOI 10.1076/ceyr.17.11.1037.5232; Srivastava K, 2008, EXP EYE RES, V87, P356, DOI 10.1016/j.exer.2008.07.001; Srivastava OP, 1999, BIOCHEM BIOPH RES CO, V258, P632, DOI 10.1006/bbrc.1999.0506; Stella DR, 2010, INVEST OPHTH VIS SCI, V51, P5153, DOI 10.1167/iovs.10-5302; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Su SP, 2010, EXP EYE RES, V91, P97, DOI 10.1016/j.exer.2010.04.010; Sulochana KN, 1999, BRIT J OPHTHALMOL, V83, P885, DOI 10.1136/bjo.83.7.885; TSUNASAWA S, 1975, J BIOCHEM, V77, P89; Tumminia SJ, 1996, J BIOL CHEM, V271, P425, DOI 10.1074/jbc.271.1.425; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; Viteri G, 2004, ARCH BIOCHEM BIOPHYS, V427, P197, DOI 10.1016/j.abb.2004.05.006; Wang S, 2013, BBA-MOL BASIS DIS, V1832, P302, DOI 10.1016/j.bbadis.2012.11.005; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yamauchi Y, 2003, J BIOCHEM, V134, P251, DOI 10.1093/jb/mvg138; Yamin R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-33; Zetterberg M, 2003, CURR EYE RES, V27, P45, DOI 10.1076/ceyr.27.2.45.15457	64	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9039	9052		10.1074/jbc.M113.510677	http://dx.doi.org/10.1074/jbc.M113.510677			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554718	hybrid, Green Published			2022-12-25	WOS:000333472100025
J	Song, Y; Lan, ZJ; Kohn, MH				Song, Ying; Lan, Zhenjiang; Kohn, Michael H.			Mitochondrial DNA Phylogeography of the Norway Rat	PLOS ONE			English	Article							WARFARIN-RESISTANCE; SUBSPECIFIC ORIGIN; POPULATION-GROWTH; MICE; MUTATIONS; ANTICOAGULANTS; POLYMORPHISM; NEUTRALITY; INFERENCE; LOCUS	Central Eastern Asia, foremost the area bordering northern China and Mongolia, has been thought to be the geographic region where Norway rats (Rattus norvegicus) have originated. However recent fossil analyses pointed to their origin in southern China. Moreover, whereas analyses of fossils dated the species' origin as,1.2-1.6 million years ago (Mya), molecular analyses yielded,0.5-2.9 Mya. Here, to study the geographic origin of the Norway rat and its spread across the globe we analyzed new and all published mitochondrial DNA cytochrome-b (cyt-b; N = 156) and D-loop (N = 212) sequences representing wild rats from four continents and select inbred strains. Our results are consistent with an origin of the Norway rat in southern China similar to 1.3 Mya, subsequent prehistoric differentiation and spread in China and Asia from an initially weakly structured ancestral population, followed by further spread and differentiation across the globe during historic times. The recent spreading occurred mostly from derived European populations rather than from archaic Asian populations. We trace laboratory strains to wild lineages from Europe and North America and these represent a subset of the diversity of the rat; leaving Asian lineages largely untapped as a resource for biomedical models. By studying rats from Europe we made the observation that mtDNA diversity cannot be interpreted without consideration of pest control and, possibly, the evolution of rodenticide resistance. However, demographic models explored by forward-time simulations cannot fully explain the low mtDNA diversity of European rats and lack of haplotype sharing with their source from Asia. Comprehensive nuclear marker analyses of a larger sample of Norway rats representing the world are needed to better resolve the evolutionary history of wild rats and of laboratory rats, as well as to better understand the evolution of anticoagulant resistance.	[Song, Ying; Lan, Zhenjiang; Kohn, Michael H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Song, Ying] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Song, Ying] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Weed & Rodent Biol & Management, Beijing 100193, Peoples R China	Rice University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Kohn, MH (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	hmkohn@rice.edu	Song, Ying/ABE-1050-2021	Song, Ying/0000-0001-5371-315X	National Institute of Health, National Heart, Lung and Blood Institute [R01HL091007-01A1-2]; Reckitt Benckiser Group plc.; Rice Startup funds; Reckitt Benckiser Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091007] Funding Source: NIH RePORTER	National Institute of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Reckitt Benckiser Group plc.; Rice Startup funds; Reckitt Benckiser Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially funded by R01HL091007-01A1-2 from the National Institute of Health, National Heart, Lung and Blood Institute, and funds from the Reckitt Benckiser Group plc., and Rice Startup funds, all to MHK. There are no conflicts of interest to declare, albeit the study was partly funded by the Reckitt Benckiser Group, and no patents, products in development or marketed products emerge from the study. The authors adhere to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin K.P., 2003, RATS MICE PEOPLE ROD; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BOYLE CM, 1960, NATURE, V188, P517, DOI 10.1038/188517a0; Burland T G, 2000, Methods Mol Biol, V132, P71; Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262; Jin C, 2008, SPECTROSC SPECT ANAL, V28, P28; Chepko-Sade BD, 1987, MAMMALIAN DISPERSAL; Diaz JC, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-43; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ESRI, 2012, ARCMAP 10 1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Grandemange A, 2010, PEST MANAG SCI, V66, P270, DOI 10.1002/ps.1869; GREAVES JH, 1977, GENET RES, V30, P257, DOI 10.1017/S0016672300017663; Hansen V, 2012, SILK ROAD; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hedrich HJ, 2000, HDB EXPT ANIMALS, P1871; JACKSON WB, 1972, SCIENCE, V176, P1343, DOI 10.1126/science.176.4041.1343; Jones EP, 2013, TRENDS GENET, V29, P298, DOI 10.1016/j.tig.2012.11.011; Kohn MH, 1999, MAMM GENOME, V10, P696, DOI 10.1007/s003359901073; Kohn MH, 2003, GENETICS, V164, P1055; Kohn MH, 2000, P NATL ACAD SCI USA, V97, P7911, DOI 10.1073/pnas.97.14.7911; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin XD, 2012, J VIROL, V86, P972, DOI 10.1128/JVI.00725-11; Long JL, 2003, INTRO MAMMALS WORLD; Lydekker R, 1896, HDB BRIT MAMMALIA; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; Pelz HJ, 2012, PEST MANAG SCI, V68, P254, DOI 10.1002/ps.2254; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prager EM, 1998, GENETICS, V150, P835; Rajabi-Maham H, 2008, MOL ECOL, V17, P627, DOI 10.1111/j.1365-294X.2007.03601.x; Rambaut A., 2007, TRACER V1 5; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Robins JH, 2008, MOL PHYLOGENET EVOL, V49, P460, DOI 10.1016/j.ympev.2008.08.001; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider S, 1999, GENETICS, V152, P1079; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Suckow MA, 2005, LAB RAT; TAJIMA F, 1989, GENETICS, V123, P585; TELLE H, 1971, WHO B, V45, P331; Verneau O, 1998, P NATL ACAD SCI USA, V95, P11284, DOI 10.1073/pnas.95.19.11284; Wu X, 2012, RES CHINAS FRONTIER, V11, P344; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yu Y., 2013, RASP RECONSTRUCT ANC	55	32	36	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88425	10.1371/journal.pone.0088425	http://dx.doi.org/10.1371/journal.pone.0088425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586325	gold, Green Published, Green Submitted			2022-12-25	WOS:000332396200018
J	Akesson, S; Weimerskirch, H				Akesson, Susanne; Weimerskirch, Henri			Evidence for Sex-Segregated Ocean Distributions of First-Winter Wandering Albatrosses at Crozet Islands	PLOS ONE			English	Article							PELAGIC SEABIRDS; WIND; ORIENTATION; MIGRATION; NAVIGATION; MIGRANTS; INITIATION; PATTERN; CUES	The highly mobile wandering albatrosses (Diomedea exulans) are adapted to navigate the extreme environment of the Southern Ocean and return to isolated islands to breed. Each year they cover several hundreds of thousands of kilometers during travels across the sea. Little is known about the dispersal flights and migration of young albatrosses. We tracked, by satellite telemetry, the departure dispersal of 13 juvenile wandering albatrosses from the Crozet Islands and compared them with tracks of 7 unrelated adults during the interbreeding season. We used the satellite tracks to identify different behavioural steps of the inherited migration program used by juvenile wandering albatrosses during their first solo-migration. Our results show that the juvenile wandering albatrosses from Crozet Islands moved to sex-specific foraging zones of the ocean using at departures selectively the wind. The results suggest that the inherited migration program used by the juvenile wandering albatrosses encode several distinct steps, based on inherited preferred departure routes, differences in migration distance between sexes, and selective use of winds. During long transportation flights the albatrosses were influenced by winds and both adult and juveniles followed approximate loxodrome (rhumbline) routes coinciding with the foraging zone and the specific latitudes of their destination areas. During the long segments of transportation flights across open seas the juveniles selected routes at more northerly latitudes than adults.	[Akesson, Susanne] Lund Univ, Dept Biol, Lund, Sweden; [Weimerskirch, Henri] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	Lund University; Centre National de la Recherche Scientifique (CNRS)	Akesson, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	susanne.akesson@biol.lu.se	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Akesson, Susanne/F-3175-2015	Weimerskirch, Henri/0000-0002-0457-586X; Akesson, Susanne/0000-0001-9039-2180	Swedish Research Council [621-2004-1686, 621-2007-5930, 621-2010-5584]; Tryggers Foundation; Institut Polaire Paul Emile Victor (IPEV) [109]; Centre for Animal Movements Research (CAnMove); Linnaeus grant from the Swedish Research Council [349-2007-8690]; Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Tryggers Foundation; Institut Polaire Paul Emile Victor (IPEV); Centre for Animal Movements Research (CAnMove); Linnaeus grant from the Swedish Research Council; Lund University	Financial support was received from the Swedish Research Council (No. 621-2004-1686, 621-2007-5930, 621-2010-5584) and Tryggers Foundation (to S. Akesson) and from Institut Polaire Paul Emile Victor (IPEV, program No109; to H. Weimerskirch). This is a report with support from the Centre for Animal Movements Research (CAnMove) financed by a Linnaeus grant (No. 349-2007-8690) from the Swedish Research Council and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able K.P., 1980, P283; Akesson S, 2005, J NAVIGATION, V58, P365, DOI 10.1017/S0373463305003401; Akesson S, 2003, AVIAN MIGRATION, P471; Akesson S, 2000, BEHAV ECOL SOCIOBIOL, V47, P140, DOI 10.1007/s002650050004; Akesson S, 1996, TRENDS ECOL EVOL, V11, P398, DOI 10.1016/0169-5347(96)30040-2; Akesson S, 2002, J AVIAN BIOL, V33, P349, DOI 10.1034/j.1600-048X.2002.02951.x; Akesson S, 1998, J AVIAN BIOL, V29, P618, DOI 10.2307/3677182; Akesson S, 2001, ANIM BEHAV, V61, P181, DOI 10.1006/anbe.2000.1562; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Alerstam T, 1996, J EXP BIOL, V199, P9; Batschelet E, 1981, CIRCULAR STAT BIOL; Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; Berthold P, 1996, CONTROL BIRD MIGRATI; Bonadonna F, 2003, AVIAN MIGRATION, P367; Emlen S. T., 1975, AVIAN BIOL, VV, P129; Fransson T, 2005, J AVIAN BIOL, V36, P6, DOI 10.1111/j.0908-8857.2005.03471.x; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Green M, 2004, ARDEA, V92, P145; Gudmundsson GA, 1998, J AVIAN BIOL, V29, P597, DOI 10.2307/3677180; Gwinner E., 1986, CIRCANNUAL RHYTHMS E; Imboden C., 1972, Vogelwarte, V26, P336; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Ketterson E.D., 1983, Current Ornithology, V1, P357; KREITHEN ML, 1974, J COMP PHYSIOL, V89, P73, DOI 10.1007/BF00696164; Nichols J., 2001, DISPERSAL; Papi F, 1996, J EXP BIOL, V199, P65; RABOL J, 1978, OIKOS, V30, P216, DOI 10.2307/3543481; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Snyder JP, 1997, FLATTENING EARTH 200; Thorup K, 2001, J AVIAN BIOL, V32, P111, DOI 10.1034/j.1600-048X.2001.320203.x; WARHAM J, 1990, PETRELS THEIR ECOLOG; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1994, P ROY SOC B-BIOL SCI, V255, P91, DOI 10.1098/rspb.1994.0013; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wiltschko R., 1995, TIEROSYCHOL; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	44	28	28	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e86779	10.1371/journal.pone.0086779	http://dx.doi.org/10.1371/journal.pone.0086779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586254	gold, Green Submitted, Green Published			2022-12-25	WOS:000332390800002
J	Zhou, D; Xiao, YY; Zhang, YY; Xu, ZQ; Cai, D				Zhou, Douglas; Xiao, Yanyang; Zhang, Yaoyu; Xu, Zhiqin; Cai, David			Granger Causality Network Reconstruction of Conductance-Based Integrate-and-Fire Neuronal Systems	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; ORIENTATION SELECTIVITY; LINEAR-DEPENDENCE; BRAIN NETWORKS; VISUAL-CORTEX; SPIKE TRAINS; MODEL; INPUT; DYNAMICS	Reconstruction of anatomical connectivity from measured dynamical activities of coupled neurons is one of the fundamental issues in the understanding of structure-function relationship of neuronal circuitry. Many approaches have been developed to address this issue based on either electrical or metabolic data observed in experiment. The Granger causality (GC) analysis remains one of the major approaches to explore the dynamical causal connectivity among individual neurons or neuronal populations. However, it is yet to be clarified how such causal connectivity, i.e., the GC connectivity, can be mapped to the underlying anatomical connectivity in neuronal networks. We perform the GC analysis on the conductance-based integrate-and-fire (I&F) neuronal networks to obtain their causal connectivity. Through numerical experiments, we find that the underlying synaptic connectivity amongst individual neurons or subnetworks, can be successfully reconstructed by the GC connectivity constructed from voltage time series. Furthermore, this reconstruction is insensitive to dynamical regimes and can be achieved without perturbing systems and prior knowledge of neuronal model parameters. Surprisingly, the synaptic connectivity can even be reconstructed by merely knowing the raster of systems, i.e., spike timing of neurons. Using spike-triggered correlation techniques, we establish a direct mapping between the causal connectivity and the synaptic connectivity for the conductance-based I&F neuronal networks, and show the GC is quadratically related to the coupling strength. The theoretical approach we develop here may provide a framework for examining the validity of the GC analysis in other settings.	[Zhou, Douglas; Xiao, Yanyang; Zhang, Yaoyu; Xu, Zhiqin; Cai, David] Shanghai Jiao Tong Univ, MOE LSC, Dept Math, Shanghai 200030, Peoples R China; [Zhou, Douglas; Xiao, Yanyang; Zhang, Yaoyu; Xu, Zhiqin; Cai, David] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai 200030, Peoples R China; [Cai, David] NYU, Courant Inst Math Sci, New York, NY USA; [Cai, David] NYU, Ctr Neural Sci, New York, NY USA; [Cai, David] New York Univ Abu Dhabi, NYUAD Inst, Abu Dhabi, U Arab Emirates	Shanghai Jiao Tong University; Shanghai Jiao Tong University; New York University; New York University	Zhou, D (corresponding author), Shanghai Jiao Tong Univ, MOE LSC, Dept Math, Shanghai 200030, Peoples R China.	zdz@sjtu.edu.cn; cai@cims.nyu.edu	Zhou, Douglas/E-5428-2019	Zhou, Douglas/0000-0001-6631-2961; Zhang, Yaoyu/0000-0001-9374-2502; Xu, Zhi-Qin/0000-0003-0627-3520; Xiao, Yanyang/0000-0002-8284-5183	Shanghai Pujiang Program [10PJ1406300]; National Science Foundation in China [11101275, 91230202]; Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry in China; NYU Abu Dhabi Research Institute [G1301]; Undergraduate Research Program in Zhiyuan College at Shanghai Jiao Tong University;  [NSF-DMS-1009575]	Shanghai Pujiang Program(Shanghai Pujiang Program); National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry in China(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NYU Abu Dhabi Research Institute; Undergraduate Research Program in Zhiyuan College at Shanghai Jiao Tong University; 	D.Z. is supported by Shanghai Pujiang Program (Grant No. 10PJ1406300), National Science Foundation in China (Grant No. 11101275 and No. 91230202), and the Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry in China. D.C. is supported by NSF-DMS-1009575. All authors are also supported by a research grant G1301 from NYU Abu Dhabi Research Institute. Y.X., Y.Z., and Z.X. were partially supported by an Undergraduate Research Program in Zhiyuan College at Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Badel L, 2008, BIOL CYBERN, V99, P361, DOI 10.1007/s00422-008-0259-4; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Bhalla US, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000098; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brette R, 2009, NEURAL COMPUT, V21, P188, DOI [10.1162/neco.2009.12-07-657, 10.1162/neco.2008.12-07-657]; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cai D, 2005, P NATL ACAD SCI USA, V102, P5868, DOI 10.1073/pnas.0501913102; Carandini M, 1996, J NEUROPHYSIOL, V76, P3425, DOI 10.1152/jn.1996.76.5.3425; Daley D.J., 2003, INTRO THEORY POINT P, V2nd ed; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Dayan P., 2001, THEORETICAL NEUROSCI; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Ding M., 2006, HDB TIME SERIES ANAL, P437, DOI DOI 10.1002/9783527609970.CH17; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Ge T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000570; Geisler C, 2005, J NEUROPHYSIOL, V94, P4344, DOI 10.1152/jn.00510.2004; Gerhard F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003138; Gerstner W., 2002, SPIKING NEURON MODEL; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Gutig R, 2003, J NEUROSCI, V23, P3697; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Hu SQ, 2012, NEUROCOMPUTING, V76, P44, DOI 10.1016/j.neucom.2010.10.017; Jia XX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001045; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kim S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001110; Kim WS, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/20006; Kispersky Tilman, 2011, Neural Syst Circuits, V1, P9, DOI 10.1186/2042-1001-1-9; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; KOMATSU Y, 1988, BRAIN RES, V442, P359, DOI 10.1016/0006-8993(88)91526-0; Lee L, 2006, NEUROIMAGE, V30, P1243, DOI 10.1016/j.neuroimage.2005.11.007; Lehnertz K, 2011, PHYSIOL MEAS, V32, P1715, DOI 10.1088/0967-3334/32/11/R01; Levnajic Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.034101; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; Marinazzo D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056215; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; Matsumura M, 1996, J NEUROSCI, V16, P7757; McIntosh A. R., 1994, Human Brain Mapping, V2, P2; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; McQuarrie A. D, 1998, REGRESSION TIME SERI; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Moreno R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288101; Napoletani D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026103; Neapolitan RE, 2009, PROBABILISTIC METHODS FOR BIOINFORMATICS WITH AN INTRODUCTION TO BAYESIAN NETWORKS, P1; Nedungadi AG, 2009, J COMPUT NEUROSCI, V27, P55, DOI 10.1007/s10827-008-0126-2; Newhall KA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041903; Newhall KA, 2010, COMMUN MATH SCI, V8, P541; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Pandit SM, 1983, TIME SERIES SYSTEM A; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Prignano L, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036112; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rangan AV, 2007, J COMPUT NEUROSCI, V22, P81, DOI 10.1007/s10827-006-8526-7; Rangan AV, 2005, P NATL ACAD SCI USA, V102, P18793, DOI 10.1073/pnas.0509481102; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Ren J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058701; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Sato JR, 2006, NEUROIMAGE, V31, P187, DOI 10.1016/j.neuroimage.2005.11.039; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Seth AK, 2008, COGN NEURODYNAMICS, V2, P49, DOI 10.1007/s11571-007-9031-z; Shandilya SG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013004; Smirnov DA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046204; Snyder Donald Lee, 1991, RANDOM POINT PROCESS, DOI DOI 10.1007/978-1-4612-3166-0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun Y, 2010, J COMPUT NEUROSCI, V28, P247, DOI 10.1007/s10827-009-0202-2; Sun Y, 2009, J COMPUT NEUROSCI, V27, P369, DOI 10.1007/s10827-009-0151-9; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; Troyer TW, 1998, J NEUROSCI, V18, P5908; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Upadhyay J, 2008, J NEUROSCI, V28, P3341, DOI 10.1523/JNEUROSCI.4434-07.2008; Van Bussel F, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00003; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wiener N., 1956, MODERN MATH ENG, P165; Yu DC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188701; Zhang J, 2013, J COMPUTATI IN PRESS; Zhang JW, 2014, J COMPUT NEUROSCI, V36, P279, DOI 10.1007/s10827-013-0472-6; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998; Zhou D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.054102; Zhou D, 2013, P NATL ACAD SCI USA, V110, P9517, DOI 10.1073/pnas.1308167110; Zhou D, 2010, J COMPUT NEUROSCI, V28, P229, DOI 10.1007/s10827-009-0201-3; Zhou D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031918	116	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e87636	10.1371/journal.pone.0087636	http://dx.doi.org/10.1371/journal.pone.0087636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586285	Green Published, gold, Green Submitted			2022-12-25	WOS:000331711900015
J	de Oliveira, LRC; Peresi, E; Golim, MD; Gatto, M; Araujo, JP; da Costa, EAPN; Ayres, JA; Fortes, MRP; Calvi, SA				Cardoso de Oliveira, Larissa Ragozo; Peresi, Eliana; Golim, Marjorie de Assis; Gatto, Mariana; Araujo Junior, Joao Pessoa; Pellison Nunes da Costa, Erika Alessandra; Ayres, Jairo Aparecido; Parise Fortes, Maria Rita; Calvi, Sueli Aparecida			Analysis of Toll-Like Receptors, iNOS and Cytokine Profiles in Patients with Pulmonary Tuberculosis during Anti-Tuberculosis Treatment	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; NITRIC-OXIDE; T-CELLS; MOLECULAR-MECHANISMS; ACTIVE TUBERCULOSIS; DISEASE-ACTIVITY; IMMUNE-RESPONSE; HOST-DEFENSE; GAMMA	Toll-like receptors (TLRs) play an important role in mycobacterial infection, although little is known about the roles of these receptors, cytokines and nitric oxide during anti-tuberculosis treatment. Our objective was to evaluate the mRNA and cell surface expression of TLR2 and TLR4; inducible nitric oxide synthase (iNOS) expression; and cytokine Th1, Th2 and Th17 profiles in pulmonary tuberculosis patients at different time points of anti-tuberculosis treatment. Peripheral blood mononuclear cells (PBMCs) were obtained from PPD+ healthy controls and from patients receiving anti-tuberculosis treatment. Gene expression quantification was performed by qPCR, cell surface expression was assessed using flow cytometry, and cytokine quantification was conducted using the CBA technique. The treated patients presented higher gene expression and higher numbers of receptors on the cell surface of lymphocytes and monocytes than did control individuals. IL-12 and IFN-gamma levels increased after the start of treatment, whereas TNF-alpha levels were reduced. TGF-beta presented the highest levels during treatment. IL-10 and IL-17 expression and production tended to increase during treatment. iNOS gene expression was reduced throughout treatment in patients. Our results suggest that anti-tuberculosis treatment modulates the immune response, inducing an increase in the expression of TLRs and pro-and anti-inflammatory cytokines to combat bacteria and reduce the inflammatory process.	[Cardoso de Oliveira, Larissa Ragozo; Peresi, Eliana; Gatto, Mariana; Pellison Nunes da Costa, Erika Alessandra; Calvi, Sueli Aparecida] Univ Estadual Paulista, Dept Trop Dis, Botucatu Sch Med, Sao Paulo, Brazil; [Golim, Marjorie de Assis] Univ Estadual Paulista, Flow Cytometry Lab, Botucatu Sch Med, Hemoctr, Sao Paulo, Brazil; [Araujo Junior, Joao Pessoa] Univ Estadual Paulista, Biosci Inst, Dept Microbiol & Immunol, Sao Paulo, Brazil; [Ayres, Jairo Aparecido] Univ Estadual Paulista, Dept Nursing, Botucatu Sch Med, Sao Paulo, Brazil; [Parise Fortes, Maria Rita] Univ Estadual Paulista, Dermatol & Radiotherapy Dept, Botucatu Sch Med, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	de Oliveira, LRC (corresponding author), Univ Estadual Paulista, Dept Trop Dis, Botucatu Sch Med, Sao Paulo, Brazil.	larissaragozo@yahoo.com.br	Gatto, Mariana/M-4755-2018; Araujo, Joao Pessoa/C-2444-2012; Lordelo, Eliana Peresi/H-4241-2013; Oliveira, Larissa R C/E-6480-2019; Araujo Jr, Joao Pessoa/Q-3043-2019	Gatto, Mariana/0000-0002-3115-0795; Araujo, Joao Pessoa/0000-0002-9153-1485; Oliveira, Larissa R C/0000-0002-9407-1496; Araujo Jr, Joao Pessoa/0000-0002-9153-1485; de Assis Golim, Marjorie/0000-0002-4824-9441; Peresi-Lordelo, Eliana/0000-0002-5320-6825	FAPESP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study has been supported by the FAPESP; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Aung H, 1996, J CLIN INVEST, V98, P1261, DOI 10.1172/JCI118910; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Chackerian AA, 2001, INFECT IMMUN, V69, P2666, DOI 10.1128/IAI.69.4.2666-2674.2001; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; DENIS M, 1990, INT J IMMUNOPHARMACO, V12, P721, DOI 10.1016/0192-0561(90)90034-K; Deveci F, 2005, MEDIAT INFLAMM, P256, DOI 10.1155/MI.2005.256; Doherty TM, 2004, J CLIN INVEST, V114, P1699, DOI 10.1172/JCI200423867; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; EUNKYEONG J, 2003, CURR OPIN INFECT DIS, V16, P205; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; FOCACCIA R, 2005, TRATADO INFECTOLOGIA; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Henderson RA, 1997, J IMMUNOL, V159, P635; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Jones BW, 2001, J LEUKOCYTE BIOL, V69, P1036; Juffermans NP, 1998, AM J RESP CRIT CARE, V157, P1328, DOI 10.1164/ajrccm.157.4.9709126; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Koch R., 1890, DEUT MED WOCHENSCHR, V16, P1029, DOI [10.1055/s-0029-1207546, DOI 10.1055/S-0029-1207546]; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Ladel CH, 1997, INFECT IMMUN, V65, P1936, DOI 10.1128/IAI.65.5.1936-1938.1997; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lin YG, 1996, INFECT IMMUN, V64, P1351, DOI 10.1128/IAI.64.4.1351-1356.1996; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 1999, J IMMUNOL, V163, P6748; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Peresi Eliana, 2008, J. bras. pneumol., V34, P942, DOI 10.1590/S1806-37132008001100009; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Prabha C, 2008, IMMUNOL LETT, V117, P26, DOI 10.1016/j.imlet.2007.11.002; Raja A, 2004, INDIAN J MED RES, V120, P213; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Schluger NW, 1998, AM J RESP CRIT CARE, V157, P679, DOI 10.1164/ajrccm.157.3.9708002; Selek S, 2012, ENVIRON TOXICOL, V27, P380, DOI 10.1002/tox.20674; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Suzuki K, 2006, ACTA HISTOCHEM CYTOC, V39, P107, DOI 10.1267/ahc.06010; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van de Veerdonk FLV, 2010, J LEUKOCYTE BIOL, V88, P227, DOI 10.1189/jlb.0809550; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Youmans G P, 1979, Pathobiol Annu, V9, P137; Yuhas Y, 2009, ANTIMICROB AGENTS CH, V53, P1539, DOI 10.1128/AAC.00961-08; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; ZHANG M, 1995, INFECT IMMUN, V63, P3231, DOI 10.1128/IAI.63.8.3231-3234.1995	73	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88572	10.1371/journal.pone.0088572	http://dx.doi.org/10.1371/journal.pone.0088572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558401	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700047
J	Ferket, BS; van Kempen, BJH; Hunink, MGM; Agarwal, I; Kavousi, M; Franco, OH; Steyerberg, EW; Max, W; Fleischmann, KE				Ferket, Bart S.; van Kempen, Bob J. H.; Hunink, M. G. Myriam; Agarwal, Isha; Kavousi, Maryam; Franco, Oscar H.; Steyerberg, Ewout W.; Max, Wendy; Fleischmann, Kirsten E.			Predictive Value of Updating Framingham Risk Scores with Novel Risk Markers in the US General Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; C-REACTIVE PROTEIN; INTIMA-MEDIA THICKNESS; SERVICES TASK-FORCE; CARDIOVASCULAR RISK; ATHEROSCLEROSIS; METAANALYSIS; INDIVIDUALS; GUIDELINES	Background: According to population-based cohort studies CT coronary calcium score (CTCS), carotid intima-media thickness (cIMT), high-sensitivity C-reactive protein (CRP), and ankle-brachial index (ABI) are promising novel risk markers for improving cardiovascular risk assessment. Their impact in the U. S. general population is however uncertain. Our aim was to estimate the predictive value of four novel cardiovascular risk markers for the U. S. general population. Methods and Findings: Risk profiles, CRP and ABI data of 3,736 asymptomatic subjects aged 40 or older from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 exam were used along with predicted CTCS and cIMT values. For each subject, we calculated 10-year cardiovascular risks with and without each risk marker. Event rates adjusted for competing risks were obtained by microsimulation. We assessed the impact of updated 10-year risk scores by reclassification and C-statistics. In the study population (mean age 56 +/- 11 years, 48% male), 70% (80%) were at low (<10%), 19% (14%) at intermediate (>= 10-<20%), and 11% (6%) at high (>= 20%) 10-year CVD (CHD) risk. Net reclassification improvement was highest after updating 10-year CVD risk with CTCS: 0.10 (95%CI 0.02-0.19). The C-statistic for 10-year CVD risk increased from 0.82 by 0.02 (95%CI 0.01-0.03) with CTCS. Reclassification occurred most often in those at intermediate risk: with CTCS, 36% (38%) moved to low and 22% (30%) to high CVD (CHD) risk. Improvements with other novel risk markers were limited. Conclusions: Only CTCS appeared to have significant incremental predictive value in the U. S. general population, especially in those at intermediate risk. In future research, cost-effectiveness analyses should be considered for evaluating novel cardiovascular risk assessment strategies.	[Ferket, Bart S.; van Kempen, Bob J. H.; Hunink, M. G. Myriam; Kavousi, Maryam; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ferket, Bart S.; van Kempen, Bob J. H.; Hunink, M. G. Myriam] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Agarwal, Isha] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Max, Wendy] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA USA; [Max, Wendy] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA USA; [Fleischmann, Kirsten E.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fleischmann, KE (corresponding author), Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA.	fleischm@medicine.ucsf.edu	Kavousi, Maryam/F-1174-2018; Franco, Óscar H/ABE-2305-2020	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Ferket, Bart/0000-0003-2754-545X	National Institutes of Health/National Heart, Lung, and Blood Institute [R21 HL112255]; AXA Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL112255] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AXA Research Fund(AXA Research Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by an National Institutes of Health/National Heart, Lung, and Blood Institute grant R21 HL112255. Maryam Kavousi is supported by the AXA Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Glasziou PP, 2001, DECISION MAKING HLTH; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Paynter NP, 2012, MED DECIS MAKING; Pencina MJ, 2012, STAT MED, V31, P1543, DOI 10.1002/sim.4508; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; van Kempen BJH, 2011, J AM COLL CARDIOL, V58, P1690, DOI 10.1016/j.jacc.2011.05.056; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88312	10.1371/journal.pone.0088312	http://dx.doi.org/10.1371/journal.pone.0088312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558385	Green Submitted, gold, Green Published			2022-12-25	WOS:000331706700031
J	Li, DL; Ma, ZY; Fu, ZJ; Ling, MY; Yan, CZ; Zhang, Y				Li, Duo-ling; Ma, Zhi-yong; Fu, Zhi-jie; Ling, Ming-ying; Yan, Chuan-zhu; Zhang, Yun			Glibenclamide Decreases ATP-Induced Intracellular Calcium Transient Elevation via Inhibiting Reactive Oxygen Species and Mitochondrial Activity in Macrophages	PLOS ONE			English	Article							EXTRACELLULAR NUCLEOTIDES; CHANNELS; CA2+; CELLS; INFLAMMATION; ACTIVATION; RECEPTORS; RELEASE; DISEASE	Increasing evidence has revealed that glibenclamide has a wide range of anti-inflammatory effects. However, it is unclear whether glibenclamide can affect the resting and adenosine triphosphate (ATP)-induced intracellular calcium ([Ca2+](i)) handling in Raw 264.7 macrophages. In the present study, [Ca2+](i) transient, reactive oxygen species (ROS) and mitochondrial activity were measured by the high-speed TILLvisION digital imaging system using the indicators of Fura 2-am, DCFDA and rhodamine-123, respectively. We found that glibenclamide, pinacidil and other unselective K+ channel blockers had no effect on the resting [Ca2+](i) of Raw 264.7 cells. Extracellular ATP (100 mM) induced [Ca2+](i) transient elevation independent of extracellular Ca2+. The transient elevation was inhibited by an ROS scavenger (tiron) and mitochondria inhibitor (rotenone). Glibenclamide and 5-hydroxydecanoate (5-HD) also decreased ATP-induced [Ca2+](i) transient elevation, but pinacidil and other unselective K+ channel blockers had no effect. Glibenclamide also decreased the peak of [Ca2+](i) transient induced by extracellular thapsigargin (Tg, 1 mu M). Furthermore, glibenclamide decreased intracellular ROS and mitochondrial activity. When pretreated with tiron and rotenone, glibenclamide could not decrease ATP, and Tg induced maximal [Ca2+](i) transient further. We conclude that glibenclamide may inhibit ATP-induced [Ca2+](i) transient elevation by blocking mitochondria K-ATP channels, resulting in decreased ROS generation and mitochondrial activity in Raw 264.7 macrophages.	[Li, Duo-ling; Ma, Zhi-yong; Ling, Ming-ying; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China; [Li, Duo-ling; Ma, Zhi-yong; Ling, Ming-ying; Zhang, Yun] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Peoples R China; [Li, Duo-ling; Yan, Chuan-zhu] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250100, Peoples R China; [Fu, Zhi-jie] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Otorhinolaryngol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Ma, ZY (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Peoples R China.	zhiyongma@yeah.net; yanczqlYY@126.com	ling, mingying/GZB-1112-2022		National 973 Basic Research Program of China [2011CB503906, 2012CB518603]; National High-tech Research and Development Program of China [2012AA02A510]; Program of Introducing Talents of Discipline to Universities [B07035]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; National Natural Science Foundation of China [30800468, 81100207]; Science and Technology Research Program of Shandong Province [2009GG10002034]; Natural Science Foundation from the Department of Science and Technology of Shandong Province [Y2005C32]	National 973 Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Program of Shandong Province; Natural Science Foundation from the Department of Science and Technology of Shandong Province	This work was supported by the National 973 Basic Research Program of China (No. 2011CB503906, No. 2012CB518603), the National High-tech Research and Development Program of China (No. 2012AA02A510), the Program of Introducing Talents of Discipline to Universities (No. B07035), the State Program of National Natural Science Foundation of China for Innovative Research Group (No. 81021001), and the grants of the National Natural Science Foundation of China (No. 30800468, 81100207), the Science and Technology Research Program of Shandong Province (2009GG10002034), and the Natural Science Foundation (Y2005C32) from the Department of Science and Technology of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballanyi K, 2004, J EXP BIOL, V207, P3201, DOI 10.1242/jeb.01106; Chen Z, 2009, BIOCHEM BIOPH RES CO, V382, P381, DOI 10.1016/j.bbrc.2009.03.030; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Ding Y, 2010, J PHARMACOL EXP THER, V335, P693, DOI 10.1124/jpet.110.171975; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; Grahnert A, 2009, PURINERG SIGNAL, V5, P309, DOI 10.1007/s11302-009-9144-4; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; Hanninen SL, 2010, CARDIOVASC RES, V88, P75, DOI 10.1093/cvr/cvq180; Hill LM, 2010, J IMMUNOL, V185, P3028, DOI 10.4049/jimmunol.1001298; Ito M, 2008, J PHARMACOL SCI, V107, P443, DOI 10.1254/jphs.08087FP; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lalevee N, 1999, BIOL REPROD, V61, P343, DOI 10.1095/biolreprod61.2.343; Ling MY, 2013, ATHEROSCLEROSIS, V226, P348, DOI 10.1016/j.atherosclerosis.2012.11.016; Ma ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061018; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; McTaggart JS, 2010, J PHYSIOL-LONDON, V588, P3201, DOI 10.1113/jphysiol.2010.191767; Mikulski Z, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-133; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Pain T, 2000, CIRC RES, V87, P460; Pfeiffer ZA, 2007, FREE RADICAL BIO MED, V42, P1506, DOI 10.1016/j.freeradbiomed.2007.02.010; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ryu SY, 2010, CELL CALCIUM, V47, P65, DOI 10.1016/j.ceca.2009.11.006; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Xi Q, 2005, CIRC RES, V97, P354, DOI 10.1161/01.RES.0000177669.29525.78; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x	31	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89083	10.1371/journal.pone.0089083	http://dx.doi.org/10.1371/journal.pone.0089083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558474	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700120
J	Mao, Y; Fang, LQ; Ai, L; Li, CY; Wang, ZB; Wu, JR; Bai, J; Li, FQ				Mao, Ying; Fang, Liaoqiong; Ai, Liang; Li, Chongyan; Wang, Zhibiao; Wu, Junru; Bai, Jin; Li, Faqi			An In Vivo Study of the Effects on Serum Glucose, Amylase and Histopathology of the Feline Pancreatic Tissue Treated by Focused Ultrasound	PLOS ONE			English	Article							CANCER STATISTICS; GEMCITABINE; PRINCIPLES; RADIATION; ABLATION; THERAPY	Pancreatic cancer is one of the most malignant neoplasms originating in the digestive system. Focused ultrasound (FUS) treatment instead of the surgery operation has been used to treat Pancreatic cancer noninvasively in clinical trials. The endocrine and exocrine glands in pancreas provide the two unique functions for a person to be healthy. It is critically important to find out if the FUS treatment can still keep the normal functions of the two glands. The goal of this study is to examine and analyze changes in histopathology and serum glucose and amylase levels of the targeted in-vivo felines after the FUS treatment. Various percentage volumes of pancreas of felines were insonified. The FUS treatment (7.5 MHz of central frequency; 5 W of acoustical power; transducer f-number = 0.33; 6 s insonification time per point) effectively generated coagulative necrosis at the insonified site while leaving tissue outside the insonified site intact. It was also observed that all felines endured well with the FUS treatment; changes introduced to pancreatic tissue after up to 50% of a pancreas by volume was insonified by the FUS procedure did not affect its normal endocrine and exocrine functions.	[Mao, Ying; Fang, Liaoqiong; Ai, Liang; Wang, Zhibiao; Bai, Jin; Li, Faqi] Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Engn Med, Chongqing & Minist Sci & Technol, Chongqing, Peoples R China; [Li, Chongyan] Natl Engn Res Ctr Ultrasound Med, Chongqing, Peoples R China; [Wu, Junru] Univ Vermont, Dept Phys, Burlington, VT 05405 USA	Chongqing Medical University; University of Vermont	Bai, J (corresponding author), Chongqing Med Univ, Coll Biomed Engn, State Key Lab Ultrasound Engn Med, Chongqing & Minist Sci & Technol, Chongqing, Peoples R China.	sajinbai@haifu.com.cn; lifaqi70@163.com			National Basic Research Program 973 of China [2012CB722402, 2011CB707900]; National Natural Science Foundation of China [81127901, 30830040, 11274404, 30970827]; HAS fund of the University of Vermont	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); HAS fund of the University of Vermont	This work is supported in part by the National Basic Research Program 973 of China (Grant No. 2012CB722402 and Grant No. 2011CB707900) and funded by National Natural Science Foundation of China (Grant No. 81127901, 30830040, 11274404 and 30970827). JW has been supported partially by HAS fund of the University of Vermont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchler M, 1987, ACUTE PANCREATITIS, P143; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; CLAVIEN PA, 1989, BRIT J SURG, V76, P1234, DOI 10.1002/bjs.1800761205; CRAMP DG, 1967, J CLIN PATHOL, V20, P910, DOI 10.1136/jcp.20.6.910; DIMAGNO EP, 1973, NEW ENGL J MED, V288, P813, DOI 10.1056/NEJM197304192881603; Hwang JH, 2009, ULTRASOUND MED BIOL, V35, P967, DOI 10.1016/j.ultrasmedbio.2008.12.006; Iovanne J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00006; Johung K, 2012, INT J RADIAT ONCOL, V82, P508, DOI 10.1016/j.ijrobp.2011.08.008; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Nakakura E. K., 2007, SURG LIVER BILIARY T, P849; Orsi F, 2010, J CANCER RES THER, V6, P414, DOI 10.4103/0973-1482.77064; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PIERRE KJ, 1976, CLIN CHEM, V22, P1219; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEINBERG WM, 1985, ANN INTERN MED, V102, P576, DOI 10.7326/0003-4819-102-5-576; Sung HY, 2011, PANCREAS, V40, P1080, DOI 10.1097/MPA.0b013e31821fde24; Ter Haar G, 2007, INT J HYPERTHER, V23, P89, DOI 10.1080/02656730601186138; Wilkowski R, 2005, J PANCREAS, V6, P216; Wu F, 2005, RADIOLOGY, V236, P1034, DOI 10.1148/radiol.2362041105; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Xie BA, 2011, INT J MED SCI, V8, P9, DOI 10.7150/ijms.8.9; Xiong LL, 2009, J PANCREAS, V10, P123; Yeo CJ, 2005, CANC PRINCIPLES PRAC; [张樯 Zhang Qiang], 2011, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V27, P571; Zhao H, 2010, ANTI-CANCER DRUG, V21, P447, DOI 10.1097/CAD.0b013e32833641a7	25	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88815	10.1371/journal.pone.0088815	http://dx.doi.org/10.1371/journal.pone.0088815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558434	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700080
J	Ophir, R; Sherman, A; Rubinstein, M; Eshed, R; Schwager, MS; Harel-Beja, R; Bar-Ya'akov, I; Holland, D				Ophir, Ron; Sherman, Amir; Rubinstein, Mor; Eshed, Ravit; Schwager, Michal Sharabi; Harel-Beja, Rotem; Bar-Ya'akov, Irit; Holland, Doron			Single-Nucleotide Polymorphism Markers from De-Novo Assembly of the Pomegranate Transcriptome Reveal Germplasm Genetic Diversity	PLOS ONE			English	Article							PUNICA-GRANATUM L.; SNP DISCOVERY; SSR-MARKERS; MICROSATELLITE MARKERS; PRUNUS-PERSICA; RNA-SEQ; CULTIVARS; RAPD; ANNOTATION; GENOTYPES	Pomegranate is a valuable crop that is grown commercially in many parts of the world. Wild species have been reported from India, Turkmenistan and Socotra. Pomegranate fruit has a variety of health-beneficial qualities. However, despite this crop's importance, only moderate effort has been invested in studying its biochemical or physiological properties or in establishing genomic and genetic infrastructures. In this study, we reconstructed a transcriptome from two phenotypically different accessions using 454-GS-FLX Titanium technology. These data were used to explore the functional annotation of 45,187 fully annotated contigs. We further compiled a genetic-variation resource of 7,155 simple-sequence repeats (SSRs) and 6,500 single-nucleotide polymorphisms (SNPs). A subset of 480 SNPs was sampled to investigate the genetic structure of the broad pomegranate germplasm collection at the Agricultural Research Organization (ARO), which includes accessions from different geographical areas worldwide. This subset of SNPs was found to be polymorphic, with 10.7% loci with minor allele frequencies of (MAF<0.05). These SNPs were successfully used to classify the ARO pomegranate collection into two major groups of accessions: one from India, China and Iran, composed of mainly unknown country origin and which was more of an admixture than the other major group, composed of accessions mainly from the Mediterranean basin, Central Asia and California. This study establishes a high-throughput transcriptome and genetic-marker infrastructure. Moreover, it sheds new light on the genetic interrelations between pomegranate species worldwide and more accurately defines their genetic nature.	[Ophir, Ron; Sherman, Amir; Rubinstein, Mor; Eshed, Ravit; Schwager, Michal Sharabi] Agr Res Org, Volcani Ctr, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel; [Harel-Beja, Rotem; Bar-Ya'akov, Irit; Holland, Doron] Agr Res Org, Dept Fruit Tree Sci, Newe Yaar Ctr, Ramat Yishai, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ophir, R (corresponding author), Agr Res Org, Volcani Ctr, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel.	ron@agri.gov.il; asherman@agri.gov.il		Ophir, Ron/0000-0002-7951-6661	Chief Scientist Office, Ministry of Agriculture & Rural Development [203-0753]	Chief Scientist Office, Ministry of Agriculture & Rural Development	The authors acknowledge funding from the Chief Scientist Office, Ministry of Agriculture & Rural Development, http://www.science.moag.gov.il/, Agricultural Biotechnology 203-0753. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-569; Asgary S, 2014, PHYTOTHER RES, V28, P193, DOI 10.1002/ptr.4977; Aviram M, 2001, ATHEROSCLEROSIS, V158, P195, DOI 10.1016/S0021-9150(01)00412-9; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Balfour IB, 1888, BOT SOCOTRA, P93; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Ben-Simhon Z, 2011, PLANTA, V234, P865, DOI 10.1007/s00425-011-1438-4; Billot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059714; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; da Maia LC, 2009, GENET MOL BIOL, V32, P822, DOI 10.1590/S1415-47572009005000091; da Silva JAT, 2013, SCI HORTIC-AMSTERDAM, V160, P85, DOI 10.1016/j.scienta.2013.05.017; Dafny-Yalin M, 2010, J AGR FOOD CHEM, V58, P4342, DOI 10.1021/jf904337t; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Ercisli S, 2011, GENET MOL RES, V10, P459, DOI 10.4238/vol10-1gmr1155; Ercisli S, 2007, BIOCHEM SYST ECOL, V35, P764, DOI 10.1016/j.bse.2007.05.014; Ercisli S, 2011, BIOL RES, V44, P345, DOI /S0716-97602011000400005; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frascaroli E, 2013, THEOR APPL GENET, V126, P133, DOI 10.1007/s00122-012-1968-6; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; GOOR A., 1956, The pomegranate; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Hajiahmadi Z, 2013, MOL BIOTECHNOL, V55, P249, DOI 10.1007/s12033-013-9676-2; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hasnaoui N., 2010, Diversity, V2, P107; Hasnaoui N, 2012, GENE, V493, P105, DOI 10.1016/j.gene.2011.11.012; Holland D., 2009, Horticultural Reviews, V35, P127; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jalikop SH, 2007, EUPHYTICA, V158, P201, DOI 10.1007/s10681-007-9443-1; Jalikop SH, 2005, ACTA HORTICULTURAE, V696; Jbir R, 2008, SCI HORTIC-AMSTERDAM, V115, P231, DOI 10.1016/j.scienta.2007.09.002; Jhanwar S, 2012, PLANT BIOTECHNOL J, V10, P690, DOI 10.1111/j.1467-7652.2012.00712.x; Kaya HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073674; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; LEVIN G M, 1981, Izvestiya Akademii Nauk Turkmenskoi SSR Seriya Biologicheskikh Nauk, P60; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Melgarejo P, 2009, SCI HORTIC-AMSTERDAM, V120, P500, DOI 10.1016/j.scienta.2008.12.013; Soriano JM, 2011, MOL BREEDING, V27, P119, DOI 10.1007/s11032-010-9511-4; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Neurath AR, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-41; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Ono NN, 2011, J INTEGR PLANT BIOL, V53, P800, DOI 10.1111/j.1744-7909.2011.01073.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pirseyedi SM, 2010, INT J MOL SCI, V11, P2010, DOI 10.3390/ijms11052010; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Pritchard JK, 2000, GENETICS, V155, P945; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Rana JC, 2007, BIODIVERS CONSERV, V16, P3963, DOI 10.1007/s10531-007-9201-7; Ranade S. A., 2009, Physiology and Molecular Biology of Plants, V15, P61, DOI 10.1007/s12298-009-0006-x; Rauscher G, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-11; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha A, 2012, BREAST CANCER RES TR, V136, P647, DOI 10.1007/s10549-012-2264-5; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Sarkhosh A, 2006, SCI HORTIC-AMSTERDAM, V111, P24, DOI 10.1016/j.scienta.2006.07.033; Seeram NP, 2006, J NUTR, V136, P2481, DOI 10.1093/jn/136.10.2481; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang L, 2012, TRANSL ONCOL, V5, P345, DOI 10.1593/tlo.12190; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weir, 1990, GENETIC DATA ANAL ME; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Xu Y, 2004, GENOME, V47, P1091, DOI [10.1139/g04-058, 10.1139/G04-058]; Yasodha R, 2008, J GENET, V87, P21, DOI 10.1007/s12041-008-0003-9; Yuan Zhaohe, 2007, Journal of Genetics and Genomics, V34, P1061, DOI 10.1016/S1673-8527(07)60121-0; Zamani Z, 2007, J HORTIC SCI BIOTECH, V82, P11, DOI 10.1080/14620316.2007.11512192; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang YP, 2012, GENET MOL RES, V11, P3032, DOI 10.4238/2012.May.30.1; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	90	51	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88998	10.1371/journal.pone.0088998	http://dx.doi.org/10.1371/journal.pone.0088998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558460	Green Submitted, Green Published, gold			2022-12-25	WOS:000331706700106
J	Peterson, MJ; Mueter, F; Criddle, K; Haynie, AC				Peterson, Megan J.; Mueter, Franz; Criddle, Keith; Haynie, Alan C.			Killer Whale Depredation and Associated Costs to Alaskan Sablefish, Pacific Halibut and Greenland Turbot Longliners	PLOS ONE			English	Article							ORCINUS-ORCA; MARINE MAMMALS; SPERM-WHALES; FISHERIES; CROZET; MODEL; GEAR	Killer whale (Orcinus orca) depredation (whales stealing or damaging fish caught on fishing gear) adversely impacts demersal longline fisheries for sablefish (Anoplopoma fimbria), Pacific halibut (Hippoglossus stenolepis) and Greenland turbot (Reinhardtius hippoglossoides) in the Bering Sea, Aleutian Islands and Western Gulf of Alaska. These interactions increase direct costs and opportunity costs associated with catching fish and reduce the profitability of longline fishing in western Alaska. This study synthesizes National Marine Fisheries Service observer data, National Marine Fisheries Service sablefish longline survey and fishermen-collected depredation data to: 1) estimate the frequency of killer whale depredation on longline fisheries in Alaska; 2) estimate depredation-related catch per unit effort reductions; and 3) assess direct costs and opportunity costs incurred by longliners in western Alaska as a result of killer whale interactions. The percentage of commercial fishery sets affected by killer whales was highest in the Bering Sea fisheries for: sablefish (21.4%), Greenland turbot (9.9%), and Pacific halibut (6.9%). Average catch per unit effort reductions on depredated sets ranged from 35.1-69.3% for the observed longline fleet in all three management areas from 1998-2012 (p < 0.001). To compensate for depredation, fishermen set additional gear to catch the same amount of fish, and this increased fuel costs by an additional 82% per depredated set (average $433 additional fuel per depredated set). In a separate analysis with six longline vessels in 2011 and 2012, killer whale depredation avoidance measures resulted in an average additional cost of $494 per depredated vessel-day for fuel and crew food. Opportunity costs of time lost by fishermen averaged $522 per additional vessel-day on the grounds. This assessment of killer whale depredation costs represents the most extensive economic evaluation of this issue in Alaska to date and will help longline fishermen and managers consider the costs and benefits of depredation avoidance and alternative policy solutions.	[Peterson, Megan J.; Mueter, Franz; Criddle, Keith] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK 99801 USA; [Haynie, Alan C.] Alaska Fisheries Sci Ctr, Resource Ecol & Fisheries Management Div, Seattle, WA USA	University of Alaska System; University of Alaska Fairbanks; National Oceanic Atmospheric Admin (NOAA) - USA	Peterson, MJ (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK 99801 USA.	mjpeterson6@alaska.edu	Criddle, Keith R./P-7080-2016	Criddle, Keith R./0000-0001-9347-2944	Rasmuson Fisheries Research Center; National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT [DGE-0801720]; National Science Foundation Arctic Social Sciences Program [1107401]; Office of Polar Programs (OPP) [1107401] Funding Source: National Science Foundation	Rasmuson Fisheries Research Center; National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT; National Science Foundation Arctic Social Sciences Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the Rasmuson Fisheries Research Center, the National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT (Award Number DGE-0801720), and the National Science Foundation Arctic Social Sciences Program (Award Number 1107401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2011, J ENVIRON ECON MANAG, V62, P386, DOI 10.1016/j.jeem.2011.07.001; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Amoako-Tuffour J, 2008, MUNICH PERSONAL REPE; Barbeaux S., 2012, ASSESSMENT GREENLAND; Becker B, 2013, BOATING MAGAZINE; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; Bjordal A., 2002, FISHERY MANAGERS GUI, V424, P21; Carothers C, 2013, MAR POLICY, V38, P515, DOI 10.1016/j.marpol.2012.08.007; Clark JM, 2010, CCAMLR SCI, V17, P163; Dalheim M., 1988, 8814 NW AL FISH CTR; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Donoghue M, 2007, WORKSH DEPR TUN LONG, P1; Fearnbach H, 2012, THESIS U ABERDEEN SC; Fisheries Economic Data Program, 2013, EFIN MONTHL MAR FUEL; Garrison LP, 2007, FISH B-NOAA, V105, P408; Hamer DJ, 2012, MAR MAMMAL SCI, V28, pE345, DOI 10.1111/j.1748-7692.2011.00544.x; Hanselman D, 2007, ALASKA SABLEFISH ASS; Hanselman D, 2010, DEV LONGLINE SURVEY, P533; Hardin J. W., 2007, GEN LINEAR MODELS EX, DOI DOI 10.1016/j.marpol.2012.12.026; Haynie AC, 2010, J ENVIRON ECON MANAG, V59, P165, DOI 10.1016/j.jeem.2009.11.001; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Henderson M.M., 1999, ALSK FISH RES B, V6, P63; Herrmann M., 2006, MARINE RESOURCE EC, V21, P129; Huppert D. D., 2004, STUDY SUPPLY EFFECTS; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Layman RC, 1996, LAND ECON, V72, P113, DOI 10.2307/3147161; Matkin C, 1986, KILLER WHALE INTERAC; Matkin C, 1986, 2262 40ABNFS NAT MAR; MCKEAN JR, 1995, LAND ECON, V71, P95; NMFS, 2012, OBS SAMPL MAN N PAC; NMFS RAM Division, 2012, PAC HAL SABL IFQ REP; NOAA Fisheries, 2013, SEAS DAT FISH IND FI; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Peterson MJ, 2013, MAR POLICY, V42, P315, DOI 10.1016/j.marpol.2013.04.001; Roche C, 2007, CCAMLR SCI, V14, P67; Sigler MF, 2008, MAR MAMMAL SCI, V24, P16, DOI 10.1111/j.1748-7692.2007.00149.x; Sivasubramaniam K., 1964, Bulletin of the Fisheries Research Station Ceylon, V17, P221; TEC Inc, 2009, CET DEPR HAW LONGL F; Tixier P, 2010, CCAMLR SCI, V17, P179; Tyedmers, 2001, FISHERIES CTR RES RE, V9, P12; US Department of Commerce, 2013, US CENS; US Department of Labor: Bureau of Labor Statistics, 2013, EC RES; US Energy Information Administration, 2013, PETR OTH LIQ PRIC; Wood S., 2007, MGCV PACKAGE; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; YANO K, 1995, FISH B-NOAA, V93, P355; Zuur Alain F., 2009, P1	47	39	39	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88906	10.1371/journal.pone.0088906	http://dx.doi.org/10.1371/journal.pone.0088906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3RA	24558446	Green Published, gold, Green Submitted			2022-12-25	WOS:000331706700092
J	Zeri, M; Sa, LDA; Manzi, AO; Araujo, AC; Aguiar, RG; von Randow, C; Sampaio, G; Cardoso, FL; Nobre, CA				Zeri, Marcelo; Sa, Leonardo D. A.; Manzi, Antonio O.; Araujo, Alessandro C.; Aguiar, Renata G.; von Randow, Celso; Sampaio, Gilvan; Cardoso, Fernando L.; Nobre, Carlos A.			Variability of Carbon and Water Fluxes Following Climate Extremes over a Tropical Forest in Southwestern Amazonia	PLOS ONE			English	Article							SURFACE-AIR EXCHANGE; RAIN-FOREST; EDDY-COVARIANCE; USE EFFICIENCY; MICROMETEOROLOGICAL OBSERVATIONS; SONIC ANEMOMETER; CO2 FLUXES; OPEN-PATH; ENERGY; DIOXIDE	The carbon and water cycles for a southwestern Amazonian forest site were investigated using the longest time series of fluxes of CO2 and water vapor ever reported for this site. The period from 2004 to 2010 included two severe droughts (2005 and 2010) and a flooding year (2009). The effects of such climate extremes were detected in annual sums of fluxes as well as in other components of the carbon and water cycles, such as gross primary production and water use efficiency. Gap-filling and flux-partitioning were applied in order to fill gaps due to missing data, and errors analysis made it possible to infer the uncertainty on the carbon balance. Overall, the site was found to have a net carbon uptake of approximate to 5 t C ha(-1) year(-1), but the effects of the drought of 2005 were still noticed in 2006, when the climate disturbance caused the site to become a net source of carbon to the atmosphere. Different regions of the Amazon forest might respond differently to climate extremes due to differences in dry season length, annual precipitation, species compositions, albedo and soil type. Longer time series of fluxes measured over several locations are required to better characterize the effects of climate anomalies on the carbon and water balances for the whole Amazon region. Such valuable datasets can also be used to calibrate biogeochemical models and infer on future scenarios of the Amazon forest carbon balance under the influence of climate change.	[Zeri, Marcelo; von Randow, Celso; Sampaio, Gilvan] Inst Nacl Pesquisas Espaciais, Ctr Ciencia Sistema Terrestre, Cachoeira Paulista, SP, Brazil; [Sa, Leonardo D. A.] Inst Nacl Pesquisas Espaciais, Ctr Reg Amazonia, Belem, Para, Brazil; [Manzi, Antonio O.] INPA, Manaus, Amazonas, Brazil; [Araujo, Alessandro C.] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Aguiar, Renata G.] Univ Fed Rondonia, Porto Velho, Rondonia, Brazil; [Cardoso, Fernando L.] Univ Fed Rondonia, Ji Parana, Rondonia, Brazil; [Nobre, Carlos A.] Minist Ciencia Tecnol & Inovacao, Secretaria Polit, Brasilia, DF, Brazil; [Nobre, Carlos A.] Minist Ciencia Tecnol & Inovacao, Programa Pesquisa, Brasilia, DF, Brazil; [Nobre, Carlos A.] Minist Ciencia Tecnol & Inovacao, Programas Desenvolvimento, Brasilia, DF, Brazil	Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Nacional de Pesquisas Espaciais (INPE); Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Rondonia; Universidade Federal de Rondonia	Zeri, M (corresponding author), Inst Nacl Pesquisas Espaciais, Ctr Ciencia Sistema Terrestre, Cachoeira Paulista, SP, Brazil.	marcelo.zeri@inpe.br	Sá, Leonardo/B-9731-2013; Manzi, Antonio/U-3141-2019; von Randow, Celso/B-3335-2009; Von Randow, Celso/AAW-8272-2020; Zeri, Marcelo/B-7701-2008; Sampaio, Gilvan/F-7482-2012; Sá, Leonardo/M-7736-2019	Sá, Leonardo/0000-0002-0402-323X; Manzi, Antonio/0000-0002-4860-6031; von Randow, Celso/0000-0003-1045-4316; Von Randow, Celso/0000-0003-1045-4316; Zeri, Marcelo/0000-0003-1244-0858; Sampaio, Gilvan/0000-0001-6956-3950; Sá, Leonardo/0000-0002-0402-323X	Sao Paulo Research Foundation (FAPESP) [2011/04101-0]; CNPq - Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico [303.728/2010-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	M. Zeri is grateful to Sao Paulo Research Foundation (FAPESP) - grant 2011/04101-0 - for the support during the preparation of this manuscript. Leonardo Sa is particularly grateful to CNPq - Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico - for his research grant (process 303.728/2010-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar RG, 2005, THESIS U FEDERAL MAT; Bolzan MJA, 2006, BRAZ J PHYS, V36, P1217, DOI 10.1590/S0103-97332006000700018; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Andreae MO, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000524; Anthoni PM, 2004, AGR FOREST METEOROL, V121, P55, DOI 10.1016/S0168-1923(03)00162-X; Aubinet M, 2003, BOUND-LAY METEOROL, V108, P397, DOI 10.1023/A:1024168428135; Bagley JE, 2014, J CLIMATE, V27, P345, DOI 10.1175/JCLI-D-12-00369.1; Bai YF, 2012, ECOL RES, V27, P615, DOI 10.1007/s11284-012-0930-z; Baker IT, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000644; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Betts AK, 2009, GEOPHYS MONOGR SER, V186, P163, DOI 10.1029/2008GM000725; Betts AK, 2004, B AM METEOROL SOC, V85, P1673, DOI 10.1175/BAMS-85-11-1673; Betts AK, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008191; Betts AK, 2010, J ADV MODEL EARTH SY, V2, DOI 10.3894/JAMES.2010.2.6; Bolzan MJA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000378; Bruno RD, 2006, HYDROL PROCESS, V20, P2477, DOI 10.1002/hyp.6211; Burba GG, 2008, GLOBAL CHANGE BIOL, V14, P1854, DOI 10.1111/j.1365-2486.2008.01606.x; Butt N, 2010, AGR FOREST METEOROL, V150, P361, DOI 10.1016/j.agrformet.2009.12.004; Campanharo ASLO, 2008, PHILOS T R SOC A, V366, P579, DOI 10.1098/rsta.2007.2118; Costa MH, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001179; Costa MH, 1999, J GEOPHYS RES-ATMOS, V104, P14189, DOI 10.1029/1998JD200126; da Rocha HR, 2004, ECOL APPL, V14, pS22; da Rocha HR, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000640; de Araujo AC, 2010, AGR FOREST METEOROL, V150, P226, DOI 10.1016/j.agrformet.2009.11.005; Dias MAFS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000335; Doughty CE, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003670; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Feigenwinter C, 2004, BOUND-LAY METEOROL, V113, P201, DOI 10.1023/B:BOUN.0000039372.86053.ff; Feigenwinter C, 2008, AGR FOREST METEOROL, V148, P12, DOI 10.1016/j.agrformet.2007.08.013; Finnigan J, 1999, AGR FOREST METEOROL, V97, P55, DOI 10.1016/S0168-1923(99)00049-0; Fisch G, 2004, THEOR APPL CLIMATOL, V78, P47, DOI 10.1007/s00704-004-0043-x; Fisher JB, 2009, GLOBAL CHANGE BIOL, V15, P2694, DOI 10.1111/j.1365-2486.2008.01813.x; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Foken T, 2004, ATMOS OCEAN SCI LIB, V29, P181; Frank JM, 2013, AGR FOREST METEOROL, V171, P72, DOI 10.1016/j.agrformet.2012.11.005; Goulden ML, 2004, ECOL APPL, V14, pS42, DOI 10.1890/02-6008; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2012, AGR FOREST METEOROL, V152, P135, DOI 10.1016/j.agrformet.2011.09.014; Hutyra LR, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000365; Kaimal J. C., 1994, ATMOSPHERIC BOUNDARY, DOI 10.1093/oso/9780195062397.001.0001; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kochendorfer J, 2012, BOUND-LAY METEOROL, V145, P383, DOI 10.1007/s10546-012-9738-1; Kruijt B, 2000, BOUND-LAY METEOROL, V94, P297, DOI 10.1023/A:1002401829007; Kruijt B, 2004, ECOL APPL, V14, pS101; Lee XH, 1998, AGR FOREST METEOROL, V91, P39, DOI 10.1016/S0168-1923(98)00071-9; Lee XH, 2002, BOUND-LAY METEOROL, V103, P277, DOI 10.1023/A:1014508928693; LEUNING R, 1992, BOUND-LAY METEOROL, V59, P297, DOI 10.1007/BF00119818; Leuning R, 2007, BOUND-LAY METEOROL, V123, P263, DOI 10.1007/s10546-006-9138-5; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Malhi Y, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000623; Marengo JA, 2008, PHILOS T R SOC B, V363, P1773, DOI 10.1098/rstb.2007.0015; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Marengo JA, 2012, THEOR APPL CLIMATOL, V107, P73, DOI 10.1007/s00704-011-0465-1; MONTGOMERY RB, 1948, J METEOROL, V5, P265, DOI 10.1175/1520-0469(1948)005<0265:VEFOHI>2.0.CO;2; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Philip JR, 1963, AUST J PHYS, P16; Potter C, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034024; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2006, AGR FOREST METEOROL, V136, P1, DOI 10.1016/j.agrformet.2006.01.007; Richardson AD, 2007, AGR FOREST METEOROL, V147, P199, DOI 10.1016/j.agrformet.2007.06.004; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Saleska SR, 2003, SCIENCE, V302, P1554, DOI 10.1126/science.1091165; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; SCHOTANUS P, 1983, BOUND-LAY METEOROL, V26, P81, DOI 10.1007/BF00164332; Stull R.B., 1988, INTRO BOUNDARY LAYER, DOI 10.1007/978-94-009-3027-8; Suyker AE, 2009, AGR FOREST METEOROL, V149, P443, DOI 10.1016/j.agrformet.2008.09.010; SWINBANK WC, 1951, J METEOROL, V8, P135, DOI 10.1175/1520-0469(1951)008<0135:TMOVTO>2.0.CO;2; Tota J, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000597; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Vickers D, 1997, J ATMOS OCEAN TECH, V14, P512, DOI 10.1175/1520-0426(1997)014<0512:QCAFSP>2.0.CO;2; von Randow C, 2004, THEOR APPL CLIMATOL, V78, P5, DOI 10.1007/s00704-004-0041-z; von Randow C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000379; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wilks A. A., 1995, STAT METHODS ATMOSPH; Wright I.R., 1996, AMAZONIAN DEFORESTAT, P473; Xu LA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046824; Yamasoe MA, 2006, ATMOS CHEM PHYS, V6, P1645, DOI 10.5194/acp-6-1645-2006; Zeng N, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/014002; Zeri M, 2013, J GEOPHYS RES-BIOGEO, V118, P581, DOI 10.1002/jgrg.20052; Zeri M, 2011, AGR ECOSYST ENVIRON, V144, P319, DOI 10.1016/j.agee.2011.09.006; Zeri M, 2011, BOUND-LAY METEOROL, V138, P413, DOI 10.1007/s10546-010-9563-3; Zeri M, 2010, AGR FOREST METEOROL, V150, P1543, DOI 10.1016/j.agrformet.2010.08.004; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	89	29	31	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88130	10.1371/journal.pone.0088130	http://dx.doi.org/10.1371/journal.pone.0088130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558378	gold, Green Submitted, Green Published			2022-12-25	WOS:000331706700024
J	Mokany, K; Westcott, DA; Prasad, S; Ford, AJ; Metcalfe, DJ				Mokany, Karel; Westcott, David A.; Prasad, Soumya; Ford, Andrew J.; Metcalfe, Daniel J.			Identifying Priority Areas for Conservation and Management in Diverse Tropical Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; BETA-DIVERSITY; WET TROPICS; ALPHA-DIVERSITY; BIODIVERSITY; PATTERNS; QUEENSLAND; TREE; SENSITIVITY; MODELS	The high concentration of the world's species in tropical forests endows these systems with particular importance for retaining global biodiversity, yet it also presents significant challenges for ecology and conservation science. The vast number of rare and yet to be discovered species restricts the applicability of species-level modelling for tropical forests, while the capacity of community classification approaches to identify priorities for conservation and management is also limited. Here we assessed the degree to which macroecological modelling can overcome shortfalls in our knowledge of biodiversity in tropical forests and help identify priority areas for their conservation and management. We used 527 plant community survey plots in the Australian Wet Tropics to generate models and predictions of species richness, compositional dissimilarity, and community composition for all the 4,313 vascular plant species recorded across the region (>1.3 million communities (grid cells)). We then applied these predictions to identify areas of tropical forest likely to contain the greatest concentration of species, rare species, endemic species and primitive angiosperm families. Synthesising these alternative attributes of diversity into a single index of conservation value, we identified two areas within the Australian wet tropics that should be a high priority for future conservation actions: the Atherton Tablelands and Daintree rainforest. Our findings demonstrate the value of macroecological modelling in identifying priority areas for conservation and management actions within highly diverse systems, such as tropical forests.	[Mokany, Karel] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Westcott, David A.; Ford, Andrew J.] CSIRO, Ecosyst Sci, Atherton, Qld, Australia; [Prasad, Soumya] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Metcalfe, Daniel J.] CSIRO, Ecosyst Sci, Dutton Park, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Indian Institute of Science (IISC) - Bangalore; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mokany, K (corresponding author), CSIRO, Ecosyst Sci, Canberra, ACT, Australia.	Karel.Mokany@csiro.au	Metcalfe, Daniel J/G-3305-2010; Ford, Andrew J/D-3761-2011; Mokany, Karel/C-1464-2009; Westcott, David A/G-5559-2010	Metcalfe, Daniel J/0000-0001-6853-7072; 	Australia-India Strategic Research Fund	Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was supported by a grant from the Australia-India Strategic Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ESTIMATION SOIL PROP; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bostock P.D., 2010, CENSUS QUEENSLAND FL; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; CARSON WP, 2008, TROPICAL FOREST COMM; Currie DJ, 2001, ECOSYSTEMS, V4, P216, DOI 10.1007/s10021-001-0005-4; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hilbert David W., 1999, Diversity and Distributions, V5, P263, DOI 10.1046/j.1472-4642.1999.00060.x; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Jones MM, 2013, J ECOL, V101, P506, DOI 10.1111/1365-2745.12053; Lehmann A, 2003, ECOL MODEL, V160, P165, DOI 10.1016/S0304-3800(02)00354-X; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Mayfield MM, 2013, AM J BOT IN PRESS; Metcalfe D. J., 2009, Pacific Conservation Biology, V15, P80; Metcalfe DJ, 2009, LIVING DYNAMIC TROPI, P123; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Mokany K, 2013, J BIOGEOGR, V40, P2299, DOI 10.1111/jbi.12175; Mokany K, 2013, J APPL ECOL, V50, P519, DOI 10.1111/1365-2664.12038; Mokany K, 2012, GLOBAL CHANGE BIOL, V18, P3149, DOI 10.1111/j.1365-2486.2012.02760.x; Mokany K, 2011, ECOL LETT, V14, P1043, DOI 10.1111/j.1461-0248.2011.01675.x; Mokany K, 2011, DIVERS DISTRIB, V17, P374, DOI 10.1111/j.1472-4642.2010.00735.x; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Neldner V. J., 2012, METHODOLOGY SURVEY M; Nix H. A, 1991, RAINFOREST ANIMALS A; Ostendorf B, 2001, ECOL MODEL, V145, P211, DOI 10.1016/S0304-3800(01)00392-1; Overton JM, 2009, DIVERS DISTRIB, V15, P731, DOI 10.1111/j.1472-4642.2009.00589.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymond O., 2009, AUSGEO NEWS, V93, P3; Sattler P., 1999, CONSERVATION STATUS; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Stanton P, 2005, VEGETATION WET TROPI; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tracey J. G., 1975, VEGETATION HUMID TRO; Tracey JG, 1982, VEGETATION HUMID TRO; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; WEBB LJ, 1968, ECOLOGY, V49, P296, DOI 10.2307/1934459; WEBB LJ, 1959, J ECOL, V47, P551, DOI 10.2307/2257290; Western A., 2004, SOIL HYDROLOGICAL PR; Wilford J, 2012, GEODERMA, V183, P124, DOI 10.1016/j.geoderma.2010.12.022; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; WILLIAMS WT, 1984, AUST J BOT, V32, P109, DOI 10.1071/BT9840109; Xu T., 2010, ANUCLIM VERSION 6 1	50	18	18	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89084	10.1371/journal.pone.0089084	http://dx.doi.org/10.1371/journal.pone.0089084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551222	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000331271500095
J	Allen, DJ; Adams, NL; Aladin, F; Harris, JP; Brown, DWG				Allen, David J.; Adams, Natalie L.; Aladin, Farah; Harris, John P.; Brown, David W. G.			Emergence of the GII-4 Norovirus Sydney2012 Strain in England, Winter 2012-2013	PLOS ONE			English	Article							GASTROENTERITIS OUTBREAKS; VARIANT; SURVEILLANCE; EVOLUTION	Norovirus is the commonest cause of acute gastrointestinal disease and is the main aetiological agent of outbreaks of gastroenteritis, particularly in semi-closed environments. Norovirus infections in England typically peak between December and March each year. The most commonly detected norovirus strains belong to the genetically diverse genogroup-II genotype-4 (GII-4) genocluster and in the previous two norovirus winter seasons the majority of GII-4 strains in circulation worldwide have been genetically similar to the GII-4 strain New Orleans 1805/2009/USA. At the beginning of the 2012/13 season a genetically distinct GII-4 strain (Sydney 2012/NSW0514/2012/AU) was described which emerged worldwide during the winter of 2012/13. Here we describe the emergence of norovirus strains genetically related to Sydney2012 in England during the 2012/13 season to replace NewOrleans2009 strains as the most commonly detected variant of GII-4 norovirus in England. Furthermore, we demonstrate that whilst the emergence of Sydney2012 coincided with an early peak in the number of norovirus outbreaks, there was not an overall increase in norovirus activity compared to the previous season. Finally, we show that the Sydney2012 strain is associated with distinct genetic changes compared to the NewOrleans2009 strain, and these changes may have contributed to the emergence of the Sydney2012 strain.	[Allen, David J.; Aladin, Farah; Brown, David W. G.] Publ Hlth England, Microbiol Serv, Virus Reference Dept, London, England; [Adams, Natalie L.; Harris, John P.] Publ Hlth England, Heath Protect Serv, Gastrointestinal Emerging & Zoonot Infect Dept, London, England; [Harris, John P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Harris, John P.] Univ Liverpool, Natl Consortium Zoonosis Res, Liverpool, Merseyside, England	Public Health England; Public Health England; University of Liverpool; University of Liverpool	Allen, DJ (corresponding author), Publ Hlth England, Microbiol Serv, Virus Reference Dept, London, England.	david.james.allen@phe.gov.uk		Allen, David/0000-0002-1194-0415; Harris, John/0000-0001-9606-9480				Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allen DJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-150; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Debbink K, 2013, J INFECT DIS; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Gallimore CI, 2005, INT J FOOD MICROBIOL, V103, P323, DOI 10.1016/j.ijfoodmicro.2005.02.003; Harris J. P., 2011, Journal of Infection Prevention, V12, P102, DOI 10.1177/1757177410392094; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2003, EMERG INFECT DIS, V9, P71; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Shanker S, 2011, J VIROL, V85, P8635, DOI 10.1128/JVI.00848-11; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Xerry J, 2008, J CLIN MICROBIOL, V46, P947, DOI 10.1128/JCM.02240-07; Zakikhany K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041625; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	28	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88978	10.1371/journal.pone.0088978	http://dx.doi.org/10.1371/journal.pone.0088978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551201	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000331266000087
J	Ferreyra, GA; Elinoff, JM; Demirkale, CY; Starost, MF; Buckley, M; Munson, PJ; Krakauer, T; Danner, RL				Ferreyra, Gabriela A.; Elinoff, Jason M.; Demirkale, Cumhur Y.; Starost, Matthew F.; Buckley, Marilyn; Munson, Peter J.; Krakauer, Teresa; Danner, Robert L.			Late Multiple Organ Surge in Interferon-Regulated Target Genes Characterizes Staphylococcal Enterotoxin B Lethality	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; A STREPTOCOCCAL INFECTIONS; DENDRITIC CELLS; I INTERFERON; BACTERIAL SUPERANTIGENS; INTRANASAL EXPOSURE; ENDOTHELIAL-CELLS; DAI DLM-1/ZBP1; MICE; EXPRESSION	Background: Bacterial superantigens are virulence factors that cause toxic shock syndrome. Here, the genome-wide, temporal response of mice to lethal intranasal staphylococcal enterotoxin B (SEB) challenge was investigated in six tissues. Results: The earliest responses and largest number of affected genes occurred in peripheral blood mononuclear cells (PBMC), spleen, and lung tissues with the highest content of both T-cells and monocyte/macrophages, the direct cellular targets of SEB. In contrast, the response of liver, kidney, and heart was delayed and involved fewer genes, but revealed a dominant genetic program that was seen in all 6 tissues. Many of the 85 uniquely annotated transcripts participating in this shared genomic response have not been previously linked to SEB. Nine of the 85 genes were subsequently confirmed by RTPCR in every tissue/organ at 24 h. These 85 transcripts, up-regulated in all tissues, annotated to the interferon (IFN)/antiviralresponse and included genes belonging to the DNA/RNA sensing system, DNA damage repair, the immunoproteasome, and the ER/metabolic stress-response and apoptosis pathways. Overall, this shared program was identified as a type I and II interferon (IFN)-response and the promoters of these genes were highly enriched for IFN regulatory matrices. Several genes whose secreted products induce the IFN pathway were up-regulated at early time points in PBMCs, spleen, and/or lung. Furthermore, IFN regulatory factors including Irf1, Irf7 and Irf8, and Zbp1, a DNA sensor/transcription factor that can directly elicit an IFN innate immune response, participated in this host-wide SEB signature. Conclusion: Global gene-expression changes across multiple organs implicated a host-wide IFN-response in SEB-induced death. Therapies aimed at IFN-associated innate immunity may improve outcome in toxic shock syndromes.	[Ferreyra, Gabriela A.; Elinoff, Jason M.; Danner, Robert L.] NIH, Funct Genom & Prote Facil, Dept Crit Care Med, Clin Res Ctr, Bethesda, MD 20892 USA; [Demirkale, Cumhur Y.; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Starost, Matthew F.] NIH, Div Vet Resources, Off Res Serv, Bethesda, MD 20892 USA; [Buckley, Marilyn; Krakauer, Teresa] US Army Med Res Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Krakauer, T (corresponding author), US Army Med Res Inst Infect Dis, Integrated Toxicol Div, Ft Detrick, MD 21702 USA.	teresa.krakauer@us.army.mil; rdanner@nih.gov			Defense Threat Reduction Agency [DTRA 3.10035]; Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000188, ZIACL008060, ZIACL001164] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); CLINICAL CENTER	This research was entirely funded by The Defense Threat Reduction Agency (#DTRA 3.10035) and the Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasheva S, 2012, J VIROL, V86, P8147, DOI 10.1128/JVI.00733-12; Barb JJ, 2009, MATH STAT COMPUTING; BERGDOLL MS, 1982, ANN INTERN MED, V96, P969, DOI 10.7326/0003-4819-96-6-969; BHARDWAJ N, 1993, J EXP MED, V178, P633, DOI 10.1084/jem.178.2.633; Brogan PA, 2004, ARTHRITIS RHEUM-US, V50, P589, DOI 10.1002/art.20021; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; CARLSSON R, 1988, J IMMUNOL, V140, P2484; Castelli J, 1998, BIOMED PHARMACOTHER, V52, P386, DOI 10.1016/S0753-3322(99)80006-7; CHEN JYJ, 1994, INFECT IMMUN, V62, P4626, DOI 10.1128/IAI.62.10.4626-4631.1994; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; Chowdhary VR, 2012, J IMMUNOL, V189, P2054, DOI 10.4049/jimmunol.1201097; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Descloux E, 2008, EUR J CLIN MICROBIOL, V27, P37, DOI 10.1007/s10096-007-0405-2; DeVries AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022997; Dinges MM, 2001, INFECT IMMUN, V69, P7169, DOI 10.1128/IAI.69.11.7169-7172.2001; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; DRAKE CG, 1992, J CLIN IMMUNOL, V12, P149, DOI 10.1007/BF00918083; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eriksson BKG, 1999, J INFECT DIS, V180, P410, DOI 10.1086/314872; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; FRASER JD, 1992, J EXP MED, V175, P1131, DOI 10.1084/jem.175.4.1131; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hakme A, 2008, DEV DYNAM, V237, P209, DOI 10.1002/dvdy.21399; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Huzella LM, 2009, RES VET SCI, V86, P241, DOI 10.1016/j.rvsc.2008.07.020; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Komisar JL, 2001, TOXICOL PATHOL, V29, P369, DOI 10.1080/019262301316905336; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; KRAKAUER T, 1994, J LEUKOCYTE BIOL, V56, P458, DOI 10.1002/jlb.56.4.458; Krakauer T, 2010, TOXINS, V2, P1963, DOI 10.3390/toxins2081963; Krakauer T, 2010, ANTIMICROB AGENTS CH, V54, P1125, DOI 10.1128/AAC.01015-09; Krakauer T, 2009, INT IMMUNOPHARMACOL, V9, P1168, DOI 10.1016/j.intimp.2009.06.004; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leung AKL, 2012, RNA BIOL, V9, P542, DOI 10.4161/rna.19899; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Madsen JM, 2001, CLIN LAB MED, V21, P593; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; MATTIX ME, 1995, TOXICOL PATHOL, V23, P262, DOI 10.1177/019262339502300304; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Mehrotra P, 2011, J BIOL CHEM, V286, P1767, DOI 10.1074/jbc.M110.157768; NAGAKI M, 1994, GASTROENTEROLOGY, V106, P450, DOI 10.1016/0016-5085(94)90604-1; NORRBYTEGLUND A, 1995, SCAND J INFECT DIS, V27, P125, DOI 10.3109/00365549509018991; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; Oudshoorn D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029870; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plaza R, 2007, INFECT IMMUN, V75, P306, DOI 10.1128/IAI.01220-06; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Roy CJ, 2005, INFECT IMMUN, V73, P2452, DOI 10.1128/IAI.73.4.2452-2460.2005; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; SARAWAR SR, 1994, J INFECT DIS, V170, P1189, DOI 10.1093/infdis/170.5.1189; Savransky V, 2003, TOXICOL PATHOL, V31, P373, DOI 10.1080/01926230390201093; SCHLIEVERT PM, 1986, LANCET, V1, P1149; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Seishima M, 2009, CLIN EXP DERMATOL, V34, pE632, DOI 10.1111/j.1365-2230.2009.03353.x; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stevens DL, 1996, INFECT DIS CLIN N AM, V10, P727, DOI 10.1016/S0891-5520(05)70324-X; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tanaka Hideharu, 1995, Journal of Burn Care and Rehabilitation, V16, P616, DOI 10.1097/00004630-199511000-00011; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Temajo NO, 2012, AUTOIMMUN REV, V11, P653, DOI 10.1016/j.autrev.2011.11.008; Tilahun AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016764; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Vitour Damien, 2007, Sci STKE, V2007, ppe20, DOI 10.1126/stke.3842007pe20; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	84	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88756	10.1371/journal.pone.0088756	http://dx.doi.org/10.1371/journal.pone.0088756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551153	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000062
J	Patel, P; Khan, N; Rani, M; Gupta, D; Jameel, S				Patel, Paresh; Khan, Nabab; Rani, Manjusha; Gupta, Deepti; Jameel, Shahid			The Expression of HIV-1 Vpu in Monocytes Causes Increased Secretion of TGF-beta that Activates Profibrogenic Genes in Hepatic Stellate Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR-BETA; INDUCED LIVER FIBROSIS; KAPPA-B ACTIVITY; C VIRUS; COINFECTED PATIENTS; COLLAGEN-I; TYPE-1; PROGRESSION; INFECTION	There is faster progression to fibrosis in persons with liver injury who are also infected with HIV. Other reports have suggested that HIV can directly infect and activate stellate cells, and the viral Tat and gp160 proteins also induce profibrogenic factors from peripheral blood mononuclear cells (PBMCs). We tested the role of HIV-1 Vpu accessory protein in promoting profibrogenic activation of hepatic stellate cells. Human stellate LX2 cells were cocultured with human monocytic U937 cells stably expressing the Vpu protein or latently infected U1 cells knocked down for Vpu expression, LX2 cells were also cultured with the supernatants from these cells. The expression of profibrogenic markers was evaluated in LX2 cells usingquantitative reverse transcription polymerase chain reaction (qRT-PCR), western blotting, immunofluorescence, flow cytometry and ELISA were used to confirm and quantitate protein expression. Monocytic cells expressing Vpu increased the expression of profibrogenic markers in LX2 cells. The culture supernatants of these cells contained increased levels of transforming growth factor beta (TGF-beta), which correlated with increased activity of the AP-1 transcription factor. Antibodies against TGF-beta or a TGF-beta receptor inhibitor (SB431452) reversed Vpu-mediated profibrogenic activation of LX2 cells, suggesting that TGF-beta mediated these effects. The cytokine macrophage migration inhibitory factor (MIF) attenuated Vpu-mediated TGF-beta secretion and profibrogenic effects on LX2 cells. Besides its other roles in pathogenesis, Vpu is likely to contribute to hepatic fibrosis through this hitherto unknown mechanism.	[Patel, Paresh; Khan, Nabab; Rani, Manjusha; Gupta, Deepti; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Jameel, S (corresponding author), Wellcome Trust DBT India Alliance, Plot 19,8-2-684-3K-19,Banjara Hills, Hyderabad, Andhra Pradesh, India.	shahid@icgeb.res.in	khan, Nabab/Z-3970-2019; Gupta, Deepti/U-1777-2019	khan, Nabab/0000-0002-8563-5341; Gupta, Deepti/0000-0001-7931-0017	Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR); Council for Scientific and Industrial Research (CSIR); ICMR	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	This work was funded by grants from the Department of Biotechnology (DBT) and Indian Council of Medical Research (ICMR). Senior Research Fellowships were awarded by the Council for Scientific and Industrial Research (CSIR) to PP, and by the ICMR to NK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrovandi GM, 1996, J VIROL, V70, P1505, DOI 10.1128/JVI.70.3.1505-1511.1996; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; BIRCHENALLROBERTS MC, 1990, MOL CELL BIOL, V10, P4978, DOI 10.1128/MCB.10.9.4978; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; GIBELLINI D, 1994, BRIT J HAEMATOL, V88, P261, DOI 10.1111/j.1365-2141.1994.tb05016.x; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; HOUSSET C, 1990, HUM PATHOL, V21, P404, DOI 10.1016/0046-8177(90)90202-G; Hu R, 1996, CLIN IMMUNOL IMMUNOP, V80, P283, DOI 10.1006/clin.1996.0125; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; KEKOW J, 1991, J CLIN INVEST, V87, P1010, DOI 10.1172/JCI115059; KEKOW J, 1990, P NATL ACAD SCI USA, V87, P8321, DOI 10.1073/pnas.87.21.8321; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li JM, 1998, MOL CELL BIOL, V18, P110, DOI 10.1128/MCB.18.1.110; Ling H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054499; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; MCELRATH MJ, 1989, P NATL ACAD SCI USA, V86, P675, DOI 10.1073/pnas.86.2.675; McIntyre Glen J, 2011, Genet Vaccines Ther, V9, P9, DOI 10.1186/1479-0556-9-9; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NOUCHI T, 1991, LIVER, V11, P100; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P369, DOI 10.1080/17402520600645712; Preaux AM, 1999, HEPATOLOGY, V30, P944, DOI 10.1002/hep.510300432; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88934	10.1371/journal.pone.0088934	http://dx.doi.org/10.1371/journal.pone.0088934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551192	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000083
J	Fazal, L; Azibani, F; Bihry, N; Coutance, G; Polidano, E; Merval, R; Vodovar, N; Launay, JM; Delcayre, C; Samuel, JL				Fazal, Loubina; Azibani, Feriel; Bihry, Nicolas; Coutance, Guillaume; Polidano, Evelyne; Merval, Regine; Vodovar, Nicolas; Launay, Jean-Marie; Delcayre, Claude; Samuel, Jane-Lise			Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice	FASEB JOURNAL			English	Article						physiopathology; heart; insulin; IGF-1 receptor	MINERALOCORTICOID RECEPTOR ANTAGONISTS; HEART-FAILURE; INSULIN-RESISTANCE; GROWTH-FACTOR; CARDIOVASCULAR-SYSTEM; ENDOTHELIAL FUNCTION; CARDIAC FIBROSIS; ANIMAL-MODELS; ANGIOGENESIS; DYSFUNCTION	Studies have shown that aldosterone would have angiogenic effects and therefore would be beneficial in the context of cardiovascular diseases. We thus investigated the potential involvement of aldosterone in triggering a cardiac angiogenic response in the context of type-2 diabetes and the molecular pathways involved. Male 3-wk-old aldosterone synthase (AS)-overexpressing mice and their control wild-type (WT) littermates were fed a standard or high-fat, high-sucrose (HFHS) diet. After 6 mo of diet treatment, mice were euthanized, and cardiac samples were assayed by RT-PCR, immunoblotting, and immunohistology. HFHS diet induced type-2 diabetes in WT (WT-D) and AS (AS-D) mice. VEGFa mRNAs decreased in WT-D (-43%, P<0.05 vs. WT) and increased in AS-D mice (+236%, P<0.01 vs. WT-D). In WT-D mouse hearts, the proapoptotic p38MAPK was activated (P<0.05 vs. WT and AS-D), whereas Akt activity decreased (-64%, P<0.05 vs. WT). The AS mice, which exhibited a cardiac up-regulation of IGF1-R, showed an increase in Akt phosphorylation when diabetes was induced (P<0.05 vs. WT and AS-D). Contrary to WT-D mice, AS-D mouse hearts did not express inflammatory markers and exhibited a normal capillary density (P<0.05 vs. WT-D). To our knowledge, this is the first study providing new insights into the mechanisms whereby aldosterone prevents diabetes-induced cardiac disorders.	[Fazal, Loubina; Azibani, Feriel; Bihry, Nicolas; Coutance, Guillaume; Polidano, Evelyne; Merval, Regine; Vodovar, Nicolas; Launay, Jean-Marie; Delcayre, Claude; Samuel, Jane-Lise] Hop Lariboisiere, INSERM, UMR S 942, F-75475 Paris 10, France; [Bihry, Nicolas; Launay, Jean-Marie; Samuel, Jane-Lise] Hop Lariboisiere, Assistance Publ Hop Paris AP HP, Dept Biochem, F-75475 Paris, France; [Fazal, Loubina; Coutance, Guillaume; Delcayre, Claude; Samuel, Jane-Lise] Paris Diderot Univ, Paris, France; [Launay, Jean-Marie] Paris Descartes Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Samuel, JL (corresponding author), Hop Lariboisiere, INSERM, UMR S 942, 41 Blvd Chapelle, F-75475 Paris 10, France.	jane-lise.samuel@inserm.fr	Coutance, Guillaume/ABE-9491-2020; Vodovar, Nicolas/S-2947-2019	Coutance, Guillaume/0000-0003-4939-2175; Samuel, Jane-Lise/0000-0002-7346-2404; Vodovar, Nicolas/0000-0001-8087-387X	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris-Diderot; Fondation de France; Interface grant INSERM-Assistance Publique-Hopitaux de Paris (APHP); Societe Francaise d'Hypertension Arterielle (SFHTA); Universite Paris Diderot; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); European Commission [305507]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Diderot; Fondation de France(Fondation de France); Interface grant INSERM-Assistance Publique-Hopitaux de Paris (APHP); Societe Francaise d'Hypertension Arterielle (SFHTA); Universite Paris Diderot; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Paris-Diderot, the Fondation de France, Interface grant INSERM-Assistance Publique-Hopitaux de Paris (APHP) and the Societe Francaise d'Hypertension Arterielle (SFHTA). L.F. is supported by a Ph.D. training grant from Universite Paris Diderot and Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC). N.V. is supported by a postdoctoral fellowship from the European Commission's Seventh Framework program under grant agreement 305507 (HOMAGE). The authors declare no conflicts of interest. L.F., C.D., and J.L.S. wrote the manuscript, researched and analyzed data, and contributed to discussion of data; F.A., J.M.L., and N.V. participated in the discussion and reviewed the manuscript; J.M.L., E.P., and R.M. researched data; N.B. and G.C. performed the echocardiography on mice; C.D. contributed to design of the experiments and discussion and reviewed and edited the manuscript; J.L.S. is the guarantor of this work and, as such, had access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Abbas A, 2011, DIABETES, V60, P2169, DOI 10.2337/db11-0197; Azibani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038197; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Cascella T, 2010, ENDOCRINOLOGY, V151, P5851, DOI 10.1210/en.2010-0350; Chatzigeorgiou A, 2009, IN VIVO, V23, P245; Cohen-Solal A, 2008, J CARD FAIL, V14, P615, DOI 10.1016/j.cardfail.2008.04.001; Cook SA, 2010, EUR HEART J, V31, P100, DOI 10.1093/eurheartj/ehp396; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Davies JI, 2004, DIABETOLOGIA, V47, P1687, DOI 10.1007/s00125-004-1510-8; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Garnier A, 2004, CIRCULATION, V110, P1819, DOI 10.1161/01.CIR.0000142858.44680.27; Gray S, 2011, TRENDS ENDOCRIN MET, V22, P394, DOI 10.1016/j.tem.2011.05.001; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huynh K, 2012, DIABETOLOGIA, V55, P1544, DOI 10.1007/s00125-012-2495-3; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Kaji K, 2010, HEPATOL RES, V40, P540, DOI 10.1111/j.1872-034X.2010.00636.x; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kim JK, 2005, DIABETES, V54, P1657, DOI 10.2337/diabetes.54.6.1657; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; Lastra G, 2010, NAT REV CARDIOL, V7, P577, DOI 10.1038/nrcardio.2010.123; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Maron BA, 2008, CURR OPIN INVEST DR, V9, P963; Messaoudi S, 2009, FASEB J, V23, P2176, DOI 10.1096/fj.08-125302; Michel F, 2004, CIRCULATION, V109, P1933, DOI 10.1161/01.CIR.0000127112.36796.9B; Milliez P, 2009, AM J PHYSIOL-HEART C, V296, pH435, DOI 10.1152/ajpheart.00591.2008; O'Neill BT, 2005, J CLIN INVEST, V115, P2059, DOI 10.1172/JCI25900; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Zannad F, 2012, EUR HEART J, V33, P2782, DOI 10.1093/eurheartj/ehs257	36	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2430	2440		10.1096/fj.13-239822	http://dx.doi.org/10.1096/fj.13-239822			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24558200				2022-12-25	WOS:000339883600005
J	Ghosh, S; Wanders, D; Stone, KP; Van, NT; Cortez, CC; Gettys, TW				Ghosh, Sujoy; Wanders, Desiree; Stone, Kirsten P.; Van, Nancy T.; Cortez, Cory C.; Gettys, Thomas W.			A systems biology analysis of the unique and overlapping transcriptional responses to caloric restriction and dietary methionine restriction in rats	FASEB JOURNAL			English	Article						obesity; animal models; insulin sensitivity; amino acid sensing	AMINO-ACID STARVATION; ADIPOSE-TISSUE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; ACTIN CYTOSKELETON; SIGNAL TRANSDUCER; OXIDATIVE STRESS; INFLAMMATION; ADIPOGENESIS; METABOLISM	Dietary methionine restriction (MR) and calorie restriction (CR) each improve metabolic health and extend life span. We used comprehensive transcriptome profiling and systems biology analysis to interrogate the unique and overlapping molecular responses in rats provided these dietary regimens for 20 mo after weaning. Microarray analysis was conducted on inguinal white adipose (IWAT), brown adipose tissue (BAT), liver, and skeletal muscle. Compared to controls, CR-induced transcriptomic responses (absolute fold change >= 1.5 and P <= 0.05) were comparable in IWAT, BAT, and liver (similar to 800 genes). MR-induced effects were largely restricted to IWAT and liver (similar to 2400 genes). Pathway enrichment and gene-coexpression analyses showed that induction of fatty acid synthesis in IWAT was common to CR and MR, whereas immunity and proinflammatory signaling pathways were specifically down-regulated in MR-treated IWAT and liver (FDR <= 0.07-0.3). BAT demonstrated consistent down-regulation of PPAR-signaling under CR and MR, whereas muscle was largely unaffected. Interactome analysis identified CR-specific down-regulation of cytoskeletal matrix components in IWAT and MR-specific up-regulation of ribosomal genes in liver (FDR <= 0.001). Transcriptomic down-regulation of inflammation genes by MR in IWAT was consistent with upstream inhibition of STAT3. Together, these results provide an integrated picture of the breadth of transcriptional responses to MR and CR among key metabolic tissues.	[Ghosh, Sujoy; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Computat Biol, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy; Wanders, Desiree; Stone, Kirsten P.; Van, Nancy T.; Cortez, Cory C.; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy] Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Res Program, Singapore, Singapore	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National University of Singapore	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Gettys, Thomas W/N-1964-2017; Ghosh, Sujoy/I-3729-2017; Stone, Kirsten/AAB-3804-2019	Gettys, Thomas W/0000-0001-7125-7995; Ghosh, Sujoy/0000-0002-7601-165X; Stone, Kirsten/0000-0001-5511-1638; Wanders, Desiree/0000-0003-2638-3954	American Diabetes Association (ADA) [1-12-BS-58]; U.S. National Institutes of Health (NIH) [DK-096311]; ADA [7-13-MI-05]; NIH [1F32DK098918-01, P20-GM103528, P30 DK072476]; Mouse Metabolic Phenotyping Center Consortium (NIH) [U24DK076169]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK098918, R01DK096311, U24DK076169, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mouse Metabolic Phenotyping Center Consortium (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Diabetes Association (ADA) grant 1-12-BS-58 (T.W.G.), U.S. National Institutes of Health (NIH) grant DK-096311 (T.W.G.), ADA grant 7-13-MI-05 (T.W.G.), NIH grant 1F32DK098918-01 (D.W.), and the Mouse Metabolic Phenotyping Center Consortium (NIH grant U24DK076169). This work also made use of the Genomics and the Cell Biology and Bioimaging core facilities at the Pennington Biomedical Research Center, supported by NIH grants P20-GM103528 (T.W.G.) and P30 DK072476. The authors acknowledge the excellent technical assistance of Kelly Dille and Mollye Baker, and the clerical support of Cindi Tramonte.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Deyl Z, 1975, Adv Exp Med Biol, V53, P359; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Higami Y, 2006, J NUTR, V136, P343, DOI 10.1093/jn/136.2.343; HITOMI Y, 1993, BIOSCI BIOTECH BIOCH, V57, P1216, DOI 10.1271/bbb.57.1216; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huffman DM, 2010, INTERD T GERONT GERI, V37, P1, DOI 10.1159/000319991; Huffman DM, 2009, BBA-GEN SUBJECTS, V1790, P1117, DOI 10.1016/j.bbagen.2009.01.008; Ishii K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-37; Jhun JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078843; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kimball SR, 2002, J NUTR, V132, P883; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; MCCAY CM, 1989, NUTRITION, V5, P155; MCGOWN E, 1973, J NUTR, V103, P109, DOI 10.1093/jn/103.1.109; Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; O'Sullivan K. E., 2013, J GASTROINTEST CANC; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; ORENTREICH N, 1993, J NUTR, V123, P269; Petrovic V, 2006, COMP BIOCHEM PHYS C, V142, P60, DOI 10.1016/j.cbpc.2005.10.004; Priceman SJ, 2013, P NATL ACAD SCI USA, V110, P13079, DOI 10.1073/pnas.1311557110; Prifti E, 2010, BIOINFORMATICS, V26, P3083, DOI 10.1093/bioinformatics/btq591; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Schiller ZA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt230; Simon R, 2007, CANCER INFORM, V3, P11; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Wanders D, 2014, BIOFACTORS, V40, P13, DOI 10.1002/biof.1111; Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhou Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-109	53	33	33	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2014	28	6					2577	2590		10.1096/fj.14-249458	http://dx.doi.org/10.1096/fj.14-249458			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AM5GA	24571921	Green Published			2022-12-25	WOS:000339883600017
J	Tan, KM; Chhor, G; Binkowski, TA; Jedrzejczak, RP; Makowska-Grzyska, M; Joachimiak, A				Tan, Kemin; Chhor, Gekleng; Binkowski, T. Andrew; Jedrzejczak, Robert P.; Makowska-Grzyska, Magdalena; Joachimiak, Andrzej			Sensor Domain of Histidine Kinase KinB of Pseudomonas A HELIX- SWAPPED DIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Biosensors; Histidine Kinases; Protein Conformation; Protein Structure; Alginate Biosynthesis; Helix-swapped Dimer; Sensor Domain; Two-component System	LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; LIGHT-SCATTERING; AERUGINOSA; PROTEINS; MECHANISM; VIRULENCE; RECEPTOR	Background: The sensor domain (SD) of histidine kinase (HK) KinB (KinB-SD) receives signals from the environment and induces a transduction cascade. Results: Structures of the KinB-SD were obtained in ligand-free, phosphate-bound, and mutant forms. Conclusion: The unique helix-swapped KinB-SD structure forms a ligand-binding cavity on the dimer interface. Significance: KinB-SD studies provide insights into the signal transduction and identity of potential signaling molecules. The overproduction of polysaccharide alginate is responsible for the formation of mucus in the lungs of cystic fibrosis patients. Histidine kinase KinB of the KinB-AlgB two-component system in Pseudomonas aeruginosa acts as a negative regulator of alginate biosynthesis. The modular architecture of KinB is similar to other histidine kinases. However, its periplasmic signal sensor domain is unique and is found only in the Pseudomonas genus. Here, we present the first crystal structures of the KinB sensor domain. The domain is a dimer in solution, and in the crystal it shows an atypical dimer of a helix-swapped four-helix bundle. A positively charged cavity is formed on the dimer interface and involves several strictly conserved residues, including Arg-60. A phosphate anion is bound asymmetrically in one of the structures. In silico docking identified several monophosphorylated sugars, including -d-fructose 6-phosphate and -d-mannose 6-phosphate, a precursor and an intermediate of alginate synthesis, respectively, as potential KinB ligands. Ligand binding was confirmed experimentally. Conformational transition from a symmetric to an asymmetric structure and decreasing dimer stability caused by ligand binding may be a part of the signal transduction mechanism of the KinB-AlgB two-component system.	[Tan, Kemin; Chhor, Gekleng; Binkowski, T. Andrew; Jedrzejczak, Robert P.; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Tan, Kemin; Makowska-Grzyska, Magdalena; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Joachimiak, A (corresponding author), Argonne Natl Lab, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209	Office of Science of the United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM094585] Funding Source: NIH RePORTER	Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Structural Biology Center at Argonne National Laboratory for their help with data collection at the 19-ID beamline and Kimberly S. Buck for help with cloning. This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-06CH11357.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chand NS, 2012, J BACTERIOL, V194, P6537, DOI 10.1128/JB.01168-12; Chand NS, 2011, VIRULENCE, V2, P553, DOI 10.4161/viru.2.6.17987; Chand NS, 2011, J BACTERIOL, V193, P2989, DOI 10.1128/JB.01546-10; Chang C, 2010, J BACTERIOL, V192, P1156, DOI 10.1128/JB.01508-09; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Cheung J, 2009, PROTEINS, V77, P235, DOI 10.1002/prot.22485; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; DERETIC V, 1987, J BACTERIOL, V169, P351, DOI 10.1128/jb.169.1.351-358.1987; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulik V, 2002, J MOL BIOL, V324, P677, DOI 10.1016/S0022-2836(02)01109-9; Lee D, 2013, PHYS CHEM CHEM PHYS, V15, P5844, DOI 10.1039/c3cp00160a; LIN SL, 1995, J MOL BIOL, V248, P151, DOI 10.1006/jmbi.1995.0208; Lowe EC, 2012, P NATL ACAD SCI USA, V109, P7298, DOI 10.1073/pnas.1200479109; Ma S, 1997, J BIOL CHEM, V272, P17952, DOI 10.1074/jbc.272.29.17952; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moore JO, 2009, STRUCTURE, V17, P1195, DOI 10.1016/j.str.2009.07.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; Soetens JC, 1997, J PHYS CHEM B, V101, P10910, DOI 10.1021/jp972113j; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wu R, 2013, PROTEIN SCI, V22, P564, DOI 10.1002/pro.2237; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	59	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12232	12244		10.1074/jbc.M113.514836	http://dx.doi.org/10.1074/jbc.M113.514836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24573685	Green Published, hybrid			2022-12-25	WOS:000335581400005
J	Batra, N; Riquelme, MA; Burra, S; Kar, R; Gu, SM; Jiang, JX				Batra, Nidhi; Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Gu, Sumin; Jiang, Jean X.			Direct Regulation of Osteocytic Connexin 43 Hemichannels through AKT Kinase Activated by Mechanical Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Connexin; Integrin; Mechanotransduction; Phosphorylation	GAP-JUNCTIONS; ATP RELEASE; BONE; PHOSPHORYLATION; CHANNELS; CELLS; MECHANOTRANSDUCTION; PROSTAGLANDIN; ASTROCYTES; DIVERSITY	Background: Opening of Cx43 hemichannels by mechanical stress releases factors important for bone remodeling; however, the regulatory mechanism is unknown. Result: Upon mechanical stimulation, AKT phosphorylates integrin 5 and Cx43, increases interaction, and opens hemichannels. Conclusion: Phosphorylation of Cx43 and 5 by AKT is critical for hemichannel opening. Significance: This is the first report demonstrating the functional importance of AKT in regulation of Cx43 hemichannels. Connexin (Cx) 43 hemichannels in osteocytes are thought to play a critical role in releasing bone modulators in response to mechanical loading, a process important for bone formation and remodeling. However, the underlying mechanism that regulates the opening of mechanosensitive hemichannels is largely unknown. We have recently shown that Cx43 and integrin 5 interact directly with each other, and activation of PI3K appears to be required for Cx43 hemichannel opening by mechanical stimulation. Here, we show that mechanical loading through fluid flow shear stress (FFSS) increased the level of active AKT, a downstream effector of PI3K, which is correlated with the opening of hemichannels. Both Cx43 and integrin 5 are directly phosphorylated by AKT. Inhibition of AKT activation significantly reduced FFSS-induced opening of hemichannels and disrupted the interaction between Cx43 and integrin 5. Moreover, AKT phosphorylation on Cx43 and integrin 5 enhanced their interaction. In contrast to the C terminus of wild-type Cx43, overexpression of the C-terminal mutant containing S373A, a consensus site previously shown to be phosphorylated by AKT, failed to bind with 5 and hence could not inhibit hemichannel opening. Together, our results suggest that AKT activated by FFSS directly phosphorylates Cx43 and integrin 5, and Ser-373 of Cx43 plays a predominant role in mediating the interaction between these two proteins and Cx43 hemichannel opening, a crucial step to mediate the anabolic function of mechanical loading in the bone.	[Batra, Nidhi; Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Gu, Sumin; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085, AR46798]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R01EY012085, R29EY012085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012085 and AR46798. This work was also supported by Welch Foundation Grant AQ-1507 (to J. X. J).	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone S, 2001, FASEB J, V15, P10; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yogo K, 2006, J REPROD DEVELOP, V52, P321, DOI 10.1262/jrd.17107	28	57	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10582	10591		10.1074/jbc.M114.550608	http://dx.doi.org/10.1074/jbc.M114.550608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563481	Green Published, hybrid			2022-12-25	WOS:000334226400030
J	Xu, YK; Lindemann, P; Vega-Ramos, J; Zhang, JG; Villadangos, JA				Xu, Yuekang; Lindemann, Petra; Vega-Ramos, Javier; Zhang, Jian-Guo; Villadangos, Jose A.			Developmental Regulation of Synthesis and Dimerization of the Amyloidogenic Protease Inhibitor Cystatin C in the Hematopoietic System*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Cells; Macrophages; Protease Inhibitor; Protein Folding; Reactive Oxygen Species (ROS); Amyloidosis; Vascular Angiopathy	MURINE DENDRITIC CELLS; ALZHEIMERS-DISEASE; TYROSINE KINASE; GM-CSF; ATHEROSCLEROSIS; MONOCYTES; BETA; INFLAMMATION; DEGRADATION; MACROPHAGES	Background: Dimerization of cystatin C initiates formation of amyloid fibrils in vascular walls. Results: Reactive oxygen species regulate cystatin C dimerization in cells of the hematopoietic system, which are major contributors to the total pool of circulating cystatin C. Conclusion: Cystatin C dimerization is regulated in hematopoietic cells. Significance: Cystatin C synthesis and dimerization might be manipulated for therapeutic gain. The cysteine protease inhibitor cystatin C is thought to be secreted by most cells and eliminated in the kidneys, so its concentration in plasma is diagnostic of kidney function. Low extracellular cystatin C is linked to pathologic protease activity in cancer, arthritis, atherosclerosis, aortic aneurism, and emphysema. Cystatin C forms non-inhibitory dimers and aggregates by a mechanism known as domain swapping, a property that reportedly protects against Alzheimer disease but can also cause amyloid angiopathy. Despite these clinical associations, little is known about the regulation of cystatin C production, dimerization, and secretion. We show that hematopoietic cells are major contributors to extracellular cystatin C levels in healthy mice. Among these cells, macrophages and dendritic cells (DC) are the predominant producers of cystatin C. Both cell types synthesize monomeric and dimeric cystatin C in vivo, but only secrete monomer. Dimerization occurs co-translationally in the endoplasmic reticulum and is regulated by the levels of reactive oxygen species (ROS) derived from mitochondria. Drugs or stimuli that reduce the intracellular concentration of ROS inhibit cystatin C dimerization. The extracellular concentration of inhibitory cystatin C is thus partly dependent on the abundance of macrophages and DC, and the ROS levels. These results have implications for the diagnostic use of serum cystatin C as a marker of kidney function during inflammatory processes that induce changes in DC or macrophage abundance. They also suggest an important role for macrophages, DC, and ROS in diseases associated with the protease inhibitory activity or amyloidogenic properties of cystatin C.	[Xu, Yuekang; Lindemann, Petra; Villadangos, Jose A.] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3052, Australia; [Zhang, Jian-Guo] Walter & Eliza Hall Inst Med Res, Div Canc & Haematol, Melbourne, Vic 3052, Australia; [Xu, Yuekang; Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Inst, Melbourne, Vic 3010, Australia; [Vega-Ramos, Javier; Villadangos, Jose A.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Xu, YK (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3052, Australia.	yuekangx@unimelb.edu.au; j.villadangos@unimelb.edu.au	Villadangos, Jose A/AAU-1404-2020; Vega-Ramos, Javier/A-9931-2015	Villadangos, Jose A/0000-0001-6771-8891; Vega-Ramos, Javier/0000-0002-9516-3624	National Health and Medical Research Council (NHMRC) of Australia [1006428, 461219]; Victorian Government's Operational Infrastructure Support Program; Gottlieb Daimler and Karl Benz Foundation Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Gottlieb Daimler and Karl Benz Foundation Fellowship	This work was supported in part by National Health and Medical Research Council (NHMRC) of Australia Grants 1006428 (to Y. X.) and 461219 (to J. G. Z.) and the Victorian Government's Operational Infrastructure Support Program.; Formerly known as Petra Schnorrer. Supported by a Gottlieb Daimler and Karl Benz Foundation Fellowship. Present address: Structural and Computational Biology Unit, EMBL Heidelberg, 69117 Heidelberg, Germany.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bobryshev YV, 2010, LAB INVEST, V90, P970, DOI 10.1038/labinvest.2010.94; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; El-Sukkari D, 2003, J IMMUNOL, V171, P5003, DOI 10.4049/jimmunol.171.10.5003; Evangelopoulos AA, 2012, INTERN MED J, V42, P517, DOI 10.1111/j.1445-5994.2011.02500.x; Ganda A, 2013, CIRCULATION, V127, P988, DOI 10.1161/CIRCULATIONAHA.112.000682; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Grubb A, 2010, SCAND J CLIN LAB INV, V70, P65, DOI 10.3109/00365511003642535; Henskens YMC, 1996, BIOL CHEM H-S, V377, P71; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; Keppler D, 2006, CANCER LETT, V235, P159, DOI 10.1016/j.canlet.2005.04.001; Kim CC, 2013, CURR OPIN IMMUNOL, V25, P593, DOI 10.1016/j.coi.2013.09.013; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Merz GS, 1997, J CELL PHYSIOL, V173, P423; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mi WQ, 2009, J ALZHEIMERS DIS, V18, P273, DOI 10.3233/JAD-2009-1147; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Nishiyama K, 2005, BRAIN RES BULL, V67, P94, DOI 10.1016/j.brainresbull.2005.05.020; PALSDOTTIR A, 1988, LANCET, V2, P603; Palsdottir A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000099; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; Rokadia HK, 2012, LUNG, V190, P283, DOI 10.1007/s00408-012-9374-z; Rosenfeld ME, 1998, SEMIN REPROD ENDOCR, V16, P249, DOI 10.1055/s-2007-1016285; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Smith ER, 2013, ATHEROSCLEROSIS, V230, P73, DOI 10.1016/j.atherosclerosis.2013.06.023; Sukhova GK, 2005, CIRC RES, V96, P368, DOI 10.1161/01.RES.0000155964.34150.F7; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Tizon B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009819; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; WARFEL AH, 1987, J EXP MED, V166, P1912, DOI 10.1084/jem.166.6.1912; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Xu YK, 2012, IMMUNOL CELL BIOL, V90, P903, DOI 10.1038/icb.2012.31; Xu YK, 2011, J IMMUNOL, V186, P3666, DOI 10.4049/jimmunol.1001934; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477	49	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9730	9740		10.1074/jbc.M113.538041	http://dx.doi.org/10.1074/jbc.M113.538041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24570004	hybrid, Green Published			2022-12-25	WOS:000333807000025
J	Appelt, S; Armougom, F; Le Bailly, M; Robert, C; Drancourt, M				Appelt, Sandra; Armougom, Fabrice; Le Bailly, Matthieu; Robert, Catherine; Drancourt, Michel			Polyphasic Analysis of a Middle Ages Coprolite Microbiota, Belgium	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; ANCIENT DNA; GUT MICROBIOME; BACTERIAL-DNA; IDENTIFICATION; ACANTHAMOEBAE; PHYLOGENIES; ASCARIS; IMPACT; COLON	Paleomicrobiological investigations of a 14th-century coprolite found inside a barrel in Namur, Belgium were done using microscopy, a culture-dependent approach and metagenomics. Results were confirmed by ad hoc PCR - sequencing. Investigations yielded evidence for flora from ancient environment preserved inside the coprolite, indicated by microscopic observation of amoebal cysts, plant fibers, seeds, pollens and mold remains. Seventeen different bacterial species were cultured from the coprolite, mixing organisms known to originate from the environment and organisms known to be gut inhabitants. Metagenomic analyses yielded 107,470 reads, of which known sequences (31.9%) comprised 98.98% bacterial, 0.52% eukaryotic, 0.44% archaeal and 0.06% viral assigned reads. Most abundant bacterial phyla were Proteobacteria, Gemmatimonadetes, Actinobacteria and Bacteroidetes. The 16 S rRNA gene dataset yielded 132,000 trimmed reads and 673 Operational Taxonomic Units. Most abundant bacterial phyla observed in the 16 S rRNA gene dataset belonged to Proteobacteria, Firmicutes, Actinobacteria and Chlamydia. The Namur coprolite yielded typical gut microbiota inhabitants, intestinal parasites Trichuris and Ascaris and systemic pathogens Bartonella and Bordetella. This study adds knowledge to gut microbiota in medieval times.	[Appelt, Sandra; Armougom, Fabrice; Robert, Catherine; Drancourt, Michel] Aix Marseille Univ, Ctr Natl Rech Sci 7278, Inst Natl Sante & Rech Med 1095,IRD 198, Unite Rech Malad Infect Trop Emergentes,UM63, Marseille, France; [Le Bailly, Matthieu] Univ Franche Comte, Ctr Natl Rech Sci, UMR Chronoenvironm 6249, F-25030 Besancon, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte	Drancourt, M (corresponding author), Aix Marseille Univ, Ctr Natl Rech Sci 7278, Inst Natl Sante & Rech Med 1095,IRD 198, Unite Rech Malad Infect Trop Emergentes,UM63, Marseille, France.	Michel.Drancourt@medicine.univ-mrs.fr	Le Bailly, Matthieu/AAA-2977-2019	Le Bailly, Matthieu/0000-0001-6320-6741				Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cleeland LM, 2013, J ARCHAEOL SCI, V40, P3060, DOI 10.1016/j.jas.2013.03.010; Cooper A, 2000, SCIENCE, V289, P1139; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; da Rocha GC, 2009, REV BRAS PARASITOL V, V18, P70, DOI 10.4322/rbpv.01803013; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Chaves SAD, 2006, PALAEOGEOGR PALAEOCL, V237, P110, DOI 10.1016/j.palaeo.2005.11.031; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dittmar K, 2009, J PARASITOL, V95, P365, DOI 10.1645/GE-1676.1; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Khechine A, 2009, MICROBIOL-SGM, V155, P2384, DOI 10.1099/mic.0.026484-0; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Giongo A, 2010, DIVERSITY-BASEL, V2, P1015, DOI DOI 10.3390/d2071015; Glass E. M., 2010, COLD SPRING HARB PRO, V2010; Greenberg DE, 2006, PLOS PATHOG, V2, P260, DOI [10.1371/journal.ppat.0020028, 10.1382/journal.ppat.0020028]; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iniguez AM, 2006, INT J PARASITOL, V36, P1419, DOI 10.1016/j.ijpara.2006.07.005; Jirku M, 2012, EMERG INFECT DIS, V18, P634, DOI 10.3201/eid1804.110984; Keita AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054679; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Loreille O, 2001, INT J PARASITOL, V31, P1101, DOI 10.1016/S0020-7519(01)00214-4; Luciani S, 2006, AM J PHYS ANTHROPOL, V129, P620, DOI 10.1002/ajpa.20314; Maggi RG., 2011, MANUAL CLIN MICROBIO, P786; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Oh CS, 2010, MEM I OSWALDO CRUZ, V105, P225, DOI 10.1590/S0074-02762010000200020; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rollo Franco, 2006, Med Secoli, V18, P725; Santiago-Rodriguez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065191; Schlaberg R, 2012, EMERG INFECT DIS, V18, P422, DOI 10.3201/eid1803.111481; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Seng P, 2013, J CLIN MICROBIOL, V51, P2182, DOI 10.1128/JCM.00492-13; Sheorey H, 2011, MANUAL CLIN MICROBIO, P2200; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Tito RY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003703; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubaldi M, 1998, AM J PHYS ANTHROPOL, V107, P285, DOI 10.1002/(SICI)1096-8644(199811)107:3<285::AID-AJPA5>3.0.CO;2-U; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Von Konig CHW, 2011, MANUAL CLIN MICROBIO, V1, P739; Watanabe K, 2008, CURR MICROBIOL, V56, P458, DOI 10.1007/s00284-008-9107-y; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	58	33	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88376	10.1371/journal.pone.0088376	http://dx.doi.org/10.1371/journal.pone.0088376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586319	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200016
J	Englund, UH; Gertow, J; Kagedal, K; Elinder, F				Englund, Ulrika H.; Gertow, Jens; Kagedal, Katarina; Elinder, Fredrik			A Voltage Dependent Non-Inactivating Na+ Channel Activated during Apoptosis in Xenopus Oocytes	PLOS ONE			English	Article							VOLUME DECREASE; CELL SHRINKAGE; NEURONAL APOPTOSIS; POTASSIUM CHANNELS; NA+/CA2+ EXCHANGER; CASPASE ACTIVATION; SODIUM-CHANNELS; ION; DEPOLARIZATION; DEATH	Ion channels in the plasma membrane are important for the apoptotic process. Different types of voltage-gated ion channels are up-regulated early in the apoptotic process and block of these channels prevents or delays apoptosis. In the present investigation we examined whether ion channels are up-regulated in oocytes from the frog Xenopus laevis during apoptosis. The two-electrode voltage-clamp technique was used to record endogenous ion currents in the oocytes. During staurosporine-induced apoptosis a voltage-dependent Na+ current increased three-fold. This current was activated at voltages more positive than 0 mV (midpoint of the open-probability curve was +55 mV) and showed almost no sign of inactivation during a 1-s pulse. The current was resistant to the Na+-channel blockers tetrodotoxin (1 mM) and amiloride (10 mM), while the Ca2+-channel blocker verapamil (50 mM) in the bath solution completely blocked the current. The intracellular Na+ concentration increased in staurosporine-treated oocytes, but could be prevented by replacing extracellular Na+ whith either K+ or Choline(+). Prevention of this influx of Na+ also prevented the STS-induced up-regulation of the caspase-3 activity, suggesting that the intracellular Na+ increase is required to induce apoptosis. Taken together, we have found that a voltage dependent Na+ channel is up-regulated during apoptosis and that influx of Na+ is a crucial step in the apoptotic process in Xenopus oocytes.	[Englund, Ulrika H.; Gertow, Jens; Kagedal, Katarina; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Elinder, F (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	fredrik.elinder@liu.se		Elinder, Fredrik/0000-0001-9125-5583; Gertow, Jens/0000-0002-5663-7209	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victoria's Freemasons Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victoria's Freemasons Foundation	This work was supported by the Swedish Research Council (www.vr.se), the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se), the Swedish Brain Foundation (www.hjarnfonden.se), the County Council of Ostergotland (www.lio.se), and the King Gustaf V and Queen Victoria's Freemasons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JN, 1997, METHODS ENZYMOLOGY, V207; Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Akanda N, 2006, BIOPHYS J, V90, P4405, DOI 10.1529/biophysj.105.080028; Ali S, 2010, IEEE T, P1, DOI [10.1109/TNANO.2010.2089696, DOI 10.1109/TNAN0.2010.2089696]; Armstrong CM, 2003, P NATL ACAD SCI USA, V100, P6257, DOI 10.1073/pnas.0931278100; Arrebola F, 2005, APOPTOSIS, V10, P1317, DOI 10.1007/s10495-005-2718-x; Arrebola F, 2005, J CELL PHYSIOL, V204, P500, DOI 10.1002/jcp.20306; Asif MH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3176441; Asif MH, 2010, MATERIALS, V3, P4657, DOI 10.3390/ma3094657; Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; BAUD C, 1982, P NATL ACAD SCI-BIOL, V79, P3188, DOI 10.1073/pnas.79.10.3188; Borjesson SI, 2011, J BIOL CHEM, V286, P39823, DOI 10.1074/jbc.M111.262725; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Charpentier C, 2002, GEN PHYSL BIOPHYS, V21, P355; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Elinder F, 2005, CELL DEATH DIFFER, V12, P1134, DOI 10.1038/sj.cdd.4401646; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirn C, 2008, J GEN PHYSIOL, V132, P199, DOI 10.1085/jgp.200810024; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Johnson CE, 2010, CELL DEATH DIFFER, V17, P170, DOI 10.1038/cdd.2009.120; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Krumschnabel G, 2007, APOPTOSIS, V12, P1755, DOI 10.1007/s10495-007-0103-7; KUPITZ Y, 1993, SCIENCE, V261, P484, DOI 10.1126/science.8392753; Liu W, 2013, TOXICOL LETT, V224, P1, DOI [10.1016/j.toxlet.2013.10.009, DOI 10.1016/J.T0XLET.2013.10.009]; Madeja M, 2000, NEUROPHARMACOLOGY, V39, P202, DOI 10.1016/S0028-3908(99)00110-0; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Poulsen KA, 2010, AM J PHYSIOL-CELL PH, V298, pC14, DOI 10.1152/ajpcell.00654.2008; Roger S, 2004, BRIT J PHARMACOL, V141, P610, DOI 10.1038/sj.bjp.0705649; Rolf S, 2000, N-S ARCH PHARMACOL, V362, P22, DOI 10.1007/s002100000257; Singleton KR, 2009, EXP EYE RES, V89, P140, DOI 10.1016/j.exer.2009.02.023; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Ulukaya E, 2011, CELL BIOCHEM FUNCT, V29, P468, DOI 10.1002/cbf.1774; Vasilyev A, 2002, J MEMBRANE BIOL, V185, P237, DOI 10.1007/s00232-001-0126-x; WEBER WM, 1995, BBA-BIOMEMBRANES, V1239, P201, DOI 10.1016/0005-2736(95)00151-R; Wei L, 2004, PFLUG ARCH EUR J PHY, V448, P325, DOI 10.1007/s00424-004-1277-2; YAMAGISHI T, 1995, EUR J PHARMACOL, V281, P151, DOI 10.1016/0014-2999(95)00240-L; Yang DP, 2013, AM J NEPHROL, V37, P264, DOI 10.1159/000348526; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114	45	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88381	10.1371/journal.pone.0088381	http://dx.doi.org/10.1371/journal.pone.0088381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586320	Green Published, gold, Green Submitted			2022-12-25	WOS:000332396200017
J	Paterson, KB; McGowan, VA; White, SJ; Malik, S; Abedipour, L; Jordan, TR				Paterson, Kevin B.; McGowan, Victoria A.; White, Sarah J.; Malik, Sameen; Abedipour, Lily; Jordan, Timothy R.			Reading Direction and the Central Perceptual Span in Urdu and English	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; EYE-MOVEMENTS; INFORMATION; FIXATION; WORDS; RECOGNITION; ASYMMETRY; ATTENTION; HEBREW	Background: Normal reading relies on the reader making a series of saccadic eye movements along lines of text, separated by brief fixational pauses during which visual information is acquired from a region of text. In English and other alphabetic languages read from left to right, the region from which useful information is acquired during each fixational pause is generally reported to extend further to the right of each fixation than to the left. However, the asymmetry of the perceptual span for alphabetic languages read in the opposite direction (i.e., from right to left) has received much less attention. Accordingly, in order to more fully investigate the asymmetry in the perceptual span for these languages, the present research assessed the influence of reading direction on the perceptual span for bilingual readers of Urdu and English. Methods and Findings: Text in Urdu and English was presented either entirely as normal or in a gaze-contingent moving-window paradigm in which a region of text was displayed as normal at the reader's point of fixation and text outside this region was obscured. The windows of normal text extended symmetrically 0.5 degrees of visual angle to the left and right of fixation, or asymmetrically by increasing the size of each window to 1.5 degrees or 2.5 degrees to either the left or right of fixation. When participants read English, performance for the window conditions was superior when windows extended to the right. However, when reading Urdu, performance was superior when windows extended to the left, and was essentially the reverse of that observed for English. Conclusion: These findings provide a novel indication that the perceptual span is modified by the language being read to produce an asymmetry in the direction of reading and show for the first time that such an asymmetry occurs for reading Urdu.	[Paterson, Kevin B.; McGowan, Victoria A.; White, Sarah J.; Malik, Sameen; Abedipour, Lily; Jordan, Timothy R.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England	University of Leicester	Paterson, KB (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	kbp3@leicester.ac.uk	White, Sarah J/L-8411-2016	White, Sarah J/0000-0003-3943-7149; Paterson, Kevin/0000-0002-8150-8628; McGowan, Victoria/0000-0003-1956-1599				Adamson MM, 2006, NEUROPSYCHOLOGY, V20, P232, DOI 10.1037/0894-4105.20.2.232; Almabruk AAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018131; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Apel JK, 2012, PSYCHON B REV, V19, P1108, DOI 10.3758/s13423-012-0291-1; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; BRADSHAW JL, 1983, BEHAV BRAIN SCI, V6, P528, DOI 10.1017/S0140525X00073775; BRIIHL D, 1995, J EXP PSYCHOL LEARN, V21, P55, DOI 10.1037/0278-7393.21.1.55; CHIARELLO C, 1988, BRAIN COGNITION, V7, P394, DOI 10.1016/0278-2626(88)90014-0; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Eviatar Z, 2004, NEUROPSYCHOLOGY, V18, P174, DOI 10.1037/0894-4105.18.1.174; FAUST M, 1993, BRAIN LANG, V44, P254, DOI 10.1006/brln.1993.1017; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Haikio T, 2009, J EXP CHILD PSYCHOL, V102, P167, DOI 10.1016/j.jecp.2008.04.002; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Ibrahim R, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-3; Ibrahim R, 2009, NEUROPSYCHOLOGY, V23, P240, DOI 10.1037/a0014193; IKEDA M, 1978, VISION RES, V18, P83, DOI 10.1016/0042-6989(78)90080-9; Inhoff AW, 1998, J EXP PSYCHOL HUMAN, V24, P20, DOI 10.1037/0096-1523.24.1.20; Jordan TR, 2013, PSYCHON B REV, V20, P551, DOI 10.3758/s13423-012-0372-1; Jordan TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023957; Jordan TR, 2011, CORTEX, V47, P992, DOI 10.1016/j.cortex.2011.02.012; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Jordan TR, 2013, PSYCHON B IN PRESS; KORIAT A, 1985, BRIT J PSYCHOL, V76, P161, DOI 10.1111/j.2044-8295.1985.tb01939.x; LIMA SD, 1985, J EXP PSYCHOL HUMAN, V11, P272, DOI 10.1037/0096-1523.11.3.272; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; MCCONKIE GW, 1976, B PSYCHONOMIC SOC, V8, P365, DOI 10.3758/BF03335168; Miellet S, 2009, PSYCHOL SCI, V20, P721, DOI 10.1111/j.1467-9280.2009.02364.x; Mirdehghan M., 2010, WRITING SYSTEMS RES, V2, P9, DOI [https://doi.org/10.1093/wsr/wsq005, DOI 10.1093/WSR/WSQ005]; MORRISON RE, 1981, PERCEPT PSYCHOPHYS, V30, P395, DOI 10.3758/BF03206156; Patching GR, 2005, MEM COGNITION, V33, P961, DOI 10.3758/BF03193205; Patching GR, 2005, INVEST OPHTH VIS SCI, V46, P2219, DOI 10.1167/iovs.03-1247; POLLATSEK A, 1981, BRAIN LANG, V14, P174, DOI 10.1016/0093-934X(81)90073-0; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; RAYNER K, 1980, PERCEPT PSYCHOPHYS, V27, P537, DOI 10.3758/BF03198682; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; UNDERWOOD NR, 1985, READ RES QUART, V20, P153, DOI 10.2307/747752; White SJ, 2005, PSYCHON B REV, V12, P466, DOI 10.3758/BF03193789; Williams CC, 2006, J EXP PSYCHOL HUMAN, V32, P1072, DOI 10.1037/0096-1523.32.4.1072	43	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88358	10.1371/journal.pone.0088358	http://dx.doi.org/10.1371/journal.pone.0088358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586316	Green Published, gold, Green Submitted			2022-12-25	WOS:000332385900010
J	Gueguen, C; Palmier, B; Plotkine, M; Marchand-Leroux, C; Bessson, VC				Gueguen, Cindy; Palmier, Bruno; Plotkine, Michel; Marchand-Leroux, Catherine; Bessson, Valerie C.			Neurological and Histological Consequences Induced by In Vivo Cerebral Oxidative Stress: Evidence for Beneficial Effects of SRT1720, a Sirtuin 1 Activator, and Sirtuin 1-Mediated Neuroprotective Effects of Poly(ADP-ribose) Polymerase Inhibition	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PREVENTS NAD(+) DEPLETION; SMALL-MOLECULE ACTIVATORS; PROMOTES CELL-SURVIVAL; DNA-DAMAGE; PARP-1 INHIBITION; ARTERY OCCLUSION; NEURONAL DEATH; RAT; RESVERATROL	Poly(ADP-ribose) polymerase and sirtuin 1 are both NAD+-dependent enzymes. In vitro oxidative stress activates poly(ADPribose) polymerase, decreases NAD(+) level, sirtuin 1 activity and finally leads to cell death. Poly(ADP-ribose) polymerase hyperactivation contributes to cell death. In addition, poly(ADP-ribose) polymerase inhibition restores NAD(+) level and sirtuin 1 activity in vitro. In vitro sirtuin 1 induction protects neurons from cell loss induced by oxidative stress. In this context, the role of sirtuin 1 and its involvement in beneficial effects of poly(ADP-ribose) polymerase inhibition were evaluated in vivo in a model of cerebral oxidative stress induced by intrastriatal infusion of malonate in rat. Malonate promoted a NAD(+) decrease that was not prevented by 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, at 4 and 24 hours. However, 3-aminobenzamide increased nuclear SIRT1 activity/expression ratio after oxidative stress. Malonate induced a neurological deficit associated with a striatal lesion. Both were reduced by 3-aminobenzamide and SRT1720, a sirtuin 1 activator, showing beneficial effects of poly(ADP-ribose) polymerase inhibition and sirtuin 1 activation on oxidative stress consequences. EX527, a sirtuin 1 inhibitor, given alone, modified neither the score nor the lesion, suggesting that endogenous sirtuin 1 was not activated during cerebral oxidative stress. However, its association with 3-aminobenzamide suppressed the neurological improvement and the lesion reduction induced by 3-aminobenzamide. The association of 3-aminobenzamide with SRT1720, the sirtuin 1 activator, did not lead to a better protection than 3-aminobenzamide alone. The present data represent the first demonstration that the sirtuin 1 activator SRT1720 is neuroprotective during in vivo cerebral oxidative stress. Furthermore sirtuin 1 activation is involved in the beneficial effects of poly(ADP-ribose) polymerase inhibition after in vivo cerebral oxidative stress.	[Gueguen, Cindy; Palmier, Bruno; Plotkine, Michel; Marchand-Leroux, Catherine; Bessson, Valerie C.] Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Bessson, VC (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, Pharmacol Circulat Cerebrale EA4475, Paris, France.	valerie.besson@parisdescartes.fr	besson, valerie C/L-7388-2017; MARCHAND-LEROUX, Catherine/L-7453-2017; BESSON, VALERIE/AAZ-9989-2020	besson, valerie C/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; BESSON, VALERIE/0000-0002-1491-2380	Universite Paris Descartes; Fondation des Gueules Cassees	Universite Paris Descartes; Fondation des Gueules Cassees	This work was supported partly by Universite Paris Descartes and by a grant from the Fondation des Gueules Cassees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2011, BRAIN, V134, P1658, DOI 10.1093/brain/awr104; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Besson VC, 2003, FREE RADICAL RES, V37, P1201, DOI 10.1080/10715760310001612568; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Caito S, 2010, BIOCHEM BIOPH RES CO, V392, P264, DOI 10.1016/j.bbrc.2009.12.161; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Cosi C, 2000, AMINO ACIDS, V19, P229, DOI 10.1007/s007260070054; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Gupta YK, 2001, METHOD FIND EXP CLIN, V23, P241, DOI 10.1358/mf.2001.23.5.662120; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hoffmann E, 2013, BRIT J CLIN PHARMACO, V75, P186, DOI 10.1111/j.1365-2125.2012.04340.x; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ichikawa T, 2013, RESPIROLOGY, V18, P332, DOI 10.1111/j.1440-1843.2012.02284.x; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Komjati K, 2005, CNS NEUROL DISORD-DR, V4, P179, DOI 10.2174/1568007053544138; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Paucard A, 2005, FUND CLIN PHARMACOL, V19, P57, DOI 10.1111/j.1472-8206.2004.00297.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Velasquez DA, 2011, DIABETES, V60, P1177, DOI 10.2337/db10-0802; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	60	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e87367	10.1371/journal.pone.0087367	http://dx.doi.org/10.1371/journal.pone.0087367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586272	Green Published, gold, Green Submitted			2022-12-25	WOS:000331717900008
J	Lu, W; Yu, JL; Ai, Q; Liu, D; Song, C; Li, LQ				Lu, Wei; Yu, Jialin; Ai, Qing; Liu, Dong; Song, Chao; Li, Luquan			Increased Constituent Ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. and a Decrease in Microflora Diversity May Be Indicators of Ventilator-Associated Pneumonia: A Prospective Study in the Respiratory Tracts of Neonates	PLOS ONE			English	Article							DENTAL PLAQUE; COMMUNITY; DIAGNOSIS; DISEASE; IDENTIFICATION; INFECTIONS	Ventilator-associated pneumonia (VAP) is a common complication and cause of death in neonates on mechanical ventilation. However, it is difficult to define the causes of VAP. To understand the causes of VAP, we undertook a prospective study based on the diversity of the microflora in VAP. The experimental group consisted of newborns who suffered from respiratory distress syndrome (RDS) and VAP, while the control group suffered from RDS without VAP. Sputa were collected within 1, 3, and 5 days of ventilation and were divided into six groups. DNA was extracted from the samples, and the 16S rDNA was PCR amplified, separated using denaturing gradient gel electrophoresis (DGGE), cloned and sequenced. The resulting sequences were compared using BLAST. The DGGE pictures were measured, and the richness, Shannon-Wiener index, and cluster maps were analyzed. No differences were found regarding the constituent ratio of any genus between the Non-VAP and VAP group within 1 day after intubation. After 1 to 3 days, the constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. in the VAP group were higher than those in the Non-VAP group, and the ratios of Serratia sp. and Achromobacter sp. were lower. After 3 to 5 days, the ratios of Klebsiella sp., Acinetobacter sp., Serratia sp., and Achromobacter sp. were lower than those in the Non-VAP group. The richness and Shannon-Wiener index of the Non-VAP group were higher than those of the VAP group from 1 to 3 days after intubation, while no differences were found within 1 day and from 3 to 5 days. We conclude that during the first three days of intubation, the microflora diversity in the lower respiratory tract was reduced due to VAP, and the greater constituent ratios of Klebsiella sp., Acinetobacter sp., and Streptococcus sp. in the sputum may be indicators of VAP.	[Lu, Wei; Yu, Jialin; Liu, Dong; Song, Chao; Li, Luquan] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Lu, Wei; Yu, Jialin; Ai, Qing; Liu, Dong; Song, Chao; Li, Luquan] Chongqing Med Univ, Childrens Hosp, Pediat Res Inst, Chongqing, Peoples R China; [Lu, Wei; Yu, Jialin; Ai, Qing; Liu, Dong; Song, Chao; Li, Luquan] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorder, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yu, JL (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.	tongxunzuozhe@163.com			National Natural Science Foundation of China [8107513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant No. 8107513 from National Natural Science Foundation of China (General Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NA, 2009, ANTIMICROB AGENTS CH, V53, P4258, DOI 10.1128/AAC.00546-09; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Balter M, 2012, SCIENCE, V336, P1246, DOI 10.1126/science.336.6086.1246; Cairns S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014759; Cao M, 2011, J MICROBIOL, V49, P1000, DOI 10.1007/s12275-011-1523-1; Celik IH, 2012, EUR J PEDIATR, V171, P311, DOI 10.1007/s00431-011-1537-z; Chalmers NI, 2008, J BACTERIOL, V190, P8145, DOI 10.1128/JB.00983-08; Craven DE, 2011, CLIN CHEST MED, V32, P547, DOI 10.1016/j.ccm.2011.06.001; Gapon M. N., 2011, Klinicheskaya Laboratornaya Diagnostika, P18; Grgurich PE, 2013, CURR OPIN INFECT DIS, V26, P140, DOI 10.1097/QCO.0b013e32835ebbd0; Hamet M, 2012, INTENS CARE MED, V38, P1272, DOI 10.1007/s00134-012-2584-2; Hancock KL, 2012, AUST FAM PHYSICIAN, V41, P63; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Kellen berger E, 2001, EMBO REP, V2, P5; Kuziemski Arkadiusz, 2012, Przegl Epidemiol, V66, P403; Nazik H, 2012, SE ASIAN J TROP MED, V43, P1178; Payne MS, 2010, PEDIATR RES, V67, P412, DOI 10.1203/PDR.0b013e3181d026c3; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Pierce-Hendry S. A., 2010, COMPEND CONTIN ED VE, V32, pE6; Pierce-Hendry Stephanie A, 2010, Compend Contin Educ Vet, V32, pE1; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Shaffer Robyn Kroop, 2013, Yale Journal of Biology and Medicine, V86, P261; Signoretto C, 2010, J CLIN MICROBIOL, V48, P347, DOI 10.1128/JCM.00932-09; Vorwerk C, 2011, EMERG MED J, V28, P948, DOI 10.1136/emj.2009.087783; Wang Fei, 2013, Zhonghua Jie He He Hu Xi Za Zhi, V36, P27; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Yalaz M, 2012, TURKISH J PEDIATR, V54, P128	30	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e87504	10.1371/journal.pone.0087504	http://dx.doi.org/10.1371/journal.pone.0087504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586277	Green Published, gold, Green Submitted			2022-12-25	WOS:000331714700005
J	Atmadibrata, B; Liu, PY; Sokolowski, N; Zhang, LH; Wong, M; Tee, AE; Marshall, GM; Liu, T				Atmadibrata, Bernard; Liu, Pei Y.; Sokolowski, Nicolas; Zhang, Lihong; Wong, Matthew; Tee, Andrew E.; Marshall, Glenn M.; Liu, Tao			The Novel Long Noncoding RNA linc00467 Promotes Cell Survival but Is Down-Regulated by N-Myc	PLOS ONE			English	Article							WNT ANTAGONIST; GENE; CHROMATIN; TRANSCRIPTION; APOPTOSIS; SEQUENCE; INSIGHTS; PROTEIN; RD3	The worst subtype of neuroblastoma is caused by MYCN oncogene amplification and N-Myc oncoprotein over-expression. Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and tumourigenesis. While Myc oncoproteins are well-known to exert tumourigenic effects by regulating the expression of protein-coding genes and microRNAs, little is known about which lncRNAs are Myc targets and whether the Myc target lncRNAs play a role in Myc-induced oncogenesis. Here we performed differential gene expression studies using lncRNA microarray in neuroblastoma cells after transfection with control or N-Myc-specific small interfering RNA (siRNA), and identified N-Myc target lncRNAs including the novel lncRNA linc00467, the expression and function of which were completely unknown. RT-PCR, chromatin immunoprecipitation and luciferase assays showed that N-Myc suppressed linc00467 gene expression through direct binding to the linc00467 gene promoter and reducing linc00467 promoter activity. While N-Myc suppressed the expression of RD3, the protein-coding gene immediately down-stream of linc00467 gene, through direct binding to the RD3 gene promoter and reducing RD3 promoter activity, linc00467 reduced RD3 mRNA expression. Moreover, Affymetrix microarray analysis revealed that one of genes significantly up-regulated by linc00467 siRNA was the tumour suppressor gene DKK1. Importantly, knocking-down linc00467 expression with siRNA in neuroblastoma cells reduced the number of viable cells and increased the percentage of apoptotic cells, and co-transfection with DKK1 siRNA blocked the effects. These findings therefore demonstrate that N-Myc-mediated suppression of linc00467 gene transcription counterintuitively blocks N-Myc-mediated reduction in RD3 mRNA expression, and reduces neuroblastoma cell survival by inducing DKK1 expression.	[Atmadibrata, Bernard; Liu, Pei Y.; Sokolowski, Nicolas; Zhang, Lihong; Wong, Matthew; Tee, Andrew E.; Marshall, Glenn M.; Liu, Tao] Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Zhang, Lihong] Fudan Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Shanghai 200433, Peoples R China; [Marshall, Glenn M.] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia; [Liu, Tao] Univ New S Wales, UNSW Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; Fudan University; University of New South Wales Sydney	Liu, T (corresponding author), Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia.	tliu@unsw.edu.au	Liu, Tao/A-3922-2015	Wong, Matthew/0000-0003-2680-961X; Liu, Tao/0000-0001-6244-7316	National Health and Medical Research Council Australia; Cancer Council New South Wales; ARC Future Fellowship	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); ARC Future Fellowship(Australian Research Council)	The authors were supported by National Health and Medical Research Council Australia and Cancer Council New South Wales project grants. TL was a recipient of an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Garding A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003373; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hosgood HD, 2009, OCCUP ENVIRON MED, V66, P848, DOI 10.1136/oem.2008.044024; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; Liu T, 2009, EUR J CANCER, V45, P1846, DOI 10.1016/j.ejca.2009.03.002; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Shou J, 2002, ONCOGENE, V21, P878, DOI 10.1038/sj.onc.1205138; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Takayama KI, 2013, EMBO J; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819	33	55	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88112	10.1371/journal.pone.0088112	http://dx.doi.org/10.1371/journal.pone.0088112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586304	Green Submitted, Green Published, gold			2022-12-25	WOS:000331711900023
J	da Silva, AA; Ranieri, TMS; Torres, FD; Vianna, FSL; Paniz, GR; Sanseverino, PB; Picon, PD; de Azevedo, PB; Costa, MH; Schuler-Faccini, L; Sanseverino, MTV				da Silva, Andre Anjos; Schilling Ranieri, Tani Maria; Torres, Fernanda Duarte; Luiz Vianna, Fernanda Sales; Paniz, Graziella Rangel; Sanseverino, Paula Baptista; Picon, Paulo Dornelles; de Azevedo, Pietro Baptista; Costa, Marta Haas; Schuler-Faccini, Lavinia; Vieira Sanseverino, Maria Teresa			Impact on Pregnancies in South Brazil from the Influenza A (H1N1) Pandemic: Cohort Study	PLOS ONE			English	Article							VIRUS-INFECTION; ASIAN INFLUENZA; OUTCOMES; WOMEN; RISK; CALIFORNIA; DEATH	Introduction: The emergence of a new subtype of the influenza virus in 2009 generated interest in the international medical community, the media, and the general population. Pregnant women are considered to be a group at risk of serious complications related to the H1N1 influenza virus. The aim of this study was to evaluate the outcomes and teratogenic effects of pregnancies exposed to the H1N1 virus during the Influenza A epidemic that occurred in the state of Rio Grande do Sul in 2009. Methods: This is an uncontrolled prospective cohort study of pregnant women with suspected symptoms of Influenza A who were reported in the Information System for Notifiable Diseases - Influenza (SINAN-Influenza) during the epidemic of 2009 (database from the state of Rio Grande do Sul, Brazil). There were 589 cases of pregnant women with suspected infection. Among these, 243 were tested by PCR and included in the analysis. The main outcome measures were: maternal deaths, pregnancy outcome, stillbirths, premature births, low birth weight, congenital malformations, and odds ratios for H1N1+ and non-H1N1 pregnant women. Results: There were one hundred and sixty-three (67%) confirmed cases of H1N1, 34 cases (14%) of seasonal Influenza A and 46 (19%) who were negative for Influenza A. There was no difference between the three groups in clinical parameters of the disease. There were 24 maternal deaths - 18 of them had H1N1. There were 8 stillbirths - 5 were children of H1N1 infected mothers. There were no differences in perinatal outcomes. Conclusions: The present data do not indicate an increase in teratogenic risk from exposure to the influenza A (H1N1) virus. These results will help to strengthen the data and clarify the health issues that arose after the pandemic.	[da Silva, Andre Anjos; Torres, Fernanda Duarte; Luiz Vianna, Fernanda Sales; Paniz, Graziella Rangel; Sanseverino, Paula Baptista; de Azevedo, Pietro Baptista; Costa, Marta Haas; Schuler-Faccini, Lavinia; Vieira Sanseverino, Maria Teresa] Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, Porto Alegre, RS, Brazil; [da Silva, Andre Anjos; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, BR-90046900 Porto Alegre, RS, Brazil; [Picon, Paulo Dornelles] Hosp Clin Porto Alegre, Dept Internal Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Schuler-Faccini, L (corresponding author), Hosp Clin Porto Alegre, Med Genet Serv, Teratogen Informat Serv, Porto Alegre, RS, Brazil.	lavinia.faccini@ufrgs.br	Vianna, Fernanda Sales Luiz/O-4337-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; Azevedo, Pietro/AAA-4264-2022; SCHULER-FACCINI, LAVINIA/K-2927-2016; Picon, Paulo/J-2448-2015; SANSEVERINO, MARIA TERESA V/G-3884-2017	SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Azevedo, Pietro/0000-0003-4496-8614; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SANSEVERINO, MARIA TERESA V/0000-0002-7404-2911	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [007/2009]	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Funding was provided by Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), n. 007/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P536; Australian and New Zealand Intensive Care Influenza Investigators, 2010, BRIT MED J, V340, pc1279; Bercini M, 2011, B EPIDEMIOLOGICO, V13, P1; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dolan GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041638; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; European Medicines Agency, 2011, CHMP ASS REP NOV INF; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerard C, 2010, CDC PROT REAL TIM RT, V68, P68; Gerardin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010896; Governo do Estado do Rio Grande do Sul, 2012, ATL SOC RIO GRAND SU; GREENBERG M, 1958, AM J OBSTET GYNECOL, V76, P897, DOI 10.1016/0002-9378(58)90027-9; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Harris, 1919, JAMA-J AM MED ASSOC, V72, P978; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jimenez MF, 2010, INT J GYNECOL OBSTET, V111, P217, DOI 10.1016/j.ijgo.2010.06.024; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mendez-Figueroa H, 2011, AM J OBSTET GYNECOL, V204, pS58, DOI 10.1016/j.ajog.2011.02.058; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Siston AM, 2010, JAMA-J AM MED ASSOC, V115, P717; Tanaka T, 2009, CAN MED ASSOC J, V181, P55, DOI 10.1503/cmaj.090866; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233; 2009, MMWR MORB MORTAL WKL, V58, P467	28	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88624	10.1371/journal.pone.0088624	http://dx.doi.org/10.1371/journal.pone.0088624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558404	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700050
J	Liu, L; Zhao, GF; Fan, HY; Zhao, XY; Li, PF; Wang, ZQ; Hu, YL; Hou, YY				Liu, Liu; Zhao, Guangfeng; Fan, Hongye; Zhao, Xiaoyin; Li, Pengfei; Wang, Zhiqun; Hu, Yali; Hou, Yayi			Mesenchymal Stem Cells Ameliorate Th1-Induced Pre-Eclampsia-Like Symptoms in Mice via the Suppression of TNF-alpha Expression	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AGONISTIC AUTOANTIBODIES; MOUSE MODEL; RAT MODEL; PREECLAMPSIA; HYPERTENSION; CYTOKINES; RECEPTOR; IMBALANCE; PROTECT	Pre-eclampsia (PE) is thought to be a pregnancy-induced autoimmune disease. Despite several strategies carried out for targeting specific factors relevant to its pathogenesis, PE remains potentially fatal to some patients. Here, we reported a way to isolate mesenchymal stem cells (MSCs) from decidua. The MSCs not only exhibited differentiation and self-renewal capacities, they also possessed immunomodulatory functions and secreted some soluble mediators including IL-6, TGF-beta, IDO, VEGF and COX-2. Most importantly, the MSCs were specifically provided with the ability to suppress T cells proliferation by IDO in response to inflammatory cytokine IFN-gamma. Moreover, we developed a Th1 cell-induced PE mouse model which displayed a high level of pathogenesis factor TNF-alpha. Strikingly, MSCs-based therapy significantly ameliorated both clinical and histopathological severity of PE symptoms including decreasing the blood pressure and proteinuria, suppressing glomerulonephritis, protecting the feto-placental development. The therapy also reversed abnormal TNF-alpha expression in uterine and splenic lymphocytes. These data suggest that MSCs may ameliorate Th1-induced PE-like symptoms in mice via the suppression of TNF-alpha and MSCs-based therapy may provide a potential novel method for PE.	[Liu, Liu; Zhao, Guangfeng; Fan, Hongye; Zhao, Xiaoyin; Li, Pengfei; Hou, Yayi] Nanjing Univ, Sch Med, Immunol Lab, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Liu; Zhao, Guangfeng; Fan, Hongye; Zhao, Xiaoyin; Li, Pengfei; Hou, Yayi] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Zhiqun; Hu, Yali] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Hou, Yayi] Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Hu, YL (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	yalihu2009@gmail.com; yayihou@nju.edu.cn	Li, Pengfei/AAQ-6289-2020; LIU, LIU/H-7876-2016	Li, Pengfei/0000-0002-5928-1578; 	National Natural Science Foundation [81072410, 81270713]; Jiangsu Province Department of Health [XK200709, JHB2011-1]; Jiangsu province health department of China [81070508]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Province Department of Health; Jiangsu province health department of China	This work supported by grants from the National Natural Science Foundation (project number: 81072410, 81270713), the Special Research Grant of Jiangsu Province Department of Health (project number: XK200709 and JHB2011-1) and Special grant for maternal-fetal medicine from Jiangsu province health department of China (project number: 81070508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Carter D, 2005, BLOOD, V106, p160B; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Conrad KP, 1997, AM J REPROD IMMUNOL, V37, P240; Darmochwal-Kolarz D, 1999, EUR J OBSTET GYN R B, V86, P165, DOI 10.1016/S0301-2115(99)00065-2; Dong MY, 2005, ACTA OBSTET GYN SCAN, V84, P788, DOI 10.1111/j.0001-6349.2005.00714.x; Goldman-Wohl DS, 2007, J REPROD IMMUNOL, V76, P54, DOI 10.1016/j.jri.2007.03.012; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Gulati R, 2005, JNMA J Nepal Med Assoc, V44, P36; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Hu Y, 2007, INT J MOL SCI, V8, P1, DOI 10.3390/i8010001; Irani RA, 2010, HYPERTENSION, V55, P1246, DOI 10.1161/HYPERTENSIONAHA.110.150540; Kanasaki K, 2009, KIDNEY INT, V76, P831, DOI 10.1038/ki.2009.284; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Liu L, 2012, EUR J IMMUNOL, V42, P2190, DOI 10.1002/eji.201142356; Liu L, 2012, STEM CELLS, V30, P1756, DOI 10.1002/stem.1156; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Parrish MR, 2010, AM J HYPERTENS, V23, P911, DOI 10.1038/ajh.2010.70; Peracoli MTS, 2011, AM J REPROD IMMUNOL, V66, P460, DOI 10.1111/j.1600-0897.2011.01016.x; Picinich SC, 2007, EXPERT OPIN BIOL TH, V7, P965, DOI 10.1517/14712598.7.7.965; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Ramesar SV, 2010, EUR J OBSTET GYN R B, V149, P22, DOI 10.1016/j.ejogrb.2009.11.005; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Saito S, 1999, CLIN EXP IMMUNOL, V117, P550; Saito S, 1999, AM J REPROD IMMUNOL, V41, P297; Shen Y, 2011, HYPERTENS PREGNANCY, V30, P465, DOI 10.3109/10641955.2010.507842; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Tang JM, 2006, EUR J CARDIO-THORAC, V30, P353, DOI 10.1016/j.ejcts.2006.02.070; Todt JC, 1996, AM J REPROD IMMUNOL, V36, P65; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Zenclussen AC, 2004, EUR J IMMUNOL, V34, P377, DOI 10.1002/eji.200324469; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	45	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e88036	10.1371/journal.pone.0088036	http://dx.doi.org/10.1371/journal.pone.0088036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	24558374	Green Published, Green Submitted, gold			2022-12-25	WOS:000331706700020
J	Decoin, V; Barbey, C; Bergeau, D; Latour, X; Feuilloley, MGJ; Orange, N; Merieau, A				Decoin, Victorien; Barbey, Corinne; Bergeau, Dorian; Latour, Xavier; Feuilloley, Marc G. J.; Orange, Nicole; Merieau, Annabelle			A Type VI Secretion System Is Involved in Pseudomonas fluorescens Bacterial Competition	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PROTEIN SECRETION; VIBRIO-CHOLERAE; OUTER-MEMBRANE; AERUGINOSA; EFFECTOR; IDENTIFICATION; PATHOGENESIS; VIRULENCE; APPARATUS	Protein secretion systems are crucial mediators of bacterial interactions with other organisms. Among them, the type VI secretion system (T6SS) is widespread in Gram-negative bacteria and appears to inject toxins into competitor bacteria and/or eukaryotic cells. Major human pathogens, such as Vibrio cholerae, Burkholderia and Pseudomonas aeruginosa, express T6SSs. Bacteria prevent self-intoxication by their own T6SS toxins by producing immunity proteins, which interact with the cognate toxins. We describe here an environmental P. fluorescens strain, MFE01, displaying an uncommon oversecretion of Hcp (hemolysin-coregulated protein) and VgrG (valine-glycine repeat protein G) into the culture medium. These proteins are characteristic components of a functional T6SS. The aim of this study was to attribute a role to this energy-consuming overexpression of the T6SS. The genome of MFE01 contains at least two hcp genes (hcp1 and hcp2), suggesting that there may be two putative T6SS clusters. Phenotypic studies have shown that MFE01 is avirulent against various eukaryotic cell models (amebas, plant or animal cell models), but has antibacterial activity against a wide range of competitor bacteria, including rhizobacteria and clinical bacteria. Depending on the prey cell, mutagenesis of the hcp2 gene in MFE01 abolishes or reduces this antibacterial killing activity. Moreover, the introduction of T6SS immunity proteins from S. marcescens, which is not killed by MFE01, protects E. coli against MFE01 killing. These findings suggest that the protein encoded by hcp2 is involved in the killing activity of MFE01 mediated by effectors of the T6SS targeting the peptidoglycan of Gram-negative bacteria. Our results indicate that MFE01 can protect potato tubers against Pectobacterium atrosepticum, which causes tuber soft rot. Pseudomonas fluorescens is often described as a major PGPR (plant growth-promoting rhizobacterium), and our results suggest that there may be a connection between the T6SS and the PGPR properties of this bacterium.	[Decoin, Victorien; Barbey, Corinne; Bergeau, Dorian; Latour, Xavier; Feuilloley, Marc G. J.; Orange, Nicole; Merieau, Annabelle] Univ Rouen, Normandie Univ, LMSM, IUT Evreux, Evreux, France	Universite de Rouen Normandie	Merieau, A (corresponding author), Univ Rouen, Normandie Univ, LMSM, IUT Evreux, EA 4312, Evreux, France.	annabelle.merieau@univ-rouen.fr		FEUILLOLEY, Marc G.J./0000-0001-6467-4336	Region Haute normandie et Ministere delegue a l'enseignement superieur et a la recherche; GRR SSE et FEDER (Europeen Union)	Region Haute normandie et Ministere delegue a l'enseignement superieur et a la recherche(Region Normandie); GRR SSE et FEDER (Europeen Union)	This research was supported by grants from Region Haute normandie et Ministere delegue a l'enseignement superieur et a la recherche, GRR SSE et FEDER (Europeen Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey C, 2012, J PROTEOME RES, V11, P206, DOI 10.1021/pr200936q; Barret M, 2013, ENV MICROBIOL REP, V5, P117, DOI 10.1111/j.1758-2229.2012.00394.x; Barret M, 2011, MICROBIOL-SGM, V157, P1726, DOI 10.1099/mic.0.048645-0; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chapalain A, 2008, CAN J MICROBIOL, V54, P19, DOI [10.1139/W07-110, 10.1139/w07-110]; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Crepin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035176; DAGLEY S, 1950, J BACTERIOL, V60, P369, DOI 10.1128/JB.60.4.369-379.1950; Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Fritsch MJ, 2013, MOL CELL PROTEOMICS, V12, P2735, DOI 10.1074/mcp.M113.030502; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Guyard-Nicodeme M, 2008, J PROTEOME RES, V7, P1218, DOI 10.1021/pr070539x; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Picot L, 2003, MICROB PATHOGENESIS, V35, P95, DOI 10.1016/S0882-4010(03)00092-5; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Sperandio D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-223; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Unterweger D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048320; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	52	44	45	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e89411	10.1371/journal.pone.0089411	http://dx.doi.org/10.1371/journal.pone.0089411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551247	Green Submitted, gold, Green Published			2022-12-25	WOS:000331271500111
J	Bedran, TBL; Grignon, L; Spolidorio, DP; Grenier, D				Lombardo Bedran, Telma Blanca; Grignon, Louis; Spolidorio, Denise Palomari; Grenier, Daniel			Subinhibitory Concentrations of Triclosan Promote Streptococcus mutans Biofilm Formation and Adherence to Oral Epithelial Cells	PLOS ONE			English	Article							INHIBITORY CONCENTRATIONS; CARIES PROCESS; IN-VITRO; ANTIBIOTICS; BACTERIA; AGENTS; HYDROPHOBICITY; CIPROFLOXACIN; VIRULENCE; STRAINS	Triclosan is a general membrane-active agent with a broad-spectrum antimicrobial activity that is commonly used in oral care products. In this study, we investigated the effect of sub-minimum inhibitory concentrations (MICs) of triclosan on the capacity of the cariogenic bacterium Streptococcus mutans to form biofilm and adhere to oral epithelial cells. As quantified by crystal violet staining, biofilm formation by two reference strains of S. mutans was dose-dependently promoted, in the range of 2.2- to 6.2-fold, by 1/2 and 1/4 MIC of triclosan. Observations by scanning electron microscopy revealed the presence of a dense biofilm attached to the polystyrene surface. Growth of S. mutans in the presence of triclosan at subMICs also increased its capacity to adhere to a monolayer of gingival epithelial cells. The expression of several genes involved in adherence and biofilm formation in S. mutans was investigated by quantitative RT-PCR. It was found that subMICs of triclosan significantly increased the expression of comD, gtfC, and luxS, and to a lesser extent of gtfB and atlA genes. These findings stress the importance of maintaining effective bactericidal concentrations of therapeutic triclosan since subMICs may promote colonization of the oral cavity by S. mutans.	[Lombardo Bedran, Telma Blanca] State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral Diag & Surg, Sao Paulo, Brazil; [Grignon, Louis; Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada; [Spolidorio, Denise Palomari] State Univ Sao Paulo, Araraquara Dent Sch, Dept Physiol & Pathol, Sao Paulo, Brazil	Universidade Estadual Paulista; Laval University; Universidade Estadual Paulista	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Grenier, Daniel/E-5557-2015; Spolidorio, Denise Madalena Palomari/P-3530-2016	Grenier, Daniel/0000-0003-0878-4674; Spolidorio, Denise Madalena Palomari/0000-0003-2376-1024	Canadian Institutes of Health Research [95335]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (# 95335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TA, 2005, INFECT IMMUN, V73, P3147, DOI 10.1128/IAI.73.5.3147-3151.2005; Davies RM, 2004, J CLIN PERIODONTOL, V31, P1029, DOI 10.1111/j.1600-051X.2004.00614.x; Dong LP, 2012, INT J ANTIMICROB AG, V39, P390, DOI 10.1016/j.ijantimicag.2012.01.009; DOYLE RJ, 1990, MICROBIAL CELL SURFA, P387; Erdeljan P, 2012, J ENDOUROL, V26, P32, DOI 10.1089/end.2011.0183; Haraszthy VI, 2006, LETT APPL MICROBIOL, V43, P256, DOI 10.1111/j.1472-765X.2006.01961.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Huang RJ, 2012, EUR J ORAL SCI, V120, P319, DOI 10.1111/j.1600-0722.2012.00971.x; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Koo H, 2009, INT J ORAL SCI, V1, P229, DOI 10.4248/IJOS.09086; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Majtan J, 2008, J APPL MICROBIOL, V104, P1294, DOI 10.1111/j.1365-2672.2007.03653.x; Mann Jonathan, 2001, Journal of Clinical Dentistry, V12, P71; Marquis A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-80; Modeer T, 1996, J CLIN PERIODONTOL, V23, P927, DOI 10.1111/j.1600-051X.1996.tb00513.x; Mustafa M, 1998, EUR J ORAL SCI, V106, P637, DOI 10.1046/j.0909-8836.1998.eos106205.x; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Phan TN, 2006, CAN J MICROBIOL, V52, P977, DOI 10.1139/W06-055; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Senadheera D, 2008, BACTERIAL SIGNAL TRA; Starner TD, 2008, ANTIMICROB AGENTS CH, V52, P137, DOI 10.1128/AAC.00607-07; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; WADE WG, 1992, J PERIODONTOL, V63, P280, DOI 10.1902/jop.1992.63.4.280; Wojnicz D, 2007, INT J ANTIMICROB AG, V29, P700, DOI 10.1016/j.ijantimicag.2007.01.007; WU Q, 1995, J BACTERIOL, V177, P1399, DOI 10.1128/jb.177.5.1399-1401.1995	30	43	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89059	10.1371/journal.pone.0089059	http://dx.doi.org/10.1371/journal.pone.0089059			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551218	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000097
J	Patton, DT; Plumb, AW; Redpath, SA; Osborne, LC; Perona-Wright, G; Abraham, N				Patton, Daniel T.; Plumb, Adam W.; Redpath, Stephen A.; Osborne, Lisa C.; Perona-Wright, Georgia; Abraham, Ninan			The Development and Survival but Not Function of Follicular B Cells Is Dependent on IL-7R alpha Tyr449 Signaling	PLOS ONE			English	Article							MARGINAL ZONE; PROTECTIVE IMMUNITY; RECEPTOR-ALPHA; DEFICIENT MICE; LYMPHOPOIESIS; IL-7; DIFFERENTIATION; MEMORY; B-1	IL-7 is a critical cytokine for lymphocyte development. Recent work has highlighted critical roles for IL-7 signaling in mature T cell homeostasis and function, but its role in B cells is less well characterized. Using a knock-in mouse possessing a Tyr to Phe mutation at position 449 (IL-7R alpha(449F/449F) mice) within the cytoplasmic SH2-binding motif of IL-7R alpha, we evaluated the role of IL-7R alpha Y449 motif in spleen B cells. IL-7R alpha(449F/449F) mice had reduced numbers and increased death of follicular B cells compared to WT, but had significantly more follicular cells than IL-7R alpha(-/-). The death of IL-7R alpha(449F/449F) follicular cells was not due to a failure to respond to BAFF or lower levels of BAFF, a critical B cell survival factor. Marginal zone B cells were unaffected by the IL-7R alpha(449F/449F) mutation. Any role for TSLP was ruled out, as TSLPR-/- mice had an identical B cell phenotype to wild-type mice. Bone marrow chimeras and the absence of IL-7R alpha on B cells suggested that IL-7 did not directly regulate mature B cells, but that an IL-7-responsive cell was influencing B cells. IL-7 was also critical at the checkpoint between the T1 and T2 stages in the spleen. IL-7R alpha(-/-) mice fail to develop T2 cells, but IL-7R alpha(449F/449F) show a reduction compared to WT but not complete absence of T2 cells. We also tested the functional responses of IL-7R alpha(449F/449F) to antigens and infection and found no difference in antibody responses to T-dependent or T-independent antigens, or to Influenza/A. IL-7 was important for generation of antibody responses to the intestinal worm H. polygyrus and for naive levels of IgA. Taken together, this suggests that IL-7 regulates follicular B cell numbers and survival in a cell-extrinsic manner, via a bone-marrow derived cell, but is not critical for antibody production outside the gut.	[Patton, Daniel T.; Plumb, Adam W.; Redpath, Stephen A.; Osborne, Lisa C.; Perona-Wright, Georgia; Abraham, Ninan] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Abraham, Ninan] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Abraham, N (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	ninan@mail.ubc.ca	Abraham, Ninan/K-5572-2012; Osborne, Lisa/K-3027-2015	Abraham, Ninan/0000-0002-2747-1246; Osborne, Lisa/0000-0002-7170-3235	Canadian Institutes for Health Research (CIHR) [MOP-84532, MOP-126060]; MSFHR Career Investigator award; CIHR Transplant Training and Michael Smith Foundation Postdoctoral Fellowships	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MSFHR Career Investigator award; CIHR Transplant Training and Michael Smith Foundation Postdoctoral Fellowships	This work is supported by the Canadian Institutes for Health Research (CIHR) (MOP-84532 and MOP-126060 to N. Abraham). N. A. holds a MSFHR Career Investigator award and D. T. P. holds CIHR Transplant Training and Michael Smith Foundation Postdoctoral Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Ceredig R, 2003, EUR J IMMUNOL, V33, P2567, DOI 10.1002/eji.200324134; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Erlandsson L, 2004, EUR J IMMUNOL, V34, P3595, DOI 10.1002/eji.200425217; Gazit R, 2004, DEVELOPMENT, V131, P903, DOI 10.1242/dev.00982; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Hardy RR, 2006, CURR OPIN IMMUNOL, V18, P547, DOI 10.1016/j.coi.2006.07.010; Jensen CT, 2008, BLOOD, V112, P2297, DOI 10.1182/blood-2008-04-150508; Lycke NY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00329; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Osborne LC, 2010, ONCOGENE, V29, P3854, DOI 10.1038/onc.2010.133; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Osborne LC, 2011, J IMMUNOL, V186, P1981, DOI 10.4049/jimmunol.1002224; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Plumb AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050199; Rauch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005456; RICH BE, 1993, J EXP MED, V177, P305, DOI 10.1084/jem.177.2.305; Shriner AK, 2010, J IMMUNOL, V185, P525, DOI 10.4049/jimmunol.0902841; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Willems L, 2011, J IMMUNOL, V187, P3587, DOI 10.4049/jimmunol.1004012	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88771	10.1371/journal.pone.0088771	http://dx.doi.org/10.1371/journal.pone.0088771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551160	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000331266000066
J	Qu, T; Huang, BY; Zhang, LL; Li, L; Xu, F; Huang, W; Li, CY; Du, YS; Zhang, GF				Qu, Tao; Huang, Baoyu; Zhang, Linlin; Li, Li; Xu, Fei; Huang, Wen; Li, Chunyan; Du, Yishuai; Zhang, Guofan			Identification and Functional Characterization of Two Executioner Caspases in Crassostrea gigas	PLOS ONE			English	Article							CELL-DEATH; CHROMATIN CONDENSATION; PACIFIC OYSTER; APOPTOSIS; ACTIVATION; PROTEIN; EXPRESSION; FAILURE; EVENTS; CPP32	Caspase-3 and caspase-7 are two key effector caspases that play important roles in apoptotic pathways that maintain normal tissue and organ development and homeostasis. However, little is known about the sequence, structure, activity, and function of effector caspases upon apoptosis in mollusks, especially marine bivalves. In this study, we investigated the possible roles of two executioner caspases in the regulation of apoptosis in the Pacific oyster Crassostrea gigas. A full-length capase-3-like gene named Cgcaspase-3 was cloned from C. gigas cDNA, encoding a predicted protein containing caspase family p20 and p10 domain profiles and a conserved caspase active site motif. Phylogenetic analysis demonstrated that both Cgcaspase-3 and Cgcaspase-1 may function as effector caspases clustered in the invertebrate branch. Although the sequence identities between the two caspases was low, both enzymes possessed executioner caspase activity and were capable of inducing cell death. These results suggested that Cgcaspase-3 and Cgcaspase-1 were two effector caspases in C. gigas. We also observed that nucleus-localized Cgcaspase-3, may function as a caspase-3-like protein and cytoplasm-localized Cgcaspase-1 may function as a caspase-7-like protein. Both Cgcaspase-3 and Cgcaspase-1 mRNA expression increased after larvae settled on the substratum, suggesting that both caspases acted in several tissues or organs that degenerated after oyster larvae settlement. The highest caspase expression levels were observed in the gills indicating that both effector caspases were likely involved in immune or metabolic processes in C. gigas.	[Qu, Tao; Huang, Baoyu; Zhang, Linlin; Li, Li; Xu, Fei; Huang, Wen; Li, Chunyan; Du, Yishuai; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Huang, Baoyu; Huang, Wen; Li, Chunyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	lili@qdio.ac.cn; gfzhang@qdio.ac.cn	li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; Zhang, Linlin/I-4970-2014; huang, wen/GXW-0661-2022; Xu, Fei/A-1736-2012; Li, Li/AEM-3636-2022; li, li/HII-4157-2022	Zhang, Linlin/0000-0003-0247-7710; Xu, Fei/0000-0002-0981-8429; 	National Basic Research Program of China (973 Program) [2010CB126401]; National Natural Science Foundation of China [31302219]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Mollusc Research and Development Center, CARS [CARS-48]; Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Mollusc Research and Development Center, CARS; Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandon	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126401), the National Natural Science Foundation of China (no. 31302219), National High Technology Research and Development Program (863 program, 2012AA10A405), Mollusc Research and Development Center, CARS(CARS-48), Taishan Scholars Climbing Program of Shandong and Oversea Taishan Scholar Program of Shandon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp TE, 2000, CELL DEATH DIFFER, V7, P984, DOI 10.1038/sj.cdd.4400733; Benjamin IJ, 2005, J CLIN INVEST, V115, P495, DOI 10.1172/JCI200524477; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evans S, 2009, AQUACULTURE, V286, P211, DOI 10.1016/j.aquaculture.2008.09.022; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Houde C, 2004, J NEUROSCI, V24, P9977, DOI 10.1523/JNEUROSCI.3356-04.2004; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lacoste A, 2002, J CELL SCI, V115, P761; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Monnier PP, 2011, J NEUROSCI, V31, P10494, DOI 10.1523/JNEUROSCI.0148-11.2011; Nasirudeen AMA, 2001, PARASITOL RES, V87, P559, DOI 10.1007/s004360100427; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Shi XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037054, 10.1371/journal.pone.0030828]; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005; Zheng TS, 1998, P NATL ACAD SCI USA, V95, P13618, DOI 10.1073/pnas.95.23.13618	33	51	55	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89040	10.1371/journal.pone.0089040	http://dx.doi.org/10.1371/journal.pone.0089040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551213	Green Published, Green Submitted, gold			2022-12-25	WOS:000331266000093
J	Zhou, Y; Shu, FR; Liang, XY; Chang, H; Shi, LY; Peng, XL; Zhu, JD; Mi, MT				Zhou, Yong; Shu, Furong; Liang, Xinyu; Chang, Hui; Shi, Linying; Peng, Xiaoli; Zhu, Jundong; Mi, Mantian			Ampelopsin Induces Cell Growth Inhibition and Apoptosis in Breast Cancer Cells through ROS Generation and Endoplasmic Reticulum Stress Pathway	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; REACTIVE OXYGEN; OXIDATIVE STRESS; DIHYDROMYRICETIN; AUTOPHAGY; PACLITAXEL; RESISTANCE; DEATH	Ampelopsin (AMP), a major bioactive constituent of Ampelopsis grossedentata, exerts a number of biological effects. In this study, we investigated its anti-cancer activity in human breast cancer cell lines, and explored the underlying mechanism of this action. Our results showed that treatment with AMP dose-dependently inhibited cell viability and induced apoptosis in MCF-7 and MDA-MB-231 breast cancer cells without cytotoxicity in human normal breast epithelial cells MCF-10A. Meanwhile, AMP dose-dependently triggered reactive oxygen species (ROS) generation in both breast cancer cells. The ROS scavenger N-acetyl-L-cysteine (NAC) strongly attenuated AMP-induced ROS production, along with cell growth inhibition and apoptosis. Furthermore, AMP was observed to activate endoplasmic reticulum (ER) stress, as evidenced by the up-regulation of ER stress-related proteins, including GRP78, p-PERK, p-elF2 alpha, cleaved ATF6 alpha and CHOP, while knockdown of ATF6 alpha or PERK markedly down-regulated AMP-induced CHOP expression. Blocking ER stress using 4-phenylbutyric acid not only down-regulated AMP-induced GRP78 and CHOP expression, but also significantly decreased AMP-induced cell growth inhibition and apoptosis, whereas ER stress inducer thapsigargin played opposing effects. Additionally, NAC inhibited AMP-induced ER stress by down-regulating GRP78 and CHOP expression. Conversely, blocking ER stress using CHOP siRNA decreased AMP-induced ROS production and cell apoptosis. Taken together, these results demonstrate that AMP has anti-tumor effects against breast cancer cells through ROS generation and ER stress pathway, which therefore provide experimental evidences for developing AMP as a new therapeutic drug for breast cancer.	[Zhou, Yong; Shu, Furong; Liang, Xinyu; Chang, Hui; Shi, Linying; Peng, Xiaoli; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Inst Mil Prevent Med,Res Ctr Med Nutr, Chongqing, Peoples R China	Army Medical University	Zhu, JD (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Chongqing Key Lab Nutr & Food Safety, Inst Mil Prevent Med,Res Ctr Med Nutr, Chongqing, Peoples R China.	zhujundong2013@126.com; mantian_mi@163.com		Chang, Hui/0000-0001-6693-2570	special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety	special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety	This work was supported by the special fund of Chongqing key laboratory (CSTC) for Nutrition and Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Di X, 2009, BIOCHEM PHARMACOL, V77, P1139, DOI 10.1016/j.bcp.2008.12.016; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jang KY, 2012, CANCER LETT, V319, P197, DOI 10.1016/j.canlet.2012.01.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang DH, 2013, CANCER LETT, V335, P404, DOI 10.1016/j.canlet.2013.02.059; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Li H, 2008, J AOAC INT, V91, P1278; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Li YC, 2012, TOXICOL APPL PHARM, V263, P21, DOI 10.1016/j.taap.2012.05.018; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu BG, 2009, EUR FOOD RES TECHNOL, V230, P325, DOI 10.1007/s00217-009-1175-0; Lo C, 2011, MELANOMA RES, V21, P267, DOI 10.1097/CMR.0b013e3283414444; Lu DY, 2012, PHYTOMEDICINE, V19, P1093, DOI 10.1016/j.phymed.2012.06.010; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mandl J, 2013, MOL ENDOCRINOL, V27, P384, DOI 10.1210/me.2012-1317; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; NI F, 2012, PLOS ONE, V7; Pierre AS, 2013, BBA-MOL CELL BIOL L, V1831, P759, DOI 10.1016/j.bbalip.2013.01.005; Quick QA, 2012, EXP THER MED, V3, P487, DOI 10.3892/etm.2011.422; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012; Shi JM, 2013, BIOCHEM PHARMACOL, V85, P913, DOI 10.1016/j.bcp.2013.01.009; SHI Y, 2012, PLOS ONE, V7; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Woo KJ, 2007, BIOCHEM PHARMACOL, V73, P68, DOI 10.1016/j.bcp.2006.09.015; Yang JG, 2011, J MED PLANTS RES, V5, P114; Yang LH, 2012, MOL MED REP, V6, P1126, DOI 10.3892/mmr.2012.1023; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zhang BL, 2012, ANTI-CANCER DRUG, V23, P590, DOI 10.1097/CAD.0b013e32835019f9; Zhang YS, 2007, MAGN RESON CHEM, V45, P909, DOI 10.1002/mrc.2051; Zhao L, 2009, AGRO FOOD IND HI TEC, V20, P14; Zhu GY, 2011, EUR J PHARMACOL, V668, P88, DOI 10.1016/j.ejphar.2011.06.008	42	79	103	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e89021	10.1371/journal.pone.0089021	http://dx.doi.org/10.1371/journal.pone.0089021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24551210	Green Submitted, Green Published, gold			2022-12-25	WOS:000331266000091
J	Liu, LY; Yu, YH; Hou, YS; Chai, JK; Duan, HJ; Chu, WL; Zhang, HJ; Hu, Q; Du, JD				Liu, Lingying; Yu, Yonghui; Hou, Yusen; Chai, Jiake; Duan, Hongjie; Chu, Wanli; Zhang, Haijun; Hu, Quan; Du, Jundong			Human Umbilical Cord Mesenchymal Stem Cells Transplantation Promotes Cutaneous Wound Healing of Severe Burned Rats	PLOS ONE			English	Article							BONE-MARROW; IN-VITRO; STROMAL CELLS; DIFFERENTIATION; THERAPY; REPAIR; INJURY	Background: Severe burns are a common and highly lethal trauma. The key step for severe burn therapy is to promote the wound healing as early as possible, and reports indicate that mesenchymal stem cell (MSC) therapy contributes to facilitate wound healing. In this study, we investigated effect of human umbilical cord MSCs (hUC-MSCs) could on wound healing in a rat model of severe burn and its potential mechanism. Methods: Adult male Wistar rats were randomly divided into sham, burn, and burn transplanted hUC-MSCs. GFP labeled hUC-MSCs or PBS was intravenous injected into respective groups. The rate of wound closure was evaluated by Image Pro Plus. GFP-labeled hUC-MSCs were tracked by in vivo bioluminescence imaging (BLI), and human-specific DNA expression in wounds was detected by PCR. Inflammatory cells, neutrophils, macrophages, capillaries and collagen types I/III in wounds were evaluated by histochemical staining. Wound blood flow was evaluated by laser Doppler blood flow meter. The levels of proinflammatory and anti-inflammatory factors, VEGF, collagen types I/III in wounds were analyzed using an ELISA. Results: We found that wound healing was significantly accelerated in the hUC-MSC therapy group. The hUC-MSCs migrated into wound and remarkably decreased the quantity of infiltrated inflammatory cells and levels of IL-1, IL-6, TNF-alpha and increased levels of IL-10 and TSG-6 in wounds. Additionally, the neovascularization and levels of VEGF in wounds in the hUC-MSC therapy group were markedly higher than those in other control groups. The ratio of collagen types I and III in the hUC-MSC therapy group were markedly higher than that in the burn group at indicated time after transplantation. Conclusion: The study suggests that hUC-MSCs transplantation can effectively improve wound healing in severe burned rat model. Moreover, these data might provide the theoretical foundation for the further clinical application of hUC-MSC in burn areas.	[Liu, Lingying; Yu, Yonghui; Hou, Yusen; Chai, Jiake; Duan, Hongjie; Chu, Wanli; Zhang, Haijun; Hu, Quan; Du, Jundong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Burn & Plast Surg, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chai, JK (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Burn & Plast Surg, Beijing, Peoples R China.	cjk304@126.com	Yu, Yonghui/AAZ-4093-2021; Duan, Hongjie/HCI-0703-2022		National Natural Science Foundation of China [81372052]; General Financial Grant from the China Postdoctoral Science Foundation [2013M532200]; First Affiliated Hospital [QN201207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Financial Grant from the China Postdoctoral Science Foundation; First Affiliated Hospital	This work was supported by the National Natural Science Foundation of China (81372052), General Financial Grant from the China Postdoctoral Science Foundation (2013M532200), and the First Affiliated Hospital to the PLA General Hospital Science Research Foundation of China (QN201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZM, 2013, CHINESE MED J-PEKING, V126, P1890, DOI 10.3760/cma.j.issn.0366-6999.20130045; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P164, DOI 10.1038/bmt.2011.81; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Chu Wan-li, 2012, Zhonghua Yi Xue Za Zhi, V92, P853; Fong CY, 2007, REPROD BIOMED ONLINE, V15, P708, DOI 10.1016/S1472-6483(10)60539-1; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Han YF, 2011, BIOCHEM BIOPH RES CO, V413, P561, DOI 10.1016/j.bbrc.2011.09.001; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Johansson U, 2008, DIABETES, V57, P2393, DOI 10.2337/db07-0981; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Leclerc T, 2011, CELL PROLIFERAT, V44, P48, DOI 10.1111/j.1365-2184.2010.00727.x; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Pillai SI, 2010, PHARM BIOL, V48, P1198, DOI 10.3109/13880200903578754; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shi YH, 2012, BURNS, V38, P95, DOI 10.1016/j.burns.2010.06.002; Suzdaltseva YG, 2008, B EXP BIOL MED+, V145, P228, DOI 10.1007/s10517-008-0057-y; Tondreau T, 2009, CYTOTHERAPY, V11, P559, DOI 10.1080/14653240903051541; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wang Y, 2009, SURGERY, V146, P198, DOI 10.1016/j.surg.2009.04.013; Yan H, 2013, CHINESE MED J-PEKING, V126, P1700, DOI 10.3760/cma.j.issn.0366-6999.20122728; Zhou YL, 2010, CHINESE MED J-PEKING, V123, P3282, DOI 10.3760/cma.j.issn.0366-6999.2010.22.021	30	153	168	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88348	10.1371/journal.pone.0088348	http://dx.doi.org/10.1371/journal.pone.0088348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586314	Green Published, gold, Green Submitted			2022-12-25	WOS:000331714700013
J	Chen, ZF; Zhang, HM; Wang, H; Matsumura, K; Wong, YH; Ravasi, T; Qian, PY				Chen, Zhang-Fan; Zhang, Huoming; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Ravasi, Timothy; Qian, Pei-Yuan			Quantitative Proteomics Study of Larval Settlement in the Barnacle Balanus amphitrite	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; STATISTICAL-MODEL; ARGININE KINASE; GENE-EXPRESSION; CYPRIS LARVAE; CYCLIC-AMP; METAMORPHOSIS; PROTEIN; MUSCLE; INVOLVEMENT	Barnacles are major sessile components of the intertidal areas worldwide, and also one of the most dominant fouling organisms in fouling communities. Larval settlement has a crucial ecological effect not only on the distribution of the barnacle population but also intertidal community structures. However, the molecular mechanisms involved in the transition process from the larval to the juvenile stage remain largely unclear. In this study, we carried out comparative proteomic profiles of stage II nauplii, stage VI nauplii, cyprids, and juveniles of the barnacle Balanus amphitrite using labelfree quantitative proteomics, followed by the measurement of the gene expression levels of candidate proteins. More than 700 proteins were identified at each stage; 80 were significantly up-regulated in cyprids and 95 in juveniles vs other stages. Specifically, proteins involved in energy and metabolism, the nervous system and signal transduction were significantly up-regulated in cyprids, whereas proteins involved in cytoskeletal remodeling, transcription and translation, cell proliferation and differentiation, and biomineralization were up-regulated in juveniles, consistent with changes associated with larval metamorphosis and tissue remodeling in juveniles. These findings provided molecular evidence for the morphological, physiological and biological changes that occur during the transition process from the larval to the juvenile stages in B. amphitrite.	[Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China; [Zhang, Huoming] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal, Saudi Arabia; [Ravasi, Timothy] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal, Saudi Arabia	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Ravasi, Timothy/B-8777-2008	Zhang, Huoming/0000-0001-5416-0358; Qian, Pei-Yuan/0000-0003-4074-9078; Ravasi, Timothy/0000-0002-9950-465X	Research Grants Council of the Hong Kong Special Administrative Region [GRF662413, AoE/P-04/04-II]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (GRF662413 and AoE/P-04/04-II) and an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) to P.-Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil AC, 2010, J EXP MAR BIOL ECOL, V392, P89, DOI 10.1016/j.jembe.2010.04.012; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; BAXTER GT, 1992, BIOL BULL, V183, P147, DOI 10.2307/1542416; Berg J.M., 2002, BIOCHEMISTRY-US, V5th ed.; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Chamberlin ME, 1997, J EXP BIOL, V200, P2789; Chandramouli KH, 2013, J PROTEOME RES, V12, P1344, DOI 10.1021/pr3010088; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chen WT, 2008, DEV NEUROBIOL, V68, P1029, DOI 10.1002/dneu.20644; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CHOU TC, 1952, J BIOL CHEM, V196, P89; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; COSTLOW JOHN D., 1959, PHYSIOL ZOOL, V32, P177; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faimali M, 2003, BIOFOULING, V19, P213, DOI 10.1080/0892701021000044228; Footitt S, 2007, J EXP BOT, V58, P2959, DOI 10.1093/jxb/erm146; Gallus L, 2010, BIOFOULING, V26, P155, DOI 10.1080/08927010903391193; GIRAUD MM, 1981, COMP BIOCHEM PHYS A, V69, P381, DOI 10.1016/0300-9629(81)92993-5; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Gunter HM, 2007, DEV GENES EVOL, V217, P603, DOI 10.1007/s00427-007-0171-2; Han Z, 2013, J PROTEOME RES, V12, P2090, DOI 10.1021/pr301083e; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130; Heikkila JJ, 1997, CELL MOL LIFE SCI, V53, P114, DOI 10.1007/PL00000573; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kaneko Y, 2006, ZOOL SCI, V23, P533, DOI 10.2108/zsj.23.533; Katti C, 2010, J EXP BIOL, V213, P2589, DOI 10.1242/jeb.043869; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knight J, 2000, J MAR BIOL ASSOC UK, V80, P113; KOULISH S, 1973, J MORPHOL, V140, P1, DOI 10.1002/jmor.1051400102; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Lagersson NC, 2002, J MAR BIOL ASSOC UK, V82, P573, DOI 10.1017/S0025315402005891; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Levine MZ, 2001, J NEUROBIOL, V49, P277, DOI 10.1002/neu.10010; Li HL, 2010, J EXP MAR BIOL ECOL, V389, P45, DOI 10.1016/j.jembe.2010.03.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; LUCAS MI, 1979, MAR BIOL, V55, P221, DOI 10.1007/BF00396822; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Maruzzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037408; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Meng W, 2008, ANAL CHEM, V80, P9797, DOI 10.1021/ac801344z; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; SCHNEIDER A, 1989, INSECT BIOCHEM, V19, P471, DOI 10.1016/0020-1790(89)90029-2; Shimizu K, 1996, J EXP ZOOL, V276, P87, DOI 10.1002/(SICI)1097-010X(19961001)276:2<87::AID-JEZ1>3.0.CO;2-9; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang H, 2013, RES VET SCI, V95, P1125, DOI 10.1016/j.rvsc.2013.07.022; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; WROBLEWSKA B, 1993, J NEUROCHEM, V61, P943, DOI 10.1111/j.1471-4159.1993.tb03606.x; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887; Zhang HM, 2007, PROTEOMICS, V7, P1654, DOI 10.1002/pmic.200600579; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v; Zhang HM, 2010, PROTEOMICS, V10, P2780, DOI 10.1002/pmic.201000066; Zhang YF, 2012, ACS CHEM BIOL, V7, P1049, DOI 10.1021/cb200545s; Zhang YF, 2011, BIOFOULING, V27, P467, DOI 10.1080/08927014.2011.583985; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x	83	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88744	10.1371/journal.pone.0088744	http://dx.doi.org/10.1371/journal.pone.0088744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24714416	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000059
J	Chen, LH; Li, CX; Sargolzaei, M; Schenkel, F				Chen, Liuhong; Li, Changxi; Sargolzaei, Mehdi; Schenkel, Flavio			Impact of Genotype Imputation on the Performance of GBLUP and Bayesian Methods for Genomic Prediction	PLOS ONE			English	Article							RELATIONSHIP MATRIX; ACCURACY; SELECTION; VALUES; RELIABILITY; NUCLEOTIDE; STRATEGIES; CATTLE; CHIPS	The aim of this study was to evaluate the impact of genotype imputation on the performance of the GBLUP and Bayesian methods for genomic prediction. A total of 10,309 Holstein bulls were genotyped on the BovineSNP50 BeadChip (50 k). Five low density single nucleotide polymorphism (SNP) panels, containing 6,177, 2,480, 1,536, 768 and 384 SNPs, were simulated from the 50 k panel. A fraction of 0%, 33% and 66% of the animals were randomly selected from the training sets to have low density genotypes which were then imputed into 50 k genotypes. A GBLUP and a Bayesian method were used to predict direct genomic values (DGV) for validation animals using imputed or their actual 50 k genotypes. Traits studied included milk yield, fat percentage, protein percentage and somatic cell score (SCS). Results showed that performance of both GBLUP and Bayesian methods was influenced by imputation errors. For traits affected by a few large QTL, the Bayesian method resulted in greater reductions of accuracy due to imputation errors than GBLUP. Including SNPs with largest effects in the low density panel substantially improved the accuracy of genomic prediction for the Bayesian method. Including genotypes imputed from the 6 k panel achieved almost the same accuracy of genomic prediction as that of using the 50 k panel even when 66% of the training population was genotyped on the 6 k panel. These results justified the application of the 6 k panel for genomic prediction. Imputations from lower density panels were more prone to errors and resulted in lower accuracy of genomic prediction. But for animals that have close relationship to the reference set, genotype imputation may still achieve a relatively high accuracy.	[Chen, Liuhong; Li, Changxi] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Li, Changxi] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Sargolzaei, Mehdi] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Schenkel, Flavio] LAlliance Boviteq Inc, Quebec City, PQ, Canada	University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Chen, LH (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	liuhong@ualberta.ca; schenkel@uoguelph.ca	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Natural Sciences and Engineering Research Council of Canada; L'Alliance Boviteq Inc., Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Alliance Boviteq Inc., Quebec, Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, and L'Alliance Boviteq Inc., Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2013, J ANIM SCI, V91, P3583, DOI 10.2527/jas.2013-6270; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dassonneville R, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-40; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang YJ, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-25; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Mulder HA, 2012, J DAIRY SCI, V95, P876, DOI 10.3168/jds.2011-4490; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Sargolzaei M, 2011, GEBV SOFTWARE; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Van Doormaal B, 2012, GENOTYPING LOW DENSI; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2011, J DAIRY SCI, V94, P6188, DOI 10.3168/jds.2011-4481; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	34	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101544	10.1371/journal.pone.0101544	http://dx.doi.org/10.1371/journal.pone.0101544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	24551186	gold, Green Submitted, Green Published			2022-12-25	WOS:000339992400017
J	Chen, CY; Borsuk, ME; Bugge, DM; Hollweg, T; Balcom, PH; Ward, DM; Williams, J; Mason, RP				Chen, Celia Y.; Borsuk, Mark E.; Bugge, Deenie M.; Hollweg, Terill; Balcom, Prentiss H.; Ward, Darren M.; Williams, Jason; Mason, Robert P.			Benthic and Pelagic Pathways of Methylmercury Bioaccumulation in Estuarine Food Webs of the Northeast United States	PLOS ONE			English	Article							SUBMARINE GROUNDWATER DISCHARGE; DISSOLVED ORGANIC-CARBON; SAN-FRANCISCO-BAY; INORGANIC MERCURY; GAS-CHROMATOGRAPHY; CONTINENTAL-SHELF; METHYL MERCURY; CHESAPEAKE BAY; TRACE-METALS; SEDIMENTS	Methylmercury (MeHg) is a contaminant of global concern that bioaccumulates and bioamagnifies in marine food webs. Lower trophic level fauna are important conduits of MeHg from sediment and water to estuarine and coastal fish harvested for human consumption. However, the sources and pathways of MeHg to these coastal fisheries are poorly known particularly the potential for transfer of MeHg from the sediment to biotic compartments. Across a broad gradient of human land impacts, we analyzed MeHg concentrations in food webs at ten estuarine sites in the Northeast US (from the Hackensack Meadowlands, NJ to the Gulf of Maine). MeHg concentrations in water column particulate material, but not in sediments, were predictive of MeHg concentrations in fish (killifish and Atlantic silversides). Moreover, MeHg concentrations were higher in pelagic fauna than in benthic-feeding fauna suggesting that MeHg delivery to the water column from methylation sites from within or outside of the estuary may be an important driver of MeHg bioaccumulation in estuarine pelagic food webs. In contrast, bulk sediment MeHg concentrations were only predictive of concentrations of MeHg in the infaunal worms. Our results across a broad gradient of sites demonstrate that the pathways of MeHg to lower trophic level estuarine organisms are distinctly different between benthic deposit feeders and forage fish. Thus, even in systems with contaminated sediments, transfer of MeHg into estuarine food webs maybe driven more by the efficiency of processes that determine MeHg input and bioavailability in the water column.	[Chen, Celia Y.; Bugge, Deenie M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Borsuk, Mark E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Hollweg, Terill] Stratus Consulting, Boulder, CO USA; [Balcom, Prentiss H.; Mason, Robert P.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Ward, Darren M.] Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA; [Williams, Jason] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA	Dartmouth College; Dartmouth College; University of Connecticut; California State University System; California State Polytechnic University, Humboldt; Washington State University	Chen, CY (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	Celia.Y.Chen@dartmouth.edu	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	NIH from the National Institute of Environmental Health Sciences [P42 ES007373]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	NIH from the National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by NIH Grant Number P42 ES007373 from the National Institute of Environmental Health Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcom PH, 2004, MAR CHEM, V90, P53, DOI 10.1016/j.marchem.2004.02.020; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; Beck AJ, 2009, ESTUAR COAST, V32, P535, DOI 10.1007/s12237-009-9140-5; Benoit JM, 1998, BIOGEOCHEMISTRY, V40, P249, DOI 10.1023/A:1005905700864; Benoit JM, 2003, ACS SYM SER, V835, P262; BLOOM N, 1989, CAN J FISH AQUAT SCI, V46, P1131, DOI 10.1139/f89-147; BLOOM N, 1988, ANAL CHIM ACTA, V208, P151, DOI 10.1016/S0003-2670(00)80743-6; BLOOM NS, 1983, MAR CHEM, V14, P49, DOI 10.1016/0304-4203(83)90069-5; Bone SE, 2007, ENVIRON SCI TECHNOL, V41, P3090, DOI 10.1021/es0622453; Chasar LC, 2009, ENVIRON SCI TECHNOL, V43, P2733, DOI 10.1021/es8027567; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Cleckner LB, 2003, J GREAT LAKES RES, V29, P134, DOI 10.1016/S0380-1330(03)70422-5; Coelho JP, 2008, MAR POLLUT BULL, V56, P1104, DOI 10.1016/j.marpolbul.2008.03.020; COMPEAU GC, 1985, APPL ENVIRON MICROB, V50, P498, DOI 10.1128/AEM.50.2.498-502.1985; Conaway CH, 2003, MAR CHEM, V80, P199, DOI 10.1016/S0304-4203(02)00135-4; Davis JA, 2012, ENVIRON RES, V119, P3, DOI 10.1016/j.envres.2012.10.002; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; DRISCOLL CT, 1995, WATER AIR SOIL POLL, V80, P499, DOI 10.1007/BF01189700; FITZGERALD WF, 1979, ANAL CHEM, V51, P1714, DOI 10.1021/ac50047a030; Fitzgerald WF, 2010, SYNTHESIS ASSESSMENT; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Fry B, 2008, MAR ECOL PROG SER, V369, P193, DOI 10.3354/meps07644; Fry B, 2012, ECOL APPL, V22, P606, DOI 10.1890/11-0921.1; Gagnon C, 1997, ENVIRON SCI TECHNOL, V31, P993, DOI 10.1021/es960364k; Galvan K, 2011, J EXP MAR BIOL ECOL, V410, P1, DOI 10.1016/j.jembe.2011.08.007; Gehrke GE, 2011, ENVIRON SCI TECHNOL, V45, P1264, DOI 10.1021/es103053y; GILL GA, 1985, DEEP-SEA RES, V32, P287, DOI 10.1016/0198-0149(85)90080-9; Gorski PR, 2008, ENVIRON POLLUT, V154, P116, DOI 10.1016/j.envpol.2007.12.004; GRIEB TM, 1990, ENVIRON TOXICOL CHEM, V9, P919, DOI [10.1897/1552-8618(1990)9[919:FAMAIF]2.0.CO;2, 10.1002/etc.5620090710]; Guo LD, 2001, ENVIRON SCI TECHNOL, V35, P885, DOI 10.1021/es001758l; Haas HL, 2009, J EXP MAR BIOL ECOL, V369, P8, DOI 10.1016/j.jembe.2008.09.027; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; Hammerschmidt CR, 2008, MAR CHEM, V109, P165, DOI 10.1016/j.marchem.2008.01.007; Hammerschmidt CR, 2006, GEOCHIM COSMOCHIM AC, V70, P918, DOI 10.1016/j.gca.2005.10.020; Hammerschmidt CR, 2004, MAR CHEM, V90, P31, DOI 10.1016/j.marchem.2004.02.024; Hesterberg D, 2001, ENVIRON SCI TECHNOL, V35, P2741, DOI 10.1021/es001960o; Heyes A, 2006, MAR CHEM, V102, P134, DOI 10.1016/j.marchem.2005.09.018; Hollweg TA, 2010, LIMNOL OCEANOGR, V55, P2703, DOI 10.4319/lo.2010.55.6.2703; Hollweg TA, 2009, MAR CHEM, V114, P86, DOI 10.1016/j.marchem.2009.04.004; HORVAT M, 1993, ANAL CHIM ACTA, V282, P153, DOI 10.1016/0003-2670(93)80364-Q; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kim EH, 2004, MAR CHEM, V86, P121, DOI 10.1016/j.marchem.2003.12.004; Kim EH, 2006, MAR CHEM, V102, P300, DOI 10.1016/j.marchem.2006.05.006; Kim E, 2008, ECOL MODEL, V218, P267, DOI 10.1016/j.ecolmodel.2008.07.008; King JK, 1999, ENVIRON TOXICOL CHEM, V18, P1362, DOI 10.1002/etc.5620180704; Kiviat E, 2002, HACKENSACK MEADOWLAN; Langer C. S., 2001, Wetlands Ecology and Management, V9, P295, DOI 10.1023/A:1011816819369; Lawrence AL, 2001, ENVIRON POLLUT, V111, P217, DOI 10.1016/S0269-7491(00)00072-5; Lawrence AL, 1999, ENVIRON SCI TECHNOL, V33, P1871, DOI 10.1021/es981328j; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Liu B, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000752; Mason RP, 2006, MAR CHEM, V102, P96, DOI 10.1016/j.marchem.2005.09.021; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1999, ENVIRON TOXICOL CHEM, V18, P2438, DOI 10.1002/etc.5620181109; Mason RP, 1999, MAR CHEM, V65, P77, DOI 10.1016/S0304-4203(99)00012-2; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Mikac N, 1999, APPL ORGANOMET CHEM, V13, P715, DOI 10.1002/(SICI)1099-0739(199910)13:10<715::AID-AOC918>3.0.CO;2-4; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Pan JF, 2004, MAR ECOL PROG SER, V276, P125, DOI 10.3354/meps276125; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickhardt PC, 2007, ENVIRON SCI TECHNOL, V41, P125, DOI 10.1021/es060966w; Pickhardt PC, 2006, ENVIRON TOXICOL CHEM, V25, P2132, DOI 10.1897/05-595R.1; Point D, 2007, ANAL BIOANAL CHEM, V389, P787, DOI 10.1007/s00216-007-1516-4; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Rolfhus KR, 2001, GEOCHIM COSMOCHIM AC, V65, P407, DOI 10.1016/S0016-7037(00)00519-6; Rolfhus KR, 2011, ECOTOXICOLOGY, V20, P1520, DOI 10.1007/s10646-011-0733-y; Rutkiewicz J, 2011, ECOTOXICOLOGY, V20, P1669, DOI 10.1007/s10646-011-0730-1; Schartup AT, 2013, ENVIRON SCI TECHNOL, V47, P695, DOI 10.1021/es302566w; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Shanley J.B., 2002, EOS T AM GEOPHYS UN, V83, P45; Skyllberg U, 2006, ENVIRON SCI TECHNOL, V40, P4174, DOI 10.1021/es0600577; Skyllberg U, 2010, ENVIRON SCI TECHNOL, V44, P1254, DOI 10.1021/es902091w; Stewart AR, 2008, CAN J FISH AQUAT SCI, V65, P2351, DOI 10.1139/F08-140; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; Sunderland EM, 2012, ENVIRON RES, V119, P27, DOI 10.1016/j.envres.2012.03.011; Sunderland EM, 2010, ENVIRON SCI TECHNOL, V44, P1698, DOI 10.1021/es9032524; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Taylor VF, 2008, ANAL BIOANAL CHEM, V392, P1283, DOI 10.1007/s00216-008-2403-3; Tseng CM, 2004, ANAL CHEM, V76, P7131, DOI 10.1021/ac049118e; United States :Environmental Protection Agency, 1998, 7473SW846 EPA; [USEPA] United States Environmental Protection Agency, 2001, EPA821R01020; USEPA United States Environmental Protection Agency, 2002, EPA821R02019; Watras CJ, 1998, SCI TOTAL ENVIRON, V219, P183, DOI 10.1016/S0048-9697(98)00228-9; WATRAS CJ, 1995, WATER AIR SOIL POLL, V84, P253, DOI 10.1007/BF00475343; WEIS P, 1986, ENVIRON POLLUT A, V40, P303, DOI 10.1016/0143-1471(86)90064-4; Wiener JG, 2012, ENVIRON POLLUT, V161, P350, DOI 10.1016/j.envpol.2011.09.025; Williams JJ, 2010, ENVIRON TOXICOL CHEM, V29, P1755, DOI 10.1002/etc.207; Wyn B, 2009, CAN J FISH AQUAT SCI, V66, P1532, DOI 10.1139/F09-097; Yee D, 2011, ENVIRON TOXICOL CHEM, V30, P88, DOI 10.1002/etc.366	95	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89305	10.1371/journal.pone.0089305	http://dx.doi.org/10.1371/journal.pone.0089305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25144712	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700137
J	Chen, CJ; Wu, TL; Lu, PL; Chen, YT; Fung, CP; Chuang, YC; Lin, JC; Siu, LK				Chen, Chao-Ju; Wu, Tsu-Lan; Lu, Po-Liang; Chen, Ying-Tsong; Fung, Chang-Phone; Chuang, Yin-Ching; Lin, Jung-Chung; Siu, L. Kristopher			Closely Related NDM-1-Encoding Plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan	PLOS ONE			English	Article							BETA-LACTAMASE; 1ST IDENTIFICATION; RESISTANCE; STRAINS; PATIENT; OXYTOCA; NDM-1; INCN	Objective: Two plasmids carrying bla(NDM-1) isolated from carbapenem-resistant Klebsiella pneumoniae (CR-KP) and carbapenem-resistant Escherichia coli (CR-EC) were sequenced. CR-KP and CR-EC were isolated from two Taiwanese patients without travel histories. Methods: Complete sequencing of the plasmids (pLK75 and pLK78) was conducted using a shotgun approach. Annotation of the contigs was performed using the RAST Server, followed by manual inspection and correction. Results: These similar plasmids were obtained from two patients with overlapping stays at the same hospital. The pLK75 and pLK78 plasmids were 56,489-bp and 56,072-bp in length, respectively. Plasmid annotation revealed a common backbone similar to the IncN plasmid pR46. The regions flanking the bla(NDM-1) genes in these plasmids were very similar to plasmid pNDM-HU01 in Japan, which contains a complex class 1 integron located next to an ISCR1 element. The ISCR1 element has been suggested to provide a powerful mechanism for mobilising antibiotic resistance genes. Conclusion: Two indigenous NDM-1-producing Enterobacteriaceae cases were identified for the first time in Taiwan, highlighting the alarming introduction of NDM-1-producing Enterobacteriaceae in this region.	[Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Chao-Ju; Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Tsu-Lan] Linkou Chang Gung Mem Hosp, Dept Clin Pathol, Taoyuan, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Chen, Ying-Tsong] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med & Med Res, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Jung-Chung; Siu, L. Kristopher] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lin, Jung-Chung] Natl Def Med Ctr, Inst Microbiol & Immunol, Taipei, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; National Chung Hsing University; National Chung Hsing University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Chi Mei Hospital; Chi Mei Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; China Medical University Taiwan; National Health Research Institutes - Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	linjungchung1@yahoo.com.tw	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	Taiwan Centers for Diseases Control [DOH101-DC-1024, DOH102-DC-1508]; National Health Research Institutes; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	Taiwan Centers for Diseases Control; National Health Research Institutes(National Health Research Institutes, Japan); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the project grants, DOH101-DC-1024 and DOH102-DC-1508, from Taiwan Centers for Diseases Control and National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Chen YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048737; Chen YT, 2009, ANTIMICROB AGENTS CH, V53, P1235, DOI 10.1128/AAC.00970-08; CLSI, 2013, PERFORMANCE STANDARD; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HALL RM, 1987, NUCLEIC ACIDS RES, V15, P7491, DOI 10.1093/nar/15.18.7491; Huang TW, 2013, ANTIMICROB AGENTS CH, V57, P4072, DOI 10.1128/AAC.02266-12; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Humphrey B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-53; Kim MN, 2012, J CLIN MICROBIOL, V50, P1433, DOI 10.1128/JCM.06855-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lai CC, 2011, DIAGN MICR INFEC DIS, V71, P474, DOI 10.1016/j.diagmicrobio.2011.09.004; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089893; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Siu LK, 1997, ANTIMICROB AGENTS CH, V41, P468, DOI 10.1128/AAC.41.2.468; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Wang SJ, 2013, DIAGN MICR INFEC DIS, V76, P248, DOI 10.1016/j.diagmicrobio.2013.02.003; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09	22	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e104899	10.1371/journal.pone.0104899	http://dx.doi.org/10.1371/journal.pone.0104899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	Green Published, Green Submitted, gold			2022-12-25	WOS:000341106100028
J	Chen, CB; Zhou, H; Zhang, XL; Ma, XL; Liu, ZJ; Liu, XG				Chen, Changbao; Zhou, Hua; Zhang, Xiaolin; Ma, Xinlong; Liu, Zhongjun; Liu, Xiaoguang			Elevated Levels of Dickkopf-1 Are Associated with beta-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANCER BONE METASTASES; HEPATOCELLULAR CARCINOMAS; NUCLEAR ACCUMULATION; EXPRESSION; PROTEIN; GENE; DKK1; REGULATOR; OSTEOSARCOMA	Background: Dickkopf-1 (DKK1) is an antagonist of Wnt/beta-catenin signaling implicated in tumorigenesis. However, the biological role of DKK1 and beta-catenin involved in chondrosarcoma has not been sufficiently investigated. This study was designed to investigate the expression profiles of DKK1 and beta-catenin, and to clarify their clinical values in chondrosarcoma. Methods: The mRNA and protein levels of DKK1 and beta-catenin in fresh chondrosarcoma and the corresponding non-tumor tissues were analyzed by Real-time PCR and Western blot, respectively. The protein expression patterns of DKK1 and bcatenin were investigated by immunohistochemistry. The associations among DKK1 level, beta-catenin accumulation, clinicopathological factors and the overall survival were separately evaluated. Results: Both DKK1 and beta-catenin levels were remarkably elevated in chondrosarcoma compared with the corresponding non-tumor tissues. High DKK1 level and positive beta-catenin accumulation in chondrosarcoma specimens were 58.7% and 53.9%, respectively. Elevated DKK1 level significantly correlated with positive beta-catenin accumulation, and they were remarkably associated with histological grade and Musculoskeletal Tumor Society stage. Furthermore, DKK1 level and bcatenin accumulation had significant impacts on the prognosis of chondrosarcoma patients. Multivariate analysis revealed that DKK1 level was an independent prognostic factor for overall survival. Conclusions: Elevated DKK1 levels associated with beta-catenin accumulation play a crucial role in chondrosarcoma. DKK1 can serve as a novel predictor of poor prognosis in patients with chondrosarcoma.	[Chen, Changbao; Zhang, Xiaolin; Ma, Xinlong] Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China; [Zhou, Hua; Liu, Zhongjun; Liu, Xiaoguang] Peking Univ, Dept Orthopaed Surg, Hosp 3, Beijing 100871, Peoples R China	Peking University	Ma, XL (corresponding author), Tianjin Hosp, Dept Spinal Surg, Tianjin, Peoples R China.	richivaldchen@gmail.com	Borsuk, Mark/AAV-1663-2020; Ward, Darren/F-1203-2010; Zhou, Hua/HGC-9504-2022; Lu, Po-Liang/D-4499-2009; Siu, Leung-Kei/C-1368-2010	Ward, Darren/0000-0002-0049-5299; Lu, Po-Liang/0000-0002-7423-6783; Mason, Robert/0000-0002-7443-4931; Hollweg, Terill/0000-0002-0165-5653; Borsuk, Mark/0000-0002-5121-1110; Zhou, hua/0000-0002-2718-4108; Chen, Ying-Tsong/0000-0003-1337-4127	National Natural Sciences Foundation of China [81102037]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021950, P42ES007373] Funding Source: NIH RePORTER	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Natural Sciences Foundation of China (81102037). http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Bertoni F., 2002, WHO CLASSIFICATION T, P247; Bovee JVMG, 2005, LANCET ONCOL, V6, P599, DOI 10.1016/S1470-2045(05)70282-5; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Chen C, 2001, ANN SURG ONCOL, V18, P2364; Chen CB, 2011, J ORTHOP RES, V29, P143, DOI 10.1002/jor.21193; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hameetman L, 2006, J PATHOL, V209, P501, DOI 10.1002/path.2008; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lee N, 2007, BRIT J CANCER, V97, P1552, DOI 10.1038/sj.bjc.6604069; Li XQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-114; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Menezes ME, 2012, INT J CANCER, V130, P1477, DOI 10.1002/ijc.26449; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Shea PJ, 2012, J BIOL CHEM, V287, P17812, DOI 10.1074/jbc.M111.311464; Rozeman LB, 2006, INT ORTHOP, V30, P437, DOI 10.1007/s00264-006-0212-x; Saito T, 2000, J PATHOL, V192, P342, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH705>3.0.CO;2-R; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Voorzanger-Rousselot N, 2007, BRIT J CANCER, V97, P964, DOI 10.1038/sj.bjc.6603959; Wunder JS, 2007, LANCET ONCOL, V8, P513, DOI 10.1016/S1470-2045(07)70169-9; Xu WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037624; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020	37	115	123	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2014	9	8							e105414	10.1371/journal.pone.0105414	http://dx.doi.org/10.1371/journal.pone.0105414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WL	25144712	gold, Green Submitted, Green Published			2022-12-25	WOS:000341106100065
J	Chen, LX; Cai, Y; Zhou, GB; Shi, XJ; Su, JH; Chen, GW; Lin, K				Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Shi, Xiaojun; Su, Jianhui; Chen, Guanwu; Lin, Kun			Rapid Sanger Sequencing of the 16S rRNA Gene for Identification of Some Common Pathogens	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; BACTERIAL IDENTIFICATION; DNA; PCR; AMPLIFICATION; SHIGELLA; SYSTEM; MYCOBACTERIA; DATABASE; SAMPLES	Conventional Sanger sequencing remains time-consuming and laborious. In this study, we developed a rapid improved sequencing protocol of 16S rRNA for pathogens identification by using a new combination of SYBR Green I real-time PCR and Sanger sequencing with FTA (R) cards. To compare the sequencing quality of this method with conventional Sanger sequencing, 12 strains, including three kinds of strains (1 reference strain and 3 clinical strains, which were previously identified by biochemical tests), which have 4 Pseudomonas aeruginosa, 4 Staphyloccocus aureus and 4 Escherichia coli, were targeted. Additionally, to validate the sequencing results and bacteria identification, expanded specimens with 90 clinical strains, also comprised of the three kinds of strains which included 30 samples respectively, were performed as just described. The results showed that although statistical differences (P<0.05) were found in sequencing quality between the two methods, their identification results were all correct and consistent. The workload, the time consumption and the cost per batch were respectively light versus heavy, 8 h versus 11 h and $420 versus $400. In the 90 clinical strains, all of the Pseudomonas aeruginosa and Staphyloccocus aureus strains were correctly identified, but only 26.7% of the Escherichia coli strains were recognized as Escherichia coli, while 33.3% as Shigella sonnei and 40% as Shigella dysenteriae. The protocol described here is a rapid, reliable, stable and convenient method for 16S rRNA sequencing, and can be used for Pseudomonas aeruginosa and Staphyloccocus aureus identification, yet it is not completely suitable for discriminating Escherichia coli and Shigella strains.	[Chen, Linxiang; Shi, Xiaojun; Lin, Kun] Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Su, Jianhui; Chen, Guanwu] Shantou Entry Exit Inspect & Quarantine Bur, Mol Biol Lab, Shantou, Guangdong, Peoples R China		Lin, K (corresponding author), Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	klin@stu.edu.cn	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Shantou Bureau of Science and Technology [[2009]387-126]; Guangdong Entry-Exit Inspection and Quarantine Bureau [2012 GDK45]; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology; Guangdong Entry-Exit Inspection and Quarantine Bureau; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology (grant No. [2009]387-126), Guangdong Entry-Exit Inspection and Quarantine Bureau (grant No. 2012 GDK45) Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye KS, 2011, JPN J INFECT DIS, V64, P246; Becker K, 2004, J CLIN MICROBIOL, V42, P4988, DOI 10.1128/JCM.42.11.4988-4995.2004; Bhattacharya D, 2003, APPL ENVIRON MICROB, V69, P1435, DOI 10.1128/AEM.69.3.1435-1441.2003; Cloud JL, 2004, J CLIN MICROBIOL, V42, P578, DOI 10.1128/JCM.42.2.578-584.2004; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Fukushima H, 2003, J CLIN MICROBIOL, V41, P5134, DOI 10.1128/JCM.41.11.5134-5146.2003; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; Menassa N, 2010, INVEST OPHTH VIS SCI, V51, P1905, DOI 10.1167/iovs.09-3737; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Tewari D, 2011, J VET DIAGN INVEST, V23, P1104, DOI 10.1177/1040638711425583; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Willi B, 2009, J CLIN MICROBIOL, V47, P4049, DOI 10.1128/JCM.01478-09; Woo PCY, 2001, DIAGN MICR INFEC DIS, V39, P85, DOI 10.1016/S0732-8893(01)00206-1; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	27	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88886	10.1371/journal.pone.0088886	http://dx.doi.org/10.1371/journal.pone.0088886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551186	gold, Green Published, Green Submitted			2022-12-25	WOS:000331271500079
J	Wang, LL; Sun, XY; Li, SY; Zhang, T; Zhang, W; Zhai, PH				Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui			Application of Organic Amendments to a Coastal Saline Soil in North China: Effects on Soil Physical and Chemical Properties and Tree Growth	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; MICROBIAL COMMUNITIES; CATION-EXCHANGE; SEWAGE-SLUDGE; BEET VINASSE; SODIC SOILS; NITROGEN; RECLAMATION; PHOSPHORUS; POTASSIUM	The ability of the following four organic amendments to ameliorate saline soil in coastal northern China was investigated from April 2010 to October 2012 in a field experiment: green waste compost (GWC), sedge peat (SP), furfural residue (FR), and a mixture of GWC, SP and FR (1: 1: 1 by volume) (GSF). Compared to a non-amended control (CK), the amendments, which were applied at 4.5 kg organic matter m(-3), dramatically promoted plant growth; improved soil structure; increased the cation exchange capacity (CEC), organic carbon, and available nutrients; and reduced the salt content, electrical conductivity (EC), and exchangeable sodium percentage (ESP). At the end of the experiment in soil amended with GSF, bulk density, EC, and ESP had decreased by 11, 87, and 71%, respectively, and total porosity and organic carbon had increased by 25 and 96% respectively, relative to the CK. The GSF treatment resulted in a significantly lower Na++K+ content than the other treatments. CEC and the contents of available N, P, and K were significantly higher in the GSF-treated soil than in the CK and were the highest in all treatments. The FR treatment resulted in the lowest pH value and Ca2+ concentration, which decreased by 8% and 39%, respectively, relative to the CK. Overall, the results indicate that a combination of green waste compost, sedge peat and furfural residue (GSF treatment) has substantial potential for ameliorating saline soils in the coastal areas of northern China, and it works better than each amendment alone. Utilization of GWC and FR can be an alternative organic amendment to substitute the nonrenewable SP in saline soil amelioration.	[Wang, Linlin; Sun, Xiangyang; Li, Suyan; Zhang, Tao; Zhang, Wei; Zhai, Penghui] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Wang, Linlin] Forestry Res Inst Hulun Buir, Hulun Buir, Inner Mongolia, Peoples R China	Beijing Forestry University	Sun, XY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	sunxy1965@126.com; lisuyan@bjfu.edu.cn	; Williams, Robert W./H-8789-2016	Habibovic, Pamela/0000-0001-8249-5155; Williams, Robert W./0000-0001-8924-4447; Deng, Hong-Wen/0000-0002-0387-8818; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs [2009BADB2B0504]; Fundamental Research Funds for the Central Universities; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR050066, R01AR064825, R01AR051190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020321, R01AG026564, P01AG018397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the Eleventh Five-Year Plan of the National Scientific and Technical Supporting Programs (No. 2009BADB2B0504), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2007, COMMUN SOIL SCI PLAN, V38, P1691, DOI 10.1080/00103620701435464; Amezketa E, 2005, AGRON J, V97, P983, DOI 10.2134/agronj2004.0236; Antil Rajinder Singh, 2007, Archives of Agronomy and Soil Science, V53, P519, DOI 10.1080/03650340701571033; BAO SD, 2005, ANAL SOIL AGROCHEMIS; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Barzegar AR, 1997, SOIL SCI SOC AM J, V61, P1131, DOI 10.2136/sssaj1997.03615995006100040020x; Bhattacharyya P, 2007, CHEMOSPHERE, V66, P1789, DOI 10.1016/j.chemosphere.2006.07.062; Brady AC, 2002, NATURE PROPERTIES SO; Clark GJ, 2007, SOIL BIOL BIOCHEM, V39, P2806, DOI 10.1016/j.soilbio.2007.06.003; Cooperband L., 2002, BUILDING SOIL ORGANI; David R, 2002, GEODERMA, V107, P271, DOI 10.1016/S0016-7061(01)00152-5; Feng YJ, 2006, PEDOSPHERE, V16, P668, DOI 10.1016/S1002-0160(06)60101-X; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Hanay A, 2004, COMPOST SCI UTIL, V12, P175, DOI 10.1080/1065657x.2004.10702177; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; JACKSON M. L., 1958, Soil Chemical Analysis.; Kahlown MA, 2003, AGR WATER MANAGE, V62, P127, DOI 10.1016/S0378-3774(03)00096-9; Kaya C, 2001, J PLANT NUTR, V24, P357, DOI 10.1081/PLN-100001394; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liang YC, 2003, GEODERMA, V115, P149, DOI 10.1016/S0016-7061(03)00084-3; Liu GQ, 2009, BIORESOURCE TECHNOL, V100, P5103, DOI 10.1016/j.biortech.2009.03.081; Mamedov AI, 2002, SOIL TILL RES, V68, P121, DOI 10.1016/S0167-1987(02)00115-0; Melero S, 2007, EUR J AGRON, V26, P327, DOI 10.1016/j.eja.2006.11.004; Oo AN, 2013, LAND DEGRAD DEV, DOI 101002/ldr2208; Page A.L., 1982, AGRONOMY SERIES, V9, DOI DOI 10.1002/JP1N.19851480319; Pocknee S, 1997, SOIL SCI SOC AM J, V61, P86, DOI 10.2136/sssaj1997.03615995006100010014x; Qadir M, 2007, ADV AGRON, V96, P197, DOI 10.1016/S0065-2113(07)96006-X; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Qadir M, 2000, LAND DEGRAD DEV, V11, P501, DOI 10.1002/1099-145X(200011/12)11:6<501::AID-LDR405>3.0.CO;2-S; RICHARDS LA, 1954, AGR HDB, V60, P98; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Ros M, 2003, SOIL BIOL BIOCHEM, V35, P463, DOI 10.1016/S0038-0717(02)00298-5; Sumner M.E., 2000, HDB SOIL SCI; Sun R, 2011, BIORESOURCES, V6, P317; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tejada M, 2006, SOIL SCI SOC AM J, V70, P900, DOI 10.2136/sssaj2005.0271; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TUCKER BM, 1954, AUST J AGR RES, V5, P706, DOI 10.1071/AR9540706; Wang Z.Q., 1993, SALINE SOIL IN CHINA; Warman PR, 2005, BIORESOURCE TECHNOL, V96, P955, DOI 10.1016/j.biortech.2004.08.003; Wichern J, 2006, GEODERMA, V137, P100, DOI 10.1016/j.geoderma.2006.08.001; Withers PJA, 2003, SOIL USE MANAGE, V19, P28, DOI 10.1111/j.1475-2743.2003.tb00276.x; Wong VNL, 2009, APPL SOIL ECOL, V41, P29, DOI 10.1016/j.apsoil.2008.08.006; Xing Y, 2012, CELL CHEM TECHNOL, V46, P249; Yazdanpanah N, 2013, AGR WATER MANAGE, V120, P39, DOI 10.1016/j.agwat.2012.08.017; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; Zhang XC, 2002, J HYDROL, V260, P194, DOI 10.1016/S0022-1694(01)00612-6	51	125	145	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2014	9	2							e89185	10.1371/journal.pone.0089185	http://dx.doi.org/10.1371/journal.pone.0089185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3RA	25229501	gold, Green Published, Green Submitted			2022-12-25	WOS:000331706700132
J	Wang, LS; Lu, WL; Zhang, L; Huang, Y; Scheib, R; Liu, XY; Myers, L; Lu, L; Farber, CR; Liu, GF; Wang, CY; Deng, HW; Williams, RW; Wang, YJ; Gu, WK; Jiao, Y				Wang, Lishi; Lu, Wenli; Zhang, Lei; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Myers, Linda; Lu, Lu; Farber, Charles R.; Liu, Gaifen; Wang, Cong-Yi; Deng, Hongwen; Williams, Robert W.; Wang, Yongjun; Gu, Weikuan; Jiao, Yan			Trps1 Differentially Modulates the Bone Mineral Density between Male and Female Mice and Its Polymorphism Associates with BMD Differently between Women and Men	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRICHORHINOPHALANGEAL-SYNDROME; MISSENSE MUTATION; GENE-EXPRESSION; POPULATION; IDENTIFICATION; METAANALYSIS; NETWORKS; LINKAGE; GROWTH	The objective of our study was to identify genetic factors that regulate bone mineral density (BMD) in mice using well defined recombinant inbred strains. For this purpose we chose the BXD recombinant inbred (RI) strains derived from progeny of the C57BL/6J (B6) and DBA/2J (D2) progenitor strains. We sampled both male and female mice (similar to 4 each) of 46 strains at 3 months-of-age, measured their BMD, and conducted QTL mapping. The data were analyzed to identify candidates genes contained within the most significant quantitative trait locus (QTL). Evaluation of candidate genes included functional assessment, single nucleotide polymorphism (SNP) genotyping and direct sequencing. We established that there was a QTL for BMD in males on chromosome 15 that has the impact larger than QTLs on all other chromosomes. The QTL on chromosome 15 was narrowed to a genomic region between 38 Mbp and 52 Mbp. By examining transcripts within this region, we found an important candidate gene: trichorhinophalangeal syndrome, type I (Trps1). SNP analysis identified a nonsynonymous SNP (rs32398060) in Trps1 that co-segregated with bone mineral density. Analysis of association between this SNP within TRPS1 and BMD in a human population confirmed its significance.	[Wang, Lishi; Lu, Wenli; Huang, Yue; Scheib, Rachel; Liu, Xiaoyun; Gu, Weikuan; Jiao, Yan] Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA; [Wang, Lishi] Inner Mongolia Med Univ, Dept Basic Med, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Lei; Deng, Hongwen] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Myers, Linda] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN USA; [Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Farber, Charles R.] Univ Virginia, Dept Med, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Dept Biochem & Mol Genet, Div Cardiol, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Liu, Gaifen; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Cong-Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Biomed Res, Wuhan 430074, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; Inner Mongolia Medical University; Tulane University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Virginia; University of Virginia; Capital Medical University; Huazhong University of Science & Technology	Gu, WK (corresponding author), Univ Tennessee, Hlth Sci Ctr, Campbell Clin, Dept Orthoped Surg & BioMed Engn, Memphis, TN 38163 USA.	wgu@uthsc.edu; yjiao2@utusc.edu	; Williams, Robert W./H-8789-2016	Habibovic, Pamela/0000-0001-8249-5155; Williams, Robert W./0000-0001-8924-4447; Deng, Hong-Wen/0000-0002-0387-8818; Farber, Charles/0000-0002-6748-4711; Wang, Cong-Yi/0000-0001-7914-168X	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [R01 AR51190]; Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221, R01 AR/AG 41398, R01 AR050066, R03 AG20321]; Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China [31100902]; National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; NIH NIA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR055081, R01AR050496, R01AR057049, R01AR050066, R01AR064825, R01AR051190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG020321, R01AG026564, P01AG018397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662] Funding Source: NIH RePORTER	National Institute of Arthritis (NIA); Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genediscovery Core at UTHSC; Veterans Administration Medical Center in Memphis, Tennessee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; Edward G. Schlieder Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was partially supported by grants from the National Institute of Arthritis (NIA) and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH)(R01 AR51190 to W.G.), Genediscovery Core at UTHSC, and the Veterans Administration Medical Center in Memphis, Tennessee. H. W. D. was partially supported by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221), the Franklin D. Dickson/Missouri Endowment and the Edward G. Schlieder Endowment. L.Z. was partially supported by National Natural Science Foundation of China (project 31100902). The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. Funding support for the Framingham Bone Mineral Density datasets was provided by NIH grants R01 AR/AG 41398, R01 AR050066 and R03 AG20321. Funding support for the Genetic Determinants of Bone Fragility (the Indiana fragility study) was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genome-wide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Beamer WG, 1999, MAMM GENOME, V10, P1043, DOI 10.1007/s003359901159; BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; CARRINGTON PR, 1994, J AM ACAD DERMATOL, V31, P331, DOI 10.1016/S0190-9622(94)70166-0; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Geisert EE, 2009, MOL VIS, V15, P1730; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishimori N, 2008, J BONE MINER RES, V23, P1529, DOI 10.1359/JBMR.080414; Jiao Y, 2008, GENOMICS, V91, P407, DOI 10.1016/j.ygeno.2007.12.010; Klein RF, 1998, J BONE MINER RES, V13, P1648, DOI 10.1359/jbmr.1998.13.11.1648; Kolta S, 2003, J CLIN DENSITOM, V6, P251, DOI 10.1385/JCD:6:3:251; Li GHY, 2011, HUM GENET, V130, P539, DOI 10.1007/s00439-011-0972-2; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2013, GENET EPIDEMIOL, V37, P25, DOI 10.1002/gepi.21690; Lynch RM, 2010, PHYSIOL GENOMICS, V41, P244, DOI 10.1152/physiolgenomics.00020.2010; Milner LC, 2010, INT REV NEUROBIOL, V91, P173, DOI 10.1016/S0074-7742(10)91006-4; NOLTORP S, 1986, ANN RHEUM DIS, V45, P31, DOI 10.1136/ard.45.1.31; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Pei YF, 2013, HUM MOL GENET; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rossi A, 2007, BRIT J DERMATOL, V157, P1021, DOI 10.1111/j.1365-2133.2007.08158.x; Sarafoglou K, 2010, CLIN GENET, V78, P591, DOI 10.1111/j.1399-0004.2010.01434.x; SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V53, pS27, DOI 10.1007/BF01673398; Soon G, 2006, CALCIFIED TISSUE INT, V78, P186, DOI 10.1007/s00223-005-0191-8; Suwanwela J, 2011, J BONE MINER RES, V26, P747, DOI 10.1002/jbmr.271; Tariq M, 2008, BRIT J DERMATOL, V159, P476, DOI 10.1111/j.1365-2133.2008.08658.x; Tremollieres F, 2010, MATURITAS, V65, P348, DOI 10.1016/j.maturitas.2009.12.023; Vaccaro M, 2009, PEDIATR DERMATOL, V26, P171, DOI 10.1111/j.1525-1470.2009.00905.x; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xiong Q, 2008, BIOINFORMATICS, V24, P1011, DOI 10.1093/bioinformatics/btn002; Xiong Q, 2009, GENOMICS, V93, P401, DOI 10.1016/j.ygeno.2008.12.008; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x	42	125	145	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e84485	10.1371/journal.pone.0084485	http://dx.doi.org/10.1371/journal.pone.0084485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	25229501	gold, Green Published, Green Submitted			2022-12-25	WOS:000329862500131
